<SEC-DOCUMENT>0001093557-25-000036.txt : 20250218
<SEC-HEADER>0001093557-25-000036.hdr.sgml : 20250218
<ACCEPTANCE-DATETIME>20250214175237
ACCESSION NUMBER:		0001093557-25-000036
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		117
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250218
DATE AS OF CHANGE:		20250214

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DEXCOM INC
		CENTRAL INDEX KEY:			0001093557
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				330857544
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51222
		FILM NUMBER:		25631453

	BUSINESS ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		8582000200

	MAIL ADDRESS:	
		STREET 1:		6340 SEQUENCE DRIVE
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>dxcm-20241231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972,d:6a987b433ae84cbfb2328647e6586107-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:srt="http://fasb.org/srt/2024" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:cyd="http://xbrl.sec.gov/cyd/2024" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:dxcm="http://www.dexcom.com/20241231" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>dxcm-20241231</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-32">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalYearFocus" id="f-33">2024</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentFiscalPeriodFocus" id="f-34">FY</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-35">0001093557</ix:nonNumeric><ix:nonNumeric contextRef="c-63" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-460">P3Y</ix:nonNumeric><ix:nonNumeric contextRef="c-65" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="f-462">P4Y</ix:nonNumeric><ix:nonNumeric contextRef="c-69" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="f-470">P1Y</ix:nonNumeric><ix:nonNumeric contextRef="c-72" name="dxcm:AmortizationPeriodForIncentiveCompensationCosts" id="f-485">P1Y</ix:nonNumeric><ix:nonFraction unitRef="number" contextRef="c-176" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-967">0.0243476</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-178" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-968">0.006662</ix:nonFraction><ix:nonFraction unitRef="number" contextRef="c-180" decimals="7" name="us-gaap:DebtInstrumentConvertibleConversionRatio1" scale="0" id="f-969">0.0061571</ix:nonFraction><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="f-995">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</ix:nonNumeric><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1002">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" id="f-1003">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" id="f-1027">http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</ix:nonNumeric><ix:nonNumeric contextRef="c-236" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="f-1231">P3Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="dxcm-20241231.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="purchaser"><xbrli:measure>dxcm:purchaser</xbrli:measure></xbrli:unit><xbrli:unit id="d"><xbrli:measure>utr:D</xbrli:measure></xbrli:unit><xbrli:unit id="trading_day"><xbrli:measure>dxcm:trading_day</xbrli:measure></xbrli:unit><xbrli:unit id="extensionoption"><xbrli:measure>dxcm:extensionOption</xbrli:measure></xbrli:unit><xbrli:unit id="segment"><xbrli:measure>dxcm:segment</xbrli:measure></xbrli:unit><xbrli:unit id="primary_market"><xbrli:measure>dxcm:primary_market</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-06-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2025-02-06</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-10-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-22"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-23"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-24"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-25"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-27"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-30"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-32"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-34"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-35"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-37"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-38"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-40"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-43"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-44"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-45"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-46"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-47"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-48"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-49"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-50"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-51"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-53"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-54"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-55"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-56"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-57"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-58"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-59"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-60"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-62"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerEMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-64"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-65"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-66"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-67"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-68"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-69"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-70"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-72"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-73"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-74"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-75"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-76"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-78"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-79"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-80"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-81"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-82"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-83"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-84"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-85"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-10-01</xbrli:startDate><xbrli:endDate>2018-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-88"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-10-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-91"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-92"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-28</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-93"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-94"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-98"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-99"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-100"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-102"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-103"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-104"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-105"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-106"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-107"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-108"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-109"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-110"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-111"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-112"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-113"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-114"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-115"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-116"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-117"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-118"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-119"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-120"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-121"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-122"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-123"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-124"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-125"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-126"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-127"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-128"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-129"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-130"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-131"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-132"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-133"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-134"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-135"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-136"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-137"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-138"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-139"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-140"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-141"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-142"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-143"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-144"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-145"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-146"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-147"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-148"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-149"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-150"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-151"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-152"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:VerilyIntangibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-153"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-154"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:AcquiredTechnologyAndIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-155"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-156"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-157"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:VerilyIntangibleMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-158"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-159"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:AcquiredTechnologyAndIntellectualPropertyMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-160"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-161"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-162"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-163"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-164"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-165"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-166"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-167"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-168"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-169"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-170"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-171"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-172"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-173"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-174"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-175"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-176"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2018-11-01</xbrli:startDate><xbrli:endDate>2018-11-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-177"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-05-01</xbrli:startDate><xbrli:endDate>2020-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-179"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-01</xbrli:startDate><xbrli:endDate>2023-05-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-181"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-182"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-183"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-02-13</xbrli:startDate><xbrli:endDate>2024-02-13</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-184"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:BofAWarrantTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-185"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:JPMWarrantTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-186"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:JPMWarrantTransactionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-04-01</xbrli:startDate><xbrli:endDate>2024-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-187"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-05-02</xbrli:startDate><xbrli:endDate>2023-05-02</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-188"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-05-02</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-189"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-190"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-191"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-192"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-193"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-194"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-195"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-196"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-197"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-06-01</xbrli:startDate><xbrli:endDate>2023-06-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-198"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-199"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-200"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-201"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-202"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-203"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-204"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-205"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-206"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-207"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-208"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-209"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-210"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-211"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-212"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-213"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-214"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-216"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherForeignMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-217"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-218"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-219"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ForeignTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-220"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ForeignTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-221"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-222"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-223"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:AMTTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-224"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:AMTTaxCreditsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-226"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-228"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-229"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-230"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-232"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-233"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-234"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-05-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-235"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-236"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-237"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-238"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-239"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-240"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-241"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-242"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-243"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-244"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-245"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-246"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-247"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-248"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-249"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-250"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-251"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-252"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-253"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-254"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-07-01</xbrli:startDate><xbrli:endDate>2024-09-30</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-255"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-256"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-10-01</xbrli:startDate><xbrli:endDate>2023-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-257"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-07-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-258"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-08-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-259"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-08-01</xbrli:startDate><xbrli:endDate>2022-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-260"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-261"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-262"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-263"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-264"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-265"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-266"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-267"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-268"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-269"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-270"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-271"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-272"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-273"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-274"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-275"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-276"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-277"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-278"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-279"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-280"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-281"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-282"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-283"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-284"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-285"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-286"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-287"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-288"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-289"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-290"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-291"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-292"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-293"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-294"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-295"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-296"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-297"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-298"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-299"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-300"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-302"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-306"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-307"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-308"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-309"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-310"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-311"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-313"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-314"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherCountriesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="c-315"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001093557</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2024-12-31</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i6a987b433ae84cbfb2328647e6586107_1"></div><div style="min-height:18pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Washington, D.C.&#160;20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">10-K</ix:nonNumeric></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.768%"><tr><td style="width:1.0%"/><td style="width:1.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentAnnualReport" format="ixt:fixed-true" id="f-2">&#9746;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the fiscal year ended <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-3"><ix:nonNumeric contextRef="c-1" name="dei:CurrentFiscalYearEndDate" format="ixt:date-monthname-day-en" id="f-4">December&#160;31</ix:nonNumeric>, 2024</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">or</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:87.768%"><tr><td style="width:1.0%"/><td style="width:1.962%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:95.838%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="f-5">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; to &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; </span></div><div style="margin-bottom:6pt;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission File Number&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-6">000-51222</ix:nonNumeric></span></div><div style="text-align:center"><img src="dxcm-20241231_g1.jpg" alt="dexcom-logo-green-rgb.jpg" style="height:38px;margin-bottom:5pt;vertical-align:text-bottom;width:250px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:20pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-7">DEXCOM, INC.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.801%"><tr><td style="width:1.0%"/><td style="width:52.194%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.996%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:43.410%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-8">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-9">33-0857544</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(State or other jurisdiction of incorporation or organization)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.983%"><tr><td style="width:1.0%"/><td style="width:45.539%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.540%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-10">6340 Sequence Drive</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-11">San Diego</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" id="f-12">CA</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-13">92121</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Address of principal executive offices)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Zip Code)</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-14">858</ix:nonNumeric>)&#160;<ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-15">200-0200</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(b) of the Act:</span></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.204%"><tr><td style="width:1.0%"/><td style="width:39.133%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.121%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-16">Common Stock, $0.001 Par Value Per Share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-17">DXCM</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-18">Nasdaq Global Select Market</ix:nonNumeric></span></td></tr></table></div><div style="margin-bottom:10pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section&#160;12(g) of the Act: None</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityWellKnownSeasonedIssuer" id="f-19">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark if the registrant is not required to file reports pursuant to Section&#160;13 or 15(d) of the Act. &#160;&#160;&#160;Yes&#160;&#9744;&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityVoluntaryFilers" id="f-20">No</ix:nonNumeric>&#160;&#9746;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90 days. &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityCurrentReportingStatus" id="f-21">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:EntityInteractiveDataCurrent" id="f-22">Yes</ix:nonNumeric>&#160;&#9746;&#160;&#160;&#160;&#160;No&#160;&#9744;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act.</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.951%"><tr><td style="width:1.0%"/><td style="width:20.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.661%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.253%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.663%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="f-23">Large accelerated filer</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:3pt;margin-top:3pt;text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller reporting company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntitySmallBusiness" format="ixt:fixed-false" id="f-24">&#9744;</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-25">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#160;&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#8217;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:IcfrAuditorAttestationFlag" format="ixt:fixed-true" id="f-26">&#9746;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. &#160;&#160;&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentFinStmtErrorCorrectionFlag" format="ixt:fixed-false" id="f-27">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant&#8217;s executive officers during the relevant recovery period pursuant to &#167;240.10D-1(b). &#160;&#160;&#160;&#9744;</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). &#160;&#160;&#160;Yes <ix:nonNumeric contextRef="c-1" name="dei:EntityShellCompany" format="ixt:fixed-false" id="f-28">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160;No&#160;&#9746;</span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of June&#160;28, 2024, the last business day of the registrant&#8217;s most recently completed second fiscal quarter, the aggregate market value of the registrant&#8217;s common stock held by non-affiliates of the registrant was approximately $<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-8" name="dei:EntityPublicFloat" scale="9" id="f-29">45.3</ix:nonFraction> billion based on the closing sales price of $113.38 per share as reported on the Nasdaq Global Select Market on that date. Shares held by persons who may be deemed affiliates have been excluded. This determination of affiliate status with respect to the foregoing calculation is not a determination for other purposes.</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate the number of shares outstanding of each of the registrant&#8217;s classes of common stock, as of the latest practicable date.</span></div><div style="margin-top:5pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.801%"><tr><td style="width:1.0%"/><td style="width:48.533%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.581%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.486%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Class</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding at February 6, 2025</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $0.001 par value per share</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-3" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="f-30">390,772,018</ix:nonFraction></span></div></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DOCUMENTS INCORPORATED BY REFERENCE</span></div><ix:nonNumeric contextRef="c-1" name="dei:DocumentsIncorporatedByReferenceTextBlock" id="f-31" escape="true"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers, which proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Form 10-K.</span></div></ix:nonNumeric><div style="margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_7"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Table of Contents</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:14.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:73.716%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.272%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_25">PART I</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_25">ITEM&#160;1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_25">Business</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_25">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_64">ITEM&#160;1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_64">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_64">27</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_112">ITEM&#160;1B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_112">Unresolved Staff Comments</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_112">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_115">ITEM 1C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_115">Cybersecurity</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_115">69</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_118">ITEM&#160;2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_118">Properties</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_118">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_121">ITEM&#160;3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_121">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_121">71</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_124">ITEM&#160;4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_124">Mine Safety Disclosures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_124">73</a></span></div></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_127">PART&#160;II</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_130">ITEM&#160;5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_130">Market for Registrant&#8217;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_130">74</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_133">ITEM&#160;6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_133">[Reserved]</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_133">75</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_139">ITEM&#160;7.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_139">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_139">76</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_163">ITEM&#160;7A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_163">Quantitative and Qualitative Disclosures about Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_163">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_175">ITEM&#160;8.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_175">Financial Statements and Supplementary Data</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_175">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_178">ITEM&#160;9.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_178">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_178">88</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_181">ITEM&#160;9A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_181">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_181">89</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_187">ITEM&#160;9B.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_187">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_187">91</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_193">ITEM 9C.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_193">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_193">91</a></span></div></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_196">PART&#160;III</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_199">ITEM&#160;10.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_199">Directors, Executive Officers and Corporate Governance</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_199">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_202">ITEM&#160;11.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_202">Executive Compensation</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_202">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_205">ITEM&#160;12.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_205">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_205">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_208">ITEM&#160;13.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_208">Certain Relationships and Related Transactions, and Director Independence</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_208">92</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_211">ITEM&#160;14.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_211">Principal Accountant Fees and Services</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_211">93</a></span></div></td></tr><tr><td colspan="9" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline"><a style="color:#ffffff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_214">PART IV</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_217">ITEM&#160;15.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_217">Exhibits</a> and<a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_217"> Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_217">94</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_220">ITEM 16.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_220">Form 10-K Summary</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_220">96</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_223">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_223">97</a></span></div></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_10"></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Except for historical financial information contained herein, the matters discussed in this Annual Report on Form 10-K may be considered forward-looking statements within the meaning of Section&#160;27A of the Securities Act of 1933, as amended, or the Securities Act, and Section&#160;21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, and subject to the safe harbor created by the Private Securities Litigation Reform Act of 1995. Such statements include declarations regarding our operations, financial condition and prospects, and business strategies, and are based on management&#8217;s intent, beliefs, expectations, and assumptions as of the date of this report. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve a number of risks, uncertainties and other factors, some of which are beyond our control. Actual results could differ materially from those indicated or implied by such forward-looking statements. Important factors that could cause actual results to differ materially from those indicated by such forward-looking statements include, but are not limited to: (i)&#160;that the information is of a preliminary nature and may be subject to further adjustment; (ii)&#160;those risks and uncertainties identified under &#8220;Risk Factors&#8221;; and (iii)&#160;the other risks detailed from time-to-time in our other reports and registration statements filed with the Securities and Exchange Commission, or the SEC. Except as required by law, we undertake no obligation to revise or update publicly any forward-looking statements, whether as a result of new information, future events or otherwise. Information that is based on estimates, forecasts, projections, market research or similar methodologies is inherently subject to uncertainties and actual events or circumstances may differ materially from events and circumstances reflected in this information. Unless otherwise expressly stated, we obtained this industry, business, market, and other data from reports, research surveys, studies, and similar data prepared by market research firms and other third parties, industry, medical and general publications, government data, and similar sources.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_19"></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Available Information</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The mailing address of our headquarters is 6340 Sequence Drive, San Diego, California, 92121, and our telephone number at that location is (858) 200-0200. Our website address is located at dexcom.com and our investor relations website is located at investors.dexcom.com. We file electronically with the SEC our annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, and amendments to those reports filed or furnished pursuant to Section 13(a) or 15(d) of the Exchange Act. We make available on our website, free of charge, copies of these reports and other information as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. The reports are also available at www.sec.gov.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We announce material information to the public about us, our products, and other matters through a variety of means, including filings with the SEC, press releases, public conference calls, presentations, webcasts, and our investor relations website in order to achieve broad, non-exclusionary distribution of information to the public and to comply with our disclosure obligations under Regulation FD. We also routinely post important information for investors on our website noted above, and we may use this website as a means of disclosing material, non-public information and for complying with our disclosure obligations under Regulation FD. Accordingly, investors should monitor the Investor Relations portion of our website noted above. Also available on our website are printable versions of our Audit Committee charter, Compensation Committee charter, Nominating and Governance Committee charter, Technology Committee charter, Corporate Governance Principles for the Board of Directors, and Code of Conduct and Business Ethics. Stockholders may request copies of these documents by mail or telephone, at the address or phone number provided above. Except as expressly set forth in this Annual Report on Form 10-K, the contents of our website and/or our investor relations website are not incorporated by reference into, or otherwise to be regarded as part of, this Annual Report on Form 10-K or in any other report or document we file with the SEC, and any references to our website and/or our investor relations website are intended to be inactive textual references only.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information disclosed by the foregoing channels could be deemed to be material information. As such, we encourage investors, the media, and others to follow the channels listed above and review the information disclosed through such channels.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;Dexcom&#8221;, &#8220;Dexcom Clarity&#8221;, and &#8220;Dexcom One&#8221;, and other trademarks of ours appearing in this report are our property. Other service marks, trademarks and trade names referred to in this Annual Report on Form 10-K are the property of their respective owners.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_22"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:4pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The below summary of risk factors provides an overview of many of the risks we are exposed to in the normal course of our business activities. As a result, the below summary risks do not contain all of the information that may be important to you, and you should read the summary risks together with the more detailed discussion of risks set forth following this section under the heading &#8220;Risk Factors,&#8221; as well as elsewhere in this Annual Report on Form 10-K. Additional risks, beyond those summarized below or discussed elsewhere in this Annual Report on Form 10-K, may apply to our activities or operations as currently conducted or as we may conduct them in the future or in the markets in which we operate or may in the future operate. Consistent with the foregoing, we are exposed to a variety of risks, including risks associated with the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities and/or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to a variety of risks due to our international operations</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">at could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to complex and evolving U.S. and foreign laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo, or 510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We are subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Sustainability (including environmental, social and governance) regulations, policies and provisions could expose us to numerous risks.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_25"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PART I</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1 - BUSINESS</span></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_28"></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation systems, the Dexcom G6 integrated Continuous Glucose Monitoring System, or G6, in 2018, and we launched the Dexcom G7, or G7,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2023. In August 2024, we launched Stelo, our new biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom G7</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2022, we obtained Conformit&#233; Europ&#233;enne Marking, or CE Mark, approval for G7. In December 2022, we obtained marketing authorization from the FDA for the G7 via the 510(k) review process. Like the G6, the G7 is an integrated continuous glucose monitoring system, or iCGM, and is classified as a Class II device by the FDA, and is subject to special controls. The glucose value algorithm, ability to communicate with approved display and mobile devices, and compatibility with Dexcom Clarity, our cloud-based reporting software, are all substantially equivalent in technical performance and capability to the G6. In the United States, the G7 is covered by Medicare and Medicaid in the majority of states and by commercial insurers, subject to satisfaction of certain eligibility and coverage criteria for individuals with both Type 1 and Type 2 diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom G7 is cleared in the United States for all people with diabetes ages two years and older, giving more people than ever access to a powerfully simple diabetes management solution. With an overall Mean Absolute Relative Difference, or MARD, of 8.2%, as well as 94.1% of values within 20% of their comparator, Dexcom G7 is the most accurate CGM cleared by the FDA and is clinically proven to lower A1C (a blood test that provides information about average levels of blood glucose, over the prior three months), reduce hyper- and hypoglycemia, and increase time in range.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G7 carries forward important features of prior generation Dexcom CGM systems:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Finger stick elimination.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No finger sticks are needed for calibration or diabetes treatment decisions, consistent with the instructions for use, unless symptoms do not match readings.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Continuous glucose readings.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automatically sends glucose readings to a Dexcom receiver or compatible display device every five minutes.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Mobile app and sharing.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compatibility with mobile device applications allows for sharing glucose information with up to 10 other people for added support and care coordination.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Designed to integrate with the world&#8217;s largest connected CGM ecosystem</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (including insulin pumps and smart insulin pens, Apple Watch, Garmin and other digital health apps).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Customizable alarms and alerts.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personalized alert schedule immediately warns the user of pending dangerous high and low blood sugar levels.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Easy sensor application.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Complete redesign of the sensor applicator allows for one-touch, simple self-insertion.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Medication blocking.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> New feature allows for more accurate glucose readings without interference from common medications taken at typical indication doses, such as acetaminophen.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Predictive low alert.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Alert feature intended to predict hypoglycemia before it hits to help avoid dangerous low blood sugar events.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Extended 10-day disposable sensor.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G7 also has a number of new or improved features compared to our prior generation devices:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">An even more discreet and low profile.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A redesigned transmitter makes for an all-in-one wearable, combining our sensor and transmitter that is 60% smaller than the G6, making it even more comfortable and easier to wear under clothing.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Faster warm up.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 30-minute sensor warm up, fastest of any CGM on the market.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Expanded time to replace sensors.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> 12-hour grace period to replace finished sensors for a more seamless transition between sessions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">New mobile app.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Redesigned and simplified mobile app with Dexcom Clarity integration.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Improved alert settings for enhanced discretion at the user&#8217;s option</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Redesigned receiver. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The optional receiver is smaller, with a more vibrant, easier to read display.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">New indications for use. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicated in the United States for wear on the back of the upper arm for ages 2 years and older or the upper buttocks for ages 2-6 years old.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less waste.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Smaller plastic components and packaging, resulting in less waste than the G6.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the foregoing, the G7 is generally consistent with our prior generation CGM systems in its technical capabilities and its indications. Since the G7 is classified by the FDA as a Class II device, it is subject to special controls and modifications of, or revisions to, the device may be made under the 510(k) process.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom G6</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, we obtained marketing authorization from the FDA for the G6 via the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process. The G6 was the first type of CGM system permitted by the FDA to be used as part of an integrated system with other compatible medical devices and electronic interfaces, which may include automated insulin delivery systems, insulin pumps, blood glucose meters or other electronic devices used for diabetes management. G6 and substantially equivalent devices of this generic type that may later receive marketing authorization are referred to as integrated continuous glucose monitoring systems, or iCGMs, and have been classified as Class II devices by the FDA. Along with this classification, the FDA established criteria, called special controls, which outline requirements for assuring CGM accuracy, reliability and clinical relevance, and which also describe the type of studies and data required to demonstrate acceptable CGM performance. The G6 is designed to automatically transfer data from the transmitter to the Dexcom receiver device as well as allow our transmitter to run an algorithm to generate a glucose value and to communicate directly to a patient&#8217;s compatible mobile device, including iPhone</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, iPod touch</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, iPad</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and certain Android</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> mobile devices. A patient&#8217;s glucose data can also be displayed on wearable devices, like the Apple Watch</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Wear OS by Google devices. The G6 transmitter has a labeled useful life of three months. Data from the G6 can be integrated with Dexcom Clarity, our cloud-based reporting software, for personalized, easy-to-understand analysis of trends that may improve diabetes management. In the United States, the G6 is covered by Medicare and Medicaid in the majority of states and by commercial insurers, subject to satisfaction of certain eligibility and coverage criteria for individuals with both Type 1 and Type 2 diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2018, we received CE Mark approval for the G6, which allows us to market the system in the European Union and the countries in Asia and Latin America that recognize the CE Mark, as well as New Zealand, though certain countries may require compliance with certain local administrative requirements and/or additional marketing authorizations (for example, the inclusion of medical devices on the Australian Register of Therapeutic Goods in Australia).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2019, we also received marketing authorization from the FDA for the Dexcom G6 Pro, or G6 Pro, which allows healthcare professionals to purchase the G6 for use by their patients. The G6 Pro has many of same features as the G6 and is intended for healthcare professionals to use with their patients ages two years and up. The G6 Pro may be used in a blinded or unblinded mode for up to 10 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the G6, the sensor is inserted by the user and is intended to be used continuously for up to 10 days, after which it may be replaced with a new disposable sensor. Our transmitter is reusable until it reaches the end of its use life, labeled as three months. Our receiver is also reusable. As we continue to establish an installed base of customers using our products, we expect to generate an increasing portion of our revenues through recurring sales of our disposable sensors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G6 carries forward important features of prior generation Dexcom CGM systems:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Continuous glucose readings.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Automatically sends glucose readings to a Dexcom receiver or compatible display device every five minutes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Mobile app and sharing.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Compatibility with mobile device applications allows for sharing glucose information with up to 10 other people for added support and care coordination.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Integration with the world&#8217;s largest connected CGM ecosystem</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (including Apple Watch, Garmin and other digital health apps).</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Customizable alarms and alerts.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Personalized alert schedule immediately warns the user of pending dangerous high and low blood sugar levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The G6 also has a number of new or improved features compared to our prior generation devices:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Finger stick elimination.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> No finger sticks are needed for calibration or diabetes treatment decisions, consistent with the instructions for use, unless symptoms do not match readings.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Easy sensor application.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Complete redesign of the sensor applicator allows for one-touch, simple self-insertion.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Discreet and low profile.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A redesigned transmitter with a 28% lower profile than the previous generation Dexcom CGM system makes the device comfortable and easy to wear under clothing.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Medication blocking.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Allows for more accurate glucose readings without interference from common medications taken at typical indication doses, such as acetaminophen.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Predictive low alert.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Alert feature intended to predict hypoglycemia before it hits to help avoid dangerous low blood sugar events.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Extended 10-day disposable sensor.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Up to 10-day sensor use allows for 43% longer wear than previous generation Dexcom CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than the foregoing, the features of the G6 are generally consistent with our prior generation CGM systems in its technical capabilities and its indications. Since the G6 is classified by the FDA as a Class II device, it is subject to special controls and modifications of, or revisions to, the device may be made under the 510(k) process.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom ONE</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we obtained CE Mark approval for our Dexcom ONE CGM system, or Dexcom ONE, which we have launched in several countries in Europe. Dexcom ONE consists of three main components: a sensor, a transmitter, and a display device consisting of either the Dexcom ONE app for users with a compatible mobile device, or a Dexcom ONE receiver. Dexcom ONE carries many of the same features as the G6, and is indicated for persons, including pregnant women, ages 2 years and older. Like our other CGM systems, Dexcom ONE is designed to replace finger stick blood glucose testing for diabetes treatment decisions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, we obtained CE Mark approval for Dexcom ONE+. This updated version of our Dexcom ONE system builds upon the software experience of Dexcom ONE with certain additional features, while allowing customers to adopt the all-in-one wearable technology of our G7 CGM system.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stelo</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2024, we launched Stelo, our new biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dexcom Share</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Dexcom Share remote monitoring system, offered for use with any current Dexcom system, uses an app on the patient&#8217;s compatible iPhone, iPod touch, iPad or Android mobile device to securely and wirelessly transmit glucose information to the cloud and then to apps on the mobile devices of up to ten designated recipients, or &#8220;followers,&#8221; who can remotely monitor a patient&#8217;s glucose information and receive alert notifications anywhere they have a wireless connection. A patient&#8217;s glucose data can also be displayed on a patient&#8217;s or follower&#8217;s wearable device, such as the Apple Watch and Wear OS by Google devices, when used in conjunction with the patient&#8217;s or follower&#8217;s compatible iPhone or Android mobile device.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data and Insulin Delivery Collaborations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into multiple collaboration agreements that leverage our technology platform to integrate our CGM products with insulin delivery systems. The general purpose of these development and commercial relationships is to integrate our technology into the insulin pump or pen product offerings of the respective partner, enabling the partner&#8217;s insulin delivery device to receive and display glucose readings from our transmitter and, in some cases, use the glucose readings for semi-automated insulin delivery. We have existing insulin delivery partnerships, and we are also working with other companies that are pursuing varying strategies surrounding semi-automated insulin delivery and data analytics to improve outcomes and ease-of-use in diabetes management.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems. These collaborations align with the strategy to seek broader access to our CGM systems for people with Type 2 diabetes, including those who are not treated with intensive insulin therapy.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Verily Collaboration</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Restated Collaboration Agreement with Verily Life Science LLC (an Alphabet Company) and Verily Ireland Limited (collectively, Verily) provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture, and commercialize those kinds of glucose monitoring products and certain CGM product companion software functionalities. In connection with the Restated Collaboration Agreement, we developed, launched and commercialized a CGM product in connection with the collaboration.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and payments for contingent sales-based milestones upon the achievement of certain revenue targets. See Note 2 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Development and Other Agreements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report and Exhibit 10.13 of this Annual Report on Form 10-K for a further description of the Restated Collaboration Agreement, including the number of shares of stock for milestone payments.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_31"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Market Opportunity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diabetes is a chronic, life-threatening disease for which there is no known cure and which has other significant adverse consequences for human health throughout the world. The disease is caused by the body&#8217;s inability to produce or effectively utilize the hormone insulin. This inability prevents the body from adequately regulating blood glucose levels. Glucose, the primary source of energy for cells, must be maintained at certain concentrations in the blood in order to permit optimal cell function and health. Normally, the pancreas provides control of blood glucose levels by secreting the hormone insulin to decrease blood glucose levels when concentrations are too high. In people with diabetes, the body does not produce sufficient levels of insulin, or fails to utilize insulin effectively, causing blood glucose levels to rise above normal. This condition is called hyperglycemia and often results in acute complications as well as chronic long-term complications such as heart disease, limb amputations, loss of kidney function and blindness. When blood glucose levels are high, people with diabetes often administer insulin in an effort to decrease blood glucose levels. Unfortunately, insulin administration can drive blood glucose levels below the normal range, resulting in hypoglycemia. In cases of severe hypoglycemia, people with diabetes risk acute complications, such as loss of consciousness or death. Due to the drastic nature of acute complications associated with hypoglycemia, many people with diabetes are reluctant to reduce blood glucose levels. Consequently, these individuals often remain in a hyperglycemic state, increasing their odds of developing long-term chronic complications. Diabetes is typically classified into two major groups: Type 1 and Type 2.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The International Diabetes Federation, or IDF, estimates that in 2021, 537&#160;million adults (aged 20-79) around the world had diabetes. IDF estimates that by 2045, the worldwide incidence of people suffering from diabetes will reach 783 million. According to the Centers for Disease Control and Prevention, or CDC, in its National Diabetes Statistics Report, 2024, or the 2024 CDC Report, crude estimates for the prevalence of diabetes in the United States as of 2021 include 38.4 million people with diabetes, of which 29.7 million people have diagnosed diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This growing diabetes prevalence and its associated health outcomes also result in sobering economic burdens for global health systems. According to the American Diabetes Association, or ADA, one in every four healthcare dollars was spent on treating people with diabetes in 2022, and the direct medical costs and indirect expenditures attributable to diabetes in the United States were an estimated $413 billion, an inflation-adjusted increase of approximately 35% since 2012. Of the $413 billion in overall expenses, the ADA estimated that approximately $307 billion were direct costs associated with diabetes care, chronic complications and excess general medical costs, and $106 billion were indirect costs. The ADA also found that in 2022, average medical expenditures among people with diagnosed diabetes were 2.6 times higher than for people without diabetes. According to the IDF, 2021 expenditures attributable to diabetes were estimated to be $966 billion globally, an increase of 27% from their previous estimate in 2019.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Type 1 Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">According to the 2024 CDC Report, as of 2021 there were an estimated 2.0 million adults and youth with diagnosed Type 1 diabetes in the United States. Type 1 diabetes is an autoimmune disorder that usually develops during childhood and is characterized by an absence of insulin, resulting from destruction of the insulin producing cells of the pancreas. Individuals with Type&#160;1 diabetes must rely on frequent insulin injections in order to regulate and maintain blood glucose levels.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Type 2 Diabetes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Type 2 diabetes is a metabolic disorder which results when the body is unable to produce sufficient amounts of insulin or becomes insulin resistant. Depending on the severity of Type 2 diabetes, individuals may require diet and nutrition management, exercise, oral medications or insulin injections to regulate blood glucose levels. We estimate that between 5.0 and 6.0&#160;million people with Type 2 diabetes in the United States must use insulin to manage their diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Type 2 diabetes is occurring with increasing frequency in young people, with the increase in prevalence related to an increase in obesity amongst children. According to the CDC, as of 2017-2020, approximately 19.7% of children and adolescents aged 2-19 years, or 14.7 million children, in the United States were obese. In the United States, the percentage of children and adolescents affected by obesity has more than tripled since the 1970s.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Importance of Glucose Monitoring</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Blood glucose levels can be affected by many factors, including the carbohydrate and fat content of meals, exercise, stress, illness or impending illness, hormonal releases, variability in insulin absorption and changes in the effects of insulin in the body. Given the many factors that affect blood glucose levels, maintaining glucose within a normal range is difficult, resulting in frequent and unpredictable excursions above or below normal blood glucose levels. People with diabetes administer insulin or ingest carbohydrates throughout the day in order to maintain blood glucose levels within normal ranges. People with diabetes frequently overcorrect and fluctuate between hyperglycemic and hypoglycemic states, often multiple times during the same day. As a result, many people with diabetes are routinely outside the normal blood glucose range. Failure to maintain blood glucose levels within the normal range leads to numerous and significant health risks. These risks include eye disease, nerve disease, kidney disease, cardiovascular disease and potentially hypoglycemic events.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitations of Existing Glucose Monitoring Products</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Single-point finger stick devices are the most prevalent devices for glucose monitoring. These devices require taking a blood sample with a finger stick, placing a drop of blood on a test strip and inserting the strip into a glucose meter that yields a single point in time blood glucose measurement. We believe that these devices suffer from several limitations, including:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Limited Information.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Even if people with diabetes test several times each day, each measurement represents a single blood glucose value at a single point in time. Given the many factors that can affect blood glucose levels, excursions above and below the normal range often occur between these discrete measurement points in time. Without the ability to determine whether their blood glucose level is rising, falling or holding constant, and the rate at which their blood glucose level is changing, the individual&#8217;s ability to effectively manage and maintain blood glucose levels within normal ranges is severely limited. Further, people with diabetes cannot test themselves during sleep, when the risk of hypoglycemia is significantly increased.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The illustrative graph below shows the limited information provided by four single-point measurements during a single day using a traditional single-point finger stick device, compared to the data provided by our continuous sensor. The continuous data indicates that, even with four finger sticks in one day, the patient&#8217;s blood glucose levels were above the target range of 80-140 milligrams per deciliter (&#8220;mg/dl&#8221;) for a period of 13.5 hours.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Single Day Continuous Data</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;padding-right:22.5pt;text-align:center"><img src="dxcm-20241231_g2.jpg" alt="Investor Presentation Glucose Chart.jpg" style="height:349px;margin-bottom:5pt;vertical-align:text-bottom;width:556px"/></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Inconvenience.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The process of measuring blood glucose levels with single-point finger stick devices can cause significant disruption in the daily activities of people with diabetes and their families. People with diabetes using single-point finger stick devices must stop whatever they are doing several times per day, self-inflict a painful prick and draw blood to measure blood glucose levels. To do so, people with diabetes must always carry a fully supplied kit that may include a spring-loaded needle, or lancet, disposable test strips, cleansing wipes and the meter, and then safely dispose of the used supplies. This process is inconvenient and may cause uneasiness in social situations.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Difficulty of Use.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To obtain a sample with single-point finger stick devices, people with diabetes generally prick one of their fingertips or, occasionally, a forearm with a lancet. They then squeeze the area to produce the blood sample and another prick may be required if a sufficient volume of blood is not obtained the first time. The blood sample is then placed on a disposable test strip that is inserted into a blood glucose meter. This task can be difficult for individuals with decreased tactile sensation and visual acuity, which are common complications of diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Pain.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Although the fingertips are rich in blood flow and provide a good site to obtain a blood sample, they are also densely populated with highly sensitive nerve endings. This makes the lancing and subsequent manipulation of the finger to draw blood painful. The pain and discomfort are compounded by the fact that fingers offer limited surface area, so tests are often performed on areas that are sore from prior tests. People with diabetes may also suffer pain when the finger prick site is disturbed during regular activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Dexcom Approach</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe continuous glucose monitoring has the potential to enable more people with diabetes to achieve and sustain tight glycemic control with minimal disruption to their daily lives.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The landmark 1993 Diabetes Control and Complications Trial, or DCCT, demonstrated that improving blood glucose control lowers the risk of developing diabetes-related complications by up to 50%. The study also demonstrated that people with Type 1 diabetes achieved sustained benefits with intensive management.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Various clinical studies and real-world evidence also demonstrate the benefits of continuous glucose monitoring in the management of Type 1 diabetes and insulin-requiring Type-2 diabetes, when compared to regimens relying on self-monitoring of blood glucose. Results of several early clinical trials established that CGM usage was associated with improved glycemic outcomes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Real-time alerts and multi-device integration further differentiate CGM-based and self-monitoring of blood glucose, or SMBG, based diabetes regimens. Alerts triggered by existing or impending abnormal glucose values are associated with less exposure to hypo- and hyperglycemia in large real-world data sets, and multi-device integration </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">allows some CGM systems to communicate with automated insulin delivery systems. One such automated insulin delivery system that uses the G6 was studied in a large clinical trial that associated its use with numerous quality-of-life and glycemic benefits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current target market consists primarily of people with Type 1 and Type 2 diabetes who utilize insulin therapy as well as certain non-insulin using people with diabetes that struggle with hypoglycemia. We also believe that our CGM systems are beginning to have a positive impact on the broader Type 2 population that does not utilize insulin or have hypoglycemia risk, a group that we estimate to be greater than 25 million people in the United States alone. We are extending our commercial efforts for this population through several channels, including through strategic partnerships. In the future, we plan to expand our product offering to people who are pregnant and cleared/approved indications to address people with pre-diabetes, people who are obese, and people in the hospital setting. Although the majority of our revenue has been generated in the United States, we have expanded our operations to include additional markets in North America, Africa, Asia Pacific, Europe, Latin America and the Middle East.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current CGM systems offer the following potential advantages to people with diabetes:</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Potential for Improved Outcomes.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Randomized clinical trials and peer reviewed published data have demonstrated that patients with diabetes who used continuous glucose monitoring devices to help manage their disease experienced significant improvements in glucose control, including when compared to patients relying solely on single-point finger stick measurements (i.e., less time in hypoglycemia and hyperglycemia) and reductions in A1c levels when compared to baseline.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Access to Real-Time Values, Trend Information and Alerts.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> People with diabetes can view their current glucose value, along with a graphical display of the historical trend information on our receiver or alternate display device. Without continuous monitoring, the individual is often unaware if his or her glucose is rising, declining or remaining constant. Access to continuous real-time glucose measurements provides people with diabetes information that may aid in attaining better glucose control. Additionally, our current CGM systems alert people with diabetes when their glucose levels approach inappropriately high or low levels so that they may intervene.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Intuitive User Interface.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We have developed a user interface that we believe is intuitive and easy to use. Our current CGM system receivers are compact with an easy-to-read color display, simple navigation tools, audible alerts and graphical display of trend information. Similar benefits are available via the interfaces we have made available on compatible mobile devices. These devices can serve as substitutes for our receivers or alternate display units in certain geographies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Convenience and Comfort.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our current CGM systems provide people with diabetes with the benefits of continuous monitoring, without having to perform finger stick tests for every measurement. Additionally, the disposable sensor that is inserted under the skin is a very thin wire, minimizing potential discomfort associated with inserting or wearing the disposable sensor. The external portion of the sensor, attached to the transmitter, is small, has a low profile and is designed to be easily worn under clothing. The wireless receiver is the size of a small smart phone and can be carried discreetly in a pocket or purse. We believe that convenience is an important factor in achieving widespread adoption of a CGM system.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Connectivity to Wearables and Others. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patients can monitor their glucose levels and trends on compatible wearable devices, such as Apple Watch and Wear OS by Google devices, when used with a compatible mobile device. Also, our Share remote monitoring systems enable users of our current CGM systems to have their sensor glucose information remotely monitored by their family, friends or other designated recipient, or follower, by wirelessly transmitting data from the user&#8217;s smart phone to the cloud and then to the follower&#8217;s mobile device. Several followers can remotely monitor a patient&#8217;s glucose information and receive secondary alert notifications from almost anywhere with an Internet connection via each follower&#8217;s mobile device.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Strategy</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our objective is to remain a leading provider of glucose biosensors and related products to enable people with diabetes and those seeking to optimize metabolic health to more effectively and conveniently manage their glucose levels. We are also developing and commercializing products that integrate our CGM technologies into the insulin delivery systems or data platforms of our respective partners. In addition, we continue to pursue development partnerships with other insulin delivery companies, including automated insulin delivery systems, as well as other players in the disease management sector. We are focusing on the following business strategies as we pursue these objectives:</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Establishing and maintaining our technology platform as the leading approach to CGM and leveraging our development expertise to rapidly bring products to market, including for expanded indications.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Supporting use of our ambulatory products through a direct sales and marketing effort, as well as key distribution arrangements.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Supporting innovation through technology integration partnerships.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Seeking broad coverage policies and reimbursement for our products from private third-party payors and national health systems.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Providing cloud-based data repository platform that enables people with diabetes to aggregate and analyze data from numerous diabetes devices and share the data with their healthcare providers and other individuals involved in their diabetes management and care.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Pursuing expansion of use of our products to other patient care settings and patient demographics, including use for people with Type 2 diabetes who are not on intensive insulin therapy, population health, patient monitoring including in the hospital setting, and people who are pregnant.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Providing a high level of customer support, service and education.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Pursuing the highest safety and quality levels for our products.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_34"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Our Technology Platform</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe we have a broad technology platform that will support the development of multiple products for continuous glucose monitoring.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sensor Technology</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The key enabling technologies for our sensors include biomaterials, membrane systems, electrochemistry and low power microelectronics. Our membrane technology consists of multiple polymer layers configured to selectively allow the appropriate mix of glucose and oxygen to travel through the membrane and react with a glucose specific enzyme to create an extremely low electrical signal, measured in pico-amperes. This electrical signal is then translated into glucose values. We believe that the capability to measure very low levels of an electrical signal and to accurately translate those measurements into glucose values is also a unique and distinguishing feature of our technology. We have also developed technology to allow sensitive electronics to be packaged in a small, fully contained, lightweight sealed unit that minimizes inconvenience and discomfort for the user.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Receiver and Transmitter Technology</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current CGM systems wirelessly transmit information from the transmitter to our receiver or to a compatible mobile device. We have developed technology for reliable transmission and reception and have consistently demonstrated a high rate of successful transmissions from transmitter to receiver or compatible mobile device in our clinical trials. Our receiver or the mobile device, via our apps, then displays both real-time and trended glucose values, and provides alerts and alarms. We have used our extensive database of continuous glucose data to create and refine software, algorithms and other technology for the display of data to customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compatible Mobile Devices</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With our G6 and G7 systems, the functionalities of our proprietary receiver can be obtained through the use of a compatible mobile device, such as an iOS or Android device, and our mobile applications, depending on the patient&#8217;s geographic location. A receiver may be required as the primary display device or a backup to the mobile device in some jurisdictions, including the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dexcom Real-Time API</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, we received FDA marketing clearance for </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">an iCGM system incorporating</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> our Real-Time Application Programming Interfaces (API), which is an added software component that expands connectivity and interoperability of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CGM digital ecosystem, enabling communication of iCGM data to client software intended to receive data through the cloud. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Real-Time API enables authorized third-party software developers to integrate real-time CGM data into their digital health apps and devices </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">for specific and permitted use cases including non-medical device application, medical device data analysis, iCGM secondary display alarm, active patient monitoring, and treatment decisions. Real-Time API is not permitted for use in environments not currently cleared for the Dexcom CGM System (e.g., hospital inpatient care), and is not intended to be used by automated insulin delivery systems.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Products in Development</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have gained our technology expertise by developing implants designed to withstand the rigors of functioning within the human body for extended periods of time, and designed to address other considerations such as device sealing, miniaturization, durability and sensor geometry.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are leveraging this technology platform with the goal of enhancing the capabilities of our current products (including obtaining expanded indications for use) and to develop additional CGM products. We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems. With the introduction of Stelo, we are also pursuing and supporting development partnerships with consumer technology product companies that seek to provide metabolic health insights to their customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other opportunities, including for people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_37"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Commercial Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in North America and certain international markets to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate patients about continuous glucose monitoring. We believe that focusing efforts on these participants is important given the instrumental role they each play in the decision-making process for diabetes therapy, and to ensure that health care professionals and patients are knowledgeable about our products and their functionality. We focus on delivering this important information to participants to drive adoption of our current CGM systems. In addition, our direct sales efforts include the use of e-commerce resources in certain international markets where we have not built a sales force.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to sell our products. We expect to continue investing in our field sales force and believe our direct, highly specialized and focused sales organization and our domestic and international distribution agreements are sufficient for us to support our sales efforts for at least the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use a variety of marketing tools to drive adoption, ensure continued use and establish brand loyalty for our CGM systems by:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">creating awareness of the benefits of continuous glucose monitoring and the advantages of our technology with endocrinologists, physicians, diabetes educators, people with diabetes and those seeking to optimize metabolic health;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">providing strong and simple educational and training programs to healthcare providers and people with diabetes to ensure easy, safe and effective use of our systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">maintaining a readily accessible telephone and web-based technical and customer support infrastructure, which includes clinicians, diabetes educators and reimbursement specialists, to help referring physicians, diabetes educators, people with diabetes and those seeking to optimize metabolic health as necessary.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct-to-consumer (DTC) marketing is one of our key initiatives to increase awareness of our CGM systems and drive new leads for people with diabetes and those seeking to optimize metabolic health to our website. In jurisdictions where DTC marketing is permitted, we currently focus on reaching people with Type 1 and people with Type 2 diabetes who use insulin. We advertise on television, in print, digital and video media, CRM, offer sponsorships, host or participate in diabetes related events, conduct public relations and maintain a brand ambassador program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_40"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Competition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants. In selling our current CGM systems, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. Collectively with us, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott and their Libre family of CGM products for many years. Medtronic markets and sells a standalone glucose monitoring product called Guardian Connect, both internationally and in the United States, and a disposable CGM system called Simplera in international markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing, insulin pumps integrated with continuous glucose monitoring systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal or bolus insulin dosing. Likewise, Abbott Diabetes Care has received FDA clearance to integrate certain versions of their Libre sensors into automated insulin delivery systems and is pursuing such integrations with third-party insulin delivery devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for the general health and wellness, or population health space. Some of the companies developing or marketing competing devices are large and well-known publicly traded companies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that the principal competitive factors in our market include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">safe, reliable and high-quality performance of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">cost of products and eligibility for reimbursement;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">comfort and ease of use of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effective sales, marketing and distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">brand awareness and strong acceptance by healthcare professionals, people with diabetes and those seeking to optimize metabolic health;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">customer service and support and comprehensive education for people with diabetes, diabetes care providers and those seeking to optimize metabolic health;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">speed of product innovation and time to market;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory expertise; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">technological leadership and superiority.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on competition, please see our Risk Factor entitled &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.&#8221;</span></div><div id="i6a987b433ae84cbfb2328647e6586107_43"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Manufacturing</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently manufacture our products at our headquarters in San Diego, California and at our manufacturing facilities in Mesa, Arizona and Penang, Malaysia, where we collectively have approximately 80,600 square feet of laboratory space and approximately 159,600 square feet of controlled environment rooms. We are currently building out a new manufacturing facility in Athenry, Ireland. We anticipate that the new facility will add substantial manufacturing capacity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are technical challenges to increasing manufacturing capacity, finding or enhancing new manufacturing facilities capable of meeting regulatory requirements, government licensure of manufacturing facilities, equipment design and automation, material procurement, problems with production yields, and quality control and assurance. While we have focused significant effort on continual improvement programs in our manufacturing operations intended to improve quality, yields and throughput, we cannot guarantee that we will be able to produce an adequate supply of product to support our commercialization efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recently experienced manufacturing and inventory challenges for G7 that have resulted, and may continue to result from time to time, in disruptions in our ability to supply certain markets, including in the U.S. and other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">countries. While we are currently working to remedy such challenges, we cannot predict when such manufacturing and inventory challenges will be remedied. If we fail to produce a sufficient amount of our products, our ability to supply our markets will be compromised and health care providers and people with diabetes&#8217; decisions to use our products may be negatively impacted. This could lead to loss of sales of and revenues from our products, could potentially decrease our market share, and/or our business, financial condition, results of operations and growth prospects could be materially adversely affected. See the section of the Risk Factors entitled &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to Manufacturing, Commercial Operations and Commercialization.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the production of our continuous glucose monitoring systems must occur in a highly controlled and clean environment to minimize particles and other yield-limiting and quality-limiting contaminants. Developing and maintaining commercial-scale manufacturing facilities has and will continue to require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture our current CGM systems with certain components supplied by outside vendors and other components that we manufacture internally. Key components that we manufacture internally include our wire-based sensors. The remaining components and assemblies are purchased from outside vendors. We then assemble, test, package and ship the finished systems, which may include a reusable transmitter, a receiver and disposable sensors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We purchase certain components and materials used in manufacturing from single sources due to quality considerations, costs or constraints resulting from regulatory or other requirements. As of December&#160;31, 2024, those single sources include suppliers of application-specific integrated circuits used in our transmitters, seals used for the applicator and certain polymers used to synthesize polymeric membranes for our sensors. For additional information, please see our Risk Factor entitled &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</span></div><div id="i6a987b433ae84cbfb2328647e6586107_46"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Third-Party Coverage and Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, coverage and reimbursement from Medicare, Medicaid or other governmental healthcare programs or systems and private third-party healthcare payors is an important element of our success. Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment, or DME, benefit category. Previously, Medicare coverage for CGM was only available to Medicare patients who take at least three doses of insulin a day, limiting CGM reimbursement for Medicare beneficiaries with intensive Type 1 and 2 diabetes. The Local Coverage Determination, or LCD, that the Centers for Medicare &amp; Medicaid Services (CMS) released in April 2023 extends Medicare CGM coverage to all patients using insulin. Further, the LCD also allows coverage for patients not taking insulin if the patient has a history of problematic hypoglycemia. We also have coverage under certain international markets and Medicaid coverage in approximately 47 states.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the eight largest private third-party payors in the United States, in terms of the number of covered lives, have issued coverage policies for the category of continuous glucose monitoring devices. In addition, we have negotiated contracted rates with all of those third-party payors for the purchase of our current CGM systems by their members. We have personnel with reimbursement expertise to assist customers in obtaining reimbursement from private third-party payors. We also maintain a field-based reimbursement team charged with calling on third-party private payors to obtain coverage decisions and contracts. We have continued our efforts to create and liberalize coverage policies with third-party payors, including obtaining reimbursement for our products under pharmacy benefits and for more people with diabetes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on third-party reimbursement, please see our see Risk Factors in the section entitled &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risks Related to Pricing and Reimbursement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</span></div><div id="i6a987b433ae84cbfb2328647e6586107_49"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Intellectual Property</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Protection of our intellectual property is a strategic priority for our business. We rely on a combination of patents, copyrights, trademarks, trade names, trade secrets, nondisclosure agreements and other measures to establish and protect our proprietary rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patent portfolio includes numerous issued and pending patent applications in the U.S. and other parts of the world, which, in the aggregate, we believe to be of material importance in the operation of our business. U.S. patents, as well as most foreign patents, are generally effective for 20 years from the date the earliest application </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">was filed. In some cases, the patent term may be extended. Our issued patents as of December&#160;31, 2024 are set to expire over a range of years, from 2025 with respect to some of our earlier patents, to 2043, subject to any extensions. We also have various registered U.S. trademarks, registered European Community trademarks, and many other trademark registrations and pending trademark applications around other parts of the world. In addition, we have entered into exclusive and non-exclusive licenses in the ordinary course of business relating to a wide array of technologies or other intellectual property rights or assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patents and patent applications seek to protect aspects of our core membrane and sensor technologies and our product concepts for continuous glucose monitoring. We believe that our patent position provides us with sufficient rights to protect our current and proposed commercial products. However, our patent applications may not result in issued patents, and any patents that have been issued or might be issued may not protect our intellectual property rights. Furthermore, we operate in an industry characterized by extensive patent litigation, and our patents may not be upheld if challenged. Any patents issued to us may be challenged by third parties as being invalid or unenforceable, and patent litigation may result in significant damage awards and injunctions that could prevent the manufacture and sale of affected products or result in significant royalty payments in order to continue selling the products. Third parties may also independently develop similar or competing technology that avoids our patents. The steps we have taken may not prevent the misappropriation of our intellectual property, particularly in international countries where the laws may not protect our proprietary rights as fully as in the United States. We also face risks associated with intellectual property infringement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also rely on trade secrets, technical know-how and continuing innovation to develop and maintain our competitive position. We seek to protect our proprietary information and other intellectual property by generally requiring our employees, consultants, contractors, suppliers, outside scientific collaborators and other advisors to execute non-disclosure and assignment of invention agreements on commencement of their employment or engagement. Agreements with our employees also forbid them from bringing the proprietary rights of third parties to us. We also generally require confidentiality or material transfer agreements from third parties that receive our confidential data or materials. We cannot guarantee that employees and third parties will abide by the confidentiality or assignment terms of these agreements. Despite measures taken to protect our intellectual property, unauthorized parties might copy aspects of our products or obtain and use information that we regard as proprietary.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_52"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Sustainability</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that taking into account the interests of our various stakeholders &#8211; including patients, caregivers, those seeking to optimize metabolic health, employees, investors, and our communities &#8211; enables us to operate in a sustainable manner, supports the success of our business and drives long-term value. We do this by holding true to our core values: Listen, Think Big, Be Dependable, and Serve with Integrity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Listen</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> &#8211; We believe in listening to our customers and our employees. We have launched a number of programs to advocate for individuals living with diabetes and we support our employees and their families through a number of benefit programs that are available. In addition, we seek to promote diversity, practice fairness, and treat everyone with respect and dignity.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Think Big </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; We seek to expand global healthcare access for people with diabetes and actively work to increase access to our products. We also have committed to operate our business in a manner that is environmentally sustainable and conserves natural resources and reduces waste.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Be Dependable </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8211; We are committed to quality and believe that is best achieved through a safe and healthy workplace as well as a Quality Management System that is compliant with all applicable regulatory requirements and which is continuously being improved.</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:19pt">Serve with Integrity &#8211;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> While oversight of our ethics and governance structure begins with our Board of Directors and Executive Leadership Team, we expect all employees to foster a culture of accountability in line with our Code of Conduct and Business Ethics. We also maintain a compliance program to help enforce ethical conduct and adherence to applicable laws and regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Governance Committee of the Board of Directors oversees and reviews Dexcom&#8217;s policies and programs concerning corporate social responsibility and Dexcom&#8217;s participation and visibility as a global corporate citizen. In addition, the Nominating and Governance Committee oversees and reviews our sustainability performance and the assessment and management of environmental, sustainability and governance risks affecting our business. Our management-level Corporate Sustainability Steering Committee, which is comprised of the functional leads from our Commercial, Operations, Human Capital, Finance and Legal departments, is responsible for, among other things, setting the strategy with respect to sustainability to align with Dexcom&#8217;s mission and long-</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">term strategy, taking into consideration environmental, social and economic dimensions (subject to direction from the Chief Executive Officer and oversight of the Nominating and Governance Committee), establishing programs, policies and practices to integrate sustainability into Dexcom&#8217;s strategy, and assisting the Nominating and Governance Committee in fulfilling its oversight responsibilities with respect to Dexcom&#8217;s performance and behavior for sustainability matters. The Corporate Sustainability Steering Committee reports to our Chief Executive Officer and provides periodic updates regarding our corporate sustainability programs, policies and practices to the Nominating and Governance Committee.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Sustainability Report is available at https://investors.dexcom.com/governance/governance-documents, which is provided for reference only and is not incorporated by reference into this Annual Report on Form 10-K.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_55"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Government Regulation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The medical devices that we manufacture are subject to regulation by numerous regulatory bodies, including the FDA and comparable international regulatory agencies. These agencies require manufacturers of medical devices to comply with applicable laws and regulations governing the development, testing, manufacturing, labeling, marketing and distribution of medical devices. Devices are generally subject to varying levels of regulatory control, the most comprehensive of which requires that a clinical evaluation program be conducted before a device receives approval for commercial distribution. In addition, healthcare regulatory bodies in the United States and around the world impose a range of requirements related to the payment for medical devices and the procedures in which they are used, including laws intended to prevent fraud, waste, and abuse of healthcare dollars.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Laws and Regulations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the U.S. federal level, our products are medical devices subject to extensive and ongoing regulation by the FDA. The U.S. Federal Food, Drug and Cosmetic Act, referred to as the FDCA, and the FDA&#8217;s implementing regulations govern product design and development, pre-clinical and clinical testing, pre-market clearance, authorization or approval, establishment registration and product listing, product manufacturing, product labeling, product storage, advertising and promotion, product sales, distribution, recalls and field actions, servicing and post-market clinical surveillance. A number of U.S. states also impose licensing and compliance regimes on companies that manufacture or distribute prescription devices in the state.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the delivery of our devices in the U.S market is subject to regulation by various U.S. Department of Health and Human Services divisions including CMS, the DHHS Office of the Inspector General, or OIG, the Department of Veterans Affairs, and comparable state agencies responsible for reimbursement and regulation of payment for health care items and services. U.S. laws and regulations are imposed primarily in connection with the Medicare, Medicaid, and TRICARE programs, as well as the government&#8217;s interest in regulating the quality and cost of health care.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FDA Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless an exemption applies, each medical device we wish to commercially distribute in the United States will require either prior 510(k) clearance, prior </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> down-classification and a related grant of marketing authorization, or prior approval from the FDA through the premarket approval, or PMA process. The FDA classifies medical devices into one of three classes. Devices requiring fewer controls because they are deemed to pose lower risk are placed in Class I or II. Class I devices are subject to general controls such as labeling, pre-market notification, and adherence to the FDA&#8217;s manufacturing requirements, which are contained in the Quality System Regulation, or QSR. Class II devices are subject to special controls such as performance standards, post-market surveillance, FDA guidelines, or particularized labeling, as well as general controls. Some Class I and Class II devices are exempted by regulation from the pre-market notification (i.e., 510(k) clearance) requirement, and/or the requirement of compliance with substantially all of the QSR. As an example, the mobile applications that comprise the Share System were classified by the FDA as Class II exempt. With the mobile applications classified as Class II exempt, we must comply with certain general and special controls required by the FDA but we do not need prior FDA review to commercialize changes to the mobile applications. Some devices are placed in Class III, which requires approval of a PMA application, if they are deemed by the FDA to pose the greatest risk, such as life-sustaining, life-supporting or certain implantable devices, or to be &#8220;not substantially equivalent&#8221; either to a previously 510(k) cleared device or to a &#8220;preamendment&#8221; Class III device in commercial distribution before May&#160;28, 1976 for which PMA applications have not been required.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a previously unclassified new medical device does not qualify for the 510(k) pre-market notification process because no predicate device to which it is substantially equivalent can be identified, the device is automatically classified into Class III. Under FDA law, the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification procedure allows a manufacturer whose novel </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">device is automatically classified into Class III to request down-classification of its medical device into Class I or Class II on the basis that the device presents low or moderate risk, rather than requiring the submission and approval of a PMA. If the FDA agrees with the down-classification, the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> applicant will then receive authorization to market the device, and a classification regulation will be established for the device type. The device can then be used as a predicate device for future 510(k) submissions by the manufacturer or a competitor.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A PMA application must be supported by valid scientific evidence, which typically requires extensive data, including technical, pre-clinical, clinical, manufacturing and labeling data, to demonstrate to the FDA&#8217;s satisfaction the safety and efficacy of the device. A PMA application also must include a complete description of the device and its components, a detailed description of the methods, facilities and controls used to manufacture the device, and proposed labeling.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our CGM devices, we have a Class I data management service which we market to clinics. This service helps healthcare providers and patients see, understand and use blood glucose meter data to diagnose and manage diabetes. The service also allows researchers to control the transfer of data from certain diabetes devices to research tools and databases according to their own research workflows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The infrastructure of the data management service is considered &#8220;medical device data systems,&#8221; or MDDS. MDDS are hardware or software products that transfer, store, convert formats, and display medical device data. An MDDS does not modify the data or modify the display of the data, and it does not by itself control the functions or parameters of any other medical device. MDDS are not intended to be used for active patient monitoring. The 21st Century Cures Act excluded certain software functions from the definition of &#8220;device&#8221;, thus products meeting the definition of MDDS (which previously might have been regulated as Class I, 510(k)-exempt devices) are no longer considered devices and thus are not subject to FDA regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional functions of, or intended uses for, our software platform may require us to obtain marketing authorization from the FDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After a device is authorized for marketing and placed in commercial distribution, numerous regulatory requirements apply. These include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establishment registration and device listing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">QSR, which requires manufacturers to follow design, testing, control, storage, supplier/contractor selection, complaint handling, documentation and other quality assurance procedures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling regulations, which prohibit the promotion of products for unapproved or off-label uses or indications and impose other restrictions on labeling, advertising and promotion;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device reporting regulations, which require that manufacturers report to the FDA if a device may have caused or contributed to a death or serious injury or malfunctioned in a way that would likely cause or contribute to a death or serious injury if it were to recur;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">voluntary and mandatory device recalls to address problems when a device is defective and/or could be a risk to health; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">corrections and removal reporting regulations, which require that manufacturers report to the FDA field corrections and product recalls or removals if undertaken to reduce a risk to health posed by the device or to remedy a violation of the FDCA that may present a risk to health.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also, the FDA may require us to conduct post-market surveillance studies or order us to establish and maintain a system for tracking our products through the chain of distribution to the patient level. The FDA and the Food and Drug Branch of the California Department of Health Services and other applicable government regulatory agencies enforce regulatory requirements by conducting periodic, unannounced inspections and market surveillance. Inspections may include the manufacturing facilities of our subcontractors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to comply with applicable regulatory requirements, including those applicable to the conduct of our clinical trials, can result in enforcement action by the FDA, which may lead to any of the following sanctions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving or refusal to approve our future continuous glucose monitoring systems or other products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to foreign governments needed to export our products for sale in other countries;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of FDA approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and our contract manufacturers, specification developers, and some suppliers of components or device accessories, are also required to manufacture our products in compliance with current Good Manufacturing Practice requirements set forth in the QSR. The QSR requires a quality system for the design, manufacture, packaging, labeling, storage, installation and servicing of marketed devices, and includes extensive requirements with respect to quality management and organization, device design, buildings, equipment, purchase and handling of components or services, production and process controls, packaging and labeling controls, device evaluation, distribution, installation, complaint handling, servicing, and record keeping. The FDA evaluates compliance with the QSR through periodic unannounced inspections that may include the manufacturing facilities of our subcontractors. If the FDA believes we or any of our contract manufacturers or regulated suppliers are not in compliance with these requirements, it can shut down our manufacturing operations, require recall of our products, refuse to approve new marketing applications, institute legal proceedings to detain or seize products, enjoin future violations, or assess civil and criminal penalties against us or our officers or other employees. Any such action by the FDA would have a material adverse effect on our business. We may be unable to comply with all applicable FDA regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. Fraud and Abuse Laws and Other Compliance Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry is subject to various U.S. federal and state laws pertaining to healthcare fraud and abuse. Violations of these laws are punishable by criminal and civil sanctions, including, in some instances, exclusion from participation in U.S. federal and state healthcare programs, including Medicare and Medicaid.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Anti-kickback Laws.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The federal Anti-Kickback Statute prohibits persons from knowingly and willfully soliciting, receiving, offering or providing remuneration directly or indirectly to induce either (i) the referral of an individual, or (ii) purchasing, ordering, recommending, or arranging for the purchase or order of a good or service, for which payment may be made, in whole or in part, under a federal healthcare program such as Medicare and Medicaid. The definition of &#8220;remuneration&#8221; has been broadly interpreted to include anything of value, including such items as gifts, discounts, the furnishing of supplies or equipment, credit arrangements, payments to consultants, waiver of payments, and providing anything at less than its fair market value. Given the breadth of this prohibition, Congress has issued a number of exceptions and has granted authority to the OIG to issue safe harbor regulations, each of which set forth certain provisions which, if satisfied in their entirety, will exempt an arrangement from being found to violate the federal Anti-Kickback Statute. The failure of a transaction or arrangement to fit precisely within one or more exceptions or safe harbors is not per se illegal; rather, each arrangement is subject to a facts and circumstances analysis to determine whether the requisite improper intent exists. Therefore, conduct and business arrangements that do not fully satisfy each applicable exception or safe harbor element may result in increased scrutiny by government enforcement authorities or invite litigation by private citizens under federal whistleblower laws. Violation of the Anti-Kickback Statute is a felony and conviction could result in the assessment of fines of up to $100,000 per violation or imprisonment for up to 10 years or both.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Civil False Claims Act.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The federal Civil False Claims Act prohibits, among other things, knowingly presenting, or causing to be presented a false claim or the knowing use of false statements or records to obtain payment from the federal government. When an entity is determined to have violated the False Claims Act, it may be subject to repayment of three times the actual damages sustained by the government, plus significant mandatory civil penalties for each separate false claim. Suits filed under the False Claims Act can be brought by any individual on behalf of the government and such individuals (known as &#8220;relators&#8221; or, more commonly, as &#8220;whistleblowers&#8221;) may share in any amounts paid by the entity to the government in fines or settlement. These whistleblower-initiated False Claims Act cases are commonly referred to as &#8220;qui tam&#8221; actions. False Claims Act cases may also be initiated by the U.S. Department of Justice or any of its local U.S. Attorneys&#8217; Offices. In addition, certain states have enacted laws modeled after the federal False Claims Act. Qui tam actions have increased significantly in recent years, causing greater numbers of healthcare companies to have to defend a false claim action, even before the validity of the claim is established and even if the government decides not to intervene in the lawsuit. Healthcare companies may decide to agree to large settlements with the government and/or whistleblowers to avoid the cost, distraction and negative publicity associated with litigation. Federal enforcement agencies also have shown increased interest in pharmaceutical and medical device companies&#8217; product promotion, health care professional engagements, and patient assistance programs, including reimbursement and co-pay support services, and a number of investigations </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">into these programs have resulted in significant civil and criminal settlements. In addition, the Affordable Care Act amended federal law to provide that the government may assert that a claim for items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act. Criminal prosecution is also possible under the Criminal False Claims Act for knowingly making or presenting a false or fictitious or fraudulent claim to the federal government.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Federal Physician Self-Referral Law. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Federal Physician Self-Referral Law, also referred to as the Stark Law, prohibits a physician (or an immediate family member of a physician) who has a financial relationship with an entity from referring patients to that entity for certain designated health services, including durable medical equipment such as the CGM receiver and supplies, payable by Medicare, unless an exception applies. The Stark Law also prohibits such an entity from presenting or causing to be presented a claim to the Medicare program for such designated health services provided pursuant to a prohibited referral, and provides that certain collections related to any such claims must be refunded in a timely manner. Exceptions to the Stark Law include, among other things, exceptions for certain financial relationships, including both ownership and compensation arrangements. The Stark Law is a strict liability statute, therefore, to the extent that the statute is implicated and an exception does not apply, the statute is violated. Violations of the Stark Law must be reported and payment for improper referrals returned to Medicare in order to avoid potential liability under the federal False Claims Act for avoiding a known obligation to return identified overpayments. In the fall of 2020, we transitioned our Medicare business to distributors and we no longer bill Medicare directly for DME and related supplies. In doing so, we have limited our exposure under the Stark Law. In addition to the Stark Law, many states have implemented similar physician self-referral prohibitions that may extend to Medicaid, third party payors, and/or self-pay patients, and may be applicable to our relationships with physicians and other health care providers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Civil Monetary Penalties Law</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Civil Monetary Penalties Law, or CMPL, authorizes the imposition of substantial civil money penalties against an entity that engages in certain prohibited activities including but not limited to violations of the Stark Law or Anti-Kickback Statute, knowing submission of a false or fraudulent claim, employment of an individual excluded from participation in federal health care programs, and the provision or offer of anything of value to a Medicare or Medicaid beneficiary that the transferring party knows or should know is likely to influence the beneficiary&#8217;s selection of a particular provider or supplier from which to receive items or services for which payment may be made in whole or part by a federal health care program, commonly known as the Beneficiary Inducement CMP. Remuneration is defined under the CMPL as any transfer of items or services for free or for less than fair market value. There are certain exceptions to the definition of remuneration for offerings that meet the Financial Need, Preventative Care, or Promoting Access to Care exceptions. Sanctions for violations of the CMPL include civil monetary penalties and administrative penalties up to and including exclusion from participation in federal health care programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the Stark Law, the Anti-Kickback Statute, the Civil Monetary Penalties Law and/or the federal False Claims Act can also form the basis for exclusion from participation in federal and state healthcare programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">State Analogs of Federal Fraud and Abuse Laws</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Many U.S. states have their own laws intended to protect against fraud and abuse in the health care industry and more broadly. In some cases these laws prohibit or regulate additional conduct beyond that covered under federal law. Penalties for violating these laws can range from fines to criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Health Insurance Portability and Accountability Act of 1996 (HIPAA). </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Health Insurance Portability and Accountability Act of 1996, as amended by the American Recovery and Reinvestment Act of 2009, and implementing regulations, collectively HIPAA, created two federal crimes: healthcare fraud and false statements relating to healthcare matters. The healthcare fraud statute prohibits knowingly and willfully executing a scheme to defraud any healthcare benefit program, including private payors. A violation of this statute is a felony and may result in fines, imprisonment or exclusion from government sponsored programs, or integrity oversight and reporting obligations to resolve allegations of non-compliance. The false statements statute prohibits knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">HIPAA and Other U.S. Privacy Laws and Regulations. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous federal and state laws, rules and regulations govern the collection, dissemination, use, privacy, security and confidentiality of personal information. HIPAA, in addition to the criminal powers above, extensively regulates the use and disclosure of individually identifiable health information, through the Privacy, Security, and Breach Notification Rules. HIPAA requires covered entities, including health plans and most health care providers, to implement administrative, physical and technical safeguards to protect the privacy and security of covered information (known as &#8220;protected health information&#8221;) and sets limits and conditions on the uses and disclosures that may be made of such protected health information. HIPAA&#8217;s Security Rule and certain provisions of the HIPAA Privacy Rule and Breach Notification Rule apply to business associates of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">covered entities (i.e., entities that provide services to covered entities that may require access and use of protected health information on behalf of covered entities), and business associates are subject to direct liability for violation of these rules. In addition, a covered entity may be subject to criminal and civil penalties as a result of a business associate violating HIPAA, if the business associate is found to be an agent of the covered entity. Covered entities must report breaches of unsecured protected health information to affected individuals without unreasonable delay and notification must also be made to the U.S. Department of Health &amp; Human Services, Office for Civil Rights (OCR) and, in certain situations involving large breaches, to the media. The OCR enforces the HIPAA Rules and performs compliance audits and investigations. In addition to enforcement by OCR, HIPAA authorizes state attorneys general to bring civil actions seeking either injunction or damages in response to HIPAA violations that impact state residents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 1, 2022, OCR issued a bulletin on the requirements under HIPAA for online tracking technologies (e.g., cookies, pixels) to protect the privacy and security of health information. This bulletin outlined OCR&#8217;s position on the use of online tracking technology vendors, when certain information received by such vendors constitutes protected health information under HIPAA, and accordingly, when business associate agreements must be executed between covered entities, like us, and such vendors. We are a covered entity under HIPAA because we are a health care provider that engages in certain electronic standard transactions. In certain circumstances, we may also be a business associate of another covered entity or of another business associate. We have assessed our responsibilities under the bulletin and undertaken a number of initiatives to support our compliance with HIPAA and other requirements relating to online tracking technologies, including updates to our cookie banners and preference center. These steps are in addition to measures we had taken previously and we continue to evaluate our compliance with applicable laws and adjust our practices to address developments in the field over time. The HIPAA Rules impose and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous other laws, regulations and legislative and regulatory initiatives at the federal and state levels addressing privacy and security of personal information. We also remain subject to federal and state privacy-related laws that may be more restrictive or contain different requirements than the privacy regulations issued under HIPAA. These laws vary and could impose additional penalties. For example, the Federal Trade Commission, or FTC, uses its consumer protection authority to initiate enforcement actions against companies relating to their use and disclosure of personally identifiable information. Specifically, FTC has asserted authority and issued enforcement actions in response to actual or perceived unfair or deceptive practices by a company in the handling of consumer information. The FTC has also pursued enforcement actions against companies for violations of its Health Breach Notification Rule and the Children&#8217;s Online Privacy Protection Act. Our use of personal information is also subject to our published privacy policies and notices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, certain states have proposed or enacted legislation that will create new data privacy and security obligations for certain entities. These laws include, for example, the California Consumer Privacy Act, or CCPA, which came into effect January 1, 2020 and was amended and expanded by the California Privacy Rights Act, or CPRA, which came into effect on January 1, 2023; the Virginia Consumer Data Protection Act, effective as of January 1, 2023; the Colorado Privacy Act and the Connecticut Data Privacy Act, both effective as of July 1, 2023; the Utah Consumer Privacy Act, effective as of December 31, 2023; the Washington My Health My Data Act and Nevada Senate Bill 370, both effective as of March 31, 2024; the Oregon Consumer Privacy Act, the Texas Data Privacy and Security Act, and the Florida Digital Bill of Rights, all effective as of July 1, 2024; the Montana Consumer Data Privacy Act, effective as of October 1, 2024; the Delaware Personal Data Privacy Act, the Nebraska Data Privacy Act, the New Hampshire Data Privacy Act, and the Iowa Act Relating to Consumer Data Protection, effective as of January 1, 2025; the Tennessee Information Protection Act, effective as of July 1, 2025; and the Indiana Consumer Data Protection Act, effective as of January 1, 2026. Several other states have enacted, or are proposing to enact, their own comprehensive privacy laws. Among other things, these state-specific laws create new data privacy obligations for covered companies and provide new privacy rights to state residents, including the right to opt out of certain disclosures of their information. A particular focus of legislatures appears to be consumer health data which is not subject to HIPAA, as evidenced by passage of the Washington My Health My Data Act and Nevada Senate Bill 370. The CCPA also created a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach, and other laws, such as the Telephone Consumer Privacy Act and the Washington My Health My Data Act, also have private rights of action for violations. Regulations implementing the California and Colorado laws have been published, but many questions remain as to how all of the new statutes will be interpreted and enforced. The effects of state data protection laws are significant and have required us to modify our data processing practices. They may also cause us to incur substantial costs and expenses to ensure ongoing compliance, particularly given our base of operations in California. Various U.S. state laws and regulations may also require us to notify affected individuals and state agencies in the event of a data breach involving individually identifiable information.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation passed, as the increased cyber-attacks during recent international conflicts have once again put a spotlight on data privacy and security in the U.S. and other jurisdictions. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">FCPA and Other Anti-Bribery and Anti-Corruption Laws. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, or FCPA, prohibits U.S. corporations and their representatives from offering, promising, authorizing or making payments to any foreign government official, government staff member, political party or political candidate in an attempt to obtain or retain business abroad. The scope of the FCPA would include interactions with certain healthcare professionals in many countries, either directly or through our contracted distributors. Our present and future business has been and will continue to be subject to various other U.S. and foreign laws, rules and/or regulations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Physician Payment Sunshine Act. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the Patient Protection and Affordable Care Act that was signed into law in March 2010, the federal government enacted the Physician Payment Sunshine Act. As a manufacturer of U.S. FDA&#8209;regulated devices reimbursable by federal healthcare programs, we are subject to this law, which requires us to track and annually report certain direct or indirect payments and other transfers of value we make to certain U.S.-licensed health care practitioners and U.S. teaching hospitals. We are also required to report certain ownership or investment interests held by physicians and their immediate family members. In 2018, the law was amended to require tracking and reporting of payments and transfers of value provided to health care practitioners besides physicians, including physician assistants, nurse practitioners, and other mid-level practitioners. </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These expanded reporting requirements took effect in 2022 for payments and transfers of value made to these additional practitioner-types in 2021.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> CMS has the potential to impose penalties of up to $1,406,728 per year (adjusted annually) for violations of the Physician Payment Sunshine Act, depending on the circumstances, and reported payments also have the potential to draw scrutiny to our relationships with health care practitioners and academic medical institutions, which may have implications under the Anti-Kickback Statute and other healthcare laws. CMS has the right to audit reporting entities for compliance. CMS began its first audits in fiscal year 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain states also have laws and regulations related to payments and other transfers of value provided to healthcare professionals and entities. Similar to the federal law, certain states have adopted marketing and/or transparency laws relevant to device manufacturers, some of which are broader in scope. Certain states also mandate that device manufacturers implement compliance programs. Other states impose restrictions on device manufacturer marketing practices and require tracking and reporting of gifts, compensation, and other remuneration to healthcare professionals and entities. The need to build and maintain a robust compliance program with different compliance and/or reporting requirements increases the possibility that a company may violate one or more of the requirements, resulting in fines and penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">International Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International sales of medical devices are subject to international government regulations, which may vary substantially from country to country. The time required to obtain approval in an international country may be longer or shorter than that required for FDA approval, and the requirements may differ. There is a trend towards harmonization of quality system standards among the European Union, United States, Canada and various other industrialized countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The regulatory framework governing medical devices is largely harmonized within the European Union, which includes most of the major countries in Europe. Other countries, such as Switzerland, have voluntarily adopted laws and regulations that mirror those of the European Union with respect to medical devices. The European Union has adopted numerous directives and standards regulating the design, manufacture, clinical trials, labeling and adverse event reporting for medical devices. To be placed on the European Union market, devices must undergo a conformity assessment and bear the CE mark, indicating that the device conforms to the essential requirements of the applicable rules. The method of assessing conformity varies depending on the class of the product, but normally involves a combination of self-assessment by the manufacturer and a third-party assessment by a &#8220;Notified Body.&#8221; This third-party assessment, which may consist of an audit of the manufacturer&#8217;s quality system and specific testing of the manufacturer&#8217;s product, is always required in order for a manufacturer to commercially distribute the product throughout the European Union, except in case of Class I medical devices (those entailing the lowest level of risk). Outside of the European Union, regulatory approval needs to be sought on a country-by-country basis in order for us to market our products. The European Union Medical Device Regulation, or MDR, went into force in 2017, and replaced the existing Directive. The MDR initially provided three years for transition and compliance, which was subsequently extended to May 2026, December 2027, or December 2028, depending on the device classification. The MDR became applicable in the European Union on May 26, 2021, changing several aspects of the existing regulatory framework. Other countries have adopted medical device regulatory regimes, such as the Classification Rules for Medical Devices published by the Hong Kong Department of Health, the Health Sciences Authority of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Singapore regulation of medical devices under the Health Products Act, and Health Canada&#8217;s risk classification system for invasive devices, among others. Each country may have its own processes and requirements for medical device licensing, approval, and regulation, therefore requiring us to seek regulatory approvals on a country-by-country basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside the United States a range of anti-bribery and anti-corruption laws, as well and some industry-specific laws and codes of conduct, apply to the medical device industry and interactions with government officials and entities and healthcare professionals. Laws include the UK Bribery Act of 2010. Further, the EU member countries have emphasized a greater focus on healthcare fraud and abuse and have indicated greater attention to the industry by the European Anti-Fraud Office. MedTech Europe, the medical device industry association, also introduced the Code of Ethical Business Practices, which came into effect on January 1, 2017. Countries in Asia have also become more active in their enforcement of anti-bribery laws and with respect to procurement and supply chain fraud.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in May 2018. The EU General Data Protection Regulation, or GDPR, applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4% of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. We expect continued costs associated with maintaining compliance with GDPR into the future. For example, on July 16, 2020, the Court of Justice of the European Union issued a judgment in Case C-311/18 that declared the EU-U.S. Privacy Shield Framework invalid (Data Protection Commissioner v Facebook Ireland Ltd and Maximillian Schrems, also knowns as &#8220;Schrems II&#8221;). In the absence of the new adequacy decision, this judgment still results in additional compliance obligations for companies that rely on mechanisms other than the Privacy Shield, like standard contractual clauses and appropriate supplementary measures to ensure a valid basis for the transfer of personal data outside of Europe. Though a new adequacy decision (the EU-U.S. Data Privacy Framework) has been adopted, and it may also be subject to challenges similar to those faced by the Privacy Shield. In view of this and other developments, data transfer risk remains a potential issue that requires regular monitoring. We expect continued costs associated with maintaining compliance with the GDPR into the future, and these requirements, as interpreted by EU data protection authorities, could negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain governments around the world are also adopting laws and regulations pertaining to mandatory corporate sustainability reporting. For example, the European Union has adopted the Corporate Sustainability Reporting Directive (CSRD) that will require us to disclose certain social, governance and environmental information and data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Environmental Regulation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to federal, state and local laws and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require an unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_58"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Advisory Boards and Consultants</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have relied upon the advice of experts in the development and commercialization of our products. Since 2005, we have used experts in various disciplines on a consulting basis as needed to solve problems or accelerate development pathways. We may continue to engage advisors from the academic, consultancy, governmental or </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other areas to assist us as necessary. Relationships between manufacturers and physicians, including in consultancy and advisory board roles, is subject to scrutiny under the federal Anti-Kickback Statute and its state law equivalents. Due to this scrutiny, we incur legal and consulting fees to ensure our relationships with physicians and other health care providers meet regulatory requirements, including that compensation paid to such physicians is within fair market value.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_61"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Human Capital</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We aim to foster an inclusive and engaging culture that values each person&#8217;s unique skill set and to continue to attract &#8211; and retain &#8211; top talent throughout the organization. 2024 represented a year of continued growth across Dexcom; our employee population grew both by number and global footprint. Our consistent support of hybrid work provides access to a broader talent pool. As of December&#160;31, 2024, we have approximately 10,300 employees around the globe, including 10,200 full-time employees.</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:26.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.566%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.678%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.352%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Country</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Female</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Male</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Grand Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Ethnically Diverse<br/>(US Only)*</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,400&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,900&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,300&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,100&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,700&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">N/A</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Grand Total**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5,200&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10,300&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">*All diversity data is self-reported. We capture ethnic diversity data in the United States only, comprised of the following categories: Black or African American, Hispanic or Latino, Asian, American Indian/Alaskan Native, Native Hawaiian or Other Pacific Islander, Two or More Races.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">**Includes full time and part time employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The human capital measures and objectives that we focus on include equity and inclusion; communications and engagement; health, safety and wellness; total rewards and pay equity; and talent growth and development.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity and Inclusion</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our journey to create a more equitable and inclusive workplace continues. As Dexcom continues to grow and scale, we believe our initiatives have been critical not only for company culture but also for the growing diversity of patients our products will benefit across the globe.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our human resources team, Employee Resource Group sponsors (ERG), and senior leaders work together to advance the broader equity strategy across the organization. We are proud to support our ERGs; their employee-led activities and initiatives foster a sense of belonging throughout all our global locations. We integrate equity and inclusion into talent conversations, especially at senior levels, making our processes fairer for all Dexcom employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Communications and Engagement</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through strategic communications, we continue to strengthen the connection between our leaders and our business goals, as well as the behaviors needed to drive a positive employee experience. We also believe by listening to our employees, we can create a dynamic workplace that will foster productivity while promoting work-life balance and connection across the organization. We have continued to seek out &#8220;the voice of the employee&#8221; through life cycle surveys. Each year, we offer an engagement survey titled &#8220;We&#8217;re Listening.&#8221; Employee engagement scores consistently remained high based on a six-factor index. Notably, a strong majority of employees indicated they are proud to work for Dexcom and see a clear link between their work and the Dexcom mission.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health, Safety and Wellness</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are deeply committed to the safety, health and wellness of our employees. The Dexcom Environmental, Health, Safety &amp; Sustainability team develops global safety practices and procedures, trains employees, and monitors compliance. Through these efforts, along with leadership commitment and investment of resources in support of workplace safety initiatives, our total US injury rate has consistently tracked below industry averages.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also provide comprehensive health and well-being programs that support our employees and their families. For example, Inspire, our global wellness program, and our global mental health and employee assistance programs are designed to help employees and their family members develop and achieve their physical, emotional, and financial well-being goals.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our goal to support our employees&#8217; needs remains constant. We continued to provide both COVID and flu vaccination clinics for employees and their families, and continued support of remote work for employees whose roles allow for it. We also continue to evaluate how to maintain a hybrid workplace beyond the pandemic to ensure that we meet our employees&#8217; ever-changing needs outside the workplace.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Total Rewards and Pay Equity</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our total rewards package includes market competitive pay, comprehensive and competitive global benefits and retirement offerings, paid time off and family leave, tuition reimbursement and on-site services. To foster a stronger sense of ownership and align the interests of employees with shareholders, we offer an Employee Stock Purchase Plan, and restricted stock units are provided to eligible employees under our broad-based stock incentive programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we continued our proactive year-end global market adjustment process intended to ensure we maintain pay equity between active employees and potential new external hires. Through this process, employees who meet predefined criteria may be eligible for an additional adjustment in base salary if they have fallen below Dexcom&#8217;s determined minimum. We believe by continuing to ensure equitable pay between existing and new hires, we will be better positioned to retain valued employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we continue to proactively review both gender and ethnicity pay equity for our global employees in the same or similar roles. The goal of these reviews is to identify and close any gaps in average pay, after accounting for legitimate business factors that may explain differences, such as performance, time in role, and tenure with the company. We have incorporated the findings into our compensation assessment cycles, and we recognize the need to regularly review pay equity to maintain our pay equity goals. With the implementation of our global market adjustment process, we conduct the gender and ethnicity review annually.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Talent Growth and Development</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to invest in new learning systems and programming to support employee development. To support the personal and professional growth of our workforce, we have built an extensive library of development offerings to empower employees at all levels to advance their skill sets and knowledge base. Because there is no one-size-fits-all approach to career development, we continue to evolve our curriculum to meet the needs of our diverse workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional details regarding our human capital and other matters can be found in our Sustainability Report. Although not incorporated by reference into this Annual Report on Form 10-K, our Sustainability Report can be accessed on our investors website at investors.dexcom.com, by clicking &#8220;Governance Documents &amp; Sustainability&#8221;.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_64"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1A - RISK FACTORS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Our short and long-term success is subject to numerous risks and uncertainties, many of which involve factors that are difficult to predict or beyond our control. Before making a decision to invest in, hold or sell our common stock, stockholders and potential stockholders should carefully consider the risks and uncertainties described below, in addition to the other information contained in or incorporated by reference into this Annual Report on Form 10-K, as well as the other information we file with the SEC, including our subsequent reports on Forms 10-Q and 8-K. If any of the following risks are realized, our business, financial condition, results of operations and prospects could be materially and adversely affected. In that case, the value of our common stock could decline and stockholders may lose all or part of their investment. Furthermore, additional risks and uncertainties of which we are currently unaware, or which we currently consider to be immaterial, could have a material adverse effect on our business, financial condition or results of operations. Refer to our disclaimer regarding forward-looking statements at the beginning of Part I, Item 1 of this Annual Report on Form 10-K.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_67"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Business and Operations</span></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_70"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Pricing and Reimbursement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we experience decreasing prices for our products and we are unable to reduce our expenses, including the per unit cost of producing our products, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have experienced, and anticipate that we will continue to experience, decreasing prices for our products due to pricing pressure from managed care organizations and other third-party payors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States and other countries, government and private sector access to health care products continues to be a subject of focus, and efforts to reduce health care costs are being made by third-party payors. Most of our customers rely on third-party payors, including government programs and private health insurance plans, to cover the cost of the G6, G7 and Dexcom One. We expect that these continuing cost reduction and containment measures could result in lower prices for these products and lower reimbursement rates, as well as could lead to patients being unable to obtain approval for coverage or payment from these third-party payors resulting in costs being shifted to patients for these products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent these cost containment efforts are not offset by greater patient access to our products, our revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to decreased pricing, we may be unable to reduce our expenses, including the cost of sourcing materials, logistics and the cost to manufacture our products. If the prices for our products decrease and/or if we are unable to offset the effects of general inflation on our operating costs through increases in the prices for our products, our business, results of operations, financial condition and cash flows will be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Although many third-party payors have adopted some form of coverage policy for continuous glucose monitoring devices, our products do not always have such coverage, including simple broad-based contractual coverage with third-party payors, and we frequently experience administrative challenges in obtaining coverage or reimbursement for our products. If we are unable to obtain adequately broad coverage or reimbursement for our products or any future products from third-party payors, our revenue may be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a medical device company, reimbursement from government and/or commercial third-party healthcare payors, including Medicare and Medicaid, is an important element of our success. The Centers for Medicare &amp; Medicaid Services, or CMS, provides coverage for &#8220;Therapeutic Continuous Glucose Monitors&#8221; as durable medical equipment eligible for coverage under Medicare Part B. Coverage criteria for therapeutic CGMs is determined by CMS under national coverage determinations as well as by local Medicare Administrative Contractors under local coverage determinations. Therefore, Medicare reimbursement for our CGM devices is subject to various coverage conditions and often requires a patient-specific coverage analysis. Medicare does not cover any items or services that are not &#8220;reasonable and necessary.&#8221; Medicare covers the CGM system, which includes supplies necessary for the use of the device, under the Durable Medical Equipment, or DME, benefit category. In order to be covered under this benefit, one component of the CGM system must meet the criteria for a durable medical device. To date, the receiver satisfied this criteria. To the extent that a receiver is not used by a Medicare beneficiary or CMS otherwise determines that the items and supplies ordered are not medically necessary, Medicare may not cover that CGM system or any associated supplies.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face a number of regulatory and commercial hurdles relating to wide-scale sales where a government or commercial third-party payor provides reimbursement, including sales to Medicare beneficiaries. If we are unable to successfully address these hurdles, reimbursement of our products may be limited to a smaller subset of people with diabetes covered by Medicare or to those people with diabetes covered by other third-party payors that have adopted policies for CGM devices allowing for coverage of these devices if certain conditions are met. Adverse coverage or reimbursement decisions relating to our products, or rescission or limitation of favorable determinations, by CMS, its Medicare Administrative Contractors, other state, federal or international payors, and/or third-party commercial payors could significantly reduce reimbursement, which could have an impact on the acceptance of, and demand for, our products and the prices that our customers are willing to pay for them.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the eight largest private third-party payors in the United States, in terms of the number of covered lives, have issued coverage policies for the category of CGM devices. In addition, we have negotiated contracted rates with all of those third-party payors for the purchase of the G6 and G7 systems by their members. Nevertheless, coverage and reimbursement-related barriers remain. Among other things, people with diabetes without insurance that covers our products bear the entire financial cost of using our products. In addition, in the United States, existing single-point finger stick devices used by people with diabetes are generally reimbursable for all or part of the product cost by Medicare or other third-party payors, which may be perceived as more advantageous for consumers. Further, while many third-party payors have adopted some form of coverage policy on CGM devices, in a sizeable percentage of cases, under durable medical equipment benefits, those coverage policies frequently are restrictive and require significant medical documentation and other requirements in order to obtain reimbursement, and as a result, we have difficulty improving the efficiency of our customer service group. Moreover, it is not uncommon for governmental, including federal and/or state, agencies and their contractors to conduct periodic routine billing and compliance reviews that may entail extensive documentation requests, cooperation with which may require significant time and resources, and may result in identification of overpayments that may need to be refunded. The commercial success of our products in both domestic and international markets will substantially depend on whether timely and comprehensive third-party reimbursement is widely available for individuals that use them.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CMS has adopted coverage guidelines for CGMs, which could have a favorable impact on us. Previously, Medicare coverage for CGM was only available to Medicare patients who take at least three doses of insulin a day, limiting CGM reimbursement for Medicare beneficiaries with intensive Type 1 and 2 diabetes. The Local Coverage Determination, or LCD, that CMS released in April 2023 extends Medicare CGM coverage to patients who use any insulin. Further, the LCD also allows coverage for patients not taking insulin if the patient has a history of problematic hypoglycemia.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nevertheless, third-party payors are increasingly attempting to contain healthcare costs by limiting both coverage and the level of reimbursement of new and existing medical devices, and, as a result, they may be restrictive, or they may not cover or provide adequate payment for our products. In order to obtain additional reimbursement arrangements, including under pharmacy benefits, we may have to agree to a net sales price lower than the net sales price we might charge in other sales channels. Our revenue may be limited by the continuing efforts of government and third-party payors to contain or reduce the costs of healthcare through various increasingly sophisticated means, such as leveraging increased competition, increasing eligibility requirements such as second opinions and other documentation, purchasing in a bundle, or redesigning benefits. In December 2021, CMS published a final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs (i.e., CGMs that do not replace standard blood glucose monitors for treatment decisions) and related supplies. This final rule expanded coverage of CGMs to include competing devices, which may continue to have a negative impact on our sales as a result of increased market competition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, 2025 will bring a new presidential administration, which may shift health policy priorities, including potential impacts on Medicare coverage and reimbursement. We are unable to predict what effect the current or any future healthcare reform will have on our business, or the effect these matters will have on our customers. Our dependence on the commercial success of our current CGM systems makes us particularly susceptible to any cost containment or reduction efforts. Accordingly, unless government and other third-party payors provide adequate coverage and reimbursement for our current CGM systems or any future products we may develop, people without coverage who have diabetes may not use our products. Furthermore, payors are increasingly basing reimbursement rates on factors such as prior approvals and the effectiveness of the product, clinical outcomes associated with the product, and any factors that negatively impact the effectiveness or clinical outcomes (or cause a perception of any such negative impact), such as the results of a clinical trial, a product defect, or a product recall, which could negatively impact the reimbursement rate. Also, the trends toward managed healthcare in the United States, which we expect to continue in 2025 and beyond, and legislative efforts intended to reduce the cost of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">government insurance programs could significantly influence the purchase of healthcare services and products and may result in lower prices for our products or the exclusion of our products from reimbursement programs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In many international markets, pricing and profitability of medical devices are subject to government control. We are susceptible to changes in government-mandated coverage requirements and other controls which could impact access to and affordability of our products. In the United States, federal and state proposals for similar controls may continue and/or increase. As we continue to expand internationally, these government controls will have an increasing effect on our business and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of the above factors may have a material adverse effect on our ability to increase or maintain our revenue or otherwise have a material adverse impact on our business, financial condition, and results of operations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_73"></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Product Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The research and development efforts we undertake independently, and in some instances in connection with our collaborations with third parties, may not result in the development of commercially viable products, the generation of significant future revenues or adequate profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to address the anticipated needs of our customers, pursue new markets for our existing products and any new products, and to remain competitive, we focus our research and development efforts and strategic third-party collaboration activities on the enhancement of our current CGM products, the development of next-generation products and the development of novel technologies and services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development of new products, or novel technologies and services and the enhancement of our current CGM products (including seeking and potentially obtaining new indications for use), is difficult, expensive and time-consuming and requires significant investment in research and development, intellectual property protection, clinical trials, regulatory approvals and in obtaining third party reimbursement. The results of our product development and commercialization efforts may be affected by a range of factors, including our ability to anticipate customer needs, innovate and develop new products (whether independently or with our partners), determine a feasible or timely regulatory pathway or approach, and launch those products cost effectively into multiple markets and geographies. If we are unable to successfully anticipate customer needs, innovate, develop new products and successfully launch them, we may not be able to generate significant future revenues or profits from these efforts. Failing to timely launch our new products and any enhancements to our existing products may cause them to become obsolete and materially and adversely affect our business and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The development and commercial launch timelines for our products depend a great deal on our ability to achieve clinical endpoints and satisfy regulatory requirements and to overcome technology challenges, and may be delayed due to scheduling issues with patients and investigators, requests from institutional review boards, or inquiries from regulators about our independent and collaborative product development activities, product performance and manufacturing supply constraints, among other factors. In addition, support of these clinical trials requires significant resources from employees involved in the production of our products, including research and development, manufacturing, quality assurance, and clinical and regulatory personnel. Even if our development and clinical trial efforts appear successful to us and our regulatory submission appears satisfactory to us, the FDA or comparable international regulator may disagree and may decide not to grant marketing authorization for the products or may require additional product testing or clinical trials or other data to be developed and submitted before approving the products, which would result in product launch delays and additional expense. Even if a product receives marketing authorization from the FDA or comparable international regulator, it may not be accepted in the marketplace by health care professionals, people with diabetes and those seeking to optimize metabolic health.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business we enter into collaborative arrangements with third parties to expand into new markets, including with insulin device manufacturers to integrate our CGM technology into the third parties&#8217; insulin delivery systems. We have also entered into collaborations with several organizations that are currently using, or are developing, programs for the treatment of Type 2 diabetes that utilize our current CGM systems. As a result of these relationships, our operating results depend, to some extent, on the ability of our partners to successfully commercialize their insulin delivery systems or monitoring products. Any factors that may limit our partners&#8217; ability to achieve widespread adoption of their systems, including competitive pressures, technological breakthroughs for the treatment or prevention of diabetes, adverse regulatory or legal actions relating to insulin pump products, or changes in reimbursement rates or policies of third-party payors relating to insulin pumps or similar products, could have an adverse impact on our operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the companies that we collaborate with are also competitors or potential competitors who may decide to terminate our collaborative arrangement. In the event of such a termination, we may be required to devote </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional resources to product development and commercialization, we may need to cancel some development programs and we may face increased competition. Additionally, collaborations may not result in the development of products that achieve commercial success and could be terminated prior to developing any products. Former collaborators may use the experience and insights they develop in the course of their collaborations with us to initiate or accelerate their development of products that compete with our products, which may create competitive disadvantages for us. Accordingly, we cannot provide assurance that any of our collaborations will result in the successful development of a commercially viable product or result in significant additional future revenues.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our products may not achieve or maintain market acceptance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that sales of our CGM systems will account for substantially all of our product revenue for the foreseeable future. If and when we receive FDA or other regulators&#8217; marketing authorization for, and begin commercialization of, our next-generation CGM systems, we expect most patients will migrate onto those systems. In the periods leading up to the launch of new or upgraded versions of our CGM systems, however, our customers&#8217; anticipation of the release of those products may cause them to cancel, change or delay current period purchases of our current products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding our prior experience in marketing and selling our products, we might be unable to successfully expand the commercialization of our existing products or begin commercialization of our next-generation CGM systems on a wide-scale for a number of reasons, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our G6 and G7 systems prompt the user to replace the sensor no later than the tenth day, which might make it expensive for users;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">widespread market acceptance of our products by health care professionals, people with diabetes and those seeking to optimize metabolic health will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the limited size of our sales force;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not have sufficient financial or other resources to adequately expand the commercialization efforts for our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expanded coverage opportunities for our competitors&#8217; CGM devices and supplies, including coverage for adjunctive CGMs, increasing competition in the marketplace;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our FDA and other regulatory authority marketing application submissions and reviews may be delayed, or cleared or approved with limited product indications and labeling;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may not be able to manufacture our products in commercial quantities commensurate with demand or at an acceptable cost;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the uncertainties associated with establishing and qualifying new manufacturing facilities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">people with diabetes may need to incur the costs of single-point finger stick devices, in addition to our systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the relative immaturity of the CGM market internationally, and limited international reimbursement of CGM systems by third-party payors and government healthcare providers outside the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of competing products and technologies, which may have a lower cost or price, allow for a convenience improvement and/or allow for improved accuracy and reliability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the introduction and market acceptance of new drug therapies for the treatment and management of diabetes and related conditions, including obesity;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name or brand recognition and more established medical product distribution channels by some of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to obtain sufficient quantities of supplies timely and at appropriate quality levels from our single- or sole-source and other key suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture products that perform in accordance with expectations of consumers; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">rapid technological change may make our technology and our products obsolete.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the risks outlined above, our G6, G7, Dexcom One, and Stelo systems are more invasive than many other self-monitored glucose testing systems, including single-point finger stick devices, and people with diabetes and those seeking to optimize metabolic health may be unwilling to insert a sensor in their body, especially for those with diabetes if their current diabetes management involves no more than two finger sticks per day. Moreover, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">people with diabetes and those seeking to optimize metabolic health may not perceive the benefits of CGM and people with diabetes may be unwilling to change their current treatment regimens. Health care professionals may not recommend or prescribe our products unless and until (i)&#160;there is more long-term clinical evidence to convince them to alter their existing treatment methods, (ii)&#160;there are additional recommendations from prominent physicians that our products are effective in monitoring glucose levels, (iii)&#160;reimbursement or insurance coverage is more widely available, and (iv) patient out of pocket cost decreases. In addition, market acceptance of our products internationally by health care professionals and people with diabetes and those seeking to optimize metabolic health will largely depend on our ability to demonstrate their relative safety, effectiveness, reliability, cost-effectiveness and ease of use. If we are unable to do so, we may not be able to generate product revenue from our international sales efforts. We cannot predict when, if ever, healthcare professionals, including physicians, and people with diabetes and those seeking to optimize metabolic health may adopt more widespread use of CGM systems, including our systems. We are also aware of the increasing use of GLP-1 products for the treatment of obesity and Type 2 diabetes. While we believe that GLP-1s are a companion product and used in conjunction with our CGM systems, these treatments could potentially compete with our CGM systems and reduce sales of our products. If our CGM systems do not achieve and maintain an adequate level of acceptance by people with diabetes, those seeking to optimize metabolic health, healthcare professionals, including physicians, and third party payors, our future revenue may be reduced and our business may be harmed.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_76"></div><div style="margin-bottom:3pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Manufacturing, Commercial Operations and Commercialization</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our manufacturing capabilities are insufficient to produce an adequate supply of product at appropriate quality levels, our growth could be limited and our business could be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our existing manufacturing facilities are designed to manufacture current and next-generation CGM systems, but may not be scaled quickly enough to permit us to manufacture one or more of our CGM systems in quantities sufficient to meet market demand. In the past, we have had difficulty scaling our manufacturing operations to provide a sufficient supply of product to support market demand and our commercialization efforts. From time to time, we have also experienced periods of backorder where we have had insufficient supply of our product and, at times, have had to limit the efforts of our sales force to introduce our products to new customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have recently experienced manufacturing and inventory challenges for G7 that have resulted, and may continue to result from time to time, in disruptions in our ability to supply certain markets, including in the U.S. and other countries. While we are currently working to remedy such challenges, we cannot predict when such manufacturing and inventory challenges will be remedied. If we fail to produce a sufficient amount of our products, our ability to supply our markets will be compromised and health care providers and people with diabetes&#8217; decisions to use our products may be negatively impacted. This could lead to loss of sales of and revenues from our products, could potentially decrease our market share, and/or our business, financial condition, results of operations and growth prospects could be materially adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, we may not adequately predict the market demand for our products, which may lead us to produce our products in the quantities we anticipate will be necessary to meet actual market demand. We will need to adequately predict the market demand for our products, remedy our recent manufacturing challenges, and increase our manufacturing capacity by a significant factor over the current level to meet or exceed the anticipated market demand by product. In addition, we may have to modify our manufacturing design, reliability and process for next-generation products that may hereafter be approved, cleared or otherwise authorized by the applicable regulatory body and commercialized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2023, we completed the initial phase of construction of our new facility in Malaysia and commenced commercial manufacturing. We also commenced construction of a new facility in Ireland to scale up manufacturing capacity. There are technical challenges to increasing manufacturing capacity, including equipment design, automation, validation and installation, contractor issues and delays, licensing and permitting delays or rejections, materials procurement, manufacturing site expansion, problems with production yields and quality control and assurance. Continuing to develop commercial-scale manufacturing facilities will require the investment of substantial additional funds and the hiring and retention of additional management, quality assurance, quality control and technical personnel who have the necessary manufacturing experience. Delays in the launch of next-generation products may result in unanticipated continuing increases in demand for current-generation products (to substitute for the unavailability of the next-generation products) which, if not adequately prepared for, may result in deficits in our ability to produce adequate amounts of the prior-generation products to meet demand at appropriate prices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to scale manufacturing capacity is subject to numerous risks and uncertainties, and may lead to variability in product quality or reliability, increased construction timelines, as well as resources required to design, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">install and maintain manufacturing equipment, among others, all of which can lead to unexpected delays in manufacturing output. In addition, any changes to our manufacturing processes may trigger the need for submissions or notifications to, and in some cases advance approval from, the FDA or other regulatory authorities because of the potential impact of changes on our previously cleared, approved and/or authorized devices. Our facilities are subject to inspections by the FDA and corresponding state and international agencies on an ongoing basis, and we must comply with Good Manufacturing Practices and the FDA Quality System Regulation, as well as certain state and local requirements. We may be unable to adequately maintain, develop and expand our manufacturing process and operations or maintain compliance with FDA and state and international agency requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to manufacture a sufficient supply of our current products or any future products for which we may receive approval or clearance, maintain control over expenses or otherwise adapt to anticipated growth, or if we underestimate growth, we may not have the capability to satisfy market demand or our contractual obligations, and our business will suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Manufacturing difficulties and/or any disruption at our facilities may adversely affect our manufacturing operations and related product sales, and increase our expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products require multiple manufacturing processes and steps. Problems with these manufacturing processes, which may not be detectable by us in a timely manner, could lead to product defects or manufacturing failures, resulting in lot failures, product recalls, product liability claims and/or insufficient inventory, any of which could negatively impact our sales. As further described in the risk factor above, we have recently experienced manufacturing and inventory challenges that have resulted, and may continue to result from time to time, in disruptions in our ability to supply certain markets, including in the U.S. and other countries.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our products are manufactured at certain facilities, with limited alternate facilities. If an event occurs at one of our facilities that results in damage to, restrictions on the use of, or closure of, one or more of such facilities, or if our distributions from those facilities are limited or restricted in any way, we may be unable to manufacture the relevant products at the previous levels or at all. Because of the time required to approve, lease, and build out a manufacturing facility, an alternate facility and/or a third-party may not be available on a timely basis to replace production capacity in the event manufacturing capacity is lost.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the majority of our operations are conducted at facilities located in San Diego, California, Mesa, Arizona, and Malaysia. We take precautions to safeguard our facilities, which include manufacturing protocols, insurance, health and safety protocols, and off-site storage of data. However, a natural or man-made disaster, such as fire, flood, earthquake, act of terrorism, cyber-attack or other disruptive event, such as a public health emergency, could cause substantial delays in our operations, damage, destroy or limit our manufacturing equipment, inventory, or records and cause us to incur additional expenses. Earthquakes are of particular significance since our manufacturing facilities in California are located in an earthquake-prone area. Wildfires are also increasingly common in southern California and present risk to our manufacturing operations. Our Arizona facility may confront water supply issues resulting from the ongoing drought in the Western United States and our Malaysia facility may confront issues related to its construction on a reclaimed wetland and the political stability of the Malaysia government. In the event our existing manufacturing facilities or equipment are affected by man-made or natural disasters, we may be unable to manufacture products for sale or meet customer demands or sales projections. If our manufacturing operations were curtailed or ceased, it would seriously harm our business. The insurance we maintain against fires, floods, earthquakes and other natural disasters and similar events may not be adequate to cover our losses in any particular case.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we experience manufacturing difficulties or disruptions, or if we fail to remedy our recent manufacturing and inventory challenges, it could result in insufficient inventory, increased costs, immediate shortages in product or component supply, and decreased sales, any of which may harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend upon third-party suppliers and outsource to other parties, making us vulnerable to supply disruptions, suboptimal quality, non-compliance and/or price fluctuations, which could harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manufacture the majority of our products and procure important third-party services, such as sterilization services, at numerous facilities worldwide. We purchase many of the components, materials and services needed to manufacture these products from numerous suppliers in various countries. We have generally been able to obtain adequate supplies of such materials, components and services. However, we also rely on single and/or sole sources for certain components and materials used in manufacturing, such as for the application-specific integrated circuit that is incorporated into the transmitter and certain polymers used to synthesize the polymeric biointerface membranes for our products. In some cases, our agreements with these and other suppliers can be terminated by </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">either party upon short notice. Our contract manufacturers may also rely on single- or sole-source suppliers to manufacture some of the components used in our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we work with our suppliers to try to ensure continuity of supply while maintaining quality, timeliness and reliability, the supply of these components, materials and services has in some cases been, and may continue to be impacted, interrupted or insufficient. Our manufacturers and suppliers may also encounter problems during manufacturing for a variety of reasons. They may fail to follow specific protocols and procedures, fail to comply with applicable regulations, or be the subject of FDA or other regulatory authority audits or inspections that result in allegations of non-compliance (for example, resulting in Form 483 Observations, Warning Letters, or other FDA enforcement actions). Our manufacturers and suppliers may also experience or be impacted by equipment malfunction, environmental factors, cyber-attacks and public health emergencies, any of which could delay or impede their ability to meet our demand.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if our sole- or single-source suppliers shift their manufacturing and assembly sites to other locations, depending on the circumstances and nature of the item supplied, in addition to quality system activities such as verification and validation, there could be a need for FDA or international regulator notifications or submissions, and the new locations could be subject to regulatory inspections. If there are regulatory delays or impediments impacting our suppliers or us for any reason, we may not be able to quickly establish additional or replacement suppliers, particularly for our single-source components, in part because of the custom nature of various parts we design. Any interruption or delay in the supply of components or materials, or our inability to obtain components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our customers and cause them to cancel orders or switch to competitive products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our reliance on these outside manufacturers and suppliers also subjects us to other risks that could harm our business, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may experience a reduction or interruption in supply, and may not be able to obtain adequate supply in a timely manner or on commercially reasonable terms from additional or replacement sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our products are technologically complex and it is difficult to develop alternative supply sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we are not a major customer of many of our suppliers, and these suppliers may therefore give other customers&#8217; needs higher priority than ours;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may make errors in manufacturing components that could negatively affect the quality, effectiveness or safety of our products or cause delays in shipment of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we may have difficulty locating and qualifying alternative suppliers for our single-source supplies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">switching components may require product redesign and submission to the FDA or international regulator of new applications (such as new 510(k) submissions or PMA supplements) which could significantly delay production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers manufacture products for a range of customers, and fluctuations in demand for the products these suppliers manufacture for others may affect their ability to deliver components to us in a timely manner or at the current pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may discontinue the production of components that are critical to our products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our suppliers may encounter financial and/or other hardships unrelated to our demand for components, including those related to changes in global economic conditions and/or disease outbreaks, which could inhibit their ability to fulfill our orders and meet our requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also outsource certain services to other parties, including inside sales, certain transaction processing, accounting, information technology, manufacturing, and other areas. Outsourcing of services to third parties could expose us to suboptimal quality of service delivery or deliverables and potentially result in repercussions such as missed deadlines or other timeliness issues, erroneous data, supply disruptions, non-compliance (including with applicable legal or regulatory requirements and industry standards) and/or reputational harm, with potential negative effects on our results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also require the suppliers, service providers and business partners of components or services for our products and related services to comply with law and certain of our policies regarding sourcing practices, but we do not control them or their practices. If any supplier, service provider or business partner violates laws or implements unethical practices, there could be disruptions to our supply chain, cancellation of our orders, a termination of the relationship with the partner or damage to our reputation, and the FDA or other regulators could seek to hold us responsible for such violations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to establish and maintain adequate sales, marketing and distribution capabilities and/or enter into and maintain arrangements with third parties to sell, market and distribute our products, we may have difficulty achieving market awareness and selling our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We must continue to develop and grow our sales and marketing organization and/or enter into partnerships or other arrangements to market and sell our products and/or collaborate with third parties, including distributors and others, to market and sell our products to maintain the commercial success of our current products and to achieve commercial success for any of our future products. In 2024, we launched Stelo in the United States and are expanding distribution capabilities for its sales. If we are unable to establish and maintain adequate sales, marketing and distribution capabilities, independently or with others, for our products, our future revenue may be reduced and our business may be harmed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Developing and managing a direct sales organization is a difficult, expensive and time-consuming process. To continue to develop our sales and marketing organization to successfully achieve market awareness and sell our products, we must:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">recruit and retain adequate numbers of effective and experienced sales and marketing personnel;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel in the benefits and risks of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">establish and maintain successful sales, marketing, training and education programs that educate health care professionals, including endocrinologists, physicians and diabetes educators, so they can appropriately inform their patients about our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">manage geographically dispersed sales and marketing operations; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">effectively train our sales and marketing personnel on the applicable advertising and promotion, and fraud and abuse laws that govern interactions with healthcare professionals and institutions as well as current and prospective patients and customers and maintain active oversight and auditing measures to ensure continued compliance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently employ sales and marketing personnel for the direct sale and marketing of certain of our products in North America, Asia Pacific, Europe and the Middle East. Our direct sales and marketing team calls on healthcare providers and people with diabetes throughout the applicable country, to the extent permissible, to raise awareness and initiate sales of our products. Our sales and marketing organization competes with the experienced, larger and well-funded marketing and sales operations of our competitors. We may not be able to successfully manage our dispersed sales force or increase our product sales at acceptable rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into distribution arrangements to leverage existing distributors (including wholesalers) already engaged in the distribution of drugs, devices and/or products in the diabetes marketplace. Some of our U.S distributors are focused on accessing underrepresented regions and or third-party payors that contract exclusively with distributors in the United States, while some of our international distributors call directly on healthcare providers and patients to market and sell our products. Because of the competition for their services, we may&#160;be unable to partner with or retain additional qualified distributors. Further, we may&#160;not be able to enter into agreements with distributors on commercially reasonable terms, if at all. Our distributors might not have the resources to continue to support our recent rapid growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our distribution agreements generated 10% or more of our total revenue during the twelve months ended December&#160;31, 2024. We cannot guarantee that these relationships will continue or that we will be able to maintain this volume of sales from these relationships in the future. A substantial decrease or loss of these sales could have a material adverse effect on our financial results and operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have also entered into arrangements with pharmacy organizations in various countries to dispense our products directly to patients. Because of the competition for their services, we may be unable to enter into new partnerships or otherwise expand our pharmacy network on commercially reasonable terms, if at all. In addition, we cannot guarantee that our existing pharmacy relationships will continue, or that we will be able to maintain or increase sales volume from these relationships in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we enter into additional arrangements with third parties to perform sales, marketing, distribution and billing services, our product margins could be lower than if we directly marketed and sold our products. To the extent that we enter into co-promotion or other marketing and sales arrangements with other companies, any revenue received will depend on the skills and efforts of others, and we cannot predict whether these efforts will be successful.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we do not adequately predict market demand or otherwise optimize and operate our distribution channel successfully, it could result in excess or insufficient inventory or fulfillment capacity, increased costs, immediate shortages in product or component supply, or harm our business in other ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We operate in a highly competitive market and face competition from large, well-established companies with significant resources, and, as a result, we may not be able to compete effectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market for glucose monitoring devices is intensely competitive, subject to rapid change and significantly affected by new product introductions and other market activities of industry participants, including enhanced software capabilities, and related data and IT platforms. Our products are based on our proprietary technology, but a number of companies and medical researchers are pursuing new technologies for the monitoring of glucose levels. FDA or other regulatory approval of a commercially viable continuous glucose monitor or sensor produced by one of our competitors could significantly reduce market acceptance of our systems. In addition, certain development efforts throughout the diabetes industry, including that of the National Institutes of Health and other supporters of diabetes research are continually seeking ways to prevent, cure or improve treatment of diabetes. Therefore, our products may be rendered obsolete by technological breakthroughs in diabetes monitoring, treatment, prevention or cure.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In selling our G6, G7 and Dexcom One, we compete directly with the Diabetes Care division of Abbott Laboratories; Medtronic plc&#8217;s Diabetes Group; Roche Diabetes Care, a division of Roche Diagnostics; privately-held LifeScan, Inc.; and Ascensia Diabetes Care, each of which manufactures and markets products for the single-point finger stick device market. In selling Stelo, we compete directly with the Diabetes Care division of Abbott Laboratories. Collectively with us, these companies currently account for the majority of the worldwide sales of self-monitored glucose testing systems. We are also aware of emerging competitors primarily located in China.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competitors manufacturing adjunctive CGMs have also recognized expanded Medicare coverage of their CGM devices and supplies following CMS&#8217; December 2021 final rule expanding the classification of DME under Medicare Parts B &amp; C to include adjunctive CGMs. These devices now directly compete with our CGM products in the Medicare market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Several companies are developing and/or commercializing products for continuous or periodic monitoring of glucose levels in the interstitial fluid under the skin that compete directly with our products. We have competed with Abbott for several years and their Libre family of CGM products. Medtronic markets and sells one or more standalone glucose monitoring products both internationally and in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medtronic and other third parties have developed or are developing insulin pumps integrated with CGM systems that provide, among other things, the ability to suspend insulin administration while the user&#8217;s glucose levels are low and to automate basal and bolus insulin dosing. Likewise, Abbott Diabetes Care has received FDA clearance to integrate certain versions of their Libre sensors into automated insulin delivery systems and is pursuing such integrations with third-party insulin delivery devices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also aware of companies outside the traditional medical device sector that are attempting to develop competitive products and services, including for general health and wellness, or population health. We are also aware of the increasing use of GLP-1 products for the treatment of obesity and Type 2 diabetes. While we believe that GLP-1s are a companion product and used in conjunction with our CGM systems, these treatments could potentially compete with our CGM systems and reduce sales of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the companies developing or marketing competing devices are large and well-known publicly traded companies, and these companies may possess competitive advantages over us, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater name recognition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established relations with healthcare professionals, customers and third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">established distribution networks;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional lines of products, and the ability to bundle products to offer higher discounts or incentives to gain a competitive advantage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater experience in conducting research and development, manufacturing, clinical trials, obtaining regulatory approval for products and marketing approved products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">duration of sensor life;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the ability to integrate multiple products to provide additional features beyond CGM systems; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">greater financial and human resources for product development, manufacturing, sales and marketing, and patent litigation.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may not be able to compete effectively against these companies or their products, which may adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to risks associated with public health issues, including pandemics, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to risks associated with public health issues, such as the previous COVID-19 pandemic, and other events beyond our control. Public health issues and crises may adversely impact our operations, supply chain and logistics network if the locations where we operate, manufacture or distribute our products; where our raw materials or products are sourced, manufactured or distributed; or where our third-party distributors, suppliers and other service providers operate, are disrupted, temporarily closed or experience worker shortages for a sustained period of time. In addition, public health issues and crises may adversely impact our customers and/or their businesses due to lockdowns, labor shortages, lost access to private health insurance plans or modified spending priorities, all of which could cause a decline in demand for our products. These disruptions could also cause economic slowdowns or increased economic uncertainty. Any of the forgoing could adversely affect our business, financial condition and results of operations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_79"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to our International Operations</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a variety of risks due to our international operations that could adversely affect our business, our operations or profitability and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in countries outside the United States, which accounted for approximately 28% of our revenue for the twelve months ended December&#160;31, 2024, are accompanied by certain financial and other risks. In addition to our offices with manufacturing and administrative and operations in countries throughout the world, we intend to continue to pursue growth opportunities in sales outside the United States, especially in Asia and Europe. Additionally, we may increase our use of administrative and support functions from locations outside the United States. These business activities could expose us to greater risks associated with our sales and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we pursue opportunities outside the United States, we may become more exposed to these risks and our ability to scale our operations effectively may be affected. For example, in 2023, we completed the initial phase of construction of our new facility in Malaysia and commenced commercial manufacturing. We also are building a new manufacturing facility in Ireland. Our international expansion efforts, including our new manufacturing facilities in Malaysia and facility under construction in Ireland, may not be successful and we may experience difficulties in scaling these functions from locations outside the United States and may not experience the expected cost efficiencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our profitability and international operations are, and will continue to be, subject to a number of risks and potential costs, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">local product preferences and product requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">longer-term receivables than are typical in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in foreign currency exchange rates;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">less intellectual property protection in some countries outside the United States than exists in the United States;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">trade protection measures and import and export licensing requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">workforce instability;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fluctuations in trade policy and tariff regulations, including potential higher tariffs on imported goods and materials and renegotiation of free trade agreements and potential retaliatory tariffs imposed by foreign countries against U.S. goods; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">political and economic instability.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, the tax laws in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. We have a significant presence in the European Union, as well as significant sales in the European Union, such that any changes in tax laws in the European Union could impact our business. The overall impact of such legislation in European Union member states is uncertain, and our business and financial condition could be adversely affected by any laws impacting our tax rate.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While it is impossible for us to predict whether these and other proposals will be implemented, or how they will ultimately impact us, they may materially impact our results of operations if, for example, our profits earned abroad are subject to U.S. income tax, or we are otherwise disallowed deductions as a result of these profits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in foreign currency exchange rates may reduce the reported value of our foreign currency denominated revenues, expenses, and cash flows. We cannot predict changes in currency exchange rates, the impact of exchange rate changes, nor the degree to which we will be able to manage the impact of currency exchange rate changes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following a 2016 referendum of voters in the United Kingdom, or the U.K, to exit from the European Union, or the E.U., the U.K. left the E.U. on January 31, 2020, which began a transition period that ended on December 31, 2020. In December 2020, the U.K. and E.U. agreed on a trade and cooperation agreement that was ratified by the parties in May 2021. The agreement sets out certain procedures for approval and recognition of medical products in each jurisdiction. Any delay in obtaining, or an inability to obtain, any marketing approvals, as a result of the trade and cooperation agreement or otherwise, could prevent us from marketing our CGM systems in the U.K. and/or the E.U. and restrict our ability to generate revenue and achieve and sustain profitability. Under the trade and cooperation agreement, U.K. service suppliers no longer benefit from automatic access to the entire E.U. single market, U.K. goods no longer benefit from the free movement of goods and there is no longer the free movement of people between the U.K. and the E.U. Depending on the application of the terms of the trade and cooperation agreement, we could face new regulatory costs and challenges which could have a material adverse effect on our business, results of operations, or financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Laws and regulations governing the export of our products could adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Department of the Treasury&#8217;s Office of Foreign Assets Control, and the Bureau of Industry and Security at the U.S. Department of Commerce, administer certain laws and regulations that restrict U.S. persons and, in some instances, non-U.S. persons, in conducting activities, and transacting business with or making investments in certain countries, governments, entities and individuals subject to U.S. economic sanctions. Due to our international operations, we are subject to such laws and regulations, which are complex, restrict our business dealings with certain countries and individuals, and are constantly changing. Further restrictions may be enacted, amended, enforced or interpreted in a manner that materially impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of these regulations are punishable by civil penalties, including fines, denial of export privileges, injunctions, asset seizures, debarment from government contracts and revocations or restrictions of licenses, as well as criminal fines and imprisonment. We have established procedures designed to assist with our compliance with such laws and regulations. However, we have only limited experience dealing with these laws and regulations and we cannot guarantee that our procedures will effectively prevent us from violating these regulations in every transaction in which we may engage. Any such violation could adversely affect our reputation, business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The failure to comply with U.S. Foreign Corrupt Practices Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions could materially adversely affect our business and result in civil and/or criminal sanctions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. Foreign Corrupt Practices Act, the UK Bribery Act and similar worldwide anti-bribery laws in non-U.S. jurisdictions generally prohibit companies and their intermediaries from making improper payments to non-U.S. government officials and, in some instances, other persons for the purpose of obtaining or retaining business. Because of the predominance of government-sponsored healthcare systems around the world, most of our customer relationships outside of the United States are with governmental entities and are therefore potentially subject to such anti-bribery laws. Global enforcement of anti-corruption laws has increased substantially in recent years, with more frequent voluntary self-disclosures by companies, aggressive investigations and enforcement proceedings by U.S. and international governmental agencies, and assessment of significant fines and penalties against companies and individuals. Our international operations create the risk of unauthorized payments or offers of payments by one of our employees, consultants, sales agents, or distributors, because these parties are not always subject to our direct oversight and control. It is our policy to implement safeguards to educate our employees and agents on these legal requirements and discourage improper practices. However, our existing safeguards and any future improvements may prove to be less than effective, and our employees, consultants, sales agents, or distributors may engage in conduct for which we might be held responsible. In addition, the government agencies may seek to hold us liable for successor liability for anti-corruption law violations committed by any companies in which we invest or that we acquire. Any alleged or actual violations of these regulations may subject us to government scrutiny, severe criminal or civil sanctions and other liabilities, including exclusion from government </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contracting, and could disrupt our business, and result in a material adverse effect on our business, financial condition, and results of operations.</span></div><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, concerns over continued sovereign debt, potential recessions, a potential U.S. federal government shutdown, monetary and financial uncertainties in Europe and other international jurisdictions, and global health pandemics. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. In addition, a recession, depression or other sustained adverse market event could materially and adversely affect our access to capital on favorable terms or at all, our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to obtain any required regulatory authorization in international jurisdictions will prevent us from marketing our products abroad.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct limited commercial and marketing efforts in certain international markets in the Asia-Pacific, North America and Europe, Middle East and Africa regions, with respect to our CGM systems and may seek to market our products in other regions in the future. Outside the United States, we can market a product only if we receive a marketing authorization and, in some cases, pricing approval, from the appropriate regulatory authorities. The marketing authorization procedures vary among countries and can involve additional testing, and the time required to obtain any required authorization or approval may differ from that required to obtain FDA marketing authorization(s). International regulatory authorization or approval processes may include all of the risks associated with obtaining FDA marketing authorization(s) in addition to other risks. We may not obtain international regulatory authorizations or approvals on a timely basis, if at all. Obtaining a marketing authorization from the FDA does not ensure authorization or approval by regulatory authorities in other countries will follow, and authorization or approval by one international regulatory authority does not ensure authorization or approval by regulatory authorities in other international jurisdictions or by the FDA. In addition, in order to obtain the authorization to market our products in certain international jurisdictions, in some cases we may need to obtain a Certificate to Foreign Government from the FDA. The FDA may refuse to issue a Certificate to Foreign Government if significant compliance-related concerns are identified. As a result, there are a range of factors that could preclude or impede our ability to file for regulatory approvals or marketing authorizations or to receive necessary approvals or authorizations to commercialize our products in any market outside the United States on a timely basis, or at all.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_82"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Privacy and Security</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to complex and evolving U.S. and international laws and regulations and other requirements regarding privacy, data protection, security, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a number of international, federal and state laws and regulations protecting the use, disclosure, and confidentiality of certain patient and consumer health and personal information, including patient records, and restricting the use and disclosure of that protected information, including state breach notification laws. Some of these laws include the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009, or HITECH, the European Union&#8217;s General Data Protection Regulation, or GDPR, the UK Data Protection Act and the UK GDPR, the California Consumer Privacy Act as amended, or CCPA, and the Washington My Health My Data Act, among others. Various U.S. state laws and regulations may also require us to notify affected individuals and state regulators in the event of a data breach involving personal information. Penalties for failure to adequately protect personal information, notify as required, or provide timely notice vary by jurisdiction. In the U.S., most state data breach notification laws consider violations to be unfair or deceptive trade practices and give the relevant state attorneys general (&#8220;AGs&#8221;) the authority to levy fines or bring enforcement actions. Such AG investigations&#8212;which are often time consuming, expensive, and burdensome&#8212;could lead to a resolution agreement, whereby certain obligations are performed and reports are made to the AG for a period of time, and/or civil penalties. Class action lawsuits against companies which experience a data breach involving personal information are also common. Additionally, the SEC and many jurisdictions have enacted or may enact laws and regulations requiring companies to disclose or otherwise provide notifications regarding data security breaches. For example, the SEC has adopted cybersecurity risk management and disclosure rules, which require the disclosure of information pertaining to cybersecurity incidents and cybersecurity risk management, strategy, and governance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As our customer base grows to include U.S. federal government agencies, we may also need comply with Federal Risk and Authorization Management Program and Cybersecurity Maturity Model Certification requirements. These frameworks, in addition to similar laws being enacted by other states and other jurisdictions, impose stringent cybersecurity standards and potentially significant non-compliance penalties, and involve the expenditure of significant resources and time and effort to comply. As these laws and regulations continue to develop in the United States and internationally, we may be required to expend significant time and resources in order to update existing processes or implement additional mechanisms as necessary to ensure compliance with such laws.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, international data protection, privacy, and other laws and regulations can be more restrictive than those in the United States. For example, data localization laws in some countries generally mandate that certain types of data collected in a particular country be stored and/or processed within that country. We may be subject to inquiries, investigations and audits in Europe and around the world, particularly in the areas of consumer and data protection, which will arise in the ordinary course of business and may increase in frequency as we continue to grow and expand our operations. Legislators and regulators may make legal and regulatory changes, or interpret and apply existing laws, in ways that make our products less useful to our customers, require us to incur substantial costs, expose us to unanticipated civil or criminal liability, or cause us to change our business practices. These changes or increased costs could negatively impact our business and results of operations in material ways.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, such as our proprietary business information and that of our clients, contractors, vendors and others as well as personally identifiable information of our customers, potential customers, vendors and others, which data may include sensitive information, in our data centers and on our networks. Our employees, contractor and vendors may also have access to and may use personal health information in the ordinary course of our business. The secure processing, maintenance and transmission of this information is critical to our operations. Despite our security measures and business controls, our information technology and infrastructure may be vulnerable to attacks by hackers (including nation states or state-sponsored organizations), viruses, malware, breaches due to employee, contractor or vendor error, or malfeasance or other disruptions or subject to the inadvertent or intentional unauthorized release of information. Any such occurrence could compromise our networks and the information stored thereon could be accessed, publicly disclosed, lost or stolen. Any such access, acquisition, disclosure or other loss of information could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information, including regulatory penalties, disrupt our operations and the services we provide to our clients or damage our reputation, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we grow and expand our administrative, customer, or IT support services, we also utilize the services of personnel and contractors located outside of the United States to perform certain functions. While we make every effort to review our applicable contracts and other payor requirements, a local, state, or federal government agency or one of our customers may find the use of offshore resources to be a violation of a legal or contractual requirement, which could result in termination of the contractual relationship, penalties, or changes in our business operations that could adversely affect our business, financial condition, and results of operations. Additionally, while we have implemented industry standard security measures for offshore access to protected health information and other personal information, unauthorized access or disclosure of such information by offshore personnel could result in legal claims or proceedings, and liability under laws that protect the privacy of personal information and may incur regulatory penalties, disrupt our operations and the services we provide to our clients, damage to our reputation, or result in the termination of contractual relationships, penalties or the loss of coverage, any of which could adversely affect our profitability, revenue and competitive position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Security breaches and other disruptions that compromise our information and expose us to liability could cause our business and reputation to suffer and could subject us to substantial liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The HIPAA Security Rule requires covered entities, including Dexcom, and business associates to implement administrative, physical, and technical safeguards to protect the integrity, confidentiality and availability of protected health information that is electronically created, received, maintained or transmitted. Covered entities are also required to report any unauthorized use or disclosure of protected health information that meets the definition of a breach under the Breach Notification Rule, to affected individuals, OCR and, depending on the number of affected individuals, the media for the affected market. In addition, HIPAA requires that business associates report breaches to their covered entity customers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of HIPAA may result in criminal and civil penalties. The OCR enforces the regulations and performs compliance audits. In addition to enforcement by OCR, HITECH further authorizes state Attorneys General to bring civil actions in response to violations of HIPAA that threaten the privacy of state residents. We have adopted breach notification policies and procedures designed to comply with the applicable requirements set forth in HIPAA. We follow and maintain a HIPAA compliance plan, which we believe complies with the HIPAA privacy and security regulations, but there can be no assurance that OCR or other regulators will agree. The HIPAA Rules have and will continue to impose significant costs on us in order to comply with these standards.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">HIPAA establishes a federal &#8220;floor&#8221; with respect to privacy, security, and breach notification requirements and does not supersede any state laws insofar as they are broader or more stringent than HIPAA. Numerous state and certain other federal laws protect the confidentiality of health information and other personal information, including but not limited to state medical privacy laws, state laws protecting personal information, state data breach notification laws, state genetic privacy laws, human subjects research laws and federal and state consumer protection laws. These additional federal and state privacy and security-related laws may be more restrictive than HIPAA and could impose additional penalties. For example, the Federal Trade Commission uses its consumer protection authority under Section 5 of the Federal Trade Act to initiate enforcement actions in response to alleged privacy violations and data breaches, including in the healthcare sector.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional data protection laws exist at the state level as well. California enacted the CCPA, which came into effect January 1, 2020, was amended and expanded by the California Privacy Rights Act (the &#8220;CPRA&#8221;), which came into effect January 1, 2023. The CCPA, among other things, creates data privacy obligations for covered companies and provide privacy rights to California residents, including the right to opt out of certain disclosures of their information. The CCPA also creates a private right of action with statutory damages for certain data breaches, thereby potentially increasing risks associated with a data breach. In addition, other states have, or may, enact similar legislation. It remains unclear what, if any, additional modifications will be made to this legislation or how it will be interpreted. The effects of the CCPA and other state privacy laws are significant and have required us to modify our data processing practices, and may cause us to incur substantial costs and expenses to comply, particularly given our base of operations in California. There are also a number of other legislative proposals worldwide, including in the United States at both the federal and state level, that could impose additional and potentially conflicting obligations in areas affecting our business. We expect to incur additional costs to ensure that our data privacy and security policies, procedures, and activities comply with applicable and evolving legal requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also subject to laws and regulations in international countries covering data privacy and other protection of health and employee information that may be more onerous than corresponding U.S. laws, including in particular the laws of Europe.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For instance, in the European Union, increasingly stringent data protection and privacy rules that have and will continue to have substantial impact on the use of patient data across the healthcare industry became effective in </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 2018. The GDPR applies across the European Union and includes, among other things, a requirement for prompt notice of data breaches to data subjects and supervisory authorities in certain circumstances and significant fines for non-compliance. The GDPR fine framework can be up to 20 million euros, or up to 4% of the company&#8217;s total global turnover of the preceding fiscal year, whichever is higher. The GDPR also requires companies processing personal data of individuals residing in the European Union to comply with EU privacy and data protection rules, even if the company itself does not have a physical presence in the European Union. Noncompliance could result in the imposition of fines, penalties, or orders to stop noncompliant activities. Due to the strong consumer protection aspects of the GDPR, companies subject to its purview are allocating substantial legal costs to the development of necessary policies and procedures and overall compliance efforts. Data transfer risk remains a potential issue as certain Data Protection Authorities continue to raise concerns about the transfer of data to the United States. Though a new framework to permit cross-border transfers - the EU-US Data Privacy Framework - came into effect in 2023, it may be challenged as well. We expect continued costs associated with maintaining compliance with GDPR into the future, and these provisions as interpreted by EU agencies and authorities could negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the laws discussed above, we may see more stringent state and federal privacy legislation in the future. We cannot predict where new legislation might arise, the scope of such legislation, or the potential impact to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cybersecurity risks and cyber incidents could result in the compromise of confidential data or critical data systems and give rise to potential harm to customers, remediation and other expenses, expose us to liability under HIPAA, consumer protection laws, or other common law theories, subject us to litigation and federal and state governmental inquiries, damage our reputation, and otherwise be disruptive to our business and operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are numerous and evolving risks to our cybersecurity and privacy from cyber threat actors. These cyber threat actors, whether internal of external to Dexcom, are becoming more frequent, sophisticated and coordinated in their attempts to access data, including, without limitation, malicious software; data privacy breaches by employees, insiders or others with authorized access; cyber or phishing-attacks; ransomware; attempts to gain unauthorized access to our data and systems; vendor breaches or supply chain attacks; and other electronic security breaches. In the ordinary course of business, we collect and store sensitive information on our network, including intellectual property, proprietary business information and personally identifiable information of individuals, such as our customers and employees. The secure maintenance of this information and technology is critical to our business operations. We have implemented and deploy multiple layers of security measures to protect the confidentiality, integrity and availability of this data and the systems and devices that store and transmit such data. We utilize security technologies, and our defenses are monitored and routinely tested internally and by external parties. Despite these efforts, threats from malicious persons and groups, new vulnerabilities and advanced new attacks against information systems create risk of cybersecurity incidents. These incidents can include, but are not limited to, gaining unauthorized access to digital systems for purposes of misappropriating assets or sensitive information, corrupting data, or causing operational disruption. Because the techniques used to obtain unauthorized access, disable or degrade service, or sabotage systems change frequently and may not immediately produce signs of intrusion, we may be unable to anticipate these incidents or techniques, timely discover them, or implement adequate preventative measures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, in response to the onset of the COVID-19 pandemic, we modified our business practices and initially implemented telework policies for certain categories of &#8220;non-essential&#8221; employees to the extent possible. We have since adopted a hybrid workplace model for our employees. Our hybrid workplace allows us to work together globally to bring our life-changing products to as many people as possible. This means we have some employees who work primarily onsite, some who work primarily offsite, and others who flex in and out of the office based on the needs of the business and the individual. We recognized the need for flexibility in our physical workplace during the COVID-19 pandemic, but also noted the potential benefits of a hybrid workplace to expand and retain our talent pool and reduce our real estate needs. The hybrid workplace does, however, introduce additional operational risk, including increased cybersecurity risk. These cyber risks include, among other risks, increased phishing, malware, and other cybersecurity attacks, vulnerability to, or disruptions of, our information technology infrastructure and systems to support remote operations, increased risk of unauthorized access, use or dissemination of confidential information, limited ability to restore the systems in the event of a systems failure or interruption, greater risk of a security breach resulting in destruction, alteration or misuse of valuable information, including proprietary business information and personally identifiable information of individuals, all of which could expose us to risks of data or financial loss, litigation and liability.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These threats can come from a variety of sources, including criminal hackers, state-sponsored intrusions, industrial espionage and malfeasance by employees, contractors, or other insiders. Cyber threats may be generic, or they may be custom-crafted against our information systems or particular personnel. Over the past several years, cyberattacks have become more prevalent and much harder to detect and defend against. These threat actors may be able to penetrate our security measures, breach our information technology systems, misappropriate or compromise confidential and proprietary information of our company and our customers, cause system disruptions and shutdowns, or introduce ransomware, malware, or vulnerabilities into our products, systems, and networks or those of our customers and partners. Our network and storage applications, as well as those of our contractors, may be vulnerable to cyber-attack, malicious intrusion, malfeasance, loss of data privacy or other significant disruption and may be subject to unauthorized access by hackers, employees, consultants or other service providers. In addition, products, hardware, software or applications we develop, or which we procure from third parties, may contain defects in design or manufacture, security flaws, or other problems that could unexpectedly compromise information security or the operation of our products. Our third-party vendors may experience security incidents of varying severity, including but not limited to increased ransomware attacks, network intrusions, and unauthorized data exfiltration. Targeted cyber-attacks or those that may result from a security incident directed at a third-party vendor could compromise our services and internal systems, resulting in interruptions, delays, or cessation of service that could disrupt business operations for us and our customers. Our proactive measures and remediation efforts may not be successful or timely. Unauthorized parties may also attempt to gain access to our systems or facilities through fraud, trickery or other forms of deceiving our employees, contractors and temporary staff.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we maintain cybersecurity insurance coverage there is no guarantee that it will be sufficient to cover the financial, legal, business, or reputational losses that may result from an interruption or breach of our systems. Our cybersecurity insurance includes coverage for a breach event covering expenses for notification, credit monitoring, investigation, crisis management, public relations and legal advice. Our cybersecurity insurance also provides coverage in relation to regulatory action defense including oversight, investigations and disclosure obligations as well as fines and penalties, potential payment card industry fines and penalties and costs related to cyber extortion; however, damages and claims arising from such incidents may not be covered and/or may exceed the amount of any coverage and do not cover the time and effort we incur investigating and responding to any incidents, which may be significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are and may continue to be subject to cybersecurity incidents that bypass our security measures. Such incidents may impact the integrity, availability or privacy of personal health information or other data subject to privacy laws or disrupt our information systems, devices or business, including our ability to deliver services to our customers. As a result, cybersecurity, physical security and the continued development and enhancement of our controls, processes and practices designed to protect our enterprise, information systems and data from attack, damage or unauthorized access remain a priority for us. As cyber threats continue to evolve, we may be required to expend significant additional resources to continue to modify or enhance our protective measures or to investigate and remediate any cybersecurity vulnerabilities. The occurrence of any of these events could result in:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">harm to customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">business interruptions and delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the loss, misappropriation, corruption or unauthorized access of data, confidential information or intellectual property;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">litigation, including potential class action litigation, and potential liability under privacy, security and consumer protection laws or other applicable laws;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">reputational damage;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">significant remediation costs, including liability for stolen customer or employee information, repairing system damage, or providing benefit to affected customers or employees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increase to insurance premiums; and</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">international, federal and state governmental inquiries, violations or sanctions, any of which could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to protect our information technology infrastructure against cyberattacks, network security breaches, service interruptions, or data corruption could significantly disrupt our operations and adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on information technology and telephone networks and systems, including the Internet, to process and transmit sensitive electronic information and to manage or support a variety of business processes and activities, </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">including sales, billing, customer service, procurement and supply chain, manufacturing, and distribution. We use enterprise information technology systems to record, process, and summarize financial information and results of operations for internal reporting purposes and to comply with regulatory financial reporting, legal, and tax requirements. System failures or outages, including any potential disruptions due to significantly increased global demand on certain cloud-based systems, or failures to adequately scale our data platforms and architectures support patient care could compromise our ability to perform these functions in a timely manner, which could harm our ability to conduct business or delay our financial reporting. Such failures could materially adversely affect our operating results and financial condition. Our information technology systems, some of which are managed by third parties, may be susceptible to damage, disruptions or shutdowns due to computer viruses, denial-of-service attacks, phishing attacks, ransomware or other malware, attacks by computer hackers (including nation states or state-sponsored organizations), failures during the process of upgrading or replacing software, databases or components thereof, power outages, hardware failures, telecommunication failures, user errors, natural disasters, terrorist attacks, the outbreak of wars or other armed conflicts, or catastrophic events. Although we have developed systems and processes that are designed to protect customer information and prevent data loss and other security breaches, including systems and processes designed to reduce the impact of a security breach at a third-party vendor, such measures cannot provide absolute security. In addition, certain countries have implemented or may implement legislative and technological actions that either do or can effectively regulate access to the internet, including the ability of internet service providers to limit access to specific websites or content. Other countries have attempted or are attempting to change or limit the legal protections available to businesses that depend on the internet for the delivery of their services. If our systems are breached or suffer severe damage, disruption or shutdown and we are unable to effectively resolve the issues in a timely manner, our business and operating results may significantly suffer and we may be subject to litigation, government enforcement actions and other actions for which we could face financial liability and other adverse consequences which may include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">additional government oversight of our operations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of existing customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in attracting new customers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">problems in determining product cost estimates and establishing appropriate pricing;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">difficulty in preventing, detecting, and controlling fraud;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disputes with customers, physicians, and other health care professionals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">increases in operating expenses, incurrence of expenses, including notification and remediation costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory fines or penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">individual actions or class actions for damages;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">loss of revenues (including through loss of coverage or reimbursement);</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product development delays;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">disruption of key business operations; and</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">diversion of attention of management and key information technology resources.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cyberattacks aimed at accessing our devices, products, and services, or related devices, products, and services, and modifying or using them in a way inconsistent with our FDA clearances and approvals could create risks to users.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Medical devices are increasingly connected to the internet, hospital networks, and other medical devices to provide features that improve healthcare and increase the ability of healthcare providers to treat patients and patients to manage their conditions. For example, we are pursuing collaborations to enable the connectivity and interoperability of our current and next-generation sensors and transmitters with third-party patient monitoring products, which may in turn be connected with the internet, hospital networks and in some cases, other medical devices. These same features may also increase cybersecurity risks and the risks of unauthorized access and use by third parties. As such, a cyberattack which intrudes, disrupts, or corrupts our devices, products, and services, or related devices, products, and services could impact the quality-of-care patients receive or the confidentiality of patient information. Additionally, modifying or using any such devices, products, or services in a way inconsistent with our FDA clearances and approvals, which may create risks to users and potential exposure to the company.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_85"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Non-Compliance with Laws, Regulations and Contractual Requirements and Healthcare Industry Shifts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We conduct business in a heavily regulated industry and if we fail to comply with applicable laws and government regulations, we could become subject to penalties, be excluded from participation in government programs, and/or be required to make significant changes to our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The healthcare industry generally, and our business specifically, is subject to extensive international, federal, state and local laws and regulations, including those relating to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">authorizations necessary for the clinical investigation and commercial marketing of products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the pricing of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the distribution of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the dispensing of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">billing for or causing the submission of claims for our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">financial relationships with physicians and other referral sources;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inducements and courtesies given to physicians and other health care providers and patients;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">labeling, advertising and promoting products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the characteristics and quality of our products and services;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">communications with payors and physicians and other healthcare stakeholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">confidentiality, maintenance and security issues associated with medical records and individually identifiable health and other personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">medical device adverse event reporting;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">prohibitions on kickbacks, including the Anti-Kickback Statute and related laws and/or regulations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">any scheme to defraud any healthcare benefit program;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">physician and other healthcare professional payment disclosure requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">use and disclosure of personal health information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">privacy of health information and personal information;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">data protection and data localization;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">mobile communications;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient access and non-discrimination;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient consent;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">false claims; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">licensure.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws and regulations are extremely complex and, in many cases, still evolving. If our operations are found to violate any of the international, federal, state or local laws and regulations which govern our activities, we may be subject to litigation, government enforcement actions, and applicable penalties associated with the violation, potentially including civil and criminal penalties, damages, fines, exclusion from participation in certain payor programs or curtailment of our operations. Compliance obligations under these various laws are oftentimes detailed and onerous, further contributing to the risk that we could be found to be out of compliance with particular requirements. The risk of being found in violation of these laws and regulations is further increased by the fact that many of them have not been fully interpreted by the regulatory authorities or the courts, particularly with respect to new and emerging technologies and remote delivery of services, and their provisions are open to a variety of interpretations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA, CMS, OIG, OCR, FTC, Department of Justice, states&#8217; attorneys general and other governmental authorities actively enforce the laws and regulations discussed above. In the United States, medical device manufacturers have been the target of numerous government prosecutions and investigations alleging violations of law, including claims asserting impermissible off-label promotion of medical devices, payments intended to influence the referral of federal or state healthcare business, and submission of false claims for government reimbursement. While we make every effort to comply with applicable laws, we cannot rule out the possibility that the government or other third parties could interpret these laws differently and challenge our practices under one or more of these laws. This likelihood of allegations of non-compliance is increased by the fact that under certain federal and state laws applicable to our business, individuals may bring an action on behalf of the government alleging violations of </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">such laws, and potentially be awarded a share of any damages or penalties ultimately awarded to the applicable government body.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA and the FTC share oversight of medical device promotion. The FDA has broad authority over device marketing (including assessment and oversight of safety and effectiveness) and over FDA-approved &#8220;promotional labeling,&#8221; while the FTC has authority over &#8220;advertising&#8221; for most medical devices (i.e., non-&#8220;restricted&#8221; devices, such as ours).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any action against us alleging a violation of these laws or regulations, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s time and attention from the operation of our business, and have a material effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of our commitment to technological advancement, we have incorporated and will continue to explore and implement AI-enabled functions into our products and services. We continue to explore how best to leverage and harness the efficiency and innovation of AI-enabled and AI-empowered technology. In our deployment of AI, we strive to continually assess its performance and continue to make improvements. AI laws and regulations have proliferated in the U.S. and globally in recent years, including in 2024. In 2024, there were 60 AI-related regulations at the U.S. federal and state levels, up from just one in 2016. In 2024 alone, the total number of AI-related regulations in the U.S. grew by 140%. On January 10, 2025, HHS released its AI Strategic Plan which largely focuses on promoting trustworthy AI through the FAVES framework (Fair, Appropriate, Valid, Effective, Safe). Additionally, the EU AI Act went into effect on August 1, 2024, which sets requirements for developers and deployers of AI systems based on a risk approach and extends its reach to those developers of AI outside of the EU where the AI product or output is used in the EU. AI regulation is continually evolving at the federal, state and international level and will continue to require financial and resource investment by us to ensure that AI tools are safe and effective, operate in a non-discriminatory manner, and comply with applicable legal and regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the laws and regulations impacting or affecting our business may change significantly in the future, which may adversely affect our business. A review of our business by courts or regulatory authorities may result in a determination that could adversely affect our operations. Also, the regulatory environment applicable to our business may change in a way that restricts or adversely impacts our operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we or our suppliers or distributors fail to comply with ongoing regulatory requirements, or if we have unanticipated problems with our products, the products could be subject to restrictions or withdrawal from the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any product for which we obtain marketing approval, clearance or authorization (and the activities related to its production, distribution, and promotion, sale, and marketing) will be subject to continual review and periodic inspections by the FDA and other regulatory bodies, which may include inspection of our manufacturing processes, complaint handling and adverse event reporting, post-approval clinical data and promotional activities for such product. The FDA&#8217;s Medical Device Reporting, or MDR, regulations require that we report to the FDA any incident in which our product may have caused or contributed to a death or serious injury, or in which our product malfunctioned and, if the malfunction were to recur, it would likely cause or contribute to a death or serious injury.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the FDA determines that there is a reasonable probability that a device intended for human use would cause serious, adverse health consequences or death, the agency may issue a cease distribution and notification order and a mandatory recall order. We may also decide to recall a product voluntarily if we find a material deficiency, including unacceptable risks to health, manufacturing defects, design errors, component failures, labeling defects, or other issues. Recalls of our products could divert the attention of our management and have an adverse effect on our reputation, financial condition, and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We and certain of our suppliers are also required to comply with the FDA&#8217;s Quality System Regulation, or QSR, and other regulations which cover the methods and documentation of the design, testing, production, control, selection and oversight of suppliers or contractors, quality assurance, labeling, packaging, storage, complaint handling, shipping and servicing of our products. The FDA may enforce the QSR through announced (through prior notification) or unannounced inspections.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with ongoing regulatory requirements can be complex, expensive and time-consuming. Failure by us or one of our suppliers or distributors to comply with statutes and regulations administered by the FDA, competent authorities and other regulatory bodies, or failure to take adequate response to any observations, could result in, among other things, any of the following actions:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">warning letters or untitled letters that require corrective action;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">delays in approving, or refusal to approve, our CGM systems;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">fines and civil or criminal penalties;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">unanticipated expenditures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA refusal to issue certificates to international governments needed to export our products for sale in other countries;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">suspension or withdrawal of clearance or approval by the FDA or other regulatory bodies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">product recall or seizure;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">administrative detention;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of production, partial suspension, or complete shutdown of production;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">interruption of the supply of components from our key component suppliers;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">operating restrictions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">court consent decrees;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">FDA orders to repair, replace, or refund the cost of devices;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">injunctions; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">criminal prosecution.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect of these events can in some cases be difficult to quantify. If any of these actions were to occur, it would harm our reputation and cause our product sales and profitability to suffer. In addition, we believe events that could be classified as reportable events pursuant to MDR regulations are generally underreported by physicians and users, and any underlying problems could be of a larger magnitude than suggested by the number or types of MDRs filed by us. Furthermore, our key component suppliers may not currently be or may not continue to be in compliance with applicable regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if regulatory approval or clearance of a product is granted, the approval or clearance may be subject to limitations on the indicated uses for which the product may be marketed or contain requirements for costly post-marketing testing or surveillance to monitor the safety or effectiveness of the product. Later discovery of previously unknown problems with our products, including software bugs, unanticipated adverse events or adverse events of unanticipated severity or frequency, manufacturing problems, or failure to comply with regulatory requirements such as the QSR, MDR reporting, or other post-market requirements may result in restrictions on such products or manufacturing processes, withdrawal of the products from the market, voluntary or mandatory recalls (through corrections or removals), fines, suspension of regulatory approvals, product seizures, injunctions, the imposition of civil or criminal penalties, or criminal prosecution. In addition, our distributors have rights to create marketing materials for their sales of our products, and may not adhere to contractual, legal or regulatory limitations that are imposed on their marketing efforts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quality problems could lead to recalls or safety alerts, reputational harm, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Quality is very important to us and our customers due to the serious and costly consequences of product failure, and our business exposes us to potential product liability risks that are inherent in the design, manufacture, and marketing of medical devices. Since the first commercial launch of our products in 2006, we have had periodic field failures related to our products and associated services, including reports of sensor errors, sensor failures, broken sensors, receiver malfunctions, audible alarms and alert failures, as well as server and transmitter failures. To comply with the FDA&#8217;s medical device reporting requirements, for example, we have filed reports of applicable field failures. Although we believe we have taken and are taking appropriate action aimed at reducing and/or eliminating field failures, we may have other product failures in the future. Product or component failures, manufacturing nonconformances, design defects, off-label use, or inadequate disclosure of product-related risks or product-related information with respect to our products, if they were to occur, could result in an unsafe condition or injury to, or death of, a patient. These problems could lead to recalls, corrections or removals of, or issuance of a safety alert relating to, our products, and could result in product liability claims and lawsuits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the production of our products must occur in a highly controlled and clean environment to minimize particles and other yield- and quality-limiting contaminants. Weaknesses in process control or minute impurities in materials may cause a substantial percentage of defective products. If we are not able to maintain stringent quality controls, or if contamination problems arise, our clinical development and commercialization efforts could be delayed, which would harm our business and our results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to meet any applicable product quality standards and our products are the subject of recalls or safety alerts, our reputation could be damaged, we could lose customers, our reputation could be harmed and our revenue and results of operations could decline.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential long-term complications from our current or future products or other CGM systems under development may not be revealed by our clinical experience to date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on our experience, complications from use of our products may include sensor errors, sensor failures, broken or detached sensor wires, or skin irritation under the adhesive dressing of the sensor. Inflammation or redness, swelling, minor infection, and minor bleeding at the sensor insertion site are also possible risks with an individual&#8217;s use of our products. However, if unanticipated long-term side-effects result from the use of our products or other glucose monitoring systems we have under development, we could be subject to liability and the adoption of our systems may become more limited. With respect to our G6 systems, our clinical trials have been limited to ten days of continuous use. It is possible that the data from our clinical studies and trials may not be indicative of long-term patient outcomes. We cannot assure you that repeated, long-term use would not result in unanticipated adverse effects, potentially even after the sensor is removed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may never receive approval, marketing authorization or clearance from the U.S. FDA and other governmental agencies to market additional CGM systems, expanded indications for use of current and future generation CGM systems, future software platforms, or any other products under development.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, via the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process, the FDA classified the G6 and substantially equivalent devices of this generic type (i.e., &#8220;integrated continuous glucose monitoring systems&#8221; or &#8220;iCGMs&#8221;) into Class II, meaning that going forward products of this generic type may utilize the 510(k) pathway. Since then we have received 510(k) clearances for modifications to the G6 and approval for G7. In 2024, the FDA cleared Stelo as an over-the-counter biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any subsequent modifications of our cleared products that could significantly affect their safety or effectiveness (for example, a significant change in design or manufacture), or that would constitute a major change in its intended use, will require us to obtain a new 510(k) clearance or could require a new </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> submission or a PMA. The FDA requires each manufacturer to make this determination initially, but the FDA may review any such decision and may disagree with a manufacturer&#8217;s determination. If the FDA disagrees with a manufacturer&#8217;s determination, the FDA may require the manufacturer to cease marketing and/or recall the modified device until appropriate clearance or approval is obtained. Under these circumstances, the FDA may also subject a manufacturer to significant regulatory fines or other penalties.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If future product candidates are not deemed by the FDA to meet the criteria for submission under the 510(k) pathway, or for down-classification under the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> process or otherwise, we would need to pursue a PMA. The PMA process requires us to prove the safety and effectiveness of our systems to the FDA&#8217;s satisfaction. This process can be expensive, prolonged and uncertain, requires detailed and comprehensive scientific and human clinical data, and may never result in the FDA granting a PMA. The FDA&#8217;s </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> classification of our G6 system under the generic name &#8220;integrated continuous glucose monitoring system,&#8221; makes it a predicate device for future 510(k) submissions. Complying with this classification requires ongoing compliance with the general controls required by the federal Food Drug and Cosmetic Act and the special controls specified by the FDA&#8217;s G6 order as a Class II device. Any future system or expanded indications for use of current generation systems will require approval of the applicable regulatory authorities. In addition, we intend to seek either 510(k) clearances or PMA approvals for certain changes and modifications to our existing software platform, but cannot predict when, if ever, those changes and modifications will be approved.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA can refuse to grant a 510(k) clearance or a </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> request for marketing authorization, or delay, limit or deny approval of a PMA application or supplement for many reasons, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not be deemed by the FDA to be substantially equivalent to appropriate predicate devices under the 510(k) pathway;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the system may not satisfy the FDA&#8217;s safety or effectiveness requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the data from pre-clinical studies and clinical trials may be insufficient to support clearance or approval;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the manufacturing process or facilities used may not meet applicable requirements; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in FDA approval policies or adoption of new regulations may require additional data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if approved or cleared by the FDA or international regulatory agencies, future generations of our CGM systems, expanded indications for use of current and future generation CGM systems, our software platforms or any other CGM system under development, may not be cleared or approved for the indications that are necessary or desirable for successful commercialization. We may not obtain the necessary regulatory approvals or clearances to market these CGM systems in the United States or outside of the United States. Any delay in, or failure to receive or maintain, clearance or approval for our products could prevent us from generating revenue from these products. The uncertain timing of regulatory approvals for future generations of our products could subject our current </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">inventory to excess or obsolescence charges, which could have an adverse effect on our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to comply with laws, regulations and contract requirements relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to laws, regulations and contractual requirements regulating the provision of, and reimbursement for, health care goods and services in our capacity as a medical device manufacturer. The laws and regulations of health care goods and services that apply to us, including those described above, are subject to evolving interpretations and enforcement discretion. We have in place a compliance program, through which we seek to reduce common industry risks of noncompliance with U.S. federal and state and applicable international laws in areas such as sales contracts, marketing materials, referral source relationships, programmatic offerings, and billing practices (among others), monitor for compliance, and address non-compliance if identified. If a governmental authority were to conclude that we are not in compliance with applicable laws and regulations, we and our officers, directors and employees could be subject to criminal and civil penalties, as well as administrative sanctions such as exclusion from participation in federal healthcare programs, including but not limited to Medicare and Medicaid. Any failure to comply with laws, regulations or contractual requirements relating to reimbursement and health care goods and services could adversely affect our reputation, business, financial condition and cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are purchased principally by individual patients, who may be eligible for insurance coverage of their devices from various third-party payors, such as governmental programs (</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Medicare, Medicaid, TRICARE, other federal and state health benefit plans, and comparable non-U.S. programs), private insurance plans, and managed care plans. The ability of our customers to obtain appropriate reimbursement for products and services</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">from third-party payors is critical because it affects which products customers purchase and the prices they are willing to pay. As a result, our products are subject to regulation regarding quality and cost by the U.S. Department of Health &amp; Human Services, including CMS, as well as comparable state and non-U.S. agencies responsible for reimbursement and regulation of health care goods and services. The principal U.S. federal laws relating to reimbursement include those that prohibit (i) the filing of false or improper claims for federal payment, known as the federal civil False Claims Act, (ii) unlawful inducements for the referral of items and services reimbursed by Federal health care programs, known as the federal Anti-Kickback Statute, and (iii) the Civil Monetary Penalties Law, including its prohibitions on Beneficiary Inducement. Many states have similar laws that apply to reimbursement by state Medicaid and other government-funded programs, as well as, in some cases, to all payors, including self-pay patients. Insurance companies can also bring a private cause of action claiming treble damages against a manufacturer for causing a false claim to be filed under the federal Racketeer Influenced and Corrupt Organizations Act, or RICO. Additionally, as a manufacturer of FDA&#8209;approved or -cleared devices reimbursable by federal healthcare programs, we are subject to the federal Physician Payments Sunshine Act, which requires us to annually report certain payments and other transfers of value we make to certain U.S.-licensed health care professionals and U.S. teaching hospitals, and under an expansion of the law to physician assistants, nurse practitioners, and other mid-level practitioners.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to the federal Anti-Kickback Statute, Congress and the OIG have established a large number of statutory exceptions and regulatory safe harbors that protect financial relationships with our customers and referral sources. An arrangement that fits squarely into an exception or safe harbor will not be deemed to violate the Anti-Kickback Statute.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We train and educate employees and marketing representatives on the Anti-Kickback Statute and their obligations thereunder, and we endeavor to comply with the applicable safe harbors. However, some of our arrangements, like many other common and non-abusive arrangements, may implicate the Anti-Kickback Statute and are not covered by a safe harbor, but nevertheless we do not believe them to present a significant risk to beneficiaries or federal healthcare programs and, as such, appear unlikely to invite government scrutiny or prosecution, warrant the imposition of sanctions, or be found to violate the statute. However, we cannot offer assurance that the government or a whistleblower would agree with our position that certain arrangements fall within a safe harbor, or that arrangements that do not squarely meet an exception or safe harbor will not be found to violate the Anti-Kickback Statute. Allegations of violations of the Anti-Kickback Statute can also trigger liability under the federal Civil Monetary Penalty Law and federal civil False Claims Act, thereby increasing the penalty structure for these violations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the period in which we directly billed Medicare, our financial relationships with referring physicians and their immediate family members were required to comply with the federal Physician Self-Referral law, commonly referred to as the Stark Law, by meeting an applicable exception. Unlike the Anti-Kickback Statute, failure to meet an exception under the Stark Law results in a violation of the Stark Law, even if such violation is unintentional. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Violations of the Stark Law create overpayment liability under the federal civil False Claims Act and can also trigger separate penalties under the Civil Monetary Penalties Law. Knowing violations of the Stark Law carry increased civil monetary penalties and would likely be classified as the knowing submission of a false claim or knowingly making a false statement to the government, triggering liability under the federal civil False Claims Act. Certain Stark Law violations can also trigger exclusion from participation in federal healthcare programs. Historical violations of the Stark Law, if any, could continue to give rise to liability during the six year statute of limitations period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Managed care trends and consolidation in the health care industry could have an adverse effect on our revenues and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Private third-party payors and other managed care organizations, such as pharmacy benefit managers, continue to take action to manage utilization and control costs. Consolidation among managed care organizations has increased the negotiating power of managed care organizations and other private third-party payors. Private third-party payors, as well as governments, increasingly employ formularies to control costs by taking into account discounts in connection with decisions about formulary inclusion or favorable formulary placement. Failure to obtain or maintain timely adequate pricing or favorable formulary placement for our products, or failure to obtain such formulary placement at favorable pricing, could adversely impact revenue. Private third-party payors, including self-insured employers, often implement formularies with co-payment tiers to encourage utilization of certain products and have also been raising co-payments required from beneficiaries, particularly for higher-cost products. Private third-party payors also use additional measures such as value-based pricing/contracting to improve their cost-containment efforts. Private third-party payors also are increasingly imposing utilization management tools, such as requiring prior authorization or requiring the patient to first fail on a lower-cost product before permitting access to a higher-cost product.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many health care industry companies, including health care systems, distributors, manufacturers, providers, and insurers, are also consolidating or vertically integrating, or have formed strategic alliances. As the health care industry consolidates, competition to provide goods and services to industry participants may become more intense. This consolidation will continue to create larger enterprises with greater negotiating power, which they can try to use to negotiate price concessions or reductions for medical devices and components produced by us.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the U.S. payor market consolidates further and we face greater pricing pressure from private third-party payors, who will continue to drive more of their patients to use lower cost alternatives, we may lose customers, our revenues may decrease and our business, financial condition, results of operations and cash flows may suffer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully complete the pre-clinical studies or clinical trials necessary to support additional PMA, de novo,&#160;or&#160;510(k) applications or supplements, we may be unable to commercialize our CGM systems under development, which could impair our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To support current and any future additional PMA, 510(k), </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">applications or supplements, we together with our partners, must successfully complete pre-clinical studies, bench-testing, and in some cases clinical trials that will demonstrate that the product is safe and effective. Product development, including pre-clinical studies and clinical trials, is a long, expensive and uncertain process and is subject to delays and failure at any stage. Furthermore, the data obtained from the studies and trials may be inadequate to support approval of an application and the FDA may request additional clinical data in support of those applications, which may result in significant additional clinical expenses and may delay product approvals. While we have in the past obtained, and may in the future obtain, an investigational device exemption, or IDE, prior to commencing clinical trials for our products, FDA approval of an IDE application permitting us to conduct testing does not mean that the FDA will consider the data gathered in the trial to be sufficient to support approval of a PMA, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">de novo</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or 510(k) application or supplement, even if the trial&#8217;s intended safety and effectiveness endpoints are achieved.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes to the regulatory landscape may impact our ability to obtain marketing authorization for future product developments.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Development or changes to the FDA or international regulatory approval standards and processes, including both legal and policy changes, could also delay or prevent the approval of our products submitted for review. For example, medical device cybersecurity continues to be an area of focus for and evolving guidance from FDA.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, at the end of 2022, Congress passed the Food and Drug Omnibus Reform Act of 2022, or FDORA which (among other things), and similarly to the 2022 FDA Guidance, requires device sponsors to submit clinical trial diversity action plans outlining the goals for increasing representation of participants from racial and ethnic minority populations that have been underrepresented in clinical trials.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any change in the laws or regulations that govern the clearance and approval processes relating to our current and future products could make it more difficult and costly to obtain clearance or approval for new products, or to produce, market and distribute existing products. The data contained in our submissions, including data drawn from our clinical trials, may not be sufficient to support clearance or approval of our products or additional or expanded indications. Medical device company stock prices have declined significantly in certain circumstances where companies have failed to meet expectations in regards to the timing of regulatory approval. If the FDA&#8217;s response causes product approval delays, or is not favorable for any of our products, our stock price (and the market price of our senior convertible notes) could decline substantially. It is uncertain how these potential changes may impact our ability to gain clearance or approval from FDA for our products in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The commencement or completion of any of our clinical trials may be delayed or halted, or be inadequate to support approval of FDA marketing applications or supplements, for numerous reasons, including, but not limited to, the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA or other regulatory authorities do not approve a clinical trial protocol or a clinical trial, or place a clinical trial on hold;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients do not enroll in clinical trials at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients or study site personnel who do not comply with clinical trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patient follow-up does not occur at the rate we expect;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients experience adverse side effects;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">patients die during a clinical trial, even though their death may not be related to our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">institutional review boards and third-party clinical investigators may delay or reject our clinical trial protocol;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators decline to participate in a trial or do not perform a trial on our anticipated schedule or consistent with the investigator agreements, clinical trial protocol, good clinical practices or other FDA or institutional review board requirements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we or third-party organizations do not perform data collection, monitoring or analysis in a timely or accurate manner or consistent with the clinical trial protocol or investigational or statistical plans;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">third-party clinical investigators have significant financial interests related to us or the study that the FDA deems to make the study results unreliable, or we or clinical investigators fail to disclose such interests;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory inspections of our clinical trials or manufacturing facilities may results in allegations or findings of noncompliance and, among other things, require us to undertake corrective action or suspend or terminate our clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in governmental regulations, policies or administrative actions applicable to our trial protocols;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the interim or final results of the clinical trial are inconclusive or unfavorable as to safety or efficacy; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the FDA concludes that the results from our trial and/or trial design are inadequate to demonstrate safety and effectiveness of the product.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, health epidemics could limit or restrict our ability to initiate, conduct or continue our clinical trials. Delays and disruption in our clinical trials could result in delays for expanded FDA clearance or approval of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The results of pre-clinical studies or other forms of early product testing do not necessarily predict future clinical trial results, and prior clinical trial results might not be repeated in subsequent clinical trials. Additionally, the FDA may disagree with our interpretation of the data from our pre-clinical studies, product testing, and clinical trials, or may find the clinical trial design, conduct or results inadequate to prove safety or effectiveness, and may require us to pursue the development of additional data, which could further delay the approval of our products. If we are unable to demonstrate the safety and effectiveness of our products in our clinical trials to the FDA&#8217;s satisfaction, where clinical data are required, we will be unable to obtain regulatory approval to market our products in the United States. In addition, the data we collect from our current clinical trials, our pre-clinical studies and other clinical trials may not be sufficient to support FDA approval, even if our endpoints are met.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also conduct clinical studies to demonstrate the relative or comparative effectiveness of CGM systems for the treatment of diabetes. These types of studies, which often require substantial investment and effort, may not show adequate, or any, clinical benefit or value for the use of CGM systems.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We depend on clinical investigators and clinical sites to enroll patients in our clinical trials and other third parties to manage the trials and to perform related data collection and analysis, and, as a result, we may face costs and delays that are outside of our control.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on clinical investigators and clinical sites to enroll patients in our clinical trials, and other third parties to manage the trial and to perform related data collection and analysis. However, we may not be able to control the amount and timing of resources that clinical sites may devote to our clinical trials. If these clinical investigators and clinical sites fail to enroll a sufficient number of patients in our clinical trials or fail to ensure compliance by patients with clinical protocols or fail to comply with regulatory requirements, we will be unable to complete these trials, which could prevent us from obtaining regulatory approvals for our products. Our agreements with clinical investigators and clinical sites for clinical testing place substantial responsibilities on these parties and, if these parties fail to perform as expected, our trials could be delayed or terminated. If these clinical investigators, clinical sites or other third parties do not carry out their contractual duties or obligations or fail to meet expected deadlines, or if the quality or accuracy of the clinical data they obtain is compromised due to their failure to adhere to our clinical protocols, regulatory requirements or for other reasons, our clinical trials may be extended, delayed or terminated, or the clinical data may be rejected by the FDA, and we may be unable to obtain regulatory approval for, or successfully commercialize, our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care policy changes, including U.S. health care reform legislation, may have a material adverse effect on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to perceived increases in health care costs in recent years, there have been and continue to be proposals by the federal government, state governments, regulators, and third-party payors to control these costs and, more generally, to reform the U.S. health care system. Certain of these proposals could limit the prices we are able to charge for our products or the amounts of reimbursement available for our products and could limit the acceptance and availability of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2020, the OIG published a Special Fraud Alert addressing manufacturer Speaker Programs, signaling both a more narrow government view of AKS compliance with respect to such programs as well as the potential for increased enforcement in this space by government oversight agencies such as the OIG and DOJ. In March 2022, the Advanced Medical Technology Association, or AdvaMed, announced revisions to its Code of Ethics on Interactions with Health Care Professionals, or Code. The revised Code, effective June 2022, addressed concerns noted in the OIG&#8217;s Special Fraud Alert, addressing things like virtual meetings, speaker programs and alcohol at events. The revised Code also addresses value-based care arrangements. We continue to assess industry responses to the Special Fraud Alert and have and may continue to make modifications to certain aspects of our speaker programs, which may have a detrimental impact on our ability to educate healthcare providers about our products and to promote use of our products, and which may in turn lead to decreased product sales and negatively impact our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive healthcare legislation, signed into law in the United States in March 2010, titled the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Affordability Reconciliation Act of 2010, collectively, the ACA, imposes certain stringent compliance, recordkeeping, and reporting requirements on companies in various sectors of the life sciences industry, and enhanced penalties for non-compliance. Despite the ACA going into effect over a decade ago, there have been numerous legal and Congressional challenges to the law&#8217;s provisions and the effect of certain provisions have made compliance costly.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As 2025 ushers in a new presidential administration, we expect material changes in health policy, enforcement initiatives, and coverage and reimbursement for health care items and services. As such, our costs to monitor these changes and respond to new requirements will increase.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict what additional new legislation, agency priorities, and rulemaking may be on the horizon as the United States continue to reassess how it pays for healthcare. As a result, we cannot quantify or predict what impact any changes might have on our business and results of operations. However, any changes that lower reimbursement for our products could materially and adversely affect our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other legal, regulatory and commercial policy influences are subjecting our industry to significant changes, and we cannot predict what new regulations or policies will emerge from U.S. federal or state governments, international governments, or third-party payors. Government and commercial payors may, in the future, consider healthcare policies and proposals intended to curb rising healthcare costs, including those that could significantly affect reimbursement for healthcare products such as our systems. These policies have included, and may in the future include: basing reimbursement policies and rates on clinical outcomes, the comparative effectiveness, and costs, of different treatment technologies and modalities; imposing price controls and taxes on medical device providers; and other measures. Future significant changes in the healthcare systems in the United States or elsewhere could also have a negative impact on the demand for our current and future products. These include changes that may reduce </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reimbursement rates for our products and changes that may be proposed or implemented by the current or future laws or regulations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_88"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property Protection and Use</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to claims of infringement or misappropriation of the intellectual property rights of others, which could prohibit us from shipping affected products, require us to obtain licenses from third parties or to develop non-infringing alternatives, and subject us to substantial monetary damages and injunctive relief. We may also be subject to other claims or suits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Third parties have asserted in the past, and may assert in the future, infringement or misappropriation claims against us with respect to our current or future products. We are aware of numerous patents issued to third parties that may relate to aspects of our business, including the design and manufacture of CGM sensors and membranes, as well as methods for continuous glucose monitoring. Whether a product infringes a patent involves complex legal and factual issues, the determination of which is often uncertain. Therefore, we cannot be certain that we have not infringed the intellectual property rights of such third parties or others. Our competitors may assert that our CGM systems or the methods we employ in the use of our systems are covered by U.S. or international patents held by them. We have in the past settled some such allegations and may need to do so again in the future. This risk is exacerbated by the fact that there are numerous issued patents and pending patent applications relating to self-monitored glucose testing systems in the medical technology field. Because patent applications may take years to issue, there may be applications now pending of which we are unaware that may later result in issued patents that our products infringe. There could also be existing patents of which we are unaware that one or more components of our system may inadvertently infringe. As the number of competitors in the market for CGM systems grows, the possibility of patent infringement by us or a patent infringement claim against us increases. If we are unable to successfully defend any such claims as they may arise or enter into or extend settlement and license agreements on acceptable terms or at all, our business operations may be harmed. We have been involved in various patent infringement actions in the past. For example, we and certain Abbott entities previously served complaints for patent infringement, validity, and other patent-related actions against each other in multiple jurisdictions, inside and outside the United States. In December 2024, we entered into a Settlement and License Agreement with Abbott to settle all pending patent infringement legal proceedings brought by Abbott against us. See &#8220;Legal Proceedings&#8221; in Part I, Item 3 below for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any infringement or misappropriation claim could cause us to incur significant costs, place significant strain on our financial resources, divert management&#8217;s attention from our business and harm our reputation. In addition, if the relevant patents are upheld as valid and enforceable and we are found to infringe such patents, we could be prohibited from selling any of our products that is found to infringe unless we could obtain licenses to use the technology covered by the patent or are able to design around the patent. We may be unable to obtain a license on terms acceptable to us, if at all, and we may not be able to redesign our products to avoid infringement. We may be unable to maintain or renew licenses on terms acceptable to us, if at all, and we may be prohibited from selling any of our products that required the technology covered by the relevant licensed patents. Even if we are able to redesign our products to avoid an infringement claim, we may not receive FDA or international regulatory approval for such changes in a timely manner or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any adverse determination in litigation or interference proceedings to which we are or may become a party relating to patents or other intellectual property rights could subject us to significant liabilities to third parties or require us to seek licenses from other third parties. If we are found to infringe third-party patents, a court could order us to pay damages to compensate the patent owner for the infringement, such as a reasonable royalty amount and/or profits lost by the patent owners, along with prejudgment and/or post-judgment interest. Furthermore, if we are found to willfully infringe third-party patents, we could, in addition to other penalties, be required to pay treble damages; and if the court finds the case to be exceptional, we may be required to pay attorneys&#8217; fees for the prevailing party. If we are found to infringe third-party copyrights or trademarks or misappropriate third-party trade secrets, based on the intellectual property at issue, a court could order us to pay statutory damages, actual damages, or profits, such as reasonable royalty or lost profits of the owners, unjust enrichment, disgorgement of profits, and/or a reasonable royalty, and the court could potentially award attorneys&#8217; fees or exemplary or enhanced damages. Although patent and intellectual property disputes in the medical device area have often been settled through licensing or similar arrangements, costs associated with such arrangements may be substantial and would likely include ongoing royalties. We may be unable to obtain necessary intellectual property licenses on satisfactory terms. If we do not obtain any such necessary licenses, we may not be able to redesign our products to avoid infringement and any redesign may not receive FDA approval or other requisite marketing authorization in a timely manner or at all. Adverse determinations in a judicial or administrative proceeding or failure to obtain necessary intellectual property </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">licenses could prevent us from manufacturing and selling our products, which would have a significant adverse impact on our business. If litigation were to be initiated by intellectual property owners, there could significant legal fees and costs incurred in defending litigation (which may include filing administrative actions to attack the intellectual property) as well as a potential monetary settlement payment to the owners, even if the matter is resolved before going to trial. Moreover, the owners may take an overly aggressive approach and/or include multiple allegations in a single litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, from time to time, we are subject to various claims, complaints and legal actions arising out of the ordinary course of business, including commercial insurance, product liability or employment-related matters. Also, from time to time, we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment-related matters. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition or results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our inability to adequately protect our intellectual property could allow our competitors and others to produce products based on our technology, which could substantially impair our ability to compete.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success and our ability to compete depend, in part, upon our ability to maintain the proprietary nature of our technologies. We rely on a combination of patent, copyright and trademark law, and trade secrets and nondisclosure agreements to protect our intellectual property. However, such methods may not be adequate to protect us or permit us to gain or maintain a competitive advantage. Our patent applications may not issue as patents in a form that will be advantageous to us, or at all. Our issued patents, and those that may issue in the future, may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related products. In addition, there are numerous recent changes to the patent laws and proposed changes to the rules of the U.S. Patent and Trademark Office, which may have a significant impact on our ability to protect our technology and enforce our intellectual property rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To protect our proprietary rights, we may in the future need to assert claims of infringement against third parties. The outcome of litigation to enforce our intellectual property rights in patents, copyrights, trade secrets or trademarks is highly unpredictable, could result in substantial costs and diversion of resources, and could have a material adverse effect on our business, financial condition and results of operations regardless of the final outcome of such litigation. In the event of an adverse judgment, a court could hold that some or all of our asserted intellectual property rights are not infringed, or are invalid or unenforceable, and could award attorney fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite our efforts to safeguard our unpatented and unregistered intellectual property rights, we may not succeed in doing so or the steps taken by us in this regard may not be adequate to detect or deter misappropriation of our technology or to prevent an unauthorized third party from copying or otherwise obtaining and using our products, technology or other information that we regard as proprietary. In addition, third parties may be able to design around our patents. Furthermore, the laws of international countries may not protect our proprietary rights to the same extent as the laws of the United States.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_91"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Litigation Risks</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We face the risk of product liability claims and may be subject to damages, fines, penalties and injunctions, among other things.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business exposes us to the risk of product liability claims that is inherent in the testing, manufacturing and marketing of medical devices, including those which may arise from the misuse (including system hacking or other unauthorized access by third parties to our systems) or malfunction of, or design flaws in, our products. This liability may vary based on the FDA classification associated with our devices. Notably, the classification of our G6 and G7 systems as Class II medical devices is likely to weaken our ability to rely on federal preemption of state law claims that assert liability against us for harms arising from use of those systems. We may be subject to product liability claims if our products cause, or merely appear to have caused, an injury. Claims may be made by customers, healthcare providers or others selling our products. The risk of product liability claims may increase given that G6 and G7 do not require confirmatory finger sticks when making treatment decisions or finger stick tests each day for calibration, although it does require finger stick tests when symptoms do not match readings and when readings are unavailable. The risk of claims may also increase if our products are subject to a product recall or seizure. An example of the difficulty of complying with the regulatory requirements associated with the manufacture of our products, we issued notifications to our customers regarding the audible alarms and alerts associated with our receivers.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have insurance at levels that we believe is appropriate, this insurance is subject to deductibles and coverage limitations. Our current product liability insurance may not continue to be available to us on acceptable terms, if at all, and, if available, the coverage may not be adequate to protect us against any future product liability claims. Further, if additional products are approved for marketing, we may seek additional insurance coverage. If we are unable to obtain insurance at an acceptable cost or on acceptable terms with adequate coverage or otherwise protect against potential product liability claims, we will be exposed to significant liabilities, which may harm our business. A product liability claim, recall or other claims with respect to uninsured liabilities or for amounts in excess of insured liabilities could result in significant costs and significant harm to our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to claims against us even if the apparent injury is due to the actions of others or misuse of the device or a partner device. Our customers, either on their own or following the advice of their physicians, may use our products in a manner not described in the products&#8217; labeling and that differs from the manner in which it was used in clinical studies and approved by the FDA. For example, G6 and G7 are designed to be used by an individual continuously for up to 10 days, but the individual might be able to circumvent the safeguards designed into the systems and use the products for longer than 10 days. Off-label use of products by customers is common, and any such off-label use of our products could subject us to additional liability, or require design changes to limit this potential off-label use once discovered. In addition, other regulatory agencies may in the future approve similar diabetes treatment indications. We expect that such diabetes treatment indications could expose us to additional liability. These liabilities could prevent or interfere with our product commercialization efforts. Defending a suit, regardless of merit, could be costly, could divert management attention and might result in adverse publicity, which could result in the withdrawal of, or inability to recruit, clinical trial volunteers or result in reduced acceptance of our products in the market.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could become the subject of governmental investigations, claims and litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Healthcare companies are subject to numerous investigations and inquiries by various governmental agencies. Further, under the False Claims Act, private parties have the right to bring&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">qui tam</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or &#8220;whistleblower,&#8221; suits against companies that submit false claims for payments to, or improperly retain overpayments from, the government. Some states have adopted similar state whistleblower and false claims provisions. Depending upon whether the underlying conduct alleged in such inquiries or investigations could be considered systemic, any resolution of any such investigations could have a material, adverse effect on our financial position and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Governmental agencies and their agents, such as CMS Medicare Administrative Contractors and other CMS contractors, as well as the OIG, state Medicaid programs, and other state and federal agencies may conduct audits of our operations, relating to covered items and services including those furnished to beneficiaries, health care providers and distributors. Commercial and government-funded managed care payors may conduct similar post-payment audits. Depending on the nature of the conduct found in such audits and whether the underlying conduct could be considered systemic, the resolution of these audits could have a material adverse effect on our financial position and results of operations. Our compliance program includes internal audit and monitoring functions designed to identify potential issues and facilitate remediation as appropriate.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any future investigations of our executives, our managers or us could result in significant liabilities or penalties to us, as well as adverse publicity. Even if we are found to have complied with applicable law, the investigation or litigation may pose a considerable expense and would divert management&#8217;s attention, and have a potentially negative impact on the public&#8217;s perception of us, all of which could negatively impact our financial position and results of operations. Further, should we be found out of compliance with any of these laws, regulations or programs, depending on the nature of the findings, our business, our financial position and our results of operations could be negatively impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to fines, penalties and injunctions if we are determined to be promoting the use of our products for unapproved or improper off-label uses or determined to have made claims that are untruthful or misleading or not adequately substantiated.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our marketing, promotional and educational materials and practices are subject to FDCA, Federal Trade Commission Act, and other applicable laws and regulations, as may be amended from time to time. If the FDA, FTC or other regulatory body with competent jurisdiction over us, our activities or products takes the position that our marketing, promotional or other materials or activities constitute improper promotion or marketing of an unapproved or improper use, or that they contain untruthful, misleading, or inadequately substantiated statements or claims, such regulatory body could request that we modify our materials or practices, or subject us to regulatory enforcement actions, including the issuance, depending on the regulatory body and the nature of the alleged violation, of a warning letter, injunction, seizure, civil fine and criminal penalties. It is also possible that other federal, state or international enforcement authorities might take action if they consider promotional, marketing or other </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">materials or activities to constitute improper promotion of an unapproved use, which could result in significant fines or penalties under other statutory authorities, such as laws prohibiting false claims for reimbursement. Recent court decisions have impacted the FDA&#8217;s enforcement activity regarding off-label promotion in light of First Amendment considerations; however, there are still significant risks in this area in part due to the potential False Claims Act exposure and the FDA&#8217;s continued focus on ensuring devices are marketed in a manner consistent with their FDA-required labeling.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not actively promoting our G6 or G7 systems for inpatient use, but if we supply them to such facilities in the future, this supply could present an increased risk of product liability claims and associated damages should an adverse event occur. Given that the G6 and G7 systems have not yet been fully evaluated or tested (by us or by the FDA) to the extent that would be required in standard circumstances for product development and marketing authorization, there could be unknown or unanticipated risks presented by use in this environment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In some instances in our advertising and promotion, we may make claims regarding our product as compared to competing products, which may subject us to heightened regulatory scrutiny, enforcement risk, and litigation risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The FDA applies a heightened level of scrutiny to comparative claims when applying its statutory standards for advertising and promotion, including with regard to its requirement that promotional labeling be truthful and not misleading. There is potential for differing interpretations of whether certain communications are consistent with a product&#8217;s FDA-required labeling, and FDA will evaluate communications on a fact-specific basis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, making comparative claims may draw concerns from our competitors. Where a company makes a claim in advertising or promotion that its product is superior to the product of a competitor (or that the competitor&#8217;s product is inferior), this creates a risk of a lawsuit by the competitor under federal and state false advertising or unfair and deceptive trade practices law, and possibly also state libel law.&#160;Such a suit may seek injunctive relief against further advertising, a court order directing corrective advertising, and compensatory and punitive damages where permitted by law.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Direct-to-consumer marketing and social media efforts may expose us to additional regulatory scrutiny.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our efforts to promote our products via direct-to-consumer marketing and social media initiatives may subject us to additional scrutiny of our practices of effective communication of risk information, benefits or claims, under the oversight of the FDA, FTC, HHS-OCR, or others.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_94"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Other Risks Related to Our Business and Financial Condition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred significant losses in the past and may incur losses in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses in the past. We have financed our operations primarily through private and public offerings of equity securities and debt and the sales of our products. We have devoted substantial resources to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">research and development relating to our current and future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">sales and marketing and manufacturing expenses associated with the commercialization of our products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">expansion of our workforce.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our research and development expenses to increase in connection with our clinical trials and other development activities related to our products, including our next-generation sensors, transmitters and receivers, as well as other collaborations. We also expect that our general and administrative expenses will continue to increase due, among other things, to the additional operational and regulatory burdens applicable to public healthcare and medical device companies. As a result, it is possible that we could incur operating losses in the future. These losses, among other things, may have an adverse effect on our stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success will depend on our ability to attract and retain our personnel and manage our human capital, while controlling labor costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We depend to a significant degree on our senior management, especially Kevin Sayer, our President and Chief Executive Officer. Our success will depend on our ability to retain our senior management and to attract and retain qualified personnel in the future, including salespersons, scientists, clinicians, engineers and other highly skilled personnel. Competition for senior management personnel, as well as salespersons, scientists, clinicians and engineers, is intense and we may not be able to retain our personnel. The loss of the services of members of our senior management, scientists, clinicians or engineers could prevent the implementation and completion of our </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">objectives, including the commercialization of our current products and the development and introduction of additional products. The loss of a member of our senior management or our professional staff would require the remaining executive officers to divert immediate and substantial attention to seeking a replacement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each of our officers may terminate their employment at any time without notice and without cause or good reason. Additionally, volatility or a lack of positive performance in our stock price may adversely affect our ability to retain key employees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue to expand our operations and grow our research and development, manufacturing, sales and marketing, product development and administrative operations. We expect this expansion to place a significant strain on our management and it will require hiring a significant number of qualified personnel. Accordingly, recruiting and retaining such personnel will be critical to our success. There is intense competition from other companies and research and academic institutions for qualified personnel in the areas of our activities. If we fail to identify, attract, retain and motivate these skilled personnel, we may be unable to continue our development and commercialization activities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may undertake reorganizations of our workforce, which may result in a temporary reduction in the number of employees in certain locations. We would undertake a reorganization to reduce operating expenses or achieve other business objectives, though we cannot guarantee any specific amount of long-term cost savings. Further, the turnover in our employee base could result in operational and administrative inefficiencies, which could adversely impact the results of our operations, stock price and customer relationships, and could make recruiting for future management and other positions more difficult.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may conduct additional financings to continue the development or commercialization of our current or future products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since inception. We expect to continue to spend substantial amounts on commercialization of our products, including growth of our manufacturing capacity, on research and development, and conducting clinical trials for our future products. Although we raised substantial net proceeds through the private sale of our convertible notes, we could need funds to continue the commercialization of our current products and to develop and commercialize future products or pursue other strategic initiatives. Additional financing may not be available on a timely basis on terms acceptable to us, or at all. Any additional financing may be dilutive to stockholders or may require us to grant a lender a security interest in our assets. The amount of funding we may need will depend on many factors, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the revenue generated by sales of our products and other future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs, timing and risks of delay of additional regulatory approvals;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the expenses we incur in manufacturing, developing, selling and marketing our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our ability to scale our manufacturing operations to meet demand for our current and any future products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs to produce our continuous glucose monitoring systems;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the rate of progress and cost of our clinical trials and other development activities;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the success of our research and development efforts;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the emergence of competing or complementary technologies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms and timing of any current or collaborative, licensing and other similar arrangements;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of ongoing compliance with legal and regulatory requirements, and third-party payors&#8217; policies;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the cost of obtaining and maintaining regulatory or payor clearance or approval for our current or future products including those integrated with other companies&#8217; products; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the acquisition of business, products and technologies, although we currently have no commitments or agreements relating to any of these types of transactions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If adequate funds are not available, we may not be able to commercialize our products at the rate we desire and/or we may have to delay the development or commercialization of our products or license to third parties the rights to commercialize products or technologies that we would otherwise seek to commercialize. We also may have to reduce sales, marketing, customer support or other resources devoted to our products. Any of these factors could harm our business and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Uncollectible uninsured and patient due accounts could adversely affect our results of operations.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary collection risks for our accounts receivable relate to the uninsured patient accounts and patient accounts for which the primary insurance carrier has paid the amounts covered by the applicable agreement, but patient responsibility amounts (exclusions, deductibles and copayments) remain outstanding. In addition, as a result of recent economic conditions, some customers have, and others may, lose access to their private health insurance plan if they lose their job. As most of our customers rely on third-party payors, including private health insurance plans, to cover the cost of our products, there has been, and may continue to be, a shift in financial responsibility to our customers for the amounts previously covered by their primary insurance carrier.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event that we are unsuccessful in collecting payments owed by patients, and/or experience increases in the amount, or deterioration in the collectability, of uninsured and patient due accounts receivable, this could adversely affect our cash flows and results of operations. We may also be adversely affected by the growth in patient responsibility accounts, as a result of increases in the adoption of plan structures, due to evolving health care policy and insurance landscapes that shift greater responsibility for care to individuals through greater exclusions, prior authorizations, and copayment and deductible amounts.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in our business strategy or restructuring of our businesses may increase our costs or otherwise affect the profitability of our businesses or the value of our assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As changes in our business environment occur we have adjusted, and may further, adjust our business strategies to meet these changes and we may otherwise decide to further restructure our operations or particular businesses or assets. Our new organization and strategies may not produce the anticipated benefits, such as supporting our growth strategies and enhancing shareholder value. Our new organization and strategies could be less successful than our previous organizational structure and strategies. In addition, external events including changing technology, changing consumer patterns, acceptance of our products and changes in macroeconomic conditions may impair the value of our assets. When these changes or events occur, we may incur costs to change our business strategy and may need to write-down the value of assets. For example, current economic conditions, including relatively high interest rates, inflation and potential economic slowdowns, as well as our business decisions, may reduce the value of some of our assets. We also make investments in existing or new businesses, including investments in the international expansion of our sales efforts and the build-out of our manufacturing facility in Malaysia and the construction of a new facility in Ireland. Additionally, we also invest in early to late-stage companies for strategic reasons and to support key business initiatives, and we may not realize a return on our equity investments. Many such companies generate net losses and the market for their products, services, or technologies may be slow to develop or never materialize. We are subject to risks associated with our equity investments including partial or complete loss of invested capital, and significant changes in the fair value of this portfolio could adversely impact our financial results. Some of these investments may have returns that are negative or low, the ultimate business prospects of the businesses related to these investments may be uncertain, and these risks may be exacerbated by current macroeconomic conditions. In any of these events, our costs may increase or returns on new investments may be lower than prior to the change in strategy or restructuring.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_97"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.222%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Relating to Our Public Company Status, Tax Laws and Growth Through Acquisition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may face risks associated with acquisitions of companies, products and technologies and our business could be harmed if we are unable to address these risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are presented with appropriate opportunities, we could acquire or make other investments in complementary companies, products or technologies. We may not realize the anticipated benefit of our acquisitions, or the realization of the anticipated benefits may require greater expenditures than anticipated by us. We will likely face risks, uncertainties and disruptions associated with the integration process, including difficulties in the integration of the operations and services of any acquired company, integration of acquired technology with our products, diversion of our management&#8217;s attention from other business concerns, the potential loss of key employees or customers of the acquired businesses and impairment charges if future acquisitions are not as successful as we originally anticipated. If we fail to successfully integrate other companies, products or technologies that we acquire, our business could be harmed. Furthermore, we may have to incur debt or issue equity or equity-linked securities to pay for any future acquisitions or investments, the issuance of which could be dilutive to our existing stockholders. In addition, our operating results may suffer because of acquisition-related costs, amortization expenses or charges relating to acquired intangible assets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance with regulations relating to public company corporate governance matters and reporting may strain our resources and divert management&#8217;s attention.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many laws and regulations, notably those adopted in connection with the Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, new SEC regulations and The Nasdaq Stock Market listing rules, impose obligations on public companies, such as ours, which have increased the scope, complexity and cost of corporate governance, reporting and disclosure practices. Compliance with these laws and regulations, including enhanced new disclosures, has required and will continue to require substantial management time and oversight and the incurrence of significant accounting and legal costs. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may require us to incur greater accounting fees. These laws, regulations, and standards are subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices. We intend to continue to invest resources to comply with evolving laws, regulations, and standards, and this investment may result in increased general and administrative expenses and a diversion of management&#8217;s time and attention from revenue-generating activities to compliance activities. If our efforts to comply with new laws, regulations, and standards differ from the activities intended by regulatory or governing bodies due to ambiguities related to their application and practice, regulatory authorities may initiate legal proceedings against us and our business may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to changes in our tax rates, new U.S. or international tax legislation or additional tax liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to taxes in the United States and numerous international jurisdictions, where a number of our subsidiaries are organized. The tax laws in the United States and in other countries in which we and our subsidiaries do business could change on a prospective or retroactive basis, and any such changes could adversely affect our business and financial condition. Further, due to economic and political conditions, tax rates in various jurisdictions may be subject to change. Our effective tax rates could be affected by numerous factors, including changes in the mix of earnings in countries with differing statutory tax rates, changes in the valuation of deferred tax assets and liabilities, and changes in tax laws or their interpretation, both in and outside the United States, including as a result of the recent change in presidential administration in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is growing pressure in many jurisdictions, including the United States, and from multinational organizations such as the OECD and the European Union to amend existing international tax rules in order to render them more responsive to current global business practices. For example, the OECD has published a package of measures for reform of the international tax rules as a product of its BEPS initiative, which was endorsed by the G20 finance ministers. Many of the initiatives in the BEPS package require amendments to the domestic tax legislation of various jurisdictions. Separately, the European Union is asserting that a number of country-specific favorable tax regimes and rulings in certain member states may violate, or have violated, European Union law, and may require rebates of some or all of the associated tax benefits to be paid by benefited taxpayers in particular cases. In 2016, the European Union adopted the &#8220;Anti-Tax Avoidance Directive,&#8221; which requires European Union member states to implement measures to prohibit tax avoidance practices, and Germany published the European Union Anti-Tax Avoidance Directive Implementation Law on June 30, 2021. We have a significant presence in the European Union, as well as significant sales in the European Union, such that any changes in tax laws in the European Union could impact our business. The overall impact of such legislation in European Union member states is uncertain, and our business and financial condition could be adversely affected by any laws impacting our tax rate. The U.S. government enacted comprehensive tax legislation that included significant changes to the taxation of business entities. These changes included, among others, (I) a permanent reduction to the corporate income tax rate, (ii) a partial limitation on the deductibility of business interest expense, (iii) a shift of the U.S. taxation of multinational corporations from a tax on worldwide income to a territorial system (along with certain rules designed to prevent erosion of the U.S. income tax base) and (iv) a one-time tax on accumulated offshore earnings held in cash and illiquid assets, with the latter taxed at a lower rate.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October 8, 2021, the OECD announced the OECD/G20 Inclusive Framework on BEPS which agreed to a two-pillar solution to address tax challenges arising from digitalization of the economy. On December 20, 2021, the OECD released Pillar Two Model Rules defining the global minimum tax rules, which contemplate a 15% minimum tax rate. The OECD continues to release additional guidance on these rules and the Framework calls for law enactment by OECD and G20 members to take effect in 2024 or 2025. These changes, when enacted by various countries in which we do business, may increase our taxes in these countries. Changes to these and other areas in relation to international tax reform, including future actions taken by international governments, could increase uncertainty and may adversely affect our tax rate and cash flow in future years.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our tax returns and other tax matters also are subject to examination by the U.S. Internal Revenue Service and other tax authorities and governmental bodies. We regularly assess the likelihood of an adverse outcome resulting from these examinations to determine the adequacy of our provision for taxes. We cannot guarantee the outcome of these examinations. If our effective tax rates were to increase, particularly in the United States, or in other countries implementing legislation to reform existing tax legislation, including the European Union and Germany, or if the ultimate determination of our taxes owed is for an amount in excess of amounts previously accrued, our financial condition, operating results and cash flows could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use our net operating losses to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to use our net operating losses, or NOLs, to offset future taxable income may be subject to certain limitations which could subject our business to higher tax liability. We may be limited in the portion of NOL carryforwards that we can use in the future to offset taxable income for U.S. federal and state income tax purposes, and federal tax credits to offset federal tax liabilities. Sections 382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state law provisions, limit the use of NOLs and tax credits after a cumulative change in corporate ownership of more than 50% occurs within a three-year period. The statutes place a formula limit on how much NOLs and tax credits a corporation can use in a tax year after a change in ownership. Avoiding an ownership change is generally beyond our control. Although the ownership changes we experienced in the past have not prevented us from using all NOLs and tax credits accumulated before such ownership changes, we could experience another ownership change that might limit our use of NOLs and tax credits in the future. In addition, realization of deferred tax assets, including net operating loss carryforwards, depends upon our future earnings in applicable tax jurisdictions. If we have insufficient future taxable income in the applicable tax jurisdiction for any reason, including any future corporate reorganization or restructuring activities, we may be limited in our ability to utilize some or all of our net operating losses to offset such income and reduce our tax liability in that jurisdiction. We utilized the majority of our remaining NOLs by the end of 2021, with the exception of the NOLs limited by Section 382 of the Internal Revenue Code of 1986. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that due to regulatory changes or changes to federal or state law, such as suspensions on the use of NOLs, or other unforeseen reasons, our existing NOLs could expire or otherwise be unavailable either in whole or in part to offset future income tax liabilities. For example, under the Coronavirus Aid, Relief, and Economic Security Act of 2020, or CARES Act, which amended certain provisions of the Tax Cuts and Jobs Act of 2017, or TCJA, NOLs arising in taxable years beginning after December 31, 2017 and before January 1, 2021 may be carried back to each of the five taxable years preceding the tax year of such loss, but NOLs arising in taxable years beginning after December 31, 2020 may not be carried back. The TCJA, as amended by the CARES Act, also provides that NOLs from tax years that began after December 31, 2017 may offset no more than 80% of current taxable income annually for taxable years beginning after December 31, 2020. Additionally, in June 2024, the State of California enacted S.B. 167, which suspends the use of NOLs for the tax period from January 1, 2024 to December 31, 2026 for net business income of $1.0 million or more, as well as limits the utilization of research and development tax credits to $5.0 million each year. The State of California also passed S.B. 175 to provide for a potential early sunset of NOLs in either 2025 or 2026 if necessary. See Note 8 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for additional information.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_100"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Common Stock</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our stock price is highly volatile and investing in our stock involves a high degree of risk, which could result in substantial losses for investors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, the market price of our common stock, like the securities of many other medical products companies, fluctuates and could continue to be volatile in the future, especially as our business continues to grow and our business plan continues to evolve. From January&#160;1, 2024 through December&#160;31, 2024, the closing price of our common stock on the Nasdaq Global Select Market was as high as $140.45 per share and as low as $64.00 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The market price of our common stock is influenced by many factors that are beyond our control, including the following:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">securities analyst coverage or lack of coverage of our common stock or changes in their estimates of our financial performance;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">actual or anticipated variations in financial condition and operating results;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">future sales of our common stock by our stockholders;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">investor perception of us and our industry;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">announcements by us or our competitors of significant agreements, acquisitions, or capital commitments or product launches or discontinuations;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">changes in market valuation or earnings of our competitors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">material business or financial announcements regarding our partners;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">general economic conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">regulatory actions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">legislation and political conditions;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global health pandemics, such as the COVID-19 pandemic;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the consummation of, and anticipated benefits of, our share repurchase programs; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">other events or factors, including the ongoing international conflicts, recessions, rising interest rates, inflation, local and national elections, international currency fluctuations, corruption, political instability and acts of war or terrorism</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please also refer to the factors described elsewhere in this &#8220;Risk Factors&#8221; section. In addition, the stock market in general has experienced extreme price and volume fluctuations that have often been unrelated and disproportionate to the operating performance of companies in our industry. These broad market and industry factors may materially reduce the market price of our common stock, regardless of our operating performance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities class action litigation has often been brought against public companies that experience periods of volatility in the market prices of their securities. For example, we have pending securities class action litigation and a derivative action pending against us. Securities class action litigation could result in substantial costs and a diversion of our management&#8217;s attention and resources, which could seriously harm our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The issuance of shares by us in the future or sales of shares by our stockholders may cause the market price of our common stock to drop significantly, even if our business is performing well.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This issuance of shares by us in the future, including by conversion of our senior convertible notes in certain circumstances, or sales of shares by our stockholders may cause the market price of our common stock to decline, perhaps significantly, even if our business is performing well. The market price of our common stock could also decline if there is a perception that sales of our shares are likely to occur in the future. This might also make it more difficult for us to sell securities in the future at a time and at a price that we deem appropriate. Also, we may issue securities in connection with future financings and acquisitions, and those shares could dilute the holdings of other stockholders.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not intend to pay dividends for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future and the terms of our credit agreement restrict our ability to declare or pay any dividends. As a result, stockholders (including holders of our senior convertible notes who receive shares of our common stock, if any, upon conversion of their notes) may only receive a return on their investment in our common stock if the market price of our common stock increases.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover effects of our charter documents and Delaware law could make a merger, tender offer or proxy contest difficult, thereby depressing the trading price of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are provisions in our certificate of incorporation and bylaws, as well as provisions in the Delaware General Corporation Law, that may discourage, delay or prevent a change of control that might otherwise be beneficial to stockholders. For example:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our Board of Directors may, without stockholder approval, issue shares of preferred stock with special voting or economic rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders do not have cumulative voting rights;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a special meeting of stockholders may only be called by a majority of our Board of Directors, upon direction of the Chairman of our Board of Directors, our Chief Executive Officer, our President or our Lead Independent Director, or a majority of our Board of Directors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our stockholders may not take action by written consent; and</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">we require advance notice for nominations for election to the Board of Directors or for proposing matters that can be acted upon by stockholders at stockholder meetings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all claims brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Our bylaws provide that the federal district courts of the United States will, to the fullest extent permitted by law, be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, or a Federal Forum Provision. Our decision to adopt a Federal Forum Provision followed a decision by the Supreme Court of the State of Delaware holding that such provisions are facially valid under Delaware law. While there can be no assurance that federal or state courts will follow the holding of the Delaware Supreme Court or determine that the Federal Forum Provision should be enforced in a particular case, application of the Federal Forum Provision means that suits brought by our stockholders to enforce any duty or liability created by the Securities Act must be brought in federal court and cannot be brought in state court. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all claims brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder. Neither the exclusive forum provision nor the Federal Forum Provision applies to suits brought to enforce any duty or liability created by the Exchange Act. Accordingly, actions by our stockholders to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder must be brought in federal court.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, our stockholders will not be deemed to have waived our compliance with the federal securities laws and the regulations promulgated thereunder.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring or holding any interest in any of our securities shall be deemed to have notice of and consented to our exclusive forum provisions, including the Federal Forum Provision. The exclusive forum provisions may limit a stockholder&#8217;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or any of our directors, officers, or other employees, which may discourage lawsuits with respect to such claims. Alternatively, if a court were to find the choice of forum provisions contained in our restated certificate of incorporation or amended and restated bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results, and financial condition.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, Section 203 of the Delaware General Corporation Law may discourage, delay, or prevent a change of control of our company. Section 203 imposes certain restrictions on mergers, business combinations, and other transactions between us and holders of 15% or more of our common stock.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_103"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Our Debt</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Increasing our financial leverage could affect our operations and profitability.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to our Second Amended and Restated Credit Agreement, or the Amended Credit Agreement, with JPMorgan Chase and other syndicate lenders, which amended and restated the credit agreement, or the Credit Agreement, we had previously entered into in December 2018 and amended in May 2020 and October 2021, respectively. The Amended Credit Agreement is a five-year $200.0 million revolving credit facility, or the Credit Facility. As of December&#160;31, 2024, we had no outstanding borrowings, $7.7 million in outstanding letters of credit, and a total available balance of $192.3 million under the Amended Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leverage ratio may affect the availability to us of additional capital resources as well as our operations in several ways, including:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the terms on which credit may be available to us could be less attractive, both in the economic terms of the credit and the legal covenants;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible lack of availability of additional credit;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the potential for higher levels of interest expense to service or maintain our outstanding debt;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possibility of additional borrowings in the future to repay our indebtedness when it comes due; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the possible diversion of capital resources from other uses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement expires in 2026. While we believe we will have the ability to service our debt, extend the term of the credit agreement, and/or obtain additional resources in the future if and when needed, that will depend upon our results of operations and financial position at the time, the then-current state of the credit and financial markets, and other factors that may be beyond our control. Therefore, we cannot give assurances that sufficient credit will be available on terms that we consider attractive, or at all, if and when necessary or beneficial to us.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with covenants in the Amended Credit Agreement could result in our inability to borrow additional funds and adversely impact our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amended Credit Agreement imposes numerous financial and other restrictive covenants on our operations, including covenants relating to our general profitability and our liquidity. As of December&#160;31, 2024, we were in compliance with the covenants imposed by the Amended Credit Agreement. If we violate these or any other covenants, any outstanding amounts under the Amended Credit Agreement could become due and payable prior to their stated maturity dates, each lender could proceed against any collateral in our operating accounts and our ability to borrow funds in the future may be restricted or eliminated. These restrictions may also limit our ability to borrow additional funds and pursue other business opportunities or strategies that we would otherwise consider to be in our best interests.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have indebtedness in the form of convertible senior notes, which could adversely affect our financial health and our ability to respond to changes in our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, we completed an offering of approximately $1.21 billion aggregate principal amount of 0.25% senior convertible notes due 2025, or 2025 Notes, which offering we refer to as the 2020 Notes Offering. In May 2023, we completed an offering of approximately $1.25 billion aggregate principal amount of 0.375% senior convertible notes due 2028, or 2028 Notes, which offering we refer to as the 2023 Notes Offering. We refer to the 2020 Notes Offering and the 2023 Notes Offering, collectively, as the Notes Offerings, and we refer to the 2025 Notes and the 2028 Notes, collectively, as the Notes. As a result of the Notes Offerings, we incurred $2.46 billion principal amount of indebtedness, the principal amount of which we may be required to pay at maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their notes upon the occurrence of a fundamental change (as defined in the indenture for each of the Notes) at a purchase price equal to 100% of the principal amount of the notes to be purchased, plus accrued and unpaid interest, if any. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. There can be no assurance that we will be able to repay this indebtedness when due, or that we will be able to refinance this indebtedness on acceptable terms or at all.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our level of debt may:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">heighten our vulnerability to adverse general economic conditions and competitive pressures;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">require us to dedicate a larger portion of our cash flow from operations to interest payments, limiting the availability of cash for other purposes;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">limit our flexibility in planning for, or reacting to, changes in our business and industry; and</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">impair our ability to obtain additional financing in the future for working capital, capital expenditures, acquisitions, general corporate purposes or other purposes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot be sure that our leverage will not materially and adversely affect our ability to finance our operations or capital needs or to engage in other business activities. In addition, we cannot be sure that additional financing will be available when required or, if available, will be on terms satisfactory to us. Further, even if we are able to obtain additional financing, we may be required to use such proceeds to repay a portion of our debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be unable to repurchase the Notes upon a fundamental change when required by the holders or repay prior to maturity any accelerated amounts due under the notes upon an event of default or redeem the Notes unless specified conditions are met under our Credit Facility, and our future debt may contain additional limitations on our ability to pay cash upon conversion, repurchase or repayment of the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes will have the right to require us to repurchase their Notes upon the occurrence of a fundamental change at a purchase price equal to 100% of the principal amount of the Notes to be purchased, plus accrued and unpaid interest, if any, to, but not including, the fundamental change purchase date. In addition, each indenture for the Notes provides that we are required to repay amounts due under each indenture in the event that there is an event of default for the Notes that results in the principal, premium, if any, and interest, if any, becoming due prior to the maturity date for the Notes. In addition, upon conversion of the Notes, unless we elect to deliver solely shares of our common stock to settle such conversion (other than cash in lieu of any fractional share), we will be required to make cash payments in respect of the Notes being converted. However, we may not have enough available cash or be able to obtain financing at the time we are required to repurchase Notes surrendered upon a fundamental change or repay prior to maturity any accelerated amounts or pay cash for Notes being converted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our ability to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes upon an event of default or pay cash upon conversions of the Notes may be limited by law, by regulatory authority </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">or by agreements governing our indebtedness outstanding at the time, including our Credit Facility. Under our Credit Facility, we are only permitted to use cash to purchase the Notes or repay prior to maturity any accelerated amounts under the Notes if we meet certain conditions that are defined under the Credit Agreement. We may not meet these conditions in the future. Our failure to repurchase Notes at a time when the repurchase is required by the respective indenture (whether upon a fundamental change or otherwise under each indenture) or pay cash payable on future conversions of the Notes as required by the indenture would constitute a default under each indenture. A default under each indenture or the fundamental change itself could also lead to a default under agreements governing our existing or future indebtedness, including our Credit Facility. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness, repurchase the Notes or make cash payments upon conversions thereof.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may still incur substantially more debt or take other actions which would intensify the risks discussed above.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may incur substantial additional debt in the future, subject to the restrictions contained in our debt instruments, some of which may be secured debt. We are not restricted under the terms of the indentures governing the Notes from incurring additional debt, securing existing or future debt, recapitalizing our debt, or taking a number of other actions that are not limited by the terms of the indenture governing the convertible senior notes that could have the effect of diminishing our ability to make payments on the Notes when due.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The capped call transactions we entered into in connection with the pricing of the 2028 Notes may affect the value of our 2028 Notes and common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the pricing of the 2028 Notes, we entered into capped call transactions, or the 2028 Capped Calls, relating to such 2028 Notes with the option counterparties. The 2028 Capped Calls relating to the 2028 Notes cover, subject to customary adjustments, the number of shares of our common stock that initially underlie the 2028 Notes. The 2028 Capped Calls are generally expected to reduce the potential dilution to stockholders upon any conversion of the 2028 Notes, and/or offset any cash payments that we are required to make in excess of the principal amount upon any conversion of the 2028 Notes, with such reduction and/or offset subject to a cap.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock in secondary market transactions following the pricing of the 2028 Notes, as applicable, and prior to the maturity of the 2028 Notes (and are likely to do so during any observation period related to a conversion of such Notes or following any repurchase of such notes by us on any fundamental change repurchase date or otherwise). This activity could also cause or avoid an increase or a decrease in the market price of our 2028 Notes or common stock, which could affect a holder&#8217;s ability to convert its 2028 Notes and, to the extent the activity occurs during any observation period related to a conversion of the 2028 Notes, it could affect the amount and value of the consideration that a holder will receive upon conversion of such 2028 Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The potential effect, if any, of these transactions and activities on the market price of the 2028 Notes or our common stock will depend in part on market conditions and cannot be ascertained at this time. Any of these activities could adversely affect the value of 2028 Notes or our common stock (and as a result, the amount and value of the consideration that a holder would receive upon the conversion of any 2028 Notes) and, under certain circumstances, a holder&#8217;s ability to convert its notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to counterparty risk with respect to the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The option counterparties to the 2028 Capped Calls are financial institutions, and we will be subject to the risk that any or all of them may default under the 2028 Capped Calls. Our exposure to the credit risk of these counterparties is not secured by any collateral. Recent global economic conditions have resulted in the actual or perceived failure or financial difficulties of many financial institutions. If a counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings, with a claim equal to our exposure at that time under our transactions with that option counterparty. Our exposure will depend on many factors but, generally, an increase in our exposure will be correlated to an increase in the market price and in the volatility of our common stock. In addition, upon a default by an option counterparty, we may suffer adverse tax consequences and more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the counterparties with respect to the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Servicing our debt requires a significant amount of cash, and we may not have sufficient cash flow from our business to pay our substantial debt.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to make scheduled payments of the principal of, to pay interest on or to refinance our indebtedness, including the Notes, depends on our future financial condition and operating performance, which is subject to </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">economic, financial, competitive and other factors beyond our control. Our business may not continue to generate cash flow from operations in the future sufficient to satisfy our obligations under the Notes, our existing indebtedness and any future indebtedness we may incur and to make necessary capital expenditures. We may not maintain a level of cash flows from operating activities sufficient to permit us to pay the principal, premium, if any, and interest on (as well as any cash due upon conversion of) our debt, including the Notes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to generate such cash flow, we may be required to adopt one or more alternatives, such as reducing or delaying investments or capital expenditures, selling assets, refinancing or obtaining additional equity capital on terms that may be onerous or highly dilutive. These alternative measures may not be successful and may not permit us to meet our scheduled debt servicing obligations. Further, we may need to refinance all or a portion of our debt on or before maturity, and our ability to refinance the Notes, existing indebtedness or future indebtedness will depend on the capital markets and our financial condition at such time. We may not be able to engage in any of these activities on commercially reasonable terms or at all, which could result in a default on the Notes or our current and future indebtedness.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Amended Credit Agreement imposes restrictions on us that may adversely affect our ability to operate our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Amended Credit Agreement contains restrictive covenants relating to our capital raising activities and other financial and operational matters which may make it more difficult for us to obtain additional capital and to pursue business opportunities, including potential acquisitions. In addition, our Amended Credit Agreement and the agreements governing the Notes each contain cross-default provisions whereby a default under one agreement would likely result in cross defaults under agreements covering other borrowings. For example, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $50.0 million, in the case of the 2025 Notes, and $50.0 million, in the case of the 2028 Notes, that causes such indebtedness to become due prior to its scheduled maturity date would cause a cross-default under the indenture governing the Notes. In addition, the occurrence of a default with respect to any indebtedness or any failure to repay debt when due in an amount in excess of $25.0 million that causes such indebtedness to become due prior to its scheduled maturity date would cause a default under our Amended Credit Agreement. The occurrence of a default under any of these borrowing arrangements would permit the holders of the Notes or the lenders under our Amended Credit Agreement to declare all amounts outstanding under those borrowing arrangements to be immediately due and payable. If the Note holders or the trustee under the indenture governing the Notes or the lenders under our Amended Credit Agreement accelerate the repayment of borrowings, we cannot assure you that we will have sufficient assets to repay those borrowings.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion of the Notes will, to the extent we deliver shares upon conversion of such Notes, dilute the ownership interest of existing stockholders, including holders who had previously converted their Notes, or may otherwise depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The conversion of some or all of the Notes will dilute the ownership interests of existing stockholders to the extent we deliver shares upon conversion of any of the Notes. Any sales in the public market of the common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of the Notes may encourage short selling by market participants because the conversion of the Notes could be used to satisfy short positions, or anticipated conversion of the Notes into shares of our common stock could depress our stock price.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The conditional conversion feature of the Notes, if triggered, may adversely affect our financial condition and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than cash in lieu of any fractional share), we would be required to settle a portion or all of our conversion obligation through the payment of cash, which could adversely affect our liquidity. In addition, even if holders of the Notes do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The accounting method for convertible debt securities that may be settled in cash, such as the Notes, may have a material effect on our reported financial results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the conditional conversion feature of the Notes is triggered, holders of the Notes will be entitled to convert the Notes at any time during specified periods at their option. If one or more holders elect to convert their Notes, unless </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">we elect to satisfy our conversion obligation by delivering solely shares of our common stock (other than by paying cash in lieu of delivering any fractional share), we may settle all or a portion of our conversion obligation in cash, which could adversely affect our liquidity. In addition, the consideration received upon the unwind or termination of the capped call transactions may not completely offset, and may be substantially less than, any cash payments in excess of the principal amount of the Notes we are required to make upon conversion of the Notes. Even if holders do not elect to convert their Notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of the Notes as a current rather than long-term liability, which would result in a material reduction of our net working capital.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The fundamental change repurchase feature of the Notes may delay or prevent an otherwise beneficial attempt to take over Dexcom.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms of the Notes require us to repurchase the Notes in the event of a fundamental change. A takeover of Dexcom would trigger an option of the holders of the Notes to require us to repurchase the Notes. In addition, if a make-whole fundamental change occurs prior to the maturity date of the Notes, we will in some cases be required to increase the conversion rate for a holder that elects to convert its Notes in connection with such make-whole fundamental change. Furthermore, each indenture for the Notes prohibits us from engaging in certain mergers or acquisitions unless, among other things, the surviving entity assumes our obligations under the notes. These and other provisions of each indenture may have the effect of delaying or preventing a takeover of Dexcom.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_106"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.029%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Risks Related to Environmental, Social and Governance Matters</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sustainability (including environmental, social and governance) regulations, policies and provisions could expose us to numerous risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increasingly, regulators, customers, investors, employees and other stakeholders are focusing on sustainability matters relating to businesses, including climate change and greenhouse gas emissions, human and civil rights, and diversity, equity and inclusion. These changing rules, regulations and stakeholder expectations may differ and conflict, and have resulted in, and are likely to continue to result in, increased general and administrative expenses and increased management time and attention spent complying with or meeting such regulations and expectations. Collecting, measuring and reporting sustainability-related data and information is subject to evolving reporting standards, including state climate-related reporting requirements, the EU&#8217;s environmental, social and governance-related disclosure requirements set forth in the Corporate Sustainability Reporting Directive, and similar proposals by other international regulatory bodies. We will also be subject to reporting requirements in California covering disclosure of greenhouse gas emissions data, climate-related financial risks, and details around emissions-related claims and carbon offsets. If our sustainability-related data, information, processes or reporting are incomplete or inaccurate, it could result in adverse regulatory consequences and/or our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, a number of governments are considering due diligence procedures to ensure strict compliance with environmental, labor, and government regulations. For example, the European Union has recently proposed broad due diligence reporting requirements for all industries operating within Europe. In addition, a number of our upstream and downstream stakeholders in our value chain have adopted, or may adopt, procurement policies that include sustainability provisions that their business partners must comply with, or they may seek to include such provisions in their terms and conditions. An increasing number of participants in the medical device industry are also joining voluntary sustainability groups or organizations, such as the Responsible Business Alliance. These sustainability regulations, provisions and initiatives are subject to change, can be unpredictable and conflicting, and may be difficult, expensive and time consuming for us to comply with, given the complexity of our value chain and the outsourced manufacturing of certain components of our products. If we are unable to comply, or are unable to cause our upstream and downstream stakeholders to comply, with such regulations, policies or provisions, it may impact our ability to do business, or otherwise present barriers to entry, which could harm our reputation, revenue and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business could be negatively impacted by evolving expectations and challenges relating to implementing sustainability (including environmental, social and governance) initiatives, setting sustainability-related goals, collecting sustainability-related data, and disclosing sustainability-related information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may communicate certain initiatives and, in the future, may communicate goals regarding sustainability-related matters (including environmental, social and governance) in our SEC filings or in other public disclosures. These sustainability-related initiatives and goals could be difficult and expensive to implement, the technologies needed to implement them may not be cost effective and may not advance at a sufficient pace, and we could be criticized for </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the accuracy, adequacy or completeness of the disclosure. Further, statements about our sustainability-related initiatives and any future sustainability-related goals, and progress against any future sustainability-related goals, may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change and audit in the future based on evolving standards, frameworks, and regulations. In addition, we could be criticized for the scope or nature of such initiatives or goals, or for any revisions to these goals. If our sustainability-related data, processes and reporting are incomplete or inaccurate, or if we fail to achieve progress with respect to any future sustainability-related goals on a timely basis, or at all, we could experience adverse regulatory consequences and/or our reputation, business, financial performance and growth could be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Climate change may have a long-term impact on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we seek to partner with organizations that mitigate their business risks associated with climate change, we recognize that there are inherent risks related to climate change wherever business is conducted. Ensuring business resiliency through mitigating risks related to climate change in the communities where we conduct our business is a priority, whether for our offices or for our stakeholders. Our manufacturing sites in California, Arizona and Malaysia and our operations in the Philippines are vulnerable to climate change effects. For example, in California and Arizona, increasing intensity of droughts throughout the states and annual periods of wildfire danger increase the probability of planned and unplanned power outages in the communities where we work and live. While this danger has a low-assessed risk of disrupting normal business operations, it has the potential impact on employees&#8217; abilities to commute to work or to work from home and stay connected effectively. Climate-related events, including the increasing frequency of extreme weather events and their impact on the U.S., the Philippines, Malaysia and other major regions&#8217; critical infrastructure, have the potential to disrupt our business, our third-party suppliers, and/or the business of our customers, and may cause us to experience higher attrition, losses, and additional costs to maintain or resume operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be liable for contamination or other harm caused by materials that we handle, and changes in environmental regulations could cause us to incur additional expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development and clinical processes involve the handling of potentially harmful biological materials as well as hazardous materials. We are subject to international and domestic (including federal, state and local) laws, rules and regulations governing the use, handling, storage and disposal of hazardous and biological materials and we incur expenses relating to compliance with these laws and regulations. If violations of environmental, health and safety laws occur, we could be held liable for damages, penalties and costs of remedial actions. These expenses or this liability could have a significant negative impact on our financial condition. We may violate environmental, health and safety laws in the future as a result of human error, equipment failure or other causes. Environmental laws could become more stringent over time, imposing greater compliance costs and increasing risks and penalties associated with violations. We are subject to potentially conflicting and changing regulatory agendas of political, business and environmental groups. Changes to or restrictions on permitting requirements or processes, hazardous or biological material storage or handling might require unplanned capital investment or relocation. Failure to comply with new or existing laws or regulations could harm our business, financial condition and results of operations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_109"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-bottom:1pt solid #58a618;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:115%">General Risk Factors</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Current uncertainty in domestic and global economic and political conditions makes it particularly difficult to predict product demand and other related matters and makes it more likely that our actual results could differ materially from expectations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations and performance depend on worldwide economic and political conditions. These conditions have been adversely impacted by continued global economic uncertainty, political instability and military hostilities in multiple geographies, monetary and financial uncertainties in Europe and other international countries, global health pandemics, rising interest rates, and domestic and global inflationary trends. These include potential reductions in the overall stability and suitability of the Euro as a single currency, given the economic and political challenges facing individual Eurozone countries. These conditions have made and may continue to make it difficult for our customers and potential customers to afford our products, and could cause our customers to stop using our products or to use them less frequently. If that were to occur, our revenue may decrease and our performance may be negatively impacted. We expect continued uncertainty and potential political disputes between countries, which could have adverse operation and economic impacts on our business.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the pressure on consumers to absorb more of their own health care costs has resulted in some cases in higher deductibles and limits on durable medical equipment, which may cause seasonality in purchasing patterns. </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, during economic uncertainty, our customers have had job losses and may continue to have issues gaining timely access to sufficient health insurance or credit, which could result in their unwillingness to purchase products or impair their ability to make timely payments to us. A recession, depression or other sustained adverse market event could materially and adversely affect our business and the value of our common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the reoccurrence of any economic slowdown or the strength or sustainability of the economic recovery, worldwide, in the United States, or in our industry. These and other economic factors could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be adversely affected by the effects of inflation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inflation has the potential to adversely affect our liquidity, business, financial condition and results of operations by increasing our overall cost structure. The existence of inflation in the economy has resulted in, and may continue to result in, higher interest rates and capital costs, supply shortages, increased costs of labor, components, manufacturing and shipping, as well as weakening exchange rates and other similar effects. As a result of inflation, we have experienced and may continue to experience cost increases. Although we may take measures to mitigate the effects of inflation, if these measures are not effective, our business, financial condition, results of operations and liquidity could be materially adversely affected. Even if such measures are effective, there could be a difference between the timing of when these beneficial actions impact our results of operations and when the cost of inflation is incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to successfully maintain effective internal control over financial reporting, investors may lose confidence in our reported financial information and our stock price and our business may be adversely impacted.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required to maintain internal control over financial reporting and our management is required to evaluate the effectiveness of our internal control over financial reporting as of the end of each fiscal year. If we are not successful in maintaining effective internal control over financial reporting, there could be inaccuracies or omissions in the consolidated financial information we are required to file with the SEC. Additionally, even if there are no inaccuracies or omissions, we will be required to publicly disclose the conclusion of our management that our internal control over financial reporting or disclosure controls and procedures are not effective. These events could cause investors to lose confidence in our reported financial information, adversely impact our stock price, result in increased costs to remediate any deficiencies, attract regulatory scrutiny or lawsuits that could be costly to resolve and distract management&#8217;s attention, limit our ability to access the capital markets or cause our stock to be delisted from The Nasdaq Stock Market or any other securities exchange on which it is then listed.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in financial accounting standards or practices or existing taxation rules or practices may cause adverse unexpected revenue and/or expense fluctuations and affect our reported results of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A change in accounting standards or practices or a change in existing taxation rules or practices can have a significant effect on our reported results and may even affect our reporting of transactions completed before the change is effective. New accounting pronouncements and taxation rules and varying interpretations of accounting pronouncements and taxation practice have occurred and may occur in the future. The method in which we market and sell our products may have an impact on the manner in which we recognize revenue. In addition, changes to existing rules or the questioning of current practices may adversely affect our reported financial results or the way we conduct our business. Additionally, changes to existing accounting rules or standards, such as the potential requirement that U.S. registrants prepare financial statements in accordance with International Financial Reporting Standards, may adversely impact our reported financial results and business, and may further require us to incur greater accounting fees.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our financial performance fails to meet the expectations of investors and public market analysts, the market price of our common stock could decline.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenues and operating results may fluctuate significantly from quarter to quarter. We believe that period-to-period comparisons of our operating results may not be meaningful and should not be relied on as an indication of our future performance. If quarterly revenues or operating results fall below the expectations of investors or public market analysts, the trading price of our common stock could decline substantially. In addition to the other risk factors set forth herein, factors that might cause quarterly fluctuations in our operating results include:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our inability to manufacture an adequate supply of product at appropriate quality levels and acceptable costs;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">possible delays in our research and development programs or in the completion of any clinical trials;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">a lack of acceptance of our products in the marketplace by physicians and people with diabetes;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the inability of customers to receive reimbursements from third-party payors;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">the purchasing patterns of our customers, including as a result of seasonality;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">failures to comply with regulatory requirements, which could lead to withdrawal of products from the market;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">our failure to continue the commercialization of any of our products;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">competition;</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">inadequate financial and other resources; and</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">global political and economic conditions, political instability and military hostilities.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">68</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_112"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1B - UNRESOLVED STAFF COMMENTS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_115"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 1C - CYBERSECURITY</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Risk Management and Strategy</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock" id="f-36" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock" id="f-37" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-38"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementProcessesIntegratedFlag" format="ixt:fixed-true" id="f-39">We have processes in place for assessing, identifying, and managing material risks from cybersecurity threats, which are integrated into our overall enterprise risk management processes.</ix:nonNumeric> The processes for assessing, identifying and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include identifying the relevant assets that could be affected, determining possible threat sources and threat events, assessing threats based on their potential likelihood and impact, and identifying controls that are in place or necessary to manage and/or mitigate such risks.</ix:nonNumeric></span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established cybersecurity and privacy programs to maintain the confidentiality, integrity, availability, and privacy of protected information and ensure compliance with relevant security/privacy regulations, contractual requirements, and industry-standard frameworks. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag" format="ixt:fixed-true" id="f-40">Our cybersecurity program includes annual review and assessment by external, independent third parties, who certify and report on these programs.</ix:nonNumeric> For example, our Information Security Management System (ISMS) is certified as being in conformity with ISO/IEC 27001 by SRI Quality System Registrar. We maintain cybersecurity and privacy policies and procedures in accordance with industry-standard control frameworks and applicable regulations, laws, and standards. All corporate cybersecurity policies are reviewed and approved by senior leadership at least annually as part of our ISMS.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementThirdPartyEngagedFlag" format="ixt:fixed-true" id="f-41">Our cybersecurity controls, which are the mechanisms in place to prevent, detect and mitigate threats in accordance with our policies and procedures, are based on the regulatory requirements to which we are subject and are monitored and tested both internally and externally by third parties at least annually.</ix:nonNumeric> These controls include regular system updates and patches, employee training on cybersecurity and privacy requirements, incident reporting, and the use of encryption to secure sensitive information. In addition, we also regularly perform phishing tests of our employees and update our training plan at least annually. We maintain business continuity and disaster recovery capabilities to mitigate interruptions to critical information systems and/or the loss of data and services from the effects of natural or man-made disasters to Dexcom locations. We also provide annual privacy and security training for all employees. Our security training incorporates awareness of cyber threats (including but not limited to malware, ransomware and social engineering attacks), password hygiene, incident reporting process, as well as physical security best practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last three fiscal years, we have not experienced any material cybersecurity incidents and the expenses we have incurred from security incidents were immaterial. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-42">As a result, we do not believe that risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected us, our results of operations and financial condition.</ix:nonNumeric> However, as discussed under &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report, cybersecurity threats pose multiple risks to us, including potentially to our results of operations and financial condition. See &#8220;Risk Factors &#8212; Risks Related to Privacy and Security.&#8221; As cybersecurity threats become more frequent, sophisticated and coordinated, it is reasonably likely that we will be required to expend greater resources as we pursue our strategy of continuously modifying and enhancing our protective measures while developing and commercializing products that incorporate our CGM technologies and integrate with the insulin delivery systems or data platforms of our partners. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag" format="ixt:fixed-false" id="f-43">The technology integration and cloud-based depository platforms we continue to focus on can make us more vulnerable to cybersecurity threats, thereby making our pursuit of such strategies more costly.</ix:nonNumeric></span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Governance</span></div><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskRoleOfManagementTextBlock" id="f-46" continuedAt="f-46-1" escape="true"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock" id="f-44" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-45" escape="true">Our Board of Directors is responsible for exercising oversight of management&#8217;s identification and management of, and planning for, risks from cybersecurity threats. <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock" id="f-47" escape="true">While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#8217;s Technology Committee.</ix:nonNumeric></ix:nonNumeric> The Technology Committee reports to the Board as necessary with respect to its activities, including making such reports and recommendations to the Board and its other committees as necessary and appropriate and consistent with its purpose, described below.</span></div></ix:nonNumeric></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-46-1"><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock" id="f-48" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Technology Committee, comprised of independent Board members, is responsible for reviewing cybersecurity, privacy, data protection and other major technology risk exposures of the Company, the steps management has taken to monitor and control such exposures, and the Company&#8217;s compliance with applicable cybersecurity and data privacy laws and industry standards. These reviews are provided at least annually. The Technology Committee receives management updates and reports, primarily through the Company&#8217;s Cybersecurity and Privacy Committee, a multidisciplinary team responsible for the overall governance, decision-making, risk management, awareness and compliance for cybersecurity and privacy activities across the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity and Privacy Committee is co-chaired by our <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag" format="ixt:fixed-true" id="f-49">Information Security Officer (ISO)</ix:nonNumeric>, Product Security Officer (PSO), and Chief Privacy Officer (CPO), and its members include executive officers of the Company, including our Chief Technology Officer, Chief Financial Officer, Chief Information Officer, and Chief Legal Officer, as well as representatives from the finance, internal audit, quality, regulatory, and legal teams. Management&#8217;s role in assessing and managing the material risks from cybersecurity threats is accomplished primarily through the committee.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock" id="f-50" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the Cybersecurity and Privacy Committee have broad ranges of expertise and experience in information technology and security. Our ISO, a co-chair of the committee, has over fifteen years of experience in the field of information security management, having previously led security operations and infrastructure and IT functions for a public university campus and a non-profit organization, and holds several licenses and certifications relating to information security, including a Certified Information Systems Security Manager from the Information Systems Audit and Control Association (ISACA), a Certified Information Systems Security Professional (CISSP) from the International Information Security System Security Certification Consortium (ISC2) and several technical cybersecurity certifications from the Global Information Assurance Certification (GIAC). Our PSO, also a co-chair of the committee, has over twenty-five years of previous experience in cyber security architecture and cyber security management for a number of large Fortune 500 technology companies and holds several certifications including CISSP from the International Information Security System Security Certification Consortium, C-CISO from EC-Council, Numerous certifications from Microsoft, CISCO, Juniper, Checkpoint among others and has completed several advanced GIAC security classes from the SANS Institute.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock" id="f-51" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ISO reports directly to our Senior Vice President, Chief Information Officer (CIO), who is a member of the committee. She has held this role at Dexcom since 2024 and is responsible for global information technology at Dexcom. Our CIO brings 30 years of diverse strategic and operational experience in IT management, data engineering, AI, digital, ecommerce, infrastructure modernization and supply chain. Prior to Dexcom, our CIO served as Senior Vice President, Chief Information Officer at Bausch + Lomb. Additionally, our CIO has held transformational roles at Johnson &amp; Johnson, Bristol Myers Squibb, American Standard and Price Waterhouse Coopers. She holds a Bachelor of Science degree in Economics and Management Information Systems from the University of Delaware. Our Executive Vice President, Chief Technology Officer (CTO) is also a member of the committee. Our CTO has held this role since 2022 and has 25 years of experience spanning consumer electronics, data storage, IoT and broadband industries. From 2011 to 2022 he worked at Technicolor (now known as Vantiva), most recently serving as Chief Technology Officer and General Manager of the Broadband Business Division. In addition to an MBA, he holds a Master of Science in Mechanical Engineering and a Bachelor of Mechanical Engineering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prevention, detection, mitigation and remediation of cybersecurity incidents at Dexcom is accomplished pursuant to various policies, procedures and processes, including incident response plans and the cybersecurity and privacy programs and controls described above under &#8220;Risk Management and Strategy.&#8221; These measures include escalation protocols through which the Cybersecurity and Privacy Committee is informed about cybersecurity and incidents by our ISO and PSO, who are informed through our business units. As described above, members of the Cybersecurity and Privacy Committee provide updates to the <ix:nonNumeric contextRef="c-1" name="cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag" format="ixt:fixed-true" id="f-52">Technology Committee of the Board</ix:nonNumeric> on a regular basis, and the full Board receives updates from the Technology Committee. In addition, there are protocols in place for immediate escalation in the event of any cybersecurity issues or developments that may require consideration between regularly scheduled Technology Committee or Board meetings.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">70</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_118"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 2 - PROPERTIES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We lease real property to support our business, including manufacturing, research and development, sales, marketing and administration. We believe our facilities are suitable and adequate for our current and near-term needs, and that we will be able to locate additional facilities as needed. The following table sets forth the locations of our manufacturing facilities:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:72.800%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.826%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:23.974%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Location</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">&#160;Lease Expiration Dates</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mesa, Arizona</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2030 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Penang, Malaysia</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2082 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(3)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Athenry, Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(4)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:3pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Excludes a renewal that would be at our option to extend the term of a lease expiring in 2028 for one additional three to five-year term.</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Excludes renewals that would be at our option to extend the term of a lease expiring in 2028 for four additional five-year terms and also excludes renewals that would be at our option to extend the term of a lease expiring in 2030 for two additional five-year terms.</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:3pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents 60-year land leases with the state authority expiring at varying dates through 2082.</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:3pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Represents a 999-year land lease with the Industrial Development Agency of Ireland.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our headquarters, research and development, and certain of our manufacturing operations are located in San Diego, California. In addition, the construction of a new manufacturing facility in Athenry, Ireland is underway. We also lease various manufacturing, administrative, warehouse and customer support real properties throughout the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had approximately 80,600 square feet of laboratory space and approximately 159,600 square feet of controlled environment rooms.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_121"></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 3 - LEGAL PROCEEDINGS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Litigation and Settlement with Abbott</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From June 2021 through December 2024, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities served patent infringement complaints against each other in multiple jurisdictions against certain continuous glucose monitoring products of each company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2021, we initiated patent infringement litigation against Abbott in the United States (U.S.D.C., Western District of Texas) and Germany (National Court (&#8220;N.C.&#8221;) in Mannheim). In May 2023, we filed additional patent infringement actions in Germany (N.C. in Munich). In July and August 2023, we initiated patent infringement litigation in the United Patent Court (&#8220;UPC&#8221;) (Paris &amp; Munich) and in Spain (Commercial Courts of Barcelona).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October and November 2023, we initiated patent infringement litigation in Germany (N.C. in Munich) and in the UPC (Paris &amp; Munich). In January 2024, we initiated patent infringement litigation in Germany (N.C. in Hamburg).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2021, one day after we initiated litigation in the U.S.D.C., Western District of Texas, Abbott initiated patent infringement litigation against Dexcom in the United States (U.S.D.C., Delaware (&#8220;D1&#8221;)). Shortly thereafter, Abbott filed additional patent infringement litigation actions in the United Kingdom (Business and Property Courts of England and Wales) and Germany (N.C. in Mannheim and Dusseldorf).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in the Business and Property Courts of England and Wales. Three trials on liability were conducted in the United Kingdom. On October 18, 2023 and June 28, 2024, judgment was handed down in favor of Dexcom, finding the Abbott patents to be invalid and not infringed. On January 15, 2024, judgment was handed down invalidating both Abbott and Dexcom&#8217;s patents.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2021, Abbott filed a breach of contract lawsuit against Dexcom in the United States (U.S.D.C., District of Delaware) alleging that Dexcom breached the parties&#8217; Settlement and License Agreement dated July 2, 2014 (&#8220;SLA&#8221;). The U.S.D.C., District of Delaware consolidated Abbott&#8217;s breach of contract lawsuit with Dexcom&#8217;s patent infringement lawsuit which had been transferred from the U.S.D.C., Western District of Texas (&#8220;D3&#8221;). Dexcom asserted counterclaims that Abbott also breached the SLA. A jury trial on Abbott&#8217;s breach of contract claims commenced on July 10, 2023. On July 14, 2023, the jury verdict determined that Abbott was not licensed to thirteen claims of certain Dexcom patents and that Abbott was licensed to five claims. In April 2022, Abbott initiated the inter partes review (&#8220;IPR&#8221;) process on the asserted claims of Dexcom&#8217;s patents in D3. The U.S. Patent and Trademark Office (the &#8220;PTO&#8221;) denied institution of one of Dexcom&#8217;s patents and instituted IPR on the other four. Ultimately, in November 2023, the PTO issued its Final Written Decision, upholding claims of two Dexcom patents to be patentable, which cover factory calibration and certain alarms and alerts, and two to be unpatentable, which cover certain sensor code and sensor configurations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In February 2023, Abbott filed patent infringement litigation against us in Germany (N.C. in Hamburg and Munich). In March 2023, Abbott filed a patent infringement litigation in the United States (U.S.D.C., Delaware (&#8220;D4&#8221;)) and we filed counterclaims for patent infringement in that action in June 2023. In June 2023, Abbott filed patent infringement litigation actions in the United Kingdom (Business and Property Courts of England and Wales). In response to the lawsuits initiated by Abbott in the United Kingdom, Dexcom also filed patent infringement counterclaims in that jurisdiction.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Abbott&#8217;s patent infringement trial, &#8220;D1&#8221;, against Dexcom commenced in the U.S.D.C., District of Delaware in March 2024. In the lead up to trial, the U.S.D.C., District of Delaware invalidated one of Abbott&#8217;s patents on factory calibration and Abbott dropped four other patents from the litigation. The claims litigated were isolated to the inserter mechanism and the wearable seal and mount of Dexcom&#8217;s G6. On March 22, 2024, a jury returned a mixed verdict. The jury found that Dexcom infringes one patent, that Dexcom did not infringe a second patent, and that Dexcom also did not infringe a third patent, which the jury also found invalid. The jury found that any infringement was not willful. It could not reach unanimity as to a fourth patent. No determination of damages was made or awarded.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commencing in January 2024, patent infringement hearings between Abbott and Dexcom were scheduled to take place in Germany wherein each sought damages and injunctive relief against the other. All but one of Abbott&#8217;s offensive hearings were either stayed or cancelled entirely due to parallel invalidity proceedings and nullity decisions. After a February 28, 2024 hearing in Munich wherein Abbott asserted patent infringement claims against Dexcom, Dexcom received a favorable non-infringement decision. On July 24, 2024, Dexcom received a decision from the Munich court related to the July 3, 2024 hearing, staying our offensive infringement proceedings pending the outcome of an opposition proceeding. On July 31, 2024, Dexcom received a decision from the Munich courts related to hearings in April 2024, dismissing our claims for infringement. On November 6, 2024, Dexcom received a favorable decision from the Munich District Court, finding Abbott infringes Dexcom&#8217;s patent and granting an injunction regarding Abbott&#8217;s LibrLinkUp application in Germany. Under the Settlement Agreement described below, Abbott obtained a license to such patent and the injunction no longer applies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, after hearings in May and June in the Paris and Munich divisions of the UPC, each division issued a decision revoking our patents asserted against Abbott.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On December 20, 2024, Dexcom and Abbott entered into a settlement and patent cross license agreement (the &#8220;Settlement Agreement&#8221;) to resolve all outstanding patent litigation between the parties (the &#8220;Litigation&#8221;).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the terms of the Settlement Agreement, Dexcom granted Abbott and its affiliates, and Abbott and its affiliates granted Dexcom and its affiliates, a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation. The Settlement Agreement does not obligate Dexcom or Abbott to pay any royalties or any other form of financial compensation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As part of the Settlement Agreement, each party, on behalf of itself and its affiliates, has also (i) entered into a covenant not to sue until December 20, 2034; and (ii) agreed on behalf of themselves and their affiliates to refrain from challenging the patents and patent applications licensed under the Settlement Agreement for periods of time which vary depending on the relevant patents or patent applications.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The description of the Settlement Agreement contained herein is qualified in its entirety by reference to the Settlement Agreement, a copy of which is filed as Exhibit 10.16 to this Annual Report on Form 10-K.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Class Action Litigation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between August 21 and October 9, 2024, three substantially similar putative class action complaints were filed against us and certain of our executive officers in the United States District Court for the Southern District of California. On December 13, 2024, the court appointed lead plaintiff court and consolidated the three actions (now captioned In Re: Dexcom, Inc. Class Action Securities Litigation, Lead Case No.: 24-cv-1485-RSH-VET). On January 27, 2025, lead plaintiff filed a consolidated complaint. The consolidated complaint alleges violations of the Securities Exchange Act against us and certain of our current and former executive officers for allegedly making false and misleading statements between April 28, 2023 and July 25, 2024, with respect to our expected revenue for fiscal 2024 and ability to capitalize on our growth potential. Our deadline to respond to the consolidated complaint is March 13, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Derivative Actions</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between September 13 and October 16, 2024, two putative stockholders filed derivative lawsuits against us and certain of our current and former executive officers and directors in the United States District Court for the Southern District of California. The derivative complaints allege factual allegations largely tracking allegations made in the Securities Class Action Litigation and seek, among other things, damages and restitution to be paid to the Company by the individual defendants, punitive damages, and attorney&#8217;s fees and costs. On December 16, 2024, the court issued an order (i) consolidating the derivative actions, (ii) appointing lead counsel in the consolidated action (captioned In Re: Dexcom, Inc. Stockholder Derivative Litigation, Lead Case No.: 24-cv-1645-RSH-VET), and (iii) staying the consolidated action until the court&#8217;s resolution of any motions to dismiss in the Securities Class Action Litigation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to vigorously defend against such claims; however, we cannot be certain of the outcome of our ongoing proceedings and, if determined adversely to us, our business and financial condition may be adversely affected.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_124"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 4 - MINE SAFETY DISCLOSURES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">73</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_127"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PART II</span></div><div><span><br/></span></div><div id="i6a987b433ae84cbfb2328647e6586107_130"></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 5 - MARKET FOR REGISTRANT&#8217;S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Information for Common Stock</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is traded on the Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stockholders</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had approximately 25 stockholders of record as of February&#160;6, 2025. The number of beneficial owners of our common stock at that date was substantially greater than the number of record holders because a large portion of our common stock is held of record through brokerage firms in &#8220;street name.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Policy</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have never declared or paid any cash dividends on our capital stock. We currently intend to retain any future earnings to finance the operation and expansion of our business, and we do not expect to declare or pay any dividends in the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Sales of Unregistered Securities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All unregistered sales of equity securities have been previously disclosed in a Form 10-Q or a current report on Form 8-K for the fiscal year ended December&#160;31, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchases of Equity Securities by the Issuer and Affiliated Purchasers</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we nor any affiliated purchaser repurchased any of our equity securities during the quarter ended December&#160;31, 2024.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company Stock Price Performance</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below compares the cumulative total stockholder return on our common stock with the cumulative total returns on the S&amp;P Health Care Equipment Select Industry index and the S&amp;P 500 index over the five-year period ended December&#160;31, 2024. The graph assumes that $100 was invested in Dexcom common stock and in each of the other indices on December&#160;31, 2019 and that all dividends were reinvested. The comparisons in the graph below are based on historical data and are not intended to forecast the possible future performance of Dexcom&#8217;s common stock.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The graph below and related information shall not be deemed &#8220;soliciting material&#8221; or be deemed to be &#8220;filed&#8221; with the SEC, nor shall such information be incorporated by reference into any future filing, except to the extent that we specifically incorporate it by reference into such filing.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><img src="dxcm-20241231_g3.jpg" alt="3454" style="height:470px;margin-bottom:5pt;vertical-align:text-bottom;width:618px"/></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* $100 invested on December&#160;31, 2019 in stock or index, including reinvestment of any dividends.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_133"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 6 - [RESERVED]</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_139"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 7 - MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">This document, including the following Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations, contains forward-looking statements that are not purely historical regarding Dexcom&#8217;s or its management&#8217;s intentions, beliefs, expectations and strategies for the future. These forward-looking statements fall within the meaning of the federal securities laws that relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as &#8220;may,&#8221; &#8220;will,&#8221; &#8220;expect,&#8221; &#8220;plan,&#8221; &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;estimate,&#8221; &#8220;intend,&#8221; &#8220;potential&#8221; or &#8220;continue&#8221; or the negative of these terms or other comparable terminology. Forward-looking statements are made as of the date of this report, deal with future events, are subject to various risks and uncertainties, and actual results could differ materially from those anticipated in those forward looking statements. The risks and uncertainties that could cause actual results to differ materially are more fully described under &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report, elsewhere in this Annual Report, and in our other reports filed with the SEC. We assume no obligation to update any of the forward-looking statements after the date of this report or to conform these forward-looking statements to actual results. You should read the following discussion and analysis together with our consolidated financial statements and related notes in Part II, Item 8 of this Annual Report.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_142"></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Who We Are</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received approval from the Food and Drug Administration, or FDA, and commercialized our first product in 2006. We launched our latest generation systems, the Dexcom G6 integrated Continuous Glucose Monitoring System, or G6, in 2018, and we launched the Dexcom G7, or G7,</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-style:italic;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in 2023. In August 2024, we launched Stelo, our new biosensor designed for adults with prediabetes and Type 2 diabetes who do not use insulin, as the first over-the-counter glucose biosensor in the U.S.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:0.1%"/><td style="width:1.711%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:96.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Global Presence</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have built a direct sales organization in North America and certain international markets to call on health care professionals, such as endocrinologists, physicians and diabetes educators, who can educate and influence patient adoption of continuous glucose monitoring. To complement our direct sales efforts, we have entered into distribution arrangements in North America and several international markets that allow distributors to sell our products.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Future Developments</span></td></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Product Development:</span><span style="color:#ff671d;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to develop future generations of technologies that are focused on improved performance and convenience and that will enable intelligent insulin administration. Over the longer term, we plan to continue to develop and improve networked platforms with open architecture, connectivity and transmitters capable of communicating with other devices. We also intend to expand our efforts to accumulate CGM patient data and metrics and apply predictive modeling and machine learning to generate interactive CGM insights that can inform patient behavior.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Partnerships:</span><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also continue to pursue and support development partnerships with insulin pump companies and companies or institutions developing insulin delivery systems, including automated insulin delivery systems. With the introduction of Stelo, we are also pursuing and supporting development partnerships with consumer technology product companies that seek to provide metabolic health insights to their customers.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">New Opportunities: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also exploring how to extend our offerings to other opportunities, including for people with pre-diabetes, people who are obese, people who are pregnant, and people in the hospital setting. Eventually, we may apply our technological expertise to products beyond glucose monitoring.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_145"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.372%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:21.012%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which we have prepared in accordance with GAAP. The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements as well as the reported revenue and expenses during the reporting periods. On an ongoing basis, we evaluate our estimates and judgments. We base our estimates on historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While our significant accounting policies are described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K, we believe that the following accounting estimates are most critical to a full understanding and evaluation of our reported financial results. Members of our senior management have discussed the development and selection of these critical accounting estimates and their disclosure in this Annual Report on Form 10-K with the Audit Committee of our Board of Directors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pharmacy Rebates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate pharmacy rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends, and channel inventory data. Estimates associated with pharmacy rebates are the most significant component of our variable consideration estimates and most at risk for material adjustment because of the time delay between the recording of the pharmacy rebate and its ultimate settlement, an interval that generally ranges from 30 to 90 days, but can last up to one year. Due to this time lag, in any given period, our adjustments to reflect actual amounts can incorporate changes of estimates related to prior periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, adjustments to these estimates to reflect actual results or updated expectations, have not been material to our overall business and generally have been less than 1% of revenue. An increase or decrease of 1% in our estimate of products sold subject to rebate during 2024, holding all other assumptions constant, would increase or decrease revenue by approximately $38.7 million.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information, see Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Revenue Recognition</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Excess and Obsolete Inventory</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We assess the value of our inventory on a quarterly basis and write down those inventories based on quality control testing data, obsolescence, or in excess of our forecasted demand to the lower of their cost or net realizable value. Our estimates of forecasted demand are based upon our analysis and assumptions including, but not limited to, expected product lifecycles, product development plans and historical usage by product. If actual market conditions are less favorable than our forecasts, or actual demand from our customers is lower than our estimates, we may be required to record additional inventory write-downs. If actual market conditions are more favorable than anticipated, inventory previously written down may be sold, resulting in lower cost of sales and higher income from operations than expected in that period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate our income taxes based on the various jurisdictions where we conduct business. Significant judgment is required in determining our worldwide income tax provision. The calculation of our tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations and the potential for future adjustment of our uncertain tax positions by the Internal Revenue Service or other taxing jurisdictions. While we believe we have appropriate support for the positions taken on our tax returns, we regularly assess the potential outcomes of examinations by tax authorities in determining the adequacy of our provision for income taxes. We continually assess the likelihood and amount of potential adjustments and adjust the income tax provision, income taxes payable, and deferred taxes in the period in which the facts that give rise to a revision become known.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the asset and liability approach to recognize deferred tax assets and liabilities for the expected future tax consequences of temporary differences between the carrying amounts and the tax basis of assets and liabilities as described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions. We maintain a valuation allowance on our California research and development tax credits, foreign tax credits and certain foreign intangible assets, as it is more likely than not that those deferred tax assets will not be realized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize and measure benefits for uncertain tax positions using a two-step approach as described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report. Significant judgment is required to evaluate uncertain tax positions and is based upon a number of factors, including changes in facts or circumstances, changes in tax law, correspondence with tax authorities during the course of audits and effective settlement of audit issues. Changes in the recognition or measurement of uncertain tax positions could result in material increases or decreases in our income tax expense in the period in which we make the change, which could have a material impact on our effective tax rate and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. Significant judgment is required in the determination of whether a potential loss is probable, reasonably possible, or remote as well as in the determination of whether a potential exposure is reasonably estimable. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_148"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.494%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.201%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.824%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.211%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Overview of Financial Results</span></td></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The most important financial indicators that we use to assess our business are revenue, gross profit, operating income, net income, and operating cash flow.</span></div></td></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Key Highlights for fiscal 2024 include the following:</span></div></td></tr><tr style="height:15pt"><td colspan="39" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Gross Profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Net Income</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Operating Cash Flow</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$4.03 billion</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$2.44 billion</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$600.0 million</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$576.2 million</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">$989.5 million</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">up 11% from 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">up 7% from 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">up 0.4% from 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">up 6% from 2023</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">up 32% from 2023</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We ended fiscal 2024 with cash, cash equivalents and short-term marketable securities totaling $2.58 billion.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_151"></div><div style="margin-bottom:3pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Results of Operations</span></td></tr><tr><td colspan="3" style="display:none"/></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Financial Overview</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For discussion related to the results of operations and changes in financial condition for fiscal 2023 compared to fiscal 2022 refer to &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; in Part II, Item 7 of our 2023 Annual Report on Form 10-K, which was filed with the SEC on February&#160;8, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:36.051%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.387%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.889%"/><td style="width:0.1%"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2024 Compared to Twelve Months Ended December&#160;31, 2023</span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024 - 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except per share amounts)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% of Revenue </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$ Change</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% Change</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">410.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,594.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,333.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">261.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,438.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">60.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,288.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">552.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">505.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,285.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,185.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,838.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,691.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">709.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense (benefit)</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(36.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.06&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.42&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.30&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.12&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The sum of the individual percentages may not equal the total due to rounding.</span></div></td></tr><tr><td colspan="36" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Not meaningful</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that the revenue we generate from the sales of our products will fluctuate from quarter to quarter. We typically experience seasonality, with lower sales in the first quarter of each year compared to the immediately preceding fourth quarter. This seasonal sales pattern relates to U.S. annual insurance deductible resets and unfunded flexible spending accounts.</span></div><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales includes direct labor and materials costs related to each product sold or produced, including assembly, test labor and scrap, as well as factory overhead supporting our manufacturing operations. Factory overhead includes facilities, material procurement and control, manufacturing engineering, quality assurance, supervision and management. These costs are primarily salary, fringe benefits, share-based compensation, facility expense, supplies and purchased services. All of our manufacturing costs are included in cost of sales. In addition, amortization of certain licensing related intangibles are also included in cost of sales.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development expenses primarily consist of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our selling, general and administrative expenses primarily consist of employee compensation for our executive, financial, sales, marketing, information technology and administrative functions. Other significant expenses include commissions, marketing and advertising, IT software license costs, insurance, professional fees for our outside legal counsel and independent auditors, litigation expenses, patent application expenses and consulting expenses.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other income (expense), net</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net consists primarily of interest and dividend income on our cash, cash equivalents and short-term marketable securities portfolio, foreign currency transaction gains and losses due to the effects of foreign currency fluctuations, realized and unrealized gains and losses on equity investments, and interest expense related to our senior convertible notes.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_154"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2024 Compared to Twelve Months Ended December&#160;31, 2023</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><img src="dxcm-20241231_g4.jpg" alt="6" style="height:340px;margin-bottom:5pt;vertical-align:text-bottom;width:405px"/><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.410%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.198%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.205%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024 - 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Change in Revenues</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">% of Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,889.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,625.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,143.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">997.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">146.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total Revenue</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">410.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11%</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2024 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2023</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The revenue increase was primarily driven by increased sales volume of our disposable sensors due to the continued growth of our worldwide customer base. We added approximately 500,000 - 600,000 net users, excluding Stelo customers, to our worldwide customer base in 2024. The increase in revenue was offset by pricing headwinds due to greater rebate eligibility and channel mix.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Disposable sensor and other revenue comprised approximately 95% of total revenue and Reusable Hardware revenue comprised approximately 5% of total revenue for the twelve months ended December&#160;31, 2024. Disposable sensor and other revenue comprised approximately 90% of total revenue and Reusable Hardware revenue comprised approximately 10% of total revenue for the twelve months ended December&#160;31, 2023.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of sales &amp; Gross profit</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales and gross profit increased primarily due to an increase in sales volume driven by the addition of approximately 500,000 - 600,000 net users, excluding Stelo customers, to our worldwide customer base in 2024.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in gross profit margin percentage in 2024 compared to 2023 was primarily driven by product and channel mix changes, higher freight costs, and non-cash charges including a $22.7 million inventory build charge, and $20.6 million in inventory damaged in transit and certain build configurations that lowered production yield.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:17.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.264%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:78.696%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2024 Compared to </span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended December&#160;31, 2023</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and development expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased primarily due to $20.5&#160;million in compensation and related costs due to higher headcount, $11.2&#160;million in clinical trials, supplies and other support costs, and $5.9&#160;million in software and data costs.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to believe that focused investments in research and development are critical to our future growth and competitive position in the marketplace, and to the development of new and updated products and services that are central to our core business strategy.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, general and administrative expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased primarily due to $33.5&#160;million in advertising and marketing costs, $30.7&#160;million in compensation and related costs due to higher headcount, $18.0&#160;million in software and data costs, and $10.1&#160;million in travel related expenses.</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income tax expense</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the twelve months ended December&#160;31, 2024 was primarily attributable to income tax expense from normal, recurring operations, partially offset by excess tax benefits recognized for share-based compensation for employees, net of nondeductible executive compensation, the Verily milestone payment, the impacts of certain foreign tax return filings and generation of research and development tax credits.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The income tax expense recorded for the twelve months ended December&#160;31, 2023 was primarily attributable to income tax expense from normal, recurring operations, as well as income taxes related to an intra-entity transfer of certain intellectual property partially offset by excess tax benefits recognized for share-based compensation for employees (net of disallowed executive compensation) and the Verily milestone payment, and generation of research and development tax credits.</span></div><div style="padding-left:6pt"><span><br/></span></div><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The decrease in our effective tax rate for the twelve months ended December&#160;31, 2024 compared to the same period in 2023 is primarily attributable to impacts of the prior year tax restructuring and the Verily milestone payment.</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_157"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Overview, Capital Resources, and Capital Requirements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our principal sources of liquidity are our existing cash, cash equivalents and marketable securities, cash generated from operations, proceeds from our senior convertible notes issuances, and access to our Credit Facility. Our primary uses of cash have been for research and development programs, selling and marketing activities, capital expenditures, acquisitions of businesses, and debt service costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that cash provided by our operations may fluctuate in future periods as a result of a number of factors, including fluctuations in our operating results, working capital requirements and capital deployment decisions. We have historically invested our cash primarily in U.S. dollar-denominated, investment grade, highly liquid obligations of U.S. government agencies, commercial paper, corporate debt, and money market funds. Certain of these investments are subject to general credit, liquidity and other market risks. The general condition of the financial markets and the economy may increase those risks and may affect the value and liquidity of investments and restrict our ability to access the capital markets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future capital requirements will depend on many factors, including but not limited to:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:11.25pt;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.418%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.725%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.307%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.732%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The evolution of the international expansion of our business and the revenue generated by sales of our approved products and any future products;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to efficiently scale our operations to meet demand for our current and any future products;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The success of our research and development efforts;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The expenses we incur in manufacturing, developing, selling and marketing our products;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs, timing and risks of delays of additional regulatory approvals;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The costs of filing, prosecuting, defending and enforcing any patent claims and other intellectual property rights;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The quality levels of our products and services;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The emergence of competing or complementary technological developments;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The terms and timing of any collaborative, licensing and other arrangements that we may establish; and</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The third-party reimbursement of our products for our customers;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The rate of progress and cost of our clinical trials and other development activities;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The acquisition of businesses, products and technologies and our ability to integrate and manage any acquired businesses, products and technologies.</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that existing cash and short-term investments and cash flows from our future operations will generally be sufficient to fund our ongoing core business. As current borrowing sources become due, we may be required to access the capital markets for additional funding. As we assess inorganic growth strategies, we may need to supplement our internally generated cash flow with outside sources. In the event that we are required to access the debt market, we believe that we will be able to secure reasonable borrowing rates. As part of our liquidity strategy, we will continue to monitor our current level of earnings and cash flow generation as well as our ability to access the market in light of those earning levels.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. We will be exposed to additional foreign currency exchange risk related to our international operations as we expand our manufacturing internationally and as our business continues to increase in international markets. See &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Foreign Currency Exchange Risk</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; in Part II, Item 7A of this Annual Report on Form 10-K for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Main Sources of Liquidity</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash, cash equivalents and short-term marketable securities</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash, cash equivalents and short-term marketable securities totaled $2.58 billion as of December&#160;31, 2024. None of those funds were restricted and $2.36 billion (approximately 92%) of those funds were located in the United States.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cash flows from Operations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the twelve months ended December&#160;31, 2024, we had positive cash flows of $989.5 million from operating activities. We anticipate that we will continue to generate positive cash flows from operations for the foreseeable future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We received net proceeds of $1.19 billion in May 2020 from the 2025 Notes offering, and net proceeds of $1.23 billion in May 2023 from the 2028 Notes offering. We used $282.6 million of the net proceeds from the offering of the 2025 Notes to repurchase a portion of our senior convertible notes due in 2022. We used $289.9 million of the net proceeds from the offering of the 2028 Notes to purchase capped call transactions and repurchase shares of our common stock in May 2023. We intend to use the remainder of the net proceeds from the 2025 Notes offering and 2028 Notes offering for general corporate purposes and capital expenditures, including working capital needs. We may also use the net proceeds to expand our current business through in-licensing or acquisitions of, or investments in, other businesses, products or technologies; however, we do not have any significant commitments with respect to any such acquisitions or investments at this time.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the 2028 Notes offering, we purchased the 2028 Capped Calls. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for more information about our senior convertible notes and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Amended Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had no outstanding borrowings, $7.7 million in outstanding letters of credit, and a total available balance of $192.3 million under the Amended Credit Agreement. We monitor counterparty risk associated with the institutional lenders that are providing the Credit Facility. We currently believe that the Credit Facility will be available to us should we choose to borrow under it. Revolving loans will be available for general corporate purposes, including working capital and capital expenditures. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for more information on the Amended Credit Agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Short-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our short-term liquidity requirements primarily consist of regular operating costs, interest payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and short-term material cash requirements as described below. As of December&#160;31, 2024, we had a working capital ratio of 1.47 and a quick ratio of 1.22, which indicates that our current assets are more than enough to cover our short-term liabilities. We expect to incur significant capital expenditures for the next year as we continue to invest in equipment and our manufacturing facilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we have outstanding senior convertible notes classified as current that will mature in November 2025. However, the outstanding principal of our senior convertible notes could be converted into cash and/or shares of our common stock prior to maturity once certain conditions are met. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for information on conversion rights prior to maturity.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our cash, cash equivalents, and marketable securities balances, projected cash contributions from our commercial operations, and borrowings under our Credit Facility will be sufficient to meet our anticipated seasonal working capital needs, all capital expenditure requirements, material cash requirements as described below, and other liquidity requirements associated with our operations for at least the next 12 months. We may use cash to repurchase shares of our common stock or for other strategic initiatives that strengthen our foundation for long-term growth.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-term Liquidity Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our long-term liquidity requirements primarily consist of interest and principal payments related to our senior convertible notes, capital expenditures for the development of our manufacturing facilities and office spaces, and long-term material cash requirements as described below. As of December&#160;31, 2024, we had a debt-to-assets ratio of 0.38, which indicates that our total assets are more than enough to cover our short-term and long-term debts. As demand grows for our products, we will continue to expand global operations to meet demand through investments in manufacturing and operations. We expect to meet our long-term liquidity requirements from our main sources of liquidity as described above to support our future operations, capital expenditures, acquisitions, and other liquidity requirements associated with our operations beyond the next 12 months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we have outstanding senior convertible notes classified as long-term that will mature in May 2028. However, the outstanding principal of our senior convertible notes could be converted into cash and/or shares of our common stock prior to maturity once certain conditions are met. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Convertible Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for information on conversion rights prior to maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Material Cash Requirements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time in the ordinary course of business, we enter into a variety of purchase arrangements including but not limited to, purchase arrangements related to capital expenditures, components used in manufacturing, and research and development activities. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Other Commitments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Purchase Commitments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the 2025 Notes and 2028 Notes include both principal and interest payments. Although the 2025 Notes and 2028 Notes mature in November 2025 and May 2028, respectively, they may be converted into cash and/or shares of our common stock prior to maturity if certain conditions are met. Any conversion prior to maturity may result in repayment of the principal amounts due under the Notes sooner than the scheduled repayment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As market conditions warrant, we may, from time to time, repurchase our outstanding debt securities or shares of our common stock, in the open market, in privately negotiated transactions, by exchange transaction or otherwise. Such repurchases, if any, will depend on prevailing market conditions, our liquidity and other factors and may be commenced or suspended at any time. The amounts involved and total consideration paid may be material. See Note 9 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder&#8217;s Equity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Share Repurchase Program and Treasury Shares</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about our 2024 Share Repurchase Program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about the terms of the Amended Credit Agreement, our senior convertible notes, and the 2028 Capped Calls.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are party to various leasing arrangements, primarily for office, manufacturing and warehouse space that expire at various times through December 2030, excluding any renewal options. We also have land leases in Penang, Malaysia that expire in 2082 and Athenry, Ireland that expire in 3023 related to our international manufacturing facilities. We anticipate incurring significant expenditures related to the build-out of our manufacturing facilities and investment in equipment. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Other Commitments&#8212;Leases</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information about our leases.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of our cash flows for the periods indicated. See the consolidated financial statements in Part II, Item 8 of this Annual Report for the complete consolidated statements of cash flows for these periods.</span></div><div style="text-align:center"><img src="dxcm-20241231_g5.jpg" alt="9538" style="height:393px;margin-bottom:5pt;vertical-align:text-bottom;width:688px"/></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we had $2.58 billion in cash, cash equivalents and short-term marketable securities, which is a decrease of $144.7 million compared to $2.72 billion as of December&#160;31, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary cash flows during the twelve months ended December&#160;31, 2024 and 2023 are described below. See the consolidated financial statements in Part II, Item 8 of this Annual Report for complete consolidated statements of cash flows for these periods.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:510.75pt"><tr><td style="width:1.0pt"/><td style="width:52.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:10.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:3.25pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:10.75pt"/><td style="width:1.0pt"/><td style="width:1.0pt"/><td style="width:208.00pt"/><td style="width:1.0pt"/></tr><tr><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Twelve Months Ended</span></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr style="height:50pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Cash Flows</span></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$576.2 million of net income and $304.5 million of net non-cash adjustments, and a net increase of $108.8 million in changes of working capital balances</span></div></td><td colspan="3" rowspan="2" style="border-right:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" rowspan="2" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$541.5 million of net income and $203.8 million of net non-cash adjustments, and a net increase of $3.2 million in changes of working capital balances</span></div></td></tr><tr style="height:38pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net non-cash adjustments were primarily related to share-based compensation and depreciation and amortization.</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr style="height:26pt"><td colspan="3" rowspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Investing Cash Flows</span></td><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$248.1 million in net proceeds from marketable securities</span></div></td><td colspan="3" rowspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$253.0 million in net purchases of marketable securities</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$358.8 million in capital expenditures</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$236.6 million in capital expenditures</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$81.3&#160;million in purchases of non-marketable equity securities</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$19.5 million in purchases of non-marketable equity securities</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #dbdbdb;padding:0 1pt"/></tr><tr style="height:38pt"><td colspan="3" rowspan="5" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Financing Cash Flows</span></td><td colspan="3" rowspan="5" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#32ad10;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$28.2 million in proceeds from issuance of common stock under our employee stock plans</span></div></td><td colspan="3" rowspan="5" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.23&#160;billion in proceeds from issuance of senior convertible notes, net of issuance costs</span></div></td></tr><tr style="height:38pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#434141;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$750.0 million in purchases of treasury stock</span></div></td><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">+</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$26.6 million in proceeds from issuance of common stock under our employee stock plans</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$787.3&#160;million in payments for conversions of senior convertible notes</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$688.7 million in purchases of treasury stock</span></div></td></tr><tr style="height:26pt"><td colspan="3" style="border-left:2pt solid #32ad10;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-left:2pt solid #32ad10;padding:2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">-</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$101.3 million in purchases of capped call transactions</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_160"></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For a description of recently issued accounting pronouncements and the potential impact on our consolidated financial statements, if any, see Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_163"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 7A - QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_166"></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The primary objective of our investment activities is to preserve our capital for the purpose of funding operations while at the same time maximizing the income we receive from our investments without significantly increasing risk. To achieve these objectives, our investment policy allows us to maintain a portfolio of cash equivalents and short-term investments in a variety of securities, including money market funds, U.S. Treasury debt and corporate debt securities. Due to the short-term nature of our investments, we believe that we have no material exposure to interest rate risk. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_169"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Market Price Sensitive Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, with such reduction and/or offset subject to a cap. See Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_172"></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A substantial portion of our operations are located in the United States, and the majority of our sales since inception have been made in U.S. dollars. Historically, our exposure to foreign currency fluctuations is more significant with respect to our revenue than our expenses, as a significant portion of our expenses are denominated in U.S. dollars, such as cost of sales and operating expenses.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to additional foreign currency exchange risk related to our foreign operations as we are now manufacturing internationally and as our business continues to increase in markets outside of the United States. Fluctuations in the rate of exchange between the U.S. dollar and foreign currencies could adversely affect our financial results, including income and losses as well as assets and liabilities in addition to risks to our revenues, revenue growth rates, and gross profit margins.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We translate the financial statements of our international subsidiaries with functional currencies other than the U.S. dollar into the U.S. dollar for consolidation using end-of-period exchange rates for assets and liabilities and average exchange rates during each reporting period for results of operations. We record net gains or losses resulting from the translation of these financial statements and the effect of exchange rate changes on intercompany receivables and payables of a long-term nature as a separate component of stockholders&#8217; equity. These adjustments will affect net income only upon sale or liquidation of the underlying investment in international subsidiaries. We also record exchange rate fluctuations resulting from the translation of the short-term intercompany balances between domestic entities and our international subsidiaries as foreign currency transaction gains or losses and include them in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. These forward contracts are not designated as hedging instruments and generally mature in one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notional principal amounts provide one measure of the transaction volume outstanding as of period end, but they do not represent the amount of our exposure to market loss. Estimates of fair value are based on applicable and commonly used pricing models using prevailing financial market information. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. We monitor and manage our financial exposures due to exchange rate fluctuations as an integral part of our overall risk management program, which recognizes the unpredictability of financial markets and seeks to reduce potentially adverse effects on our financial results.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_175"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 8 - FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required is set forth under &#8220;Report of Independent Registered Public Accounting Firm,&#8221; &#8220;Consolidated Balance Sheets,&#8221; &#8220;Consolidated Statements of Operations,&#8221; &#8220; Consolidated Statements of Comprehensive Income,&#8221; &#8220;Consolidated Statements of Stockholders&#8217; Equity,&#8221; &#8220;Consolidated Statements of Cash Flows&#8221; and &#8220;Notes to Consolidated Financial Statements&#8221; on pages </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_247">F-10</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to </span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_475">F-47</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of this Annual Report and is incorporated into this Item 8 by reference.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The report of Dexcom&#8217;s independent registered public accounting firm (PCAOB ID:<ix:nonNumeric contextRef="c-1" name="dei:AuditorFirmId" id="f-53">42</ix:nonNumeric>) with respect to the above-referenced financial statements and their report on internal control over financial reporting are included in Item 8 and Item 9A of this Form 10-K. Their consent appears as Exhibit 23.1 of this Form 10-K.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_178"></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9 - CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_181"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9A - CONTROLS AND PROCEDURES</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulations under the Exchange Act require public companies to maintain &#8220;disclosure controls and procedures,&#8221; as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act. Disclosure controls and procedures include, without limitation, controls and other procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is accumulated and timely communicated to management, including our Chief Executive Officer (our principal executive officer) and Chief Financial Officer (our principal financial officer), recorded, processed, summarized, and reported within the time periods specified in the SEC&#8217;s rules and forms. Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report. Based on their evaluation as of December&#160;31, 2024, our Chief Executive Officer and our Chief Financial Officer concluded that our disclosure controls and procedures were effective at a reasonable assurance level as of such date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Management&#8217;s Report on Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting as defined in Rule 13a-15(f) under the Exchange Act. Our internal control over financial reporting is designed to provide reasonable assurance to our management and Board of Directors regarding the preparation and fair presentation of published financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation of the Chief Executive and Chief Financial Officers, assessed the effectiveness of our internal control over financial reporting as of December&#160;31, 2024. In making this assessment, our management used the criteria set forth by the 2013 Committee of Sponsoring Organizations of the Treadway Commission (COSO) in Internal Control&#8212;Integrated Framework. Based on this assessment, our management, with the participation of the Chief Executive and Chief Financial Officers, believes that, as of December&#160;31, 2024, our internal control over financial reporting is effective based on those criteria. The effectiveness of our internal control over financial reporting as of December&#160;31, 2024 has been audited by Ernst&#160;&amp; Young LLP, an Independent Registered Public Accounting Firm, as stated in their report which is included herein.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The certifications of our Chief Executive Officer and Chief Financial Officer required under Section&#160;302 of the Sarbanes-Oxley Act have been filed as Exhibits 31.1 and 31.2 to this report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Limitation on Effectiveness of Controls</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It should be noted that any system of controls, including ours, however well designed and operated, can provide only reasonable, and not absolute, assurance that the objectives of the system are met. The design of any control system is based, in part, upon the benefits of the control system relative to its costs. Control systems can be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the control. In addition, over time, controls may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these and other inherent limitations of control systems, we cannot guarantee that any design will succeed in achieving its stated goals under all potential future conditions, regardless of how remote.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span><br/></span></div><div id="i6a987b433ae84cbfb2328647e6586107_184"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of DexCom, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Opinion on Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited DexCom, Inc.&#8217;s internal control over financial reporting as of December&#160;31, 2024, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework) (the COSO criteria). In our opinion, DexCom, Inc. (the Company) maintained, in all material respects, effective internal control over financial reporting as of December&#160;31, 2024, based on the COSO criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of the Company as of December&#160;31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2024, and the related notes and financial statement schedule listed in the Index at Item 15(a) and our report dated February&#160;14, 2025 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s management is responsible for maintaining effective internal control over financial reporting and for its assessment of the effectiveness of internal control over financial reporting included in the accompanying Management&#8217;s Report on Internal Control over Financial Reporting. Our responsibility is to express an opinion on the Company&#8217;s internal control over financial reporting based on our audit. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether effective internal control over financial reporting was maintained in all material respects.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit included obtaining an understanding of internal control over financial reporting, assessing the risk that a material weakness exists, testing and evaluating the design and operating effectiveness of internal control based on the assessed risk, and performing such other procedures as we considered necessary in the circumstances. We believe that our audit provides a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Definition and Limitations of Internal Control Over Financial Reporting</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A company&#8217;s internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company&#8217;s internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the company&#8217;s assets that could have a material effect on the financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ Ernst &amp; Young LLP</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;14, 2025</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_187"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9B - OTHER INFORMATION</span></div></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_3749"></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trading Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended December&#160;31, 2024, no Section 16 officers or directors <ix:nonNumeric contextRef="c-4" name="ecd:NonRule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-54"><ix:nonNumeric contextRef="c-4" name="ecd:Rule10b51ArrAdoptedFlag" format="ixt:fixed-false" id="f-55">adopted</ix:nonNumeric></ix:nonNumeric>, modified, or <ix:nonNumeric contextRef="c-4" name="ecd:NonRule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-56"><ix:nonNumeric contextRef="c-4" name="ecd:Rule10b51ArrTrmntdFlag" format="ixt:fixed-false" id="f-57">terminated</ix:nonNumeric></ix:nonNumeric> a &#8220;Rule 10b5-1 trading arrangement&#8221; or &#8220;non-Rule 10b5-1 trading arrangement&#8221; (each as defined in Item 408 of Regulation S-K of the Exchange Act).</span></div><div id="i6a987b433ae84cbfb2328647e6586107_193"></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 9C - DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_196"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PART III</span></div><div><span><br/></span></div><div id="i6a987b433ae84cbfb2328647e6586107_199"></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 10 - DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning our directors required by this Item is incorporated by reference to the section in the Proxy Statement entitled &#8220;Proposal No.&#160;1 &#8211; Election of Directors.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning our executive officers required by this Item is incorporated by reference to the section in the Proxy Statement entitled &#8220;Executive Officers.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have adopted a written code of ethics for financial employees that applies to our principal executive officer, principal financial officer, principal accounting officer, controller and other employees of the finance department designated by our Chief Financial Officer. This code of ethics, titled the &#8220;Code of Conduct and Business Ethics&#8221;, is publicly available on our Internet website at https://investors.dexcom.com/governance/governance-documents. The information contained on our Internet website is not incorporated by reference into this Annual Report on Form 10-K. When required by the rules of Nasdaq, or the SEC, we will disclose any future amendment to, or waiver of, any provision of the code of ethics for our principal executive officer and principal financial officer or any member or members of our board of directors on our website within four business days following the date of such amendment or waiver.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning the Audit Committee of the Board of Directors required by this Item is incorporated by reference to the sections of the Proxy Statement entitled &#8220;Committees of the Board and Meetings&#8221; and &#8220;Meetings of the Board of Directors; Director Attendance.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning material changes to the procedures by which stockholders may recommend nominees to the Board of Directors required by this Item is incorporated by reference to information set forth in the Proxy Statement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning the Company&#8217;s insider trading policies and compliance with Section 16(a) required by this Item is incorporated by reference to the sections of the Proxy Statement entitled &#8220;Insider Trading Policy; Anti-Hedging&#8221; and &#8220;Delinquent Section 16(a) Reports&#8221;, respectively.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_202"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 11 - EXECUTIVE COMPENSATION</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item concerning executive compensation and our Compensation Committee is incorporated by reference to the sections in the Proxy Statement entitled &#8220;Executive Compensation,&#8221; &#8220;2024 Summary Compensation Table,&#8221; &#8220;Grants of Plan-Based Awards for 2024,&#8221; &#8220;Outstanding Equity Awards at December 31, 2024,&#8221; &#8220;2024 Option Exercises and Stock Vested,&#8221; &#8220;Executive Nonqualified Deferred Compensation Plan,&#8221; &#8220;Severance and Change in Control Arrangements,&#8221; &#8220;2024 Director Compensation Table,&#8221; &#8220;Risks from Compensation Policies and Practices,&#8221; &#8220;Chief Executive Officer Pay Ratio,&#8221; &#8220;Compensation Committee Interlocks and Insider Participation,&#8221; and &#8220;Compensation Committee Report.&#8221;</span></div><div id="i6a987b433ae84cbfb2328647e6586107_205"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 12 - SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item is incorporated by reference to the sections in the Proxy Statement entitled &#8220;Security Ownership of Certain Beneficial Owners and Management&#8221; and &#8220;Equity Compensation Plan Information.&#8221;</span></div><div id="i6a987b433ae84cbfb2328647e6586107_208"></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 13 - CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information required by this Item with respect to director independence is incorporated by reference to the section in the Proxy Statement entitled &#8220;Director Independence.&#8221;</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning certain relationships and related transactions required by this Item is incorporated by reference to the section in the Proxy Statement entitled &#8220;Certain Transactions With Related Persons.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_211"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 14 - PRINCIPAL ACCOUNTANT FEES AND SERVICES</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information concerning principal accountant fees and services required by this Item is incorporated by reference to the section in the Proxy Statement entitled &#8220;Proposal No. 2 &#8211; Ratification of Independent Registered Public Accounting Firm.&#8221;</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">93</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_214"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">PART IV</span></div><div><span><br/></span></div><div id="i6a987b433ae84cbfb2328647e6586107_217"></div><div style="-sec-extract:summary;margin-bottom:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:67.5pt;text-indent:-67.5pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 15 - EXHIBIT AND FINANCIAL STATEMENT SCHEDULES </span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The following documents are filed as part of this Annual Report:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. Financial Statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consolidated financial statements listed in Part II, Item&#160;8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Financial Statement Schedules.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_499">Schedule II &#8211; Valuation and Qualifying Accounts</a></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial statement schedules not listed above have been omitted because information required to be set forth therein is not applicable, not required, or the information required by such schedules is shown in the consolidated financial statements or the notes thereto.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Exhibits.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit Description</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Incorporated by Reference</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Provided<br/>Herewith</span></td></tr><tr style="height:21pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Form</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Date of<br/>First Filing</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Exhibit<br/>Number</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312522171920/d368741dex31.htm">Restated Certificate of Incorporation of DexCom, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 10, 2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355724000180/dxcm9302024exhibit31.htm">Amended and Restated Bylaws of DexCom, Inc.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">October 24, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000104746905007514/a2153933zex-4_01.htm">Form of Specimen Certificate for DexCom, Inc. common stock.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">S-1/A</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">333-122454</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 24, 2005</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.01</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001093557/000119312518340482/d667223dex41.htm">Indenture, dated November 30, 2018, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.75% Convertible Senior Notes due 2023).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December 3, 2018</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001093557/000119312520143408/d926678dex41.htm">Indenture, dated May 14, 2020, between DexCom, Inc. and U.S. Bank National Association (including the form of 0.25% Convertible Senior Notes due 2025).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May 15, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523137248/d300995dex41.htm">Indenture, dated May 5, 2023, between DexCom, Inc. and U.S. Bank Trust Company, National Association (including the form of 0.375% Convertible Senior Notes due 2028).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">May 5, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit45.htm">Description of Securities Registered Under Section 12 of the Exchange Act.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312511208448/dex1028.htm">Offer letter between DexCom, Inc. and Kevin Sayer, dated May&#160;3, 2011.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">August 3, 2011</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.28</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355716000511/dxcm03312016ex1036.htm">Sublease between DexCom, Inc. and Entropic Communications, LLC, dated February 1, 2016.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">April 27, 2016</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.36</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355719000137/exhibit1002dexcomincexecut.htm">DexCom, Inc. Executive Deferred Compensation Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 4, 2019</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.02</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355720000029/dxcm12312019exhibit1040.htm">Third Amendment to Office Lease between DexCom, Inc. and John Hancock Life Insurance Company, dated January 9, 2019.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 13, 2020</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.40</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355721000024/dxcm12312020ex1043doindemn.htm">Form of Indemnity Agreement between DexCom, Inc. and each of its directors and executive officers.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 11, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.43</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/0001093557/000109355721000084/dxcmex1012021bonusplan.htm">DexCom, Inc. Incentive Bonus Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 17, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355722000014/dxcm-12312021ex1039locamen.htm">Second Amended and Restated Credit Agreement dated October 13, 2021 by and among DexCom, Inc., Bank of America, Silicon Valley Bank and Union Bank, and JPMorgan Chase Bank, as Administrative Agent.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.39</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/dxcm12312022ex1009-officel.htm">Office Lease Agreement, dated March 31, 2006, between DexCom, Inc. and Kilroy Realty, L.P., as amended on August 18, 2010 and October 1, 2014.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 9, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.09</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355723000024/dxcm12312022ex1018-fourtha.htm">Fourth Amendment to Office Lease between DexCom, Inc. and Sequence Tech. Center CA LLC, dated September 9, 2019, as amended on October 21, 2019, May 25, 2021, and December 23, 2022.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 9, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.18</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000119312523149463/d446905dex101.htm">DexCom, Inc. Amended and Restated Severance and Change in Control Plan.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">May 19, 2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355723000174/dxcm6302023ex1006-firstame.htm">First Amendment to Second Amended and Restated Credit Agreement, dated June 1, 2023 by and between DexCom, Inc. and JPMorgan Chase Bank National Association.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-Q</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">July 27, 2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.06</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/dxcm12312023ex1012-2015emp.htm">2015 Employee Stock Purchase Plan and forms of subscription agreements.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 8, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.13**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/dxcm12312023ex1014-amended.htm">Amended and Restated Collaboration and License Agreement, dated November 20, 2018, by and between DexCom, Inc. and Verily Life Sciences LLC (formerly Google Life Sciences LLC).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 8, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.14</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.14**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355724000024/dxcmexhibit101.htm">Warrant Termination Agreement between DexCom, Inc. and Bank of America, N.A., dated February 13, 2024.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 15, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.15*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1015.htm">Severance Agreement and General Release, dated October 22, 2024, between DexCom, Inc. and Teri Lawver.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.16**</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm">Confidential Settlement and Patent License Agreement</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm">,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm"> dated December 20, 2024,</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm"> </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm">between </a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1016.htm">Abbott Diabetes Care Inc. and DexCom, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.17*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit1017.htm">Amended and Restated 2015 Equity Incentive Plan and forms of award agreements.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit191.htm"><ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-58">Insider Trading Policy.</ix:nonNumeric></a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit211.htm">List of Subsidiaries.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit231.htm">Consent of Independent Registered Public Accounting Firm.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i6a987b433ae84cbfb2328647e6586107_223">Power of Attorney (see signature page of this Form 10-K).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">95</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:7.964%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.864%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.771%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.572%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.689%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.671%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.389%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit311.htm">Certification of Chief Executive Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit312.htm">Certification of Chief Financial Officer Pursuant to Securities Exchange Act Rule 13a-14(a).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.1***</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit321.htm">Certification of Chief Executive Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.2***</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="dxcm12312024-exhibit322.htm">Certification of Chief Financial Officer Pursuant to 18 U.S.C. Section 1350 and Securities Exchange Act Rule 13a-14(b).</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97.1*</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1093557/000109355724000021/dxcm12312023ex971-compensa.htm">Compensation Recovery Policy.</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10-K</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">000-51222</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 8, 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97.1</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.INS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cover Page Interactive Data File (Embedded within the Inline XBRL document and included in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td></tr></table></div><div style="margin-bottom:10pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:4.341%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.459%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Represents a management contract or compensatory plan, contract or arrangement.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">**</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of this exhibit have been omitted pursuant to Item 601(b)(10)(iv) of Regulation S-K.</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification is not deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act, or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except to the extent that Dexcom specifically incorporates it by reference.</span></div></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_220"></div><div style="margin-bottom:1pt;margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">ITEM 16 - FORM 10-K SUMMARY</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_223"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of Section&#160;13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:39.981%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.894%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.139%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:41.009%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DEXCOM, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Registrant)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: February&#160;14, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ JEREME M. SYLVAIN</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Jereme M. Sylvain,</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Executive Vice President and Chief Financial Officer</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">POWER OF ATTORNEY</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Kevin R. Sayer and Jereme M. Sylvain, jointly and severally, his or her attorneys-in-fact, each with the power of substitution, for him or her in any and all capacities, to sign any amendments to this Annual Report on Form 10-K and to file same, with exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto each of said attorneys-in-fact and agents, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that each of said attorneys-in-fact, or his substitutes, may do or cause to be done by virtue hereof.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:41.005%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:36.473%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.176%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Signature</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Title</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Date</span></td></tr><tr style="height:18pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;KEVIN R. SAYER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chairman of the Board of Directors, President and Chief&#160;Executive&#160;Officer (Principal Executive Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kevin R. Sayer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:24pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;JEREME M. SYLVAIN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive Vice President and Chief Financial Officer (Principal Financial and Accounting Officer)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Jereme M. Sylvain</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;MARK G. FOLETTA</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lead Independent Director<br/></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Mark G. Foletta</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;STEVEN R. ALTMAN</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Steven R. Altman</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;NICHOLAS AUGUSTINOS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nicholas Augustinos</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/><td colspan="6" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;RICHARD A. COLLINS</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Richard A. Collins</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;KAREN DAHUT</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Karen Dahut</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;RIMMA DRISCOLL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Rimma Driscoll</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;BRIDGETTE P. HELLER</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Bridgette P. Heller</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;KYLE MALADY</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Kyle Malady</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/&#160;ERIC J. TOPOL</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Director</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February 14, 2025</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Eric J. Topol, M.D.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">97</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_226"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#32ad10;border-top:1pt solid #32ad10;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">DexCom, Inc.</span></td></tr><tr><td colspan="3" style="background-color:#32ad10;border-bottom:1pt solid #32ad10;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Index to Consolidated Financial Statements</span></td></tr></table></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:90.712%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.088%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Page</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_229">Report of Independent Registered Public Accounting Firm</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_229">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_232">Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_232">4</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_235">Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_235">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_238">Consolidated Statements of Comprehensive Income</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_238">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_241">Consolidated Statements of Stockholders&#8217; Equity </a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_241">7</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_244">Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_244">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><a style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_247">Notes to Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F-<a style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:none" href="#i6a987b433ae84cbfb2328647e6586107_247">10</a></span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-1</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_229"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the Stockholders and the Board of Directors of DexCom, Inc.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Opinion on the Financial Statements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have audited the accompanying consolidated balance sheets of DexCom, Inc. (the Company) as of December&#160;31, 2024 and 2023, the related consolidated statements of operations, comprehensive income, stockholders&#8217; equity and cash flows for each of the three years in the period ended December&#160;31, 2024, and the related notes and financial statement schedule listed in the Index at Item 15(a) (collectively referred to as the &#8220;consolidated financial statements&#8221;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&#160;31, 2024 and 2023, and the results of its operations and its cash flows for each of the three years in the period ended December&#160;31, 2024, in conformity with U.S. generally accepted accounting principles.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the Company&#8217;s internal control over financial reporting as of December&#160;31, 2024, based on criteria established in Internal Control&#8212;Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013 framework), and our report dated February&#160;14, 2025 expressed an unqualified opinion thereon.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis for Opinion</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These financial statements are the responsibility of the Company&#8217;s management. Our responsibility is to express an opinion on the Company&#8217;s financial statements based on our audits. We are a public accounting firm registered with the PCAOB and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Audit Matter</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The critical audit matter communicated below is a matter arising from the current period audit of the financial statements that was communicated or required to be communicated to the audit committee and that: (1) relates to accounts or disclosures that are material to the financial statements and (2) involved our especially challenging, subjective or complex judgments. The communication of the critical audit matter does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matter below, providing a separate opinion on the critical audit matter or on the account or disclosure to which it relates.</span></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.357%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Estimation of variable consideration for revenue recognition</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:59pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Description of the Matter</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:103%">As discussed in Note 1 of the consolidated financial statements, the Company includes an estimate of variable consideration in the calculation of the transaction price at the time of sale. The Company estimates reductions for pharmacy rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></td></tr><tr style="height:50pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Auditing management&#8217;s determination of variable consideration relating to pharmacy rebates involved a high degree of subjectivity in evaluating management&#8217;s estimates. In estimating pharmacy rebates, management applies contracted rates to estimates of products sold subject to rebate, known market events or trends and channel inventory data.</span></div></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:81.357%"/><td style="width:0.1%"/></tr><tr style="height:41pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">How We Addressed the Matter in Our Audit</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:2.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtained an understanding, evaluated the design and tested the operating effectiveness of controls over the Company&#8217;s processes to determine pharmacy rebates, including the underlying assumptions.</span></div></td></tr><tr style="height:98pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our audit procedures also included, among others, evaluating the significant assumptions and the accuracy and completeness of the underlying data used in management&#8217;s calculations. This included testing contractual rates, management&#8217;s estimates of products sold subject to rebate, and inventory held by third parties at the end of the period, through a combination of underlying data validation by inspection of source documents, agreement to underlying contracts, and review for consistency against historical data. In addition, we inspected the results of the Company&#8217;s analysis of pharmacy rebates claimed and evaluated the estimates made based on historical experience.</span></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">/s/ <ix:nonNumeric contextRef="c-1" name="dei:AuditorName" id="f-59">Ernst &amp; Young LLP</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have served as the Company&#8217;s auditor since 2000.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:AuditorLocation" id="f-60">San Diego, California</ix:nonNumeric></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;14, 2025</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-3</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_232"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.783%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.368%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Balance Sheets</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.250%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.253%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except share and par value data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Assets</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-61">606.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-62">566.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-63">1,973.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities" format="ixt:num-dot-decimal" scale="6" id="f-64">2,157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="f-65">1,005.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" scale="6" id="f-66">973.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-67">542.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-68">559.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid and other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-69">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-70">168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-71">4,301.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="6" id="f-72">4,425.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-73">1,339.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-74">1,113.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-75">62.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="6" id="f-76">71.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-77">22.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Goodwill" scale="6" id="f-78">25.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-79">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="6" id="f-80">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-81">481.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxAssetsNet" scale="6" id="f-82">419.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-83">173.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-84">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-85">6,484.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="6" id="f-86">6,264.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liabilities and Stockholders&#8217; Equity</span></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-87">1,585.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-88">1,345.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-89">112.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-90">171.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current portion of long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" format="ixt:num-dot-decimal" scale="6" id="f-91">1,204.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ConvertibleNotesPayableCurrent" format="ixt:fixed-zero" scale="6" id="f-92">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-93">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-94">21.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-95">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="6" id="f-96">18.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-97">2,932.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-98">1,556.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term senior convertible notes</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-99">1,237.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ConvertibleLongTermNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-100">2,434.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term operating lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-101">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-102">80.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-103">147.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-104">125.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-105">4,381.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="6" id="f-106">4,195.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commitments and contingencies</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-5" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-107"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="c-6" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="f-108"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-109"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="f-110">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-111"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockSharesAuthorized" scale="6" id="f-112">5.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-113"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-114"><ix:nonFraction unitRef="shares" contextRef="c-6" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="0" id="f-115"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="0" id="f-116">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-117">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="6" id="f-118">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="c-5" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-119"><ix:nonFraction unitRef="usdPerShare" contextRef="c-6" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="f-120">0.001</ix:nonFraction></ix:nonFraction> par value, <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-121"><ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:CommonStockSharesAuthorized" scale="6" id="f-122">800.0</ix:nonFraction></ix:nonFraction> million shares authorized; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-123">408.9</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-124">390.7</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2024; and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesIssued" scale="6" id="f-125">407.2</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-126">385.4</ix:nonFraction> million shares issued and outstanding, respectively, at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-127">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CommonStockValueOutstanding" scale="6" id="f-128">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional paid-in capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-129">2,093.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AdditionalPaidInCapitalCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-130">3,514.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accumulated other comprehensive loss</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-131">8.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="6" id="f-132">16.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Retained earnings</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-133">1,597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="f-134">1,021.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Treasury stock, at cost; <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-135">18.2</ix:nonFraction> million shares at December&#160;31, 2024 and <ix:nonFraction unitRef="shares" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockCommonShares" scale="6" id="f-136">21.8</ix:nonFraction> million shares at December&#160;31, 2023</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-137">1,581.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:TreasuryStockCommonValue" format="ixt:num-dot-decimal" scale="6" id="f-138">2,451.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-139">2,102.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" format="ixt:num-dot-decimal" scale="6" id="f-140">2,068.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-141">6,484.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-142">6,264.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-4</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_235"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Operations</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.525%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.207%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except per share data)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-143">4,033.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-144">3,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-145">2,909.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-146">1,594.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-147">1,333.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-148">1,026.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross profit</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-149">2,438.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-150">2,288.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="6" id="f-151">1,883.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-152">552.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-153">505.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ResearchAndDevelopmentExpense" scale="6" id="f-154">484.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-155">1,285.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-156">1,185.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="6" id="f-157">1,007.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total operating expenses</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-158">1,838.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-159">1,691.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="6" id="f-160">1,491.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-161">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-162">597.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-163">391.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-164">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-165">112.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-166">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-167">709.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-168">710.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-169">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-170">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-171">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-172">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-173">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-174">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-175">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-176">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-177">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-178">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares used to compute basic net income per share</span></td><td colspan="2" style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-179">393.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-180">386.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-181">389.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted net income per share</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-182">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-183">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-184">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares used to compute diluted net income per share</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-185">412.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-186">425.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;border-bottom:3pt double #000;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-187">427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-5</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_238"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="3" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Comprehensive Income</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:56.794%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.208%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-188">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-189">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-190">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other comprehensive income (loss), net of tax:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Translation adjustments and other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-191">8.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-192">9.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="6" id="f-193">9.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unrealized gain (loss) on marketable debt securities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-194">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-195">4.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" scale="6" id="f-196">2.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other comprehensive income (loss), net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-197">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-198">5.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-199">12.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-200">584.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-201">536.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="6" id="f-202">329.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-6</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_241"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.834%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Stockholders&#8217; Equity</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:51.457%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:7.728%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.130%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.758%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.212%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.423%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Common&#160;Stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Other Comprehensive Income (Loss)</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Retained Earnings</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Treasury Stock</span></td><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2021</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-9" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-203">388.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-204">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-205">2,108.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-206">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-207">138.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-13" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-208">206.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-209">2,042.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-210">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-211">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-212">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-213">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-214">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-215">189.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-216">189.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-217">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of treasury stock</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-218">6.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-219">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-220">557.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax benefit related to Senior Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="f-221">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="f-222">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-223">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-224">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-225">13.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-226">17.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-15" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" scale="6" id="f-227">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" scale="6" id="f-228">33.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-17" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" scale="6" id="f-229">33.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" format="ixt:fixed-zero" scale="6" id="f-230">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-231">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-232">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Capitalization of sales-based milestones</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" scale="6" id="f-233">152.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" scale="6" id="f-234">152.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-18" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-235">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-236">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-19" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-237">12.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-238">12.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2022</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-20" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-239">386.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-20" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-240">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-21" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-241">2,258.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-22" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-242">11.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-23" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-243">479.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-24" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-244">595.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-245">2,131.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-246">1.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-247">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-248">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-249">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-250">3.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-251">323.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-252">323.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-253">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of treasury stock, including excise tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-254">6.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-255">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-256">689.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-257">689.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Tax benefit related to Senior Convertible Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="f-258">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" scale="6" id="f-259">4.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-260">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-261">13.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" scale="6" id="f-262">13.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Benefit of note hedge upon conversions of 2023 Notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-26" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" scale="6" id="f-263">12.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" format="ixt:num-dot-decimal" scale="6" id="f-264">1,496.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-28" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" format="ixt:num-dot-decimal" scale="6" id="f-265">1,490.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge" scale="6" id="f-266">6.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase of capped call transactions, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-267">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" scale="6" id="f-268">76.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-27" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-269">150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-270">150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-29" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-271">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-272">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-30" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-273">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-274">5.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2023</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-31" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-275">385.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-31" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-276">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-32" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-277">3,514.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-33" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-278">16.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-34" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-279">1,021.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-35" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-280">2,451.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-281">2,068.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock under equity incentive plans</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan" scale="6" id="f-282">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock for Employee Stock Purchase Plan</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-283">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-284">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" scale="6" id="f-285">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-286">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-287">188.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" scale="6" id="f-288">188.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones" format="ixt:fixed-zero" scale="6" id="f-289">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of treasury stock, including excise tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-290">10.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-291">749.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TreasuryStockValueAcquiredCostMethod" scale="6" id="f-292">749.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Exercise and settlement of warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-293">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" sign="-" name="dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-294">1,431.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-38" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" format="ixt:num-dot-decimal" scale="6" id="f-295">1,431.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" format="ixt:fixed-zero" scale="6" id="f-296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-37" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-297">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="6" id="f-298">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-39" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-299">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-300">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other comprehensive income, net of tax</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-40" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-301">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="6" id="f-302">8.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Balance at December 31, 2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-41" decimals="-5" name="us-gaap:CommonStockSharesOutstanding" scale="6" id="f-303">390.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-41" decimals="-5" name="us-gaap:StockholdersEquity" scale="6" id="f-304">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-42" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-305">2,093.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-43" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" scale="6" id="f-306">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-44" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-307">1,597.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-45" decimals="-5" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-308">1,581.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="6" id="f-309">2,102.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-7</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_244"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Consolidated Statements of Cash Flows</span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating activities</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net income</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-310">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-311">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-312">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Adjustments to reconcile net income to cash provided by operating activities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-313">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-314">186.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-315">155.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-316">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-317">150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ShareBasedCompensation" scale="6" id="f-318">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Non-cash interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-319">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-320">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaidInKindInterest" scale="6" id="f-321">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-322">43.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-323">55.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-324">21.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other non-cash income and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-325">47.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-326">85.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherNoncashIncomeExpense" scale="6" id="f-327">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts receivable, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-328">35.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-329">260.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="6" id="f-330">199.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Inventory</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-331">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-332">252.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="6" id="f-333">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prepaid and other assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-334">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-335">19.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="6" id="f-336">131.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and liabilities, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-337">6.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-338">4.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" scale="6" id="f-339">5.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accounts payable and accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-340">211.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-341">466.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" scale="6" id="f-342">295.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Accrued payroll and related expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-343">60.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-344">37.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities" scale="6" id="f-345">8.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Deferred revenue and other liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-346">8.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-347">2.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncreaseDecreaseInOtherDeferredLiability" scale="6" id="f-348">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash provided by operating activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-349">989.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-350">748.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="6" id="f-351">669.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Investing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchase of marketable securities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-352">2,576.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-353">3,200.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt" format="ixt:num-dot-decimal" scale="6" id="f-354">2,266.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from sale and maturity of marketable securities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-355">2,824.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-356">2,947.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-357">2,127.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of property and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-358">358.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-359">236.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="6" id="f-360">364.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisitions, net of cash acquired</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-361">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" format="ixt:fixed-zero" scale="6" id="f-362">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired" scale="6" id="f-363">3.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of non-marketable equity securities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-364">81.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-365">19.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsToAcquireOtherInvestments" scale="6" id="f-366">14.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-367">15.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-368">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:PaymentsForProceedsFromOtherInvestingActivities" scale="6" id="f-369">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-370">207.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-371">507.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="6" id="f-372">521.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Financing activities</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Net proceeds from issuance of common stock</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-373">28.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-374">26.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="6" id="f-375">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of treasury stock</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-376">750.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-377">688.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-378">557.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Proceeds from issuance of convertible notes, net of issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-379">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="6" id="f-380">1,230.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-381">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Purchases of capped call transactions</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:fixed-zero" scale="6" id="f-382">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" scale="6" id="f-383">101.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" format="ixt:fixed-zero" scale="6" id="f-384">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Payments for conversions of senior convertible notes</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-385">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" scale="6" id="f-386">787.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RepaymentsOfConvertibleDebt" format="ixt:fixed-zero" scale="6" id="f-387">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other financing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-388">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-389">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:ProceedsFromPaymentsForOtherFinancingActivities" scale="6" id="f-390">17.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Net cash used in financing activities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-391">734.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-392">318.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="6" id="f-393">552.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Effect of exchange rate changes on cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-394">7.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-395">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-396">5.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Increase (decrease) in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-397">39.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-398">75.8</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="6" id="f-399">410.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-400">567.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-401">643.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="6" id="f-402">1,053.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-403">607.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-404">567.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-405">643.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Reconciliation of cash, cash equivalents and restricted cash, end of period:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-406">606.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-407">566.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" scale="6" id="f-408">642.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted cash</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-409">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-410">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:RestrictedCash" scale="6" id="f-411">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-412">607.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-413">567.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="6" id="f-414">643.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:64.104%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental disclosure of non-cash investing and financing transactions:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares issued for repurchase and conversions of senior convertible notes</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:fixed-zero" scale="6" id="f-415">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" format="ixt:num-dot-decimal" scale="6" id="f-416">1,501.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentAmount1" scale="6" id="f-417">35.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Shares received under note hedge upon conversion of 2023 Notes</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" format="ixt:fixed-zero" scale="6" id="f-418">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" format="ixt:num-dot-decimal" scale="6" id="f-419">1,490.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge" scale="6" id="f-420">33.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Acquisition of property and equipment included in accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-421">75.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-422">53.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" scale="6" id="f-423">25.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Supplemental cash flow information:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid during the year for interest</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-424">11.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-425">12.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InterestPaidNet" scale="6" id="f-426">12.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash paid during the year for income taxes</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-427">198.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-428">212.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxesPaid" scale="6" id="f-429">114.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See accompanying notes</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-9</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_247"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Notes to Consolidated Financial Statements</span></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr></table></div><div id="i6a987b433ae84cbfb2328647e6586107_250"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="f-430" continuedAt="f-430-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. Organization and Significant Accounting Policies</span></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_253"></div><ix:continuation id="f-430-1" continuedAt="f-430-2"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_256"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConsolidationPolicyTextBlock" id="f-432" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="f-431" escape="true"><ix:continuation id="f-430-2" continuedAt="f-430-3"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div></ix:continuation></ix:nonNumeric></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_265"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:UseOfEstimates" id="f-433" escape="true"><ix:continuation id="f-430-3" continuedAt="f-430-4"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_268"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" id="f-434" continuedAt="f-434-1" escape="true"><ix:continuation id="f-430-4" continuedAt="f-430-5"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-434-1"><ix:continuation id="f-430-5" continuedAt="f-430-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_271"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" id="f-435" escape="true"><ix:continuation id="f-430-6" continuedAt="f-430-7"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of <ix:nonNumeric contextRef="c-1" name="dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" format="ixt-sec:durday" id="f-436">90</ix:nonNumeric> days or less at the time of purchase to be cash equivalents.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_274"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:MarketableSecuritiesPolicy" id="f-437" escape="true"><ix:continuation id="f-430-7" continuedAt="f-430-8"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income. Interest income and realized gains and losses on marketable debt securities are included in other income (expense), net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income (loss) from equity investments in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities, supranational securities, and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Short-Term Marketable Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information on our marketable securities.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_277"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReceivablesPolicyTextBlock" id="f-438" escape="true"><ix:continuation id="f-430-8" continuedAt="f-430-9"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount, net of prompt pay discounts, for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectible.&#160;Generally, receivable balances that are more than one year past due are deemed uncollectible.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_280"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ConcentrationRiskCreditRisk" id="f-439" escape="true"><ix:continuation id="f-430-9" continuedAt="f-430-10"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" id="f-440" escape="true"><ix:continuation id="f-430-10" continuedAt="f-430-11"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:46.414%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.115%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.701%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue**</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-46" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-441">40</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-47" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-442">35</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-48" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-443">32</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-49" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-444">18</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-50" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-445">20</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-51" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-446">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer C</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-52" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-447">35</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-53" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-448">30</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-54" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-449">26</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-55" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-450">21</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-56" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-451">23</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-57" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-452">42</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-58" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-453">37</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-59" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-454">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-60" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-455">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-61" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-456">27</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer E</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-62" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="f-457">10</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Total revenue for each customer is net of fees, cash discounts, and rebates directly allocable to that customer. Rebates paid to other entities are excluded; therefore, the combined value may exceed 100%.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_283"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:InventoryPolicyTextBlock" id="f-458" escape="true"><ix:continuation id="f-430-11" continuedAt="f-430-12"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We capitalize inventory produced in preparation for commercial launches when it becomes probable that the product will receive regulatory approval and that the related costs will be recoverable through the commercialization of the product. A number of factors are considered, including the status of the regulatory application approval process, management&#8217;s judgment of probable future commercial use, and net realizable value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record adjustments to inventory for potential excess or obsolete inventory, as well as inventory that does not pass quality control testing, in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is disposed of or sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of sales could be required.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_286"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="f-459" continuedAt="f-459-1" escape="true"><ix:continuation id="f-430-12" continuedAt="f-430-13"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We also capitalize certain costs incurred for the development of enterprise-level business and finance software that we use internally in our operations. Costs incurred in the application development phase are capitalized while costs related to planning and other preliminary project activities and to post-implementation activities are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally <span style="-sec-ix-hidden:f-460">three</span> to <ix:nonNumeric contextRef="c-64" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-461">five years</ix:nonNumeric> for computer software and hardware, including internal use software, <span style="-sec-ix-hidden:f-462">four</span> to <ix:nonNumeric contextRef="c-66" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-463">fifteen years</ix:nonNumeric> for machinery and equipment, and <ix:nonNumeric contextRef="c-67" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-464">five years</ix:nonNumeric> for furniture and fixtures. Leasehold and land improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or <ix:nonNumeric contextRef="c-68" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen" id="f-465">forty years</ix:nonNumeric>. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-459-1"><ix:continuation id="f-430-13" continuedAt="f-430-14"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_289"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="f-466" continuedAt="f-466-1" escape="true"><ix:continuation id="f-430-14" continuedAt="f-430-15"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but are tested annually for impairment during the fourth fiscal quarter and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-467"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-468"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="us-gaap:GoodwillImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-469">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> significant goodwill impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2024 and 2023 primarily consisted of the divestiture of our non-diabetes distribution business and translation adjustments on our foreign currency denominated goodwill.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_292"></div><ix:continuation id="f-466-1" continuedAt="f-466-2"><ix:continuation id="f-430-15" continuedAt="f-430-16"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in intangibles and other assets, net in our consolidated balance sheets. We amortize intangible assets with a finite life, such as the customer relationships, acquired technology and intellectual property, trademarks and trade name, and other intangibles, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:f-470">one</span> to <ix:nonNumeric contextRef="c-70" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:durwordsen" id="f-471">fourteen years</ix:nonNumeric>. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-466-2"><ix:continuation id="f-430-16" continuedAt="f-430-17"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For transactions other than a business combination, we also capitalize as intangible assets the cost of certain milestones payable by us to collaborative partners and incurred at or after the product has obtained regulatory approval for marketing. The intangible assets associated with these milestones are amortized over the remaining estimated useful life of the underlying asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded <ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-472"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-473"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill" format="ixt:fixed-zero" scale="0" id="f-474">no</ix:nonFraction></ix:nonFraction></ix:nonFraction> significant intangible asset impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_295"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxPolicyTextBlock" id="f-475" escape="true"><ix:continuation id="f-430-17" continuedAt="f-430-18"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rate on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under tax law and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax expense for basis differences related to global intangible low-taxed income (&#8220;GILTI&#8221;) as a period cost if and when incurred. GILTI is a category of income that is earned abroad by U.S.-controlled foreign corporations (CFCs) and is subject to special treatment under the U.S. tax code.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_298"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:StandardProductWarrantyPolicy" id="f-476" escape="true"><ix:continuation id="f-430-18" continuedAt="f-430-19"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_301"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CommitmentsAndContingenciesPolicyTextBlock" id="f-477" escape="true"><ix:continuation id="f-430-19" continuedAt="f-430-20"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-14</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_304"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="f-478" escape="true"><ix:continuation id="f-430-20" continuedAt="f-430-21"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of two elements, net income and other comprehensive income (loss). We report all components of comprehensive income, including net income, in our financial statements in the period in which they are recognized. Total comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income and the components of other comprehensive income (loss), including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_307"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="f-479" continuedAt="f-479-1" escape="true"><ix:continuation id="f-430-21" continuedAt="f-430-22"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. We also refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used, which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes, but is not limited to: rebates, chargebacks, product returns provision, and prompt payment discounts. We classify these items as a reduction of accounts receivable when we are not required to make a payment and as a liability when we are required to make a payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span><br/></span></div><ix:continuation id="f-479-1"><ix:continuation id="f-430-22" continuedAt="f-430-23"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We estimate our product returns primarily based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts, which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discounts based on eligible sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record revenue from sales of Components upon transfer of control of the product to the customer. We typically determine transfer of control based on when the product is shipped or delivered and title passes to the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from <ix:nonNumeric contextRef="c-71" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-480">30</ix:nonNumeric> to <ix:nonNumeric contextRef="c-72" name="dxcm:ContractPaymentTermsNumberofDays" format="ixt-sec:durday" id="f-481">90</ix:nonNumeric> days.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2024 included unbilled accounts receivable of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnbilledContractsReceivable" scale="6" id="f-482">15.2</ix:nonFraction> million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when cash payments have been received prior to satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-483">9.5</ix:nonFraction> million as of December&#160;31, 2024 and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-484">7.4</ix:nonFraction> million as of December&#160;31, 2023. These balances are included in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Compensation Costs</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:f-485">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_316"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="f-486" escape="true"><ix:continuation id="f-430-23" continuedAt="f-430-24"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consists of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology includes certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_319"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementAccountingPolicy" id="f-487" continuedAt="f-487-1" escape="true"><ix:continuation id="f-430-24" continuedAt="f-430-25"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Agreements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into agreements with collaboration partners for the development and commercialization of our products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-487-1"><ix:continuation id="f-430-25" continuedAt="f-430-26"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we account for these agreements, we consider the unique nature, terms and facts and circumstances of each transaction. Below are some example activities and how we account for them:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Payments to collaboration partners through issuance of common stock as consideration in an asset acquisition are considered share-based payment to non-employees in exchange for goods within the scope of ASC Topic 718, &#8220;Compensation - Stock Compensation.&#8221; The amount and the timing of the cost recognition of such milestones in our financial statements is driven by the accounting for the specific type of equity instrument under ASC 718 that aligns with the terms of the agreement, including any performance conditions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with in-process research and development (&#8220;IPR&amp;D&#8221;) in an asset acquisition incurred prior to regulatory approval is expensed as it does not have an alternative future use and is recorded as research and development expense.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with IPR&amp;D in an asset acquisition incurred at or after regulatory approval is usually capitalized as an intangible asset and amortized over the periods in which the related products are expected to contribute to future cash flows.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_322"></div><ix:continuation id="f-430-26" continuedAt="f-430-27"><ix:nonNumeric contextRef="c-1" name="us-gaap:AdvertisingCostsPolicyTextBlock" id="f-488" continuedAt="f-488-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-488-1">We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.</ix:continuation> Advertising expense was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="f-489">194.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="f-490">180.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AdvertisingExpense" scale="6" id="f-491">160.6</ix:nonFraction> million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_325"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeLeasesPolicyTextBlock" id="f-492" escape="true"><ix:continuation id="f-430-27" continuedAt="f-430-28"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease right-of-use assets and liabilities with terms of more than 12 months are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to determine the present value is our collateralized incremental borrowing rate unless the interest rate implicit in the lease is readily determinable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis within operating expenses over the lease term. For finance leases, lease expense is recognized as interest and depreciation; interest using the effective interest method and depreciation on a straight-line basis over the shorter of the estimated useful lives of the assets or, in the instance where title does not transfer at the end of the lease term, the lease term. Short-term leases with lease terms of 12 months or less are not recorded on the balance sheet and are recognized on a straight line basis over the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain lease components and non-lease components. For certain asset classes, we have elected to account for both of those components as a single lease component. We use a portfolio approach to account for the right-of-use assets and liabilities associated with certain machinery and equipment leases. Variable lease payments may include payments associated with non-lease components, payments that do not depend on a rate or index, or other costs. Variable lease payments are recognized in the period in which the obligation for those payments are incurred.</span></div></ix:continuation></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_328"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="f-493" continuedAt="f-493-1" escape="true"><ix:continuation id="f-430-28" continuedAt="f-430-29"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-493-1"><ix:continuation id="f-430-29" continuedAt="f-430-30"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based restricted stock units, or RSUs, at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. We estimate the fair value of these performance/market-based RSUs, or PSUs, at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the PSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of PSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the PSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_331"></div><ix:continuation id="f-430-30" continuedAt="f-430-31"><ix:nonNumeric contextRef="c-1" name="us-gaap:EarningsPerSharePolicyTextBlock" id="f-494" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from RSUs, PSUs, warrants, our senior convertible notes, and collaborative sales-based milestones. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="f-495" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.601%"/><td style="width:0.1%"/></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-496">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-497">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-498">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-499">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-500">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InterestOnConvertibleDebtNetOfTax" scale="6" id="f-501">11.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income - diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-502">587.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-503">554.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLossAttributableToParentDiluted" scale="6" id="f-504">352.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-505">1.46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-506">1.40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareBasic" scale="0" id="f-507">0.88</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-1" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-508">1.42</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-7" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-509">1.30</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-8" decimals="2" name="us-gaap:EarningsPerShareDiluted" scale="0" id="f-510">0.82</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-511">393.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-512">386.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" scale="6" id="f-513">389.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive potential securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborative sales-based milestones</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-73" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-514">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-74" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-515">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-75" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" format="ixt:fixed-zero" scale="6" id="f-516">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-517">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-518">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-78" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-519">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior convertible notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-79" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-520">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-80" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-521">26.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-81" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-522">26.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-82" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-523">2.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-83" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-524">11.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-84" decimals="-5" name="us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" scale="6" id="f-525">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-526">412.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-527">425.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" scale="6" id="f-528">427.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="f-529" continuedAt="f-529-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders were as follows:</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-529-1"><ix:continuation id="f-430-31" continuedAt="f-430-32"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-76" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-530">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-77" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="6" id="f-531">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-78" decimals="-5" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="6" id="f-532">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_334"></div><ix:nonNumeric contextRef="c-1" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="f-533" escape="true"><ix:continuation id="f-430-32"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2023-07, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, or CODM, and included within each reported measure of segment profit or loss. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, reflecting the application of the new standard in each prior reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires greater disaggregation of information about a reporting entity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s effective tax rate reconciliation as well as information on income taxes paid. The ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity&#8217;s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disaggregated disclosure of certain costs and expenses in the notes of the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Securities and Exchange Commission Final Rules Not Yet Implemented</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 6, 2024, the SEC adopted SEC Release Nos. 33-11275; 34-99678, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to require the disclosure of certain climate-related information in registration statements and annual reports, including Scope 1 and 2 emissions and information about climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, a company&#8217;s business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in audited financial statements. The disclosure requirements would have begun phasing in for our reports and registration statements including financial information in the fiscal year ending December 31, 2025, however, in April 2024, the SEC issued an order staying the final rules until the completion of judicial review. The SEC has since indicated that it intends to establish a new implementation period following the stay order. We are currently evaluating the impact of this final rule on our disclosures.</span></div></ix:continuation></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-19</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_340"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CollaborativeArrangementDisclosureTextBlock" id="f-534" continuedAt="f-534-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. Development and Other Agreements</span></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily agreed to jointly develop a certain next-generation CGM product, and potentially additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. In connection with the Restated Collaboration Agreement, we developed, launched and commercialized a CGM product in connection with the collaboration.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $<ix:nonFraction unitRef="usdPerShare" contextRef="c-85" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-535">29.57</ix:nonFraction> per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, we made an initial payment for an upfront fee of $<ix:nonFraction unitRef="usd" contextRef="c-86" decimals="-5" name="dxcm:CollaborativeArrangementUpfrontFee" scale="6" id="f-536">250.0</ix:nonFraction> million through the issuance of <ix:nonFraction unitRef="shares" contextRef="c-87" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="6" id="f-537">7.4</ix:nonFraction> million shares of our common stock. We recorded a $<ix:nonFraction unitRef="usd" contextRef="c-87" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="f-538">217.7</ix:nonFraction> million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-85" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-539">29.57</ix:nonFraction> per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $<ix:nonFraction unitRef="usd" contextRef="c-88" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="f-540">3.2</ix:nonFraction> million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $<ix:nonFraction unitRef="usd" contextRef="c-89" decimals="-5" name="dxcm:CollaborativeResearchAndDevelopmentFee" scale="6" id="f-541">87.1</ix:nonFraction> million research and development charge in our consolidated statements of operations. This charge is associated with in-process research and development obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued <ix:nonFraction unitRef="shares" contextRef="c-90" decimals="INF" name="dxcm:SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" scale="6" id="f-542">2.9</ix:nonFraction> million shares of our common stock in connection with our achievement of the related milestone.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-534-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received approval from the Food and Drug Administration and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $<ix:nonFraction unitRef="usd" contextRef="c-91" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-543">152.4</ix:nonFraction> million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) <ix:nonFraction unitRef="shares" contextRef="c-92" decimals="-5" name="dxcm:PotentialFutureCommonStockIssuableSharesNewIssues" scale="6" id="f-544">5.2</ix:nonFraction> million shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-85" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-545">29.57</ix:nonFraction> per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful life of <ix:nonNumeric contextRef="c-93" name="us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" format="ixt-sec:durmonth" id="f-546">64</ix:nonNumeric> months through March 2028. The related amortization expense is recognized in cost of sales in our consolidated statements of operations and disclosed in Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Intangibles, Net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, we issued <ix:nonFraction unitRef="shares" contextRef="c-94" decimals="-5" name="dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues" scale="6" id="f-547">3.7</ix:nonFraction> million shares of our common stock in connection with our achievement of the first sales-based milestone. See the effective tax rate reconciliation in Note 8 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information on the tax benefits related to the collaboration agreement milestone share-based payments for the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2024, we issued <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-548"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-5" name="dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues" scale="6" id="f-549">1.5</ix:nonFraction></ix:nonFraction> million shares of our common stock in connection with our achievement of the second sales-based milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones were paid in cash or shares of our common stock, at our election.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-21</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_346"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueMeasurementInputsDisclosureTextBlock" id="f-550" continuedAt="f-550-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. Fair Value Measurements</span></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_349"></div><ix:continuation id="f-550-1" continuedAt="f-550-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of our Level 3 financial instruments based on unobservable inputs and other estimation techniques due to the absence of quoted market prices and inherent lack of liquidity.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock" id="f-551" continuedAt="f-551-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2024, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-552">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-553">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-554">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-555">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-100" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-556">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-101" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-557">1,150.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-102" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-558">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-559">1,150.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-104" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-560">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-105" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-561">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-106" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-562">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-563">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-108" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-564">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-109" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-565">511.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-110" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-566">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-567">511.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-568">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-569">1,973.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-570">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-571">1,973.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-572">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-573">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="f-574">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NotesReceivableFairValueDisclosure" scale="6" id="f-575">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-576">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-577">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-578">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-579">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-97" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-580">154.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-98" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-581">1,973.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-99" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-582">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-583">2,138.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-550-2" continuedAt="f-550-3"><ix:continuation id="f-551-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-584">315.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-585">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" format="ixt:fixed-zero" scale="6" id="f-586">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:CashEquivalentsAtCarryingValue" scale="6" id="f-587">315.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-115" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-588">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-116" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-589">1,612.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-117" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-590">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-591">1,612.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-119" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-592">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-120" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-593">184.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-121" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-594">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-595">184.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-123" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-596">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-124" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-597">360.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-125" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-598">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-599">360.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-600">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-601">2,157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:fixed-zero" scale="6" id="f-602">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-603">2,157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-604">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-605">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-606">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsFairValueDisclosure" scale="6" id="f-607">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-112" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" scale="6" id="f-608">331.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-113" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-609">2,157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-114" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:fixed-zero" scale="6" id="f-610">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="f-611">2,488.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-612"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="dxcm:FairValueAssetsLevel3TransfersAmount" format="ixt:fixed-zero" scale="0" id="f-613">no</ix:nonFraction></ix:nonFraction> transfers into or out of Level 3 securities during the twelve months ended December&#160;31, 2024 and 2023.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_355"></div><ix:continuation id="f-550-3" continuedAt="f-550-4"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" id="f-614" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:70.098%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.937%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-615">1,163.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-616">1,262.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-617">1,122.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-618">1,281.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-619">2,286.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:ConvertibleDebtFairValueDisclosures" format="ixt:num-dot-decimal" scale="6" id="f-620">2,544.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Senior Convertible Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_358"></div><ix:continuation id="f-550-4" continuedAt="f-550-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we conduct business globally in many currencies, we are exposed to foreign exchange rate changes. To limit this exposure, we enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally <ix:nonNumeric contextRef="c-133" name="us-gaap:DerivativeTermOfContract" format="ixt-sec:durwordsen" id="f-621">one month</ix:nonNumeric>. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2024 and December&#160;31, 2023, the notional amounts of outstanding foreign currency forward contracts were $<ix:nonFraction unitRef="usd" contextRef="c-134" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-622">66.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-135" decimals="-5" name="us-gaap:DerivativeNotionalAmount" scale="6" id="f-623">71.0</ix:nonFraction> million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-23</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_361"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-550-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-624">119.3</ix:nonFraction> million as of December&#160;31, 2024 and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" scale="6" id="f-625">38.5</ix:nonFraction> million as of December&#160;31, 2023. We include the carrying values of these investments in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-626"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:fixed-zero" scale="0" id="f-627">no</ix:nonFraction></ix:nonFraction> significant impairment losses on assets and liabilities measured at fair value on a non-recurring basis during the twelve months ended December&#160;31, 2024 and December&#160;31, 2023. During the fourth quarter 2022, we vacated a leased building and made it available for sublease, resulting in an impairment of its asset group which consisted primarily of leasehold improvements and right-of-use asset. We recorded $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-628">23.0</ix:nonFraction>&#160;million in impairment losses during the twelve months ended December&#160;31, 2022. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Other Commitments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-24</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_367"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:AdditionalFinancialInformationDisclosureTextBlock" id="f-629" continuedAt="f-629-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. Balance Sheet Details and Other Financial Information</span></div></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_370"></div><ix:continuation id="f-629-1" continuedAt="f-629-2"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Marketable Securities</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock" id="f-630" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:7pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></div></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-631">1,149.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-632">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-633">0.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-103" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-634">1,150.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-635">312.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-636">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-637">0.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-107" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-638">312.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-639">511.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-640">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-641">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-111" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-642">511.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-643">1,972.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-644">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-645">1.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-646">1,973.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:48.169%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.039%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-647">1,611.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-648">1.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-649">0.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-118" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-650">1,612.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-651">184.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" format="ixt:fixed-zero" scale="6" id="f-652">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-653">0.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-122" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-654">184.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" scale="6" id="f-655">360.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-656">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-657">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-126" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" scale="6" id="f-658">360.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" format="ixt:num-dot-decimal" scale="6" id="f-659">2,157.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" scale="6" id="f-660">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" scale="6" id="f-661">0.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" format="ixt:num-dot-decimal" scale="6" id="f-662">2,157.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the estimated market values of our short-term debt securities with contractual maturities up to <ix:nonNumeric contextRef="c-71" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="f-663">12</ix:nonNumeric> months and up to <ix:nonNumeric contextRef="c-72" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="f-664">18</ix:nonNumeric> months were $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-665">1.73</ix:nonFraction>&#160;billion and $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" format="ixt:num-dot-decimal" scale="6" id="f-666">247.7</ix:nonFraction>&#160;million, respectively. As of December 31, 2023, the estimated market value of our short-term debt securities with contractual maturities up to <ix:nonNumeric contextRef="c-7" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durmonth" id="f-667">12</ix:nonNumeric> months was $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-7" name="us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent" format="ixt:num-dot-decimal" scale="9" id="f-668">2.16</ix:nonFraction>&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the twelve months ended December&#160;31, 2024, 2023 and 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2024 were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_373"></div><ix:continuation id="f-629-2" continuedAt="f-629-3"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, unrealized gains or losses on equity investments were <ix:nonFraction unitRef="usd" contextRef="c-1" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-669">not</ix:nonFraction> significant. During the twelve months ended December&#160;31, 2023, and 2022, we had <ix:nonFraction unitRef="usd" contextRef="c-7" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-670"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="INF" name="us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss" format="ixt:fixed-zero" scale="0" id="f-671">no</ix:nonFraction></ix:nonFraction> unrealized gains or losses on equity investments. Realized gains from the sale of an equity investment were not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-25</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_376"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-629-3" continuedAt="f-629-4"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" id="f-672" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsReceivableGross" format="ixt:num-dot-decimal" scale="6" id="f-673">1,014.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableGross" scale="6" id="f-674">983.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-675">9.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AllowanceForDoubtfulAccountsReceivable" scale="6" id="f-676">9.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts receivable, net</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsReceivableNet" format="ixt:num-dot-decimal" scale="6" id="f-677">1,005.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsReceivableNet" scale="6" id="f-678">973.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve for prompt payment cash discounts recorded against accounts receivable, excluding allowance for doubtful accounts, was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount" format="ixt:num-dot-decimal" scale="6" id="f-679">17.3</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount" format="ixt:num-dot-decimal" scale="6" id="f-680">13.7</ix:nonFraction>&#160;million, $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount" format="ixt:num-dot-decimal" scale="6" id="f-681">8.3</ix:nonFraction>&#160;million as of December&#160;31, 2024, 2023, and 2022, respectively.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_379"></div><ix:continuation id="f-629-4" continuedAt="f-629-5"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="f-682" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-683">327.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="6" id="f-684">319.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-685">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="6" id="f-686">30.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-687">187.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="6" id="f-688">210.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-689">542.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:InventoryNet" scale="6" id="f-690">559.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, 2023 and 2022, we recorded excess and obsolete inventory charges of $<ix:nonFraction unitRef="usd" contextRef="c-136" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="f-691">53.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-137" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="f-692">16.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-138" decimals="-5" name="us-gaap:InventoryWriteDown" scale="6" id="f-693">13.9</ix:nonFraction> million respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_382"></div><ix:continuation id="f-629-5" continuedAt="f-629-6"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Prepaid and Other Current Assets</span></td></tr></table><ix:nonNumeric contextRef="c-1" name="dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock" id="f-694" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-695">76.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PrepaidExpenseCurrent" scale="6" id="f-696">58.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-697">11.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:PrepaidInventoryCurrent" scale="6" id="f-698">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-699">18.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:DeferredCompensationPlanAssetsCurrent" scale="6" id="f-700">15.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-701">27.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:IncomeTaxesReceivable" scale="6" id="f-702">13.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-703">39.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsCurrent" scale="6" id="f-704">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-705">173.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="6" id="f-706">168.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_385"></div><ix:continuation id="f-629-6" continuedAt="f-629-7"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="f-707" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-139" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-708">53.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-140" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-709">34.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Building</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-141" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-710">291.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-142" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-711">190.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-67" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-712">40.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-143" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-713">36.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-144" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-714">76.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-145" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-715">65.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-146" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-716">908.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-147" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-717">683.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-148" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-718">293.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-149" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-719">283.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-150" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-720">354.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-151" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentGross" scale="6" id="f-721">328.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-722">2,018.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-723">1,622.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-724">678.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" scale="6" id="f-725">509.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-726">1,339.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" format="ixt:num-dot-decimal" scale="6" id="f-727">1,113.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2024, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-728">181.2</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-729">147.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:Depreciation" scale="6" id="f-730">144.1</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2024, 2023 and 2022 recorded in operating expenses was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-731">5.1</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-732">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="6" id="f-733">2.2</ix:nonFraction> million, respectively.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-26</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_388"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-629-7" continuedAt="f-629-8"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;Intangibles, Net</span></div></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="f-734" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of December&#160;31, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible asset</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-152" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-735">3.3</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-736">152.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-737">59.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-152" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-738">92.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-153" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-739">1.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-740">17.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-741">13.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-153" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-742">4.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-154" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-743">7.2</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-744">19.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-745">14.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-154" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-746">4.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-155" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-747">1.6</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-748">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-749">2.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-155" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-750">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-156" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-751">0.0</ix:nonNumeric></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-752">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-753">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-156" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-754">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-755">3.4</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-756">193.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-757">90.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-758">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:45.829%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-157" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-759">4.3</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-760">152.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-761">31.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-157" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-762">121.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-158" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-763">2.4</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-764">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-765">15.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-158" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-766">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-159" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-767">0.8</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-768">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-769">12.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-159" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-770">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-160" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-771">2.6</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-772">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-773">2.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-160" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-774">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-161" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-775">0.0</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-776">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-777">0.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-161" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" format="ixt:fixed-zero" scale="6" id="f-778">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-6" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" format="ixt-sec:duryear" id="f-779">4.1</ix:nonNumeric></span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="6" id="f-780">195.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="6" id="f-781">61.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-782">134.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 2 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Development and Other Agreements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Excludes Verily intangible asset.</span></div></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" id="f-783" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total amortization expense of finite-lived intangible assets for the twelve months ended December&#160;31, 2024, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:50.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.543%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.546%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales" scale="6" id="f-784">29.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales" scale="6" id="f-785">30.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales" scale="6" id="f-786">4.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-787">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-788">8.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="f-789">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization of intangible assets</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" scale="6" id="f-790">36.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" scale="6" id="f-791">38.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" scale="6" id="f-792">11.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="f-793" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents estimated future amortization of the Company&#8217;s finite-lived intangible assets as of December&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="6" id="f-794">32.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="6" id="f-795">31.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="6" id="f-796">29.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="6" id="f-797">7.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" scale="6" id="f-798">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" scale="6" id="f-799">1.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="6" id="f-800">103.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-27</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_391"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-629-8" continuedAt="f-629-9"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Assets</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsTableTextBlock" id="f-801" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-802">119.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:LongTermInvestments" scale="6" id="f-803">38.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-804">13.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:LongTermDeposits" scale="6" id="f-805">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-806">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:OtherLongTermAssets" scale="6" id="f-807">22.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-808">173.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAssetsNoncurrent" scale="6" id="f-809">75.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_394"></div><ix:continuation id="f-629-9" continuedAt="f-629-10"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="f-810" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-811">345.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="f-812">276.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFeesCurrent" scale="6" id="f-813">38.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:AccruedTaxAuditAndLegalFeesCurrent" scale="6" id="f-814">42.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:PharmacyRebatesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-815">1,135.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:PharmacyRebatesCurrent" scale="6" id="f-816">950.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-817">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-818">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax payable</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-819">3.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccruedIncomeTaxesCurrent" scale="6" id="f-820">7.5</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-821">18.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredCompensationLiabilityCurrent" scale="6" id="f-822">15.2</ix:nonFraction></span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-823">37.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="6" id="f-824">40.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-825">1,585.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="6" id="f-826">1,345.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_397"></div><ix:continuation id="f-629-10" continuedAt="f-629-11"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Payroll and Related Expenses</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" id="f-827" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-828">74.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:AccruedWagesBonusesAndTaxesCurrent" scale="6" id="f-829">139.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-830">37.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AccruedEmployeeBenefitsCurrent" scale="6" id="f-831">31.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-832">112.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" scale="6" id="f-833">171.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_400"></div><ix:continuation id="f-629-11" continuedAt="f-629-12"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Warranty</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock" id="f-834" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-835">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-836">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-837">12.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" scale="6" id="f-838">47.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" scale="6" id="f-839">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses" scale="6" id="f-840">43.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-841">53.9</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-842">51.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ProductWarrantyAccrualPayments" scale="6" id="f-843">43.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-844">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-845">12.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:StandardProductWarrantyAccrual" scale="6" id="f-846">12.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_403"></div><ix:continuation id="f-629-12" continuedAt="f-629-13"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Long-Term Liabilities</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" id="f-847" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease obligations</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-848">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-849">58.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-850">9.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="6" id="f-851">7.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset retirement obligation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetRetirementObligation" scale="6" id="f-852">17.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetRetirementObligation" scale="6" id="f-853">15.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-854">44.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:OtherTaxLiabilitiesNoncurrent" scale="6" id="f-855">38.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-856">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="6" id="f-857">5.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-858">147.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:OtherLiabilitiesNoncurrent" scale="6" id="f-859">125.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-28</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_406"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-629-13"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div></td></tr></table><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" id="f-860" escape="true"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and dividend income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-861">134.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-862">135.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InvestmentIncomeInterestAndDividend" scale="6" id="f-863">23.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-864">19.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-865">20.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InterestExpenseNonoperating" scale="6" id="f-866">18.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-867">6.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-868">2.0</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OtherNonoperatingExpense" scale="6" id="f-869">5.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-870">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-871">112.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-872">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></ix:nonNumeric></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-29</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_412"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:DebtDisclosureTextBlock" id="f-873" continuedAt="f-873-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. Debt</span></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_415"></div><ix:continuation id="f-873-1" continuedAt="f-873-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Senior Convertible Notes</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" id="f-874" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-127" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-875">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-128" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-876">1,207.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-129" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-877">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-130" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-878">1,250.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-879">2,457.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="6" id="f-880">2,457.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-881">16.1</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:UnamortizedDebtIssuanceExpense" scale="6" id="f-882">23.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amount of senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-131" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-883">2,441.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-132" decimals="-5" name="us-gaap:ConvertibleNotesPayable" format="ixt:num-dot-decimal" scale="6" id="f-884">2,434.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ConvertibleDebtTableTextBlock" id="f-885" continuedAt="f-885-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-162" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-886">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-163" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-887">56.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-164" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-888">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-165" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-889">33.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-166" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" format="ixt:fixed-zero" scale="6" id="f-890">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-167" decimals="-5" name="us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" scale="6" id="f-891">89.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock" id="f-892" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:57.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.353%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual coupon interest</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-893">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-894">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InterestExpenseDebtExcludingAmortization" scale="6" id="f-895">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-896">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-897">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AmortizationOfFinancingCosts" scale="6" id="f-898">5.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-899">14.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-900">16.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InterestExpenseDebt" scale="6" id="f-901">14.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-168" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-902">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-169" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-903">1.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-170" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-904">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-171" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-905">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-172" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-906">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-173" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-907">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-174" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="f-908">0.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:7pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on our unsecured senior convertible notes due 2023, or the 2023 Notes, began accruing upon issuance and was payable semi-annually on June 1 and December 1 of each year until the 2023 Notes matured on December 1, 2023. Interest on our unsecured senior convertible notes due 2025, or the 2025 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on our unsecured senior convertible notes due 2028, or the 2028 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The 2023 Notes matured on December 1, 2023 and are no longer outstanding.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding in the relevant period.</span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-30</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_418"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Convertible Debt Summary</span></div><ix:continuation id="f-885-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key details of the 2023 Notes, 2025 Notes, and 2028 Notes:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.326%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.180%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.204%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.373%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.695%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.260%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Senior Convertible Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Offering Completion Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Maturity Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stated Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Principal Amount<br/>Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Proceeds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Initial Conversion Rate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(per $1,000 principal amount)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Conversion Price<br/>(per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Settlement Methods</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023 Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">November 2018</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;1, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-909">0.75</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-175" decimals="INF" name="us-gaap:DebtInstrumentFaceAmount" scale="6" id="f-910">850.0</ix:nonFraction> million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:ProceedsFromConvertibleDebt" scale="6" id="f-911">836.6</ix:nonFraction> million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24.3476&#160;shares </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-912">41.07</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">November&#160;15, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-177" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-913">0.25</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-177" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" scale="9" id="f-914">1.21</ix:nonFraction> billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-178" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" scale="9" id="f-915">1.19</ix:nonFraction> billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.6620 shares </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-177" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-916">150.11</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May&#160;15, 2028</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-179" decimals="INF" name="us-gaap:DebtInstrumentInterestRateStatedPercentage" scale="-2" id="f-917">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-179" decimals="-7" name="us-gaap:DebtInstrumentFaceAmount" format="ixt:num-dot-decimal" scale="9" id="f-918">1.25</ix:nonFraction>&#160;billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-7" name="us-gaap:ProceedsFromConvertibleDebt" format="ixt:num-dot-decimal" scale="9" id="f-919">1.23</ix:nonFraction>&#160;billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.1571 shares</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usdPerShare" contextRef="c-179" decimals="2" name="us-gaap:DebtInstrumentConvertibleConversionPrice1" scale="0" id="f-920">162.41</ix:nonFraction></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Net proceeds are calculated by deducting the initial purchasers&#8217; discounts and estimated costs directly related to the offering from the aggregate principal amount of the applicable series of notes.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Subject to adjustments as defined in the applicable indentures.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2025 Notes and 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The 2023 Notes, while outstanding, could be settled in cash, stock, or a combination thereof, solely at our discretion.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2023 Notes matured on December&#160;1, 2023 and are no longer outstanding.</span></div></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We use the if-converted method for assumed conversion of our senior convertible notes to compute the weighted average shares of common stock outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No principal payments are due on any of our senior convertible notes prior to maturity. Other than restrictions relating to certain fundamental changes and consolidations, mergers or asset sales and customary anti-dilution adjustments, the indentures relating to our senior convertible notes include customary terms and covenants, including certain events of default after which the senior convertible notes may be due and payable immediately.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Note Hedge</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the offering of the 2023 Notes, in November 2018 we entered into convertible note hedge transactions, or the 2023 Note Hedge, with <ix:nonFraction unitRef="purchaser" contextRef="c-181" decimals="INF" name="dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" format="ixt-sec:numwordsen" scale="0" id="f-921">two</ix:nonFraction> of the initial purchasers of the 2023 Notes, which we refer to as the 2023 Counterparties, entitling us to purchase up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-182" decimals="-5" name="dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" scale="6" id="f-922">20.7</ix:nonFraction> million&#160;shares of our common stock. The 2023 Note Hedge expired on December&#160;1, 2023. See below for a description of conversion activity related to the 2023 Notes and shares received as the result of exercising the remaining portion of the 2023 Note Hedge in 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Warrants</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2018, we also sold warrants, or the 2023 Warrants, to the 2023 Counterparties to acquire up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-176" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="6" id="f-923">20.7</ix:nonFraction> million shares of our common stock. The 2023 Warrants required net share settlement and a pro-rated number of warrants expired on each of the <ix:nonFraction unitRef="d" contextRef="c-176" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-924">60</ix:nonFraction> scheduled trading days following March&#160;1, 2024. We received&#160;$<ix:nonFraction unitRef="usd" contextRef="c-176" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfWarrants" scale="6" id="f-925">183.8</ix:nonFraction> million&#160;in cash proceeds from the sale of the 2023 Warrants, which we recorded in&#160;additional paid-in capital during 2018. The 2023 Warrants could have had a dilutive effect on our earnings per share to the extent that the price of our common stock during a given measurement period exceeded the strike price of the 2023 Warrants. The strike price of the 2023 Warrants was initially $<ix:nonFraction unitRef="usdPerShare" contextRef="c-175" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="f-926">49.60</ix:nonFraction> per share, subject to certain adjustments under the terms of the warrant agreements. We use the treasury share method for assumed conversion of the 2023 Warrants when computing the weighted average common shares outstanding for diluted earnings per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 13, 2024, we entered into a warrant termination agreement with one of the 2023 Counterparties to terminate outstanding warrants to purchase an aggregate of <ix:nonFraction unitRef="shares" contextRef="c-183" decimals="-5" name="us-gaap:DebtConversionConvertedInstrumentSharesIssued1" scale="6" id="f-927">10.3</ix:nonFraction> million shares of our common stock. In consideration of the termination of these warrants, we delivered <ix:nonFraction unitRef="shares" contextRef="c-184" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-928">6.0</ix:nonFraction> million shares of our common stock to the holder.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the first quarter of 2024, a portion of the 2023 Warrants was exercised and we issued <ix:nonFraction unitRef="shares" contextRef="c-185" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-929">1.9</ix:nonFraction> million shares of our common stock in addition to the aforementioned <ix:nonFraction unitRef="shares" contextRef="c-184" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-930">6.0</ix:nonFraction> million shares issued in connection with the warrant termination agreement.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the second quarter of 2024, the remaining portion of the 2023 Warrants was exercised and we issued <ix:nonFraction unitRef="shares" contextRef="c-186" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" scale="6" id="f-931">4.6</ix:nonFraction> million shares of our common stock in connection with the exercise.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2028 Capped Call Transactions</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2023, in connection with the offering of the 2028 Notes, we entered into privately negotiated capped call transactions, or the 2028 Capped Calls, with certain financial institutions. The 2028 Capped Calls cover, subject to anti-dilution adjustments substantially similar to those applicable to the 2028 Notes, the number of shares of our common stock initially underlying the 2028 Notes. The 2028 Capped Calls are expected generally to reduce potential dilution to our common stock upon conversion of the 2028 Notes and/or offset any cash payments that we are required to make in excess of the principal amount of converted 2028 Notes, as the case may be, with such reduction and/or offset subject to a cap. The 2028 Capped Calls have an initial cap price of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-187" decimals="INF" name="dxcm:DebtInstrumentCapCallTransactionCapPricePerShare" scale="0" id="f-932">212.62</ix:nonFraction> per share, subject to adjustments, which represents a premium of <ix:nonFraction unitRef="number" contextRef="c-187" decimals="INF" name="dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" scale="-2" id="f-933">80</ix:nonFraction>% over the closing price of our common stock of $<ix:nonFraction unitRef="usdPerShare" contextRef="c-188" decimals="INF" name="us-gaap:SharePrice" scale="0" id="f-934">118.12</ix:nonFraction> per share on the Nasdaq Global Select Market on May&#160;2, 2023. The cost to purchase the 2028 Capped Calls of $<ix:nonFraction unitRef="usd" contextRef="c-180" decimals="-5" name="dxcm:PaymentsForPurchasesOfCappedCallTransactions" scale="6" id="f-935">101.3</ix:nonFraction> million was recorded as a reduction to additional paid-in capital in our consolidated balance sheets as the 2028 Capped Calls met the criteria for classification in stockholders&#8217; equity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Activity for Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2023 Notes matured on December&#160;1, 2023 and all outstanding principal was settled. There was no conversion activity for the 2025 Notes or 2028 Notes for the twelve months ended December&#160;31, 2024. <ix:nonNumeric contextRef="c-1" name="dxcm:ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" id="f-936" continuedAt="f-936-1" escape="true">See the following table for the details of conversion activity for the 2023 Notes for the fiscal year ended December 31, 2023:</ix:nonNumeric></span></div><ix:continuation id="f-936-1"><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:22.730%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.935%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.344%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.147%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Converted Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Principal Amount Converted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Issued for Settlement</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Received from Exercise of 2023 Note Hedge</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1/1/2023 - 12/31/2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="c-189" decimals="-5" name="dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" scale="6" id="f-937">774.8</ix:nonFraction> million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-189" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:num-dot-decimal" scale="6" id="f-938">12.2</ix:nonFraction>&#160;million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-189" decimals="-5" name="dxcm:SharesReceivedFromBenefitOfNoteHedge" scale="6" id="f-939">12.2</ix:nonFraction> million</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Conversion Rights for Senior Convertible Notes</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our outstanding senior convertible notes have the right to require us to repurchase for cash all or a portion of their notes at <ix:nonFraction unitRef="number" contextRef="c-190" decimals="INF" name="dxcm:DebtInstrumentCovenantRepurchasePricePercentage" scale="-2" id="f-940">100</ix:nonFraction>% of their principal amount, plus any accrued and unpaid interest, upon the occurrence of a fundamental change (as defined in the applicable indenture relating to the notes). We are also required to increase the conversion rate for holders who convert their notes in connection with certain fundamental changes occurring prior to the maturity date or following the delivery by Dexcom of a notice of redemption.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table outlines the conversion options related for each of our senior convertible notes:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.122%"><tr><td style="width:1.0%"/><td style="width:16.451%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.389%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.760%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Conversions Rights at the Option of the Holders for the 2025 Notes and 2028 Notes, which we refer to collectively as the Notes</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Conversion Rights at the Option of the Holders</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes have the ability to convert all or a portion of their notes in multiples of $1,000 principal amount, at their option prior to 5:00 p.m., New York City time, on the business day immediately preceding August&#160;15, 2025 and February&#160;15, 2028 for the 2025 Notes and 2028 Notes, respectively, only under the following circumstances:</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circumstance 1</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During any calendar quarter commencing after the applicable period (and only during such calendar quarter), if the last reported sale price of Dexcom&#8217;s common stock for at least <ix:nonFraction unitRef="d" contextRef="c-191" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-941">20</ix:nonFraction> trading days (whether or not consecutive) during the period of <ix:nonFraction unitRef="d" contextRef="c-192" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-942">30</ix:nonFraction> consecutive trading days ending on the last trading day of the immediately preceding calendar quarter is greater than or equal to <ix:nonFraction unitRef="number" contextRef="c-191" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-943">130</ix:nonFraction>% of the applicable conversion price for the Notes on each applicable trading day</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circumstance 2</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the <ix:nonFraction unitRef="trading_day" contextRef="c-193" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-944">five</ix:nonFraction> business day period after any <ix:nonFraction unitRef="trading_day" contextRef="c-194" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-945">five</ix:nonFraction> consecutive trading day period in which the trading price per $1,000 principal amount of the Notes for each trading day of that <ix:nonFraction unitRef="trading_day" contextRef="c-194" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" format="ixt-sec:numwordsen" scale="0" id="f-946">five</ix:nonFraction> consecutive trading day period was less than <ix:nonFraction unitRef="number" contextRef="c-194" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" scale="-2" id="f-947">98</ix:nonFraction>% of the product of the last reported sale price of Dexcom&#8217;s common stock and the applicable conversion rate of the Notes on each such trading day</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circumstance 3</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we call any or all of the Notes for redemption, at any time prior to the close of business on the scheduled trading day immediately preceding the redemption date (only with respect to the notes called or deemed called for redemption)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circumstance 4</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon the occurrence of specified corporate events</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Circumstance 5</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the Notes may convert all or a portion of their Notes regardless of the foregoing circumstances prior to the close of business on the business day immediately preceding the maturity date for the 2025 Notes and prior to the close of business on the second scheduled trading day immediately preceding the maturity date for the 2028 Notes</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Circumstance 1 is available after the calendar quarter ended September&#160;30, 2020 and September&#160;30, 2023 for the 2025 Notes and 2028 Notes, respectively.</span></div></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Circumstance 5 is available on or after August&#160;15, 2025 and February&#160;15, 2028 for the 2025 Notes and 2028 Notes, respectively. </span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:16.297%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:80.919%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Conversion Right at the Option of the Company for the 2025 Notes and 2028 Notes</span></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Conversion Right at Our Option</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom may redeem for cash all or part of the Notes, at its option, if the last reported sale price of our common stock has been at least <ix:nonFraction unitRef="number" contextRef="c-162" decimals="INF" name="dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" scale="-2" id="f-948">130</ix:nonFraction>% of the conversion price then in effect for at least <ix:nonFraction unitRef="trading_day" contextRef="c-195" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-949">20</ix:nonFraction> trading days (whether or not consecutive) during any <ix:nonFraction unitRef="trading_day" contextRef="c-196" decimals="INF" name="us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" scale="0" id="f-950">30</ix:nonFraction> consecutive trading day period ending on, and including, the trading day immediately preceding the date on which Dexcom provides notice of redemption. The redemption price will be equal to <ix:nonFraction unitRef="number" contextRef="c-162" decimals="INF" name="us-gaap:DebtInstrumentRedemptionPricePercentage" scale="-2" id="f-951">100</ix:nonFraction>% of the principal amount of the Notes to be redeemed plus accrued and unpaid interest to, but excluding, the redemption date</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"/></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Dexcom does not have the right to redeem the Notes prior to May&#160;20, 2023 and May&#160;20, 2026 for the 2025 Notes and 2028 Notes, respectively. Dexcom has the right to redeem the notes on or after May&#160;20, 2023 and prior to August&#160;15, 2025 for the 2025 Notes, and on or after May&#160;20, 2026 and prior to February&#160;15, 2028 for the 2028 Notes.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-33</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_430"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-873-2"><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement, as amended, or the Amended Credit Agreement, which we had previously entered into in October 2021. The Amended Credit Agreement is a <ix:nonNumeric contextRef="c-197" name="us-gaap:DebtInstrumentTerm" format="ixt-sec:durwordsen" id="f-952">five-year</ix:nonNumeric> revolving credit facility, or the Credit Facility, that provides for an available principal amount of $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-953">200.0</ix:nonFraction> million which can be increased up to $<ix:nonFraction unitRef="usd" contextRef="c-198" decimals="INF" name="dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" scale="6" id="f-954">500.0</ix:nonFraction> million at our option subject to customary conditions and approval of our lenders. The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock" id="f-955" continuedAt="f-955-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:84.864%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.936%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available principal amount </span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-956">200.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="f-957">25.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-199" decimals="-5" name="us-gaap:LineOfCredit" format="ixt:fixed-zero" scale="6" id="f-958">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-200" decimals="-5" name="us-gaap:LettersOfCreditOutstandingAmount" scale="6" id="f-959">7.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity" scale="6" id="f-960">192.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. <ix:continuation id="f-955-1" continuedAt="f-955-2">The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Loan, each as defined in the Amended Credit Agreement under the captions &#8220;ABR Spread&#8221;, &#8220;Term Benchmark&#8221;, and &#8220;RFR Spread&#8221;, or &#8220;Unused Commitment Fee Rate&#8221;, respectively, are outlined in the following table:</ix:continuation></span></div><ix:continuation id="f-955-2"><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:17.961%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.879%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:25.881%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ABR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term Benchmark/RFR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unused Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-201" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-961">0.375</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-202" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-962">1.375</ix:nonFraction>%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-203" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-963">0.175</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maximum</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-204" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-964">1.000</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-205" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="f-965">2.000</ix:nonFraction>%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-206" decimals="INF" name="us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" scale="-2" id="f-966">0.250</ix:nonFraction>%</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we have no other material guarantee facilities or lines of credit.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-34</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_439"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeFinanceLeasesTextBlock" id="f-971" continuedAt="f-971-1" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeasesTextBlock" id="f-970" continuedAt="f-970-1" escape="true"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. Leases and Other Commitments</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_442"></div><ix:continuation id="f-971-1" continuedAt="f-971-2"><ix:continuation id="f-970-1" continuedAt="f-970-2"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have leases for certain machinery and facilities, including office, manufacturing and warehouse space facilities under various domestic and international operating and finance lease arrangements. We also have land leases in Penang, Malaysia that expire through 2082 and in Athenry, Ireland that expire in 3023 for the build-out of our international manufacturing facilities. Our leases, excluding our land leases in Malaysia and Ireland, have remaining lease terms of up to <ix:nonNumeric contextRef="c-70" name="us-gaap:LesseeOperatingLeaseRemainingLeaseTerm" format="ixt-sec:durwordsen" id="f-972">sixteen years</ix:nonNumeric>. Some of the leases include <ix:nonFraction unitRef="extensionoption" contextRef="c-69" decimals="INF" name="dxcm:LesseeOperatingLeaseNumberOfOptionsToExtend" format="ixt-sec:numwordsen" scale="0" id="f-973">one</ix:nonFraction> or more options to extend the leases for up to <ix:nonNumeric contextRef="c-70" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="f-974">five years</ix:nonNumeric> per option. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="f-976" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="f-975" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:75.508%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.867%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-977">26.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="6" id="f-978">9.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-979">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="6" id="f-980">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-981">20.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="6" id="f-982">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-983">15.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="6" id="f-984">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-985">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="6" id="f-986">5.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-987">6.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="6" id="f-988">54.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future lease cost</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="6" id="f-989">99.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="6" id="f-990">90.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-991">12.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="6" id="f-992">26.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of future payments</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiability" scale="6" id="f-993">87.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiability" scale="6" id="f-994">64.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-995">Less: Current portion</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="6" id="f-996">22.5</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="6" id="f-997">6.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term portion</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="6" id="f-998">65.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="6" id="f-999">58.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="f-1000">17.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:AssetRetirementObligation" format="ixt:num-dot-decimal" scale="6" id="f-1001">15.7</ix:nonFraction>&#160;million as of December&#160;31, 2024 and 2023, respectively, are included in <span style="-sec-ix-hidden:f-1002"><span style="-sec-ix-hidden:f-1003">other long-term liabilities</span></span> in our consolidated balance sheets.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LeaseCostTableTextBlock" id="f-1004" continuedAt="f-1004-1" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-1005">7.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-1006">6.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="6" id="f-1007">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="f-1008">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="f-1009">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:FinanceLeaseInterestExpense" scale="6" id="f-1010">3.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1011">22.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1012">22.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingLeaseCost" scale="6" id="f-1013">22.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use asset impairment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-1014">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" format="ixt:fixed-zero" scale="6" id="f-1015">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingLeaseImpairmentLoss" scale="6" id="f-1016">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-1017">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-1018">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ShortTermLeaseCost" scale="6" id="f-1019">3.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-1020">9.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-1021">8.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:VariableLeaseCost" scale="6" id="f-1022">8.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1023">45.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1024">43.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:LeaseCost" scale="6" id="f-1025">49.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-971-2" continuedAt="f-971-3"><ix:continuation id="f-970-2" continuedAt="f-970-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the result of the Company&#8217;s transition to a flexible working environment, we vacated a building in San Diego during the fourth quarter of 2022 and made it available for sublease. This resulted in an impairment indicator. We tested the asset group as of November 30, 2022 consisting primarily of the leasehold improvements and right-of-use asset for recoverability by comparing its carrying value to an estimate of future undiscounted cash flows. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group were below its carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the asset group by discounting the estimated future cash flows using level 3 fair value inputs under ASC 820 as described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. As a result of the impairment test, we recorded a non-cash charge of $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ImpairmentOfLongLivedAssetsHeldForUse" format="ixt:num-dot-decimal" scale="6" id="f-1026">23.0</ix:nonFraction>&#160;million for the twelve months ended December 31, 2022 in the &#8220;<span style="-sec-ix-hidden:f-1027">Selling, general and administrative</span>&#8221; caption of our consolidated statements of operations. The fair value of the asset group immediately subsequent to the impairment was $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:ImpairedLongLivedAssetsFairValue" format="ixt:num-dot-decimal" scale="6" id="f-1028">2.5</ix:nonFraction>&#160;million and was categorized as Level 3 within the ASC 820, &#8220;Fair Value Measurements&#8221; fair value hierarchy.</span></div><ix:continuation id="f-1004-1"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to our leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.642%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1029">27.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1030">28.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingLeasePayments" scale="6" id="f-1031">26.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-1032">3.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-1033">3.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="6" id="f-1034">3.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1035">13.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1036">4.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:FinanceLeasePrincipalPayments" scale="6" id="f-1037">15.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1038">8.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1039">7.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="6" id="f-1040">15.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1041">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1042">4.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="6" id="f-1043">16.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1044">4.2</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1045">5.0</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-25" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1046">5.5</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1047">12.6</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-6" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1048">14.1</ix:nonNumeric> years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-25" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="f-1049">15.2</ix:nonNumeric> years</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1050">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1051">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-25" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1052">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-5" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1053">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-6" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1054">5.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-25" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="f-1055">5.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" scale="6" id="f-1056">16.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" scale="6" id="f-1057">16.5</ix:nonFraction> million, and $<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:LesseeOperatingLeasesLeaseCostAmortization" scale="6" id="f-1058">16.4</ix:nonFraction> million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_445"></div><ix:continuation id="f-971-3" continuedAt="f-971-4"><ix:continuation id="f-970-3" continuedAt="f-970-4"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-971-4"><ix:continuation id="f-970-4">We are party to various purchase arrangements related to our operational, manufacturing, and research and development activities. We had approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" scale="6" id="f-1059">954.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear" scale="6" id="f-1060">793.0</ix:nonFraction> million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within <ix:nonNumeric contextRef="c-1" name="dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" format="ixt-sec:durwordsen" id="f-1061"><ix:nonNumeric contextRef="c-7" name="dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" format="ixt-sec:durwordsen" id="f-1062">one year</ix:nonNumeric></ix:nonNumeric>, as of December&#160;31, 2024 and December&#160;31, 2023, respectively</ix:continuation></ix:continuation>.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-36</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_448"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:LegalMattersAndContingenciesTextBlock" id="f-1063" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. Contingencies</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between June 2021 through the year ended December&#160;31, 2024, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities served patent infringement complaints against each other in multiple jurisdictions against certain continuous glucose monitoring products of each company. On December 20, 2024, we and Abbott entered into a settlement and patent cross license agreement (the &#8220;Settlement Agreement&#8221;) to resolve all outstanding patent litigation between the parties (the &#8220;Litigation&#8221;). Under the terms of the Settlement Agreement, we granted Abbott and its affiliates, and Abbott and its affiliates granted Dexcom and its affiliates, a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation. The Settlement Agreement does not obligate us or Abbott to pay any royalties or any other form of financial compensation. As part of the Settlement Agreement, each party, on behalf of itself and its affiliates, has also (i) entered into a covenant not to sue until December 20, 2034; and (ii) agreed on behalf of themselves and their affiliates to refrain from challenging the patents and patent applications licensed under the Settlement Agreement for periods of time which vary depending on the relevant patents or patent applications.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding the securities class action litigation and the derivative action, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to defend against these claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-37</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_451"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:IncomeTaxDisclosureTextBlock" id="f-1064" continuedAt="f-1064-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. Income Taxes</span></td></tr></table></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" id="f-1065" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1066">659.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1067">732.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" scale="6" id="f-1068">463.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1069">49.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1070">22.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" scale="6" id="f-1071">72.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1072">709.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1073">710.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1074">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" id="f-1075" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1076">157.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1077">149.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CurrentFederalTaxExpenseBenefit" scale="6" id="f-1078">32.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1079">16.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1080">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CurrentStateAndLocalTaxExpenseBenefit" scale="6" id="f-1081">26.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1082">2.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1083">56.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CurrentForeignTaxExpenseBenefit" scale="6" id="f-1084">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income taxes</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1085">176.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1086">223.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CurrentIncomeTaxExpenseBenefit" scale="6" id="f-1087">71.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1088">55.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1089">93.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:DeferredFederalIncomeTaxExpenseBenefit" scale="6" id="f-1090">4.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1091">2.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1092">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit" scale="6" id="f-1093">17.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1094">13.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1095">24.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DeferredForeignIncomeTaxExpenseBenefit" scale="6" id="f-1096">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1097">43.8</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1098">55.0</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1099">21.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1100">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1101">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1102">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock" id="f-1104" escape="true"><ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock" id="f-1103" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year of Expiration</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-207" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1105">12.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-208" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1106">20.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-209" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1107">162.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-210" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1108">167.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-211" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1109">5.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-212" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1110">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UK</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-213" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:fixed-zero" scale="6" id="f-1111">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-214" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:fixed-zero" scale="6" id="f-1112">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-215" decimals="-5" name="us-gaap:OperatingLossCarryforwards" format="ixt:fixed-zero" scale="6" id="f-1113">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-216" decimals="-5" name="us-gaap:OperatingLossCarryforwards" scale="6" id="f-1114">6.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-217" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:fixed-zero" scale="6" id="f-1115">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-218" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" format="ixt:fixed-zero" scale="6" id="f-1116">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credits</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-219" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1117">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-220" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1118">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-221" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1119">124.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-222" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1120">111.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California AMT Credits</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-223" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1121">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-224" decimals="-5" name="us-gaap:TaxCreditCarryforwardAmount" scale="6" id="f-1122">0.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr></table></div></ix:nonNumeric></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:UnusedExpiredFederalIncomeTaxCredits" scale="6" id="f-1123">1.1</ix:nonFraction> million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of U.S. research and development tax credits that will expire unused, and is therefore, not reflected in the tax credit carryforwards above. In addition, the related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period.</span></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1064-1" continuedAt="f-1064-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" id="f-1124" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:74.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.598%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1125">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwards" scale="6" id="f-1126">18.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1127">265.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment" scale="6" id="f-1128">233.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="f-1129">79.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" scale="6" id="f-1130">71.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1131">22.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" scale="6" id="f-1132">27.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets" scale="6" id="f-1133">263.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets" scale="6" id="f-1134">279.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="f-1135">87.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" scale="6" id="f-1136">91.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" sign="-" name="dxcm:DeferredTaxAssetsConvertibleDebt" scale="6" id="f-1137">16.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" sign="-" name="dxcm:DeferredTaxAssetsConvertibleDebt" scale="6" id="f-1138">20.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-1139">748.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsGross" scale="6" id="f-1140">741.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1141">221.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1142">264.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-1143">526.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsNet" scale="6" id="f-1144">477.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" scale="6" id="f-1145">59.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" scale="6" id="f-1146">60.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" scale="6" id="f-1147">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxLiabilitiesOther" format="ixt:fixed-zero" scale="6" id="f-1148">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-1149">59.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredIncomeTaxLiabilities" scale="6" id="f-1150">60.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-1151">466.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" scale="6" id="f-1152">416.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we further analyzed the prior year intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries. As a result, we reclassified the specific intellectual property from a patent to patent rights according to Irish law. This changed the applicable enacted statutory tax rate from capital gains to passive at 25%.There was no impact to the income statement as the change in rate was fully offset by a change in valuation allowance. The total ending deferred tax asset as of December&#160;31, 2024 is $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther" format="ixt:num-dot-decimal" scale="6" id="f-1153">142.4</ix:nonFraction>&#160;million, which remains fully offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a valuation allowance of $<ix:nonFraction unitRef="usd" contextRef="c-225" decimals="-5" name="us-gaap:DeferredTaxAssetsValuationAllowance" scale="6" id="f-1154">221.9</ix:nonFraction> million against our California research and development tax credits, foreign tax credits, and certain foreign intangible assets. During the year ended December&#160;31, 2024, the valuation allowance decreased by $<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" scale="6" id="f-1155">42.4</ix:nonFraction> million primarily due to the change in tax rate applied to the fair value of certain intellectual property located in Ireland in connection with the intra-entity transfer of this property, partially offset by the generation of California research and development tax credits.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1064-2" continuedAt="f-1064-3"><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" id="f-1156" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.350%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.600%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. federal statutory tax rate</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1157">148.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1158">149.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" scale="6" id="f-1159">82.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1160">10.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1161">7.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes" scale="6" id="f-1162">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent items</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="f-1163">10.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="f-1164">2.7</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:EffectiveIncomeTaxReconciliationPermanentItems" scale="6" id="f-1165">0.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1166">24.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1167">28.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" scale="6" id="f-1168">23.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credit</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" scale="6" id="f-1169">1.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" format="ixt:fixed-zero" scale="6" id="f-1170">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsForeign" format="ixt:fixed-zero" scale="6" id="f-1171">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1172">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1173">15.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential" scale="6" id="f-1174">27.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1175">3.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1176">5.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" scale="6" id="f-1177">1.2</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration agreement milestone share-based payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" scale="6" id="f-1178">32.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" scale="6" id="f-1179">72.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" scale="6" id="f-1180">52.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="f-1181">51.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="f-1182">19.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate" scale="6" id="f-1183">1.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" format="ixt:fixed-zero" scale="6" id="f-1184">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" scale="6" id="f-1185">63.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" format="ixt:fixed-zero" scale="6" id="f-1186">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-1187">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-1188">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationOtherAdjustments" scale="6" id="f-1189">1.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1190">42.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1191">10.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" scale="6" id="f-1192">8.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes at effective rates</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1193">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1194">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1195">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" id="f-1196" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January&#160;1, 2022</span></div></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1197">46.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1198">0.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1199">6.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1200">52.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions </span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1201">0.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1202">6.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1203">59.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" scale="6" id="f-1204">0.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" scale="6" id="f-1205">6.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefits" scale="6" id="f-1206">66.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" scale="6" id="f-1207">40.7</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1208">37.0</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" format="ixt:num-dot-decimal" scale="6" id="f-1209">32.5</ix:nonFraction>&#160;million, respectively, would affect our annual effective tax rate if recognized. The indirect effect of the unrecognized tax benefits that, if recognized, would affect our annual effective tax rate is not material for all years presented. Also, the amount of unrecognized tax benefits that, if recognized, would result in adjustments to other tax accounts, is not material for all years presented. Interest and penalties are classified as a component of income tax expense and are not material for all years presented. Although the timing and outcome of audit settlements are uncertain, we do not anticipate a significant change to the unrecognized tax benefits in the next twelve months.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1064-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to our global business activities, we file income tax returns and are subject to routine compliance audits in numerous jurisdictions, including those material jurisdictions listed in the following table. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. <ix:nonNumeric contextRef="c-1" name="us-gaap:SummaryOfIncomeTaxExaminationsTextBlock" id="f-1210" continuedAt="f-1210-1" escape="true">The years remaining subject to audit, by major jurisdiction, are as follows:</ix:nonNumeric></span></div><ix:continuation id="f-1210-1"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:86.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.035%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Federal and state)</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1999 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2024</span></td></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate under a Special Corporate Income Tax Preferential rate in the Philippines, which is in effect for the next <ix:nonNumeric contextRef="c-1" name="dxcm:PreferentialTaxRatePeriod" format="ixt-sec:duryear" id="f-1211">10</ix:nonNumeric> years. The prior tax holiday ended in 2023. The impact of the both the tax holiday and preferential rate is immaterial for all years presented. We have been granted a tax incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which provides for a tax holiday of up to <ix:nonNumeric contextRef="c-1" name="dxcm:PossibleExtensionPeriodofTaxHoliday" format="ixt-sec:duryear" id="f-1212">15</ix:nonNumeric> years, which will not be triggered until we meet certain milestones related to the commencement of operations. The tax incentive had no effect on foreign taxes during 2024, 2023, or 2022. As of December&#160;31, 2024, the tax holiday in Malaysia has not yet been triggered, therefore we are subject to the statutory rate and the related tax expense has been included in total tax expense for 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have approximately $<ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:UndistributedEarningsOfForeignSubsidiaries" format="ixt:num-dot-decimal" scale="6" id="f-1213">89.3</ix:nonFraction>&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December&#160;31, 2024. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with these undistributed earnings. If we determine that all or a portion of such foreign earnings are no longer indefinitely reinvested, we may be subject to additional foreign withholding taxes and U.S. state income taxes. Determination of the amount of unrecognized deferred tax liability on these unremitted earnings is not practicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organization for Economic Co-operation and Development has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as Pillar 2), with certain aspects of Pillar 2 effective January 1, 2024 and other aspects effective January 1, 2025. While it is uncertain whether the United States will enact legislation to adopt Pillar 2, certain countries in which we operate have adopted legislation, and other countries in which we operate are in the process of introducing legislation to implement Pillar 2. We have assessed the impact of Pillar 2 on our financial statements and the impact is immaterial.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the State of California enacted S.B. 167, which suspends the use of net operating losses (&#8220;NOLs&#8221;) for the tax period from January 1, 2024 to December 31, 2026 for net business income of $1.0&#160;million or more, as well as limits the utilization of research and development tax credits to $5.0&#160;million each year. The State of California also passed S.B. 175 to provide for a potential early sunset of NOLs in either 2025 or 2026 if necessary. We have analyzed the effect of both these laws on our financial statements. We are estimating $<ix:nonFraction unitRef="usd" contextRef="c-226" decimals="-5" name="us-gaap:IncomeTaxReconciliationTaxCreditsResearch" format="ixt:num-dot-decimal" scale="6" id="f-1214">2.8</ix:nonFraction>&#160;million utilization of our California research and development tax credits for tax year ending December&#160;31, 2024, resulting in a corresponding valuation allowance release of the same amount.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-41</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_454"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:CompensationAndEmployeeBenefitPlansTextBlock" id="f-1215" continuedAt="f-1215-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_457"></div><ix:continuation id="f-1215-1" continuedAt="f-1215-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer various defined contribution plans for U.S. and international employees. The largest defined contribution plan is the 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to <ix:nonFraction unitRef="number" contextRef="c-227" decimals="INF" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" scale="-2" id="f-1216">90</ix:nonFraction>% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match <ix:nonFraction unitRef="number" contextRef="c-227" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" scale="-2" id="f-1217">50</ix:nonFraction>% of contributions up to <ix:nonFraction unitRef="number" contextRef="c-227" decimals="INF" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" scale="-2" id="f-1218">6</ix:nonFraction>% of eligible compensation. Total matching contributions under the 401(k) Plan were $<ix:nonFraction unitRef="usd" contextRef="c-227" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1219">17.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-228" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" scale="6" id="f-1220">14.9</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-229" decimals="-5" name="us-gaap:DefinedContributionPlanCostRecognized" format="ixt:num-dot-decimal" scale="6" id="f-1221">11.1</ix:nonFraction>&#160;million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. Our contributions for other defined contribution plans are not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_460"></div><ix:continuation id="f-1215-2" continuedAt="f-1215-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees may purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. Payroll deductions may not exceed <ix:nonFraction unitRef="number" contextRef="c-5" decimals="INF" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" scale="-2" id="f-1222">10</ix:nonFraction>% of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will be <ix:nonFraction unitRef="number" contextRef="c-1" decimals="INF" name="dxcm:EmployeePurchasePriceFloorPercentage" scale="-2" id="f-1223">85</ix:nonFraction>% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. A total of <ix:nonFraction unitRef="shares" contextRef="c-5" decimals="INF" name="dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" scale="6" id="f-1224">6.0</ix:nonFraction> million shares of common stock are reserved for issuance under the 2015 ESPP. The 2015 ESPP shall continue until the earlier to occur of (a) termination of the 2015 ESPP by our Board of Directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May&#160;28, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued approximately <ix:nonFraction unitRef="shares" contextRef="c-230" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-1225">0.4</ix:nonFraction> million, <ix:nonFraction unitRef="shares" contextRef="c-231" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-1226">0.3</ix:nonFraction> million and <ix:nonFraction unitRef="shares" contextRef="c-232" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" scale="6" id="f-1227">0.3</ix:nonFraction> million shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. As of December&#160;31, 2024, approximately <ix:nonFraction unitRef="shares" contextRef="c-233" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1228">2.1</ix:nonFraction> million shares remained available for future issuance under the 2015 ESPP.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_463"></div><ix:continuation id="f-1215-3" continuedAt="f-1215-4"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, RSUs, and PSUs to employees, directors or consultants of the Company. On May 30, 2019, our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue up to&#160;<ix:nonFraction unitRef="shares" contextRef="c-234" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" scale="6" id="f-1229">39.2</ix:nonFraction> million&#160;shares of our common stock under the 2015 Plan. As of December&#160;31, 2024, approximately <ix:nonFraction unitRef="shares" contextRef="c-235" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1230">12.5</ix:nonFraction> million shares remained available for future issuance under the 2015 Plan. We issue new shares of common stock to satisfy RSU and PSU vesting under our employee equity incentive plans.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="f-1215-4" continuedAt="f-1215-5">RSU awards typically vest in annual installments over <span style="-sec-ix-hidden:f-1231">three</span> or <ix:nonNumeric contextRef="c-237" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1232">four years</ix:nonNumeric> and vesting is subject to continued service. PSUs are granted to a group of senior officers and the number of shares of our common stock to be received at vesting will range from <ix:nonFraction unitRef="number" contextRef="c-238" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1233">0</ix:nonFraction>% to <ix:nonFraction unitRef="number" contextRef="c-239" decimals="INF" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" scale="-2" id="f-1234">200</ix:nonFraction>% of the target award based on the achievement of pre-established performance and market goals. PSUs vest approximately <ix:nonNumeric contextRef="c-240" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="f-1235">three years</ix:nonNumeric> from the date of grant, subject to continued employment through that date and certification by the Compensation Committee</ix:continuation>.</span></div><div id="i6a987b433ae84cbfb2328647e6586107_466"></div><ix:continuation id="f-1215-5" continuedAt="f-1215-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet determined the ultimate disposition of repurchased shares and, consequently, we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1215-6" continuedAt="f-1215-7"><ix:nonNumeric contextRef="c-1" name="dxcm:ScheduleOfTreasuryShareActivityTableTextBlock" id="f-1236" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our treasury share activity for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:62.272%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.527%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.381%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.531%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Notes conversions</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:fixed-zero" scale="6" id="f-1237">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" format="ixt:fixed-zero" scale="6" id="f-1238">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" scale="6" id="f-1239">0.4</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares received from Note Hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" format="ixt:fixed-zero" scale="6" id="f-1240">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" scale="6" id="f-1241">12.2</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="dxcm:SharesReceivedFromExerciseOfNoteHedge" scale="6" id="f-1242">0.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with the Restated Collaboration Agreement</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-1243">1.5</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-1244">3.7</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-1245">2.9</ix:nonFraction>)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2022 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-241" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1246">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-242" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1247">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-243" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1248">6.6</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2023 Share Repurchase Program</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-244" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1249">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-245" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1250">4.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-246" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1251">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2024 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-247" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1252">10.4</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-248" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1253">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-249" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1254">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased with 2028 Notes proceeds</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-250" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1255">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-251" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1256">1.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-252" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:fixed-zero" scale="6" id="f-1257">&#8212;</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-1" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-1258">12.5</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-7" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" format="ixt:fixed-zero" scale="6" id="f-1259">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-8" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" format="ixt:fixed-zero" scale="6" id="f-1260">&#8212;</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-253" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" scale="6" id="f-1261">750.0</ix:nonFraction> million of our outstanding common stock, with a repurchase period ending no later than June 30, 2025 (the &#8220;2024 Share Repurchase Program&#8221;). Repurchases of our common stock under the 2024 Share Repurchase Program were permitted to be made from time to time in the open market, in privately negotiated transactions or by other methods, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act and other applicable federal and state laws and regulations. The 2024 Share Repurchase Program was completed in August 2024. We repurchased <ix:nonFraction unitRef="shares" contextRef="c-254" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1262">10.4</ix:nonFraction> million shares of our common stock for $<ix:nonFraction unitRef="usd" contextRef="c-254" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-1263">750.0</ix:nonFraction> million under the 2024 Share Repurchase Program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="INF" name="dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount" scale="6" id="f-1264">500.0</ix:nonFraction> million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#8220;2023 Share Repurchase Program&#8221;). On October 31, 2023, we entered into an accelerated share repurchase agreement (&#8220;2023 ASR&#8221;) with Bank of America, N.A. to repurchase $<ix:nonFraction unitRef="usd" contextRef="c-255" decimals="INF" name="dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount" scale="6" id="f-1265">500.0</ix:nonFraction> million of our common stock. The final notional amount under the 2023 ASR was $<ix:nonFraction unitRef="usd" contextRef="c-256" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" scale="6" id="f-1266">500.0</ix:nonFraction> million or approximately <ix:nonFraction unitRef="shares" contextRef="c-256" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" scale="6" id="f-1267">4.7</ix:nonFraction> million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2023 ASR, less a discount. The 2023 ASR concluded on December 14, 2023. The 2023 Share Repurchase Program was completed in December 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $<ix:nonFraction unitRef="usd" contextRef="c-257" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-1268">700.0</ix:nonFraction>&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#8220;2022 Share Repurchase Program&#8221;). On August 1, 2022, we entered into an accelerated share repurchase agreement (&#8220;2022 ASR&#8221;) with JPMorgan Chase Bank, National Association to repurchase up to $<ix:nonFraction unitRef="usd" contextRef="c-258" decimals="-5" name="dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount" format="ixt:num-dot-decimal" scale="6" id="f-1269">700.0</ix:nonFraction>&#160;million of our common stock on an accelerated basis. The final notional amount under the 2022 ASR was $<ix:nonFraction unitRef="usd" contextRef="c-259" decimals="-5" name="us-gaap:PaymentsForRepurchaseOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="f-1270">557.7</ix:nonFraction>&#160;million or approximately <ix:nonFraction unitRef="shares" contextRef="c-259" decimals="-5" name="us-gaap:TreasuryStockSharesAcquired" format="ixt:num-dot-decimal" scale="6" id="f-1271">6.6</ix:nonFraction>&#160;million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2022 ASR, less a discount. The 2022 ASR concluded on September 1, 2022. The 2022 Share Repurchase Program and the remaining authorization of $<ix:nonFraction unitRef="usd" contextRef="c-260" decimals="-5" name="srt:StockRepurchaseProgramAuthorizedAmount1" format="ixt:num-dot-decimal" scale="6" id="f-1272">142.3</ix:nonFraction>&#160;million expired on June 30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 ASR and 2023 ASR were forward contracts indexed to our own common stock. The forward contracts met all of the applicable criteria for equity classification, so we did not account for them as a derivative instrument. We have reflected the shares delivered to us by the financial institution as treasury shares as of the dates they were delivered to us in computing weighted average shares outstanding for both basic and diluted net income per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Treasury Share Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, we issued <ix:nonFraction unitRef="shares" contextRef="c-36" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" scale="6" id="f-1273">12.5</ix:nonFraction> million treasury shares to settle the 2023 Warrants. See Note 5 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Debt&#8212;Senior Convertible Notes&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements for more information.</span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1215-7" continuedAt="f-1215-8"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, we issued <ix:nonFraction unitRef="shares" contextRef="c-95" decimals="-5" name="dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone" scale="6" id="f-1274"><ix:nonFraction unitRef="shares" contextRef="c-96" decimals="-5" name="dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues" scale="6" id="f-1275">1.5</ix:nonFraction></ix:nonFraction> million treasury shares in connection with our achievement of the second sales-based milestone under the Restated Collaboration Agreement. See Note 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Development and Other Agreements&#8212;Collaboration with Verily Life Sciences&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements for more information.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_469"></div><ix:continuation id="f-1215-8" continuedAt="f-1215-9"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock" id="f-1276" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and PSU activity under the 2015 Plan for the twelve months ended December&#160;31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:49.923%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.602%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nonvested RSU and PSU Activity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Available for Grant</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-261" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1277">16.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-262" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1278">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-262" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1279">76.88</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-263" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="6" id="f-1280">1.9</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-264" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="f-1281">1.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-264" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1282">96.79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-263" decimals="-5" name="dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" format="ixt:fixed-zero" scale="6" id="f-1283">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-264" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1284">1.6</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-264" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1285">63.90</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-263" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="6" id="f-1286">0.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-264" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1287">0.4</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-264" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1288">92.54</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-265" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1289">15.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-266" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1290">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-266" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1291">94.08</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-266" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="f-1292">325.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-267" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="6" id="f-1293">1.6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-268" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="f-1294">1.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-268" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1295">112.01</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-267" decimals="-5" name="dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" format="ixt:fixed-zero" scale="6" id="f-1296">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-268" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1297">1.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-268" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1298">88.57</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-267" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="6" id="f-1299">0.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-268" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1300">0.2</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-268" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1301">106.34</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-269" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1302">13.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-270" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1303">2.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-270" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1304">105.98</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-270" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="f-1305">361.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-271" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" scale="6" id="f-1306">1.7</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-272" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="6" id="f-1307">1.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-272" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1308">131.17</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-271" decimals="-5" name="dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" format="ixt:fixed-zero" scale="6" id="f-1309">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-272" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="6" id="f-1310">1.3</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-272" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="f-1311">102.09</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-271" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" scale="6" id="f-1312">0.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="shares" contextRef="c-272" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="6" id="f-1313">0.3</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-272" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="f-1314">115.59</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-273" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" scale="6" id="f-1315">12.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="shares" contextRef="c-235" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1316">3.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usdPerShare" contextRef="c-235" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="f-1317">121.17</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" scale="6" id="f-1318">234.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest-date fair value of RSUs and PSUs that vested during the twelve months ended December&#160;31, 2024, 2023 and 2022 was $<ix:nonFraction unitRef="usd" contextRef="c-274" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1319">174.5</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="c-275" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1320">157.8</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="c-276" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="f-1321">160.1</ix:nonFraction> million, respectively. As of December&#160;31, 2024, <ix:nonFraction unitRef="shares" contextRef="c-277" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1322">2.7</ix:nonFraction> million unvested RSUs and <ix:nonFraction unitRef="shares" contextRef="c-278" decimals="-5" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="6" id="f-1323">0.3</ix:nonFraction> million unvested PSUs were outstanding under the 2015 Plan.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_472"></div><ix:continuation id="f-1215-9" continuedAt="f-1215-10"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and ESPP. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="f-1324" continuedAt="f-1324-1" escape="true">The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</ix:nonNumeric></span></div><ix:continuation id="f-1324-1"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:59.280%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.619%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.622%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-279" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1325">14.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-280" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1326">14.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-281" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1327">11.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-282" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1328">52.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-283" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1329">45.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-284" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1330">42.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-285" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1331">103.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-286" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1332">90.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-287" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1333">72.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1334">170.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1335">150.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="f-1336">126.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:12pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total tax benefit related to share-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1337">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1338">40.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" scale="6" id="f-1339">43.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:continuation><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, unrecognized estimated compensation costs related to RSUs and PSUs totaled $<ix:nonFraction unitRef="usd" contextRef="c-235" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="f-1340">203.8</ix:nonFraction> million and are expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="c-272" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="f-1341">1.7</ix:nonNumeric> years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSUs at the date of grant using the intrinsic value method. We estimate the fair value of PSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. <ix:nonNumeric contextRef="c-1" name="us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" id="f-1342" continuedAt="f-1342-1" escape="true">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods.</ix:nonNumeric></span></div></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1342-1"><ix:continuation id="f-1215-10"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:55.771%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.793%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1343">4.80</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-289" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1344">5.27</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-290" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1345">5.20</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-291" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1346">5.47</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-292" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1347">0.60</ix:nonFraction>%&#160;- <ix:nonFraction unitRef="number" contextRef="c-293" decimals="4" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="f-1348">3.34</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-294" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1349">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-295" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1350">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-296" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" format="ixt:fixed-zero" scale="-2" id="f-1351">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-288" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1352">42</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-289" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1353">85</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-290" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1354">34</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="c-291" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1355">48</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-292" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1356">45</ix:nonFraction>%&#160;- <ix:nonFraction unitRef="number" contextRef="c-293" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="f-1357">55</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-294" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1358">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-295" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1359">0.5</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-296" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear" id="f-1360">0.5</ix:nonNumeric></span></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-45</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_475"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="us-gaap:SegmentReportingDisclosureTextBlock" id="f-1361" continuedAt="f-1361-1" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.430%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.780%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. Business Segment and Geographic Information</span></td></tr></table></div></ix:nonNumeric><div id="i6a987b433ae84cbfb2328647e6586107_3673"></div><ix:continuation id="f-1361-1" continuedAt="f-1361-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our business on a global consolidated basis within <ix:nonFraction unitRef="segment" contextRef="c-1" decimals="INF" name="us-gaap:NumberOfReportableSegments" format="ixt-sec:numwordsen" scale="0" id="f-1362">one</ix:nonFraction> reportable segment, which is consistent with how our chief operating decision maker (CODM), our President and Chief Executive Officer, reviews our business, makes investment and resource allocation decisions, and assesses operating performance. The majority of our revenue is generated in the United States. The CGM segment derives revenues from the sale of disposable sensors and our Reusable Hardware.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of segment profit or loss that are most consistent with U.S. GAAP used by the CODM to assess performance and allocate resources are operating income and net income. Our CODM also reviews total assets, as reported on our consolidated balance sheets, and purchases of property and equipment, as reported on our consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM uses operating income and net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the Company, acquire companies, or invest in other companies. Operating income is also used to monitor budget versus actual results.</span></div><ix:nonNumeric contextRef="c-1" name="us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" id="f-1363" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1364">4,033.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1365">3,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1366">2,909.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-1367">1,594.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-1368">1,333.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:CostOfGoodsAndServicesSold" format="ixt:num-dot-decimal" scale="6" id="f-1369">1,026.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payroll related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:PayrollRelatedExpenses" scale="6" id="f-1370">767.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:PayrollRelatedExpenses" scale="6" id="f-1371">726.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:PayrollRelatedExpenses" scale="6" id="f-1372">621.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:ShareBasedPaymentArrangementOperatingExpense" scale="6" id="f-1373">156.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:ShareBasedPaymentArrangementOperatingExpense" scale="6" id="f-1374">136.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:ShareBasedPaymentArrangementOperatingExpense" scale="6" id="f-1375">115.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:MarketingExpense" scale="6" id="f-1376">298.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:MarketingExpense" scale="6" id="f-1377">264.6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:MarketingExpense" scale="6" id="f-1378">228.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel related expenses</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:TravelAndEntertainmentExpense" scale="6" id="f-1379">64.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:TravelAndEntertainmentExpense" scale="6" id="f-1380">55.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:TravelAndEntertainmentExpense" scale="6" id="f-1381">37.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply expenses and clinical trials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:SupplyExpensesAndClinicalTrials" scale="6" id="f-1382">64.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:SupplyExpensesAndClinicalTrials" scale="6" id="f-1383">46.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:SupplyExpensesAndClinicalTrials" scale="6" id="f-1384">50.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consulting &amp; professional fees</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="f-1385">227.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="f-1386">222.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ProfessionalFees" scale="6" id="f-1387">196.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment, office &amp; facility expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:EquipmentOfficeAndFacilityExpenses" scale="6" id="f-1388">83.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:EquipmentOfficeAndFacilityExpenses" scale="6" id="f-1389">84.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:EquipmentOfficeAndFacilityExpenses" scale="6" id="f-1390">80.3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT software and data</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:InformationTechnologyAndDataProcessing" scale="6" id="f-1391">130.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:InformationTechnologyAndDataProcessing" scale="6" id="f-1392">106.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:InformationTechnologyAndDataProcessing" scale="6" id="f-1393">86.5</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-1394">39.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-1395">41.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DepreciationAndAmortization" scale="6" id="f-1396">46.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-1397">5.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-1398">6.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:SegmentReportingOtherItemAmount" scale="6" id="f-1399">29.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1400">600.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1401">597.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:OperatingIncomeLoss" scale="6" id="f-1402">391.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1403">109.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1404">112.7</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:OtherNonoperatingIncomeExpense" scale="6" id="f-1405">0.4</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1406">709.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1407">710.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="6" id="f-1408">390.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1409">132.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1410">168.9</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:IncomeTaxExpenseBenefit" scale="6" id="f-1411">49.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-1412">576.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-1413">541.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-1414">341.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes amounts stated in other significant expense captions.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other segment items are primarily composed of impairment of assets and bad debt expense.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.145%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.823%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.420%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:15.424%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other segment disclosures</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1415">217.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1416">186.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" scale="6" id="f-1417">155.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for long-lived assets</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1418">358.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1419">236.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:SegmentExpenditureAdditionToLongLivedAssets" scale="6" id="f-1420">364.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant noncash items other than depreciation and amortization expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1421">43.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1422">55.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" sign="-" name="us-gaap:DeferredIncomeTaxExpenseBenefit" scale="6" id="f-1423">21.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes depreciation and amortization recorded in both cost of sales and operating expenses. </span></div></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:continuation id="f-1361-2" continuedAt="f-1361-3"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Other Income (Expense), Net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our interest income and interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Stockholders&#8217; Equity&#8212;Share-Based Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our share-based compensation expense.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_481"></div><ix:continuation id="f-1361-3" continuedAt="f-1361-4"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by major sales channel and by geographic region. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Concentration of Credit Risk and Significant Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our major customers that represent 10% or more of our total revenue.</span></div></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_487"></div><ix:continuation id="f-1361-4" continuedAt="f-1361-5"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Customer Sales Channel</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. <ix:nonNumeric contextRef="c-1" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="f-1424" continuedAt="f-1424-1" escape="true">The following table sets forth revenue by major sales channel for the twelve months ended December&#160;31, 2024, 2023 and 2022:</ix:nonNumeric></span></div><ix:continuation id="f-1424-1"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-297" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1425">3,430.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-297" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1426">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-298" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1427">3,095.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-298" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1428">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-299" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1429">2,470.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-299" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1430">85</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-300" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1431">602.9</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-300" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1432">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-301" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1433">526.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-301" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1434">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-302" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1435">439.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-302" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1436">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1437">4,033.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1438">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1439">3,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1440">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1441">2,909.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1442">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_484"></div><ix:continuation id="f-1361-5" continuedAt="f-1361-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Geographic Region</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, 2023 and 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. <ix:nonNumeric contextRef="c-1" name="us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock" id="f-1443" continuedAt="f-1443-1" escape="true">The following table sets forth revenue by our <ix:nonFraction unitRef="primary_market" contextRef="c-1" decimals="INF" name="dxcm:NumberOfPrimaryGeographicMarkets" format="ixt-sec:numwordsen" scale="0" id="f-1444">two</ix:nonFraction> primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</ix:nonNumeric></span></div><ix:continuation id="f-1443-1" continuedAt="f-1443-2"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:31.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.441%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.532%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.446%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-303" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1445">2,889.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-303" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1446">72</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-304" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1447">2,625.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-304" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1448">72</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-305" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1449">2,142.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-305" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1450">74</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-306" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1451">1,143.2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-306" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1452">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-307" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1453">997.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-307" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1454">28</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-308" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="6" id="f-1455">767.8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-308" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1456">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1457">4,033.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-1" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1458">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1459">3,622.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-7" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1460">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" format="ixt:num-dot-decimal" scale="6" id="f-1461">2,909.8</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="c-8" decimals="2" name="dxcm:RevenuePercentage" scale="-2" id="f-1462">100</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div></ix:continuation></ix:continuation><div id="i6a987b433ae84cbfb2328647e6586107_490"></div><ix:continuation id="f-1361-6"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets by Geographic Region</span></div><ix:continuation id="f-1443-2"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our long-lived assets, which consists of property and equipment, net, and operating lease right-of-use assets by geographic region:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.036%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-309" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1463">464.6</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-310" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1464">544.1</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-311" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1465">632.1</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-312" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1466">515.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other countries </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-313" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1467">306.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-314" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1468">125.0</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1469">1,402.7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:NoncurrentAssets" format="ixt:num-dot-decimal" scale="6" id="f-1470">1,184.5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No other individual country represented more than 10% of long-lived assets for the periods presented, except for Ireland with $<ix:nonFraction unitRef="usd" contextRef="c-315" decimals="-5" name="us-gaap:NoncurrentAssets" scale="6" id="f-1471">185.7</ix:nonFraction> million of long-lived assets at December&#160;31, 2024.</span></div></td></tr></table></div></ix:continuation></ix:continuation><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-47</span></div></div></div><div id="i6a987b433ae84cbfb2328647e6586107_499"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div><span><br/></span></div></div><ix:nonNumeric contextRef="c-1" name="srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" id="f-1472" escape="true"><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE II</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(In millions)</span></td></tr></table></div><div style="margin-bottom:2pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:61.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.038%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for doubtful accounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning Balance</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1473">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1474">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1475">5.4</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" sign="-" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1476">0.1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1477">2.0</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense" scale="6" id="f-1478">2.4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" format="ixt:fixed-zero" scale="6" id="f-1479">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" format="ixt:fixed-zero" scale="6" id="f-1480">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" scale="6" id="f-1481">0.5</ix:nonFraction>)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:fixed-zero" scale="6" id="f-1482">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:fixed-zero" scale="6" id="f-1483">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesRecoveries" format="ixt:fixed-zero" scale="6" id="f-1484">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1485">9.2</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1486">9.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"/><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="usd" contextRef="c-25" decimals="-5" name="us-gaap:ValuationAllowancesAndReservesBalance" scale="6" id="f-1487">7.3</ix:nonFraction>&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div></ix:nonNumeric><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F-48</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>2
<FILENAME>dxcm12312024-exhibit45.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i641610c1d9a74815a752931804128efc_1"></div><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 4.5</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DESCRIPTION OF THE REGISTRANT&#8217;S SECURITIES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">REGISTERED PURSUANT TO SECTION 12 OF THE SECURITIES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><br></font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXCHANGE ACT OF 1934</font></div><div style="margin-bottom:6pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">As of December 31, 2024, DexCom, Inc. (the &#8220;Company,&#8221; &#8220;we&#8221; or &#8220;our&#8221;) had one class of securities registered under Section 12 of the Securities Exchange Act of 1934&#58; our common stock.</font></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Description of Capital Stock</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summary of the terms of our capital stock is based upon our restated certificate of incorporation and our restated bylaws. The summary is not complete, and is qualified by reference to our restated certificate of incorporation and our restated bylaws, each of which are incorporated by reference as exhibits to the Annual Report on Form 10-K to which this Exhibit 4.5 is attached and are incorporated by reference herein. We encourage you to read our restated certificate of incorporation, our restated bylaws, and the applicable provisions of the Delaware General Corporation Law, or DGCL, for additional information.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Authorized Shares</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have authorized capital stock consisting of 800,000,000 shares of common stock, $0.001 par value per share, and 5,000,000 shares of undesignated preferred stock, $0.001 par value per share.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend rights</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of our common stock are entitled to receive dividends out of funds legally available if our board of directors, in its discretion, determines to issue dividends and then only at the times and in the amounts that our board of directors may determine.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Voting rights</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of our common stock are entitled to one vote for each share held on all matters submitted to a vote of stockholders.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">No preemptive or similar rights</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is not entitled to preemptive rights, and is not subject to conversion, redemption or sinking fund provisions.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right to receive liquidation distributions</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon our liquidation, dissolution or winding-up, the assets legally available for distribution to our stockholders would be distributable ratably among the holders of our common stock and any participating preferred stock outstanding at that time, subject to prior satisfaction of all outstanding debt and liabilities and the preferential rights of and the payment of liquidation preferences, if any, on any outstanding shares of our preferred stock.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Preferred Stock</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our board of directors is authorized, subject to limitations prescribed by the DGCL, to issue from time to time up to 5,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each series and to fix the designation, powers, preferences and rights of the shares of each series and any of their qualifications, limitations or restrictions, in each case without further vote or action by our stockholders. Our board of directors is also able to increase or decrease the number of shares of any series of preferred stock, but not below the number of shares of that series then outstanding, without any further vote or action by our stockholders. Our board of directors may be able to authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of our company and might adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. We have no current plan to issue any shares of preferred stock.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exclusive Forum</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restated bylaws provide that the Court of Chancery of the State of Delaware is the exclusive forum for any derivative action or proceeding brought on our behalf, any action asserting a breach of fiduciary duty owed by, or other wrongdoing by, any of our directors, officers, stockholders, employees or agents to us or our stockholders, any action asserting a claim against us or any of our directors, officers, stockholders, employees or agents arising pursuant to the DGCL, our restated certificate of incorporation, or our restated bylaws or as to which the DGCL confers jurisdiction on the Court of Chancery of the State of Delaware, any action to interpret, apply, enforce or determine the validity of our restated certificate of incorporation, or our restated bylaws, or any action asserting a claim against us  or any of our directors, officers, stockholders, employees or agents that is governed by the internal affairs doctrine. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. Our restated bylaws further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Anti-Takeover Provisions</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The provisions of the DGCL, our restated certificate of incorporation, and our restated bylaws could have the effect of delaying, deferring or discouraging another person from acquiring control of our company. These provisions, which are summarized below, may have the effect of discouraging takeover bids. They are also designed, in part, to encourage persons seeking to acquire control of us to negotiate first with our board of directors. We believe that the benefits of increased protection of our potential ability to negotiate with an unfriendly or unsolicited acquirer outweigh the disadvantages of discouraging a proposal to acquire us because negotiation of these proposals could result in an improvement of their terms.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Delaware Law</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the provisions of Section 203 of the DGCL regulating corporate takeovers. In general, DGCL Section 203 prohibits a publicly held Delaware corporation from engaging in a business combination with an interested stockholder for a period of three years following the date on which the person became an interested stockholder unless&#58;</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prior to the date of the transaction, the board of directors of the corporation approved either the business combination or the transaction which resulted in the stockholder becoming an interested stockholder&#59;</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, (i) shares owned by persons who are directors and also officers and (ii) shares owned by employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#59; or</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">at or subsequent to the date of the transaction, the business combination is approved by the board of directors of the corporation and authorized at an annual or special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66.67% of the outstanding voting stock that is not owned by the interested stockholder.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Generally, a business combination includes a merger, asset or stock sale, or other transaction or series of transactions together resulting in a financial benefit to the interested stockholder. An interested stockholder is a person who, together with affiliates and associates, owns or, within three years prior to the determination of interested stockholder status, did own 15% or more of a corporation&#8217;s outstanding voting stock. We expect the existence of this provision to have an anti-takeover effect with respect to transactions our board of directors does not approve in advance. We also anticipate that DGCL Section 203 may also discourage attempts that might result in a premium over the market price for the shares of common stock held by stockholders.</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restated Certificate of Incorporation and Restated Bylaws Provisions</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our restated certificate of incorporation and our restated bylaws include a number of provisions that could deter hostile takeovers or delay or prevent changes in control of our company, including the following&#58;</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Board of directors vacancies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our restated certificate of incorporation and restated bylaws authorize only our board of directors to fill vacant directorships, including newly created seats. In addition, the number of directors constituting our board of directors is permitted to be set only by a resolution adopted by a majority vote of our entire board of directors. These provisions would prevent a stockholder from increasing the size of our board of directors and then gaining control of our board of directors by filling the resulting vacancies with its own nominees. This makes it more difficult to change the composition of our board of directors but promotes continuity of management.</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Stockholder action&#59; special meetings of stockholders</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our restated certificate of incorporation provides that our stockholders may not take action by written consent, but may only take action at annual or special meetings of our stockholders. As a result, a holder controlling a majority of our capital stock would not be able to amend our restated bylaws or remove directors without holding a meeting of our stockholders called in accordance with our restated bylaws. Further, our restated bylaws and restated certificate of incorporation provide that special meetings of our stockholders may be called only by a majority of our board of directors, the chairperson of our board of directors, our chief executive officer, our president or our lead independent director, thus prohibiting a stockholder from calling a special meeting. These provisions might delay the ability of our stockholders to force consideration of a proposal or for stockholders controlling a majority of our capital stock to take any action, including the removal of directors.</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Advance notice requirements for stockholder proposals and director nominations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our restated bylaws provide advance notice procedures for stockholders seeking to bring business before our annual meeting of stockholders or to nominate candidates for election as directors at our annual meeting of stockholders. Our restated bylaws also specify certain requirements regarding the form and content of a stockholder&#8217;s notice. Among other requirements, in connection with director nominations by stockholders, our restated bylaws require&#58; (i) timely providing information regarding the stockholder making the director nomination(s), their affiliates and the director nominee(s), including that such information is to be updated as of the record date for the applicable meeting&#59; (ii) that any notice of director nomination be accompanied by written questionnaires required of our directors completed and signed by any proposed director nominee(s)&#59; and (iii) limiting the number of nominees a stockholder may nominate for election at a meeting to the number of directors to be elected at such meeting. These provisions might preclude our stockholders from bringing matters before our annual meeting of stockholders or from making nominations for directors at our annual meeting of stockholders if the proper procedures are not followed. We expect that these provisions might also discourage or deter a potential acquirer from conducting a solicitation of proxies to elect the acquirer&#8217;s own slate of directors or otherwise attempting to obtain control of our company.</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">No cumulative voting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The DGCL provides that stockholders are not entitled to the right to cumulate votes in the election of directors unless a corporation&#8217;s certificate of incorporation provides otherwise. Our restated certificate of incorporation does not provide for cumulative voting.</font></div><div style="margin-top:4pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:14.5pt">Issuance of undesignated preferred stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Our board of directors has the authority, without further action by the stockholders, to issue up to 5,000,000 shares of undesignated preferred stock with rights and preferences, including voting rights, designated from time to time by our board of directors. The existence of authorized but unissued shares of preferred stock would enable our board of directors to render more difficult or to discourage an attempt to obtain control of us by means of a merger, tender offer, proxy contest or other means.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Listing</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock is listed on The Nasdaq Global Select Market under the symbol &#8220;DXCM.&#8221;</font></div><div style="margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transfer Agent and Registrar</font></div><div style="margin-top:4pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The transfer agent and registrar for our Common Stock is Equiniti Trust Company, LLC. Its address is PO Box 500 Newark, NJ 07101 and its telephone number is (718) 921-8200.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.15
<SEQUENCE>3
<FILENAME>dxcm12312024-exhibit1015.htm
<DESCRIPTION>EX-10.15
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i2d71dcd65f1a480fb4359b12578a74fe_35"></div><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.15</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SEVERANCE AGREEMENT AND GENERAL RELEASE</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RECITALS</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Severance Agreement and General Release (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is made by and between Teri Lawver (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Dexcom, Inc., its subsidiaries, affiliates, successors, and assigns (&#8220;Company&#8221; or &#8220;Employer&#8221;) (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Executive is currently employed by Company as Executive Vice President, Chief Commercial Officer&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, Executive&#8217;s employment will end on December 31, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, capitalized terms not defined herein shall have the meaning set forth in the Severance &#38; CIC Plan&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Parties wish to conclude their relationship amicably and resolve any and all disputes, claims, complaints, grievances, charges, actions, petitions and demands that the Executive may have against Company, including but not limited to, any and all claims arising out of or in any way related to Executive&#8217;s employment with Company or separation of employment from the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW THEREFORE, in consideration of the promises made herein, the Parties hereby agree as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination of Employment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive&#8217;s employment will be terminated as of the Termination Date.  Executive will be paid, at Executive&#8217;s regular rate of pay, for all hours worked and for all accrued but unused vacation and any unreimbursed, reasonable business expenses on the Termination Date, regardless of whether Executive signs this Agreement.  Executive acknowledges that these amounts are all of the amounts owed to Executive by Company through the Termination Date.  As of the Termination Date, Executive is not to hold Executive out as an employee, agent, or authorized representative of Company, or to negotiate or enter into any agreements on behalf of Company, or to otherwise attempt to bind Company.  Within two weeks of the public announcement of this Agreement, Executive will be transitioned from the current role of Executive Vice President, Chief Commercial Officer to Special Advisor.  As Special Advisor, Executive will report to the CEO and is expected to advise and support on the Executive&#8217;s transition and support various needs which may be identified by Company management in the future.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Separation Benefits&#59; Consulting Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Provided that Executive (a) timely executes and does not revoke this Agreement, (b) executes the Transition Consulting Services Agreement (attached as Exhibit 1) prior to Executive&#8217;s Termination Date, (c) complies with the Restrictive Covenants (as defined below), to the extent permitted by applicable law, (d) timely executes and does not revoke the Service Date Release (attached as Exhibit 2), Executive will be provided with the following severance benefits to which Executive would not otherwise be entitled&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.64pt;text-decoration:underline">Severance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  An amount equivalent to seven (7) months of Executive&#8217;s current base salary, for a total of $362,250.16, minus applicable withholdings, made in a single lump sum payment within thirty (30) days following the expiration of the consideration and revocation periods set forth in the Service Date Release and in any event not later than March 15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of the year following the end of the Consulting Period (as defined below)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:70.26pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.64pt;text-decoration:underline">Relocation Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Reimbursement for reasonable relocation costs (e.g. lease-break costs, selling car costs, moving fees) through the Company&#8217;s preferred relocation vendor for up to $25,000&#59; and</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:68.04pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.64pt;text-decoration:underline">Transitional Consulting Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  On January 1, 2025, Executive will transition to a consultant pursuant to the Transition Consulting Services Agreement (Exhibit 1, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consulting Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and provide the services pursuant to the Consulting Agreement until March 31, 2025 unless terminated earlier in accordance with the terms of the Consulting Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Consulting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:67.48pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.64pt;text-decoration:underline">Non-Disparagement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company agrees that it will instruct the CEO and its Section 16 Officers not to disparage the Executive during the twelve (12) month period following the Termination Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive will receive a separate notice explaining Executive&#8217;s right to continuation and conversion of Executive&#8217;s health benefits under the Consolidated Omnibus Reconciliation Act of 1985 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">COBRA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and&#47;or any applicable state law.  Executive understands that Executive must elect COBRA benefits and make payments directly.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Executive acknowledges and agrees that the payments and benefits set forth above fully supersede and extinguish any obligations owed by Company to Executive under any other contract or agreement Executive may have with Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Executive&#8217;s signature below, Executive acknowledges and agrees that the terms set forth in this Agreement include compensation and benefits to which Executive is not otherwise entitled.  Furthermore, Executive acknowledges that, except as expressly set forth above, after Executive&#8217;s execution of this Agreement, Executive will not be entitled to any other or further compensation, remuneration, or benefits from Company.  Executive specifically acknowledges that Executive&#8217;s entitlement to any of the benefits set forth in this Agreement, including but not limited to those set forth in this Section 2, are contingent upon Executive executing and not revoking or breaching this Agreement.  In the event that Executive executes this Agreement and then subsequently revokes the Agreement, Executive will not be entitled to any of the benefits under this Agreement, including but not limited to those set forth in this Section 2.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement Regarding Bonus and Equity Eligibility</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive acknowledges and agrees that Executive shall not be eligible for payment of any bonus amount with respect to the 2024 performance year or the 2025 performance year.  Executive shall not be granted or eligible to receive any new or additional Company equity awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Treatment of Equity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive&#8217;s Company equity awards, including but not limited to restricted stock units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and performance-based RSUs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), will continue to vest until Executive&#8217;s last day of Service (as defined and in accordance with the terms of the 2015 Amended &#38; Restated Equity Incentive Plan), which, for the avoidance of doubt, shall include Executive&#8217;s provision of services pursuant to this Agreement and the Consulting Agreement, pursuant to the written awards agreements governing their grant.  Executive&#8217;s Company equity awards will cease vesting on termination of Executive&#8217;s Service, and shall continue to be governed by the Company Equity Plan and the written award agreements governing their grant.  Executive shall not be entitled to payment or settlement of any RSUs or PSUs which, pursuant to their terms, expire unvested on termination of Executive&#8217;s Service.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Waiver of Payments and Benefits Under Severance &#38; CIC Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive hereby acknowledges and agrees that neither Executive&#8217;s entry into this Agreement nor Executive&#8217;s termination of employment or consulting shall constitute a Qualifying Termination for purposes of the Amended and Restated Severance and Change in Control Plan (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Severance &#38; CIC Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and Executive hereby waives any right or entitlement to payments or benefits under the Severance &#38; CIC Plan payable upon a Qualifying Termination (as defined in the Severance &#38; CIC Plan).  Further, Executive acknowledges and agrees that Executive&#8217;s participation in the Severance and CIC Plan shall cease on the Effective Date, and Executive shall have no right to any payments or benefits thereunder.  Executive acknowledges and agrees that notwithstanding the foregoing waiver of payments and benefits under the Severance and CIC Plan, in consideration of the payments and benefits to be provided under this Agreement, Executive shall remain subject to the covenants provided under Section 3 of the Severance and CIC Plan, as more fully addressed in Section 12 below.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Tax Treatment</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All payments made under this Agreement will be subject to reduction to reflect taxes or other charges required to be withheld by law.  Executive understands and agrees that Company is neither providing tax nor legal advice, nor is Company making representations regarding tax obligations or consequences, if any, related to this Agreement, and that Executive shall not seek any indemnification from Company in this regard.  Executive understands that Executive (and not the Company) will be responsible for Executive&#8217;s own tax liability that may arise as a result of this Agreement, without regard to the amount withheld or reported by the Company to applicable tax authorities, and Executive acknowledges and assumes all responsibility for the payment of any such taxes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Confidential Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive hereby acknowledges that, following Executive&#8217;s Termination Date, Executive remains subject to Executive&#8217;s obligations under the Executive&#8217;s Proprietary Information and Inventions Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Confidentiality Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) previously executed by Executive which requires, among other provisions, the assignment of patent rights to any invention made during Executive&#8217;s employment at the Company and non-disclosure of proprietary information.  Executive agrees that Executive will not take, copy, use, or distribute in any form or manner documents or information that Company deems proprietary, including without limitation research and development materials, information regarding customers, clients, business partners, or prospective customers, clients, or business partners, financial information, business and strategic plans, software programs and codes, access codes, and other similar materials or information.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Return of Company Property</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive agrees to return to Company any and all Company property in Executive&#8217;s possession, including without limitation any computer or other electronic devices&#59; software programs&#59; other Company equipment, tools, records, or technical materials&#59; information related to Company customers, clients and business contacts&#59; marketing information&#59; pricing information&#59; cellular phones&#59; personnel materials or files, handbooks, manuals, or policies&#59; memoranda, notes, and drafts thereof&#59; and any other documents or property (and any summaries or copies thereof), developed by Executive and&#47;or obtained by Executive or on Executive&#8217;s behalf, directly or indirectly, pursuant to Executive&#8217;s employment with Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Release of Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive agrees that the foregoing consideration represents settlement in full of all outstanding obligations owed to Executive by Company.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THIS IS A GENERAL RELEASE OF ALL CLAIMS.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for the Severance Amounts and benefits being provided to Executive, Executive, on Executive&#8217;s own behalf, and on behalf of Executive&#8217;s respective heirs, family members, executors, administrators, attorneys, representatives, and assigns, hereby fully and forever releases Company and its legal representatives, officers, directors, fiduciaries, employees, investors, shareholders, insurers, agents, administrators, affiliates, divisions, subsidiaries, predecessor and successor corporations, and assigns, both in their individual and corporate capacities (including its current and former parent companies, subsidiaries, and other affiliated companies as well as any of their current and former insurers, directors, officers, agents, shareholders, and employees), (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Releasees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), of and from any and all claims and causes of action, demands, duties, obligations, agreements, promises, liabilities, damages, costs, and&#47;or fees, whether known or unknown, suspected or unsuspected, including without limitation&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims relating to or arising from Executive&#8217;s employment relationship with Company and the termination of that relationship, including any claims relating to Executive&#8217;s election to receive benefits under the Severance &#38; CIC Plan instead of any other plan, contract, or agreement&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims relating to, or arising from, Executive&#8217;s right to purchase, or actual purchase of, shares of stock of Company, including, without limitation, any claims for fraud&#59; misrepresentation&#59; breach of fiduciary duty&#59; breach of duty under applicable state corporate law&#59; and securities fraud under any state or federal law&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims under the law of any jurisdiction including without limitation wrongful discharge of employment&#59; constructive discharge from employment&#59; termination in violation of public policy&#59; discrimination&#59; breach of contract, both express and implied&#59; breach of a covenant of good faith and fair dealing, both express and implied&#59; promissory estoppel&#59; negligent and intentional infliction of emotional distress&#59; negligent and intentional misrepresentation&#59; negligent and intentional interference with contract or prospective economic advantage&#59; unfair business practices&#59; defamation&#59; libel&#59; slander&#59; negligence&#59; personal injury&#59; assault&#59; battery&#59; invasion of privacy&#59; false imprisonment&#59; and conversion&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims for violation of any federal, state or municipal statute, including without limitation all employment laws, including without limitation the California Fair Employment and Housing Act&#59; the California Unruh Act&#59; the Age Discrimination in Employment Act, as amended&#59; Title VII of the Civil Rights Act of 1964, as amended&#59; the Civil Rights Act of 1866&#59; the Civil Rights Act of 1871&#59; the Americans with Disabilities Act&#59; the Older Workers&#8217; Benefits Protection Act&#59; the Family Medical Leave Act&#59; the Equal Pay Act&#59; the Employee Retirement Income Security Act of 1974&#59; the National Labor Relations Act&#59; the California Constitution&#59; the California Labor Code&#59; the California Business &#38; Professions Code&#59; the California Government Code&#59; the California Civil Code&#59; and all other laws against discrimination or applicable to employment that may be the subject of a release under applicable law&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims for violation of the federal, or any state, constitution&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims arising out of any other laws and regulations relating to employment or employment discrimination&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any and all claims arising out of any personnel policies, contracts of employment, any other contracts, severance pay agreements, and covenants of good faith and fair dealing&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any claim for any loss, cost, damage, or expense arising out of any dispute over the non-withholding or other tax treatment of any of the proceeds received by Executive as a result of this Agreement&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">any claim or damage arising out of Executive&#8217;s employment with or separation from Company under any common law theory or any federal, state, or local statute or ordinance not specifically referred to above&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">any and all claims for unpaid or withheld wages, severance, benefits, bonuses, commissions, and other compensation of any kind that Executive may have against the Releasees&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:18.22pt">any and all claims for attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive specifically agrees that this Agreement includes without limitation any and all claims that were raised, or that reasonably could have been raised, under the applicable Wage Order, Labor Code sections 201, 202, 203, 212, 226, 226.3, 226.7, 510, 512, 515, 558, 1194, and 1198, as well as claims under the Business &#38; Professions Code sections 17200, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Labor Code sections 2698, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based on alleged violations of Labor Code provisions.  Executive further covenants that Executive will not seek to initiate any proceedings seeking penalties under Labor Code sections 2699, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">et seq.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> based upon the Labor Code provisions specified above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Executive understands and agrees that, to the fullest extent permitted by law, Executive is precluded from filing or pursuing any legal claim of any kind against any of the Releasees at any time in the future, in any federal, state, or municipal court, or other tribunal, arising out of any of the claims that Executive has waived by virtue of executing this Agreement.  By Executive&#8217;s signature below, Executive represents that Executive has not filed any such legal claims against any of the Releasees in any federal, state, or municipal court, or other tribunal.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Nothing in this Agreement shall be construed to waive&#58; (a) any claims that cannot be waived as a matter of law&#59; (b) indemnification rights the Executive has from the Company&#59; (c) any rights to vested benefits, the rights to which are governed by the terms of the applicable plan documents and agreements&#59; and (d) any rights to continued vesting of RSUs under applicable plan documents and agreements, including this Agreement.  In addition, this Agreement does not prevent Executive from filing an administrative charge against any Releasee that may not be released as a matter of law&#59; however, Executive waives the right to receive future monetary recovery directly from the Company, including payments by the Company that result from any complaints or charges that Executive files with any governmental agency or that are filed on Executive&#8217;s behalf (this waiver does not apply to any future monetary recovery Executive may receive directly from the government).  This release does not waive any rights or claims that may arise after the date that Executive executed this Agreement.  Nothing in this Agreement precludes Executive from communicating or cooperating in any way with any government agency including but not limited to the EEOC, NLRB, SEC, and&#47;or similar state or local agencies.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Nothing in this Agreement will affect the ability of Executive or Company to enforce rights or entitlements specifically provided for under this Agreement as set forth above, or any rights or claims that may arise after the date that Executive executed this Agreement.  By Executive&#8217;s signature below, Executive represents that&#58; (a) upon Executive&#8217;s receipt of the payments described in Section 2 above, Executive is not aware of any unpaid wages, vacation, bonuses, expense reimbursements, or other amounts owed to Executive by Company&#59;  (b) however, to the extent Executive is aware of any claims for unpaid wages, severance, benefits, bonuses, commissions, and other compensation of any kind, there is a bona fide dispute between the Parties regarding the fact of and amount of such claims, and Executive further agrees to release such claims and acknowledges that Executive's release is not barred or void under Labor Code section 206.5&#59; (c) Executive has not been denied any request for leave to which Executive believes Executive was legally entitled, and Executive was not otherwise deprived of any of Executive&#8217;s rights under the Family and Medical Leave Act or any similar state or local statute&#59; and (d) Executive has not assigned or transferred, or purported to assign or transfer, to any person, entity, or individual whatsoever, any of the claims released in the foregoing general release and waiver.  Company&#8217;s obligations under this Agreement are contingent upon Executive&#8217;s compliance with all terms and conditions provided for herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Release of Unknown Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  For the purpose of implementing a full and complete release, Executive expressly acknowledges that the releases given in this Agreement are intended to include, without limitation, claims that Executive did not know or suspect to exist in Executive&#8217;s favor at the time of the date of Executive&#8217;s execution of this Agreement, regardless of whether the knowledge of such claims, or the facts upon with they might be based, would have materially affected the settlement of this matter&#59; and that the Severance Amounts and other benefits provided under this Agreement was also for the release of those claims and contemplates the extinguishment of any such unknown claims, despite the fact that California Civil Code section 1542 may provide otherwise.  Executive expressly waives any right or benefit available to Executive in any capacity under the provisions of California Civil Code section 1542, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;padding-right:54pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Age Discrimination in Employment Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement is intended to satisfy the requirements of the Older Workers&#8217; Benefit Protection Act, 29 U.S.C. &#167; 626(f).  Executive is advised, by and through this Agreement, to consult with an attorney before executing this Agreement.  Executive acknowledges, agrees and understands that&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">under the general release detailed above, Executive is waiving and releasing, among other claims, any rights and claims that may exist under the Age Discrimination in Employment Act (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ADEA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive has read and understands the terms of this Agreement&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the waiver and release of claims set forth in the release above does not apply to any rights or claims that may arise under the ADEA after the date of execution of this Agreement, nor does it prohibit Executive from challenging the validity of this Agreement&#8217;s waiver and release of claims under the Age Discrimination Act of 1967, as amended&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">the payments and other consideration that are being provided to Executive are of significant value and are in addition to what Executive otherwise would be entitled&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive, through this Agreement, is being advised in writing to consult with an attorney before signing this Agreement&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">Executive has obtained and considered such legal counsel as Executive deems necessary&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive is entering into this Agreement freely, knowingly, and voluntarily&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Executive is being given a period of twenty-one (21) days within which to review and consider this Agreement before signing it, though Executive may sign earlier, and if Executive fails to sign and return this Agreement within the twenty-one (21) day consideration period, Company&#8217;s offer and this Agreement will expire on its own terms&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">Executive may revoke acceptance of this Agreement by providing written notice to Company within seven (7) days following its execution, and any notice of revocation of this Agreement must be in writing and transmitted by hand or by e-mail to &#91;***&#93;, with a copy to &#91;***&#93;&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">Because of Executive&#8217;s right to revoke this Agreement, this Agreement shall not become effective and enforceable until the eighth (8th) day after the return of an executed copy of this Agreement by Executive to Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive hereby acknowledges that prior to and following Executive&#8217;s Termination Date, Executive remains subject to Executive&#8217;s obligations under the Confidentiality Agreement.  Executive understands and agrees that Executive&#8217;s entitlement to the compensation and benefits due under this Agreement is conditioned upon Executive&#8217;s continued compliance, to the fullest extent permitted by law, with the terms and conditions of this Agreement, Section 3 of the Severance &#38; CIC Plan, and the Confidentiality Agreement (the forgoing obligations, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictive Covenants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Executive understands that nothing in Section 3(c) of the Severance &#38; CIC Plan, which is incorporated herein by reference, shall apply on occasions when Executive is subpoenaed or ordered by a court or other governmental authority to testify or give evidence and must respond truthfully, nor does this provision prohibit Executive from cooperating with any government agency.  Executive further agrees not to otherwise interfere with Company&#8217;s business operations, including, without limitation, Company&#8217;s efforts to market and sell its products for the twelve (12) month period following the end of the term of the Dexcom Consulting Agreement between the parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Cooperation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive agrees that Executive will not counsel or assist any attorneys or their clients in the presentation or prosecution of any disputes, differences, grievances, claims, charges, or complaints by any third party against Company or any officer, director, employee, agent, representative, shareholder, or attorney of Company, unless under a subpoena or other court order to do so.  Executive further agrees both to immediately notify Company upon receipt of any court order, subpoena, or any legal discovery device that seeks or might require the disclosure or production of the existence or terms of this Agreement, and to furnish, within three (3) business days of its receipt, a copy of such subpoena or legal discovery device to Company.  Nothing in this Agreement shall be construed to prohibit Executive from reporting conduct to, providing truthful information to or participating in any investigation or proceeding conducted by any federal or state government agency or self-regulatory organization.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Injunctive Relief</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive's breach of any obligation or covenant set forth in this Agreement will have a material and adverse effect upon the Company and will cause the Company irreparable harm, and damages arising from any breach may be difficult to ascertain. Consequently, in addition to all of the remedies otherwise available to the Company, including, but not limited to, the recovery of monetary damages incurred in enforcing this Agreement, the Company shall have the right to injunctive relief to restrain and enjoin any actual or threatened breach of the provisions of this Agreement. All of the Company's remedies for breach of this Agreement shall be cumulative and the pursuit of one remedy shall not be deemed to exclude any other remedies. Executive agrees and consents that the Company shall be entitled to injunctive relief&#59; both preliminary and permanent, without bond.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Non-Admissibility&#59; No Admission of Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive agrees that this Agreement shall not be admissible as evidence in any future proceeding of any kind, except in court on a claim of breach of this Agreement.  The Parties understand and acknowledge that this Agreement constitutes a compromise and settlement of disputed claims.  No action taken by the Parties hereto, or either of them, either previously or in connection with this Agreement shall be deemed or construed to be&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">an admission of the truth or falsity of any claims heretofore made&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">an acknowledgment or admission by either Party of any fault or liability whatsoever to the other Party or to any third party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Knowledge of Wrongdoing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive represents that Executive has no knowledge of any wrongdoing involving improper or false claims against a federal or state governmental agency, or any other wrongdoing that involves Executive or other present or former Company employees.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Contingent Obligation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Company&#8217;s continuing obligations under this Agreement are contingent upon Executive&#8217;s compliance with all terms and conditions provided for herein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Fees and Costs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Parties shall each bear their own costs, attorneys&#8217; fees, and other fees incurred in connection with the execution of this Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To the extent (i) any payments to which Executive becomes entitled under this Agreement, or any agreement or plan referenced herein, in connection with Executive&#8217;s termination of employment with the Company constitute deferred compensation subject to Section 409A of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;) and (ii) Executive is deemed at the time of such termination of employment to be a &#8220;specified&#8221; employee under Section 409A of the Code, then such payment or payments shall not be made or commence until the earlier of (i) the expiration of the six (6)&#8209;month period measured from the date of Executive&#8217;s &#8220;separation from service&#8221; (as such term is at the time defined in regulations under Section 409A of the Code) with the Company&#59; or (ii) the date of Executive&#8217;s death following such separation from service&#59; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Executive, including the additional twenty percent (20%) tax for which Executive would otherwise be liable under Section 409A(a)(1)(B) of the Code in the absence of such deferral. Upon the expiration of the applicable deferral period, any payments which would have otherwise been made during that period (whether in a single sum or in installments) in the absence of this paragraph shall be paid to Executive or Executive&#8217;s beneficiary in one lump sum (without interest). Except as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in&#8209;kind benefit under this Agreement (or otherwise referenced herein) is determined to be subject to (and not exempt from) Section 409A of the Code, the amount of any such expenses eligible for reimbursement, or the provision of any in&#8209;kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement or in kind benefits to be provided in any other calendar year, in no event shall any expenses be reimbursed after the last day of the calendar year following the calendar year in which Executive incurred such expenses, and in no event shall any right to reimbursement or the provision of any in&#8209;kind benefit be subject to liquidation or exchange for another benefit. To the extent that any provision of this Agreement is ambiguous as to its exemption or compliance with Section 409A, the provision will be read in such a manner so that all payments hereunder are exempt from Section 409A to the maximum permissible extent, and for any payments where such construction is not tenable, that those payments comply with Section 409A to the maximum permissible extent. To the extent any payment under this Agreement may be classified as a &#8220;short&#8209;term deferral&#8221; within the meaning of Section 409A, such payment shall be deemed a short&#8209;term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A. Payments pursuant to this Agreement (or referenced in this Agreement), and each installment thereof, are intended to constitute separate payments for purposes of Section 1.409A&#8209;2(b)(2) of the regulations under Section 409A. Any termination of Executive&#8217;s employment is intended to constitute a separation from service and will be determined consistent with the rules relating to a &#8220;separation from service&#8221; as such term is defined in Treasury Regulation Section 1.409A&#8209;1.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Representations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Parties represent that they each have had the opportunity to consult with an attorney, at their own expense, and have carefully read and understand the scope and effect of the provisions of this Agreement.  Neither Party has relied upon any representations or statements made by the other Party hereto which are not specifically set forth in this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  In the event that any provision in this Agreement becomes or is declared by a court of competent jurisdiction to be illegal, unenforceable, or void, this Agreement shall continue in full force and effect without said provision so long as the remaining provisions remain intelligible and continue to reflect the original intent of the Parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Entire Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive acknowledges that this Agreement, including the Transition Consulting Services Agreement and Service Date Release, is a full and accurate embodiment of the understanding between Executive and Company, and that it supersedes any prior agreements or understandings made by the Parties, except (i) any confidentiality, non-disclosure, trade secret, assignment of inventions, and other intellectual property provisions to which Executive&#8217;s employment was subject, including specifically the Confidentiality Agreement, which will remain in effect subsequent to the execution of this Agreement and (ii) the Severance &#38; CIC Plan will remain in effect with respect to Section 3 (Covenants) and Section 6 (Golden Parachute Taxes) thereof, which are hereby incorporated by reference herein.  The terms of this Agreement may not be modified, except by mutual consent of the Parties.  Any and all modifications must be reduced to writing and signed by the Parties to be effective.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Company&#8217;s Successors</font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  </font><font style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall require any successor (whether direct or indirect and whether by purchase, merger, consolidation, liquidation or otherwise) to all or substantially all of the Company&#8217;s business and&#47;or assets, by an agreement in substance and form satisfactory to the Executive, to assume this Agreement and to agree expressly to perform this Agreement in the same manner and to the same extent as the Company would be required to perform it in the absence of a succession.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline"> Governing Law and Venue</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement shall be deemed to have been executed and delivered within the State of California, and it shall be construed, interpreted, governed, and enforced in accordance with the laws of the State of California, without regard to choice of law principles.  In the event of any dispute in connection with this Agreement, the venue in which said dispute will be resolved will be in Princeton, New Jersey.  The prevailing party to any action for breach of this Agreement shall be entitled to its reasonable attorneys&#8217; fees and costs.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Good Faith Compliance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Parties agree to cooperate in good faith and to do all things necessary to effectuate this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Voluntary Execution of Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement is executed voluntarily and without any duress or undue influence on the part or behalf of the Parties hereto, with the full intent of releasing all claims.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d71dcd65f1a480fb4359b12578a74fe_52"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE PARTIES TO THIS AGREEMENT HAVE READ THE FOREGOING AGREEMENT AND FULLY UNDERSTAND EACH AND EVERY PROVISION CONTAINED HEREIN.  WHEREFORE, THE PARTIES HAVE EXECUTED THIS AGREEMENT ON THE DATES SHOWN BELOW.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:465.75pt"><tr><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:187.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:24.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:24.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:186.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#47;22&#47;2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sadie Stern</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For&#58;</font></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dexcom, Inc.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sadie Stern</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Its&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Human Resources Officer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10&#47;21&#47;2024</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Teri Lawver</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Teri Lawver</font></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d71dcd65f1a480fb4359b12578a74fe_68"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT 1</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Transition Consulting Services Agreement</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d71dcd65f1a480fb4359b12578a74fe_83"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSULTING AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Consulting Agreement (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is entered into by and between DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and Teri Lawver (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), effective as of January 1, 2025 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  Pursuant to this Agreement, on January 1, 2025, the Executive will first start providing consulting services to the Company.  This Agreement serves as the Consulting Agreement referenced in, and attached to, the Severance Agreement and General Release between Executive and the Company dated on or about October 21, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Separation Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  In exchange for Executive&#8217;s execution of this Agreement, Executive will be eligible to receive certain benefits, subject to the terms and conditions of this Agreement.  Defined terms used, but not defined, in this Agreement shall have the meaning ascribed in the Separation Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Consulting Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive agrees to be available to the Company&#8217;s Chief Executive Officer and Company management for consultations by telephone, email or in person, to provide advice and transitional services (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consulting Services</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The Company shall reimburse Executive for all required and pre-approved travel expenses.  The effectiveness of this Agreement is contingent upon Executive&#8217;s execution and compliance with the terms and conditions of the Separation Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Compensation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive shall receive a fee based on a rate of $51,750.02 per month.  Any partial month will be paid on a pro rata basis.  However, Executive will be eligible to continue to vest in Executive&#8217;s Company equity awards pursuant to Section 2 of the Separation Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Independent Contractor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive&#8217;s relationship with the Company will be that of an independent contractor, and Executive will not be an agent, employee or representative of the Company.  Executive understands that Executive will have no authority to enter into contracts or create obligations on behalf of the Company.  Accordingly, Executive acknowledges that Executive will not be eligible for any employee benefits.  Executive understands that Executive (and not the Company) will be responsible for Executive&#8217;s own tax liability that may arise as a result of this Agreement, without regard to the amount withheld or reported by the Company to applicable tax authorities, and Executive acknowledges and assumes all responsibility for the payment of any such taxes.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Continuing Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive remains bound by Executive&#8217;s obligations under the Separation Agreement, including the Restrictive Covenants, and agrees to comply with all such obligations while Executive provides Consulting Services and thereafter pursuant to the terms of thereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Company Policies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Executive hereby acknowledges and agrees to comply with all applicable Company policies, including, but not limited to, the clawback policies and conflict of interest policies during the period Executive provides the Consulting Services to the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Consulting Period and Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Consulting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement and the Consulting Services will continue until March 31, 2025, at which time it will automatically expire, unless terminated earlier in accordance with this Agreement (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consulting Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  The provisions of this Agreement shall survive the termination of Executive&#8217;s services for any reason to the extent necessary to enable the parties to enforce their respective rights under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company may terminate this Agreement immediately without notice for Cause (as defined in the Company&#8217;s Severance &#38; CIC Plan) or upon Executive&#8217;s material breach of any provision of this Agreement or the Separation Agreement.  Executive may terminate this Agreement for any reason upon ten (10) days written notice.  The parties may otherwise terminate this Agreement only by mutual agreement set forth in writing signed by both parties.  If the Company terminates this Agreement for Cause or Executive terminates this Agreement for any reason prior to the final day of the Consulting Period, Executive will no longer be eligible to receive the benefits pursuant to Section 2 of the Separation Agreement or as set forth herein.  Executive&#8217;s Consulting Services will be deemed terminated concurrently with any termination of this Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Governing Law&#59; Severability&#59; Integration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The terms contained in this Agreement shall be governed by and construed in accordance with the laws of the State of California, without giving effect to that body of laws pertaining to conflict of laws, and can be amended only in writing and by joint agreement of both Executive and the Company.  If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto.  If such provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable provision had (to the extent not enforceable) never been contained in this Agreement.  This Agreement and the Separation Agreement constitute the complete and exclusive understanding and agreement of Executive and the Company and supersedes all prior understanding and agreements, whether written or oral, with respect to the subject matter hereof.  This Agreement may be executed in two or more counterparts, including by electronic signature transmission, with the same force and effect as if each of the signatories had executed the same instrument.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Arbitration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  To ensure rapid and economical resolution of any and all disputes that might arise in connection with this Agreement, Executive and the Company agree that any and all disputes, claims, and causes of action, in law or equity, arising from or relating to this Agreement or its enforcement, performance, breach, or interpretation, will be resolved solely and exclusively by final, binding, and confidential arbitration, by a single arbitrator, in Princeton, New Jersey and conducted by the American Arbitration Association under its then-existing employment rules and procedures. Nothing in this section, however, is intended to prevent either party from obtaining injunctive relief in court to prevent irreparable harm pending the conclusion of any such arbitration. The prevailing party to any arbitration or litigation hereunder shall be entitled to all reasonable attorneys&#8217; fees and costs, including without limitation any arbitration costs.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature Page Follows&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d71dcd65f1a480fb4359b12578a74fe_101"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN WITNESS WHEREOF,</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the parties hereto have executed this Agreement as of the Effective Date.</font></div><div style="text-indent:36pt"><font><br></font></div><div style="text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:325.50pt"><tr><td style="width:1.0pt"></td><td style="width:28.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:39.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:102.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:73.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DEXCOM, INC.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">By&#58;</font></div></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Sadie Stern</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Name&#58;</font></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Sadie Stern</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Title&#58;</font></div></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">EVP, Chief Human Resources Officer</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:0 1pt"></td></tr><tr style="height:29pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="12" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Read, Acknowledged and Agreed&#58;</font></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:justify;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXECUTIVE&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#47;s&#47; Teri Lawver</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:44pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Teri Lawver</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center;text-indent:36pt"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Signature Page to Consulting Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i2d71dcd65f1a480fb4359b12578a74fe_116"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SERVICE DATE RELEASE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(To be signed on or after March 31, 2025)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned Executive (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">you</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and DexCom, Inc. (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have entered into an Agreement dated October 21, 2024 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) regarding the release of claims by Executive in connection with the termination of Executive&#8217;s employment by DexCom.  Capitalized terms used in this Service Date Release that are not defined in this document are defined elsewhere in the Agreement.  Pursuant to Section 2 of the Agreement, Executive hereby represents, warrants and agrees as follows as of the date Executive returns this Service Date Release to DexCom&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The Agreement is binding upon the parties and enforceable according to its terms.  Executive has fully complied with the Agreement and is not aware of any breach of the Agreement. Executive confirms, acknowledges and agrees that each representation and warranty of Executive set forth in the Agreement is true and correct as of the date Executive executes this Service Date Release.  Executive acknowledges confirms, acknowledges and agrees to continue to abide by each representation and warranty of Executive set forth in the Agreement, including, without limitation, the obligations set forth in Sections 9 and 10.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Executive&#8217;s employment with DexCom was terminated on the December 31, 2024 and Executive&#8217;s Transition Services Consulting Agreement was terminated on March 31, 2025, and Executive shall be owed no payments by DexCom except as set forth in the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">You, on behalf of yourself and your spouse, successors, heirs, and assigns, hereby forever irrevocably release and discharge DexCom and its affiliates, and subsidiaries, and the officers, shareholders, employees, directors, contractors, attorneys, and agents of each of them, and the successors, heirs and assigns of all of the foregoing (collectively &#34;Releasees&#34;), from all claims, demands, complaints, rights, actions, defenses, counterclaims, proceedings, liability, damages, losses, expenses and other amounts and remedies that you have ever had, have now or may in the future have, of any kind whatsoever that can be released (&#8220;Claims&#8221;), whether known or not known, and whether or not matured or liquidated, including, without limitation, and by way of example only, claims under any employment laws, including, but not limited to, claims of unlawful discharge, breach of contract, breach of the covenant of good faith and fair dealing, fraud, violation of public policy, defamation, personal injury, emotional distress, claims for additional compensation or benefits arising out of your employment or your separation of employment, claims under Title VII of the 1964 Civil Rights Act, as amended, the Civil Rights Act of 1866, the Civil Rights Act of 1871, the Fair Labor Standards Act, the Americans with Disabilities Act, the Family Medical Leave Act, the Equal Pay Act, the Employee Retirement Income Security Act of 1974, the National Labor Relations Act, the Genetic Information Nondiscrimination Act (GINA), the Immigration Reform and Control Act (IRCA), the Arizona Wage Act, the Arizona Equal Pay Act, the Arizona Employment Protection Act, the Arizona Civil Rights Act, the Arizona Occupational Health and Safety Act, the Arizona Right to Work Act, the Arizona Drug Testing of Employees Act, the Arizona Medical Marijuana Act, the Arizona criminal code, the Florida Civil Rights Act, the Florida Whistleblower Protection Act, the Florida Workers' Compensation Law Retaliation provision, the Florida Wage Discrimination Law, the Florida Minimum Wage Act, the Florida Equal Pay Law, the Florida AIDS Act, the Florida Discrimination on the Basis of Sickle Cell Trait Law, the Florida OSHA, the Florida Constitution, the Florida Fair Housing Act, Miami-Dade County Code, Chapter 11A, Broward County Human Rights Act, Palm Beach County Code, Article VI, the Oregon Family Leave Act, Chapter 659A of the Oregon Revised Statutes (including without limitation the Oregon Whistleblower Law, Oregon's Unlawful Discrimination Against Injured Workers Law, Oregon's Unlawful Discrimination for Service in Uniformed Service Law, Oregon's Leave of Absence for State Service Law, Oregon's Military Family Leave Act, Oregon's Unlawful Discrimination Against Persons with Disabilities Law, Oregon's Initiating or Aiding Administrative, Criminal or Civil Proceeding Law), the Virginia Human Rights Act (VHRA), the Virginians with Disabilities Act (VDA), the Virginia Equal Pay law, the Virginia Genetic Testing Law, the Virginia Occupational Safety and Health Act (VOSH), the Virginia Fraud Against Taxpayers Act, the Virginia Minimum Wage Act, the Virginia Payment of Wage Law, the Virginia Fraud and Abuse Whistleblower Protection Act, and the Virginia Right-to-Work Law, the California Fair Employment and Housing Act, the California Unruh Act, the California Constitution, the California Labor Code, the California Business &#38; Professions Code, the California Government Code, the California Civil Code and any other laws and&#47;or regulations relating to employment or employment discrimination, including, without limitation, claims based on age or under </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Age Discrimination in Employment Act or Older Workers Benefit Protection Act, and any claims relating to or arising from any equity in or rights relating to equity in DexCom.  You covenant and agree not to sue or otherwise institute or cause to be instituted, or assist any other person or entity in instituting or causing to be instituted any Claims against any Releasee except as set forth below, and except for your compliance with a valid court order or subpoena, provided that you give DexCom reasonable advance written notice of such court order or subpoena and cooperate with DexCom&#8217;s efforts to quash or otherwise terminate or limit such court order or subpoena.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This general release, discharge and waiver of claims excludes, and you do not waive, release, or discharge&#58; (a) any right to file an administrative charge or complaint with the Equal Employment Opportunity Commission, or other similar federal or state administrative agencies, although you waive any right to monetary relief related to such a charge or administrative complaint&#59; and (b) any other claims which cannot be waived by law&#59; (c) indemnification rights you have from DexCom&#59; and (d) any rights to vested benefits, such as vested RSUs and 401(k) plan benefits, the rights to which are governed by the terms of the applicable plan documents and agreements.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below, you represent and warrant that you have not been denied any request for leave to which you believe you were legally entitled, and you were not otherwise deprived of any of your rights under the Family and Medical Leave Act or any similar state or local statute&#59; and you have not assigned or transferred, or purported to assign or transfer, to any person, entity, or individual whatsoever, any of the claims released in the foregoing general release and waiver.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below, you expressly waive all rights afforded to you by Section 1542 of the Civil Code of the State of California, which provides as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:72pt;padding-right:36pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT IF KNOWN BY HIM OR HER WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#34;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You represent and agree that you are fully informed of your rights under Section 1542 and knowingly and intentionally waive such rights.  The release in this Section is final and irrevocable, and an independent covenant binding notwithstanding any breach of this Agreement by DexCom.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">ADEA Waiver &#47; Review of Terms of Agreement.  By your signature below, you acknowledge, agree and understand that&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">Under the general release detailed above, you are waiving and releasing, among other claims, any rights and claims that may exist under the Age Discrimination in Employment Act (&#8220;ADEA&#8221;)&#59; the waiver and release of claims set forth in the release above does not apply to any rights or claims that may arise under the ADEA after the date of execution of this Agreement&#59; the payments and other consideration that are being provided to you are of significant value and are in addition to what you otherwise would be entitled&#59; you have been advised to consult with your own attorney concerning the terms of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">You acknowledge that you have been given twenty-one (21) days to consider this Agreement and, by signing below, affirm that you were advised to consult with an attorney prior to signing this Agreement.</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">You also understand you may revoke this Agreement within seven (7) days of signing below.  Revocation must be made by must be in writing and transmitted by hand or by e-mail to &#91;***&#93; and &#91;***&#93;, and which must be received by DexCom no later than the close of business on the seventh (7th) calendar day after execution (or the next business day thereafter, if the seventh (7th) calendar day is not a business day).</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:455.25pt"><tr><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:49.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:158.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:16.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:27.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:158.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXECUTIVE&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.16
<SEQUENCE>4
<FILENAME>dxcm12312024-exhibit1016.htm
<DESCRIPTION>EX-10.16
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i82e31882f2424a6c8955a58d32af7533_1"></div><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.16</font></div><div style="margin-bottom:12pt;margin-top:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY &#91;***&#93;, HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND IS THE TYPE THAT THE REGISTRANT TREATS AS PRIVATE AND CONFIDENTIAL.</font></div><div><font><br></font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CONFIDENTIAL SETTLEMENT AND PATENT LICENSE AGREEMENT</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This CONFIDENTIAL SETTLEMENT AND PATENT LICENSE AGREEMENT (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is made and entered as of December 20, 2024 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) by and between Abbott Diabetes Care Inc., a Delaware corporation having a principal place of business at 1420 Harbor Bay Parkway, Alameda CA 94502 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ADC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and DexCom, Inc., a Delaware corporation, having a principal place of business at 6340 Sequence Drive, San Diego, CA 92121 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). ADC and DexCom are each individually referred to herein as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; and collectively as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221; Each Party and its Affiliates are also referred to herein, collectively, as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RECITALS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, ADC and its Affiliates have asserted certain patents against DexCom and its Affiliates, as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and DexCom and its Affiliates have asserted certain patents against ADC and its Affiliates, as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit B</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Asserted Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, ADC, DexCom, and their respective Affiliates, have filed various lawsuits, administrative challenges, and other proceedings against each other, as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits&#160;C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (collectively, and including the Pending Patent Challenges, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Proceedings</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, ADC and DexCom previously entered into a Settlement and License Agreement dated July 2, 2014 (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">2014 Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, each Covered Party denies that it has ever infringed the Asserted Patents, contests the validity and enforceability of the Asserted Patents, has filed counterclaims and defenses alleging noninfringement, invalidity and unenforceability, and has filed administrative challenges alleging the invalidity and unpatentability of the Asserted Patents&#59; </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, this Agreement is intended to end the Covered Parties&#8217; global legal disputes related to Covered Products and, by granting each other licenses in respect of all patents relating to the Covered Products, is intended to give the Covered Parties the opportunity to use the technologies and thereby promote competition&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, the Parties acknowledge that this Agreement should not be admissible in any future patent proceedings to which any Covered Party is a party as evidence of a reasonable royalty or other comparison, even if such other proceeding involves any Patents with similar technology&#59; and </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WHEREAS, to avoid the time and expense of the Proceedings, and without any admission of liability or fault, the Parties desire to enter into a full, final, complete, and global settlement of the Proceedings on the terms and conditions set forth herein.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, in consideration of the foregoing and mutual covenants in this Agreement and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Parties agree as follows&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE I</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DEFINITIONS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Agreement, the following terms shall have the following meanings&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#91;***&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ADC Covered Product</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Covered Product of ADC and its Affiliates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">ADC Covered Sensor Product</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Covered Sensor Product of ADC and its Affiliates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Entity that now or hereafter, directly, or indirectly through one or more intermediaries, Controls, is Controlled by, or is under common Control with a Covered Party, but only for so long as such Control exists. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">After-Acquired Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section&#160;8.4.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AID</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means automatic insulin delivery.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AID Software</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means insulin delivery software that determines an insulin dose and&#47;or instructs an insulin pump or insulin pen to administer the determined insulin dose on an automatic basis.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">AID System</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the combination of either an insulin pump or an insulin pen with AID Software.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as to a Party or other Entity, (a)&#160;a transaction or series of transactions that results in the sale, exchange, transfer or other disposition of all or substantially all of the Party&#8217;s or other Entity&#8217;s assets that are subject to this Agreement&#59; (b)&#160;a merger or consolidation in which (i)&#160;the Party or other Entity is not the surviving Entity or (ii)&#160;the Party or other Entity is the surviving Entity, where in either case (whether (i) or (ii) of this (b)) the Entities who Controlled such Party or other Entity immediately before the consummation of such merger or consolidation do not, immediately after consummation of such merger or consolidation, Control such Party or other Entity&#59; or (c)&#160;a transaction or series of transactions (which may include without limitation a tender offer for the Party&#8217;s or other Entity&#8217;s stock or the issuance, sale, or exchange of stock of such Party or other Entity if the Entities who Controlled such Party or other Entity immediately before the initial such transaction do not, immediately after consummation of such transaction or any of such series of transactions, Control such Party or other Entity&#59; provided, however, notwithstanding anything to the contrary in this Agreement, neither (i)&#160;the issuance of securities by a Party or other Entity through a public offering, nor (ii) the transfer of ownership or Control in a Party or other Entity to one or more of its Affiliates, shall, in either case (whether (i) or (ii) of this (c)) constitute a Change of Control. A Change of Control of a Party&#8217;s or Entity&#8217;s Controlling parent constitutes a &#8220;Change of Control&#8221; of such Party or Entity. &#8220;Change of Control,&#8221; as to a Party or other Entity, includes any Change of Control that results from a bankruptcy proceeding involving such Party or Entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any and all claims, defenses, demands, causes of action, suits, choses in action, controversies, actions, judgments, liens, indebtednesses, damages, losses, attorney&#8217;s fees, expert&#8217;s fees, expenses, liabilities, and proceedings of whatever kind and character, whether known or unknown, asserted or unasserted.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">CNS Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the ten-year (10-year) period commencing on the Effective Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; when referring to an Entity means having the power, direct or indirect, to direct or cause the direction of the management and policies of an Entity whether by ownership, contract, or otherwise. For the avoidance of doubt, ownership of more than fifty percent (50%) of the voting securities of the subject Entity shall constitute &#8220;Control.&#8221; </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; or &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Controlled</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; when referring to a Patent, Trade Dress or Design Right means that a Covered Party has the right to grant a sublicense or covenant with respect to such Patent, Trade Dress or Design Right as set forth in this Agreement, without violating any of the applicable terms of the relevant in-license, and provided further that such sublicensing does not impose any additional obligations (including payment of royalties or other amounts) or restrictions on such Covered Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covered Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means each Party and its Affiliates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Covered Products</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as to a Covered Party, any &#91;***&#93; manufactured by or on behalf of or sold by or on behalf of such Covered Party that &#91;***&#93; (any such sensor product, a &#8220;Covered Sensor Product&#8221;) as well as &#91;***&#93;, but excluding any Excluded Products, Knock-off Products and Knock-off Element Products. Covered Products, as to a Covered Party, also includes any &#91;***&#93;, and any future generations of such products.  For DexCom, Covered Products include but are not limited to the &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.16</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Design Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means registered or unregistered rights under the law of any jurisdiction, worldwide, in and to any and all aspects of the original appearance of a product, including its shape, design, configuration, color, texture, materials, packaging, ornamentation, and surface decoration.  For purposes of this Agreement, Design Rights do not include trademarks, tradenames, service marks, logos or corporate names, or rights therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.17</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person, trust, corporation, partnership, joint venture, limited liability company, association, unincorporated organization or other legal or governmental entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.18</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded Products</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;any Excluded &#91;***&#93; Products or (ii) any &#91;***&#93; products of &#91;***&#93; or its Affiliates that have a &#91;***&#93; product.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.19</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Excluded &#91;***&#93; Products</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any &#91;***&#93; products of a &#91;***&#93; that are &#91;***&#93; of a Covered Party for &#91;***&#93; as a &#91;***&#93; for &#91;***&#93;, which products are &#91;***&#93; of &#91;***&#93; and may be sold by the Covered Party only to &#91;***&#93;.  For clarity, in no event will any customization of a Covered Party&#8217;s Covered Product (including for purposes of interoperability between a Covered Product and a Third Party&#8217;s product or to meet &#91;***&#93; requirements (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, &#91;***&#93;)) be deemed to render such Covered Product an Excluded &#91;***&#93; Product.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.20</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Knock-off Products</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any &#91;***&#93; products of &#91;***&#93; that are &#91;***&#93; by the applicable &#91;***&#93; as of &#91;***&#93; by a Covered Party, which products are &#91;***&#93; of any of the non-acquiring Party&#8217;s then in &#91;***&#93; Covered Sensor Products &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.21</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Knock-off Element Products</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.22</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Licensed Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means all Patents owned or Controlled by a Covered Party at any time during the term of this Agreement (a) that have been or are asserted as of the Effective Date in any Proceeding between the Covered Parties (including the Asserted Patents)&#59; or (b) that (i)&#160;cover any Covered Products or &#91;***&#93; thereof, or would be infringed by such &#91;***&#93; absent the licenses set forth in this Agreement and (ii)&#160;claim, have claimed, or are otherwise entitled to, priority from &#91;***&#93; in the world as of the Effective Date by such Covered Party and its Affiliates in existence as of the Effective Date&#59; or (c) that claim, have claimed, or are otherwise entitled to, priority from &#91;***&#93; in the world as of the Effective Date and that were as of the Effective Date &#91;***&#93; (i) ADC or its Subsidiaries as of the Effective Date or (ii)&#160;DexCom or its Subsidiaries as of the Effective Date&#59; and (d) any Related Patents of the Patents described in the foregoing (a)-(c). A &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Related Patent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Patent that is a continuation, division, continuation in part, reissue, utility model, design patent, reissue from a reexamination, or the like, of a Licensed Patent or that otherwise claims, has claimed, or is otherwise entitled to priority from a Licensed Patent or any application from which a Licensed Patent also claims priority. Notwithstanding the foregoing, &#8220;Licensed Patents&#8221; excludes Patents &#91;***&#93; except to the extent such Patents are Related Patents. This definition of &#8220;Licensed Patents&#8221; and &#8220;Related Patent&#8221; does not disclaim or limit any implied licenses.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.23</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.24</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#91;***&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.25</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Pending Patent Challenges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Patent challenges that are pending between the Covered Parties, as set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibits&#160;C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> C.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.26</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;all classes or types of patents in any country or jurisdiction, including utility patents, utility models, design patents, invention certificates, reexamination certificates, and reissue patents&#59; (ii)&#160;all applications for all classes and types of patents in any country or jurisdiction, including provisional applications, nonprovisional applications, continuations, divisionals, and continuations-in-part&#59; and (iii)&#160;all rights to inventions for which applications may be filed in any country or jurisdiction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.27</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any Entity that now or hereafter, directly, or indirectly through one or more intermediaries, is Controlled by a Covered Party, but only for so long as such Control exists.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.28</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Third Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Entity other than (i) a Party to this Agreement or (ii) an Affiliate of a Party to this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.29</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;***&#93; Combination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section&#160;2.3.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.30</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#91;***&#93; Protections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section&#160;2.4(i).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.31</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Trade Dress</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means registered or unregistered rights under the law of any jurisdiction, worldwide, in and to the overall look and feel of a product (including any packaging and its presentation in advertising and promotion) that provides an indication of its source and distinguishes it from others.  For purposes of this Agreement, Trade Dress does not include trade names, brand names, logos or corporate names, or rights therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.32</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt">&#91;***&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE II</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">LICENSES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">License Grants</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt;text-decoration:underline">License to Abbott</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. DexCom, on behalf of itself and its Affiliates, hereby grants to ADC and its Affiliates (excepting any After-Acquired Affiliates), a nonexclusive, irrevocable, perpetual, non-transferable (except as authorized in Article&#160;VIII), worldwide, fully paid-up and royalty-free license, with no right to sublicense, under the Licensed Patents, to make, have made, use, have used, sell, have sold, offer to sell, have offered for sale, import, have imported, store or keep (or have stored or have kept) for those purposes, and otherwise transfer, have transferred, dispose of, or have disposed of, Covered Products.  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt;text-decoration:underline">License to DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ADC, on behalf of itself and its Affiliates, hereby grants to DexCom and its Affiliates (excepting any After-Acquired Affiliates), a nonexclusive, irrevocable, perpetual, non-transferable (except as authorized in Article&#160;VIII), worldwide, fully paid-up and royalty-free license, with no right to sublicense, under the Licensed Patents, to make, have made, use, have used, sell, have sold, offer to sell, have offered for sale, import, have imported, store or keep (or have stored or have kept) for those purposes, and otherwise transfer, have transferred, dispose of, or have disposed of, Covered Products.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#91;***&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">&#91;***&#93; Combinations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent any Covered Product of a Covered Party is used in combination with &#91;***&#93; (each, a &#8220;&#91;***&#93; Combination&#8221; and any of the foregoing &#91;***&#93; products or components in (a) or (b), a &#8220;&#91;***&#93;&#8221;), no Covered Party shall &#91;***&#93; provided that &#91;***&#93;.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">&#91;***&#93; Protections</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt;text-decoration:underline">Assertions Against &#91;***&#93; Combinations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To the extent that a Covered Party &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt;text-decoration:underline">Remedies</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Covered Party &#91;***&#93;. In addition, if &#91;***&#93; is ordered &#91;***&#93; Covered Product in any &#91;***&#93; Combination &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Supplier Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything in Sections&#160;2.4(i) and (ii), &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Further Assurances</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that an arbitrator or court of competent jurisdiction determines that any provision of this Section&#160;2.4 or the application thereof is unenforceable in whole or in part, in any jurisdiction anywhere in the world, the Parties agree to amend such provision as may be necessary to give effect to the intent of the Parties as set forth above.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE III</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RELEASES AND DISMISSALS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Releases</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt;text-decoration:underline">Release of Abbott</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. DexCom, on behalf of itself and its Affiliates, fully and forever irrevocably and unconditionally releases, acquits, and discharges ADC and its Affiliates, and their predecessors, successors, assigns, directors, employees, and officers, from all Claims that were or could have been asserted as of the Effective Date, arising out of or in any way related to, in any manner or degree, (a)&#160;the Licensed Patents or the direct or indirect (including induced or contributory) infringement thereof by any Covered Products (alone or in combination with other products) as of the Effective Date, (b)&#160;the Proceedings or the facts raised in the Proceedings, and (c) the 2014 Agreement. The releases set forth in this Section&#160;3.1(i) do not apply to any Claims arising out of or in any way related to, in any manner or degree, any breach of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt;text-decoration:underline">Release of DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ADC, on behalf of itself and its Affiliates, fully and forever irrevocably and unconditionally releases, acquits, and discharges DexCom and its Affiliates, and their predecessors, successors, assigns, directors, employees, and officers, from all Claims that were or could have been asserted as of the Effective Date, arising out of or in any way related to, in any manner or degree, (a)&#160;the Licensed Patents or the direct or indirect (including induced or contributory) infringement thereof by any Covered Products (alone or in combination with other products) as of the Effective Date, (b)&#160;the Proceedings or the facts raised in the Proceedings, and (c) the 2014 Agreement. The releases set forth in this Section&#160;3.1(ii) do not apply to any Claims arising out of or in any way related to, in any manner or degree, any breach of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Statutory Acknowledgement.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  The releases set forth in Section 3.1 are full and final releases by which each Party, on behalf of itself and its Affiliates, waives all rights and benefits they may have had in the past, now have, or in the future may have in connection with the Claims released in Section&#160;3.1 under the terms of any statute or provision of law that provides that a general release does not extend to Claims which a Party and its Affiliates do not know or suspect to exist in their favor at the time of executing this release by the Parties.  The Parties and their Affiliates understand and accept the risk that they may have substantial Claims that are presently unknown, and they nevertheless release all such Claims within the scope of the foregoing releases. Specifically, each Party, on behalf of itself and its Affiliates, hereby expressly waives any rights they may have under California Civil Code Section 1542 (and any other law of similar effect in any jurisdiction), in connection with the Claims released in Section 3.1, which provides that&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#8220;A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS THAT THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY.&#8221;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Stipulated Dismissal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Within five (5) business days after the Effective Date, the parties to the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall cause their respective counsel to execute and file the stipulated motion and proposed order in the form set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;D</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, or in such other form as required for approval by the relevant courts, for an order fully and finally dismissing the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with prejudice. The parties to the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall promptly proceed with any and all additional procedures needed to dismiss with prejudice the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Where dismissal of a Proceeding listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is only available on a &#8220;without prejudice&#8221; basis, the parties to the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> shall promptly proceed with any and all additional procedures needed to dismiss without prejudice the Proceedings listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Where dismissal of a Proceeding listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> is not possible, the Covered Parties and their respective counsel shall immediately cease all efforts to litigate that Proceeding.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Inter Partes Review</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As of the Effective Date and through the final disposition of each Pending Patent Challenge listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> that is an inter partes review between the Covered Parties (each an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IPR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; and collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">IPRs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), to the extent permitted by law, each Covered Party agrees not to voluntarily participate or assist others in prosecution of the IPRs, provided that, for the avoidance of doubt, the foregoing shall not restrict the provision of testimony, documents, assistance or information or any other actions that such Covered Party is legally obligated or compelled to provide.  Within five (5) business days after the Effective Date, the Parties shall jointly request a conference with the Patent Trial and Appeal Board of the PTO (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PTAB</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) seeking authorization to file a joint motion to terminate.  No later than the date therefor set by the PTAB, the Parties shall cause their respective counsel to execute and file with the PTO appropriate papers requesting termination of each of the IPRs as to the Parties without the rendering of a final decision, in the form set forth in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;E</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Notwithstanding the foregoing, the Parties acknowledge that the decision as to whether to terminate the IPRs is at the discretion of the PTO, neither Party shall have any liability hereunder if, notwithstanding its compliance with this Section&#160;3.4, the PTO does not terminate the IPRs, and the PTO&#8217;s termination of the IPRs is not a condition for any of the rights or obligations under this Agreement.  If the PTO does not terminate an IPR, the owner of the Patent challenged in that IPR may continue to prosecute or litigate the IPR, including any appeals, to the extent necessary to secure or uphold its challenged Patents.  In this provision, &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PTO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Patent and Trademark Office.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Other Pending Patent Challenges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Within five (5) business days after the Effective Date, the Covered Parties to any other Pending Patent Challenges listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.1 </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall cause their respective counsel to jointly dismiss all other Pending Patent Challenges or, where dismissal is not possible, cease all efforts to challenge or invalidate claims in any Pending Patent Challenges. Notwithstanding the foregoing, the Patent owner in any Pending Patent Challenge may continue to prosecute or litigate such Proceedings, including any appeals, to the extent necessary to secure or uphold its challenged Patents, including with respect to the Pending Patent Challenges listed in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit C.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Agreement Enforceability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Parties acknowledge and agree that this Agreement is enforceable according to its terms with respect to the final dismissal with prejudice of all Claims as between the parties in the Proceedings. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Costs and Attorneys&#8217; Fees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Parties agree that each Party shall bear its own costs and attorneys&#8217; fees relating to the Proceedings, and the dismissal thereof, and to the negotiation of this Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE IV</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">COVENANTS NOT TO SUE</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Covenant to Abbott</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. DexCom, on behalf of itself and its Affiliates, covenants and agrees that it and each of its Affiliates will not assert at any time before the expiration of the CNS Period any Claim (other than against any Excluded Product, Knock-off Product, or, Knock-off Element Product) against ADC or its Affiliates for direct or indirect (including induced or contributory) infringement of any Patent (including any Licensed Patents), Trade Dress or Design Right owned or Controlled by DexCom or its Affiliates.  For clarity, this Section 4.1 is subject to Section 4.5.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Covenant to &#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. DexCom, on behalf of itself and its Affiliates, covenants and agrees that it and each of its Affiliates will not assert at any time before the expiration of the CNS Period any Claim against &#91;***&#93; for direct or indirect (including induced or contributory) infringement of any Patent (including any Licensed Patents), Trade Dress or Design Right owned or Controlled by DexCom or its Affiliates in connection with or relating to &#91;***&#93; making, having made, using, offering for sale, selling, distributing, importing, having imported, storing or keeping for those purposes, or otherwise transferring, having transferred, disposing of, or having disposed of Covered Products of ADC or its Affiliates (&#91;***&#93;, in such capacity, an &#8220;&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">**</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#93;&#8221;).  For clarity, this Section 4.2 is subject to Section 4.5.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Covenant to DexCom</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ADC, on behalf of itself and its Affiliates, covenants and agrees that it and each of its Affiliates will not assert at any time before the expiration of the CNS Period any Claim (other than against any Excluded Product, Knock-off Product, or Knock-off Element Product) against DexCom or its Affiliates for direct or indirect (including induced or contributory) infringement of any Patent (including any Licensed Patents), Trade Dress or Design Right owned or Controlled by ADC or its Affiliates.  For clarity, this Section 4.3 is subject to Section 4.5.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Covenant to &#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. ADC, on behalf of itself and its Affiliates, covenants and agrees that it and each of its Affiliates will not assert at any time before the expiration of the CNS Period any Claim against &#91;***&#93; for direct or indirect (including induced or contributory) infringement of any Patent (including any Licensed Patents), Trade Dress or Design Right owned or controlled by ADC or its Affiliates in connection with or relating to &#91;***&#93; making, having made, using, offering for sale, selling, distributing, importing, having imported, storing or keeping for those purposes, or otherwise transferring, having transferred, disposing of, or having disposed of Covered Products of DexCom or its Affiliates (&#91;***&#93;, in such capacity, a &#8220;&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">***</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#93;&#8221;).  For clarity, this Section 4.4 is subject to Section 4.5.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">&#91;***&#93;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Covered Parties acknowledge and agree that &#91;***&#93; during the CNS Period for any acts that would be actionable were it not for the existence of the covenants set forth in this Article&#160;IV.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Breach of this Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The covenants of a Party set forth in this Article&#160;IV do not apply to any Claims arising out of or in connection with any breach by the other Party of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">ADR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the covenants set forth in this Article&#160;IV, the Covered Parties may invoke and enforce decisions pursuant to the alternative dispute resolution provisions under Article IX. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">&#91;***&#93; CNS Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. &#91;***&#93; the CNS Period, the Parties&#8217; respective Presidents or General Counsel shall &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">False Advertising And Unfair Competition Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Agreement restricts or limits any Covered Party&#8217;s rights to assert or defend any Claim for false advertising, unfair competition or unfair business practices, including regarding the accuracy of marketing claims made by the other Covered Party.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE V</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">COVENANT NOT TO CHALLENGE</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Contesting Validity of Patents During CNS Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the exceptions set forth in Section&#160;5.7, each Covered Party shall not during the CNS Period in any way contest the validity, enforceability, priority, ownership, inventorship, patent term extension or adjustment application, or granted patent term extension or adjustment of any Patent owned by the other Covered Party, in any court, government agency, or other venue worldwide, unless such Patent is asserted or threatened to be asserted against (i) such Covered Party (or any of its Affiliates), or (ii) an &#91;***&#93; in breach of Section 4.2, or (iii) a &#91;***&#93; in breach of Section 4.4, or (iv) &#91;***&#93; or &#91;***&#93; in breach of Section 2.2(ii).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Assisting in Contesting Validity of Patents During CNS Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the exceptions set forth in Section&#160;5.7, each Covered Party shall not during the CNS Period voluntarily assist any Third Party in any way in contesting the validity, enforceability, priority, ownership, inventorship, patent term extension or adjustment application, or granted patent term extension or adjustment of any Patent owned by the other Covered Party, in any court, government agency, or other venue worldwide, unless such Patent is asserted or threatened to be asserted against (i) such Covered Party (or any of its Affiliates), or (ii) an &#91;***&#93; in breach of Section 4.2, or (iii) a &#91;***&#93; in breach of Section 4.4, or (iv) &#91;***&#93; or &#91;***&#93; in breach of Section 2.2(ii).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Contesting Validity of Licensed Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the exceptions set forth in Section&#160;5.7, each Covered Party shall not during the term of this Agreement in any way contest the validity, enforceability, priority, ownership, inventorship, patent term extension or adjustment application, or granted patent term extension or adjustment of any Licensed Patent owned or Controlled by the other Covered Party, in any court, government agency, or other venue worldwide, unless such Patent is asserted or threatened to be asserted against (i) such Covered Party (or any of its Affiliates), or (ii) an &#91;***&#93; in breach of Section 4.2, or (iii) a &#91;***&#93; in breach of Section 4.4, or (iv) &#91;***&#93; or &#91;***&#93; in breach of Section 2.2(i).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Assisting in Contesting Validity of Licensed Patents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the exceptions set forth in Section&#160;5.7, each Covered Party shall not during the term of this Agreement voluntarily assist any Third Party in any way in contesting the validity, enforceability, priority, ownership, inventorship, patent term extension or adjustment application, or granted patent term extension or adjustment of any Licensed Patent owned or Controlled by the other Covered Party, in any court, government agency, or other venue worldwide, unless such Patent is asserted or threatened to be asserted against (i) such Covered Party (or any of its Affiliates), or (ii) an &#91;***&#93; in breach of Section 4.2, or (iii) a &#91;***&#93; in breach of Section 4.4 or (iv) &#91;***&#93; or &#91;***&#93; in breach of Section 2.2(i).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Admissions&#59; Exceptions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding the foregoing, (a)&#160;nothing in this Article&#160;V shall be interpreted as an admission by any Covered Party of the validity or invalidity of any Patent, or as an admission by any Covered Party of its direct or indirect (including induced or contributory) infringement of any&#160;Patent&#59; (b) the foregoing covenants in Sections 5.1 through 5.4 shall not apply to any challenge of (1) a Patent owned or Controlled by &#91;***&#93; or (2) a &#91;***&#93;, in each case if such challenge was filed prior to the &#91;***&#93; date of such &#91;***&#93;&#59; and (c)&#160;nothing in this Article&#160;V prevents a Covered Party from (i) complying with &#91;***&#93;, complying with &#91;***&#93; at &#91;***&#93;, serving as &#91;***&#93;, or engaging in other activities in response to the requests of any &#91;***&#93; or in accordance with applicable &#91;***&#93; or that such Covered Party is otherwise &#91;***&#93; or &#91;***&#93; to participate in or provide, or (ii) making arguments or comments (whether in the course of patent prosecution, administrative proceeding, or litigation) with respect to a Patent that is owned or Controlled by a Covered Party, where such Patent is referenced as prior art (or as evidence of the state of the art) in such patent prosecution, administrative proceeding, or litigation with respect to any Patent owned or Controlled by the Covered Party making such arguments or comments.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Permitted Challenges</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For clarity, and notwithstanding anything to the contrary in Section&#160;10.5, permitted challenges in defense of any assertion of a Patent against a Covered Party (or against an &#91;***&#93; in breach of Section 4.2, a &#91;***&#93; in breach of Section 4.4, or &#91;***&#93; or &#91;***&#93; in breach of Section 2.2(i) or 2.2(ii)) include interferences, opposition proceedings, IPR proceedings, post-grant review (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">PGR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) proceedings, reexaminations, revocation and nullity proceedings, derivation proceedings, or any other administrative proceedings for bringing a Patent challenge administered by any U.S. or foreign governmental body. A Covered Party may file any of the proceedings described in the previous sentence in defense of a suit or administrative proceeding asserting a Patent against such Covered Party without complying with the alternative dispute resolutions provisions in Article IX.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Exceptions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding Section&#160;5.1 and Section&#160;5.2, &#91;***&#93;, each Party may (itself or through any of its Affiliates) &#91;***&#93; or &#91;***&#93; in &#91;***&#93; to Patents owned or Controlled by the other Party or its Affiliates that are not &#91;***&#93;, provided that a statute, regulation, rule or other applicable law has &#91;***&#93;. Prior to bringing any such challenge, however, the challenging Party shall &#91;***&#93; to the other Party and the other Party shall &#91;***&#93;. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE VI</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">REPRESENTATIONS AND WARRANTIES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">General Representations and Warranties by Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Party represents and warrants that it has the corporate power and authority to enter into this Agreement, and to carry out the terms and perform its obligations set forth in this Agreement, and that the person executing this Agreement on its behalf has the authority to act for and bind such Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Additional Representations and Warranties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Party represents and warrants that&#58; (i) it and its Affiliates (either alone or in combination) has all rights to claim and recover for alleged infringement of its Licensed Patents, and has all legal rights necessary to grant the licenses, covenants, and releases provided for in this Agreement&#59; (ii) it has the full right and authority to enter into this Agreement on behalf of and bind all of its Affiliates, and shall cause all such Affiliates to comply with and grant all necessary rights, licenses, covenants, and releases to effect this Agreement, and all other terms and conditions of this Agreement, and shall be directly liable to the other Party and its Affiliates for any breach of this Agreement by any of such Party&#8217;s Affiliates, including any failure by any Affiliate to grant any such right, license, covenant, or release&#59; (iii) neither it nor any of its Affiliates has transferred or assigned or purported to transfer or assign to any Entity any Claims purported to be herein released&#59; (iv) neither it nor any of its Affiliates has instituted any pending lawsuit or other pending proceeding against the other Party or any of its Affiliates, involving any Patent (including any Licensed Patents), Trade Dress or Design Right, other than the Proceedings&#59; and (v) neither it nor any of its Affiliates have participated in any way (directly or indirectly) in any transaction the purpose or effect of which is to avoid or prevent the other Party and its Affiliates from receiving or enjoying any part of the benefit of any of the rights, licenses, covenants, or releases provided for in this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE VII</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TERM</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Term</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The term of this Agreement shall commence upon the Effective Date and shall continue until the tenth (10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) anniversary of the Effective Date or until the expiration of the last-to-expire Patent that is a Licensed Patent, whichever is later.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Neither this Agreement nor any of the rights, licenses, covenants, and releases granted by each Party (on its own behalf or on behalf of its Affiliates) hereunder may be terminated for any reason, and no Party shall have the right to seek rescission of this Agreement or any other remedy that seeks to invalidate, terminate, void, or undo this Agreement.  </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Survival</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The provisions of Article X, Sections 2.3, 2.4, 9.1, 9.2(v) (but only with respect to a court action or administrative proceeding commenced in breach of Section&#160;9.2 prior to expiration of this Agreement) and this Section 7.3, will survive expiration of this Agreement. Section 10.5 shall survive expiration of this Agreement only until the statute of limitations has run for any Claim for breach of this Agreement and has run for any Claim for direct or indirect (including induced or contributory) infringement of the last-to-expire U.S. Licensed Patent.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE VIII</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ASSIGNMENT AND TRANSFER</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Assignment of Licensed Patents by Covered Parties.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Each Party agrees, on behalf of itself and each of its Affiliates, that if such Party (or its Affiliate) assigns, or grants any enforcement rights with respect to, a Licensed Patent to a Third Party, then all of the licenses, releases, covenants, and other rights granted by them and all their obligations set forth in this Agreement with respect to such Licensed Patents (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Patent Obligations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall run with such Licensed Patents, and that such Party shall ensure that any assignee, transferee, or successor to any of the Licensed Patents (including an Acquiring Entity (as defined in Section 8.3) or a surviving Entity in connection with a Change of Control of such Covered Party where the separate corporate existence of the Covered Party ceases (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Surviving Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;)), or any other Entity (such as an exclusive licensee) that obtains any enforcement rights with respect to any of the Licensed Patents, agrees in writing, prior to such assignment, transfer or grant, to be bound by the relevant Patent Obligations (including the obligation to obtain such written agreement from any subsequent assignee, transferee, successor or grantee of such Licensed Patents).  Similarly, following such assignment, transfer or grant, the other Covered Party shall remain bound by the covenants made by such Covered Party in Article V with respect to such Licensed Patents.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Limitation on Assignments.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">  Except as expressly set forth in this Article VIII, neither Party may assign this Agreement or its rights or obligations hereunder without the other Party&#8217;s prior written consent.  Subject to the foregoing, this Agreement shall inure to the benefit of each Party&#8217;s permitted successors and assigns.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Sale or Transfer&#59; Change of Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Each Party shall have the right to assign this Agreement in connection with a Change of Control of such Party, provided that in the event of any Change of Control of a Party (such Party and its Affiliates immediately prior to such Change of Control, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Change of Control Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), (1) the license granted by the other Party under Section&#160;2.1 and the covenants made by the other Party under Article&#160;IV shall be limited to only (a)&#160;the Change of Control Party&#8217;s Covered Products that were &#91;***&#93; the &#91;***&#93; of such Change of Control&#59; and (b)&#160;improvements, updates, future versions, or successor products (however named) that are based upon the Change of Control Party&#8217;s Covered Products that were &#91;***&#93; the &#91;***&#93; of such Change of Control&#59; and (unless included in the foregoing clause (1)(a) or (1)(b)) do not cover any products that are the &#91;***&#93; as or &#91;***&#93; products that were &#91;***&#93; before the &#91;***&#93; of such Change of Control by the Third Party acquiror or its Affiliates existing immediately prior to such consummation (such Third Party acquiror and such Affiliates, individually and collectively, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquiring Entity</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and shall not extend otherwise to the Acquiring Entity or any other businesses of the Acquiring Entity&#59; (2) the covenants of both the Change of Control Party and the other Covered Party under Articles IV and V shall continue to apply with respect to such Change of Control Party (or Surviving Entity) and the other Covered Party&#59; (3) notwithstanding anything to the contrary, (a) the Patents &#91;***&#93; by the Acquiring Entity shall not be &#8220;Licensed Patents&#8221; and shall not be subject to the license granted to the other Covered Party in Section&#160;2.1, and (b) the Patents, Trade Dress, Design &#91;***&#93; by the Acquiring Entity shall not be subject to (i) the covenants made by the Change of Control Party in Article&#160;IV, or (ii) (if DexCom is the Change of Control Party) the license granted and covenant made by DexCom in Section 2.2&#59; and (4) the covenants of the Change of Control Party under Article V shall apply to the Acquiring Entity solely with respect to the Licensed Patents owned by such other Covered Party and any other Patents owned by such other Covered Party that claim the making, apparatus, or method of using, &#91;***&#93; product.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">After-Acquired Affiliates</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding anything in this Agreement to the contrary, if a Covered Party acquires or gains Control of any Third Party after the Effective Date (such acquired or newly-Controlled Third Party, an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">After-Acquired Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), such After-Acquired Affiliate &#91;***&#93; the licenses set forth in this Agreement and &#91;***&#93; the releases and covenants set forth in this Agreement &#91;***&#93; for &#91;***&#93; to the date of its acquisition by such Covered Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Patent Laundering</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Without limiting any other express restrictions on the rights and licenses granted under this Agreement or implying any right not expressly granted under this Agreement, the Parties acknowledge and agree that the licenses and covenants granted under this Agreement do not cover &#91;***&#93; that a Covered Party may &#91;***&#93; for the primary purpose of &#91;***&#93; or &#91;***&#93; that occur for such primary purpose, and other similar &#91;***&#93;.  Any product made, have made, used, have used, sold, have sold, offered for sale, have offered for sale, imported, have imported, stored or kept for such primary purpose shall not be a Covered Product.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE IX</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ALTERNATIVE DISPUTE RESOLUTION</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Alternative Dispute Resolution Procedure</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event of any dispute between the Covered Parties arising under, arising from, or related to this Agreement, the aggrieved Party must give written notice to the other Party. In the event of an alleged breach, the breaching Party (or Party alleged to be in breach) has &#91;***&#93; to cure the breach.  If such breach (or alleged breach) is not cured within &#91;***&#93; (including if the Party alleged to be in breach disputes the breach), the aggrieved Party may invoke the dispute resolution procedures of this Section&#160;9.1.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt;text-decoration:underline">Negotiations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties will attempt to settle amicably all disputes arising under, arising from, or related to this Agreement, by good faith negotiations of &#91;***&#93;, or &#91;***&#93;, for a period of at least &#91;***&#93; following receipt of a dispute notice, which period may be extended by mutual agreement between the Parties. If the Parties are unable to resolve their dispute within such period, either Party may submit the matter to binding arbitration, as the sole and exclusive dispute resolution method.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Arbitral Tribunal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Within &#91;***&#93; following institution of the arbitration proceeding, each Party will select &#91;***&#93; and &#91;***&#93; will &#91;***&#93; a &#91;***&#93; within &#91;***&#93; after their appointment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Discovery</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Other than by agreement of the Parties or on an order by the arbitral tribunal for good cause shown, there shall be no more than &#91;***&#93; requests for production, &#91;***&#93; interrogatories, &#91;***&#93; fact witness depositions, and &#91;***&#93; 30(b)(6) topics per side.  The Parties shall be allowed no more than &#91;***&#93; expert witnesses. Each Party may provide an expert report from each expert of &#91;***&#93; and each expert may be deposed. The Parties shall exchange contentions on their dispute within &#91;***&#93; of selection of &#91;***&#93;.  The Federal Rules of Civil Procedure shall govern the parties&#8217; discovery obligations under this Section 9.1(iv).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Hearing</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The hearing before the arbitral tribunal shall be held on &#91;***&#93; within &#91;***&#93; of the selection of &#91;***&#93;. The Federal Rules of Evidence shall govern the admissibility of evidence at the hearing. At least &#91;***&#93; before the hearing, each Party shall submit (a)&#160;&#91;***&#93;, (b)&#160;a &#91;***&#93;, and (c)&#160;&#91;***&#93;.  Within &#91;***&#93; after the hearing, each Party may submit a &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Arbitral Decision</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The arbitral tribunal shall rule on each disputed issue within &#91;***&#93; after the hearing. Such ruling shall &#91;***&#93; of the Parties on each disputed issue but may &#91;***&#93; on some issues and &#91;***&#93; on other issues. The arbitral tribunal will not &#91;***&#93; or otherwise &#91;***&#93; of its ruling.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.9pt;text-decoration:underline">Available Remedies&#59; Damages</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The arbitral tribunal may award &#91;***&#93; Agreement but may not grant &#91;***&#93; (including, without limitation, &#91;***&#93; relief or other orders of &#91;***&#93;) or &#91;***&#93;, or other &#91;***&#93;.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(viii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:17.68pt;text-decoration:underline">Fee shifting</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The losing Party pays both Parties&#8217; reasonable fees and costs (including reasonable attorneys&#8217; and experts&#8217; fees). The arbitral tribunal may reduce a fee-shifting award pro rata for a victory that is only partial.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ix)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Effect of Arbitral Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The rulings of the arbitral tribunal and the allocation of fees and expenses shall be binding upon the Parties, subject only to judicial review under the Federal Arbitration Act (9 U.S.C. &#167;&#167; 10 and 11) and may be entered as a final judgment in any court having jurisdiction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(x)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as necessary for judicial review or entry of final judgment or as required by law, the existence of the dispute, any settlement negotiations, the arbitration hearing, the arbitration ruling, and any arbitration submissions shall remain confidential.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(xi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Condition Precedent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Compliance with these alternative dispute resolution provisions is a condition precedent to filing any court action or administrative proceeding that involves, at least in part, a dispute between the Covered Parties arising under, arising from, or related to this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt;text-decoration:underline">Pre-Suit Notice for Infringement Claims</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt;text-decoration:underline">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Party that believes that it or any of its Affiliates has a claim of Patent, Trade Dress or Design Right infringement against the other Party or that Party&#8217;s Affiliates relating to any Covered Products of the other Party or its Affiliates, prior to initiating any court action or administrative proceeding in any court or administrative agency anywhere in the world asserting infringement, shall first send notice of such potential claim to the opposing Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt;text-decoration:underline">Negotiations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties will attempt to settle amicably such potential claim by good faith negotiations of &#91;***&#93;, or &#91;***&#93;, for a period of at least &#91;***&#93; following receipt of a dispute notice, which period may be extended by mutual agreement between the Parties.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt;text-decoration:underline">Binding Arbitration</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Parties are unable to resolve their dispute within such period, either party may within &#91;***&#93; submit for binding arbitration under the alternative dispute resolution procedure described in Section&#160;9.1 above whether the potential claim asserts a Licensed Patent against a Covered Product or is otherwise barred by this Agreement. The arbitral tribunal shall have authority to decide &#91;***&#93; are Licensed Patents asserted &#91;***&#93;. At least one member of the arbitral tribunal resolving a dispute under this provision shall be &#91;***&#93; with &#91;***&#93;.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt;text-decoration:underline">Condition Precedent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Compliance with these pre-suit notice procedures, including the conclusion of any binding arbitration instituted under these procedures, shall be a condition precedent to a Covered Party filing any court action or administrative proceeding asserting a claim of Patent, Trade Dress or Design Right infringement against the other Covered Party relating to any Covered Products of such other Covered Party. The damages and statute of limitations period for such a claim of Patent, Trade Dress or Design Right infringement shall be tolled for the period during which the Covered Parties are engaged in pre-suit notice procedures.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt;text-decoration:underline">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***&#93;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ARTICLE X</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MISCELLANEOUS PROVISIONS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Confidentiality</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The terms of this Agreement are confidential. Except for a press release or other announcements agreed to by representatives of the Parties in connection with this settlement, none of the Covered Parties may issue a press release or other public announcement regarding this Agreement or the transactions contemplated herein. ADC may disclose Section 2.2 to &#91;***&#93;.  No Party shall otherwise disclose the terms of this Agreement without the other Party&#8217;s written consent (other than to its Affiliates subject to obligations of confidentiality at least as stringent as those contained herein) except&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">to any governmental body having jurisdiction and specifically requiring such disclosure&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">in response to a subpoena or as otherwise may be required by law&#59;  </font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">in confidence, to a Party&#8217;s directors, accountants, legal counsel, tax advisors and other financial and legal advisors&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">as required during the course of litigation and subject to a protective order&#59; provided, however, that any production under a protective order would be protected under an &#8220;Outside Attorneys&#8217; Eyes Only&#8221; designation prohibiting disclosure to in-house counsel or higher confidentiality designation, which higher confidentiality designation, for the avoidance of doubt, must be at least as restrictive as &#8220;Outside Attorneys&#8217; Eyes Only&#8221;&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">for the purposes of disclosure in connection with the Securities and Exchange Act of 1934, as amended, the Securities Act of 1933, as amended, and any other reports or disclosures filed with the Securities and Exchange Commission or other financial regulatory authorities, or any other filings, reports or disclosures that may be required under applicable laws or regulations&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vi)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">with obligations of confidentiality at least as stringent as those contained herein, to a counterparty in connection with a proposed merger, acquisition, financing or similar transaction or a proposed exclusive license, sale, or transfer of rights to the Licensed Patents&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(vii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19.9pt">as required to enforce the terms of this Agreement&#59; provided, however, that prior to any disclosure pursuant to paragraphs (i), (ii), (iv) or (v), the Party making any such disclosure shall&#58; (a) take reasonable actions in an effort to minimize the nature and extent of such disclosure&#59; and (b) provide at least ten (10) days&#8217; advance written notice to the other Party of such disclosure and its contents. Nothing in this provision shall impose obligations on the Parties that would be contrary to or impede compliance with their obligations under any applicable law or rule, or shall restrict the Parties, their directors, accountants, legal counsel, tax advisors, and other financial and legal advisors, from disclosing information that is already publicly known through no fault of the disclosing Party.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Notices</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  All notices required or permitted to be given hereunder must be in writing and must be delivered by prepaid air courier or by registered or certified airmail, postage prepaid, addressed as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:55.8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:360.00pt"><tr><td style="width:1.0pt"></td><td style="width:97.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:259.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:67pt"><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For ADC&#58;</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbott Laboratories<br>Attention&#58; General Counsel<br>100 Abbott Park Road<br>Abbott Park, Illinois 60064</font></td></tr><tr style="height:122pt"><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For DexCom&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dexcom, Inc.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; Chief Legal Officer</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6340 Sequence Drive</font></div><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, CA 92121<br><br>with a copy to&#58;<br>Dexcom, Inc.</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attention&#58; General Counsel</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6340 Sequence Drive</font></div><div style="padding-left:2.77pt;padding-right:2.77pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, CA 92121</font></div></td></tr></table></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Such notices shall be deemed to have been served when received by addressee.  Any Party may give written notice of a change of address and, after notice of such change has been received, any notice or request must thereafter be given to such Party as above provided at such changed address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.3</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Licenses in Bankruptcy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Without acknowledging that this Agreement is an executory contract, the Parties agree that all rights, licenses, releases, and immunities granted under or pursuant to this Agreement by each of the Parties are, and shall otherwise be deemed to be, for the purpose of Section 365(n) of the US Bankruptcy Code, as amended (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Bankruptcy Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), licenses of rights to &#8220;intellectual property&#8221; as defined under Section 101(35A) of the Bankruptcy Code. The Parties agree that each of the Parties shall retain and may fully exercise all of their respective rights and elections under the Bankruptcy Code. The Parties further agree that, in the event that any proceeding shall be instituted by or against a Party seeking to adjudicate it as bankrupt or insolvent, or seeking liquidation, winding up, reorganization, arrangement, adjustment, protection, relief, or composition of that Party or that Party&#8217;s debt under any law relating to bankruptcy, insolvency, reorganization, or relief of debtors, or seeking an entry of an order for relief or the appointment of a receiver, trustee, or other similar official for that Party or any substantial part of its property, or if a Party hereto shall take any action to authorize any of the foregoing actions, the other Party shall have the right to retain and enforce their respective rights under this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Choice of Law</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement and matters connected with the performance thereof shall be construed, interpreted, and governed in all respects in accordance with the laws of the United States of America and the State of Delaware, without reference to conflict of laws principles, provided that all issues of substantive patent law arising under, arising from, or related to this Agreement for any Patent, Trade Dress, or Design Right shall be determined by the substantive law of the country or relevant jurisdiction of such Patent, Trade Dress, or Design Right.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Choice of Venue &#38; Jurisdiction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 5.6 and Article IX, the Parties agree that any disputes and litigation related to this Agreement, its construction, and matters connected with its performance, and any Claim for direct or indirect (including induced or contributory) infringement at any time, under any U.S. Patent (including any U.S. Licensed Patents), U.S. Trade Dress or U.S. Design Right against a Covered Party, shall be subject to the exclusive jurisdiction of the United States District Court for the District of Delaware, to the extent permitted by law. This includes jurisdiction to resolve any disputes between Covered Parties arising under, arising from, or related to this Agreement over whether any patents, foreign or U.S., are Licensed Patents, if such dispute was not resolved by the arbitration procedure of Article IX. The Court of Chancery of the State of Delaware shall have exclusive jurisdiction pursuant to 10 Del. C. Section 346, to the extent subject matter jurisdiction is lacking in federal court.  Subject to Article IX, the Parties hereby consent to, and waive any challenge to, the jurisdiction and venue of the Delaware state and federal courts over these matters. A Party that obtains a judgment against the other Party in the courts identified in this section may enforce that judgment in any court that has jurisdiction over the Parties. Notwithstanding anything in this Section 10.5 to the contrary, nothing herein will restrict either Party from initiating, pursuing, or otherwise participating in any Patent challenges, including, without limitation, any interferences, opposition proceedings, IPR proceedings, PGR proceedings, revocation and nullity proceedings, or any other administrative proceedings administered by any U.S. or foreign governmental body, to the extent any such Patent challenges or other proceedings are permitted by this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.6</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Injunctive Relief</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Agreement shall be interpreted to preclude the Covered Parties from seeking injunctive relief after this Agreement expires against any products or activity that are not licensed or released hereunder. No Covered Party shall use the existence or effect of this Agreement, any arbitration under this Agreement, or the 2014 Agreement to argue in any court or administrative proceeding that the other Covered Party has not suffered, or will not suffer, irreparable harm or otherwise is not entitled to injunctive relief.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.7</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Further Acts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties agree to perform any further acts and execute and deliver any further documents that may be reasonably necessary to carry out this Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.8</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Parties intend that if a court holds that any provision or part of this Agreement is invalid or unenforceable, the court will modify that provision or part to the minimum extent necessary to make it valid and enforceable, or if it cannot be made valid and enforceable, will sever and delete that part. That modification or severance will not affect the validity or enforceability of the remainder of this Agreement, which will continue in full force and effect. The Parties agree to negotiate in good faith an enforceable substitute provision for any invalid, illegal, or unenforceable provision that most nearly achieves the intent of the provision.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.9</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:16.55pt;text-decoration:underline">Mistake</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In entering and making this Agreement, the Parties assume the risk of any mistake of fact or law, and any mistakes of fact or law will not be grounds for seeking rescission or otherwise challenging the validity of this Agreement. This Agreement is final and binding on the Parties regardless of any mistake of fact or law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.10</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">Entire Agreement&#59; Termination of the 2014 Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement embodies the entire understanding of the Parties with respect to the subject matter hereof, and merges all prior discussions among them, and none of the Covered Parties shall be bound by any conditions, definitions, warranties, understandings, or representations with respect to the subject matter hereof other than as expressly provided herein.  No oral explanation or oral information by any Party hereto shall alter the meaning or interpretation of this Agreement. The 2014 Agreement is hereby terminated in its entirety and superseded by this Agreement and all rights and obligations under the 2014 Agreement (including any terms which expressly or impliedly purport to survive its termination) cease as of the Effective Date.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.11</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">Modification&#59; Waiver</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  No modification or amendment to this Agreement will be effective unless in writing and signed by authorized representatives of the Parties. No waiver of any provision, breach, or default of this Agreement will be valid unless in a writing signed by the waiving Party that specifies what is being waived. A valid waiver under this Section&#160;10.11 will be limited in scope to the waiver specified and will not constitute a waiver of any other provision, breach, or default under this Agreement. A Party&#8217;s failure or delay in enforcing any provision of this Agreement will not operate as a waiver.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.12</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">Consultation with Counsel</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Party acknowledges that it knows and understands the contents of this Agreement and has been represented by counsel of its choice in connection with this Agreement and has entered into this Agreement knowingly and voluntarily.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.13</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">Construction&#59; Language</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any rule of construction to the effect that ambiguities are to be resolved against the drafting party will not be applied in the construction or interpretation of this Agreement.  As used in this Agreement, the words &#8220;include&#8221; and &#8220;including&#8221; and variations thereof will not be deemed to be terms of limitation, but rather will be deemed to be followed by the words &#8220;without limitation.&#8221;  The headings in this Agreement will not be referred to in connection with the construction or interpretation of this Agreement.  This Agreement is in the English language only, which language shall be controlling in all respects, and all notices under this Agreement shall be in the English language.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.14</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">Counterparts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement may be executed in counterparts or duplicate originals, all of which shall be regarded as one and the same instrument, and which shall be the official and governing version in the interpretation of this Agreement.  This Agreement may be executed by facsimile, electronic or digital signatures and such signatures shall be deemed to bind each Party as if they were original signatures.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.15</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.99pt;text-decoration:underline">No Admissions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The terms and conditions of this Agreement are for the purpose of settlement only. Neither the fact of a Party&#8217;s entry into this Agreement nor the terms hereof nor any acts undertaken pursuant hereto shall constitute an admission or concession by either Party of liability or wrongdoing on the part of such Party. Neither the fact of a Party&#8217;s entry into this Agreement nor the terms hereof nor any acts undertaken pursuant hereto shall be offered or admitted in evidence in any legal proceeding against any Party other than one to enforce rights and obligations arising out of this Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#91;Signature page follows&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_4"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Parties hereto have caused this Agreement to be signed below.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:157.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:76.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:33.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:157.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abbott Diabetes Care Inc.</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dexcom, Inc.</font></td></tr><tr style="height:15pt"><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On behalf of itself and its Affiliates </font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">On behalf of itself and its Affiliates</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JARED WATKIN</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R SAYER</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JARED WATKIN</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KEVIN R SAYER</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">EVP DIABETES CARE</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title&#58;</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CEO &#38; PRESIDENT</font></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 DEC 2024</font></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20 DECEMBER 2024</font></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_221"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT A</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSERTED PATENTS (ADC)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_401"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT B</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ASSERTED PATENTS (DEXCOM)</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_415"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT C-1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEEDINGS &#38; PENDING PATENT CHALLENGES <br>THE PARTIES MUST SEEK TO DISMISS OR TERMINATE</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_447"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT C-2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROCEEDINGS &#38; PENDING PATENT CHALLENGES <br>THE PATENT OWNER MAY LEAVE PENDING <br>SOLELY FOR THE PURPOSE OF DEFENDING <br>THE VALIDITY OF THE PATENT OWNER&#8217;S PATENTS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_429"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT D</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DISMISSAL STIPULATION AND ORDER FOR U.S. DISTRICT COURT CASES</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_518"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOINT STIPULATION TO DISMISS</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">FEDERAL CIRCUIT APPEAL NOS. 24-1449, -1450</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_463"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXHIBIT E</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">UNOPPOSED MOTION TO DISMISS PRE-INSTITUTION PROCEEDINGS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i82e31882f2424a6c8955a58d32af7533_230"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOINT MOTION TO TERMINATE POST-INSTITUTION PROCEEDINGS</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;***&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.17
<SEQUENCE>5
<FILENAME>dxcm12312024-exhibit1017.htm
<DESCRIPTION>EX-10.17
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i59f984d5714c434ea6ef939759514250_1"></div><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 10.17</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:700;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Adopted by the Board on April 18, 2019)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PURPOSE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The purpose of this Plan is to provide incentives to attract, retain and motivate eligible persons whose present and potential contributions are important to the success of the Company, and any Parents and Subsidiaries that exist now or in the future, by offering them an opportunity to participate in the Company&#8217;s future performance through the grant of Awards. Capitalized terms not defined elsewhere in the text are defined in Section&#160;28.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SHARES SUBJECT TO THE PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Number of Shares Available</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Sections&#160;2.5, and 21 and any other applicable provisions hereof, the total number of Shares reserved and available for grant and issuance pursuant to this Plan as of the date of adoption of this Plan by the Board, is 39,200,000 Shares, plus (i) Shares that are subject to stock options or other awards granted under the Company&#8217;s 2005 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Prior Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) on the Effective Date (as defined below), that cease to be subject to such stock options or other awards by forfeiture or otherwise after the Effective Date for any reason other than the exercise of a stock option or SAR, (ii) Shares issued under the Prior Plan that are repurchased by the Company at the original issue price&#59; or (iii)&#160;Shares that are subject to stock options or other awards granted under the Prior Plan that otherwise terminate without Shares being issued.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lapsed, Returned Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Shares subject to Awards, and Shares issued under this Plan under any Award, will again be available for grant and issuance in connection with subsequent Awards under this Plan to the extent such Shares&#58; (a)&#160;are subject to issuance upon exercise of an Option or SAR granted under this Plan but which cease to be subject to the Option or SAR for any reason other than exercise of the Option or SAR&#59; (b)&#160;are subject to Awards granted under this Plan that are forfeited or are repurchased by the Company at the original issue price&#59; (c)&#160;are subject to Awards granted under this Plan that otherwise terminate without such Shares being issued&#59; or (d)&#160;are surrendered pursuant to an Exchange Program. To the extent an Award under this Plan is paid out in cash rather than Shares, such cash payment will not result in reducing the number of Shares available for issuance under this Plan. Shares used to pay the exercise price of an Award, Shares withheld to satisfy the tax withholding obligations related to an Award or Shares repurchased by the Company for any reason other than Shares repurchased at their original issue price, in each case will not become available for future grant or sale under this Plan. Except as set forth above, any Awards granted including but not limited to Awards granted as SARs shall reduce the number of shares granted on a one-for-one Share for Share basis and any Shares withheld shall not again be made available for Awards under the Plan. To the extent that any Award is forfeited, repurchased or terminates without Shares being issued, Shares may again be available for issuance under this Plan. For the avoidance of doubt, Shares that otherwise become available for grant and issuance because of the provisions of this Section&#160;2.2 shall not include Shares subject to Awards that initially became available because of the substitution clause in Section&#160;21.2 hereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Minimum Share Reserve</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At all times the Company shall reserve and keep available a sufficient number of Shares as shall be required to satisfy the requirements of all outstanding Awards granted under this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No more than 39,200,000 Shares shall be issued pursuant to the exercise of ISOs.</font></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:198pt"></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:100%;position:relative;top:-3.15pt;vertical-align:baseline">1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"> Reflects June 10, 2022 four-for-one forward stock split.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Adjustment of Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the number of outstanding Shares is changed by an extraordinary cash dividend, a stock dividend, recapitalization, spin-off, stock split, reverse stock split, subdivision, combination, reclassification or similar change in the capital structure of the Company, without consideration, then (a)&#160;the number of Shares reserved for issuance and future grant under this Plan set forth in Sections&#160;2.1 and 2.2, (b)&#160;the Exercise Prices of and number of Shares subject to outstanding Options and SARs, (c)&#160;the number of Shares subject to other outstanding Awards, (d)&#160;the maximum number of Shares that may be issued as ISOs set forth in Section&#160;2.4, and (e)&#160;the maximum number of Shares that may be issued to an individual or to a new Employee in any one calendar year set forth in Section&#160;3 or to a Non-Employee Director in Section&#160;12 shall be proportionately adjusted, subject to any required action by the Board or the stockholders of the Company and in compliance with applicable securities laws&#59; provided that fractions of a Share will not be issued but will either be replaced by a cash payment equal to the Fair Market Value of such fraction of a Share or will be rounded up (down in the case of ISOs) to the nearest whole Share, as determined by the Committee&#59; and provided further that the Exercise Price of any Option may not be decreased to below the par value of the Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting &#47; Acceleration Restriction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards shall not provide for any vesting prior to at least twelve (12) months from grant. In addition, the Committee will not permit the discretionary acceleration of vesting of Awards. Notwithstanding the foregoing, the Committee may permit (i) acceleration of vesting of Awards in the event of the Participant&#8217;s death or Disability, or Change of Control and (ii) the vesting of Awards on any basis prior to twelve (12) months from grant or any acceleration of vesting of Awards representing up to an aggregate of five percent (5%) of the Shares reserved and available for grant under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ELIGIBILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ISOs may be granted only to an eligible Employee. All other Awards may be granted to an eligible Employee, Consultant, Director or Non-Employee Director&#59; provided such Consultant, Director or Non-Employee Director renders bona fide services not in connection with the offer and sale of securities in a capital-raising transaction. No Participant will be eligible to be granted more than 4,000,000 Shares in any calendar year under this Plan pursuant to the grant of Awards except that a new Employee (including a new Employee who is also an officer or director of the Company or any Parent, Subsidiary or Affiliate) is eligible to be granted up to a maximum of 8,000,000 Shares in the calendar year in which such Employee commences employment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ADMINISTRATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee Composition&#59; Authority</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Plan will be administered by the Committee or by the Board acting as the Committee. Subject to the general purposes, terms and conditions of this Plan, and to the direction of the Board, the Committee will have full power to implement and carry out this Plan, except, however, the Board shall establish the terms for the grant of an Award to Non-Employee Directors. The Committee will have the authority to&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">construe and interpret this Plan, any Award Agreement and any other agreement or document executed pursuant to this Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">prescribe, amend and rescind rules and regulations relating to this Plan or any Award&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">select persons to receive Awards&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the form and terms and conditions, not inconsistent with the terms of this Plan, of any Award granted hereunder. Such terms and conditions include, but are not limited to, the exercise price, subject to Section 2.6, the time or times when Awards may vest and be exercised (which may be based on performance criteria) or settled, subject to Section 2.6, any vesting acceleration or waiver of forfeiture restrictions, the method to satisfy tax withholding obligations or any other tax liability legally due, and any restriction or limitation regarding any Award or the Shares relating thereto, based in each case on such factors as the Committee will determine&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the number of Shares or other consideration subject to Awards&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the Fair Market Value and interpret the applicable provisions of this Plan and the definition of Fair Market Value in connection with circumstances that impact the Fair Market Value, if necessary&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine whether Awards will be granted singly, in combination with, in tandem with, in replacement of, or as alternatives to, other Awards under this Plan or any other incentive or compensation plan of the Company or any Parent or Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">grant waivers of Plan or Award conditions&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the vesting, exercisability and payment of Awards&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">correct any defect, supply any omission or reconcile any inconsistency in this Plan, any Award or any Award Agreement&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine whether an Award has been earned&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">determine the terms and conditions of any, and to institute any Exchange Program approved by stockholders&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reduce or waive any criteria with respect to Performance Factors&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adjust Performance Factors to take into account changes in law and accounting or tax rules as the Committee deems necessary or appropriate to reflect the impact of extraordinary or unusual items, events or circumstances to avoid windfalls or hardships, including without limitation (i) restructurings, discontinued operations, extraordinary items, and other unusual or non-recurring charges, (ii) an event either not directly related to the operations of the Company or not within the reasonable control of the Company&#8217;s management, or (iii) a change in accounting standards required by generally accepted accounting principles&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">adopt terms and conditions, rules and&#47;or procedures (including the adoption of any subplan under this Plan and any country addenda to the Award Agreements) relating to the operation and administration of this Plan to accommodate grants to participants residing outside of the United States and comply with the requirements of local law and procedures&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">make all other determinations necessary or advisable for the administration of this Plan&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">delegate any of the foregoing to a subcommittee consisting of one or more executive officers pursuant to a specific delegation as permitted by applicable law, including Section&#160;157(c) of the Delaware General Corporation Law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Committee&#160;Interpretation and Discretion</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any determination made by the Committee with respect to any Award shall be made in its sole discretion at the time of grant of the Award or, unless in contravention of any express term of this Plan or Award, at any later time, and such determination shall be final and binding on the Company and all persons having an interest in any Award under this Plan. Any dispute regarding the interpretation of this Plan or any Award Agreement shall be submitted by the Participant or Company to the Committee for review. The resolution of such a dispute by the Committee shall be final and binding on the Company and the Participant. The Committee may delegate to one or more executive officers the authority to review and resolve disputes with respect to Awards held by Participants who are not Insiders, and such resolution shall be final and binding on the Company and the Participant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Section&#160;16 of the Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards granted to Participants who are subject to Section&#160;16 of the Exchange Act must be approved by two or more &#8220;non-employee directors&#8221; (as defined in the regulations promulgated under Section&#160;16 of the Exchange Act).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Documentation</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Award Agreement for a given Award, this Plan and any other documents may be delivered to, and accepted by, a Participant or any other person in any manner (including electronic distribution or posting) that meets applicable legal requirements.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Foreign Award Recipients</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision of this Plan to the contrary, in order to comply with the laws and practices in countries other than the United States in which the Company and its Subsidiaries and Affiliates operate or have employees or other individuals eligible for Awards, the Committee, in its sole discretion, shall have the power and authority to&#58; (i)&#160;determine which Subsidiaries and Affiliates shall be covered by this Plan&#59; (ii)&#160;determine which individuals outside the United States are eligible to participate in this Plan, which may include individuals who provide services to the Company, Subsidiary or Affiliate under an agreement with a foreign nation or agency&#59; (iii)&#160;modify the terms and conditions of any Award granted to individuals who are located outside the United States or who are foreign nationals to comply with applicable foreign laws, policies, customs and practices&#59; (iv)&#160;establish subplans and modify exercise procedures and other terms and procedures, to the extent determined necessary or advisable by the Committee and provided that (a) no such subplans and&#47;or modifications shall increase the share limitations contained in Section&#160;2.1 hereof and (b) in such instance, such subplans and&#47;or modifications shall be attached to this Plan as appendices&#59; and (v)&#160;take any action, before or after an Award is made, that the Committee determines to be necessary or advisable to obtain approval or comply with any local governmental regulatory exemptions or approvals. Notwithstanding the foregoing, the Committee may not take any actions hereunder, and no Award shall be granted, that would violate the Exchange Act or any other applicable United States securities law, the Code or any other applicable United States governing statute or law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">OPTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An Option is the right but not the obligation to purchase a Share, subject to certain conditions, if applicable, granted to an eligible Employee, Consultant or Director. All Options shall be granted pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of Options</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Option granted under this Plan will be identified as an Incentive Stock Options within the meaning of the Code (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">ISO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or a Nonqualified Stock Option (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">NSO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Applicable conditions may be based on completion of a specified number of years of service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of an Option that is being earned upon satisfaction of performance goals based on Performance Factors, the Committee shall&#58; (a)&#160;determine the nature, length and starting date of any Performance Period for the Option&#59; (b)&#160;select from among the Performance Factors to be used to measure performance goals, if any&#59; and (c)&#160;determine the number of Shares that may be earned by the Participant. Performance Periods may overlap and a Participant may participate simultaneously with respect to Options that are subject to different Performance Periods and having performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Date of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Option&#8217;s date of grant will be that date on which the Committee makes the determination to grant such Option, or any such future date specified by the Committee. The Award Agreement will be delivered to the Participant within a reasonable time after the date of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, Options will vest and be exercisable within the times or upon the conditions as set forth in the Award Agreement&#59;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no Option will be exercisable after the expiration of ten (10) years from the date of grant&#59; and&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;that no ISO granted to a person who, at the time the ISO is granted, directly or by attribution owns more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or of any Parent or Subsidiary of the Company (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Ten Percent Stockholder</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) will be exercisable after the expiration of five (5) years from the date the ISO is granted. The Committee also may provide for Options to vest and be exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of Shares as the Committee determines.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Exercise Price of an Option will be determined by the Committee when the Option is granted&#59; provided that&#58; (i)&#160;the Exercise Price of an Option will be not less than one hundred percent (100%) of the Fair Market Value of the Shares on the date of grant and (ii)&#160;the Exercise Price of any ISO granted to a Ten Percent Stockholder will be not less than one hundred ten percent (110%) of the Fair Market Value of the Shares on the date of grant. Payment for the Shares purchased must be made in accordance with Section&#160;11 of this Plan, the Award Agreement and any procedures established by the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Method of Exercise</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Option granted hereunder will vest and be exercisable at such times and under such conditions as determined by the Committee and set forth in the Award Agreement, subject to the terms and conditions of this Plan. An Option may not be exercised for a fraction of a Share. An Option will be deemed exercised when the Company receives&#58; (i)&#160;notice of exercise (in such form as the Committee may specify from time to time) from the person entitled to exercise the Option, and (ii)&#160;full payment for the Shares with respect to which the Option is exercised plus payment or provision for applicable withholding taxes. Shares issued upon exercise of an Option will be issued in the name of the Participant. Notwithstanding the exercise of the Option, until such time as the Shares are issued (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company), no right to vote or receive dividends or any other rights as a stockholder will exist with respect to the Shares. The Company will issue (or cause to be issued) such Shares promptly after the Option is exercised. No adjustment will be made for a dividend or other right for which the record date is prior to the date the Shares are issued, except as provided in Section&#160;2.5 of this Plan. Exercising an Option in any manner will decrease the number of Shares thereafter available, both for purposes of this Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Participant&#8217;s Service terminates for any reason except a termination by the Company for Cause or because of the Participant&#8217;s death or Disability, then the Participant may exercise such Participant&#8217;s Options only to the extent that such Options would have been exercisable by the Participant on the&#160;date Participant&#8217;s Service terminates, no later than three (3) months after the date Participant&#8217;s Service terminates (or such shorter or longer time period as may be determined by the Committee, with any exercise beyond three (3) months after the date Participant&#8217;s Service terminates deemed to be the exercise of an NSO), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Death</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Participant&#8217;s Service terminates because of the Participant&#8217;s death (or the Participant dies within three (3) months after Participant&#8217;s Service terminates for any reason except a termination by the Company for Cause or because of the Participant&#8217;s Disability), then the Participant&#8217;s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant&#8217;s Service terminates and must be exercised by the Participant&#8217;s legal representative, or authorized assignee, no later than twelve (12) months after the date Participant&#8217;s Service terminates (or such shorter or longer time period as may be determined by the Committee), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Participant&#8217;s Service terminates because of the Participant&#8217;s Disability, then the Participant&#8217;s Options may be exercised only to the extent that such Options would have been exercisable by the Participant on the date Participant&#8217;s Service terminates and must be exercised by the Participant (or the Participant&#8217;s legal representative or authorized assignee) no later than twelve (12) months after the date Participant&#8217;s Service terminates (with any exercise beyond (a)&#160; three (3) months after the date Participant&#8217;s employment terminates when the termination of Service is for a Disability that is not a &#8220;permanent and total disability&#8221; as defined in Section&#160;22(e)(3) of the Code, or (b)&#160;twelve (12) months after the date Participant&#8217;s employment terminates when the termination of Service is for a Disability that is a &#8220;permanent and total disability&#8221; as defined in Section&#160;22(e)(3) of the Code, deemed to be exercise of an NSO), but in any event no later than the expiration date of the Options.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Participant is terminated by the Company for Cause, then Participant&#8217;s Options shall expire on the date Service terminates, or at such later time and on such conditions as are determined by the Committee, but in any event no later than the expiration date of the Options. Unless otherwise provided in the Award Agreement, Cause shall have the meaning set forth in this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on Exercise</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may specify a minimum number of Shares that may be purchased on any exercise of an Option, provided that such minimum number will not prevent a Participant from exercising the Option for the full number of Shares for which it is then exercisable.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Limitations on ISOs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. With respect to Awards granted as ISOs, to the extent that the aggregate Fair Market Value of the Shares with respect to which such ISOs are exercisable for the first time by the Participant during any calendar year (under all plans of the Company and any Parent or Subsidiary) exceeds one hundred thousand dollars ($100,000), such Options will be treated as NSOs. For purposes of this Section&#160;5.7, ISOs will be so evaluated in the order in which they were granted, beginning with the grant first in time. The Fair Market Value of the Shares will be determined as of the Option&#8217;s date of grant. In the event that the Code or the regulations promulgated thereunder are amended after the Effective Date to provide for a different limit on the Fair Market Value of Shares permitted to be subject to ISOs, such different limit will be automatically incorporated herein and will apply to any Options granted after the effective date of such amendment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Modification, Extension or Renewal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee may modify, extend or renew outstanding Options and authorize the grant of new Options in substitution therefor, provided that any such action may not, without the written consent of a Participant, impair any of such Participant&#8217;s rights under any Option previously granted. Subject to Section&#160;18, the Committee may (a)&#160;reduce the Exercise Price of outstanding Options or (b)&#160;grant Options in substitution for cancelled options or other Awards authorized under the Plan. Any outstanding ISO that is modified, extended, renewed or otherwise altered will be treated in accordance with Section&#160;424(h) of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Notice of Disqualifying Dispositions of Shares Acquired on Exercise of an ISO</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If a Participant sells or otherwise disposes of any Shares acquired pursuant to the exercise of an ISO on or before the later of (a) the date two years after the Date of Grant, and (b) the date one year after the exercise of the ISO (in either case, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disqualifying Disposition</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the Company may require the Participant to immediately notify the Company in writing of such Disqualifying Disposition.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">No Disqualification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any other provision in this Plan, no term of this Plan relating to ISOs will be interpreted, amended or altered, nor will any discretion or authority granted under this Plan be exercised, so as to disqualify this Plan under Section&#160;422 of the Code or, without the consent of the Participant affected, to disqualify any ISO under Section&#160;422 of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESTRICTED STOCK AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A Restricted Stock Award is an offer by the Company to sell Shares subject to restrictions (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to an eligible Employee, Consultant, or Director. The Committee will determine to whom an offer will be made, the number of Shares the Participant may purchase, the Purchase&#160;Price, the restrictions applicable to the Shares and all other terms and conditions of the Restricted Stock Award, subject to this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restricted Stock Purchase Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. All purchases under a Restricted Stock Award will be evidenced by an Award Agreement. Except as may otherwise be provided in an Award Agreement, a Participant accepts a Restricted Stock Award by signing and delivering to the Company an Award Agreement with full payment of the Purchase Price plus payment or provision for applicable withholding taxes, within thirty (30) days from the date the Award Agreement was delivered to the Participant. If the Participant does not accept such Award within thirty (30) days, then such Restricted Stock Award will terminate, unless the Committee determines otherwise.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Purchase Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Purchase Price for a Restricted Stock Award will be determined by the Committee and may be less than Fair Market Value but not less than the par value of the Shares on the date the Restricted Stock Award is granted. Payment of the Purchase Price must be made in accordance with Section&#160;11 of this Plan, and the Award Agreement and in accordance with any procedures established by the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of Restricted Stock Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, Restricted Stock Awards will be subject to such restrictions as the Committee may impose or are required by law. Applicable restrictions may be based on completion of a specified number of years of service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of a Restricted Stock Award that is being earned upon satisfaction of performance goals based on Performance Factors, the Committee shall&#58; (a)&#160;determine the nature, length and starting date of any Performance Period for the Restricted Stock Award&#59; (b)&#160;select from among the Performance Factors to be used to measure performance goals, if any&#59; and (c)&#160;determine the number of Shares that may be earned by the Participant. Performance Periods may overlap and a Participant may participate simultaneously with respect to Restricted Stock Awards that are subject to different Performance Periods and having performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STOCK BONUS AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A Stock Bonus Award is an award of Shares made to an eligible Employee, Consultant, or Director in consideration for Services to be rendered or for past Services already rendered to the Company or any Parent or Subsidiary, as permitted by law. All Stock Bonus Awards shall be made pursuant to an Award Agreement. No payment from the Participant will be required for Shares awarded pursuant to a Stock Bonus Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of Stock Bonus Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine to whom a Stock Bonus Award will be made, the number of Shares under the Stock Bonus Award, the restrictions, if any, applicable to such Shares and all other terms and conditions of the Stock Bonus Award, subject to this Plan. Applicable restrictions may be based upon completion of a specified number of years of service with the Company or upon satisfaction of performance goals based on Performance Factors during a Performance Period as set out in advance in the Award Agreement. Prior to the grant of any Stock Bonus Award that is being earned upon satisfaction of performance goals, the Committee shall&#58; (a)&#160;determine the nature, length and starting date of any Performance Period for the Stock Bonus Award&#59; (b)&#160;select from among the Performance Factors to be used to measure performance goals&#59; and (c)&#160;determine the number of Shares that may be awarded to the Participant. Performance Periods may overlap and a Participant may participate simultaneously with respect to Stock Bonus Awards that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Payment to Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. As determined in the sole discretion of the Committee, a Stock Bonus Award may be paid in the form of cash, whole Shares, or a combination thereof, based on the Fair Market Value (as of the date of payment) of the Shares earned under such Stock Bonus Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">STOCK APPRECIATION RIGHTS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A Stock Appreciation Right (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SAR</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an award to an eligible Employee, Consultant, or Director that may be settled in cash, or Shares (which may consist of Restricted Stock), having a value equal to (a)&#160;the difference between the Fair Market Value on the date of exercise over the Exercise Price multiplied by (b)&#160;the number of Shares with respect to which the SAR is being settled (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement). All SARs shall be made pursuant to an Award Agreement.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of SARs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee will determine the terms of each SAR including, without limitation&#58; (a)&#160;the number of Shares subject to the SAR&#59; (b)&#160;the Exercise Price and the time or times during which the SAR may be settled&#59; (c)&#160;the consideration to be distributed on settlement of the SAR&#59; and (d)&#160;the effect of the Participant&#8217;s termination of Service on each SAR. The Exercise Price of the SAR will be determined by the Committee when the SAR is granted, and may be not less than Fair Market Value or the par value of the Shares. A SAR may be awarded upon satisfaction of Performance Factors, if any, during any Performance Period as are set out in advance in the Award Agreement. Prior to the grant of any SAR that is being earned upon satisfaction of performance goals, then the Committee will&#58; (x)&#160;determine the nature, length and starting date of any Performance Period for each SAR&#59; and (y)&#160;select from among the Performance Factors to be used to measure the performance, if any. Performance Periods may overlap and Participants may participate simultaneously with respect to SARs that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Exercise Period and Expiration Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, a SAR will be exercisable within the times or upon the occurrence of events determined by the Committee and set forth in the Award Agreement. The SAR Agreement shall set forth the expiration date&#59; provided that no SAR will be exercisable after the expiration of ten (10) years from the date the SAR is granted. The Committee may also provide for SARs to become exercisable at one time or from time to time, periodically or otherwise (including, without limitation, upon the attainment during a Performance Period of performance goals based on Performance Factors), in such number of Shares or percentage of the Shares subject to the SAR as the Committee determines. Notwithstanding the foregoing, the rules of Section&#160;5.6 also will apply to SARs.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form of Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Upon exercise of a SAR, a Participant will be entitled to receive payment from the Company in an amount determined by multiplying (i)&#160;the difference between the Fair Market Value of a Share on the date of exercise over the Exercise Price&#59; times (ii)&#160;the number of Shares with respect to which the SAR is exercised (subject to any maximum number of Shares that may be issuable as specified in an Award Agreement). At the discretion of the Committee, the payment from the Company for the SAR exercise may be in cash, in Shares of equivalent value, or in some combination thereof. The portion of a SAR being settled may be paid currently or on a deferred basis with such interest or dividend equivalent, if any, as the Committee determines, provided that the terms of the SAR and any deferral satisfy the requirements of Section&#160;409A of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">RESTRICTED STOCK UNITS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A Restricted Stock Unit (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is an award to an eligible Employee, Consultant, or Director covering a number of Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock). All RSUs shall be made pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine the terms of an RSU including, without limitation&#58; (a)&#160;the number of Shares subject to the RSU&#59; (b)&#160;the time or times during which the RSU may be settled&#59; (c)&#160;the consideration to be distributed on settlement&#59; and (d)&#160;the effect of the Participant&#8217;s termination of Service on each RSU. An RSU may be awarded upon satisfaction of such performance goals based on Performance Factors during any Performance Period as are set out in advance in the Award Agreement. Prior to the grant of any RSU that is being earned upon satisfaction of performance goals, the Committee will&#58; (x)&#160;determine the nature, length and starting date of any Performance Period for the RSU&#59; (y)&#160;select from among the Performance Factors to be used to measure the performance, if any&#59; and (z)&#160;determine the number of Shares deemed subject to the RSU. Performance Periods may overlap and participants may participate simultaneously with respect to RSUs that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Form and Timing of Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Payment of earned RSUs shall be made as soon as practicable after the date(s) determined by the Committee and set forth in the Award Agreement. The Committee, in its sole discretion, may settle earned RSUs in cash, Shares, or a combination of both. The Committee may also permit a Participant to defer payment under a RSU to a date or dates after the RSU is earned provided that the terms of the RSU and any deferral satisfy the requirements of Section&#160;409A of the Code.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PERFORMANCE AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A Performance Award is an award to an eligible Employee, Consultant, or Director of Performance Shares or a cash bonus denominated in Shares that may be settled in cash, or by issuance of those Shares (which may consist of Restricted Stock). Grants of Performance Awards shall be made pursuant to an Award Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Terms of Performance Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to Section 2.6, the Committee will determine the terms of a Performance Award including, without limitation&#58; (a) the number of Shares or amount of cash subject to the Performance Award&#59; (b) the time or times during which the Performance Award may be settled&#59; and (c) the consideration to be distributed on settlement, and the effect of the Participant&#8217;s termination of Service on each Performance Award. A Performance Award may be awarded upon satisfaction of performance goals based on Performance Factors during any Performance Period as set out in advance in the Award Agreement. Prior to the grant of any Performance Award that is being earned upon satisfaction of performance goals, the Committee will&#58; (x) determine the nature, length and starting date of any Performance Period for the Performance Award&#59; (y) select from among the Performance Factors to be used to measure such performance goals, if any&#59; and (z) determine the number of Shares deemed subject to the Performance Award. Performance Periods may overlap and participants may participate simultaneously with respect to Performance Awards that are subject to different Performance Periods and performance goals based on different Performance Factors and other criteria.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Termination of Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as otherwise set forth in the Award Agreement or as otherwise determined by the Committee, vesting ceases on the date Participant&#8217;s Service terminates.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PAYMENT FOR SHARE PURCHASES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Payment from a Participant for Shares purchased pursuant to this Plan may be made in cash or by check or, where approved for the Participant by the Committee and where permitted by law (and to the extent not otherwise set forth or prohibited in the applicable Award Agreement)&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by cancellation of indebtedness of the Company to the Participant&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by surrender of Shares held by the Participant that have a Fair Market Value on the date of surrender equal to the aggregate exercise price of the Shares as to which said Award will be exercised or settled&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by waiver of compensation due or accrued to the Participant for services rendered or to be rendered to the Company or a Parent or Subsidiary of the Company&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by consideration received by the Company pursuant to a broker-assisted or other form of cashless exercise program implemented by the Company in connection with this Plan&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by any combination of the foregoing&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">by any other method of payment as is permitted by applicable law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless determined otherwise by the Committee, all payments under any of the methods indicated above shall be made in United States dollars.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GRANTS TO NON-EMPLOYEE DIRECTORS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Non-Employee Directors are eligible to receive any type of Award offered under this Plan except ISOs. Awards pursuant to this Section&#160;12 may be automatically made pursuant to policy adopted by the Board, or made from time to time as determined in the discretion of the Board. The aggregate number of Shares subject to Awards granted under this Section 12 to a Non-Employee Director in any calendar year shall not exceed 120,000 Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Eligibility</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Awards pursuant to this Section&#160;12 shall be granted only to Non-Employee Directors. A Non-Employee Director who is elected or re-elected as a member of the Board will be eligible to receive an Award under this Section&#160;12.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Vesting, Exercisability and Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Except as set forth in Section&#160;6 and 21, Awards shall vest, be exercisable and be settled as determined by the Board. With respect to Options and SARs, the exercise price granted to Non-Employee Directors shall be not less than the Fair Market Value of the Shares at the time that such Option or SAR is granted.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Election to receive Awards in Lieu of Cash</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Non-Employee Director may elect to receive his or her annual retainer payments and&#47;or meeting fees from the Company in the form of cash or Awards or in a combination thereof, as determined by the Board. Such Awards shall be issued under this Plan. An election under this Section&#160;12.3 shall be filed with the Company on the form prescribed by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">WITHHOLDING TAXES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Withholding Generally</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Whenever Shares are to be issued in satisfaction of Awards granted under this Plan or the applicable tax event occurs, the Company may require the Participant to remit to the Company, or to the Parent, Subsidiary or Affiliate employing the Participant, an amount sufficient to satisfy applicable U.S.&#160;federal, state, local and international withholding tax requirements or any other tax or social insurance liability legally due from the Participant prior to the delivery of Shares pursuant to exercise or settlement of any Award. Whenever payments in satisfaction of Awards granted under this Plan are to be made in cash, such payment will be net of an amount sufficient to satisfy applicable U.S.&#160;federal, state, local and international withholding tax and social insurance requirements or any other tax liability legally due from the Participant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Stock Withholding</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Committee, or its delegate(s), as permitted by applicable law, in its sole discretion and pursuant to such procedures as it may specify from time to time and to limitations of local law, may require or permit a Participant to satisfy such tax withholding obligation or any other tax liability legally due from the Participant, in whole or in part by (without limitation) (i) paying cash, (ii) electing to have the Company withhold otherwise deliverable cash or Shares having a Fair Market Value equal to up to the maximum statutory amount permitted to be withheld, (iii) delivering to the Company Shares having a Fair Market Value equal to up to the maximum amount permitted to be withheld or (iv) withholding from the proceeds of the sale of otherwise deliverable Shares acquired pursuant to an Award either through a voluntary sale or through a mandatory sale arranged by the Company. The Fair Market Value of the Shares to be withheld or delivered will be determined as of the date that the taxes are required to be withheld.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TRANSFERABILITY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Transfer Generally</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless determined otherwise by the Committee or pursuant to Section&#160;14.2, an Award may not be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than by will or by the laws of descent and distribution. If the Committee makes an Award transferable, including, without limitation, by instrument to an inter vivos or testamentary trust in which the Awards are to be passed to beneficiaries upon the death of the trustor (settlor) or by gift or by domestic relations order to a Permitted Transferee, such Award will contain such additional terms and conditions as the Committee deems appropriate. All Awards shall be exercisable&#58; (i)&#160;during the Participant&#8217;s lifetime only by (A)&#160;the Participant, or (B)&#160;the Participant&#8217;s guardian or legal representative&#59; (ii)&#160;after the Participant&#8217;s death, by the legal representative of the Participant&#8217;s heirs or legatees&#59; and (iii)&#160;in the case of all awards except ISOs, by a Permitted Transferee.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Beneficiaries</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each Participant under this Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under this Plan is to be paid in case of such Participant&#8217;s death before he or she receives any or all of such benefit. Each such designation shall&#160;revoke all prior designations by the same Participant, shall be in a form prescribed by the Committee, and will be effective only when filed by such Participant in writing with the Company during such Participant&#8217;s lifetime. In the absence of any such beneficiary designation, benefits remaining unpaid or rights remaining unexercised at such Participant&#8217;s death shall be paid to or exercised by such Participant&#8217;s executor, administrator, or legal representative.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">PRIVILEGES OF STOCK OWNERSHIP&#59; RESTRICTIONS ON SHARES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Voting and Dividends</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No Participant will have any of the rights of a stockholder with respect to any Shares until the Shares are issued to the Participant, except for any Dividend Equivalent Rights permitted by an applicable Award Agreement. After Shares are issued to the Participant, the Participant will be a stockholder and have all the rights of a stockholder with respect to such Shares, including the right to vote and receive all dividends or other distributions made or paid with respect to such Shares&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that if such Shares are Restricted Stock, then any new, additional or different securities the Participant may become entitled to receive with respect to such Shares by virtue of a stock dividend, stock split or any other change in the corporate or capital structure of the Company will be subject to the same restrictions as the Restricted Stock&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Participant will have no right to such stock dividends or stock distributions with respect to Unvested Shares, and any such dividends or stock distributions shall be accrued and paid only at such time if any, as such Unvested Shares become vested Shares. The Committee, in its discretion, may provide in the Award Agreement evidencing any Award that the Participant shall be entitled to Dividend Equivalent Rights with respect to the payment of cash dividends on Shares subject to such Award during the period beginning on the date the Award is granted and ending, with respect to each Share subject to the Award, on the earlier of the date on which the Award is exercised or settled or the date on which they are forfeited&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that under no circumstances may Dividend Equivalent Rights be granted for any Option or SAR and </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that no Dividend Equivalent Right shall be paid with respect to Unvested Shares, and any such dividends or stock distributions shall be accrued and paid only at such time, if any, as such Unvested Shares become vested Shares. Such Dividend Equivalent Rights, if any, shall be credited to the Participant in the form of additional whole Shares as of the date of payment of such cash dividends on Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Restrictions on Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. At the discretion of the Committee, the Company may reserve to itself and&#47;or its assignee(s) a right to repurchase (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Right of Repurchase</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) a portion of any or all Unvested Shares held by a Participant following such Participant&#8217;s termination of Service at any time within ninety (90) days after the later of the date Participant&#8217;s Service terminates and the date the Participant purchases Shares under this Plan, for cash and&#47;or cancellation of purchase money indebtedness, at the Participant&#8217;s Purchase Price or Exercise Price, as the case may be.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CERTIFICATES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All Shares or other securities whether or not certificated, delivered under this Plan will be subject to such stock transfer orders, legends and other restrictions as the Committee may deem necessary or advisable, including restrictions under any applicable U.S. federal, state or foreign securities law, or any rules, regulations and other requirements of the SEC or any stock exchange or automated quotation system upon which the Shares may be listed or quoted and any non-U.S. exchange controls or securities law restrictions to which the Shares are subject.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ESCROW&#59; PLEDGE OF SHARES</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To enforce any restrictions on a Participant&#8217;s Shares, the Committee may require the Participant to deposit all certificates representing Shares, together with stock powers or other instruments of transfer approved by the Committee, appropriately endorsed in blank, with the Company or an agent designated by the Company to hold in escrow until such restrictions have lapsed or terminated, and the Committee may cause a legend or legends referencing such restrictions to be placed on the certificates. Any Participant who is permitted to execute a promissory note as partial or full consideration for the purchase of Shares under this Plan will be required to pledge and deposit with the Company all or part of the Shares so purchased as collateral to secure the payment of the Participant&#8217;s obligation to the Company under the promissory note&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Committee may require or accept other or additional forms of collateral to secure the payment of such obligation and, in any event, the Company will have full recourse against the Participant under the promissory note notwithstanding any pledge of the Participant&#8217;s Shares or other collateral. In connection with any pledge of the Shares, the Participant will be required to execute and deliver a written pledge agreement in such form as the Committee will from time to time approve. The Shares purchased with the promissory note may be released from the pledge on a pro rata basis as the promissory note is paid.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">EXCHANGE AND BUYOUT OF AWARDS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. An Exchange Program, including but not limited to any repricing of Options or SARs is not permitted without prior stockholder approval.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SECURITIES LAW AND OTHER REGULATORY COMPLIANCE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> An Award will not be effective unless such Award is in compliance with all applicable U.S. and foreign federal and state securities and exchange control laws, rules and regulations of any governmental body, and the requirements of any stock exchange or automated quotation system upon which the Shares may then be listed or quoted, as they are in effect on the date of grant of the Award and also on the date of exercise or other issuance. Notwithstanding any other provision in this Plan, the Company will have no obligation to issue or deliver certificates for Shares under this Plan prior to&#58; (a)&#160;obtaining any approvals from governmental agencies that the Company determines are necessary or advisable&#59; and&#47;or (b)&#160;completion of any registration or other qualification of such Shares under any state or federal or foreign law or ruling of any governmental body that the Company determines to be necessary or advisable. The Company will be under no obligation to register the Shares with the SEC or to effect compliance with the registration, qualification or listing requirements of any foreign or state securities laws, exchange control laws, stock exchange or automated quotation system, and the Company will have no liability for any inability or failure to do so.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NO OBLIGATION TO EMPLOY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Nothing in this Plan or any Award granted under this Plan will confer or be deemed to confer on any Participant any right to continue in the employ of, or to continue any other relationship with, the Company or any Parent, Subsidiary or Affiliate or limit in any way the right of the Company or any Parent, Subsidiary or Affiliate to terminate Participant&#8217;s employment or other relationship at any time.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CORPORATE TRANSACTIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assumption or Replacement of Awards by Successor</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In the event that the Company is subject to a Corporate Transaction, outstanding Awards acquired under this Plan shall be subject to the documentation evidencing the Corporate Transaction, which need not treat all outstanding Awards in an identical manner. Such agreement, without the Participant&#8217;s consent, shall provide for one or more of the following with respect to all outstanding Awards as of the effective date of such Corporate Transaction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The continuation of an outstanding Award by the Company (if the Company is the successor entity).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The assumption of an outstanding Award by the successor or acquiring entity (if any) of such Corporate Transaction (or by its parents, if any), which assumption, will be binding on all selected Participants&#59; provided that the exercise price and the number and nature of shares issuable upon exercise of any such option or stock appreciation right, or any award that is subject to Section&#160;409A of the Code, will be adjusted appropriately pursuant to Section&#160;424(a) of the Code.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The substitution by the successor or acquiring entity in such Corporate Transaction (or by its parents, if any) of an equivalent award with substantially the same terms for such outstanding Award (except that the exercise price and the number and nature of shares issuable upon exercise of any such option or stock appreciation right, or any award that is subject to Section&#160;409A of the Code, will be adjusted appropriately pursuant to Section&#160;424(a) of the Code).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A payment to the Participant equal to the excess of (i)&#160;the Fair Market Value of the Shares subject to the Award as of the effective date of such Corporate Transaction over (ii)&#160;the Exercise Price or Purchase Price of Shares, as the case may be, subject to the Award in connection with the cancellation of the Award. Such payment will be made in the form of cash, cash equivalents, or securities of the surviving corporation or its parent with a Fair Market Value equal to the required amount. The successor corporation may provide substantially similar consideration to Participants as was provided to stockholders (after taking into account the existing provisions of the Awards). Subject to Section&#160;409A of the Code, such payment may be made in installments, may be deferred until the date or dates when the Award would have become exercisable or such Shares would have vested, and such payment may be subject to vesting based on the Participant&#8217;s continuing such payment initially will be calculated without regard to whether or not the Award is then exercisable or such Shares are then vested. In addition, any escrow, holdback, earnout or similar provisions in the agreement for such Corporate Transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of Shares. If the Exercise Price of the Shares subject to an Option exceeds the Fair Market Value of such Shares, then the Option may be cancelled without making a payment to the Participant. For purposes of this subsection, the Fair Market Value of any security will be determined without regard to any vesting conditions that may apply to such security.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall have full power and authority to assign the Company&#8217;s right to repurchase or re-acquire or forfeiture rights to such successor or acquiring corporation. Notwithstanding the foregoing, solely upon a Corporate Transaction in which the successor or acquiring corporation refuses to assume, convert, replace or substitute Awards, as provided above, pursuant to a Corporate Transaction notwithstanding any other provision in this Plan to the contrary, and unless otherwise determined by the Committee, all Awards granted under this Plan shall accelerate in full as of the time of consummation of the Corporate Transaction. In such event, the Committee will notify the Participant in writing or electronically that such Award will be exercisable for a period of time determined by the Committee in its sole discretion, and such Award will terminate upon the expiration of such period. Awards need not be treated similarly in a Corporate Transaction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Assumption of Awards by the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company, from time to time, also may substitute or assume outstanding awards granted by another company, whether in connection with an acquisition of such other company or otherwise, by either&#59; (a)&#160;granting an Award under this Plan in substitution of such other company&#8217;s award&#59; or (b)&#160;assuming such award as if it had been granted under this Plan if the terms of such assumed award could be applied to an Award granted under this Plan. Such substitution or assumption will be permissible if the holder of the substituted or assumed award would have been eligible to be granted an Award under this Plan if the other company had applied the rules of this Plan to such grant. In the event the Company assumes an award granted by another company, the terms and conditions of such award will remain unchanged (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">except</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;that the Purchase Price or the Exercise Price, as the case may be, and the number and nature of Shares issuable upon exercise or settlement of any such Award will be adjusted appropriately pursuant to Section&#160;424(a) of the Code). In the event the Company elects to grant a new Option in substitution rather than assuming an existing option, such new Option may be granted with a similarly adjusted Exercise Price. Substitute Awards shall not reduce the number of Shares authorized for grant under this Plan or authorized for grant to a Participant in a calendar year.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">21.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Non-Employee Directors&#8217; Awards</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Notwithstanding any provision to the contrary herein, in the event of a Corporate Transaction, the vesting of all Awards granted to Non-Employee Directors shall accelerate and such Awards shall become exercisable (as applicable) in full prior to the consummation of such event at such times and on such conditions as the Committee determines.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ADOPTION AND STOCKHOLDER APPROVAL</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> This Plan shall be submitted for the approval of the Company&#8217;s stockholders, consistent with applicable laws, within twelve (12) months before or after the date this Plan is adopted by the Board.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">TERM OF PLAN&#47;GOVERNING LAW</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Unless earlier terminated as provided herein, this Plan will become effective on the Effective Date and will terminate ten (10) years from the date this Plan is adopted by the Board. After this Plan is terminated or expires, no Awards may be granted but Awards previously granted shall remain outstanding in accordance with their applicable terms and conditions and this Plan&#8217;s terms and conditions. This Plan and all Awards granted hereunder shall be governed by and construed in accordance with the laws of the State of Delaware (excluding its conflict of laws rules).</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">AMENDMENT OR TERMINATION OF PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Board may at any time terminate or amend this Plan in any respect, including, without limitation, amendment of any form of Award Agreement or instrument to be executed pursuant to this Plan&#59;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">however</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that the Board will not, without the approval of the stockholders of the Company, amend this Plan in any manner that requires such stockholder approval&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">provided further</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, that a Participant&#8217;s Award shall be governed by the version of this Plan then in effect at the time such Award was granted.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NONEXCLUSIVITY OF THE PLAN&#59; UNFUNDED PLAN</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Neither the adoption of this Plan by the Board, the submission of this Plan to the stockholders of the Company for approval, nor any provision of this Plan will be construed as creating any limitations on the power of the Board to adopt such additional compensation arrangements as it may deem desirable, including, without limitation, the granting of stock awards and bonuses otherwise than under this Plan, and such arrangements may be either generally applicable or applicable only in specific cases.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">26.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">INSIDER TRADING POLICY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Each Participant who receives an Award shall comply with any policy adopted by the Company from time to time covering transactions in the Company&#8217;s securities by Employees, officers and&#47;or directors of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">27.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">ALL AWARDS SUBJECT TO COMPANY CLAWBACK OR RECOUPMENT POLICY</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> All Awards held by an executive officer shall be subject to clawback, recoupment or forfeiture (i) to the extent that such executive officer is determined to have engaged in fraud or intentional illegal conduct materially contributing to a financial restatement, as determined by the Board in its sole discretion, (ii) as provided under any clawback, recoupment or forfeiture policy adopted by the Board or (iii) required by law. Such clawback, recoupment or forfeiture policy, in addition to any other remedies available under applicable law, may require the cancellation of outstanding Awards and the recoupment of any gains realized with respect to Awards.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">DEFINITIONS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As used in this Plan, and except as elsewhere defined herein, the following terms will have the following meanings&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.1.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Affiliate</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i)&#160;any entity that, directly or indirectly, is controlled by, controls or is under common control with, the Company and (ii)&#160;any entity in which the Company has a significant equity interest, in either case as determined by the Committee, whether now or hereafter existing.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.2.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any award under this Plan, including any Option, Restricted Stock, Stock Bonus, Stock Appreciation Right, Restricted Stock Unit or award of Performance Shares.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Award Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to each Award, the written or electronic agreement between the Company and the Participant setting forth the terms and conditions of the Award and country-specific appendix thereto for grants to non-U.S. Participants, which shall be in substantially a form (which need not be the same for each Participant) that the Committee (or in the case of Award agreements that are not used for Insiders, the Committee&#8217;s delegate(s)) has from time to time approved, and will comply with and be subject to the terms and conditions of this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.4.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Board of Directors of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.5.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means termination of the Participant&#8217;s Service on the basis of the Participant&#8217;s conviction (or a plea of </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nolo contendere</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) of fraud, misappropriation, embezzlement or any other act or acts of dishonesty constituting a felony and resulting or intended to result directly or indirectly in a substantial gain or personal enrichment to the Participant at the expense of the Company or any Subsidiary.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.6.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Code</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Internal Revenue Code of 1986, as amended, and the regulations promulgated thereunder.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.7.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Committee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the Compensation Committee of the Board or those persons to whom administration of this Plan, or part of this Plan, has been delegated as permitted by law.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.8.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Common Stock</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the common stock of the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.9.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Dexcom, Inc., or any successor corporation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.10.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including an advisor or independent contractor, engaged by the Company or a Parent, Subsidiary or Affiliate to render services to such entity.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.11.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i)&#160;any &#8220;person&#8221; (as such term is used in Sections&#160;13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities&#59; provided, however, that for purposes of this subclause (i)&#160;the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction&#59; (ii)&#160;the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; (iii)&#160;the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation&#59; (iv)&#160;any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section&#160;424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company) or (v)&#160;a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction. For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section&#160;409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section&#160;409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.12.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a member of the Board.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.13.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means in the case of ISOs, total and permanent disability as defined in Section&#160;22(e)(3) of the Code and in the case of other Awards, that the Participant is unable to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or can be expected to last for a continuous period of not less than 12 months.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.14.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dividend Equivalent Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the right of a Participant, granted at the discretion of the Committee or as otherwise provided by the Plan, to receive a credit for the account of such Participant in an amount equal to the cash dividends paid on one Share for each Share represented by an Award held by such Participant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.15.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date the Plan is approved by the stockholders of the Company which shall be within twelve (12) months of the approval of the Plan by the Board.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.16.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any person, including officers and Directors, providing services as an employee to the Company or any Parent, Subsidiary or Affiliate. Neither service as a Director nor payment of a director&#8217;s fee by the Company will be sufficient to constitute &#8220;employment&#8221; by the Company.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.17.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Exchange Act of 1934, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.18.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Program</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a program pursuant to which (i)&#160;outstanding Awards are surrendered, cancelled or exchanged for cash, the same type of Award or a different Award (or combination thereof) or (ii)&#160;the exercise price of an outstanding Award is increased or reduced.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.19.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exercise Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, with respect to an Option, the price at which a holder may purchase the Shares issuable upon exercise of an Option and with respect to a SAR, the price at which the SAR is granted to the holder thereof.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.20.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Market Value</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means, as of any date, the value of a Share determined as follows&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if such Common Stock is publicly traded and is then listed on a national securities exchange, its closing price on the date of determination on the principal national securities exchange on which the Common Stock is listed or admitted to trading as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Journal or such other source as the Committee deems reliable&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if such Common Stock is publicly traded but is neither listed nor admitted to trading on a national securities exchange, the average of the closing bid and asked prices on the date of determination as reported in </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The Wall Street Journal</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or such other source as the Committee deems reliable&#59; or</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">if none of the foregoing is applicable, by the Board or the Committee in good faith.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.21.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Insider</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an officer or director of the Company or any other person whose transactions in the Company&#8217;s Common Stock are subject to Section&#160;16 of the Exchange Act.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.22.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">IRS</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Internal Revenue Service.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.23.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Non-Employee Director</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a Director who is not an Employee of the Company or any Parent or Subsidiary.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.24.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Option</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award of an option to purchase Shares pursuant to Section&#160;5.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.25.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Parent</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with the Company if each of such corporations other than the Company owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.26.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a person who holds an Award under this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.27.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means cash or stock granted pursuant to Section&#160;10 or Section&#160;12 of this Plan.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.28.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Factors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any of the factors selected by the Committee and specified in an Award Agreement, from among the following objective measures, either individually, alternatively or in any combination, applied to the Company as a whole or any business unit or Subsidiary, either individually, alternatively, or in any combination, on a GAAP or non-GAAP basis, and measured, to the extent applicable on an absolute basis or relative to a pre-established target, to determine whether the performance goals established by the Committee with respect to applicable Awards have been satisfied&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Profit Before Tax&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Billings&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(c)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(d)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net revenue&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(e)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings (which may include earnings before interest and taxes, earnings before taxes, and net earnings, or as otherwise adjusted)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(f)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(g)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating margin&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(h)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating profit&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(i)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Controllable operating profit, or net operating profit&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(j)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net Profit&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(k)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross margin&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(l)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating expenses or operating expenses as a percentage of revenue&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(m)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(n)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Earnings per share&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(o)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total stockholder return&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(p)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market share&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(q)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Return on assets or net assets&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(r)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s stock price&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(s)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Growth in stockholder value relative to a pre-determined index&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(t)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Return on equity&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(u)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Return on invested capital&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(v)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash Flow (including free cash flow or operating cash flows)&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(w)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash conversion cycle&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(x)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Economic value added&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(y)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Individual confidential business objectives&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(z)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract awards or backlog&#59;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(aa)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Overhead or other expense reduction&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(bb)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Credit rating&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(cc)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Strategic plan development and implementation&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(dd)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Succession plan development and implementation&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ee)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Improvement in workforce diversity&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ff)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer indicators&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(gg)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">New product invention or innovation&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(hh)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attainment of research and development milestones&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ii)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Improvements in productivity&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(jj)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bookings&#59;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(kk)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Attainment of objective operating goals and employee metrics&#59; and</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(ll)&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any other metric that is capable of measurement as determined by the Committee.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.29.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period of service determined by the Committee, not to exceed five (5) years, during which years of service or performance is to be measured for the Award.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.30.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Performance Share</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section&#160;10 or Section&#160;12 of this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.31.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Permitted Transferee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any child, stepchild, grandchild, parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law (including adoptive relationships) of the Employee, any person sharing the Employee&#8217;s household (other than a tenant or employee), a trust in which these persons (or the Employee) have more than 50% of the beneficial interest, a foundation in which these persons (or the Employee) control the management of assets, and any other entity in which these persons (or the Employee) own more than 50% of the voting interests.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.32.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall have the meaning as such term is used in Sections&#160;13(d) and 14(d) of the Exchange Act.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.33.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means this DexCom, Inc. 2015 Equity Incentive Plan, as amended.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.34.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Purchase Price</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the price to be paid for Shares acquired under this Plan, other than Shares acquired upon exercise of an Option or SAR.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.35.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Award</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an award of Shares pursuant to Section&#160;6 or Section&#160;12 of this Plan, or issued pursuant to the early exercise of an Option.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.36.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock Unit</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section&#160;9 or Section&#160;12 of this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.37.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities and Exchange Commission.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.38.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Securities Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the United States Securities Act of 1933, as amended.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.39.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Service</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; shall mean service as an Employee, Consultant, Director or Non-Employee Director, to the Company or a Parent, Subsidiary or Affiliate of the Company, subject to such further limitations as may be set forth in this Plan or the applicable Award Agreement. An Employee will not be deemed to have ceased to provide Service in the case of (i) medical leave, (ii) military leave, or (iii) any other leave of absence approved by the Company. In the case of any Employee on an approved leave of absence, Awards shall not vest during such leave of absence, except as (A) may be required by applicable Law, or (B) as otherwise provided by the Committee or the Company in writing. At such time as such Employee returns to regular and continuous service with the Company following the leave of absence, the vesting schedule applicable to the Awards shall recommence, and, if applicable, the total period of the vesting schedule will be extended by a number of days equal to the total number of days of Employee&#8217;s leave of absence, except that in no event may an Award be exercised after the expiration term set forth in the Award Agreement. Similarly, if Employee&#8217;s schedule reduces to a less than a full-time service arrangement, except as otherwise provided by the Committee or the Company in writing, Awards shall vest on a proportionately and commensurately slower schedule, except that in no event may an Award be exercised after the expiration term set forth in the Award Agreement. No fractional shares may be issued. In the event of military leave, if required by applicable laws, vesting shall continue for not less than the longest period that vesting continues under any other statutory or Company approved leave of absence and, upon a Participant&#8217;s returning from military leave (under conditions that would entitle him or her to protection upon such return under the Uniform Services Employment and Reemployment Rights Act), he or she shall be given vesting credit with respect to Awards to the same extent as would have applied had the Participant continued to provide services to the Company throughout the leave on the same terms as he or she was providing services immediately prior to such leave. Except as set forth in this Section 28.39, an employee shall have terminated employment as of the date he or she ceases to provide Services (regardless of whether the termination is in breach of local employment laws or is later found to be invalid) and employment shall not be extended by any notice period or garden leave mandated by local law, provided however, that a change in status from an employee to a consultant or advisor shall not terminate the service provider&#8217;s Service, unless determined by the Committee, in its discretion. The Committee will have sole discretion to determine whether a Participant has ceased to provide Services and the effective date on which the Participant ceased to provide Services.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.40.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means shares of the Company&#8217;s Common Stock and the common stock of any successor security.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.41.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Appreciation Right</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section&#160;8 or Section&#160;12 of this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.42.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Bonus</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means an Award granted pursuant to Section&#160;7 or Section&#160;12 of this Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.43.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Subsidiary</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means any corporation (other than the Company) in an unbroken chain of corporations beginning with the Company if each of the corporations other than the last corporation in the unbroken chain owns stock possessing fifty percent (50%) or more of the total combined voting power of all classes of stock in one of the other corporations in such chain.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.44.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Treasury Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means regulations promulgated by the United States Treasury Department.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">28.45.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unvested Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means Shares that have not yet vested or are subject to a right of repurchase in favor of the Company (or any successor thereto).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;</font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_295"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF RESTRICTED STOCK UNIT AWARD</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANT NUMBER&#58;</font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:310.50pt"><tr><td style="width:1.0pt"></td><td style="width:211.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:94.75pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________________</font></div></td><td colspan="3" style="padding:0 1pt"><div style="padding-left:5.72pt;padding-right:-2.63pt"><font><br></font></div></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address 2&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_____________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">City, State Zip&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.75pt;padding-left:5.72pt;padding-right:-2.63pt"><font><br></font></div></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.206%"><tr><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Commencement Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon a termination of Service as set forth in the RSU Agreement.</font></div></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58;</font></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:432.75pt"><tr><td style="width:1.0pt"></td><td style="width:178.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:250.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.20pt;text-decoration:underline">Shares</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:3.42pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.20pt;text-decoration:underline">Vest Date&#47;Performance Conditions</font></div></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.8pt;padding-right:-0.28pt;text-align:right"><font><br></font></div></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.8pt;padding-right:-0.28pt;text-align:right"><font><br></font></div></td></tr><tr style="height:16pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.85pt;padding-right:-0.28pt;text-align:right"><font><br></font></div></td></tr><tr style="height:13pt"><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.8pt;padding-right:-2.63pt"><font><br></font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-top:2.8pt;padding-right:-0.28pt;text-align:right"><font><br></font></div></td></tr></table></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">To be inserted as applicable</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Acceleration&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing Vesting Schedule, the RSUs are eligible for vesting acceleration under the Company&#8217;s Severance and Change in Control Plan, subject to the terms and conditions thereof.&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">To be inserted as applicable</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Acceleration&#58;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing Vesting Schedule, if the Participant is subject to a Qualifying Termination (as defined below) during a Change in Control Period (as defined below), then, subject to Participant&#8217;s delivery to the Company of a general release (in a form prescribed by the Company) of all known and unknown claims that Participant may then have against the Company or persons affiliated with the Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and satisfaction of all conditions to make the Release effective, within sixty (60) days following Participant&#8217;s Qualifying Termination (such sixty (60) day period, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Release Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the then-unvested RSUs shall accelerate and become vested and settled with respect to 100% of the shares subject thereto.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accelerated vesting described above shall be effective as of the Qualifying Termination, subject to delivery of the effective Release&#59; provided, that, if the Qualified Termination occurs prior to the Change in Control (as defined below), then any unvested portion of Participant&#8217;s RSUs will remain outstanding for three (3) months following the Qualifying Termination (provided that in no event will the RSUs remain outstanding beyond the tenth anniversary of the Date of Grant). In the event that the proposed Change in Control is terminated without having been completed, any unvested portion of Participant&#8217;s RSUs automatically will be forfeited.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision in the Plan, the Notice or this Agreement to the contrary, if the successor or acquiring corporation (if any) of the Company refuses to assume, convert, replace or substitute the unvested RSUs in connection with a Corporate Transaction (as defined in the Plan) as provided in Section 21.1 of the Plan, then such RSUs shall accelerate and become vested and settled with respect to 100% of the shares subject thereto effective immediately prior to the Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the Participant has been convicted of, or has pleaded guilty or nolo contendere to, any felony or crime involving moral turpitude, (ii) the Participant has (X) engaged in willful misconduct which is injurious to the Company or materially failed or refused to perform the material duties lawfully and reasonably assigned to the Participant or has performed such material duties with gross negligence or (Y) breached any material term or condition of this Plan, the Participant&#8217;s Employee Proprietary Information and Inventions Agreement with the Company, any written Company policy or the Company&#8217;s written code of conduct that has been made available to Participant prior to such breach or any other material agreement with the Company, in any case after written notice by the Company of such misconduct, performance issue, gross negligence or breach of terms or conditions and an opportunity to cure within thirty (30) days of such written notice thereof from the Company, unless such misconduct, performance issue, gross negligence or breach is, by its nature, not curable, or (iii) the Participant has committed any act of fraud, theft, embezzlement, misappropriation of funds, breach of fiduciary duty or other willful act of material dishonesty against the Company that results in material harm to the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation, provided that the transaction or series of transactions pursuant to subsections (i), (ii) or (iii) also qualifies as a &#8220;change in control event&#8221; under U.S. Treasury Regulation 1.409A-3(i)(5).</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means the period commencing three (3) months prior to a Change in Control (only if after a Potential Change in Control) and ending twelve (12) months following a Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">has the meaning set forth in Section 22(e)(3) of the Code.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events or conditions, without Participant&#8217;s express written consent&#58;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">a material reduction in Participant&#8217;s base salary as an employee of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">a material reduction in the Participant&#8217;s duties, responsibilities or authority at the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">a change in the geographic location at which Participant must perform services that results in an increase in the one-way commute of Participant by more than 50 miles.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to each of subsection (i), (ii), and (iii) above, Participant must provide notice to the Company of the condition giving rise to &#8220;Good Reason&#8221; within one hundred twenty (120) days of Participant&#8217;s knowledge of the existence of such condition, and the Company will have thirty (30) days following such notice to remedy such condition. Participant must resign Participant&#8217;s employment no later than thirty (30) days following expiration of the Company&#8217;s thirty (30) day cure period.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date of execution of a definitive agreement providing for a Change in Control if such transaction is consummated.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Qualifying Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means a termination of employment resulting from (i) a termination by the Company of the Participant&#8217;s employment for any reason other than Cause, death or Disability, and (ii) if upon or within (12)&#160;months following a Change in Control, a voluntary resignation by the Participant of his or her employment for Good Reason. Termination due to Participant&#8217;s death or Participant&#8217;s Disability will in no event constitute a Qualifying Termination.&#93;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your employment or consulting relationship or Service with the Company or the relevant Subsidiary is for an unspecified duration, can be terminated at any time (i.e., is &#8220;at-will&#8221;) other than as required by applicable local law, and that nothing in this Notice, the RSU Agreement or the Plan changes the nature of that relationship nor shall create or amend an employment or consulting relationship with the Company by virtue of this Notice or your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You acknowledge that the vesting of the RSUs pursuant to this Notice is subject to your continuous Service as an Employee, Director or Consultant of the Company or the relevant Subsidiary (as applicable). You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below, or by accepting this Notice and the RSU Agreement via the Company&#8217;s designated electronic acceptance procedure, you confirm that you have read this Notice, the RSU Agreement and the Plan, you agree to be bound by them and you freely and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Notice, the RSU Agreement and any other Restricted Stock Unit Award grant materials by the Company, its affiliates and Subsidiaries (including your employer), and any third parties assisting in the implementation, administration and management of the Plan, for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that the Company, its Subsidiaries (including your employer) may collect, hold, process, disclose and transfer certain personal data about you. For the purposes of this Notice and the RSU Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data&#8221; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">means certain personal and&#47;or sensitive information about you, including, but not limited to, your name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor and any other information required by providers for the purpose of implementing, administering and managing the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that Data will be transferred to E*TRADE Financial (&#8220;E*TRADE&#8221;) or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of Data may be located in the United States or elsewhere, where you may not have the same rights under applicable data protection and privacy law as in your home jurisdiction. You authorize the Company, E*TRADE and any other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the plan.</font></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:216pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:52.579%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:12.20pt">DEXCOM, INC.</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:7.55pt;padding-right:-2.63pt"><font><br></font></div><div style="margin-top:0.05pt;padding-right:-3.38pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:13.05pt">By&#58;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:31.87pt;padding-right:-2.63pt"><font><br></font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"><div style="padding-left:31.87pt;padding-right:-2.63pt"><font><br></font></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_318"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice. Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Regardless of any action the Company and&#47;or Participant&#8217;s employer(s) (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) take with respect to any foreign, federal, state, or local income tax, social insurance (including if permissible under local law, any statutory employer&#8217;s contribution to social insurance), national insurance contributions, payroll tax, payment on account, or other tax-related withholding with respect to this Agreement, as a result of Participant&#8217;s participation in the Plan and&#47;or any aspect of the RSUs (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), Participant agrees and acknowledges that the ultimate liability for all Tax-Related Items is the responsibility of Participant and that the Company and&#47;or the Employer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">are not making any representations and are not committing to take any actions regarding any Tax- Related Items, including, but not limited to, the grant of the RSUs, the vesting of the RSUs, the delivery of Shares upon vesting of the RSUs, the subsequent sale of Shares acquired upon vesting of the RSUs, and the receipt of any dividends&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate Participant&#8217;s liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before any Tax-Related Items become due, Participant will pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy those Tax-Related Items. If permissible under local law, Participant authorizes the Company and&#47;or the Employer to withhold all applicable Tax-Related Items legally payable by or due with respect to and&#47;or on behalf of Participant by one or a combination of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">withholding a number of Shares to be issued upon settlement of the RSUs&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.24pt">withholding from proceeds of the sale of Shares acquired upon settlement of the RSUs either through a voluntary sale or through a mandatory sale arrangement by the Company (whether through a broker or otherwise) on Participant&#8217;s behalf pursuant to this authorization and without further consent.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company or the Employer may withhold or account for Tax-Related Items by considering applicable statutory withholding amounts or other applicable withholding rates, including maximum rates, applicable in Participant&#8217;s jurisdiction(s).  In the event of over-withholding, Participant may receive a refund from the Company or the Employer of any over-withheld amount in cash and will have no entitlement to the equivalent in Shares.  If not refunded, Participant may need to seek a refund from the responsible tax authority to the extent Participant wishes to obtain a refund.  If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, Participant will be deemed to have been issued the full number of Shares to which Participant is entitled pursuant to the vesting of the RSUs even though a portion of those Shares will be withheld for the purpose of satisfying the Tax-Related Items.  Further, if Participant is subject to Tax-Related Items in more than one jurisdiction, Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Participant will pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan or any aspect of the RSUs that cannot be satisfied by any of the means described in the preceding paragraph. The Company may refuse to deliver Shares to Participant if Participant fails to meet his&#47;her obligations for the Tax-Related Items, as described herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote from such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the Notice, if Participant&#8217;s Service terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs and the underlying Shares shall immediately terminate. For the avoidance of doubt, Participant shall not be entitled to any compensation for the loss of any rights or opportunities under the Plan other than as provided for herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant acknowledges that there may be tax consequences upon settlement of the RSUs, the disposition of the Shares, if any, received in connection therewith, or at such other times that may be applicable in Participant&#8217;s jurisdiction(s) and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations regarding Participant&#8217;s participation in the Plan. Participant should consult a personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan. Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Country-Specific Terms and Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant&#8217;s participation in the Plan will be subject to any special terms and conditions set forth in Appendix A to this Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appendix A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for Participant&#8217;s country of residence, if any. Appendix A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if Participant relocates to another country, any special terms and conditions applicable to RSUs granted in such country may apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reserves the right to impose other requirements on the RSUs and any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Shares may be listed or quoted at the time of such issuance or transfer.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If one or more provisions of this Agreement (including the Appendix) are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, U.S.A, without giving effect to principles of conflicts of law.  In addition, for purposes of any action, lawsuit or other proceedings brought to enforce this Agreement, relating to it, or arising from it, the parties hereby submit to and consent to the sole and exclusive jurisdiction of the state and federal courts of the State of California.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8217;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s service, for any reason, with or without cause, subject to compliance with applicable local laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Recipient Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through Participant&#8217;s acceptance of this grant, Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal and&#47;or sensitive data as described in this document by and among, as applicable, the Company, its affiliates and its subsidiaries for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company holds certain personal and&#47;or sensitive information about him or her, including, but not limited to, his or her name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor and any other information required by providers for the purpose of implementing, administering and managing the Plan (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Participant also understands and unambiguously consents to the fact that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in Participant&#8217;s country or elsewhere, and that Participant&#8217;s country may have different data privacy laws and protections than the laws in the recipient's country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing Participant&#8217;s participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom Participant may elect to deposit any Shares acquired. Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting the Data Privacy Officer at &#91;***&#93;. Participant understands, however, that refusing or withdrawing his or her consent may affect his or her ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact the Data Privacy Officer at &#91;***&#93;.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">By acknowledging and accepting this RSU grant, Participant agrees that the granting of this RSU is completely at the discretion of the Committee pursuant to the Plan, that Participant does not expect that future awards will be granted under the Plan, or any other plan, and that Participant waives any claim for losses under the Agreement of the Plan in connection with termination of Service.  All decisions with respect to future RSU or other grants, if any, will be at the sole discretion of the Committee.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The RSU grant is non-transferrable and non-assignable.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Board at any time.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The grant of this award is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of awards, or benefits in lieu of awards, even if awards have been granted repeatedly in the past.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Participant is voluntarily participating in the Plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">This RSU grant and the Shares subject to the RSUs, and the income from and value of same, are an extraordinary item that do not constitute compensation of any kind for services of any kind rendered to the Company or its Subsidiaries (including, as applicable, the Employer) and which is outside the scope of Participant&#8217;s Service contract, if any.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">This RSU grant and the Shares subject to the RSUs, and the income from and value of same, are not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, holiday pay, pension or retirement benefits or similar payments.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The future value of the underlying Shares is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">Unless otherwise agreed with the Company in writing, the RSUs and the Shares subject to the RSUs, and the income and value of same, are not granted as consideration for, or in connection with, the service Participant may provide as a director of a Subsidiary.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(j)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">For purposes of the RSUs, Participant&#8217;s Service will be considered terminated as of the date Participant is no longer actively providing services to the Company, the Employer or any Subsidiary of the Company (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where Participant is employed or the terms of Participant&#8217;s service or employment agreement, if any), and unless otherwise expressly provided in this Agreement or determined by the Company, Participant&#8217;s right to vest in the RSUs under the Plan, if any, will terminate as of such date and will not be extended by any notice period (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">., Participant&#8217;s period of service would not include any contractual notice period or any period of &#8220;garden leave&#8221; or similar period mandated under employment laws in the jurisdiction where Participant employed or the terms of Participant&#8217;s service or employment agreement, if any).  The Committee shall have the exclusive discretion to determine when Participant is no longer actively&#160;providing services for purposes of the RSUs (including whether Participant may still be considered to be&#160;providing services while on a leave of absence).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(k)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">Neither the Company, the Employer nor any Subsidiary of the Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shall be liable for any foreign exchange rate fluctuation between Participant&#8217;s local currency and the United States Dollar that may affect the value of the RSUs or the subsequent sale of any Shares acquired upon settlement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Translations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant receives this Agreement or any other document or communication related to the Plan or this grant in a language other than English and the meaning in the translation is different than in the English version, the terms expressed in the English version will govern.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Insider Trading&#47;Market Abuse Laws</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant may be subject to insider trading restrictions and&#47;or market abuse laws in applicable jurisdictions, including, but not limited to, Participant&#8217;s country, which may affect Participant&#8217;s ability to accept, acquire, sell, or otherwise dispose of Shares, rights to Shares (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the RSUs) or rights linked to the value of Shares under the Plan during such times as Participant is considered to have &#8220;inside information&#8221; regarding the Company (as defined by the laws in the applicable jurisdictions).  Local insider trading laws and regulations may prohibit the cancellation or amendment of orders Participant placed before Participant possessed inside information.  Furthermore, Participant could be prohibited from (a) disclosing the inside information to any third party, and (b) &#8220;tipping&#8221; third parties or causing them otherwise to buy or sell securities.  Any restrictions under these laws or regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy.  Neither the Company nor any Subsidiary will be responsible for such restrictions or liable for the failure on Participant&#8217;s part to know and abide by such restrictions.  Participant should consult with a personal legal advisor to ensure compliance with local laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Regulatory, Tax and Foreign Assent&#47;Account Reporting Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant acknowledges that the laws of the country in which Participant is working at the time of grant, vesting or the sale of Shares received pursuant to this RSU grant (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject Participant to additional procedural or regulatory requirements that Participant is and will be solely responsible for and must fulfill.  Depending upon the country to which laws Participant is subject, Participant may have certain foreign asset&#47;account and&#47;or tax  reporting requirements that may affect Participant&#8217;s ability to acquire or hold Shares under the Plan or cash received from participating in the Plan (including from any dividends or dividend equivalents or sale proceeds arising from the sale of Shares) in a brokerage or bank account outside Participant&#8217;s country of residence.  Participant&#8217;s country may require that Participant report such accounts, assets or transactions to the applicable authorities in Participant&#8217;s country.  Participant also may be required to repatriate cash received from participating in the Plan to Participant&#8217;s country within a certain period of time after receipt.  Participant is responsible for knowledge of and compliance with any such regulations and should speak with a personal tax, legal and financial advisors regarding same.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.11pt">&#91;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">To be inserted as applicable&#58;  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of this Agreement, a termination of employment will be determined consistent with the rules relating to a &#8220;separation from service&#8221; as defined in Section 409A of the Internal Revenue Code and the regulations thereunder (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Notwithstanding anything else provided herein, to the extent any payments provided under this RSU Agreement in connection with Participant&#8217;s termination of employment constitute deferred compensation subject to Section 409A, and Participant is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A, then such payment shall not be made or commence until the earlier of (i) the expiration of the six-month period measured from Participant&#8217;s separation from service from the Company or (ii) the date of Participant&#8217;s death following such a separation from service&#59; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Participant including, without limitation, the additional tax for which Participant would otherwise be liable under Section 409A(a)(1)(B) in the absence of such a deferral. To the extent any payment under this RSU Agreement may be classified as a &#8220;short-term deferral&#8221; within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.&#93;</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">***</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By Participant&#8217;s signature and the signature of the Company&#8217;s representative on the Notice, or by Participant accepting this Agreement via the Company&#8217;s electronic acceptance procedure, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_340"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL COUNTRY-SPECIFIC TERMS AND CONDITIONS OF THE DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (RESTRICTED STOCK UNITS)</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A includes additional terms and conditions that govern the RSUs granted to Participant under the Plan if Participant resides in one of the countries listed below. Capitalized terms used but not defined in this Appendix A are defined in the Plan and&#47;or the Agreement, and have the meanings set forth therein.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant is a citizen or resident of a country other than the one in which Participant is currently working and&#47;or residing, transfers to another country after the Date of Grant, or is considered a resident of another country for local law purposes, the Company shall, in its discretion, determine the extent to which the special terms and conditions contained herein shall be applicable to Participant.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A also includes information regarding exchange controls and certain other issues of which Participant should be aware with respect to Participant&#8217;s participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of November 2024. Such laws are often complex and change frequently. As a result, the Company strongly recommends that Participant not rely on the information noted in this Appendix A as the only source of information relating to the consequences of Participant&#8217;s participation in the Plan because the information may be out of date at the time that Participant vests in the RSUs or sells Shares acquired under the Plan.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the information contained herein is general in nature and may not apply to Participant&#8217;s particular situation, and the Company is not in a position to assure Participant of a particular result. Accordingly, Participant is advised to seek appropriate professional advice as to how the relevant laws in Participant&#8217;s country may apply to Participant&#8217;s situation.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, if Participant is a citizen or resident of a country other than the one in which Participant is currently working and&#47;or residing, transfers employment after the Date of Grant, or is considered a resident of another country for local law purposes, the information contained herein may not be applicable to Participant, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CANADA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs Settled in Shares Only</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any discretion contained in the Plan, or any provision in the Agreement to the contrary, RSUs shall be paid in Shares only and do not provide any right for Participant to receive a cash payment.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Termination</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provision replaces the subsection (j) of the Nature of Grant section of the Agreement&#58;</font></div><div style="padding-right:10.15pt;text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Subject to the terms of the Notice, if Participant&#8217;s Service terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs and the underlying Shares (if any) shall immediately terminate. For the avoidance of doubt, Participant shall not be entitled to any compensation for the loss of any rights or opportunities under the Plan other than as provided for herein.  Notwithstanding the definition of &#8220;Service&#8221; in the Plan, for purposes of the RSUs, the termination of Participant&#8217;s Service with the Company or the Employer will be considered to occur on the date that is the earliest of (i) the date on which Participant&#8217;s Service is terminated or (ii) the date Participant receives written notice of termination of Service from the Employer, in all cases regardless of any notice period, pay in lieu of such notice or related payments or damages provided or required to be provided under local law (including, but not limited to, statutory law, regulatory law and&#47;or common law).  For greater certainty, Participant will not earn or be entitled to any pro-rated vesting for that portion of time before the date on which Participant&#8217;s right to vest terminates, nor will Participant be entitled to any compensation for lost vesting. Notwithstanding the foregoing, if applicable employment standards legislation explicitly requires continued vesting during a statutory notice period, Participant acknowledges that Participant&#8217;s right to vest in the RSUs under the Plan, if any, will terminate effective as of the last day of Participant&#8217;s minimum statutory notice period, but Participant will not earn or be entitled to pro-rated vesting if an applicable vesting date falls after the end of Participant&#8217;s statutory notice period, nor will Participant be entitled to any compensation for lost vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following provisions shall apply if Participant is a resident of Quebec&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Notice and Consent</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Data Privacy section of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company and the Employer to disclose and discuss his or her participation in the Plan with their advisors. Finally, Participant authorizes the Company and the Employer to record such information and to keep such information in his or her employee file.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GERMANY</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Control Information</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-border payments in excess of &#8364;12,500 must be reported monthly to the German Federal Bank (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bundesbank</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">). If Participant is a German resident and he or she makes or receives a payment in excess of this amount in connection with Participant&#8217;s participation in the Plan, Participant must report the payment to Bundesbank electronically using the &#8220;General Statistics Reporting Portal&#8221; (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allgemeines Meldeportal Statistik</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) available via Bundesbank&#8217;s website (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.bundesbank.de</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">).  In addition, Participant may be required to report the acquisition of securities (e.g., Shares) to the </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Bundesbank </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">via email or telephone if the value of the securities acquired exceeds &#8364;12,500.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Participant is responsible for complying with applicable reporting requirements and should consult with a personal legal advisor to ensure compliance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">MALAYSIA</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Notification Obligation</font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant is a director of a Malaysian Subsidiary, Participant is subject to certain notification requirements under the Malaysian Companies Act.  Among these requirements is an obligation to notify the Malaysian Subsidiary in writing when Participant receives or disposes of an interest (</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">e.g.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, RSUs or Shares) in the Company or any Subsidiary.  Such notifications must be made within 14 days of receiving or disposing of any interest in the Company or any Subsidiary.  </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Participant is responsible for complying with applicable reporting requirements and should consult with a personal legal advisor to ensure compliance.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NETHERLANDS</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider-Trading Notification</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant should be aware of the Dutch insider-trading rules, which may impact the sale of Shares issued to Participant at vesting and settlement of the RSUs. In particular, Participant may be prohibited from effectuating certain transactions involving Shares if Participant has inside information about the Company. If Participant is uncertain whether the insider-trading rules apply to Participant, Participant should consult his or her personal legal advisor.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWEDEN</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Taxes</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following provision supplements the Withholding Taxes section of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without limiting the Company&#8217;s and any Subsidiary&#8217;s authority to satisfy their withholding obligations for Tax-Related Items as set forth in Section 2 of the Agreement, in accepting the grant of the RSUs, Participant authorizes the Company and&#47;or a Subsidiary to withhold Shares or to sell Shares otherwise deliverable to Participant upon vesting&#47;settlement to satisfy Tax-Related Items, regardless of whether the Company and&#47;or the Subsidiary have an obligation to withhold such Tax-Related Items.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWITZERLAND</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Securities Law Notification</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither this document nor any other materials relating to the RSUs constitute a prospectus according to article 35 et seq. of the Swiss Federal Act on Financial Services (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">FinSA</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and neither this document nor any other materials relating to the RSUs may be publicly distributed nor otherwise made publicly available in Switzerland to any person other than an employee of the Company.  Neither this document nor any other offering or marketing material relating to the RSUs have been or will be filed with, or approved or supervised by, any Swiss reviewing body according to article 51 FinSA or any Swiss regulatory authority (in particular, the Swiss Financial Market Supervisory Authority (FINMA)).</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED KINGDOM</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Taxes</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Withholding Taxes section of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Without limitation to the Withholding Taxes section of the Agreement, Participant hereby agrees that Participant is liable for all Tax-Related Items and hereby covenants to pay all such Tax-related Items, as and when requested by the Company or the Employer, as applicable, or by HM Revenue &#38; Customs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HMRC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) (or any other relevant authority). Participant also hereby agrees to indemnify and keep indemnified the Company and the Employer, as applicable, against any Tax-Related Items that they are required to pay or withhold or have paid or will pay on Participant&#8217;s behalf to HMRC (or any other relevant authority).  If payment or withholding of the Tax-Related Items (including the Employer's Liability, as defined below) is not made within 90 days of the end of the UK tax year in which an event giving rise to Tax-Related Items occurs (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003, the amount of any uncollected Tax-Related Items will constitute a loan owed by Participant to the Employer, effective on the Due Date.   Participant agrees that the loan will bear interest at the then-current Official Rate of HMRC, it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Withholding Taxes section of the Agreement.  Participant also authorizes the Company to delay the issuance of Shares to Participant unless and until the loan is repaid.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant will not be eligible for such a loan to cover the Tax-Related Items. In the event that Participant is a director or executive officer and the Tax-Related Items are not collected from or paid by Participant by the Due Date, the amount of any uncollected Tax-Related Items will constitute a benefit to Participant on which additional income tax and national insurance contributions (including the Employer's Liability, as defined below) will be payable. Participant will be responsible for reporting and paying any income tax and national insurance contributions (including the Employer's Liability, as defined below) due on this additional benefit directly to HMRC under the self-assessment regime.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Election&#47;recoverability of employer national insurance contributions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of Participant&#8217;s participation in the Plan and the vesting of the RSUs (if any), Participant agrees to accept any liability for secondary Class 1 national insurance contributions (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer's Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) which may be payable by the Company and&#47;or the Employer in connection with the RSUs and any event giving rise to Tax- Related Items. To accomplish the foregoing, Participant agrees to execute a joint election with the Company and&#47;or the Employer (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the form of such Election being formally approved by HMRC, and&#47;or any other agreements, consents or elections required to accomplish the transfer of the Employer's Liability to Participant. Participant further agrees to execute such other joint elections, other agreements, consents or elections (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Agreement(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as may be required by the Company and&#47;or the Employer between Participant and the Company, any successor to the Company and&#47;or the Employer in order to transfer the Employer&#8217;s Liability to Participant or in order to provide for the reimbursement of the Employer&#8217;s Liability by Participant to the Company and&#47;or the Employer.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant does not enter into the Election when Participant accepts the Agreement, if the Election is revoked and&#47;or abolished at any time by HMRC or if Participant fails to enter into any Other Agreement as required by the Company, any successor to the Company and&#47;or the Employer, the Company may choose, in its sole discretion, not to allow Participant to vest in the RSUs and they will cease to vest, become null and void, and no Shares will be acquired under the Plan, without any liability to the Company, the Employer and&#47;or any Subsidiary. Participant further agrees that the Company and&#47;or the Employer may collect the Employer's Liability by any of the means set forth in the Withholding Taxes section of the Agreement.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, this requirement will apply to all Participants that work in the U.K. during any period from grant through the vesting date of the RSUs regardless of whether Participant was in the U.K. at the time of grant or vesting.</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED STATES</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Tax Consequences provision of the Agreement&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU. The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement. Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code. Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation. Participant should consult with a personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_4"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANT NUMBER&#58;&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:195.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address 2&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_____________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">City, State Zip&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.206%"><tr><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Commencement Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58;</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:245.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Shares</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Vest Date&#47;Performance Conditions</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your employment or consulting relationship or service with the Company or the relevant Subsidiary is for an unspecified duration, can be terminated at any time (i.e., is &#8220;at-will&#8221;) other than as required by applicable local law, and that nothing in this Notice, the RSU Agreement or the Plan changes the nature of that relationship nor shall create an employment or consulting relationship with the Company by virtue of this Notice or your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company&#160;or the relevant Subsidiary (as applicable). You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below you confirm that you have read this Notice, the RSU Agreement and the Plan, you agree to be bound by them and you freely and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Notice, the RSU Agreement and any other Restricted Stock Unit Award grant materials by the Company, its affiliates and Subsidiaries (including your employer), and any third parties assisting in the implementation, administration and management of the Plan, for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that the Company, its Subsidiaries (including your employer) may collect, hold, process, disclose and transfer certain personal data about you. For the purposes of this Notice and the RSU Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data&#8221;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> means certain personal and&#47;or sensitive information about you, including, but not limited to, your name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor and any other information required by providers for the purpose of implementing, administering and managing the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that Data will be transferred to E*TRADE Financial (&#8220;E*TRADE&#8221;) or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of Data may be located in the United States or elsewhere, where you may not have the same rights under applicable data protection and privacy law as in your home jurisdiction. You authorize the Company, E*TRADE and any other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the plan.</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_7"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice.  Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Regardless of any action the Company and&#47;or Participant&#8217;s employer(s) (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) take with respect to any foreign, federal, state, or local income tax, social insurance (including if permissible under local law, any statutory employer&#8217;s contribution to social insurance), national insurance contributions, payroll tax, payment on account, or other tax-related withholding with respect to this Agreement, as a result of Participant&#8217;s participation in the Plan and&#47;or any aspect of the RSUs (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), Participant agrees and acknowledges that the ultimate liability for all Tax-Related Items is the responsibility of Participant and that the Company and&#47;or the Employer&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">are not making any representations and are not committing to take any actions regarding any Tax-Related Items, including, but not limited to, the grant of the RSUs, the vesting of the RSUs, the delivery of Shares upon vesting of the RSUs, the subsequent sale of Shares acquired upon vesting of the RSUs, and the receipt of any dividends&#59; and</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before any Tax-Related Items become due, Participant will pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy those Tax-Related Items.  If permissible under local law, Participant authorizes the Company and&#47;or the Employer to withhold all applicable Tax-Related Items legally payable by or due with respect to and&#47;or on behalf of Participant by one or a combination of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;withholding from the Shares to be issued, the number of Shares having a fair market value (determined on the date that the amount of tax to be withheld is determined) equal to the amount required to be withheld for Tax-Related Items, or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;arranging to have sold on Participant&#8217;s behalf through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) a sufficient number of Shares that is equal to the amount required to be withheld for Tax-Related Items.  The Company shall arrange to sell or withhold a whole number of shares to satisfy the minimum tax withholding obligation, and to the extent that any tax obligation balance remains, such amount shall be withheld from your following payroll cycle.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, Participant will be deemed to have been issued the full number of Shares to which Participant is entitled pursuant to the vesting of the RSUs even though a portion of those Shares will be withheld for the purpose of satisfying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if Participant has relocated to a different jurisdiction between the date of grant and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Participant will pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan or any aspect of the RSUs that cannot be satisfied by any of the means described in the preceding paragraph.  The Company may refuse to deliver Shares to Participant if Participant fails to meet his&#47;her obligations for the Tax-Related Items, as described herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote from such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If dividends are declared and paid on Shares, dividend equivalent payments, if any (whether in cash or Shares), shall be credited to Participant at such time as Shares as issued in settlement of vested RSUs.  Such dividend equivalent payments shall have the same vesting requirements as the underlying RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Subject to the terms of the Notice, if Participant&#8217;s service terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate.  For the avoidance of doubt, Participant shall not be entitled to any compensation for the loss of any rights or opportunities under the Plan other than as provided for herein.  In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations prior to such settlement or disposition.  You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan.  Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Country-Specific Terms and Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant&#8217;s participation in the Plan will be subject to any special terms and conditions set forth in Appendix A to this Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appendix A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for Participant&#8217;s country of residence, if any.  Appendix A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if Participant relocates to another country, any special terms and conditions applicable to RSUs granted in such country may apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reserves the right to impose other requirements on the RSUs and any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them.  Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded.  No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement.  The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Shares may be listed or quoted at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If one or more provisions of this Agreement (including the Appendix) are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith.  In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, U.S.A, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8217;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s service, for any reason, with or without cause, subject to compliance with applicable local laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Recipient Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Through Participant&#8217;s acceptance of this grant, Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal and&#47;or sensitive data as described in this document by and among, as applicable, the Company, its affiliates and its subsidiaries for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Plan.  Participant understands that the Company holds certain personal and&#47;or sensitive information about him or her, including, but not limited to, his or her name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor and any other information required by providers for the purpose of implementing, administering and managing the Plan (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).  Participant also understands and unambiguously consents to the fact that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in Participant&#8217;s country or elsewhere, and that Participant&#8217;s country may have different data privacy laws and protections than the laws in the recipient's country.  Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative.  Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom Participant may elect to deposit any Shares acquired.  Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan.  Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative.  Participant understands, however, that refusing or withdrawing his or her consent may affect his or her ability to participate in the Plan.  For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">By acknowledging and accepting this RSU grant, Participant agrees that the granting of this RSU is completely at the discretion of the Committee pursuant to the Plan, that Participant does not expect that future awards will be granted under the Plan, or any other plan, and that Participant waives any claim for losses under the Agreement of the Plan in connection with termination of employment.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The RSU grant is non-transferrable and non-assignable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Board at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The grant of this award is voluntary and occasional and does not create any contractual or other right to receive future grants of awards, or benefits in lieu of awards, even if awards have been granted repeatedly in the past.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Participant is voluntarily participating in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">This RSU grant is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or its affiliates (including, as applicable, Participant&#8217;s employer) and which is outside the scope of Participant&#8217;s employment contract, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">This RSU grant is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The future value of the underlying Shares is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">For the purposes of this Agreement, termination of service shall be the last day of active service provided by Participant to the Company or one of its affiliates and such period shall not be extended by any notice of termination or similar period including any period of garden leave.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Translations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Participant receives this Agreement or any other document or communication related to the Plan or this grant in a language other than English and the meaning in the translation is different than in the English version, the terms expressed in the English version will govern.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any applicable law or facilitate the administration of the Plan.  Participant agrees to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.  Furthermore, Participant acknowledges that the laws of the country in which Participant is working at the time of grant, vesting or the sale of Shares received pursuant to this RSU grant (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject Participant to additional procedural or regulatory requirements that Participant is and will be solely responsible for and must fulfill.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By your signature and the signature of the Company&#8217;s representative on the Notice, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement.  Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement.  Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_10"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL COUNTRY-SPECIFIC TERMS AND CONDITIONS OF THE DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (RESTRICTED STOCK UNITS)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A includes additional terms and conditions that govern the RSUs granted to you under the Plan if you reside in one of the countries listed below.  Capitalized terms used but not defined in this Appendix A are defined in the Plan and&#47;or the Agreement, and have the meanings set forth therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A also includes information regarding exchange controls and certain other issues of which you should be aware with respect to your participation in the Plan.  The information is based on the securities, exchange control and other laws in effect in the respective countries as of August 2017.  Such laws are often complex and change frequently.  As a result, the Company strongly recommends that you not rely on the information noted in this Appendix A as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the RSUs or sell Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the information contained herein is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of a particular result.  Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, if you are a citizen or resident of a country other than the one in which you are currently working, transfer employment after the grant date, or are considered a resident of another country for local law purposes, the information contained herein may not be applicable to you, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CANADA</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs Settled in Shares Only</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any discretion contained in the Plan, or any provision in the Agreement to the contrary, RSUs shall be paid in Shares only and do not provide any right for Participant to receive a cash payment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following provisions shall apply if Participant is a resident of Quebec&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Language Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Les Parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de cette convention, ainsi que de tous documents, avis et proc&#233;dures judiciaires, ex&#233;cut&#233;s, donn&#233;s ou intent&#233;s en vertu de, ou li&#233;s directement ou indirectement &#224; la pr&#233;sente convention.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Notice and Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Data Privacy section of the Agreement&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan.  Participant further authorizes the Company and the Employer to disclose and discuss his or her participation in the Plan with their advisors.  Finally, Participant authorizes the Company and the Employer to record such information and to keep such information in his or her employee file.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Control Information</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-border payments in excess of &#8364;12,500 must be reported monthly to the German Federal Bank.  If Participant uses a German bank to transfer a cross-border payment in excess of &#8364;12,500 in connection with the sale of Shares acquired under the Plan, the bank will make the report for him or her.  In addition, Participant must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 on a monthly basis.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NETHERLANDS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider-Trading Notification</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant should be aware of the Dutch insider-trading rules, which may impact the sale of Shares issued to Participant at vesting and settlement of the RSUs.  In particular, Participant may be prohibited from effectuating certain transactions involving Shares if Participant has inside information about the Company.  If Participant is uncertain whether the insider-trading rules apply to Participant, Participant should consult his or her personal legal advisor.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWEDEN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Taxes</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Withholding Taxes section of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If payment or withholding of the Tax-Related Items (including the Employer's Liability, as defined below) is not made within 90 days of the end of the UK tax year in which vesting occurs (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003, the amount of any uncollected Tax-Related Items will constitute a loan owed by Participant to the Employer, effective on the Due Date.  Participant agrees that the loan will bear interest at the then-current Official Rate of Her Majesty's Revenue and Customs (&#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HMRC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Withholding Taxes section of the Agreement.  Participant also authorizes the Company to delay the issuance of Shares to Participant unless and until the loan is repaid.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant will not be eligible for such a loan to cover the Tax-Related Items.  In the event that Participant is a director or executive officer and the Tax-Related Items are not collected from or paid by Participant by the Due Date, the amount of any uncollected Tax-Related Items will constitute a benefit to Participant on which additional income tax and national insurance contributions (including the Employer's Liability, as defined below) will be payable.  Participant will be responsible for reporting and paying any income tax and national insurance contributions (including the Employer's Liability, as defined below) due on this additional benefit directly to HMRC under the self-assessment regime.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Election&#47;recoverability of employer national insurance contributions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of Participant&#8217;s participation in the Plan and the vesting of the RSUs (, Participant agrees to accept any liability for secondary Class 1 national insurance contributions (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer's Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;) which may be payable by the Company and&#47;or the Employer in connection with the RSUs and any event giving rise to Tax-Related Items.  To accomplish the foregoing, Participant agrees to execute a joint election with the Company and&#47;or the Employer (the &#34;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#34;), the form of such Election being formally approved by HMRC, and&#47;or any other agreements, consents or elections required to accomplish the transfer of the Employer's Liability to Participant.  Participant further agrees to execute such other joint elections, other agreements, consents or elections (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Agreement(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as may be required by the Company and&#47;or the Employer between Participant and the Company, any successor to the Company and&#47;or the Employer in order to transfer the Employer&#8217;s Liability to Participant or in order to provide for the reimbursement of the Employer&#8217;s Liability by Participant to the Company and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant does not enter into the Election when Participant accepts the Agreement, if the Election is revoked and&#47;or abolished at any time by HMRC or if Participant fails to enter into any Other Agreement as required by the Company, any successor to the Company and&#47;or the Employer, the Company may choose, in its sole discretion, not to allow Participant to vest in the RSUs and they will cease to vest, become null and void, and no Shares will be acquired under the Plan, without any liability to the Company, the Employer and&#47;or any Affiliate.  Participant further agrees that the Company and&#47;or the Employer may collect the Employer's Liability by any of the means set forth in the Withholding Taxes section of the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, this requirement will apply to all Participants that work in the U.K. during any period from grant through the vesting date of the RSUs regardless of whether Participant was in the U.K. at the time of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED STATES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Tax Consequences provision of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU.  The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law.  Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement.  Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code.  Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation.  You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_13"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.<br>AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN<br>NOTICE OF RESTRICTED STOCK UNIT AWARD<br>GRANT NUMBER&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> _____________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:250.75pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:195.25pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address 2&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_____________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">City, State Zip&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.206%"><tr><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Commencement Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58;</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:245.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Shares</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Vest Date&#47;Performance Conditions</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Acceleration&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing Vesting Schedule, if the Participant is subject to a Qualifying Termination (as defined below) during a Change in Control Period (as defined below), then, subject to Participant&#8217;s delivery to the Company of a general release (in a form prescribed by the Company) of all known and unknown claims that Participant may then have against the Company or persons affiliated with the Company (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Release</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), and satisfaction of all conditions to make the Release effective, within sixty (60) days following Participant&#8217;s Qualifying Termination (such sixty (60) day period, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Release Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the then-unvested RSUs shall accelerate and become vested and settled with respect to 100% of the shares subject thereto.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accelerated vesting described above shall be effective as of the Qualifying Termination, subject to delivery of the effective Release&#59; provided, that, if the Qualified Termination occurs prior to the Change in Control (as defined below), then any unvested portion of Participant&#8217;s RSUs will remain outstanding for three (3) months following the Qualifying Termination (provided that in no event will the RSUs remain outstanding beyond the tenth anniversary of the Date of Grant). In the event that the proposed Change in Control is terminated without having been completed, any unvested portion of Participant&#8217;s RSUs automatically will be forfeited.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any other provision in the Plan, the Notice or this Agreement to the contrary, if the successor or acquiring corporation (if any) of the Company refuses to assume, convert, replace or substitute the unvested RSUs in connection with a Corporate Transaction (as defined in the Plan) as provided in Section 21.1 of the Plan, then such RSUs shall accelerate and become vested and settled with respect to 100% of the shares subject thereto effective immediately prior to the Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cause</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means (i) the Participant has been convicted of, or has pleaded guilty or nolo contendere to, any felony or crime involving moral turpitude, (ii) the Participant has (X) engaged in willful misconduct which is injurious to the Company or materially failed or refused to perform the material duties lawfully and reasonably assigned to the Participant or has performed such material duties with gross negligence or (Y) breached any material term or condition of this Plan, the Participant&#8217;s Employee Proprietary Information and Inventions Agreement with the Company, any written Company policy or the Company&#8217;s written code of conduct that has been made available to Participant prior to such breach or any other material agreement with the Company, in any case after written notice by the Company of such misconduct, performance issue, gross negligence or breach of terms or conditions and an opportunity to cure within thirty (30) days of such written notice thereof from the Company, unless such misconduct, performance issue, gross negligence or breach is, by its nature, not curable, or (iii) the Participant has committed any act of fraud, theft, embezzlement, misappropriation of funds, breach of fiduciary duty or other willful act of material dishonesty against the Company that results in material harm to the Company.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then outstanding voting securities&#59; or (ii) the consummation of the sale or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; or (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation, provided that the transaction or series of transactions pursuant to subsections (i), (ii) or (iii) also qualifies as a &#8220;change in control event&#8221; under U.S. Treasury Regulation 1.409A-3(i)(5).</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Control Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the period commencing three (3) months prior to a Change in Control (only if after a Potential Change in Control) and ending twelve (12) months following a Change in Control.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; has the meaning set forth in Section 22(e)(3) of the Code.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Good Reason</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events or conditions, without Participant&#8217;s express written consent&#58;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">a material reduction in Participant&#8217;s base salary as an employee of the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">a material reduction in the Participant&#8217;s duties, responsibilities or authority at the Company&#59; or</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">a change in the geographic location at which Participant must perform services that results in an increase in the one-way commute of Participant by more than 50 miles.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to each of subsection (i), (ii), and (iii) above, Participant must provide notice to the Company of the condition giving rise to &#8220;Good Reason&#8221; within one hundred twenty (120) days of Participant&#8217;s knowledge of the existence of such condition, and the Company will have thirty (30) days following such notice to remedy such condition. Participant must resign Participant&#8217;s employment no later than thirty (30) days following expiration of the Company&#8217;s thirty (30) day cure period.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Potential Change in Control</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the date of execution of a definitive agreement providing for a Change in Control if such transaction is consummated.</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Qualifying Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means a termination of employment resulting from (i) a termination by the Company of the Participant&#8217;s employment for any reason other than Cause, death or Disability, and (ii) if upon or within (12) months following a Change in Control, a voluntary resignation by the Participant of his or her employment for Good Reason. Termination due to Participant&#8217;s death or Participant&#8217;s Disability will in no event constitute a Qualifying Termination.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your employment or consulting relationship or service with the Company or the relevant Subsidiary is for an unspecified duration, can be terminated at any time (i.e., is &#8220;at-will&#8221;) other than as required by applicable local law, and that nothing in this Notice, the RSU Agreement or the Plan changes the nature of that relationship nor shall create an employment or consulting relationship with the Company by virtue of this Notice or your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company or the relevant Subsidiary (as applicable).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below you confirm that you have read this Notice, the RSU Agreement and the Plan, you agree to be bound by them</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and you freely and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Notice, the RSU Agreement and any other Restricted Stock Unit Award grant materials by the Company, its affiliates and Subsidiaries (including your employer), and any third parties assisting in the implementation, administration and management of the Plan, for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that the Company, its Subsidiaries (including your employer) may collect, hold, process, disclose and transfer certain personal data about you. For the purposes of this Notice and the RSU Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means certain personal and&#47;or sensitive information about you, including, but not limited to, your name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor and any other information required by providers for the purpose of implementing, administering and managing the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that Data will be transferred to E*TRADE Financial (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">E*TRADE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of Data may be located in the United States or elsewhere, where you may not have the same rights under applicable data protection and privacy law as in your home jurisdiction. You authorize the Company, E*TRADE and any other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the plan.</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_16"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.<br>AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE<br>DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice. Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Regardless of any action the Company and&#47;or Participant&#8217;s employer(s) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) take with respect to any foreign, federal, state, or local income tax, social insurance (including if permissible under local law, any statutory employer&#8217;s contribution to social insurance), national insurance contributions, payroll tax, payment on account, or other tax-related withholding with respect to this Agreement, as a result of Participant&#8217;s participation in the Plan and&#47;or any aspect of the RSUs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Participant agrees and acknowledges that the ultimate liability for all Tax-Related Items is the responsibility of Participant and that the Company and&#47;or the Employer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">are not making any representations and are not committing to take any actions regarding any Tax- Related Items, including, but not limited to, the grant of the RSUs, the vesting of the RSUs, the delivery of Shares upon vesting of the RSUs, the subsequent sale of Shares acquired upon vesting of the RSUs, and the receipt of any dividends&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before any Tax-Related Items become due, Participant will pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy those Tax-Related Items. If permissible under local law, Participant authorizes the Company and&#47;or the Employer to withhold all applicable Tax-Related Items legally payable by or due with respect to and&#47;or on behalf of Participant by one or a combination of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">withholding from the Shares to be issued, the number of Shares having a fair market value (determined on the date that the amount of tax to be withheld is determined) equal to the amount required to be withheld for Tax-Related Items, or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">arranging to have sold on Participant&#8217;s behalf through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) a sufficient number of Shares that is equal to the amount required to be withheld for Tax-Related Items.  The Company shall arrange to sell or withhold a whole number of shares to satisfy the minimum tax withholding obligation, and to the extent that any tax obligation balance remains, such amount shall be withheld from your following payroll cycle.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, Participant will be deemed to have been issued the full number of Shares to which Participant is entitled pursuant to the vesting of the RSUs even though a portion of those Shares will be withheld for the purpose of satisfying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if Participant has relocated to a different jurisdiction between the date of grant and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Participant will pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan or any aspect of the RSUs that cannot be satisfied by any of the means described in the preceding paragraph. The Company may refuse to deliver Shares to Participant if Participant fails to meet his&#47;her obligations for the Tax-Related Items, as described herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote from such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If dividends are declared and paid on Shares, dividend equivalent payments, if any (whether in cash or Shares), shall be credited to Participant at such time as Shares as issued in settlement of vested RSUs. Such dividend equivalent payments shall have the same vesting requirements as the underlying RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of the Notice, if Participant&#8217;s service terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate. For the avoidance of doubt, Participant shall not be entitled to any compensation for the loss of any rights or opportunities under the Plan other than as provided for herein. In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations prior to such settlement or disposition. You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan. Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Country-Specific Terms and Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Participant&#8217;s participation in the Plan will be subject to any special terms and conditions set forth in Appendix A to this Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appendix A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for Participant&#8217;s country of residence, if any. Appendix A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if Participant relocates to another country, any special terms and conditions applicable to RSUs granted in such country may apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reserves the right to impose other requirements on the RSUs and any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Shares may be listed or quoted at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If one or more provisions of this Agreement (including the Appendix) are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, U.S.A, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant&#8217;s service, for any reason, with or without cause, subject to compliance with applicable local laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Recipient Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through Participant&#8217;s acceptance of this grant, Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal and&#47;or sensitive data as described in this document by and among, as applicable, the Company, its affiliates and its subsidiaries for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company holds certain personal and&#47;or sensitive information about him or her, including, but not limited to, his or her name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor and any other information required by providers for the purpose of implementing, administering and managing the Plan (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Participant also understands and unambiguously consents to the fact that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in Participant&#8217;s country or elsewhere, and that Participant&#8217;s country may have different data privacy laws and protections than the laws in the recipient&#8217;s country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom Participant may elect to deposit any Shares acquired. Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Participant understands, however, that refusing or withdrawing his or her consent may affect his or her ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">By acknowledging and accepting this RSU grant, Participant agrees that the granting of this RSU is completely at the discretion of the Committee pursuant to the Plan, that Participant does not expect that future awards will be granted under the Plan, or any other plan, and that Participant waives any claim for losses under the Agreement of the Plan in connection with termination of employment.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The RSU grant is non-transferrable and non-assignable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Board at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The grant of this award is voluntary and occasional and does not create any contractual or other right to receive future grants of awards, or benefits in lieu of awards, even if awards have been granted repeatedly in the past.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Participant is voluntarily participating in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">This RSU grant is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or its affiliates (including, as applicable, Participant&#8217;s employer) and which is outside the scope of Participant&#8217;s employment contract, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">This RSU grant is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The future value of the underlying Shares is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">For the purposes of this Agreement, termination of service shall be the last day of active service provided by Participant to the Company or one of its affiliates and such period shall not be extended by any notice of termination or similar period including any period of garden leave.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Translations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If Participant receives this Agreement or any other document or communication related to the Plan or this grant in a language other than English and the meaning in the translation is different than in the English version, the terms expressed in the English version will govern.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any applicable law or facilitate the administration of the Plan. Participant agrees to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant acknowledges that the laws of the country in which Participant is working at the time of grant, vesting or the sale of Shares received pursuant to this RSU grant (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject Participant to additional procedural or regulatory requirements that Participant is and will be solely responsible for and must fulfill.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By your signature and the signature of the Company&#8217;s representative on the Notice, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of this Agreement, a termination of employment will be determined consistent with the rules relating to a &#8220;separation from service&#8221; as defined in Section 409A of the Internal Revenue Code and the regulations thereunder (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Notwithstanding anything else provided herein, to the extent any payments provided under this RSU Agreement in connection with Participant&#8217;s termination of employment constitute deferred compensation subject to Section 409A, and Participant is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A, then such payment shall not be made or commence until the earlier of (i) the expiration of the six-month period measured from Participant&#8217;s separation from service from the Company or (ii) the date of Participant&#8217;s death following such a separation from service&#59; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Participant including, without limitation, the additional tax for which Participant would otherwise be liable under Section 409A(a)(1)(B) in the absence of such a deferral. To the extent any payment under this RSU Agreement may be classified as a &#8220;short-term deferral&#8221; within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</font></div><div><font><br></font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_19"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL COUNTRY-SPECIFIC TERMS AND CONDITIONS OF THE DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (RESTRICTED STOCK UNITS)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A includes additional terms and conditions that govern the RSUs granted to you under the Plan if you reside in one of the countries listed below. Capitalized terms used but not defined in this Appendix A are defined in the Plan and&#47;or the Agreement, and have the meanings set forth therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A also includes information regarding exchange controls and certain other issues of which you should be aware with respect to your participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of August 2017. Such laws are often complex and change frequently. As a result, the Company strongly recommends that you not rely on the information noted in this Appendix A as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the RSUs or sell Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the information contained herein is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of a particular result. Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, if you are a citizen or resident of a country other than the one in which you are currently working, transfer employment after the grant date, or are considered a resident of another country for local law purposes, the information contained herein may not be applicable to you, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs Settled in Shares Only</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any discretion contained in the Plan, or any provision in the Agreement to the contrary, RSUs shall be paid in Shares only and do not provide any right for Participant to receive a cash payment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following provisions shall apply if Participant is a resident of Quebec&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Language Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Les Parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de cette convention, ainsi que de tous documents, avis et proc&#233;dures judiciaires, ex&#233;cut&#233;s, donn&#233;s ou intent&#233;s en vertu de, ou li&#233;s directement ou indirectement &#224; la pr&#233;sente convention.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Notice and Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Data Privacy section of the Agreement&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company and the Employer to disclose and discuss his or her participation in the Plan with their advisors. Finally, Participant authorizes the Company and the Employer to record such information and to keep such information in his or her employee file.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Control Information</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-border payments in excess of &#8364;12,500 must be reported monthly to the German Federal Bank. If Participant uses a German bank to transfer a cross-border payment in excess of &#8364;12,500 in connection with the sale of Shares acquired under the Plan, the bank will make the report for him or her. In addition, Participant must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 on a monthly basis.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NETHERLANDS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider-Trading Notification</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant should be aware of the Dutch insider-trading rules, which may impact the sale of Shares issued to Participant at vesting and settlement of the RSUs. In particular, Participant may be prohibited from effectuating certain transactions involving Shares if Participant has inside information about the Company. If Participant is uncertain whether the insider-trading rules apply to Participant, Participant should consult his or her personal legal advisor.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWEDEN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Taxes</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Withholding Taxes section of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If payment or withholding of the Tax-Related Items (including the Employer&#8217;s Liability, as defined below) is not made within 90 days of the end of the UK tax year in which vesting occurs (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003, the amount of any uncollected Tax-Related Items will constitute a loan owed by Participant to the Employer, effective on the Due Date. Participant agrees that the loan will bear interest at the then-current Official Rate of Her Majesty&#8217;s Revenue and Customs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HMRC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Withholding Taxes section of the Agreement. Participant also authorizes the Company to delay the issuance of Shares to Participant unless and until the loan is repaid.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant will not be eligible for such a loan to cover the Tax-Related Items. In the event that Participant is a director or executive officer and the Tax-Related Items are not collected from or paid by Participant by the Due Date, the amount of any uncollected Tax-Related Items will constitute a benefit to Participant on which additional income tax and national insurance contributions (including the Employer&#8217;s Liability, as defined below) will be payable. Participant will be responsible for reporting and paying any income tax and national insurance contributions (including the Employer&#8217;s Liability, as defined below) due on this additional benefit directly to HMRC under the self-assessment regime.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Election&#47;recoverability of employer national insurance contributions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of Participant&#8217;s participation in the Plan and the vesting of the RSUs (, Participant agrees to accept any liability for secondary Class 1 national insurance contributions (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer&#8217;s Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which may be payable by the Company and&#47;or the Employer in connection with the RSUs and any event giving rise to Tax- Related Items. To accomplish the foregoing, Participant agrees to execute a joint election with the Company and&#47;or the Employer (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the form of such Election being formally approved by HMRC, and&#47;or any other agreements, consents or elections required to accomplish the transfer of the Employer&#8217;s Liability to Participant. Participant further agrees to execute such other joint elections, other agreements, consents or elections (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Agreement(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as may be required by the Company and&#47;or the Employer between Participant and the Company, any successor to the Company and&#47;or the Employer in order to transfer the Employer&#8217;s Liability to Participant or in order to provide for the reimbursement of the Employer&#8217;s Liability by Participant to the Company and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant does not enter into the Election when Participant accepts the Agreement, if the Election is revoked and&#47;or abolished at any time by HMRC or if Participant fails to enter into any Other Agreement as required by the Company, any successor to the Company and&#47;or the Employer, the Company may choose, in its sole discretion, not to allow Participant to vest in the RSUs and they will cease to vest, become null and void, and no Shares will be acquired under the Plan, without any liability to the Company, the Employer and&#47;or any Affiliate. Participant further agrees that the Company and&#47;or the Employer may collect the Employer&#8217;s Liability by any of the means set forth in the Withholding Taxes section of the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, this requirement will apply to all Participants that work in the U.K. during any period from grant through the vesting date of the RSUs regardless of whether Participant was in the U.K. at the time of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED STATES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Tax Consequences provision of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU. The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement. Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code. Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation. You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_22"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.<br>AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN<br>NOTICE OF RESTRICTED STOCK UNIT AWARD<br>GRANT NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">_____________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:238.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:208.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Address 2&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_____________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">City, State Zip&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">__________________</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.206%"><tr><td style="width:1.0%"></td><td style="width:12.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:85.567%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Number of RSUs&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">______________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Date of Grant&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_________________</font></div></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Commencement Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">_______________</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Expiration Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Vesting Schedule&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58;</font></td></tr></table></div><div><font><br></font></div><div style="padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:450.00pt"><tr><td style="width:1.0pt"></td><td style="width:200.50pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:245.50pt"></td><td style="width:1.0pt"></td></tr><tr style="height:20pt"><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Shares</font></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Vest Date&#47;Performance Conditions</font></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:18pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="padding-left:18pt"><font><br></font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Acceleration&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Notwithstanding the foregoing Vesting Schedule, the RSUs are eligible for vesting acceleration under the Company&#8217;s Severance and Change in Control Plan, subject to the terms and conditions thereof.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your employment or consulting relationship or service with the Company or the relevant Subsidiary is for an unspecified duration, can be terminated at any time (i.e., is &#8220;at-will&#8221;) other than as required by applicable local law, and that nothing in this Notice, the RSU Agreement or the Plan changes the nature of that relationship nor shall create an employment or consulting relationship with the Company by virtue of this Notice or your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company or the relevant Subsidiary (as applicable).</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Statement&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By signing below you confirm that you have read this Notice, the RSU Agreement and the Plan, you agree to be bound by them and you freely and unambiguously consent to the collection, use and transfer, in electronic or other form, of your personal data as described in this Notice, the RSU Agreement and any other Restricted Stock Unit Award grant materials by the Company, its affiliates and Subsidiaries (including your employer), and any third parties assisting in the implementation, administration and management of the Plan, for the exclusive purpose of implementing, administering and managing your participation in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that the Company, its Subsidiaries (including your employer) may collect, hold, process, disclose and transfer certain personal data about you. For the purposes of this Notice and the RSU Agreement, the term &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means certain personal and&#47;or sensitive information about you, including, but not limited to, your name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in your favor and any other information required by providers for the purpose of implementing, administering and managing the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that Data will be transferred to E*TRADE Financial (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">E*TRADE</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or such other stock plan service provider as may be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. You understand that the recipients of Data may be located in the United States or elsewhere, where you may not have the same rights under applicable data protection and privacy law as in your home jurisdiction. You authorize the Company, E*TRADE and any other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer data, in electronic or other form, for the sole purpose of implementing, administering and managing your participation in the plan.</font></div><div style="margin-bottom:24pt;padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="padding-left:216pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By&#58;</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_25"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.<br>AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE<br>DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice. Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding Taxes</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Regardless of any action the Company and&#47;or Participant&#8217;s employer(s) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) take with respect to any foreign, federal, state, or local income tax, social insurance (including if permissible under local law, any statutory employer&#8217;s contribution to social insurance), national insurance contributions, payroll tax, payment on account, or other tax-related withholding with respect to this Agreement, as a result of Participant&#8217;s participation in the Plan and&#47;or any aspect of the RSUs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax-Related Items</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), Participant agrees and acknowledges that the ultimate liability for all Tax-Related Items is the responsibility of Participant and that the Company and&#47;or the Employer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">are not making any representations and are not committing to take any actions regarding any Tax- Related Items, including, but not limited to, the grant of the RSUs, the vesting of the RSUs, the delivery of Shares upon vesting of the RSUs, the subsequent sale of Shares acquired upon vesting of the RSUs, and the receipt of any dividends&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:32.5pt">do not commit to structure the terms of the grant or any aspect of the RSUs to reduce or eliminate your liability for Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before any Tax-Related Items become due, Participant will pay or make adequate arrangements satisfactory to the Company and&#47;or the Employer to satisfy those Tax-Related Items. If permissible under local law, Participant authorizes the Company and&#47;or the Employer to withhold all applicable Tax-Related Items legally payable by or due with respect to and&#47;or on behalf of Participant by one or a combination of the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">withholding from the Shares to be issued, the number of Shares having a fair market value (determined on the date that the amount of tax to be withheld is determined) equal to the amount required to be withheld for Tax-Related Items, or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">arranging to have sold on Participant&#8217;s behalf through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) a sufficient number of Shares that is equal to the amount required to be withheld for Tax-Related Items.  The Company shall arrange to sell or withhold a whole number of shares to satisfy the minimum tax withholding obligation, and to the extent that any tax obligation balance remains, such amount shall be withheld from your following payroll cycle.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the obligation for Tax-Related Items is satisfied by withholding a number of Shares as described herein, Participant will be deemed to have been issued the full number of Shares to which Participant is entitled pursuant to the vesting of the RSUs even though a portion of those Shares will be withheld for the purpose of satisfying the Tax-Related Items.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, if Participant has relocated to a different jurisdiction between the date of grant and the date of any taxable event, Participant acknowledges that the Company and&#47;or the Employer (or former employer, as applicable) may be required to withhold or account for Tax-Related Items in more than one jurisdiction.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, Participant will pay to the Company or the Employer any amount of Tax-Related Items that the Company or the Employer may be required to withhold or account for as a result of Participant&#8217;s participation in the Plan or any aspect of the RSUs that cannot be satisfied by any of the means described in the preceding paragraph. The Company may refuse to deliver Shares to Participant if Participant fails to meet his&#47;her obligations for the Tax-Related Items, as described herein.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote from such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If dividends are declared and paid on Shares, dividend equivalent payments, if any (whether in cash or Shares), shall be credited to Participant at such time as Shares as issued in settlement of vested RSUs. Such dividend equivalent payments shall have the same vesting requirements as the underlying RSUs.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Subject to the terms of the Notice, if Participant&#8217;s service terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate. For the avoidance of doubt, Participant shall not be entitled to any compensation for the loss of any rights or opportunities under the Plan other than as provided for herein.  In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations prior to such settlement or disposition. You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan. Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Country-Specific Terms and Conditions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Participant&#8217;s participation in the Plan will be subject to any special terms and conditions set forth in Appendix A to this Agreement (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Appendix A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) for Participant&#8217;s country of residence, if any. Appendix A constitutes part of this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, if Participant relocates to another country, any special terms and conditions applicable to RSUs granted in such country may apply to Participant to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the Company reserves the right to impose other requirements on the RSUs and any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require Participant to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Shares may be listed or quoted at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If one or more provisions of this Agreement (including the Appendix) are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms. This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, U.S.A, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant&#8217;s service, for any reason, with or without cause, subject to compliance with applicable local laws.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">14.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Recipient Data Privacy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Through Participant&#8217;s acceptance of this grant, Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of his or her personal and&#47;or sensitive data as described in this document by and among, as applicable, the Company, its affiliates and its subsidiaries for the exclusive purpose of implementing, administering and managing Participant&#8217;s participation in the Plan. Participant understands that the Company holds certain personal and&#47;or sensitive information about him or her, including, but not limited to, his or her name, home address and telephone&#47;fax number, date of birth, social insurance number or other identification number, family size, marital status, gender, beneficiary information, emergency contacts, passport&#47;visa information, salary and benefit information, personal bank account number, tax related information, tax identification number, nationality, job title, any Shares or directorships held in the Company, details of all RSUs or any other entitlement to Shares awarded, canceled, exercised, vested, unvested or outstanding in Participant&#8217;s favor and any other information required by providers for the purpose of implementing, administering and managing the Plan (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Data</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Participant also understands and unambiguously consents to the fact that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in Participant&#8217;s country or elsewhere, and that Participant&#8217;s country may have different data privacy laws and protections than the laws in the recipient&#8217;s country. Participant understands that he or she may request a list with the names and addresses of any potential recipients of the Data by contacting his or her local human resources representative. Participant authorizes the recipients to receive, possess, use, retain and transfer the Data, in electronic or other form, for the purposes of implementing, administering and managing my participation in the Plan, including any requisite transfer of such Data as may be required to a broker or other third party with whom Participant may elect to deposit any Shares acquired. Participant understands that Data will be held only as long as is necessary to implement, administer and manage his or her participation in the Plan. Participant understands that he or she may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing his or her local human resources representative. Participant understands, however, that refusing or withdrawing his or her consent may affect his or her ability to participate in the Plan. For more information on the consequences of Participant&#8217;s refusal to consent or withdrawal of consent, Participant understands that he or she may contact his or her local human resources representative.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">15.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Nature of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">By acknowledging and accepting this RSU grant, Participant agrees that the granting of this RSU is completely at the discretion of the Committee pursuant to the Plan, that Participant does not expect that future awards will be granted under the Plan, or any other plan, and that Participant waives any claim for losses under the Agreement of the Plan in connection with termination of employment.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The RSU grant is non-transferrable and non-assignable.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Board at any time.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The grant of this award is voluntary and occasional and does not create any contractual or other right to receive future grants of awards, or benefits in lieu of awards, even if awards have been granted repeatedly in the past.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">Participant is voluntarily participating in the Plan.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:26.57pt">This RSU grant is an extraordinary item that does not constitute compensation of any kind for services of any kind rendered to the Company or its affiliates (including, as applicable, Participant&#8217;s employer) and which is outside the scope of Participant&#8217;s employment contract, if any.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">This RSU grant is not part of normal or expected compensation or salary for any purpose, including, but not limited to, calculating any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(h)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:23.78pt">The future value of the underlying Shares is unknown and cannot be predicted with certainty.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">For the purposes of this Agreement, termination of service shall be the last day of active service provided by Participant to the Company or one of its affiliates and such period shall not be extended by any notice of termination or similar period including any period of garden leave.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">16.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Translations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If Participant receives this Agreement or any other document or communication related to the Plan or this grant in a language other than English and the meaning in the translation is different than in the English version, the terms expressed in the English version will govern.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">17.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Imposition of Other Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company reserves the right to impose other requirements on Participant&#8217;s participation in the Plan, on the RSUs and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with any applicable law or facilitate the administration of the Plan. Participant agrees to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Furthermore, Participant acknowledges that the laws of the country in which Participant is working at the time of grant, vesting or the sale of Shares received pursuant to this RSU grant (including any rules or regulations governing securities, foreign exchange, tax, labor, or other matters) may subject Participant to additional procedural or regulatory requirements that Participant is and will be solely responsible for and must fulfill.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By your signature and the signature of the Company&#8217;s representative on the Notice, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement. Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement. Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement. Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">18.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Code Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. For purposes of this Agreement, a termination of employment will be determined consistent with the rules relating to a &#8220;separation from service&#8221; as defined in Section 409A of the Internal Revenue Code and the regulations thereunder (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Section 409A</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). Notwithstanding anything else provided herein, to the extent any payments provided under this RSU Agreement in connection with Participant&#8217;s termination of employment constitute deferred compensation subject to Section 409A, and Participant is deemed at the time of such termination of employment to be a &#8220;specified employee&#8221; under Section 409A, then such payment shall not be made or commence until the earlier of (i) the expiration of the six-month period measured from Participant&#8217;s separation from service from the Company or (ii) the date of Participant&#8217;s death following such a separation from service&#59; provided, however, that such deferral shall only be effected to the extent required to avoid adverse tax treatment to Participant including, without limitation, the additional tax for which Participant would otherwise be liable under Section 409A(a)(1)(B) in the absence of such a deferral. To the extent any payment under this RSU Agreement may be classified as a &#8220;short-term deferral&#8221; within the meaning of Section 409A, such payment shall be deemed a short-term deferral, even if it may also qualify for an exemption from Section 409A under another provision of Section 409A. Payments pursuant to this section are intended to constitute separate payments for purposes of Section 1.409A-2(b)(2) of the Treasury Regulations.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_28"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">APPENDIX A</font></div><div style="margin-bottom:12pt;margin-top:12pt;padding-left:2.8pt;padding-right:2.8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADDITIONAL COUNTRY-SPECIFIC TERMS AND CONDITIONS OF THE DEXCOM, INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN (RESTRICTED STOCK UNITS)</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A includes additional terms and conditions that govern the RSUs granted to you under the Plan if you reside in one of the countries listed below. Capitalized terms used but not defined in this Appendix A are defined in the Plan and&#47;or the Agreement, and have the meanings set forth therein.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Appendix A also includes information regarding exchange controls and certain other issues of which you should be aware with respect to your participation in the Plan. The information is based on the securities, exchange control and other laws in effect in the respective countries as of August 2017. Such laws are often complex and change frequently. As a result, the Company strongly recommends that you not rely on the information noted in this Appendix A as the only source of information relating to the consequences of your participation in the Plan because the information may be out of date at the time that you vest in the RSUs or sell Shares acquired under the Plan.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, the information contained herein is general in nature and may not apply to your particular situation, and the Company is not in a position to assure you of a particular result. Accordingly, you are advised to seek appropriate professional advice as to how the relevant laws in your country may apply to your situation.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finally, if you are a citizen or resident of a country other than the one in which you are currently working, transfer employment after the grant date, or are considered a resident of another country for local law purposes, the information contained herein may not be applicable to you, and the Company shall, in its discretion, determine to what extent the terms and conditions contained herein shall apply.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">CANADA</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RSUs Settled in Shares Only</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding any discretion contained in the Plan, or any provision in the Agreement to the contrary, RSUs shall be paid in Shares only and do not provide any right for Participant to receive a cash payment.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The following provisions shall apply if Participant is a resident of Quebec&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Language Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Parties acknowledge that it is their express wish that the Agreement, as well as all documents, notices and legal proceedings entered into, given or instituted pursuant hereto or relating directly or indirectly hereto, be drawn up in English.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Les Parties reconnaissent avoir exig&#233; la r&#233;daction en anglais de cette convention, ainsi que de tous documents, avis et proc&#233;dures judiciaires, ex&#233;cut&#233;s, donn&#233;s ou intent&#233;s en vertu de, ou li&#233;s directement ou indirectement &#224; la pr&#233;sente convention.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Data Privacy Notice and Consent</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Data Privacy section of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant hereby authorizes the Company and the Company&#8217;s representatives to discuss with and obtain all relevant information from all personnel, professional or not, involved in the administration and operation of the Plan. Participant further authorizes the Company and the Employer to disclose </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and discuss his or her participation in the Plan with their advisors. Finally, Participant authorizes the Company and the Employer to record such information and to keep such information in his or her employee file.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">GERMANY</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exchange Control Information</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cross-border payments in excess of &#8364;12,500 must be reported monthly to the German Federal Bank. If Participant uses a German bank to transfer a cross-border payment in excess of &#8364;12,500 in connection with the sale of Shares acquired under the Plan, the bank will make the report for him or her. In addition, Participant must report any receivables, payables, or debts in foreign currency exceeding an amount of &#8364;5,000,000 on a monthly basis.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">NETHERLANDS</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notifications</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider-Trading Notification</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Participant should be aware of the Dutch insider-trading rules, which may impact the sale of Shares issued to Participant at vesting and settlement of the RSUs. In particular, Participant may be prohibited from effectuating certain transactions involving Shares if Participant has inside information about the Company. If Participant is uncertain whether the insider-trading rules apply to Participant, Participant should consult his or her personal legal advisor.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWEDEN</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SWITZERLAND</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no country-specific provisions.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED KINGDOM</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Withholding Taxes</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Withholding Taxes section of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If payment or withholding of the Tax-Related Items (including the Employer&#8217;s Liability, as defined below) is not made within 90 days of the end of the UK tax year in which vesting occurs (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Due Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) or such other period specified in Section 222(1)(c) of the U.K. Income Tax (Earnings and Pensions) Act 2003, the amount of any uncollected Tax-Related Items will constitute a loan owed by Participant to the Employer, effective on the Due Date. Participant agrees that the loan will bear interest at the then-current Official Rate of Her Majesty&#8217;s Revenue and Customs (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">HMRC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), it will be immediately due and repayable, and the Company or the Employer may recover it at any time thereafter by any of the means referred to in the Withholding Taxes section of the Agreement. Participant also authorizes the Company to delay the issuance of Shares to Participant unless and until the loan is repaid.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if Participant is a director or executive officer of the Company (within the meaning of Section 13(k) of the U.S. Securities and Exchange Act of 1934, as amended), Participant will not be eligible for such a loan to cover the Tax-Related Items. In the event that Participant is a director or executive officer and the Tax-Related Items are not collected from or paid by Participant by the Due Date, the amount of any uncollected Tax-Related Items will constitute a benefit to Participant on which additional income tax and national insurance contributions (including the </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Employer&#8217;s Liability, as defined below) will be payable. Participant will be responsible for reporting and paying any income tax and national insurance contributions (including the Employer&#8217;s Liability, as defined below) due on this additional benefit directly to HMRC under the self-assessment regime.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Joint Election&#47;recoverability of employer national insurance contributions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a condition of Participant&#8217;s participation in the Plan and the vesting of the RSUs (, Participant agrees to accept any liability for secondary Class 1 national insurance contributions (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employer&#8217;s Liability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) which may be payable by the Company and&#47;or the Employer in connection with the RSUs and any event giving rise to Tax- Related Items. To accomplish the foregoing, Participant agrees to execute a joint election with the Company and&#47;or the Employer (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Election</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), the form of such Election being formally approved by HMRC, and&#47;or any other agreements, consents or elections required to accomplish the transfer of the Employer&#8217;s Liability to Participant. Participant further agrees to execute such other joint elections, other agreements, consents or elections (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Agreement(s)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) as may be required by the Company and&#47;or the Employer between Participant and the Company, any successor to the Company and&#47;or the Employer in order to transfer the Employer&#8217;s Liability to Participant or in order to provide for the reimbursement of the Employer&#8217;s Liability by Participant to the Company and&#47;or the Employer.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Participant does not enter into the Election when Participant accepts the Agreement, if the Election is revoked and&#47;or abolished at any time by HMRC or if Participant fails to enter into any Other Agreement as required by the Company, any successor to the Company and&#47;or the Employer, the Company may choose, in its sole discretion, not to allow Participant to vest in the RSUs and they will cease to vest, become null and void, and no Shares will be acquired under the Plan, without any liability to the Company, the Employer and&#47;or any Affiliate. Participant further agrees that the Company and&#47;or the Employer may collect the Employer&#8217;s Liability by any of the means set forth in the Withholding Taxes section of the Agreement.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the avoidance of doubt, this requirement will apply to all Participants that work in the U.K. during any period from grant through the vesting date of the RSUs regardless of whether Participant was in the U.K. at the time of grant.</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">UNITED STATES</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms and Conditions</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This provision supplements the Tax Consequences provision of the Agreement&#58;</font></div><div style="margin-bottom:12pt;margin-top:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU. The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law. Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement. Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code. Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation. You should consult your personal tax advisor for information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_31"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.<br>AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN<br>NOTICE OF RESTRICTED STOCK UNIT AWARD<br>GRANT NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; ________________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Address</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Commencement Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration Date&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in one annual installment (i.e., 100% of the RSUs subject to this Notice will vest upon the earlier of the first anniversary of the Date of Grant or the date of the next annual meeting of stockholders).</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Transaction&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a Corporate Transaction occurs then the vesting and (if applicable) exercisability of the RSUs shall be accelerated in full and any reacquisition or repurchase rights held by the Company with respect to the shares of Common Stock subject to such acceleration shall lapse in full, as appropriate.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities&#59; provided, however, that for purposes of this subclause (i) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction&#59; (ii) the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">surviving entity or its parent outstanding immediately after such merger or consolidation&#59; (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company) or (v) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction. For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your relationship or service with the Company is for an unspecified duration, and that nothing in this Notice, the RSU Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference. Participant has read both the RSU Agreement and the Plan.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEXCOM, INC.</font></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58; ___________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print Name&#58; __________________________</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; ________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Its&#58; _________________________________</font></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_34"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice.  Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding and Net Issuance of the Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  When, under applicable tax laws, Participant incurs tax liability in connection with the vesting or settlement of any RSUs or issuance of Shares in connection therewith that is subject to tax withholding by the Company, the Company may, at the Compensation Committee&#8217;s election, satisfy the minimum tax withholding obligation on behalf of the Participant by either (a) withholding from the Shares to be issued, the number of Shares having a fair market value (determined on the date that the amount of tax to be withheld is determined) equal to the amount required to be withheld for income and employment taxes, or (b) arranging to have sold on Participant&#8217;s behalf through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) a sufficient number of Shares that is equal to the amount required to be withheld.  The Company shall arrange to sell or withhold a whole number of shares to satisfy the minimum tax withholding obligation, and to the extent that any tax obligation balance remains, such amount shall be withheld from your following payroll cycle, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   Dividends, if any (whether in cash or Shares), shall not be credited to Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Participant&#8217;s service Terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate.  In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">U.S. Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations prior to such settlement or disposition.  Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU.  The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law.  Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement.  Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code.  Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation.  You should consult your personal tax advisor for more information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan.  Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Common Stock may be listed or quoted at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law&#59; Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8217;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s service, for any reason, with or without cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By your signature and the signature of the Company&#8217;s representative on the Notice, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement.  Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement.  Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_37"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">NOTICE OF RESTRICTED STOCK UNIT AWARD</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">GRANT NUMBER&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">______</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc. (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same meanings in this Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Name</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; ________________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Address</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) have been granted an award of Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Plan subject to the terms and conditions of the Plan, this Notice and the attached Award Agreement (Restricted Stock Units) (hereinafter &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSU Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Number of RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Date of Grant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Commencement Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#58; _______________________</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Expiration Date&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The date on which settlement of all RSUs granted hereunder occurs, with earlier expiration upon the Termination Date.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vesting Schedule&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Subject to the limitations set forth in this Notice, the Plan and the RSU Agreement, the RSUs will vest in accordance with the following schedule&#58; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">in three annual installments (i.e., 33.3% of the RSUs subject to this Notice will vest upon the first anniversary of the Date of Grant&#59; 33.3% of the RSUs subject to this Notice will vest upon the second anniversary of the Date of Grant&#59; and 33.3% of the RSUs subject to this Notice will vest upon the third anniversary of the Date of Grant).</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify;text-indent:-144pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Transaction&#58;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;If a Corporate Transaction occurs then the vesting and (if applicable) exercisability of the RSUs shall be accelerated in full and any reacquisition or repurchase rights held by the Company with respect to the shares of Common Stock subject to such acceleration shall lapse in full, as appropriate.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Corporate Transaction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; means the occurrence of any of the following events&#58; (i) any &#8220;person&#8221; (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becomes the &#8220;beneficial owner&#8221; (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing more than fifty percent (50%) of the total voting power represented by the Company&#8217;s then-outstanding voting securities&#59; provided, however, that for purposes of this subclause (i) the acquisition of additional securities by any one Person who is considered to own more than fifty percent (50%) of the total voting power of the securities of the Company will not be considered a Corporate Transaction&#59; (ii) the consummation of the sale, transfer or disposition by the Company of all or substantially all of the Company&#8217;s assets&#59; (iii) the consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being </font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">converted into voting securities of the surviving entity or its parent) more than fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation&#59; (iv) any other transaction which qualifies as a &#8220;corporate transaction&#8221; under Section 424(a) of the Code wherein the stockholders of the Company give up all of their equity interest in the Company (except for the acquisition, sale or transfer of all or substantially all of the outstanding shares of the Company) or (v) a change in the effective control of the Company that occurs on the date that a majority of members of the Board is replaced during any twelve (12) month period by members of the Board whose appointment or election is not endorsed by a majority of the members of the Board prior to the date of the appointment or election. For purpose of this subclause (v), if any Person is considered to be in effective control of the Company, the acquisition of additional control of the Company by the same Person will not be considered a Corporate Transaction. For purposes of this definition, Persons will be considered to be acting as a group if they are owners of a corporation that enters into a merger, consolidation, purchase or acquisition of stock, or similar business transaction with the Company. Notwithstanding the foregoing, to the extent that any amount constituting deferred compensation (as defined in Section 409A of the Code) would become payable under this Plan by reason of a Corporate Transaction, such amount shall become payable only if the event constituting a Corporate Transaction would also qualify as a change in ownership or effective control of the Company or a change in the ownership of a substantial portion of the assets of the Company, each as defined within the meaning of Code Section 409A, as it has been and may be amended from time to time, and any proposed or final Treasury Regulations and IRS guidance that has been promulgated or may be promulgated thereunder from time to time.</font></div><div style="margin-bottom:12pt;padding-left:180pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, a Corporate Transaction shall not be deemed to result from any transaction precipitated by the Company&#8217;s insolvency, appointment of a conservator, or determination by a regulatory agency that the Company is insolvent, nor from any transaction the sole purpose of which is to change the state of the Company&#8217;s incorporation or to create a holding company that will be owned in substantially the same proportions by the persons who held the Company&#8217;s securities immediately before such transaction.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You understand that your relationship or service with the Company is for an unspecified duration, and that nothing in this Notice, the RSU Agreement or the Plan changes the at-will nature of that relationship. You acknowledge that the vesting of the RSUs pursuant to this Notice is earned only by continuing service as an Employee, Director or Consultant of the Company. You also understand that this Notice is subject to the terms and conditions of both the RSU Agreement and the Plan, both of which are incorporated herein by reference. Participant has read both the RSU Agreement and the Plan.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:468.00pt"><tr><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:232.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">PARTICIPANT</font></div></td><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DEXCOM, INC.</font></td></tr><tr style="height:33pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Signature&#58; ___________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Print Name&#58; __________________________</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58; ________________________________</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Its&#58; _________________________________</font></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i59f984d5714c434ea6ef939759514250_40"></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AWARD AGREEMENT (RESTRICTED STOCK UNITS) TO THE</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM INC. AMENDED AND RESTATED 2015 EQUITY INCENTIVE PLAN</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless otherwise defined herein, the terms defined in the DexCom, Inc.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) Amended and Restated 2015 Equity Incentive Plan (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) shall have the same defined meanings in this Award Agreement (Restricted Stock Units) (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Agreement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You have been granted Restricted Stock Units (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">RSUs</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) subject to the terms, restrictions and conditions of the Plan, the Notice of Restricted Stock Unit Award (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Notice</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and this Agreement.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Settlement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Settlement of RSUs shall be made within the earlier of (i) 90 days following the applicable date of vesting under the vesting schedule or (ii) March 15 of the year following the year of vesting as set forth in the Notice.  Settlement of RSUs shall be in Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Withholding and Net Issuance of the Shares</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  When, under applicable tax laws, Participant incurs tax liability in connection with the vesting or settlement of any RSUs or issuance of Shares in connection therewith that is subject to tax withholding by the Company, the Company may, at the Compensation Committee&#8217;s election, satisfy the minimum tax withholding obligation on behalf of the Participant by either (a) withholding from the Shares to be issued, the number of Shares having a fair market value (determined on the date that the amount of tax to be withheld is determined) equal to the amount required to be withheld for income and employment taxes, or (b) arranging to have sold on Participant&#8217;s behalf through such means as the Company may determine in its sole discretion (whether through a broker or otherwise) a sufficient number of Shares that is equal to the amount required to be withheld.  The Company shall arrange to sell or withhold a whole number of shares to satisfy the minimum tax withholding obligation, and to the extent that any tax obligation balance remains, such amount shall be withheld from your following payroll cycle, if applicable.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Stockholder Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Unless and until such time as Shares are issued in settlement of vested RSUs, Participant shall have no ownership of the Shares allocated to the RSUs and shall have no right to dividends or to vote such Shares.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Dividend Equivalents</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.   Dividends, if any (whether in cash or Shares), shall not be credited to Participant.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The RSUs and any interest therein shall not be sold, assigned, transferred, pledged, hypothecated, or otherwise disposed of.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Termination</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If Participant&#8217;s service Terminates for any reason, all unvested RSUs shall be forfeited to the Company forthwith, and all rights of Participant to such RSUs shall immediately terminate.  In case of any dispute as to whether Termination has occurred, the Committee shall have sole discretion to determine whether such Termination has occurred and the effective date of such Termination.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">U.S. Tax Consequences</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Participant acknowledges that there will be tax consequences upon settlement of the RSUs or disposition of the Shares, if any, received in connection therewith, and Participant should consult a tax adviser regarding Participant&#8217;s tax obligations prior to such settlement or disposition.  Upon vesting of the RSU, Participant will include in income the fair market value of the Shares subject to the RSU.  The included amount will be treated as ordinary income by Participant and will be subject to withholding by the Company when required by applicable law.  Upon disposition of the Shares, any subsequent increase or decrease in value will be treated as short-term or long-term capital gain or loss, depending on whether the Shares are held for more than one year from the date of settlement.  Further, an RSU may be considered a deferral of compensation that may be subject to Section 409A of the Code.  Section 409A of the Code imposes special rules to the timing of making and effecting certain amendments of this RSU with respect to distribution of any deferred compensation.  You should consult your personal tax advisor for more information on the actual and potential tax consequences of this RSU.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Acknowledgement</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The Company and Participant agree that the RSUs are granted under and governed by the Notice, this Agreement and the provisions of the Plan.  Participant&#58; (i) acknowledges receipt of a copy of the Plan and the Plan prospectus, (ii) represents that Participant has carefully read and is familiar with their provisions, and (iii) hereby accepts the RSUs subject to all of the terms and conditions set forth herein and those set forth in the Plan and the Notice.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.67pt;text-decoration:underline">Entire Agreement&#59; Enforcement of Rights</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  This Agreement, the Plan and the Notice constitute the entire agreement and understanding of the parties relating to the subject matter herein and supersede all prior discussions between them. Any prior agreements, commitments or negotiations concerning the purchase of the Shares hereunder are superseded. No modification of or amendment to this Agreement, nor any waiver of any rights under this Agreement, shall be effective unless in writing and signed by the parties to this Agreement. The failure by either party to enforce any rights under this Agreement shall not be construed as a waiver of any rights of such party.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Compliance with Laws and Regulations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  The issuance of Shares will be subject to and conditioned upon compliance by the Company and Participant with all applicable state and federal laws and regulations and with all applicable requirements of any stock exchange or automated quotation system on which the Company&#8217;s Common Stock may be listed or quoted at the time of such issuance or transfer.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">Governing Law&#59; Severability</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  If one or more provisions of this Agreement are held to be unenforceable under applicable law, the parties agree to renegotiate such provision in good faith. In the event that the parties cannot reach a mutually agreeable and enforceable replacement for such provision, then (i) such provision shall be excluded from this Agreement, (ii) the balance of this Agreement shall be interpreted as if such provision were so excluded and (iii) the balance of this Agreement shall be enforceable in accordance with its terms.  This Agreement and all acts and transactions pursuant hereto and the rights and obligations of the parties hereto shall be governed, construed and interpreted in accordance with the laws of the State of California, without giving effect to principles of conflicts of law.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:22.11pt;text-decoration:underline">No Rights as Employee, Director or Consultant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.  Nothing in this Agreement shall affect in any manner whatsoever the right or power of the Company, or a Parent or Subsidiary of the Company, to terminate Participant</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#8217;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s service, for any reason, with or without cause.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By your signature and the signature of the Company&#8217;s representative on the Notice, Participant and the Company agree that this RSU is granted under and governed by the terms and conditions of the Plan, the Notice and this Agreement.  Participant has reviewed the Plan, the Notice and this Agreement in their entirety, has had an opportunity to obtain the advice of counsel prior to executing this Agreement, and fully understands all provisions of the Plan, the Notice and this Agreement.  Participant hereby agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions relating to the Plan, the Notice and this Agreement.  Participant further agrees to notify the Company upon any change in Participant&#8217;s residence address.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-19.1
<SEQUENCE>6
<FILENAME>dxcm12312024-exhibit191.htm
<DESCRIPTION>EX-19.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="id01f39b887654d15976e87a7446eb05d_113"></div><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 19.1</font></div><div style="text-align:right"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:8pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider Trading Policy</font></div><div style="margin-bottom:8pt;margin-top:12pt;text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">As Adopted by the Board of Directors<br>on March&#160;11, 2005 and amended through January 1, 2025</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:30.46pt">PURPOSE</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is illegal for any employee, officer or director of DexCom, Inc. (collectively, with its subsidiaries, the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Company</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) to trade in the securities of the Company while in the possession of material nonpublic information about the Company. A &#8220;trade&#8221; as referenced in this Insider Trading Policy (this &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Policy</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) generally refers to purchases, sales or gifts of securities. It is also illegal for any employee, officer or director of the Company to give material nonpublic information to others who may trade on the basis of that information.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to comply with U.S. federal and state securities laws governing (i)&#160;trading in Company securities while in the possession of material nonpublic information concerning the Company and (ii) disclosing (&#8220;tipping&#8221;) material nonpublic information to others, and in order to prevent even the appearance of improper trading or tipping, the Company has adopted this Policy for all of its employees, officers and directors.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.69pt">SCOPE</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Covered Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Policy covers all employees, officers and directors of the Company (which includes its direct and indirect subsidiaries), their family members and entities (such as trusts, partnerships and corporations) over which such employees, officers or directors have or share voting or investment control (collectively referred to herein as &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">employees, officers or directors</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;). For purposes of this Policy, a &#8220;family member&#8221; includes a person&#8217;s spouse, parents, children, siblings, mothers and fathers-in-law, sons and daughters-in-law, brothers and sisters-in-law, and anyone (other than domestic employees) who shares such person&#8217;s home. Employees, officers and directors are responsible for ensuring compliance by their family members and entities over which they exercise voting or investment control. This Policy also applies to former employees, officers and directors until the third full trading day after any material nonpublic information known to such individual has become public or is no longer material to the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Covered Transactions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Policy applies to any and all transactions in the Company&#8217;s securities, including shares of Company common stock and options to purchase Company common stock or other rights to acquire Company common stock, such as restricted stock units, however acquired, and any other type of securities that the Company may issue, such as shares of preferred stock, convertible debentures, warrants and exchange-traded options or other derivative securities. Additionally, this Policy applies to any and all transactions in securities of another company while in possession of material nonpublic information obtained in the course of employment or service as an employee, officer or director of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Company Transactions</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. From time to time, the Company may engage in transactions in the Company&#8217;s securities. It is the Company&#8217;s policy to comply with all applicable U.S. federal and state securities laws or stock exchange listing standards when engaging in transactions in the Company&#8217;s securities.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">10b5-1 Trading Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Policy allows for trades by employees, officers and directors made in compliance with Rule 10b5-1 (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rule 10b5-1</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) promulgated by the Securities and Exchange Commission (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">SEC</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) under the Securities Exchange Act of 1934, as amended (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exchange Act</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), subject to the approval of the Compliance Officer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:24.92pt">INSIDER DEFINITIONS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Section 16 Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Board of Directors of the Company has designated the executive officers and directors who are subject to the additional reporting provisions and trading restrictions of Section&#160;16 of the Exchange Act, and the underlying rules and regulations promulgated by the SEC. Each such person, and each person and entity affiliated or associated with any such officer or director, is referred herein as a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 16 Party</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,&#8221; and collectively the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Section 16 Parties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Access Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company has designated (i) all DexCom Vice Presidents and above&#59; (ii) all directors and above in the Legal, Finance and Corporate Development departments&#59; and (iii) such other persons as determined by the Compliance Officer from time to time, as an &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Access Person</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; (other than the Section 16 Parties) because such individuals may have regular access to material nonpublic information in the normal course of their duties for the Company. The Chief Legal Officer and Chief Financial Officer (or his or her respective designees), with input from the Section&#160;16 Parties (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Executive Leadership Team</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and relevant departmental team leaders, shall determine and maintain the list of Access Persons.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Director-Level Employees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Each employee at a &#8220;director&#8221; level (or equivalent such as &#8220;principal&#8221;) or above who is not a Section&#160;16 Party or an Access Person is a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Director-Level Employee</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">INSIDER TRADING COMPLIANCE OFFICER</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has designated the Company&#8217;s Chief Legal Officer, or his or her designee, as its insider trading compliance officer (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compliance Officer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), for purposes of administering, interpreting, and enforcing this Policy. In the event of the Chief Legal Officer&#8217;s (or his or her designee&#8217;s) unavailability, the Company&#8217;s Chief Financial Officer or Chief Executive Officer shall be authorized to serve as Compliance Officer in the interim. The Chief Legal Officer and Chief Financial Officer may each designate his or her responsibilities under this Policy to another employee of the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt">DEFINITION OF &#8220;MATERIAL NONPUBLIC INFORMATION</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">&#8220;Material&#8221; Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Information is &#8220;material&#8221; if it might be of significance to a reasonable investor, as part of the total mix of available information, in determining whether to purchase, sell or hold Company securities. Information may be significant for this purpose even if it would not alone determine the investor&#8217;s decision. Both positive and negative information may be material. While it is not possible to identify all information that would be deemed &#8220;material,&#8221; the following examples include certain types of information that ordinarily would be considered material&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Financial performance, especially quarterly and year-end earnings, and significant changes in financial performance or liquidity.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant financial and operational forecasts.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Results or material data of clinical or pre-clinical testing or trials, or other significant development milestones.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant communications to or from, or receipt of information from, United States or foreign regulatory authorities regarding products and&#47;or products under development, including inspections, approvals or other regulatory actions.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Operational metrics of the Company or its partners, such as customer counts and associated retention or attrition rates, performance or other metrics, employee counts and distribution by geography or function and any changes in such metrics.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Potential material mergers and acquisitions or material sales of Company assets or subsidiaries.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock splits, public or private securities&#47;debt offerings, or changes in Company dividend policies or amounts.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant changes in senior management.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Strategic plans including customer, product (including product introductions), pricing, geography and market strategies and shifts.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developments regarding significant customers, suppliers or partners, such as the potential acquisition or loss of a significant contract, development agreement or strategic relationship.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developments with respect to significant lawsuits.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Changes in the Company&#8217;s auditor or notification that the Company may no longer rely on an auditor&#8217;s report.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Significant cybersecurity incident experienced by the Company.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">&#8220;Nonpublic&#8221; Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Material information is &#8220;nonpublic&#8221; if it has not been widely disseminated to the public, for example, through major newswire services, national news services, webcasts or financial news services. Even after the Company has released information to the press or the information has been reported, information will be considered public, i.e., no longer &#8220;nonpublic,&#8221; only at the opening of trading on the third full trading day following the Company&#8217;s widespread public release of the information. For the purposes of this Policy, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">trading day</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; is a day on which the Nasdaq Stock Market is open for trading.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Consult the Compliance Officer for Guidance</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Employees, officers or directors who are unsure whether the information that they possess is material or nonpublic must consult the Compliance Officer for guidance before trading in any Company securities.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">STATEMENT OF COMPANY POLICY AND PROCEDURES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Prohibited Activities</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Trading on Material Nonpublic Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may trade in Company securities while possessing material nonpublic information concerning the Company (except for trades made under Rule 10b5-1 Plans in compliance with this Policy and applicable law). It does not matter that there may exist a justifiable reason for a purchase or sale apart from the nonpublic information&#59; if the employee, officer or director has material nonpublic information, the prohibition still applies.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Tipping of Material Nonpublic Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may disclose material nonpublic information concerning the Company to any outside person (including, without limitation, family members, analysts, individual investors and members of the investment community and news media), unless required as part of the regular duties of such employee, director or officer for the Company or authorized by the Compliance Officer. In any instance in which such information is disclosed to outsiders, the Company will take such steps as are necessary to preserve the confidentiality of the information, including requiring the outsider to agree in writing to comply with the terms of this Policy and&#47;or to sign a confidentiality agreement. All inquiries from outsiders regarding material nonpublic information about the Company must be forwarded to the Compliance Officer.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Trading Advice While In Possession Of Material Nonpublic Information</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may give trading advice of any kind about the Company to anyone while possessing material nonpublic information about the Company, except that employees, officers or directors should advise others not to trade if doing so might violate the law or this Policy. The Company strongly discourages all employees, officers and directors from giving trading advice concerning the Company to others even when the employees, officers and directors do not possess material nonpublic information about the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Hedging</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may acquire, sell, or trade in any interest or position relating to the future price of Company securities, such as a put option, a call option or a short sale (including a short sale &#8220;against the box&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Pledging</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may hold Company securities in a margin account or pledge Company securities as collateral for a loan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No &#8220;Shadow&#8221; Trading</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may (a)&#160;trade in the securities of any other public company while possessing material nonpublic information obtained in the course of service as an employee, officer or director, (b)&#160;&#8220;tip&#8221; or disclose such material nonpublic information concerning any other public company to anyone, or (c)&#160;give trading advice of any kind to anyone concerning any other public company while possessing such material nonpublic information.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Gifts</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may make a gift or other transfer without consideration of Company securities during a period when that employee, officer or director is not permitted to trade.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Social Media</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No employee, officer or director may participate, in any manner other than passive observation, in any of the investment or stock-related Internet &#8220;chat&#8221; rooms, blogs, social media sites or message boards relating to the Company.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Affiliate Entity Trading Restriction</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No entity over which an employee, officer or director has or shares voting or investment control may distribute securities of the Company to its limited partners, general partners or stockholders during a period when the employee, officer or director is not permitted to trade, unless the limited partners, general partners or stockholders of that entity have agreed in writing to hold the securities until the next open trading window described below.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Trading Windows and Blackout Periods</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Trading During Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. No director, officer or employee subject to a Blackout Period may trade in Company securities during a Blackout Period (i.e. a Quarterly Blackout Period or a Special Blackout Period). This Blackout restriction does not apply to transactions described below under &#8220;Transfers Pursuant To Rule 10b5-1&#8221; (Section VI.C) and &#8220;Transactions Not Involving a Purchase or Sale&#8221; (Section VI.E). Prior to trading, each director, officer and employee must also follow the other restrictions of this Policy, including obtaining approval of the trade as set forth in &#8220;Procedures for Approving Trades&#8221; below, if applicable.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Quarterly Blackout</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Trading in the Company&#8217;s securities is prohibited during the period beginning at the close of trading on the fifteen (15th) day of the last month of the then-current quarter (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Close Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) and ending on the third business day following the Company&#8217;s widespread public release of quarterly or year-end operating results (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Quarterly Blackout</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Special Blackout.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compliance Officer may designate certain event-driven blackout periods (the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Special Blackout Periods</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) that apply to particular individuals or groups of persons, for such time as is determined by the Compliance Officer. No director, officer or employee is permitted to disclose to anyone, either internally or externally, not subject to a Special Blackout Period the existence of a Special Blackout Period.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Procedures for Approving Trades</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Preclearance Required for Trades by Section 16 Parties, Access Persons, and Director-Level Employees</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Section 16 Party, an Access Person, and a Director-Level Employee may not trade in Company securities until such person receives approval to trade as further set forth below in the section titled &#8220;Preclearance Procedures.&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Preclearance Procedures</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Section 16 Party, an Access Person, and a Director-Level Employee may not engage in any transaction in Company securities without first obtaining pre-clearance of the transaction from the Compliance Officer and Chief Financial Officer in accordance with the following procedures&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The requestor must notify the Compliance Officer of the amount and nature of the proposed trade(s) no later than two business days prior to the Quarterly Close Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The requestor must certify to the Compliance Officer no earlier than two business days prior to the proposed trade(s) that&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">Such person is not in possession of material nonpublic information concerning the Company and, to such person&#8217;s knowledge, he or she will have no material nonpublic information as of the proposed trade date&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">Such person is acting in good faith&#59; and</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">the proposed trade(s) do not violate the trading restrictions of Section 16 of the Exchange Act, Rule 144 of the Securities Act (if applicable) or any other securities laws&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">The Executive Leadership Team member with oversight of such requestor (unless such requestor is a member of the Executive Leadership Team, in which case, this provision shall not be applicable) must certify to the Chief Financial Officer and Compliance Officer no earlier than two business days prior to the proposed trade(s) that such requestor is not in possession of material nonpublic information concerning the Company&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The Chief Financial Officer and the Compliance Officer must each approve the trade(s), in each case, at his or her discretion, and has certified such approval.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of the notifications, certifications, and approvals in this preclearance section, adequate notification or certification means that such notification or certification was completed via writing or via electronic means such as via the E-Trade platform. With respect to trades by the Chief Financial Officer or Compliance Officer, any proposed trades must be approved by the other officer, or the Chief Executive Officer.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Post-Approval Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. If the Chief Financial Officer and the Compliance Officer grant preclearance of a trade, the requestor may make the trade at any time within, but not after, five trading days of receipt of preclearance approval. If the requestor becomes aware of material nonpublic information concerning the Company before the trade is executed, the preclearance shall be void and the trade must not be completed.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Transfers Pursuant to Rule 10b5-1</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Rule 10b5-1 Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Section 16 Parties and Access Persons are prohibited from trading in Company Securities other than&#58; (i) pursuant to a written contract, letter of instruction or plan that complies with the requirements of Rule 10b5-1 and this Policy (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rule 10b5-1 Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or (ii) non-10b-5 Trades described below.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Rule 10b5-1 Plan Requirements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No trades shall be treated as having been made pursuant to a Rule 10b5-1 Plan under this Policy unless&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The Rule 10b5-1 Plan complies with the requirements of Rule 10b5-1&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The Compliance Officer has approved the Rule 10b5-1 Plan, and has certified such approval at least 90 days in advance of the first trade thereunder&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:28.23pt">The person establishing the Rule 10b5-1 Plan has certified to the Compliance Officer in writing of the terms of the proposed Rule 10b5-1 Plan no later than two business days prior to the Quarterly Close Date&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The Rule 10b5-1 Plan must have a term of at least twelve months but no longer than 24 months&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt">The person establishing the Rule 10b5-1 Plan has certified to the Compliance Officer in writing (and shall not have withdrawn such certification prior to such adoption) no earlier than two business days prior to the date that the Rule 10b5-1 Plan is formally established, that as of such date and as of the adoption date of the Rule 10b5-1 Plan&#58;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">such person is not and to such person&#8217;s knowledge, will not be, aware of material nonpublic information concerning the Company&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">all such trades to be made pursuant to Rule 10b5-1 Plan will be made in accordance with the applicable SEC rules&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">such person is adopting the Rule 10b5-1 Plan in good faith and not as part of a plan or scheme to evade the prohibitions of Section 10(b) of the Exchange Act and Rule 10b-5&#59;</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.12pt">such person will act in good faith with respect to the Rule 10b5-1 Plan throughout its duration&#59; and</font></div><div style="margin-bottom:12pt;padding-left:144pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">the Rule 10b5-1 Plan complies with the terms of this Policy.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the purposes of the notifications, certifications, and approvals in this Rule 10b5-1 Plan section, adequate notification or certification means that such notification or certification was completed via electronic means such as via the E-Trade platform. With respect to Rule 10b5-1 Plans by the Compliance Officer, any proposed plans must be approved by the Chief Financial Officer or the Chief Executive Officer.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No such approval by the Compliance Officer and&#47;or acknowledgement of the Rule 10b5-1 Plan by the Company shall be considered the Compliance Officer&#8217;s or the Company&#8217;s determination that the Rule 10b5-1 Plan satisfies the requirements of Rule 10b5-1. It is the sole responsibility of the person establishing the Rule 10b5-1 Plan to ensure that such plan complies with the requirements of Rule 10b5-1. The Company reserves the right to prevent any transactions in Company securities, even those pursuant to a Rule 10b5-1 Plan, if the Compliance Officer determines that prevention of such transaction is necessary to comply with securities law or contractual obligations.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Post-Plan Approval Matters</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The person establishing the Rule 10b5-1 Plan must notify the Compliance Officer promptly via email and withdraw the certification if any changes of circumstances prior to the adoption date of the Rule 10b5-1 Plan have or will render such certification to be inaccurate as of that time.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Cooling-Off Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The first trade under a Rule 10b5-1 Plan may not occur until the later of (A) the 91st day after the adoption of the Rule 10b5-1 Plan and (B) the third business day following the disclosure of the Company&#8217;s financial results in a Form 10-Q or Form 10-K for the completed fiscal quarter in which the Rule 10b5-1 Plan was adopted (but not to exceed 120 days following the adoption of the Rule 10b5-1 Plan), following the Compliance Officer&#8217;s approval of the Rule 10b5-1 Plan. This waiting period is referred to as the &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cooling-Off Period</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Rule 10b5-1 Plan Modifications&#59; Amendments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any Rule 10b5-1 Plan amendment, modification, or termination requires the prior approval of the Compliance Officer. Scheduled sales or purchases of Company pursuant to a Rule 10b5-1 Trading Plan will not be halted during the pendency of an amendment, suspension, or termination request. Modifying or changing the amount, price, or timing of the purchase or sale of Company securities underlying the Rule 10b5-1 Plan (or a modification or change to a written formula or algorithm, or computer program that affects the amount, price, or timing of the purchase or sale of such securities) (any such modification or change, a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plan Modification</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;) is deemed to be the same as terminating such person&#8217;s existing Rule 10b5-1 Plan and entering into a new Rule 10b5-1 Plan and must satisfy all of the conditions set forth above in &#8220;Rule 10b5-1 Plan Requirements&#8221; with respect to such amendment. As a result, the approval process for a Plan Modification is the same as the approval process for initially adopting a Rule 10b5-1 Plan, including being subject to a new Cooling-Off Period. The Company has the right at any time to require additional and&#47;or different requirements in connection with the amendment or termination of a trading plan in order to protect the requestor and the Company from potential liability.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company discourages making multiple Plan Modifications, as that may give the appearance that such person is trading on material nonpublic information under the guise of that plan. Plan Modifications can only be made during a trading window and not during any Blackout Period and only when such person is not in possession of material nonpublic information. For other modifications to a Rule 10b5-1 Plan, such requestor must notify the Compliance Officer of such modification in writing at least two business days prior to the modification and such modification must be approved by the Compliance Officer.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Obligation to Approve Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The existence of the foregoing approval procedures does not in any way obligate the Compliance Officer to approve any trades requested or to approve any Rule 10b5-1 Plan. The Compliance Officer may reject any trading requests or Rule 10b5-1 Plans at his or her sole reasonable discretion.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">No Single-Trade Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">. </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No person may adopt a single-trade Rule 10b5-1 Plan.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Multiple Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A person may have only one Rule 10b5-1 Plan in effect at any point in time, subject to the express approval of the Compliance Officer&#59; </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">provided that</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> a person may adopt a new Rule 10b5-1 Plan to replace an existing one, but only if the first scheduled trade under the new Rule 10b5-1 Plan does not occur before the later of (i) the last scheduled trade of the existing Rule 10b5-1 Plan&#59; and (ii) the one year anniversary of the adoption date of the existing Rule 10b5-1 Plan. For the avoidance of doubt, the new Rule 10b5-1 Plan must also comply with all other provisions governing Rule 10b5-1 Plans set forth in this Policy, including, without limitation, the Cooling-Off Period.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Other Trading Arrangements</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Employees, officers or directors are prohibited from entering into &#8220;non-Rule 10b5-1 trading arrangements&#8221; (as defined in Regulation S-K Item 408(c)) unless otherwise approved in advance by the Compliance Officer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">E.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Non-10b5 Trades</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Non-10b5 Trades Permissible for Section 16 Parties and Access Persons</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Section 16 Parties and Access Persons are prohibited from selling or disposing of Company Securities other than&#58; (i) pursuant to a Rule 10b5-1 Plan, or (ii) Non-10b-5 Trades.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Non-10b5 Trade Definition</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A Non-10b5 Trade is a (a)&#160;purchase of shares on the open market, (b)&#160;gift or transfer without consideration may be made by a Section 16 Party or Access Person to (i)&#160;any member of such person&#8217;s immediate family (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Gift Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), (ii)&#160;any trust for the direct or indirect benefit of such Section 16 Party or Access Person or the immediate family of such person (&#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Trust Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or (iii)&#160;any charitable foundation established by such Section 16 Party or Access Person over which such person has dispositive power (a &#8220;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Charitable Transfer</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;), or (c)&#160;gift or transfer by a Section 16 Party or Access Person to any donor advised fund or similar entity that is not a Rule 10b5-1 Plan.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Additional Requirements for Gifts, Trust Transfers, and Charitable Transfers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. In addition to the other restrictions on trading and the other procedures set forth in this Policy, in the case of a Gift Transfer, a Trust Transfer, or a Charitable Transfer, the transferee must agree in writing prior to receiving the transferred Company securities&#58; (i) to be bound by the terms of this Policy&#59; and (ii) to solely trade or dispose of the transferred Company securities pursuant to a Rule 10b5-1 Plan.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">F.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:27.13pt;text-decoration:underline">Transactions Not Involving A Purchase Or Sale</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Employee Stock Purchase Plan</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The trading prohibitions and restrictions set forth in this Policy do not apply to periodic wage withholding contributions by the Company or employees to any of the Company&#8217;s Employee Stock Purchase Plan that are used to purchase Company securities pursuant to the employees&#8217; advance instructions. However, no officers or employees may alter their instructions regarding the level of withholding or purchase by the employee of Company securities under such plan while in the possession of material nonpublic information. Any sale of securities acquired under such plan is subject to the prohibitions and restrictions of this Policy.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.67pt;text-decoration:underline">Equity Incentive Plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading prohibitions and restrictions of this Policy do not apply to the exercise of a stock option or settlement of a restricted stock unit or other form of equity award, or to the exercise of a tax withholding right pursuant to which an election has been made to have the Company withhold shares subject to such awards to satisfy tax withholding requirements, provided that such sales are arranged pursuant to advanced instructions from the compensation committee of the board of directors. The Policy does apply, however, to any sales of stock, including as part of a broker-assisted cashless exercise of an option, or any other market sale for the purpose of generating the cash needed to pay the exercise price of an option or satisfy tax withholding requirements.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:21.03pt">POTENTIAL CIVIL, CRIMINAL AND DISCIPLINARY SANCTIONS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Civil and Criminal Penalties</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The consequences of prohibited insider trading or tipping can be severe. Persons violating insider trading or tipping rules may be required to disgorge the profit made or the loss avoided, pay civil penalties up to three (3) times the profit made or loss avoided, pay a criminal fine of up to $5 million (individual violators) or $25 million (entity violators) and serve a jail term of up to twenty (20) years. The Company and&#47;or the supervisors of the person violating the rules may also be required to pay major civil or criminal penalties and could under certain circumstances be subject to private lawsuits by contemporaneous traders for damages suffered as a result of illegal insider trading or tipping by persons under the Company&#8217;s control.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Company Discipline</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Violation of this Policy or U.S. federal or state insider trading or tipping laws by any employee, officer or director may subject a director to dismissal proceedings and an officer or employee to disciplinary action by the Company up to and including termination for cause. A violation of this Policy is not necessarily the same as a violation of law. In fact, for the reasons indicated above, this Policy is intended to be broader than the law. The Company reserves the right to determine, in its own discretion and on the basis of the information available to it, whether this Policy has been violated. The Company may determine that specific conduct violates this Policy, whether or not the conduct also violates the law. It is not necessary for the Company to await the filing or conclusion of a civil or criminal action against the alleged violator before taking disciplinary action.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Reporting of Violations</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Any employee, officer or director who violates this Policy or any U.S. federal or state laws governing insider trading or tipping, or knows of any such violation by any other employee, officer or director, must report the violation immediately to the Compliance Officer. Alternatively, an employee, officer or director may report such violation anonymously through the procedures set forth in the Company&#8217;s Code of Conduct and Ethics for Employees and Directors.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:18.26pt">INQUIRIES</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please direct all inquiries regarding any of the provisions or procedures of this policy to the Compliance Officer.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:23.8pt">MISCELLANEOUS</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Waivers</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Chief Financial Officer and the Chief Legal Officer, acting together, may approve such waivers of this policy as they may deem appropriate provided that such waivers shall be immaterial and consistent with the spirit of this policy. Our board of directors reserves the right in its sole discretion to modify or grant waivers to this Policy. Any amendment or waiver may be publicly disclosed if required by applicable laws, rules and regulations. For the avoidance of doubt, unless explicitly stated by the board of directors, any waiver, amendment or modification of this Policy by the Board shall not be considered a waiver of the Company&#8217;s Code of Business Conduct and Ethics.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.57pt;text-decoration:underline">Effective Date</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The effective date of this Policy is January 1, 2025. The amendments to this Policy would not apply to any existing Rule 10b5-1 Plan that was entered into prior to the effective date of this Policy, except to the extent that a Plan Modification is made to such plan after the effective date of this Policy.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">C.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Communication</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This Policy will be communicated to all employees, officers and directors upon its amendment and restatement by the Company, and to all new employees, officers and directors at the start of their employment or relationship with the Company in accordance with the Company&#8217;s internal policies.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">D.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:26.01pt;text-decoration:underline">Amendments</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The Company may change these procedures or adopt such other procedures in the future as the Company considers appropriate in order to carry out the purposes of this Policy.</font></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:28.8pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:justify"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:29.669%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:68.131%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Term</font></div></td><td colspan="3" style="border-left:0.5pt solid #999999;border-right:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Definition</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Access Persons</font></div></td><td colspan="3" style="border-left:0.5pt solid #999999;border-right:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:37.72pt;padding-right:2.77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:27.12pt">all Dexcom Vice Presidents and above&#59; </font></div><div style="padding-left:37.72pt;padding-right:2.77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.9pt">all directors and above in the Legal, Finance and Corporate Development departments&#59; and </font></div><div style="padding-left:37.72pt;padding-right:2.77pt;text-indent:-36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:22.68pt">such other persons as determined by the Compliance Officer from time to time</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director-Level Employees</font></div></td><td colspan="3" style="border-left:0.5pt solid #999999;border-right:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each employee at a &#8220;director&#8221; level (or equivalent such as &#8220;principal&#8221;) or above who is not a Section&#160;16 Party or an Access Person.</font></div></td></tr><tr><td colspan="3" style="border-left:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Leadership Team</font></div></td><td colspan="3" style="border-left:0.5pt solid #999999;border-right:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Chief Legal Officer and Chief Financial Officer, and the Section&#160;16 Parties</font></div></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #999999;border-left:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Section 16 Parties</font></div></td><td colspan="3" style="border-bottom:0.5pt solid #999999;border-left:0.5pt solid #999999;border-right:0.5pt solid #999999;border-top:0.5pt solid #999999;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:2.77pt;padding-right:2.77pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The executive officers and directors who are subject to the additional reporting provisions and trading restrictions of Section&#160;16 of the Exchange Act, and the underlying rules and regulations promulgated by the SEC.</font></div></td></tr></table></div><div style="height:28.8pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-21.1
<SEQUENCE>7
<FILENAME>dxcm12312024-exhibit211.htm
<DESCRIPTION>EX-21.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i85dd7181af57407183915d7831969e3f_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 21.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DEXCOM, INC.</font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.427%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.373%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">SUBSIDIARY</font></div><div style="margin-bottom:2pt;padding-left:36pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">(Name under which subsidiary does business)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">JURISDICTION&#160;OF INCORPORATION</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;padding-left:36pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEXCOM INTERNATIONAL LIMITED</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="margin-bottom:1pt;padding-left:9pt;padding-right:2.25pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CYPRUS</font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROADRUNNER GREEN LIMITED</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">IRELAND</font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DEXCOM (MALAYSIA) SDN. BHD.</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><div style="padding-left:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MALAYSIA</font></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>8
<FILENAME>dxcm12312024-exhibit231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i0207ba43d79a47388deff9d531c7892c_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 23.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</font></div><div><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consent to the incorporation by reference in the following Registration Statements&#58;</font></div><div style="text-align:justify"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Registration Statement (Form S-3 Nos. 333-206619, 333-211101, and 333-261265) of DexCom, Inc.,</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Registration Statement (Form S-8 No. 333-204699) pertaining to the 2015 Equity Incentive Plan and the 2015 Employee Stock Purchase Plan of DexCom, Inc., and</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Registration Statement (Form S-8 Nos. 333-218562 and 333-234682) pertaining to the Amended and Restated 2015 Equity Incentive Plan of DexCom, Inc.&#59;</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of our reports dated February&#160;14, 2025, with respect to the consolidated financial statements and schedule of DexCom, Inc. and the effectiveness of internal control over financial reporting of DexCom, Inc. included in this Annual Report (Form 10-K) of DexCom, Inc. for the year ended December&#160;31, 2024.</font></div><div style="text-align:justify"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#47;s&#47; Ernst &#38; Young LLP</font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">February&#160;14, 2025</font></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>9
<FILENAME>dxcm12312024-exhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1b30d59cdd6a4e4887772faa8edb0c07_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Kevin R. Sayer, certify that&#58;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 14, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>10
<FILENAME>dxcm12312024-exhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i1fe0ad5ea23245499b384ba50cd4a34e_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Jereme M. Sylvain, certify that&#58;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. I have reviewed this annual report on Form 10-K of DexCom, Inc.&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c) evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d) disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div style="margin-top:9pt;text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font><br></font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:44.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.438%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.971%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.364%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 14, 2025</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>11
<FILENAME>dxcm12312024-exhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="if2e9abf2128147cd845d1edfd77df40d_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.1</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Kevin R. Sayer, President and Chief Executive Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the annual report on Form 10-K for the year ended December&#160;31, 2024 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;14, 2025</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; KEVIN R. SAYER</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Kevin R. Sayer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chairman of the Board of Directors, President and</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>12
<FILENAME>dxcm12312024-exhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8b9eb52f1431466288abea7025de22c9_1"></div><div style="min-height:42.75pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 32.2</font></div><div style="text-align:right"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18 U.S.C. SECTION 1350</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The undersigned, Jereme M. Sylvain, Executive Vice President and Chief Financial Officer of DexCom, Inc. (the &#8220;Company&#8221;), pursuant to 18 U.S.C. &#167;1350, hereby certifies that&#58;</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i) the annual report on Form 10-K for the year ended December&#160;31, 2024 of the Company (the &#8220;Report&#8221;) fully complies with the requirements of Section&#160;13(a) or 15(d) of the Securities Exchange Act of 1934&#59; and</font></div><div style="margin-top:5pt;text-align:justify;text-indent:24.75pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated&#58; February&#160;14, 2025</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:46.637%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; JEREME M. SYLVAIN</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jereme M. Sylvain</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Executive Vice President and Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>13
<FILENAME>dxcm-20241231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dxcm="http://www.dexcom.com/20241231" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.dexcom.com/20241231">
  <xs:import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/cyd-af-sub/2024" schemaLocation="https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="dxcm-20241231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.dexcom.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AuditInformation" roleURI="http://www.dexcom.com/role/AuditInformation">
        <link:definition>0000002 - Document - Audit Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheets" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets">
        <link:definition>9952151 - Statement - Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofOperations" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations">
        <link:definition>9952153 - Statement - Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofComprehensiveIncome" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome">
        <link:definition>9952154 - Statement - Consolidated Statements of Comprehensive Income</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofStockholdersEquity" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity">
        <link:definition>9952155 - Statement - Consolidated Statements of Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedStatementsofCashFlows" roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows">
        <link:definition>9952156 - Statement - Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies">
        <link:definition>9952157 - Disclosure - Organization and Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreements" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements">
        <link:definition>9952158 - Disclosure - Development and Other Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://www.dexcom.com/role/FairValueMeasurements">
        <link:definition>9952159 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformation" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation">
        <link:definition>9952160 - Disclosure - Balance Sheet Details and Other Financial Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://www.dexcom.com/role/Debt">
        <link:definition>9952161 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitments" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitments">
        <link:definition>9952162 - Disclosure - Leases and Other Commitments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Contingencies" roleURI="http://www.dexcom.com/role/Contingencies">
        <link:definition>9952163 - Disclosure - Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.dexcom.com/role/IncomeTaxes">
        <link:definition>9952164 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquity" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity">
        <link:definition>9952165 - Disclosure - Employee Benefit Plans and Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformation" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation">
        <link:definition>9952166 - Disclosure - Business Segment and Geographic Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS">
        <link:definition>9952167 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesPolicies" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies">
        <link:definition>9955511 - Disclosure - Organization and Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesTables" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables">
        <link:definition>9955512 - Disclosure - Organization and Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables">
        <link:definition>9955513 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationTables" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables">
        <link:definition>9955514 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://www.dexcom.com/role/DebtTables">
        <link:definition>9955515 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsTables" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsTables">
        <link:definition>9955516 - Disclosure - Leases and Other Commitments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesTables" roleURI="http://www.dexcom.com/role/IncomeTaxesTables">
        <link:definition>9955517 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityTables" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables">
        <link:definition>9955518 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationTables" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables">
        <link:definition>9955519 - Disclosure - Business Segment and Geographic Information (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>9955520 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails">
        <link:definition>9955521 - Disclosure - Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails">
        <link:definition>9955522 - Disclosure - Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails" roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails">
        <link:definition>9955523 - Disclosure - Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DevelopmentandOtherAgreementsDetails" roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails">
        <link:definition>9955524 - Disclosure - Development and Other Agreements (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails">
        <link:definition>9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>9955526 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails">
        <link:definition>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails">
        <link:definition>9955528 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails">
        <link:definition>9955529 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails">
        <link:definition>9955530 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails">
        <link:definition>9955531 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails">
        <link:definition>9955532 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails">
        <link:definition>9955533 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails">
        <link:definition>9955534 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails">
        <link:definition>9955535 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails">
        <link:definition>9955536 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails">
        <link:definition>9955537 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails">
        <link:definition>9955538 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails">
        <link:definition>9955539 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails">
        <link:definition>9955540 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails">
        <link:definition>9955541 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails" roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails">
        <link:definition>9955542 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" roleURI="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails">
        <link:definition>9955543 - Disclosure - Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofConvertedValueofNotesDetails" roleURI="http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails">
        <link:definition>9955544 - Disclosure - Debt - Schedule of Converted Value of Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails">
        <link:definition>9955545 - Disclosure - Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofKeyDetailsofConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails">
        <link:definition>9955546 - Disclosure - Debt - Schedule of Key Details of Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2023NoteHedgeDetails" roleURI="http://www.dexcom.com/role/Debt2023NoteHedgeDetails">
        <link:definition>9955547 - Disclosure - Debt - 2023 Note Hedge (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2023WarrantsDetails" roleURI="http://www.dexcom.com/role/Debt2023WarrantsDetails">
        <link:definition>9955548 - Disclosure - Debt - 2023 Warrants (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt2028CappedCallTransactionsDetails" roleURI="http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails">
        <link:definition>9955549 - Disclosure - Debt - 2028 Capped Call Transactions (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionActivityforSeniorConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails">
        <link:definition>9955550 - Disclosure - Debt - Conversion Activity for Senior Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtConversionRightsforSeniorsConvertibleNotesDetails" roleURI="http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails">
        <link:definition>9955551 - Disclosure - Debt - Conversion Rights for Seniors Convertible Notes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails">
        <link:definition>9955552 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtRevolvingCreditAgreementDetails" roleURI="http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails">
        <link:definition>9955553 - Disclosure - Debt - Revolving Credit Agreement (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsNarrativeDetails" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails">
        <link:definition>9955554 - Disclosure - Leases and Other Commitments - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails">
        <link:definition>9955555 - Disclosure - Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1">
        <link:definition>9955555 - Disclosure - Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails">
        <link:definition>9955556 - Disclosure - Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesandOtherCommitmentsOtherInformationDetails" roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails">
        <link:definition>9955557 - Disclosure - Leases and Other Commitments - Other Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails">
        <link:definition>9955558 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails">
        <link:definition>9955559 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails">
        <link:definition>9955560 - Disclosure - Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesNarrativeDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails">
        <link:definition>9955561 - Disclosure - Income Taxes - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails">
        <link:definition>9955562 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails">
        <link:definition>9955563 - Disclosure - Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails">
        <link:definition>9955564 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails">
        <link:definition>9955565 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails">
        <link:definition>9955566 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails">
        <link:definition>9955567 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails">
        <link:definition>9955568 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails" roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails">
        <link:definition>9955569 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationNarrativeDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails">
        <link:definition>9955570 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationSummaryDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails">
        <link:definition>9955571 - Disclosure - Business Segment and Geographic Information - Summary (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails">
        <link:definition>9955572 - Disclosure - Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BusinessSegmentandGeographicInformationGeographicInformationDetails" roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails">
        <link:definition>9955573 - Disclosure - Business Segment and Geographic Information - Geographic Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails">
        <link:definition>9955574 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="dxcm_AuditInformationAbstract" abstract="true" name="AuditInformationAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" abstract="false" name="DebtSecuritiesAvailableForSaleAndEquitySecurities" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" abstract="false" name="StockIssuedDuringPeriodSharesAchievementOfMilestone" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" abstract="false" name="StockIssuedDuringPeriodValueAchievementOfMilestones" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SharesReceivedFromExerciseOfNoteHedge" abstract="false" name="SharesReceivedFromExerciseOfNoteHedge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" abstract="false" name="StockIssuedDuringPeriodValueExerciseOfNoteHedge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" abstract="false" name="StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" abstract="false" name="StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" abstract="false" name="IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PaymentsForPurchasesOfCappedCallTransactions" abstract="false" name="PaymentsForPurchasesOfCappedCallTransactions" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" abstract="false" name="TreasuryStockValueBenefitReceivedFromNoteHedge" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" abstract="false" name="PrepaidAndOtherCurrentAssetsTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" abstract="false" name="ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" abstract="false" name="ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" abstract="false" name="ScheduleOfTreasuryShareActivityTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:textBlockItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ComputerSoftwareAndHardwareMember" abstract="true" name="ComputerSoftwareAndHardwareMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" abstract="false" name="MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_ContractPaymentTermsNumberofDays" abstract="false" name="ContractPaymentTermsNumberofDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_AmortizationPeriodForIncentiveCompensationCosts" abstract="false" name="AmortizationPeriodForIncentiveCompensationCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_CustomerAMember" abstract="true" name="CustomerAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CustomerBMember" abstract="true" name="CustomerBMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CustomerCMember" abstract="true" name="CustomerCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CustomerDMember" abstract="true" name="CustomerDMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CustomerEMember" abstract="true" name="CustomerEMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CollaborativeSalesBasedMilestoneMember" abstract="true" name="CollaborativeSalesBasedMilestoneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_RestrictedAndPerformanceStockUnitsMemberMember" abstract="true" name="RestrictedAndPerformanceStockUnitsMemberMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DevelopmentAgreementsTable" abstract="true" name="DevelopmentAgreementsTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsAxis" abstract="true" name="PaymentsUnderCollaborationAgreementsAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_PaymentsUnderCollaborationAgreementsDomain" abstract="true" name="PaymentsUnderCollaborationAgreementsDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementInitialPaymentMember" abstract="true" name="CollaborativeArrangementInitialPaymentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementMilestonePaymentsMember" abstract="true" name="CollaborativeArrangementMilestonePaymentsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_VerilyLifeSciencesMember" abstract="true" name="VerilyLifeSciencesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DevelopmentAgreementsLineItems" abstract="true" name="DevelopmentAgreementsLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_CollaborativeArrangementUpfrontFee" abstract="false" name="CollaborativeArrangementUpfrontFee" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_CollaborativeResearchAndDevelopmentFee" abstract="false" name="CollaborativeResearchAndDevelopmentFee" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" abstract="false" name="SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" abstract="false" name="PotentialFutureCommonStockIssuableSharesNewIssues" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" abstract="false" name="PotentialCommonStockIssuableOrIssuedSharesNewIssues" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_FairValueAssetsLevel3TransfersAmount" abstract="false" name="FairValueAssetsLevel3TransfersAmount" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2025Member" abstract="true" name="ConvertibleNotesDue2025Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2028Member" abstract="true" name="ConvertibleNotesDue2028Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ReceiverProductComponentMember" abstract="true" name="ReceiverProductComponentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" abstract="false" name="AccountsReceivableAllowanceForCreditLossCashDiscount" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PrepaidInventoryCurrent" abstract="false" name="PrepaidInventoryCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredCompensationPlanAssetsCurrent" abstract="false" name="DeferredCompensationPlanAssetsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_VerilyIntangibleMember" abstract="true" name="VerilyIntangibleMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AcquiredTechnologyAndIntellectualPropertyMember" abstract="true" name="AcquiredTechnologyAndIntellectualPropertyMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" abstract="false" name="AmortizationOfIntangibleAssetsIncludedInCostOfSales" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" abstract="false" name="AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LongTermDeposits" abstract="false" name="LongTermDeposits" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OtherLongTermAssets" abstract="false" name="OtherLongTermAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AccruedTaxAuditAndLegalFeesCurrent" abstract="false" name="AccruedTaxAuditAndLegalFeesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PharmacyRebatesCurrent" abstract="false" name="PharmacyRebatesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_AccruedWagesBonusesAndTaxesCurrent" abstract="false" name="AccruedWagesBonusesAndTaxesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" abstract="false" name="StandardProductWarrantyAccrualChargesToCostsAndExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OtherTaxLiabilitiesNoncurrent" abstract="false" name="OtherTaxLiabilitiesNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ConvertibleNotesDue2023Member" abstract="true" name="ConvertibleNotesDue2023Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_CashInterestExpenseAbstract" abstract="true" name="CashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_NonCashInterestExpenseAbstract" abstract="true" name="NonCashInterestExpenseAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" abstract="false" name="NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" abstract="false" name="DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_JPMWarrantTransactionsMember" abstract="true" name="JPMWarrantTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_BofAWarrantTransactionsMember" abstract="true" name="BofAWarrantTransactionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" abstract="false" name="StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" abstract="false" name="DebtInstrumentCapCallTransactionCapPricePerShare" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" abstract="false" name="DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" abstract="false" name="DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SharesReceivedFromBenefitOfNoteHedge" abstract="false" name="SharesReceivedFromBenefitOfNoteHedge" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermAxis" abstract="true" name="DebtInstrumentConversionTermAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermDomain" abstract="true" name="DebtInstrumentConversionTermDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermOneMember" abstract="true" name="DebtInstrumentConversionTermOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentConversionTermTwoMember" abstract="true" name="DebtInstrumentConversionTermTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_DebtInstrumentCovenantRepurchasePricePercentage" abstract="false" name="DebtInstrumentCovenantRepurchasePricePercentage" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" abstract="false" name="DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_LondonInterbankOfferedRateLIBOR1Member" abstract="true" name="LondonInterbankOfferedRateLIBOR1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" abstract="false" name="LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" abstract="false" name="LesseeOperatingLeaseNumberOfOptionsToExtend" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_ImpairedLongLivedAssetsFairValue" abstract="false" name="ImpairedLongLivedAssetsFairValue" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_LesseeOperatingLeasesLeaseCostAmortization" abstract="false" name="LesseeOperatingLeasesLeaseCostAmortization" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" abstract="false" name="RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_OtherStatesMember" abstract="true" name="OtherStatesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_OtherForeignMember" abstract="true" name="OtherForeignMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ResearchDevelopmentTaxCreditsMember" abstract="true" name="ResearchDevelopmentTaxCreditsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ForeignTaxCreditsMember" abstract="true" name="ForeignTaxCreditsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AMTTaxCreditsMember" abstract="true" name="AMTTaxCreditsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_UnusedExpiredFederalIncomeTaxCredits" abstract="false" name="UnusedExpiredFederalIncomeTaxCredits" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_PreferentialTaxRatePeriod" abstract="false" name="PreferentialTaxRatePeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_PossibleExtensionPeriodofTaxHoliday" abstract="false" name="PossibleExtensionPeriodofTaxHoliday" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" abstract="false" name="DeferredTaxAssetsFixedAssetsAndIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredTaxAssetsConvertibleDebt" abstract="false" name="DeferredTaxAssetsConvertibleDebt" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" abstract="false" name="DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxReconciliationPermanentItems" abstract="false" name="EffectiveIncomeTaxReconciliationPermanentItems" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" abstract="false" name="EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" abstract="false" name="EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_A401kPlanMember" abstract="true" name="A401kPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlan2015Member" abstract="true" name="EmployeeStockPurchasePlan2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_EquityIncentivePlan2015Member" abstract="true" name="EquityIncentivePlan2015Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_A2024ShareRepurchaseProgramMember" abstract="true" name="A2024ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" abstract="true" name="RestrictedStockUnitsRSUsAndPerformanceSharesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_AcceleratedShareRepurchaseASRMember" abstract="true" name="AcceleratedShareRepurchaseASRMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_ShareRepurchaseProgramMember" abstract="true" name="ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_EmployeePurchasePriceFloorPercentage" abstract="false" name="EmployeePurchasePriceFloorPercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" abstract="false" name="EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" abstract="false" name="AcceleratedShareRepurchaseAgreementAuthorizedAmount" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_A2022ShareRepurchaseProgramMember" abstract="true" name="A2022ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_A2023ShareRepurchaseProgramMember" abstract="true" name="A2023ShareRepurchaseProgramMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_A2028NotesMember" abstract="true" name="A2028NotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_IncreaseDecreaseInTreasuryStockRollForward" abstract="true" name="IncreaseDecreaseInTreasuryStockRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" abstract="true" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="dxcm_EmployeeStockPurchasePlanMember" abstract="true" name="EmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="dxcm_NumberOfPrimaryGeographicMarkets" abstract="false" name="NumberOfPrimaryGeographicMarkets" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="dxcm_RevenuePercentage" abstract="false" name="RevenuePercentage" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:percentItemType"/>
  <xs:element id="dxcm_PayrollRelatedExpenses" abstract="false" name="PayrollRelatedExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_ShareBasedPaymentArrangementOperatingExpense" abstract="false" name="ShareBasedPaymentArrangementOperatingExpense" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_SupplyExpensesAndClinicalTrials" abstract="false" name="SupplyExpensesAndClinicalTrials" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_EquipmentOfficeAndFacilityExpenses" abstract="false" name="EquipmentOfficeAndFacilityExpenses" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="dxcm_OtherCountriesMember" abstract="true" name="OtherCountriesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" abstract="false" name="SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>14
<FILENAME>dxcm-20241231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_a6adf2b7-1ad6-4e8f-a20e-cda98ddbd3a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_cd237360-486d-419b-b018-5329e285e8d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6adf2b7-1ad6-4e8f-a20e-cda98ddbd3a1" xlink:to="loc_us-gaap_LiabilitiesCurrent_cd237360-486d-419b-b018-5329e285e8d9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_0e413512-3a59-403a-870d-bfdcaf510876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6adf2b7-1ad6-4e8f-a20e-cda98ddbd3a1" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_0e413512-3a59-403a-870d-bfdcaf510876" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_66be1715-62a6-4154-b69a-3b3f49ad38b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6adf2b7-1ad6-4e8f-a20e-cda98ddbd3a1" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_66be1715-62a6-4154-b69a-3b3f49ad38b2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3dd210ed-18b4-461b-88de-0142180ac978" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_a6adf2b7-1ad6-4e8f-a20e-cda98ddbd3a1" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_3dd210ed-18b4-461b-88de-0142180ac978" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_82e40b81-4162-4d6d-bdf6-f298ab58ae96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_CommitmentsAndContingencies_82e40b81-4162-4d6d-bdf6-f298ab58ae96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_cce6d499-d2a9-4d80-98d6-ff9e6746e2c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_cce6d499-d2a9-4d80-98d6-ff9e6746e2c7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_0142372b-0421-4e44-8377-ca210ecf9a6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_CommonStockValueOutstanding_0142372b-0421-4e44-8377-ca210ecf9a6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d8aa395e-2a5f-4f4b-a71d-559e4636b94f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_d8aa395e-2a5f-4f4b-a71d-559e4636b94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1b10ed8f-90da-4df0-bf97-218b4b31a07e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_1b10ed8f-90da-4df0-bf97-218b4b31a07e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e5eb12b0-16ea-43b8-baad-bc5355b8a07b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_e5eb12b0-16ea-43b8-baad-bc5355b8a07b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_216d62e3-0825-4c69-81f5-7057a5f34919" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_911b79ab-70a2-48a8-ade4-b607a347346b" xlink:to="loc_us-gaap_TreasuryStockCommonValue_216d62e3-0825-4c69-81f5-7057a5f34919" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_abc0bb38-5d09-4fc9-8681-b093f1ffbcad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b0599f94-ddc0-481f-a5d6-1c0e6ae46d01" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abc0bb38-5d09-4fc9-8681-b093f1ffbcad" xlink:to="loc_us-gaap_Liabilities_b0599f94-ddc0-481f-a5d6-1c0e6ae46d01" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_6d8b66fd-360c-42d4-984c-582c0bf82be3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abc0bb38-5d09-4fc9-8681-b093f1ffbcad" xlink:to="loc_us-gaap_CommitmentsAndContingencies_6d8b66fd-360c-42d4-984c-582c0bf82be3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1784159-0b98-48d6-845d-b728d488fd19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_abc0bb38-5d09-4fc9-8681-b093f1ffbcad" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_f1784159-0b98-48d6-845d-b728d488fd19" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c57af09-9462-45a3-8d86-e69b0cbe8337" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_2c57af09-9462-45a3-8d86-e69b0cbe8337" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_fdf9da2f-6fbc-4093-b785-b84ec244b341" xlink:href="dxcm-20241231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_fdf9da2f-6fbc-4093-b785-b84ec244b341" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_c6a9deec-9897-4a46-ba65-e8a799bba403" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_c6a9deec-9897-4a46-ba65-e8a799bba403" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_e195fc97-2f9b-48b5-a704-3d2f09eb88bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:to="loc_us-gaap_InventoryNet_e195fc97-2f9b-48b5-a704-3d2f09eb88bf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bd2ac16d-b730-45a0-a6c0-269c7c2b8bbf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_11dacb6e-5c44-47d1-9fe7-f94aa1f7d8a3" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bd2ac16d-b730-45a0-a6c0-269c7c2b8bbf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_972e4278-1927-4ae0-a696-c35cda0afc14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_972e4278-1927-4ae0-a696-c35cda0afc14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_71ae0949-3740-4fb2-af69-d6b686338eaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_71ae0949-3740-4fb2-af69-d6b686338eaa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5b9ddae2-6d86-41b7-8934-b71c58654b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_5b9ddae2-6d86-41b7-8934-b71c58654b14" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_4a770a73-3ffd-46a4-8c45-14a58608bb84" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_4a770a73-3ffd-46a4-8c45-14a58608bb84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_854bc9fe-7660-4905-ab00-30f396baf611" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_1c367a53-5885-4f1e-ba9b-954834515c9c" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_854bc9fe-7660-4905-ab00-30f396baf611" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_0f643b6f-3e90-4f12-b092-ec6b006bf017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_0f643b6f-3e90-4f12-b092-ec6b006bf017" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_29182813-89d9-41d8-9157-7cfe5a153105" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_Goodwill_29182813-89d9-41d8-9157-7cfe5a153105" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_48774b41-7d13-4fad-b8ee-25780c5d08e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_48774b41-7d13-4fad-b8ee-25780c5d08e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2ddca695-250d-4a17-b6e5-5710be5cd045" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_2ddca695-250d-4a17-b6e5-5710be5cd045" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_f3c6d26a-6135-4e5e-a5b9-967fe6e6aca3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_f3c6d26a-6135-4e5e-a5b9-967fe6e6aca3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_a40b981a-00c2-465c-b124-07d8ad1e2367" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_AssetsCurrent_a40b981a-00c2-465c-b124-07d8ad1e2367" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_284d846e-ad9a-4663-a68b-4d0686a9c608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_a872d414-886b-4fec-8d25-8d69f14842e9" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_284d846e-ad9a-4663-a68b-4d0686a9c608" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_ee7a975b-389b-4720-a5d6-49b4757836e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f28dcbfa-ec0a-40dd-93a4-a210f49fadc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ee7a975b-389b-4720-a5d6-49b4757836e1" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_f28dcbfa-ec0a-40dd-93a4-a210f49fadc9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_5825ed13-d5da-408a-b9e7-200ac70f91c9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_ee7a975b-389b-4720-a5d6-49b4757836e1" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_5825ed13-d5da-408a-b9e7-200ac70f91c9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af89c0c6-7c05-4b63-a318-fcf40f21596e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_50571e17-aed1-4cab-8d1a-1e22dfe6bcea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af89c0c6-7c05-4b63-a318-fcf40f21596e" xlink:to="loc_us-gaap_OperatingIncomeLoss_50571e17-aed1-4cab-8d1a-1e22dfe6bcea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_06c212c5-d048-4b9c-9cd9-82741c706600" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_af89c0c6-7c05-4b63-a318-fcf40f21596e" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_06c212c5-d048-4b9c-9cd9-82741c706600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_9c074a93-3a14-4683-8cae-95a943b1dd7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_fef53b0b-4c51-457a-83fb-2044dbc8d608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9c074a93-3a14-4683-8cae-95a943b1dd7d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_fef53b0b-4c51-457a-83fb-2044dbc8d608" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a472ea09-adc3-4dfa-a563-2d4beb18384b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_9c074a93-3a14-4683-8cae-95a943b1dd7d" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_a472ea09-adc3-4dfa-a563-2d4beb18384b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_adbaca7d-c5cf-4749-af9b-6d639e326807" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_244dcee9-e1fc-49c1-bf2d-ace6e51df02f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adbaca7d-c5cf-4749-af9b-6d639e326807" xlink:to="loc_us-gaap_GrossProfit_244dcee9-e1fc-49c1-bf2d-ace6e51df02f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_05030bdd-e715-4013-86b2-dbef0ede287e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_adbaca7d-c5cf-4749-af9b-6d639e326807" xlink:to="loc_us-gaap_OperatingExpenses_05030bdd-e715-4013-86b2-dbef0ede287e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_a321447d-047a-4640-b0f1-391a3761bede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1d1c8a0b-70f6-46dc-8480-d8981901b932" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a321447d-047a-4640-b0f1-391a3761bede" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1d1c8a0b-70f6-46dc-8480-d8981901b932" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1d39fd02-2207-4eac-8716-ec5627c3449a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_a321447d-047a-4640-b0f1-391a3761bede" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1d39fd02-2207-4eac-8716-ec5627c3449a" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ef1ac250-be97-4cc5-93a2-763680873b46" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_89051a2c-b377-451b-a084-e8ca13980438" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ef1ac250-be97-4cc5-93a2-763680873b46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_89051a2c-b377-451b-a084-e8ca13980438" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d8eb2c9c-37ee-4b0f-b0ca-9e5ab34a759f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_ef1ac250-be97-4cc5-93a2-763680873b46" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_d8eb2c9c-37ee-4b0f-b0ca-9e5ab34a759f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_b92da816-720e-470f-8066-bc5b192ff64f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_0b9b3187-1602-4d2f-9a54-9fda5c492645" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b92da816-720e-470f-8066-bc5b192ff64f" xlink:to="loc_us-gaap_NetIncomeLoss_0b9b3187-1602-4d2f-9a54-9fda5c492645" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f123d8ae-a079-4b67-8b62-c9c6355d975b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_b92da816-720e-470f-8066-bc5b192ff64f" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_f123d8ae-a079-4b67-8b62-c9c6355d975b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_69ad80c9-0800-4003-8b48-052cbf3d5111" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_69ad80c9-0800-4003-8b48-052cbf3d5111" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a0b1581-1997-4445-a47c-11bc8a4d3326" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_5a0b1581-1997-4445-a47c-11bc8a4d3326" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_695f8644-9e8b-4583-88f4-82a69e0f3b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_695f8644-9e8b-4583-88f4-82a69e0f3b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_07b8c6bc-4295-4c7f-a1a0-1099eaed5037" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_07b8c6bc-4295-4c7f-a1a0-1099eaed5037" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_dc648800-fc61-4b25-bd62-d6be88f84d4d" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_dc648800-fc61-4b25-bd62-d6be88f84d4d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_01ee39e6-7fbf-49b3-acb4-75152a0591f5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_191b12aa-c732-48fc-8393-118e395d9e50" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_01ee39e6-7fbf-49b3-acb4-75152a0591f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e65ff766-bc24-456b-b179-284fcd87464b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_e65ff766-bc24-456b-b179-284fcd87464b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_40941dcb-1fe6-4fdc-948c-c9717fcf07fa" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_40941dcb-1fe6-4fdc-948c-c9717fcf07fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_f68edfed-3bfd-4870-95d7-73174bbbed0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_f68edfed-3bfd-4870-95d7-73174bbbed0e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02fb4e92-26b2-4577-81fa-3157d097d161" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_02fb4e92-26b2-4577-81fa-3157d097d161" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3efe826e-c259-494b-b32d-85f51a17e6ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_NetIncomeLoss_3efe826e-c259-494b-b32d-85f51a17e6ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_4bca833a-779c-46a5-8283-d587b35e522c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_ShareBasedCompensation_4bca833a-779c-46a5-8283-d587b35e522c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dcd242ed-5d9d-44a6-a216-dfc93b6be1ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dcd242ed-5d9d-44a6-a216-dfc93b6be1ae" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a7f2d41c-9a64-4d3c-8d56-993999c4c7be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a7f2d41c-9a64-4d3c-8d56-993999c4c7be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_8d0cef62-669f-48b0-b0dd-c5144a673797" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_8d0cef62-669f-48b0-b0dd-c5144a673797" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_dde005f5-75bd-4017-94d4-a900106aa018" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_PaidInKindInterest_dde005f5-75bd-4017-94d4-a900106aa018" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0e2a49b2-c0f8-4b9c-b0c2-7a14e3171796" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_0e2a49b2-c0f8-4b9c-b0c2-7a14e3171796" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_d4ba0788-0617-4cfb-a769-a01b9c6b7e21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_d4ba0788-0617-4cfb-a769-a01b9c6b7e21" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_9976e95f-be5f-4fcb-b427-c19da5a2dea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:calculationArc order="13" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_4a5ae1b7-fe12-4bf2-82cf-65295eb4e46d" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_9976e95f-be5f-4fcb-b427-c19da5a2dea9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_170be9a2-040e-4ce9-bbe3-2d45cb36432a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dc4fa982-e569-4bb3-9f94-0fe217b9c0fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_170be9a2-040e-4ce9-bbe3-2d45cb36432a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_dc4fa982-e569-4bb3-9f94-0fe217b9c0fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_9029434d-c77b-4e7c-8993-8ef11d72aa57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_170be9a2-040e-4ce9-bbe3-2d45cb36432a" xlink:to="loc_us-gaap_RestrictedCash_9029434d-c77b-4e7c-8993-8ef11d72aa57" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3edbd738-54b0-4bfc-a414-fbe4b3d11490" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_110417f7-e84e-46c9-bbe0-7fbbb4b15d15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3edbd738-54b0-4bfc-a414-fbe4b3d11490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_110417f7-e84e-46c9-bbe0-7fbbb4b15d15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4cedcad5-66d8-46b3-92d9-1ef62bd180ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3edbd738-54b0-4bfc-a414-fbe4b3d11490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4cedcad5-66d8-46b3-92d9-1ef62bd180ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e27c0ff6-c918-4697-91ee-5740807e5593" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3edbd738-54b0-4bfc-a414-fbe4b3d11490" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_e27c0ff6-c918-4697-91ee-5740807e5593" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3d2e75a-df8e-412d-9c8d-572c346028e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3edbd738-54b0-4bfc-a414-fbe4b3d11490" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_c3d2e75a-df8e-412d-9c8d-572c346028e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1be66ec3-fac8-470f-b205-ce678460e9d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_1be66ec3-fac8-470f-b205-ce678460e9d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0eb67459-f257-4201-96ed-541df219b706" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_0eb67459-f257-4201-96ed-541df219b706" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2de951a8-c880-41c7-9e6e-8cd9e7b15634" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_2de951a8-c880-41c7-9e6e-8cd9e7b15634" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7be8c72e-9b75-4ff9-bb0f-d70bee59347c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_7be8c72e-9b75-4ff9-bb0f-d70bee59347c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_f9127192-8e7c-4649-8c67-3f36c2df41e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_f9127192-8e7c-4649-8c67-3f36c2df41e3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0de65bed-eb11-418d-8967-faa26c6b1ae2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_60d9ff32-7c08-4e80-93c1-d5a308579306" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_0de65bed-eb11-418d-8967-faa26c6b1ae2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81bb6547-3d77-4dc3-a2c7-f89a45b98df0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dfe03f9-dafc-4231-b17e-56eb0162df93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81bb6547-3d77-4dc3-a2c7-f89a45b98df0" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_0dfe03f9-dafc-4231-b17e-56eb0162df93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e019332d-b929-494b-97db-91af1731d5ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_81bb6547-3d77-4dc3-a2c7-f89a45b98df0" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_e019332d-b929-494b-97db-91af1731d5ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_d360fae0-96f1-4e54-ae0d-5c7d64685078" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_98c179e9-6a5e-461b-ad09-a60e2f513759" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_d360fae0-96f1-4e54-ae0d-5c7d64685078" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_98c179e9-6a5e-461b-ad09-a60e2f513759" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_dd46bcc0-4436-4356-9370-06d281819b56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_d360fae0-96f1-4e54-ae0d-5c7d64685078" xlink:to="loc_us-gaap_NetIncomeLoss_dd46bcc0-4436-4356-9370-06d281819b56" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_a261ed43-b718-4cc6-a3f4-be5c554ef6dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_f3caa1d3-954d-445e-9f57-e624cc86cfec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a261ed43-b718-4cc6-a3f4-be5c554ef6dc" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_f3caa1d3-954d-445e-9f57-e624cc86cfec" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_765987b7-cc52-4df5-a3c6-03cfa89cadc7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a261ed43-b718-4cc6-a3f4-be5c554ef6dc" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_765987b7-cc52-4df5-a3c6-03cfa89cadc7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_8663708f-34af-4742-ae10-94f48931ffe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a261ed43-b718-4cc6-a3f4-be5c554ef6dc" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_8663708f-34af-4742-ae10-94f48931ffe6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a81b67ec-cf67-4ff9-a38e-0aa6c8a909e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsFairValueDisclosure_a261ed43-b718-4cc6-a3f4-be5c554ef6dc" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_a81b67ec-cf67-4ff9-a38e-0aa6c8a909e9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af34395c-1fd6-4359-b47a-3a4d132da067" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_57bbe614-6fca-41c9-9955-768b95e2a9ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af34395c-1fd6-4359-b47a-3a4d132da067" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_57bbe614-6fca-41c9-9955-768b95e2a9ca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_450c712c-54a5-4cc7-b2b2-33ba0b60c6aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af34395c-1fd6-4359-b47a-3a4d132da067" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_450c712c-54a5-4cc7-b2b2-33ba0b60c6aa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2032b5ba-34ce-46ca-a2f0-65a1e447103c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_af34395c-1fd6-4359-b47a-3a4d132da067" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_2032b5ba-34ce-46ca-a2f0-65a1e447103c" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_fc7a970f-6b80-4b5f-aabe-350c9fe10104" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_fe4214ba-6f45-4042-b3d2-21f12acaaa07" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_fc7a970f-6b80-4b5f-aabe-350c9fe10104" xlink:to="loc_us-gaap_AccountsReceivableGross_fe4214ba-6f45-4042-b3d2-21f12acaaa07" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f6afc26e-0a65-40b3-871c-72aa54a7c470" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsReceivableNet_fc7a970f-6b80-4b5f-aabe-350c9fe10104" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_f6afc26e-0a65-40b3-871c-72aa54a7c470" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_b05b143d-2cf9-4ca0-bd76-8b555ac6aa32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_385e2b93-20c0-4cbe-84ac-a310149e33b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b05b143d-2cf9-4ca0-bd76-8b555ac6aa32" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_385e2b93-20c0-4cbe-84ac-a310149e33b1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3a3156b0-4e1b-44fd-a80d-154d8e8cbad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b05b143d-2cf9-4ca0-bd76-8b555ac6aa32" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_3a3156b0-4e1b-44fd-a80d-154d8e8cbad0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5780fe3d-eb0a-4976-b8fc-74e63cc3d6c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_b05b143d-2cf9-4ca0-bd76-8b555ac6aa32" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_5780fe3d-eb0a-4976-b8fc-74e63cc3d6c8" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_25ea4755-11f8-4250-b8bf-dce84cd01fb3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_25ea4755-11f8-4250-b8bf-dce84cd01fb3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_b7371694-22bf-44f1-9fbb-c581e95aab74" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:to="loc_us-gaap_OtherAssetsCurrent_b7371694-22bf-44f1-9fbb-c581e95aab74" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_0e8120fa-e9e0-4397-a08a-0f72616e6391" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:to="loc_us-gaap_IncomeTaxesReceivable_0e8120fa-e9e0-4397-a08a-0f72616e6391" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_0fb15510-f538-459d-b123-42ce05aaf0e4" xlink:href="dxcm-20241231.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:to="loc_dxcm_PrepaidInventoryCurrent_0fb15510-f538-459d-b123-42ce05aaf0e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_a6e681a9-9f56-452a-b199-e68e85d4508f" xlink:href="dxcm-20241231.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_418829e5-f925-4027-91d4-8abc4b448f15" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_a6e681a9-9f56-452a-b199-e68e85d4508f" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9783b1e9-390d-4e99-a1ee-d33205a6ec3a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_37aaf184-2b0e-4a69-af0f-d575ad8e5b71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_9783b1e9-390d-4e99-a1ee-d33205a6ec3a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_37aaf184-2b0e-4a69-af0f-d575ad8e5b71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cd8eae42-3421-4092-a1fb-2a0f6308d40e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_11b16fd5-64a2-48b0-9adf-7e125edc03f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cd8eae42-3421-4092-a1fb-2a0f6308d40e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_11b16fd5-64a2-48b0-9adf-7e125edc03f2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_111f672f-48fe-4a41-9c97-fd12a204530e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_cd8eae42-3421-4092-a1fb-2a0f6308d40e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_111f672f-48fe-4a41-9c97-fd12a204530e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d9a9ee0-a97d-412f-a58e-e9a1d7c598e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8eb0ff6f-e0d7-453a-a187-6f6d5f37a946" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d9a9ee0-a97d-412f-a58e-e9a1d7c598e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_8eb0ff6f-e0d7-453a-a187-6f6d5f37a946" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f69b18c5-d998-470c-a617-e238e518d546" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_1d9a9ee0-a97d-412f-a58e-e9a1d7c598e3" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_f69b18c5-d998-470c-a617-e238e518d546" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_4227e813-a4d1-407e-b78f-7295da3cf858" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_c022c167-aa10-42e0-b8ce-381c5c3ef072" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_4227e813-a4d1-407e-b78f-7295da3cf858" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_c022c167-aa10-42e0-b8ce-381c5c3ef072" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_f6c80934-31bd-45ad-921f-c71c578b235d" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_4227e813-a4d1-407e-b78f-7295da3cf858" xlink:to="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_f6c80934-31bd-45ad-921f-c71c578b235d" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e155562c-0a87-47be-bb98-5e7e56a9ff87" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_e155562c-0a87-47be-bb98-5e7e56a9ff87" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8081f582-ef93-400a-9d59-57157bcef8ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_8081f582-ef93-400a-9d59-57157bcef8ff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6efd3102-b675-483a-a901-ab8f345137cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_6efd3102-b675-483a-a901-ab8f345137cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0e5f161a-01fa-4d81-b9a1-fa08cf460aa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_0e5f161a-01fa-4d81-b9a1-fa08cf460aa0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_19a7f3ac-8b47-4890-8eb9-e76bf5ec0f3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_19a7f3ac-8b47-4890-8eb9-e76bf5ec0f3d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_783786ec-3cff-493e-a682-2b74f9e8a429" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_e2e82121-fce9-4b9d-8e93-88f17b82cf3f" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_783786ec-3cff-493e-a682-2b74f9e8a429" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_abd15afc-7c5f-43ad-bea7-0e0d9ec001dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_2d25ec88-b3df-430c-9749-27ef407bc948" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_abd15afc-7c5f-43ad-bea7-0e0d9ec001dc" xlink:to="loc_us-gaap_LongTermInvestments_2d25ec88-b3df-430c-9749-27ef407bc948" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_6fce9b5b-416c-4fa1-bd37-b53e746e1667" xlink:href="dxcm-20241231.xsd#dxcm_LongTermDeposits"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_abd15afc-7c5f-43ad-bea7-0e0d9ec001dc" xlink:to="loc_dxcm_LongTermDeposits_6fce9b5b-416c-4fa1-bd37-b53e746e1667" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_4db4d99c-8f53-457f-80f3-907285c1aa73" xlink:href="dxcm-20241231.xsd#dxcm_OtherLongTermAssets"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherAssetsNoncurrent_abd15afc-7c5f-43ad-bea7-0e0d9ec001dc" xlink:to="loc_dxcm_OtherLongTermAssets_4db4d99c-8f53-457f-80f3-907285c1aa73" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_547a037d-0bf5-4c06-80be-594ca85c2852" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_547a037d-0bf5-4c06-80be-594ca85c2852" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent_d6a9e83c-a637-420d-ac42-9de64b95e4d1" xlink:href="dxcm-20241231.xsd#dxcm_AccruedTaxAuditAndLegalFeesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent_d6a9e83c-a637-420d-ac42-9de64b95e4d1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebatesCurrent_c3789fee-d6f7-4230-a1ce-269a1a1a5a46" xlink:href="dxcm-20241231.xsd#dxcm_PharmacyRebatesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_dxcm_PharmacyRebatesCurrent_c3789fee-d6f7-4230-a1ce-269a1a1a5a46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_b48190eb-4385-4284-8248-f7fcdaa343ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_b48190eb-4385-4284-8248-f7fcdaa343ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_a6ef3386-b70a-4ce3-ae09-391b0be46a95" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_a6ef3386-b70a-4ce3-ae09-391b0be46a95" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_6e8e037c-1ed1-460d-95ce-0d823275644f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_6e8e037c-1ed1-460d-95ce-0d823275644f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9d52f0f7-abc8-4fe8-9dd5-8d93cb5a1fa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_63ed33be-8ef8-46ea-b1df-264167e1878a" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_9d52f0f7-abc8-4fe8-9dd5-8d93cb5a1fa5" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_85a9ef3e-9169-4338-99b8-2e5c334c54aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_89b131fc-f291-4583-bd62-23357b2ccfc2" xlink:href="dxcm-20241231.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_85a9ef3e-9169-4338-99b8-2e5c334c54aa" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_89b131fc-f291-4583-bd62-23357b2ccfc2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_36034806-0429-403f-91a5-997374ced0e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_85a9ef3e-9169-4338-99b8-2e5c334c54aa" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_36034806-0429-403f-91a5-997374ced0e2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_904ee385-d990-4f6c-ab28-edd8fd6672cb" xlink:href="dxcm-20241231.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_904ee385-d990-4f6c-ab28-edd8fd6672cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_5b0195f5-bcf2-41fd-b1b5-5633d35b5fb1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_5b0195f5-bcf2-41fd-b1b5-5633d35b5fb1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b40bab54-b877-4ef0-9ebf-82667fa92bbe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_b40bab54-b877-4ef0-9ebf-82667fa92bbe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f8ad7b82-3d84-4a68-9559-0a6162f218ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_f8ad7b82-3d84-4a68-9559-0a6162f218ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_25d677c6-dd02-4e7a-9837-13f4b86f9e19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetRetirementObligation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_3c606ab7-e6cf-458a-b63d-dae9b022e3c7" xlink:to="loc_us-gaap_AssetRetirementObligation_25d677c6-dd02-4e7a-9837-13f4b86f9e19" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_1ce606ef-f75a-44c8-ade2-6c63e323dd76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_f9b144e4-da4b-45ef-88e8-f0ad6cc12d93" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_1ce606ef-f75a-44c8-ade2-6c63e323dd76" xlink:to="loc_us-gaap_InterestExpenseNonoperating_f9b144e4-da4b-45ef-88e8-f0ad6cc12d93" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_4b016969-77b4-463f-85cd-e7ff4f7d9a49" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_1ce606ef-f75a-44c8-ade2-6c63e323dd76" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_4b016969-77b4-463f-85cd-e7ff4f7d9a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_3422a41d-029b-4136-9072-7b1c085c0c57" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense_1ce606ef-f75a-44c8-ade2-6c63e323dd76" xlink:to="loc_us-gaap_OtherNonoperatingExpense_3422a41d-029b-4136-9072-7b1c085c0c57" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_4465cd4f-29f2-4a70-aef4-0d45d321ab7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_190c222c-11b6-4bdd-afda-a27123ed6154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_4465cd4f-29f2-4a70-aef4-0d45d321ab7f" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_190c222c-11b6-4bdd-afda-a27123ed6154" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_a7fac6f7-2c8f-435e-b45e-a9f0336f0cea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ConvertibleNotesPayable_4465cd4f-29f2-4a70-aef4-0d45d321ab7f" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_a7fac6f7-2c8f-435e-b45e-a9f0336f0cea" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_0e6ff7f9-da49-4340-baa3-6490fc7c9c72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_abd439c7-ddbe-48f3-85f0-a0216062797e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_0e6ff7f9-da49-4340-baa3-6490fc7c9c72" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_abd439c7-ddbe-48f3-85f0-a0216062797e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_a29fdceb-a20c-4a78-8bbb-8d5e3f21ad33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InterestExpenseDebt_0e6ff7f9-da49-4340-baa3-6490fc7c9c72" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_a29fdceb-a20c-4a78-8bbb-8d5e3f21ad33" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0c50458-a6e9-4851-a674-c56353c9e81a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9f6b8893-e696-4e63-bca2-ce068788388b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0c50458-a6e9-4851-a674-c56353c9e81a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_9f6b8893-e696-4e63-bca2-ce068788388b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_314ba67b-0bdd-40d4-ad88-dafbd2851c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_f0c50458-a6e9-4851-a674-c56353c9e81a" xlink:to="loc_us-gaap_OperatingLeaseLiability_314ba67b-0bdd-40d4-ad88-dafbd2851c2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bef6d142-9f2b-4e96-8468-3a17e0497246" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6aa014ee-b6c9-449c-b5b5-6ac6a92b1292" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bef6d142-9f2b-4e96-8468-3a17e0497246" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_6aa014ee-b6c9-449c-b5b5-6ac6a92b1292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_d05c22eb-f251-4e0c-a38f-5527218c98a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_bef6d142-9f2b-4e96-8468-3a17e0497246" xlink:to="loc_us-gaap_FinanceLeaseLiability_d05c22eb-f251-4e0c-a38f-5527218c98a1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_bc417618-6597-4825-a82f-ca10b6d83dc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_60118cf0-671d-4355-8b2a-8712a925d054" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_bc417618-6597-4825-a82f-ca10b6d83dc2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_60118cf0-671d-4355-8b2a-8712a925d054" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_806f95de-7752-4c30-b8f9-3c8311ab9b00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_bc417618-6597-4825-a82f-ca10b6d83dc2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_806f95de-7752-4c30-b8f9-3c8311ab9b00" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_a05feaec-f5f1-40ab-9c70-2b045416795d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_dd2965ca-4daf-401f-9027-647ab43d3ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a05feaec-f5f1-40ab-9c70-2b045416795d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_dd2965ca-4daf-401f-9027-647ab43d3ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9392fb23-1bc2-4a33-8cbe-f2288efc8d98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_a05feaec-f5f1-40ab-9c70-2b045416795d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_9392fb23-1bc2-4a33-8cbe-f2288efc8d98" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_679a9634-7cb8-47ee-8a27-0b80e898a8d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_679a9634-7cb8-47ee-8a27-0b80e898a8d6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_42a9954c-0cf7-4bde-93da-d30aa36b2364" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_42a9954c-0cf7-4bde-93da-d30aa36b2364" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fccd5a31-c411-4be9-87df-1955c8b3c889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_fccd5a31-c411-4be9-87df-1955c8b3c889" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_63771c84-fa6c-4b70-89af-04bfe27facdf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_63771c84-fa6c-4b70-89af-04bfe27facdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7853f7ba-fe3e-4e09-a374-25f0eccc4294" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7853f7ba-fe3e-4e09-a374-25f0eccc4294" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7b34d54b-153a-455f-a7f3-fabe89973dd0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1d3c2992-0b49-4608-8e54-d8a29cbd443e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7b34d54b-153a-455f-a7f3-fabe89973dd0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c1ea2ccc-f74a-4e0b-8a6f-173a56e67e2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_c1ea2ccc-f74a-4e0b-8a6f-173a56e67e2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dc13f42d-2d91-4b88-9de4-ac3ac8e0b476" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_dc13f42d-2d91-4b88-9de4-ac3ac8e0b476" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3e758df6-202b-4b9c-8373-8bc487a9093a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_3e758df6-202b-4b9c-8373-8bc487a9093a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6ace3b38-7803-47bf-b4bf-63789e8b117a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_6ace3b38-7803-47bf-b4bf-63789e8b117a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fdd8d996-0d1c-4af4-ab0d-9b9b01c3f15b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_fdd8d996-0d1c-4af4-ab0d-9b9b01c3f15b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd3abef4-4886-4dfc-87aa-e8f9aeb90213" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_c12da41a-6221-4ee1-9ebd-0d59390704b7" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd3abef4-4886-4dfc-87aa-e8f9aeb90213" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_50546cb2-6f4e-499c-87f9-5f9b964036ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_50546cb2-6f4e-499c-87f9-5f9b964036ce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_bb2b72f6-5137-4c3c-8feb-5a329591adcf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_bb2b72f6-5137-4c3c-8feb-5a329591adcf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_d21df0ad-aaa8-49d8-8565-2c8177d59d71" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_OperatingLeaseCost_d21df0ad-aaa8-49d8-8565-2c8177d59d71" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_7a20ddfd-22f8-4654-9c66-b9a84b491f56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_7a20ddfd-22f8-4654-9c66-b9a84b491f56" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_4bb8ceb0-e6d6-4a41-8d85-3d60f76d2643" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_ShortTermLeaseCost_4bb8ceb0-e6d6-4a41-8d85-3d60f76d2643" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_7a46707d-285a-4e7e-b42b-01e1f492dda2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_5e5bfb00-a535-44ca-8979-597eed09003e" xlink:to="loc_us-gaap_VariableLeaseCost_7a46707d-285a-4e7e-b42b-01e1f492dda2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b357da68-db7c-4dcf-bff8-45d6be3ccd68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a4bd349d-7a9b-49a3-9416-ec924b486aa9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b357da68-db7c-4dcf-bff8-45d6be3ccd68" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a4bd349d-7a9b-49a3-9416-ec924b486aa9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3e435217-3972-46a0-a250-b983b90afde9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_b357da68-db7c-4dcf-bff8-45d6be3ccd68" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_3e435217-3972-46a0-a250-b983b90afde9" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8a21829f-6f50-44a4-8713-f25bfc6519e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d4fa6769-b138-4508-87a4-393271e6709e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8a21829f-6f50-44a4-8713-f25bfc6519e1" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_d4fa6769-b138-4508-87a4-393271e6709e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_41f768bb-23fd-4fa5-ae86-92817f67c4a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8a21829f-6f50-44a4-8713-f25bfc6519e1" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_41f768bb-23fd-4fa5-ae86-92817f67c4a3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7ecacab3-9362-4143-b8b3-fc91dd173c6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_8a21829f-6f50-44a4-8713-f25bfc6519e1" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_7ecacab3-9362-4143-b8b3-fc91dd173c6b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_6482685d-8b05-4552-bade-aed9abeaf8ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1d16e8b1-9caa-4e6e-adfd-651ed9e2442e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6482685d-8b05-4552-bade-aed9abeaf8ad" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_1d16e8b1-9caa-4e6e-adfd-651ed9e2442e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f8a409e1-8876-4a86-bd0a-a499e1b169d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_6482685d-8b05-4552-bade-aed9abeaf8ad" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_f8a409e1-8876-4a86-bd0a-a499e1b169d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_23ad9cea-9a93-49b8-b452-17925f034378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4056ee19-b583-45f1-a2e6-2e5f3c84d344" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_23ad9cea-9a93-49b8-b452-17925f034378" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_4056ee19-b583-45f1-a2e6-2e5f3c84d344" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b058da4f-f5d5-42c2-b236-96409722df6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_23ad9cea-9a93-49b8-b452-17925f034378" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_b058da4f-f5d5-42c2-b236-96409722df6f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4bddb1ca-29da-4e29-96cd-6774b0707e51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_23ad9cea-9a93-49b8-b452-17925f034378" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_4bddb1ca-29da-4e29-96cd-6774b0707e51" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c0292dc3-d899-443e-84c0-7f2477d00690" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_c0292dc3-d899-443e-84c0-7f2477d00690" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_639c85e7-159b-4d95-b450-d3ab1c829d96" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_639c85e7-159b-4d95-b450-d3ab1c829d96" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_c99cb3ca-f093-4d22-a9d0-79afea6be088" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_c99cb3ca-f093-4d22-a9d0-79afea6be088" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0549aa24-31b2-4f48-ab06-d0b3d9e7b508" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_0549aa24-31b2-4f48-ab06-d0b3d9e7b508" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_c9fa2f74-e27a-460c-9f34-b0c92b08bea1" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_c9fa2f74-e27a-460c-9f34-b0c92b08bea1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_958e1590-8f62-4022-add4-f9968e7d21c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_958e1590-8f62-4022-add4-f9968e7d21c0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_bb9ba346-3145-4d93-99d1-577d7c265e84" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsGross_f0b1ab55-598d-4e72-8d41-5ee7ffcb72d3" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_bb9ba346-3145-4d93-99d1-577d7c265e84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6735bb0d-f9df-4849-9097-82eca25efbdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_ae075c46-64e0-451b-a719-e5452ea5cd98" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6735bb0d-f9df-4849-9097-82eca25efbdc" xlink:to="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_ae075c46-64e0-451b-a719-e5452ea5cd98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_4e2554a9-e97a-4071-b4b2-902f8ed83585" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities_6735bb0d-f9df-4849-9097-82eca25efbdc" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_4e2554a9-e97a-4071-b4b2-902f8ed83585" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e84084aa-adf8-499f-a7cc-23d7d9ba31cb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_a19fc407-a8bb-49b9-8908-5c984cbf3e18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e84084aa-adf8-499f-a7cc-23d7d9ba31cb" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_a19fc407-a8bb-49b9-8908-5c984cbf3e18" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_23f88624-9483-416b-8668-d3964f3a4e47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_e84084aa-adf8-499f-a7cc-23d7d9ba31cb" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_23f88624-9483-416b-8668-d3964f3a4e47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_11a471bd-30aa-4553-8ef1-98a2acbf7af2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ed5cd3e-f98e-4391-b03a-a39a10882a3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_11a471bd-30aa-4553-8ef1-98a2acbf7af2" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_7ed5cd3e-f98e-4391-b03a-a39a10882a3e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_7b33ce9a-4d66-42c4-9bd2-0a3985f36966" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_DeferredTaxAssetsNet_11a471bd-30aa-4553-8ef1-98a2acbf7af2" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_7b33ce9a-4d66-42c4-9bd2-0a3985f36966" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a9c941f4-3ea2-4d58-b850-a1538c4df9be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_a9c941f4-3ea2-4d58-b850-a1538c4df9be" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bb3948de-3704-4dea-bee5-7996d7fe573c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_bb3948de-3704-4dea-bee5-7996d7fe573c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_a448d347-149a-4a39-92d8-1093da70fc5a" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_a448d347-149a-4a39-92d8-1093da70fc5a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_502d3af5-3b74-4486-aa7f-174f55af644c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_502d3af5-3b74-4486-aa7f-174f55af644c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_37b4ca52-afff-408b-8922-f1688603c1f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_37b4ca52-afff-408b-8922-f1688603c1f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c4c1a24a-cbc4-4410-a58f-c6993fe2eff2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_c4c1a24a-cbc4-4410-a58f-c6993fe2eff2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a780858c-7565-4af4-8721-222415491817" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_a780858c-7565-4af4-8721-222415491817" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6c7588b4-7de0-40e2-8047-c2d3df7724b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_6c7588b4-7de0-40e2-8047-c2d3df7724b9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a94a4253-b258-494f-8255-8210666723e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_a94a4253-b258-494f-8255-8210666723e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_2cc82fc7-70f2-4657-ba31-5920852111a2" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_2cc82fc7-70f2-4657-ba31-5920852111a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_09db702c-0220-4bb4-8740-d58bfe42890b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_09db702c-0220-4bb4-8740-d58bfe42890b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_884bdb83-7d34-4894-9b04-010b8d39ceb6" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit_d1878a83-a62f-4456-a4ce-9c015399a434" xlink:to="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_884bdb83-7d34-4894-9b04-010b8d39ceb6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"/>
  <link:calculationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationTechnologyAndDataProcessing_c8f79a9d-f87e-47d4-95f4-a59cb5eebcc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InformationTechnologyAndDataProcessing"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_InformationTechnologyAndDataProcessing_c8f79a9d-f87e-47d4-95f4-a59cb5eebcc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SupplyExpensesAndClinicalTrials_e5f872bc-1fea-4611-a64e-8761ee229217" xlink:href="dxcm-20241231.xsd#dxcm_SupplyExpensesAndClinicalTrials"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_dxcm_SupplyExpensesAndClinicalTrials_e5f872bc-1fea-4611-a64e-8761ee229217" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_fdf978e8-f8cf-41ed-9f06-96235a46dd9e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_fdf978e8-f8cf-41ed-9f06-96235a46dd9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquipmentOfficeAndFacilityExpenses_f3d71d44-ec1d-49dc-b3b2-b5bec8f8f3ed" xlink:href="dxcm-20241231.xsd#dxcm_EquipmentOfficeAndFacilityExpenses"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_dxcm_EquipmentOfficeAndFacilityExpenses_f3d71d44-ec1d-49dc-b3b2-b5bec8f8f3ed" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PayrollRelatedExpenses_ac20efec-b5b4-4025-880e-1d90502b6d43" xlink:href="dxcm-20241231.xsd#dxcm_PayrollRelatedExpenses"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_dxcm_PayrollRelatedExpenses_ac20efec-b5b4-4025-880e-1d90502b6d43" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_4c1e174a-4ba9-404f-954d-63b85435afe2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_4c1e174a-4ba9-404f-954d-63b85435afe2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_e2c3fd23-df8c-469c-ace2-a2df31a6751b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_DepreciationAndAmortization_e2c3fd23-df8c-469c-ace2-a2df31a6751b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_a0c60a8a-6860-4719-bf8e-ec8245a237dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:calculationArc order="8" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_ProfessionalFees_a0c60a8a-6860-4719-bf8e-ec8245a237dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_1ab71e9d-a267-4039-8927-d003bfe18756" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_MarketingExpense_1ab71e9d-a267-4039-8927-d003bfe18756" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense_20b3a042-704e-4d4b-b314-da66e5d2ba35" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedPaymentArrangementOperatingExpense"/>
    <link:calculationArc order="10" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense_20b3a042-704e-4d4b-b314-da66e5d2ba35" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense_a8d34b40-62b0-486e-8c41-1884b6b480b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_3f662dd9-899b-4ca0-8860-661e02c07e1a" xlink:to="loc_us-gaap_TravelAndEntertainmentExpense_a8d34b40-62b0-486e-8c41-1884b6b480b8" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>15
<FILENAME>dxcm-20241231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:to="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:to="loc_us-gaap_EquityComponentDomain_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:to="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_046096b9-0226-4046-987f-738fc0020cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_CommonStockMember_046096b9-0226-4046-987f-738fc0020cd1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ec6a6189-dc2f-47ab-9443-e59a722d4dad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ec6a6189-dc2f-47ab-9443-e59a722d4dad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed70c1e-4230-476d-9790-a808719271c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed70c1e-4230-476d-9790-a808719271c4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c0415b0d-a0ba-4148-a72c-37b39bef7654" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_RetainedEarningsMember_c0415b0d-a0ba-4148-a72c-37b39bef7654" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_67e7a610-442e-4b41-95b9-d0fa4227914d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_67e7a610-442e-4b41-95b9-d0fa4227914d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_404702a7-5a0f-44ff-9326-a52a0d3152b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_404702a7-5a0f-44ff-9326-a52a0d3152b7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82bf7a55-71f5-495c-a235-5f6420acfa73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockholdersEquity_82bf7a55-71f5-495c-a235-5f6420acfa73" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_b5a1c583-76c5-4f4d-937c-a565e282d815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_b5a1c583-76c5-4f4d-937c-a565e282d815" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_755c9447-cb31-42ba-936f-c971fb0fa079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_755c9447-cb31-42ba-936f-c971fb0fa079" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4904eb0d-c834-4194-93f2-fd09d88b5cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4904eb0d-c834-4194-93f2-fd09d88b5cb6" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_33a3ddcb-64f0-4737-8910-9724bc4e42ba" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_33a3ddcb-64f0-4737-8910-9724bc4e42ba" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_7bc6e96f-f76b-4690-8fac-3e6f8ec8daa4" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_7bc6e96f-f76b-4690-8fac-3e6f8ec8daa4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c32efb37-46e4-4f77-97be-e9750d41b2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c32efb37-46e4-4f77-97be-e9750d41b2d0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_34e3e7ff-56b0-44d6-8b96-cdbfe26fb876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_34e3e7ff-56b0-44d6-8b96-cdbfe26fb876" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_5f8fce6e-01fc-4215-a837-ffdde1f20fa1" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_5f8fce6e-01fc-4215-a837-ffdde1f20fa1" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c0e0109a-d45f-4669-beec-0481aa108085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c0e0109a-d45f-4669-beec-0481aa108085" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5feed974-3e33-4bc3-b830-8170c5dc3373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5feed974-3e33-4bc3-b830-8170c5dc3373" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_185d093f-e7ec-4824-b15d-5453f007a445" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_185d093f-e7ec-4824-b15d-5453f007a445" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_626b8753-3451-49fa-bc5b-d9a91daea061" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_626b8753-3451-49fa-bc5b-d9a91daea061" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_94890ad5-fa6b-4a68-93ac-605294d8c8c5" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_94890ad5-fa6b-4a68-93ac-605294d8c8c5" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_3eb86bf4-0b6e-490f-96a3-6313f58c3b4a" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_3eb86bf4-0b6e-490f-96a3-6313f58c3b4a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_c7b45163-bcd4-4484-bb03-366449411ef4" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_c7b45163-bcd4-4484-bb03-366449411ef4" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d7745500-c9fe-4573-94f1-3d3804b5043d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d7745500-c9fe-4573-94f1-3d3804b5043d" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_d7d2fc9a-e89d-4cf1-b7f4-bafadb8b9a49" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_d7d2fc9a-e89d-4cf1-b7f4-bafadb8b9a49" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d57a20f-656d-4f90-8c99-d6a84a41ce40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_NetIncomeLoss_3d57a20f-656d-4f90-8c99-d6a84a41ce40" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6c8b3a52-9652-42f1-8afd-a69ac9d5293b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6c8b3a52-9652-42f1-8afd-a69ac9d5293b" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a829544e-112a-43ff-b378-f51361c9e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4887ee6b-28e9-483c-886b-1119fa8b7363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_65af15f4-1dba-4bf1-a403-9c05a302771b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_65af15f4-1dba-4bf1-a403-9c05a302771b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ComputerSoftwareAndHardwareMember_42c91add-db56-4678-a0f0-38df3ed04ef9" xlink:href="dxcm-20241231.xsd#dxcm_ComputerSoftwareAndHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_dxcm_ComputerSoftwareAndHardwareMember_42c91add-db56-4678-a0f0-38df3ed04ef9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8ec89eef-ed9e-4942-8dae-e0bd385d772d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8ec89eef-ed9e-4942-8dae-e0bd385d772d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4a36c506-8520-4ffa-8603-a87327114b11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4a36c506-8520-4ffa-8603-a87327114b11" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_93bbd369-e4cd-4123-af67-30eb19af8b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_BuildingMember_93bbd369-e4cd-4123-af67-30eb19af8b67" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:to="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_98126eae-8032-420e-873d-e5da0565861c_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:to="loc_srt_RangeMember_98126eae-8032-420e-873d-e5da0565861c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:to="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49e80cab-0f19-440f-9880-ae7bfbef3a16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:to="loc_srt_MinimumMember_49e80cab-0f19-440f-9880-ae7bfbef3a16" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a85ef769-d0e8-41d7-9e58-6411b4a7ba7f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:to="loc_srt_MaximumMember_a85ef769-d0e8-41d7-9e58-6411b4a7ba7f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_e5a600e8-4aea-4ef0-8aca-8d1b65820eee" xlink:href="dxcm-20241231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_e5a600e8-4aea-4ef0-8aca-8d1b65820eee" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_16a3878a-adc4-41b4-8740-278868deeb98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_16a3878a-adc4-41b4-8740-278868deeb98" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ba026b24-b2dc-44d2-8d91-226be69d658b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ba026b24-b2dc-44d2-8d91-226be69d658b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_739f9f30-babe-4d0d-ba4e-1ab987a3c84d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_739f9f30-babe-4d0d-ba4e-1ab987a3c84d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_35f3adf0-d259-4b46-8638-e053740a6044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_35f3adf0-d259-4b46-8638-e053740a6044" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_1843f479-a388-4543-905c-0d911e482a66" xlink:href="dxcm-20241231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_1843f479-a388-4543-905c-0d911e482a66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_e8b6213f-46c5-465b-adfd-a393cc4e8592" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_UnbilledContractsReceivable_e8b6213f-46c5-465b-adfd-a393cc4e8592" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_80c53704-ca89-4b44-9179-0743ff9dea63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_80c53704-ca89-4b44-9179-0743ff9dea63" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_6962694b-1f0a-4133-9853-acc9b3ef9245" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_6962694b-1f0a-4133-9853-acc9b3ef9245" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b1c49d43-8120-49f4-bad3-0e70870c1314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_AdvertisingExpense_b1c49d43-8120-49f4-bad3-0e70870c1314" xlink:type="arc" order="9"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:to="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c16d4e89-d433-4d07-b58e-331d5eecd193" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c16d4e89-d433-4d07-b58e-331d5eecd193" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c842aacc-f4f0-4a56-8b97-eab8d9dbc791_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_c842aacc-f4f0-4a56-8b97-eab8d9dbc791_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c40b0198-4fd1-4c86-8155-dd3bac6ec7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:to="loc_us-gaap_SalesRevenueNetMember_c40b0198-4fd1-4c86-8155-dd3bac6ec7b2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_777b6d2c-90b8-4e7e-a811-a2bfabc43ada" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:to="loc_us-gaap_AccountsReceivableMember_777b6d2c-90b8-4e7e-a811-a2bfabc43ada" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_65fbaa1c-c772-4e78-b9a5-fb3295f51269_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:to="loc_srt_NameOfMajorCustomerDomain_65fbaa1c-c772-4e78-b9a5-fb3295f51269_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:to="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember_bf35c075-6ac7-41b3-8701-dd30050c4ff3" xlink:href="dxcm-20241231.xsd#dxcm_CustomerAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerAMember_bf35c075-6ac7-41b3-8701-dd30050c4ff3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember_90e63c4e-5d34-4394-91a9-c5192769f057" xlink:href="dxcm-20241231.xsd#dxcm_CustomerBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerBMember_90e63c4e-5d34-4394-91a9-c5192769f057" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember_21682a78-1d46-4d93-b303-ca373f014d3f" xlink:href="dxcm-20241231.xsd#dxcm_CustomerCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerCMember_21682a78-1d46-4d93-b303-ca373f014d3f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember_7061bf68-0469-4e39-9015-10827fc202bd" xlink:href="dxcm-20241231.xsd#dxcm_CustomerDMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerDMember_7061bf68-0469-4e39-9015-10827fc202bd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerEMember_284070f6-2f28-41aa-8070-e3d0b9191671" xlink:href="dxcm-20241231.xsd#dxcm_CustomerEMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerEMember_284070f6-2f28-41aa-8070-e3d0b9191671" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8397a1d0-acad-4d62-b4f7-07698a805960" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8397a1d0-acad-4d62-b4f7-07698a805960" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_272b2b9b-8c8f-407a-9621-ea7ebd6e1307_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_272b2b9b-8c8f-407a-9621-ea7ebd6e1307_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeSalesBasedMilestoneMember_d536288e-0a80-4bf3-82d9-b496db296811" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeSalesBasedMilestoneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_dxcm_CollaborativeSalesBasedMilestoneMember_d536288e-0a80-4bf3-82d9-b496db296811" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_f92beda3-794e-48cf-9ea0-8272ce92d3c3" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedAndPerformanceStockUnitsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_f92beda3-794e-48cf-9ea0-8272ce92d3c3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_2200fa92-e0d5-459c-8b25-3455ed278a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_2200fa92-e0d5-459c-8b25-3455ed278a02" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8f649025-2bf1-4e54-a89b-d9b04367b030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_us-gaap_WarrantMember_8f649025-2bf1-4e54-a89b-d9b04367b030" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28cc6e3d-fc8e-4475-a65e-18dfbdd4f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_NetIncomeLoss_28cc6e3d-fc8e-4475-a65e-18dfbdd4f97f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8d737849-12c6-4d2d-ad43-60efe7e3699a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8d737849-12c6-4d2d-ad43-60efe7e3699a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4519a741-0d32-48fa-842b-a355c8bcb075" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4519a741-0d32-48fa-842b-a355c8bcb075" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0d84f662-1ceb-48e8-b8fb-40428d3941d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_EarningsPerShareBasic_0d84f662-1ceb-48e8-b8fb-40428d3941d3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_30f983dc-b4f9-4fea-8db7-05682f8f42e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_30f983dc-b4f9-4fea-8db7-05682f8f42e1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_088db6db-6b5f-41f6-9814-fbf2bbd98597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_088db6db-6b5f-41f6-9814-fbf2bbd98597" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a0ce440b-8785-4663-bb5e-4d8004bbb8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a0ce440b-8785-4663-bb5e-4d8004bbb8b4" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1cffda3e-2491-4105-8d1b-6aeeee780e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1cffda3e-2491-4105-8d1b-6aeeee780e3e" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1f2baa34-f6fc-4f71-939a-657d2a29a4b6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_1f2baa34-f6fc-4f71-939a-657d2a29a4b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_15ef4c77-bb5f-4bf7-997d-eaeed418d990" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedAndPerformanceStockUnitsMemberMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_15ef4c77-bb5f-4bf7-997d-eaeed418d990" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d26ff49d-a129-4d8b-803b-3a597c1fd90e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d26ff49d-a129-4d8b-803b-3a597c1fd90e" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_2266ea78-e347-49db-9e6e-5e2f00aa7921_default" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_2266ea78-e347-49db-9e6e-5e2f00aa7921_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_5fe4618d-5e67-4058-a023-3c7530dfaa9b" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_5fe4618d-5e67-4058-a023-3c7530dfaa9b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_9677e18f-0949-4062-afa8-42f083561285" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_9677e18f-0949-4062-afa8-42f083561285" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_8e1d48f1-f60f-41e9-9727-a7dc70faf7c7" xlink:href="dxcm-20241231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:to="loc_dxcm_VerilyLifeSciencesMember_8e1d48f1-f60f-41e9-9727-a7dc70faf7c7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4add974c-4ba1-4404-9b3a-4be75a1b017a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_4add974c-4ba1-4404-9b3a-4be75a1b017a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_12b420b8-ecd7-4c23-a5b3-6697f2f1d17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:to="loc_us-gaap_CollaborativeArrangementMember_12b420b8-ecd7-4c23-a5b3-6697f2f1d17e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_e02cf2dc-7b76-4e0e-b609-7b9327ff718d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_SharePrice_e02cf2dc-7b76-4e0e-b609-7b9327ff718d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_cedbe9e5-0a2d-447d-86e2-3855b849163c" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_cedbe9e5-0a2d-447d-86e2-3855b849163c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_65d27cf8-0b60-45b9-bbe0-f58d274dc8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_65d27cf8-0b60-45b9-bbe0-f58d274dc8ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_ed0e8909-9834-49e9-bd92-fb106a9f06ed" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_ed0e8909-9834-49e9-bd92-fb106a9f06ed" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_7593d1c0-8623-42a5-a81f-461bf989e229" xlink:href="dxcm-20241231.xsd#dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_7593d1c0-8623-42a5-a81f-461bf989e229" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e284034-9736-4217-8a88-eb8c41a43d73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e284034-9736-4217-8a88-eb8c41a43d73" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_35ca8f28-ab28-4bd9-b163-9103622d843a" xlink:href="dxcm-20241231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_35ca8f28-ab28-4bd9-b163-9103622d843a" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a0429af7-40a1-4adc-9fa9-d4d4c1c9da75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a0429af7-40a1-4adc-9fa9-d4d4c1c9da75" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_508581da-a3ee-49d3-90b1-fab38e4ce9d8" xlink:href="dxcm-20241231.xsd#dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_508581da-a3ee-49d3-90b1-fab38e4ce9d8" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b8c0032d-18fa-42aa-ad66-38a373d86ea7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b8c0032d-18fa-42aa-ad66-38a373d86ea7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b8377ebd-ebd5-460a-b225-08120dc5218f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b8377ebd-ebd5-460a-b225-08120dc5218f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_502fedd7-ffec-4b8a-b1bf-bfc0635328ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_CommercialPaperMember_502fedd7-ffec-4b8a-b1bf-bfc0635328ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5b43f056-dcac-4ebc-9f16-bc599a1e3bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5b43f056-dcac-4ebc-9f16-bc599a1e3bdb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a17332b3-d77e-41e5-b254-3a2553e9a6ce_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_a17332b3-d77e-41e5-b254-3a2553e9a6ce_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8949837e-0e69-4959-926f-bca968ec5077" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8949837e-0e69-4959-926f-bca968ec5077" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d3e11920-489b-44d9-9d2b-830e741617c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d3e11920-489b-44d9-9d2b-830e741617c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8584a2f1-981a-4023-aab6-169ccd7788d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8584a2f1-981a-4023-aab6-169ccd7788d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_c3f490b6-0456-4397-843d-b04b457f257f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_c3f490b6-0456-4397-843d-b04b457f257f" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf95755-454d-42e1-931b-e53de226d8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf95755-454d-42e1-931b-e53de226d8a2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_6b62f4a7-1a54-418d-8bf3-6396083278b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_6b62f4a7-1a54-418d-8bf3-6396083278b0" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2cf521ab-ed41-447b-971f-bc8db1a57199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2cf521ab-ed41-447b-971f-bc8db1a57199" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4442d95a-3544-42fe-9dd0-f12dbd893eee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4442d95a-3544-42fe-9dd0-f12dbd893eee" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:to="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_7368e53d-ee2a-4edc-b6c7-957dedd4d49e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:to="loc_us-gaap_HedgingDesignationDomain_7368e53d-ee2a-4edc-b6c7-957dedd4d49e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b07950a-f729-48b0-b810-e2422ad2f8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b07950a-f729-48b0-b810-e2422ad2f8fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_bbd2e302-234b-4eab-b5dd-f4f780f09b15_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_bbd2e302-234b-4eab-b5dd-f4f780f09b15_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b00af712-9fa2-4182-8986-f2786d4f743e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b00af712-9fa2-4182-8986-f2786d4f743e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_0726461a-bc14-445f-9a31-b7d54fcaf169" xlink:href="dxcm-20241231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_0726461a-bc14-445f-9a31-b7d54fcaf169" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_dbcc0fd0-299f-43c7-bae1-742693eb2695" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_DerivativeTermOfContract_dbcc0fd0-299f-43c7-bae1-742693eb2695" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_88c4690e-e103-4084-9c4a-73914f7e1200" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_DerivativeNotionalAmount_88c4690e-e103-4084-9c4a-73914f7e1200" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_32a4a8a2-3522-42db-b060-36b8a75ead6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_32a4a8a2-3522-42db-b060-36b8a75ead6f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7526b8ed-5601-45f3-a1a3-54986066208b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7526b8ed-5601-45f3-a1a3-54986066208b" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:to="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_e77ba11b-0a6e-4762-985e-aefdb55285d7" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_e77ba11b-0a6e-4762-985e-aefdb55285d7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_19b5e4b3-d946-4c0d-be62-cb17076663bd" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_19b5e4b3-d946-4c0d-be62-cb17076663bd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_efe2fd54-ee13-4009-b863-f1351f1c9238_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_efe2fd54-ee13-4009-b863-f1351f1c9238_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a89f5791-2e02-4f3b-b320-51b408ccfb80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:to="loc_us-gaap_SeniorNotesMember_a89f5791-2e02-4f3b-b320-51b408ccfb80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c1cef473-f778-441c-a83b-9033964eb739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c1cef473-f778-441c-a83b-9033964eb739" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1576ddd3-327e-4788-b81f-4c4332f140dd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_1576ddd3-327e-4788-b81f-4c4332f140dd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3f75031c-3b3a-4271-8664-4607bb962ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3f75031c-3b3a-4271-8664-4607bb962ea9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f03174ec-f4c7-457e-9249-892ef57ec2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_CommercialPaperMember_f03174ec-f4c7-457e-9249-892ef57ec2d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e4d0a9f8-894c-4e4f-aa10-1434166b06b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e4d0a9f8-894c-4e4f-aa10-1434166b06b7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4b462081-1dcb-4d23-9031-e732b533d941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4b462081-1dcb-4d23-9031-e732b533d941" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b79c9538-ad36-4671-aca8-5067593fda80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b79c9538-ad36-4671-aca8-5067593fda80" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_276a964e-bc9b-4fdf-a4b2-fbefe2837e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_276a964e-bc9b-4fdf-a4b2-fbefe2837e2a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9de463aa-f3c2-4807-99d7-d37016a75ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9de463aa-f3c2-4807-99d7-d37016a75ef6" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:to="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5879afbc-1445-4303-8466-331b201315b6_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:to="loc_srt_ProductsAndServicesDomain_5879afbc-1445-4303-8466-331b201315b6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:to="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember_51ee9639-7df2-4323-adcf-e54678b78a67" xlink:href="dxcm-20241231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:to="loc_dxcm_ReceiverProductComponentMember_51ee9639-7df2-4323-adcf-e54678b78a67" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:to="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_acc4f9f6-5588-4743-8677-2623005337cd_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:to="loc_srt_RangeMember_acc4f9f6-5588-4743-8677-2623005337cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:to="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bd97d792-df53-4fa7-a2fd-73fd2b72120d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:to="loc_srt_MinimumMember_bd97d792-df53-4fa7-a2fd-73fd2b72120d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7d34c81-cd50-48eb-97a9-63320cfce98d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:to="loc_srt_MaximumMember_b7d34c81-cd50-48eb-97a9-63320cfce98d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57d61bec-79a0-4487-96d3-d009311b5717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_DebtInstrumentTerm_57d61bec-79a0-4487-96d3-d009311b5717" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0fbe6ca7-5682-4391-aff9-24a58d4552f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0fbe6ca7-5682-4391-aff9-24a58d4552f4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cc76f9f4-423c-44d8-a2fe-8e4be4602f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cc76f9f4-423c-44d8-a2fe-8e4be4602f14" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d78b5c3-c8e4-4c7c-8727-284902f3aaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d78b5c3-c8e4-4c7c-8727-284902f3aaf1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_40d16c2f-7366-432a-8198-c512509b8fe0" xlink:href="dxcm-20241231.xsd#dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_40d16c2f-7366-432a-8198-c512509b8fe0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_d8d1ae96-2668-475e-9169-788ef6c05a76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_InventoryWriteDown_d8d1ae96-2668-475e-9169-788ef6c05a76" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9371c5be-1a51-436d-a9cd-eeec0084948e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_Depreciation_9371c5be-1a51-436d-a9cd-eeec0084948e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d1d86af6-0755-42fd-975c-8a656716eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d1d86af6-0755-42fd-975c-8a656716eddd" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ab3e06-079c-498a-92a8-9f2439f151f8_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_02ab3e06-079c-498a-92a8-9f2439f151f8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_7fc6b444-62f5-4641-ae04-2768af7e6366" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_LandMember_7fc6b444-62f5-4641-ae04-2768af7e6366" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_74f48817-9be9-464d-9768-c75f1d1ae09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_BuildingMember_74f48817-9be9-464d-9768-c75f1d1ae09f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_458a82e4-80f2-40d5-8b89-93f91bec6ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_458a82e4-80f2-40d5-8b89-93f91bec6ea5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ComputerSoftwareAndHardwareMember_b8ac53e8-e0e0-44e2-9983-760c2d44ede6" xlink:href="dxcm-20241231.xsd#dxcm_ComputerSoftwareAndHardwareMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_dxcm_ComputerSoftwareAndHardwareMember_b8ac53e8-e0e0-44e2-9983-760c2d44ede6" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_c256d3d7-f832-4078-ab18-94172c40088a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_EquipmentMember_c256d3d7-f832-4078-ab18-94172c40088a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0d48e08d-1220-40dd-9cb7-86ed2cc5c62c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0d48e08d-1220-40dd-9cb7-86ed2cc5c62c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_18ec28fd-63a5-428d-9655-8c018d7c9ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_ConstructionInProgressMember_18ec28fd-63a5-428d-9655-8c018d7c9ce1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_79633342-20a6-4e11-b725-51436c5168fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_79633342-20a6-4e11-b725-51436c5168fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_703ffaea-0b21-42b0-ab7b-8e6ab1ecafe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_703ffaea-0b21-42b0-ab7b-8e6ab1ecafe6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_34ed0374-6dd8-4f42-88c1-263fabdc0380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_34ed0374-6dd8-4f42-88c1-263fabdc0380" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_060ee32a-cce7-40fe-976b-02454a340adc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_060ee32a-cce7-40fe-976b-02454a340adc" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyIntangibleMember_7569d236-63d6-4efb-83f1-6205f5c9090b" xlink:href="dxcm-20241231.xsd#dxcm_VerilyIntangibleMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_dxcm_VerilyIntangibleMember_7569d236-63d6-4efb-83f1-6205f5c9090b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6aa12adf-4ea5-4676-a79c-20513d5d41ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6aa12adf-4ea5-4676-a79c-20513d5d41ed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_f12725e0-ea25-4ac4-a510-dd236955a019" xlink:href="dxcm-20241231.xsd#dxcm_AcquiredTechnologyAndIntellectualPropertyMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_f12725e0-ea25-4ac4-a510-dd236955a019" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d593d7eb-45d2-4dc5-909a-811b02bbf04c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d593d7eb-45d2-4dc5-909a-811b02bbf04c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4ee0fc6d-a477-4e86-b3ce-6d9900326380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4ee0fc6d-a477-4e86-b3ce-6d9900326380" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3e94c5d-eb97-43fd-bff7-87d2e1c6deb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3e94c5d-eb97-43fd-bff7-87d2e1c6deb8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_881e2954-40bf-49d6-a890-57f381000680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_881e2954-40bf-49d6-a890-57f381000680" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5517e05-74ff-4fa0-9608-e20623ce9471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5517e05-74ff-4fa0-9608-e20623ce9471" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cc40ba9-9cc5-4408-88e5-1e4c39e0b60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cc40ba9-9cc5-4408-88e5-1e4c39e0b60c" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:to="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_4c963039-ba91-4c97-8e11-1a5258b5b7cd_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_4c963039-ba91-4c97-8e11-1a5258b5b7cd_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b689c49-4cf8-4d67-a684-23c18141ce28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:to="loc_us-gaap_SeniorNotesMember_0b689c49-4cf8-4d67-a684-23c18141ce28" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5c7a056e-2b58-4502-8da9-ab5b4489c620_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5c7a056e-2b58-4502-8da9-ab5b4489c620_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_c9f6b0c6-7571-44b7-82dd-a6e64e68a7db" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_c9f6b0c6-7571-44b7-82dd-a6e64e68a7db" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_cfda345a-ed28-4ebc-8090-5d5ca03aae79" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_cfda345a-ed28-4ebc-8090-5d5ca03aae79" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fc84de84-7d85-4c25-9a2c-0b96e9ad7d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fc84de84-7d85-4c25-9a2c-0b96e9ad7d8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_d811874f-7a91-416d-b9b5-86d0161e5d20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_d811874f-7a91-416d-b9b5-86d0161e5d20" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_73be2a40-cb60-499e-94f5-b084c8f77f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_ConvertibleNotesPayable_73be2a40-cb60-499e-94f5-b084c8f77f4f" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofConvertedValueofNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:to="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:to="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_973de7a8-27f0-488d-b321-ddda2e5f0823_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_973de7a8-27f0-488d-b321-ddda2e5f0823_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_a5ec38b2-a6cb-4c92-a62c-de592cdab8b8" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_a5ec38b2-a6cb-4c92-a62c-de592cdab8b8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_44e68759-f4ea-4c7b-a5db-3ba1349e77c4" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_44e68759-f4ea-4c7b-a5db-3ba1349e77c4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_ec0e402d-8c66-4ab3-8560-6dc39e147ae7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_ec0e402d-8c66-4ab3-8560-6dc39e147ae7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_675a025a-3ae7-4399-8e8a-2ad8b39bb347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:to="loc_us-gaap_SeniorNotesMember_675a025a-3ae7-4399-8e8a-2ad8b39bb347" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_f6e7e7bb-c995-4097-9f55-8bb7082cc08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_f6e7e7bb-c995-4097-9f55-8bb7082cc08a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:to="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_4700769d-3dbd-4369-af94-316b8b893216_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_4700769d-3dbd-4369-af94-316b8b893216_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_15728fec-0dbf-4098-9089-20beff6a7994" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_15728fec-0dbf-4098-9089-20beff6a7994" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_6a91c54a-5140-47aa-9382-cf6767b6fab3" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_6a91c54a-5140-47aa-9382-cf6767b6fab3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a3aefae2-fcae-4cee-b8a6-fad84a1f089f" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a3aefae2-fcae-4cee-b8a6-fad84a1f089f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:href="dxcm-20241231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_03c615bb-2ca0-443d-99be-378cdc6270ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_03c615bb-2ca0-443d-99be-378cdc6270ad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:href="dxcm-20241231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f4d77538-153d-4455-bef5-a6f8255c1b09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f4d77538-153d-4455-bef5-a6f8255c1b09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_566d162e-f53d-4dc4-a53a-2c18ba9c84f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:to="loc_us-gaap_InterestExpenseDebt_566d162e-f53d-4dc4-a53a-2c18ba9c84f2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_66ec129b-7abf-492b-a2d5-1aecbff3ad21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_66ec129b-7abf-492b-a2d5-1aecbff3ad21" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofKeyDetailsofConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6a11b715-a755-47bc-ad73-2a3460f90976" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6a11b715-a755-47bc-ad73-2a3460f90976" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_34fcec45-317f-4f3b-a1d4-7c3362e6bc25" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_34fcec45-317f-4f3b-a1d4-7c3362e6bc25" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_1e8a30f4-feb0-470c-b462-a3dd68087433" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_1e8a30f4-feb0-470c-b462-a3dd68087433" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_89220346-e45d-490f-b15b-58690f1335f6_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_89220346-e45d-490f-b15b-58690f1335f6_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_211d8a54-d3d7-47ad-bda8-adb9eab20a89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:to="loc_us-gaap_SeniorNotesMember_211d8a54-d3d7-47ad-bda8-adb9eab20a89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecc85d5a-e326-4009-b9c6-68b3fac36a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecc85d5a-e326-4009-b9c6-68b3fac36a00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_79a4016f-b415-498e-8c2b-7c2610e023af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_79a4016f-b415-498e-8c2b-7c2610e023af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_c499d487-211d-4e77-b31c-3d36b3466d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_c499d487-211d-4e77-b31c-3d36b3466d37" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3f0ab6d6-08b9-4690-b7c3-d7a213e7efc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3f0ab6d6-08b9-4690-b7c3-d7a213e7efc8" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0a2a255d-2140-47e2-9b6a-cc40b05a4555" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0a2a255d-2140-47e2-9b6a-cc40b05a4555" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2023NoteHedgeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2023NoteHedgeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Debt2023NoteHedgeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:to="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3bb50d75-1d5e-48fd-b52f-4eb67a447a65_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3bb50d75-1d5e-48fd-b52f-4eb67a447a65_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_7af75398-17c6-403f-93fd-2ab69ddca04c" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_7af75398-17c6-403f-93fd-2ab69ddca04c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_799d919d-f68d-40e9-a126-2d09d814ea61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:to="loc_us-gaap_HedgingDesignationDomain_799d919d-f68d-40e9-a126-2d09d814ea61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:to="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_88bec21f-0465-4069-ba74-61edb19d3426" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_88bec21f-0465-4069-ba74-61edb19d3426" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8597a888-4ead-4826-9374-fb2e4b602745_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8597a888-4ead-4826-9374-fb2e4b602745_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6e18da5d-ad03-4690-857e-4b46c0955412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:to="loc_us-gaap_SeniorNotesMember_6e18da5d-ad03-4690-857e-4b46c0955412" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_cdcf268e-bc37-44e6-aa1b-d9d99f980bed" xlink:href="dxcm-20241231.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_cdcf268e-bc37-44e6-aa1b-d9d99f980bed" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_4570b23f-dc1f-46c4-90d7-512cb8f187fa" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_4570b23f-dc1f-46c4-90d7-512cb8f187fa" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2023WarrantsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2023WarrantsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Debt2023WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_e23acf96-83f7-455c-824a-3ea1181f6188_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_e23acf96-83f7-455c-824a-3ea1181f6188_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_a8b1089c-9f7e-4d5c-b8e8-2ea09a3ae059" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_a8b1089c-9f7e-4d5c-b8e8-2ea09a3ae059" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_d4284249-a4ea-4c08-8601-e1d643c4d4e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_d4284249-a4ea-4c08-8601-e1d643c4d4e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7ddcc7f6-1513-4a06-a419-038ff76777a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:to="loc_us-gaap_SeniorNotesMember_7ddcc7f6-1513-4a06-a419-038ff76777a1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_JPMWarrantTransactionsMember_61a4539f-f355-47c3-98d4-a7e678fa7872" xlink:href="dxcm-20241231.xsd#dxcm_JPMWarrantTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:to="loc_dxcm_JPMWarrantTransactionsMember_61a4539f-f355-47c3-98d4-a7e678fa7872" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BofAWarrantTransactionsMember_5616b72f-471d-4c98-a1c5-05d575abc5e3" xlink:href="dxcm-20241231.xsd#dxcm_BofAWarrantTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:to="loc_dxcm_BofAWarrantTransactionsMember_5616b72f-471d-4c98-a1c5-05d575abc5e3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_65581103-9801-44c9-8693-f9ccdb95eaba_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:to="loc_us-gaap_ClassOfStockDomain_65581103-9801-44c9-8693-f9ccdb95eaba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:to="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_555dec95-534c-4082-b573-9fae7f1df2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:to="loc_us-gaap_CommonStockMember_555dec95-534c-4082-b573-9fae7f1df2fa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b6adc1cf-fe68-4913-b1be-d2792ecdf29c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b6adc1cf-fe68-4913-b1be-d2792ecdf29c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_463dd951-17a4-4f54-8a89-a3da6b7e0624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_463dd951-17a4-4f54-8a89-a3da6b7e0624" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_74f83575-ca41-49d4-8f6e-bec8faca9b97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_74f83575-ca41-49d4-8f6e-bec8faca9b97" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_37116a86-90d1-4aa4-898d-f0a934973728" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_37116a86-90d1-4aa4-898d-f0a934973728" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_d9e870a1-6fb7-453f-97b4-4e35eecba61d" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_d9e870a1-6fb7-453f-97b4-4e35eecba61d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_bc8d5ec4-eb05-482b-abfd-f20e59335cdb" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_bc8d5ec4-eb05-482b-abfd-f20e59335cdb" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2028CappedCallTransactionsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_932bf6ec-d2b9-4676-b826-1198e2c66a9a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_932bf6ec-d2b9-4676-b826-1198e2c66a9a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_c485e456-5702-4501-9bae-267bb9c0ad4c" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_c485e456-5702-4501-9bae-267bb9c0ad4c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_92515b72-93ed-4b14-bb43-197a0285aff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:to="loc_us-gaap_SeniorNotesMember_92515b72-93ed-4b14-bb43-197a0285aff6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_fefc3149-2851-47b4-b3af-380092f8dfa5" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_fefc3149-2851-47b4-b3af-380092f8dfa5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_23db4ee3-9856-4f60-b84b-64a5118d5f24" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_23db4ee3-9856-4f60-b84b-64a5118d5f24" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5b22f6e4-2a30-4292-9c64-c8aa8095b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_us-gaap_SharePrice_5b22f6e4-2a30-4292-9c64-c8aa8095b6b9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_86d826b6-3016-4d3f-8ef0-bb8b8f291025" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_86d826b6-3016-4d3f-8ef0-bb8b8f291025" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtConversionActivityforSeniorConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:to="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d94c009c-8a06-4d94-9864-4ce46a722af0_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d94c009c-8a06-4d94-9864-4ce46a722af0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_be65ed0c-722c-4069-ada4-3bc3b1d88020" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_be65ed0c-722c-4069-ada4-3bc3b1d88020" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_b30ce307-1643-4722-b3aa-06cfa6b4930f_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_b30ce307-1643-4722-b3aa-06cfa6b4930f_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d29ceb39-db3e-411a-8f75-6aee6e4239d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:to="loc_us-gaap_SeniorNotesMember_d29ceb39-db3e-411a-8f75-6aee6e4239d9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_919f5a36-fe06-4ceb-aa9c-4e1402fddfd3" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_919f5a36-fe06-4ceb-aa9c-4e1402fddfd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f1be1b4c-5531-44a2-84a8-90611b9153ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f1be1b4c-5531-44a2-84a8-90611b9153ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_b182ea3f-66f7-4acb-82b6-a4f67bcaf483" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_b182ea3f-66f7-4acb-82b6-a4f67bcaf483" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtConversionRightsforSeniorsConvertibleNotesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6035ee06-ddea-4c69-93cb-bf7535a94f5b" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6035ee06-ddea-4c69-93cb-bf7535a94f5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_addf80e3-bd57-4f2f-b019-7f14a1e124dd" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_addf80e3-bd57-4f2f-b019-7f14a1e124dd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_393df6dc-b940-4b6a-909f-daf3aa7b19a5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_393df6dc-b940-4b6a-909f-daf3aa7b19a5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_711d517b-332d-4f13-8632-0519b9f5f897" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:to="loc_us-gaap_SeniorNotesMember_711d517b-332d-4f13-8632-0519b9f5f897" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_9236b067-d21d-41cb-b814-16a73896e6cc_default" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_9236b067-d21d-41cb-b814-16a73896e6cc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_e09708b0-1bdd-44d4-94f5-b27af611db80" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_e09708b0-1bdd-44d4-94f5-b27af611db80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_fd35148d-dce5-4011-b099-9d18e9103f3e" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_fd35148d-dce5-4011-b099-9d18e9103f3e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_894c7624-cdad-45b0-8061-cc9a51042d39_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:to="loc_srt_RangeMember_894c7624-cdad-45b0-8061-cc9a51042d39_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:to="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5c24c911-6d3d-4e03-ac2b-f2601d95e683" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:to="loc_srt_MinimumMember_5c24c911-6d3d-4e03-ac2b-f2601d95e683" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81202e61-6384-481c-8ad5-025afc154451" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:to="loc_srt_MaximumMember_81202e61-6384-481c-8ad5-025afc154451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_9aea4bbe-f4e6-4a92-a5de-ff689cadcb5b" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_9aea4bbe-f4e6-4a92-a5de-ff689cadcb5b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0bbe316d-f19a-4286-a5fb-21822d565874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0bbe316d-f19a-4286-a5fb-21822d565874" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_e538211a-5ad4-4eac-b3b4-80227c515d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_e538211a-5ad4-4eac-b3b4-80227c515d2b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_1c5705af-c0e7-492a-b724-68993d558cbe" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_1c5705af-c0e7-492a-b724-68993d558cbe" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3deb058d-f008-4f01-853e-867c11408174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3deb058d-f008-4f01-853e-867c11408174" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_adb2a020-d82a-4a12-b968-ec3483d32190_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_adb2a020-d82a-4a12-b968-ec3483d32190_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3cdff034-0c39-4cbf-b001-c0fd11b62fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:to="loc_us-gaap_LineOfCreditMember_3cdff034-0c39-4cbf-b001-c0fd11b62fc9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_b15d82f8-7db7-4f8a-a803-a37088df173c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:to="loc_us-gaap_CreditFacilityDomain_b15d82f8-7db7-4f8a-a803-a37088df173c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:to="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cf54dc98-551b-4d71-ade5-bdc44be4b67c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:to="loc_us-gaap_LetterOfCreditMember_cf54dc98-551b-4d71-ade5-bdc44be4b67c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_19d8089f-617b-463c-8e73-9b1cc8fb0958_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:to="loc_srt_RangeMember_19d8089f-617b-463c-8e73-9b1cc8fb0958_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:to="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ba1f17e5-4c9a-4baa-8608-7e437a0cc6bf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:to="loc_srt_MinimumMember_ba1f17e5-4c9a-4baa-8608-7e437a0cc6bf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e7496fe-a63d-45c7-bec3-aabbb3c38c5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:to="loc_srt_MaximumMember_8e7496fe-a63d-45c7-bec3-aabbb3c38c5b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:to="loc_us-gaap_VariableRateDomain_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:to="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_77c40746-4b05-440a-bca5-874c840ec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:to="loc_us-gaap_BaseRateMember_77c40746-4b05-440a-bca5-874c840ec5c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member_d3d0ef71-14db-4569-a6d1-f355ec2a1b8b" xlink:href="dxcm-20241231.xsd#dxcm_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:to="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member_d3d0ef71-14db-4569-a6d1-f355ec2a1b8b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02270cd4-000e-4c28-96fa-9a8571c40c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02270cd4-000e-4c28-96fa-9a8571c40c91" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_73b24815-5414-4d7b-a82a-a0903b9aaeba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCredit_73b24815-5414-4d7b-a82a-a0903b9aaeba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_e85c4f71-ffee-439f-8ab0-65f79f4d32c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_e85c4f71-ffee-439f-8ab0-65f79f4d32c8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b7b88304-4795-43ee-9372-4aec8170906e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b7b88304-4795-43ee-9372-4aec8170906e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7ab66a80-a754-464b-b1bc-970e50b0e710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7ab66a80-a754-464b-b1bc-970e50b0e710" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_375d2424-ce75-4f85-8746-72d60f37955c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_375d2424-ce75-4f85-8746-72d60f37955c" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtRevolvingCreditAgreementDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_6e204176-a585-415d-bf74-800579ff1a31_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_6e204176-a585-415d-bf74-800579ff1a31_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_15c32941-1fc4-4449-b9ff-68824f21d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:to="loc_us-gaap_LineOfCreditMember_15c32941-1fc4-4449-b9ff-68824f21d1cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_5e575183-ed3c-42fc-a7e5-9082aa089ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_us-gaap_DebtInstrumentTerm_5e575183-ed3c-42fc-a7e5-9082aa089ab4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cbdfbddb-98fa-422a-a4b3-2ac054a10d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cbdfbddb-98fa-422a-a4b3-2ac054a10d91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_501b328d-81f1-4869-b864-53b9de465ac7" xlink:href="dxcm-20241231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_501b328d-81f1-4869-b864-53b9de465ac7" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:to="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_22b20a17-edde-4d41-a04f-e5761a1d1897_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:to="loc_srt_RangeMember_22b20a17-edde-4d41-a04f-e5761a1d1897_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:to="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_046b74bb-36fc-4908-9809-a49c0aa525e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:to="loc_srt_MaximumMember_046b74bb-36fc-4908-9809-a49c0aa525e3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6f698b3-9de6-43d2-a5fe-4a0e983cc548" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:to="loc_srt_MinimumMember_a6f698b3-9de6-43d2-a5fe-4a0e983cc548" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_90de00c1-e3fc-4a5b-9bf4-cc407e24098a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_90de00c1-e3fc-4a5b-9bf4-cc407e24098a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_022f5129-114c-47aa-8bb0-03737c339167" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_022f5129-114c-47aa-8bb0-03737c339167" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a9295931-410f-437d-a640-c107830a7f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a9295931-410f-437d-a640-c107830a7f7d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_7d90eadb-60d9-41dc-aa0b-c961b7746fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetRetirementObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_AssetRetirementObligation_7d90eadb-60d9-41dc-aa0b-c961b7746fb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1a9b621-da60-4b9c-b253-d97f45775401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1a9b621-da60-4b9c-b253-d97f45775401" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_bfb6936c-b46d-4bed-989e-c34d0c2b6a30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_bfb6936c-b46d-4bed-989e-c34d0c2b6a30" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_1831ed19-5bfa-441a-b345-d26dd586fd67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_1831ed19-5bfa-441a-b345-d26dd586fd67" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ImpairedLongLivedAssetsFairValue_cc93d744-591f-4d92-89cf-ddff90b99e43" xlink:href="dxcm-20241231.xsd#dxcm_ImpairedLongLivedAssetsFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_ImpairedLongLivedAssetsFairValue_cc93d744-591f-4d92-89cf-ddff90b99e43" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_5e790511-efa3-459f-af59-6a4d30baea12" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_5e790511-efa3-459f-af59-6a4d30baea12" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_b91470cb-181a-4b84-9127-ff567d67145f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_b91470cb-181a-4b84-9127-ff567d67145f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_58d82a15-7873-4d2a-9a84-fc1bd1377044" xlink:href="dxcm-20241231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_58d82a15-7873-4d2a-9a84-fc1bd1377044" xlink:type="arc" order="10"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_ef52dfb3-651a-4309-a976-1f6c40dc5d3b_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_ef52dfb3-651a-4309-a976-1f6c40dc5d3b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_acd2e2bd-d2fd-469d-8ad5-68e327ff9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_DomesticCountryMember_acd2e2bd-d2fd-469d-8ad5-68e327ff9ff1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d2034092-3744-4e0e-ad1c-35bcc835ec48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d2034092-3744-4e0e-ad1c-35bcc835ec48" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d00f30d4-e23d-4ec3-a4d8-0750155bd98d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_ForeignCountryMember_d00f30d4-e23d-4ec3-a4d8-0750155bd98d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c74fcc22-dfae-428f-9ac2-afce7b031d6a_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:to="loc_srt_SegmentGeographicalDomain_c74fcc22-dfae-428f-9ac2-afce7b031d6a_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:to="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_7bcff274-5c53-4334-8d60-bf3237998f56" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_stpr_CA_7bcff274-5c53-4334-8d60-bf3237998f56" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember_cd07a045-2ff6-4a78-b591-857d6b239e32" xlink:href="dxcm-20241231.xsd#dxcm_OtherStatesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_dxcm_OtherStatesMember_cd07a045-2ff6-4a78-b591-857d6b239e32" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_55f1b005-67f7-43ea-a7da-ccdd7e53b63f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_country_GB_55f1b005-67f7-43ea-a7da-ccdd7e53b63f" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherForeignMember_7003651d-67f2-4be4-9a58-4825ffc6b2dd" xlink:href="dxcm-20241231.xsd#dxcm_OtherForeignMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_dxcm_OtherForeignMember_7003651d-67f2-4be4-9a58-4825ffc6b2dd" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_2c2fba46-d449-4d92-b543-3996bc1b56f1_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_2c2fba46-d449-4d92-b543-3996bc1b56f1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchDevelopmentTaxCreditsMember_f19a4f0d-dbfe-4482-a733-65612c5a0c3d" xlink:href="dxcm-20241231.xsd#dxcm_ResearchDevelopmentTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_ResearchDevelopmentTaxCreditsMember_f19a4f0d-dbfe-4482-a733-65612c5a0c3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ForeignTaxCreditsMember_ac5f7cb6-4dca-4d58-8685-f28388a0fc58" xlink:href="dxcm-20241231.xsd#dxcm_ForeignTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_ForeignTaxCreditsMember_ac5f7cb6-4dca-4d58-8685-f28388a0fc58" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AMTTaxCreditsMember_a4fbcc53-d6da-4b97-8aa2-08643c6ed5af" xlink:href="dxcm-20241231.xsd#dxcm_AMTTaxCreditsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_AMTTaxCreditsMember_a4fbcc53-d6da-4b97-8aa2-08643c6ed5af" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c7aabcdc-cb0a-4276-b3d6-6d06ab33afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c7aabcdc-cb0a-4276-b3d6-6d06ab33afa6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_547bc4be-36f6-40f8-ac5d-f89c9575d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_547bc4be-36f6-40f8-ac5d-f89c9575d0a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:to="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d64ca1da-b411-44e5-b13d-edfc5ca86dfb_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:to="loc_srt_SegmentGeographicalDomain_d64ca1da-b411-44e5-b13d-edfc5ca86dfb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:to="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_e4c9c20c-b78f-4d64-a196-f44a5627fb3a" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:to="loc_stpr_CA_e4c9c20c-b78f-4d64-a196-f44a5627fb3a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_a91b169a-7c2e-4dcd-9165-035afe4492a3" xlink:href="dxcm-20241231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_a91b169a-7c2e-4dcd-9165-035afe4492a3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7bc961a8-e9a7-47d3-88a7-ef96e92de889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7bc961a8-e9a7-47d3-88a7-ef96e92de889" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_484f6f80-dcd9-453e-9e09-fe2c7ab9a6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_484f6f80-dcd9-453e-9e09-fe2c7ab9a6d7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_92b62a21-1246-4df1-9075-4cc959858546" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_92b62a21-1246-4df1-9075-4cc959858546" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_752709c7-fce5-4d47-9c9f-991bd38096f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_752709c7-fce5-4d47-9c9f-991bd38096f9" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PreferentialTaxRatePeriod_7963f64c-5e21-483e-8ca1-6587c8632784" xlink:href="dxcm-20241231.xsd#dxcm_PreferentialTaxRatePeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_PreferentialTaxRatePeriod_7963f64c-5e21-483e-8ca1-6587c8632784" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_79e019a1-4c5f-4d20-91fd-d5edaa0f291b" xlink:href="dxcm-20241231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_79e019a1-4c5f-4d20-91fd-d5edaa0f291b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c01f31f6-f467-4a34-9cf2-6bf3d56611fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c01f31f6-f467-4a34-9cf2-6bf3d56611fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1940040c-d897-40d7-8d73-0397e3cd7b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1940040c-d897-40d7-8d73-0397e3cd7b14" xlink:type="arc" order="8"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:to="loc_us-gaap_PlanNameDomain_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:to="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember_5d74be83-03d1-49c7-bc9a-87edbf55d039" xlink:href="dxcm-20241231.xsd#dxcm_A401kPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_A401kPlanMember_5d74be83-03d1-49c7-bc9a-87edbf55d039" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_598e2e4e-6d5b-4631-b1cc-dd944dd6a12a" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_598e2e4e-6d5b-4631-b1cc-dd944dd6a12a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquityIncentivePlan2015Member_ec193ff4-cf82-4df2-8de2-5b83cee43166" xlink:href="dxcm-20241231.xsd#dxcm_EquityIncentivePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_EquityIncentivePlan2015Member_ec193ff4-cf82-4df2-8de2-5b83cee43166" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2024ShareRepurchaseProgramMember_b7a15c81-528a-4ab4-9229-347e1af3a93c" xlink:href="dxcm-20241231.xsd#dxcm_A2024ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_A2024ShareRepurchaseProgramMember_b7a15c81-528a-4ab4-9229-347e1af3a93c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91df1d21-a214-46b8-9ee0-487cf6f04ca2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_91df1d21-a214-46b8-9ee0-487cf6f04ca2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_b0013a13-76c9-40ed-a5a6-515008e2795e" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_b0013a13-76c9-40ed-a5a6-515008e2795e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bfc47601-fb37-4ed0-ba0d-78b3b3535a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bfc47601-fb37-4ed0-ba0d-78b3b3535a41" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_36474479-ee49-4d5a-ad73-125fa64a2cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_us-gaap_PerformanceSharesMember_36474479-ee49-4d5a-ad73-125fa64a2cdc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_cc90d15d-08be-4f8f-9b8a-84f59592fa93_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:to="loc_srt_RangeMember_cc90d15d-08be-4f8f-9b8a-84f59592fa93_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:to="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eac654ae-2558-4b13-8f92-ce0012f216fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:to="loc_srt_MinimumMember_eac654ae-2558-4b13-8f92-ce0012f216fb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25eaa6c0-d2b9-4cb1-a228-98fe2255015a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:to="loc_srt_MaximumMember_25eaa6c0-d2b9-4cb1-a228-98fe2255015a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_fd2116b4-3e8b-45e6-bbde-f7243de3ce61_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:to="loc_us-gaap_EquityComponentDomain_fd2116b4-3e8b-45e6-bbde-f7243de3ce61_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:to="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ec24402-0eb0-482c-ae82-efe44f6e9e32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:to="loc_us-gaap_CommonStockMember_9ec24402-0eb0-482c-ae82-efe44f6e9e32" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_66dad60f-09f5-48d1-864b-d753b66ddc1b_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:to="loc_srt_ShareRepurchaseProgramDomain_66dad60f-09f5-48d1-864b-d753b66ddc1b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:to="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseASRMember_30557d3f-ba7c-4da5-96b8-b3a412a96322" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseASRMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:to="loc_dxcm_AcceleratedShareRepurchaseASRMember_30557d3f-ba7c-4da5-96b8-b3a412a96322" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_91a5ca71-f0f4-4f22-8e47-03d86995d1af" xlink:href="dxcm-20241231.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_91a5ca71-f0f4-4f22-8e47-03d86995d1af" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_ba11a90e-41b2-4aac-9fd2-ebf776443ce7_default" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_ba11a90e-41b2-4aac-9fd2-ebf776443ce7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_20c0aa83-5a5c-4a7d-a14f-cbaf96a3da65" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_20c0aa83-5a5c-4a7d-a14f-cbaf96a3da65" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e6eb77b-3c88-4fb3-ba2a-525c97b32585_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_4e6eb77b-3c88-4fb3-ba2a-525c97b32585_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_e102af5a-0c9d-40bc-9e80-8eb680f76786" xlink:href="dxcm-20241231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:to="loc_dxcm_VerilyLifeSciencesMember_e102af5a-0c9d-40bc-9e80-8eb680f76786" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c2332459-8daf-493d-b207-0d1eb15c2b1d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_c2332459-8daf-493d-b207-0d1eb15c2b1d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d371b903-6ba4-4320-b02c-7e1a4f83b43a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d371b903-6ba4-4320-b02c-7e1a4f83b43a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4081ef40-37fc-4a6a-af7a-696992dd68c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4081ef40-37fc-4a6a-af7a-696992dd68c4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_5b87fdf3-166b-4ff9-87eb-55f95771b9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_5b87fdf3-166b-4ff9-87eb-55f95771b9bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2aa2f42b-c75f-4fce-afad-c1ba5fca53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2aa2f42b-c75f-4fce-afad-c1ba5fca53bc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_6d631476-7c72-49b9-bc90-cef6bab08761" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_6d631476-7c72-49b9-bc90-cef6bab08761" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_f5ff7be7-dd3c-4fab-99ae-7c2c756801d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_f5ff7be7-dd3c-4fab-99ae-7c2c756801d0" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_b3077e31-6524-443f-9db5-ff0f98bdcb7a" xlink:href="dxcm-20241231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_b3077e31-6524-443f-9db5-ff0f98bdcb7a" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_cd0b8694-e75d-4c79-a031-c88e4199e18b" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_cd0b8694-e75d-4c79-a031-c88e4199e18b" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a6dfbe3f-03ad-4e79-bf20-bedb23db5f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a6dfbe3f-03ad-4e79-bf20-bedb23db5f9d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9d2f7dd1-c12c-4041-afd2-d6417b2b5990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9d2f7dd1-c12c-4041-afd2-d6417b2b5990" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0dcfbf2b-101a-4e77-bae7-91d889b99a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0dcfbf2b-101a-4e77-bae7-91d889b99a3f" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2871c15-febb-4abb-b2c2-be0241c0ddd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2871c15-febb-4abb-b2c2-be0241c0ddd6" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4a0a87e-95fd-4471-838a-c205ae54421a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4a0a87e-95fd-4471-838a-c205ae54421a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9df82a2-84b9-4c51-a818-f0a6afd3ac04" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9df82a2-84b9-4c51-a818-f0a6afd3ac04" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_32f81891-66e8-44e0-8d29-505d7d10d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_32f81891-66e8-44e0-8d29-505d7d10d2ec" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b812f7f8-91a8-4e12-966c-d2913113babc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b812f7f8-91a8-4e12-966c-d2913113babc" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_e4974b44-0599-4675-8a10-cfd465fc32a2" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_e4974b44-0599-4675-8a10-cfd465fc32a2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_e67f2863-b5eb-412c-83fe-58c4b3060c7b" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_e67f2863-b5eb-412c-83fe-58c4b3060c7b" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_d5e94cfb-53e7-4d27-829b-d67a096a29eb" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_d5e94cfb-53e7-4d27-829b-d67a096a29eb" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_c3804399-ed05-42ec-9830-4a1f6ddf0aa6" xlink:href="dxcm-20241231.xsd#dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_c3804399-ed05-42ec-9830-4a1f6ddf0aa6" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8d8d8ffa-2317-4716-a8d3-e01b56dc71fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8d8d8ffa-2317-4716-a8d3-e01b56dc71fc" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20756712-0f8d-4c25-bfca-20b1c1fec53b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20756712-0f8d-4c25-bfca-20b1c1fec53b" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f45b6b00-0fb4-4c5f-a76a-93ab0a2cee8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f45b6b00-0fb4-4c5f-a76a-93ab0a2cee8d" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2f7d0dcc-f1ab-46ec-a64c-f2bfc8f6f163" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2f7d0dcc-f1ab-46ec-a64c-f2bfc8f6f163" xlink:type="arc" order="22"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:to="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_03651b58-f607-4059-bf0e-2c1138ad87c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:to="loc_us-gaap_PlanNameDomain_03651b58-f607-4059-bf0e-2c1138ad87c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:to="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2022ShareRepurchaseProgramMember_2e6afcf1-bd3e-40b3-b318-022e578effe3" xlink:href="dxcm-20241231.xsd#dxcm_A2022ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2022ShareRepurchaseProgramMember_2e6afcf1-bd3e-40b3-b318-022e578effe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2023ShareRepurchaseProgramMember_fc704c62-67cf-4df1-bb2b-8b825559c594" xlink:href="dxcm-20241231.xsd#dxcm_A2023ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2023ShareRepurchaseProgramMember_fc704c62-67cf-4df1-bb2b-8b825559c594" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2024ShareRepurchaseProgramMember_2fa07f6c-1d5a-46cc-b8bb-433837266a17" xlink:href="dxcm-20241231.xsd#dxcm_A2024ShareRepurchaseProgramMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2024ShareRepurchaseProgramMember_2fa07f6c-1d5a-46cc-b8bb-433837266a17" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2028NotesMember_e18b501b-dd39-4081-aeb3-e3b1f5ea7f4c" xlink:href="dxcm-20241231.xsd#dxcm_A2028NotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2028NotesMember_e18b501b-dd39-4081-aeb3-e3b1f5ea7f4c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseInTreasuryStockRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:to="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b64c1053-07ba-4f41-809e-d764d95f8461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b64c1053-07ba-4f41-809e-d764d95f8461" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_a0352602-41e1-43a8-b580-881b004d4a0e" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_a0352602-41e1-43a8-b580-881b004d4a0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_7655e8eb-7c6d-4880-b41f-0933fddfdab7" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_7655e8eb-7c6d-4880-b41f-0933fddfdab7" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e4e81e08-10b6-4431-8a8a-cb1d6aa1b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e4e81e08-10b6-4431-8a8a-cb1d6aa1b67a" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_4c9ba953-646a-4e1e-9a50-07cfcb82d2d0" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_4c9ba953-646a-4e1e-9a50-07cfcb82d2d0" xlink:type="arc" order="5"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:to="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_16b15baa-6b5c-4a08-af98-54917faf8e63_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:to="loc_us-gaap_PlanNameDomain_16b15baa-6b5c-4a08-af98-54917faf8e63_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:to="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquityIncentivePlan2015Member_1e910b1e-5577-433b-ac15-804c51fb7a3d" xlink:href="dxcm-20241231.xsd#dxcm_EquityIncentivePlan2015Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:to="loc_dxcm_EquityIncentivePlan2015Member_1e910b1e-5577-433b-ac15-804c51fb7a3d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:to="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43933b65-fe81-461c-9a4f-28cfb6cf7720_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_43933b65-fe81-461c-9a4f-28cfb6cf7720_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_3053ec00-e55c-4fd5-a1c4-0ecfe408b769" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:to="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_3053ec00-e55c-4fd5-a1c4-0ecfe408b769" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_304fd7ae-be40-4847-a71e-7f2708df7458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_304fd7ae-be40-4847-a71e-7f2708df7458" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_b13128d8-623f-431f-90b7-731e6bb3dcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_b13128d8-623f-431f-90b7-731e6bb3dcb2" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_abe4e4be-9f39-4f48-b4f6-ab1492fa8f42" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_abe4e4be-9f39-4f48-b4f6-ab1492fa8f42" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c4565a46-af86-457f-8cc0-8c922c130338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c4565a46-af86-457f-8cc0-8c922c130338" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7be39f27-bfa5-4c84-8d50-a4af830f6597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d8792bff-51db-4324-b63f-41d8dfabb14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d8792bff-51db-4324-b63f-41d8dfabb14e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42ea5335-dba8-400b-a69b-8c55e41e0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42ea5335-dba8-400b-a69b-8c55e41e0e33" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09d3748b-140f-4c17-9939-43f563f18d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09d3748b-140f-4c17-9939-43f563f18d7e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2a61aaef-54cb-4c4b-b413-231ec2f948d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2a61aaef-54cb-4c4b-b413-231ec2f948d1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9ee654ba-72c3-4aff-abff-730954c00e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9a82712c-21dc-497c-971d-533381ea37d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9a82712c-21dc-497c-971d-533381ea37d7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afb5897c-5482-41a4-a33e-54ad47ea3e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afb5897c-5482-41a4-a33e-54ad47ea3e81" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_08b2ddb1-7357-4672-8c74-e63610945113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_08b2ddb1-7357-4672-8c74-e63610945113" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83f4487e-6763-4420-90f8-45c39d12eb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83f4487e-6763-4420-90f8-45c39d12eb9b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3d230be5-8cc5-46aa-bdbc-91ebf3fca30c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_363c0698-a255-4dee-b6db-6feb30b11958" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_363c0698-a255-4dee-b6db-6feb30b11958" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c8819c97-134c-4616-8876-f715fa267b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_CostOfSalesMember_c8819c97-134c-4616-8876-f715fa267b2a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbcf3da2-6f9c-4c91-a8bb-da3d795cf0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbcf3da2-6f9c-4c91-a8bb-da3d795cf0c1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62deb774-7134-44b0-91a1-3e1806e6c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62deb774-7134-44b0-91a1-3e1806e6c5c1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_21860c31-e485-4d40-9c54-2fca03e78bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_21860c31-e485-4d40-9c54-2fca03e78bb4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0e9336fb-5a5e-4a70-bab4-805840294cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0e9336fb-5a5e-4a70-bab4-805840294cc6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:to="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_bb441705-5fce-4f3d-af18-59ae41630a07_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:to="loc_srt_RangeMember_bb441705-5fce-4f3d-af18-59ae41630a07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:to="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_87408317-6574-4216-96f9-f482692a1248" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:to="loc_srt_MinimumMember_87408317-6574-4216-96f9-f482692a1248" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ded10390-25df-40c9-8a51-06b3a0a5cca2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:to="loc_srt_MaximumMember_ded10390-25df-40c9-8a51-06b3a0a5cca2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:to="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_3069a7b6-13bb-40ca-ad74-96baebacbec9_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:to="loc_us-gaap_PlanNameDomain_3069a7b6-13bb-40ca-ad74-96baebacbec9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:to="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_3c7496b3-aa14-4230-a7d4-0b56786b1fe1" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_3c7496b3-aa14-4230-a7d4-0b56786b1fe1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_44095800-d4bc-4c80-9210-b2b62b98d2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_44095800-d4bc-4c80-9210-b2b62b98d2e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ff89d733-77d9-49bc-9091-dcef7f349415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ff89d733-77d9-49bc-9091-dcef7f349415" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7ca690d4-95cc-41c4-8e3c-5875504f2068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7ca690d4-95cc-41c4-8e3c-5875504f2068" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d47fa370-64fe-4259-a67a-039e47649b43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d47fa370-64fe-4259-a67a-039e47649b43" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:to="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_f8ab647f-b63a-43e5-8503-bd01e957d2f7_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:to="loc_srt_SegmentGeographicalDomain_f8ab647f-b63a-43e5-8503-bd01e957d2f7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:to="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_904211a1-588e-4382-987f-22baee140be4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:to="loc_country_US_904211a1-588e-4382-987f-22baee140be4" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_68ff2ba6-a6b4-4ac4-b878-142ded45f58d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:to="loc_us-gaap_NonUsMember_68ff2ba6-a6b4-4ac4-b878-142ded45f58d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5cf386a2-d9f6-4366-808a-a26e6c12a023_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_5cf386a2-d9f6-4366-808a-a26e6c12a023_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_9cfcd5dc-b31b-41b2-b6be-bf7d26f36ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_9cfcd5dc-b31b-41b2-b6be-bf7d26f36ef0" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_36c23bcc-21ac-4e3c-8786-2968ffc43a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_36c23bcc-21ac-4e3c-8786-2968ffc43a7c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28713fe1-1ecf-4c16-a2ea-9f859ddeba12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28713fe1-1ecf-4c16-a2ea-9f859ddeba12" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_b32f388c-141d-4631-9fa8-02bd894963a3" xlink:href="dxcm-20241231.xsd#dxcm_RevenuePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:to="loc_dxcm_RevenuePercentage_b32f388c-141d-4631-9fa8-02bd894963a3" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationGeographicInformationDetails"/>
  <link:definitionLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:to="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_ad83340e-4308-4efa-b212-eb3bca185f68_default" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:to="loc_srt_SegmentGeographicalDomain_ad83340e-4308-4efa-b212-eb3bca185f68_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:to="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb5d2e3f-6743-4b2f-acf1-db7cc40c43e2" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_US_cb5d2e3f-6743-4b2f-acf1-db7cc40c43e2" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY_8cb3fa82-2df5-4fbd-9fa2-c97c9578f2a1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_MY"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_MY_8cb3fa82-2df5-4fbd-9fa2-c97c9578f2a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherCountriesMember_8f92fcd9-c526-476d-b87f-8a86236e9d21" xlink:href="dxcm-20241231.xsd#dxcm_OtherCountriesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_dxcm_OtherCountriesMember_8f92fcd9-c526-476d-b87f-8a86236e9d21" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_f2f71adc-5765-4855-94d9-0ff24e043183" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_IE_f2f71adc-5765-4855-94d9-0ff24e043183" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_f7f833ea-5d9b-40a5-b5c7-7c52df65d2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:to="loc_us-gaap_NoncurrentAssets_f7f833ea-5d9b-40a5-b5c7-7c52df65d2e7" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="simple" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd#eedm"/>
  <link:definitionLink xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="41"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>16
<FILENAME>dxcm-20241231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_46a3beb9-1ddd-477d-831a-ee90a7daf86d_terseLabel_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. government agencies</link:label>
    <link:label id="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">US Government Corporations and Agencies Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:to="lab_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_f3ac6a99-b3af-4baf-85bf-344bbc5389af_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale of warrants</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfWarrants_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_0693f867-4bbf-45e5-b1df-04c77c8a82c7_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_9d52df3e-13ca-41d8-acb0-78589e2609c4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum payroll deductions (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_cc8bf31f-f8a9-4e34-a347-31ca4dcb9b60_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustments to reconcile net income to cash provided by operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_0314c0e4-9dac-44a3-bf9e-4e1445551cd5_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">U.S. federal statutory tax rate</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_9e70560d-326b-455b-b088-829536fe7af2_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c3145cf0-c6a8-4238-a54f-60ef97d13ebf_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_9a1a835c-9531-4ae0-ad3e-6e3fdfefd35a_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Increase (decrease) in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_7fff9b95-e680-4ea1-8d28-057650c3ec7e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Operating Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_e15b3848-1c1f-4f03-89fa-3934b36e0d23_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityDomain_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain" xlink:to="lab_us-gaap_IncomeTaxAuthorityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_6839a7c1-c1e9-415a-9eeb-a143b5a446da_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation plan liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredCompensationLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCompensationLiabilityCurrent" xlink:to="lab_us-gaap_DeferredCompensationLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_faa23dbd-6ed3-4ccf-b037-32fa05c7998a_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonNeosMember_terseLabel_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-NEOs</link:label>
    <link:label id="lab_ecd_NonNeosMember_label_en-US" xlink:label="lab_ecd_NonNeosMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-NEOs [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonNeosMember" xlink:to="lab_ecd_NonNeosMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_9257693f-a13e-4ec0-8fd9-ad51fd27d8f5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total tax benefit related to share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense, Tax Benefit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_ed7ebe2c-b940-4486-9b37-373321b0db21_verboseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_8a1191f7-9107-4470-add9-aafaa1b65fa5_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with the Restated Collaboration Agreement (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_d99e5b6c-13ee-43f4-bc5f-24a9761a7496_negatedTerseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with the Restated Collaboration Agreement (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Achievement Of Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:to="lab_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_6cbc33b9-6fff-4c1f-9101-29e9eb47bbb3_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Tax Credit Carryforwards</link:label>
    <link:label id="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Tax Credit Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_faf42c43-4dbe-476a-b5bf-fcecea2ab928_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Distributor</link:label>
    <link:label id="lab_us-gaap_SalesChannelThroughIntermediaryMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Through Intermediary [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelThroughIntermediaryMember" xlink:to="lab_us-gaap_SalesChannelThroughIntermediaryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_234a94cb-0966-4705-9048-b58533e8c255_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_581e8b93-7e4b-4025-913a-1456686fad3a_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_436dd527-c352-4255-ba90-1ad1d4282b3b_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net Income Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_8bba4266-bc1d-43a5-ab1c-7349c352acdc_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization and Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_5a3228cc-f4fa-4a01-88ef-4873e23e74c9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:to="lab_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_38648374-f65a-438d-a15a-71a9e3b6af76_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Land and land improvements</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_c0657b5c-29cf-4658-bfdb-c752d059b876_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gain (loss) on marketable debt securities</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:to="lab_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgDiscLineItems_label_en-US" xlink:label="lab_ecd_AwardTmgDiscLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Disclosures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="lab_ecd_AwardTmgDiscLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_901b2dba-d029-49ba-a710-ed3dd90dcc0f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_1a49094d-8bc9-43e7-a2a7-1c5078e713b8_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_country_US_7c24fe36-7777-4906-8cf1-15e805de60df_terseLabel_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_country_US_label_en-US" xlink:label="lab_country_US" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED STATES</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_US" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_US" xlink:to="lab_country_US" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_c5c264d9-bb68-4308-b81a-ea464dcc99eb_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_0d274284-e58b-4d41-a8ce-1a6bf0780b74_totalLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_fbd19aa2-85db-43ad-ba2b-561c5da5ccaf_terseLabel_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_ce51fb59-bfad-4b51-a8b7-5d36e9e6afa8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Intrinsic&#160;Value</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_dd341121-c8cc-4e47-bdb3-49eb9e1726d6_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_2e190b93-cce4-4cd1-9268-633d1b100b77_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_d5d001cf-8621-4cfd-8dc8-4a4ce686309e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock under equity incentive plans (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Benefit Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_ad9515e3-a564-42ce-a07c-f230f188a26e_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from issuance of convertible notes, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromConvertibleDebt" xlink:to="lab_us-gaap_ProceedsFromConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_37172c43-36c5-4b1f-9d33-1664210e0baf_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermTwoMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term Two [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermTwoMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6d175397-7ae1-4202-ad26-0f7119ea74f0_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash provided by operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_69d0057e-868d-4362-b410-0bd71021d095_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_a7c7b0d1-ea76-47e7-9f0e-f641c1be5592_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid expenses</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseCurrent" xlink:to="lab_us-gaap_PrepaidExpenseCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_abf07952-7d5b-4875-9031-ba80210397d2_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt instrument, convertible principal amount settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised And Settled</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Principal Amount Exercised And Settled</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:to="lab_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_255bf22c-50da-4bc4-851d-969591165abb_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Method</link:label>
    <link:label id="lab_ecd_AwardTmgMethodTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMethodTextBlock" xlink:to="lab_ecd_AwardTmgMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrByIndTable_terseLabel_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual</link:label>
    <link:label id="lab_ecd_TradingArrByIndTable_label_en-US" xlink:label="lab_ecd_TradingArrByIndTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="lab_ecd_TradingArrByIndTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_d36a3b81-36df-40d2-ba89-0ff591df5e35_verboseLabel_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued wages, bonus and taxes</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_label_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:label id="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent_documentation_en-US" xlink:label="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accrued Wages, Bonuses and Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:href="dxcm-20241231.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:to="lab_dxcm_AccruedWagesBonusesAndTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_e029ca5b-bd3c-4fd0-a3e4-dcdfcad10399_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermAxis_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis" xlink:to="lab_dxcm_DebtInstrumentConversionTermAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_a73a073f-4585-4167-b491-d12f79c44b70_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_f4877b4d-0267-486c-92f7-c8866975488e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term of finance leases (in years)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingPoliciesProcLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="lab_ecd_InsiderTradingPoliciesProcLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_bcef34b0-c754-433e-8cfa-adac8a23b76a_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation, Amount</link:label>
    <link:label id="lab_ecd_AdjToCompAmt_label_en-US" xlink:label="lab_ecd_AdjToCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAmt" xlink:to="lab_ecd_AdjToCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_bb26c443-c018-4970-b334-c3abb094f422_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional paid-in capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalCommonStock_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid in Capital, Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="lab_us-gaap_AdditionalPaidInCapitalCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryCompAmt" xlink:to="lab_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_c34d1066-e77d-4faa-bb1b-bda58e00eb97_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_4fb7a7d2-847d-451d-af69-65b4016322aa_negatedLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets and liabilities, net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Lease Assets and Liabilities, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:to="lab_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureAmt_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureAmt" xlink:to="lab_ecd_CoSelectedMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ResearchDevelopmentTaxCreditsMember_3ffda918-5e83-4725-a8bc-73d7ce9fa58c_terseLabel_en-US" xlink:label="lab_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">R&amp;D credits</link:label>
    <link:label id="lab_dxcm_ResearchDevelopmentTaxCreditsMember_label_en-US" xlink:label="lab_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research &amp; Development Tax Credits [Member]</link:label>
    <link:label id="lab_dxcm_ResearchDevelopmentTaxCreditsMember_documentation_en-US" xlink:label="lab_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Research &amp; Development Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:href="dxcm-20241231.xsd#dxcm_ResearchDevelopmentTaxCreditsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:to="lab_dxcm_ResearchDevelopmentTaxCreditsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TabularListTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tabular List, Table</link:label>
    <link:label id="lab_ecd_TabularListTableTextBlock_label_en-US" xlink:label="lab_ecd_TabularListTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tabular List [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TabularListTableTextBlock" xlink:to="lab_ecd_TabularListTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_5f71dc9c-7049-42e3-a733-c39e63274d72_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_93ba5667-87fb-481d-8ff6-fd400bf9ad32_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_510ad130-9028-4150-bfb3-03ac29e2b87a_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock and officers compensation</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:to="lab_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_1c4ec00c-ce75-4ce8-b67f-f2669b62bd79_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total by which the notes&#8217; if-converted value exceeds their principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, If-converted Value in Excess of Principal</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:to="lab_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_44a133b5-07f0-472f-858e-3359cac78ae7_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_a8f1309f-0710-43ec-bfaa-02e638802ead_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AuditInformationAbstract_label_en-US" xlink:label="lab_dxcm_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:label id="lab_dxcm_AuditInformationAbstract_documentation_en-US" xlink:label="lab_dxcm_AuditInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Audit Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AuditInformationAbstract" xlink:href="dxcm-20241231.xsd#dxcm_AuditInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AuditInformationAbstract" xlink:to="lab_dxcm_AuditInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityDomain_5d7dd168-b47a-450a-944e-be6e87fc567d_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityDomain_label_en-US" xlink:label="lab_us-gaap_CreditFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityDomain" xlink:to="lab_us-gaap_CreditFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerEMember_729eb1a6-9447-4dc6-9f59-00c250eeee2b_terseLabel_en-US" xlink:label="lab_dxcm_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer E</link:label>
    <link:label id="lab_dxcm_CustomerEMember_label_en-US" xlink:label="lab_dxcm_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer E [Member]</link:label>
    <link:label id="lab_dxcm_CustomerEMember_documentation_en-US" xlink:label="lab_dxcm_CustomerEMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer E</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerEMember" xlink:href="dxcm-20241231.xsd#dxcm_CustomerEMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerEMember" xlink:to="lab_dxcm_CustomerEMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_3e372543-a6cb-47e7-9927-7dba9238576e_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_f4cfe37b-1be0-4fb6-b4aa-f8096f6ecd22_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_38c89bdf-bbc9-46f0-b734-4f81abfa8a9f_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income (loss), net of tax:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_ad07d2c6-0033-455b-9956-f49a2be3f0f0_terseLabel_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock repurchase program, authorized amount</link:label>
    <link:label id="lab_srt_StockRepurchaseProgramAuthorizedAmount1_label_en-US" xlink:label="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program, Authorized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:to="lab_srt_StockRepurchaseProgramAuthorizedAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_0b5cfa80-6932-4ad6-aee3-e7705e750025_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Costs incurred</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualPayments_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard and Extended Product Warranty Accrual, Decrease for Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualPayments" xlink:to="lab_us-gaap_ProductWarrantyAccrualPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_e9e09fe0-30b5-4bb6-931b-7991f4bbaf30_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward</link:label>
    <link:label id="lab_us-gaap_ForeignExchangeForwardMember_label_en-US" xlink:label="lab_us-gaap_ForeignExchangeForwardMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Exchange Forward [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignExchangeForwardMember" xlink:to="lab_us-gaap_ForeignExchangeForwardMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_65368289-e1c7-45d1-8d45-2e84b3b4df43_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation expense</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_3507ac8c-15d5-4bd4-a83c-2a140a4363d7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_08d17d1a-03db-42bc-bd19-1ff9a5a33e16_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_4f52617b-dd4b-4f70-8c8a-2a7a533d2ed5_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other financing activities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from (Payments for) Other Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:to="lab_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9e4520aa-a21d-4108-bb5b-dc990d555fbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Security, Excluded EPS Calculation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_02e3673e-7408-49a6-b655-7114bc966dbd_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Comprehensive income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_9f57297b-28bc-4c8e-a934-e287c9b1cf90_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax payable</link:label>
    <link:label id="lab_us-gaap_AccruedIncomeTaxesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Income Taxes, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedIncomeTaxesCurrent" xlink:to="lab_us-gaap_AccruedIncomeTaxesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_83e80a32-f780-4d26-9eed-0ed00dbb8375_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate of finance leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AMTTaxCreditsMember_37a3159c-e936-42b7-be60-22520712247e_terseLabel_en-US" xlink:label="lab_dxcm_AMTTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">AMT Tax Credits</link:label>
    <link:label id="lab_dxcm_AMTTaxCreditsMember_label_en-US" xlink:label="lab_dxcm_AMTTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AMT Tax Credits [Member]</link:label>
    <link:label id="lab_dxcm_AMTTaxCreditsMember_documentation_en-US" xlink:label="lab_dxcm_AMTTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">AMT Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AMTTaxCreditsMember" xlink:href="dxcm-20241231.xsd#dxcm_AMTTaxCreditsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AMTTaxCreditsMember" xlink:to="lab_dxcm_AMTTaxCreditsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_830aad03-e7b0-43f8-8ea4-9ea2bbeba5d1_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_c648e453-5902-40ce-bf4a-7807c190f0e4_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_b40068a7-fc32-4265-bd37-8e8b296fac3e_terseLabel_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Corporate debt</link:label>
    <link:label id="lab_us-gaap_CorporateDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Corporate Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CorporateDebtSecuritiesMember" xlink:to="lab_us-gaap_CorporateDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_285d0af1-a9d5-476c-bcf4-82bbc4cc1027_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of conversion price (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_label_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:label id="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:to="lab_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_68638449-b43c-4502-9cd5-31551aa1dafe_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Work-in-process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_8159520d-bd6b-4e01-b338-ffacbe2325b6_terseLabel_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:label id="lab_dei_IcfrAuditorAttestationFlag_label_en-US" xlink:label="lab_dei_IcfrAuditorAttestationFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">ICFR Auditor Attestation Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_IcfrAuditorAttestationFlag" xlink:to="lab_dei_IcfrAuditorAttestationFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_faf637e6-5142-4537-b3f2-8c128bf58de8_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncurrentAssets_9a67f421-86ba-427f-9462-61828b2f3b91_terseLabel_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total long-lived assets</link:label>
    <link:label id="lab_us-gaap_NoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_NoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncurrentAssets" xlink:to="lab_us-gaap_NoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_8bcbbcd2-cded-497e-8156-df0ff13aab63_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_c25052dd-c866-4c4f-bc19-a21a3ce41726_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrExpirationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expiration Date</link:label>
    <link:label id="lab_ecd_TrdArrExpirationDate_label_en-US" xlink:label="lab_ecd_TrdArrExpirationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Expiration Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrExpirationDate" xlink:to="lab_ecd_TrdArrExpirationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_4d4535a0-0ff8-4998-8ce9-c9b3cde3651c_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_2e7fe9ea-b69e-4c3e-9209-21bad93a4206_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_fc8857ad-a746-4747-b2a1-f7d99f4b73a4_negatedLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnAmt" xlink:to="lab_ecd_TotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_48c4f2c5-2c7e-4856-9933-2347e74edb8c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_f4192754-eddc-4ab8-84cf-f6b03af8332d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of trading days</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="lab_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_b1a90809-4cb6-45d9-9e7a-6a0694da4ea8_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss carryforwards</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:to="lab_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_172fab85-5e60-4dce-a9e0-396aaadee375_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsFairValueDisclosure" xlink:to="lab_us-gaap_OtherAssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock_6fc85747-43ed-4547-97cb-a0c2756291cd_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Conversion Activity for Senior Convertible Notes</link:label>
    <link:label id="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Conversion Activity For Senior Convertible Notes [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Conversion Activity For Senior Convertible Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:to="lab_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquipmentMember_721199f2-0d7c-46fa-8260-d9c9edeb5eb6_terseLabel_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_EquipmentMember_label_en-US" xlink:label="lab_us-gaap_EquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquipmentMember" xlink:to="lab_us-gaap_EquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherLongTermAssets_8ae42f43-810c-4277-91e5-c64ff00e49e1_terseLabel_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_label_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:label id="lab_dxcm_OtherLongTermAssets_documentation_en-US" xlink:label="lab_dxcm_OtherLongTermAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Long -Term Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets" xlink:href="dxcm-20241231.xsd#dxcm_OtherLongTermAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherLongTermAssets" xlink:to="lab_dxcm_OtherLongTermAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_de7266a3-1c94-4c66-bafb-5dd7608b6d86_terseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalization of sales-based milestones</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid In Capital, Collaborative Research And Development Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_1f3eba43-2c61-426b-82fb-0fdab1af1e8e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_b3232b7d-adab-44eb-8493-9783e308256a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote</link:label>
    <link:label id="lab_ecd_NamedExecutiveOfficersFnTextBlock_label_en-US" xlink:label="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="lab_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_6f19dd60-ee04-47b4-83c6-2bd1f8e24426_verboseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_e359a58e-221a-44c7-914f-41d48bf3b72d_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets and Other Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseASRMember_68595dd9-2918-4386-b22a-05f78ed1a619_terseLabel_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseASRMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchase (ASR)</link:label>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseASRMember_label_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseASRMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchase (ASR) [Member]</link:label>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseASRMember_documentation_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseASRMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchase (ASR)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseASRMember" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseASRMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AcceleratedShareRepurchaseASRMember" xlink:to="lab_dxcm_AcceleratedShareRepurchaseASRMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_1afe2e4d-fab9-4779-bf8b-5823eabec4ce_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_74d503da-962c-4f0e-9785-7d0cecd9bf9c_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_e86202be-4ad4-4b27-a658-4acfda428856_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares used to compute diluted net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_8b448891-38c1-4515-b328-d22e3a0a5573_totalLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Diluted weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_41347a85-4d01-4769-bafb-d42dc8b450ce_terseLabel_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:label id="lab_srt_CondensedFinancialStatementsCaptionsLineItems_label_en-US" xlink:label="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements, Captions [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:to="lab_srt_CondensedFinancialStatementsCaptionsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_terseLabel_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
    <link:label id="lab_ecd_MnpiDiscTimedForCompValFlag_label_en-US" xlink:label="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:to="lab_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_1296a5cc-0937-4ea8-813e-136a7c982185_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current portion of long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayableCurrent_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayableCurrent" xlink:to="lab_us-gaap_ConvertibleNotesPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_4cc5e4c2-8778-4a36-887f-f4a920a15db2_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_585677c4-8303-4126-96f1-ce5d2e34db9d_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_90bf271c-f611-457a-b902-9162809799c5_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total gross deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGross_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGross" xlink:to="lab_us-gaap_DeferredTaxAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_5d35d82b-5122-4360-9947-d1e12d2e827d_terseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fixed and intangible assets</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Fixed Assets and Intangible Assets</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Fixed Assets and Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:to="lab_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_86a35b7b-cf35-4590-aaa9-2382fd9eeb45_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development and Other Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:to="lab_us-gaap_CollaborativeArrangementDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_3fa56686-852c-4637-81fa-d4a50feff4db_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_09ea361c-9d83-47a0-b89d-96125fe92fb8_terseLabel_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding letters of credit</link:label>
    <link:label id="lab_us-gaap_LettersOfCreditOutstandingAmount_label_en-US" xlink:label="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letters of Credit Outstanding, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LettersOfCreditOutstandingAmount" xlink:to="lab_us-gaap_LettersOfCreditOutstandingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_8536718f-a37c-4da8-a198-ebc749b66c7f_terseLabel_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period for incentive compensation costs (in years)</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_label_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:label id="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts_documentation_en-US" xlink:label="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Period For Incentive Compensation Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:to="lab_dxcm_AmortizationPeriodForIncentiveCompensationCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_d247bb83-649c-4c08-bb61-c807101cf644_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_884e1e8e-c38c-47dc-941b-b92bcdd23d0a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total matching contributions</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanCostRecognized_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanCostRecognized" xlink:to="lab_us-gaap_DefinedContributionPlanCostRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_d504cd9c-6923-467d-bfa2-8b72f96e62e7_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_1e47edbf-0d4e-495a-8040-c74ac1458f83_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Payments for conversions of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_RepaymentsOfConvertibleDebt_label_en-US" xlink:label="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Repayments of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RepaymentsOfConvertibleDebt" xlink:to="lab_us-gaap_RepaymentsOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_84b7e7ab-6633-4c3c-8d99-e01bf78502f9_verboseLabel_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Charges to costs and expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_label_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:label id="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_documentation_en-US" xlink:label="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual Charges To Costs And Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:href="dxcm-20241231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:to="lab_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_a7aca4cd-a8ef-40d3-9f5f-7ebc78e079a5_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_165cc232-0146-41ec-99bb-cfb498691853_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock reserved for issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_4a178691-43ea-46d5-8b6a-0049b50aec27_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_terseLabel_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Executive Categories</link:label>
    <link:label id="lab_ecd_AllExecutiveCategoriesMember_label_en-US" xlink:label="lab_ecd_AllExecutiveCategoriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Executive Categories [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="lab_ecd_AllExecutiveCategoriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_4d15e481-6c66-4d63-bfce-e265f9a6d999_terseLabel_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dilutive potential securities (in shares)</link:label>
    <link:label id="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_label_en-US" xlink:label="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:to="lab_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_9be480ee-cd67-48ae-91d6-025335d433b0_terseLabel_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of initial purchasers</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_label_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:label id="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_documentation_en-US" xlink:label="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Initial Purchasers For Convertible Note Hedge Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:href="dxcm-20241231.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:to="lab_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_b811859e-1d61-41d9-8b7e-b314381977ed_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtSecuritiesMember_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtSecuritiesMember" xlink:to="lab_us-gaap_ConvertibleDebtSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward_10b854ef-f637-40e0-9e4b-050ca8695d2c_terseLabel_en-US" xlink:label="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Treasury Stock [Roll Forward]</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward_label_en-US" xlink:label="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Treasury Stock [Roll Forward]</link:label>
    <link:label id="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward_documentation_en-US" xlink:label="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Increase (Decrease) In Treasury Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseInTreasuryStockRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:to="lab_dxcm_IncreaseDecreaseInTreasuryStockRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_fbe52e39-b1dd-4081-b844-ed3710ef7664_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
    <link:label id="lab_ecd_ChangedPeerGroupFnTextBlock_label_en-US" xlink:label="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Changed Peer Group, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:to="lab_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_50701cce-2dce-4057-bc0c-5d9e15f34a41_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_c267d176-b084-4f3c-8bf7-eaf7e863aef3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividend yield (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_abd27041-f53e-43a4-b7e3-c27d55685761_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_9d189c37-2bd7-4151-a6ef-bee8adf8326a_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effective interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_a791aa5d-0524-4d59-84e6-85ffac99e6b0_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:label id="lab_us-gaap_DerivativeContractTypeDomain_label_en-US" xlink:label="lab_us-gaap_DerivativeContractTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Contract [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeContractTypeDomain" xlink:to="lab_us-gaap_DerivativeContractTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_cd74a56d-c636-40b5-8116-753064793461_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="lab_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_b1c65352-9f40-4841-87be-907bff198124_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contractual coupon interest</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebtExcludingAmortization_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt, Excluding Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:to="lab_us-gaap_InterestExpenseDebtExcludingAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_d1276a65-ad41-465e-a9c6-06c4ed61997c_totalLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Amortized Cost</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Amortized Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_625f39bc-5060-4362-ba8d-6045edb46d3c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_137ab113-b85b-4c64-a9a7-80b0525c658b_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_755d4828-bf1c-41b2-8869-5624b6cb23f4_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PayrollRelatedExpenses_5755f6b5-de3e-4ffd-82f2-3924c622c83e_terseLabel_en-US" xlink:label="lab_dxcm_PayrollRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payroll related expenses</link:label>
    <link:label id="lab_dxcm_PayrollRelatedExpenses_label_en-US" xlink:label="lab_dxcm_PayrollRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payroll Related Expenses</link:label>
    <link:label id="lab_dxcm_PayrollRelatedExpenses_documentation_en-US" xlink:label="lab_dxcm_PayrollRelatedExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payroll Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PayrollRelatedExpenses" xlink:href="dxcm-20241231.xsd#dxcm_PayrollRelatedExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PayrollRelatedExpenses" xlink:to="lab_dxcm_PayrollRelatedExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_842d9a3f-ef7f-4510-aba4-ffd2d3c4545d_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
    <link:label id="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock_label_en-US" xlink:label="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="lab_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_c80ab1b5-70ed-423e-9457-48735202cc83_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_f1f2a530-f21f-4b45-bfb8-909418cf8a34_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_9b22ee45-837b-4233-8472-ce2692dc1ef4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_54ac7d2b-5b2d-490e-b747-2571cf2a6182_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total lease cost</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_14800950-bff5-43f9-8ef2-b1079dca726b_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_NonRule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:to="lab_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_298b40b6-dbc6-4f5c-bd27-4c24e4bae960_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense_56df0f82-e6bf-4628-84a2-668c9b8f42ab_terseLabel_en-US" xlink:label="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock-based compensation expense</link:label>
    <link:label id="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense_label_en-US" xlink:label="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Operating Expense</link:label>
    <link:label id="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense_documentation_en-US" xlink:label="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Operating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedPaymentArrangementOperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:to="lab_dxcm_ShareBasedPaymentArrangementOperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgTotalCompAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="lab_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_OutstandingRecoveryIndName_label_en-US" xlink:label="lab_ecd_OutstandingRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingRecoveryIndName" xlink:to="lab_ecd_OutstandingRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableLeaseCost_95bc97a1-a539-4696-a42f-952a8bb74d40_terseLabel_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable lease cost</link:label>
    <link:label id="lab_us-gaap_VariableLeaseCost_label_en-US" xlink:label="lab_us-gaap_VariableLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableLeaseCost" xlink:to="lab_us-gaap_VariableLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_0b5ba13c-b0f9-48c8-b2f9-e2381c42f375_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Goodwill impairment charges</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_02086f5b-67a0-442a-9f58-1ecfa4c3b00d_verboseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_01c76398-158d-40a2-b012-519faaa159c2_terseLabel_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential future common stock issuable (in shares)</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_label_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_documentation_en-US" xlink:label="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Future Common Stock Issuable, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:href="dxcm-20241231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:to="lab_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_cfdbbcb4-a745-4bc4-a744-d7f8ca5acf6c_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative research and development fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_label_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Research And Development Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeResearchAndDevelopmentFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Research and Development Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:to="lab_dxcm_CollaborativeResearchAndDevelopmentFee" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined</link:label>
    <link:label id="lab_ecd_AwardTmgPredtrmndFlag_label_en-US" xlink:label="lab_ecd_AwardTmgPredtrmndFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing Predetermined [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgPredtrmndFlag" xlink:to="lab_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NumberOfPrimaryGeographicMarkets_a17e9026-0e22-4bf0-840e-6f3f6f64b908_terseLabel_en-US" xlink:label="lab_dxcm_NumberOfPrimaryGeographicMarkets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of primary geographic markets</link:label>
    <link:label id="lab_dxcm_NumberOfPrimaryGeographicMarkets_label_en-US" xlink:label="lab_dxcm_NumberOfPrimaryGeographicMarkets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number Of Primary Geographic Markets</link:label>
    <link:label id="lab_dxcm_NumberOfPrimaryGeographicMarkets_documentation_en-US" xlink:label="lab_dxcm_NumberOfPrimaryGeographicMarkets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Number Of Primary Geographic Markets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfPrimaryGeographicMarkets" xlink:href="dxcm-20241231.xsd#dxcm_NumberOfPrimaryGeographicMarkets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NumberOfPrimaryGeographicMarkets" xlink:to="lab_dxcm_NumberOfPrimaryGeographicMarkets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_20900065-3dca-4a86-b67f-f9b27b14a98b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Redemption price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentRedemptionPricePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Redemption Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:to="lab_us-gaap_DebtInstrumentRedemptionPricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_143faa1c-aaa0-4691-ba4d-18275bfa9515_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_d3393909-adf8-48e6-9e7d-da4388d5b653_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Diluted net income per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_7945946f-19c2-42a5-83e7-90531a955bcf_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of operating lease right-of-use asset</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases, Lease Cost, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:to="lab_dxcm_LesseeOperatingLeasesLeaseCostAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_ceef30a4-aa00-4530-8faa-ca35a8139942_terseLabel_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash interest expense:</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_CashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_CashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Cash Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract" xlink:href="dxcm-20241231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CashInterestExpenseAbstract" xlink:to="lab_dxcm_CashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_1434edc4-5655-4307-8304-69d9deefc35f_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_abfbb3dd-f722-4487-a152-fc490cd1da04_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_6bfbd050-5af1-412c-8d55-08596faaf71f_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets Amortization Expense</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_8b382f92-1ccb-43e1-bff8-5d2855d6abc3_terseLabel_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_StateAndLocalJurisdictionMember_label_en-US" xlink:label="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">State and Local Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StateAndLocalJurisdictionMember" xlink:to="lab_us-gaap_StateAndLocalJurisdictionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_47e213a4-82c1-47bc-9d22-26b85b0bdbc2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Domestic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_a43726e1-5b18-4905-a619-7d26061bf62c_totalLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current income taxes</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_terseLabel_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement does not require Recovery</link:label>
    <link:label id="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock_label_en-US" xlink:label="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Does Not Require Recovery [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="lab_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_1ea09be7-2a42-4fa9-bb38-55d5a6c821d7_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common received vesting percentage</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_70f2e3a2-663d-41c1-a5e0-52ea20e28a69_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_15d4d7db-0bbb-4b53-ad30-6c7fce1586c9_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax liabilities:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_92a47b83-e03c-4a12-98bb-2b38537391c2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_ee9de063-38f9-4b90-b788-0d5cbca9fbff_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_ca63d3bd-5dad-49da-87e3-c96983f0c615_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_ab8c5476-5371-4110-938f-56624dacc4b6_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_f23c0aa4-0a88-4b4f-a338-6f4fe8b629a3_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Research and development credits</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsResearch" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_91780026-8294-41a3-9074-82cd0dcc50ff_negatedLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_DeferredTaxLiabilitiesOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesOther" xlink:to="lab_us-gaap_DeferredTaxLiabilitiesOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_cdcb49a2-5ef0-4b1b-8e3d-a04bf3269c7b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of vested awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_d021ee21-f33d-4c5d-9b61-78aee6517b94_terseLabel_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer contract payment terms (in days)</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_label_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:label id="lab_dxcm_ContractPaymentTermsNumberofDays_documentation_en-US" xlink:label="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Contract Payment Terms, Number of Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:href="dxcm-20241231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ContractPaymentTermsNumberofDays" xlink:to="lab_dxcm_ContractPaymentTermsNumberofDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_bcceee70-3b6b-4084-81bd-818e7bf164d9_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_65b96f77-ef0d-42e8-b4d4-c288721a3f83_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Income taxes at effective rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_a14b22fe-2998-4e9a-a6ad-981dccc47598_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_389853ed-2829-4492-b18c-9eef6151311d_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Notional amount of outstanding hedge to currency risk</link:label>
    <link:label id="lab_us-gaap_DerivativeNotionalAmount_label_en-US" xlink:label="lab_us-gaap_DerivativeNotionalAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Notional Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeNotionalAmount" xlink:to="lab_us-gaap_DerivativeNotionalAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_b63aa2fd-ed04-479c-a10c-b2bbb3349247_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs recognized weighted average period (in years)</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_d0b90035-346d-4455-8581-2d6c26d74a0d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_2184c699-14e2-4006-9466-3239914b6a6c_verboseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Total revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_82dca5f2-4432-4bec-b091-46ca9c9a4df6_negatedTerseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Tax benefit related to Senior Convertible Notes</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_5cefe66c-6ef4-40bf-9b1d-1b31c7640a2f_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intellectual property transfer</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intellectual Property Transfer</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Intellectual Property Transfer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:to="lab_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_f2a09925-1d29-4418-8b3c-783331fa7da4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EquityIncentivePlan2015Member_67530e57-cd45-4aae-b289-f2b4f369eda0_terseLabel_en-US" xlink:label="lab_dxcm_EquityIncentivePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">EIP 2015</link:label>
    <link:label id="lab_dxcm_EquityIncentivePlan2015Member_label_en-US" xlink:label="lab_dxcm_EquityIncentivePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2015 [Member]</link:label>
    <link:label id="lab_dxcm_EquityIncentivePlan2015Member_documentation_en-US" xlink:label="lab_dxcm_EquityIncentivePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equity Incentive Plan 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquityIncentivePlan2015Member" xlink:href="dxcm-20241231.xsd#dxcm_EquityIncentivePlan2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EquityIncentivePlan2015Member" xlink:to="lab_dxcm_EquityIncentivePlan2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_529de152-d57b-45d7-9240-f642535d602f_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_ede99c0f-7ab5-43bd-8dff-695a2abbd13e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory write-down</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_a19f244e-baf5-4ccb-8e6c-9406d5397d10_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_46a5f935-d386-4c42-b4f4-95bc558b4904_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_6f91a59e-a8c1-4c17-9974-1ea1ed49ef84_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxAuthorityAxis_label_en-US" xlink:label="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Jurisdiction [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis" xlink:to="lab_us-gaap_IncomeTaxAuthorityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllAdjToCompMember_terseLabel_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation</link:label>
    <link:label id="lab_ecd_AllAdjToCompMember_label_en-US" xlink:label="lab_ecd_AllAdjToCompMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Adjustments to Compensation [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="lab_ecd_AllAdjToCompMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_084f790a-79b9-4d8a-8180-cba86779e645_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_dc800ea4-26b7-4c4b-a69c-9a2fbc727366_totalLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ba69da10-4529-4faf-b454-39ad537c1e89_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Prepaid and other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_de37eb22-2fa3-4620-8732-762c0338e72a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Income (Expense), Net</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Nonoperating Income (Expense) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_e6a1af5f-b9ca-430b-929d-919f64aa2818_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAxis_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis" xlink:to="lab_us-gaap_TaxCreditCarryforwardAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_889cdd16-a30b-482d-aa57-a2329e563478_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_323421f3-9352-4f41-a252-99ba3853ddfd_terseLabel_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred compensation plan assets</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_label_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:label id="lab_dxcm_DeferredCompensationPlanAssetsCurrent_documentation_en-US" xlink:label="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Compensation Plan Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:href="dxcm-20241231.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:to="lab_dxcm_DeferredCompensationPlanAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_5f7d3b25-b4dc-4a2a-a9e8-a38298229add_terseLabel_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Maturity threshold of investments classified to cash equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_label_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:label id="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_documentation_en-US" xlink:label="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Maturity Threshold Of Investments Classified To Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:href="dxcm-20241231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:to="lab_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_e9aa8c48-f10c-406f-8f06-72b28dec0f66_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock, $0.001 par value, 800.0 million shares authorized; 408.9 million and 390.7 million shares issued and outstanding, respectively, at December&#160;31, 2024; and 407.2 million and 385.4 million shares issued and outstanding, respectively, at December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_2994194b-9863-4aee-a377-b1e515fbf638_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted cash</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_e65ac0c3-6e00-45a6-8cda-92e62d65e99a_terseLabel_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Convertible notes receivable</link:label>
    <link:label id="lab_us-gaap_NotesReceivableFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Notes Receivable, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NotesReceivableFairValueDisclosure" xlink:to="lab_us-gaap_NotesReceivableFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_b730dbfd-6158-4a6d-8875-4a6fcf80ea68_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_a323e2ba-8a7a-4cde-9ef5-dfbdffbea866_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
    <link:label id="lab_ecd_ErrCompAnalysisTextBlock_label_en-US" xlink:label="lab_ecd_ErrCompAnalysisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneous Compensation Analysis [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompAnalysisTextBlock" xlink:to="lab_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_9870d327-35a9-475a-a8db-a19465ff5ed5_verboseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable trade</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_a3f88c3f-843c-4fa3-9177-914a22d57392_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_b44bd4fc-7c17-4b76-a0a6-e4f2f230bb62_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_611aa55e-e572-4e70-96bf-ef5906b79a20_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_c67025cc-2937-43da-a83d-4058a8487c20_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Liabilities and Stockholders&#8217; Equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDeterminationDate_terseLabel_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:label id="lab_ecd_RestatementDeterminationDate_label_en-US" xlink:label="lab_ecd_RestatementDeterminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDeterminationDate" xlink:to="lab_ecd_RestatementDeterminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_VerilyIntangibleMember_fd25f7b8-ff3b-4d1f-b1f5-fdc2921fde71_terseLabel_en-US" xlink:label="lab_dxcm_VerilyIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Verily intangible asset</link:label>
    <link:label id="lab_dxcm_VerilyIntangibleMember_label_en-US" xlink:label="lab_dxcm_VerilyIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Verily Intangible [Member]</link:label>
    <link:label id="lab_dxcm_VerilyIntangibleMember_documentation_en-US" xlink:label="lab_dxcm_VerilyIntangibleMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Verily Intangible</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyIntangibleMember" xlink:href="dxcm-20241231.xsd#dxcm_VerilyIntangibleMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyIntangibleMember" xlink:to="lab_dxcm_VerilyIntangibleMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_83a9e827-0ff4-4fca-8b26-cd9074d3d801_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_358f952e-28d1-4749-82e4-48cb7ee818a0_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermOneMember_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermOneMember" xlink:to="lab_dxcm_DebtInstrumentConversionTermOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_b2d467c0-f3c5-4d1b-9048-47dd2a5eed7b_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Noncurrent available-for-sale securities</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTable_terseLabel_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure</link:label>
    <link:label id="lab_ecd_PvpTable_label_en-US" xlink:label="lab_ecd_PvpTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTable" xlink:to="lab_ecd_PvpTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_9c5b5c28-37fb-4b2e-94e6-591963a774f3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_ea5c526d-cef1-42c6-a551-f31f5fe66a9b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTable_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTable" xlink:to="lab_us-gaap_ConcentrationRiskTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_723b3189-9545-4e1e-af1b-c83dccc559a0_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ErrCompRecoveryTable_terseLabel_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery</link:label>
    <link:label id="lab_ecd_ErrCompRecoveryTable_label_en-US" xlink:label="lab_ecd_ErrCompRecoveryTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="lab_ecd_ErrCompRecoveryTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_47588344-b86a-4cf5-9b18-2c80894d7387_terseLabel_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Possible extension period of tax holiday (in years)</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_label_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:label id="lab_dxcm_PossibleExtensionPeriodofTaxHoliday_documentation_en-US" xlink:label="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Possible Extension Period of Tax Holiday</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:href="dxcm-20241231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:to="lab_dxcm_PossibleExtensionPeriodofTaxHoliday" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_e8b66620-74bb-4903-903d-a0f1249fb572_terseLabel_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of purchase obligations (in years)</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_label_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term</link:label>
    <link:label id="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_documentation_en-US" xlink:label="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:href="dxcm-20241231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:to="lab_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member_31ccd1b3-6cd2-4870-a7c3-6efd46b5a9c6_terseLabel_en-US" xlink:label="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member_label_en-US" xlink:label="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR) 1 [Member]</link:label>
    <link:label id="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member_documentation_en-US" xlink:label="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">London Interbank Offered Rate (LIBOR) 1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:href="dxcm-20241231.xsd#dxcm_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:to="lab_dxcm_LondonInterbankOfferedRateLIBOR1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_07767205-6674-4d8f-ba74-b8518973b2f7_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:to="lab_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock_f5b1baab-8945-4303-a907-84ab74c634c4_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Treasury Share Activity Table Text Block</link:label>
    <link:label id="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Treasury Share Activity [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Treasury Share Activity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfTreasuryShareActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:to="lab_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_stpr_CA_f1676535-4ac4-4c7d-b3b3-923cb820c633_terseLabel_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">California</link:label>
    <link:label id="lab_stpr_CA_label_en-US" xlink:label="lab_stpr_CA" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">CALIFORNIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_stpr_CA" xlink:to="lab_stpr_CA" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_61e87dc7-1bc0-4a6e-9a27-ac4866ce04ed_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Balance Sheet Details and Other Financial Information</link:label>
    <link:label id="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Financial Information Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:to="lab_us-gaap_AdditionalFinancialInformationDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_e77cb1d9-f0fa-491c-8191-bc6d01d1cb56_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_42c70fb2-1a1c-4302-b4fd-faa806b21465_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A2022ShareRepurchaseProgramMember_07e5686e-d55e-49fc-a77e-fa656bc9ab8f_terseLabel_en-US" xlink:label="lab_dxcm_A2022ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2022 Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_A2022ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_A2022ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2022 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_A2022ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_A2022ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2022 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2022ShareRepurchaseProgramMember" xlink:href="dxcm-20241231.xsd#dxcm_A2022ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A2022ShareRepurchaseProgramMember" xlink:to="lab_dxcm_A2022ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_861b6b04-5a01-43d6-8dbf-6f9f77535a9e_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Converted Value of Notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtTableTextBlock" xlink:to="lab_us-gaap_ConvertibleDebtTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1791513c-5fa9-4100-baca-9032bc52d246_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_9e9ec537-009c-45d4-bb34-44d47bc3a97f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
    <link:label id="lab_ecd_PeerGroupIssuersFnTextBlock_label_en-US" xlink:label="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Issuers, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:to="lab_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_be996d04-0e42-483a-9bc3-5b41db18dc2c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Maturity of Finance Lease Liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_d6bb4966-ecf9-4fed-bc0e-c96787fcb94b_terseLabel_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other tax liabilities</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_label_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:label id="lab_dxcm_OtherTaxLiabilitiesNoncurrent_documentation_en-US" xlink:label="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Tax Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:href="dxcm-20241231.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:to="lab_dxcm_OtherTaxLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8a5429bb-ac8d-4a3c-ba4f-b25540ffb641_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:to="lab_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_a983f6f8-8530-4e28-b710-022f57ea2832_terseLabel_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense:</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_label_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-Cash Interest Expense [Abstract]</link:label>
    <link:label id="lab_dxcm_NonCashInterestExpenseAbstract_documentation_en-US" xlink:label="lab_dxcm_NonCashInterestExpenseAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Non-Cash Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract" xlink:href="dxcm-20241231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract" xlink:to="lab_dxcm_NonCashInterestExpenseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_789f95a7-658f-43da-8437-703201767467_terseLabel_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trademarks and trade name</link:label>
    <link:label id="lab_us-gaap_TrademarksAndTradeNamesMember_label_en-US" xlink:label="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trademarks and Trade Names [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TrademarksAndTradeNamesMember" xlink:to="lab_us-gaap_TrademarksAndTradeNamesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherForeignMember_80ade79c-8f0d-4372-8f73-57200d030c71_terseLabel_en-US" xlink:label="lab_dxcm_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other foreign</link:label>
    <link:label id="lab_dxcm_OtherForeignMember_label_en-US" xlink:label="lab_dxcm_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Foreign [Member]</link:label>
    <link:label id="lab_dxcm_OtherForeignMember_documentation_en-US" xlink:label="lab_dxcm_OtherForeignMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherForeignMember" xlink:href="dxcm-20241231.xsd#dxcm_OtherForeignMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherForeignMember" xlink:to="lab_dxcm_OtherForeignMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoMember_terseLabel_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO</link:label>
    <link:label id="lab_ecd_PeoMember_label_en-US" xlink:label="lab_ecd_PeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoMember" xlink:to="lab_ecd_PeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndName_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_TrdArrIndName_label_en-US" xlink:label="lab_ecd_TrdArrIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndName" xlink:to="lab_ecd_TrdArrIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_bda25313-bd25-4e18-afd9-503c8b64e64a_terseLabel_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee purchase price floor (as a percent)</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_label_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Purchase Price Floor Percentage</link:label>
    <link:label id="lab_dxcm_EmployeePurchasePriceFloorPercentage_documentation_en-US" xlink:label="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee purchase price floor, percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage" xlink:href="dxcm-20241231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeePurchasePriceFloorPercentage" xlink:to="lab_dxcm_EmployeePurchasePriceFloorPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerDMember_50c51aba-e925-44ff-90b2-0da971c97c10_terseLabel_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer D</link:label>
    <link:label id="lab_dxcm_CustomerDMember_label_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer D [Member]</link:label>
    <link:label id="lab_dxcm_CustomerDMember_documentation_en-US" xlink:label="lab_dxcm_CustomerDMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer D</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember" xlink:href="dxcm-20241231.xsd#dxcm_CustomerDMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerDMember" xlink:to="lab_dxcm_CustomerDMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_35d408e7-2e75-41b7-8d95-b08035915e92_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityPublicFloat_75ff93a3-a0de-4c72-923b-2d749b3b90ee_terseLabel_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:label id="lab_dei_EntityPublicFloat_label_en-US" xlink:label="lab_dei_EntityPublicFloat" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Public Float</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityPublicFloat" xlink:to="lab_dei_EntityPublicFloat" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_ddcac476-5df3-4485-b48b-31094794dfc3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Remaining lease terms (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_92a632ba-1bd0-4cbf-8881-3319cefcaeab_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost; 18.2 million shares at December&#160;31, 2024 and 21.8 million shares at December&#160;31, 2023</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonValue" xlink:to="lab_us-gaap_TreasuryStockCommonValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_af38f31b-bc95-4205-a464-be24b5fd9181_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unused capacity fee (as a percent)</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Unused Capacity, Commitment Fee Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:to="lab_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_15e1c61c-bc51-4313-9af6-0ff047ac3513_terseLabel_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Percentage of Total Revenues and Accounts Receivable by Customer</link:label>
    <link:label id="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_label_en-US" xlink:label="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedules of Concentration of Risk, by Risk Factor [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:to="lab_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_1e9eae4d-3174-4c4f-96b8-92559f370086_terseLabel_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:label id="lab_srt_ValuationAndQualifyingAccountsAbstract_label_en-US" xlink:label="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract" xlink:to="lab_srt_ValuationAndQualifyingAccountsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</link:label>
    <link:label id="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_label_en-US" xlink:label="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:to="lab_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_0673ad9e-109a-469b-825e-924ff8856a00_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_AggtErrCompAmt_label_en-US" xlink:label="lab_ecd_AggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompAmt" xlink:to="lab_ecd_AggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_44c83897-121f-4639-90ed-1ff5a71cb7dd_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestones</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Achievement Of Milestones</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:to="lab_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_d874ac30-c566-4f6b-b687-0fcd62135ed4_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_c7a31c36-6f59-479d-b538-d2653849351f_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance amount</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_ea056c24-3a26-468b-83c7-61904f93d0c1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: valuation allowance</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_DeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
    <link:label id="lab_ecd_AggtErrCompNotYetDeterminedTextBlock_label_en-US" xlink:label="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="lab_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_9d862e98-cec9-4c67-ba73-5b2d95bc2872_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_0d962b6d-c138-4f06-9aed-c88ecb432334_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoTotalCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoTotalCompAmt_label_en-US" xlink:label="lab_ecd_PeoTotalCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Total Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoTotalCompAmt" xlink:to="lab_ecd_PeoTotalCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_f4312b1f-5d7e-4bb8-804e-7174614145de_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_c2715894-4d60-4208-86ed-daa4b90410bc_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_a17b81e7-74fd-4f77-9947-e89cadc22b4b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_b4d043e5-7a97-4bad-82ee-37d8c02114a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common&#160;Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_1a689383-4234-4b79-b2f8-539e06f21029_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:label id="lab_srt_ScheduleOfCondensedFinancialStatementsTable_label_en-US" xlink:label="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Condensed Financial Statements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:to="lab_srt_ScheduleOfCondensedFinancialStatementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_fbaa81d3-b043-4831-8f11-9952028ab6fa_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_8ee9e9e0-a200-46c3-b118-9c0d13937dbf_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingAbstract_label_en-US" xlink:label="lab_us-gaap_SegmentReportingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingAbstract" xlink:to="lab_us-gaap_SegmentReportingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1d7a04fe-4721-412d-94ab-bbe5af4f05e9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_b8b219af-6dc0-4f8b-9cf9-893b3c48fa9e_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Write-offs and adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_label_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments</link:label>
    <link:label id="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_documentation_en-US" xlink:label="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:href="dxcm-20241231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:to="lab_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_2b73f5b1-a569-4832-9427-07bf594bc2a4_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other segment items</link:label>
    <link:label id="lab_us-gaap_SegmentReportingOtherItemAmount_label_en-US" xlink:label="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting, Other Segment Item, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingOtherItemAmount" xlink:to="lab_us-gaap_SegmentReportingOtherItemAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_2b703000-b7d9-4c1a-bc77-7ae72f012fbc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_08e195dd-1267-418c-977e-105bbcbaae9f_verboseLabel_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Available for Grant</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_label_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Available for Grant [Roll Forward]</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_documentation_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:to="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b692315d-1c7a-463c-b413-2ed5eae5091c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock counterparties to acquire with warrants purchased (in shares)</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:label id="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt_label_en-US" xlink:label="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="lab_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_de2a5493-56d0-4315-81ed-b367123711cc_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing, How MNPI Considered [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="lab_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_49122bf0-bdab-48dd-8bb6-7e450e6f1fb5_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_42366561-7603-4299-9f89-a9e4abc612c0_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Business Segment and Geographic Information</link:label>
    <link:label id="lab_us-gaap_SegmentReportingDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingDisclosureTextBlock" xlink:to="lab_us-gaap_SegmentReportingDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_95d55378-dd59-41a4-be4e-4515f32d6565_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProfessionalFees_7dbee7f1-25eb-42ac-9b9f-c2877d323d7c_terseLabel_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Consulting &amp; professional fees</link:label>
    <link:label id="lab_us-gaap_ProfessionalFees_label_en-US" xlink:label="lab_us-gaap_ProfessionalFees" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Professional Fees</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProfessionalFees" xlink:to="lab_us-gaap_ProfessionalFees" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrIndTitle_terseLabel_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title</link:label>
    <link:label id="lab_ecd_TrdArrIndTitle_label_en-US" xlink:label="lab_ecd_TrdArrIndTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Individual Title</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrIndTitle" xlink:to="lab_ecd_TrdArrIndTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_c809084f-75c2-49bb-a1da-02525ba9237d_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration agreement milestone share-based payment</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Collaboration Agreement Milestone, Share-based Payment</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Collaboration Agreement Milestone, Share-based Payment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:to="lab_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_d6d864cb-061f-4898-a052-d9dd78880266_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Income (Loss) before Income Taxes Subject to Taxes</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_07ca6f27-1ebd-4dee-b390-98c4c4b8474a_periodStartLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_e2e43862-a829-4a73-a65f-11553bd183be_periodEndLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefits_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefits" xlink:to="lab_us-gaap_UnrecognizedTaxBenefits" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_76102212-522f-4bfe-a6dc-050edc8febd9_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_a9403b16-80b1-4bc1-835a-37c6c81b7338_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorLocation_8293e2c5-9a8f-4abc-bbaf-71f44f1bbdb8_terseLabel_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:label id="lab_dei_AuditorLocation_label_en-US" xlink:label="lab_dei_AuditorLocation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Location</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorLocation" xlink:to="lab_dei_AuditorLocation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_129a160e-cc63-4ac6-819a-20d34eb7ccad_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued liabilities and reserves</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeSalesBasedMilestoneMember_8ba52ccd-0ada-43ef-9cbf-5a66e5491ae1_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative sales-based milestones</link:label>
    <link:label id="lab_dxcm_CollaborativeSalesBasedMilestoneMember_label_en-US" xlink:label="lab_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Sales-based Milestone [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeSalesBasedMilestoneMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Sales-based Milestone</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeSalesBasedMilestoneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:to="lab_dxcm_CollaborativeSalesBasedMilestoneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="lab_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_368cab5a-1c6f-4d35-96bc-a7332a87e733_terseLabel_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_label_en-US" xlink:label="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Income and Interest Expense Disclosure [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:to="lab_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_6ff93ed4-0af1-4062-9249-73738af625e7_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total available balance</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Remaining Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_30e133df-23cf-4bb4-9140-16e83866e961_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_31e36bc2-dad0-466d-bb59-8991e5dd35b1_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock</link:label>
    <link:label id="lab_us-gaap_PaymentsForRepurchaseOfCommonStock_label_en-US" xlink:label="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for Repurchase of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:to="lab_us-gaap_PaymentsForRepurchaseOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_a5d0bd5c-5243-4c01-ad98-f3dcbb122bbe_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivables and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receivable [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesPolicyTextBlock" xlink:to="lab_us-gaap_ReceivablesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_cd18aad5-c7f8-4f89-ada5-5b4ad999f336_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Segment Reporting Information, by Segment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:to="lab_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_ccfdd56c-de05-45fe-9f22-5e9e0a1caef2_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in statutory tax rates</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_42d33a04-a8c5-4c8b-8e7f-ec2f1121ac36_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted&#160; Average Grant&#160;Date Fair&#160;Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_c8a186aa-9f11-4086-99c4-2e759aa6cfda_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ForeignTaxCreditsMember_d8f91c8a-afde-4dfa-82ac-8520ac61c69f_terseLabel_en-US" xlink:label="lab_dxcm_ForeignTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax credits</link:label>
    <link:label id="lab_dxcm_ForeignTaxCreditsMember_label_en-US" xlink:label="lab_dxcm_ForeignTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Credits [Member]</link:label>
    <link:label id="lab_dxcm_ForeignTaxCreditsMember_documentation_en-US" xlink:label="lab_dxcm_ForeignTaxCreditsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Foreign Tax Credits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ForeignTaxCreditsMember" xlink:href="dxcm-20241231.xsd#dxcm_ForeignTaxCreditsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ForeignTaxCreditsMember" xlink:to="lab_dxcm_ForeignTaxCreditsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_4342981d-0379-44ad-915f-2e712983f69b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_32dfc1ff-f128-4bc6-9a3d-e14522b3c301_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_9a9c19af-60cd-4116-89ed-08c27b17ee0f_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_terseLabel_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Available</link:label>
    <link:label id="lab_ecd_TrdArrSecuritiesAggAvailAmt_label_en-US" xlink:label="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement, Securities Aggregate Available Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="lab_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="lab_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3ecd9a22-6f12-4cd3-a3b8-90fefe538bae_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LongTermDeposits_f869cbd3-6ec9-432e-8704-9dc03063aa27_terseLabel_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_label_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:label id="lab_dxcm_LongTermDeposits_documentation_en-US" xlink:label="lab_dxcm_LongTermDeposits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Long -Term Deposits</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits" xlink:href="dxcm-20241231.xsd#dxcm_LongTermDeposits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LongTermDeposits" xlink:to="lab_dxcm_LongTermDeposits" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_terseLabel_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Securities</link:label>
    <link:label id="lab_ecd_AwardUndrlygSecuritiesAmt_label_en-US" xlink:label="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Underlying Securities Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:to="lab_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PerformanceSharesMember_3c8dbe31-0e30-4c7b-94f8-ff2d7ddcbdd8_terseLabel_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PSUs</link:label>
    <link:label id="lab_us-gaap_PerformanceSharesMember_label_en-US" xlink:label="lab_us-gaap_PerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Performance Shares [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PerformanceSharesMember" xlink:to="lab_us-gaap_PerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_0d48ccce-7f57-4920-83d5-0e433c7ac075_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_3905afe1-647c-40ec-a472-ea24e104afd7_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A2023ShareRepurchaseProgramMember_f94d2b37-269f-4618-afc5-4fd567624b39_terseLabel_en-US" xlink:label="lab_dxcm_A2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2023 Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_A2023ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_A2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2023 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_A2023ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_A2023ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2023 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2023ShareRepurchaseProgramMember" xlink:href="dxcm-20241231.xsd#dxcm_A2023ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A2023ShareRepurchaseProgramMember" xlink:to="lab_dxcm_A2023ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_2b693694-a996-4600-8ebd-230870a6c18a_negatedLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Loss on disposal of machinery and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_terseLabel_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs)</link:label>
    <link:label id="lab_us-gaap_StockAppreciationRightsSARSMember_label_en-US" xlink:label="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Appreciation Rights (SARs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:to="lab_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_9b41a0ec-38e0-45fd-b5b7-88b84b860de3_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_9c0fe939-bead-46eb-9d18-6910cf633f59_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_d995b064-e968-4531-9264-553d162f320f_negatedTerseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Fixed assets and acquired intangibles assets</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_label_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Fixed Assets And Intangible Assets</link:label>
    <link:label id="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Fixed Assets And Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:to="lab_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_4f3a44c3-ec9b-4cd4-b101-58ec1218e0c2_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_9ff068de-10e9-4dcc-8f5f-6f4c998c3bf1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RecoveryOfErrCompDisclosureLineItems_label_en-US" xlink:label="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recovery of Erroneously Awarded Compensation Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="lab_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_bc1d26cf-a817-407c-b3f4-1afc38d51c2c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total principal amount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentFaceAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentFaceAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Face Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentFaceAmount" xlink:to="lab_us-gaap_DebtInstrumentFaceAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_9d3c8a7a-18f3-409f-a2fb-aabaaec476e9_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_8c8e5d7a-34f5-4050-940d-d74ecd077bbf_terseLabel_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label id="lab_us-gaap_TypeOfArrangementAxis_label_en-US" xlink:label="lab_us-gaap_TypeOfArrangementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TypeOfArrangementAxis" xlink:to="lab_us-gaap_TypeOfArrangementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingExpense_cb8143a2-7ce3-451d-a6e2-e9a4df68d64a_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingExpense_label_en-US" xlink:label="lab_us-gaap_AdvertisingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingExpense" xlink:to="lab_us-gaap_AdvertisingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PreferentialTaxRatePeriod_feb546bf-2fe1-4ff4-8532-e58b680b965c_terseLabel_en-US" xlink:label="lab_dxcm_PreferentialTaxRatePeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferential tax rate period (in years)</link:label>
    <link:label id="lab_dxcm_PreferentialTaxRatePeriod_label_en-US" xlink:label="lab_dxcm_PreferentialTaxRatePeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferential Tax Rate Period</link:label>
    <link:label id="lab_dxcm_PreferentialTaxRatePeriod_documentation_en-US" xlink:label="lab_dxcm_PreferentialTaxRatePeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Preferential Tax Rate Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PreferentialTaxRatePeriod" xlink:href="dxcm-20241231.xsd#dxcm_PreferentialTaxRatePeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PreferentialTaxRatePeriod" xlink:to="lab_dxcm_PreferentialTaxRatePeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_39900937-6623-41f5-96d3-f6749f2e794b_terseLabel_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credit carryforwards subject to expiration</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_label_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unused Expired Federal Income Tax Credits</link:label>
    <link:label id="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits_documentation_en-US" xlink:label="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Federal income tax credits likely to expire unused as a result of limitations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:href="dxcm-20241231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:to="lab_dxcm_UnusedExpiredFederalIncomeTaxCredits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_8f50272b-df3a-4e6a-8f7f-fd881af97d6c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_3929ba3f-c215-4fca-9ba5-986758575c32_verboseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_e73407ab-d8f1-411c-bd6e-adc428e668d7_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Other investing activities</link:label>
    <link:label id="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_label_en-US" xlink:label="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments for (Proceeds from) Other Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:to="lab_us-gaap_PaymentsForProceedsFromOtherInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_34ba3416-8f7e-4602-bb35-c030293edf2f_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Initial payment on collaborative agreement</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementUpfrontFee_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Upfront Fee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementUpfrontFee" xlink:to="lab_dxcm_CollaborativeArrangementUpfrontFee" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_label_en-US" xlink:label="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:to="lab_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorName_aa6c9a47-4a84-45e8-b35b-8ee6db0dd7ba_terseLabel_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:label id="lab_dei_AuditorName_label_en-US" xlink:label="lab_dei_AuditorName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorName" xlink:to="lab_dei_AuditorName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_02c98207-9bc8-4270-84bb-73ee64089f24_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_c6436d04-7a7f-4873-bc20-9c6ca99de7df_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current:</link:label>
    <link:label id="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_016c7d08-a042-4d3b-9bcd-a8c746688db7_terseLabel_en-US" xlink:label="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_label_en-US" xlink:label="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Shares [Member]</link:label>
    <link:label id="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_documentation_en-US" xlink:label="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) and Performance Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:to="lab_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_terseLabel_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</link:label>
    <link:label id="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_label_en-US" xlink:label="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:to="lab_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_dfc92e14-8131-4ce0-bef4-609f71d30f44_terseLabel_en-US" xlink:label="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash discounts reserve</link:label>
    <link:label id="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_label_en-US" xlink:label="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Cash Discount</link:label>
    <link:label id="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_documentation_en-US" xlink:label="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Cash Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:href="dxcm-20241231.xsd#dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:to="lab_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_11bc29ea-20f9-4fc3-82eb-f6ac5df13fdf_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_6a1f7cac-4f2d-496d-9903-342ab90beada_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization, Nonproduction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationAndAmortization" xlink:to="lab_us-gaap_DepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_48476eea-fbea-453d-adc7-56efa6f3e765_terseLabel_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Option to increase revolving line of credit</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_label_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount</link:label>
    <link:label id="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_documentation_en-US" xlink:label="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:href="dxcm-20241231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:to="lab_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_4ca17452-5d22-4099-bb8c-4846028598d7_terseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleLongTermNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleLongTermNotesPayable" xlink:to="lab_us-gaap_ConvertibleLongTermNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_6f90cfb5-cdbf-403b-9ede-8b34fa795c1f_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock authorized in ESPP (in shares)</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:to="lab_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote</link:label>
    <link:label id="lab_ecd_AdjToPeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToPeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToPeoCompFnTextBlock" xlink:to="lab_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_b572f8b2-6224-4444-8564-d0411045a082_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_e9484895-e8a4-4b57-a943-96a4c9305d66_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total property and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RevenuePercentage_6820eb4d-6f91-47a2-935a-ddd9de648585_terseLabel_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of revenue (as a percent)</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_label_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:label id="lab_dxcm_RevenuePercentage_documentation_en-US" xlink:label="lab_dxcm_RevenuePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Revenue, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage" xlink:href="dxcm-20241231.xsd#dxcm_RevenuePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RevenuePercentage" xlink:to="lab_dxcm_RevenuePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_d53a5f3b-743e-4740-a070-198873a0cc63_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Other</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_f0023b3e-8f78-4d52-a920-8a3a0ac76981_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_a38f0a2c-6fae-45cb-8cd6-0db2b40a378f_terseLabel_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument</link:label>
    <link:label id="lab_us-gaap_DesignatedAsHedgingInstrumentMember_label_en-US" xlink:label="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Designated as Hedging Instrument [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:to="lab_us-gaap_DesignatedAsHedgingInstrumentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Other Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</link:label>
    <link:label id="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:to="lab_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_a8c60478-ed15-4a94-8ff6-fa1bb5a553b5_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_2ffc6ce9-c16a-4fae-aa49-2f7eec52dcf7_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cost of sales</link:label>
    <link:label id="lab_us-gaap_CostOfGoodsAndServicesSold_label_en-US" xlink:label="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cost of Goods and Services Sold</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfGoodsAndServicesSold" xlink:to="lab_us-gaap_CostOfGoodsAndServicesSold" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_68e83d4f-9068-45cb-8902-6c1b519bcefc_terseLabel_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Advertising Costs</link:label>
    <link:label id="lab_us-gaap_AdvertisingCostsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Advertising Cost [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:to="lab_us-gaap_AdvertisingCostsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_eaf053cb-0392-43c0-a1f7-c1d93703d2c0_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income tax receivables</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesReceivable_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Receivable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesReceivable" xlink:to="lab_us-gaap_IncomeTaxesReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_d2ed2d61-37a4-442b-aa1b-09e6a4fd8831_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_38b09c07-7585-40dd-bc2c-0fcec19d7bde_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_9f6c825b-d2a4-45c7-9e62-681987d3a3da_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other long-term liabilities</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_779fdc80-4c7f-4696-860e-ada19e12f104_terseLabel_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_label_en-US" xlink:label="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Movement in Standard Product Warranty Accrual [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:to="lab_us-gaap_MovementInStandardProductWarrantyAccrualRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_df464918-6c34-4c53-ba8a-b54120320ad5_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commitments and contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_22393061-763c-4d42-862f-c275b473065a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-Based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_7f774ef5-bfdb-4f4f-b2be-a69c3d913138_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrTerminationDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Termination Date</link:label>
    <link:label id="lab_ecd_TrdArrTerminationDate_label_en-US" xlink:label="lab_ecd_TrdArrTerminationDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Termination Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrTerminationDate" xlink:to="lab_ecd_TrdArrTerminationDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_13b5db6b-c34d-4a83-8a00-398bad57132d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_6d65c227-13bd-433d-8e71-f3ab699e1849_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_a4bbda85-e308-4d73-93a2-9b18513ed4e2_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenue from External Customers by Geographic Areas</link:label>
    <link:label id="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue from External Customers by Geographic Areas [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:to="lab_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_d400142f-093f-4059-b78c-8a81131d7418_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets:</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsGrossAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Gross [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:to="lab_us-gaap_DeferredTaxAssetsGrossAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_0a4c6d01-7b4b-41e3-be7b-9354622f90b8_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_7df0e98a-c1ee-47db-9798-a223ad4e0a5d_verboseLabel_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Fair value of outstanding senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleDebtFairValueDisclosures_label_en-US" xlink:label="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Debt, Fair Value Disclosures</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:to="lab_us-gaap_ConvertibleDebtFairValueDisclosures" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_ef01504b-97b2-46ab-823b-a057801d05ba_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_88ce756b-9e23-4095-a76d-014e8d752be0_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net income</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TradingArrAxis_terseLabel_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Arrangement:</link:label>
    <link:label id="lab_ecd_TradingArrAxis_label_en-US" xlink:label="lab_ecd_TradingArrAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TradingArrAxis" xlink:to="lab_ecd_TradingArrAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_0e87807f-618f-4446-b0af-04c247f0eaff_terseLabel_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses</link:label>
    <link:label id="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_label_en-US" xlink:label="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Reconciliation of Other Items from Segments to Consolidated [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:to="lab_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PvpTableTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure, Table</link:label>
    <link:label id="lab_ecd_PvpTableTextBlock_label_en-US" xlink:label="lab_ecd_PvpTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PvpTableTextBlock" xlink:to="lab_ecd_PvpTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="lab_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_48349b37-6600-4a13-b3d3-ad3506e2745c_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_f5c331cc-4d00-4a5e-a714-1148d277f794_terseLabel_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Verily Life Sciences</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_label_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:label id="lab_dxcm_VerilyLifeSciencesMember_documentation_en-US" xlink:label="lab_dxcm_VerilyLifeSciencesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Verily Life Sciences [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember" xlink:href="dxcm-20241231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_VerilyLifeSciencesMember" xlink:to="lab_dxcm_VerilyLifeSciencesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_1cbb2365-5666-43b4-898b-846249228159_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingExpense" xlink:to="lab_us-gaap_OtherNonoperatingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_fd62515b-f9b0-44fa-ae32-e8561e1cd42d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_7d199e4e-c3a9-4317-a85b-701d3d7c6b72_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_ffba7344-cffa-48ab-b265-7a8501b19e92_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_CurrentFederalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Federal Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentFederalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_91041fa2-f63a-46f3-b506-c8379822430e_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Effect of exchange rate changes on cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryIndName_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryIndName" xlink:to="lab_ecd_ForgoneRecoveryIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_19de6c52-ce38-4f01-85ae-41de14f8eb40_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average remaining lease term of operating leases (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_b18a2220-b08c-4ba4-a1b9-424a5ec1288c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Other non-cash income and expenses</link:label>
    <link:label id="lab_us-gaap_OtherNoncashIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNoncashIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Noncash Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncashIncomeExpense" xlink:to="lab_us-gaap_OtherNoncashIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiCnsdrdFlag_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Considered [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="lab_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerBMember_6cdd8720-6bb4-4132-bfe5-0aabbdc30316_terseLabel_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer B</link:label>
    <link:label id="lab_dxcm_CustomerBMember_label_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer B [Member]</link:label>
    <link:label id="lab_dxcm_CustomerBMember_documentation_en-US" xlink:label="lab_dxcm_CustomerBMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember" xlink:href="dxcm-20241231.xsd#dxcm_CustomerBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerBMember" xlink:to="lab_dxcm_CustomerBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_ad6c3ed0-bf48-4a74-b616-8744be316ee9_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_70a2081f-3c32-4eba-b183-1ea103767c4c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Decreases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_fc6cb125-b7ca-4c9b-8d4d-527f3eeb2c1c_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_terseLabel_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:label id="lab_ecd_OutstandingAggtErrCompAmt_label_en-US" xlink:label="lab_ecd_OutstandingAggtErrCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OutstandingAggtErrCompAmt" xlink:to="lab_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_5bf3e41a-0717-463a-890e-196a6efaaf7f_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value of Senior Convertible Notes</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:to="lab_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_7252145d-cd18-4e2e-9f3a-6b1759f8b9f2_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue and other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Other Deferred Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherDeferredLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_11ac686a-6def-47de-9fdc-de1eeb3ea74e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Foreign tax credit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:to="lab_us-gaap_IncomeTaxReconciliationTaxCreditsForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_terseLabel_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:label id="lab_ecd_PeoActuallyPaidCompAmt_label_en-US" xlink:label="lab_ecd_PeoActuallyPaidCompAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoActuallyPaidCompAmt" xlink:to="lab_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToCompAxis_terseLabel_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation:</link:label>
    <link:label id="lab_ecd_AdjToCompAxis_label_en-US" xlink:label="lab_ecd_AdjToCompAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="lab_ecd_AdjToCompAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_2719132b-9301-4497-b571-1ea2d265163b_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerAMember_d7ec8bc3-b201-44d1-afc3-36a6072b19ee_terseLabel_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer A</link:label>
    <link:label id="lab_dxcm_CustomerAMember_label_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer A [Member]</link:label>
    <link:label id="lab_dxcm_CustomerAMember_documentation_en-US" xlink:label="lab_dxcm_CustomerAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember" xlink:href="dxcm-20241231.xsd#dxcm_CustomerAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerAMember" xlink:to="lab_dxcm_CustomerAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_f34370b4-58ab-45ee-9b61-e9f71aeb09b1_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated other comprehensive loss</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsSvcCstMember" xlink:to="lab_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_477277bf-bed9-4c6f-999f-3ef604af9c84_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares used to compute basic net income per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3c8aee37-a4ea-4dba-a134-54b513a22b4f_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Basic weighted average shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_terseLabel_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
    <link:label id="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock_label_en-US" xlink:label="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Price or TSR Estimation Method [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="lab_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_d5d2ede7-cf5b-483f-a811-7f4a733552e4_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capped call, cap price (in usd per share)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Cap Call Transaction, Cap Price Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:to="lab_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_9038e302-cba5-4803-957e-53e0ce7b9337_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:to="lab_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_b7bc1f09-3a26-4945-a14d-313c6343cf38_terseLabel_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Organization And Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscIndName_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:to="lab_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_93b5d12f-1aa1-4b16-92b1-a588df20ba83_verboseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_a356965c-b5d8-4afb-8b9a-d5d671d55f8f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_c0f0387e-7e2d-4554-9443-51441802030d_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_e4c8cdfd-2d2c-4595-93e1-58f132a28dae_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued during period, shares, exercise and settlement of remaining warrants (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exercise and Settlement of Remaining Warrants</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exercise and Settlement of Remaining Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:to="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_f984db18-170c-48ad-a8ba-c12bf1db9c3d_negatedTerseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes (in shares)</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_4a406ad8-054a-48f0-87bd-d84f8c300e03_verboseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares received from note hedge (in shares)</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Received From Exercise of Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares Received From Exercise of Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:to="lab_dxcm_SharesReceivedFromExerciseOfNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_9f8d269d-8d68-4ea4-87e9-f73a2c3a4c36_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlanMember" xlink:to="lab_dxcm_EmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_9fcd3a8b-25ae-4618-a205-a8bc7e6877bc_negatedTerseLabel_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Shares received under note hedge upon conversion of 2023 Notes</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_label_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:label id="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_documentation_en-US" xlink:label="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Benefit Received From Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:href="dxcm-20241231.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:to="lab_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_f7c35cb5-0bbf-4c13-bfff-07f8adce88ab_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental disclosure of non-cash investing and financing transactions:</link:label>
    <link:label id="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_ca2e90fd-91ea-4c34-91c2-22e5ae6fba7b_negatedTerseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_b527c3d1-aab2-4bea-9635-f7924f24ca1d_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of capped call transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_label_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:label id="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions_documentation_en-US" xlink:label="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Payments For Purchases Of Capped Call Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:to="lab_dxcm_PaymentsForPurchasesOfCappedCallTransactions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_08c82f0b-fc60-4c90-831d-260920236bfc_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_d5c6f9a4-b320-47ec-9ac2-cf1c5f108d71_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expenditures for long-lived assets</link:label>
    <link:label id="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_label_en-US" xlink:label="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment, Expenditure, Addition to Long-Lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:to="lab_us-gaap_SegmentExpenditureAdditionToLongLivedAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_418381fe-e538-4869-bf8e-a16df657c6cf_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Losses</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_404a6157-0787-497a-8714-ebe0aefbb26c_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Lease Expense and Other Information</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CustomerCMember_cf409b8e-5c47-4b57-91a6-508df4fa827b_terseLabel_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer C</link:label>
    <link:label id="lab_dxcm_CustomerCMember_label_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer C [Member]</link:label>
    <link:label id="lab_dxcm_CustomerCMember_documentation_en-US" xlink:label="lab_dxcm_CustomerCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Customer C [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember" xlink:href="dxcm-20241231.xsd#dxcm_CustomerCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CustomerCMember" xlink:to="lab_dxcm_CustomerCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_a730f36a-1a4c-435c-abdf-a7f31de406c7_terseLabel_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_label_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested</link:label>
    <link:label id="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_documentation_en-US" xlink:label="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:to="lab_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_558080ad-0411-4d4f-9b05-1e2c1d043834_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized tax benefits that would impact effective tax rate</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits that Would Impact Effective Tax Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_378eb5b2-0822-41b2-89fa-e9caeb7c4f48_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_SegmentReportingInformationLineItems_label_en-US" xlink:label="lab_us-gaap_SegmentReportingInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Segment Reporting Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems" xlink:to="lab_us-gaap_SegmentReportingInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllTradingArrangementsMember_terseLabel_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Trading Arrangements</link:label>
    <link:label id="lab_ecd_AllTradingArrangementsMember_label_en-US" xlink:label="lab_ecd_AllTradingArrangementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Trading Arrangements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllTradingArrangementsMember" xlink:to="lab_ecd_AllTradingArrangementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_85f771d9-b39a-431a-8853-22e90fc3f318_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Basic and Diluted Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_d1568438-d136-414f-a58c-01742e61e92a_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vesting period (in years)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SupplyExpensesAndClinicalTrials_8e882609-71a2-4a2f-a085-94ef23c16e7e_terseLabel_en-US" xlink:label="lab_dxcm_SupplyExpensesAndClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supply expenses and clinical trials</link:label>
    <link:label id="lab_dxcm_SupplyExpensesAndClinicalTrials_label_en-US" xlink:label="lab_dxcm_SupplyExpensesAndClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supply Expenses And Clinical Trials</link:label>
    <link:label id="lab_dxcm_SupplyExpensesAndClinicalTrials_documentation_en-US" xlink:label="lab_dxcm_SupplyExpensesAndClinicalTrials" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Supply Expenses And Clinical Trials</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SupplyExpensesAndClinicalTrials" xlink:href="dxcm-20241231.xsd#dxcm_SupplyExpensesAndClinicalTrials"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SupplyExpensesAndClinicalTrials" xlink:to="lab_dxcm_SupplyExpensesAndClinicalTrials" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_ed771489-2c90-42e4-8803-fb26e34004fe_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax credits</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardAmount_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardAmount" xlink:to="lab_us-gaap_TaxCreditCarryforwardAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
    <link:label id="lab_ecd_Rule10b51ArrAdoptedFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:to="lab_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_terseLabel_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures</link:label>
    <link:label id="lab_ecd_AwardsCloseToMnpiDiscTable_label_en-US" xlink:label="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="lab_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_24e2af7e-635e-4ab7-8060-0dbbc987b416_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion ratio</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionRatio1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5d053167-5d54-4511-b40b-3f882f6ab65c_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Conversions of 2023 Notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_2ad232b1-ee1b-4cf7-9536-594f84b9360e_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Repurchase and conversions of notes (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_5cc890da-0202-4083-a606-99d7654eede0_negatedNetLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with 2023 Notes conversions (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PayVsPerformanceDisclosureLineItems_label_en-US" xlink:label="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pay vs Performance Disclosure [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="lab_ecd_PayVsPerformanceDisclosureLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_terseLabel_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:label id="lab_ecd_PeerGroupTotalShareholderRtnAmt_label_en-US" xlink:label="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="lab_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_c13af534-0ba2-443b-b352-a8fd305aae0b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred:</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_a3d0b6be-ee66-4e99-8ae3-c7cb2c4e1072_totalLabel_en-US" xlink:label="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total amortization of intangible assets</link:label>
    <link:label id="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_label_en-US" xlink:label="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Of Intangibles Included In Cost Of Sales And Operating Expenses</link:label>
    <link:label id="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_documentation_en-US" xlink:label="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Of Intangibles Included In Cost Of Sales And Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:to="lab_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_a3ef6b8f-724b-41e2-b9fe-a1de2e9b5d62_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock issued upon conversion of senior notes (in shares)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:to="lab_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_terseLabel_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:label id="lab_ecd_OtherPerfMeasureAmt_label_en-US" xlink:label="lab_ecd_OtherPerfMeasureAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Performance Measure, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_OtherPerfMeasureAmt" xlink:to="lab_ecd_OtherPerfMeasureAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_5d4cda3e-f77a-427a-a9bc-72c1554f5b06_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TravelAndEntertainmentExpense_6b2fde5a-2762-48b1-b034-a7c8ea278c2b_terseLabel_en-US" xlink:label="lab_us-gaap_TravelAndEntertainmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Travel related expenses</link:label>
    <link:label id="lab_us-gaap_TravelAndEntertainmentExpense_label_en-US" xlink:label="lab_us-gaap_TravelAndEntertainmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Travel and Entertainment Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TravelAndEntertainmentExpense" xlink:to="lab_us-gaap_TravelAndEntertainmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_5f27ba09-41cd-46b2-8b24-c96241a7ee0e_terseLabel_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contingencies</link:label>
    <link:label id="lab_us-gaap_LegalMattersAndContingenciesTextBlock_label_en-US" xlink:label="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Legal Matters and Contingencies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:to="lab_us-gaap_LegalMattersAndContingenciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_38042ac4-0c23-4fe3-bf78-fb4b772f8807_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases and Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_75871fbe-3f13-4fe6-be06-196b6189483a_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ca50641e-71c9-44e8-a07c-5498a4eb5dc6_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Balance at beginning of period ( in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_5f883464-01f9-40f5-be2f-bf7f5b8c35cb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Balance at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_123361bf-3d4c-4e45-be27-d2be692bb58b_terseLabel_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Documents incorporated by reference</link:label>
    <link:label id="lab_dei_DocumentsIncorporatedByReferenceTextBlock_label_en-US" xlink:label="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="lab_dei_DocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_97335824-32a4-42e1-b0c6-8bb911ffb5df_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating lease cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_dafc3afc-f510-43f2-b49b-958bf5f82b59_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_476bf1e6-2230-4f6d-bcc6-27c79ce27eec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stock available for issuance for future awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_b0063a48-e528-4683-9c13-45cbaeea66b9_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_bea88897-5297-42d7-a5e9-d8db60a1490e_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Number of shares available for grant at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_a3bc347b-ebba-4532-b6fb-094060682b41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_db2028ec-eb8b-4c48-9e42-0c3b4648e055_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_c1eff363-c495-42d7-9b03-aada5aa7742c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest on lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_919a0150-68d2-413a-89a6-1ecd5e2ddbdc_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelAxis_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_6e40fa8f-aaf8-4ae3-98a6-137e5fdbdee1_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_99ea7c2e-d761-4107-8966-3e256cbfa67f_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_0b6c328c-2b7a-4fad-a88b-e6fa9d12d8e9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Asset, Finite-Lived [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_2891781b-b44d-48ff-81fa-f4325df490bb_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to prior year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_40eee204-c936-44e9-a9b2-9eba06db73b4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock, including excise tax (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_3a2f2a22-74a3-4545-ae03-4e114a0206ec_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_cdabd2ff-da9c-486e-bc55-6358e6906f48_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares repurchased under the Share Repurchase Program (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockSharesAcquired_label_en-US" xlink:label="lab_us-gaap_TreasuryStockSharesAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Shares, Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockSharesAcquired" xlink:to="lab_us-gaap_TreasuryStockSharesAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_a4009186-4648-44f8-a312-f5319b7baaed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Foreign Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredForeignIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e65f62fe-0915-4fb0-84ca-fa4b1864ab47_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_145e450e-781c-48ed-a44f-3f37938c191f_terseLabel_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_InterestOnConvertibleDebtNetOfTax_label_en-US" xlink:label="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest on Convertible Debt, Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:to="lab_us-gaap_InterestOnConvertibleDebtNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_38c2761a-bf07-4a0c-b917-73fcfac21744_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury Stock</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonMember" xlink:to="lab_us-gaap_TreasuryStockCommonMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_235497f3-82ab-4d10-8c86-0ef1590ae567_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_e5576af1-f7ef-4efd-9394-1b35df88d562_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_a83a7fa9-de45-4d59-9f3e-a2b9f20e0349_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_44ef1382-74e7-4094-b798-592bc14f881c_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_22669872-cf55-4084-9e87-f00115d83036_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsCurrent" xlink:to="lab_us-gaap_OtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_73d699e5-6dd8-4458-a49b-b6e9e0ff8506_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_feda2aaa-202d-4ea9-a86f-e70274f75e7b_verboseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Debt securities, available-for-sale</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9fa2a58e-a7dc-440a-9af2-e0e6515e0ae1_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Estimated Market Value</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="lab_us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_49507907-7bf4-4913-803c-a889dd7dffb9_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_d936c83e-b657-4d0d-adef-2338232c09b3_verboseLabel_en-US" xlink:label="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense included in cost of sales</link:label>
    <link:label id="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_label_en-US" xlink:label="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization Of Intangible Assets Included In Cost Of Sales</link:label>
    <link:label id="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_documentation_en-US" xlink:label="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Amortization Of Intangible Assets Included In Cost Of Sales</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:to="lab_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_9e72f75a-2d44-4c51-a23b-9c198a2eb3e6_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recoveries</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesRecoveries_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesRecoveries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_99cbedbf-5307-4d8b-b2a3-abe3e6bc6e6d_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net deferred tax assets (liabilities)</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="lab_us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_c52ccc93-c62e-40a9-bf44-2d71d1a60ef6_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_2e2ac138-e01c-4287-aedf-f16679ba10df_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest and dividend income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterestAndDividend_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Investment Income, Interest and Dividend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterestAndDividend" xlink:to="lab_us-gaap_InvestmentIncomeInterestAndDividend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_6c9490c5-7f68-4a22-aba5-a1dae0f2226c_terseLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Valuation allowance, deferred tax asset, increase (decrease), amount</link:label>
    <link:label id="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_label_en-US" xlink:label="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="lab_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_terseLabel_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</link:label>
    <link:label id="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember_label_en-US" xlink:label="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:to="lab_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_484b73bc-ec46-4e05-b33f-c2e4c219b489_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_30094c7c-7f9e-4d99-a413-9dc5b5d48173_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock for employee stock purchase plan (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Employee Stock Purchase Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_7316e026-a6b7-4cc0-8839-7808cada2257_terseLabel_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employee Benefit Plans and Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_label_en-US" xlink:label="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation and Employee Benefit Plans [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:to="lab_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_291829de-cdc2-428b-bfdf-a2abf6d02291_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_274836f9-e85c-43c0-af39-32070ab3c4fb_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b1bbf357-60bd-49c2-bd1b-19bc8e5cf710_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_eef49311-6aeb-462e-b4de-5f1140adfacb_terseLabel_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_label_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses [Table Text Block]</link:label>
    <link:label id="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Payroll and Related Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:to="lab_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_fdb5a843-73bb-49f7-8ddf-5e7580621e97_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_CurrentForeignTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Foreign Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentForeignTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_094f8935-0c7f-46ba-b0c5-2228f69d6d64_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_a9b792fd-0a54-4a14-8a85-1f71f0febaf4_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Treasury stock, at cost (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockCommonShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockCommonShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Common, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockCommonShares" xlink:to="lab_us-gaap_TreasuryStockCommonShares" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="lab_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_b97ab8b3-d9cc-4585-ba75-0cc43152c39d_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_56f202d3-773a-4a43-bb62-5a67d56956af_terseLabel_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term lease cost</link:label>
    <link:label id="lab_us-gaap_ShortTermLeaseCost_label_en-US" xlink:label="lab_us-gaap_ShortTermLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Short-Term Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShortTermLeaseCost" xlink:to="lab_us-gaap_ShortTermLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_a391583f-4b45-4aa4-91df-272359de3e98_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Vested (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_a7cb385b-99b0-42a4-8b13-8376a79900bc_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_5c3636ce-b360-41ea-ae8a-148bc5acea1a_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise and settlement of warrants (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_2e01a153-a133-48a5-b676-f25479308ab1_negatedLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Shares issued in connection with 2023 Warrants (in shares)</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exercise and Settlement of Warrants</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, Exercise and Settlement of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:to="lab_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_17c623e3-a79f-4835-b996-8bab97746fa2_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_3100a568-2e6a-4005-aea7-7725e78e47ab_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_c76cb506-c002-466a-bf0e-1007851f07de_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A2024ShareRepurchaseProgramMember_c3c819a1-be8c-4d84-9b63-001fabc92a8f_terseLabel_en-US" xlink:label="lab_dxcm_A2024ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2024 Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_A2024ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_A2024ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2024 Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_A2024ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_A2024ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2024 Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2024ShareRepurchaseProgramMember" xlink:href="dxcm-20241231.xsd#dxcm_A2024ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A2024ShareRepurchaseProgramMember" xlink:to="lab_dxcm_A2024ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_2f31d15d-7cb4-4b4e-9541-20567576f60d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basis spread on variable rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaidInKindInterest_e1f27dd3-bbc6-4da0-b126-f9da684282ca_terseLabel_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-cash interest expense</link:label>
    <link:label id="lab_us-gaap_PaidInKindInterest_label_en-US" xlink:label="lab_us-gaap_PaidInKindInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Paid-in-Kind Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaidInKindInterest" xlink:to="lab_us-gaap_PaidInKindInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_f01042a3-d191-49ed-9550-75c15a77496f_terseLabel_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Direct</link:label>
    <link:label id="lab_us-gaap_SalesChannelDirectlyToConsumerMember_label_en-US" xlink:label="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Sales Channel, Directly to Consumer [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:to="lab_us-gaap_SalesChannelDirectlyToConsumerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_375e7cc7-842e-4fac-94a5-2c308484bd6f_terseLabel_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current State and Local Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:to="lab_us-gaap_CurrentStateAndLocalTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherCountriesMember_99c664e2-850d-400b-8baa-c2daa6b5bf1b_terseLabel_en-US" xlink:label="lab_dxcm_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other countries</link:label>
    <link:label id="lab_dxcm_OtherCountriesMember_label_en-US" xlink:label="lab_dxcm_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Countries [Member]</link:label>
    <link:label id="lab_dxcm_OtherCountriesMember_documentation_en-US" xlink:label="lab_dxcm_OtherCountriesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other Countries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherCountriesMember" xlink:href="dxcm-20241231.xsd#dxcm_OtherCountriesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherCountriesMember" xlink:to="lab_dxcm_OtherCountriesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_terseLabel_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
    <link:label id="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_label_en-US" xlink:label="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="lab_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_aa0e8251-e753-47b1-aa48-5b4cc834ff88_terseLabel_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Short-Term Marketable Securities</link:label>
    <link:label id="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:to="lab_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_1dd7458b-b178-483d-9286-1735521e6eb2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_872f1e5b-966b-4c35-9c4f-81415e395e8c_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_ce7f94d0-d639-465c-a661-8c912a699635_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_f6e3d45c-e0ac-4306-aaf8-a4378e8328a6_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_50245363-ea43-4dc4-8515-6d9cada83e55_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease cost:</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_23e66d60-02cb-4238-9864-1d3c8240191f_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Available principal amount and letters of credit sub-facility</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_5d33713b-fbb4-4f72-86a9-3da80a6834e1_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_1d628c1d-20e9-4c31-86df-a1a14c82f837_terseLabel_en-US" xlink:label="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Potential common stock issued shares (in shares)</link:label>
    <link:label id="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_label_en-US" xlink:label="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Potential Common Stock Issuable Or Issued, Shares, New Issues</link:label>
    <link:label id="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_documentation_en-US" xlink:label="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Potential Common Stock Issuable Or Issued, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:href="dxcm-20241231.xsd#dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:to="lab_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_terseLabel_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
    <link:label id="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag_label_en-US" xlink:label="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Policies and Procedures Adopted [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="lab_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PharmacyRebatesCurrent_44ef1b4f-32bc-4e36-a37c-3f5dc9f3c863_verboseLabel_en-US" xlink:label="lab_dxcm_PharmacyRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued rebates</link:label>
    <link:label id="lab_dxcm_PharmacyRebatesCurrent_label_en-US" xlink:label="lab_dxcm_PharmacyRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pharmacy Rebates, Current</link:label>
    <link:label id="lab_dxcm_PharmacyRebatesCurrent_documentation_en-US" xlink:label="lab_dxcm_PharmacyRebatesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Pharmacy Rebates, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebatesCurrent" xlink:href="dxcm-20241231.xsd#dxcm_PharmacyRebatesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PharmacyRebatesCurrent" xlink:to="lab_dxcm_PharmacyRebatesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNet_11d00d97-b850-4a5b-8678-1e14d499d183_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNet_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNet" xlink:to="lab_us-gaap_AccountsReceivableNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_b33125fa-ff47-4585-84cb-20008a6aef5c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Common stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_28c6ffe3-07ec-43a4-996f-63b5e37ca42d_terseLabel_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_label_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments Under Collaboration Agreements [Domain]</link:label>
    <link:label id="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain_documentation_en-US" xlink:label="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Payments Under Collaboration Agreements [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:to="lab_dxcm_PaymentsUnderCollaborationAgreementsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_59e1295b-e64a-4105-9aae-b788854b03ca_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Acquisitions, net of cash acquired</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Businesses, Net of Cash Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:to="lab_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A2028NotesMember_04971381-80a5-42b3-84a1-cb14758b79d3_terseLabel_en-US" xlink:label="lab_dxcm_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028 Notes</link:label>
    <link:label id="lab_dxcm_A2028NotesMember_label_en-US" xlink:label="lab_dxcm_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">2028 Notes [Member]</link:label>
    <link:label id="lab_dxcm_A2028NotesMember_documentation_en-US" xlink:label="lab_dxcm_A2028NotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">2028 Notes</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2028NotesMember" xlink:href="dxcm-20241231.xsd#dxcm_A2028NotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A2028NotesMember" xlink:to="lab_dxcm_A2028NotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_94b6b6e3-1b79-49ae-beb9-27dd5f346dd9_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityVoluntaryFilers_329eed63-b575-4731-9ce8-7425d351bb6d_terseLabel_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:label id="lab_dei_EntityVoluntaryFilers_label_en-US" xlink:label="lab_dei_EntityVoluntaryFilers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Voluntary Filers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityVoluntaryFilers" xlink:to="lab_dei_EntityVoluntaryFilers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_137649b1-91ea-4e62-acf5-4b742a481da5_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Renewal term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_0a0d1729-537c-4bf3-a2be-c0e70122cf52_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseNonoperating_label_en-US" xlink:label="lab_us-gaap_InterestExpenseNonoperating" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Nonoperating</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseNonoperating" xlink:to="lab_us-gaap_InterestExpenseNonoperating" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_8777b9f2-c1df-4747-9629-4fc2aaff737e_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationDomain_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationDomain" xlink:to="lab_us-gaap_HedgingDesignationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_f9bd92a3-e113-4cd6-9f91-d0284262f1ad_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_240b8ee5-9712-49c9-a95c-eac4b479f89c_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_061de50f-f356-466a-9e53-103577f59d65_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Deferred income taxes</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_01e631a1-d16a-469b-867f-473b1c9c6ab6_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other comprehensive income (loss), net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_b2665646-f9f2-42a1-8aec-9ff762b89a9c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other comprehensive income, net of tax</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_3b393ebd-8507-4bc3-85f0-33bda68703f1_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable, net</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_a27be331-3f1c-43fe-8cf8-fccaad3619ed_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversion price of convertible notes (in usd per share)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Conversion Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:to="lab_us-gaap_DebtInstrumentConvertibleConversionPrice1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_9ae715bf-6ceb-42ed-b7fa-54c8a482ed64_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_3c211f08-4734-46f9-bdd4-f4b5f15fa892_terseLabel_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquisition of property and equipment included in accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_label_en-US" xlink:label="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Noncash or Part Noncash Acquisition, Fixed Assets Acquired</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:to="lab_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_d609600a-e6f6-4f75-8d0d-4106513ea7a0_terseLabel_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Receiver Product Component</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_label_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:label id="lab_dxcm_ReceiverProductComponentMember_documentation_en-US" xlink:label="lab_dxcm_ReceiverProductComponentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Receiver Product Component [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember" xlink:href="dxcm-20241231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ReceiverProductComponentMember" xlink:to="lab_dxcm_ReceiverProductComponentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost</link:label>
    <link:label id="lab_ecd_PnsnAdjsPrrSvcCstMember_label_en-US" xlink:label="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Adjustments Prior Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:to="lab_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_e425b143-e965-45bd-8806-1b927bd7b60a_terseLabel_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Employer matching contribution (as a percent)</link:label>
    <link:label id="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_label_en-US" xlink:label="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Defined Contribution Plan, Employer Matching Contribution, Percent of Match</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:to="lab_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_OtherStatesMember_bbadc8d7-90eb-4b58-8dc2-e88467d2c2a5_terseLabel_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other states</link:label>
    <link:label id="lab_dxcm_OtherStatesMember_label_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other States [Member]</link:label>
    <link:label id="lab_dxcm_OtherStatesMember_documentation_en-US" xlink:label="lab_dxcm_OtherStatesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Other States</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember" xlink:href="dxcm-20241231.xsd#dxcm_OtherStatesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_OtherStatesMember" xlink:to="lab_dxcm_OtherStatesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommercialPaperMember_ef46a5c8-e7e0-40cf-ba28-ccdeec8a88f5_terseLabel_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Commercial paper</link:label>
    <link:label id="lab_us-gaap_CommercialPaperMember_label_en-US" xlink:label="lab_us-gaap_CommercialPaperMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commercial Paper [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommercialPaperMember" xlink:to="lab_us-gaap_CommercialPaperMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
    <link:label id="lab_ecd_PnsnBnftsAdjFnTextBlock_label_en-US" xlink:label="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pension Benefits Adjustments, Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:to="lab_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_terseLabel_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
    <link:label id="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock_label_en-US" xlink:label="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Total Shareholder Return Vs Peer Group [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="lab_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentAnnualReport_fca954c9-6b31-4c6e-b0ff-ffdacaabe1e9_terseLabel_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:label id="lab_dei_DocumentAnnualReport_label_en-US" xlink:label="lab_dei_DocumentAnnualReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Annual Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentAnnualReport" xlink:to="lab_dei_DocumentAnnualReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_51cef884-af36-4532-8ff9-131f3af08135_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09f2641c-9035-491d-8ddf-60fb60ca73a6_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EquipmentOfficeAndFacilityExpenses_ca6acf98-f6b5-491a-846e-04e9cfd7fc39_terseLabel_en-US" xlink:label="lab_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equipment, office &amp; facility expenses</link:label>
    <link:label id="lab_dxcm_EquipmentOfficeAndFacilityExpenses_label_en-US" xlink:label="lab_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equipment, Office And Facility Expenses</link:label>
    <link:label id="lab_dxcm_EquipmentOfficeAndFacilityExpenses_documentation_en-US" xlink:label="lab_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Equipment, Office And Facility Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:href="dxcm-20241231.xsd#dxcm_EquipmentOfficeAndFacilityExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:to="lab_dxcm_EquipmentOfficeAndFacilityExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_25f7b6af-a69c-4932-b318-5962c602fe12_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Risk free interest rate (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_ee84189c-261a-4877-88bd-ba6b67046f2d_verboseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Amortization expense included in operating expenses</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonUsMember_17eaabf2-1917-4bf8-8609-069a66cb0fc3_terseLabel_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">International</link:label>
    <link:label id="lab_us-gaap_NonUsMember_label_en-US" xlink:label="lab_us-gaap_NonUsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-US [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonUsMember" xlink:to="lab_us-gaap_NonUsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_b1df7443-0374-408d-a20e-b34ac0f00694_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5b67c779-4a38-467c-b63c-5fe4a6034a91_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Loss Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Commitments and Contingencies, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_ad09ccc8-7937-4d4b-ad52-ddfafd7a239f_verboseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_3b191daa-6eae-4616-8e15-b7e3e5f4a884_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_8531edb0-0312-4361-a06a-1d481fec1768_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_46850a23-1ee4-4562-bc94-ac2c3d1bd1c7_periodStartLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_e43a127d-3df8-4182-94da-5bca6a43cb3b_periodEndLabel_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_ValuationAllowancesAndReservesBalance_label_en-US" xlink:label="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ValuationAllowancesAndReservesBalance" xlink:to="lab_us-gaap_ValuationAllowancesAndReservesBalance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_c0c29c39-222f-4553-bb45-2630ad24d351_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Imputed interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_00d775f0-1c4c-4bd6-9716-eb34f0eb54f0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_87bc78f6-8f24-4720-80b2-03244c7fae2a_totalLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total accounts payable and accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_PeoName_terseLabel_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:label id="lab_ecd_PeoName_label_en-US" xlink:label="lab_ecd_PeoName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">PEO Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_PeoName" xlink:to="lab_ecd_PeoName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6e8595be-3310-4513-b00e-837287df789c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_219ebac7-9d46-4a97-886e-bcf18920dc11_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="lab_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_3fd29736-c8ed-4a7a-9ded-fddda7c8b176_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Income Tax Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxAssetsNet" xlink:to="lab_us-gaap_DeferredIncomeTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonPeoNeoMember_terseLabel_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-PEO NEO</link:label>
    <link:label id="lab_ecd_NonPeoNeoMember_label_en-US" xlink:label="lab_ecd_NonPeoNeoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonPeoNeoMember" xlink:to="lab_ecd_NonPeoNeoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_e1594d8e-9b88-4e7a-a2b8-7cacc94591dd_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible asset, useful life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_7853e885-43d5-4bd8-8624-2ab4793f89bf_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Weighted Average Useful Life (in years)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_efddad92-8e60-4eca-9c4f-f9b69944c4db_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_label_en-US" xlink:label="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:to="lab_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_c1a6e198-fc6e-45d0-947f-b45352e8e357_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_94fa5720-62a8-4155-9165-364ca02ff618_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance lease obligations</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_9ffb0edf-cb4a-4ba0-949e-5e7732cf5b13_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Long-term portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_760917cf-b3d4-4f7c-aa2a-bcae8fb883de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Receivable</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_92d92f29-c11a-4b18-9c39-6786fa546bc4_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementMember_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementMember" xlink:to="lab_us-gaap_CollaborativeArrangementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_2d0136e4-35a3-472f-9535-1064e45b0b37_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Other Adjustments, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:to="lab_us-gaap_IncomeTaxReconciliationOtherAdjustments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_de252162-9098-4a14-a847-a1b1093164f6_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Recent Accounting Guidance</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_3a6c76a1-7880-4c58-8cee-b46141aaa566_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_190668a1-b24f-486c-ac8b-da4f9cf411bb_terseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Warranty Accrual</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyPolicy_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyPolicy" xlink:to="lab_us-gaap_StandardProductWarrantyPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_01456ea7-ebab-4f71-b7b2-4ab5e01b95d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_21d2d028-bf83-4f3c-b9bf-62f07250a625_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_dfab5de7-9191-42c1-b294-06a5b4d72f64_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureName_terseLabel_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Name</link:label>
    <link:label id="lab_ecd_MeasureName_label_en-US" xlink:label="lab_ecd_MeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureName" xlink:to="lab_ecd_MeasureName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_e44d8ebb-c640-4ce8-8cb8-039684802b0a_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_bd522813-799c-4dcf-aa2e-85554bfb5a02_verboseLabel_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other accrued employee benefits</link:label>
    <link:label id="lab_us-gaap_AccruedEmployeeBenefitsCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Employee Benefits, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:to="lab_us-gaap_AccruedEmployeeBenefitsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_be987651-725e-4886-a854-db1e7b834c7c_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaid_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Taxes Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaid" xlink:to="lab_us-gaap_IncomeTaxesPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_4843cfa4-1887-4d44-bf2a-c04219e0e21b_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_362e3a98-83be-46ce-bdb4-cd3c295c38a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of RSU and PSU Activity</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_311793bb-9e13-4a05-8696-9ef0b1b41092_totalLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total net deferred tax assets</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsNet_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsNet" xlink:to="lab_us-gaap_DeferredTaxAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_78771b5a-2cc3-460d-b952-4e1530017d97_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Interest rate on convertible notes (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Interest Rate, Stated Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateStatedPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_e6ffe9c5-51a8-4ead-9c0d-8d8cdd32b68d_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_b69e330c-3843-4673-bfd9-1e878877e1b8_verboseLabel_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares received from Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_label_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Received From Benefit Of Note Hedge</link:label>
    <link:label id="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge_documentation_en-US" xlink:label="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares Received From Benefit Of Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:to="lab_dxcm_SharesReceivedFromBenefitOfNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b74b4b42-3330-4904-8219-4be17684cb5e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Supplemental cash flow information:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_c4deb69c-33bf-4979-84d5-cae27a2b24c0_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Capitalized research and development expenses</link:label>
    <link:label id="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_label_en-US" xlink:label="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Asset, In-Process Research and Development</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:to="lab_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_866ed406-ee6d-412c-8a21-dfe7fde6e12b_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_2f6dcc56-006b-4b42-9761-2aff0e8ecd57_terseLabel_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</link:label>
    <link:label id="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_label_en-US" xlink:label="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:to="lab_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AuditorFirmId_280bc17d-54df-4c17-aa3d-896d85affef1_terseLabel_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:label id="lab_dei_AuditorFirmId_label_en-US" xlink:label="lab_dei_AuditorFirmId" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Auditor Firm ID</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AuditorFirmId" xlink:to="lab_dei_AuditorFirmId" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_22c9b3f3-fa48-46c2-a9af-4c681d8e229b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Operating income</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_76aa7101-7997-47d4-b76b-edd5c4b292bb_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_ec32e648-7a5a-4525-96bc-049d9a91bd1b_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in valuation allowance</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="lab_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_476cde68-01d8-41e4-a6fa-1f748454b51d_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_563cf45e-4919-4857-ac05-58d6d5d15738_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_terseLabel_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
    <link:label id="lab_ecd_Rule10b51ArrTrmntdFlag_label_en-US" xlink:label="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:to="lab_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_786685be-dfaf-494c-a70d-cb635577399e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_ac41795c-acab-477b-9070-0dfe03d91d43_terseLabel_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketable Securities</link:label>
    <link:label id="lab_us-gaap_MarketableSecuritiesPolicy_label_en-US" xlink:label="lab_us-gaap_MarketableSecuritiesPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketable Securities, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketableSecuritiesPolicy" xlink:to="lab_us-gaap_MarketableSecuritiesPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_6693014c-5744-4056-bdd4-d7e63f0ac815_terseLabel_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:label id="lab_us-gaap_HedgingDesignationAxis_label_en-US" xlink:label="lab_us-gaap_HedgingDesignationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Hedging Designation [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_HedgingDesignationAxis" xlink:to="lab_us-gaap_HedgingDesignationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_076c8f6d-a53f-4800-9f46-21acbebae8d1_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use asset impairment</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseImpairmentLoss" xlink:to="lab_us-gaap_OperatingLeaseImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_936fabbd-f295-4aff-9841-9dd04bd1d014_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent_03c28a51-5c5f-4849-a01a-59972520dc78_verboseLabel_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued tax, audit, and legal fees</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent_label_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accrued Tax Audit And Legal Fees, Current</link:label>
    <link:label id="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent_documentation_en-US" xlink:label="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:href="dxcm-20241231.xsd#dxcm_AccruedTaxAuditAndLegalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:to="lab_dxcm_AccruedTaxAuditAndLegalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_ebdcea4f-de6b-4016-b7c1-19c1c11ce034_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementInitialPaymentMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Initial Payment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:to="lab_dxcm_CollaborativeArrangementInitialPaymentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_082e9f50-5fbe-4d5e-8bb2-6168bf488cce_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_6aa65663-9c77-4610-8926-e29cecdf189f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrealized gains recognized during the reporting period on equity investments still held at the reporting date</link:label>
    <link:label id="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_label_en-US" xlink:label="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt and Equity Securities, Unrealized Gain (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:to="lab_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_5c47a2ec-4b3f-46ad-89d1-6a4713fba40f_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Right-of-use assets obtained in exchange for operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_terseLabel_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change</link:label>
    <link:label id="lab_ecd_UndrlygSecurityMktPriceChngPct_label_en-US" xlink:label="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Underlying Security Market Price Change, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:to="lab_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_ec2c6f34-cdfe-4f77-b080-614840697529_terseLabel_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_TaxCreditCarryforwardNameDomain_label_en-US" xlink:label="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="lab_us-gaap_TaxCreditCarryforwardNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_IndividualAxis_terseLabel_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Individual:</link:label>
    <link:label id="lab_ecd_IndividualAxis_label_en-US" xlink:label="lab_ecd_IndividualAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Individual [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_IndividualAxis" xlink:to="lab_ecd_IndividualAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_6646cae0-499c-4cf3-970d-a5e30360ebbc_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_5aa039d1-ceb7-41c7-9006-d41872e7d6bc_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected life (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_a0dbe63b-ab4d-4161-95f2-453f195b8f5f_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_cbaab8b1-89f7-4bab-995b-fe8fd1a926b9_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total inventory</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_02a4086c-92bb-4a64-a0da-feda542638fe_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e5ddb0ff-cf3e-4092-9b9a-e629f8089121_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_9f6d06d6-484f-4363-9e56-6ec48e82634d_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_91070e76-8ddf-4498-aff1-aa795c72af6c_terseLabel_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Purchase obligations</link:label>
    <link:label id="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_label_en-US" xlink:label="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Recorded Unconditional Purchase Obligation, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:to="lab_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_41508ddf-b51a-4924-a0a3-98ca1ca85df8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_5b2457c2-d096-4aaa-a99e-a55afcbe341b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return</link:label>
    <link:label id="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_label_en-US" xlink:label="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="lab_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_d1344ed6-72ae-4974-b88a-0def7d52d261_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of derivative contract</link:label>
    <link:label id="lab_us-gaap_DerivativeTermOfContract_label_en-US" xlink:label="lab_us-gaap_DerivativeTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeTermOfContract" xlink:to="lab_us-gaap_DerivativeTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_361c21cd-f58e-48c8-82ed-85b5e87751e8_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_bcce96c2-bb38-4d0c-ac80-7721d9b4da51_terseLabel_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accelerated share repurchase agreement, authorized amount</link:label>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_label_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchase Agreement, Authorized Amount</link:label>
    <link:label id="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_documentation_en-US" xlink:label="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Accelerated Share Repurchase Agreement, Authorized Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:to="lab_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_4f3fc66e-060f-46b1-914d-bea758ecde81_negatedTerseLabel_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchase of capped call transactions, net of tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_label_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:label id="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_documentation_en-US" xlink:label="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:to="lab_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_6b428a4d-5a87-4e56-834d-e57273a7a784_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Unamortized debt issuance costs</link:label>
    <link:label id="lab_us-gaap_UnamortizedDebtIssuanceExpense_label_en-US" xlink:label="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unamortized Debt Issuance Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnamortizedDebtIssuanceExpense" xlink:to="lab_us-gaap_UnamortizedDebtIssuanceExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrAdoptionDate_terseLabel_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adoption Date</link:label>
    <link:label id="lab_ecd_TrdArrAdoptionDate_label_en-US" xlink:label="lab_ecd_TrdArrAdoptionDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Adoption Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrAdoptionDate" xlink:to="lab_ecd_TrdArrAdoptionDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_e77fc1e9-1449-4638-8e3a-5b96c932a371_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Deferred revenue, long-term</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_country_GB_fc7390ed-9b4c-495c-8a62-8b909cb753bc_terseLabel_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">UK</link:label>
    <link:label id="lab_country_GB_label_en-US" xlink:label="lab_country_GB" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">UNITED KINGDOM</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_GB" xlink:to="lab_country_GB" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_2a77cb58-4fc7-4dbe-8bb1-bdc3a8facd16_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Holder's repurchase price percentage in event of fundamental change (as a percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Covenant Repurchase Price, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:to="lab_dxcm_DebtInstrumentCovenantRepurchasePricePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_dbdd7902-b010-46fc-90ea-c82dfea86b46_terseLabel_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Short-term marketable securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_label_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:label id="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_documentation_en-US" xlink:label="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-For-Sale And Equity Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:href="dxcm-20241231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:to="lab_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</link:label>
    <link:label id="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_label_en-US" xlink:label="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:to="lab_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_e00f34c6-1ecc-4854-b420-d94ef9bd6f3e_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DerivativeInstrumentRiskAxis_label_en-US" xlink:label="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Derivative Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis" xlink:to="lab_us-gaap_DerivativeInstrumentRiskAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardExrcPrice_terseLabel_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise Price</link:label>
    <link:label id="lab_ecd_AwardExrcPrice_label_en-US" xlink:label="lab_ecd_AwardExrcPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardExrcPrice" xlink:to="lab_ecd_AwardExrcPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_d1f854e6-b96f-42bb-a074-368c76ba2a9b_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_c1640083-55d7-43ea-af18-71fd60a11eae_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accrued payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Employee Related Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_TrdArrDuration_terseLabel_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Arrangement Duration</link:label>
    <link:label id="lab_ecd_TrdArrDuration_label_en-US" xlink:label="lab_ecd_TrdArrDuration" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Arrangement Duration</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_TrdArrDuration" xlink:to="lab_ecd_TrdArrDuration" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_4e14f451-98ff-4d4e-9a4d-c584a8514dcb_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Sale of stock premium (as percent)</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:to="lab_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_4dfe4265-a8c7-45c2-939e-12422ba4ba69_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net operating loss</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwards_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwards" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwards" xlink:to="lab_us-gaap_OperatingLossCarryforwards" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_ed5dd643-7097-4c81-81f4-beabefd8bb80_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases and Other Commitments</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_a533386d-621d-4b2f-af3a-ec4e5e835fc3_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity, Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DomesticCountryMember_033789bc-4535-4031-a784-0d2bd045f460_terseLabel_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DomesticCountryMember_label_en-US" xlink:label="lab_us-gaap_DomesticCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Domestic Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DomesticCountryMember" xlink:to="lab_us-gaap_DomesticCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermInvestments_c0158c2c-e2c6-4bf3-9633-e034621ba377_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-marketable equity securities</link:label>
    <link:label id="lab_us-gaap_LongTermInvestments_label_en-US" xlink:label="lab_us-gaap_LongTermInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermInvestments" xlink:to="lab_us-gaap_LongTermInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_62331549-ab4c-48df-9b03-013a2e0e5b76_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsTable_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Agreements [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsTable" xlink:to="lab_dxcm_DevelopmentAgreementsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_terseLabel_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
    <link:label id="lab_ecd_MtrlTermsOfTrdArrTextBlock_label_en-US" xlink:label="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Material Terms of Trading Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="lab_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_100e578a-83d1-4f8c-8cd8-3793e050b751_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Term of debt instrument (in months)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_172d3728-bd4e-45ec-80a8-554c92e0820d_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Term of debt instrument (in years)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTerm_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTerm" xlink:to="lab_us-gaap_DebtInstrumentTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_e81b84c6-a442-42d9-8549-5e67b21e6b36_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Present value of future payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_2267ff81-0f2c-469c-93eb-2c22b65b642a_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AllIndividualsMember_terseLabel_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">All Individuals</link:label>
    <link:label id="lab_ecd_AllIndividualsMember_label_en-US" xlink:label="lab_ecd_AllIndividualsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">All Individuals [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="lab_ecd_AllIndividualsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_721d36f9-644b-403c-a474-1383ce5371e3_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_f345e3e5-6773-47a2-8e55-7f9f9cec41c0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_25afd118-c6d3-4677-8f86-54175bc96851_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Convertible Notes due 2025</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2025 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2025Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2025Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2025</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2025Member" xlink:to="lab_dxcm_ConvertibleNotesDue2025Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_97f61bc3-d638-4a22-9c8d-bd1e95039e8f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_5a0b0a62-d3d0-4edb-9d38-0a4ecc9152f5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Other Long-Term Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Other Assets and Other Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_12da0c36-0f2c-4523-894f-1a757e5d8adf_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e87bef95-a95e-45b1-bb0d-ee23a8667d64_totalLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total other income (expense), net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_0feb75b9-1abd-4b26-8bf0-37ad6853c81b_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_ade1377e-0e8a-4a9b-93bb-35c419500cec_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangibles, net</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_b60a7eef-6e23-4494-a34a-63e4518a962d_terseLabel_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_label_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:label id="lab_dxcm_DevelopmentAgreementsLineItems_documentation_en-US" xlink:label="lab_dxcm_DevelopmentAgreementsLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Development Agreements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems" xlink:to="lab_dxcm_DevelopmentAgreementsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_3d1538a6-f8d2-4dd4-b5bd-b363197b28a1_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_1566625e-8a36-46ea-9f69-ba5fe418e0b0_totalLabel_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Carrying amount of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_ConvertibleNotesPayable_label_en-US" xlink:label="lab_us-gaap_ConvertibleNotesPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConvertibleNotesPayable" xlink:to="lab_us-gaap_ConvertibleNotesPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_5fedd178-c868-4277-aeb8-32710c77bbaa_terseLabel_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Gross Unrealized Gains</link:label>
    <link:label id="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_label_en-US" xlink:label="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="lab_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_27b8cd8e-c223-42c2-80cb-d66a28728e95_terseLabel_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Transfers in or out of Level 3 securities</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_label_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:label id="lab_dxcm_FairValueAssetsLevel3TransfersAmount_documentation_en-US" xlink:label="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Fair Value, Assets, Level 3 Transfers, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:href="dxcm-20241231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:to="lab_dxcm_FairValueAssetsLevel3TransfersAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_4fe8c4f7-e869-400f-be7a-e48e248388b3_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unrecognized compensation costs related to unvested restricted stock units</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_437325de-b1c7-4424-8643-0dce5e55b81f_terseLabel_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_label_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:label id="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember_documentation_en-US" xlink:label="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Milestone Payments [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:to="lab_dxcm_CollaborativeArrangementMilestonePaymentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_4985af0e-ec39-4535-b264-62dc8ffbf61e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Availability and Outstanding Borrowings on Credit Agreement</link:label>
    <link:label id="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Line of Credit Facilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:to="lab_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InformationTechnologyAndDataProcessing_8f3235d4-1557-4b25-8352-d64518f47f6f_terseLabel_en-US" xlink:label="lab_us-gaap_InformationTechnologyAndDataProcessing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">IT software and data</link:label>
    <link:label id="lab_us-gaap_InformationTechnologyAndDataProcessing_label_en-US" xlink:label="lab_us-gaap_InformationTechnologyAndDataProcessing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Information Technology and Data Processing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationTechnologyAndDataProcessing" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InformationTechnologyAndDataProcessing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InformationTechnologyAndDataProcessing" xlink:to="lab_us-gaap_InformationTechnologyAndDataProcessing" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_92699725-0999-4e72-bca4-2d8fa2ef113e_terseLabel_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Undistributed foreign earnings</link:label>
    <link:label id="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries_label_en-US" xlink:label="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Undistributed Earnings of Foreign Subsidiaries</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:to="lab_us-gaap_UndistributedEarningsOfForeignSubsidiaries" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_0850f24f-be12-4a10-9170-d3677f8d7dce_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_0ea74592-db2e-4acb-b886-56f814d153a7_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid inventory</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_label_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:label id="lab_dxcm_PrepaidInventoryCurrent_documentation_en-US" xlink:label="lab_dxcm_PrepaidInventoryCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid Inventory, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent" xlink:href="dxcm-20241231.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidInventoryCurrent" xlink:to="lab_dxcm_PrepaidInventoryCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_f1ac0419-33ec-4f6e-82a9-5ada2650632d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Expected volatility of common stock (as a percent)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_8ca452e0-3dda-4d9a-8e8f-42a1dd0060d8_negatedTerseLabel_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Convertible debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_label_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:label id="lab_dxcm_DeferredTaxAssetsConvertibleDebt_documentation_en-US" xlink:label="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Deferred Tax Assets, Convertible Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:to="lab_dxcm_DeferredTaxAssetsConvertibleDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_cc3c6c9c-1a77-4796-adf5-e8bfc1ec3236_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Federal</link:label>
    <link:label id="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Federal Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredFederalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_fa7dda51-3fc8-490f-9172-7e5dc72a98c6_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramDomain_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramDomain" xlink:to="lab_srt_ShareRepurchaseProgramDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_2d69bf73-47d1-42d0-ad7a-efcb1dd5272a_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="lab_us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_97fdc3d2-55cb-46d2-bfab-1de5ec96fbde_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proceeds from sale and maturity of marketable securities</link:label>
    <link:label id="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_label_en-US" xlink:label="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:to="lab_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_b2ef354f-e7e4-45ad-881c-5f2025fa80e9_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_49ff2786-017d-4802-b3f8-9d254a755353_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Impairment losses</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment, Long-Lived Asset, Held-for-Use</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:to="lab_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_MeasureAxis_terseLabel_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Measure:</link:label>
    <link:label id="lab_ecd_MeasureAxis_label_en-US" xlink:label="lab_ecd_MeasureAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Measure [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_MeasureAxis" xlink:to="lab_ecd_MeasureAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_be3c1f54-02d9-4555-b48c-875d388d677d_terseLabel_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increases related to current year tax positions</link:label>
    <link:label id="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_label_en-US" xlink:label="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:to="lab_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_13013bdb-9642-4ca0-9e92-1ae3ba21c168_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsTable_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable" xlink:to="lab_us-gaap_OperatingLossCarryforwardsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharePrice_f95319b7-7319-4c0a-9144-1c432dce69f9_terseLabel_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Closing stock price (in usd per share)</link:label>
    <link:label id="lab_us-gaap_SharePrice_label_en-US" xlink:label="lab_us-gaap_SharePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharePrice" xlink:to="lab_us-gaap_SharePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_aa454e73-bce3-4a00-bb32-76eeece202a4_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_92b36d02-51dd-44d1-97e7-851d7567736b_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Issuance of common stock in connection with acquisition, shares (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_471025a9-7b19-4497-bdf6-aa7e8c0c4882_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8ed0982c-63e2-4803-bd8d-81b9d01cd1c0_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_terseLabel_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description</link:label>
    <link:label id="lab_ecd_NonGaapMeasureDescriptionTextBlock_label_en-US" xlink:label="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Non-GAAP Measure Description [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="lab_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_805e4a90-393a-43a2-bc1c-20810ea99751_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_95e64fd7-5ba4-4d08-9c3b-dd4eb1f63306_verboseLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Accrued warranty</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_3e4a0a85-01ae-4fb1-8f3c-a2e7232ad994_periodStartLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_4ed3ad0c-b2c0-4d08-8bb6-2c20bfc914b0_periodEndLabel_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StandardProductWarrantyAccrual_label_en-US" xlink:label="lab_us-gaap_StandardProductWarrantyAccrual" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Standard Product Warranty Accrual</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StandardProductWarrantyAccrual" xlink:to="lab_us-gaap_StandardProductWarrantyAccrual" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_f9002820-4388-422d-aaba-a8a277e5e3b8_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_fc4fe1a5-3e49-4f85-8772-7a80d8758d5a_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Preferred stock, par value (in usd per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_1ab3af00-70b4-4788-8ab6-b24457bdfacf_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash, end of period:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_JPMWarrantTransactionsMember_1bf903a0-455b-4912-8354-1f784321f21a_terseLabel_en-US" xlink:label="lab_dxcm_JPMWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">JPM Warrant Transactions</link:label>
    <link:label id="lab_dxcm_JPMWarrantTransactionsMember_label_en-US" xlink:label="lab_dxcm_JPMWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">JPM Warrant Transactions [Member]</link:label>
    <link:label id="lab_dxcm_JPMWarrantTransactionsMember_documentation_en-US" xlink:label="lab_dxcm_JPMWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">JPM Warrant Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_JPMWarrantTransactionsMember" xlink:href="dxcm-20241231.xsd#dxcm_JPMWarrantTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_JPMWarrantTransactionsMember" xlink:to="lab_dxcm_JPMWarrantTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_terseLabel_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
    <link:label id="lab_ecd_Additional402vDisclosureTextBlock_label_en-US" xlink:label="lab_ecd_Additional402vDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Additional 402(v) Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_Additional402vDisclosureTextBlock" xlink:to="lab_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_2c6352b6-b374-47c0-a4e5-3753dacaf7d0_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_832b748d-e0d7-4843-b64e-08adbb923ed5_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_f4c28d79-959a-48cf-ae9f-495668455891_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_25adf6e8-7e21-46f6-b9c8-9c2cea36e315_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_country_IE_840cba7d-5baf-425e-a6cc-c8916c005e73_terseLabel_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Ireland</link:label>
    <link:label id="lab_country_IE_label_en-US" xlink:label="lab_country_IE" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">IRELAND</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_IE" xlink:to="lab_country_IE" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_63abc341-c8f3-4f78-84d6-74081c444fd4_totalLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total interest expense recognized on senior notes</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_2aa27cab-c63e-4ef9-8232-18107396105f_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ImpairedLongLivedAssetsFairValue_c0db94e1-004a-4eae-9d07-3145c58ef716_terseLabel_en-US" xlink:label="lab_dxcm_ImpairedLongLivedAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair value of impaired long-lived asset</link:label>
    <link:label id="lab_dxcm_ImpairedLongLivedAssetsFairValue_label_en-US" xlink:label="lab_dxcm_ImpairedLongLivedAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets, Fair Value</link:label>
    <link:label id="lab_dxcm_ImpairedLongLivedAssetsFairValue_documentation_en-US" xlink:label="lab_dxcm_ImpairedLongLivedAssetsFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Impaired Long-Lived Assets, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ImpairedLongLivedAssetsFairValue" xlink:href="dxcm-20241231.xsd#dxcm_ImpairedLongLivedAssetsFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ImpairedLongLivedAssetsFairValue" xlink:to="lab_dxcm_ImpairedLongLivedAssetsFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_97eb425f-339d-4616-bb5b-f73d2bcf80aa_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cash paid during the year for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_a09d3b39-6bd7-46a5-a448-922073c8385b_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_cfeb8b73-bfcf-4576-ad25-4fff00f5569d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_bed5d438-0a26-4038-b267-63fce1d80f05_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_6bb38e29-c9cb-4f37-bc59-811b9ebbce11_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableGross_855425de-02b0-4378-a397-d81f2a371d22_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableGross_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Accounts Receivable, before Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableGross" xlink:to="lab_us-gaap_AccountsReceivableGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_8c334f98-a244-4362-a6c1-5f4bf1d5b12f_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeniorNotesMember_c64f66d3-c925-4f67-a427-c44ae1f0d671_terseLabel_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Notes</link:label>
    <link:label id="lab_us-gaap_SeniorNotesMember_label_en-US" xlink:label="lab_us-gaap_SeniorNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeniorNotesMember" xlink:to="lab_us-gaap_SeniorNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_6b337cf3-6c31-407f-920e-76af0946657b_terseLabel_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Shares issued for repurchase and conversions of senior convertible notes</link:label>
    <link:label id="lab_us-gaap_DebtConversionConvertedInstrumentAmount1_label_en-US" xlink:label="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Conversion, Converted Instrument, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:to="lab_us-gaap_DebtConversionConvertedInstrumentAmount1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_edc66ed2-a14f-4d02-869a-fb65d9864626_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Years Remaining Subject to Audit by Major Jurisdiction</link:label>
    <link:label id="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Income Tax Examinations [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:to="lab_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_6e9715be-f06b-49ef-86dc-9345648b4065_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Long-Term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_c77f192a-6912-42a6-ae82-09eebbd03611_terseLabel_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Carrying values of investments</link:label>
    <link:label id="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_label_en-US" xlink:label="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Securities without Readily Determinable Fair Value, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:to="lab_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_d13cc9d9-9c6d-47d6-a611-981244bf3c4f_terseLabel_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:label id="lab_dei_EntityWellKnownSeasonedIssuer_label_en-US" xlink:label="lab_dei_EntityWellKnownSeasonedIssuer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityWellKnownSeasonedIssuer" xlink:to="lab_dei_EntityWellKnownSeasonedIssuer" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_de6c667b-02f0-4c1f-a55c-3eb5fb6fea31_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Intangibles, other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_43ca333b-975e-4225-a0e3-8a3ba1124f0e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_47a4eceb-778e-4290-b958-7636bc61620f_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_d30b82e1-0929-4f4b-97d3-e0edf0dc591d_terseLabel_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">ESPP 2015</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_label_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 2015 [Member]</link:label>
    <link:label id="lab_dxcm_EmployeeStockPurchasePlan2015Member_documentation_en-US" xlink:label="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Employee Stock Purchase Plan 2015</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EmployeeStockPurchasePlan2015Member" xlink:to="lab_dxcm_EmployeeStockPurchasePlan2015Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_6de7c209-f7c0-4b1e-b2f1-0849987321a1_terseLabel_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_label_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Member]</link:label>
    <link:label id="lab_dxcm_ShareRepurchaseProgramMember_documentation_en-US" xlink:label="lab_dxcm_ShareRepurchaseProgramMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Share Repurchase Program</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember" xlink:href="dxcm-20241231.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ShareRepurchaseProgramMember" xlink:to="lab_dxcm_ShareRepurchaseProgramMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_d620fc30-75f1-4898-a923-4e4fff4db6f8_terseLabel_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Operating Loss Carryforwards</link:label>
    <link:label id="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_label_en-US" xlink:label="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Summary of Operating Loss Carryforwards [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:to="lab_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8884e8bd-a1a0-4a5f-8167-af9101de16d3_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_9c42c021-cb2f-4a3e-bc3e-16ac160ce161_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Convertible Notes due 2023</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2023Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2023Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2023 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2023Member" xlink:to="lab_dxcm_ConvertibleNotesDue2023Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_53257102-b622-45e7-8a40-fcda7744e727_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Weighted average discount rate of operating leases (as a percent)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_84027ff6-fca1-49d6-99de-ef33466c9d85_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net cash used in financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_5be4deb2-e047-45a2-8b06-4d34a5d0fa62_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label id="lab_us-gaap_OperatingLossCarryforwardsLineItems_label_en-US" xlink:label="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Loss Carryforwards [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="lab_us-gaap_OperatingLossCarryforwardsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CreditFacilityAxis_cf39777d-decc-40f3-98d9-8c978fc2631f_terseLabel_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:label id="lab_us-gaap_CreditFacilityAxis_label_en-US" xlink:label="lab_us-gaap_CreditFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Credit Facility [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CreditFacilityAxis" xlink:to="lab_us-gaap_CreditFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_64d349e1-e2de-46cf-8d32-d190df6d0b95_terseLabel_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">RSUs and PSUs</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_label_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted And Performance Stock Units Member [Member]</link:label>
    <link:label id="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_documentation_en-US" xlink:label="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Restricted And Performance Stock Units Member</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedAndPerformanceStockUnitsMemberMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:to="lab_dxcm_RestrictedAndPerformanceStockUnitsMemberMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_59c6989b-b619-47a9-8705-c8495e1c32cc_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote</link:label>
    <link:label id="lab_ecd_AdjToNonPeoNeoCompFnTextBlock_label_en-US" xlink:label="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="lab_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_24581bc4-8d41-4e65-b235-1daefabb54cb_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_18d75d20-e15a-462a-bad3-b5c42486199e_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_b8ea81ed-7aa6-42b4-b32f-a863296c7980_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Translation adjustments and other</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_1f720f37-30ad-4458-857d-669220a0cbed_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State</link:label>
    <link:label id="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred State and Local Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_0185536b-ca97-4780-95a6-0582bd5e604f_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Accrued Warranty</link:label>
    <link:label id="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Product Warranty Liability [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardGrantDateFairValue_terseLabel_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value as of Grant Date</link:label>
    <link:label id="lab_ecd_AwardGrantDateFairValue_label_en-US" xlink:label="lab_ecd_AwardGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardGrantDateFairValue" xlink:to="lab_ecd_AwardGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_01fdb486-bf45-4490-9629-ac81d9439556_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Foreign rate differential</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:to="lab_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_5a8a742c-296d-42a5-bb6d-ff2c32345265_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_8ece12c3-beca-4863-aba6-1aeb01236c3c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_09edc92a-a7f8-4bdc-81b4-b44ef6bca9aa_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization period (in months)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets, Remaining Amortization Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_9a8081f8-f4d3-4d5b-9d01-1633183b5720_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_4ef62e03-55be-480a-8b1c-f871152713a3_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_63c13639-7402-4f1d-990e-7b9be19bd662_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Net income - diluted</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAttributableToParentDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Income (Loss) Attributable to Parent, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:to="lab_us-gaap_NetIncomeLossAttributableToParentDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_df70eea9-4336-4c02-8304-ca91eae4f3a0_terseLabel_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unbilled accounts receivable</link:label>
    <link:label id="lab_us-gaap_UnbilledContractsReceivable_label_en-US" xlink:label="lab_us-gaap_UnbilledContractsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Unbilled Contracts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnbilledContractsReceivable" xlink:to="lab_us-gaap_UnbilledContractsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_f69585e5-68d4-4830-a428-1238b14b4f0a_terseLabel_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaboration Agreements</link:label>
    <link:label id="lab_us-gaap_CollaborativeArrangementAccountingPolicy_label_en-US" xlink:label="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement, Accounting Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:to="lab_us-gaap_CollaborativeArrangementAccountingPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_02ac4b6c-0be2-4f7a-b601-519c5bc43e0e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Share-Based Compensation Expenses</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_22082899-100f-44d1-8222-df406d93fd99_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_RestatementDateAxis_terseLabel_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restatement Determination Date:</link:label>
    <link:label id="lab_ecd_RestatementDateAxis_label_en-US" xlink:label="lab_ecd_RestatementDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_RestatementDateAxis" xlink:to="lab_ecd_RestatementDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_959bce12-96a9-4ba9-ac46-891c801e6d97_terseLabel_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label id="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember_label_en-US" xlink:label="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="lab_us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_d4c411d4-ffc1-4552-9eff-b9e2bb65a44c_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_73df816c-32ca-46c9-8872-757eca34dae3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_667a33bb-b7d1-4975-b99d-2b365fa6ef99_terseLabel_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:label id="lab_dei_DocumentFinStmtErrorCorrectionFlag_label_en-US" xlink:label="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Financial Statement Error Correction [Flag]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFinStmtErrorCorrectionFlag" xlink:to="lab_dei_DocumentFinStmtErrorCorrectionFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_3d83c601-2c0f-4f23-8c90-6d1dc5b92a30_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_82e7f77d-5f45-4e09-a35c-a0df0d4341ab_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetRetirementObligation_b70952e3-cc4c-4d3e-b444-dcc330b265f5_terseLabel_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Asset retirement obligation</link:label>
    <link:label id="lab_us-gaap_AssetRetirementObligation_label_en-US" xlink:label="lab_us-gaap_AssetRetirementObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Asset Retirement Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetRetirementObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetRetirementObligation" xlink:to="lab_us-gaap_AssetRetirementObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_942095f8-5150-4e41-81e1-f50798f6f60c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_e962a629-d7e5-4970-8b15-c7026d0884f7_terseLabel_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Permanent items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_label_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:label id="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_documentation_en-US" xlink:label="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Effective Income Tax Reconciliation, Permanent Items</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:to="lab_dxcm_EffectiveIncomeTaxReconciliationPermanentItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_801fde1d-df8b-44a8-8980-81d59852e960_terseLabel_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Number of options to extend (in extension options)</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_label_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Options To Extend</link:label>
    <link:label id="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_documentation_en-US" xlink:label="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Number Of Options To Extend</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:to="lab_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_c6613e41-a65d-4928-95aa-e8c9fdc1abd0_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_50d71667-38b2-4a69-8c42-c6104853c336_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Intangible asset impairment charges</link:label>
    <link:label id="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Impairment of Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_76fe4f69-849c-465a-a95c-5373b7d0d3f7_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_e865a432-5471-4373-a6d9-f5bf9b9674b7_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskLineItems_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskLineItems" xlink:to="lab_us-gaap_ConcentrationRiskLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_0ffa5f67-0f23-4499-922e-fe3cf0e04a97_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">State income tax, net of federal benefit</link:label>
    <link:label id="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_label_en-US" xlink:label="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:to="lab_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_a554fdaa-1425-4172-8eb1-0436f8c778e7_negatedTotalLabel_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="resource" xml:lang="en-US">Total deferred tax liabilities</link:label>
    <link:label id="lab_us-gaap_DeferredIncomeTaxLiabilities_label_en-US" xlink:label="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Deferred Tax Liabilities, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredIncomeTaxLiabilities" xlink:to="lab_us-gaap_DeferredIncomeTaxLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_e95bdc46-3a24-44bc-baad-384f97e10f3c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Basic net income per share (in usd per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_1bb01c7c-32d2-4f83-b629-7ecf13680b93_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Net proceeds from issuance of common stock</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_93d65d40-2fb1-4ac2-baf9-56176b2f053f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Operating cash flows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_country_MY_448f9be8-c317-49c4-972e-1f8fe438ff3b_terseLabel_en-US" xlink:label="lab_country_MY" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Malaysia</link:label>
    <link:label id="lab_country_MY_label_en-US" xlink:label="lab_country_MY" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">MALAYSIA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_MY"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_MY" xlink:to="lab_country_MY" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_terseLabel_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
    <link:label id="lab_ecd_AwardTmgMnpiDiscTextBlock_label_en-US" xlink:label="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Award Timing MNPI Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:to="lab_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_terseLabel_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost</link:label>
    <link:label id="lab_ecd_AggtPnsnAdjsSvcCstMember_label_en-US" xlink:label="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Aggregate Pension Adjustments Service Cost [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="lab_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_A401kPlanMember_d1871360-3303-4d5f-9789-5087a3fe6136_terseLabel_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">401(k) Plan</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_label_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:label id="lab_dxcm_A401kPlanMember_documentation_en-US" xlink:label="lab_dxcm_A401kPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">401(k) Plan [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember" xlink:href="dxcm-20241231.xsd#dxcm_A401kPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_A401kPlanMember" xlink:to="lab_dxcm_A401kPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_5a0a27ac-7ae2-40d4-9175-44442400e8d0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_BofAWarrantTransactionsMember_140541b8-c6ad-4cd0-87bd-6358f5fbba3a_terseLabel_en-US" xlink:label="lab_dxcm_BofAWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">BofA Warrant Transactions</link:label>
    <link:label id="lab_dxcm_BofAWarrantTransactionsMember_label_en-US" xlink:label="lab_dxcm_BofAWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">BofA Warrant Transactions [Member]</link:label>
    <link:label id="lab_dxcm_BofAWarrantTransactionsMember_documentation_en-US" xlink:label="lab_dxcm_BofAWarrantTransactionsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">BofA Warrant Transactions</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BofAWarrantTransactionsMember" xlink:href="dxcm-20241231.xsd#dxcm_BofAWarrantTransactionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_BofAWarrantTransactionsMember" xlink:to="lab_dxcm_BofAWarrantTransactionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_98b468ff-c9fe-4bed-8bfc-777b410f6997_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_5463fd78-64c4-4fa8-b4ba-77868809fa8a_terseLabel_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:label id="lab_srt_ShareRepurchaseProgramAxis_label_en-US" xlink:label="lab_srt_ShareRepurchaseProgramAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share Repurchase Program [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ShareRepurchaseProgramAxis" xlink:to="lab_srt_ShareRepurchaseProgramAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_29882f12-1f13-446e-9fbe-a935d230c2b3_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Concentration of Credit Risk and Significant Customers</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_ccb33bfa-9b12-42b6-bcac-e8372c584431_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCredit_0ab3de62-78e5-4498-b9dc-2b4dc7a85d27_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outstanding borrowings</link:label>
    <link:label id="lab_us-gaap_LineOfCredit_label_en-US" xlink:label="lab_us-gaap_LineOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Long-Term Line of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCredit" xlink:to="lab_us-gaap_LineOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_e9ecae81-31d0-4a67-8af1-71ffc449c126_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_46253269-99df-4ab5-8db5-84e909958368_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Fair Value Hierarchy for Financial Assets</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Assets Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ComputerSoftwareAndHardwareMember_34f25985-3505-4144-842f-0107d911229d_terseLabel_en-US" xlink:label="lab_dxcm_ComputerSoftwareAndHardwareMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Computer software and hardware</link:label>
    <link:label id="lab_dxcm_ComputerSoftwareAndHardwareMember_label_en-US" xlink:label="lab_dxcm_ComputerSoftwareAndHardwareMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Computer Software And Hardware [Member]</link:label>
    <link:label id="lab_dxcm_ComputerSoftwareAndHardwareMember_documentation_en-US" xlink:label="lab_dxcm_ComputerSoftwareAndHardwareMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Computer Software And Hardware</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ComputerSoftwareAndHardwareMember" xlink:href="dxcm-20241231.xsd#dxcm_ComputerSoftwareAndHardwareMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ComputerSoftwareAndHardwareMember" xlink:to="lab_dxcm_ComputerSoftwareAndHardwareMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_83e83d16-f954-4d15-b083-a3d217feda5b_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:to="lab_us-gaap_FairValueMeasurementInputsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_df81f487-ffd8-4932-8513-edd1467c30a7_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MarketingExpense_c969c287-09b9-4d53-b391-fb1793a2cc4d_terseLabel_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Marketing expense</link:label>
    <link:label id="lab_us-gaap_MarketingExpense_label_en-US" xlink:label="lab_us-gaap_MarketingExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Marketing Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MarketingExpense" xlink:to="lab_us-gaap_MarketingExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_f4b92e0b-33fb-4326-98b4-ad026082798d_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_fd783d1d-6154-43ab-8d12-dcd26962ce0b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise price of warrants or rights (in usd per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_4b452b47-506b-419c-b7e0-b689d532ee87_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Proportion of applicable conversion price (as a percent)</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:to="lab_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_da62de40-cba5-4f2a-b4c8-0306f741f901_terseLabel_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Prepaid and Other Current Assets</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_label_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid And Other Current Assets [Table Text Block]</link:label>
    <link:label id="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_documentation_en-US" xlink:label="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Prepaid And Other Current Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:href="dxcm-20241231.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:to="lab_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_aaa6118e-ac73-4573-8ef3-8ef189f4d3ec_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_f286c015-e120-4e30-b393-670a08a5cec7_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_35dc1a51-732d-4783-825e-e0aadac98198_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_fbbac93a-18aa-4374-9b66-959e03904f1b_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_8a5429ef-e286-4916-a550-12293111af8c_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Conversions of 2023 Notes</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_8eb50b94-a2b7-4389-a03c-16c030ecf8c8_negatedLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Forfeited (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_15146e75-0330-4f02-9f45-912d35631ce1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Intangible Assets and Weighted Average Amortization Period</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_terseLabel_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year</link:label>
    <link:label id="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_label_en-US" xlink:label="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:to="lab_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCountryMember_5a7f0991-db42-4c12-ad40-eca8632b81c1_verboseLabel_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Foreign</link:label>
    <link:label id="lab_us-gaap_ForeignCountryMember_label_en-US" xlink:label="lab_us-gaap_ForeignCountryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Foreign Tax Jurisdiction [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCountryMember" xlink:to="lab_us-gaap_ForeignCountryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_b51d6451-f1a2-43a9-8dcd-4017d0acf8a8_terseLabel_en-US" xlink:label="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Acquired technology and intellectual property</link:label>
    <link:label id="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_label_en-US" xlink:label="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Acquired Technology And Intellectual Property [Member]</link:label>
    <link:label id="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_documentation_en-US" xlink:label="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Acquired Technology And Intellectual Property</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:href="dxcm-20241231.xsd#dxcm_AcquiredTechnologyAndIntellectualPropertyMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:to="lab_dxcm_AcquiredTechnologyAndIntellectualPropertyMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_ca27128f-a332-467b-b762-a651fd71e601_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_f1d988c0-493a-4951-a4b0-a85ba57bc6e8_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_c8f27b15-d2e5-4296-9192-35ff76c04e9a_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of treasury stock, including excise tax</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValueAcquiredCostMethod_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Treasury Stock, Value, Acquired, Cost Method</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:to="lab_us-gaap_TreasuryStockValueAcquiredCostMethod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_ee2d7265-6f6f-4037-a74e-1550a5765d16_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_d57c6c59-c35d-49d2-a71b-75a5239d7da3_verboseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Other accrued liabilities</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_5ce06fe9-7744-4029-a88b-732e49e2093b_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total assets measured at fair value on a recurring basis</link:label>
    <link:label id="lab_us-gaap_AssetsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_AssetsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Assets, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsFairValueDisclosure" xlink:to="lab_us-gaap_AssetsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_671f25d4-a2d8-4d30-83de-996e285cfc37_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Outside of the United States</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Foreign</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_bfecb4a5-7bfb-47eb-9f6c-0849478afece_verboseLabel_en-US" xlink:label="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Shares Issued In Connection With The Restated Collaboration Agreement</link:label>
    <link:label id="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_label_en-US" xlink:label="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Shares Issued In Connection With The Restated Collaboration Agreement</link:label>
    <link:label id="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_documentation_en-US" xlink:label="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Shares Issued In Connection With The Restated Collaboration Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:href="dxcm-20241231.xsd#dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:to="lab_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_280825fc-5f52-4226-a1a4-270c740bdd63_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2029</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_232f2185-f73b-43fe-9134-77f1d83ba907_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_2627b81c-ba29-4e4f-8d62-0127a8b7ae77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Less: Current portion</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_c7533583-b7ea-4281-995b-f6697ec65a60_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BaseRateMember_84d40e13-ab91-4da6-9957-35bf6acace04_terseLabel_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Base Rate</link:label>
    <link:label id="lab_us-gaap_BaseRateMember_label_en-US" xlink:label="lab_us-gaap_BaseRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Base Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BaseRateMember" xlink:to="lab_us-gaap_BaseRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_58f4071e-7e42-493f-b731-a3788bea3d1b_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total future lease cost</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_3d69b06c-1cf6-43f9-bff6-830425be5c45_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Unvested awards (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6f8f05a6-9b6a-40eb-a122-2d85e9e4dffb_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xml:lang="en-US">Nonvested at beginning of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ad0923de-c34c-4d86-8f9d-cbed7e103eb6_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xml:lang="en-US">Nonvested at end of period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_InsiderTradingArrLineItems_label_en-US" xlink:label="lab_ecd_InsiderTradingArrLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Insider Trading Arrangements [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="lab_ecd_InsiderTradingArrLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_421b6df6-2f28-4204-a27f-9eb5be344c7c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerSalesChannelDomain_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Contract with Customer, Sales Channel [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:to="lab_us-gaap_ContractWithCustomerSalesChannelDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_03b7d8f5-86b9-45e7-bc96-802d64627094_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_316c2eee-8455-4c0a-bec9-e9e0af85eaa3_terseLabel_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_label_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Debt Instrument Conversion Term [Domain]</link:label>
    <link:label id="lab_dxcm_DebtInstrumentConversionTermDomain_documentation_en-US" xlink:label="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">[Domain] for Debt Instrument Conversion Term [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain" xlink:to="lab_dxcm_DebtInstrumentConversionTermDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_3f17ce35-9d5e-4378-a144-ec9d0bd1c11f_terseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Exercise and settlement of warrants</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Exercise and Settlement of Warrants</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Exercise and Settlement of Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:to="lab_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a9213e82-735e-44d8-9740-0795893cb4ec_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_07a5d596-6cd9-4802-b838-13738b12c22f_totalLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xml:lang="en-US">Total prepaid and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_2e93995f-9df0-47df-a757-90628e93ff96_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_1e436a7a-c50a-4042-8408-355a522c283a_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits</link:label>
    <link:label id="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_90331436-7f48-457c-987c-69aa2406405f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Purchases of non-marketable equity securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireOtherInvestments_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Other Investments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireOtherInvestments" xlink:to="lab_us-gaap_PaymentsToAcquireOtherInvestments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_6d3398f3-d841-48e4-8e67-13910c4a4959_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_f65c9fcb-a1cc-4569-b3d3-b63e5461fde0_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_591d5525-43b9-4467-9134-d81639c0e1ba_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_fca81cf3-ecda-4776-a3cf-35c46e50023b_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Retained Earnings</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_05160b69-71d4-4f3b-930d-dfaba27431d0_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amortization of debt issuance costs</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCosts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amortization of Debt Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCosts" xlink:to="lab_us-gaap_AmortizationOfFinancingCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_54f216e8-8752-40fa-8063-a2ff30a3a9f6_negatedTerseLabel_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xml:lang="en-US">Benefit of note hedge upon conversions of 2023 Notes</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_label_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Exercise of Note Hedge</link:label>
    <link:label id="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_documentation_en-US" xlink:label="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Stock Issued During Period, Value, Exercise of Note Hedge</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:to="lab_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_4510a32b-9918-47d9-8611-0735d06582f8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Revenues from External Customers and Long-Lived Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:to="lab_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_d7fe0f02-3331-4da8-a741-8ac860d4d143_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs)</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_c6b7d9af-d09a-4286-8620-b3d2b8d9e98f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_bc63b974-d90d-4042-be74-4a34eb4b2a77_terseLabel_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Convertible Notes due 2028</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_label_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2028 [Member]</link:label>
    <link:label id="lab_dxcm_ConvertibleNotesDue2028Member_documentation_en-US" xlink:label="lab_dxcm_ConvertibleNotesDue2028Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Convertible Notes Due 2028</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dxcm_ConvertibleNotesDue2028Member" xlink:to="lab_dxcm_ConvertibleNotesDue2028Member" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_terseLabel_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Executive Category:</link:label>
    <link:label id="lab_ecd_ExecutiveCategoryAxis_label_en-US" xlink:label="lab_ecd_ExecutiveCategoryAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Executive Category [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="lab_ecd_ExecutiveCategoryAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_5cc60a35-ba24-4403-94b7-fa39b838f42c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit)</link:label>
    <link:label id="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_421aabab-a5f6-47d7-9af6-1afc56f60de9_verboseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Statement of Income Location, Balance [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_d51cf692-6ad6-4c2e-b05f-2c0202bf91d8_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xml:lang="en-US">Purchase of marketable securities</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Payments to Acquire Debt Securities, Available-for-Sale</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:to="lab_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LetterOfCreditMember_1f1c05b7-12fd-434a-91ec-faf34f2b5a0d_terseLabel_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Letter of Credit</link:label>
    <link:label id="lab_us-gaap_LetterOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LetterOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Letter of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LetterOfCreditMember" xlink:to="lab_us-gaap_LetterOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ecd_CoSelectedMeasureName_terseLabel_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:label id="lab_ecd_CoSelectedMeasureName_label_en-US" xlink:label="lab_ecd_CoSelectedMeasureName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Company Selected Measure Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ecd_CoSelectedMeasureName" xlink:to="lab_ecd_CoSelectedMeasureName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>17
<FILENAME>dxcm-20241231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:8ed1c56a-770f-4e8b-9438-fee6cac0ea2e,g:30ae0d3e-76e8-41e2-ad9f-25e264a56972-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.dexcom.com/role/CoverPage" xlink:type="simple" xlink:href="dxcm-20241231.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_9d04f07e-dcd9-4a1f-a4a6-42371d7f4278" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentType_9d04f07e-dcd9-4a1f-a4a6-42371d7f4278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentAnnualReport_a21bcd0b-f2bc-47da-92e3-d3778aaf6855" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentAnnualReport_a21bcd0b-f2bc-47da-92e3-d3778aaf6855" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_523a7bb4-ed40-443d-a416-a471a88b36e8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentPeriodEndDate_523a7bb4-ed40-443d-a416-a471a88b36e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_70aef315-b0f2-4d75-a8a9-f319a3e5262f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_CurrentFiscalYearEndDate_70aef315-b0f2-4d75-a8a9-f319a3e5262f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_0d86932e-aa1b-495a-926c-a25fe128287b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentTransitionReport_0d86932e-aa1b-495a-926c-a25fe128287b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a953758a-2de9-48c8-8ecb-86ce4c2ff071" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityFileNumber_a953758a-2de9-48c8-8ecb-86ce4c2ff071" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_a1b1f535-d961-46e2-9800-00b04250abdd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityRegistrantName_a1b1f535-d961-46e2-9800-00b04250abdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_fdf02ec0-9987-40ee-902d-9c3f19849e8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityIncorporationStateCountryCode_fdf02ec0-9987-40ee-902d-9c3f19849e8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_24a1dbd1-0145-4b4a-bf5b-48f7eaceb1f2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityTaxIdentificationNumber_24a1dbd1-0145-4b4a-bf5b-48f7eaceb1f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_7ee78ce9-1cb0-4fbf-8a0d-5a997fc77c7a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityAddressAddressLine1_7ee78ce9-1cb0-4fbf-8a0d-5a997fc77c7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_0a2d9199-e071-4226-b199-01391798ac88" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityAddressCityOrTown_0a2d9199-e071-4226-b199-01391798ac88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d1fbec0a-f5c6-4a2e-ae28-bfabf97ed5ae" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityAddressStateOrProvince_d1fbec0a-f5c6-4a2e-ae28-bfabf97ed5ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_ca7fa6f8-3ad8-4f46-a372-bf93747dcd4f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityAddressPostalZipCode_ca7fa6f8-3ad8-4f46-a372-bf93747dcd4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_f4e81ece-6e5e-4ad4-b0bd-fcf064d88be5" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_CityAreaCode_f4e81ece-6e5e-4ad4-b0bd-fcf064d88be5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_dfb3899e-b2ba-4863-ad38-e2232bd80a6f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_LocalPhoneNumber_dfb3899e-b2ba-4863-ad38-e2232bd80a6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_9bafff4f-13a7-4349-a2a8-f5f30b87bb34" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_Security12bTitle_9bafff4f-13a7-4349-a2a8-f5f30b87bb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_49ef9803-9576-4e47-802c-3d68cc69be72" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_TradingSymbol_49ef9803-9576-4e47-802c-3d68cc69be72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_c89c34bc-913f-4bcc-9c13-77e7c7dd7aed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_SecurityExchangeName_c89c34bc-913f-4bcc-9c13-77e7c7dd7aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityWellKnownSeasonedIssuer_35d079c9-5da1-42b0-8ffa-c7a2d6c31708" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityWellKnownSeasonedIssuer_35d079c9-5da1-42b0-8ffa-c7a2d6c31708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityVoluntaryFilers_b5ddfa1a-bc31-4304-8b34-53ed55f9cb55" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityVoluntaryFilers_b5ddfa1a-bc31-4304-8b34-53ed55f9cb55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_caa64b59-78ae-4f82-b808-28605a01e5c9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityCurrentReportingStatus_caa64b59-78ae-4f82-b808-28605a01e5c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_4d457e7d-f222-46da-a79a-289c04aa4932" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityInteractiveDataCurrent_4d457e7d-f222-46da-a79a-289c04aa4932" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_832c5edc-1c99-47e5-bb7d-3e450d35959c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityFilerCategory_832c5edc-1c99-47e5-bb7d-3e450d35959c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_0d019908-5f51-45ec-b1ed-07e3b09778a0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntitySmallBusiness_0d019908-5f51-45ec-b1ed-07e3b09778a0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_baba9e68-48d5-482e-85aa-7644d41250f9" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityEmergingGrowthCompany_baba9e68-48d5-482e-85aa-7644d41250f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_IcfrAuditorAttestationFlag_d7f7e13a-e41f-494e-86c0-1121c7b486b8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_IcfrAuditorAttestationFlag"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_IcfrAuditorAttestationFlag_d7f7e13a-e41f-494e-86c0-1121c7b486b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFinStmtErrorCorrectionFlag_0838896e-d4e1-4afc-b581-784ac36fa0b7" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFinStmtErrorCorrectionFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentFinStmtErrorCorrectionFlag_0838896e-d4e1-4afc-b581-784ac36fa0b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_ecff7e7e-9344-4c1e-ac14-dedb28ce58e6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityShellCompany_ecff7e7e-9344-4c1e-ac14-dedb28ce58e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityPublicFloat_c8152bfe-8241-41fa-aecc-915ade4ff2ab" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityPublicFloat_c8152bfe-8241-41fa-aecc-915ade4ff2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_ef2b1de8-eb42-4c4f-9601-3af9eadeb582" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_ef2b1de8-eb42-4c4f-9601-3af9eadeb582" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentsIncorporatedByReferenceTextBlock_16c65d23-c1d0-45ed-88fb-850a9a5ede43" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentsIncorporatedByReferenceTextBlock_16c65d23-c1d0-45ed-88fb-850a9a5ede43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_2081634a-8df9-43f6-bd9d-7f66d67ff119" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="32" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_AmendmentFlag_2081634a-8df9-43f6-bd9d-7f66d67ff119" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_fd8e534c-46f0-497a-983f-9c69bc48c0de" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="33" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentFiscalYearFocus_fd8e534c-46f0-497a-983f-9c69bc48c0de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_1bfab179-a328-41c1-9630-7856f44beb34" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="34" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_DocumentFiscalPeriodFocus_1bfab179-a328-41c1-9630-7856f44beb34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_2146621a-dc7b-4412-a5bf-4835f1b98f61" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="35" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_0a07612d-4f25-4acf-bfc3-410d4928d7ff" xlink:to="loc_dei_EntityCentralIndexKey_2146621a-dc7b-4412-a5bf-4835f1b98f61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/AuditInformation" xlink:type="simple" xlink:href="dxcm-20241231.xsd#AuditInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/AuditInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AuditInformationAbstract_8d163571-1ba3-47a8-a0e9-ef7e518221f5" xlink:href="dxcm-20241231.xsd#dxcm_AuditInformationAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorName_c4cd76c3-a659-406d-832a-a87c5d338ce4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorName"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_AuditInformationAbstract_8d163571-1ba3-47a8-a0e9-ef7e518221f5" xlink:to="loc_dei_AuditorName_c4cd76c3-a659-406d-832a-a87c5d338ce4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorLocation_ca173f60-2940-420d-8b38-f29eb160e2ef" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorLocation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_AuditInformationAbstract_8d163571-1ba3-47a8-a0e9-ef7e518221f5" xlink:to="loc_dei_AuditorLocation_ca173f60-2940-420d-8b38-f29eb160e2ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AuditorFirmId_a6483dc9-0c7d-445d-af6e-0f62e634a20c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditorFirmId"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_AuditInformationAbstract_8d163571-1ba3-47a8-a0e9-ef7e518221f5" xlink:to="loc_dei_AuditorFirmId_a6483dc9-0c7d-445d-af6e-0f62e634a20c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e8195323-fb10-4a15-bb5e-84575c20d3a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e8195323-fb10-4a15-bb5e-84575c20d3a2" xlink:to="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53845457-94f5-4fd6-a91b-45a449f3c511" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_53845457-94f5-4fd6-a91b-45a449f3c511" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_922663bb-7397-440b-a2f3-e6643eeb7ce1" xlink:href="dxcm-20241231.xsd#dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities_922663bb-7397-440b-a2f3-e6643eeb7ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_beb7a0bb-eda1-4b4f-8515-7f86e03da1d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_beb7a0bb-eda1-4b4f-8515-7f86e03da1d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_2393fa86-3566-4c87-8e72-d3db2103663c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_us-gaap_InventoryNet_2393fa86-3566-4c87-8e72-d3db2103663c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eee3b62f-4aba-4921-87af-f7f96c7882d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_eee3b62f-4aba-4921-87af-f7f96c7882d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_09fb9a08-a874-4ea2-b756-7b04e0f2efdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_ce5d7298-febf-4f8e-bfd0-2220d2939ad1" xlink:to="loc_us-gaap_AssetsCurrent_09fb9a08-a874-4ea2-b756-7b04e0f2efdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9b0f3c31-6ce2-458c-8f6e-ba278b4997c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_9b0f3c31-6ce2-458c-8f6e-ba278b4997c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc991fa2-f540-4837-998e-d3f2e2d3162b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_dc991fa2-f540-4837-998e-d3f2e2d3162b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_ae7d9c67-b3ee-4293-b537-d0bdda3b9bfb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_Goodwill_ae7d9c67-b3ee-4293-b537-d0bdda3b9bfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c6600d8-40cd-4106-bb0e-7f0e72037b69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_5c6600d8-40cd-4106-bb0e-7f0e72037b69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxAssetsNet_7c8be2ac-49e8-43b6-b3ab-140fc45e79ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxAssetsNet"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_DeferredIncomeTaxAssetsNet_7c8be2ac-49e8-43b6-b3ab-140fc45e79ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_1e81a51e-cae4-445b-b0f9-93be38ed19d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_1e81a51e-cae4-445b-b0f9-93be38ed19d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_70fb67f1-6cd4-4c6d-9810-d3b05b264df3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Assets"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_a2d43a9d-995a-4365-90d9-e07d01e2cca3" xlink:to="loc_us-gaap_Assets_70fb67f1-6cd4-4c6d-9810-d3b05b264df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e8195323-fb10-4a15-bb5e-84575c20d3a2" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_920c5d32-d86f-4450-8ebc-c867b4297bf4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_920c5d32-d86f-4450-8ebc-c867b4297bf4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_25e69078-c89f-43f5-93ab-1f2755552338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_25e69078-c89f-43f5-93ab-1f2755552338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayableCurrent_0e438bb6-9eba-4e03-b323-00162497c971" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayableCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_ConvertibleNotesPayableCurrent_0e438bb6-9eba-4e03-b323-00162497c971" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e3c3951-503f-4557-8a69-d8458fbdaf09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_8e3c3951-503f-4557-8a69-d8458fbdaf09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_90173f95-52b9-4bbd-bd86-84240aa3afa0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_90173f95-52b9-4bbd-bd86-84240aa3afa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_41d5158e-c57e-4c01-b0cf-8ea127898006" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_021897f3-3fa5-46e2-8dba-2756d704d4b2" xlink:to="loc_us-gaap_LiabilitiesCurrent_41d5158e-c57e-4c01-b0cf-8ea127898006" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleLongTermNotesPayable_a8177a25-6e64-4601-817a-775ff1968368" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleLongTermNotesPayable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_ConvertibleLongTermNotesPayable_a8177a25-6e64-4601-817a-775ff1968368" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_acaa3d05-7f39-4b3d-82fc-09e3609bc801" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_acaa3d05-7f39-4b3d-82fc-09e3609bc801" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_5b2d59eb-238f-4d4d-b9c1-0dc673baf4bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_5b2d59eb-238f-4d4d-b9c1-0dc673baf4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_c7fdf484-a528-4847-9f7f-137ed64f0fc2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_Liabilities_c7fdf484-a528-4847-9f7f-137ed64f0fc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_b877f94d-bb85-4a28-bb25-d800252377e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_CommitmentsAndContingencies_b877f94d-bb85-4a28-bb25-d800252377e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_870a7d67-d5fa-41df-9cca-3804ef1ab80a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_870a7d67-d5fa-41df-9cca-3804ef1ab80a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_a0d7549f-b16b-4e08-8c26-1aecd781c99a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_CommonStockValueOutstanding_a0d7549f-b16b-4e08-8c26-1aecd781c99a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff201b7a-1561-48a4-944f-8044f4010b31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_AdditionalPaidInCapitalCommonStock_ff201b7a-1561-48a4-944f-8044f4010b31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e641687-edbf-4003-84ab-21647017a135" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_2e641687-edbf-4003-84ab-21647017a135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a1499e9-e3d8-4a39-a049-f144cbdc87d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_0a1499e9-e3d8-4a39-a049-f144cbdc87d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonValue_c6cf38f5-89f8-4623-89ed-11e9feee2497" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonValue"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_TreasuryStockCommonValue_c6cf38f5-89f8-4623-89ed-11e9feee2497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a2fa8e8-3ff8-4593-903a-0c4a42a9d6e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_978f9338-2b4e-453f-b48f-cd3524f9b317" xlink:to="loc_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_6a2fa8e8-3ff8-4593-903a-0c4a42a9d6e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfe1d8a7-a833-419a-b5fa-049e446cce3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_45a3458b-4f68-4f25-a231-3b8a5755a8fb" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_bfe1d8a7-a833-419a-b5fa-049e446cce3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1a0bfcb6-5401-4555-aa27-ff3b4f3f936d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_1a0bfcb6-5401-4555-aa27-ff3b4f3f936d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_d647b897-6571-4784-953f-e4bd9c20a32c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_d647b897-6571-4784-953f-e4bd9c20a32c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_f732f11e-48b6-4261-aa30-1f7049bb2950" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_PreferredStockSharesIssued_f732f11e-48b6-4261-aa30-1f7049bb2950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_2f0e41a7-190e-4a6d-bb18-d312c855b1b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_2f0e41a7-190e-4a6d-bb18-d312c855b1b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_23f3fa55-3a1c-4ee5-9405-5c51dd2ef008" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_23f3fa55-3a1c-4ee5-9405-5c51dd2ef008" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_38780fdc-a900-4370-970c-d7a4cdec1ad2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_38780fdc-a900-4370-970c-d7a4cdec1ad2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_774271f2-92cf-40a3-87db-ea200954174f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_CommonStockSharesIssued_774271f2-92cf-40a3-87db-ea200954174f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_07482a7f-a4d0-454c-a816-196b4c641811" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_07482a7f-a4d0-454c-a816-196b4c641811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonShares_00907b6b-6d1e-4792-8f6f-ccfae5073219" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonShares"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_dc6723db-ebb6-436f-99c8-bd5b66cf9068" xlink:to="loc_us-gaap_TreasuryStockCommonShares_00907b6b-6d1e-4792-8f6f-ccfae5073219" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23ff4cc1-b1a2-455c-967e-7e6cb5dd3ef9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_23ff4cc1-b1a2-455c-967e-7e6cb5dd3ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_ab0336fb-08a8-4106-b126-28c7a20412bb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_ab0336fb-08a8-4106-b126-28c7a20412bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_50719d60-4cd6-4b17-8521-304e2d1c495a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_GrossProfit_50719d60-4cd6-4b17-8521-304e2d1c495a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_a7fe921d-dc66-4c1e-aa38-a68882adb0ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_OperatingExpensesAbstract_a7fe921d-dc66-4c1e-aa38-a68882adb0ac" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_ce2b3b53-af49-4d10-930e-f3b1aefb2443" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a7fe921d-dc66-4c1e-aa38-a68882adb0ac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_ce2b3b53-af49-4d10-930e-f3b1aefb2443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b33dba99-20a8-4e78-9bad-f4898251bd9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a7fe921d-dc66-4c1e-aa38-a68882adb0ac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_b33dba99-20a8-4e78-9bad-f4898251bd9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c0509a95-33fb-44d4-8d24-d967f12603ef" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_a7fe921d-dc66-4c1e-aa38-a68882adb0ac" xlink:to="loc_us-gaap_OperatingExpenses_c0509a95-33fb-44d4-8d24-d967f12603ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_2c2b290a-d49f-4d8f-856f-5d937ef9a9f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_OperatingIncomeLoss_2c2b290a-d49f-4d8f-856f-5d937ef9a9f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_a9adea1e-c475-47a8-ae72-a34b57e97280" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_a9adea1e-c475-47a8-ae72-a34b57e97280" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_249bbf16-2039-49fe-8e7a-ee463f879f09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_249bbf16-2039-49fe-8e7a-ee463f879f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_1c951819-a4f9-4a41-8aaa-64a6b8d91b26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_1c951819-a4f9-4a41-8aaa-64a6b8d91b26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_947d10cb-e65b-47b1-a484-d8b81c90a47e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_NetIncomeLoss_947d10cb-e65b-47b1-a484-d8b81c90a47e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_70318d1c-ea05-4104-8f2a-a8daf614d6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_EarningsPerShareBasic_70318d1c-ea05-4104-8f2a-a8daf614d6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08470c12-d0fc-4e87-b93e-0a57b29389a3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_08470c12-d0fc-4e87-b93e-0a57b29389a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_9eed6e75-6678-4da8-8888-d65f4aa780a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_EarningsPerShareDiluted_9eed6e75-6678-4da8-8888-d65f4aa780a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b3a336d-80b4-473b-ad32-a6ce191ddd9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_d19c11d0-7c85-4abc-a8ff-e7ddd7f29209" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_2b3a336d-80b4-473b-ad32-a6ce191ddd9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofComprehensiveIncome"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48c5d46a-50bd-491e-898e-edaf2396baa3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_71c017f4-0653-402e-a607-00700d917a56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48c5d46a-50bd-491e-898e-edaf2396baa3" xlink:to="loc_us-gaap_NetIncomeLoss_71c017f4-0653-402e-a607-00700d917a56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9316ab1e-10a2-4fd5-9181-2748c36ada8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48c5d46a-50bd-491e-898e-edaf2396baa3" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9316ab1e-10a2-4fd5-9181-2748c36ada8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_97b60d48-4d71-4b94-a7a1-5e5c35a10e9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9316ab1e-10a2-4fd5-9181-2748c36ada8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_97b60d48-4d71-4b94-a7a1-5e5c35a10e9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3f3963fe-a6d8-4636-9cb6-595c32afb148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9316ab1e-10a2-4fd5-9181-2748c36ada8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3f3963fe-a6d8-4636-9cb6-595c32afb148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9822b246-3e2f-463c-8a36-8ed5018339fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9316ab1e-10a2-4fd5-9181-2748c36ada8a" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_9822b246-3e2f-463c-8a36-8ed5018339fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_ea60e6f4-27f8-49ac-9cd7-43f194ba3cb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_48c5d46a-50bd-491e-898e-edaf2396baa3" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_ea60e6f4-27f8-49ac-9cd7-43f194ba3cb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a9d9012-5288-447d-a7f3-4f21311a8a1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_2a9d9012-5288-447d-a7f3-4f21311a8a1d" xlink:to="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_f32ac4f5-f7c2-4150-af92-9754aa2a8ef0" xlink:to="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_046096b9-0226-4046-987f-738fc0020cd1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_CommonStockMember_046096b9-0226-4046-987f-738fc0020cd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_ec6a6189-dc2f-47ab-9443-e59a722d4dad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_ec6a6189-dc2f-47ab-9443-e59a722d4dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed70c1e-4230-476d-9790-a808719271c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_4ed70c1e-4230-476d-9790-a808719271c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_c0415b0d-a0ba-4148-a72c-37b39bef7654" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_RetainedEarningsMember_c0415b0d-a0ba-4148-a72c-37b39bef7654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockCommonMember_67e7a610-442e-4b41-95b9-d0fa4227914d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockCommonMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_2687aa01-10c9-44f7-8e1e-099ef551fcf3" xlink:to="loc_us-gaap_TreasuryStockCommonMember_67e7a610-442e-4b41-95b9-d0fa4227914d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_02269d1f-eb47-47c9-bac6-2d045cbe4606" xlink:to="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_0a4ca5e4-1fef-445c-ae66-711584398424" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_404702a7-5a0f-44ff-9326-a52a0d3152b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_404702a7-5a0f-44ff-9326-a52a0d3152b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_82bf7a55-71f5-495c-a235-5f6420acfa73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockholdersEquity_82bf7a55-71f5-495c-a235-5f6420acfa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_b5a1c583-76c5-4f4d-937c-a565e282d815" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan_b5a1c583-76c5-4f4d-937c-a565e282d815" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_755c9447-cb31-42ba-936f-c971fb0fa079" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_755c9447-cb31-42ba-936f-c971fb0fa079" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4904eb0d-c834-4194-93f2-fd09d88b5cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_4904eb0d-c834-4194-93f2-fd09d88b5cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_33a3ddcb-64f0-4737-8910-9724bc4e42ba" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_33a3ddcb-64f0-4737-8910-9724bc4e42ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_7bc6e96f-f76b-4690-8fac-3e6f8ec8daa4" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones_7bc6e96f-f76b-4690-8fac-3e6f8ec8daa4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_c32efb37-46e4-4f77-97be-e9750d41b2d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_c32efb37-46e4-4f77-97be-e9750d41b2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_34e3e7ff-56b0-44d6-8b96-cdbfe26fb876" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockValueAcquiredCostMethod"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_TreasuryStockValueAcquiredCostMethod_34e3e7ff-56b0-44d6-8b96-cdbfe26fb876" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_5f8fce6e-01fc-4215-a837-ffdde1f20fa1" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt_5f8fce6e-01fc-4215-a837-ffdde1f20fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c0e0109a-d45f-4669-beec-0481aa108085" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c0e0109a-d45f-4669-beec-0481aa108085" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5feed974-3e33-4bc3-b830-8170c5dc3373" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_5feed974-3e33-4bc3-b830-8170c5dc3373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_185d093f-e7ec-4824-b15d-5453f007a445" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_185d093f-e7ec-4824-b15d-5453f007a445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_626b8753-3451-49fa-bc5b-d9a91daea061" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge_626b8753-3451-49fa-bc5b-d9a91daea061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_94890ad5-fa6b-4a68-93ac-605294d8c8c5" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax_94890ad5-fa6b-4a68-93ac-605294d8c8c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_3eb86bf4-0b6e-490f-96a3-6313f58c3b4a" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_3eb86bf4-0b6e-490f-96a3-6313f58c3b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_c7b45163-bcd4-4484-bb03-366449411ef4" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants_c7b45163-bcd4-4484-bb03-366449411ef4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d7745500-c9fe-4573-94f1-3d3804b5043d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_d7745500-c9fe-4573-94f1-3d3804b5043d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_d7d2fc9a-e89d-4cf1-b7f4-bafadb8b9a49" xlink:href="dxcm-20241231.xsd#dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee_d7d2fc9a-e89d-4cf1-b7f4-bafadb8b9a49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3d57a20f-656d-4f90-8c99-d6a84a41ce40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_NetIncomeLoss_3d57a20f-656d-4f90-8c99-d6a84a41ce40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6c8b3a52-9652-42f1-8afd-a69ac9d5293b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_6c8b3a52-9652-42f1-8afd-a69ac9d5293b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_a829544e-112a-43ff-b378-f51361c9e59e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_a829544e-112a-43ff-b378-f51361c9e59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_4887ee6b-28e9-483c-886b-1119fa8b7363" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_fdd4ddbe-62af-4486-a8ea-c70a13882261" xlink:to="loc_us-gaap_StockholdersEquity_4887ee6b-28e9-483c-886b-1119fa8b7363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="dxcm-20241231.xsd#ConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0546607-e269-4d7f-8168-07ecd0d474b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0546607-e269-4d7f-8168-07ecd0d474b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_1d844630-b9ec-43d6-a5c8-d6c9db782a1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0546607-e269-4d7f-8168-07ecd0d474b4" xlink:to="loc_us-gaap_NetIncomeLoss_1d844630-b9ec-43d6-a5c8-d6c9db782a1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0546607-e269-4d7f-8168-07ecd0d474b4" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_12441d21-bf78-4117-b786-2d24879a4cb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_12441d21-bf78-4117-b786-2d24879a4cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e7041e56-ec11-4117-b92a-29ae3df5c79f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_ShareBasedCompensation_e7041e56-ec11-4117-b92a-29ae3df5c79f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaidInKindInterest_b17acff4-a50f-4a66-96b8-af88f6578ad0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaidInKindInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_PaidInKindInterest_b17acff4-a50f-4a66-96b8-af88f6578ad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bff8dd-d091-4932-bda3-dc3dc245718a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_14bff8dd-d091-4932-bda3-dc3dc245718a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncashIncomeExpense_48384006-a154-4d88-b727-e24f499d7c64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNoncashIncomeExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_OtherNoncashIncomeExpense_48384006-a154-4d88-b727-e24f499d7c64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_766f5384-0016-48c7-8952-c3211802e378" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a8ad8ff8-e0e7-4d59-b27e-1f8c36d9180d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_a8ad8ff8-e0e7-4d59-b27e-1f8c36d9180d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_42391a4a-51b4-4855-85e3-303d80dbe2f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_42391a4a-51b4-4855-85e3-303d80dbe2f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0ae43d01-ccf7-490a-835b-f0f22abe5fcd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_0ae43d01-ccf7-490a-835b-f0f22abe5fcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_98110c87-8734-4bdb-b157-7a5f1f6e1f6e" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet_98110c87-8734-4bdb-b157-7a5f1f6e1f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8bee999f-bede-47f5-9581-0b1dc45e47fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_8bee999f-bede-47f5-9581-0b1dc45e47fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_93cac165-9b6a-420d-8f38-21e90fd0fd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities_93cac165-9b6a-420d-8f38-21e90fd0fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_8980cadc-e26e-46c0-ae50-a604de4fa4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncreaseDecreaseInOtherDeferredLiability"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_78da1f42-9a22-4fdf-b931-24d8578a9a19" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherDeferredLiability_8980cadc-e26e-46c0-ae50-a604de4fa4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_451a797f-1150-49a5-8da1-8d946a0c9caa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_f0546607-e269-4d7f-8168-07ecd0d474b4" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_451a797f-1150-49a5-8da1-8d946a0c9caa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_32298d20-a18f-40c5-9f00-fb728da48d3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt_32298d20-a18f-40c5-9f00-fb728da48d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3b0d31b0-cb4b-45f4-a381-d2713e270545" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3b0d31b0-cb4b-45f4-a381-d2713e270545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9f60356b-b0fd-4934-baad-c61c6a8ff0b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_9f60356b-b0fd-4934-baad-c61c6a8ff0b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_16861851-3be6-4da2-b2e3-6ca6ce38340e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired_16861851-3be6-4da2-b2e3-6ca6ce38340e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireOtherInvestments_60cbd2c0-f525-48f7-8fb2-fea43ce37ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsToAcquireOtherInvestments"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_PaymentsToAcquireOtherInvestments_60cbd2c0-f525-48f7-8fb2-fea43ce37ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ee4d47a7-e8b9-40af-8129-7f1522d91e55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForProceedsFromOtherInvestingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_PaymentsForProceedsFromOtherInvestingActivities_ee4d47a7-e8b9-40af-8129-7f1522d91e55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_427e9a78-ca62-4095-b2e6-e402d7911d7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_5f53ea7d-027f-40d0-af99-a3169061eb73" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_427e9a78-ca62-4095-b2e6-e402d7911d7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_eafa4342-82f1-476e-9042-9ec5716a84e9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_eafa4342-82f1-476e-9042-9ec5716a84e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c7b4d921-60b8-4a36-9db3-82aa2c70e33f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_c7b4d921-60b8-4a36-9db3-82aa2c70e33f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_2efa771d-573d-47c8-b6bd-f407bfc3f123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_2efa771d-573d-47c8-b6bd-f407bfc3f123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_436cdfcd-c761-487b-8631-8fde79dbd43f" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_436cdfcd-c761-487b-8631-8fde79dbd43f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RepaymentsOfConvertibleDebt_f6bc2b57-a101-4070-b007-10f30b79901a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RepaymentsOfConvertibleDebt"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_RepaymentsOfConvertibleDebt_f6bc2b57-a101-4070-b007-10f30b79901a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7b92c922-f399-4d68-a8ff-baf2583de727" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromPaymentsForOtherFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities_7b92c922-f399-4d68-a8ff-baf2583de727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_756c50a6-ac34-4c10-b768-79c232cde047" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_db5ae188-e08a-4c8c-bff2-8814d5a42a14" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_756c50a6-ac34-4c10-b768-79c232cde047" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dded409d-fa18-45f3-ac87-e42e6ee2452c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_dded409d-fa18-45f3-ac87-e42e6ee2452c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_09237345-9937-4df2-b32c-723b25e9557c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_09237345-9937-4df2-b32c-723b25e9557c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f565d73f-6d2b-437b-8f3b-19d3de3a44f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_f565d73f-6d2b-437b-8f3b-19d3de3a44f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab02bc66-2e5b-48da-a8e1-6450c53147d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_ab02bc66-2e5b-48da-a8e1-6450c53147d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6a8234b9-dbd3-4578-b00f-c8ded72666a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6a8234b9-dbd3-4578-b00f-c8ded72666a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_37e909d6-b6d3-424c-bffe-d1313bee94f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6a8234b9-dbd3-4578-b00f-c8ded72666a8" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_37e909d6-b6d3-424c-bffe-d1313bee94f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7b4a117a-be0c-4303-ac7c-4a2737bf91bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6a8234b9-dbd3-4578-b00f-c8ded72666a8" xlink:to="loc_us-gaap_RestrictedCash_7b4a117a-be0c-4303-ac7c-4a2737bf91bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ca28288-2912-44a9-b8cc-531a0d5ec86a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_6a8234b9-dbd3-4578-b00f-c8ded72666a8" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_9ca28288-2912-44a9-b8cc-531a0d5ec86a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_b65421e3-972c-40e6-b842-2c9d88db737a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_b65421e3-972c-40e6-b842-2c9d88db737a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_7f1b1e78-1821-48eb-87d4-b3a070a7d3fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentAmount1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_b65421e3-972c-40e6-b842-2c9d88db737a" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentAmount1_7f1b1e78-1821-48eb-87d4-b3a070a7d3fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_fa71d111-3f9a-4f94-af7b-9780e056748b" xlink:href="dxcm-20241231.xsd#dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_b65421e3-972c-40e6-b842-2c9d88db737a" xlink:to="loc_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge_fa71d111-3f9a-4f94-af7b-9780e056748b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_644a32d9-7c05-4ef6-9af5-d65012ae2a2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract_b65421e3-972c-40e6-b842-2c9d88db737a" xlink:to="loc_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1_644a32d9-7c05-4ef6-9af5-d65012ae2a2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_8716648c-3a6d-4117-b239-2ba711178f40" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_b8bf243e-229a-4d70-a3fd-47780396fd72" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_8716648c-3a6d-4117-b239-2ba711178f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_365a45da-8ac9-41b5-869f-f6a587d8d2f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8716648c-3a6d-4117-b239-2ba711178f40" xlink:to="loc_us-gaap_InterestPaidNet_365a45da-8ac9-41b5-869f-f6a587d8d2f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaid_74dd6039-a4b7-42f6-b013-872467a71181" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesPaid"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_8716648c-3a6d-4117-b239-2ba711178f40" xlink:to="loc_us-gaap_IncomeTaxesPaid_74dd6039-a4b7-42f6-b013-872467a71181" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_35c289aa-4cd2-44fa-a2de-5b74acb5a86b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b7328076-8b7b-4d14-bfa2-83acf413d5dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_35c289aa-4cd2-44fa-a2de-5b74acb5a86b" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_b7328076-8b7b-4d14-bfa2-83acf413d5dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DevelopmentandOtherAgreements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cea9c3b-6dca-4804-806a-15ae11d56869" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_740334fd-26d1-48d6-803a-feb86b7a96e6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_4cea9c3b-6dca-4804-806a-15ae11d56869" xlink:to="loc_us-gaap_CollaborativeArrangementDisclosureTextBlock_740334fd-26d1-48d6-803a-feb86b7a96e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_30b93d30-63b0-4619-a9d2-68df04f7f384" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4f02ea14-5e9d-4ce8-aad1-dc2311b438e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementInputsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_30b93d30-63b0-4619-a9d2-68df04f7f384" xlink:to="loc_us-gaap_FairValueMeasurementInputsDisclosureTextBlock_4f02ea14-5e9d-4ce8-aad1-dc2311b438e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fadfb37-1898-4fc5-85d6-0ddf6bfe44d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_a7c685d0-2853-4dc6-bb6c-946788797607" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdditionalFinancialInformationDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fadfb37-1898-4fc5-85d6-0ddf6bfe44d7" xlink:to="loc_us-gaap_AdditionalFinancialInformationDisclosureTextBlock_a7c685d0-2853-4dc6-bb6c-946788797607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2ce77b15-4334-4388-88bd-b8a08b253568" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_3bd11dfc-de19-4c39-b8cc-fcfb4f43ed0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2ce77b15-4334-4388-88bd-b8a08b253568" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_3bd11dfc-de19-4c39-b8cc-fcfb4f43ed0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitments" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitments"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitments" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_3c8c164d-557f-4b7d-89c4-a6e56414f23a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_0c22bf72-08f1-450c-a8a4-7e7b0c036a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c8c164d-557f-4b7d-89c4-a6e56414f23a" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_0c22bf72-08f1-450c-a8a4-7e7b0c036a21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_8e8ffb15-f520-48e3-9f32-f3ca7e92f6fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_3c8c164d-557f-4b7d-89c4-a6e56414f23a" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_8e8ffb15-f520-48e3-9f32-f3ca7e92f6fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Contingencies" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Contingencies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Contingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d21c47c6-4a28-4b76-92cc-486d6f2176a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3db264a0-381f-4e35-9094-c89a2020ecff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LegalMattersAndContingenciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_d21c47c6-4a28-4b76-92cc-486d6f2176a2" xlink:to="loc_us-gaap_LegalMattersAndContingenciesTextBlock_3db264a0-381f-4e35-9094-c89a2020ecff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxes" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f624f5-cadc-4129-82cf-e6552385804a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_37fa130f-c577-4f66-a23b-9b04670310ae" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f624f5-cadc-4129-82cf-e6552385804a" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_37fa130f-c577-4f66-a23b-9b04670310ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c87922aa-4fbb-46c1-9f10-9e1bf4788042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_4c27658f-6983-4567-8165-620153f445ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CompensationAndEmployeeBenefitPlansTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_c87922aa-4fbb-46c1-9f10-9e1bf4788042" xlink:to="loc_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock_4c27658f-6983-4567-8165-620153f445ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformation"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_ca4ba4f6-d8fc-46f2-87ae-1428b73496f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingDisclosureTextBlock_d8152db1-e23c-4082-925e-8230a382f3f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_ca4ba4f6-d8fc-46f2-87ae-1428b73496f4" xlink:to="loc_us-gaap_SegmentReportingDisclosureTextBlock_d8152db1-e23c-4082-925e-8230a382f3f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="simple" xlink:href="dxcm-20241231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_8a44c746-6b40-47bd-b1e0-4e7ef33755db" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_46b3987e-afd5-4546-8878-3382f13f80a9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_8a44c746-6b40-47bd-b1e0-4e7ef33755db" xlink:to="loc_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock_46b3987e-afd5-4546-8878-3382f13f80a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_81d3af73-15d6-4e51-b844-aa01bcf5c83e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_81d3af73-15d6-4e51-b844-aa01bcf5c83e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_932f6782-8c91-4415-85d8-61d7697bbea2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_932f6782-8c91-4415-85d8-61d7697bbea2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5351beac-f33e-4e56-9934-cdad643fb989" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_UseOfEstimates_5351beac-f33e-4e56-9934-cdad643fb989" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_dd8267a5-9e73-4898-875e-d2a12e9012d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_FairValueMeasurementPolicyPolicyTextBlock_dd8267a5-9e73-4898-875e-d2a12e9012d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c1e2ed19-c792-432e-9387-dcd3477f552d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_CashAndCashEquivalentsPolicyTextBlock_c1e2ed19-c792-432e-9387-dcd3477f552d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketableSecuritiesPolicy_0e0afc76-b583-45cd-aef4-2084f9a60e9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketableSecuritiesPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_MarketableSecuritiesPolicy_0e0afc76-b583-45cd-aef4-2084f9a60e9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesPolicyTextBlock_034563a6-a97c-4f38-bb7b-1a20cc548dca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReceivablesPolicyTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ReceivablesPolicyTextBlock_034563a6-a97c-4f38-bb7b-1a20cc548dca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_26815d1e-b44a-4ac6-a3f1-951d03d47595" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_26815d1e-b44a-4ac6-a3f1-951d03d47595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_20a6fff1-0774-4dea-ae81-7b674d05d0eb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_20a6fff1-0774-4dea-ae81-7b674d05d0eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_63f146fe-3d23-48c2-9f57-09427bf24a26" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_63f146fe-3d23-48c2-9f57-09427bf24a26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_65c95635-f125-4a14-9ae0-75ed512fc5d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_65c95635-f125-4a14-9ae0-75ed512fc5d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_9cc8c226-e1ff-4bd1-aad2-82f41ac50716" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_9cc8c226-e1ff-4bd1-aad2-82f41ac50716" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyPolicy_fae05eb4-e238-4faf-b65e-92c00f492072" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyPolicy"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_StandardProductWarrantyPolicy_fae05eb4-e238-4faf-b65e-92c00f492072" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5eba703f-493d-4a94-8d98-0d65034d1e10" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_CommitmentsAndContingenciesPolicyTextBlock_5eba703f-493d-4a94-8d98-0d65034d1e10" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b6ab7a14-3866-4587-83f6-1dff857bf385" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_b6ab7a14-3866-4587-83f6-1dff857bf385" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_db4a6a90-af5b-43f2-be69-50a9798988c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_db4a6a90-af5b-43f2-be69-50a9798988c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_0e02e01e-a857-436f-91cf-45708ce8d6b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_0e02e01e-a857-436f-91cf-45708ce8d6b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementAccountingPolicy_ab20cd55-75c3-4668-b652-49780b9a455e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementAccountingPolicy"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_CollaborativeArrangementAccountingPolicy_ab20cd55-75c3-4668-b652-49780b9a455e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingCostsPolicyTextBlock_5590feb0-0378-4ac0-beff-eda4d9b5b930" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingCostsPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_AdvertisingCostsPolicyTextBlock_5590feb0-0378-4ac0-beff-eda4d9b5b930" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_11ab6b55-d216-4df2-9cc0-c7ede4d4cae6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_11ab6b55-d216-4df2-9cc0-c7ede4d4cae6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f77f0a1a-fe81-41ed-915c-f50b1cbd0ede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_f77f0a1a-fe81-41ed-915c-f50b1cbd0ede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_9273dd5b-6a91-458c-a31d-00d408bce6b5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_9273dd5b-6a91-458c-a31d-00d408bce6b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2d0cac96-11bb-4557-bab4-56eb4e577642" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_a441bfdc-4eaf-4202-9498-a4bbcfc6741d" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_2d0cac96-11bb-4557-bab4-56eb4e577642" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e561f9e-a910-4a33-8a03-da28f57ff5e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ad03f3ac-9824-438b-a298-a748d3a5ccb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e561f9e-a910-4a33-8a03-da28f57ff5e7" xlink:to="loc_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock_ad03f3ac-9824-438b-a298-a748d3a5ccb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454b90ee-cd5d-4266-b559-f195da926b2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e561f9e-a910-4a33-8a03-da28f57ff5e7" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_454b90ee-cd5d-4266-b559-f195da926b2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e6801245-d02a-43cd-bdd4-d1eed375af30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_6e561f9e-a910-4a33-8a03-da28f57ff5e7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_e6801245-d02a-43cd-bdd4-d1eed375af30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_1d6d2cbb-13fe-419b-bc78-58e011decb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_bf44d8a0-6ec0-43cc-a548-726437940587" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1d6d2cbb-13fe-419b-bc78-58e011decb8a" xlink:to="loc_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock_bf44d8a0-6ec0-43cc-a548-726437940587" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_a3064351-29d0-42f8-8f95-c695137a58b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_1d6d2cbb-13fe-419b-bc78-58e011decb8a" xlink:to="loc_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock_a3064351-29d0-42f8-8f95-c695137a58b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_55bb2d8a-d6fc-4cbf-adaf-5debdb92c9d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock_55bb2d8a-d6fc-4cbf-adaf-5debdb92c9d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4ede8d54-a8c6-4536-8d2d-b022b17afede" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock_4ede8d54-a8c6-4536-8d2d-b022b17afede" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b167e895-54d8-4ad8-9c57-046fcef81369" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b167e895-54d8-4ad8-9c57-046fcef81369" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_78509d10-541e-470c-9ca0-f7468ae964fd" xlink:href="dxcm-20241231.xsd#dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock_78509d10-541e-470c-9ca0-f7468ae964fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_85120359-aea6-433e-82c5-3160c8358ae3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_85120359-aea6-433e-82c5-3160c8358ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_99fc551e-9636-4430-b37c-dcd655f47bb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_99fc551e-9636-4430-b37c-dcd655f47bb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_436a85c7-bb39-4184-a085-570a5fa1abd4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock_436a85c7-bb39-4184-a085-570a5fa1abd4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c643175c-1f6c-43d3-bc9f-104a786cf2a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_c643175c-1f6c-43d3-bc9f-104a786cf2a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_57de3059-b50e-44a8-8bb8-05bc9a16caa5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsTableTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsTableTextBlock_57de3059-b50e-44a8-8bb8-05bc9a16caa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_86c8ae66-e821-4c93-b9fb-7d914289762e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_86c8ae66-e821-4c93-b9fb-7d914289762e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_76ce234b-defe-483c-a1d6-d399ca04b4e0" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock_76ce234b-defe-483c-a1d6-d399ca04b4e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_b89e296e-4f9b-4911-b19f-8c3603dd16fb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock_b89e296e-4f9b-4911-b19f-8c3603dd16fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_7a099997-98df-414c-9670-cbc0a5b85a53" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock_7a099997-98df-414c-9670-cbc0a5b85a53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_3b6b0973-da7b-4b91-a24d-639ee279d048" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_1fceb79e-4a2f-46ca-bb8c-adac79b2a7f1" xlink:to="loc_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock_3b6b0973-da7b-4b91-a24d-639ee279d048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_2550efe7-8c32-4a0f-92a1-05785b1d52c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:to="loc_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock_2550efe7-8c32-4a0f-92a1-05785b1d52c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtTableTextBlock_c0c9b7d8-9635-4269-9bf7-b2a631e455c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:to="loc_us-gaap_ConvertibleDebtTableTextBlock_c0c9b7d8-9635-4269-9bf7-b2a631e455c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_4d8987d5-e87c-47e2-9636-0c5c3ad9875f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:to="loc_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock_4d8987d5-e87c-47e2-9636-0c5c3ad9875f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock_3e78d8f2-2ce9-4312-9dc5-2c785744d687" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:to="loc_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock_3e78d8f2-2ce9-4312-9dc5-2c785744d687" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_d358e5c1-2a21-4434-9f92-02bd8894c771" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_049a3b07-8390-4cd5-9509-9afc80b24034" xlink:to="loc_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock_d358e5c1-2a21-4434-9f92-02bd8894c771" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_af0f165a-287b-4d80-a708-8dd92b7d7b6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_69a9a853-4b44-465a-8f62-ae5bb2135c16" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af0f165a-287b-4d80-a708-8dd92b7d7b6a" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_69a9a853-4b44-465a-8f62-ae5bb2135c16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e530c35f-7568-4b1a-8d8a-0823e5121e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af0f165a-287b-4d80-a708-8dd92b7d7b6a" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_e530c35f-7568-4b1a-8d8a-0823e5121e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_6f4926c4-6365-468c-ac12-d4512c799994" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_af0f165a-287b-4d80-a708-8dd92b7d7b6a" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_6f4926c4-6365-468c-ac12-d4512c799994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_62edda93-cac4-45b6-a0b5-fdfe6d0f2bf8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock_62edda93-cac4-45b6-a0b5-fdfe6d0f2bf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ff2fe607-3a20-4c70-a711-bdc8498f082d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_ff2fe607-3a20-4c70-a711-bdc8498f082d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_0e409e3b-3e33-4d2d-b68b-064a8f1fa24e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock_0e409e3b-3e33-4d2d-b68b-064a8f1fa24e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_43bd4b69-aaff-41ab-9a6f-9697d79e46c3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock_43bd4b69-aaff-41ab-9a6f-9697d79e46c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c7802eca-0c1e-4fd7-ba78-1cc6c24c4097" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_c7802eca-0c1e-4fd7-ba78-1cc6c24c4097" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0710face-f3e2-4c83-8952-4bafe0342ff8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_0710face-f3e2-4c83-8952-4bafe0342ff8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9cc8afb3-37d8-4374-9b7c-2080807028e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock_9cc8afb3-37d8-4374-9b7c-2080807028e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_e510c804-420d-4184-b44e-f7e3d473d918" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SummaryOfIncomeTaxExaminationsTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_9b4bb331-d48a-47b1-9ca7-dc2a8f7e45f3" xlink:to="loc_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock_e510c804-420d-4184-b44e-f7e3d473d918" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_10a73ed0-a745-482a-a353-995b1b6d6e3d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock_7d623cb3-3967-439b-a69c-f5cfd753e60f" xlink:href="dxcm-20241231.xsd#dxcm_ScheduleOfTreasuryShareActivityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_10a73ed0-a745-482a-a353-995b1b6d6e3d" xlink:to="loc_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock_7d623cb3-3967-439b-a69c-f5cfd753e60f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_04a4a219-7a11-4b7a-8383-93323dfb8632" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_10a73ed0-a745-482a-a353-995b1b6d6e3d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock_04a4a219-7a11-4b7a-8383-93323dfb8632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e9c3d203-624a-4d0f-8253-fa13d716be12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_10a73ed0-a745-482a-a353-995b1b6d6e3d" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_e9c3d203-624a-4d0f-8253-fa13d716be12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_4f4836d3-53ab-4f16-9d64-02f7e1eaae17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_10a73ed0-a745-482a-a353-995b1b6d6e3d" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock_4f4836d3-53ab-4f16-9d64-02f7e1eaae17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationTables"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_a80f1861-39e5-4321-8507-f243f69d45f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_ceb55830-d8da-4a23-9a9d-9f90a0ab62ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a80f1861-39e5-4321-8507-f243f69d45f7" xlink:to="loc_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock_ceb55830-d8da-4a23-9a9d-9f90a0ab62ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_db8fcce0-63a1-470c-8c0a-e6e9fc7d10e3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a80f1861-39e5-4321-8507-f243f69d45f7" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_db8fcce0-63a1-470c-8c0a-e6e9fc7d10e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_00fce455-1539-4ea7-8f2a-8effcc4c8035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_a80f1861-39e5-4321-8507-f243f69d45f7" xlink:to="loc_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock_00fce455-1539-4ea7-8f2a-8effcc4c8035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e62ec32f-4ffb-430c-a752-9d7248713b13" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e62ec32f-4ffb-430c-a752-9d7248713b13" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_65af15f4-1dba-4bf1-a403-9c05a302771b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ComputerSoftwareAndHardwareMember_42c91add-db56-4678-a0f0-38df3ed04ef9" xlink:href="dxcm-20241231.xsd#dxcm_ComputerSoftwareAndHardwareMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_dxcm_ComputerSoftwareAndHardwareMember_42c91add-db56-4678-a0f0-38df3ed04ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_8ec89eef-ed9e-4942-8dae-e0bd385d772d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_8ec89eef-ed9e-4942-8dae-e0bd385d772d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_4a36c506-8520-4ffa-8603-a87327114b11" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_4a36c506-8520-4ffa-8603-a87327114b11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_93bbd369-e4cd-4123-af67-30eb19af8b67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e38f7f5d-e95d-494c-9a3e-b0e3cb2c5724" xlink:to="loc_us-gaap_BuildingMember_93bbd369-e4cd-4123-af67-30eb19af8b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:to="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_98126eae-8032-420e-873d-e5da0565861c" xlink:to="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_49e80cab-0f19-440f-9880-ae7bfbef3a16" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:to="loc_srt_MinimumMember_49e80cab-0f19-440f-9880-ae7bfbef3a16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_a85ef769-d0e8-41d7-9e58-6411b4a7ba7f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9e562932-533c-4b4c-bcb9-64e1da4c200b" xlink:to="loc_srt_MaximumMember_a85ef769-d0e8-41d7-9e58-6411b4a7ba7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:href="dxcm-20241231.xsd#dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable_d8063827-7bd1-4cb5-b147-b4b1b8381240" xlink:to="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_e5a600e8-4aea-4ef0-8aca-8d1b65820eee" xlink:href="dxcm-20241231.xsd#dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents_e5a600e8-4aea-4ef0-8aca-8d1b65820eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_16a3878a-adc4-41b4-8740-278868deeb98" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_16a3878a-adc4-41b4-8740-278868deeb98" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_ba026b24-b2dc-44d2-8d91-226be69d658b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_ba026b24-b2dc-44d2-8d91-226be69d658b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_739f9f30-babe-4d0d-ba4e-1ab987a3c84d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_739f9f30-babe-4d0d-ba4e-1ab987a3c84d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_35f3adf0-d259-4b46-8638-e053740a6044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill_35f3adf0-d259-4b46-8638-e053740a6044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ContractPaymentTermsNumberofDays_1843f479-a388-4543-905c-0d911e482a66" xlink:href="dxcm-20241231.xsd#dxcm_ContractPaymentTermsNumberofDays"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_ContractPaymentTermsNumberofDays_1843f479-a388-4543-905c-0d911e482a66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnbilledContractsReceivable_e8b6213f-46c5-465b-adfd-a393cc4e8592" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnbilledContractsReceivable"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_UnbilledContractsReceivable_e8b6213f-46c5-465b-adfd-a393cc4e8592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_80c53704-ca89-4b44-9179-0743ff9dea63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_80c53704-ca89-4b44-9179-0743ff9dea63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_6962694b-1f0a-4133-9853-acc9b3ef9245" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationPeriodForIncentiveCompensationCosts"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_dxcm_AmortizationPeriodForIncentiveCompensationCosts_6962694b-1f0a-4133-9853-acc9b3ef9245" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdvertisingExpense_b1c49d43-8120-49f4-bad3-0e70870c1314" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AdvertisingExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems_53033f83-ffc1-49c3-80a9-5f7099808fc8" xlink:to="loc_us-gaap_AdvertisingExpense_b1c49d43-8120-49f4-bad3-0e70870c1314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_48e372ed-3378-4198-a67a-bf9870657c83" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_48e372ed-3378-4198-a67a-bf9870657c83" xlink:to="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7b0fc3eb-a73a-47f5-852f-a4cb5c6eb452" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_c16d4e89-d433-4d07-b58e-331d5eecd193" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_4893e657-6ccb-485a-bf34-edb791c9e153" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_c16d4e89-d433-4d07-b58e-331d5eecd193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_c842aacc-f4f0-4a56-8b97-eab8d9dbc791" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_c40b0198-4fd1-4c86-8155-dd3bac6ec7b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:to="loc_us-gaap_SalesRevenueNetMember_c40b0198-4fd1-4c86-8155-dd3bac6ec7b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_777b6d2c-90b8-4e7e-a811-a2bfabc43ada" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_4fc12adb-874e-4503-afcf-225a3fbc508b" xlink:to="loc_us-gaap_AccountsReceivableMember_777b6d2c-90b8-4e7e-a811-a2bfabc43ada" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_65fbaa1c-c772-4e78-b9a5-fb3295f51269" xlink:to="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerAMember_bf35c075-6ac7-41b3-8701-dd30050c4ff3" xlink:href="dxcm-20241231.xsd#dxcm_CustomerAMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerAMember_bf35c075-6ac7-41b3-8701-dd30050c4ff3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerBMember_90e63c4e-5d34-4394-91a9-c5192769f057" xlink:href="dxcm-20241231.xsd#dxcm_CustomerBMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerBMember_90e63c4e-5d34-4394-91a9-c5192769f057" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerCMember_21682a78-1d46-4d93-b303-ca373f014d3f" xlink:href="dxcm-20241231.xsd#dxcm_CustomerCMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerCMember_21682a78-1d46-4d93-b303-ca373f014d3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerDMember_7061bf68-0469-4e39-9015-10827fc202bd" xlink:href="dxcm-20241231.xsd#dxcm_CustomerDMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerDMember_7061bf68-0469-4e39-9015-10827fc202bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CustomerEMember_284070f6-2f28-41aa-8070-e3d0b9191671" xlink:href="dxcm-20241231.xsd#dxcm_CustomerEMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_159cfa70-e7ee-4d03-9d5a-2d7b3d234595" xlink:to="loc_dxcm_CustomerEMember_284070f6-2f28-41aa-8070-e3d0b9191671" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTable_303f1703-9a06-4e09-8211-ab1ffa8ab26f" xlink:to="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8397a1d0-acad-4d62-b4f7-07698a805960" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskLineItems_e6c69c3d-9f62-4702-83e7-bb9ce5752717" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8397a1d0-acad-4d62-b4f7-07698a805960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56f25363-6ff5-471e-a326-849266e558c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_56f25363-6ff5-471e-a326-849266e558c0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_272b2b9b-8c8f-407a-9621-ea7ebd6e1307" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeSalesBasedMilestoneMember_d536288e-0a80-4bf3-82d9-b496db296811" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeSalesBasedMilestoneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_dxcm_CollaborativeSalesBasedMilestoneMember_d536288e-0a80-4bf3-82d9-b496db296811" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_f92beda3-794e-48cf-9ea0-8272ce92d3c3" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedAndPerformanceStockUnitsMemberMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_f92beda3-794e-48cf-9ea0-8272ce92d3c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtSecuritiesMember_2200fa92-e0d5-459c-8b25-3455ed278a02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_us-gaap_ConvertibleDebtSecuritiesMember_2200fa92-e0d5-459c-8b25-3455ed278a02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_8f649025-2bf1-4e54-a89b-d9b04367b030" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_ae1310b4-1fa6-4415-9155-024e8ed4b609" xlink:to="loc_us-gaap_WarrantMember_8f649025-2bf1-4e54-a89b-d9b04367b030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9037cacd-cbe1-43e1-b97a-9ed4e2b76d45" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_28cc6e3d-fc8e-4475-a65e-18dfbdd4f97f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_NetIncomeLoss_28cc6e3d-fc8e-4475-a65e-18dfbdd4f97f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8d737849-12c6-4d2d-ad43-60efe7e3699a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestOnConvertibleDebtNetOfTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_InterestOnConvertibleDebtNetOfTax_8d737849-12c6-4d2d-ad43-60efe7e3699a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4519a741-0d32-48fa-842b-a355c8bcb075" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLossAttributableToParentDiluted"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_NetIncomeLossAttributableToParentDiluted_4519a741-0d32-48fa-842b-a355c8bcb075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_0d84f662-1ceb-48e8-b8fb-40428d3941d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_EarningsPerShareBasic_0d84f662-1ceb-48e8-b8fb-40428d3941d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_30f983dc-b4f9-4fea-8db7-05682f8f42e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_EarningsPerShareDiluted_30f983dc-b4f9-4fea-8db7-05682f8f42e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_088db6db-6b5f-41f6-9814-fbf2bbd98597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_088db6db-6b5f-41f6-9814-fbf2bbd98597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a0ce440b-8785-4663-bb5e-4d8004bbb8b4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_a0ce440b-8785-4663-bb5e-4d8004bbb8b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1cffda3e-2491-4105-8d1b-6aeeee780e3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2f861497-c19d-44ec-9fef-abc105d2b7f4" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_1cffda3e-2491-4105-8d1b-6aeeee780e3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4e3cc1bc-bfc8-4137-bc8d-7e465b433ec5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_3ace4de2-733b-488a-8a29-d0bab3471113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4e3cc1bc-bfc8-4137-bc8d-7e465b433ec5" xlink:to="loc_us-gaap_AccountingPoliciesAbstract_3ace4de2-733b-488a-8a29-d0bab3471113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_3ace4de2-733b-488a-8a29-d0bab3471113" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_1f2baa34-f6fc-4f71-939a-657d2a29a4b6" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_15ef4c77-bb5f-4bf7-997d-eaeed418d990" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedAndPerformanceStockUnitsMemberMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_6553cd03-cb7d-465b-95df-213060bef26a" xlink:to="loc_dxcm_RestrictedAndPerformanceStockUnitsMemberMember_15ef4c77-bb5f-4bf7-997d-eaeed418d990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_9a4c70a8-8080-48ea-8740-982858ea1613" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d26ff49d-a129-4d8b-803b-3a597c1fd90e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_481c20ab-2a9c-4471-b485-f86c253750b3" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_d26ff49d-a129-4d8b-803b-3a597c1fd90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DevelopmentandOtherAgreementsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_49b2fade-d160-4812-aba2-572556ff1a21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_49b2fade-d160-4812-aba2-572556ff1a21" xlink:to="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_2266ea78-e347-49db-9e6e-5e2f00aa7921" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementInitialPaymentMember_5fe4618d-5e67-4058-a023-3c7530dfaa9b" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementInitialPaymentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:to="loc_dxcm_CollaborativeArrangementInitialPaymentMember_5fe4618d-5e67-4058-a023-3c7530dfaa9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_9677e18f-0949-4062-afa8-42f083561285" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_c1cecc81-0234-469e-8f90-72d5fcb68ace" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_9677e18f-0949-4062-afa8-42f083561285" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_3aefe526-feaa-4fc7-a05a-7de2fdc0f7fa" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_8e1d48f1-f60f-41e9-9727-a7dc70faf7c7" xlink:href="dxcm-20241231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_d37e5388-6ce2-4d91-831f-975efcbd8f06" xlink:to="loc_dxcm_VerilyLifeSciencesMember_8e1d48f1-f60f-41e9-9727-a7dc70faf7c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_4add974c-4ba1-4404-9b3a-4be75a1b017a" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_12b420b8-ecd7-4c23-a5b3-6697f2f1d17e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_48d25a46-61a2-4ba8-8464-8ab8234f8775" xlink:to="loc_us-gaap_CollaborativeArrangementMember_12b420b8-ecd7-4c23-a5b3-6697f2f1d17e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:href="dxcm-20241231.xsd#dxcm_DevelopmentAgreementsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsTable_9a178cff-4d58-45de-8cf8-7a0558bd0e9a" xlink:to="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_e02cf2dc-7b76-4e0e-b609-7b9327ff718d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_SharePrice_e02cf2dc-7b76-4e0e-b609-7b9327ff718d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementUpfrontFee_cedbe9e5-0a2d-447d-86e2-3855b849163c" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementUpfrontFee"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_CollaborativeArrangementUpfrontFee_cedbe9e5-0a2d-447d-86e2-3855b849163c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_65d27cf8-0b60-45b9-bbe0-f58d274dc8ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_65d27cf8-0b60-45b9-bbe0-f58d274dc8ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeResearchAndDevelopmentFee_ed0e8909-9834-49e9-bd92-fb106a9f06ed" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeResearchAndDevelopmentFee"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_CollaborativeResearchAndDevelopmentFee_ed0e8909-9834-49e9-bd92-fb106a9f06ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_7593d1c0-8623-42a5-a81f-461bf989e229" xlink:href="dxcm-20241231.xsd#dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement_7593d1c0-8623-42a5-a81f-461bf989e229" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e284034-9736-4217-8a88-eb8c41a43d73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_8e284034-9736-4217-8a88-eb8c41a43d73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_35ca8f28-ab28-4bd9-b163-9103622d843a" xlink:href="dxcm-20241231.xsd#dxcm_PotentialFutureCommonStockIssuableSharesNewIssues"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues_35ca8f28-ab28-4bd9-b163-9103622d843a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a0429af7-40a1-4adc-9fa9-d4d4c1c9da75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1_a0429af7-40a1-4adc-9fa9-d4d4c1c9da75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_508581da-a3ee-49d3-90b1-fab38e4ce9d8" xlink:href="dxcm-20241231.xsd#dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DevelopmentAgreementsLineItems_937eb365-8d4d-495c-9fd4-e1ba678c2e8a" xlink:to="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_508581da-a3ee-49d3-90b1-fab38e4ce9d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bfb34b93-bb64-42e6-b2e8-70ec6b2332cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bfb34b93-bb64-42e6-b2e8-70ec6b2332cf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:to="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_b8c0032d-18fa-42aa-ad66-38a373d86ea7" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b8377ebd-ebd5-460a-b225-08120dc5218f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_b8377ebd-ebd5-460a-b225-08120dc5218f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_502fedd7-ffec-4b8a-b1bf-bfc0635328ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_CommercialPaperMember_502fedd7-ffec-4b8a-b1bf-bfc0635328ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_5b43f056-dcac-4ebc-9f16-bc599a1e3bdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_5d72ac0d-ea0a-4697-bc9d-520e8e4a03ad" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_5b43f056-dcac-4ebc-9f16-bc599a1e3bdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_a17332b3-d77e-41e5-b254-3a2553e9a6ce" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_8949837e-0e69-4959-926f-bca968ec5077" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_8949837e-0e69-4959-926f-bca968ec5077" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_d3e11920-489b-44d9-9d2b-830e741617c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_d3e11920-489b-44d9-9d2b-830e741617c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_8584a2f1-981a-4023-aab6-169ccd7788d3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_61bc518e-a3ed-4460-b93b-1249d647fe6c" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_8584a2f1-981a-4023-aab6-169ccd7788d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_aae2cdb0-8097-4c90-96de-f94f49dbfad1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_c3f490b6-0456-4397-843d-b04b457f257f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_c3f490b6-0456-4397-843d-b04b457f257f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf95755-454d-42e1-931b-e53de226d8a2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_eaf95755-454d-42e1-931b-e53de226d8a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NotesReceivableFairValueDisclosure_6b62f4a7-1a54-418d-8bf3-6396083278b0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NotesReceivableFairValueDisclosure"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_NotesReceivableFairValueDisclosure_6b62f4a7-1a54-418d-8bf3-6396083278b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsFairValueDisclosure_2cf521ab-ed41-447b-971f-bc8db1a57199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_OtherAssetsFairValueDisclosure_2cf521ab-ed41-447b-971f-bc8db1a57199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsFairValueDisclosure_4442d95a-3544-42fe-9dd0-f12dbd893eee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetsFairValueDisclosure"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8292ac5f-bc77-46d1-9474-d7d943ab6817" xlink:to="loc_us-gaap_AssetsFairValueDisclosure_4442d95a-3544-42fe-9dd0-f12dbd893eee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b41696f3-d6e3-4a6d-a594-ce1215608374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b41696f3-d6e3-4a6d-a594-ce1215608374" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:to="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_7368e53d-ee2a-4edc-b6c7-957dedd4d49e" xlink:to="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b07950a-f729-48b0-b810-e2422ad2f8fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_d5eb3c13-52df-4358-b474-4c40dc0421b9" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_3b07950a-f729-48b0-b810-e2422ad2f8fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeInstrumentRiskAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:to="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeContractTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeInstrumentRiskAxis_bbd2e302-234b-4eab-b5dd-f4f780f09b15" xlink:to="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignExchangeForwardMember_b00af712-9fa2-4182-8986-f2786d4f743e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignExchangeForwardMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DerivativeContractTypeDomain_dd7facd9-497b-4b6b-85e3-1d3d70a04d97" xlink:to="loc_us-gaap_ForeignExchangeForwardMember_b00af712-9fa2-4182-8986-f2786d4f743e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_522e1059-3c97-44c0-a0b9-2ee6a5d2548f" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_FairValueAssetsLevel3TransfersAmount_0726461a-bc14-445f-9a31-b7d54fcaf169" xlink:href="dxcm-20241231.xsd#dxcm_FairValueAssetsLevel3TransfersAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_dxcm_FairValueAssetsLevel3TransfersAmount_0726461a-bc14-445f-9a31-b7d54fcaf169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeTermOfContract_dbcc0fd0-299f-43c7-bae1-742693eb2695" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeTermOfContract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_DerivativeTermOfContract_dbcc0fd0-299f-43c7-bae1-742693eb2695" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeNotionalAmount_88c4690e-e103-4084-9c4a-73914f7e1200" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DerivativeNotionalAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_DerivativeNotionalAmount_88c4690e-e103-4084-9c4a-73914f7e1200" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_32a4a8a2-3522-42db-b060-36b8a75ead6f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount_32a4a8a2-3522-42db-b060-36b8a75ead6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7526b8ed-5601-45f3-a1a3-54986066208b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_8730bb95-3cdd-4755-b076-2aef3f288042" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_7526b8ed-5601-45f3-a1a3-54986066208b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_5e9ed0ec-7faa-4799-9664-a7734d7a032c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_5e9ed0ec-7faa-4799-9664-a7734d7a032c" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:to="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_8db8dcc4-2d4f-4068-b10b-4c3a04caf92a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_e77ba11b-0a6e-4762-985e-aefdb55285d7" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_e77ba11b-0a6e-4762-985e-aefdb55285d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_19b5e4b3-d946-4c0d-be62-cb17076663bd" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1a4e1c8d-1f30-45a8-b4c6-2cfd2b5a658d" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_19b5e4b3-d946-4c0d-be62-cb17076663bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_efe2fd54-ee13-4009-b863-f1351f1c9238" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_a89f5791-2e02-4f3b-b320-51b408ccfb80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_f346b2fa-0c25-40b5-9259-53f7cefc765e" xlink:to="loc_us-gaap_SeniorNotesMember_a89f5791-2e02-4f3b-b320-51b408ccfb80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_59e32146-5439-4786-88da-4824baef004e" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c1cef473-f778-441c-a83b-9033964eb739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleDebtFairValueDisclosures"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_5180de45-2546-4ca2-b5b5-ebec8ba172a6" xlink:to="loc_us-gaap_ConvertibleDebtFairValueDisclosures_c1cef473-f778-441c-a83b-9033964eb739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f582c86-4f75-40d1-bee2-538f38321d0e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8f582c86-4f75-40d1-bee2-538f38321d0e" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:to="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_1576ddd3-327e-4788-b81f-4c4332f140dd" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3f75031c-3b3a-4271-8664-4607bb962ea9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember_3f75031c-3b3a-4271-8664-4607bb962ea9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommercialPaperMember_f03174ec-f4c7-457e-9249-892ef57ec2d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommercialPaperMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_CommercialPaperMember_f03174ec-f4c7-457e-9249-892ef57ec2d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CorporateDebtSecuritiesMember_e4d0a9f8-894c-4e4f-aa10-1434166b06b7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CorporateDebtSecuritiesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_b86d0f03-abc6-4c1f-b9c3-ae89b54db949" xlink:to="loc_us-gaap_CorporateDebtSecuritiesMember_e4d0a9f8-894c-4e4f-aa10-1434166b06b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_9e06615f-c318-4ea4-826b-e2b606b3b3a2" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4b462081-1dcb-4d23-9031-e732b533d941" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_4b462081-1dcb-4d23-9031-e732b533d941" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b79c9538-ad36-4671-aca8-5067593fda80" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_b79c9538-ad36-4671-aca8-5067593fda80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_276a964e-bc9b-4fdf-a4b2-fbefe2837e2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_276a964e-bc9b-4fdf-a4b2-fbefe2837e2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9de463aa-f3c2-4807-99d7-d37016a75ef6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_6f33c953-cd33-48ce-916e-17d6c40dfa7d" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecurities_9de463aa-f3c2-4807-99d7-d37016a75ef6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_95012e6f-1db0-4a8c-9d17-35cca13c8fd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ScheduleOfCondensedFinancialStatementsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_95012e6f-1db0-4a8c-9d17-35cca13c8fd6" xlink:to="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:to="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5879afbc-1445-4303-8466-331b201315b6" xlink:to="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ReceiverProductComponentMember_51ee9639-7df2-4323-adcf-e54678b78a67" xlink:href="dxcm-20241231.xsd#dxcm_ReceiverProductComponentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_71cd0e26-50d8-4313-bc33-cd7a1589e82f" xlink:to="loc_dxcm_ReceiverProductComponentMember_51ee9639-7df2-4323-adcf-e54678b78a67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:to="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_acc4f9f6-5588-4743-8677-2623005337cd" xlink:to="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_bd97d792-df53-4fa7-a2fd-73fd2b72120d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:to="loc_srt_MinimumMember_bd97d792-df53-4fa7-a2fd-73fd2b72120d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_b7d34c81-cd50-48eb-97a9-63320cfce98d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_9da32e8a-582f-4b4a-949e-a89d1e161b47" xlink:to="loc_srt_MaximumMember_b7d34c81-cd50-48eb-97a9-63320cfce98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CondensedFinancialStatementsCaptionsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ScheduleOfCondensedFinancialStatementsTable_550855b9-8177-46de-9272-ffdb78b5237f" xlink:to="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_57d61bec-79a0-4487-96d3-d009311b5717" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_DebtInstrumentTerm_57d61bec-79a0-4487-96d3-d009311b5717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0fbe6ca7-5682-4391-aff9-24a58d4552f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent_0fbe6ca7-5682-4391-aff9-24a58d4552f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cc76f9f4-423c-44d8-a2fe-8e4be4602f14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_cc76f9f4-423c-44d8-a2fe-8e4be4602f14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d78b5c3-c8e4-4c7c-8727-284902f3aaf1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss_2d78b5c3-c8e4-4c7c-8727-284902f3aaf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_40d16c2f-7366-432a-8198-c512509b8fe0" xlink:href="dxcm-20241231.xsd#dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount_40d16c2f-7366-432a-8198-c512509b8fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_d8d1ae96-2668-475e-9169-788ef6c05a76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_InventoryWriteDown_d8d1ae96-2668-475e-9169-788ef6c05a76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_9371c5be-1a51-436d-a9cd-eeec0084948e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_Depreciation_9371c5be-1a51-436d-a9cd-eeec0084948e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d1d86af6-0755-42fd-975c-8a656716eddd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CondensedFinancialStatementsCaptionsLineItems_4d25fa11-5438-4902-ae7d-9cb1aa1f7356" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d1d86af6-0755-42fd-975c-8a656716eddd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aacfef44-aab3-49f4-8443-d1155964218b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableGross_1b15dbe3-3c52-4c50-a691-661a0cecf0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aacfef44-aab3-49f4-8443-d1155964218b" xlink:to="loc_us-gaap_AccountsReceivableGross_1b15dbe3-3c52-4c50-a691-661a0cecf0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_128a7e39-81d2-41c5-b49b-a5019d16b546" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivable"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aacfef44-aab3-49f4-8443-d1155964218b" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivable_128a7e39-81d2-41c5-b49b-a5019d16b546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNet_b74cd664-abb2-4b43-8388-597dce2996b8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsReceivableNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_aacfef44-aab3-49f4-8443-d1155964218b" xlink:to="loc_us-gaap_AccountsReceivableNet_b74cd664-abb2-4b43-8388-597dce2996b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b894584-03b4-4145-ac94-331bc10982e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2b894584-03b4-4145-ac94-331bc10982e7" xlink:to="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d25c39d5-fede-4842-86be-d4b2cd7cd9c6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_d25c39d5-fede-4842-86be-d4b2cd7cd9c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_917cafa5-4c11-4c22-8f82-55e6bf692f1c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_917cafa5-4c11-4c22-8f82-55e6bf692f1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0671cf53-e09a-46c5-a1b5-c8a69ed53668" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_0671cf53-e09a-46c5-a1b5-c8a69ed53668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_aa7616e2-2ca1-4168-951f-43b9d53bc9ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_7b7cc94e-beb8-4fad-a82d-d6d3e6098cb5" xlink:to="loc_us-gaap_InventoryNet_aa7616e2-2ca1-4168-951f-43b9d53bc9ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseCurrent_e2496b7c-d53d-41de-86bd-37ab6a5d530f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_us-gaap_PrepaidExpenseCurrent_e2496b7c-d53d-41de-86bd-37ab6a5d530f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PrepaidInventoryCurrent_002de086-8ece-4a39-9554-57d6119d32b6" xlink:href="dxcm-20241231.xsd#dxcm_PrepaidInventoryCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_dxcm_PrepaidInventoryCurrent_002de086-8ece-4a39-9554-57d6119d32b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredCompensationPlanAssetsCurrent_6f78d789-0e8d-4a16-b448-7caacb3ba516" xlink:href="dxcm-20241231.xsd#dxcm_DeferredCompensationPlanAssetsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_dxcm_DeferredCompensationPlanAssetsCurrent_6f78d789-0e8d-4a16-b448-7caacb3ba516" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesReceivable_b303e920-5dbc-44d9-a10d-1bd5f83f6740" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxesReceivable"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_us-gaap_IncomeTaxesReceivable_b303e920-5dbc-44d9-a10d-1bd5f83f6740" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsCurrent_6fdd7e3d-0cd2-4d20-90e2-0df656ac3210" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_us-gaap_OtherAssetsCurrent_6fdd7e3d-0cd2-4d20-90e2-0df656ac3210" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf4804f3-e39e-45b4-aebd-03a4b306e1d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_46a080f2-581a-4df9-8b10-ac4044b180ac" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_bf4804f3-e39e-45b4-aebd-03a4b306e1d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd2f9693-b136-47c7-874d-c54a007a5089" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_dd2f9693-b136-47c7-874d-c54a007a5089" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_02ab3e06-079c-498a-92a8-9f2439f151f8" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_7fc6b444-62f5-4641-ae04-2768af7e6366" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_LandMember_7fc6b444-62f5-4641-ae04-2768af7e6366" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_74f48817-9be9-464d-9768-c75f1d1ae09f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_BuildingMember_74f48817-9be9-464d-9768-c75f1d1ae09f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_458a82e4-80f2-40d5-8b89-93f91bec6ea5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_458a82e4-80f2-40d5-8b89-93f91bec6ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ComputerSoftwareAndHardwareMember_b8ac53e8-e0e0-44e2-9983-760c2d44ede6" xlink:href="dxcm-20241231.xsd#dxcm_ComputerSoftwareAndHardwareMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_dxcm_ComputerSoftwareAndHardwareMember_b8ac53e8-e0e0-44e2-9983-760c2d44ede6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquipmentMember_c256d3d7-f832-4078-ab18-94172c40088a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquipmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_EquipmentMember_c256d3d7-f832-4078-ab18-94172c40088a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_0d48e08d-1220-40dd-9cb7-86ed2cc5c62c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_0d48e08d-1220-40dd-9cb7-86ed2cc5c62c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_18ec28fd-63a5-428d-9655-8c018d7c9ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a086a19f-aa01-48ed-ae59-68b0fff0e680" xlink:to="loc_us-gaap_ConstructionInProgressMember_18ec28fd-63a5-428d-9655-8c018d7c9ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_20fa4932-b83e-4b8b-a861-7954c4b32e5a" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_79633342-20a6-4e11-b725-51436c5168fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_79633342-20a6-4e11-b725-51436c5168fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_703ffaea-0b21-42b0-ab7b-8e6ab1ecafe6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization_703ffaea-0b21-42b0-ab7b-8e6ab1ecafe6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_34ed0374-6dd8-4f42-88c1-263fabdc0380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization_34ed0374-6dd8-4f42-88c1-263fabdc0380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_060ee32a-cce7-40fe-976b-02454a340adc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_3107d359-79c3-4ce7-b526-82dd3c2325cc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization_060ee32a-cce7-40fe-976b-02454a340adc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_531a9190-ec65-42ff-b8ec-cb4dc4f17bea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_531a9190-ec65-42ff-b8ec-cb4dc4f17bea" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_4eab80fb-8328-4bbc-af3b-9c9b8bd3847a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyIntangibleMember_7569d236-63d6-4efb-83f1-6205f5c9090b" xlink:href="dxcm-20241231.xsd#dxcm_VerilyIntangibleMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_dxcm_VerilyIntangibleMember_7569d236-63d6-4efb-83f1-6205f5c9090b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_6aa12adf-4ea5-4676-a79c-20513d5d41ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_CustomerRelationshipsMember_6aa12adf-4ea5-4676-a79c-20513d5d41ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_f12725e0-ea25-4ac4-a510-dd236955a019" xlink:href="dxcm-20241231.xsd#dxcm_AcquiredTechnologyAndIntellectualPropertyMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_dxcm_AcquiredTechnologyAndIntellectualPropertyMember_f12725e0-ea25-4ac4-a510-dd236955a019" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TrademarksAndTradeNamesMember_d593d7eb-45d2-4dc5-909a-811b02bbf04c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TrademarksAndTradeNamesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_TrademarksAndTradeNamesMember_d593d7eb-45d2-4dc5-909a-811b02bbf04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_4ee0fc6d-a477-4e86-b3ce-6d9900326380" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_9c11c446-7097-4e8a-b934-6b45413d69e2" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_4ee0fc6d-a477-4e86-b3ce-6d9900326380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_58a9f56f-e5e5-4dbf-8b0c-129ff192ef81" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3e94c5d-eb97-43fd-bff7-87d2e1c6deb8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_b3e94c5d-eb97-43fd-bff7-87d2e1c6deb8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_881e2954-40bf-49d6-a890-57f381000680" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_881e2954-40bf-49d6-a890-57f381000680" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5517e05-74ff-4fa0-9608-e20623ce9471" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_e5517e05-74ff-4fa0-9608-e20623ce9471" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cc40ba9-9cc5-4408-88e5-1e4c39e0b60c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_ad72d75e-e6f6-468e-b928-9a08c7a448f8" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_5cc40ba9-9cc5-4408-88e5-1e4c39e0b60c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9e543de-d134-4845-8ca1-1dfb1d0ac4de" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_2cf7a84d-0b97-4862-a555-c44ad496c91d" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9e543de-d134-4845-8ca1-1dfb1d0ac4de" xlink:to="loc_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales_2cf7a84d-0b97-4862-a555-c44ad496c91d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_40607279-5a07-4eaa-9395-61b858640df0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9e543de-d134-4845-8ca1-1dfb1d0ac4de" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_40607279-5a07-4eaa-9395-61b858640df0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_8311bad8-9da2-40b0-b0ea-76ff7be9b780" xlink:href="dxcm-20241231.xsd#dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e9e543de-d134-4845-8ca1-1dfb1d0ac4de" xlink:to="loc_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses_8311bad8-9da2-40b0-b0ea-76ff7be9b780" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_282be441-6402-417a-bcd0-cd1be2f94123" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_282be441-6402-417a-bcd0-cd1be2f94123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_867678d7-e154-457d-bdfe-bf3ae4f174ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_867678d7-e154-457d-bdfe-bf3ae4f174ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_689fbd1d-d518-468b-aff4-122211cee45c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_689fbd1d-d518-468b-aff4-122211cee45c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_df426084-1c99-4254-b2f0-ecfdb5168900" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_df426084-1c99-4254-b2f0-ecfdb5168900" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2abc05bb-0c3e-41fd-b801-48c19d0c9003" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive_2abc05bb-0c3e-41fd-b801-48c19d0c9003" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f7c41bfe-8386-4a30-87fe-dc2e98e75fb0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive_f7c41bfe-8386-4a30-87fe-dc2e98e75fb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9c2257f5-9897-481c-a764-3a837e9b5b77" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2cb9a8a3-1120-4223-9d08-40da3a004c9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_9c2257f5-9897-481c-a764-3a837e9b5b77" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efd59297-9544-4822-ab38-c82ac626e4d8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermInvestments_d7d4871a-d4ea-46b1-8b85-c9b1ac547a27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongTermInvestments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efd59297-9544-4822-ab38-c82ac626e4d8" xlink:to="loc_us-gaap_LongTermInvestments_d7d4871a-d4ea-46b1-8b85-c9b1ac547a27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LongTermDeposits_1dce9208-bf60-4a95-b39e-16ba224feb54" xlink:href="dxcm-20241231.xsd#dxcm_LongTermDeposits"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efd59297-9544-4822-ab38-c82ac626e4d8" xlink:to="loc_dxcm_LongTermDeposits_1dce9208-bf60-4a95-b39e-16ba224feb54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherLongTermAssets_3f0903ab-aa18-4c2a-b6f4-589f16b9bfab" xlink:href="dxcm-20241231.xsd#dxcm_OtherLongTermAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efd59297-9544-4822-ab38-c82ac626e4d8" xlink:to="loc_dxcm_OtherLongTermAssets_3f0903ab-aa18-4c2a-b6f4-589f16b9bfab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_995381f4-be7f-4455-beeb-104223b8d80d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_efd59297-9544-4822-ab38-c82ac626e4d8" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_995381f4-be7f-4455-beeb-104223b8d80d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_e992bc2f-7638-4470-85fc-94c045d02bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_e992bc2f-7638-4470-85fc-94c045d02bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent_accc0633-9102-4b0e-bc4a-930e52dace79" xlink:href="dxcm-20241231.xsd#dxcm_AccruedTaxAuditAndLegalFeesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_dxcm_AccruedTaxAuditAndLegalFeesCurrent_accc0633-9102-4b0e-bc4a-930e52dace79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PharmacyRebatesCurrent_1bf426ff-2ee2-4f97-9979-f8979f14c9cc" xlink:href="dxcm-20241231.xsd#dxcm_PharmacyRebatesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_dxcm_PharmacyRebatesCurrent_1bf426ff-2ee2-4f97-9979-f8979f14c9cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_125d27b9-93a6-445e-823c-04c848672a5e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_125d27b9-93a6-445e-823c-04c848672a5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedIncomeTaxesCurrent_29297e69-62de-4107-88d0-69cb1d15a17f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedIncomeTaxesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_AccruedIncomeTaxesCurrent_29297e69-62de-4107-88d0-69cb1d15a17f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCompensationLiabilityCurrent_f24ae915-4f4c-4f38-a2f6-fc13e3eebc9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredCompensationLiabilityCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_DeferredCompensationLiabilityCurrent_f24ae915-4f4c-4f38-a2f6-fc13e3eebc9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ad9a5e7b-b8d2-45c6-8fa1-73d09b6330d6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_ad9a5e7b-b8d2-45c6-8fa1-73d09b6330d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_22cbf782-dde9-427b-8054-a8b704f58efd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_2dc2229f-14c0-40c0-9a3e-ac25fb3afec3" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_22cbf782-dde9-427b-8054-a8b704f58efd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9838c8b-6230-47ec-a709-22770e40ae6a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_bcfd17cc-95d0-45d7-ab3d-d60021857bca" xlink:href="dxcm-20241231.xsd#dxcm_AccruedWagesBonusesAndTaxesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9838c8b-6230-47ec-a709-22770e40ae6a" xlink:to="loc_dxcm_AccruedWagesBonusesAndTaxesCurrent_bcfd17cc-95d0-45d7-ab3d-d60021857bca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8a64f340-dda0-4e93-b8b8-5c26c1dc3da2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AccruedEmployeeBenefitsCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9838c8b-6230-47ec-a709-22770e40ae6a" xlink:to="loc_us-gaap_AccruedEmployeeBenefitsCurrent_8a64f340-dda0-4e93-b8b8-5c26c1dc3da2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5c78695d-737d-435f-896d-f5b5e5f55d92" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_f9838c8b-6230-47ec-a709-22770e40ae6a" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5c78695d-737d-435f-896d-f5b5e5f55d92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ea134a32-e126-4079-9216-0de456f6f892" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MovementInStandardProductWarrantyAccrualRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ea134a32-e126-4079-9216-0de456f6f892" xlink:to="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_f3637383-2e2d-4add-887d-57a32cdedf6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_f3637383-2e2d-4add-887d-57a32cdedf6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_2e25d1c4-6d3c-474e-9935-d9429bff2d75" xlink:href="dxcm-20241231.xsd#dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:to="loc_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses_2e25d1c4-6d3c-474e-9935-d9429bff2d75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualPayments_9dd037c4-f0c9-4f57-8789-3f7975d331c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProductWarrantyAccrualPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:to="loc_us-gaap_ProductWarrantyAccrualPayments_9dd037c4-f0c9-4f57-8789-3f7975d331c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StandardProductWarrantyAccrual_9a044535-8b10-4edc-ad4d-90994758ac3e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StandardProductWarrantyAccrual"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MovementInStandardProductWarrantyAccrualRollForward_ec16d611-bc26-4687-afd8-af03a1aa8a79" xlink:to="loc_us-gaap_StandardProductWarrantyAccrual_9a044535-8b10-4edc-ad4d-90994758ac3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_59b83b04-ea02-4de2-a7ab-b2750dafba9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_59b83b04-ea02-4de2-a7ab-b2750dafba9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_84f4389d-7152-4612-853c-ff2b42616987" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_84f4389d-7152-4612-853c-ff2b42616987" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_df2d4033-7f9d-4181-8b66-6d42aee252b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_us-gaap_AssetRetirementObligation_df2d4033-7f9d-4181-8b66-6d42aee252b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherTaxLiabilitiesNoncurrent_69b371e3-2f2c-4722-a1ff-4fad2a9dadda" xlink:href="dxcm-20241231.xsd#dxcm_OtherTaxLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_dxcm_OtherTaxLiabilitiesNoncurrent_69b371e3-2f2c-4722-a1ff-4fad2a9dadda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_2c85ba67-a97c-461c-b446-4281517901fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_2c85ba67-a97c-461c-b446-4281517901fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_da2a679d-2b7d-42c7-a16c-043b6aeb1b8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_8cfa0dd0-937d-4574-889f-17613684d768" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_da2a679d-2b7d-42c7-a16c-043b6aeb1b8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b16a189d-9402-4cc1-9238-882206ed5edd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterestAndDividend_9851cfbc-e5b2-4124-b6b9-0e8fda9d1b51" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InvestmentIncomeInterestAndDividend"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b16a189d-9402-4cc1-9238-882206ed5edd" xlink:to="loc_us-gaap_InvestmentIncomeInterestAndDividend_9851cfbc-e5b2-4124-b6b9-0e8fda9d1b51" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseNonoperating_6fc811e0-2332-4eaf-b239-64f71f83702c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseNonoperating"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b16a189d-9402-4cc1-9238-882206ed5edd" xlink:to="loc_us-gaap_InterestExpenseNonoperating_6fc811e0-2332-4eaf-b239-64f71f83702c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingExpense_8cc60d59-979c-42af-8fe6-cfe633739d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingExpense"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b16a189d-9402-4cc1-9238-882206ed5edd" xlink:to="loc_us-gaap_OtherNonoperatingExpense_8cc60d59-979c-42af-8fe6-cfe633739d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_98188227-7487-4599-9462-55578b91cf00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_b16a189d-9402-4cc1-9238-882206ed5edd" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_98188227-7487-4599-9462-55578b91cf00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_7e65eee4-dba6-4100-a6a4-57e8e52790ed" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_7e65eee4-dba6-4100-a6a4-57e8e52790ed" xlink:to="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_4c963039-ba91-4c97-8e11-1a5258b5b7cd" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_0b689c49-4cf8-4d67-a684-23c18141ce28" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dce50534-dee7-4266-b45f-7b1b53dbebd9" xlink:to="loc_us-gaap_SeniorNotesMember_0b689c49-4cf8-4d67-a684-23c18141ce28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:to="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5c7a056e-2b58-4502-8da9-ab5b4489c620" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_c9f6b0c6-7571-44b7-82dd-a6e64e68a7db" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_c9f6b0c6-7571-44b7-82dd-a6e64e68a7db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_cfda345a-ed28-4ebc-8090-5d5ca03aae79" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39fcfe00-97af-47fb-887b-b23e472923b1" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_cfda345a-ed28-4ebc-8090-5d5ca03aae79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_2fc3a77f-6816-4911-bcc4-5ffb510440e7" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7a4f2253-03b4-4ec9-bcf3-209d101a4b02" xlink:to="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_fc84de84-7d85-4c25-9a2c-0b96e9ad7d8c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_fc84de84-7d85-4c25-9a2c-0b96e9ad7d8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnamortizedDebtIssuanceExpense_d811874f-7a91-416d-b9b5-86d0161e5d20" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnamortizedDebtIssuanceExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_UnamortizedDebtIssuanceExpense_d811874f-7a91-416d-b9b5-86d0161e5d20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConvertibleNotesPayable_73be2a40-cb60-499e-94f5-b084c8f77f4f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ConvertibleNotesPayable"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract_5fda047b-1698-4a34-b76d-26e34e278495" xlink:to="loc_us-gaap_ConvertibleNotesPayable_73be2a40-cb60-499e-94f5-b084c8f77f4f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofConvertedValueofNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_2eeacbce-8620-4296-80d3-2e1edb1fa724" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_2eeacbce-8620-4296-80d3-2e1edb1fa724" xlink:to="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:to="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_973de7a8-27f0-488d-b321-ddda2e5f0823" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_a5ec38b2-a6cb-4c92-a62c-de592cdab8b8" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_a5ec38b2-a6cb-4c92-a62c-de592cdab8b8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_44e68759-f4ea-4c7b-a5db-3ba1349e77c4" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_a3ada885-0af4-4003-be14-2d864fb52a64" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_44e68759-f4ea-4c7b-a5db-3ba1349e77c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_ec0e402d-8c66-4ab3-8560-6dc39e147ae7" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_675a025a-3ae7-4399-8e8a-2ad8b39bb347" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_0fa04fa9-b2b7-4dca-8629-8505140828c1" xlink:to="loc_us-gaap_SeniorNotesMember_675a025a-3ae7-4399-8e8a-2ad8b39bb347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9104aba5-b96b-4f55-ad70-dc32cc51106e" xlink:to="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_f6e7e7bb-c995-4097-9f55-8bb7082cc08a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_aa732fa6-03f8-412b-8202-85bc1a7cfb8a" xlink:to="loc_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal_f6e7e7bb-c995-4097-9f55-8bb7082cc08a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_62f55f1a-3a58-4ddc-a84c-b76039beb76d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_62f55f1a-3a58-4ddc-a84c-b76039beb76d" xlink:to="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:to="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_4700769d-3dbd-4369-af94-316b8b893216" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_15728fec-0dbf-4098-9089-20beff6a7994" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_15728fec-0dbf-4098-9089-20beff6a7994" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_6a91c54a-5140-47aa-9382-cf6767b6fab3" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_6a91c54a-5140-47aa-9382-cf6767b6fab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_a3aefae2-fcae-4cee-b8a6-fad84a1f089f" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_67abbb41-9f20-4250-8907-760f6cfbbf94" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_a3aefae2-fcae-4cee-b8a6-fad84a1f089f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_e2a09ba6-78c5-44cf-a5d1-2243a657e035" xlink:to="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:href="dxcm-20241231.xsd#dxcm_CashInterestExpenseAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebtExcludingAmortization_03c615bb-2ca0-443d-99be-378cdc6270ad" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebtExcludingAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_CashInterestExpenseAbstract_2da522f0-4c8d-49ed-87de-160b21499a13" xlink:to="loc_us-gaap_InterestExpenseDebtExcludingAmortization_03c615bb-2ca0-443d-99be-378cdc6270ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:href="dxcm-20241231.xsd#dxcm_NonCashInterestExpenseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCosts_f4d77538-153d-4455-bef5-a6f8255c1b09" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AmortizationOfFinancingCosts"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:to="loc_us-gaap_AmortizationOfFinancingCosts_f4d77538-153d-4455-bef5-a6f8255c1b09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_566d162e-f53d-4dc4-a53a-2c18ba9c84f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_NonCashInterestExpenseAbstract_04b6478c-d287-4937-b4b3-fc7172e30897" xlink:to="loc_us-gaap_InterestExpenseDebt_566d162e-f53d-4dc4-a53a-2c18ba9c84f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_66ec129b-7abf-492b-a2d5-1aecbff3ad21" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_7949de4b-3960-4945-885a-9e4d1c5ef9dc" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_66ec129b-7abf-492b-a2d5-1aecbff3ad21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtScheduleofKeyDetailsofConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e5e51946-bc5d-4ea7-9a2e-7864274a8461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e5e51946-bc5d-4ea7-9a2e-7864274a8461" xlink:to="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:to="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_5f0d1230-eb85-45e1-9e17-45b7bbc0bd76" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6a11b715-a755-47bc-ad73-2a3460f90976" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6a11b715-a755-47bc-ad73-2a3460f90976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_34fcec45-317f-4f3b-a1d4-7c3362e6bc25" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_34fcec45-317f-4f3b-a1d4-7c3362e6bc25" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_1e8a30f4-feb0-470c-b462-a3dd68087433" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_552ed25a-5421-4600-af0e-8307222d3891" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_1e8a30f4-feb0-470c-b462-a3dd68087433" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_89220346-e45d-490f-b15b-58690f1335f6" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_211d8a54-d3d7-47ad-bda8-adb9eab20a89" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_c7d9715e-c73d-45b5-b30f-1ed224b22ac3" xlink:to="loc_us-gaap_SeniorNotesMember_211d8a54-d3d7-47ad-bda8-adb9eab20a89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_9b5eb4e9-5375-40fd-bf53-2b3f1d071608" xlink:to="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecc85d5a-e326-4009-b9c6-68b3fac36a00" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentInterestRateStatedPercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentInterestRateStatedPercentage_ecc85d5a-e326-4009-b9c6-68b3fac36a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentFaceAmount_79a4016f-b415-498e-8c2b-7c2610e023af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentFaceAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentFaceAmount_79a4016f-b415-498e-8c2b-7c2610e023af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromConvertibleDebt_c499d487-211d-4e77-b31c-3d36b3466d37" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromConvertibleDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_ProceedsFromConvertibleDebt_c499d487-211d-4e77-b31c-3d36b3466d37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3f0ab6d6-08b9-4690-b7c3-d7a213e7efc8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionRatio1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionRatio1_3f0ab6d6-08b9-4690-b7c3-d7a213e7efc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0a2a255d-2140-47e2-9b6a-cc40b05a4555" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleConversionPrice1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_4e8b7b20-a0e1-4206-9ce3-c9789cbe4b94" xlink:to="loc_us-gaap_DebtInstrumentConvertibleConversionPrice1_0a2a255d-2140-47e2-9b6a-cc40b05a4555" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2023NoteHedgeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2023NoteHedgeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt2023NoteHedgeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_fe5b182e-09d4-415b-b994-4ddf5196512f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_fe5b182e-09d4-415b-b994-4ddf5196512f" xlink:to="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3bb50d75-1d5e-48fd-b52f-4eb67a447a65" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_7af75398-17c6-403f-93fd-2ab69ddca04c" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_19acd58c-dd56-446b-a61b-2bb728b0ce73" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_7af75398-17c6-403f-93fd-2ab69ddca04c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_HedgingDesignationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationAxis_799d919d-f68d-40e9-a126-2d09d814ea61" xlink:to="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DesignatedAsHedgingInstrumentMember_88bec21f-0465-4069-ba74-61edb19d3426" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DesignatedAsHedgingInstrumentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_HedgingDesignationDomain_c6e2b58a-6cf7-40ee-8a35-4408523654ba" xlink:to="loc_us-gaap_DesignatedAsHedgingInstrumentMember_88bec21f-0465-4069-ba74-61edb19d3426" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_8597a888-4ead-4826-9374-fb2e4b602745" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_6e18da5d-ad03-4690-857e-4b46c0955412" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_dbea1d3b-e20d-4346-a024-af97d868c3e0" xlink:to="loc_us-gaap_SeniorNotesMember_6e18da5d-ad03-4690-857e-4b46c0955412" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_5279d8af-b927-4dea-abfd-00f57b8e9401" xlink:to="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_cdcf268e-bc37-44e6-aa1b-d9d99f980bed" xlink:href="dxcm-20241231.xsd#dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:to="loc_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions_cdcf268e-bc37-44e6-aa1b-d9d99f980bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_4570b23f-dc1f-46c4-90d7-512cb8f187fa" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_6730b378-a3a3-4f0d-96a3-a3c7cccb465e" xlink:to="loc_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares_4570b23f-dc1f-46c4-90d7-512cb8f187fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2023WarrantsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2023WarrantsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt2023WarrantsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_5fc5cf46-2f86-4062-b83f-ecd0497f310b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_5fc5cf46-2f86-4062-b83f-ecd0497f310b" xlink:to="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_e23acf96-83f7-455c-824a-3ea1181f6188" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_a8b1089c-9f7e-4d5c-b8e8-2ea09a3ae059" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_fec9b7d1-660e-4a27-8852-1674bce8606e" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_a8b1089c-9f7e-4d5c-b8e8-2ea09a3ae059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_d4284249-a4ea-4c08-8601-e1d643c4d4e2" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_7ddcc7f6-1513-4a06-a419-038ff76777a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_e6a85de7-06dc-4db9-a848-ba8ee3ed9ce6" xlink:to="loc_us-gaap_SeniorNotesMember_7ddcc7f6-1513-4a06-a419-038ff76777a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_9c8e2825-cc1b-4e91-80cd-ee3d01ae72a1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_JPMWarrantTransactionsMember_61a4539f-f355-47c3-98d4-a7e678fa7872" xlink:href="dxcm-20241231.xsd#dxcm_JPMWarrantTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:to="loc_dxcm_JPMWarrantTransactionsMember_61a4539f-f355-47c3-98d4-a7e678fa7872" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_BofAWarrantTransactionsMember_5616b72f-471d-4c98-a1c5-05d575abc5e3" xlink:href="dxcm-20241231.xsd#dxcm_BofAWarrantTransactionsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_c5daa5a4-bf86-4ddd-a89f-8cd8463ff679" xlink:to="loc_dxcm_BofAWarrantTransactionsMember_5616b72f-471d-4c98-a1c5-05d575abc5e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_65581103-9801-44c9-8693-f9ccdb95eaba" xlink:to="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_555dec95-534c-4082-b573-9fae7f1df2fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_8da9f050-4b90-4709-bf83-c19ec82c6cd2" xlink:to="loc_us-gaap_CommonStockMember_555dec95-534c-4082-b573-9fae7f1df2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0e39fcc4-630c-4f04-9d62-27042f549d91" xlink:to="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b6adc1cf-fe68-4913-b1be-d2792ecdf29c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_DebtConversionConvertedInstrumentSharesIssued1_b6adc1cf-fe68-4913-b1be-d2792ecdf29c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_463dd951-17a4-4f54-8a89-a3da6b7e0624" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_463dd951-17a4-4f54-8a89-a3da6b7e0624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfWarrants_74f83575-ca41-49d4-8f6e-bec8faca9b97" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProceedsFromIssuanceOfWarrants"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfWarrants_74f83575-ca41-49d4-8f6e-bec8faca9b97" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_37116a86-90d1-4aa4-898d-f0a934973728" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_37116a86-90d1-4aa4-898d-f0a934973728" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_d9e870a1-6fb7-453f-97b4-4e35eecba61d" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_d9e870a1-6fb7-453f-97b4-4e35eecba61d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_bc8d5ec4-eb05-482b-abfd-f20e59335cdb" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_f160a08d-b9c5-4c10-8b89-0e522e0d34f1" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants_bc8d5ec4-eb05-482b-abfd-f20e59335cdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#Debt2028CappedCallTransactionsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_54fca6d6-4352-4075-aa90-77a26d3546c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_54fca6d6-4352-4075-aa90-77a26d3546c7" xlink:to="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:to="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_932bf6ec-d2b9-4676-b826-1198e2c66a9a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2028Member_c485e456-5702-4501-9bae-267bb9c0ad4c" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2028Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_beedca04-c740-4c45-80b0-2d2147f10a17" xlink:to="loc_dxcm_ConvertibleNotesDue2028Member_c485e456-5702-4501-9bae-267bb9c0ad4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_dc0a69c0-d3cc-407c-a3b6-f12ecbda297b" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_92515b72-93ed-4b14-bb43-197a0285aff6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_9ea0142b-71f6-41a4-a823-f94f1e4b4ac3" xlink:to="loc_us-gaap_SeniorNotesMember_92515b72-93ed-4b14-bb43-197a0285aff6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_0b868a65-e9d8-414e-8682-30e7eb6338ea" xlink:to="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_fefc3149-2851-47b4-b3af-380092f8dfa5" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCapCallTransactionCapPricePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare_fefc3149-2851-47b4-b3af-380092f8dfa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_23db4ee3-9856-4f60-b84b-64a5118d5f24" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage_23db4ee3-9856-4f60-b84b-64a5118d5f24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharePrice_5b22f6e4-2a30-4292-9c64-c8aa8095b6b9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_us-gaap_SharePrice_5b22f6e4-2a30-4292-9c64-c8aa8095b6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_86d826b6-3016-4d3f-8ef0-bb8b8f291025" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsForPurchasesOfCappedCallTransactions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_44135917-63a6-4038-a118-72ed883d5315" xlink:to="loc_dxcm_PaymentsForPurchasesOfCappedCallTransactions_86d826b6-3016-4d3f-8ef0-bb8b8f291025" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtConversionActivityforSeniorConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_e3115b07-3c33-46a1-b795-b1b87d06ccd8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_e3115b07-3c33-46a1-b795-b1b87d06ccd8" xlink:to="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:to="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d94c009c-8a06-4d94-9864-4ce46a722af0" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_be65ed0c-722c-4069-ada4-3bc3b1d88020" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_81101da5-8d75-41ae-b11d-3d134f7d666a" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_be65ed0c-722c-4069-ada4-3bc3b1d88020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_b30ce307-1643-4722-b3aa-06cfa6b4930f" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_d29ceb39-db3e-411a-8f75-6aee6e4239d9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_2a3aa330-a215-43ec-9a55-f63438e77edc" xlink:to="loc_us-gaap_SeniorNotesMember_d29ceb39-db3e-411a-8f75-6aee6e4239d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_b3ed977b-9c85-4e6f-92ee-e1da4cf8a54c" xlink:to="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_919f5a36-fe06-4ceb-aa9c-4e1402fddfd3" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled_919f5a36-fe06-4ceb-aa9c-4e1402fddfd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f1be1b4c-5531-44a2-84a8-90611b9153ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_f1be1b4c-5531-44a2-84a8-90611b9153ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_b182ea3f-66f7-4acb-82b6-a4f67bcaf483" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromBenefitOfNoteHedge"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_b0b3dbd2-02f2-4264-94b3-8d7f5747b9b2" xlink:to="loc_dxcm_SharesReceivedFromBenefitOfNoteHedge_b182ea3f-66f7-4acb-82b6-a4f67bcaf483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtConversionRightsforSeniorsConvertibleNotesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_58b34cd8-0584-445f-a15c-d91507c067fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_58b34cd8-0584-445f-a15c-d91507c067fe" xlink:to="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_d5f33df2-b78f-4a21-b25d-c8dc2b863b4a" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2023Member_6035ee06-ddea-4c69-93cb-bf7535a94f5b" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2023Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:to="loc_dxcm_ConvertibleNotesDue2023Member_6035ee06-ddea-4c69-93cb-bf7535a94f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ConvertibleNotesDue2025Member_addf80e3-bd57-4f2f-b019-7f14a1e124dd" xlink:href="dxcm-20241231.xsd#dxcm_ConvertibleNotesDue2025Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_39d7bbcf-cb0e-4fe1-a7d6-e8fc95031f69" xlink:to="loc_dxcm_ConvertibleNotesDue2025Member_addf80e3-bd57-4f2f-b019-7f14a1e124dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_393df6dc-b940-4b6a-909f-daf3aa7b19a5" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeniorNotesMember_711d517b-332d-4f13-8632-0519b9f5f897" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeniorNotesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8aea3cc9-cdf5-4b37-98db-43091c5f232e" xlink:to="loc_us-gaap_SeniorNotesMember_711d517b-332d-4f13-8632-0519b9f5f897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermAxis_9236b067-d21d-41cb-b814-16a73896e6cc" xlink:to="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermOneMember_e09708b0-1bdd-44d4-94f5-b27af611db80" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:to="loc_dxcm_DebtInstrumentConversionTermOneMember_e09708b0-1bdd-44d4-94f5-b27af611db80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentConversionTermTwoMember_fd35148d-dce5-4011-b099-9d18e9103f3e" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentConversionTermTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_DebtInstrumentConversionTermDomain_0b4bf71d-f5dc-4f02-aca4-03a7efe13eb4" xlink:to="loc_dxcm_DebtInstrumentConversionTermTwoMember_fd35148d-dce5-4011-b099-9d18e9103f3e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_894c7624-cdad-45b0-8061-cc9a51042d39" xlink:to="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_5c24c911-6d3d-4e03-ac2b-f2601d95e683" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:to="loc_srt_MinimumMember_5c24c911-6d3d-4e03-ac2b-f2601d95e683" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_81202e61-6384-481c-8ad5-025afc154451" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_17c92239-5afe-4f7d-acb6-adf1b18748d2" xlink:to="loc_srt_MaximumMember_81202e61-6384-481c-8ad5-025afc154451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_86abc0b6-c810-4cce-8559-e2da7bd20e35" xlink:to="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_9aea4bbe-f4e6-4a92-a5de-ff689cadcb5b" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentCovenantRepurchasePricePercentage"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_dxcm_DebtInstrumentCovenantRepurchasePricePercentage_9aea4bbe-f4e6-4a92-a5de-ff689cadcb5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0bbe316d-f19a-4286-a5fb-21822d565874" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1_0bbe316d-f19a-4286-a5fb-21822d565874" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_e538211a-5ad4-4eac-b3b4-80227c515d2b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger_e538211a-5ad4-4eac-b3b4-80227c515d2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_1c5705af-c0e7-492a-b724-68993d558cbe" xlink:href="dxcm-20241231.xsd#dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock_1c5705af-c0e7-492a-b724-68993d558cbe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3deb058d-f008-4f01-853e-867c11408174" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentRedemptionPricePercentage"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_3f7bae85-eb9e-42e3-91d9-e2dcf597f5f2" xlink:to="loc_us-gaap_DebtInstrumentRedemptionPricePercentage_3deb058d-f008-4f01-853e-867c11408174" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_87185e5e-256b-41eb-9433-5cb04204c248" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_87185e5e-256b-41eb-9433-5cb04204c248" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_adb2a020-d82a-4a12-b968-ec3483d32190" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_3cdff034-0c39-4cbf-b001-c0fd11b62fc9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_72258d50-ed22-410f-a2cd-afca5fac5d0d" xlink:to="loc_us-gaap_LineOfCreditMember_3cdff034-0c39-4cbf-b001-c0fd11b62fc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CreditFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityAxis_b15d82f8-7db7-4f8a-a803-a37088df173c" xlink:to="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LetterOfCreditMember_cf54dc98-551b-4d71-ade5-bdc44be4b67c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LetterOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CreditFacilityDomain_5b990be2-1153-4904-ac86-4f32b2d09362" xlink:to="loc_us-gaap_LetterOfCreditMember_cf54dc98-551b-4d71-ade5-bdc44be4b67c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_19d8089f-617b-463c-8e73-9b1cc8fb0958" xlink:to="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_ba1f17e5-4c9a-4baa-8608-7e437a0cc6bf" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:to="loc_srt_MinimumMember_ba1f17e5-4c9a-4baa-8608-7e437a0cc6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_8e7496fe-a63d-45c7-bec3-aabbb3c38c5b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c80b67bb-9314-47c0-b2d0-7d426bf2fd8c" xlink:to="loc_srt_MaximumMember_8e7496fe-a63d-45c7-bec3-aabbb3c38c5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_2eb415bb-38f6-4f45-8b33-bb5a7e874a4a" xlink:to="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BaseRateMember_77c40746-4b05-440a-bca5-874c840ec5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_BaseRateMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:to="loc_us-gaap_BaseRateMember_77c40746-4b05-440a-bca5-874c840ec5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member_d3d0ef71-14db-4569-a6d1-f355ec2a1b8b" xlink:href="dxcm-20241231.xsd#dxcm_LondonInterbankOfferedRateLIBOR1Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_7f61ec54-9e5d-49bc-b2f8-4ef5ebec7017" xlink:to="loc_dxcm_LondonInterbankOfferedRateLIBOR1Member_d3d0ef71-14db-4569-a6d1-f355ec2a1b8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_eacc0d9b-ad9b-44fd-963d-0b9a79e0d505" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02270cd4-000e-4c28-96fa-9a8571c40c91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_02270cd4-000e-4c28-96fa-9a8571c40c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCredit_73b24815-5414-4d7b-a82a-a0903b9aaeba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCredit_73b24815-5414-4d7b-a82a-a0903b9aaeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LettersOfCreditOutstandingAmount_e85c4f71-ffee-439f-8ab0-65f79f4d32c8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LettersOfCreditOutstandingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LettersOfCreditOutstandingAmount_e85c4f71-ffee-439f-8ab0-65f79f4d32c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b7b88304-4795-43ee-9372-4aec8170906e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity_b7b88304-4795-43ee-9372-4aec8170906e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7ab66a80-a754-464b-b1bc-970e50b0e710" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_7ab66a80-a754-464b-b1bc-970e50b0e710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_375d2424-ce75-4f85-8746-72d60f37955c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_eadd02fc-be99-4755-a047-c5e9bb2d1fee" xlink:to="loc_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage_375d2424-ce75-4f85-8746-72d60f37955c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#DebtRevolvingCreditAgreementDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_478ae5b9-1063-445c-b824-dd92d85b3fb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_478ae5b9-1063-445c-b824-dd92d85b3fb4" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_6e204176-a585-415d-bf74-800579ff1a31" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_15c32941-1fc4-4449-b9ff-68824f21d1cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_3bdc28d4-bfa3-4a32-a154-31687c033e56" xlink:to="loc_us-gaap_LineOfCreditMember_15c32941-1fc4-4449-b9ff-68824f21d1cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_253dc6de-e77d-43e7-8ec8-9dc39ab1d9fe" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTerm_5e575183-ed3c-42fc-a7e5-9082aa089ab4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DebtInstrumentTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_us-gaap_DebtInstrumentTerm_5e575183-ed3c-42fc-a7e5-9082aa089ab4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cbdfbddb-98fa-422a-a4b3-2ac054a10d91" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_cbdfbddb-98fa-422a-a4b3-2ac054a10d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_501b328d-81f1-4869-b864-53b9de465ac7" xlink:href="dxcm-20241231.xsd#dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_f92feb63-9e1b-4a43-9738-a2343216afb5" xlink:to="loc_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount_501b328d-81f1-4869-b864-53b9de465ac7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_92457757-c7d0-495d-8659-727f1d89d09c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_92457757-c7d0-495d-8659-727f1d89d09c" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:to="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_22b20a17-edde-4d41-a04f-e5761a1d1897" xlink:to="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_046b74bb-36fc-4908-9809-a49c0aa525e3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:to="loc_srt_MaximumMember_046b74bb-36fc-4908-9809-a49c0aa525e3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_a6f698b3-9de6-43d2-a5fe-4a0e983cc548" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_93ef59d1-b6c1-428f-b3d7-2cd5a208a7fb" xlink:to="loc_srt_MinimumMember_a6f698b3-9de6-43d2-a5fe-4a0e983cc548" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_477847dc-f7a8-42bf-b24d-0b53b326812b" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_90de00c1-e3fc-4a5b-9bf4-cc407e24098a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRemainingLeaseTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm_90de00c1-e3fc-4a5b-9bf4-cc407e24098a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_022f5129-114c-47aa-8bb0-03737c339167" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend_022f5129-114c-47aa-8bb0-03737c339167" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a9295931-410f-437d-a640-c107830a7f7d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_a9295931-410f-437d-a640-c107830a7f7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetRetirementObligation_7d90eadb-60d9-41dc-aa0b-c961b7746fb9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AssetRetirementObligation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_AssetRetirementObligation_7d90eadb-60d9-41dc-aa0b-c961b7746fb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1a9b621-da60-4b9c-b253-d97f45775401" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList_d1a9b621-da60-4b9c-b253-d97f45775401" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_bfb6936c-b46d-4bed-989e-c34d0c2b6a30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentOfLongLivedAssetsHeldForUse"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse_bfb6936c-b46d-4bed-989e-c34d0c2b6a30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_1831ed19-5bfa-441a-b345-d26dd586fd67" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration_1831ed19-5bfa-441a-b345-d26dd586fd67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ImpairedLongLivedAssetsFairValue_cc93d744-591f-4d92-89cf-ddff90b99e43" xlink:href="dxcm-20241231.xsd#dxcm_ImpairedLongLivedAssetsFairValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_ImpairedLongLivedAssetsFairValue_cc93d744-591f-4d92-89cf-ddff90b99e43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_5e790511-efa3-459f-af59-6a4d30baea12" xlink:href="dxcm-20241231.xsd#dxcm_LesseeOperatingLeasesLeaseCostAmortization"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_LesseeOperatingLeasesLeaseCostAmortization_5e790511-efa3-459f-af59-6a4d30baea12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_b91470cb-181a-4b84-9127-ff567d67145f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear_b91470cb-181a-4b84-9127-ff567d67145f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_58d82a15-7873-4d2a-9a84-fc1bd1377044" xlink:href="dxcm-20241231.xsd#dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_e887072d-eab8-45c9-a59f-65eb6266c601" xlink:to="loc_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm_58d82a15-7873-4d2a-9a84-fc1bd1377044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_72328ed1-baaa-49ad-9f8c-b0bb4aca1491" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_72328ed1-baaa-49ad-9f8c-b0bb4aca1491" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1e738e59-fb87-4460-92f5-9e0f1db6480a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_1e738e59-fb87-4460-92f5-9e0f1db6480a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34d07b33-f7d8-4c76-b63c-f496ff74c199" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_34d07b33-f7d8-4c76-b63c-f496ff74c199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cd5d310-4f97-4bff-8c2b-af528728e146" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_1cd5d310-4f97-4bff-8c2b-af528728e146" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_32b740fc-cef2-415b-bedb-987886bbf936" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_32b740fc-cef2-415b-bedb-987886bbf936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_47c565b9-5b48-4950-9d14-f8f58f059b47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_47c565b9-5b48-4950-9d14-f8f58f059b47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_54f5aea2-2a6c-455b-a884-e3678a7e8a47" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_54f5aea2-2a6c-455b-a884-e3678a7e8a47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6267d1cf-fd11-4984-b263-cb4e2d585033" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_6267d1cf-fd11-4984-b263-cb4e2d585033" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b9af236a-3c79-4256-9bbf-d792b40f11e4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b9af236a-3c79-4256-9bbf-d792b40f11e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_af5034af-267d-4931-a9e5-02954e54ef75" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_OperatingLeaseLiability_af5034af-267d-4931-a9e5-02954e54ef75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_aaedc823-120c-4080-8400-b576614c2c1b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_aaedc823-120c-4080-8400-b576614c2c1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_483eb40e-2cf7-454d-b7da-2540ff2db783" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_f2ef4a09-d58f-4a73-b26c-50cb5fd4035e" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_483eb40e-2cf7-454d-b7da-2540ff2db783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_72328ed1-baaa-49ad-9f8c-b0bb4aca1491" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0065010a-2555-4ea3-91f3-a53452f8152e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_0065010a-2555-4ea3-91f3-a53452f8152e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a5002f0c-0ecc-4322-9dde-d81b2eb4657b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_a5002f0c-0ecc-4322-9dde-d81b2eb4657b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a425d106-962a-48dc-8162-4bcab96f6ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_a425d106-962a-48dc-8162-4bcab96f6ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_80945aae-5809-4f7c-920a-68899864f772" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_80945aae-5809-4f7c-920a-68899864f772" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_277518f9-24b6-446a-bcf9-d62be55307f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_277518f9-24b6-446a-bcf9-d62be55307f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_86f204cd-ed13-4344-a20b-373d0ba9293c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_86f204cd-ed13-4344-a20b-373d0ba9293c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_912fc997-565b-45f5-912e-bbd742e1c8df" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_912fc997-565b-45f5-912e-bbd742e1c8df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2ea19714-0ebb-481b-8363-932077a2baeb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_2ea19714-0ebb-481b-8363-932077a2baeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_7ac2a41b-22e6-401e-a3dc-aedc3ba78703" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiability_7ac2a41b-22e6-401e-a3dc-aedc3ba78703" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_54acb32f-76e6-4a53-82bf-c16171bf5ee4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_54acb32f-76e6-4a53-82bf-c16171bf5ee4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4096fbab-7e0e-4541-ac1d-9e5db946972e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_35a4ab3b-35b4-4c2a-a69e-5871190a79a5" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_4096fbab-7e0e-4541-ac1d-9e5db946972e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_682988da-8fb4-473b-b84e-044600704fdb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_72328ed1-baaa-49ad-9f8c-b0bb4aca1491" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_682988da-8fb4-473b-b84e-044600704fdb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityAbstract_76e53fca-1d2e-46be-9f87-1445a9e7b761" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseLiabilityAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_FinanceLeaseLiabilityAbstract_76e53fca-1d2e-46be-9f87-1445a9e7b761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a515b3cb-8486-43ed-b502-8b9902b47866" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_76e53fca-1d2e-46be-9f87-1445a9e7b761" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_a515b3cb-8486-43ed-b502-8b9902b47866" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_297f7027-a280-41a2-81f1-9d60bf585b30" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilityAbstract_76e53fca-1d2e-46be-9f87-1445a9e7b761" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_297f7027-a280-41a2-81f1-9d60bf585b30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_8050ce0c-d961-40d9-8833-afd8a972e4ca" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_OperatingLeaseCost_8050ce0c-d961-40d9-8833-afd8a972e4ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseImpairmentLoss_20898b31-69f6-4d6e-9e7d-4df1007a84be" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_OperatingLeaseImpairmentLoss_20898b31-69f6-4d6e-9e7d-4df1007a84be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShortTermLeaseCost_e33db788-8f5a-411a-8b96-9c1a91242c2c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShortTermLeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_ShortTermLeaseCost_e33db788-8f5a-411a-8b96-9c1a91242c2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableLeaseCost_6b3fab48-e0c3-4c8a-a6b3-84065fce7148" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_VariableLeaseCost"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_VariableLeaseCost_6b3fab48-e0c3-4c8a-a6b3-84065fce7148" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_15f09394-900d-4014-bdf0-556abd9d7bd2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c5cc4404-91c9-45ce-a2c4-0c7f18fe211d" xlink:to="loc_us-gaap_LeaseCost_15f09394-900d-4014-bdf0-556abd9d7bd2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#LeasesandOtherCommitmentsOtherInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_75a4be53-f74b-4ef5-8b4c-8430e40d020d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_OperatingLeasePayments_75a4be53-f74b-4ef5-8b4c-8430e40d020d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_355d8a64-7792-427d-9ce7-7ca6ff6c7d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_355d8a64-7792-427d-9ce7-7ca6ff6c7d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_14e06064-d4c8-42a7-b921-7c40e3215c2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_14e06064-d4c8-42a7-b921-7c40e3215c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f7cb8c16-57ce-4274-abba-f23b7baadd2f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_f7cb8c16-57ce-4274-abba-f23b7baadd2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_733618cd-2894-42f4-bcfd-93c79fcfdcaa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_733618cd-2894-42f4-bcfd-93c79fcfdcaa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ef552b0-0e55-49a4-847e-b20623379b7f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_5ef552b0-0e55-49a4-847e-b20623379b7f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_521b1ca2-ef6b-4186-bf82-1f797b486ea6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_521b1ca2-ef6b-4186-bf82-1f797b486ea6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1270a757-0f41-4c69-855f-8cb027806f65" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1270a757-0f41-4c69-855f-8cb027806f65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3d56d434-55b8-4763-bf8e-29e77709e24c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_a84565a7-975f-4801-8ffb-beb6a3b3ddb6" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_3d56d434-55b8-4763-bf8e-29e77709e24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_4015c412-d971-4c79-a790-0596f840e110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a022a98d-7df7-41da-8315-28ed5d3ced34" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4015c412-d971-4c79-a790-0596f840e110" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic_a022a98d-7df7-41da-8315-28ed5d3ced34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f8961467-31bd-4aca-8ed3-9b35de0e1ee6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4015c412-d971-4c79-a790-0596f840e110" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign_f8961467-31bd-4aca-8ed3-9b35de0e1ee6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a96fc26c-478a-41a5-9d65-8fc9842fd443" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_4015c412-d971-4c79-a790-0596f840e110" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_a96fc26c-478a-41a5-9d65-8fc9842fd443" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_33baf741-6d22-4a53-bf06-9d6435dd8d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33baf741-6d22-4a53-bf06-9d6435dd8d8d" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c5df73cc-4a5d-4be6-bfdf-a73c027d1b29" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentFederalTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:to="loc_us-gaap_CurrentFederalTaxExpenseBenefit_c5df73cc-4a5d-4be6-bfdf-a73c027d1b29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a157dd63-087f-45c5-8245-1744f696e03d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentStateAndLocalTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:to="loc_us-gaap_CurrentStateAndLocalTaxExpenseBenefit_a157dd63-087f-45c5-8245-1744f696e03d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ea5af090-8d5e-4e3d-ac1e-e331d4796322" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentForeignTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:to="loc_us-gaap_CurrentForeignTaxExpenseBenefit_ea5af090-8d5e-4e3d-ac1e-e331d4796322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4e38dcc2-ef73-4e25-bf82-42cf53d20782" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CurrentIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract_0a8583fd-97aa-46ac-9b75-a1eb9123f5bf" xlink:to="loc_us-gaap_CurrentIncomeTaxExpenseBenefit_4e38dcc2-ef73-4e25-bf82-42cf53d20782" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33baf741-6d22-4a53-bf06-9d6435dd8d8d" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fe9aed6f-68fe-41ef-97d7-57c790d89a58" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredFederalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:to="loc_us-gaap_DeferredFederalIncomeTaxExpenseBenefit_fe9aed6f-68fe-41ef-97d7-57c790d89a58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_165925a0-720d-40d9-aa15-a628380803cc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:to="loc_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit_165925a0-720d-40d9-aa15-a628380803cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b8885398-684b-4f2e-ab52-79f1e80ce0c5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredForeignIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:to="loc_us-gaap_DeferredForeignIncomeTaxExpenseBenefit_b8885398-684b-4f2e-ab52-79f1e80ce0c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4f97fbe8-5c51-4f5a-85e1-fb3d4c7ae448" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract_48e57b53-1372-4747-acd4-e6f1db88eb6b" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_4f97fbe8-5c51-4f5a-85e1-fb3d4c7ae448" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_05b47269-519a-48a2-841d-7caee20b349b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_33baf741-6d22-4a53-bf06-9d6435dd8d8d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_05b47269-519a-48a2-841d-7caee20b349b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_84e9a0e2-ad77-4518-8fb2-8b6c3e31cc8e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_84e9a0e2-ad77-4518-8fb2-8b6c3e31cc8e" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxAuthorityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityAxis_ef52dfb3-651a-4309-a976-1f6c40dc5d3b" xlink:to="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DomesticCountryMember_acd2e2bd-d2fd-469d-8ad5-68e327ff9ff1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DomesticCountryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_DomesticCountryMember_acd2e2bd-d2fd-469d-8ad5-68e327ff9ff1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StateAndLocalJurisdictionMember_d2034092-3744-4e0e-ad1c-35bcc835ec48" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StateAndLocalJurisdictionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_StateAndLocalJurisdictionMember_d2034092-3744-4e0e-ad1c-35bcc835ec48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCountryMember_d00f30d4-e23d-4ec3-a4d8-0750155bd98d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ForeignCountryMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxAuthorityDomain_62db9db3-7175-4621-b557-bc7bec0f5007" xlink:to="loc_us-gaap_ForeignCountryMember_d00f30d4-e23d-4ec3-a4d8-0750155bd98d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c74fcc22-dfae-428f-9ac2-afce7b031d6a" xlink:to="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_7bcff274-5c53-4334-8d60-bf3237998f56" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_stpr_CA_7bcff274-5c53-4334-8d60-bf3237998f56" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherStatesMember_cd07a045-2ff6-4a78-b591-857d6b239e32" xlink:href="dxcm-20241231.xsd#dxcm_OtherStatesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_dxcm_OtherStatesMember_cd07a045-2ff6-4a78-b591-857d6b239e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_GB_55f1b005-67f7-43ea-a7da-ccdd7e53b63f" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_GB"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_country_GB_55f1b005-67f7-43ea-a7da-ccdd7e53b63f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherForeignMember_7003651d-67f2-4be4-9a58-4825ffc6b2dd" xlink:href="dxcm-20241231.xsd#dxcm_OtherForeignMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_53e618fb-81ab-49bf-a5c1-2e154e32e2fc" xlink:to="loc_dxcm_OtherForeignMember_7003651d-67f2-4be4-9a58-4825ffc6b2dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardAxis_2c2fba46-d449-4d92-b543-3996bc1b56f1" xlink:to="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ResearchDevelopmentTaxCreditsMember_f19a4f0d-dbfe-4482-a733-65612c5a0c3d" xlink:href="dxcm-20241231.xsd#dxcm_ResearchDevelopmentTaxCreditsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_ResearchDevelopmentTaxCreditsMember_f19a4f0d-dbfe-4482-a733-65612c5a0c3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ForeignTaxCreditsMember_ac5f7cb6-4dca-4d58-8685-f28388a0fc58" xlink:href="dxcm-20241231.xsd#dxcm_ForeignTaxCreditsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_ForeignTaxCreditsMember_ac5f7cb6-4dca-4d58-8685-f28388a0fc58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AMTTaxCreditsMember_a4fbcc53-d6da-4b97-8aa2-08643c6ed5af" xlink:href="dxcm-20241231.xsd#dxcm_AMTTaxCreditsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TaxCreditCarryforwardNameDomain_569aaff6-349f-4dc1-99cc-88a56850a34a" xlink:to="loc_dxcm_AMTTaxCreditsMember_a4fbcc53-d6da-4b97-8aa2-08643c6ed5af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_99ef1a50-abeb-43e1-aae9-7adbf16b937b" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwards_c7aabcdc-cb0a-4276-b3d6-6d06ab33afa6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:to="loc_us-gaap_OperatingLossCarryforwards_c7aabcdc-cb0a-4276-b3d6-6d06ab33afa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TaxCreditCarryforwardAmount_547bc4be-36f6-40f8-ac5d-f89c9575d0a9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TaxCreditCarryforwardAmount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_69761d01-f589-4bbb-b23a-c32de8389d8a" xlink:to="loc_us-gaap_TaxCreditCarryforwardAmount_547bc4be-36f6-40f8-ac5d-f89c9575d0a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f7fb25-1158-4dc8-b33f-7d756c7160b1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_f0f7fb25-1158-4dc8-b33f-7d756c7160b1" xlink:to="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:to="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_d64ca1da-b411-44e5-b13d-edfc5ca86dfb" xlink:to="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_stpr_CA_e4c9c20c-b78f-4d64-a196-f44a5627fb3a" xlink:href="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd#stpr_CA"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_e23ed351-143b-45b9-a468-73b68914eaed" xlink:to="loc_stpr_CA_e4c9c20c-b78f-4d64-a196-f44a5627fb3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsTable_a8e5298b-82db-4b69-a59f-3424fb1c1a5c" xlink:to="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_a91b169a-7c2e-4dcd-9165-035afe4492a3" xlink:href="dxcm-20241231.xsd#dxcm_UnusedExpiredFederalIncomeTaxCredits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_UnusedExpiredFederalIncomeTaxCredits_a91b169a-7c2e-4dcd-9165-035afe4492a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7bc961a8-e9a7-47d3-88a7-ef96e92de889" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther_7bc961a8-e9a7-47d3-88a7-ef96e92de889" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_484f6f80-dcd9-453e-9e09-fe2c7ab9a6d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_484f6f80-dcd9-453e-9e09-fe2c7ab9a6d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_92b62a21-1246-4df1-9075-4cc959858546" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_92b62a21-1246-4df1-9075-4cc959858546" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_752709c7-fce5-4d47-9c9f-991bd38096f9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate_752709c7-fce5-4d47-9c9f-991bd38096f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PreferentialTaxRatePeriod_7963f64c-5e21-483e-8ca1-6587c8632784" xlink:href="dxcm-20241231.xsd#dxcm_PreferentialTaxRatePeriod"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_PreferentialTaxRatePeriod_7963f64c-5e21-483e-8ca1-6587c8632784" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_79e019a1-4c5f-4d20-91fd-d5edaa0f291b" xlink:href="dxcm-20241231.xsd#dxcm_PossibleExtensionPeriodofTaxHoliday"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_dxcm_PossibleExtensionPeriodofTaxHoliday_79e019a1-4c5f-4d20-91fd-d5edaa0f291b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c01f31f6-f467-4a34-9cf2-6bf3d56611fa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UndistributedEarningsOfForeignSubsidiaries"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_UndistributedEarningsOfForeignSubsidiaries_c01f31f6-f467-4a34-9cf2-6bf3d56611fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1940040c-d897-40d7-8d73-0397e3cd7b14" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLossCarryforwardsLineItems_f482de48-c0b9-4f56-b84e-7455f60c5278" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_1940040c-d897-40d7-8d73-0397e3cd7b14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_307ff117-c1ba-430b-9519-b8da619d6093" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGrossAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_307ff117-c1ba-430b-9519-b8da619d6093" xlink:to="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7db843ed-2425-47ca-a0ce-36e450bbe15b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwards"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards_7db843ed-2425-47ca-a0ce-36e450bbe15b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_406b5b72-3be3-4d23-88fd-c7bc0e894581" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment_406b5b72-3be3-4d23-88fd-c7bc0e894581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_835abb6c-d1c5-4998-84c4-f39629f88a70" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_835abb6c-d1c5-4998-84c4-f39629f88a70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d6cc8366-38bb-4077-a973-8e0356f8044f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_d6cc8366-38bb-4077-a973-8e0356f8044f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_002f6076-04a9-4044-bf8c-6809444fb3d3" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets_002f6076-04a9-4044-bf8c-6809444fb3d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_a587333c-f909-496d-984b-5f694abed626" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_a587333c-f909-496d-984b-5f694abed626" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxAssetsConvertibleDebt_d4980d1a-d3a8-43fc-9c06-e59467b8d18e" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxAssetsConvertibleDebt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_dxcm_DeferredTaxAssetsConvertibleDebt_d4980d1a-d3a8-43fc-9c06-e59467b8d18e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsGross_b6ec831f-03bb-4f95-bcd6-8897531f88af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsGross"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsGross_b6ec831f-03bb-4f95-bcd6-8897531f88af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c8df000d-9e0e-4bf6-b0be-d0741fed9110" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsValuationAllowance_c8df000d-9e0e-4bf6-b0be-d0741fed9110" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsNet_49ef88ab-6ffd-42d7-8113-b16c892e8c69" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxAssetsGrossAbstract_d544c033-d07d-4234-bdf1-4f2cc361959f" xlink:to="loc_us-gaap_DeferredTaxAssetsNet_49ef88ab-6ffd-42d7-8113-b16c892e8c69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e794c631-b930-4674-856f-ecbe7bb62708" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_307ff117-c1ba-430b-9519-b8da619d6093" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e794c631-b930-4674-856f-ecbe7bb62708" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_ed71d911-611a-4002-b1e3-2dcd692da0a7" xlink:href="dxcm-20241231.xsd#dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e794c631-b930-4674-856f-ecbe7bb62708" xlink:to="loc_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets_ed71d911-611a-4002-b1e3-2dcd692da0a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxLiabilitiesOther_1f7bc58d-0eda-4084-af9b-bcaf252a5ebf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxLiabilitiesOther"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e794c631-b930-4674-856f-ecbe7bb62708" xlink:to="loc_us-gaap_DeferredTaxLiabilitiesOther_1f7bc58d-0eda-4084-af9b-bcaf252a5ebf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxLiabilities_6f0aac9e-5036-45a3-b4e2-8f917b876729" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxLiabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DeferredTaxLiabilitiesAbstract_e794c631-b930-4674-856f-ecbe7bb62708" xlink:to="loc_us-gaap_DeferredIncomeTaxLiabilities_6f0aac9e-5036-45a3-b4e2-8f917b876729" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_63997e9c-5406-4ce5-ad88-3d9d5d3d8610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_307ff117-c1ba-430b-9519-b8da619d6093" xlink:to="loc_us-gaap_DeferredTaxAssetsLiabilitiesNet_63997e9c-5406-4ce5-ad88-3d9d5d3d8610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_8d9e1aeb-a785-4978-8f2f-e05bd3c390d4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_8d9e1aeb-a785-4978-8f2f-e05bd3c390d4" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_47dd38bf-0689-4b2a-b557-39f698a57b9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate_47dd38bf-0689-4b2a-b557-39f698a57b9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a5cb3f15-28a5-4f54-a87e-35c81ac3424b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes_a5cb3f15-28a5-4f54-a87e-35c81ac3424b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_bb3a669a-5c76-45c1-a7a4-df9df3d6b127" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxReconciliationPermanentItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_dxcm_EffectiveIncomeTaxReconciliationPermanentItems_bb3a669a-5c76-45c1-a7a4-df9df3d6b127" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_baa22ecc-596e-4169-a2af-f1152d228457" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsResearch"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsResearch_baa22ecc-596e-4169-a2af-f1152d228457" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_21b4b338-0042-4753-ba70-5b99720765ff" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationTaxCreditsForeign"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationTaxCreditsForeign_21b4b338-0042-4753-ba70-5b99720765ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_466a2d15-95e9-4f78-83f8-39fdf1d1cfb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential_466a2d15-95e9-4f78-83f8-39fdf1d1cfb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5bc03ad9-697d-4d0d-b8fb-22f880b43843" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost_5bc03ad9-697d-4d0d-b8fb-22f880b43843" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_a598ea46-240d-4264-8eb7-3bf9284a4e1c" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment_a598ea46-240d-4264-8eb7-3bf9284a4e1c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_8ab76320-ffa2-43de-9e52-c40fc7b8f7d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate_8ab76320-ffa2-43de-9e52-c40fc7b8f7d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_107d2dc4-3d0d-4409-9779-5949bd5fff0f" xlink:href="dxcm-20241231.xsd#dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer_107d2dc4-3d0d-4409-9779-5949bd5fff0f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_14a322d7-16e2-4aa2-9089-d07e44e206f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationOtherAdjustments"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationOtherAdjustments_14a322d7-16e2-4aa2-9089-d07e44e206f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f8981421-c9ac-41b8-95a2-a73892006daa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance_f8981421-c9ac-41b8-95a2-a73892006daa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_d6350327-f854-4a41-a98a-bb9ba72e85a8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract_c2d095aa-cd21-4b18-baba-cf676f86db2d" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_d6350327-f854-4a41-a98a-bb9ba72e85a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_66d0871e-4fe1-47d0-b08c-b7b5d868b154" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_66d0871e-4fe1-47d0-b08c-b7b5d868b154" xlink:to="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_ba6667cd-2899-4e05-bfb4-2804933623cf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_ba6667cd-2899-4e05-bfb4-2804933623cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_20fa30e7-e750-4843-81cd-8ca32be2b6ab" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions_20fa30e7-e750-4843-81cd-8ca32be2b6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c341997c-9f2b-43c6-8f70-64da53c9b100" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions_c341997c-9f2b-43c6-8f70-64da53c9b100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_386f02cc-fa72-47c1-8fb3-bfd4714a13e8" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:to="loc_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions_386f02cc-fa72-47c1-8fb3-bfd4714a13e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrecognizedTaxBenefits_bb1fe0f2-e26f-4e90-963d-8e578165da36" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_UnrecognizedTaxBenefits"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward_8690a9b8-b364-4c91-98b1-12eb35754241" xlink:to="loc_us-gaap_UnrecognizedTaxBenefits_bb1fe0f2-e26f-4e90-963d-8e578165da36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f12c3cd-e102-446c-b38d-744b5550ef06" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_9f12c3cd-e102-446c-b38d-744b5550ef06" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_5fc96431-bbf5-4b8e-92fa-3535f82f3f6e" xlink:to="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A401kPlanMember_5d74be83-03d1-49c7-bc9a-87edbf55d039" xlink:href="dxcm-20241231.xsd#dxcm_A401kPlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_A401kPlanMember_5d74be83-03d1-49c7-bc9a-87edbf55d039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlan2015Member_598e2e4e-6d5b-4631-b1cc-dd944dd6a12a" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlan2015Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_EmployeeStockPurchasePlan2015Member_598e2e4e-6d5b-4631-b1cc-dd944dd6a12a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquityIncentivePlan2015Member_ec193ff4-cf82-4df2-8de2-5b83cee43166" xlink:href="dxcm-20241231.xsd#dxcm_EquityIncentivePlan2015Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_EquityIncentivePlan2015Member_ec193ff4-cf82-4df2-8de2-5b83cee43166" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2024ShareRepurchaseProgramMember_b7a15c81-528a-4ab4-9229-347e1af3a93c" xlink:href="dxcm-20241231.xsd#dxcm_A2024ShareRepurchaseProgramMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_8277eff5-3471-4af9-9f93-8eb52cfc9581" xlink:to="loc_dxcm_A2024ShareRepurchaseProgramMember_b7a15c81-528a-4ab4-9229-347e1af3a93c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_91df1d21-a214-46b8-9ee0-487cf6f04ca2" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_b0013a13-76c9-40ed-a5a6-515008e2795e" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_b0013a13-76c9-40ed-a5a6-515008e2795e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_bfc47601-fb37-4ed0-ba0d-78b3b3535a41" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_bfc47601-fb37-4ed0-ba0d-78b3b3535a41" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PerformanceSharesMember_36474479-ee49-4d5a-ad73-125fa64a2cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PerformanceSharesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fd31958a-bbb9-409d-9d0f-7b61bf7d058d" xlink:to="loc_us-gaap_PerformanceSharesMember_36474479-ee49-4d5a-ad73-125fa64a2cdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_cc90d15d-08be-4f8f-9b8a-84f59592fa93" xlink:to="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_eac654ae-2558-4b13-8f92-ce0012f216fb" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:to="loc_srt_MinimumMember_eac654ae-2558-4b13-8f92-ce0012f216fb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_25eaa6c0-d2b9-4cb1-a228-98fe2255015a" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_59da13ce-7b35-4148-baa1-e1366bb9cd50" xlink:to="loc_srt_MaximumMember_25eaa6c0-d2b9-4cb1-a228-98fe2255015a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_fd2116b4-3e8b-45e6-bbde-f7243de3ce61" xlink:to="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_9ec24402-0eb0-482c-ae82-efe44f6e9e32" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_34e3c834-5071-4edb-87f6-5aee322cc739" xlink:to="loc_us-gaap_CommonStockMember_9ec24402-0eb0-482c-ae82-efe44f6e9e32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ShareRepurchaseProgramDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramAxis_66dad60f-09f5-48d1-864b-d753b66ddc1b" xlink:to="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseASRMember_30557d3f-ba7c-4da5-96b8-b3a412a96322" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseASRMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:to="loc_dxcm_AcceleratedShareRepurchaseASRMember_30557d3f-ba7c-4da5-96b8-b3a412a96322" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareRepurchaseProgramMember_91a5ca71-f0f4-4f22-8e47-03d86995d1af" xlink:href="dxcm-20241231.xsd#dxcm_ShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ShareRepurchaseProgramDomain_6648948b-628b-42a2-9de9-1207ac0c1ab8" xlink:to="loc_dxcm_ShareRepurchaseProgramMember_91a5ca71-f0f4-4f22-8e47-03d86995d1af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:href="dxcm-20241231.xsd#dxcm_PaymentsUnderCollaborationAgreementsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsAxis_ba11a90e-41b2-4aac-9fd2-ebf776443ce7" xlink:to="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_20c0aa83-5a5c-4a7d-a14f-cbaf96a3da65" xlink:href="dxcm-20241231.xsd#dxcm_CollaborativeArrangementMilestonePaymentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_PaymentsUnderCollaborationAgreementsDomain_59935bad-18c7-488a-ae52-e47771491282" xlink:to="loc_dxcm_CollaborativeArrangementMilestonePaymentsMember_20c0aa83-5a5c-4a7d-a14f-cbaf96a3da65" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_4e6eb77b-3c88-4fb3-ba2a-525c97b32585" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_VerilyLifeSciencesMember_e102af5a-0c9d-40bc-9e80-8eb680f76786" xlink:href="dxcm-20241231.xsd#dxcm_VerilyLifeSciencesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_cffaf5a4-efe0-4549-bc91-c31cb11e3e6d" xlink:to="loc_dxcm_VerilyLifeSciencesMember_e102af5a-0c9d-40bc-9e80-8eb680f76786" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TypeOfArrangementAxis"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TypeOfArrangementAxis_c2332459-8daf-493d-b207-0d1eb15c2b1d" xlink:to="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CollaborativeArrangementMember_d371b903-6ba4-4320-b02c-7e1a4f83b43a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CollaborativeArrangementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ArrangementsAndNonarrangementTransactionsMember_f5cf2949-d828-4402-83bc-3ecd362e8cc4" xlink:to="loc_us-gaap_CollaborativeArrangementMember_d371b903-6ba4-4320-b02c-7e1a4f83b43a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7d62cbfe-1e75-4541-aec1-df3dda5fcd3f" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4081ef40-37fc-4a6a-af7a-696992dd68c4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_4081ef40-37fc-4a6a-af7a-696992dd68c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_5b87fdf3-166b-4ff9-87eb-55f95771b9bf" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch_5b87fdf3-166b-4ff9-87eb-55f95771b9bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2aa2f42b-c75f-4fce-afad-c1ba5fca53bc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_2aa2f42b-c75f-4fce-afad-c1ba5fca53bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DefinedContributionPlanCostRecognized_6d631476-7c72-49b9-bc90-cef6bab08761" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DefinedContributionPlanCostRecognized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_DefinedContributionPlanCostRecognized_6d631476-7c72-49b9-bc90-cef6bab08761" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_f5ff7be7-dd3c-4fab-99ae-7c2c756801d0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate_f5ff7be7-dd3c-4fab-99ae-7c2c756801d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeePurchasePriceFloorPercentage_b3077e31-6524-443f-9db5-ff0f98bdcb7a" xlink:href="dxcm-20241231.xsd#dxcm_EmployeePurchasePriceFloorPercentage"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_EmployeePurchasePriceFloorPercentage_b3077e31-6524-443f-9db5-ff0f98bdcb7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_cd0b8694-e75d-4c79-a031-c88e4199e18b" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized_cd0b8694-e75d-4c79-a031-c88e4199e18b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a6dfbe3f-03ad-4e79-bf20-bedb23db5f9d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans_a6dfbe3f-03ad-4e79-bf20-bedb23db5f9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9d2f7dd1-c12c-4041-afd2-d6417b2b5990" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_9d2f7dd1-c12c-4041-afd2-d6417b2b5990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0dcfbf2b-101a-4e77-bae7-91d889b99a3f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0dcfbf2b-101a-4e77-bae7-91d889b99a3f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2871c15-febb-4abb-b2c2-be0241c0ddd6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_b2871c15-febb-4abb-b2c2-be0241c0ddd6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4a0a87e-95fd-4471-838a-c205ae54421a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_a4a0a87e-95fd-4471-838a-c205ae54421a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9df82a2-84b9-4c51-a818-f0a6afd3ac04" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StockRepurchaseProgramAuthorizedAmount1"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_srt_StockRepurchaseProgramAuthorizedAmount1_a9df82a2-84b9-4c51-a818-f0a6afd3ac04" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_32f81891-66e8-44e0-8d29-505d7d10d2ec" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_32f81891-66e8-44e0-8d29-505d7d10d2ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b812f7f8-91a8-4e12-966c-d2913113babc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PaymentsForRepurchaseOfCommonStock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_PaymentsForRepurchaseOfCommonStock_b812f7f8-91a8-4e12-966c-d2913113babc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_e4974b44-0599-4675-8a10-cfd465fc32a2" xlink:href="dxcm-20241231.xsd#dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount_e4974b44-0599-4675-8a10-cfd465fc32a2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_e67f2863-b5eb-412c-83fe-58c4b3060c7b" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_e67f2863-b5eb-412c-83fe-58c4b3060c7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_d5e94cfb-53e7-4d27-829b-d67a096a29eb" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_d5e94cfb-53e7-4d27-829b-d67a096a29eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_c3804399-ed05-42ec-9830-4a1f6ddf0aa6" xlink:href="dxcm-20241231.xsd#dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues_c3804399-ed05-42ec-9830-4a1f6ddf0aa6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8d8d8ffa-2317-4716-a8d3-e01b56dc71fc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_8d8d8ffa-2317-4716-a8d3-e01b56dc71fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20756712-0f8d-4c25-bfca-20b1c1fec53b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_20756712-0f8d-4c25-bfca-20b1c1fec53b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f45b6b00-0fb4-4c5f-a76a-93ab0a2cee8d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_f45b6b00-0fb4-4c5f-a76a-93ab0a2cee8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2f7d0dcc-f1ab-46ec-a64c-f2bfc8f6f163" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_393e8155-ca41-4307-b926-52b0331774af" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2f7d0dcc-f1ab-46ec-a64c-f2bfc8f6f163" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41d8b52e-cc41-4837-a0ea-fceeb130939c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_41d8b52e-cc41-4837-a0ea-fceeb130939c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:to="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_03651b58-f607-4059-bf0e-2c1138ad87c7" xlink:to="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2022ShareRepurchaseProgramMember_2e6afcf1-bd3e-40b3-b318-022e578effe3" xlink:href="dxcm-20241231.xsd#dxcm_A2022ShareRepurchaseProgramMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2022ShareRepurchaseProgramMember_2e6afcf1-bd3e-40b3-b318-022e578effe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2023ShareRepurchaseProgramMember_fc704c62-67cf-4df1-bb2b-8b825559c594" xlink:href="dxcm-20241231.xsd#dxcm_A2023ShareRepurchaseProgramMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2023ShareRepurchaseProgramMember_fc704c62-67cf-4df1-bb2b-8b825559c594" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2024ShareRepurchaseProgramMember_2fa07f6c-1d5a-46cc-b8bb-433837266a17" xlink:href="dxcm-20241231.xsd#dxcm_A2024ShareRepurchaseProgramMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2024ShareRepurchaseProgramMember_2fa07f6c-1d5a-46cc-b8bb-433837266a17" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_A2028NotesMember_e18b501b-dd39-4081-aeb3-e3b1f5ea7f4c" xlink:href="dxcm-20241231.xsd#dxcm_A2028NotesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_99cff582-5694-465b-bd70-962418ff576b" xlink:to="loc_dxcm_A2028NotesMember_e18b501b-dd39-4081-aeb3-e3b1f5ea7f4c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a667bc80-2e60-483a-9981-50733f0e3e68" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:href="dxcm-20241231.xsd#dxcm_IncreaseDecreaseInTreasuryStockRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_9b972450-05ca-4027-9baf-5472d30253a4" xlink:to="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b64c1053-07ba-4f41-809e-d764d95f8461" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_b64c1053-07ba-4f41-809e-d764d95f8461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedNetLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_a0352602-41e1-43a8-b580-881b004d4a0e" xlink:href="dxcm-20241231.xsd#dxcm_SharesReceivedFromExerciseOfNoteHedge"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_SharesReceivedFromExerciseOfNoteHedge_a0352602-41e1-43a8-b580-881b004d4a0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_7655e8eb-7c6d-4880-b41f-0933fddfdab7" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone_7655e8eb-7c6d-4880-b41f-0933fddfdab7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockSharesAcquired_e4e81e08-10b6-4431-8a8a-cb1d6aa1b67a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TreasuryStockSharesAcquired"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_us-gaap_TreasuryStockSharesAcquired_e4e81e08-10b6-4431-8a8a-cb1d6aa1b67a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_4c9ba953-646a-4e1e-9a50-07cfcb82d2d0" xlink:href="dxcm-20241231.xsd#dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_IncreaseDecreaseInTreasuryStockRollForward_03a9f1fb-cd9d-4fdf-890f-e53e45e04669" xlink:to="loc_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants_4c9ba953-646a-4e1e-9a50-07cfcb82d2d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1af626d7-e901-44ac-943e-75d689ba16b2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_1af626d7-e901-44ac-943e-75d689ba16b2" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:to="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_16b15baa-6b5c-4a08-af98-54917faf8e63" xlink:to="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquityIncentivePlan2015Member_1e910b1e-5577-433b-ac15-804c51fb7a3d" xlink:href="dxcm-20241231.xsd#dxcm_EquityIncentivePlan2015Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_f1fbf2b9-29ee-462b-ac24-2a6f78c12610" xlink:to="loc_dxcm_EquityIncentivePlan2015Member_1e910b1e-5577-433b-ac15-804c51fb7a3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:to="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_43933b65-fe81-461c-9a4f-28cfb6cf7720" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_3053ec00-e55c-4fd5-a1c4-0ecfe408b769" xlink:href="dxcm-20241231.xsd#dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_312a744a-4548-488f-9ce0-378c4ead08ee" xlink:to="loc_dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember_3053ec00-e55c-4fd5-a1c4-0ecfe408b769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_613a04e1-e2ef-49f4-93d1-85942ab387ee" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_304fd7ae-be40-4847-a71e-7f2708df7458" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_304fd7ae-be40-4847-a71e-7f2708df7458" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_b13128d8-623f-431f-90b7-731e6bb3dcb2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_b13128d8-623f-431f-90b7-731e6bb3dcb2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_abe4e4be-9f39-4f48-b4f6-ab1492fa8f42" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested_abe4e4be-9f39-4f48-b4f6-ab1492fa8f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c4565a46-af86-457f-8cc0-8c922c130338" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_c4565a46-af86-457f-8cc0-8c922c130338" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7be39f27-bfa5-4c84-8d50-a4af830f6597" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward_e82c8e01-985e-4dce-b5dd-d5a5fda57105" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_7be39f27-bfa5-4c84-8d50-a4af830f6597" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d8792bff-51db-4324-b63f-41d8dfabb14e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_d8792bff-51db-4324-b63f-41d8dfabb14e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42ea5335-dba8-400b-a69b-8c55e41e0e33" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_42ea5335-dba8-400b-a69b-8c55e41e0e33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09d3748b-140f-4c17-9939-43f563f18d7e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_09d3748b-140f-4c17-9939-43f563f18d7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2a61aaef-54cb-4c4b-b413-231ec2f948d1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_2a61aaef-54cb-4c4b-b413-231ec2f948d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9ee654ba-72c3-4aff-abff-730954c00e5d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_a312f202-a4f2-437a-a69e-e6f1144cca55" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_9ee654ba-72c3-4aff-abff-730954c00e5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9a82712c-21dc-497c-971d-533381ea37d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_9a82712c-21dc-497c-971d-533381ea37d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afb5897c-5482-41a4-a33e-54ad47ea3e81" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_afb5897c-5482-41a4-a33e-54ad47ea3e81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_08b2ddb1-7357-4672-8c74-e63610945113" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_08b2ddb1-7357-4672-8c74-e63610945113" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83f4487e-6763-4420-90f8-45c39d12eb9b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_83f4487e-6763-4420-90f8-45c39d12eb9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3d230be5-8cc5-46aa-bdbc-91ebf3fca30c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward_fc463571-65e0-46bd-bfe2-c1b1eb9bcad7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_3d230be5-8cc5-46aa-bdbc-91ebf3fca30c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_363c0698-a255-4dee-b6db-6feb30b11958" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2c45cef6-2656-4170-8398-ea3df92a26cd" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested_363c0698-a255-4dee-b6db-6feb30b11958" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19cf03d5-2bde-42f1-8d96-5161304331cd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_19cf03d5-2bde-42f1-8d96-5161304331cd" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_3ba07f5d-fbb8-4ce5-a429-dbaf4c397164" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_c8819c97-134c-4616-8876-f715fa267b2a" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_CostOfSalesMember_c8819c97-134c-4616-8876-f715fa267b2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbcf3da2-6f9c-4c91-a8bb-da3d795cf0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_fbcf3da2-6f9c-4c91-a8bb-da3d795cf0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62deb774-7134-44b0-91a1-3e1806e6c5c1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_9c307ca8-6b30-425d-8379-58460a8bd1e1" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_62deb774-7134-44b0-91a1-3e1806e6c5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6fcd69fc-b761-4385-b3ec-58d30a9cf613" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_21860c31-e485-4d40-9c54-2fca03e78bb4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_21860c31-e485-4d40-9c54-2fca03e78bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0e9336fb-5a5e-4a70-bab4-805840294cc6" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_1b15592d-3361-41ba-9d8e-aab08888181f" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_0e9336fb-5a5e-4a70-bab4-805840294cc6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_17a49b8b-e8a5-4cbc-9049-b2d7de2e7ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_17a49b8b-e8a5-4cbc-9049-b2d7de2e7ef0" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:to="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_bb441705-5fce-4f3d-af18-59ae41630a07" xlink:to="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_87408317-6574-4216-96f9-f482692a1248" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:to="loc_srt_MinimumMember_87408317-6574-4216-96f9-f482692a1248" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ded10390-25df-40c9-8a51-06b3a0a5cca2" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_b5b23cbe-6d58-4d7b-9ec0-3eddb3146bb3" xlink:to="loc_srt_MaximumMember_ded10390-25df-40c9-8a51-06b3a0a5cca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:to="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_3069a7b6-13bb-40ca-ad74-96baebacbec9" xlink:to="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EmployeeStockPurchasePlanMember_3c7496b3-aa14-4230-a7d4-0b56786b1fe1" xlink:href="dxcm-20241231.xsd#dxcm_EmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_940045ff-6ea3-452e-8418-1b9adb9e4d12" xlink:to="loc_dxcm_EmployeeStockPurchasePlanMember_3c7496b3-aa14-4230-a7d4-0b56786b1fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_0e875bf6-3ed8-4fb9-af31-aa5f38a0425e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_44095800-d4bc-4c80-9210-b2b62b98d2e1" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_44095800-d4bc-4c80-9210-b2b62b98d2e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ff89d733-77d9-49bc-9091-dcef7f349415" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_ff89d733-77d9-49bc-9091-dcef7f349415" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7ca690d4-95cc-41c4-8e3c-5875504f2068" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_7ca690d4-95cc-41c4-8e3c-5875504f2068" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d47fa370-64fe-4259-a67a-039e47649b43" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_0925420f-1d03-4697-961e-883dc2752225" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_d47fa370-64fe-4259-a67a-039e47649b43" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_50d20ade-f14e-497e-9cbe-cd313fe274fd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_521f6076-8b2b-4240-b8df-eb3458816cc5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_50d20ade-f14e-497e-9cbe-cd313fe274fd" xlink:to="loc_us-gaap_NumberOfReportableSegments_521f6076-8b2b-4240-b8df-eb3458816cc5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_NumberOfPrimaryGeographicMarkets_1558ebc0-aa96-4ac8-8dc1-15f62a27cbc1" xlink:href="dxcm-20241231.xsd#dxcm_NumberOfPrimaryGeographicMarkets"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_50d20ade-f14e-497e-9cbe-cd313fe274fd" xlink:to="loc_dxcm_NumberOfPrimaryGeographicMarkets_1558ebc0-aa96-4ac8-8dc1-15f62a27cbc1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationSummaryDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_5e9508f5-8365-48b3-9bfd-22fad916634c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_5e9508f5-8365-48b3-9bfd-22fad916634c" xlink:to="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:to="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_f8ab647f-b63a-43e5-8503-bd01e957d2f7" xlink:to="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_904211a1-588e-4382-987f-22baee140be4" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:to="loc_country_US_904211a1-588e-4382-987f-22baee140be4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonUsMember_68ff2ba6-a6b4-4ac4-b878-142ded45f58d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NonUsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_d8ff8689-9ffb-4c6f-a11d-f244b92fd19c" xlink:to="loc_us-gaap_NonUsMember_68ff2ba6-a6b4-4ac4-b878-142ded45f58d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ContractWithCustomerSalesChannelDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelAxis_5cf386a2-d9f6-4366-808a-a26e6c12a023" xlink:to="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelThroughIntermediaryMember_9cfcd5dc-b31b-41b2-b6be-bf7d26f36ef0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelThroughIntermediaryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:to="loc_us-gaap_SalesChannelThroughIntermediaryMember_9cfcd5dc-b31b-41b2-b6be-bf7d26f36ef0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesChannelDirectlyToConsumerMember_36c23bcc-21ac-4e3c-8786-2968ffc43a7c" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SalesChannelDirectlyToConsumerMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ContractWithCustomerSalesChannelDomain_930b7911-592c-4089-a2eb-1b82b735dbcb" xlink:to="loc_us-gaap_SalesChannelDirectlyToConsumerMember_36c23bcc-21ac-4e3c-8786-2968ffc43a7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable_0b16b538-1805-476d-884d-b905f558862d" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28713fe1-1ecf-4c16-a2ea-9f859ddeba12" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_28713fe1-1ecf-4c16-a2ea-9f859ddeba12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_RevenuePercentage_b32f388c-141d-4631-9fa8-02bd894963a3" xlink:href="dxcm-20241231.xsd#dxcm_RevenuePercentage"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_937d036b-1c1b-4b40-ad24-9cabf177d4dc" xlink:to="loc_dxcm_RevenuePercentage_b32f388c-141d-4631-9fa8-02bd894963a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4535c3b6-0c98-4d97-857d-1e4a3fec80f7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_4535c3b6-0c98-4d97-857d-1e4a3fec80f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfGoodsAndServicesSold_63f1c9fb-7bd3-4aec-a2e1-c10d7ff969d2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CostOfGoodsAndServicesSold"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_CostOfGoodsAndServicesSold_63f1c9fb-7bd3-4aec-a2e1-c10d7ff969d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_PayrollRelatedExpenses_80dee8eb-b847-4acf-aa9c-99e178f77d5b" xlink:href="dxcm-20241231.xsd#dxcm_PayrollRelatedExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_dxcm_PayrollRelatedExpenses_80dee8eb-b847-4acf-aa9c-99e178f77d5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense_2b0ddb8b-0a69-4aea-aa8e-9b37594ad0f5" xlink:href="dxcm-20241231.xsd#dxcm_ShareBasedPaymentArrangementOperatingExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_dxcm_ShareBasedPaymentArrangementOperatingExpense_2b0ddb8b-0a69-4aea-aa8e-9b37594ad0f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MarketingExpense_d5edce5b-5ad3-4f3b-93f4-13d84c70688e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_MarketingExpense"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_MarketingExpense_d5edce5b-5ad3-4f3b-93f4-13d84c70688e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TravelAndEntertainmentExpense_9ca27bad-2413-4fb5-8ec2-54f053c96340" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_TravelAndEntertainmentExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_TravelAndEntertainmentExpense_9ca27bad-2413-4fb5-8ec2-54f053c96340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SupplyExpensesAndClinicalTrials_dc2ca639-9dd9-484a-93d5-f11d67b3f342" xlink:href="dxcm-20241231.xsd#dxcm_SupplyExpensesAndClinicalTrials"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_dxcm_SupplyExpensesAndClinicalTrials_dc2ca639-9dd9-484a-93d5-f11d67b3f342" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProfessionalFees_b0c873dd-8b01-4e85-9605-a35c07a2c8f4" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ProfessionalFees"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_ProfessionalFees_b0c873dd-8b01-4e85-9605-a35c07a2c8f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_EquipmentOfficeAndFacilityExpenses_d124f480-83aa-4105-8e5c-0b63d1f9260f" xlink:href="dxcm-20241231.xsd#dxcm_EquipmentOfficeAndFacilityExpenses"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_dxcm_EquipmentOfficeAndFacilityExpenses_d124f480-83aa-4105-8e5c-0b63d1f9260f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InformationTechnologyAndDataProcessing_37ec227b-580f-4826-b006-ed2d37e4cde0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_InformationTechnologyAndDataProcessing"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_InformationTechnologyAndDataProcessing_37ec227b-580f-4826-b006-ed2d37e4cde0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationAndAmortization_ad558ea9-912e-4fce-b614-00566c6bc044" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationAndAmortization"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_DepreciationAndAmortization_ad558ea9-912e-4fce-b614-00566c6bc044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingOtherItemAmount_bb05c62d-1ccf-4baf-82ec-2ab1110f65aa" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingOtherItemAmount"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_SegmentReportingOtherItemAmount_bb05c62d-1ccf-4baf-82ec-2ab1110f65aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_ab9bcae9-8db8-45d4-a200-2f669bf1b8bd" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_OperatingIncomeLoss_ab9bcae9-8db8-45d4-a200-2f669bf1b8bd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_5c58f883-cc52-447f-9109-c1f0620347d7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_5c58f883-cc52-447f-9109-c1f0620347d7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5b7a8f25-fdb3-463e-b918-f84dbbddb92d" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_5b7a8f25-fdb3-463e-b918-f84dbbddb92d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_a7bd679f-b5a7-42ea-a12b-a90c78f6a283" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_a7bd679f-b5a7-42ea-a12b-a90c78f6a283" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_4da9ea67-d000-43a3-99e8-13ff0dcbb1e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_NetIncomeLoss_4da9ea67-d000-43a3-99e8-13ff0dcbb1e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_82511e5b-c0e8-4d95-b71c-8f709ba89a18" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_82511e5b-c0e8-4d95-b71c-8f709ba89a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_d8b16735-7370-482b-a750-0bb92f82c475" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentExpenditureAdditionToLongLivedAssets"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_SegmentExpenditureAdditionToLongLivedAssets_d8b16735-7370-482b-a750-0bb92f82c475" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed7e94da-669a-427b-a72f-756e1dad43e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_DeferredIncomeTaxExpenseBenefit"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_8369ec50-9d08-4128-9483-855c5a89ce27" xlink:to="loc_us-gaap_DeferredIncomeTaxExpenseBenefit_ed7e94da-669a-427b-a72f-756e1dad43e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#BusinessSegmentandGeographicInformationGeographicInformationDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingAbstract_4937e746-877c-4f75-8f2f-915999d9fdba" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingAbstract_4937e746-877c-4f75-8f2f-915999d9fdba" xlink:to="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:to="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_ad83340e-4308-4efa-b212-eb3bca185f68" xlink:to="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_US_cb5d2e3f-6743-4b2f-acf1-db7cc40c43e2" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_US"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_US_cb5d2e3f-6743-4b2f-acf1-db7cc40c43e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_MY_8cb3fa82-2df5-4fbd-9fa2-c97c9578f2a1" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_MY"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_MY_8cb3fa82-2df5-4fbd-9fa2-c97c9578f2a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_OtherCountriesMember_8f92fcd9-c526-476d-b87f-8a86236e9d21" xlink:href="dxcm-20241231.xsd#dxcm_OtherCountriesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_dxcm_OtherCountriesMember_8f92fcd9-c526-476d-b87f-8a86236e9d21" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_IE_f2f71adc-5765-4855-94d9-0ff24e043183" xlink:href="https://xbrl.sec.gov/country/2024/country-2024.xsd#country_IE"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_4fee6d13-d775-4684-a47c-3fa140d15cb9" xlink:to="loc_country_IE_f2f71adc-5765-4855-94d9-0ff24e043183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SegmentReportingInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable_1aeb206a-9236-4951-af42-c37d189a2acb" xlink:to="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NoncurrentAssets_f7f833ea-5d9b-40a5-b5c7-7c52df65d2e7" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NoncurrentAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SegmentReportingInformationLineItems_2d69b53f-0d3c-4786-8f54-c96264f4c93f" xlink:to="loc_us-gaap_NoncurrentAssets_f7f833ea-5d9b-40a5-b5c7-7c52df65d2e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="simple" xlink:href="dxcm-20241231.xsd#SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"/>
  <link:presentationLink xlink:role="http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_srt_ValuationAndQualifyingAccountsAbstract_97057728-561d-49f8-8d4d-7ed5181d782c" xlink:href="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd#srt_ValuationAndQualifyingAccountsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ValuationAndQualifyingAccountsAbstract_97057728-561d-49f8-8d4d-7ed5181d782c" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_04c28763-7914-4095-b6a7-f3713c5c7f5b" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_04c28763-7914-4095-b6a7-f3713c5c7f5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_ee3e6bac-109f-4152-a56e-45c1083df400" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense_ee3e6bac-109f-4152-a56e-45c1083df400" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_eea0928f-34ee-40ca-be4a-23b59327d825" xlink:href="dxcm-20241231.xsd#dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:to="loc_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments_eea0928f-34ee-40ca-be4a-23b59327d825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_7a7672e8-ea81-4c87-a085-f0505d4b2186" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesRecoveries"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesRecoveries_7a7672e8-ea81-4c87-a085-f0505d4b2186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ValuationAllowancesAndReservesBalance_a968dafa-33b4-4f2b-a340-39934122b7c0" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ValuationAllowancesAndReservesBalance"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward_d8506c12-918d-45e2-ace5-19f3f5f13af2" xlink:to="loc_us-gaap_ValuationAllowancesAndReservesBalance_a968dafa-33b4-4f2b-a340-39934122b7c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgDiscLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiDiscTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgPredtrmndFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgPredtrmndFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgMnpiCnsdrdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_MnpiDiscTimedForCompValFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaap_AwardTypeAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_EmployeeStockOptionMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StockAppreciationRightsSARSMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="loc_us-gaap_StockAppreciationRightsSARSMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardUndrlygSecuritiesAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardExrcPrice" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardExrcPrice" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AwardGrantDateFairValue" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_AwardGrantDateFairValue" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AwardTmgDiscLineItems" xlink:to="loc_ecd_UndrlygSecurityMktPriceChngPct" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompRecoveryTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompRecoveryTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDateAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_RestatementDateAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ErrCompRecoveryTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonNeosMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonNeosMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllIndividualsMember" xlink:to="loc_ecd_NonNeosMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDeterminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDeterminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ErrCompAnalysisTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ErrCompAnalysisTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingAggtErrCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingAggtErrCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OutstandingRecoveryCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_OutstandingRecoveryCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_RecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ExecutiveCategoryAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ExecutiveCategoryAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_ExecutiveCategoryAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllExecutiveCategoriesMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllExecutiveCategoriesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_ExecutiveCategoryAxis" xlink:to="loc_ecd_AllExecutiveCategoriesMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_PeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllExecutiveCategoriesMember" xlink:to="loc_ecd_NonPeoNeoMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_AdjToCompAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AdjToCompAxis" xlink:to="loc_ecd_AllAdjToCompMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtPnsnAdjsSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsSvcCstMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnAdjsPrrSvcCstMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AggtPnsnAdjsSvcCstMember" xlink:to="loc_ecd_PnsnAdjsPrrSvcCstMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_ecd_EqtyAwrdsAdjsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsMember" xlink:to="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember" xlink:to="loc_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PvpTable" xlink:to="loc_ecd_MeasureAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PvpTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PvpTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NamedExecutiveOfficersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupIssuersFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_ChangedPeerGroupFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoActuallyPaidCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoActuallyPaidCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToPeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToPeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgTotalCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TabularListTableTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TabularListTableTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_TotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeerGroupTotalShareholderRtnAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_us-gaap_NetIncomeLoss" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_CoSelectedMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_CoSelectedMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_OtherPerfMeasureAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_OtherPerfMeasureAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AdjToCompAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_AdjToCompAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PeoName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PeoName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MeasureName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_MeasureName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_NonGaapMeasureDescriptionTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Additional402vDisclosureTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_Additional402vDisclosureTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_PnsnBnftsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock"/>
    <link:presentationArc order="31" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_PayVsPerformanceDisclosureLineItems" xlink:to="loc_ecd_EqtyAwrdsAdjFnTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingArrLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrByIndTable" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TradingArrByIndTable" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TradingArrAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_TradingArrAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllTradingArrangementsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrAxis" xlink:to="loc_ecd_AllTradingArrangementsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_IndividualAxis" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_TradingArrByIndTable" xlink:to="loc_ecd_IndividualAxis" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllIndividualsMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_IndividualAxis" xlink:to="loc_ecd_AllIndividualsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_MtrlTermsOfTrdArrTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndName" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrIndTitle" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrIndTitle" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrAdoptionDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrAdoptionDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_Rule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_NonRule10b51ArrTrmntdFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrTerminationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrTerminationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrExpirationDate" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrExpirationDate" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrDuration" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrDuration" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingArrLineItems" xlink:to="loc_ecd_TrdArrSecuritiesAggAvailAmt" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_InsiderTradingPoliciesProcLineItems" xlink:to="loc_ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>dxcm-20241231_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20241231_g1.jpg
M_]C_X  02D9)1@ ! @$$L 2P  #_X@Q824-#7U!23T9)3$4  0$   Q(3&EN
M;P(0  !M;G1R4D="(%A96B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@
M<U)'0@                  ]M8  0    #3+4A0("
M                                             !%C<')T   !4
M #-D97-C   !A    &QW='!T   !\    !1B:W!T   "!    !1R6%E:   "
M&    !1G6%E:   "+    !1B6%E:   "0    !1D;6YD   "5    '!D;61D
M   "Q    (AV=65D   #3    (9V:65W   #U    "1L=6UI   #^    !1M
M96%S   $#    "1T96-H   $,     QR5%)#   $/   " QG5%)#   $/
M" QB5%)#   $/   " QT97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L
M971T+5!A8VMA<F0@0V]M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV
M-BTR+C$              !)S4D="($E%0S8Q.38V+3(N,0
M                                                    6%E:(
M     /-1  $    !%LQ865H@                     %A96B        !O
MH@  ./4   .06%E:(        &*9  "WA0  &-I865H@        )*    ^$
M  "VSV1E<V,         %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M    %DE%0R!H='1P.B\O=W=W+FEE8RYC:
M                                  !D97-C         "Y)14,@-C$Y
M-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M     "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M
M('-21T(                             9&5S8P         L4F5F97)E
M;F-E(%9I97=I;F<@0V]N9&ET:6]N(&EN($E%0S8Q.38V+3(N,0
M    +%)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR
M+C$                                  '9I97<      !.D_@ 47RX
M$,\4  /MS  $$PL  UR>     5A96B       $P)5@!0    5Q_G;65A<P
M       !                         H\    "<VEG(     !#4E0@8W5R
M=@        0     !0 *  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4
M %D 7@!C &@ ;0!R '< ? "! (8 BP"0 )4 F@"? *0 J0"N +( MP"\ ,$
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M])5?E<F6-):?EPJ7=9?@F$R8N)DDF9"9_)IHFM6;0INOG!R<B9SWG62=TIY
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M]XKX&?BH^3CYQ_I7^N?[=_P'_)C]*?VZ_DO^W/]M____[@ .061O8F4 9
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MQ\C)RM+3U-76U]C9VN+CY.7FY^CIZO+S]/7V]_CY^O_:  P#   !$0(1 #\
M_?R@",T % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M[R<E]TKK\#KO^&GO%W_00_\ )>V_^-5O_:57^;\(_P"1V_ZP8G^?_P DA_\
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?YOPC_D'^L&)_G_ /)(?_(A_P -/>+O^@A_Y+VW_P :H_M*K_-^$?\ (/\
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M()[Z>+IU-I+7I>S^YZGMT<SHUK<LXZNR3:3O>VSL_334]&KK/3"@ H * "@
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M ,DA_P#(A_PT]XN_Z"'_ )+VW_QJC^TJO\WX1_R#_6#$_P __DD/_D30TO\
M:K\5:?,LDEU'<(N<Q201!&R".3$L;\9R-K#D#.1D&HYI53O>_DTOT29I3XCQ
M,'=R4O)QC;_R51?XG7?\-G^(/^?:P_[]S?\ Q^NC^V*G:/W/_P"2.S_6JO\
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ME0RDCC<.HX7G7:/_ )-_P$>-+BUVTIZVTO.ZOZ<JO]Z]3B?^&S_$'_/M8?\
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M_P#DD/\ Y$X'_A:WB#_H*W__ (%S?_%US?6JG\TO_ G_ )GG?VC7_P"?D_\
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M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
M_/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X
M_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\
MD'^M5#^6?W1_^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_
M^3#_ (;/\/\ _/M?_P#?N'_X_1_;%/M+[E_\D'^M5#^6?W1_^3#_ (;/\/\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M18BKLU%-6M%6^=W=I^C7EJ>!ZIJMQK<S7%U+)/,^-TDCL[M@ #+,23@  9/
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M 4 % !0 4 % !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@
M#DD\ <TF[:LF4E%7>B2NV]%8^9?'?[66A>%U9+$MJ%P&9=L>4B!5@#F9EP01
MN*-$LJMMZJ&#5X]?-(4_A]Y^6B^__*Y\KC.)*-#2'ON[VT6C[M?<TG?\3Y-\
M8_M8>(?$VZ.V>.QA;S%Q"N9"C\ -*^XAU'1XA$<DM@';M\2MFE2>WNK7;?[W
M^:L?'XKB2O6TC:"U^%:V?F[ZKNK=^UOG35-5N-;F:XNI9)YGQNDD=G=L  99
MB2<  #)X  Z"O*E)S=V[ON]3YFI4E4?-)MM]6VWVW9GU!F% !0 4 % !0 4
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MLX)4-M8=4<!@2C ,N>0#7MTZL:BO%W1]A0Q$,1'F@U)=T_*]GV>NSU1OUJ=
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!P/Q,^(-O\ #'3)=2N!
MOV86.(,JM+(QPJ*3^+,0&*HKL%;;@\N)KJA%R?R7=_U^!YV/QL<%3=26MME=
M*[>RU^][Z)NSL?G#K7[6/BG5) \,\-JH4 QPP(5)R3N)F$K9.<<,%P!\N<D_
M*3S2K+9I>B7ZW/S*KQ)B)NZ:CIM&*MZ^]S/\3(_X:>\7?]!#_P E[;_XU6?]
MI5?YOPC_ )&/^L&)_G_\DA_\B'_#3WB[_H(?^2]M_P#&J/[2J_S?A'_(/]8,
M3_/_ .20_P#D0_X:>\7?]!#_ ,E[;_XU1_:57^;\(_Y!_K!B?Y__ "2'_P B
M'_#3WB[_ *"'_DO;?_&J/[2J_P WX1_R#_6#$_S_ /DD/_D0_P"&GO%W_00_
M\E[;_P"-4?VE5_F_"/\ D'^L&)_G_P#)(?\ R(?\-/>+O^@A_P"2]M_\:H_M
M*K_-^$?\@_U@Q/\ /_Y)#_Y$/^&GO%W_ $$/_)>V_P#C5']I5?YOPC_D'^L&
M)_G_ /)(?_(GT'X!_;-6XD\K7;98U9N)[8,50$J!OB=F; ^9F=&9L841$\UZ
ME#.+Z37S7^3_ *\CZ/!<57=JT;:_%&]EMNFV^[;3?9(^V= U^U\46L5[92K-
M;S+NCD7H1T/!Y!!R&4@,K J0""*^AIU%45UJF?=T:T:\5.#NFM&OZ^]=-F:]
M:&P4 % !0!P/C3XHZ-\/=HU.[C@=\;8_F>0@[L-Y<89]GRL-^-N1MSD@5RUL
M3"C\3M^+^Y7?0\[%YA2PG\225^FK?76R3=M-[6/D;QI^VG]U=$L_0M)=_P#
MLJ(XG_W2',G]Y?+Z-7AULX_D7SE_DG^OR/C<7Q7_ ,^H^KG\]+1?IK?Y=3Y<
M\3_&_P 1^,(_)O-0F,>UU9(]L*NK@!E<0J@<$#&'W  D#&XY\:IC:E31R?RT
MW]+7/D\1F]?$*TINUFK*T4T][\J5_F>55Q'D!0 4 % !0 4 % !0 4 % !0
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M?7=[O?79=;'SW7EGS84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MB]0>AX/!!&0RD%64E2""16E.HZ;NM&C:C6E0DIP=FGHU_7WKKLS]UZ_2#^@
MH * "@ H * "@ H * "@ H * "@ H X'X@_$S3/AC;BXU*79OW"*-06DE95R
M511^ +,512RAG7<,\M?$QH*\GZ+J_P"ON/.QN/IX*/-4=KWLMV[*^B_5V6JN
MU<^%_''[8^IZHTD>D0QVD)X260"6?AR=V#^Z7<N 4*R;<MB0G:5^<K9O*6D%
M9=WJ]_N_/U/@<7Q14G=4DHKHW[TM]^RNNEG;74^3M:\07GB2037UQ-<R!0H>
M:1I&"@DA07).,DG'3))[UXDZCGK)M^KO^9\=5KRK.\VY.UKR;;M\S'K,Q"@
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M^V?_ ,B_;?\ 7_'_ .B9Z\/./X:_Q+\I'QO%7\"/_7Q?^DS/S)KX\_*PH *
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M3K6C5]R7?>+V6^ZUOOHEO(^N:]P^R"@ H * "@ H * "@ H * "@ H * "@
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MYI-MOJVV^V[,^H,PH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M_3YVN[NW4\YKD/,"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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MN]3\IJ5)5'S2;;?5MM]MV9]09A0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M+%8Y&0%B !G YP ,]A7YS6AR2<5T;7W.Q^"8NDJ-24%M&<DK[V3:.8K$Y H
M* "@ H * "@ H * +%I=R6$B30NT<D;!D=25964Y#*1R"#R".0>::=M45&3B
M[K1IW36CN%W=R7\CS3.TDDC%G=B69F8Y+,3R23R2>2>:&[ZL)2<G=ZMN[;U=
MRO2)"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#8T#7[KPO
M=17ME*T-Q"VZ.1>H/0\'@@C(92"K*2I!!(K2G4=-W6C1M1K2H24X.S3T:_K[
MUUV9^R/PM^)5K\5=-74+96C.XQS1-R8Y5 ++NP PPP*L.JD9"MN1?O<-B%B(
M\R]&O,_;<NQ\<=3YXZ:V:?1Z:>>^C_)Z'HU=9Z8Y: '4 % 'GWQ6_P"1?U7_
M *\+O_T2]<N*_AR_PR_)GG9C_ J?]>Y_^DL_$VOST_"@H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^NOA
M)^U;?>$MMKK/F7MH-Y\W.^Z4GD#<[@2)G(PY# -P^U%C/NX3-)4])^\M==Y?
MB]?ZUZ'V66<1SH>[5O..NN\_O;U7KKKO9)'Z/:!K]KXHM8KVRE6:WF7='(O0
MCH>#R"#D,I 96!4@$$5]73J*HKK5,_3J-:->*G!W36C7]?>NFS->M#8* "@
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MK?@[;/M=(^BZ]4^F"@ H * "@ H * "@ H * /@C]L?X;?ZGQ!;)Z07>U?\
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M]Y^/XW'U,;+FJ.]KV6R5W?1?J[O17;L<#7*><% !0 4 % !0 4 % !0 4 %
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M_$#Q*=.EI&]G+K)>G1?BU:]M4?'M>"?%A0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!]&? /XXW'PWOHK>\GD;27R
MDD9W2"'.XB2)<Y3#MF0(#O4L=CN$QZN!QKH22;]WJM[>:^>_Y7/ILFS>6#FH
MR;]F]&M7;=W2Z:O6VZOHW8_5NTNX[^-)H762.10R.I#*RL,AE(X((Y!'!'-?
M;)WU1^O1DI*ZU35TUJK%BF4% !0 4 % !0 4 % !0 4 % !0 4 % 'Y.?M5Z
M7-I_BJZDD7:EQ'!)$<@[D$2Q$\$D?/&ZX.#QG&""?B,TBU5=^J37W)?FC\?X
MCIN&)DW]I1:].51_.+/G.O*/F0H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ^A/V:/'TG@GQ!!#\QM[
M]EMI4&3\SL!$^-RKE7(!8[BL;2!02U>IEU?V51+I+1_/;\?PN?29!C7AJR72
M;46O-O1[K9]>S=C]:Z^X/V(<M #J "@#S[XK?\B_JO\ UX7?_HEZY<5_#E_A
ME^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >J_"WXOZE\*KI9;9VDM
M=Q,UHSD12!L!CCD+)A1MD W# !W)N1NW#8N6'=UMU73_ (?S/7R[,ZF!E>+O
M&^L6]'M]STT?YK0_6SP/XXL?B)8QW]A)OB?AE/#QN,;HY%R=KC(R.000RED9
M6/W%&M&M'FCM_6A^Q83%PQ<%.#NG]Z?9^?\ PZT.NK<[0H * "@ H * "@ H
M * "@ H * "@ H * "@ H R-?U^U\+VLM[>RK#;PKNDD;H!T' Y))P%4 LS$
M* 20*SJ5%35WHD8UJT:$7.;LDM6_Z^Y==D?DW\;OC==?%RZVKNATZ%B8(">2
M>GFRXX,A&<#E8U)5227=_B<;C7B'VBME^K\_R_/\?S;-I8^7:"?NQ_5^?Y;+
MJWX77FGSX4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5C.6,:*W;YGJUHKI+SN]=].7;8_/"OE3\V"@ H * "@ H * "@ H * "@ H
M^F_V5OAW_P )GK@O)1FVT[;,W/68D^0O#*PPRF3(#+^[V,,.*]C+,/[6=WM'
M7Y].OS^1]5P[@?K%;F?PT[2_[>^SU3W5^JTL]S]5*^T/UP* "@ H * "@ H
M* "@ H \Y^*7Q*M?A5IK:A<JTAW".&)>#)*P)5=V"%&%)9CT4' 9MJ-R8G$+
M#QYGZ)>9YF8X^.!I\\M=;)+J]=/+;5_F]#\A?''CB^^(E])?W\F^5^%4<)&@
MSMCC7)VH,G Y))+,6=F8_"UJTJTN:6_]:'XSB\7/%S<YN[?W)=EY?\.]3D*P
M.(* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6
MK9M1HRKR4(*[;T2_K[WTW9^W'A30_P#A&-/M;#?YGV:WBAWXV[O+0)NVY.,X
MSC)QTR:_0Z4/9Q4>R2^Y6/WC#4?8PC"]^6,8WVV27GV-^M3H"@ H * "@ H
M* "@ H KW=W'81O-,ZQQQJ6=V(5551DLQ/  '))X YI-VU9,I**N]$E=MZ*Q
M^7?[07[04GQ)D;3]/9H]+C;D\JURRGAW'41@\QQGG.)'&_:L7QN/Q_M_=C\/
MY_\  [+YOR_)\ZSIXQ\D-*:?HY/N_+LOF];)?+E>,?)A0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'UU^S'\
M<?\ A"[@:3J<^W39<^2S\K!,S \MD;(GRV_@JKD/\@,KGW<MQOLGR2?NO;R?
MZ+]>VI]EP_F_U>7LZC]Q[7Z2OWZ)]>B>NFK/TUKZ\_5 H * "@ H * "@ H
M* "@ H * "@ H _.']M719(-4L;XE?+FM6A49.X-#(SL2,8P1,NW!)R&R!@9
M^3SF%I*7=6^YW_4_,N*Z352$^CA;SO%MO_TI?B?%U?/GPP4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % '[L>']:C\26=O?0AA'<PQS(& #!9%#@, 2,X/."1GN:_2*<^=*2ZI/[]3
M^@*%55HJ:VE%-7WLU<V5K0V'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_
M)GG9C_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H ]=^"_Q4F^%&II=9D>
MTD^6ZA0C]XF#@@-P70G>GW2>4WJKL:[L'BGAY7Z/=?UV_P"!U/9RK,7@:BEJ
MXO2275?/JMUMVNDV?KWH&OVOBBUBO;*59K>9=T<B]".AX/((.0RD!E8%2 01
M7W5.HJBNM4S]GHUHUXJ<'=-:-?U]ZZ;,UZT-@H * "@ H * "@ H * "@ H
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MA6,Q3Q5251_:>W9;);+9)*_4Y"L#B"@ H * "@ H * "@ H * "@ H _7O\
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MM_+_ )7WVTLD_O"OI3]!"@ H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 =O:?#37+^-)H=-OI(Y%#(ZVTK*RL,AE(7!!'((X(Y
MKH6&F]5&7_@+_P COC@*TE=0FTU=-0DU;[CT7_AF'Q=_T#__ "8MO_CM=?\
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MA18XXU"HB@*JJHP%4#@ #@ < <5](E;1'W\8J*LM$E9):*Q8IE!0 4 % !0
M4 % 'RK\>?V<K?Q["U]I4<<&IIN9E4*B7.268/T E))*RG[Q.V0[2KQ^+CLO
M59<T=)?=?_@^?W^7R.<Y%'%+GII*:N^B4NNOGV?79]U^85W:26$CPS(T<D;%
M71@5964X*L#R"#P0>0>*^.:MHS\IE%Q=GHT[-/1W*](D* "@ H * "@ H *
M"@ H _2[]D'XAMX@TV72KF9I+BS8&$.5S]F8 *J<[V$; @Y&$5XD#8VJOUV4
MXCGBXMZQV]/^!^&A^I<,8[VM-TY.[@]+V^#1675V?W72\C[!KWC[0* "@ H
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M[M:^2_X/Y>J9\3Q%FOL8^Q@US23YNMHM;=KM/U2Z:IGYLU\D?EX4 % !0 4
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M * "@ H * "@ H * /T7_9R_9R_L#R]:UJ/_ $KA[:V<?ZGN)) ?^6O=$/\
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M7P]0Q%[+DD^L=%M;X=K=7:S?<^3?%W['VNZ*Q;3WAOX]RA0&$,N"N2S)(=@
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M=QW\:30NLD<BAD=2&5E89#*1P01R".".:_0$[ZH_<8R4E=:IJZ:U5BQ3*"@
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M5?\ KPN__1+URXK^'+_#+\F>=F/\"I_U[G_Z2S\3:_/3\*"@ H * "@ H *
M"@ H * "@ H * /KK]C#_D8+G_KPD_\ 1T%>[D_\1_X7^<3[+A7^/+_KV_\
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MT7AW*8N*KSU=WRKHK-J[\[K3MOO:WWA7TI^@A0 4 % !0 4 % !0 4 % !0
M4 ?CK\=_AJOPNUJ2TB93;S+]HMP-V4B=W"QMN))*%2N<MN4*Q(+%5^#QV']A
M.RV>J]&WI^!^*9Q@/J55Q6S7-'?1-M6UOM:V^N_D>-5YYX@4 % !0 4 % !0
M 4 % !0!^S7P4\=M\1="M;Z5E-QM,=QAE)\V,[6+!0H0N )=F!M5U R,$_?X
M.O[:"D]]GZK^K_,_;\IQGUNC&;WM:6JW6G2UK[VZ7/5:[3UPH * "@ H * "
M@ H * "@#\H_VBO@BOPKNDN;+<VG73,(P0Q,#CDQ,YX((R8B3O*JX()0N_Q6
M88+ZN[KX7^#[?Y=?NN?D.>93]1DI0^"3=M]'VO\ EUT=]KOYLKR#Y<* "@ H
M * "@ H * "@ H * "@#]<_V>_BW_P +4TS_ $ALZA:[4NL)L5MQ;RY%QE?G
M53N VX=7PBH4S]S@,7]8CK\2WT^Y_P!=>A^RY)F?UZG[WQQLI:6WO9]M4M?.
M^B5CWRO3/H0H * "@ H * "@ H * "@#\C/VA/BW_P +4U/_ $=LZ?:[DM<I
ML9MP7S)&SEOG91M!VX14RBN7S\-C\7]8EI\*VT^]_P!=.A^-YWF?UZI[OP1N
MHZ6WM=]]6M/*VB=SP.O,/G0H * "@ H * "@ H * "@ H * /TV_92^$G_")
M6/\ ;-TN+N]C'E8?(6U?8ZY X#N0'.2Q"A!\C>8I^PRO">SCSO>2TU^SH_Q_
MR\S]4X<RSV$/:R^*:TU^P[-?-[]=+;.Z/KFO</L@H * "@ H * "@ H * *]
MW=QV$;S3.L<<:EG=B%5549+,3P !R2> .:3=M63*2BKO1)7;>BL?CK\:/BI-
M\5]3>ZS(EI'\MK"Y'[M,#)(7@.Y&]_O$<)O944U\%C,4\1*_1;+^N_\ P.A^
M*9KF+QU1RU45I%/HOEU>[W[7:2/(JX3Q@H * "@ H * "@ H * "@ H * /5
M?A!\+;KXJZDEM$K?98V1KN8':(XB><,0P\Q@"(UP<MR1L5V7MPF&>(E9;=7Y
M?Y]CU\LRZ6.J**^%-<SVLON>KZ+]$S]@] T"U\+VL5E91+#;PKMCC7H!U/)Y
M))R68DLS$L222:^[ITU35EHD?M-&C&A%0@K)+1+^OO?7=FO6AL% !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?F%^U?\
M4E\8:DNEVK-]EL&=9.&4/<@E7X)PPC V(Q4$,9<%D92?CLTQ/M)<JVC>_K_P
M/\S\IXCS'ZQ4]G'X:;=]U>>SZZVV3MWW3/DVO$/CPH * "@ H * "@ H * "
M@ H L6EI)?R)#"C222,%1%!9F9C@*H'))/  Y)XII7T148N3LM6W9):NY^O?
MP&^%:_"O25BD&;RXVRW3$)E7*C$09<Y2/D#YF!8NXP'VC[K X7ZO"W5ZO;[O
ME_F?L^39=]1IV?Q2LY;;VVTZ+U>MVMSVRO1/="@ H * "@ H * "@ H * "@
M#\\?VMOA NER#Q!8HJQ2L$NXT1N)6+$3DC*@/PCGY/WFT_.\K$?+9KA.7]Y'
M9[^O?^NOJ?FW$N6<C]O!:-VDDGN[^]VUV>VMMVV?#U?.'P04 % !0 4 % !0
M 4 % !0 4 % 'Z>_LB^/I/%&CR:=/N:33F15<Y.89=QC7)8DE"KJ  JK&(U&
M<&OL<JK^TARO[/Y/;\ONL?JW#.-=>DX/>FTK_P!UWMU>UFNB2L?65>V?8!0
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MR6_^7S/D^),9["CR+>H[:-K16;_1-=;^I^65?&'Y*% !0 4 % !0 4 % !0
M4 % !0 4 ?L'\!OA6OPKTE8I!F\N-LMTQ"95RHQ$&7.4CY ^9@6+N,!]H^[P
M.%^KPMU>KV^[Y?YG[3DV7?4:=G\4K.6V]MM.B]7K=K<]LKT3W0H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@#PO]H+XI
M-\+M':6W91?7#>5; A6P>KR;"1D(O0X91(T892K$5YN/Q/L(76[T7^?]=;'@
M9UF/U*E>/Q2=H[/U=F^B]=6KJS/R$KX4_& H * "@ H * "@ H * "@ H *
M/KK]D?X;?\)+J;:M<)FVL,>7N7*O<,/EQE2I\M<N<%71S"PX->[E6'YY<[VC
MMZ_=TW\G8^RX:P'MJGM9+W8;><GMNK:+7>Z?*S]-:^O/U0* "@ H * "@ H
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M,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]5_Z\+O\ ]$O7+BOX<O\
M#+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_
M8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O_P!*@?IK7UY^J!0 4 %
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M5+?RI+[];_C^!^2\38AU*_+TA%+?2[7,W;INE\D?+E>,?)A0 4 % !0 4 %
M!0 4 % !0 4 ?3?[*WP[_P"$SUP7DHS;:=MF;GK,2?(7AE8893)D!E_=[&&'
M%>QEF']K.[VCK\^G7Y_(^JX=P/UBMS/X:=I?]O?9ZI[J_5:6>Y^JE?:'ZX%
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MHKYON_Z_ _<\!@HX*FJ<=;;NR5V]WI]RWT25W8[ZNH]$* "@ H * "@ H *
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
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MXZ?+'1+XI=$O\^RZ^EVOUS\#^!['X=V,=A81[(DY9CR\CG&Z21L#<YP,G@
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MW_EW_P!Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\
M7A:?^B4K]"PO\./^&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0
M4 % 'X(5^9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E
M?H6%_AQ_PQ_)'[KEW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\
M1+URXK^'+_#+\F>=F/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@
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MQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0
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MDK:(_>XQ459:)*R2T5BQ3*"@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * /DW]L77VTSP_':I*JM=72*\?R[GBC5I#@'G
M"N(BS+C!*J3AL'Q,WJ<M.W=K3R6OYV/C^**W)144_BFKK2[23?X-+5>7<_,*
MOCC\I"@ H * "@ H * "@ H * "@ H ^V?V)]#^T:AJ%_OQY-O'#LQ][SWW[
MMV>-ODXQ@YW9R-O/T.30O*4NR2^]W_0^[X3HWG.=]HJ-O\3O_P"V?B?HM7U9
M^EA0 4 % !0 4 % !0 4 % !0 4 % !0!Y5\<=%CU[PUJ<,I8*MK),"I .Z
M><@Y!X+( W<KD @X(XL;#GIR3[-_=K^AY&;TE5P]1/\ D;T[Q]Y?BM3\9:^
M/Q * "@ H * "@ H * "@ H * "@"Q:7<EA(DT+M')&P9'4E65E.0RD<@@\@
MCD'FFG;5%1DXNZT:=TUH[G[D>%-<_P"$GT^UO]GE_:;>*;9G=M\Q ^W=@9QG
M&<#/7 K]&I3]I%2[I/[U<_?,-6]M",[6YHQE;?=)^7<WZU.@* "@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
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M%G=B69F8Y+,3R23R2>2>:_-F[ZL_G^4G)W>K;NV]7<KTB0H * "@ H * "@
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M?:T:,:,>6.W]:GZ]A,)#"04(*R7WM]WY_P##+0ZZMSM"@ H * "@ H * "@
MH * "@ H _/C]MCQ+YEQI^F*T@V1R7$BY_=MYC>7&<9Y=?+EY(^4/P3N8#Y?
M.:FL8^3?EKHOR9^<<65[RA3UT3D^VKLOFK/[_-GPO7S9\ % !0 4 % !0 4
M% !0 4 % !0!])_LG:+)JGBF"9"H6UAGFD!)R5*&$!< Y.Z53S@;0QSG /KY
M7#FJI]DW^%OU/J.&Z3GB$U]F,F_2W+^<D?JY7VI^O!0 4 % !0 4 % !0 4
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M\,?R1^ZY=_ I_P#7N'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
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M9)?>[_H?=\)T;SG.^T5&W^)W_P#;/Q/T6KZL_2PH * "@ H * "@ H * "@
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MP:K_ -?]W_Z.>OSW%?Q)?XI?FS\*S'^/4_Z^3_\ 2F<#7*><% !0 4 % !0
M4 % !0 4 % !0!^@_P"Q'JDTMOJ=JS9ACDMY$7 X>59%<YQDY$2#!) V\ $G
M/U&32;4ET33^^_\ DC]'X2J-QJ1Z)Q:7FU)/_P!)1]T5](??A0 4 % !0 4
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MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X?^DH] 6NH]$=0 4
M>??%;_D7]5_Z\+O_ -$O7+BOX<O\,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H
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MT+"_PX_X8_DC]UR[^!3_ .O</_24=]74>B% !0 4 % !0 4 % !0 4 % !0
M4 % !0!D:_H%KXHM9;*]B6:WF7;)&W0CJ.1R"#@JP(96 8$$ UG4IJHK/5,Q
MK48UXN$U=-:I_P!?<^FZ/R;^-WP1NOA'=;EW3:=,Q$$Y'(/7RI<<"0#.#PLB
M@LH!#HGQ.-P3P[[Q>S_1^?Y_E^/YME,L!+O!OW9?H_/\]UU2\+KS3Y\* "@
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MH?"/_+S_ +A_^WGWO7TQ^AA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!^%_BO7/^$GU"ZO\ 9Y?VFXEFV9W;?,<O
MMW8&<9QG SUP*_.*L_:2<N[;^]W/P+$UO;3E.UN:4I6WW;?EW,"LCF"@ H *
M "@ H * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^
M!3_Z]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 % !0 4 % 'XG?%;_D8-5_
MZ_[O_P!'/7Y[BOXDO\4OS9^%9C_'J?\ 7R?_ *4S@:Y3S@H * "@ H * "@
MH * "@ H * /JK]CS5(=/\2-'(VU[BSECB&"=SAHY2. 0/DC=LG XQG) /M9
M3)*IKUBTOO3_ "1]=PO44*]G]J$DO6\9?E%GZBU]D?K 4 % !0 4 % !0 4
M% 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9/SP*
M "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/
MW7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_,)_[?/_:%
M?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4
M% !0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_
M )%_2O\ KPM/_1*5^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\
M5O\ D7]5_P"O"[_]$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H
M* "@ H * "@ H * "@ H ^NOV,/^1@N?^O"3_P!'05[N3_Q'_A?YQ/LN%?X\
MO^O;_P#2H'Z:U]>?J@4 % !0 4 % !0 4 % !0 4 % 'YL_MIZ7-%K%G=,N(
M9+/RT;(Y>*5V<8SD8$J') !W<$D''R6<1:FGT<;?<W_FC\PXKIM58RZ.%D_-
M2;?_ *4CXVKP#X@* "@ H * "@ H * "@ H * "@#U7X':U)H/B73)H@I9KJ
M.$A@2-LY\ESP1R%<E>P;!((R#VX*?)4BUW2^_3]3U\HJNEB*;7\Z6O:7NO\
M!Z'[-5]^?MX4 % !0 4 % !0 4 ?!'[<'_,)_P"WS_VA7S.=?9_[>_\ ;3\\
MXM_Y=_\ <3_VP^!Z^9/SP* "@ H * "@ H * "@ H * "@ H _>^OTP_H8*
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MQD\K&I#,"2B/Z6"P3Q#[16[_ $7G^7Y_093E,L?+M!/WI?HO/\MWT3_630-
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M/Q/.S&I[.C.5[6A*SO;6S2U[WM;S/Q.K\]/PH* "@ H * "@ H * "@ H *
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MN'_I*.^KJ/1"@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
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MGAWWB]G^C\_S_+\?S;*98"7>#?NR_1^?Y[KJEX77FGSX4 % !0 4 % !0 4
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M;_Q/\HGZIPK_  )?]?'_ .DP/KFO</L@H * "@ H * "@ H * "@ H * "@
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M 4 % !0!^]]?IA_0P4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
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MZ)-OOLC]#OV??V:6\*2+JNN1J;Q&S;V^5=82#Q*Y4E6D[Q@$K&,/DR8\KZG
M9=[/WI[]%O;S]>W;UV_2LER'V#]I67O)^['1I>;M=-]NV^^WVC7T!]P% !0
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MJJC 50.  . !P!Q7V25M$?K$8J*LM$E9):*Q8IE!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % !0!^FW[&'
M_(OW/_7_ "?^B8*^PR?^&_\ $_RB?JG"O\"7_7Q_^DP/KFO</L@H * "@ H
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M]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H * "@ H *
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M_P#2F?LO#_\ NT/^W_\ TN1[Y7IGT(4 % !0 4 % !0 4 % !0 4 % !0 4
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M?_<3_P!L/@>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H *
M"@ H * "@#X(_;@_YA/_ &^?^T*^9SK[/_;W_MI^><6_\N_^XG_MA\#U\R?G
M@4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0!]-_#O]E;7/&>);P?V=;'/S3*3,?O#Y8,JPPR@'S#'\
MK!UWCBO8P^63JZOW5Y[]>G^=CZK \.UL1K+W(_WE[W7[.CW76VCNKGZ#_#?X
M1:3\+8?+L(LRG=ON9 K3N&(.TN%7"#:N$4*ORAB"Y9C]1A\)##KW5KW>Y^CX
M#+*>"5H+76\G9R=^E[+31:+3KOJ>FUV'JA0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 <CXX\#V/Q$L9+"_CWQ/RK#AXW&=LD;8.U
MQDX/(()5@R,RG"M1C6CRRV_K4XL7A(8N#A-73^]/NO/_ (9Z'Y&?%3X5WWPG
MOC:W0WQ/EK>X4825!W'7:XR Z$DJ2.61D=OAL5A98>5GMT??^NJ/QO,<NG@9
M\LM4_AET:_S[KIZ6;\QKC/*"@ H * "@ H * "@ H * "@ H ^H_V??V?9/B
M3(NH:@K1Z7&W Y5KEE."B'J(P>))!SG,:'?N:+V<!@/;^]+X?S_X'=_)>7UF
M2Y*\8^>>E-/T<GV7EW?R6MVOU$M+2.PC2&%%CCC4*B* JJJC 50.  . !P!Q
M7V25M$?K$8J*LM$E9):*Q8IE!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % 'X(5^9G\\A0 4 % !0 4 % !0 4 % !0 4 % 'ZY_LP_\ (HZ?_P!O
M'_I3+7W.6_PH_/\ ]*9^R\/_ .[0_P"W_P#TN1[Y7IGT(4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!\C?MG_\ (OVW
M_7_'_P"B9Z\/./X:_P 2_*1\;Q5_ C_U\7_I,S\R:^//RL* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?F5^V?_ ,C!;?\
M7A'_ .CIZ^0SC^(O\*_.1^5\5?QX_P#7M?\ I4SY%KPCXT* "@ H * "@ H
M* "@ H * "@ H _;'X4_\B_I7_7A:?\ HE*_0L+_  X_X8_DC]UR[^!3_P"O
M</\ TE'?5U'HA0 4 % !0 4 % !0!\$?MP?\PG_M\_\ :%?,YU]G_M[_ -M/
MSSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/\ R+^E
M?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'?5U'HA0 4 % !0 4 % !
M0 4 % 'P1^W!_P PG_M\_P#:%?,YU]G_ +>_]M/SSBW_ )=_]Q/_ &P^!Z^9
M/SP* "@ H * "@ H * "@ H * "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_A
MC^2/W7+OX%/_ *]P_P#24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A
M0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN
M7?P*?_7N'_I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_ /1+URXK^'+_  R_)GG9
MC_ J?]>Y_P#I+/Q-K\]/PH* "@ H * "@ H * "@ H * "@ H ^NOV,/^1@N
M?^O"3_T=!7NY/_$?^%_G$^RX5_CR_P"O;_\ 2H'Z:U]>?J@4 % !0 4 % !0
M 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@
M>OF3\\"@ H * "@ H * "@ H * "@ H * /WOK],/Z&"@ H * "@ H * "@#
MX(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N'_I*.^KJ/1"@ H * "@
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M "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H * /VQ^%/\
MR+^E?]>%I_Z)2OT+"_PX_P"&/Y(_=<N_@4_^O</_ $E'H"UU'HCJ "@#S[XK
M?\B_JO\ UX7?_HEZY<5_#E_AE^3/.S'^!4_Z]S_])9^)M?GI^%!0 4 % !0
M4 % !0 4 % !0 4 % 'UU^QA_P C!<_]>$G_ *.@KW<G_B/_  O\XGV7"O\
M'E_U[?\ Z5 _36OKS]4"@ H * "@ H * "@ H * "@ H ^"/VX/^83_V^?\
MM"OF<Z^S_P!O?^VGYYQ;_P N_P#N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4
M % !0 4 ?O?7Z8?T,% !0 4 % !0 4 % 'P1^W!_S"?^WS_VA7S.=?9_[>_]
MM/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H * "@ H * "@
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M 4 % !0 4 % !0 4 % !0!R/CCQQ8_#NQDO[^39$G"J.7D<YVQQKD;G.#@<
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M,OX4OE_Z4CY[B#_=I_\ ;G_I<3\C*^&/QH* "@ H * "@ H * "@ H * "@
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M -H5\SG7V?\ M[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H *
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M'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 >NZ'\!?$_B'?Y.FW"[,9\X"WSNSC;YYCW=.=N=O&<9&>Z&!J3VB_GI^=CV
M:.38BK>T):?S>Y_Z5:_R/9= _8RUJ^:)KVYM;:-US(%+RRQDKD+L"JC$'"MB
M3:.2&; !]"GD\WNTOO;_ $7XGMT>%:LK<\HQ36MKR:TVM9)^?O>ESVS0/V,M
M%L5B:]N;JYD1LR!2D44@#9"[ K.H(PK8DW'DAER /0IY/!;MO[DOU?XGO4>%
M:4;<\I2:>MK13UVM9M>?O>ECV30_@+X8\/;_ "=-MVWXSYP-QC;G&WSS)MZ\
M[<;N,YP,>A# TX;17SU_.Y[=')L/2O:$=?YO?_\ 2KV^1Z[7<>R% !0 4 %
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
M"@ H * "@ H * "@ H * "@#X(_;@_YA/_;Y_P"T*^9SK[/_ &]_[:?GG%O_
M "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1?TK_
M *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@ H *
M/@C]N#_F$_\ ;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0
M 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_1*5^A87^''_#'\D?NN7?P*?_7N
M'_I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_F$_P#;Y_[0KYG.OL_]O?\
MMI^><6_\N_\ N)_[8? ]?,GYX% !0 4 % !0 4 % !0 4 % !0!^V/PI_P"1
M?TK_ *\+3_T2E?H6%_AQ_P ,?R1^ZY=_ I_]>X?^DH[ZNH]$* "@ H * "@
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MZT-@H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC7(W.<' X
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M/#I+[,I)^M^;\I(^DZ]<^H"@ H * "@ H * "@ H * "@ H * "@ H * "@
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M*^9SK[/_ &]_[:?GG%O_ "[_ .XG_MA\#U\R?G@4 % !0 4 % !0 4 % !0
M4 % '[8_"G_D7]*_Z\+3_P!$I7Z%A?X<?\,?R1^ZY=_ I_\ 7N'_ *2COJZC
MT0H * "@ H * "@ H * "@ H _!"OS,_GD* "@ H * "@ H * "@ H * "@#
M]L?A3_R+^E?]>%I_Z)2OT+"_PX_X8_DC]UR[^!3_ .O</_24>@+74>B.H *
M//OBM_R+^J_]>%W_ .B7KEQ7\.7^&7Y,\[,?X%3_ *]S_P#26?B;7YZ?A04
M% !0 4 % !0 4 % !0 4 % !0!]=?L8?\C!<_P#7A)_Z.@KW<G_B/_"_SB?9
M<*_QY?\ 7M_^E0/TUKZ\_5 H * "@ H * "@ H * "@ H * /@C]N#_F$_\
M;Y_[0KYG.OL_]O?^VGYYQ;_R[_[B?^V'P/7S)^>!0 4 % !0 4 % !0 4 %
M!0 4 =O\-+2._P!<TV&9%DCDOK971@&5E:5058'@@C@@\$<5T897G%/^:/YH
M[\!%2K03U3J033U5N9'[<5^B'[N% !0 4 % !0 4 % 'P1^W!_S"?^WS_P!H
M5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H * "@ H * "@
M H * /VB^#GA:'PAH-C;QP?9Y&MXI)T*E7,[HIE,F[YM^[@AON@!  JA1^@8
M2DJ<$K6T3?JUJ?N.5X=8>C"*7*W&+DK6?,TKWOK>_P!VVR/3:[#U0H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@#D?''CBQ^'=C)?W\FR).%4<O(YSMCC
M7(W.<' X  +,516885JT:,>:6W]:'%B\7#"0<YNR7WM]EY_\.]#\C/BI\5+[
MXL7QNKH[(DRMO;J<I$A[#IN<X!=R 6('"HJ(OPV*Q4L1*[VZ+M_75GXWF.8S
MQT^:6B7PQZ)?Y]WU]+)>8UQGE!0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 ?HO^SE^T;_;_EZ+K4G^E<);7+G_ %W81R$_\M>R.?\ 6_=/[W!E^KR_
M,.?W)[]'W\GY_GZ[_I>19[[6U*J_>VC)]?)^?9]?7?[8KZ$^["@ H * "@ H
M * "@ H * "@ H * "@ H * "@#\$*_,S^>0H * "@ H * "@ H * "@ H *
M "@#]%_V)]<^T:?J%ALQY-Q'-OS][STV;=N.-ODYSDYW8P-O/U>33O&4>S3^
M]6_0_2^$ZUX3A;:2E?\ Q*W_ +9^)]L5]"?=A0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % ' _%;_D7]5_Z\+O\ ]$O7
M+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$ZOST_"@H * "@ H * "@ H * "@ H
M* "@#]L?A3_R+^E?]>%I_P"B4K]"PO\ #C_AC^2/W7+OX%/_ *]P_P#24=]7
M4>B% !0 4 % !0 4 % !0 4 % !0 4 % !0!^87[9-W'<>(H51U9H[&)9 ""
M48R2N%8#H=K*V#SM93T(KX[-W>HO**_-L_*>*9)UU;I3BGY/FD_R:9\FUXA\
M>% !0 4 % !0 4 % !0 4 % !0!ZK\#M%DU[Q+ID,14,MU',2Q(&V ^<XX!Y
M*H0O8M@$@9([<%#GJ12[I_=K^AZ^44G5Q%-+^=/7M'WG^"T/V:K[\_;PH *
M"@ H * "@ H * /@C]N#_F$_]OG_ +0KYG.OL_\ ;W_MI^><6_\ +O\ [B?^
MV'P/7S)^>!0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%
M_AQ_PQ_)'[KEW\"G_P!>X?\ I*.^KJ/1"@ H * "@ H * "@ H * /@C]N#_
M )A/_;Y_[0KYG.OL_P#;W_MI^><6_P#+O_N)_P"V'P/7S)^>!0 4 % !0 4
M% !0 4 % !0 4 ?MC\*?^1?TK_KPM/\ T2E?H6%_AQ_PQ_)'[KEW\"G_ ->X
M?^DH[ZNH]$* "@ H * "@ H * "@ H * /P0K\S/YY"@ H * "@ H * "@ H
M * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1Z
MM=1Z(Z@ H \^^*W_ "+^J_\ 7A=_^B7KEQ7\.7^&7Y,\[,?X%3_KW/\ ])9^
M)M?GI^%!0 4 % !0 4 % !0 4 % !0 4 % 'UU^QA_R,%S_UX2?^CH*]W)_X
MC_PO\XGV7"O\>7_7M_\ I4#]-:^O/U0* "@ H * "@ H * "@ H * "@#X(_
M;@_YA/\ V^?^T*^9SK[/_;W_ +:?GG%O_+O_ +B?^V'P/7S)^>!0 4 % !0
M4 % !0 4 % !0 4 ?3?[)&A_VMXGCFW[?LEO--C&=^X"#;G(V_ZW=GG[N,<Y
M'L95#FJ7[)O]/U/JN&J/M,0G?X(REZ_9_P#;K_(_52OM#]<"@ H * "@ H *
M "@#XG_;8T/[1I^GW^_'DW$D.S'WO/3?NW9XV^3C&#G=G(V\_/9S"\8R[-K[
MU?\ 0^$XLHWA"=]I.-O\2O\ ^V?B?G17RA^:!0 4 % !0 4 % !0 4 % !0
M4 % '[WU^F']#!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % 'G/Q*^*6F
M_"JU6YU!FS(VV*&,!I9",;MJDJ,*#EF)"C@9W,BMR8C$QPZO+Y);GF8_,:>!
MCS3ZO1+5OTU6W5_JT?E)\5/BI??%B^-U='9$F5M[=3E(D/8=-SG +N0"Q X5
M%1%^*Q6*EB)7>W1=OZZL_(<QS&>.GS2T2^&/1+_/N^OI9+S&N,\H* "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * /T7_ &<OVC?[?\O1=:D_TKA+
M:Y<_Z[L(Y"?^6O9'/^M^Z?WN#+]7E^8<_N3WZ/OY/S_/UW_2\BSWVMJ55^]M
M&3Z^3\^SZ^N_VQ7T)]V% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 ?A!JNE
MS:)<2VMPNR:"1XY%R#M=&*L,@D'!!&02#V)%?FTHN#:>Z=G\C^?:E-TY.,M'
M%M->:=GL9]09A0 4 % !0 4 % !0 4 % !0 4 ?:/[%6M20:I?6("^7-:K,Q
MP=P:&144 YQ@B9MV03D+@C!S]!DT[2<>ZO\ <[?J?<\*56JDX='"_G>+27_I
M3_ _1ZOK#]-"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M#-)3Q%W]F$FO72/Y29^IE?9GZT% !0 4 % !0 4 % !0!\$?MP?\PG_M\_\
M:%?,YU]G_M[_ -M/SSBW_EW_ -Q/_;#X'KYD_/ H * "@ H * "@ H * "@
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MR2268L[,Q^&K5I5I<TM_ZT/QO%XN>+FYS=V_N2[+R_X=ZG(5@<04 % !0 4
M% !0 4 % !0![I\-?V>=:^*%JU[:^3#;AMJ27#.@E(R&\L*CDA2,%B N[*@D
MJX7TL/@)UU=62\[Z_<F?08#)*N-CSQLE?1R;5^]K)[=_ET=N)^(/PSU/X8W
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M\K'[GEDE*A3MK^[@M.ZBD_N:LST:NL],* "@ H * "@ H * "@ H * "@ H
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MA'[J% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % 'YI?MD^$5TC6+?4D"A;Z$A_F8L98-JEB#P!L:)5VGDJQ*@\M\CF
M]+EFI?S+\5_P+'Y;Q3AO9U547VXZ[WO&RO\ <TM.S^?Q[7@GQ84 % !0 4 %
M !0 4 % !0 4 % 'Z+_L3ZY]HT_4+#9CR;B.;?G[WGILV[<<;?)SG)SNQ@;>
M?J\FG>,H]FG]ZM^A^E\)UKPG"VTE*_\ B5O_ &S\3[8KZ$^["@ H * "@ H
M* "@ H * "@ H * "@ H _"CQ!K4GB2\N+Z8*)+F:29PH(4-(Q<A023C)XR2
M<=S7YO4GSMR?5M_?J?S_ %ZKK2<WO*3;MM=NYCUF8A0 4 % !0 4 % !0 4
M% !0 4 ?JY^R=HL>E^%H)D+%KJ:>:0$C 8.80%P!@;8E/.3N+'., ?:Y7#EI
M)]VW^-OT/U[ANDH8=-?:E)OUOR_E%'TG7KGU 4 % !0 4 % !0 4 % 'P1^W
M!_S"?^WS_P!H5\SG7V?^WO\ VT_/.+?^7?\ W$_]L/@>OF3\\"@ H * "@ H
M * "@ H * "@ H _;'X4_P#(OZ5_UX6G_HE*_0L+_#C_ (8_DC]UR[^!3_Z]
MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * "@#ZZ_8P_Y&"Y_Z\)/_1T%>[D_\1_X7^<3[+A7^/+_ *]O
M_P!*@?IK7UY^J!0 4 % !0 4 % !0 4 % !0!@>*]<_X1C3[J_V>9]FMY9MF
M=N[RT+[=V#C.,9P<=<&LJL_9Q<NR;^Y7.?$UO8PE.U^6,I6VV3?GV/POK\X/
MP$* "@ H * "@ H * "@ H * "@ H _=#PIH?_",:?:V&_S/LUO%#OQMW>6@
M3=MR<9QG&3CIDU^CTH>SBH]DE]RL?OV&H^QA&%[\L8QOMLDO/L;]:G0% !0
M4 % !0 4 % !0!^*WQ=T!O#/B#4;4Q+"JW4K1QKM"K%(WF1;0O &QE(48VCY
M2 00/S[%T_9U)+;5Z>3U7X'X9F='V-:<;6]]V2M:S=UMY-:=#SFN0\P* "@
MH * "@ H * "@ H * "@#]5/V2-<_M;PQ'#LV_9+B:'.<[]Q$^[&!M_UNW'/
MW<YYP/M,JGS4[=FU^OZGZYPU6]IATK?!*4?7[7_MUOD?3=>P?5!0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M5Z1(4 % !0 4 % !0 4 % !0!]L_LY?M&_V!Y>BZU)_HO"6URY_U/81R$_\
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M%&$[W;BKNUO>6CZ+JGY=M#OJZCT0H * "@ H * "@ H * "@ H * "@ H *
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M_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 % !0 4 %
M!0 4 % !0!\$?MP?\PG_ +?/_:%?,YU]G_M[_P!M/SSBW_EW_P!Q/_;#X'KY
MD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\ 7A:?^B4K]"PO\./^
M&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5^9G\\A0
M4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_PQ_)'[KE
MW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\ 1+URXK^'+_#+\F>=
MF/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#ZZ_8P_P"1
M@N?^O"3_ -'05[N3_P 1_P"%_G$^RX5_CR_Z]O\ ]*@?IK7UY^J!0 4 % !0
M 4 % !0 4 % !0!^=/[9_C'[;?6FD1ME+>,S2A9,CS)>$5XQP'1%W*6R=LW
M .6^4SBM>2AV5WKU?EZ?F?FG%6*YIQI+[*YGKU>UUW25UY2^_P")J^>/A H
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M)_[?/_:%?,YU]G_M[_VT_/.+?^7?_<3_ -L/@>OF3\\"@ H * "@ H * "@
MH * "@ H _;'X4_\B_I7_7A:?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5
MU'HA0 4 % !0 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?
M^7?_ '$_]L/@>OF3\\"@ H * "@ H * "@ H * "@ H _;'X4_\ (OZ5_P!>
M%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1WU=1Z(4 % !0 4 % !0 4 % !0
M 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%_2O^O"T_\ 1*5^
MA87^''_#'\D?NN7?P*?_ %[A_P"DH] 6NH]$=0 4 >??%;_D7]5_Z\+O_P!$
MO7+BOX<O\,OR9YV8_P "I_U[G_Z2S\3:_/3\*"@ H * "@ H * "@ H * "@
M H * /KK]C#_ )&"Y_Z\)/\ T=!7NY/_ !'_ (7^<3[+A7^/+_KV_P#TJ!^F
MM?7GZH% !0 4 % !0 4 % !0 4 5[N[CL(WFF=8XXU+.[$*JJHR68G@ #DD\
M <TF[:LF4E%7>B2NV]%8_%;XH^-/^%A:S=ZF%V)/)^[7&"(T41Q[AN8;]BKO
MP2-V<8&!7Y]B:WMIN7=_@M%WZ(_#,PQ?UNK*IMS/3T2275ZV2OYG URGG!0
M4 % !0 4 % !0 4 % !0!8M+22_D2&%&DDD8*B*"S,S' 50.22> !R3Q32OH
MBHQ<G9:MNR2U=S]H?A1X!C^&FCV^G+M,BKNG=<?/,_+MG:I8 _*A8;A&J*>E
M?H&%H>P@H_?Z]>WR\C]QRW!+!THPZI7D^\GOT5^ROK9(]&KK/3"@ H * "@
MH * "@ H * *]W:1W\;PS(LD<BE71@&5E88*L#P01P0>".*35]&3**DK/5-6
M:>JL?B?\2/"+>!-8O--(8+!,PCW,K,8C\T3,5XRR%6. ,$X*J<@?GF(I>RFX
M]G^'3\#\*Q^&^JU94_Y9.U[-VW3T[IIG$5SG % !0 4 % !0 4 % !0 4 %
M!0!^JG[)_C'_ (2;P\EM(VZ:QD:$[I-[F,_/$Q!Y1 &,2#D8B.#@;5^TRNMS
MT[=8NV]]-U_DO0_7.&\5[:ARO>#<=[NVZ]%K9>FG9?3=>P?5!0 4 % !0 4
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MKS3L]C/J#,* "@ H * "@ H * "@ H * /JK]G+X\S> KB/2KYM^F3R!59F
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MA7S.=?9_[>_]M/SSBW_EW_W$_P#;#X'KYD_/ H * "@ H * "@ H * "@ H
M* /VQ^%/_(OZ5_UX6G_HE*_0L+_#C_AC^2/W7+OX%/\ Z]P_])1WU=1Z(4 %
M !0 4 % !0 4 % !0!\$?MP?\PG_ +?/_:%?,YU]G_M[_P!M/SSBW_EW_P!Q
M/_;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%/_ "+^E?\ 7A:?^B4K
M]"PO\./^&/Y(_=<N_@4_^O</_24=]74>B% !0 4 % !0 4 % !0 4 % 'X(5
M^9G\\A0 4 % !0 4 % !0 4 % !0 4 ?MC\*?^1?TK_KPM/_ $2E?H6%_AQ_
MPQ_)'[KEW\"G_P!>X?\ I*/0%KJ/1'4 % 'GWQ6_Y%_5?^O"[_\ 1+URXK^'
M+_#+\F>=F/\  J?]>Y_^DL_$VOST_"@H * "@ H * "@ H * "@ H * "@#Z
MZ_8P_P"1@N?^O"3_ -'05[N3_P 1_P"%_G$^RX5_CR_Z]O\ ]*@?IK7UY^J!
M0 4 % !0 4 % !0 4 % 'YT_M0_'?^W6F\.V Q;QR;+N5EYDDB?/EH",A$=1
MN?@NRX7$8)E^4S+'<]Z<=D]7YI[??_5M_P TXASCVMZ$-D[2=MVGLO)-:OJ]
MM-_B:OGCX0* "@ H * "@ H * "@ H * "@#[)_9'^%:^([MM<N1F&RD"P(0
MC*\^W)+9R1Y09'7@9=D97!C93[^587G?.]HO3;?_ ('Y^A]OPUEWMI>VEM!V
MBM'>5OTNFM-VFGH?I-7UI^GA0 4 % !0 4 % !0 4 % !0 4 ?!'[:?@O_CS
MUM6_Z=)%)_WY8RHV_P#74.2W_//"_>-?,YQ1VG_V[^;7Z_@?GG%>$^&K_P!N
M-??)=/6^O;3<^!Z^9/SP* "@ H * "@ H * "@ H * "@#UWX+_%2;X4:FEU
MF1[23Y;J%"/WB8." W!="=Z?=)Y3>JNQKNP>*>'E?H]U_7;_ ('4]G*LQ>!J
M*6KB]))=5\^JW6W:Z39^O>@:_:^*+6*]LI5FMYEW1R+T(Z'@\@@Y#*0&5@5(
M!!%?=4ZBJ*ZU3/V>C6C7BIP=TUHU_7WKILS7K0V"@ H * "@ H * "@ H *
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MN9^B7D?B&8X^6.J<\M-+)+HM=//?5_DM#SFN0\P* "@ H * "@ H * "@ H
M* /5?@S\-6^*FL1V!9D@"M+<2+MW+$F =H8]68J@(#;2V\JRJ17;@\/]8GR]
M-WZ?UH>OE6 ^O55#96;DU:]EZ]VTNMKWL['[)6EI'81I#"BQQQJ%1% 5551@
M*H'  '  X XK[Y*VB/VV,5%66B2LDM%8L4R@H * "@ H * "@ H ^+OVLOA
MNMVIU^R11<6R_P"EA48O-%\H5_ER,Q#)8D#]UDEP(E4_/YIA.9>T6ZW\U_P/
MRZZ'P_$F6>TC[:"UBO>LG=K17T[=?+=Z)'YPU\F?F(4 % !0 4 % !0 4 %
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MW!_S"?\ M\_]H5\SG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@
MH * "@ H * "@ H _;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z
M]P_])1WU=1Z(4 % !0 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 %
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MO)>?Y>NWPF>Y[[*]*D_>VE)=/)>?=]/7;\Z*^4/S0* "@ H * "@ H * "@
MH * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@ #)9B0JJ"Q( )K2G3=1V6K9M
M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [DMXPI;D;W)+2/@LQ&YRS;<D+
MG:. *_0:%)48J*Z+_A_Q/W/!X586G&FOLK?N]V]WNVW;H==6YVA0 4 % !0
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MGH^OW[=#]2P.;T<9I%VE_++277Y/17T;LM['KM=Q[(4 % !0 4 % !0 4 %
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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M# '#*K9 ^!K4G2DXO='XGBL-+"S=.6\7TU6UT_FG?\SF*Q.0* "@ H * "@
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MU=RO2)"@ H * "@ H * "@ H * "@#8T#0+KQ1=165E$TUQ,VV.->I/4\G@
M#)9B0JJ"Q( )K2G3=1V6K9M1HRKR4(*[;T2_K[WTW9^U/@+P?#X!TRVTR [D
MMXPI;D;W)+2/@LQ&YRS;<D+G:. *_0:%)48J*Z+_ (?\3]SP>%6%IQIK[*W[
MO=O=[MMVZ'75N=H4 % !0 4 % !0 4 % !0 4 % 'P1^W!_S"?\ M\_]H5\S
MG7V?^WO_ &T_/.+?^7?_ '$_]L/@>OF3\\"@ H * "@ H * "@ H * "@ H
M_;'X4_\ (OZ5_P!>%I_Z)2OT+"_PX_X8_DC]UR[^!3_Z]P_])1WU=1Z(4 %
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MO_\ P+F_^+H^M5/YI?\ @3_S#^T:_P#S\G_X'+_,/^%K>(/^@K?_ /@7-_\
M%T?6JG\TO_ G_F']HU_^?D__  .7^8?\+6\0?]!6_P#_  +F_P#BZ/K53^:7
M_@3_ ,P_M&O_ ,_)_P#@<O\ ,X&N4\X* "@ H * "@ H * "@ H * "@ H *
M "@#ZC_9]_9]D^),BZAJ"M'I<;<#E6N64X*(>HC!XDD'.<QH=^YHO9P& ]O[
MTOA_/_@=W\EY?69+DKQCYYZ4T_1R?9>7=_):W:_4ROLS]:"@ H * "@ H *
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M/B#+/K4.>"O."V25VKZKOINOFDKL_+*OC#\E"@ H * "@ H * "@ H * "@
MH _3W]E#XI-XPTUM+NF7[58*BQ\*I>V "IP#EC&1L=@H 4Q9+.S$_8Y7B?:1
MY7O&UO3_ ('^1^K<.9C]8I^SE\5-*VRO#9==;;-V[;MGUE7MGV 4 % !0 4
M% !0 4 % !0!0U72X=;MY;6X7?#/&\<BY(W(ZE6&001D$C((([$&IE%333V:
ML_F9U*:J1<9:J2::\FK/8_)/XW?!&Z^$=UN7=-ITS$03D<@]?*EQP) ,X/"R
M*"R@$.B?#XW!/#OO%[/]'Y_G^7X[FV4RP$N\&_=E^C\_SW75+PNO-/GPH *
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MY%_2O^O"T_\ 1*5^A87^''_#'\D?NN7?P*?_ %[A_P"DH[ZNH]$* "@ H *
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MHB@*JJHP%4#@ #@ < <5]<E;1'ZE&*BK+1)626BL6*904 % !0 4 % !0 4
M% !0 4 % !0 4 % !0!R/CCP/8_$2QDL+^/?$_*L.'C<9VR1M@[7&3@\@@E6
M#(S*<*U&-:/++;^M3BQ>$ABX.$U=/[T^Z\_^&>A^-OCCP/??#N^DL+^/9*G*
ML.4D0YVR1M@;D.#@\$$%6"NK*/@:U&5&7++?^M3\3Q>$GA)N$U9K[FNZ\O\
MAGJ<A6!Q!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'Y#GF5?4IWBGR2V\GK[M_P 5?==[-GSG7E'S(4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!^B_[.7[.7]@>7
MK6M1_P"E</;6SC_4]Q)(#_RU[HA_U7WC^]P(OJ\OR_D]^>_1=O-^?Y>NWZ7D
M61>RM5JKWMXQ?3S?GV73UV^V*^A/NPH * "@ H * "@ H * "@ H * "@ H
M^"/VX/\ F$_]OG_M"OF<Z^S_ -O?^VGYYQ;_ ,N_^XG_ +8? ]?,GYX% !0
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M ->%W_Z)>N7%?PY?X9?DSSLQ_@5/^O<__26?B;7YZ?A04 % !0 4 % !0 4
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M5G:_39^:NG\O0YBL3D"@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MMT??^NJ/Q3,<NG@9\LM4_AET:_S[KIZ6;\QKC/*"@ H * "@ H * "@ H *
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M,OR9YV8_P*G_ %[G_P"DL_$VOST_"@H * "@ H * "@ H * "@ H * "@ H
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M0PPP&&4@J>#C<J,O)B,-'$*TODUN>9C\NIXZ/+/H]&M&O31[]5^J1^8?Q4^
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M^AAHT%:*]7U?]?<?J>"P%/!1Y::M>UWNW96U?Z*RU=DKG?5U'HA0 4 % !0
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MO%27S79_U^!^XX#&QQM-5(Z7W5T[-;K3[UMHT[*YWU=1Z(4 % !0 4 % !0
M4 % !0 4 <CXX\#V/Q$L9+"_CWQ/RK#AXW&=LD;8.UQDX/(()5@R,RG"M1C6
MCRRV_K4XL7A(8N#A-73^]/NO/_AGH?E'\6O@CJ7PCD4W&V:TE9EBN(P=I()P
MK@_<D*C=MRRD9VN^Q]OQ6*P4L/OJGLU_6C/R',LIJ8!^]K%MVDMO1]G;6WW-
MV9XU7GGB!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MP/URLHOX5[TO\*^:>KLM-5>_0_8JTM(["-(846..-0J(H"JJJ,!5 X  X '
M'%?>I6T1^UQBHJRT25DEHK%BF4% !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M 4-5TN'6[>6UN%WPSQO'(N2-R.I5AD$$9!(R"".Q!J914TT]FK/YF=2FJD7&
M6JDFFO)JSV/Q&\:>&)/!FI76G2[BUM,\89D*%U!^1]I)P'7#KR058$$C!/YW
M6I^RDXOHVNWS/PC%X=X>I*#^S)K56NNCMYK5',5B<@4 % !0 4 % !0 4 %
M!0 4 ?9/[''CAM+U.;2)),0W<9DB0[S^_B&3MP=J[H]Y<D#=Y<8W9 5O?RBM
MRR<'M)76^Z_X'Y(^WX7Q?)4=)O2:NEK\2_!75[][+4_2:OK3]/"@ H * "@
MH * "@ H * "@ H KW=I'?QO#,BR1R*5=& 965A@JP/!!'!!X(XI-7T9,HJ2
ML]4U9IZJQ\(?%O\ 9$^]=^&_]@&Q=OP9HYI'_P!UBDA_OD2?<CKYK%Y3UI^7
MN_\ !;_/[^A^?9GPS]JAY>XW][4I/\'YZ[(^%]4TJXT29K>ZBD@F3&Z.1&1U
MR 1E6 (R"",CD$'H:^<E%P=FK/L]#X"I3E3?+)--=&FGWV9GU!F% !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '3^$?!M_X[NA9Z; T\
MY5FV@@ *O5F9B%4=!EB 6*J/F8 [4J,JKM%79UX;"SQ4N2FKNU^FR\W9+Y^A
M^A_PD_92L?"6VZUGR[V[&\>5C?:J#P#M= 9'QDY<!06X3<BR'ZK"97&GK/WG
MKIO'\5K_ %IU/TG+.'(4/>JVG+73>'W-:OUTUVNDSZYKW#[(* "@ H * "@
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M?^B4K]"PO\./^&/Y(_=<N_@4_P#KW#_TE'?5U'HA0 4 % !0 4 % !0 4 %
M!0!^"%?F9_/(4 % !0 4 % !0 4 % !0 4 % '[8_"G_ )%_2O\ KPM/_1*5
M^A87^''_  Q_)'[KEW\"G_U[A_Z2CT!:ZCT1U !0!Y]\5O\ D7]5_P"O"[_]
M$O7+BOX<O\,OR9YV8_P*G_7N?_I+/Q-K\]/PH* "@ H * "@ H * "@ H *
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MVOV5EOH>FUV'JA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M5?\  _(_,N*<'R355?;5I:.UTE;7S733X6^Y\75\^?#!0 4 % !0 4 % !0
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MP_\ 24=]74>B% !0 4 % !0 4 % !0 4 ?!'[<'_ #"?^WS_ -H5\SG7V?\
MM[_VT_/.+?\ EW_W$_\ ;#X'KYD_/ H * "@ H * "@ H * "@ H * /VQ^%
M/_(OZ5_UX6G_ *)2OT+"_P ./^&/Y(_=<N_@4_\ KW#_ -)1WU=1Z(4 % !0
M 4 % !0 4 % !0 4 ?@A7YF?SR% !0 4 % !0 4 % !0 4 % !0!^V/PI_Y%
M_2O^O"T_]$I7Z%A?X<?\,?R1^ZY=_ I_]>X?^DH] 6NH]$=0 4 >??%;_D7]
M5_Z\+O\ ]$O7+BOX<O\ #+\F>=F/\"I_U[G_ .DL_$VOST_"@H * "@ H *
M"@ H * "@ H * -_0_"FH>)]_P!@M;BY\O&_R8GDV[L[=VP'&<'&>N#Z5K"E
M*I\*;MV3?Y'31PTZU^2,I6WY8M[^B?8W_P#A5/B#_H%7_P#X"3?_ !%:_5:G
M\LO_  %_Y'1_9U?_ )]S_P# )?Y!_P *I\0?] J__P# 2;_XBCZK4_EE_P"
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M_P"&8?%W_0/_ /)BV_\ CM5_9M7^7\8_YFO^K^)_D_\ )X?_ "0?\,P^+O\
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MG;'&BHBY))PJ@ 9)).!R23U->G&*@K)679:'T5.G&FN6*22Z))+OLB_5&@4
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M(8UC4L0 6(0 9P ,]< #M7K0IJ&D4EZ*WY'U%*A&BK02BKWM%)*_R->M#8*
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M_P#_  $F_P#B*/JM3^67_@+_ ,@_LZO_ ,^Y_P#@$O\ (/\ A5/B#_H%7_\
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M7_\ X"3?_$4?5:G\LO\ P%_Y!_9U?_GW/_P"7^0?\*I\0?\ 0*O_ /P$F_\
MB*/JM3^67_@+_P @_LZO_P ^Y_\ @$O\@_X53X@_Z!5__P" DW_Q%'U6I_++
M_P !?^0?V=7_ .?<_P#P"7^0?\*I\0?] J__ / 2;_XBCZK4_EE_X"_\@_LZ
MO_S[G_X!+_(/^%4^(/\ H%7_ /X"3?\ Q%'U6I_++_P%_P"0?V=7_P"?<_\
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MZMSM"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M!_PQAX?_ .?F_P#^_D/_ ,8H_L>GWE]Z_P#D0_U5H?S3^^/_ ,@'_#&'A_\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M'_\ GYO_ /OY#_\ &*/['I]Y?>O_ )$/]5:'\T_OC_\ (!_PQAX?_P"?F_\
M^_D/_P 8H_L>GWE]Z_\ D0_U5H?S3^^/_P @'_#&'A__ )^;_P#[^0__ !BC
M^QZ?>7WK_P"1#_56A_-/[X__ "!Z;I?[.?A72)EGCTZ-G7.!(\LJ<@CF.5W1
MNO&Y3@X(P0".N.7THN_+][;_  ;:/5IY'AJ;NH+3NY27W2;7X'JNB^'[/PW&
M8;&WAMHRQ8I#&L:EB "Q" #. !GK@ =J[84U#2*2]%;\CUZ5"-%6@E%7O:*2
M5_D:]:&P4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M 'D7Q4^"^G_%[[/]ODN(_LWF;/)9%SYFS=NWH^?N#&,=^O;AQ6#CB;<U]+[6
MZV[I]CQLQRJ&/Y>=R7+>W*TM[=T^QY'_ ,,8>'_^?F__ ._D/_QBN'^QZ?>7
MWK_Y$\;_ %5H?S3^^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_
M %5H?S3^^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^
M^/\ \@'_  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_
M  QAX?\ ^?F__P"_D/\ \8H_L>GWE]Z_^1#_ %5H?S3^^/\ \@'_  QAX?\
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M=]74>B% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 .6
M@!U !0 F* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
M #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #%
M !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B
M@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q
M0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8
MH ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,
M4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &
M* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #
M% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !
MB@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@
MQ0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0
M8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H
M,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4
M&* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &* #% !B@ Q0 8H ,4 &*
*#% !C% "T ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>dxcm-20241231_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20241231_g2.jpg
M_]C_X  02D9)1@ !  $ > !X  #__@ ?3$5!1"!496-H;F]L;V=I97,@26YC
M+B!6,2XP,0#_VP"$  4%!0@%" P'!PP,"0D)# T,# P,#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T!!0@("@<*# <'# T,
M"@P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#?_$ :(   $% 0$! 0$!           ! @,$!08'" D*"P$  P$!
M 0$! 0$! 0        $" P0%!@<("0H+$  " 0,# @0#!04$!    7T! @,
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M P$  A$#$0 _ /LN@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@#(UO7;+P[;&\U"011 X'!+,Q!(5%&2S'!X'09)( )
M!YY;?&?09Y1$RW4*DX\R2)-@YQD[)7?'?[F<=J .PUSQC9: ;03"28:BX2%H
M0C+SLPS%I$^4^8I!7=D9XZ9 .JH * "@ H * "@ H * .?\ $/B6U\-1127(
MDD:XE6&**%5:1W;H%#,@P.Y+#J!R2 0#H* "@ H * ,2;7[>'5(M%*R-<30M
M< J%\M8U)7+DL&!9@0N%89ZD4 2Z[K,/A^QEU&Y5WB@ +",*7.YE0;0S*O5A
MU8<9^E '/R^/;"%=-9H[C&ML%M\+'\A+1)^^_>_*,RK]SS. WH 0#8T[Q%;:
MC?76F()([FQ*^8L@5=RN,K)'AFW1D$<D*1E<@9% &]0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M'&0KKMY'*@4 >A4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M<^A0'H] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 1SP1W$;
M0S*LD;J596 *LI&""#P01P0: .5T_P !Z'I<Z75M:JLL1)CW22R+&3WCCDD>
M.,YY!15(/3% '2WEI%?P26EPN^&>-XI%R1N1U*LN5(894D94@CJ"#0!7&D6@
MLETLQ*UFD2P")\NOE(H15)8DG"@#));C.<\T 96C^#=(T&;[38VXCFV[ [22
MRLJ?W4,KOL7V3:.W2@#IJ "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * ,NTUS3[Z4V]K=6\\R_>CCFC=QCU56+#\10 M]K>GZ6P2]NK>V9O
MNK--'&3] [*3^% %]9HW3S593&1N#@@KMQG=NZ8QSG.,4 4;'6;#5"RV5S;W
M+1_>$,L<A7M\P1FQ^- &E0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 >$>)KVZ^(FLGPQIDIBTVS^:_G3G>RG!C!Z':WR*IX,@=R&6,4]
M@'7WP72R@>71+Z\CNT4M$'D4*S#D*6C2,KNZ!LX4G)!% '8?#;Q9-XFL'BO@
M5O[!_(N01@L1G:Y7^%FVLKC &]&( ! " ]%H * "@ H * "@ H * "@ H *
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M2F-<A(U!"KCWBDEVCJ0F.PH ]PMKB*\B2>!EDBE4.CJ<JRL,@@CJ"#D4@)J
M/$_A2@NM3UW4& +RWI16/4+YD[E0>P.4R/\ 97T%,#VRD 4 >*G]U\1A_P!-
M;#^2'_XBF![52 * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .0\<^)_^$2T
MF74% >8%8X5;H9'.!GN0JAG(&"0I&1G( .=^&GA2XTB*;6-482:CJI663@9C
M5B7"9_O,6W2!<*"%0 A 2 >@:OI5OK=I+87BAX9U*L#U&>C*>S*<,I'((!%
M'C?PMUN;01?>&];81/I(:=2QR%@',N#WC7*2H0.5E)Z "F!'<>*-9^(]T++P
MP9=.TZ(GS[]AM9O0+@@CU5$;S#D,YC4$4 >B>"/!B>"[:6 3O=R7,OFR2.H3
M)V@<+N<^I)+$DFD!VM !0!XKJO[CXC6!Z>=8O^B7G_Q I@>U4@"@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M !0 4 % !0 4 % 'B'Q%'_"0^(M(\-]82QNYQV9 6X/H1'#*!_OBF![?2 *
M/F3XVV4NF:E!J-J2AU"VDM90O\6S (/^^DBK_P  %,#W_P -:0-!TNUTX=;>
M%$8^KXS(?H7+'\:0&Y0 4 % 'B'Q/<:'K6C>(&XBAF,$[8/RH6#=LYS&\QQW
MV^],#VV.195#H0RL 592""",@@C@@CD$<$4@'4 % !0 4 % !0 4 % !0 4
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M?^$BO_\ GK_XY'_\17'_ &SCO^?W_E.E_P#(&WU##_R?^33_ /D@_P"$BO\
M_GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY
M'_\ $4?VSCO^?W_E.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']L
MX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\ $4?VSCO^?W_E
M.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4
M,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\ $4?VSCO^?W_E.E_\@'U##_R?^33_
M /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/
M^$BO_P#GK_XY'_\ $4?VSCO^?W_E.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_
M ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\
M$4?VSCO^?W_E.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G
M]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\ $4?VSCO^?W_E.E_\
M@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\
MR?\ DT__ )(/^$BO_P#GK_XY'_\ $4?VSCO^?W_E.E_\@'U##_R?^33_ /D@
M_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO
M_P#GK_XY'_\ $4?VSCO^?W_E.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1
M_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\ $4?V
MSCO^?W_E.E_\@'U##_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3
MI?\ R ?4,/\ R?\ DT__ )(/^$BO_P#GK_XY'_\ $4?VSCO^?W_E.E_\@'U#
M#_R?^33_ /D@_P"$BO\ _GK_ ..1_P#Q%']LX[_G]_Y3I?\ R ?4,/\ R?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 (S!06/  R3Z
M4 >*_!L&^&JZR1_Q_7S8)ZX7=+_[7_,8[4P/:Z0!0 4 % !0 4 % !0!A>)/
M#MIXHL7T^]7*/RK#[T<@!VR(>S+D^S E6!5B" 8/@CP#:>"$E^SR/<2W.S?)
M(%& F[:J*H^498ELL<\?W10!QFKM_P (]X^M+Q_EAU:W^SEO60#RU7W^9+<?
M\"'I3 ]NI % !0 4 % 'D6I?\?<__7:3_P!#-?B.._WK$?\ 7ZK_ .ER/O\
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MD/FLT_Y=?]O_ /MAVM??GS84 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %  3CD\ 4 9
M-MK^FWDWV:WN[::<=8XYXGD&.OR*Q;CZ4 27VLV&ELJ7MS;VS/\ =$TT<9;M
M\H=E)YXXH OB5"GFAALQNW9&W;C.[/3&.<],<T 4+'6;#5"RV5S;W+1_>$,L
M<A7M\P1FQ^- &E0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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MVLGF?(F\_-B)F? .Z,L,  SX$:3PA8:>DP:/4=2AM950M^YBFN&9K8E@'!C
M"L"!U(&4P2 =?XKTVT\/WNCZAI\4=K(=0AL6\E%0/#<HZE'"[0P4H"N0=I)*
MX/4 ]3I % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 >)?%H?VI>Z-H?5+N[W2#_
M &0T<>?^^9)/RI@>V*HC 50%50  .  .  .P%(!: "@ H * "@ H * "@ H
M* *&JV(U.SGLB=@N8982W7 D1DSCVSF@#Y\MKWQ=\+]/6.XM[6;2[24@N&#,
M1+(3\I$BN 78[2T606&X$4P/HFSNDOH([F+F.>-)$_W74,OZ$4@+- !0 4 >
M1:E_Q]S_ /7:3_T,U^(X[_>L1_U^J_\ I<C[_#_P:?\ @A_Z2BE7 =1CQ^'M
M,AN?M\=G:I=EF<SK!$)MSY#-Y@3?N8$ACNR<G/4UU/$5G#V+JU'3LER.<N6R
MV7+>UE965M+&*I4U+G4(J6_-RJ]WOK:Y:O\ 3+358Q#?00W408,$FC25 P!
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M_P Q'_<+_P!R'S6:?\NO^W__ &P[6OOSYL* "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#&\0S7]OI\SZ1$+B^"@0QLR*"S,%W$NR+A%)?!8;MNWJ0* /,_"\.M^'E9
MVT26XO;DAKJ\DU"S,DK'KW.V-3]R)3A1CDGDL#9MK+6/"E[?&QLQJEIJ-R]V
MK+/%!)%+( 'CD\X_-'E1L*%MH_AR<! 9Z^![]]$FC=HX]4FU%M610288[C>K
M+$&Z[=J[=PX#-GD#)8&B;/6?%%]8R:G:#3;339?M3C[1',T]PJE8P@B)"HA9
MF)?YB#@ <Y0'I= !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MI:6ZZO,.L* "@ H [7P?_P M_P#MG_[4K[[AS_F(_P"X7_N0^:S3_EU_V_\
M^V':U]^?-A0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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M',C%)"A8!U"ISP#C+  TIM>U;5K^YLM!2T6+3V$4T]WYK*\Y4,8HDB*D>6"
M[L3@GA2,$@#)O&=S8:'_ &G>V<D-]YOV9;5MR"2<OY:>6S $Q/\ ?#X^Z" 6
MP"0!(M?UG2+ZUM->2S,.HL8HI;3SAY4X7<L<@E9MP<9"NNWD<J!0!Z%0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
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MX3?]^W_PH^HXK_H'K?\ @J?_ ,B'UBC_ ,_(?^!Q_P P_LR[_P">$W_?M_\
M"CZCBO\ H'K?^"I__(A]8H_\_(?^!Q_S#^S+O_GA-_W[?_"CZCBO^@>M_P""
MI_\ R(?6*/\ S\A_X''_ ##^S+O_ )X3?]^W_P */J.*_P"@>M_X*G_\B'UB
MC_S\A_X''_,/[,N_^>$W_?M_\*/J.*_Z!ZW_ (*G_P#(A]8H_P#/R'_@<?\
M,/[,N_\ GA-_W[?_  H^HXK_ *!ZW_@J?_R(?6*/_/R'_@<?\P_LR[_YX3?]
M^W_PH^HXK_H'K?\ @J?_ ,B'UBC_ ,_(?^!Q_P P_LR[_P">$W_?M_\ "CZC
MBO\ H'K?^"I__(A]8H_\_(?^!Q_S#^S+O_GA-_W[?_"CZCBO^@>M_P""I_\
MR(?6*/\ S\A_X''_ ##^S+O_ )X3?]^W_P */J.*_P"@>M_X*G_\B'UBC_S\
MA_X''_,/[,N_^>$W_?M_\*/J.*_Z!ZW_ (*G_P#(A]8H_P#/R'_@<?\ ,/[,
MN_\ GA-_W[?_  H^HXK_ *!ZW_@J?_R(?6*/_/R'_@<?\P_LR[_YX3?]^W_P
MH^HXK_H'K?\ @J?_ ,B'UBC_ ,_(?^!Q_P P_LR[_P">$W_?M_\ "CZCBO\
MH'K?^"I__(A]8H_\_(?^!Q_S#^S+O_GA-_W[?_"CZCBO^@>M_P""I_\ R(?6
M*/\ S\A_X''_ ##^S+O_ )X3?]^W_P */J.*_P"@>M_X*G_\B'UBC_S\A_X'
M'_,/[,N_^>$W_?M_\*/J.*_Z!ZW_ (*G_P#(A]8H_P#/R'_@<?\ ,/[,N_\
MGA-_W[?_  H^HXK_ *!ZW_@J?_R(?6*/_/R'_@<?\P_LR[_YX3?]^W_PH^HX
MK_H'K?\ @J?_ ,B'UBC_ ,_(?^!Q_P P_LR[_P">$W_?M_\ "CZCBO\ H'K?
M^"I__(A]8H_\_(?^!Q_S#^S+O_GA-_W[?_"CZCBO^@>M_P""I_\ R(?6*/\
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MMC+'.I'W@-WEO@^@5]Y_W >H% '=^&]4&M:9:WX.3<01NWLY4;Q_P%PP/N*
M-J@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@#.U?4H]'LI[^;[EM$\I'3.Q2=H]V(P/<B@#RWX/Z;-):W
M/B&].ZYU>9GR0!\B,_( Z!I"_  &U4QQBF!['2 * "@ H * "@ H * "@ H
M* "@ H * "@#F_%%S$ME):2J'^UH\14_W&4JQ/T!X]\>E?*YWFJRFBO9I2KU
M+JFGLK;SDNRNDEU;71,]+!X7ZU/WM(1^)]^R7K^1YWIC/HT"6EBSPP19V1J[
M%1DECP2>K$DYZDD]:_&Y9QF$I^U>)JWO>RDU'_P!6A;RY;'UJPE!+E5.-O2[
M^_?\3T30-:;4 89\>:HR".-P[\#@$=\<$=!P:_4\@SJ69*6%Q=OK$%S*222J
M1V;LK)2BVKI633NDK,^:QV#6'M4I? W:V_*_7L_/[SI*^[/%"@ H * "@ H
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M5S=>-+[3HDLKNRM;"Y6^N'NX?)'F1*PBBB#<R'<S;F7Y0,-DG& #U2D 4 %
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MON_T70];KZT\L* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@#!O?$-O83-!(LA9,9*A2.0&&,N#T/I7SF
M)SC#X.K+#58U7*%KN*BUK%25KS3V:Z;GJ4L#4KP56#@D[VNW?1M=(OMW*O\
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M 4 >A>$O^/1_^NS?^@)7Z=P]_NL_^OTO_2*9\CF?\:/^!?\ I4CJ*^O/$"@
MH * "@ H * "@ H * "@ H S-9U:'0K*;4+G/E6Z%VVC+''  ''+$@#) R>2
M!0!Q;>.+ZP2&[U736L]/N7C3SQ<QRM%YI C::%44HIR-Q5G*]"-Q"D N3>+K
MVYN[FST;3S?BP<1SR/<QVR^;C<8X]R.78#J3L4'J0,$@#T\>61T9];=)$$3F
M![<@&87 <)Y '0L6(P0<;3N.,$  2R\6W:7L%AK-B=.-Z&%M(+A+A&=!N,3E
M43RY-O*CY@QX5B: .YH * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * /!=%M?MGQ'OYST
MM8-V?<PV\('Y.WY&F![U2 * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@#QGXX0'^Q8+I.)+:\C8-W *2#_T+8?PI@>PV\PN(DE7I(JL/HP!_K2 EH *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
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M![9" ]%H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MH/(H \R^"^H--HKZ?*"LVG7$D3*>H5SY@]OOF1<9.-ON*8'KU( H * "@ H
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M ^VP'^[P_P"WO_2Y&+7@'IA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 >A>$O^/1_^NS?^@)7Z=P]_NL_^OTO_ $BF?(YG_&C_ (%_Z5(ZBOKSQ H
M* "@ H * "@ H * "@ H * ,;Q#J4VD:?->6L$EY/$H\N")6=W=F"J-J L5!
M;<^ 2$#'M0!Y/X8U3[!,=3U33]9N]6N0%DG.GR".%2<^3;@M^[B7.-V S]6Q
MG:&!O6UU=^#-1U".6SO+VTO[@WMO):0F;$DB*LL4@7_5G<HVLQ"D<Y% &5_P
MBFI_V ;@1@:JVI_VSY&5!\WS0_D[AA=_ECZ;_E[4 :EU<W7C2^TZ)+*[LK6P
MN5OKA[N'R1YD2L(HH@W,AW,VYE^4##9)Q@ ]4I % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 >*>)O]+\?:1;'E8K9Y?H0+EO_ &DOZ4P/:Z0!0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0!#<V\=W$]O,H>*5&1U/1E8%6!]B"10!X?X-NI
M_ &M/X2OR6LKMC+I\Q'=NB9Z?/C:P_AF7(&),TP/=J0!0 4 % !0 4 % !0
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M "8?7L1_/_Y+#_Y$/^$=L/\ GE_X_)_\71_8V!_Y\_\ E2K_ /)A]>Q'\_\
MY+#_ .1#_A';#_GE_P"/R?\ Q=']C8'_ )\_^5*O_P F'U[$?S_^2P_^1#_A
M';#_ )Y?^/R?_%T?V-@?^?/_ )4J_P#R8?7L1_/_ .2P_P#D0_X1VP_YY?\
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M']C8'_GS_P"5*O\ \F'U[$?S_P#DL/\ Y$T+2RAL$,<"[%)W$9)Y( SEB3T
MKT\/AJ6#@Z6&CRQ<N9J\I:M)7O)M[)>1R5:LZ[YZKNTK;)::OHEW9:KL, H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M /%+K][\1K?_ *96!_5)O_BZ8'M=( H * "@ H * "@ H * "@ H * "@ H
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M1[&D!MRSQP &1E0$X&XA<GT&<<T .1U<;E(8>H.1^E #J "@ H * "@ H *
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M- 'D7P1U+SM)GTYV#/87+  =HY?F4CV:19B*8'M%( H * "@ H * "@ H *
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M: .QH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H \4^''^F^)-?OCR4N!"I_V1+,/Y1)3
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MD 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!%<3I:Q/-(<)$K.Q]%4$D_D*
M/'?@I"TFFW>I2##WMX[?4*JG.?\ ?=Q^%,#V>D 4 % !0 4 % !0 4 % !0
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MR"#R""."".AI +0 4 % 'B/B<_\ "0>-],TQ?FBTQ#=2^BO_ *T9'OY=N/\
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M/H0#IO!^C?\ "/Z/::>1AXHE,G_75_GD_P#'V;\,4 =+0 4 % !0 4 % !0
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MGQ)\5R7<@:72-& 2($_NY)@W!QC#!V#.?6-(P_RL%I[ >^4@"@ H \3\;?\
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M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0!XAXP_XJ;QAINACYH+ ?:YQVS_K-K>Q6.-1_P!=3[FF![?2
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * (IX([J-X
M)E#QRJR.IY#*P(92/0@D'VH XK1?AMH&A2--;VJO(QX:<F;8/1!)N"_[P&_L
M6QQ0!TDN@:;-_K+2V?\ WH(C_-: . ^(G@>QO=%G>P@@M+BT!ND:&)(V;RE8
MLA**I(9-V!G&\*>U '3^ ]=?Q'HEK?S8,SJR2X_OQNT9/L6VA\?[5 %?XCWG
MV'PY?R XW0&+_O\ ,L6/Q#T +\.;/[!X<L(L8W0"7_O\3+G_ ,?H [6@ H *
M /%OBKITNF367BVQ4F;39$6<#/S0%LKN]%!9XV/7$WHO# ]8TG5;?6[2*_LV
M\R&=0RGN/56'9E.58=0P(I :- 'GWQ.\1MX;T.62$XN+D_9X><$-(#N<=\H@
M8@]FVYH O> /#9\+:-#9/S,V9IO:63!*_P#  %3)Z[<\9P #LZ "@ H * "@
M H * "@ H * "@ H \O^(7@VYU<PZSHI$6K6!#(1A3,BG(C).!N4YV[OE8,R
M-PP( #PM\3K/5 UIK)32M1@;9+%.WEHS#J4:3&#D<QL=RG !<'- 'I<$\=U&
MLT#K+&XRKHP96!Z%64D$>X.* ): .+^(FKOHF@7EU$=LIC$2$=0TS+%D>ZAR
MP_W: *_PTT1=#T"UC  DN$%S*>Y:8!AG@<K'L3VV]3U(!WE !0 4 >-?&FW:
M+3K358>)M/NT93C( ?G)]/WD<?7CMU(I@>L:9?)JEI#>Q9$=S%',H/4+(@<
M^^#S2 NT % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!XEX /\ ;?BC6=<',2,+
M6-C_ ! ,J\?\ MT/T84P/;:0!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 R2-95,;@,K@JP/0@C!!]B* /$?AE<-X9U._\
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M* .%^#VKG4-"6TE/[_3Y'MW4_>"YWQY'8 ,8Q_US([&@#U6@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H P(O$ME/JK:'$Q
MDNHH#<2;<%(U#HFQFW9$A,BL%VG"\L0< @%C7=<M?#EE)J-ZQ6&$9(7!9B3A
M40$@%V.  2!W) !( ('\264&E)KD[&&T>".X!<?.%E5612JELN=RKM4M\QP"
M1S0!FZ7XTMM1NDL)K>\L)YT9X%O(1$)@@RPC*NX+*OS%&VL!SB@#L* "@ H
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MZ*2 >X4@"@ H * "@#DO%_@VR\8VRP7>Z.2(EH9DP'C)QG&>"K8&Y3UP""&
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MG@\&D!8H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MY77HD[Z^KCZ_(\ KXH^2"@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H QK[Y[J!.P.[]<_P#LM?1X/W,'
MBJBW:4?P:_\ ;CW<+[F%Q$UU7+^#7_MQLU\X>$% !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MOELY@W"E5Z1E*-O\237_ *0_O1\YFL&X4ZG12<?_  ))K_TEG@]?&'R@4 %
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MI]I*5_\ $K?AR_B>O5]0?1!0 4 % $4\I@C>0*SE%9MJC+-M!.U1W8XP!W-
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M%T_Y+B>/IEMP'MD_XBOH\=[^%PM5;*/*WY\L?_D6>[C/>P^&J+I'E;\[1_\
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M_P# DFO_ $E_@>#U\:?*!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M< Y)QS7"TZ"A6HQ4;MQ:6BVNFETV=[?\/CF.&A1Y:M)*-VTTMMKII=.M[?\
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M<=0I/#PG1Y==^9M)[I7C:W7;JSZ.GA\71I^QA*ERZ[\S:ONE[MK?+JR#X/\
M_'K=_P#76/\ ]!-1DWP5/\4?R9&5?!4_Q+\CGOA5IMKJ,UT+N&*X")$5$L:2
M!26?.-X.,X&<5PY32IU95%5A&5E&W-%2MJ]KIG'EE.%2515(QE91MS).VK[G
M)Q6T1\2+;E$\G^TA'Y>T;-GVG;LV8V[=OR[<8QQC%>8HQ^N*%ER^WMRV5K>T
MM:VUK:6VL<"BOK2A9<OMK6MI;GM:VUK:6.W^(VA6XOK"ST^&&V:Z+1_NXUC!
M9GC52VQ1G&[KV&:]?,L/!5:-*A&,'.Z]V*BKMQ2O9=+GIYA1C[2E3HQC%SNM
M$EJVDKV72YK:TN@^ HX+5K%+Z64$LTH1FVJ0&<LZO@D_=155>#RO?JK_ %7+
M5"FZ*J2EJW))NRT;NT]7T227H=%;ZOEZA3=)5)/=RLW9;N[3^222]#EO&MGH
M5U%!=:(\2W$Q0&VB[AUROR+E8Y%.%93MZD'YA@^;CH86<85,(XJ<FKPCU36F
MBTC)/1K3[S@QD,/)1J85Q4W;W(]4UIHM(M;-:?>=-=Z7HOP_L(GOK=-0O)\@
M"0*P9E +8#AE2-"0,A&8Y&<]O1G2PV5THNM356K+O9W:WM>Z45=*]F]5N=TJ
M6'R^G%U8*I4EWL[M;[W22O:]F]AMKI6C>/["22PMTT^]@XVQ[54,PRNX( KQ
MN00&**XVMC'(*A1PV9TI2HP5*K'HK))M:7LDG%VM>R>C^9&E0S"G*5*"IU(]
M%9)-K2]K)IVWLGHRMX#\,V+:=-J-S;B^NHWD3R#AMIC _=[&.SS&/.YAP" O
M?=GE^%I>QE7J0]K43DN1V=N7[-GI=[W?1JWGG@L/3]E*M.'M)IR7+O:W2STN
M^[Z;>8^K>'[F&2'6M+_LF3&$VP%7;W1TAB(93C(8;3D9)&10ZV$G&4,7A_8/
MI:%F_1J,6FO-6]=@=7#2BXXFA[%]+1LWZ-1C9KST.:\ ^%+?Q#>2R7&Y[.UQ
MP?E,A8ML#8)P-JEG"MD':,X.:\_+\)#%5)2G=TX=-N9N]KVVT5VD^R.+ X6.
M(G)SNZ</ES-WM?Y*[L^QZ#;IIU_>'39-">"V8LBW1MM@R,_,S"-616Q\KB4G
M)&0.H]R*HU:CP\L&XPU2J>SMMU;44TGT?,WL>O%4JE3V,L*XPU2GR6VZM\J:
M3Z/F['D/C'0!X;U)[2,DPLJRQ$G+;&R,-P.5967/< 'J<#Y?&X?ZI6=*/PM*
M4>]GT?HTU^)\]BZ'U:JZ:^%I./>S[^C30WP7_P AJS_Z[+_6E@?]YI?XT+!_
M[Q3_ ,2/;_%W@'_A*;M+S[3]GV0K%M\GS,[7=]V?-3'W\8QVSGG ^OQF7_7*
MBJ^TY+14;<O-LV[WYEW['U&*P/UJ:J<_+:*C;EOLV[WYEW(]'TO3OAO!++=W
M>]YPI(8!"PCW8$<09F8Y<Y.3V^Z,YFC2HY3&4JM2[E;>R;Y;V48W;>_=_(FE
M2I9;&4JE2[E;?2_+?X8W;>_G\CQW1;S2KK5I;W6PRP2/)*L:@LN]WW!9-OS%
M5!/ 7YB!N^7(;Y:A.A.O*KB[J#<I))-J[=[2MK9>2UZZ:/YRC.C*M*KBKJ+;
MDDE=7;O9VULO37KIH_4]!O=&\17;V<&DQ+:@-Y=UY";7V^O[I3&6YV_.6]0I
MX'T>'GA\54=*&&BJ>MJG(K.W?W5RWZ:M^C/>H3H8F;IQP\5#6T^56=O^W5:_
M36_H<C!X=M=-\7QZ<(UDM&)98Y0)!M:W9]K!@<A7R%W9. I))YKS(X:%+,(T
M.5.GNHR]Y6<&[.^]GM?LNIYRH0I8U4;)PW2>JLX-V=^SVOV1TGBB[T#PI>A&
MTZ*YFG5'9=L:Q1QC*C8A1DWDJQ("@L?O.!M [\7/"8*HDZ$9RDDVK148QVT5
MFKNS>VO5[';B9X;"5+.C&4I)-JR48K;16:OHWMKU>QG?$;PY80V$.K:?$L!9
MT#+& B&.1693L&%# @#Y0"0QW9P,89EAJ4:4<30BHW:32T3C)-IVVNG;;OKL
M8X_#TXTXXBC%1NU=+1---K3:]^W?4N6FBZ3X,T5-2U2W6\N9PGR2*K_/(NY8
ME#!D4(H)=\$G#')^51K"A0R_#+$8B"J5)6TDD]9*ZBD[I65[O?1^2-8T:."H
M*M7@ISE;1I/5JZBKW2LKW?D_)&SX0M]!\2)+>PV,,4@*I+"Z)(B$ E6C!7:
MP)!*JFXKRO )ZL%'"XM2K1HQC+12BTI)6V<;JROY)7MJCHPD<-B5*K&E%/12
MBTFEV:TLK^25[:HX[P1X0MM6N+J^O$WV]M,\<<(SAG4[CD#&552NU!PQ.",#
M!\O 8.%>=2M55X0FTHK9M:ZI=$K676_W^=@\+"K*=6HKPC)I1[M:ZKLE:RZ_
MGU6G6^G>()GL;G0Y+")E/ESFW\K.!_$ZQH8V_N_.X8\$\X/HTHT<3)T:F#E2
MBU[LW#EV[M17*^VKOL=].-+$2=*>%=-6TER<NW=J*Y7VU=SQ3Q'HYT'4)K D
ML(F&QCU*, R$\ 9VL V.-P.*^2Q-'ZM5G1W47H^Z:NOG9Z^9\SB*7U>K*EO9
MZ/NGJOP>OF8E<ARA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 4;^T^
MUQ[5P&4Y4G]>GK7J8'%?4ZG/)-P:M)*WR>NEU^K/1PF(^JU.:5W%JTDOP>O;
M_,HFTO+@;)I%"=P.I_(#^?X5Z2Q6!PS]IAJ,G46SD]$_G)V^2^9WK$82@^?#
MTI.:V<ME]\G^"^8FDQA)9@OW5(4?0%O\*K,ZCG1PSG\4HN;]6HO3RU_ >83<
MJ5!R^*47)^K4=O+7\#=KY<^>"@ H * "@ H * "@ H * "@ H * "@ H * /
M?/A!>![*YM "&BF64MV(E0( /<>22?\ >%?:9-.].I2MK&:E?_$K?AR?B?69
M5.].=/JI*5_\2M_[;^)Z]7U!]$% !0 4 % &!%XELI]5;0XF,EU% ;B3;@I&
MH=$V,V[(D)D5@NTX7EB#@$ SM4\:6VG73V,-O>7\]NJO.MG")1"&&5\PLZ ,
MP^947<Q'.V@"]_PE>F_V5_;OFC[#LW[\'/7;LVXW>9O^39C.[B@"CI?C2VU&
MZ2PFM[RPGG1G@6\A$0F"#+",J[@LJ_,4;:P'.* .PH \9^,-S(D-G;@XBD>:
M1EP.6C$:H<XR,"5Q@$ [N02!CY3.I-1I03]UN3:\XJ*7GHI/[]>A\UFTFHTX
M+9N3:\TDE_Z4_O/"Z^./E@H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@!.E&^B#?1&);G[==&<?ZN(;5]S_DD
M^W%?35U]0PBPC?[VJ^:?DM-/P4?/WK'T%9?4\,L,_P")4?-+R6G^27G[QN5\
MR?/A0 4 % !0!Z[\(/\ C]N?^N*_^ABOI\F_B5/\"_,^ARK^)/\ PK\S*N+:
MVN_&#PWN/(>[(8,< G&44^S/M4COG'>N:483S!PK? ZCO?9Z:+YNR,)1A/'.
M-7X74=[[/LOF[(]<UJ/7+>:.UT*.U@LR@#2L%!B()!^3(&T+C:%C?D') Q7T
M]=8J,HT\'&G&E;63M[K]+[6M:T7YV/H*RQ$91IX6,(T[:R=O=^7:VUD_,YKX
MN'=IULR\J;C@CD<QN1STY'3UK@SC6C3:VY__ &UG'FFM*#6W/_[:QGQ1/_$E
MM!V\Z/\ ]$25.:_[M2_QQ_\ 2)$YE_N]/_%'_P!)D8WPDU:*WEN-/E8*\^R2
M+/&XH&#J/4X*L .<!CVXY,GK1C*="32<K./FU>Z];6:7DSFRNJHRG1D[.5G'
MSM>Z^ZS^\9IWPXO+#6$FEV)86\ZRK+O7+*KAHT"YWAR=JMN '7:S'&52RRI3
MQ"E*RHPFI*5UJD[Q5M[[)W^3>@J>7U*==2E94HR4E*ZU2=TK;WV3O\FSH/'F
MI)I&LZ7>2?ZN(R%^O"%D5C@ DE5)( ZD8KNS"JJ&)PU66T>:_HVDW\D[G9C:
MBHUZ%26RO?TND_N3-OQ0/$$YBN?#DZ/;N@W(!;G)R2)%>52&5E(! ;C;D Y-
M=>*^MRY:F FG!K5>Y_X$G):IKSZ:;G5B?K,N6>"DG%K5>Y_X$G);->?3S/./
M&1\2V5F(M8N89;>=E!1!"&)7#C@11O\ *5&2I(S@$X->#C?KE.GRXJI&4)-:
M+EO=:_RQ>C6MM#Q<7];IT^7$3BX2:T7+?37^5/2W0[B>PFU[PA!:V $LK06P
M W*HS&Z;QN8A05VMD$CD8Z\5[$J<L3E\*='63A325TOA:OJW;2S/4<)5\%&%
M+63C#2Z7PM7U>FEF?/5W;/9326THQ)"[1N <X9&*L,]^0>:^'G!TY2IRWBW%
M^J=F?(2BZ<G"6\6T_5.S/3?ACXFATB:2PO'$<-R0R.QPJR 8(8]@ZX&2< J!
MWKZ#*L5&A*5&J[1G9IO926FOJK:^7F>WEV)C1DZ51VC+5-[*2[^J_+S-[4_A
MC=)>&]T2Y6W#,74,SQM%N!R(Y(@Q(Y( PN%.TD]3VU<JFJGM<'44;MM7;BXW
MWY913T[;::79UU,NFI^UPLU&[NM7%QOV<;Z=MM-#MM+B/@^Q>36K]KG+;_,E
M9R1A0/+C#L[N>"0%&23PM>O27U"DY8NLYZWO)O33X8W;;]%]QZ=)?4Z;>)JN
M6M[R;TTV5VV_E]QR'P?_ ./6[_ZZQ_\ H)KR\F^"I_BC^3/.RKX*G^)?D87P
MBNXXKVXMW.'FB4H#W\MCN ]\-G'H">U<6334:DX-V<HIKSY7K^?YG+E4DJDX
M/=Q5OD]?S+T?@*_C\0G4)-B627?VH2EUY7S?-5-N=P;.%)("]2"> =EE]58O
MV\K*DJGM.:ZU7-S)6WOT=TEV-5@JBQ/MI65-5.?FNMN;F2MO?IV+_P 1;\:7
MJVEWC9VP,SM@9.T21[@/<KD#WK?,JGL:^'JO:+;?HG&_X&N/G[*M0J/:+;?I
M=7_ F\?>&KKQ5]EOM)V7"!"IPZKE6(974L0I')W<Y'& ><7F&%GC?9UL-::M
M;=+1ZIINRMO?6_D7CL//%\E7#VDK6W2T>J:OIWOU.1\0^$K3P;;VU[Y[/?!X
MF\D[2CLA#2%2 K+&I'#$-U4'DY'EXG!T\!"G5YVZMXODT:;5G*VB:BN[OT74
M\ZOA88*,*O.W5O%\NC3:U=MFDN^O1=3M/&&CGQW86U_I#K*T0<A"P7<) I9"
M3PLB,H&UBHY.3P*];&T/[2I4ZV%:DXWTNE=.UUV4DUL[=3T\72^OTX5<.TVK
MZ7M>]KKR::V=NHGA+2SX TZYO]798WFV'RPP8CRP^Q 1PTC,[#"EE  .>M+!
MTO[,HU*V*:3E;W4T_A3LO.3;>UUMKN+"TO[/I3JXAI.5M+I[)V7FVV]KHY3P
MCHNI:I'-JVF7ZVUR[NSP*"07)8J)0?D ;)*DHX /'.0/-P="M64\3AZRA-MM
MP2OK=M<R>EGT=G;[S@PM&K54L10JJ,VVW%=];<RVUZ.S/3M!?6;Q)8?$=O;)
M"%X8,C;_ %W(&D3;C)))0C@;#DD?0X=XB:E''TX*-M[IW]5>2M;KIZ'N4'7F
MI1QD(*-M[IW]5=JWGIZ''?#_ %6QM=4O].MV589IM]KSPP0N"JG/(VE3&.I4
M$\UY>75:4*]:A3:492O3\[-W2[Z6MULCS<#5IPK5:,&N64KP\[7NE\K6\D6Y
M[/QM]J>&&YB^S@L4F=;8*5S\H*B$R!R,9^3;G/S8YK24,R]HXPJ1Y-;2:IVM
MT32@Y7^5O,T<,?SN,9QY=;2:A:W33EO?Y6\SR3Q;+J3WYCU>5)[F%%CW1^7@
M+EF"_NU49!8DA@&&>>,5\SC'6=7EQ4E*<4E=<MDM6E[J7=[JY\_BG5=2V(DI
M3BDKJUK:NWNI=^JN+X+_ .0U9_\ 79?ZT8'_ 'FE_C08/_>*?^)'8_%2XEM-
M:@E@=HI%M(RK(2K#]]/T(P17JYM*4,3"4&TU35FG9KWI]4>CF<G"O&46TU35
MFG9_%,[;2;NU^(VCM;7@4740VN1C<DF/DG0=0'[@8!^=.5Z^O1G#-<.Z=6WM
M(Z/NI=)KR?\ FMCU*4H9E0<*EN=:/NGTDO7_ #6QRWPXT&"VU*\M]2C1KRSV
M"-7 8 $MOD16'/2,J^,A7!&-U>;EF'C"M5A7BG4IVY4]>KO))_\ ;MG;9^9P
M9?0C&K4A62]I"UD]>]VD_P#MVS[/S/1--EUY]0?^T%M[?3T++&$(+29XCP2S
M$8'WLB/)'"X->[2>*=5^W4(T5=1MO+^7JWZ_#KT/8IO$NJ_;*$:2NE;>7\O5
MOUV]#C+\$>.K<D8S&"/<?9Y1Q^((^HKRJFF9P]/_ &R1YL],PAZ?^V2.2^*O
M_(9'_7O'_-Z\S-O]Y_[<C^;//S/^/_VY'\V=WX]_Y%B'_MV_] KV<P_W*'_<
M/\CU<=_ND?\ MS\A^K6A\>^'8&T]E-Q$8W,>X#]XB%)(B3C:?F)4M@'"G(5L
MTZT/[2PD'0:YX\KM?[25I1\GK=7WTZ.XZL?K^%BZ+7,K.U^J5G'RWTOY=&7O
MAWX:F\.03"\VK<SF-FC5@Q2-0X3=@D9+&3D$@XX8X.-LMPLL)&?M;*I+E;BG
M>T5>U[::OFVT\S7 8>6&C+VEE.5FTG>R5[7MIO?;[S)^&^IQ$7VF;Q'<&YEF
M3.,D, A*@_>*% 2,=".HSCERRK']]A[VGSRDO1V6G>UM?4Y\OJ+][0O:7/*2
M^>FG>UAB6?CII'C-S"BI]V1EMMK_ .Z%A9P?]]$'O24,T<G'VD4EM)JG9^EH
M-_>D)0S%MKGBDMFU"S]+1;^](\>\17-[<7TG]I2+/<QD1NZ>7M^48P#&%3CH
M>,@@@\@U\MB95)59?6)*4UHVN6VG^%):?\.?.XB5251^V:E-:-JUM/\ #9:?
M\.8E<ARA0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0!C:5]^;_?
M_JU?1YG\&&7_ $Z_2)[N/^##K_IW^D39KYP\(* "@ H * "@ H 2@"!;N!FV
M+(A;T#*3^6<U;A-*[B[=[.Q?))*[B[>C+%00% !0 4 % !0 4 >^_""S5+*Y
MNP3NEF6(KV B0,".^29B#_NCWK[3)H)4ZE7JYJ-O\*NO_2W]Q];E4+4YU.KD
MHV_PJ_\ [=^!Z[7U!]"% !0 4 13PB>-XB60.K+N4X8;@1E3V89R#V/- 'EV
MC:%9^'O%:6EBGEI_8TCL22SR.;V+=)(YR7=L<D^P    8&GX#"FYUJ0_ZTZM
M.K>OEI'%Y8^@R^VD!YSM0V#P-@6G_"7^6 #E3;^<#C.2-N<^W /N6!Z)X_\
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M$W'SO))K_P!)=_D>$5\:?*!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0!%+,D W2,%'O_ $'4_A6U.E4KODI1<GY+
M;U>R^9K3I3JOEIQ<GY?J]E\S+&L(SJJHVQCMW'C].?YU[CRF<:<IRJ1YXQ<N
M1:Z+7>ZM]S5^I[#RV<82E*<>>,7+D6NWG=6^YJXV(_;+TR#E(1@'MGD?S)_*
MM*B^IX!49:5*TN9KJEH_R44UW;151?5<&J4M)U7S-=4M'^2BGYMFW7S)X 4
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M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M7VF30M3J5;ZRFHV_PJ__ +?^!]9E4+4YU.KDHV_PJ_\ [=^!Z]7U!]$% !0
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M>+?WMDRRN@VVG-+LFK+[XM_>V7)_ACH<L7E)%)"W'[U)7+\=>)"\?S=_W?\
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M89;0B[RYI>4I6_\ 25%_B1W'PIT:>0NC7,"G&(XY%*K@ <&2.1^<9.YSR3C
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M ($I?A8FM_ACH<$?EO%),W/[QY7#\].(S''QV^3ZYJXY5A8QY7&4G_,Y._\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@#E]7\66^E7(L(X;F^NRGF-!:1B5XX\X#R%G1$#'A07W'L.1D A3QOIC:8V
MKEG6&.0PM&T;"=9P0OD&+KYN2/E'KG.WF@!VD>+[?5+K^SY(+JPNC'YJ17D0
MB:1!PS1E7=6V_P 0R&'IP< '64 % %:]LH-1A>UNHTFAE&UXW 96'7D'T(!!
MZ@@$8(!H \9@^#$%KJD5S'<;]-BF,_V*1&8 X&%#%R&!*J&9E#%5"G=3 ]O
MQP*0",H<%6 *D$$$9!!X(([@]Q0!R4_@'P]<'<^GVH)_NQ*GZ)M% ',ZU\(]
M(O5633-VDW41RDT!8X/;<A<=#R"C1M_M$<4 8_\ PJ">_P#^0SK%]>K_ '02
MO'I^]DG'_COX4P-ZP^$/AVP5U\EYFDC>/?,^]E#J5+(NT1B0 Y5]A*-@K@T@
M.9^&"2>%]:U+PI*YD2+;<P%AC(P@)QG&7CDA) [H?0X8'NE( H * "@ H *
M"@ H * "@ H * &22)"C22,$1 69F("JH&223P !R2> .30!X/K/B._^)-ZV
M@^&Y#!IT8_TR]P0'4Y!1>AV-RJJ,-,<Y(B!)>P'JOA?PEI_A*V%M8H-^/WDS
M >;*>I+L #C/W4'RJ.@SDE =-0 4 % !0 4 % 'P[_PENM?]!"]_\"I__BZ^
M)]O5_P"?D_\ P*7^9_4/]EX#_H$PW_@BE_\ (A_PENM?]!"]_P# J?\ ^+H]
MO5_Y^3_\"E_F']EX#_H$PW_@BE_\B'_"6ZU_T$+W_P "I_\ XNCV]7_GY/\
M\"E_F']EX#_H$PW_ ((I?_(A_P );K7_ $$+W_P*G_\ BZ/;U?\ GY/_ ,"E
M_F']EX#_ *!,-_X(I?\ R(?\);K7_00O?_ J?_XNCV]7_GY/_P "E_F']EX#
M_H$PW_@BE_\ (A_PENM?]!"]_P# J?\ ^+H]O5_Y^3_\"E_F']EX#_H$PW_@
MBE_\B'_"6ZU_T$+W_P "I_\ XNCV]7_GY/\ \"E_F']EX#_H$PW_ ((I?_(A
M_P );K7_ $$+W_P*G_\ BZ/;U?\ GY/_ ,"E_F']EX#_ *!,-_X(I?\ R(?\
M);K7_00O?_ J?_XNCV]7_GY/_P "E_F']EX#_H$PW_@BE_\ (A_PENM?]!"]
M_P# J?\ ^+H]O5_Y^3_\"E_F']EX#_H$PW_@BE_\B'_"6ZU_T$+W_P "I_\
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M-_X(I?\ R(?\);K7_00O?_ J?_XNCV]7_GY/_P "E_F']EX#_H$PW_@BE_\
M(A_PENM?]!"]_P# J?\ ^+H]O5_Y^3_\"E_F']EX#_H$PW_@BE_\B'_"6ZU_
MT$+W_P "I_\ XNCV]7_GY/\ \"E_F']EX#_H$PW_ ((I?_(A_P );K7_ $$+
MW_P*G_\ BZ/;U?\ GY/_ ,"E_F']EX#_ *!,-_X(I?\ R(?\);K7_00O?_ J
M?_XNCV]7_GY/_P "E_F']EX#_H$PW_@BE_\ (A_PENM?]!"]_P# J?\ ^+H]
MO5_Y^3_\"E_F']EX#_H$PW_@BE_\B'_"6ZU_T$+W_P "I_\ XNCV]7_GY/\
M\"E_F']EX#_H$PW_ ((I?_(A_P );K7_ $$+W_P*G_\ BZ/;U?\ GY/_ ,"E
M_F']EX#_ *!,-_X(I?\ R)ZK\(-<U#4M7FBO;JXN8ULY&"3322*&$T #!78@
M, 2 <9P2.YKU,#4G.HU.4FN1NS;?6/=GP?%6#PV%P5.IAJ%&E)XB$7*G3A!M
M>SJNS<8IVND[;72['T;7T1^-!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M>H% !0 4 >P_!/\ Y#4__7E)_P"C[>O7R_\ BR_P/_TJ)^=<8?[A2_["8?\
MIJL?4-?3GX8% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
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M:-P&1P58'H01@@^Q'% 'B'PGN$T"75M N76,6-T9%=V"@J?W18DD<8BC//\
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H X/QSKT]A;_ -G:9_R$
M;J*1E8?\N\$:YEN&]-H^6/\ O2E<9P10!R4&N:@_AK1[>&>07NK316S7+,7D
M1&:1I9 S[B9 BX4G)YR"" :8&T8[CP?K-A;K=W5Y9:H98)$NYC,T<R)OBDC=
ML, YRK(/E[@$X 0'I] !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % &;K&FI
MK%C/82_<N8GB)]-ZD!OJI((]Q0!Y%\+/$T>FQ'PIJS"VO[*9XXE<X$BLQ?:C
M'@L&+;1GYT*%,CHP/;Z0!0 4 >$:S9KXY\:?V1>%GT_2;<2M$&*J\C"-CDC!
MR3*BM@@[8R 1DFF![=9V4&GQ+;VL:00I]V.-0BCZ*H &3R>.3R:0%F@ H *
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M_P#UY2?^C[>O7R_^++_ _P#TJ)^=<8?[A2_["8?^FJQ]0U].?A@4 % !0 4
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M;UZ^7_Q9?X'_ .E1/SKC#_<*7_83#_TU6/J&OIS\,"@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * /C[_A5GB7_GS_ /(]M_\
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M_P"4J_\ \J#_ (59XE_Y\_\ R/;?_'J/J=?^3_R:/_R0?ZRY5_T$_P#E*O\
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M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .:U?Q?I
M.A3"VO9PDQ7?Y:1RS.%[,R0I(R@]BP /:@"U'XDTR6P.K+<Q&R ),V[Y1@X(
M.>0V>-A&[.!C)% $&C>+-+\02-#83B26-0S1LDD3[3T8)*B,R]/F4%>1SR*
M.BH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * .6U&32?
M"/VG6[C$,ESL\U]S/),T:[8HXT9C\V.%2,*.,MPI8 'DBZ5<1K8F_C^S1ZSK
MXO#:=HT\LM&CCIN8J&D7O\H8 @@,#O/%Q^RZ[H=S$/WK7$]NQ'5HI(OF5N#E
M5/S@'A3DC!.:0'I% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0!Y/JWAGQ%=ZVVK)_9MS# -ME%=27.(!@;I/+CBV&9SR7+/MXVXPN&!
MK:AH&L^(;$+J+V=MJ%I<QW-G+:^<\:O$./-$JJV&RRL%R,$'!(Q2 EL] U74
M=3M]4UY[0#3TD%M!:>:R^9,H5Y9&F53D*,(@!"]<Y!+ '>T % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !
M0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M% !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
M % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % '*>,]=FT#3_-LU5[NXFBMK
M=7SM\V9MJE@.2%&6QW( Z&@# :[UGPO?V4>I7@U*TU&7[*Q-O' T,[*6B*&+
M 9'*LI5\LH&030!Z50 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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M/5_^_DG_ ,50 ?9D]7_[^2?_ !5 !]F3U?\ [^2?_%4 'V9/5_\ OY)_\50
M?9D]7_[^2?\ Q5 !]F3U?_OY)_\ %4 'V9/5_P#OY)_\50 ?9D]7_P"_DG_Q
M5 !]F3U?_OY)_P#%4 'V9/5_^_DG_P 50 ?9D]7_ ._DG_Q5 !]F3U?_ +^2
M?_%4 'V9/5_^_DG_ ,50 ?9D]7_[^2?_ !5 !]F3U?\ [^2?_%4 'V9/5_\
MOY)_\50 ?9D]7_[^2?\ Q5 !]F3U?_OY)_\ %4 'V9/5_P#OY)_\50 ?9D]7
M_P"_DG_Q5 !]F3U?_OY)_P#%4 'V9/5_^_DG_P 50 ?9D]7_ ._DG_Q5 !]F
M3U?_ +^2?_%4 'V9/5_^_DG_ ,50 ?9D]7_[^2?_ !5 !]F3U?\ [^2?_%4
M'V9/5_\ OY)_\50 ?9D]7_[^2?\ Q5 !]F3U?_OY)_\ %4 'V9/5_P#OY)_\
M50 ?9D]7_P"_DG_Q5 !]F3U?_OY)_P#%4 'V9/5_^_DG_P 50 ?9D]7_ ._D
MG_Q5 !]F3U?_ +^2?_%4 'V9/5_^_DG_ ,50 ?9D]7_[^2?_ !5 !]F3U?\
M[^2?_%4 'V9/5_\ OY)_\50 ?9D]7_[^2?\ Q5 !]F3U?_OY)_\ %4 'V9/5
M_P#OY)_\50!*B",8&?Q8M^K$G\* '4 % !0 4 % !0 4 (RAP58 J0001D$'
M@@CN#W% &=8Z-8:66:RMK>V9_O&&*.,M_O%%7/XT :5 !0 4 % !0 4 % !0
M 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
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MQP01$I/(:F!ZQ8,7MHF8DDQH23R22HR2?6D!:H * "@ H * "@ H * "@ H
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M NTKYA$WF;L<==V 6![7H5K+8Z=:VUP=TT%M#'(<YRZ1JKG/?+ \T@-2@ H
M* "@ H * "@#S'Q\BQ7NF7FH1M/H]M+,;M0C2(DC1@6\LT:YWQHX/\)"<YW;
M@M &=H\UGJGB>*\\.*!91VLBWTL,9C@E<G]PGW55Y4/.0"0H(SP0&!Z_2 *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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MAF#[<_.QPSJ%P 00#T&@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "
M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M,D1ZC+,<$C"L": /0/'CFYUSPZ44I,;CS'0C#JADM6(;CL%D&.Q!Z9H ]GH
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
M* "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
M H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M"@ H "0HR> .I]* ,R'6;*XADN(IDDBMPS2,IW!54$ECC)VX4E2 0P&5)% %
MRUN8KR)+B!M\<BAE;D9!]C@@]B" 0<@@$$4 3T % !0 4 % !0 4 4XM0@F2
M65&RENSI(<,-K1_?&",G'JN0>Q- $]O.EU$D\1W1RJKH<$95@&4X(!&00<$
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MS0L'C<!E8="#_GD'D'@\T 4I]8M+9WBE?:\1A##:YP9V*1<A2#O92.,[<9;
MYH LV=Y%?Q">W;?&VX X(SM8J>& /# CIVR.* +- %>SNXK^%+FW;?%*H9&P
M1D'OA@"/Q - "7EY%81&>X;9&NT$X)QN8*.%!/+$#I[GB@"6*59=VT,-C%3N
M5EY'7&X#<OHRY4]B: )* "@ H * "@ H K6=Y%?PK<6[;XGR5;!&<$@\, 1R
M#U% %F@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
M "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@
MH * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H *
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MCY<8X(P #FGT]_LL:O;3.?[.CCLU6"0&"\!_>LPVKY#F7RY#,^Q71"0[ $,
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M@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H * "@ H
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M !)YP ,\4 24 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0
M4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 %
M!0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4 % !0 4
' % !0!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>dxcm-20241231_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20241231_g3.jpg
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MMX_[.TRTNHUN=:NY6"PVEMO.'D<G/&0J*[G"JQ !\K?%[_@I%^VO_P $[?\
M@A:W[6'_  4 ^%6G:=\?='TU-#CT8W]I<6^J:O-.8+.\E^Q2-$,Q$7,T4;*,
MQ2JNP%0/SX_8(_X( _M%_P#!;3X&V?\ P40_X*;_ +>/CW[9X_EFOO".BV02
MXEAM!*Z)<-YY,-M$Y5C';01*JQ;"&&[8OOO_  7?_:#T'_@K;_P;II^VA^S7
MX#\66'AK3/'EAKEQI_B73(X+PVEM/<:=<2[(9)5>))KC)=6(VQ.QP%./KO\
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MEAI>H:RL@95OI+$2W<$Z!T*22A8YMQ3S&!9#7S-\'_AS^T5_P;Q_\%V_@_\
ML.? W]KZ]^(O@3XH:WH=OXE\*!6AB2TU6_:R*W=D)9(XKN$ 7,<Z%69-I.U'
M92 ?0W_!;3]MG]MC]O[_ (*K>'_^"$7[ _Q7O/ FGKY"?$/Q-IEY);R74SV7
MV^X$LT)$GV2VLR"849?.F9XWSA ,?X\_\&D_Q'_91^#&K_M'?L#_ /!07XAG
MXO\ A32Y-5C5T_LXZW+ AD>&WFM91+;2N ?+WM*I;",0&+KQFJ_$+PS_ ,$[
M_P#@\5UWX@?M+ZG#H/A7XA%_[*\3:HXBM8X=4TA([><R-@+$+R)K5I"0J%7)
M(52:_<_]K+]JGX/?L<?LX>*?VF_C/XNL=-\.^&=&EO6FN;E5^V2",F&VAR?W
MDLS[4C1<EF8 "@#\P/\ @G%_P5N^*'_!2S_@@5^TQ?\ QGUK=\4_A5\)?$VG
M:]KMB! ^I0R:%=RV.HD1X$4S>7,C;  7MRXV[]J_"W_!K-_P6#\<_LW?M6Q_
ML@?M0>/]6O/ 7QENXX_#.J^(;Z65-+\0 ^3"R22D_NKG;]F?&0)5@/RA7-=3
M_P &Y7P?\9:'_P $9O\ @H3\>]4TZ6'0_%7PLU'1](E9"J33Z?H&LRW!7U"C
M48!D<9R.H..:_8\_X)13?\%&?^#;23XE?"#0FD^+OPF^*'B'6/!KV:8N-4M!
M#9M=Z8"O)9U198AU\Z)%&T2N: /KK]KGQYXXLO\ @\1^!G@FS\9:K%HUQX,M
MVN-(BU&5;65O[+U<Y:(-L8Y53DCL/2OVSK^6+_@E[^WC\0_^"AO_  <!?LJ_
M&;XOV[MXNT3PG_PC/B34G;)U6YLM*U51>GT>6-XVD''[WS, +BOZG: /P-_X
M*.?M+_MN?\%M?^"Q.K?\$;?V/?CKJ'PW^%_@"6ZM_'^MZ5-*C7;6>Q=1NKH0
MNCW$<=PZVL-KO6-I-KN1NW1T/VQ_^#93XS?\$Q/V>M?_ &Y/^";/[?GQ#C\:
M_#G2Y=?UW3IV%E)J-G;J9;J2&6U9?F2-7<P2K(LJJR$Y(#8__!-/XD>%/^">
MW_!UO^T3\._VFM8@\.CXIZIXFLO#6JZO((87EU35K76M/W2OA0)X$"*<X:5T
M4<D"OV"_X+!?M3?"3]D;_@G%\7/B1\6O$]E8K?>!-4TC0+&YG59-5U.[M)8+
M:TA0G,C-(Z[MH.U [GY48@ ^ #_P5.\<_P#!2K_@US^,_P"T-XHO_P"S/B/X
M2T2;P[XQO-&8VWFZA!-9R+>1!"#$)H)X7(7"B0RJN%4"OF3_ ((X?\$")O\
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MXN:E/#XC\./J,UQ;Z>)W5M1T](V8JC1MMO;4#;D(81\L3D[/_!:#]L[XH_\
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MUZ]X(M=8O[&^C\4>$Y%-TBP2K*JH=P!5\8)ST-?SJ?\ !4?_ ()<>)_V O\
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M2;0?!/C&UN+>ZTC4;?S;K3XV^TQ1.P>T>YA$FQ#,_DG'04 ?0WBSXK?%&/\
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MYKW[-GBFS@A\43A1ISQ:9=3+/"R.2LF0!D8(KYQ_X+L?\K3?[%7_ %[^!?\
MU+]2K]=_^"H.@:CXK_X)I?M#^%]'MGFO-1^!OBVVM(8URSRR:-=*B@=R6(%
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M'^O7VE>./$-_HB:UJ>F2-9RW<L&I3VC7/[K;L\\0"8JN%_>\ # JS_P:1?\
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M$VE_\)'=ZQ_:>OQ0I/YEPL2LF(55=H\H8XSR:^CZ* /SV^'G_!N7^R-\(?\
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ME_KOB.]UR[LO"]]!;+I^CRZG,9)3 40281'EB0,3\DASG%=K^P!_P1U^$/\
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M !!^&\=FNF:EX7M[9UNVL[PW=J\HE0DM'(SC(/S*P4\**^X** /S._X*'_\
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M,_X>_P#!,GXK?M9>/=2\/?#3Q;#K'ASQ5):69U(6\-K>6T%A)E"C11)>NJ'
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M=VD"%F>SM=3MFN7P/X8X6DF8]EA8T ;_ /P3]_X(E_M2?\%__A/+_P %%_\
M@IE^W/XV@TWQAJ=Y_P (5H&EHDI\B&=X7G2.8F"RMQ-'(D<$47S!"^5##=):
M>-?VTO\ @UL_X*3?#KX#?$#]IO6/B9^S3\4)HUC@UUY EE:F=(+F6*%W<6MW
M:&6*1O)81SQ.@8*6 B_1'_@UY_:H^$7Q^_X)(?#KX;^"_%%D_B;X:VMQH7B_
M0%G7[38R"[GD@E:/.[RYH71UDQM+>8H)9& _/O\ X.Z?B1X6_;0_;E_9R_X)
MY_ #5;;7_'NC7U_::Q::9()S97NM7&G06UK(4SLE"VAE=#RJ21L< B@#F/\
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MF8)K*:Z6PU&TM[E,L(I9(HK@%,G:;=ASB@#J/A)_P9_>.OC;\*;#XU_MF_\
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M]@?Q)XY^#)U_4+R&[\,VLMI<VVCWT<SJ\5SIS/+]G9@$E6*&Y2/RI4*@ @
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MS)\1/'/BW]DCP[<*GPWU;QLTC>3?_:%$26^]5V;[<S/(BJAVK;-(B,X!Y/\
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MYH%K]GBBC?*++(SD-G B_P""4/Q,_:(_X)4_\%Y_$G_!%+Q_^T5XC^(GPO\
M%&D/=>!Y_%-VTLEA<#2QJD,D>YF$.8DN;>1$VI)(J.%! %9>FQ+\*_\ @]UO
M[CQC*+6#QAHH;0[BX.U9_,\&QHH4GCF6VEB'JR@#DXIWQ,MS\6_^#V+PI9^#
M91<KX/T.%]>G@.Y;;RO"T\K!R.G-Q#&?1G - '[Q450L_%'AG4-7F\/V'B*P
MGO[<$W%E#=HTT0! )9 =RX) Y'<5=FFAMX7N+B58XT4L[NV H')))Z"@#\9O
M^#L']J7XM^+==^!?_!*#]EKQ+>6OCSXL^+;74=273;^2WE6W:<V6GPN\?S+%
M+<R32,>WV$'IFM+_ (-&_P!M/XA^,/@[\4/^"=/[1.MZA)X]^#?BNXN+2WUJ
M[:6Z6PGG>.YMR7)9OL]]'+N)/'VR,#I7YT6'_!1CX\?'K_@O/XX_X*L? W]A
M/QO^T/H?@76+G3/!&A^%K&]>WTVS6WEL-.NI9+:SNO*+PK/<K&RC,TK.&^2F
M?![_ (* _&7]E'_@X$T#_@HU\<?V,?&/[//A?XQ>(FL?&7A;Q;97D,,UI>)!
M;ZC>)-<VML9D2Z:&_<!#MD !)!% 'TK_ ,'F_P 2?C!X%_:A^ %M\(_'GB/2
M+VX\+ZDUO%X>U.>"26X%[ (RJPL"S[L!>ISTK[2_9!_X*KVG_!3O_@@-\8_B
M[>:ZEK\3O!?P7\2Z3\1+:SD\J6'4XM%N6BOXPN"D=PBB92  L@EC4GRB:^<?
M^#EC:_\ P6@_8*Z$'QIIGT(_X2+3Z^;?^"LWP4^)7_!OQ^W;\2?'_P  O#<T
MGP"_:I^&_B/0+C0;7Y;:PN+VSFCEM /NH]I<SQW,' S;RO"IXD( /??^"2OQ
M"\?:S_P:A_M*^,-7\<:Q=:O:P>-OLNJ7.IRR7,.W2K4KME9BRX))&#P37A?_
M  1;_P""%?B'_@JS^PY_PU)XH_X*)_%/P;J[>+=0TA=.L)GO+8);K$5D.^=&
M))DY&0./>O7/^"0G_*I!^TY_UP\<?^FFUKZH_P"#//\ Y0_I_P!E1UO_ - M
M: /FS_@EO^U+^W3_ ,$EO^"S(_X(N?MJ?M!ZG\3_  )XO14\#^(]:NYIGM99
MK9KBQN+<SN\L,4Q1[:2UWLB3'<APK-)^\5?S[?MA>)M _;;_ .#P'X.Z#^S[
MK%OKT/PU?1(?$FIZ5,)K>%M+^U:G> RH2OR+((&YXE!C^]Q7]!- '\Z7_!9?
M_@@;-_P34_83\5?MC>!?^"A_Q=\2ZEHNK:;;Q:+JM]Y,$@N[V*!B6CDW#:)"
M1CN*]3_X(V?\$!(OV@_V>?@5_P %$_$W_!03XLP:I?7%CXGN/":W?FV3O:WY
M86Q9Y-S1OY #9&<,:^NO^#L+_E"9\1/^QB\._P#IVMJ]6_X-[?\ E##^S]_V
M)3?^EEQ0!^>/[,_Q.\81?\'COQ3\(ZU\0M2708--U#RM+NM6D%G&?["LR,1L
MVP'))Z=37N'_  >%?$S4O#?_  2W\,W_ ,._B#/87S?&G2D>;1=6:*8Q'3=5
M)4F)@=N0N1TR!7P'\=O^"?'PF_X*<_\ !U7\9OV4?C5XN\1:)H6H-+J$M_X6
MG@CNUDMM%LY$4-/%*FTGKE,XZ$55_P""_7_!NO\ LB?\$H/V*M&_:4^!'Q@^
M(^O:SJ/Q$L?#\UEXMO["6U6WFL[Z=G M[2%_,#6R $L1AFX/! !]#?\ !>GX
MA^/_  [_ ,&S7[&OBKP_XYUBQU2^7P!]MU*SU.6*XN-_@R^=]\BL&?<P#').
M2 3S3_V9O^#;7X-_'']F_P"'WQJ\1_\ !7[XFZ5J/C#P1I.MW^EQ:];E;.:[
MLXIWA&Z?=A&D*\\\<UB?\' /_*KY^Q7_ +OP]_\ 4*OJ]!_9+_X- /\ @FI\
M>/V5OAG\<?%_QP^.=MJWC/X?:-KNJ6^F^)=&2WBN+NQAN)$B5])=EC#R,%#,
MQ  RQ/- 'Z-_\$F/^">GA;_@G!^S]K?PC\'_ +3/B+XJV>N^+IM;_P"$@\27
M*2RP,UM;6YMT9'8;!]GW=?O2-6=_P72_:A^-_P"QM_P2J^+G[0G[.C20^+]'
MTJSM]+U**$2-IBW=_;6DMXJD$%H8IWD4D$*RJS J#7H?_!.S]@#X-_\ !,S]
MF/3OV4/@/XE\3:MX=TS4[R^@O?%UY;SWK27,IE<,]O!!&5#'@! 0.I/6L;_@
MJ?\ MK_LY_L%?L>:Y\:?VL?A)XA\;> +^YBT#Q#H/A[1+74#-#>J\6)X;J>&
M(P,?W3;FZRJ,'/ !^$?_  3=_P"".7[%W_!6+]G6Q^/7C;_@L3KLW[2>NI=3
M76@:CK]O)?:3?^:ZQ+/#=/\ ;KM3M5C-&ZJV\A3\O/ZQ_P#!O?\ "W_@KE\
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M=;]F7]EG2/C%XF\)Z1\1O#7AG0-1NO#^IRQ-;K?>)KZT>X6-6"O(J/D;NNT
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M;VT$8C1=QR6; R68EF)))))-?B5_P?$_\DC_ &>/^QC\1?\ I/8T ?LMX_\
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M;O44GU^\\$:5IOC-5(W1ZS9ZS8V]V64?=\QT\]5_N3IZU^?'['W_  0$^/\
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M#\-/V5/BIK&LZ?X>\;^%M"T_5;SP_<117L412]?,3S12HK90<LC#&>*^M_\
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M(8?\%"/B1=^,M3\.I>?\()XCU.^DNKF.6UB6Y^SK/+^]FM)[$FYB\SYHA&$
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M^*'Q<\6^*;O>OS^4?[/L;8$_W3#9)*HZ8F)ZDU][_P#!Y-X0TSXA?M??LH^
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MZ(74>Z62Y1" 1&9%C;!#HRDK7Z2?M0?LM? ?]LSX'ZW^SG^TA\/;3Q+X1U^
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M** /+/@;^R3\-/@W^QKX9_8AU2-O%7A#P_\ #^W\(72:[ C'5=/CM!:NLZ*
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M_!7_ /X(O_!S_@L1H'@3P_\ %WXO>)O"<?@.\U"XL9/#<%NYN3=I KB3SD;
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M[ <?Q \<^/?%XU3Q/X7\,:W::++K=],)&EU"YNKHF,$$$L<%F:3@$DU\"?\
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M.-?^"7[/7_!8WX:> ;J2STC3_'=O>6=K;';'#)KSW%O?[0.%W1A5('90.@H
M^RY_^#AW5O$/@W6/VG?@S_P3 ^-/C3]GC0;JX2^^,VF"TA%Q:V\ACN+^UTV5
MA-/:H5<F4L@4(V\1E'"_??P+^-WPP_:3^#WAOX]?!?Q5!K?A7Q9I$.I:'JD
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MD4%CZ#F@#<HK'_X275_^A0O?^^EH_P"$EU?_ *%"]_[Z6@#8HK'_ .$EU?\
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M%"]_[Z6C_A)=7_Z%"]_[Z6@#8HK'_P"$EU?_ *%"]_[Z6C_A)=7_ .A0O?\
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M_P#?2T ;%%8EQXMU"UA:XN?"MVD:#+.SJ !^=.3Q1JLB!T\(WA##((=>1^=
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M>_\ 7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L?Q+_R%]'_Z_3_Z":V*Q_$O_(7T?_K]/_H)H V****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#'LO^1W
MO?\ KRB_F:V*Q[+_ )'>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *Q[+_D=[W_KRB_F:V*Q[+_D=[W_ *\HOYF@
M#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MB@ HHHH **** "BBB@ HHHH Q_ __((E_P"OV;_T*MBL?P/_ ,@B7_K]F_\
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MHH **** ,?P/_P @B7_K]F_]"K8K'\#_ /((E_Z_9O\ T*MB@ HHHH ****
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MZ\HOYFMBL>R_Y'>]_P"O*+^9K8H **** "BBB@ HHHH **** "BBB@ HHHH
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MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q_$O\
MR%]'_P"OT_\ H)K8K'\2_P#(7T?_ *_3_P"@F@#8HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** ,>R_Y'>]_Z\HOYFMBL>R_Y
M'>]_Z\HOYFMB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *Q[+_ )'>]_Z\HOYFMBL>R_Y'>]_Z\HOYF@#8HHHH **** "BBB@
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M^1WO?^O*+^9K8K'LO^1WO?\ KRB_F:V* "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K'LO^1WO?^O*+^9K8K'LO^1WO?^O*+^9H
M V**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M#'\#_P#((E_Z_9O_ $*MBL?P/_R")?\ K]F_]"K8H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** ,WQC_ ,BQ>_\ 7 U<T[_D'P?]
M<5_D*I^,?^18O?\ K@:N:=_R#X/^N*_R% $U%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?DU_P59_9*_;Q_93_ &G/CK_P4A_8S^&>@_$[
MP5\9/@C/X;^,G@S4=<33M2T5;33FMTU6SDD^25(X(U9HAN=CYBA#N5T]$_X(
MQ_\ !3S]D3]I^+X=?LK^-/@3K_PY^/7@GX0:3;Z59_$7PG':WNM:1#8QJ;K2
M[LY::U=<S!,H61V=5=5=QP7_  4P_;6_;,_86_:*_:"\*?M7Z!XP\6_LU_%S
MX.W-I\)/%'AGPC'=6O@K61ILL,MC?/:PB5%GFDD;S9F<[?)VY59?+\U_8&O_
M !=_P4\_;Y_8]^/WP.^"_BK0OAE^RM\%6TWQ9\3?$6A2Z=%XCU>ZT=+/^S+
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M]OGQ[8:5H5G;0)X&TLI#;VJ(BDR-D@ 8&<#\J /;_P#A,?#'_0:@_P"^J/\
MA,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4 4_\ A,?#'_0:@_[Z
MH_X3'PQ_T&H/^^JN?V=I_P#SXP_]^A1_9VG_ //C#_WZ% %/_A,?#'_0:@_[
MZH_X3'PQ_P!!J#_OJKG]G:?_ ,^,/_?H4?V=I_\ SXP_]^A0!3_X3'PQ_P!!
MJ#_OJC_A,?#'_0:@_P"^JN?V=I__ #XP_P#?H4?V=I__ #XP_P#?H4 4_P#A
M,?#'_0:@_P"^J/\ A,?#'_0:@_[ZJY_9VG_\^,/_ 'Z%']G:?_SXP_\ ?H4
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M^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\ WZ%']G:?_P ^,/\
MWZ% %/\ X3'PQ_T&H/\ OJC_ (3'PQ_T&H/^^JN?V=I__/C#_P!^A1_9VG_\
M^,/_ 'Z% %/_ (3'PQ_T&H/^^J/^$Q\,?]!J#_OJKG]G:?\ \^,/_?H4?V=I
M_P#SXP_]^A0!3_X3'PQ_T&H/^^J/^$Q\,?\ 0:@_[ZJY_9VG_P#/C#_WZ%']
MG:?_ ,^,/_?H4 4_^$Q\,?\ 0:@_[ZH_X3'PQ_T&H/\ OJKG]G:?_P ^,/\
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M_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@"G_P )CX8_Z#4'_?5'_"8^&/\
MH-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* .?\)>)=!L=,DAN]4BC8W4K
M!6/8MP:U/^$Q\,?]!J#_ +ZJIX+LK.72I&EM(F/VR49:,'C=6O\ V=I__/C#
M_P!^A0!3_P"$Q\,?]!J#_OJC_A,?#'_0:@_[ZJY_9VG_ //C#_WZ%']G:?\
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MY2?9+^DNK1]<_'_]JCX$_LR:$-:^,'CVUT^22,M9Z9&?-O+OM^[A7+,,\;B
MH/5A7P5^T!_P6_\ B;XCFGT;]G7P-:^'+(Y6/6=;1;J]8=F6+_4Q'V;S?K7D
M7[//[#/[57[=_B:3XE^(=1O+;2;^?=?^-O$\DDAN><'R58[[@CH,808VEEQB
MOT-_9R_X)B?LL?L]0P:FW@]/%6O1 %];\2Q+/M?UB@(\J+!Z$*7']\U^<PS'
MCSC7WL OJ>%>TW\<EW3W].5173F9\)''\9\6ZX-?5<.]I/XFO)[_ /@-ETYF
M?F;XF@_;Q_:E\,ZC\1O%D7CSQ/H%A9RWUY?W8F&G10QJ9':,';#P%+;8QGCI
M7BM?T02VMK/:M93VT;PO&4>%T!5E(P5(Z$8XQ7Y4_MT?\$I?BA\*/%E_\0/V
M>?"MWXC\(7<S3+I>FQF:]TG)R8O*&7FB'.UU!(48<#&YODN,?#G,LLPL,9AZ
MD\2]?:-J\EV:6KMO?5VWVO;YGBK@3'Y?AXXJC4EB'KSMZM=FEJ[;WU=M]KV^
M-:*T/^$2\5?VO_8'_",ZA]OW;?L7V*3SMV<8V8W9S[5]<_L,?\$IOBC\6/%E
MAX__ &A?"MWX<\'VDRS-I>I1F&]U;!R(A$</#$?XG8*2IP@.=R_GF49%FF=X
MR.&PE)RDWJ[.T?.3Z)?\-J?#99D^8YOBE0PU-MMZNVB\V^B_I:GE7AS]C/\
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MB@#'\#_\@B7_ *_9O_0JV*Q_ _\ R")?^OV;_P!"K8H **** "BBB@ HHHH
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M*_R%4_&/_(L7O_7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_
M /8B:5_Z,:O=*\+\ _\ *03Q_P#]B)I7_HQJ /=**** "BBB@ HHHH ****
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M2KN/[H_Y_P!U/?\ YY9_ZZ?\\VK]#Z^$X.X?QF;XW_63.E>K/6G![0CT=O\
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M&=FW(+ U^*WQ!^(?C?XK>+[WQ[\1/$UWJ^KZA*9+N^O)-SN>P'95 X"@!5
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M_P CO>_]>47\S6Q6/9?\CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%%
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M_(L7O_7 U<T[_D'P?]<5_D*I^,?^18O?^N!JYIW_ "#X/^N*_P A0!-1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %>%^ ?^4@GC_P#[$32O_1C5[I7A?@'_ )2">/\ _L1-*_\ 1C4
M>Z4444 %%%% !1110 4444 %%%% &;XQ_P"18O?^N!JYIW_(/@_ZXK_(53\8
M_P#(L7O_ %P-7-._Y!\'_7%?Y"@":BBB@ HHHH **** "BBB@ HHHH ****
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MFQU K]@O@M\(O!_P'^%VB_"7P)9^3INBV:PQ%@-\S]7E?'5W<L['U8U\P_\
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M%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?BKOA,-]TY?K=K_P%=.8]5CC2)!%$@55 "JHP /2EHHK]F/U8**** "BBB@
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MO4$$5YO\$OC'\,/'_P"W)XZ\5^#?&EEJ&G7'@G3HX;NW<E'=)"' R.HW#\Z
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M0?\ ?59>O>)=!N=3TR:#5(F6&Z+2L#]T;>IH Z:BLW_A,?#'_0:@_P"^J/\
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M^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH A_L[3_\
MGQA_[]"C^SM/_P"?&'_OT*FHH A_L[3_ /GQA_[]"C^SM/\ ^?&'_OT*FHH
MA_L[3_\ GQA_[]"C^SM/_P"?&'_OT*FHH R/%UC91^&KQX[.)6$)P5C (JWI
M^GV#6$!-E"285R3&/05#XQ_Y%B]_ZX&KFG?\@^#_ *XK_(4 ']G:?_SXP_\
M?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:
M?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\ SXP_]^A4
MU% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H4?V=I_\
MSXP_]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_ ,^,/_?H
M4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\ ?H4?V=I__/C#_P!^A4U% $/]G:?_
M ,^,/_?H4?V=I_\ SXP_]^A4U% $/]G:?_SXP_\ ?H5D>([*S35=)5+2(!KP
MA@(QR-IK=K'\2_\ (7T?_K]/_H)H TO[.T__ )\8?^_0H_L[3_\ GQA_[]"I
MJ* (?[.T_P#Y\8?^_0H_L[3_ /GQA_[]"IJ* (?[.T__ )\8?^_0H_L[3_\
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M,/\ WZ%344 0_P!G:?\ \^,/_?H4?V=I_P#SXP_]^A4U% $/]G:?_P ^,/\
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MZ%?,/_!3?]ART_:<^%1\:_#_ $:,>-_#%N\FFK#& VI6WWGM#CJW5H\]&RO
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M/9?\CO>_]>47\S6Q0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8]E_R.][_P!>47\S6Q6/9?\ ([WO_7E%_,T ;%%%% !1110
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M5J/AOPMK%Q]ET_P'X/\ -GO=7W=$N98U$ET3_P \D58^F48C=7T-_P $^O\
M@W \2>)C8_%#]O75)=(L#MF@^'VC78^USCJ!>7*$B 'O'$2^#R\; BOT"_X)
MR_L,?L6_LN_"32?&O[,'AJ+4I]?TJ.:7QSJVV?4[^-P"5:3 $"YX,,810R_,
M"P)KZ3K[^G4A5@IP=TU=-;-/9GVL*D*D%*#NGJGW1SOPK^$OPR^!_@>R^&OP
MA\"Z9X<T'3TVVFEZ3:+#$GJQ ^\YZL[99CR23S714458PHHHH S?&/\ R+%[
M_P!<#5S3O^0?!_UQ7^0JGXQ_Y%B]_P"N!JYIW_(/@_ZXK_(4 34444 %%%%
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MF33?!EVT<D2MK(D EFO?+=R-RY((993&WDJ ?K-1110 4444 %%%% !1110
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M%%% !1110!C^!_\ D$2_]?LW_H5;%8_@?_D$2_\ 7[-_Z%6Q0 4444 %%%%
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M?^O*+^9K8K'LO^1WO?\ KRB_F: -BBBB@ HHHH **** "BBB@ HHHH ****
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MIV\40F>+9(_G)L?<A.W!X(.>:^L:* /P7_;(_P""@W_!N!_P4U^,,E[\>?\
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MJGXQ_P"18O?^N!JYIW_(/@_ZXK_(5]*>^34444 %%%% !1110 4444 %%%%
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MHH **** "BBB@ HHHH **** ,WQC_P BQ>_]<#5S3O\ D'P?]<5_D*I^,?\
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M<'E.#CA<-'EA'[WW;[M]6%8_B7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\
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MYFMBL>R_Y'>]_P"O*+^9H V**** "BBB@ HHHH **** "BBB@ HHHH ****
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M** ,?_A)=7_Z%"]_[Z6C_A)=7_Z%"]_[Z6MBF3SP6L#W-S,D<<:%I))& 55
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M9^0M%?K=!_P:T>=K<^C?\-TX\F%9/,_X5CUSVQ_:=7/^(5+_ *OQ_P#,7_\
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M7O\ WTM;%% &/_PDNK_]"A>_]]+1_P )+J__ $*%[_WTM;%% &/_ ,)+J_\
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MX275_P#H4+W_ +Z6MBB@#'_X275_^A0O?^^EH_X275_^A0O?^^EK8HH Q_\
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M*Q_ _P#R")?^OV;_ -"K8H **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%/VEO#%W\-M9EPAU0.U[I$K],F55$L&3V="BCK)QFOT(\)^+_"?CWP[:>+_
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MG\(_@0M_\)_V.A8>./%Z;H;GQ,S;]&TM^A*,I_TV0>B$1 X)=\%*^!?VT_\
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MZK*/K7W)\!O^"(7_  3B^ ZP7<7P+B\7:C"!G4O'5T=1,A'=K=@MM^40J?\
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MX#L/#OA_3DQ;V%A%@,Q W22,<M+(V 6D<EF/))KK0 !@"B@3=PHHHH$%%%%
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M*/Q$T_5=#TS5I!-?>.?B5=3_ &B[4_QQQ29N+@D<JQ C/'[P4#MW/:/VZ/\
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MS8' /(C4+&N3M4$G/LE%%!(4444 %%%% !1110 4444 %%%% !1110 4444
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MB_\ \$1?^":'QB,MU>_LW67AZ\E)(O/!]]/IOEY_NPQ.(/SC-?E-_P %L?\
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M*_R%4_&/_(L7O_7 U<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_
M /8B:5_Z,:O=*\+\ _\ *03Q_P#]B)I7_HQJ /=**** "BBB@ HHHH ****
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M"E!0@DDMDM$%%%%,L**** "BHKZ^LM,LY=1U*\BM[>",R3SSR!$C0#)9F/
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M33Y8+OP[?NP-UIUT&N-%\36BM@.,$).G) =2LL98C,;;A7](E<!^TE^R_P#
MW]K?X:7/PG^/?@*TUS29\M 91MGLIL8$]O*/FAD&?O*>1D'*D@\=?"*H^>#M
M(^7SCAJEC*GUK"2]E76MUHF_.W7S7SN>)_\ !.S_ (*V?LZ_M_:+#X>TZ\3P
MO\0(;?=J/@K4[D%Y<#+2VDA %S'U)P Z@'<@&&/U77\__P#P4,_X(T_M'_\
M!/[79/CA\#M8U7Q/X$TZZ%W:>)M)W1ZIX?*MN1KI8L%-I Q<QX3(RPB)53]"
M?\$VO^#AZ6PBL/@U^WS-)-&NV#3_ (DVEON=1T OX4&6]//C&>F]"=TE9TL7
M*$O9UU9]^AR9?Q+5P]?ZGFT?9U%M+[+_ $7JM/0_7RBL_P *>+/"_COPW9>,
M?!/B.QU?2=2MUGT_4]-NDG@N8FZ.DB$JRGU!K0KT-S[)-25T%%%% PK\A?\
M@ZM_YH/_ -S1_P"XBOUZHH&M#^0NBOZ]*Q[+_D=[W_KRB_F:!\Q_)'7]>E%%
M F[A1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH Q_
M_P#R")?^OV;_ -"K8K'\#_\ ((E_Z_9O_0JV* "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#-\8_\BQ>_P#7 U<T[_D'P?\ 7%?Y
M"J?C'_D6+W_K@:N:=_R#X/\ KBO\A0!-1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %>%^ ?^4@GC_\
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MHOYF@#8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,?P/_R")?\ K]F_]"K8K'\#_P#((E_Z_9O_ $*MB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH S?&/_(L7O_7 U<T[_D'P
M?]<5_D*I^,?^18O?^N!JYIW_ "#X/^N*_P A0!-1110 4444 %%%% !1110
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ML\0(BW'A/X3Z?,OF7;XW1W6IR$%;2VZ,L;!I)00WEF/E_)/C-^U)_P %"/\
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M5C^)?^0OH_\ U^G_ -!- &Q1110 4444 %%%% !1110 4444 %%%% !1110
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M]+7=A\'%T[5H:_UV/KLEX8HU<"Z69891G%Z235VG_A>Z\^EC\#OB5_P;[_\
M!2_X93M>>%O V@>+5MVWK=>%?%,*L,=&5;O[/(3[!2:Y,ZW_ ,%I?V.?EN+O
MX[>&+&UZ"Y74+C35QZ;Q);'\,\5_0[_PDNK_ /0H7O\ WTM'_"2ZO_T*%[_W
MTM4\OIIWA)HWGP3@Z<N;"UITWZW_ ,G^)^!_P\_X.$O^"EO@)DA\1>.?#?BL
M0_*8_$GA2%"<=F-G]G8_7.:]W^'W_!T?\3+)4B^*O[)6A:F3@23^'O$TUB!Z
MD)-%/GZ;A]:_4OXA?";X/_%M'3XJ_LS>'_$P<8<>(/#]G>9'_;5&KPGX@_\
M!(#_ ()P_$=I)M5_8FM=/F?E9?#^IW.G;#ZA+>9(_P "I'M2^KXV'PU+^O\
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MC;I:6/@:YABC&$BB"*JCT ' J3_A)=7_ .A0O?\ OI:/J,Y?%4;#_5#$U?\
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M 5CV7_([WO\ UY1?S-;%8]E_R.][_P!>47\S0!L4444 %%%% !1110 4444
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M%?Y"@":BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH *\+\ _\I!/'_P#V(FE?^C&KW2O"_ /_ "D$\?\
M_8B:5_Z,:@#W2BBB@ HHHH **** "BBB@ HHHH S?&/_ "+%[_UP-7-._P"0
M?!_UQ7^0JGXQ_P"18O?^N!JYIW_(/@_ZXK_(4 34444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M /\ RD$\?_\ 8B:5_P"C&KW2O"_ /_*03Q__ -B)I7_HQJ /=**** "BBB@
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M_P#8B:5_Z,:O=*\+\ _\I!/'_P#V(FE?^C&H ]THHHH **** "BBB@ HHHH
M**** ,WQC_R+%[_UP-7-._Y!\'_7%?Y"J?C'_D6+W_K@:N:=_P @^#_KBO\
M(4 34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8_
MB7_D+Z/_ -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$T ;%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110!CV7_ ".][_UY1?S-;%8]
ME_R.][_UY1?S-;% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S0!L4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &/X'_Y!$O_ %^S
M?^A5L5C^!_\ D$2_]?LW_H5;% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!F^,?^18O?^N!JYIW_(/@_P"N*_R%4_&/_(L7O_7
MU<T[_D'P?]<5_D* )J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ KPOP#_RD$\?_ /8B:5_Z,:O=*\+\
M _\ *03Q_P#]B)I7_HQJ /=**** "BBB@ HHHH **** "BBB@#-\8_\ (L7O
M_7 U<T[_ )!\'_7%?Y"J?C'_ )%B]_ZX&KFG?\@^#_KBO\A0!-1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5C^)?^0OH_P#U^G_T
M$UL5C^)?^0OH_P#U^G_T$T ;%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!CV7_([WO_ %Y1?S-;%8]E_P CO>_]>47\S6Q0
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8]E_R
M.][_ ->47\S6Q6/9?\CO>_\ 7E%_,T ;%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!C^!_^01+_ -?LW_H5;%8_@?\ Y!$O
M_7[-_P"A5L4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% &;XQ_Y%B]_ZX&KFG?\ (/@_ZXK_ "%4_&/_ "+%[_UP-7-._P"0?!_U
MQ7^0H FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M -?I_P#036Q6/XE_Y"^C_P#7Z?\ T$T ;%%%% !1110 4444 %%%% !1110
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MQEI]C;6I>YO;N\A6*%<CYF(!('X5I:-^V%\9[S1[2\L_V(?'$T,MM&\4L=U
M5=2H(8>Q'-=;^W/_ ,FC^/?^P"__ *&M=U\+O^29^'?^P%:?^B4H \B_X:Y^
M.'_1C/CO_P "8*/^&N?CA_T8SX[_ / F"O>J* /!?^&N?CA_T8SX[_\  F"C
M_AKGXX?]&,^._P#P)@KWJB@#P7_AKGXX?]&,^.__  )@H_X:Y^.'_1C/CO\
M\"8*]ZHH \%_X:Y^.'_1C/CO_P "8*/^&N?CA_T8SX[_ / F"O>J* /!?^&N
M?CA_T8SX[_\  F"C_AKGXX?]&,^._P#P)@KWJB@#P7_AKGXX?]&,^.__  )@
MH_X:Y^.'_1C/CO\ \"8*]ZHH \%_X:Y^.'_1C/CO_P "8*/^&N?CA_T8SX[_
M / F"O>J* /!?^&N?CA_T8SX[_\  F"C_AKGXX?]&,^._P#P)@KWJB@#P7_A
MKGXX?]&,^.__  )@H_X:Y^.'_1C/CO\ \"8*]ZHH \%_X:Y^.'_1C/CO_P "
M8*/^&N?CA_T8SX[_ / F"O>J* /!?^&N?CA_T8SX[_\  F"N:\<?MN?$S1/$
M7AO3];_8Z\7V=QJ.IM#IUO<WL(>[E"$E(P <MCGG%?3]>%_M8?\ );/@?_V/
M<O\ Z3-0!#_PUS\</^C&?'?_ ($P4?\ #7/QP_Z,9\=_^!,%>]44 >"_\-<_
M'#_HQGQW_P"!,%'_  US\</^C&?'?_@3!7O5% '@O_#7/QP_Z,9\=_\ @3!1
M_P -<_'#_HQGQW_X$P5[U10!X+_PUS\</^C&?'?_ ($P4?\ #7/QP_Z,9\=_
M^!,%>]44 >"_\-<_'#_HQGQW_P"!,%'_  US\</^C&?'?_@3!7O5% '@O_#7
M/QP_Z,9\=_\ @3!1_P -<_'#_HQGQW_X$P5[U10!X+_PUS\</^C&?'?_ ($P
M4?\ #7/QP_Z,9\=_^!,%>]44 >"_\-<_'#_HQGQW_P"!,%'_  US\</^C&?'
M?_@3!7O5% '@O_#7/QP_Z,9\=_\ @3!1_P -<_'#_HQGQW_X$P5[U10!X+_P
MUS\</^C&?'?_ ($P4?\ #7/QP_Z,9\=_^!,%>]44 >"_\-<_'#_HQGQW_P"!
M,%'_  US\</^C&?'?_@3!7O5% 'S!I?[;GQ,NOBEJGA>U_8Z\7R:I:Z9!-=:
M:E["9H8F)VNPQ@*>W-=+_P -<_'#_HQGQW_X$P5-X!_Y2">/_P#L1-*_]&-7
MNE '@O\ PUS\</\ HQGQW_X$P4?\-<_'#_HQGQW_ .!,%>]44 >"_P##7/QP
M_P"C&?'?_@3!1_PUS\</^C&?'?\ X$P5[U10!X+_ ,-<_'#_ *,9\=_^!,%'
M_#7/QP_Z,9\=_P#@3!7O5% '@O\ PUS\</\ HQGQW_X$P4?\-<_'#_HQGQW_
M .!,%>]44 >"_P##7/QP_P"C&?'?_@3!1_PUS\</^C&?'?\ X$P5[U10!X+_
M ,-<_'#_ *,9\=_^!,%'_#7/QP_Z,9\=_P#@3!7O5% '@O\ PUS\</\ HQGQ
MW_X$P4?\-<_'#_HQGQW_ .!,%>]44 >"_P##7/QP_P"C&?'?_@3!1_PUS\</
M^C&?'?\ X$P5[U10!X+_ ,-<_'#_ *,9\=_^!,%'_#7/QP_Z,9\=_P#@3!7O
M5% '@O\ PUS\</\ HQGQW_X$P4?\-<_'#_HQGQW_ .!,%>]44 >"_P##7/QP
M_P"C&?'?_@3!7-:7^VY\3+KXI:IX7M?V.O%\FJ6NF0376FI>PF:&)B=KL,8"
MGMS7T_7A?@'_ )2">/\ _L1-*_\ 1C4 0_\ #7/QP_Z,9\=_^!,%'_#7/QP_
MZ,9\=_\ @3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P5[U1
M0!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,
M9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^C&?'?_@3!1_PUS\<
M/^C&?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_'#_HQGQW_P"!,%>]
M44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7O5% '@O_  US\</^
MC&?'?_@3!1_PUS\</^C&?'?_ ($P5[U10!X+_P -<_'#_HQGQW_X$P4?\-<_
M'#_HQGQW_P"!,%>]44 >"_\ #7/QP_Z,9\=_^!,%'_#7/QP_Z,9\=_\ @3!7
MO5% '@O_  US\</^C&?'?_@3!1_PUS\</^C&?'?_ ($P5[U10!\P?"S]MSXF
M>*/#L^H>%OV.O%^IVZ:G<0O<65["R+*CX="2!\RG@UTO_#7/QP_Z,9\=_P#@
M3!4W_!/?_DB>K?\ 8]ZS_P"E)KW2@#P7_AKGXX?]&,^._P#P)@H_X:Y^.'_1
MC/CO_P "8*]ZHH \%_X:Y^.'_1C/CO\ \"8*/^&N?CA_T8SX[_\  F"O>J*
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MIS7UMX9L)&58;>WM00)KEQ)"V'# B=  H621 #]!:*^ /V?_ -M#]NO]DO\
M;U\%_P#!.K_@IMXI\&^.8?BWHE_>?!_XP^#M$;23?WUA&);S3+^R+-''*(R'
M1XB%.^-?G:0^7]_T %%%% !1110 4444 %%%% !117R3_P %//\ @KK\$?\
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MQ^PI\%?CC\2M1CO/$?C/X2^'-=U^[BMTA2>]N],M[B=UC0!4#22,0J@ 9P
M*]:H **** "BBB@ HHHH **** "BLSQIXS\)_#GP=JWQ"\>^(K/1]"T'3)]1
MUK5M0G$5O96D$;2S3RNW"(B*S,QX 4FORT\"_P#!?_Q7^V!_P6)^!'[+?[(7
MAK4;?X">*KKQ-:ZIX^UOPXT*>.+JQTFYN"-.:= \=M;31PYD&UY&D*L%4 .
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M,\:>,_"?PY\':M\0O'OB*ST?0M!TR?4=:U;4)Q%;V5I!&TLT\KMPB(BLS,>
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M  4-_P"NOP__ /33-5#]L+X9?MD?\$\/^"N6J?\ !5']G+]E;Q#\</AW\5?
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MWHVKZU_8^F16WV_4+C68))[N;RU'FS2.Q9I&RS$Y)-?IKHO_ "!K3_KUC_\
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M*^+?PF\<6GB_X<ZMJ32'3KB\@()M+U8PQ,$F$);8^&C4%2K,#\T?M,_L]?\
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MW\5OB1:67A&WBU"*YQX3T>R2UTV4F-F$+3%[B5HCA@2"PR>/B/\ :7_X)_\
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M!?$(6HU_P/\ "OP]X?UP6,_FP_;++3;>VF\M\#>GF1MAL#(P<"O5* "BBB@
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MB_M"2QC@N)8[4W&WS#"LDLCB/=M#.QQDDU\8_#?]A[_@HC^WG^WI\,_VX?\
M@IYX5\$_#?PI\#VN;SX9?!_P9K[:O<3ZQ.J!K_4+T*L9"&.)D6/O"@VJ-YE^
M^_C!X8U3QO\ "7Q3X,T01_;=7\.7UE:><^U/-EMWC3<>PW,,F@#XK_X-A/\
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M_BRZ\8_%SQ1%S%=:S=$,\4)P"8H^0&(&]WD?"APB_ 7["7[!?_!Q)^PAXO\
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M]M#X8>(O!O['_P"V5I'A3P7>>#_L>M?"J3PVD5SXMDWS-<V[ZR&,MG'/"T<
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M!<.O?Z$()E:".WF=461I6@;S6W;5C8;3NX\R_P""0/[*_P 9OV9OV</$^O\
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M[ HPCSS'[&/P%_X.(_V!_P!GS0_V:OV:_P!BS]CK1O#VBP 22'7M9-UJ5R5
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MK:C;PW1*W)BFMV\N)@[&)RV&91D _06BOPU_X*1_%_XP?\$H?A;;_M4?L_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M*8W(V)L#E7#*.@_X-J/&GQ:^)7QO_;;^(GQS\!_\(MXKUCX^^?KOAK[4D_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%%U_P=2?M ^$;GQ)?R:3;?LXZ3-;Z6]XYMXI3+H^76,G:K'<W(&>3ZU]._\
M!9/5=3T/_@E'^T/K&BZE/9W=M\(M<DMKJUF:.2)Q9R$,K*05(/<<T ?2U%?&
M?_!-/]I'X8?L^?\ !#_X*_M(?M-?%6VT+PYHOP>TB\\0^)M>NG8+NA106/S/
M+([LJJBAG=V55#,P!POAA_P<1?\ !.OXB>-_#OA;Q!)\1_ FE>,;Y+/P;XX^
M(GPZO=(T#7)G_P!6(+Z5=@#CD-+Y:XZD4 ?=-%>-_MJ_M\_LM?\ !/KX<V/Q
M+_:@^(IT:VUC4ETWP_I=CI\U]J.LWK#*V]K:P*TDS],D#:NX;F7(SX=\!?\
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MXVT*Z;Q/X?\ ''C"&ZN/A[JD:DPO8_:)%FEBE;8NR-6RC2F7+1Q.WMO[6_\
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M2"*[/]BS]M7X"?M^_ VW_:*_9MUV^U'PO=:G=6$-SJ.F26DIGMY/+E'ER ,
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M(US\-;[X5Z+8R:;XDFN(O#]OK[&W_=Z1$Y$<P6UM%DGGC!"S7C1[MP=1]BT
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M.G^%4\.:?+#;>'-,DEMA.R,9"&6)AN)QGFODW_AO+_@M+_T5;XO_ /@CF_\
MC%?T<44#N?SC_P##>7_!:7_HJWQ?_P#!'-_\8KD/CS^UM_P4\^)WPHU7P/\
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MI(Y([B[LHF!*NZM& "?D5-F638L8!^;W_!!K_@F#^V!^T=_P2V^'/QA^%/\
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M+\,_!#]J+_@IA\8_BK\#/!U_;7&B?![Q +2""ZCMFS;6VH7L*B6]@0! $(3
M4;"F!@ ^B/\ @C/X)UWX>?\ !*']GGPKXEM9(+V+X2:)//!*N'B\ZU28(P/1
M@) ".Q&*^F*CM+2UL+6*QL;:.&"&-8X88D"I&@& J@<  #  J2@ HHHH *^"
M_P#@O-\:/VMO@O\ "3P%JG[)7B7Q3INHWOB.YBU>3PM9O-(\(MP5#A4;"[NG
M3FOO2BLZL'4@XIV./'X6>-P<Z,9N#E]I;K6_D?SH_P##=W_!9_\ Z*I\7?\
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M\9OCU\,/!GC:'Q%X/^'&JZMHLM[\0+^XA2Y@MG>,O$[E9%W 94\&OT'\ _\
M!.GX>^ /^"E?CG_@IE8>/]9G\2>.O %KX4OO#DT40L;:W@:T99HV"^87/V1,
M@DCYCQTKT;]K+]G?P_\ M;_LR^//V8?%>OWFE:9X]\+7NAW^I:<J-/;17,31
MM)&'!4L V1D$4 ?A]^W=)\3-<_X(H_\ !,_X8^#[7P[<:5XE\;^$8-0L_&LD
MR:#>WJVH%G;:FT/S_8W+S>:%YV*S#E01])?\%&O@M_P7A_:?_8G\<? K]KO2
M?V$/"OP[U/3(QK'B:\\4>(;%-$\N:-X;I+BZ0PP.DBIM9QC)Q@YQ7VAXE_X)
M*?LN_$O_ ()L>'/^"87QFCU3Q+X+\,>'+'3-+UMYDM]4MI[--L%_#(B[8KA>
M3D*5(9D961F4^"ZU_P $!O'_ ,:=%TCX-?MF_P#!5KXV?%KX0:+>V]PGPTU5
M;2R&J+;N&AAU&_A'GWJ JI.[:V5#*R, P .!_:$^/VD_!:Y_8C^ 5E^RGX?_
M &G_ -KVU^&D5Y\/=:LO'!@T+3D32XHK_7?MT@\N>*<6[RQL8\OY.\-&XB#>
M%_\ !7W7?^"J6N?$?]D7Q3^W]X:^ OA71Q^U9X7_ .$5\._#6^U.]UR.Y\XF
M26XNKG;#Y"J%!6%>7:,D_*!7Z)?MU?\ !(KX>?M9^.?AG\=?@Q\;/$OP1^)_
MP@LI-/\  7C;P);0.MKISIY9L9;25?+EMPI953*@+(ZG<K%:\H^)W_!OMI7[
M1VI^%_BM^UI_P4!^+7Q&^*/@SQ78:UX5\::F+*UL]'6VE$QMK72K>);6))I%
MA:5R&D8P1@,H!! ,:U_Y6RKC_LRP?^I M._X(0_\GG?\% O^SH;W^=Q7U7'_
M ,$_? 4?_!2V3_@IH/'6L?\ "2R?";_A CX<\N+["+3[<+S[1NV^9YNX;<9V
MX[9KS?X1_P#!(?3_ -G_ /X*,^*?V\_@C^UM\0-!T?Q_KD^M?$#X1*\,NAZW
MJ,EK-!YSD@.H5YFG .XB0##!0% !X)_P:5^!O"?AS_@F1K7B_1]"MH-3\1?%
MW7Y=8ODB ENC#)'#$';J51%PJ]!N8CECG1_X-[-/L?#WQU_;P\):':1VFF:?
M^U_XB%C86ZA8K<&60811PHPBC X 4#M7UE_P39_X)^^ O^":7[-O_#-/PX\=
M:OXBTW_A)-0UG^T=;CB2?S+N02.F(E"[5(P.,^M'[%/_  3]\!?L2?$#XU?$
M'P7XZU?6;CXV?%&^\;ZU!JD<2II]U<NS-!!Y:@F,;C@MEN.M 'E?_!Q#\&/%
MWQ[_ .",7QX\ >!K*6YU&#PW::TMO I9Y(=,U*TU*=0HY8^3:28 Y)QCFO4O
M^"5/QU\!?M(?\$X?@K\6/ASJMM<V%W\-])M;A+9PPM+RVM8[>ZMFQT:*>*2,
MCU2O?IX(;F%[:YA62.12LD;J"K*1@@@]0:_.?7/^#>^U^$OQ$\0>-_\ @FQ_
MP4)^+/[-VF>*[]K[7/ OA66*_P##XN6^]);V<S(("1P/F;8,*FU $ !]+?'_
M /X*4? ;]GK]M/X2?L%:YHOB'7?'WQ@CO)M'L_#=I!.FD6UN-QN[\/,CQ0.J
M7!5T60_Z++E1C-?&7@#]K/XQ^/?VZOVA]$_X(J_\$WO NIZIIOC6/1OC;\;O
MB9XYGL;+5M?M/-C^SQVT8>:1(29ANB(4@YV*&C+_ $E_P3Y_X(V_ S]A?XIZ
M_P#M.^*/BIXT^,'QG\4VOV;6_BI\2]3^UWZV_P N;>U7&+>(A$!Y=\*%#A,(
M.)\3_P#!$SQEX&_:6^(/[0_["?\ P43^(WP*@^+.M-K'Q%\):)H>G:M87VH.
M7:6ZMEO4/V261W=RP#D,[!2%VJH!\Y?\$P3^U%!_P<H_'JW_ &Q]5^&TWQ$F
M_9VTV7Q'#\*(+R/2(#]JTKR(Q]L)GDE6!H]SO@D,, # KOO^#5GX?^$]%_92
M^.'CVRT6W75]?_:6\2Q:GJ'E#S9H;=+400ENI1#),RKT!F<_Q&O=OV-/^"*7
MP0_8@_;.U']MKX:?'#XA:_XH\2> IO#OCF7QQJZZG-XCN9;V.[DU2XG959+@
MM#!&%C"Q*D0 09)KU#_@G5_P3]\!?\$Y/A%XE^$'P\\=:OX@M/$OQ!U3Q9<W
M>M1Q+)#<7OE;X5$2@;%\H8)YY.30!^47_!)6_P#^"OVM?M"?M??%/]B[P?\
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MM=M87T?F7*QW4<0,VX*$ML<F("OH[]KS_@COX;^.7[3I_;C_ &7_ -J/QS\
M_C'=Z0FE^(/%G@=8+BU\0VB*JQIJ%C<#R[ED5(U5B1Q&FX,40KJ?L*_\$D_
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G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>dxcm-20241231_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20241231_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8\@;WA)$BKD@;BN,\9KTB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **\K^+O[;G[*GP%^*>D?!+XO?&C2]"\5:]#;RZ1HMW',
M9;E)YG@B92B%?FEC=1DCE:]4H ***^>/C;_P5@_X)X?L[^*9_!/Q5_:CT*UU
M:TE,5Y8:5;76J26T@."DHLHIO+<'JK8([B@#Z'HKQW]G+_@H#^QI^UKJ#Z+^
MSY^T%H7B#44B,AT@-):WIC RSBVN4CE91W8*0.^*]BH **** "BBB@ HHHH
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MGW\/+7QQ\;]5NYKO5)7BT'P[I$2RWVI2( 7V*S*JHFY=TCL%7<!RS*I_-/\
MX-PM._8.\2?$BZBUSP/?1_'#1;66YT>_U[5%GM+BU(*RR6$01!#,BMAU?S)-
MA+(^TR*G*?\ !<O6_'7BW_@L'X(\'0^!XO%8TZR\.VWAWPC?S".VU=I;MI#:
ML6(4+/*YB9B1Q@$_**![L^J_@[_P<F_LP>,_'>G>%?C#\%_%O@'3=7918^([
MYX[JU16; EE"!76+U=%DQWXR1[S_ ,%#?^"I/@#_ ()XV7A'7_&GPEU_Q3HO
MC&.<Z=K/AVZMS DD0C;8Q=A]Y)%=",A@&Q]TU\0_\% O#W_!6G_@H+\%M/\
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MZ7J%M\*Y-0T?Q+HT*S:OX4UY$2ZCA+!1/&R,RS0[B%+*<J2H95W+GZ2K\?\
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MQ#^[@15')=E591&N/F&]U..H7I7UC^P5_P %%/V??^"AO@&_\8?!>XU"SO\
M19HXM?\ #NM0I'>6#2!C&Y",RO&^U]KJQSL8$*017Y8?#"7_ (+F_P#!([PW
M=?##PS\"CXH\!6U]-<_9;?PXNNZ8Y<_O)?-LRMS"C8Y65DQ_=!)S]9_\$/OV
M[_V7/VC-;\1?"3P'^R#X4^$WCZPTG^T-4_X1338HX-9M$F2-W\S8LJF.29!Y
M4C/@/E6.&"@-'Z*U_.U_P5R^'.L?%/\ X*Z_%_PIH()N8K)M3"!<ETL?#4=Z
MZ@=R4MV ]S7]$M?B_K&B:7XE_P"#H&]\.:Y9K<66H:E-;7EN_P!V6*3PBRNI
M]BI(_&@$?3'_  2,_;/T[1_^",=_\4?$5ZDUS\&]+UJRO$E?F06L;7=K'CWB
MF@B7U*XK\0/%'@[Q2?!VC_&KQ-=22GQ;X@U.*.28?/.]O]F>6;/<,]T1]8VK
MVZZ^./C#]C3X.?M'?\$\]0DN6F\0^,;+3?-Q@0_V;?3"Y<>TR1PJ?50,<5W'
M_!2[X)?\*!_9)_9)\"W%IY-Y<_#[4=8U%67#BXO[J"\97_VE\X1^VP#M04MS
M]O/VW?VZO@1^P)\)T^*WQPU&\=+RZ^R:-HNDPK+>ZE<;2Q2)695 51N9V954
M8&<LJM\3Z;_P<Z?!2+4;.Y\9?LE>.M,T.\D_=:K%?6\S.F?O)&PC5\#J!)^-
M>L?\%K_VFOV&?@-X(\+Z3^U/^S38_%;Q+J9NSX0\.S%89+:/]T)YFNL%[:-F
M$2_(&9V484A"5^.O^"HOQA_X*>?&[]AR74OCO^QGX.^%7PFT_4--DL;22X5]
M7C?>([>..,S;H H;:5,$1"[ATXH)2/TZ^,'[>WP<^&?[$%S^WMX<AO/%/@Y-
M*L]0M(]+"QSW,5Q<Q6P $NW8ZO+\RM@J48'D5\B^*_\ @YK_ &5M%\*^'-9\
M._!;Q9JVHZPDTNJZ0MU;Q-I,:3R1(KOEA)*X3S B\!'0E@3BO/[-I6_X-5B9
MG+'^SY "?3_A,C@?@,"O1/\ @W0_9W^#^I?L&:GX^\4?#?1-6U/Q-XRO8[^[
MU32XKAWMH$A2*#,BG]VK"1PO3=(30%D>_?MQ_P#!6[]G?]@_P7X>O_B=H&N7
MGBSQ1I,>H:;X$LTB%_;0N.6NV+F.!5?='D%RSHP0,%8CPWP[_P ')?[+EU\-
M]:\4>-?@QXQ\/^(-,@M[G3_#%V86.L6\LZ1%[:<E59D#^8RLJY16*EL''S'^
MT/IFB?%C_@Y9L/!GQNM8KO18/%FCV]KI^HJ&@9(](AGMHBK<,DDY5BIR&,I&
M#G%?5G_!R;X*^'>J?L#6?C/Q#IUFNNZ/XSL8O#EZR*)@9EE$T"-UV-$K.R="
M85./E& -#TCXU_M:_L[?M5_\$B->_:K^*?PL\1W'P\U_27?4_"]O?QPZB\<.
MK"U"K*C;5/FQ!\@_=XK)_P""7OQM_93\#_\ !-KQ5\<OV8_A-XFT#P3X5NM<
MU6ZT#7-56ZO9Y;6U2>;9(6(&]44*"< ]:^?O"7_*K1+_ -B]>_\ J4RU;_X)
M._\ * [XQ_\ 8+\:?^FD4!8[S3/^#D/]DK5OA/)XVL?A5XQG\22ZS+8:7X&M
M4@FO;E$ACD-T[HQ2*#,FP$Y=F1MJD*Q7T;_@GO\ \%K_ -G?]OKXCR_!;3_!
MFM>#O%YM9;G3],U>6.:'4(XQND6&:/&9%4%RC*OR@D%MK8^9/^#6OX>^$V\%
M_%7XIS:';2:X-6L-,@U&2(&6&V$4DK1HQY579E+ ?>\M,YVC'G>G:%I7@O\
MX.@_[-\,6,5E!)XODG:*V0(IDN?#QEF; [N\LC'U+'UH'9'[5U^5O_!0%O"9
M_P"#@+X%K^T/_9__  @P\(1?8?[?V?V?YW_$S\O=YG[O=]K\C.?^F>>-M?JE
M7F'[3G[&/[,/[9/A^R\-?M*?"'3_ !/;Z;*TFG2S336]Q:%L;Q'/;NDJ!MJ[
ME# -M7(.!0)'YW?\$?O$O@OP;_P4I_:X\6^ =5L+'X4Z4]_>7%[I[JNF6Z1:
ME,\,B%/D$2PB\*%?EV [>*]!_P""4/AW7?VZ?VQOB7_P5F^)FES)IC7LOAGX
M1V-XO-I8QC9),H/W6$16,LO!DGNN]87_  4Z\%?"W]F3X0^$/^"3W_!/KX:Z
M?X;\3?'77X8]6M[":629-,60(\US/*SS.LC+M+NS 0P7 X%2_$7XT_M,_"']
MI[P!_P $7O\ @FGXC\.>#1X/\%13:YXS\1:2ETTDHM6NY&,;)(B^8&61B$9F
MEN3RBJ20#]-Z*^+/^"//_!0+XR_M?:;\1/@W^TK8::/'WPKUV.PU74])@\F'
M48W>>+>8Q\JR));2ABH52&0A0<U]IT""BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#XN_X+6?L"_'/_@H#\&/!_@'X$W>@PWV
MA>)WU"].O:@]O&8C;/&-I2-R6W,.,#BOH/\ 8M^$/BOX _LE_#KX)^.I+1]9
M\+>$;+3=3:PF,D)FBB5&V,54LN1P2!]*].HH _*[]JW_ ((F?M->%_V\[;]L
M?_@G7XF\*Z#&VJ1ZZ=-UG4);46&I[R;B.-(XG#VTP)+)D#$LD> FVO8O^"I_
M_!*+QQ^W]HW@[X\_#;Q)IO@OXP^%]*ABF26]E:SN0&\X0"YC3S$>&=I#%,$Y
MWG<JY!3[OHH'=GY)>/?^">?_  7/_;>F\,_"S]KOX^>&]#\)>'-02Z.K6-W;
M^?)*JM']I$=E&C3SA&8+YC1K\['())/ZE_"/X::/\'/A?H'PJT#4M0O;/P_I
M,-C#>ZM=M<75R(T"F661N7D8@LQZ9)P ,"NBHH%<_(<_\&[?Q'_X>%_\+(6]
M\*_\*6_X3O\ MG^S/MTGVS^S]_VC[#Y'E;=N_P#T?.__ %?S=>*_5+XS_"/P
M5\>_A-XB^"_Q%T]KG0_$^D3Z=J44;;7$<B%=R-@[74D,K=F4'M7344#NS\CO
MAI_P35_X+5?\$]]1\1?#O]A;XX>%]8\%:]>-<0O>R6R/%(5"+<-;WD3+!/L5
M0QB9U8*N<[5"_3'_  2/_P""9'Q<_8G/B+XK_M'?&>?Q-XV\5(R3:;8:I<3:
M?IZ22B:5R9=HFN9) I:38-N"%+!F)^V:* N?G?\ L:_\$N?VEO@-_P %8/B)
M^VGXXOO##^#_ !3K'B6ZTR*QU622]"7]Z9X-\9B55.P_-AC@],U8_P""W/\
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M_@H7^P!XRT7^W;JYAO+G3-7NT@ELKM;86LA3S5,4T$L0.Y696!D< $$$>?\
M[7W_  1V_P""KO[<NE:/\7?VA/CUX'U3QG:RFTM/"4$CVNG:/IY4LS)+'"0\
MSR!=PVG@#]XP 5?U[HH'<^"_^"K/_!/']J#]N[]E3X4?#7P&WABT\4>%Y8;G
MQ/'J6KR1VRR_81%(L,BPL9 )<X)5<K@X'2OHWPM\!/'.C?\ !/+3OV7KN6P/
MB6U^#$/A:61+AC:_;ETD6A(?;GR_,'WMN=O..U>ST4"/A;_@BI_P3A^.?[!'
M@'XB^$?VB'\-WG_"6W]E):1:+?O=1O%'%,DBR"2),9\P#&"",U\\:G_P1V_X
M*0_L-?M*:S\3O^"77QATF#PYKY>-+35;V%9K2V9]XM[F&ZBDAN%C)PDHS)@$
M[5).?UPHH'<_(+QC_P $,/V__&'[3/@7]IWXE?'?PWXV\3/KMAK'Q"U*_P!0
MD@6&6"[1A;VB+;@/&D$:!>(ES\JHJJ"?U]HHH%<\_P#VH/V9_A5^UY\$M:^
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M:=;B=FD=$,LTDJ1DD(JIL(4L&)'W;10%PK\]$_X)?_M)K_P6W_X>#F^\,_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MYZ_;2N_V*_BEXB\._LM?M-:G)#KNO2)/X7>&UGCEMY)7:%7CNA&8D+,A0HY(
M)"[E^Z:^A:\=_:]_8G^$_P"V/X<L=.\=37FG:II#NVD:[IC*)[??C<C!@1)&
M2JDJ<$$9!7)SX^?T,9B<JJ4\-3A4D[>Y4^&2OJO)M;-W2=KGE9U1Q6(RZ=/#
MTX5).WNS^&2OJO)VV;T3L?G7\&F^+O[&NH?#CXR_##XK7<^D>,?&U_H]_P"#
MY';;/':WPMVW1Y*2[T88D"JT;D8ZBN^_:@_:+UZ\_P""ADOC'XP_!;Q!XG\+
M?#:]EM?"GA_3H66![E&7%U(S(0^7'F<#GRXE)(4Y]E_83_X)@:-\.+K2_C#^
MT -7O?%&B:G<MHFAZA>126=B%N',-R%C9]SL,2@;L*SY*[@"/M.OSC(N#<XQ
M&2QIU*KP\7*G.--KVEG&.O-&327-/W^35)I77;X3)N%<UKY3&$ZCH1YH34&N
M>SC'7F4K)<TO>Y=4K*Z/RK_8<_:T_L+]OWQ=XT_X53J\_P#PLWQ$;+['&_SZ
M/]KU)&\R;Y.0F[#<+T[5^ID.K:7<7KZ=!J5N]Q&"9($F4NN/50<CJ/SKR'X)
M?L7>#?@?^T%XV_:&T7Q?J=[J'CB:XDO;"Z2,0VYEN//(0J QP>!D]*\U^ GP
M';2_^"EOQ'^-WA>PUTZ(V@2VFJZAJ^GFWADU:>X@<P6FY09HDAA!,@R-SCD@
M@GW>'<-G?#6$IX;$I5'5K26EERQ?-)STOS7M=K3EO:Y[&18?-\@PT,/B$JCJ
MU9=ERI\S<M+WONUI;:YY7_P18"^$_BS\;/A_K+B+4H+ZRWP.</\ Z//?1RG'
MLTB _P"\*I?\$L=?T6S_ &@?V@/CG?Z@(?#=@T]U=:@$9T2%[NYN-XV@E@(X
MF;@$X^M>V?M$?\$L?AK\:/BC??&#P/\ $W7O VLZTK+K_P#8N&AOM^!(Q7<I
M5G ^?YBK'DKDDGU?]F;]DSX3_LL_"N3X4^!;"6\MKV1Y=9O=4VR2ZC(RA&,F
M %V[1M" 8 ]26)\_)N&,\PN*P>&JPC&EA)5I1GS7Y_:7Y5RJS5N;WK[VT9Q9
M7P]G&&Q.%P]2,52PTJLHSO?GY[\ONK56OK?Y'DW[0'PI_9,_X*4?!^X^+^C?
M$^]N;7PE8ZC;Z;K%E(]O!97 1)9&EBGC5F "1DYP"G0\AJY/_@FC^VE(_P"Q
M]K?C#]H_Q'%9:-X#U6'38=>^P-M^S.D8BB9($.61G5,A>0Z9YR3-XK_X(Q?"
MZ\U_43\.OCCXL\+^'-8FWZEX8M'$L+KG(C#%AE1_")!(1ZFOH+P'^R-\"?A[
M\ )_V:-'\(+/X6O;:2+4X+R3=+?/(!OFED&"920I#+C;M7;M"J!VX++.)JN>
M/,)T*="HJ<XS:DY1K3LE!N*U48VOJ^:VB.K"9?Q!4S=XZ=&%&:A)2:DW&K*U
MH-Q6JC&U]7S6T/FS]OSX%?L]_'OX#ZE_P4 \"?$&];5+#1K6Z\.ZH)0+.9(9
MMJ0F"6,,&9V88;#"0C(ZJ?</V!_C[XH^.7[)7AGXJ?%6ZMX=3F-Q:7=^X6&.
M[:&=XA,!PH+!.0,#<&P .!XNO_!%3X:?;AHDG[0OC5O!ZWOVD>%R\>-V?[_W
M-V.-WE9QWKW7XX?L6?"[XQ_LYV'[,>G7%SX:\.Z9-;/8KI**SQ+#NPO[P'=D
ML2S'+$DDDDDT\KP'$5#-:^9RPL:4I4[.G&HK5:M[\]]5%;I-WE9ZW*R[!9[1
MS&MF#P\:;=.S@IZ5:E[\]]5%;I7N]=3Y@_X+IV<TN@?"OQK:CSK&SU/48WEC
M.5+2I:NG(XY6%\?2K/\ P7&\0:7KGPI^&VE:-=)=3:MK<]WIZP'<9XA @#*!
MU!,R8^HKZ?\ &7[''PH^(W[,6D?LL^.Q=W^CZ+I-G9Z?J2NL=W!);1"*.Y1@
M"JR8SG@J0S @@D5Y%\%/^"2'PO\ AI\2M'^(OCWXK^(?&O\ PC;HWAW2M6"I
M;VAC;=&&&YBRHWS!%V+D#((XKASOAS/L9B<9&A2CR8V-'FDY+]TZ=E+3>2:V
MMU./-\BSK%XC%1HTURXM4N9\R_=N&CTWDK;6ZGU)X/TNXT/PCI6B79S+9Z=!
M!*<Y^9(U4_J*^%_VUK2UU#_@KO\ !FPO8%EAG\/Z?'-$XR'4WVH @^Q!K[YK
MQCXJ_L6>#?BO^U'X2_:GU7QAJ=KJGA&S@M[33+=(S;SB*:>4%R1N!)G8'!Z*
M*^KXFRK$YEEU&AAU=QJ4Y.[M[L9)O?R/I.(,MQ&/P-*C05W&I3D[O[,9)O\
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MX\/B<-BZ?/0FIQVO%IK[T%%%%=!N%%%% !1110 4444 %%%% !1110 4444
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MT$_^25/_ ) _1*BOSM_X?X_]6H_^7U_]PT?\/\?^K4?_ "^O_N&C_B)7!/\
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M%\.\+# Y7B<-#:&(JQ7I%I?H?=<"X:.#R[$4([0K5(KY-(****^^/M0HHHH
M**** "BBB@ HHHH **** "BBB@ KP'_@J/\ \F&_$'_KTLO_ $X6U>_5X#_P
M5'_Y,-^(/_7I9?\ IPMJ\3B7_DG,9_UZJ?\ I#/(S_\ Y$6+_P"O53_TEGXL
MT445_&1_*04444 %%%% !1110 4444 %%%% !1110 5[_P#\$M_^3\OA_P#]
M?5]_Z;[FO *]_P#^"6__ "?E\/\ _KZOO_3?<U[?#/\ R4>"_P"OM/\ ]+B>
MMD'_ "/<)_U]I_\ I2/VEHHHK^S3^K@HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH POB-\,/AY\7?#,O@
MWXG>#-.UW2Y7#M9:E;+*@<9PZYY5ADX88(SP:\T_9%_8G^%_[*/AQX=*T;2=
M0\0RW5RTOB5-*$5RUO),SI &9G951"J8# -L!(KVBBN&KEF K8V&,G33JP32
ME;5)V_RT[:VM=WXZF7X*KBXXJ=-.I%-*5M4G;_+3MK;=G(_%SX#?!SX\:1#H
M?Q@^'.EZ_;VS%K7[?;YD@)QDQR##QYP,[2,X&:;\(OV?_@O\!-,GTGX/?#;2
M] BNF!NFL;?][/CIYDC9=\9. Q.,G'6NPHK3ZC@OK7UGV4?:;<W*N:W^*U_Q
M-/J>$^L?6/9Q]I_-9<WW[GAOPO\ V9=6T/\ ;(\8_M/:UX>T+1H+[1O['T>T
MTB1I)M15YDFEU"[8JH65BB1A!G"J<G@%NU^,/[+W[/OQ^N+>]^,'PHTG7+FT
M39;WES"4G1,YV>;&5<KDD[2<9)XYKO:*YJ649?3PTZ$J:E"<G*2DDTW)W;:M
M;TT.>EE>!IT)47!2C*3DU))IMN^UK?@<IHWP+^#WAWX:S_!W0?AOI%GX7NH7
MBNM$MK-4@G5QA]X'WRW<G)/<FN,_X8%_8P_Z-L\*?^"U:]>HK6KE>65E%5*$
M)**LKQB[+LKK1>1I4R[+ZJBIT8OE5E>*=EV6FB/.K3]DC]FBP\#7?PSLO@IH
M$6@7]\EY>Z0ED!!-.@PLC+W8 <&L;_A@7]C#_HVSPI_X+5KUZBHED^4S24L/
M!V5E[D=%V6FQ$LKRR=N:A!VT7NQT7;8X>?\ 9K^ ES\,H?@Q<?"C17\*6]R;
MB#06M!]F24NS[PGKN9C]2:VKCX7_  YO?A]'\*+[P3IEQX:BL([*/0[FS62V
M%N@"I'Y; C"A1CTP/2MZBNB."P</AIQ6G+LOA_EVV\MC>.$PL/AIQ6G+LOA[
M>GEL>9?##]C3]ESX,^)O^$S^&GP3T33-57/E7ZPM++#D8/EM(S>5D9'R8X)'
M0UZ;113PV$PF"I^SP].,([VBDE]RL/#X;#82GR4(*$>T4DON1ROB/X'_  C\
M7?$+3?BQXF^'NF7WB31XDCTO6KBW#7%JB.[J$;L TCD>[&H;O]G_ ."E]\48
M_C9>?#+1Y/%L14Q^('M ;E2L?E*=_J(_E'M7844I8+!R=W3B]>;9?$MI;;KO
MN)X3"R=W3COS;+XEL_5=]SE;'X'_  BTSXG77QHT_P"'NF0^*[V+R[K7TMP+
MF5-BIM+]QM11]%%=5116M*C1HIJG%1NVW96NWNWYOJS2G2I4K\D4KN[LK7;W
M;\WW"BBBM#0**** "BBB@ HHHH **** "BBB@ HHHH *\!_X*C_\F&_$'_KT
MLO\ TX6U>_5X#_P5'_Y,-^(/_7I9?^G"VKQ.)?\ DG,9_P!>JG_I#/(S_P#Y
M$6+_ .O53_TEGXLT445_&1_*04444 %%%% !1110 4444 %%%% !1110 5[_
M /\ !+?_ )/R^'__ %]7W_ION:\ KW__ ();_P#)^7P__P"OJ^_]-]S7M\,_
M\E'@O^OM/_TN)ZV0?\CW"?\ 7VG_ .E(_:6BBBO[-/ZN"BBB@ HHHH ****
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MO^ODORB?T#X9?\DV_P#KY+\HA1117Z@?H84444 %%%% !1110 4444 %%%%
M!1110 5X#_P5'_Y,-^(/_7I9?^G"VKWZO ?^"H__ "8;\0?^O2R_].%M7B<2
M_P#).8S_ *]5/_2&>1G_ /R(L7_UZJ?^DL_%FBBBOXR/Y2"BBB@ HHHH ***
M* "BBB@ HHHH **** "O?_\ @EO_ ,GY?#__ *^K[_TWW-> 5[__ ,$M_P#D
M_+X?_P#7U??^F^YKV^&?^2CP7_7VG_Z7$];(/^1[A/\ K[3_ /2D?M+1117]
MFG]7!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %?E-_P4$\>Z]\
M9_VEOBMX+^*7Q1O-&TSP#H6_P9X7%SY<-_<!K88VM\KNZ2R3$X+E5 !VKQ^K
M-? /_!1JT_8C_:*TOXAZWX;U><?%7X;Z63J'V:VFM#.L-RENT<HFC"7"H7QO
M3G!7#E<5\!XC8>IBLB4858Q:;ER2ER^T2A*Z5M6U\26S:U/B>.Z$\1D_+"I%
M--RY92MSI1E=+NU\26SMJ>T?L&_LN_'K]F75M:TK7_B_!XA^'>I6D<_AG3+N
MYFDO;&4[&&0R".-2K.K*C$,51@!DBO'=#_86_:W_ &P/B7XM\>?MA_$3Q-X'
MMXKD?\(GHFDZK!<0Q(Q<J$$4KQHD:A >CR%B2P(R8OV!M7^,O[./[:M]^QCK
MGQ2N/%OA>7PPNHVHG9B-/8P13H55F8P<.49 VUMRMUQ6]^VQ^V+\3OC5\4)/
MV$OV+HWNM=O'>T\5>([>7:MF@XFA20?ZM4&1++U!RB_-7@^TX?J\.TGB854J
M-2=-8?G<N>K_ ")K62BW>-FDM;WV/'Y\DJY%3>(A42I3E!4.:_/4_DNM9*+=
MXV:2ZW+/_!'_ ..'Q5\:)\0/@O\ $#QI<>)['P7?P)HVN7,[3,4=YXS'YC$E
MHSY(= 2=H+#I@#W_ /;@^-FO_L[_ ++'B_XM^%$0ZIIUE%%IKR(&6*>>>.W2
M4@\'89=^#P=N#UJ#]C+]DOP=^QQ\'T\":/?+>ZE=2?:_$6M.FS[7<;<< _=B
M0#"KG@9)Y8FN@_:$T#X._%3X#>)_"?Q4\66%IX6OM/:'5=6?4(XX[/YE9)?,
M8[59)!&R[N,A>#G%?6Y5@,VP'!OU2K4MB%3G9N5^5OF<4Y?W+I7\NQ]+EN#S
M/!<*_5JM2U?DG9M_"W=Q5_[ETK^78_/>7]EWXUK^QG'_ ,%!;3]J7Q8WC;[/
M_;,T+:C)L^S>?LV"3?NWA?GY^0\IMQ\U>W>-_P#@H/XZD_X)<67[0FFWD=KX
MTU:X7P\U[#$H$-\)'62X5>@8PQ-*H PK..,#%>1>/?V?OVB/ G[#OB&TL?VT
M?#.O?!/3;6>;2!HUMON-1<7)6.UWE/W:-=8RHF< Y !'%<AXP\!^(+;_ ((Q
M>&-:EM9!"_Q3;5.5/%N4NK0,?8R8Q]1ZU^7T\5CLG5:&$ISI-X-RG>7-S5$T
MG5BU*6]W:6E]TC\\AB<9E:JQPT)TV\*Y2O+FO--)U(M2EO=VEI?>QI_$+X'?
M'C]EG]F?P-^WEX4_:-\37'BC6I[&\UJSN[QWA\J[B::(-N8F4 ;$=9,AMYZ8
MP?8?V]OVL_B=\1/ ?P5^&?P<\33^&'^,5K:76IZE9S,DD"7!MXUMPZD,%#S/
MOP02(P,X+ Q?MT^,-!O?^"17P]EM[^)O[3T[PY!:JKC)ECM0SI]5\IP?0J:E
M^+'[.7PM\>_L/_ ^R^('QOTCX>>.-'\.VEQX/U'6+Q8O.=XH))("N0YVL8#N
M7)C;''S$'T*N$Q&$AB\#EDVH2P]"HUSVO)R2E:4G[LJD;]5=V.VIAJ^&AB<'
ME\VH2HT9M<]KMR7-:3>CG&_579P/QL\*_$W_ (),?&;P)XY\$_''7O$GA7Q)
M-*GB#1]8F)$PA:+SP4!*Y9)MT;@;D92"2#S^ED4L<T:S0N&1U#*P/!!Z&OR;
M_P""E/PK_:GTB?P':?M-?''2_&/BC4YKBST#1- LA'%;0@Q!I3B.+=)+(\:_
M<Y\O&XXPOZJ:;/IOAW3=/T#4-6MTG2VBAC2295:4@!> 3DY(KZC@FK*CF^8X
M2%.5*A!TG"$W=P<HOF7Q2MS64K7=K]+GT7"525+,\=AH0E3HP=-QA)W<7*+N
MMY6O9.U]#X:_;\U[QY\7OV\?!7[)?BSXN:CX'\ ZGI27$MW9W?V=;R5EG8EF
M)"NS/$L"!LJK'."6P:W['MYXS_9[_P""C&H_LG?#GXR:IXV\!R:/)<7JW][]
MI7376W$H8E3L219-L3% H;S0&&X#$7[7-F_[97_!2W1?V-?B)K+:3X1\/68G
MC-E%$MU>3/8"[<I*ZL06!6/'*@1,=I;FJ?PE\,Q?L _\%-=*_9S^#^N3:KX6
M\<Z9 VJ6>HQQ2W5J66<H#,J*V4:+S,< QR8()PU?-59U/]998[7V<<8J;J\S
MYEHDZ/)>SI\VG-O;7E9\_4E4_P!8)8S7D6*4/:<SYEHDZ7)>W)?3FWMK9GZ(
MU^+OQJ^)7Q5\!_ME>/\ XHZ!XFU22U\(?%RZG:T&H2>6H&I3M&I7.-A,6PCI
M\P'>OVBK\I-.^&/_  MKXJ_MB>&(;?S+FV;5]2LP!EO-M-9>X 7W81E/^!8K
MW/$RAB,33P=.A)J?-4:MWC3<E^*/8\0:-?$0PM.BVI<TVK=XP<E^*/H3_@KG
M\8-5UOX1_#CX6?"G7)TOOB)X@AN;":SG9'FME11&N5.0'DN83[[/K57_ ((=
M:_KNO_"#QO/KNM7=Z\?B2!8WN[EI"H^SC@%B<"O /V,?%VO?M<?M0?"?2/$%
MO(]E\*/ $J3*QR#]D,P@F'I\TMFI_P"N?XU[I_P0C_Y(YXY_[&:#_P!)Q7AY
M'F53/..,-FB;4*BJ0BNEJ=*#?_DTY?<>1E&/GG'%]#,4WR5%.*7^"G!O_P F
ME(^[****_;3]<"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Y3_X++?\
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MKQ.)?^2<QG_7JI_Z0SR,_P#^1%B_^O53_P!)9^+-%%%?QD?RD%%%% !1110
M4444 %%%% !1110 4444 %>__P#!+?\ Y/R^'_\ U]7W_ION:\ KW_\ X);_
M /)^7P__ .OJ^_\ 3?<U[?#/_)1X+_K[3_\ 2XGK9!_R/<)_U]I_^E(_:6BB
MBO[-/ZN"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *^/O\ @H3_
M ,$T?#7QU@UOXY_"*UU"#Q])9J'TNQGB2WUEQM3]YYA41OY?5@P#!>02<U]@
MT5Y><9-E^>X&6%Q<.:+V[Q=K*47T:OI]SNM#SLURK!9S@Y8;%1O%[=T^C3Z-
M?\/H>#_LD_L'_#K]EO3=1\1Z/K6JZGXQU^P\K5/$VL2I+<19 8QQ@#"J'"L<
MEBQ098@ #Q.Y_P""%_P7O+F2\N_CEXNEEE<O++)#;,SL3DDDIR2>]?<E%>=7
MX/X;Q.%I8>KAHN%._*M=.:UWHU=NRNWJ<-;A?(,1AZ="I03A"_*M=+[O1ZMV
MU;U/FS]G#_@GG\,OV0/#OCB?1/B!KVIV_B;0&M-1-S:(\D$2)+EHDB3<[X<X
M7!)(  K$_P""<?[,6F^&_P!EGQC\/_''A?4CX9\:^)]0ETRP\0V_D7EQH[P1
M6\4DT8P89'6-GQP0"I'8U]745=#AC*<+7HRH4U&%*,XJ.Z_>6YKW;TWT\]^A
M='A[+<-6I2HP48TU-*.Z]^U[W;TWT\SXKT__ ((K?#"#4UTC4?C]XRNO!R7_
M -K3PH9$1"_^U(/E)QP7$:MC.".M?4GB?X"_"CQ;\&)?V?=5\(6X\)2:6FGI
MI4&46&%,>7L/560JK!NH90>M=A16V7\-Y%E<*D<-0C%5%:6[NOY=6_=_N[>1
MK@L@R?+H3CAZ*2FK2W=UVUOIY;>1\9^$_P#@B_\ "'2?%&GR^,/C+XJ\1>%]
M)NVGT[PG?,B0KEMQ1W4XVM@;MBQEO45[M^U?^Q_\+?VN?AO;?#[QR+BP;39_
M/T74],"K+8OMVD*""K1E<!D(P<#&" 1ZM148;A?A_"82KA:6'BJ=7XEJ[I;*
M[;=ET2>G2Q&'X=R3"X6IAZ=!*%3XEJ[VVU;;TZ:Z=+'RW^S_ /\ !++X:_"7
MXF6'Q?\ B/\ $[7_ !_KFC;/[$?73B&S*?ZMPA9V9DZIEMJGD+D CNOV@/V)
M_!G[0?QO\$?''7_&.J6%[X'NK>>RLK..,Q7!BN5N '+ D LN#C'%>U45='AK
M(Z&">$A02IN2DUKK)---MN[:LMV52R#)Z.$>&A12@VI-:ZR333;O=M66[/ O
MVM?^">_PM_:I\2:?\1V\3:KX5\7:9&L=KXBT-P'=%)9!(IQN*$G:RLK#.,D
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MY=D-?$X>7+.*NG9.VJZ--?@</_P_Q_ZM1_\ +Z_^X:/^'^/_ %:C_P"7U_\
M<-?G;17\Z?\ $2N-O^@K_P DI_\ R!^%?Z_\6_\ 03_Y)3_^0/T2_P"'^/\
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MW_05_P"24_\ Y /]?^+?^@G_ ,DI_P#R!^B7_#_'_JU'_P OK_[AH_X?X_\
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M110 4444 %%%% !1110 5[__ ,$M_P#D_+X?_P#7U??^F^YKP"O?_P#@EO\
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MUK/_ +%O4/\ T%:_7>OZ8\)/^25E_P!?)?E$_H'PR_Y)M_\ 7R7Y1"BBBOU
M_0PHHHH **** "BBB@ HHHH **** "BBB@ KP'_@J/\ \F&_$'_KTLO_ $X6
MU>_5X#_P5'_Y,-^(/_7I9?\ IPMJ\3B7_DG,9_UZJ?\ I#/(S_\ Y$6+_P"O
M53_TEGXLT445_&1_*04444 %%%% !1110 4444 %%%% !1110 5[_P#\$M_^
M3\OA_P#]?5]_Z;[FO *]_P#^"6__ "?E\/\ _KZOO_3?<U[?#/\ R4>"_P"O
MM/\ ]+B>MD'_ "/<)_U]I_\ I2/VEHHHK^S3^K@HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "OB7_@NE_R;=X3_ .QXC_\ 2.YK[:KXE_X+I?\
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M %%%% !1110 5[__ ,$M_P#D_+X?_P#7U??^F^YKP"O?_P#@EO\ \GY?#_\
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M_DJH_P#7N/YR/Y^\3?\ DI%_U[C^<@HHHK\P/SP**** "BBB@ HHHH ****
M"BBB@ HHHH ^K?\ @C/_ ,GK6?\ V+>H?^@K7Z[U^1'_  1G_P"3UK/_ +%O
M4/\ T%:_7>OZ8\)/^25E_P!?)?E$_H'PR_Y)M_\ 7R7Y1"BBBOU _0PHHHH
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M(_\ TCN:^0X]_P"20QG^']4?+\:?\DOBO\/ZH_+6BBBOY&/YC"BBB@ HHHH
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M *<+:O$XE_Y)S&?]>JG_ *0SR,__ .1%B_\ KU4_])9^+-%%%?QD?RD%%%%
M!1110 4444 %%%% !1110 4444 %>_\ _!+?_D_+X?\ _7U??^F^YKP"O?\
M_@EO_P GY?#_ /Z^K[_TWW->WPS_ ,E'@O\ K[3_ /2XGK9!_P CW"?]?:?_
M *4C]I:***_LT_JX**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K
MXE_X+I?\FW>$_P#L>(__ $CN:^VJ^)?^"Z7_ ";=X3_['B/_ -([FOD./?\
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M\3B7_DG,9_UZJ?\ I#/(S_\ Y$6+_P"O53_TEGXLT445_&1_*04444 %%%%
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M%% !1110 4444 %%%% !1110 5X#_P %1_\ DPWX@_\ 7I9?^G"VKWZO ?\
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MOW#R?.SCR\_^S=,\5VE?%]>T? GX[_ZGP3XVO/1+"_E;\!&Y/Z-^!K](XO\
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MO_3?<UX!7O\ _P $M_\ D_+X?_\ 7U??^F^YKVN&?^2CP7_7VG_Z7$]7(/\
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MRG_P66_Y,HO?^QCT_P#]#:OR'K]>/^"RW_)E%[_V,>G_ /H;5^0]?S-XM_\
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MAE_R3;_Z^2_*(4445^H'Z&%%%% !1110 4444 %%%% !1110 4444 %> _\
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MBW_R54?^O<?SD?S]XF_\E(O^O<?SD%%%%?F!^>!1110 4444 %%%% !1110
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M5_(Q_,84444 %%%% !1110 4444 %%%% !1110 5]M_\$+?^3D?%G_8CR?\
MI9;5\25]M_\ !"W_ ).1\6?]B/)_Z66U?7<!_P#)7X/_ !?HSZ?@S_DJ,+_B
M_1GZDT445_71_3H4444 %%%% !1110 4444 %%%% !1110 4444 ?*?_  66
M_P"3*+W_ +&/3_\ T-J_(>OUX_X++?\ )E%[_P!C'I__ *&U?D/7\S>+?_)5
M1_Z]Q_.1_/WB;_R4B_Z]Q_.04445^8'YX%%%% !1110 4444 %%%% !1110
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M%% !1110 4444 ?*?_!9;_DRB]_[&/3_ /T-J_(>OUX_X++?\F47O_8QZ?\
M^AM7Y#U_,WBW_P E5'_KW'\Y'\_>)O\ R4B_Z]Q_.04445^8'YX%%%% !111
M0 4444 %%%% !1110 4444 ?5O\ P1G_ .3UK/\ [%O4/_05K]=Z_(C_ ((S
M_P#)ZUG_ -BWJ'_H*U^N]?TQX2?\DK+_ *^2_*)_0/AE_P DV_\ KY+\HA11
M17Z@?H84444 %%%% !1110 4444 %%%% !1110 5X#_P5'_Y,-^(/_7I9?\
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MG_I+/Q9HHHK^,C^4@HHHH **** "BBB@ HHHH **** "BBB@ KW_ /X);_\
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MJ'_R(?ZN\/\ _0'2_P#!</\ (^=O^'4'[ 7_ $03_P NG5?_ )*H_P"'4'[
M7_1!/_+IU7_Y*KZ)HH_U7X9_Z :/_@J'_P B'^KO#_\ T!TO_!</\CYV_P"'
M4'[ 7_1!/_+IU7_Y*H_X=0?L!?\ 1!/_ "Z=5_\ DJOHFBC_ %7X9_Z :/\
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MG_ETZK_\E4?\.H/V O\ H@G_ )=.J_\ R57T311_JOPS_P! -'_P5#_Y$/\
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 ?EK_P '0GP8\ 7/P"\
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MT=X+^-?BO6=1T6WNXH=/U2WMEAD$]O) Q8QH&X$A(P>H% :6.Y^)(_X)_?\
M!9WP3K/[.UC\7=2UZV\">(+>_P!<M- ^T:=/:W9BNK>+<US;@2J-TW"!E#HN
M[L#\V_\ !!?XU^/_  A^T!\8_P#@GK_PD\/B7P'\-M0OW\(:Y':1(46'4FM6
MR\8 D$X82C);!1MIP:]2_::_X(.?!GXR?&[6/CY\$_COXN^%.M>)9)7\2V_A
MHAK:\>5MTS*H>-XS(V6==[(6.0@YS[K^P/\ \$[/@#_P3R^'E[X,^#D%[>ZC
MK,L<WB'Q)K#H]YJ#H"$4[%54B3<^R-1@;F)+,2Q TL>]4444""BBB@ HHHH
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MXMM$T6VD N-6OF4F.WCSTR%+,Y!"(K-@X /KL,,-O"EO;Q+'&BA41%P% X
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3?BOXK_X)A^-=,TKQ!KNBVOAQ-&\1IJUQ=V%^EP[:E+#!;![6&!88B_F ?\
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M?#?P_P".]8\)7V@7>M:':7]UH.J1E+G39)H4D:VF5@I62,L48$ AE/ Z5N4
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M_DJC_AU!^P%_T03_ ,NG5?\ Y*KZ)HKQ/]5^&?\ H!H_^"H?_(GD?ZN\/_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
8% !1110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>dxcm-20241231_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 dxcm-20241231_g5.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M"'X+ZAX8UOQGXV>WBFN="T#RU2Q64 Q+/*Y^61U(98U5VVD$A0R[O/?V:/\
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M+K?B34/%_P!K:RL-!DA$D,<!B!=_,8<,TH5<=2K>E8O[<'_!8CX"_L.7F@^
MO&'@;Q#K_C_7M*@OAX)T)8FFT]9>%2YE+;58L&4*@=CMSM"E2?@C4OB-IO\
MP5V_X+7_  KN='1;OP?X6\-Z-J=Y&GS0I%;VRZI<QNO;-W.+1L\\ 'IQ[+_P
M5@_X)M_MQS_MK6/_  41_81N5U378;6T>;3H9[=;[3KJV@\@20Q77[JXB>%5
MS'RV[?\ (P- 61WWPC_X.)OV>O$7Q3T_X6_M ? ?QG\+Y-4FCCMM4UY4DMH-
M[;5>?(CDBC)X\P(RCJ< $C]#%964,K @C((/6OP[\2?\%7_CIX5^(OAK2/\
M@KG_ ,$W/#7BX:.\L>FW_B;P*]AJ<,;E/.EA2[5[:X^XC;51%) ^=<YK]J_A
MMXQ\)_$3X=:!\0/ 4Z2Z%KNBVNH:+)'%L5[2:%9(2%_A!1EX[4":L?*__!>#
MQ#\3_#?_  3-\=77PQFNH3<3V%KK\]D2)(],DN42?E>0K91'[;'<'@FOS_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KYK_X*7_\
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M6NEIH^JR37 >?4[>Y3>C1(%'EQ-G#'!P.>M?HC110!^<'[4/_!*?]I[XP?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(O[3'[)*7/QFOQ>>-/ _B>_\(^+-0  ^V7=FR$3' 'S-%+#N/=]QP,X')?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'B]\,VFO?#7]GS]M_P")'P[^%_B>\FGU;X<Z,+>:&!9R?.AL[F0>9:1N"05
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M0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\
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MVH_X0?2/^?F]_P# MJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV**
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M?_ MJ/\ A!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P#
MMJV** ,?_A!](_Y^;W_P+:C_ (0?2/\ GYO?_ MJV** ,?\ X0?2/^?F]_\
M MJ/^$'TC_GYO?\ P+:MBB@#'_X0?2/^?F]_\"VH_P"$'TC_ )^;W_P+:MBB
M@#'_ .$'TC_GYO?_  +:C_A!](_Y^;W_ ,"VK8HH Q_^$'TC_GYO?_ MJ/\
MA!](_P"?F]_\"VK8HH Q_P#A!](_Y^;W_P "VH_X0?2/^?F]_P# MJV** *^
MFZ=!I5J+2W>1E#$YE<L>?<U8HHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**;//#:P/<W,JQQQH6D=S@*H&22>PJGX;\2^'?&6@VOBCPGKEIJ6FWT(EL[^
MQN%EAG0]&1U)##W%3S1YN6^O87-'FY;ZEZBBBJ&%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_?\ -\JRSGO_ /7S2?!X-_P_\^+9T_\ U'_"B]-_M#;T^T?:+'R\^_EYQ[4
M?:'C;QAX?^'G@S5_'_BV_%KI6AZ9<:AJ=RPR(;>&-I)'_!5)_"OA?X3?%W_@
MKM^V9\))OVQO@+XW^'G@GPYJ,ES<^ /ACKOAQKN;6+**1D0WEX7#0R2E& ,>
M%((/R @U]$_\%-!J)_X)Y_&K^R]WF_\ "M-8W;.OE_99/,_#9NS[4[_@F@+
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M4);I15GZJUG\S,^$GP,^$/P'T.3PY\(/A[IN@6D\@>Y2P@P\[ 8#2.<O(0.
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MX275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\
MA)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^
MA0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_
M^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_
M +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^
M^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**
MQ_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X2
M75_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X
M275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H
M4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A
M0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH
M V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^E
MH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8H
MK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275
M_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7
M_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?
M^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O
M?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6
M@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_
MX275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^A0O?^^EH V**Q_\
MA)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HK'_X275_^A0O?^^EH_X275_^
MA0O?^^EH V**Q_\ A)=7_P"A0O?^^EH_X275_P#H4+W_ +Z6@#8HJOIMY/?6
MHGN+"2V8L1Y4I&?KQ5B@ HHHH **** "BBB@ KR/]NG]E'0OVV?V6?%7[.&M
MZT=,;7;6-].U18]_V.\AE2:"0KD;E\Q%#*""49@""<UZY10!^62P?\%@/^&F
M_P#A1TGP^^'3?$0_ 7_A'6\?'Q.YLO[+_M+9_;!BV>8;C=\OE[/O_/LV_)7W
MM^Q!^RQH/[%G[+GA+]F[0-9;4E\/64GVW4WBV&\NYI7GGE"Y.U3+(^U<DJH4
M9.,UZKY,7F^?Y2[]NW?MYQUQGTIU 'S5XN_96^*FM?\ !5OPI^V+9+IW_"':
M/\(9_#=X7O"+K[:]Y<3#;%MY3;*OS9ZYXK5_X*"_'']H+X!>$_ GBGX#Q^')
M5U7XE:/H?B*UUV)Y)[BUO;E+8)9HK*7GWR!N^$1VP=M?0%9NM^#O"7B;4-,U
M;Q'X7T[4+K1;PW>CW-[9)+)8W!C:,RPLP)B?8[IN7!VNPS@F@#YO_;N_9(^.
M/CGXO?#[]LW]D+5]$@^)WPW%S:?V1XD=TL?$.E7"D2V<LB9,;#<Y0\ &5B2I
M"D<?X1_9N_;4_:\_:N\"?M$?MQ>"/"W@/PI\*)IK_P (> ?#^N_VI/?ZO(H4
M7ES.JA D>U'0#Y@R 8PS$_:5% [GR%^T;^R[^U3\*/VR9/V\_P!AW2_#GB+4
M?$?AN+1/B/\ #[Q+J)L4U>. K]GN[>YP5CF141#OP J<;MY F_98_99_:<\<
M?M>:C^WY^W!9^'M'\1V_AC_A'? /@3PW?->0:!8M(7EEFN" );ARSC*Y&V1N
MGRJGUO10(^)M1_9R_;D_8J_:3^(GQ9_8C\ ^$_B%X'^*VK?VYK7@G7]?_LJZ
MT?6FSY]Q#,RF-XI22[ _-T4 ; S]]^P%^R)\8OA/XW^(G[5G[5NO:/J'Q5^*
MU_;2:O;>'R[6.B:?;1^7;6$#N-S[5P&;H=B#+%2[?3=% 'C/P4\*_M-_$GP'
M\0_ '[<&C>$Y-/UO5K_3M MO"[2;9] FB,86XW$XF*LX;''-?-/PH^$'_!7K
M]C3X23_L=_ ;P=\._&_AO3GN+;P!\3-<\0M:7&C64LC,@O+,H3-)$7)41[E&
M /G VU]^44 >-?L#_LBZ5^Q'^S)H?P*MM?.L:E!)-?\ B/7&0J=1U*X<R3S8
M/.W)"+GG9&N><URW_!5W]EWXH?MC_L2^)/@'\'5TXZ_JM_ITUJ-4NS!#MAO(
MI7RX5L':AQQR:^CJ* /D+_@I]^Q#\<OVE_@QX U?]F?7+#2?B?\ #S5/,T?4
MKR],"+:7%HUM>1"0*V"W[ING(CQWK%_;/_X)N^/?'7_!*WPW^PE^SPNDOJOA
MZ/1HQ+J-V;>"X:V.ZYF+;3AI)"\F,<ESTK[7HH **** "BBB@ HHHH ****
M"N9^-7_)'/%O_8LW_P#Z3R5TU<S\:O\ DCGBW_L6;_\ ])Y*Y\7_ +I4_P +
M_(PQ/^[3]'^1^ -%%%?P^?R$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !7[A?\ !/K_ ),K^&__ &+$/\VK\/:_<+_@GU_R97\-_P#L6(?YM7Z_X.?\
MCO$?]>__ &Z)^H>%?_(WK_\ 7O\ ]N1[%1117]$G[H%%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %<S\:O^2.>+?\ L6;_ /\ 2>2NFKF?C5_R1SQ;
M_P!BS?\ _I/)7/B_]TJ?X7^1AB?]VGZ/\C\ :***_A\_D(**** "BBB@ HHH
MH **** "BBB@ HHHH **** "OW"_X)]?\F5_#?\ [%B'^;5^'M?N%_P3Z_Y,
MK^&__8L0_P VK]?\'/\ D=XC_KW_ .W1/U#PK_Y&]?\ Z]_^W(]BHHHK^B3]
MT"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KF?C5_P D<\6_]BS?_P#I/)735S/QJ_Y(YXM_[%F__P#2>2N?
M%_[I4_PO\C#$_P"[3]'^1^ -%%%?P^?R$%%%% !1110 4444 %%%% !1110
M4444 %%%% !7[A?\$^O^3*_AO_V+$/\ -J_#VOW"_P""?7_)E?PW_P"Q8A_F
MU?K_ (.?\CO$?]>__;HGZAX5_P#(WK_]>_\ VY'L5%%%?T2?N@4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 9GC7Q%_PA_@W5O%OV/[1_9>F3W?V?S-GF^5&S[=V#MSMQG!QGH:^ /^'^
M/_5J/_E]?_<-?=GQJ_Y(YXM_[%F__P#2>2OP!K\B\3>*,]X>Q&&CE];D4U)O
MW8RO9JWQ1??H?F/B#Q%G&1UL/'!5>124K^[%WLU;XD^_0_1+_A_C_P!6H_\
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M#]$O^'^/_5J/_E]?_<-'_#_'_JU'_P OK_[AK\[:*/\ B)7&W_05_P"24_\
MY /]?^+?^@G_ ,DI_P#R!^B7_#_'_JU'_P OK_[AH_X?X_\ 5J/_ )?7_P!P
MU^=M%'_$2N-O^@K_ ,DI_P#R ?Z_\6_]!/\ Y)3_ /D#]\_V??BS_P +V^"O
MAOXP?V!_97_"0Z8EY_9WVOS_ +/NS\OF;$W].NT?2NQKQW_@GU_R97\-_P#L
M6(?YM7L5?T]E->KB<JH5JKO*4(MONW%-[:;G]#9;6J8C+J-6H[RE"+;\VDV%
M%%%>@=H4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5S/QJ_P"2.>+?^Q9O_P#TGDKI
MJYGXU?\ )'/%O_8LW_\ Z3R5SXO_ '2I_A?Y&&)_W:?H_P C\ :***_A\_D(
M**** "BBB@ HHHH **** "BBB@ HHHH **** "OW"_X)]?\ )E?PW_[%B'^;
M5^'M?N%_P3Z_Y,K^&_\ V+$/\VK]?\'/^1WB/^O?_MT3]0\*_P#D;U_^O?\
M[<CV*BBBOZ)/W0**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** .9^-7_)'/%O\ V+-__P"D\E?@#7[_ 'QJ
M_P"2.>+?^Q9O_P#TGDK\ :_ _&?_ 'O!_P"&?YQ/Q;Q7_P!YPOI/\XA1117X
MF?D@4444 %%%% !1110 4444 %%%% !1110 4444 ?N%_P $^O\ DROX;_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,X74(&8A(P6( !)P. * ZG+_ /!/!?\ AE[]OCXQ_L;W'^CZ)XXTRQ^)_@:
M_*F+E$@U)4'3B?:JJ.BP$_3Y%_X*O+_PT?X;_:+_ &P;G]_I'@_QCH7PN\#3
M'E0EG<?:-4=>Q#7;IM<=0",G%?5O_!5;P_\ &3X)0?!;]OS]G?P#J&N>+OAY
M]HT/5=(TZQDFENM.U"P>,&2-%8LD4R@@8X:;/;(\W_;F_9(\=?!O_@A!X:^
M^A^$=5UGQ6NI:3J?B6VL+&2ZNI=2N;AKJ\9@@+/LEE9-Q'W47I0!^H%%%% @
MHHHH I7WB+1--G^RW^I1Q2  [&/.*B_X3'PQ_P!!J#_OJKTMG:3-OFM8W;U9
M 33?[.T__GQA_P"_0H I_P#"8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\
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M &Y'JO\ PF/AC_H-0?\ ?5'_  F/AC_H-0?]]5<_L[3_ /GQA_[]"C^SM/\
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M<_L[3_\ GQA_[]"C^SM/_P"?&'_OT* *?_"8^&/^@U!_WU1_PF/AC_H-0?\
M?57/[.T__GQA_P"_0H_L[3_^?&'_ +]"@"G_ ,)CX8_Z#4'_ 'U1_P )CX8_
MZ#4'_?57/[.T_P#Y\8?^_0H_L[3_ /GQA_[]"@#COC-XM\-R_!_Q7%'K$)9O
M#5\% /4_9WK\$J_?CXT6%@OP=\6,ME""/#-_@B,?\^[U^ ]?@?C/_O>#_P ,
M_P XGXMXK_[SA?2?YQ"BBBOQ,_) HHHH **** "BBB@ HHHH **** "BBB@
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M_?5'_"8^&/\ H-0?]]5<_L[3_P#GQA_[]"C^SM/_ .?&'_OT* *?_"8^&/\
MH-0?]]4?\)CX8_Z#4'_?57/[.T__ )\8?^_0H_L[3_\ GQA_[]"@"G_PF/AC
M_H-0?]]4?\)CX8_Z#4'_ 'U5S^SM/_Y\8?\ OT*/[.T__GQA_P"_0H I_P#"
M8^&/^@U!_P!]4?\ "8^&/^@U!_WU5S^SM/\ ^?&'_OT*/[.T_P#Y\8?^_0H
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M7X7WGB._\$Z.UI+XL\1RZ[KK-<R2?:+^2&&%Y0'8[ 4@B&U<*-N0,DYZ.B@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YGXU?\
MD<\6_P#8LW__ *3R5TU<S\:O^2.>+?\ L6;_ /\ 2>2N?%_[I4_PO\C#$_[M
M/T?Y'X T445_#Y_(04444 %%%% !1110 4444 %%%% !1110 4444 %?N%_P
M3Z_Y,K^&_P#V+$/\VK\/:_<+_@GU_P F5_#?_L6(?YM7Z_X.?\CO$?\ 7O\
M]NB?J'A7_P C>O\ ]>__ &Y'L5%%%?T2?N@4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M KF?C5_R1SQ;_P!BS?\ _I/)735S/QJ_Y(YXM_[%F_\ _2>2N?%_[I4_PO\
M(PQ/^[3]'^1^ -%%%?P^?R$%%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM/(O^1)A?^O</_24?UED_P#R*,/_ ->X?^DH****]4](**** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M%?T2?N@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%^#'P6\3_$"_\)?#;XA_%"WTGXF>(K"[-L5L,*PM7GZ11R@R,S'@"')RH8$
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MX,^.WPL?1/$][,<0P:QI5ND\%Q(1T+6ZQP*#UR_X?+7[6.@:OXP_X(Z?$?\
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M !#7@G_H%_\ )ZG_ ,F'^H'"7_0-_P"3U/\ Y,_.?_APEJ'_ $=+#_X1A_\
MDRC_ (<):A_T=+#_ .$8?_DROT8HH_XAKP3_ - O_D]3_P"3#_4#A+_H&_\
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M $=+#_X1A_\ DROT8HH_XAKP3_T"_P#D]3_Y,/\ 4#A+_H&_\GJ?_)GYS_\
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M&'_!-#0O!FMS_"VU\9_\)==WL B36?[/^R_9UA;.?(FW[O.Z?+C;WSQ\=?\
M$4[XG_Z,S@_\.!_][JZG_@ZA_P"1$^#'_87UO_T59U^-U!22L?K1_P 13OB?
M_HS.#_PX'_WNH_XBG?$__1F<'_AP/_O=7Y+T4#LC]:/^(IWQ/_T9G!_X<#_[
MW4?\13OB?_HS.#_PX'_WNK\EZ* LC]:/^(IWQ/\ ]&9P?^' _P#O=1_Q%.^)
M_P#HS.#_ ,.!_P#>ZOR7HH"R/UH_XBG?$_\ T9G!_P"' _\ O=1_Q%.^)_\
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M9O!_X7__ -[Z/^(I+Q/_ -&;P?\ A?\ _P![Z_)VBCZ]BOYOP7^0?ZW<0_\
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M -&9P?\ AP/_ +W5^2]% 61^M'_$4[XG_P"C,X/_  X'_P![J/\ B*=\3_\
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MU9F/]B\;_P#0;LO_  &/^-'V+QO_ -!NR_\  8_XUL44",?[%XW_ .@W9?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% '\X7_!;K_E*1\6/^O_ $W_ --5G7RI7U7_ ,%NO^4I'Q8_Z_\
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MPO>_^FZZK^DZOYL?^")__*47X2?]A>]_]-UU7])U!,MPHHHH)"BBB@ HHHH
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MA11161YX4444 %%%% !1110 4444 %%%% !1110 5^P?_!K+_P BQ\:_^O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MCXF1ZMI'_!QY\)-0\;Q+%+JGPHE_L\J<QK+]@U5753_OI,!_O#UK;_X+6?\
M!577OV8)+']D?]GKQ#;:;X^\3VD;ZSXIN)=L?ANRF8HC*V#MG<!FWD$Q1C>
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M,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4/%'A;PSXW\.WOA#QGX>LM6
MTG4K9K?4--U*U2>"YB88:.2-P5=2.H((KYW_ &8?^"5G[*W[+?QK\5_&OP=\
M.]!GO=8UB.\\+12:(-WA>(6ZQO!;2/(Y^=P\F]0A'F%1P*^EZ*F4(2:;6J.>
MKA,-7JPJ5()RCJF^G]?\'<^./^"IO[,?Q5\4^-_A%^VG^SEX*N?$'C;X1^,(
M);W0-/*BXU?1II4^T0H6(RRX( R/DGF/4 5ZY\4O^">W[$O[07C:Z^+GQ?\
MV;M!UWQ!JT4)O=3U6WD\^0)$D<:L-PQM1%7&!C;7M=%3[*',VU>YA_9V%=:I
M.<5)3:;32:NE:ZOU:LGZ>IY!\%OV!?V-_P!G7QLOQ'^"/[/GA_PWKB6LENNI
MZ="ZRB)\;TR6(P<#\JK?%W_@G9^Q#\>OB*OQ:^+O[-/AC6_$6Y&GU.XM&1KH
MJ %,ZHRK<8  _>AN !T %>T44_9T[6LK&OU+!>R]G[*/+>]N56OWM:US-O/!
MWA6^\'R_#^?P_:C1)M-;3WTJ*$1P"U,?EF$*N J;#M &,#@5B_!CX&?"/]G?
MP0GPW^"7@*P\-Z%%<R7$>F:<A6(2R'+O@DG)(%=91565[F_LZ?.IV5UI?K;L
M<-XI_9H^ WC;XS:+^T/XK^&&F7WC;PY:"UT/Q'/&QN;.$&4A$(. ,SRGI_RT
M-<_^T)^PM^R+^U7JMIK_ .T#\!-!\2:C91"*WU*YA>*Y6,$D1F:%D=D!)(1B
M5!)XY->LT4G"#5FC.>%PU2+C*":;NTTM7W?=GEOBSPEI/[*'[+7B#1_V4/@C
M;)<:'H5U)X5\(^&M/1!<W[(1$-HQN+2E2[L2<;F)->;_ /!)/]CO6_V,/V.-
M(\%>/(2OC'Q'>2^(/&6]P[QWUP% A9N<F.)(HVP2"ZN0<-7TU12]G'G4NVAG
M]2H_6H5OY(N,5T5[7:^Y+T.6^,?P3^%/[07@6?X9_&CP-8^(M!NIHY;C2]10
MM$[QL&1B 0<A@"*YCXE?L6?LJ_&'P[X4\)?$_P"!F@ZWIO@>U%MX2L[^W+)I
MD(2)/+CYX7;!$,'.?+7TKU"BFXQ>Z-:F'P]5OG@G?1W2=TM5?T>IP_B;]FOX
M$^,OC3HO[17BCX8Z9>^-_#ME]DT3Q),C&YLX,S'RT.< ?OYNW_+0UW%%%-)+
M8N-.G!MQ25]7YONPHHHIEA1110!^3G_!U#_R(GP8_P"POK?_ **LZ_&ZOV1_
MX.H?^1$^#'_87UO_ -%6=?C=06M@HHHH&%%%% !1110 4444 %%%% !1110
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M!^S[_P -5:#\6+&#X>;9F'BK6K>;3;8B*9H7(^UI$Q'FJ4!V_,W"Y)%?$_\
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MQ1^$OQ&^%UKJ]EXLDTA(;KP;=_9%E6SN9U.;F-N(UDD+2.74Y4(P/J_[=_[
M?_"[OB!#^U'\"?C[J?PQ^*_ASPK<6/\ ;.FVL=W!JNF?.YM;NU<@2)N+ /D@
M9Y5]B!? ?^";_P"VA^U%^SUI_P"SW^S-^U?X'\,W/@/XJ>";.+X2^-?#,DBS
MVYCLXGBL;^-^#)L>)-RJHW."#(-Q0&?3_P"U/^T-\2)?VF/AI^Q1^SWXD&E>
M)_$\K>(O&FO)9PW#Z)X8M'_>E8YD=!+=2@6T;LK!,N< [6'%_MZ_M,_M@:+^
MUE\*_P!CK]B;5?!UAXC\8:%K&L:[?^-+&6>UMK6W53 Q\G+H&:.=,A6RS(.
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M)=7_ .A0O?\ OI:/^$EU?_H4+W_OI: -BBL?_A)=7_Z%"]_[Z6C_ (275_\
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MW"7_ %S_ )XKKP'^]1^?Y'TO"'_)0T?^WO\ TEGZY45C_P#"2ZO_ -"A>_\
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M^"(/P0L?B1I\G]N^ OB!_:FOZ69 XTV&_EO)4B9AD91Y((VQD!Y6 )')^_\
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M##P-\2/ACK_B"ZU?P;#X@\1MIEUX5DN3N>VE4C%Q;HP!41G<V"<J6*C[QHH
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M=?\ !*WPW^PE^SPNDOJOAZ/1HQ+J-V;>"X:V.ZYF+;3AI)"\F,<ESTK[7HH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@#\G/\ @ZA_Y$3X,?\ 87UO_P!%6=?C=7[(_P#!U#_R
M(GP8_P"POK?_ **LZ_&Z@M;!1110,**** "BBB@ HHHH **** "BBB@ HHHH
M *^IO^")_P#RE%^$G_87O?\ TW75?+-?4W_!$_\ Y2B_"3_L+WO_ *;KJ@'L
M?TG4444&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%9/A_QYX)\5ZSK'AWPQXMT[4+
M_P /W:6NNV5G>))+I\[1K(L<RJ28V*,K -@D,#T-:U&XE)25TPHHHH&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% 'Y.?\'4/_(B?!C_L+ZW_ .BK.OQNK]D?^#J'_D1/@Q_V%];_ /15G7XW
M4%K8****!A1110 4444 %%%% !1110 4444 %%%% !7U-_P1/_Y2B_"3_L+W
MO_INNJ^6:^IO^")__*47X2?]A>]_]-UU0#V/Z3J***#,**** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M2B_"3_L+WO\ Z;KJ@'L?TG4444&84444 %%%% !1110 4444 %%%% !1110
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M^G1=-ONZ=N@44451N%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M45DWWCWP1I?C+3_AWJ7B[38-?U6TGNM,T::\1;J[@A*B66.(G<ZH73<P&!N&
M>M:U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&+_@GY_P2M:;QE\4QXA^)=UI]MX4L/%]O:FV:ZOYD<->A2S%95MHII=V3F5
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M_P#P1NO?VJ?&D>[7/BU^U&NI7%UC_7PPZ=JRYR>O^DR7OY_6@KJ?T$> 69_
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MW $C+_:"_P""C;_#[X\W7[+O[.?[-_BCXO\ CS2--CO_ !/IOAV[@M+31()
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6:U&H72"-@>JB-A'C^ZH%>;1?\%6=>M_V2%_9SD_9I^)P_:%7PI_PC:^"?\
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M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
M@F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_A
MN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\
M$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ
M;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%X
MT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\
M*_\ HFGA_P#\$T'_ ,10!PO_  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]
M]2?_ !%=U_PJ;X5_]$T\/_\ @F@_^(H_X5-\*_\ HFGA_P#\$T'_ ,10!PO_
M  W=^R'_ -%XT3_OJ3_XBC_AN[]D/_HO&B?]]2?_ !%=U_PJ;X5_]$T\/_\
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MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
M!-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *
MF^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/
M^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?
M"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]
M2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\
MPW=^R'_T7C1/^^I/_B*/^&[OV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\
MX)H/_B*/^%3?"O\ Z)IX?_\ !-!_\10!PO\ PW=^R'_T7C1/^^I/_B*/^&[O
MV0_^B\:)_P!]2?\ Q%=U_P *F^%?_1-/#_\ X)H/_B*/^%3?"O\ Z)IX?_\
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M^VY\2-3^ ^J_#CQ!\//B%I=N\\GA7Q,H+7$:8\P1/A6,B9!:-T1MIW#< VT
M^MZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@#F],^%/A'2/BCJGQ@LX9QK6KZ;!8WKM.3&88B2@"=CD]
M>]=)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 ?G%_P %\/V(?$7BCP;I7_!0
MK]G[S=/\?_"LQ7>KW.GC;-/IL$GFI= CK):O^\S_ ,\C)DGRU%>/?\$N?AK\
M4_\ @K/^V[J'_!2_]JS2[=_#_@5[6P\+Z/$C?9'U."-6CCB5B3Y<!<W+<\S3
MH>1N%?I'^WWI.J:]^PO\9=$T/3;B]O;SX6:_#:6=I"TDL\K:=.JHB*"68D@
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M$PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5^<7_!?#]B'Q%XH\&Z5_P4*_9^\W3_ !_\
M*S%=ZO<Z>-LT^FP2>:ET".LEJ_[S/_/(R9)\M17Z.UY)^WWI.J:]^PO\9=$T
M/3;B]O;SX6:_#:6=I"TDL\K:=.JHB*"68D@  9).*!K<_-S_ ()<_#7XI_\
M!6?]MW4/^"E_[5FEV[^'_ KVMAX7T>)&^R/J<$:M''$K$GRX"YN6YYFG0\C<
M*_7ZO@O_ (-T_ WC;X??L$:EH7C[P=JNAWS?$;495L]8T^2VE,9M;,!PDB@[
M200#C'!]*^]* 9^2?_!JS_R+GQN_Z_O#_P#Z!J%'_!SS_P CW^SK_P!?VO\
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M 8!;'Z\T444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HKX/\
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MOR+_ .(J+_JQ+_S)_P#][*^Z?^"9'[?O_#QKX"ZO\;O^%3?\(;_97B^XT/\
MLS^WO[1\WRK6UN/.\SR(=N?M.W;M.-F=QS@53Q5"K+E@[OYG3@N(,HS&O['#
MU.:6]K26WJDCZ+HHHKH/9"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BN
M0_:#^*W_  HCX!^./CA_8/\ :O\ PAOA#4]=_LO[5Y'VS[):R7'D^9M?R]_E
M[=^UMN<[3C%?EI_Q%6_]6'?^90_^]E [-GZ]45^0O_$5;_U8=_YE#_[V4?\
M$5;_ -6'?^90_P#O90%F?KU17(?L^?%;_A>_P#\#_'#^P?[*_P"$R\(:9KO]
ME_:O/^Q_:[6.X\GS-J>9L\S;OVKNQG:,XKKZ!!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!^$'[7W_)V?Q1_[*+K?_I?-7G5>B_M??\ )V?Q1_[*+K?_ *7S
M5YU7\2YI_P C.O\ XY?^E,_D?,?^1A6_Q2_-A7ZK_P#!#3_DTSQ#_P!E%N__
M $@L*_*BOU7_ ."&G_)IGB'_ +*+=_\ I!85]UX4_P#)71_P3_(^Q\-O^2GC
M_@D?9M?*W_!1[]H7XQ:#XE^'G['7[-&OIH_CKXM:I+;_ /"1%-[:)ID*@W%R
M@_YZ;2Q5AR%BDQAMK#ZIKXB_;JOK3X)_\%._V<?VE_'$ZVWA26'4_#-YJ<QV
MPV-W/!/'"9'/"!C=9R>-L4A. I-?U ?T.;=G_P $2?V1IM)%[XM\2^/M8\7L
MFZ;Q[<^,;A=2\_',J8/E@[CD!D;'&2>25_83^,7QL^$_[37C+_@G3^TAX]N/
M%M[X;TF/7/ /C'4,_:M3TAF13'.Q),DB&11DDME)1N*JIK[!!!&0:^'_  3J
M5I\=?^"X>O>,_ DZW6D_"_X6+H>OZC;G=#_:$L[L+?<."X\^0$=C;2#JN* /
M2+S_ (*Q_LGRR3:;X(C\8^+M6M;NZAO]"\)>$+F^O+-+>3RY)YD4 1Q;L@,Q
M&[!(!'->O?L^?M(_!O\ :C^'<?Q0^"OC"/5=*,[V]SNB:&:SG0 O#-$X#1N
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M%_P3S^&.E^&--L9-+OO!L+ZG$(E:.>YE4_;!(.C$S&56!]"#0!Z#^SS^TO\
M"']J7PIJ?C?X+>(FU32])U^XT>XO/(9$>YA5&<QD_P"LC*R(5<<,#Q6#^W5^
MTY#^R!^RWXI^.R6,5W?Z9:I#HMG.3LGO9I%BA#8P2BL^]@""51L$&O#?^"'U
MGX8T_P#9R^(5AX(=&T6#XUZY'I#1MN4VJPV8B(/<; O-:_\ P6\^'FO>/_\
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MB_&O]N#]F+X6>(]8U73[+6KS7X+B\T2]^S7<2B.T;,<F#L.5'..A->F>%?\
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M$P/&?Q$TFT^'/[0_[<_Q%\=> K.>&1O"%W%;VOVY86#1QW=S&#+<)E03G!)
M(*L 1]:T4 165E9Z;9PZ=I]K'!;V\2QP0Q(%6-%&%50.    !4M%% !1110
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MQG!KVG]HOX)Z+^T=\$/$GP.\1:Q=:?9>)=.:SN;VR53+"I8'<H8$9X[UVM%
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MOG- '"_\$TOAGXI^$'["?PU\ ^-=+FL=4MM \^\LKA"LENUQ-)<"-U/*LHE
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M_P $M?'FI^"D^!WBK]OSXF:E\,T@2U/A%H;1)Y+-/NVKWH0NT6T!=NT#:,8
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M/'7[6WA;5]0EUCQS',MSILZQ_9[)IY8YKAHL#=F22)6.3W(KW>B@#P?X-?\
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5** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512001520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover Page - USD ($)<br> $ in Billions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Feb. 06, 2025</div></th>
<th class="th"><div>Jun. 28, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-51222<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">DEXCOM, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">33-0857544<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6340 Sequence Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">San Diego<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">92121<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">858<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">200-0200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 Par Value Per Share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">DXCM<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Large Accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFinStmtErrorCorrectionFlag', window );">Document Financial Statement Error Correction [Flag]</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">390,772,018<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentsIncorporatedByReferenceTextBlock', window );">Documents incorporated by reference</a></td>
<td class="text"><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Portions of the registrant&#8217;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders (the &#8220;Proxy Statement&#8221;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers, which proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Form 10-K.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2024<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001093557<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFinStmtErrorCorrectionFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates whether any of the financial statement period in the filing include a restatement due to error correction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection w<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 4: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFinStmtErrorCorrectionFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentsIncorporatedByReferenceTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Documents incorporated by reference.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-23<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentsIncorporatedByReferenceTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602136976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Audit Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AuditInformationAbstract', window );"><strong>Audit Information [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">San Diego, California<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AuditInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Audit Information [Abstract]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AuditInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516309664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 606.1<span></span>
</td>
<td class="nump">$ 566.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities', window );">Short-term marketable securities</a></td>
<td class="nump">1,973.3<span></span>
</td>
<td class="nump">2,157.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net</a></td>
<td class="nump">1,005.7<span></span>
</td>
<td class="nump">973.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory</a></td>
<td class="nump">542.6<span></span>
</td>
<td class="nump">559.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid and other current assets</a></td>
<td class="nump">173.7<span></span>
</td>
<td class="nump">168.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">4,301.4<span></span>
</td>
<td class="nump">4,425.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Property and equipment, net</a></td>
<td class="nump">1,339.9<span></span>
</td>
<td class="nump">1,113.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">62.8<span></span>
</td>
<td class="nump">71.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">22.8<span></span>
</td>
<td class="nump">25.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangibles, net</a></td>
<td class="nump">103.4<span></span>
</td>
<td class="nump">134.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxAssetsNet', window );">Deferred tax assets</a></td>
<td class="nump">481.2<span></span>
</td>
<td class="nump">419.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">173.0<span></span>
</td>
<td class="nump">75.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">6,484.5<span></span>
</td>
<td class="nump">6,264.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">1,585.1<span></span>
</td>
<td class="nump">1,345.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued payroll and related expenses</a></td>
<td class="nump">112.0<span></span>
</td>
<td class="nump">171.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayableCurrent', window );">Current portion of long-term senior convertible notes</a></td>
<td class="nump">1,204.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Short-term operating lease liabilities</a></td>
<td class="nump">22.5<span></span>
</td>
<td class="nump">21.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">8.0<span></span>
</td>
<td class="nump">18.4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">2,932.0<span></span>
</td>
<td class="nump">1,556.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleLongTermNotesPayable', window );">Long-term senior convertible notes</a></td>
<td class="nump">1,237.0<span></span>
</td>
<td class="nump">2,434.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term operating lease liabilities</a></td>
<td class="nump">65.0<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other long-term liabilities</a></td>
<td class="nump">147.9<span></span>
</td>
<td class="nump">125.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">4,381.9<span></span>
</td>
<td class="nump">4,195.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December&#160;31, 2024 and December&#160;31, 2023</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock, $0.001 par value, 800.0 million shares authorized; 408.9 million and 390.7 million shares issued and outstanding, respectively, at December&#160;31, 2024; and 407.2 million and 385.4 million shares issued and outstanding, respectively, at December&#160;31, 2023</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">2,093.8<span></span>
</td>
<td class="nump">3,514.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive loss</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(16.7)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Retained earnings</a></td>
<td class="nump">1,597.6<span></span>
</td>
<td class="nump">1,021.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonValue', window );">Treasury stock, at cost; 18.2 million shares at December&#160;31, 2024 and 21.8 million shares at December&#160;31, 2023</a></td>
<td class="num">(1,581.2)<span></span>
</td>
<td class="num">(2,451.1)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">2,102.6<span></span>
</td>
<td class="nump">2,068.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 6,484.5<span></span>
</td>
<td class="nump">$ 6,264.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Securities, Available-For-Sale And Equity Securities</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14A<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 12: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 13: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 30: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset recognized for present right to economic benefit, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleLongTermNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleLongTermNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-1<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 15: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(14))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 28: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 29: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(21))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-5<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br><br>Reference 21: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481404/852-10-50-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of nonredeemable preferred shares and preferred shares redeemable solely at option of issuer, held by shareholders. Excludes preferred shares repurchased and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated undistributed earnings (deficit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483550/848-10-65-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (c)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479832/842-10-65-8<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-24<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-23<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483421/250-10-45-5<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-5<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (h)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (i)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480528/815-20-65-6<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 105<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479343/105-10-65-6<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480016/944-40-65-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482615/740-10-65-8<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479654/326-10-65-4<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-5<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481674/830-30-50-1<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-17<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481694/830-30-45-20<br><br>Reference 34: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-11<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 205<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478009/946-205-45-3<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-3<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 43: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 44: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 45: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 46: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-15<br><br>Reference 47: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-16<br><br>Reference 48: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4I<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481175/810-10-55-4I<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476166/350-60-65-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602152096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock authorized (in shares)</a></td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in usd per share)</a></td>
<td class="nump">$ 0.001<span></span>
</td>
<td class="nump">$ 0.001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock authorized (in shares)</a></td>
<td class="nump">800,000,000.0<span></span>
</td>
<td class="nump">800,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock issued (in shares)</a></td>
<td class="nump">408,900,000<span></span>
</td>
<td class="nump">407,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock outstanding (in shares)</a></td>
<td class="nump">390,700,000<span></span>
</td>
<td class="nump">385,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockCommonShares', window );">Treasury stock, at cost (in shares)</a></td>
<td class="nump">18,200,000<span></span>
</td>
<td class="nump">21,800,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockCommonShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of previously issued common shares repurchased by the issuing entity and held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockCommonShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514440256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Operations - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,033.0<span></span>
</td>
<td class="nump">$ 3,622.3<span></span>
</td>
<td class="nump">$ 2,909.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,594.8<span></span>
</td>
<td class="nump">1,333.4<span></span>
</td>
<td class="nump">1,026.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">2,438.2<span></span>
</td>
<td class="nump">2,288.9<span></span>
</td>
<td class="nump">1,883.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">552.4<span></span>
</td>
<td class="nump">505.8<span></span>
</td>
<td class="nump">484.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">1,285.8<span></span>
</td>
<td class="nump">1,185.4<span></span>
</td>
<td class="nump">1,007.7<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">1,838.2<span></span>
</td>
<td class="nump">1,691.2<span></span>
</td>
<td class="nump">1,491.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">597.7<span></span>
</td>
<td class="nump">391.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">109.0<span></span>
</td>
<td class="nump">112.7<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">709.0<span></span>
</td>
<td class="nump">710.4<span></span>
</td>
<td class="nump">390.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">168.9<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 576.2<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">$ 341.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in usd per share)</a></td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Shares used to compute basic net income per share (in shares)</a></td>
<td class="nump">393.6<span></span>
</td>
<td class="nump">386.0<span></span>
</td>
<td class="nump">389.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in usd per share)</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Shares used to compute diluted net income per share (in shares)</a></td>
<td class="nump">412.7<span></span>
</td>
<td class="nump">425.5<span></span>
</td>
<td class="nump">427.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482916/730-10-50-1<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 912<br> -SubTopic 730<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479532/912-730-25-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513609312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Comprehensive Income - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 576.2<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">$ 341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income (loss), net of tax:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Translation adjustments and other</a></td>
<td class="nump">8.6<span></span>
</td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(9.8)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax', window );">Unrealized gain (loss) on marketable debt securities</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">4.1<span></span>
</td>
<td class="num">(2.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Total other comprehensive income (loss), net of tax</a></td>
<td class="nump">8.7<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="num">(12.1)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive income</a></td>
<td class="nump">$ 584.9<span></span>
</td>
<td class="nump">$ 536.4<span></span>
</td>
<td class="nump">$ 329.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10A<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-10A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514787664">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Statements of Stockholders' Equity - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common&#160;Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income (Loss)</div></th>
<th class="th"><div>Retained Earnings</div></th>
<th class="th"><div>Treasury Stock</div></th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at beginning of period ( in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">388.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at beginning of period at Dec. 31, 2021</a></td>
<td class="nump">$ 2,042.1<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2,108.7<span></span>
</td>
<td class="nump">$ 0.5<span></span>
</td>
<td class="nump">$ 138.7<span></span>
</td>
<td class="num">$ (206.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">$ 22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones', window );">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</a></td>
<td class="num">$ (0.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(189.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">189.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.6)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, including excise tax</a></td>
<td class="num">(557.7)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(557.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt', window );">Tax benefit related to Senior Convertible Notes</a></td>
<td class="num">$ (0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="nump">$ 17.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">33.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 126.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">126.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee', window );">Capitalization of sales-based milestones</a></td>
<td class="nump">152.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">152.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">341.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">341.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">(12.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">386.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2022</a></td>
<td class="nump">2,131.8<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">2,258.1<span></span>
</td>
<td class="num">(11.6)<span></span>
</td>
<td class="nump">479.9<span></span>
</td>
<td class="num">(595.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">$ 26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</a></td>
<td class="nump">3.7<span></span>
</td>
<td class="nump">3.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones', window );">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</a></td>
<td class="num">$ (0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(323.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">323.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, including excise tax</a></td>
<td class="num">(689.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(689.0)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt', window );">Tax benefit related to Senior Convertible Notes</a></td>
<td class="num">$ (4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(4.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes</a></td>
<td class="num">$ (13.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(13.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="num">(12.2)<span></span>
</td>
<td class="num">(12.2)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes</a></td>
<td class="nump">$ 6.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,496.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,490.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax', window );">Purchase of capped call transactions, net of tax</a></td>
<td class="num">$ (76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(76.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">$ 150.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">150.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">541.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">541.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="num">$ (5.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(5.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2023</a></td>
<td class="nump">385.4<span></span>
</td>
<td class="nump">385.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2023</a></td>
<td class="nump">$ 2,068.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">3,514.6<span></span>
</td>
<td class="num">(16.7)<span></span>
</td>
<td class="nump">1,021.4<span></span>
</td>
<td class="num">(2,451.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan', window );">Issuance of common stock under equity incentive plans (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan', window );">Issuance of common stock for Employee Stock Purchase Plan</a></td>
<td class="nump">$ 28.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">28.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones', window );">Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(188.1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">188.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock, including excise tax (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(10.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockValueAcquiredCostMethod', window );">Purchases of treasury stock, including excise tax</a></td>
<td class="num">$ (749.5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(749.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversions of 2023 Notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Benefit of note hedge upon conversions of 2023 Notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,431.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,431.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Share-based compensation expense</a></td>
<td class="nump">170.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">170.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">576.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">576.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive income, net of tax</a></td>
<td class="nump">$ 8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Balance at end of period (in shares) at Dec. 31, 2024</a></td>
<td class="nump">390.7<span></span>
</td>
<td class="nump">390.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Balance at end of period at Dec. 31, 2024</a></td>
<td class="nump">$ 2,102.6<span></span>
</td>
<td class="nump">$ 0.4<span></span>
</td>
<td class="nump">$ 2,093.8<span></span>
</td>
<td class="num">$ (8.0)<span></span>
</td>
<td class="nump">$ 1,597.6<span></span>
</td>
<td class="num">$ (1,581.2)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Collaborative Research And Development Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromExerciseOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Exercise of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromExerciseOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise and Settlement of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Achievement Of Milestones</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Exercise and Settlement of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Value, Exercise of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-13<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481089/718-20-55-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(16)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-19<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 20<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -SubTopic 10<br> -Topic 810<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate change in value for stock issued during the period as a result of employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(19))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.6-05(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 14: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480418/310-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValueAcquiredCostMethod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481549/505-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValueAcquiredCostMethod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602260656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Consolidated Statements of Cash Flows - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 576.2<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">$ 341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net income to cash provided by operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">217.7<span></span>
</td>
<td class="nump">186.0<span></span>
</td>
<td class="nump">155.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">170.4<span></span>
</td>
<td class="nump">150.8<span></span>
</td>
<td class="nump">126.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaidInKindInterest', window );">Non-cash interest expense</a></td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="num">(43.8)<span></span>
</td>
<td class="num">(55.0)<span></span>
</td>
<td class="num">(21.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNoncashIncomeExpense', window );">Other non-cash income and expenses</a></td>
<td class="num">(47.3)<span></span>
</td>
<td class="num">(85.8)<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable, net</a></td>
<td class="num">(35.0)<span></span>
</td>
<td class="num">(260.1)<span></span>
</td>
<td class="num">(199.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="nump">12.4<span></span>
</td>
<td class="num">(252.6)<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid and other assets</a></td>
<td class="num">(5.8)<span></span>
</td>
<td class="nump">19.3<span></span>
</td>
<td class="num">(131.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet', window );">Operating lease right-of-use assets and liabilities, net</a></td>
<td class="num">(6.5)<span></span>
</td>
<td class="num">(4.5)<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued liabilities</a></td>
<td class="nump">211.7<span></span>
</td>
<td class="nump">466.5<span></span>
</td>
<td class="nump">295.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities', window );">Accrued payroll and related expenses</a></td>
<td class="num">(60.0)<span></span>
</td>
<td class="nump">37.2<span></span>
</td>
<td class="nump">8.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability', window );">Deferred revenue and other liabilities</a></td>
<td class="num">(8.0)<span></span>
</td>
<td class="num">(2.6)<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash provided by operating activities</a></td>
<td class="nump">989.5<span></span>
</td>
<td class="nump">748.5<span></span>
</td>
<td class="nump">669.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt', window );">Purchase of marketable securities</a></td>
<td class="num">(2,576.3)<span></span>
</td>
<td class="num">(3,200.4)<span></span>
</td>
<td class="num">(2,266.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities', window );">Proceeds from sale and maturity of marketable securities</a></td>
<td class="nump">2,824.4<span></span>
</td>
<td class="nump">2,947.4<span></span>
</td>
<td class="nump">2,127.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(358.8)<span></span>
</td>
<td class="num">(236.6)<span></span>
</td>
<td class="num">(364.8)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired', window );">Acquisitions, net of cash acquired</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(3.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireOtherInvestments', window );">Purchases of non-marketable equity securities</a></td>
<td class="num">(81.3)<span></span>
</td>
<td class="num">(19.5)<span></span>
</td>
<td class="num">(14.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities', window );">Other investing activities</a></td>
<td class="num">(15.5)<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(207.5)<span></span>
</td>
<td class="num">(507.2)<span></span>
</td>
<td class="num">(521.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Net proceeds from issuance of common stock</a></td>
<td class="nump">28.2<span></span>
</td>
<td class="nump">26.6<span></span>
</td>
<td class="nump">22.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="num">(750.0)<span></span>
</td>
<td class="num">(688.7)<span></span>
</td>
<td class="num">(557.7)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,230.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(101.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RepaymentsOfConvertibleDebt', window );">Payments for conversions of senior convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(787.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities', window );">Other financing activities</a></td>
<td class="num">(13.0)<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(17.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash used in financing activities</a></td>
<td class="num">(734.8)<span></span>
</td>
<td class="num">(318.6)<span></span>
</td>
<td class="num">(552.5)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash, cash equivalents and restricted cash</a></td>
<td class="num">(7.4)<span></span>
</td>
<td class="nump">1.5<span></span>
</td>
<td class="num">(5.8)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Increase (decrease) in cash, cash equivalents and restricted cash</a></td>
<td class="nump">39.8<span></span>
</td>
<td class="num">(75.8)<span></span>
</td>
<td class="num">(410.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">567.5<span></span>
</td>
<td class="nump">643.3<span></span>
</td>
<td class="nump">1,053.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">607.3<span></span>
</td>
<td class="nump">567.5<span></span>
</td>
<td class="nump">643.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash, end of period:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">606.1<span></span>
</td>
<td class="nump">566.3<span></span>
</td>
<td class="nump">642.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">607.3<span></span>
</td>
<td class="nump">567.5<span></span>
</td>
<td class="nump">643.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosure of non-cash investing and financing transactions:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentAmount1', window );">Shares issued for repurchase and conversions of senior convertible notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1,501.9<span></span>
</td>
<td class="nump">35.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge', window );">Shares received under note hedge upon conversion of 2023 Notes</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(1,490.3)<span></span>
</td>
<td class="num">(33.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1', window );">Acquisition of property and equipment included in accounts payable and accrued liabilities</a></td>
<td class="nump">75.4<span></span>
</td>
<td class="nump">53.2<span></span>
</td>
<td class="nump">25.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental cash flow information:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid during the year for interest</a></td>
<td class="nump">11.4<span></span>
</td>
<td class="nump">12.4<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaid', window );">Cash paid during the year for income taxes</a></td>
<td class="nump">$ 198.0<span></span>
</td>
<td class="nump">$ 212.3<span></span>
</td>
<td class="nump">$ 114.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) in Operating Lease Assets and Liabilities, Net</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Treasury Stock, Value, Benefit Received From Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -SubTopic 230<br> -Topic 830<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 830<br> -SubTopic 230<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477401/830-230-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 23<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-23<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-22<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherDeferredLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherDeferredLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-24<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncashIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncashIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaidInKindInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaidInKindInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForProceedsFromOtherInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash (inflow) outflow from investing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForProceedsFromOtherInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireOtherInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to acquire investments classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireOtherInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromPaymentsForOtherFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromPaymentsForOtherFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-11<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-11<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 12<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RepaymentsOfConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RepaymentsOfConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-8<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513301248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Organization and Significant Accounting Policies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1. Organization and Significant Accounting Policies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Organization and Business</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our,&#8221; the &#8220;company,&#8221; or &#8220;Dexcom&#8221; refer to DexCom, Inc. and its subsidiaries.</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income. Interest income and realized gains and losses on marketable debt securities are included in other income (expense), net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income (loss) from equity investments in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities, supranational securities, and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Short-Term Marketable Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information on our marketable securities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount, net of prompt pay discounts, for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectible.&#160;Generally, receivable balances that are more than one year past due are deemed uncollectible.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer C</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer E</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Total revenue for each customer is net of fees, cash discounts, and rebates directly allocable to that customer. Rebates paid to other entities are excluded; therefore, the combined value may exceed 100%.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We capitalize inventory produced in preparation for commercial launches when it becomes probable that the product will receive regulatory approval and that the related costs will be recoverable through the commercialization of the product. A number of factors are considered, including the status of the regulatory application approval process, management&#8217;s judgment of probable future commercial use, and net realizable value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record adjustments to inventory for potential excess or obsolete inventory, as well as inventory that does not pass quality control testing, in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is disposed of or sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of sales could be required.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We also capitalize certain costs incurred for the development of enterprise-level business and finance software that we use internally in our operations. Costs incurred in the application development phase are capitalized while costs related to planning and other preliminary project activities and to post-implementation activities are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally <span style="-sec-ix-hidden:f-460">three</span> to five years for computer software and hardware, including internal use software, <span style="-sec-ix-hidden:f-462">four</span> to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold and land improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but are tested annually for impairment during the fourth fiscal quarter and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no significant goodwill impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2024 and 2023 primarily consisted of the divestiture of our non-diabetes distribution business and translation adjustments on our foreign currency denominated goodwill.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in intangibles and other assets, net in our consolidated balance sheets. We amortize intangible assets with a finite life, such as the customer relationships, acquired technology and intellectual property, trademarks and trade name, and other intangibles, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:f-470">one</span> to fourteen years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For transactions other than a business combination, we also capitalize as intangible assets the cost of certain milestones payable by us to collaborative partners and incurred at or after the product has obtained regulatory approval for marketing. The intangible assets associated with these milestones are amortized over the remaining estimated useful life of the underlying asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded no significant intangible asset impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rate on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under tax law and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax expense for basis differences related to global intangible low-taxed income (&#8220;GILTI&#8221;) as a period cost if and when incurred. GILTI is a category of income that is earned abroad by U.S.-controlled foreign corporations (CFCs) and is subject to special treatment under the U.S. tax code.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of two elements, net income and other comprehensive income (loss). We report all components of comprehensive income, including net income, in our financial statements in the period in which they are recognized. Total comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income and the components of other comprehensive income (loss), including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. We also refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used, which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes, but is not limited to: rebates, chargebacks, product returns provision, and prompt payment discounts. We classify these items as a reduction of accounts receivable when we are not required to make a payment and as a liability when we are required to make a payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We estimate our product returns primarily based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts, which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discounts based on eligible sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record revenue from sales of Components upon transfer of control of the product to the customer. We typically determine transfer of control based on when the product is shipped or delivered and title passes to the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2024 included unbilled accounts receivable of $15.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when cash payments have been received prior to satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months were $9.5 million as of December&#160;31, 2024 and $7.4 million as of December&#160;31, 2023. These balances are included in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Compensation Costs</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:f-485">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consists of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology includes certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Agreements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into agreements with collaboration partners for the development and commercialization of our products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we account for these agreements, we consider the unique nature, terms and facts and circumstances of each transaction. Below are some example activities and how we account for them:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Payments to collaboration partners through issuance of common stock as consideration in an asset acquisition are considered share-based payment to non-employees in exchange for goods within the scope of ASC Topic 718, &#8220;Compensation - Stock Compensation.&#8221; The amount and the timing of the cost recognition of such milestones in our financial statements is driven by the accounting for the specific type of equity instrument under ASC 718 that aligns with the terms of the agreement, including any performance conditions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with in-process research and development (&#8220;IPR&amp;D&#8221;) in an asset acquisition incurred prior to regulatory approval is expensed as it does not have an alternative future use and is recorded as research and development expense.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with IPR&amp;D in an asset acquisition incurred at or after regulatory approval is usually capitalized as an intangible asset and amortized over the periods in which the related products are expected to contribute to future cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses. Advertising expense was $194.2 million, $180.8 million and $160.6 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease right-of-use assets and liabilities with terms of more than 12 months are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to determine the present value is our collateralized incremental borrowing rate unless the interest rate implicit in the lease is readily determinable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis within operating expenses over the lease term. For finance leases, lease expense is recognized as interest and depreciation; interest using the effective interest method and depreciation on a straight-line basis over the shorter of the estimated useful lives of the assets or, in the instance where title does not transfer at the end of the lease term, the lease term. Short-term leases with lease terms of 12 months or less are not recorded on the balance sheet and are recognized on a straight line basis over the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain lease components and non-lease components. For certain asset classes, we have elected to account for both of those components as a single lease component. We use a portfolio approach to account for the right-of-use assets and liabilities associated with certain machinery and equipment leases. Variable lease payments may include payments associated with non-lease components, payments that do not depend on a rate or index, or other costs. Variable lease payments are recognized in the period in which the obligation for those payments are incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based restricted stock units, or RSUs, at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. We estimate the fair value of these performance/market-based RSUs, or PSUs, at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the PSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of PSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the PSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from RSUs, PSUs, warrants, our senior convertible notes, and collaborative sales-based milestones. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">341.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income - diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.42&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.30&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">393.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">386.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">389.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive potential securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborative sales-based milestones</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior convertible notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">427.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2023-07, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, or CODM, and included within each reported measure of segment profit or loss. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, reflecting the application of the new standard in each prior reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires greater disaggregation of information about a reporting entity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s effective tax rate reconciliation as well as information on income taxes paid. The ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity&#8217;s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disaggregated disclosure of certain costs and expenses in the notes of the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Securities and Exchange Commission Final Rules Not Yet Implemented</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 6, 2024, the SEC adopted SEC Release Nos. 33-11275; 34-99678, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to require the disclosure of certain climate-related information in registration statements and annual reports, including Scope 1 and 2 emissions and information about climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, a company&#8217;s business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in audited financial statements. The disclosure requirements would have begun phasing in for our reports and registration statements including financial information in the fiscal year ending December 31, 2025, however, in April 2024, the SEC issued an order staying the final rules until the completion of judicial review. The SEC has since indicated that it intends to establish a new implementation period following the stay order. We are currently evaluating the impact of this final rule on our disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480424/946-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 810<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/810/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 205<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/205/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512820176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementDisclosureTextBlock', window );">Development and Other Agreements</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">2. Development and Other Agreements</span></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration with Verily Life Sciences</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#8220;Verily&#8221;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily agreed to jointly develop a certain next-generation CGM product, and potentially additional CGM products, for which we will have exclusive commercialization rights.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#8217;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. In connection with the Restated Collaboration Agreement, we developed, launched and commercialized a CGM product in connection with the collaboration.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In consideration of Verily&#8217;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and payments for contingent sales-based milestones upon the achievement of certain revenue targets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Upfront and Incentive payments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7.4 million shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Contingent milestones</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with in-process research and development obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2022, we received regulatory approval and issued 2.9 million shares of our common stock in connection with our achievement of the related milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2022, we received approval from the Food and Drug Administration and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) 5.2 million shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful life of 64 months through March 2028. The related amortization expense is recognized in cost of sales in our consolidated statements of operations and disclosed in Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Intangibles, Net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the fourth quarter of 2023, we issued 3.7 million shares of our common stock in connection with our achievement of the first sales-based milestone. See the effective tax rate reconciliation in Note 8 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information on the tax benefits related to the collaboration agreement milestone share-based payments for the periods presented.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the first quarter of 2024, we issued 1.5 million shares of our common stock in connection with our achievement of the second sales-based milestone.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All milestones were paid in cash or shares of our common stock, at our election.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/808/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602187344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3. Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair values of our Level 3 financial instruments based on unobservable inputs and other estimation techniques due to the absence of quoted market prices and inherent lack of liquidity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2024, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,138.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,488.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers into or out of Level 3 securities during the twelve months ended December&#160;31, 2024 and 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fair Value of Senior Convertible Notes</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,163.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,262.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,122.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,281.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,286.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,544.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For more information on the carrying values of our senior convertible notes, see Note 5 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt&#8212;Senior Convertible Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency and Derivative Financial Instruments</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we conduct business globally in many currencies, we are exposed to foreign exchange rate changes. To limit this exposure, we enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As of December&#160;31, 2024 and December&#160;31, 2023, the notional amounts of outstanding foreign currency forward contracts were $66.0 million and $71.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments were $119.3 million as of December&#160;31, 2024 and $38.5 million as of December&#160;31, 2023. We include the carrying values of these investments in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no significant impairment losses on assets and liabilities measured at fair value on a non-recurring basis during the twelve months ended December&#160;31, 2024 and December&#160;31, 2023. During the fourth quarter 2022, we vacated a leased building and made it available for sublease, resulting in an impairment of its asset group which consisted primarily of leasehold improvements and right-of-use asset. We recorded $23.0&#160;million in impairment losses during the twelve months ended December&#160;31, 2022. See Note 6 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases and Other Commitments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementInputsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 820<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/820/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementInputsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512495584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock', window );">Balance Sheet Details and Other Financial Information</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4. Balance Sheet Details and Other Financial Information</span></div></td></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Short-Term Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:7pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></div></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,149.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,972.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,611.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the estimated market values of our short-term debt securities with contractual maturities up to 12 months and up to 18 months were $1.73&#160;billion and $247.7&#160;million, respectively. As of December 31, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.16&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the twelve months ended December&#160;31, 2024, 2023 and 2022 were not significant.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2024 were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Equity Investments</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, unrealized gains or losses on equity investments were not significant. During the twelve months ended December&#160;31, 2023, and 2022, we had no unrealized gains or losses on equity investments. Realized gains from the sale of an equity investment were not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,014.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">983.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts receivable, net</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,005.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">973.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Reserve for prompt payment cash discounts recorded against accounts receivable, excluding allowance for doubtful accounts, was $17.3&#160;million, $13.7&#160;million, $8.3&#160;million as of December&#160;31, 2024, 2023, and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">559.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, 2023 and 2022, we recorded excess and obsolete inventory charges of $53.5 million, $16.6 million and $13.9 million respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Prepaid and Other Current Assets</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Building</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">908.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">683.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">283.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">354.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">328.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,018.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,622.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(678.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(509.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,339.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,113.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2024, 2023 and 2022 was $181.2 million, $147.4 million and $144.1 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2024, 2023 and 2022 recorded in operating expenses was $5.1 million, $0.7 million and $2.2 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">&#160;Intangibles, Net</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of December&#160;31, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible asset</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.5)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(90.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31.0)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(61.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 2 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Development and Other Agreements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Excludes Verily intangible asset.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total amortization expense of finite-lived intangible assets for the twelve months ended December&#160;31, 2024, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization of intangible assets</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents estimated future amortization of the Company&#8217;s finite-lived intangible assets as of December&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Assets</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Payable and Accrued Liabilities</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">345.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">276.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,135.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">950.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax payable</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,585.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,345.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:14pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Payroll and Related Expenses</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accrued Warranty</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53.9)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:12pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Long-Term Liabilities</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease obligations</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset retirement obligation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:18pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Other Income (Expense), Net</span></div></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and dividend income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalFinancialInformationDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalFinancialInformationDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602082896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5. Debt</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Senior Convertible Notes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,250.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,250.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,457.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,457.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amount of senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,441.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,434.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual coupon interest</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:7pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on our unsecured senior convertible notes due 2023, or the 2023 Notes, began accruing upon issuance and was payable semi-annually on June 1 and December 1 of each year until the 2023 Notes matured on December 1, 2023. Interest on our unsecured senior convertible notes due 2025, or the 2025 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on our unsecured senior convertible notes due 2028, or the 2028 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The 2023 Notes matured on December 1, 2023 and are no longer outstanding.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding in the relevant period.</span></div></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revolving Credit Agreement</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Terms of the Revolving Credit Agreement</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement, as amended, or the Amended Credit Agreement, which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, or the Credit Facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders. The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available principal amount </span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">192.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Loan, each as defined in the Amended Credit Agreement under the captions &#8220;ABR Spread&#8221;, &#8220;Term Benchmark&#8221;, and &#8220;RFR Spread&#8221;, or &#8220;Unused Commitment Fee Rate&#8221;, respectively, are outlined in the following table:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:17.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ABR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term Benchmark/RFR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unused Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.375%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.375%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.175%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maximum</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.000%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.000%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.250%</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, we have no other material guarantee facilities or lines of credit.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 405<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477092/405-40-50-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/470/tableOfContent<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1C<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1C<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513241872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases and Other Commitments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases and Other Commitments</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. Leases and Other Commitments</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have leases for certain machinery and facilities, including office, manufacturing and warehouse space facilities under various domestic and international operating and finance lease arrangements. We also have land leases in Penang, Malaysia that expire through 2082 and in Athenry, Ireland that expire in 3023 for the build-out of our international manufacturing facilities. Our leases, excluding our land leases in Malaysia and Ireland, have remaining lease terms of up to sixteen years. Some of the leases include one or more options to extend the leases for up to five years per option. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future lease cost</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of future payments</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-995">Less: Current portion</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term portion</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $17.0&#160;million and $15.7&#160;million as of December&#160;31, 2024 and 2023, respectively, are included in <span style="-sec-ix-hidden:f-1002"><span style="-sec-ix-hidden:f-1003">other long-term liabilities</span></span> in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use asset impairment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the result of the Company&#8217;s transition to a flexible working environment, we vacated a building in San Diego during the fourth quarter of 2022 and made it available for sublease. This resulted in an impairment indicator. We tested the asset group as of November 30, 2022 consisting primarily of the leasehold improvements and right-of-use asset for recoverability by comparing its carrying value to an estimate of future undiscounted cash flows. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group were below its carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the asset group by discounting the estimated future cash flows using level 3 fair value inputs under ASC 820 as described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. As a result of the impairment test, we recorded a non-cash charge of $23.0&#160;million for the twelve months ended December 31, 2022 in the &#8220;<span style="-sec-ix-hidden:f-1027">Selling, general and administrative</span>&#8221; caption of our consolidated statements of operations. The fair value of the asset group immediately subsequent to the impairment was $2.5&#160;million and was categorized as Level 3 within the ASC 820, &#8220;Fair Value Measurements&#8221; fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to our leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2 years</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was $16.7 million, $16.5 million, and $16.4 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></td></tr></table></div>We are party to various purchase arrangements related to our operational, manufacturing, and research and development activities. We had approximately $954.9 million and $793.0 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year, as of December&#160;31, 2024 and December&#160;31, 2023, respectively<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases and Other Commitments</a></td>
<td class="text"><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6. Leases and Other Commitments</span></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have leases for certain machinery and facilities, including office, manufacturing and warehouse space facilities under various domestic and international operating and finance lease arrangements. We also have land leases in Penang, Malaysia that expire through 2082 and in Athenry, Ireland that expire in 3023 for the build-out of our international manufacturing facilities. Our leases, excluding our land leases in Malaysia and Ireland, have remaining lease terms of up to sixteen years. Some of the leases include one or more options to extend the leases for up to five years per option. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future lease cost</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of future payments</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-995">Less: Current portion</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term portion</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $17.0&#160;million and $15.7&#160;million as of December&#160;31, 2024 and 2023, respectively, are included in <span style="-sec-ix-hidden:f-1002"><span style="-sec-ix-hidden:f-1003">other long-term liabilities</span></span> in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use asset impairment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As the result of the Company&#8217;s transition to a flexible working environment, we vacated a building in San Diego during the fourth quarter of 2022 and made it available for sublease. This resulted in an impairment indicator. We tested the asset group as of November 30, 2022 consisting primarily of the leasehold improvements and right-of-use asset for recoverability by comparing its carrying value to an estimate of future undiscounted cash flows. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group were below its carrying value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determined the fair value of the asset group by discounting the estimated future cash flows using level 3 fair value inputs under ASC 820 as described in Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Intangible Assets and Other Long-Lived Assets</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221;. As a result of the impairment test, we recorded a non-cash charge of $23.0&#160;million for the twelve months ended December 31, 2022 in the &#8220;<span style="-sec-ix-hidden:f-1027">Selling, general and administrative</span>&#8221; caption of our consolidated statements of operations. The fair value of the asset group immediately subsequent to the impairment was $2.5&#160;million and was categorized as Level 3 within the ASC 820, &#8220;Fair Value Measurements&#8221; fair value hierarchy.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to our leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2 years</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was $16.7 million, $16.5 million, and $16.4 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Purchase Commitments</span></td></tr></table></div>We are party to various purchase arrangements related to our operational, manufacturing, and research and development activities. We had approximately $954.9 million and $793.0 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year, as of December&#160;31, 2024 and December&#160;31, 2023, respectively<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/842-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512511168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LegalMattersAndContingenciesTextBlock', window );">Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7. Contingencies</span></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Litigation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Between June 2021 through the year ended December&#160;31, 2024, we and certain Abbott Diabetes Care, Inc. (&#8220;Abbott&#8221;) entities served patent infringement complaints against each other in multiple jurisdictions against certain continuous glucose monitoring products of each company. On December 20, 2024, we and Abbott entered into a settlement and patent cross license agreement (the &#8220;Settlement Agreement&#8221;) to resolve all outstanding patent litigation between the parties (the &#8220;Litigation&#8221;). Under the terms of the Settlement Agreement, we granted Abbott and its affiliates, and Abbott and its affiliates granted Dexcom and its affiliates, a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation. The Settlement Agreement does not obligate us or Abbott to pay any royalties or any other form of financial compensation. As part of the Settlement Agreement, each party, on behalf of itself and its affiliates, has also (i) entered into a covenant not to sue until December 20, 2034; and (ii) agreed on behalf of themselves and their affiliates to refrain from challenging the patents and patent applications licensed under the Settlement Agreement for periods of time which vary depending on the relevant patents or patent applications.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to uncertainty surrounding the securities class action litigation and the derivative action, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to defend against these claims vigorously in all of these actions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LegalMattersAndContingenciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 450<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/450/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LegalMattersAndContingenciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512461744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8. Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">659.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">463.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">709.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income taxes</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(93.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year of Expiration</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UK</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credits</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California AMT Credits</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> $1.1 million</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> of U.S. research and development tax credits that will expire unused, and is therefore, not reflected in the tax credit carryforwards above. In addition, the related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of our deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">263.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">748.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">741.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(221.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(264.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">526.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">477.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.6)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.4)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">466.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">416.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, we further analyzed the prior year intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries. As a result, we reclassified the specific intellectual property from a patent to patent rights according to Irish law. This changed the applicable enacted statutory tax rate from capital gains to passive at 25%.There was no impact to the income statement as the change in rate was fully offset by a change in valuation allowance. The total ending deferred tax asset as of December&#160;31, 2024 is $142.4&#160;million, which remains fully offset by a valuation allowance.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain a valuation allowance of $221.9 million against our California research and development tax credits, foreign tax credits, and certain foreign intangible assets. During the year ended December&#160;31, 2024, the valuation allowance decreased by $42.4 million primarily due to the change in tax rate applied to the fair value of certain intellectual property located in Ireland in connection with the intra-entity transfer of this property, partially offset by the generation of California research and development tax credits.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. federal statutory tax rate</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent items</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credit</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration agreement milestone share-based payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes at effective rates</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January&#160;1, 2022</span></div></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions </span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $40.7 million, $37.0&#160;million and $32.5&#160;million, respectively, would affect our annual effective tax rate if recognized. The indirect effect of the unrecognized tax benefits that, if recognized, would affect our annual effective tax rate is not material for all years presented. Also, the amount of unrecognized tax benefits that, if recognized, would result in adjustments to other tax accounts, is not material for all years presented. Interest and penalties are classified as a component of income tax expense and are not material for all years presented. Although the timing and outcome of audit settlements are uncertain, we do not anticipate a significant change to the unrecognized tax benefits in the next twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to our global business activities, we file income tax returns and are subject to routine compliance audits in numerous jurisdictions, including those material jurisdictions listed in the following table. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. The years remaining subject to audit, by major jurisdiction, are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Federal and state)</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1999 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2024</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate under a Special Corporate Income Tax Preferential rate in the Philippines, which is in effect for the next 10 years. The prior tax holiday ended in 2023. The impact of the both the tax holiday and preferential rate is immaterial for all years presented. We have been granted a tax incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which provides for a tax holiday of up to 15 years, which will not be triggered until we meet certain milestones related to the commencement of operations. The tax incentive had no effect on foreign taxes during 2024, 2023, or 2022. As of December&#160;31, 2024, the tax holiday in Malaysia has not yet been triggered, therefore we are subject to the statutory rate and the related tax expense has been included in total tax expense for 2024.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have approximately $89.3&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December&#160;31, 2024. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with these undistributed earnings. If we determine that all or a portion of such foreign earnings are no longer indefinitely reinvested, we may be subject to additional foreign withholding taxes and U.S. state income taxes. Determination of the amount of unrecognized deferred tax liability on these unremitted earnings is not practicable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Organization for Economic Co-operation and Development has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as Pillar 2), with certain aspects of Pillar 2 effective January 1, 2024 and other aspects effective January 1, 2025. While it is uncertain whether the United States will enact legislation to adopt Pillar 2, certain countries in which we operate have adopted legislation, and other countries in which we operate are in the process of introducing legislation to implement Pillar 2. We have assessed the impact of Pillar 2 on our financial statements and the impact is immaterial.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2024, the State of California enacted S.B. 167, which suspends the use of net operating losses (&#8220;NOLs&#8221;) for the tax period from January 1, 2024 to December 31, 2026 for net business income of $1.0&#160;million or more, as well as limits the utilization of research and development tax credits to $5.0&#160;million each year. The State of California also passed S.B. 175 to provide for a potential early sunset of NOLs in either 2025 or 2026 if necessary. We have analyzed the effect of both these laws on our financial statements. We are estimating $2.8&#160;million utilization of our California research and development tax credits for tax year ending December&#160;31, 2024, resulting in a corresponding valuation allowance release of the same amount.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income tax.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 270<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.5.Q1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/740/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 14<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046618280608">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock', window );">Employee Benefit Plans and Stockholders' Equity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9. Employee Benefit Plans and Stockholders&#8217; Equity</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Defined Contribution Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We offer various defined contribution plans for U.S. and international employees. The largest defined contribution plan is the 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to 90% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match 50% of contributions up to 6% of eligible compensation. Total matching contributions under the 401(k) Plan were $17.6 million, $14.9 million and $11.1&#160;million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. Our contributions for other defined contribution plans are not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees may purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. Payroll deductions may not exceed 10% of the participant&#8217;s cash compensation subject to certain limitations, and the purchase price will be 85% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. A total of 6.0 million shares of common stock are reserved for issuance under the 2015 ESPP. The 2015 ESPP shall continue until the earlier to occur of (a) termination of the 2015 ESPP by our Board of Directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May&#160;28, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We issued approximately 0.4 million, 0.3 million and 0.3 million shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. As of December&#160;31, 2024, approximately 2.1 million shares remained available for future issuance under the 2015 ESPP.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, RSUs, and PSUs to employees, directors or consultants of the Company. On May 30, 2019, our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are authorized to issue up to&#160;39.2 million&#160;shares of our common stock under the 2015 Plan. As of December&#160;31, 2024, approximately 12.5 million shares remained available for future issuance under the 2015 Plan. We issue new shares of common stock to satisfy RSU and PSU vesting under our employee equity incentive plans.</span></div>RSU awards typically vest in annual installments over <span style="-sec-ix-hidden:f-1231">three</span> or four years and vesting is subject to continued service. PSUs are granted to a group of senior officers and the number of shares of our common stock to be received at vesting will range from 0% to 200% of the target award based on the achievement of pre-established performance and market goals. PSUs vest approximately three years from the date of grant, subject to continued employment through that date and certification by the Compensation Committee<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share Repurchase Program and Treasury Shares</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have not yet determined the ultimate disposition of repurchased shares and, consequently, we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our treasury share activity for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.272%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Notes conversions</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares received from Note Hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with the Restated Collaboration Agreement</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.5)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2022 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2023 Share Repurchase Program</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2024 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased with 2028 Notes proceeds</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2024, our Board of Directors authorized and approved a share repurchase program of up to $750.0 million of our outstanding common stock, with a repurchase period ending no later than June 30, 2025 (the &#8220;2024 Share Repurchase Program&#8221;). Repurchases of our common stock under the 2024 Share Repurchase Program were permitted to be made from time to time in the open market, in privately negotiated transactions or by other methods, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act and other applicable federal and state laws and regulations. The 2024 Share Repurchase Program was completed in August 2024. We repurchased 10.4 million shares of our common stock for $750.0 million under the 2024 Share Repurchase Program.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2023 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2023, our Board of Directors authorized and approved a share repurchase program of up to $500.0 million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#8220;2023 Share Repurchase Program&#8221;). On October 31, 2023, we entered into an accelerated share repurchase agreement (&#8220;2023 ASR&#8221;) with Bank of America, N.A. to repurchase $500.0 million of our common stock. The final notional amount under the 2023 ASR was $500.0 million or approximately 4.7 million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2023 ASR, less a discount. The 2023 ASR concluded on December 14, 2023. The 2023 Share Repurchase Program was completed in December 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2022 Share Repurchase Program</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#8220;2022 Share Repurchase Program&#8221;). On August 1, 2022, we entered into an accelerated share repurchase agreement (&#8220;2022 ASR&#8221;) with JPMorgan Chase Bank, National Association to repurchase up to $700.0&#160;million of our common stock on an accelerated basis. The final notional amount under the 2022 ASR was $557.7&#160;million or approximately 6.6&#160;million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2022 ASR, less a discount. The 2022 ASR concluded on September 1, 2022. The 2022 Share Repurchase Program and the remaining authorization of $142.3&#160;million expired on June 30, 2023.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2022 ASR and 2023 ASR were forward contracts indexed to our own common stock. The forward contracts met all of the applicable criteria for equity classification, so we did not account for them as a derivative instrument. We have reflected the shares delivered to us by the financial institution as treasury shares as of the dates they were delivered to us in computing weighted average shares outstanding for both basic and diluted net income per share.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Treasury Share Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, we issued 12.5 million treasury shares to settle the 2023 Warrants. See Note 5 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Debt&#8212;Senior Convertible Notes&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, we issued 1.5 million treasury shares in connection with our achievement of the second sales-based milestone under the Restated Collaboration Agreement. See Note 2 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8220;Development and Other Agreements&#8212;Collaboration with Verily Life Sciences&#8221;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to the consolidated financial statements for more information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Equity Award Activity</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and PSU activity under the 2015 Plan for the twelve months ended December&#160;31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nonvested RSU and PSU Activity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Available for Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.88&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63.90&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94.08&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88.57&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105.98&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">361.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102.09&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121.17&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total vest-date fair value of RSUs and PSUs that vested during the twelve months ended December&#160;31, 2024, 2023 and 2022 was $174.5 million, $157.8 million and $160.1 million, respectively. As of December&#160;31, 2024, 2.7 million unvested RSUs and 0.3 million unvested PSUs were outstanding under the 2015 Plan.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our share-based compensation expense is associated with RSUs, PSUs, and ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total tax benefit related to share-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, unrecognized estimated compensation costs related to RSUs and PSUs totaled $203.8 million and are expected to be recognized over a weighted-average period of approximately 1.7 years.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value RSUs at the date of grant using the intrinsic value method. We estimate the fair value of PSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.80% - 5.27%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.20% - 5.47%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.60%&#160;- 3.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42% - 85%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34% - 48%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45%&#160;- 55%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndEmployeeBenefitPlansTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/710/tableOfContent<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 712<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/712/tableOfContent<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 715<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/715/tableOfContent<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndEmployeeBenefitPlansTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602106128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingDisclosureTextBlock', window );">Business Segment and Geographic Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"><tr><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.430%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:20.780%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">10. Business Segment and Geographic Information</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We manage our business on a global consolidated basis within one reportable segment, which is consistent with how our chief operating decision maker (CODM), our President and Chief Executive Officer, reviews our business, makes investment and resource allocation decisions, and assesses operating performance. The majority of our revenue is generated in the United States. The CGM segment derives revenues from the sale of disposable sensors and our Reusable Hardware.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The measures of segment profit or loss that are most consistent with U.S. GAAP used by the CODM to assess performance and allocate resources are operating income and net income. Our CODM also reviews total assets, as reported on our consolidated balance sheets, and purchases of property and equipment, as reported on our consolidated statements of cash flows.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our CODM uses operating income and net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the Company, acquire companies, or invest in other companies. Operating income is also used to monitor budget versus actual results.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,594.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,333.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,026.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payroll related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">767.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">726.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">621.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">298.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">228.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel related expenses</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply expenses and clinical trials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consulting &amp; professional fees</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">196.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment, office &amp; facility expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT software and data</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">709.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">341.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes amounts stated in other significant expense captions.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other segment items are primarily composed of impairment of assets and bad debt expense.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other segment disclosures</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for long-lived assets</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">358.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant noncash items other than depreciation and amortization expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes depreciation and amortization recorded in both cost of sales and operating expenses. </span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Other Income (Expense), Net</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our interest income and interest expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 9 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Employee Benefit Plans and Stockholders&#8217; Equity&#8212;Share-Based Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our share-based compensation expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disaggregate revenue by major sales channel and by geographic region. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 1 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Organization and Significant Accounting Policies&#8212;Concentration of Credit Risk and Significant Customers</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our major customers that represent 10% or more of our total revenue.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Customer Sales Channel</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the twelve months ended December&#160;31, 2024, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,430.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,095.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,470.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">526.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">439.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue by Geographic Region</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the twelve months ended December&#160;31, 2024, 2023 and 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,889.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,625.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,142.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,143.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">997.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">767.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets by Geographic Region</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our long-lived assets, which consists of property and equipment, net, and operating lease right-of-use assets by geographic region:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">464.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">544.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">632.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other countries </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,402.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,184.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No other individual country represented more than 10% of long-lived assets for the periods presented, except for Ireland with $185.7 million of long-lived assets at December&#160;31, 2024.</span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 34<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/280/tableOfContent<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513316944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ValuationAndQualifyingAccountsAbstract', window );"><strong>SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock', window );">SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</a></td>
<td class="text"><div style="margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">DexCom, Inc.</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SCHEDULE II</span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#8211; </span><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">VALUATION AND QUALIFYING ACCOUNTS</span></div></td></tr><tr><td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">(In millions)</span></td></tr></table></div><div style="margin-bottom:2pt;margin-top:2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Allowance for doubtful accounts</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning Balance</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Write-offs and adjustments</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.5)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Recoveries</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending Balance</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.2&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 09<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ValuationAndQualifyingAccountsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ValuationAndQualifyingAccountsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602237456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 576.2<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">$ 341.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517953248">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Arrangements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TradingArrByIndTable', window );"><strong>Trading Arrangements, by Individual</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrAdoptedFlag', window );">Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrAdoptedFlag', window );">Non-Rule 10b5-1 Arrangement Adopted</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_Rule10b51ArrTrmntdFlag', window );">Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonRule10b51ArrTrmntdFlag', window );">Non-Rule 10b5-1 Arrangement Terminated</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonRule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonRule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_Rule10b51ArrTrmntdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_Rule10b51ArrTrmntdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TradingArrByIndTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection a<br> -Paragraph 2<br> -Subparagraph A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TradingArrByIndTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513272752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515844928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cybersecurity Risk Management and Strategy Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems', window );"><strong>Cybersecurity Risk Management, Strategy, and Governance [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock', window );">Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have processes in place for assessing, identifying, and managing material risks from cybersecurity threats, which are integrated into our overall enterprise risk management processes. The processes for assessing, identifying and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include identifying the relevant assets that could be affected, determining possible threat sources and threat events, assessing threats based on their potential likelihood and impact, and identifying controls that are in place or necessary to manage and/or mitigate such risks.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established cybersecurity and privacy programs to maintain the confidentiality, integrity, availability, and privacy of protected information and ensure compliance with relevant security/privacy regulations, contractual requirements, and industry-standard frameworks. Our cybersecurity program includes annual review and assessment by external, independent third parties, who certify and report on these programs. For example, our Information Security Management System (ISMS) is certified as being in conformity with ISO/IEC 27001 by SRI Quality System Registrar. We maintain cybersecurity and privacy policies and procedures in accordance with industry-standard control frameworks and applicable regulations, laws, and standards. All corporate cybersecurity policies are reviewed and approved by senior leadership at least annually as part of our ISMS.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cybersecurity controls, which are the mechanisms in place to prevent, detect and mitigate threats in accordance with our policies and procedures, are based on the regulatory requirements to which we are subject and are monitored and tested both internally and externally by third parties at least annually. These controls include regular system updates and patches, employee training on cybersecurity and privacy requirements, incident reporting, and the use of encryption to secure sensitive information. In addition, we also regularly perform phishing tests of our employees and update our training plan at least annually. We maintain business continuity and disaster recovery capabilities to mitigate interruptions to critical information systems and/or the loss of data and services from the effects of natural or man-made disasters to Dexcom locations. We also provide annual privacy and security training for all employees. Our security training incorporates awareness of cyber threats (including but not limited to malware, ransomware and social engineering attacks), password hygiene, incident reporting process, as well as physical security best practices.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the last three fiscal years, we have not experienced any material cybersecurity incidents and the expenses we have incurred from security incidents were immaterial. As a result, we do not believe that risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected us, our results of operations and financial condition. However, as discussed under &#8220;Risk Factors&#8221; in Part I, Item 1A of this Annual Report, cybersecurity threats pose multiple risks to us, including potentially to our results of operations and financial condition. See &#8220;Risk Factors &#8212; Risks Related to Privacy and Security.&#8221; As cybersecurity threats become more frequent, sophisticated and coordinated, it is reasonably likely that we will be required to expend greater resources as we pursue our strategy of continuously modifying and enhancing our protective measures while developing and commercializing products that incorporate our CGM technologies and integrate with the insulin delivery systems or data platforms of our partners. The technology integration and cloud-based depository platforms we continue to focus on can make us more vulnerable to cybersecurity threats, thereby making our pursuit of such strategies more costly.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag', window );">Cybersecurity Risk Management Processes Integrated [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock', window );">Cybersecurity Risk Management Processes Integrated [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have processes in place for assessing, identifying, and managing material risks from cybersecurity threats, which are integrated into our overall enterprise risk management processes. The processes for assessing, identifying and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include identifying the relevant assets that could be affected, determining possible threat sources and threat events, assessing threats based on their potential likelihood and impact, and identifying controls that are in place or necessary to manage and/or mitigate such risks.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag', window );">Cybersecurity Risk Management Third Party Engaged [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag', window );">Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag', window );">Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock', window );">Cybersecurity Risk Board of Directors Oversight [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors is responsible for exercising oversight of management&#8217;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#8217;s Technology Committee. The Technology Committee reports to the Board as necessary with respect to its activities, including making such reports and recommendations to the Board and its other committees as necessary and appropriate and consistent with its purpose, described below.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text">Our Board of Directors is responsible for exercising oversight of management&#8217;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#8217;s Technology Committee.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock', window );">Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Technology Committee, comprised of independent Board members, is responsible for reviewing cybersecurity, privacy, data protection and other major technology risk exposures of the Company, the steps management has taken to monitor and control such exposures, and the Company&#8217;s compliance with applicable cybersecurity and data privacy laws and industry standards. These reviews are provided at least annually. The Technology Committee receives management updates and reports, primarily through the Company&#8217;s Cybersecurity and Privacy Committee, a multidisciplinary team responsible for the overall governance, decision-making, risk management, awareness and compliance for cybersecurity and privacy activities across the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity and Privacy Committee is co-chaired by our Information Security Officer (ISO), Product Security Officer (PSO), and Chief Privacy Officer (CPO), and its members include executive officers of the Company, including our Chief Technology Officer, Chief Financial Officer, Chief Information Officer, and Chief Legal Officer, as well as representatives from the finance, internal audit, quality, regulatory, and legal teams. Management&#8217;s role in assessing and managing the material risks from cybersecurity threats is accomplished primarily through the committee.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskRoleOfManagementTextBlock', window );">Cybersecurity Risk Role of Management [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Board of Directors is responsible for exercising oversight of management&#8217;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#8217;s Technology Committee. The Technology Committee reports to the Board as necessary with respect to its activities, including making such reports and recommendations to the Board and its other committees as necessary and appropriate and consistent with its purpose, described below.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Technology Committee, comprised of independent Board members, is responsible for reviewing cybersecurity, privacy, data protection and other major technology risk exposures of the Company, the steps management has taken to monitor and control such exposures, and the Company&#8217;s compliance with applicable cybersecurity and data privacy laws and industry standards. These reviews are provided at least annually. The Technology Committee receives management updates and reports, primarily through the Company&#8217;s Cybersecurity and Privacy Committee, a multidisciplinary team responsible for the overall governance, decision-making, risk management, awareness and compliance for cybersecurity and privacy activities across the Company.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Cybersecurity and Privacy Committee is co-chaired by our Information Security Officer (ISO), Product Security Officer (PSO), and Chief Privacy Officer (CPO), and its members include executive officers of the Company, including our Chief Technology Officer, Chief Financial Officer, Chief Information Officer, and Chief Legal Officer, as well as representatives from the finance, internal audit, quality, regulatory, and legal teams. Management&#8217;s role in assessing and managing the material risks from cybersecurity threats is accomplished primarily through the committee.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the Cybersecurity and Privacy Committee have broad ranges of expertise and experience in information technology and security. Our ISO, a co-chair of the committee, has over fifteen years of experience in the field of information security management, having previously led security operations and infrastructure and IT functions for a public university campus and a non-profit organization, and holds several licenses and certifications relating to information security, including a Certified Information Systems Security Manager from the Information Systems Audit and Control Association (ISACA), a Certified Information Systems Security Professional (CISSP) from the International Information Security System Security Certification Consortium (ISC2) and several technical cybersecurity certifications from the Global Information Assurance Certification (GIAC). Our PSO, also a co-chair of the committee, has over twenty-five years of previous experience in cyber security architecture and cyber security management for a number of large Fortune 500 technology companies and holds several certifications including CISSP from the International Information Security System Security Certification Consortium, C-CISO from EC-Council, Numerous certifications from Microsoft, CISCO, Juniper, Checkpoint among others and has completed several advanced GIAC security classes from the SANS Institute.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ISO reports directly to our Senior Vice President, Chief Information Officer (CIO), who is a member of the committee. She has held this role at Dexcom since 2024 and is responsible for global information technology at Dexcom. Our CIO brings 30 years of diverse strategic and operational experience in IT management, data engineering, AI, digital, ecommerce, infrastructure modernization and supply chain. Prior to Dexcom, our CIO served as Senior Vice President, Chief Information Officer at Bausch + Lomb. Additionally, our CIO has held transformational roles at Johnson &amp; Johnson, Bristol Myers Squibb, American Standard and Price Waterhouse Coopers. She holds a Bachelor of Science degree in Economics and Management Information Systems from the University of Delaware. Our Executive Vice President, Chief Technology Officer (CTO) is also a member of the committee. Our CTO has held this role since 2022 and has 25 years of experience spanning consumer electronics, data storage, IoT and broadband industries. From 2011 to 2022 he worked at Technicolor (now known as Vantiva), most recently serving as Chief Technology Officer and General Manager of the Broadband Business Division. In addition to an MBA, he holds a Master of Science in Mechanical Engineering and a Bachelor of Mechanical Engineering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prevention, detection, mitigation and remediation of cybersecurity incidents at Dexcom is accomplished pursuant to various policies, procedures and processes, including incident response plans and the cybersecurity and privacy programs and controls described above under &#8220;Risk Management and Strategy.&#8221; These measures include escalation protocols through which the Cybersecurity and Privacy Committee is informed about cybersecurity and incidents by our ISO and PSO, who are informed through our business units. As described above, members of the Cybersecurity and Privacy Committee provide updates to the Technology Committee of the Board on a regular basis, and the full Board receives updates from the Technology Committee. In addition, there are protocols in place for immediate escalation in the event of any cybersecurity issues or developments that may require consideration between regularly scheduled Technology Committee or Board meetings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Management Positions or Committees Responsible [Text Block]</a></td>
<td class="text">While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#8217;s Technology Committee.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock', window );">Cybersecurity Risk Management Expertise of Management Responsible [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Members of the Cybersecurity and Privacy Committee have broad ranges of expertise and experience in information technology and security. Our ISO, a co-chair of the committee, has over fifteen years of experience in the field of information security management, having previously led security operations and infrastructure and IT functions for a public university campus and a non-profit organization, and holds several licenses and certifications relating to information security, including a Certified Information Systems Security Manager from the Information Systems Audit and Control Association (ISACA), a Certified Information Systems Security Professional (CISSP) from the International Information Security System Security Certification Consortium (ISC2) and several technical cybersecurity certifications from the Global Information Assurance Certification (GIAC). Our PSO, also a co-chair of the committee, has over twenty-five years of previous experience in cyber security architecture and cyber security management for a number of large Fortune 500 technology companies and holds several certifications including CISSP from the International Information Security System Security Certification Consortium, C-CISO from EC-Council, Numerous certifications from Microsoft, CISCO, Juniper, Checkpoint among others and has completed several advanced GIAC security classes from the SANS Institute.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock', window );">Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ISO reports directly to our Senior Vice President, Chief Information Officer (CIO), who is a member of the committee. She has held this role at Dexcom since 2024 and is responsible for global information technology at Dexcom. Our CIO brings 30 years of diverse strategic and operational experience in IT management, data engineering, AI, digital, ecommerce, infrastructure modernization and supply chain. Prior to Dexcom, our CIO served as Senior Vice President, Chief Information Officer at Bausch + Lomb. Additionally, our CIO has held transformational roles at Johnson &amp; Johnson, Bristol Myers Squibb, American Standard and Price Waterhouse Coopers. She holds a Bachelor of Science degree in Economics and Management Information Systems from the University of Delaware. Our Executive Vice President, Chief Technology Officer (CTO) is also a member of the committee. Our CTO has held this role since 2022 and has 25 years of experience spanning consumer electronics, data storage, IoT and broadband industries. From 2011 to 2022 he worked at Technicolor (now known as Vantiva), most recently serving as Chief Technology Officer and General Manager of the Broadband Business Division. In addition to an MBA, he holds a Master of Science in Mechanical Engineering and a Bachelor of Mechanical Engineering.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The prevention, detection, mitigation and remediation of cybersecurity incidents at Dexcom is accomplished pursuant to various policies, procedures and processes, including incident response plans and the cybersecurity and privacy programs and controls described above under &#8220;Risk Management and Strategy.&#8221; These measures include escalation protocols through which the Cybersecurity and Privacy Committee is informed about cybersecurity and incidents by our ISO and PSO, who are informed through our business units. As described above, members of the Cybersecurity and Privacy Committee provide updates to the Technology Committee of the Board on a regular basis, and the full Board receives updates from the Technology Committee. In addition, there are protocols in place for immediate escalation in the event of any cybersecurity issues or developments that may require consideration between regularly scheduled Technology Committee or Board meetings.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag', window );">Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskManagementThirdPartyEngagedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskManagementThirdPartyEngagedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskRoleOfManagementTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection c<br> -Paragraph 2<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection c<br> -Paragraph 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskRoleOfManagementTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Section 106<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16K<br> -Subsection b<br> -Paragraph 1<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>cyd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>i:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514102064">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Principles of Consolidation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Fair Value Measurements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#8217;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;1&#8212;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;2&#8212;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Level&#160;3&#8212;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Cash and Cash Equivalents</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketableSecuritiesPolicy', window );">Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Marketable Securities</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#8217; equity in our consolidated balance sheets and included in comprehensive income. Interest income and realized gains and losses on marketable debt securities are included in other income (expense), net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income (loss) from equity investments in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities, supranational securities, and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; and Note 4 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Balance Sheet Details and Other Financial Information&#8212;Short-Term Marketable Securities</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements for more information on our marketable securities.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReceivablesPolicyTextBlock', window );">Accounts Receivables and Allowance for Doubtful Accounts</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are generally recorded at the invoiced amount, net of prompt pay discounts, for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectible.&#160;Generally, receivable balances that are more than one year past due are deemed uncollectible.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Significant Customers</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Significant Customers</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Inventory</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We capitalize inventory produced in preparation for commercial launches when it becomes probable that the product will receive regulatory approval and that the related costs will be recoverable through the commercialization of the product. A number of factors are considered, including the status of the regulatory application approval process, management&#8217;s judgment of probable future commercial use, and net realizable value.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record adjustments to inventory for potential excess or obsolete inventory, as well as inventory that does not pass quality control testing, in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is disposed of or sold.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of sales could be required.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We also capitalize certain costs incurred for the development of enterprise-level business and finance software that we use internally in our operations. Costs incurred in the application development phase are capitalized while costs related to planning and other preliminary project activities and to post-implementation activities are expensed as incurred.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally <span style="-sec-ix-hidden:f-460">three</span> to five years for computer software and hardware, including internal use software, <span style="-sec-ix-hidden:f-462">four</span> to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold and land improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets and Other Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Goodwill</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but are tested annually for impairment during the fourth fiscal quarter and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#8217;s reporting structure and the availability of discrete financial information.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We perform the first step of our annual impairment analysis by either comparing a reporting unit&#8217;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#8217;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#8217;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#8217;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#8217;s market capitalization as a part of our analysis.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#8217;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no significant goodwill impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The change in goodwill for the twelve months ended December&#160;31, 2024 and 2023 primarily consisted of the divestiture of our non-diabetes distribution business and translation adjustments on our foreign currency denominated goodwill.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Intangible Assets and Other Long-Lived Assets</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangible assets are included in intangibles and other assets, net in our consolidated balance sheets. We amortize intangible assets with a finite life, such as the customer relationships, acquired technology and intellectual property, trademarks and trade name, and other intangibles, on a straight-line basis over their estimated useful lives, which range from <span style="-sec-ix-hidden:f-470">one</span> to fourteen years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For transactions other than a business combination, we also capitalize as intangible assets the cost of certain milestones payable by us to collaborative partners and incurred at or after the product has obtained regulatory approval for marketing. The intangible assets associated with these milestones are amortized over the remaining estimated useful life of the underlying asset.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recorded no significant intangible asset impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rate on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under tax law and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize income tax expense for basis differences related to global intangible low-taxed income (&#8220;GILTI&#8221;) as a period cost if and when incurred. GILTI is a category of income that is earned abroad by U.S.-controlled foreign corporations (CFCs) and is subject to special treatment under the U.S. tax code.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyPolicy', window );">Warranty Accrual</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Warranty Accrual</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock', window );">Loss Contingencies</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Loss Contingencies</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Income</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Comprehensive income consists of two elements, net income and other comprehensive income (loss). We report all components of comprehensive income, including net income, in our financial statements in the period in which they are recognized. Total comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income and the components of other comprehensive income (loss), including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Revenue Recognition</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. We also refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In determining how revenue should be recognized, a five-step process is used, which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contracts and Performance Obligations</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Transaction Price</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Variable Consideration</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes, but is not limited to: rebates, chargebacks, product returns provision, and prompt payment discounts. We classify these items as a reduction of accounts receivable when we are not required to make a payment and as a liability when we are required to make a payment.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Estimates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Rebates</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Chargebacks</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Product Returns</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with the terms of their distribution agreements, most distributors do not have rights of return. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We estimate our product returns primarily based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Prompt Payment Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We provide customers with prompt payment discounts, which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discounts based on eligible sales and contractual discount rates.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record revenue from sales of Components upon transfer of control of the product to the customer. We typically determine transfer of control based on when the product is shipped or delivered and title passes to the customer.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable as of December&#160;31, 2024 included unbilled accounts receivable of $15.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We record deferred revenue when cash payments have been received prior to satisfaction of the related performance obligation.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months were $9.5 million as of December&#160;31, 2024 and $7.4 million as of December&#160;31, 2023. These balances are included in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Deferred Cost of Sales</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Incentive Compensation Costs</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been <span style="-sec-ix-hidden:f-485">one</span> year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expense costs of research and development as we incur them. Our research and development expenses primarily consists of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our technology includes certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementAccountingPolicy', window );">Collaboration Agreements</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Collaboration Agreements</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into agreements with collaboration partners for the development and commercialization of our products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When we account for these agreements, we consider the unique nature, terms and facts and circumstances of each transaction. Below are some example activities and how we account for them:</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">Payments to collaboration partners through issuance of common stock as consideration in an asset acquisition are considered share-based payment to non-employees in exchange for goods within the scope of ASC Topic 718, &#8220;Compensation - Stock Compensation.&#8221; The amount and the timing of the cost recognition of such milestones in our financial statements is driven by the accounting for the specific type of equity instrument under ASC 718 that aligns with the terms of the agreement, including any performance conditions.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with in-process research and development (&#8220;IPR&amp;D&#8221;) in an asset acquisition incurred prior to regulatory approval is expensed as it does not have an alternative future use and is recorded as research and development expense.</span></div><div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt">The value associated with IPR&amp;D in an asset acquisition incurred at or after regulatory approval is usually capitalized as an intangible asset and amortized over the periods in which the related products are expected to contribute to future cash flows.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingCostsPolicyTextBlock', window );">Advertising Costs</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Advertising Costs</span></td></tr></table></div>We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease right-of-use assets and liabilities with terms of more than 12 months are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to determine the present value is our collateralized incremental borrowing rate unless the interest rate implicit in the lease is readily determinable.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For operating leases, lease expense is recognized on a straight-line basis within operating expenses over the lease term. For finance leases, lease expense is recognized as interest and depreciation; interest using the effective interest method and depreciation on a straight-line basis over the shorter of the estimated useful lives of the assets or, in the instance where title does not transfer at the end of the lease term, the lease term. Short-term leases with lease terms of 12 months or less are not recorded on the balance sheet and are recognized on a straight line basis over the lease term.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our lease agreements may contain lease components and non-lease components. For certain asset classes, we have elected to account for both of those components as a single lease component. We use a portfolio approach to account for the right-of-use assets and liabilities associated with certain machinery and equipment leases. Variable lease payments may include payments associated with non-lease components, payments that do not depend on a rate or index, or other costs. Variable lease payments are recognized in the period in which the obligation for those payments are incurred.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-Based Compensation</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We value time-based restricted stock units, or RSUs, at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. We estimate the fair value of these performance/market-based RSUs, or PSUs, at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the PSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of PSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the PSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Net Income Per Share</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Potentially dilutive common shares consist of shares issuable from RSUs, PSUs, warrants, our senior convertible notes, and collaborative sales-based milestones. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Guidance</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Guidance</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Pronouncements</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2023-07, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, or CODM, and included within each reported measure of segment profit or loss. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, reflecting the application of the new standard in each prior reporting period.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Issued Accounting Pronouncements Not Yet Adopted</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2023, the FASB issued ASU 2023-09, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Improvements to Income Tax Disclosures</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires greater disaggregation of information about a reporting entity</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8217;</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">s effective tax rate reconciliation as well as information on income taxes paid. The ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity&#8217;s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In November 2024, the FASB issued ASU 2024-03, </span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Disaggregation of Income Statement Expenses</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ASU requires disaggregated disclosure of certain costs and expenses in the notes of the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Securities and Exchange Commission Final Rules Not Yet Implemented</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 6, 2024, the SEC adopted SEC Release Nos. 33-11275; 34-99678, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to require the disclosure of certain climate-related information in registration statements and annual reports, including Scope 1 and 2 emissions and information about climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, a company&#8217;s business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in audited financial statements. The disclosure requirements would have begun phasing in for our reports and registration statements including financial information in the fiscal year ending December 31, 2025, however, in April 2024, the SEC issued an order staying the final rules until the completion of judicial review. The SEC has since indicated that it intends to establish a new implementation period following the stay order. We are currently evaluating the impact of this final rule on our disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for advertising cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 35<br> -Topic 720<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementAccountingPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for collaborative arrangements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 808<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479402/808-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementAccountingPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 450<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477850/954-450-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478898/942-825-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481203/810-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-30/tableOfContent<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/350-20/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-20<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 25<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-25<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-28<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 330<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478411/912-330-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/330/tableOfContent<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-4<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 270<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482989/270-10-45-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketableSecuritiesPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment classified as marketable security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477268/942-320-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketableSecuritiesPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -SubTopic 360<br> -Topic 958<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477798/958-360-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481569/310-20-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 730<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483044/730-10-05-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 17<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-17<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 19<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-19<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-18<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-20<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483426/235-10-50-4<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Topic 606<br> -Publisher FASB<br> -URI https://asc.fasb.org/606/tableOfContent<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.C.Q3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.1.Q5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.3.Q2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2.Q6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -Name Accounting Standards Codification<br> -Publisher FASB<br> -URI https://asc.fasb.org/718/tableOfContent<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for standard warranties including the methodology for measuring the liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-11<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -SubTopic 10<br> -Topic 275<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-12<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602070736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock', window );">Schedule of Percentage of Total Revenues and Accounts Receivable by Customer</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:46.414%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.115%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.701%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Revenue**</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Accounts Receivable</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">As of December 31, </span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer A</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer B</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer C</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer D</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer E</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Less than 10%</span></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">** Total revenue for each customer is net of fees, cash discounts, and rebates directly allocable to that customer. Rebates paid to other entities are excluded; therefore, the combined value may exceed 100%.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the computation of basic and diluted net income per share for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.601%"></td><td style="width:0.1%"></td></tr><tr style="height:21pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except per share data)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">341.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income - diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">587.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">554.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">352.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income per common share</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.40&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.88&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.42&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.30&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.82&#160;</span></td><td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">393.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">386.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">389.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dilutive potential securities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborative sales-based milestones</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior convertible notes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Diluted weighted average shares outstanding</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">412.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">425.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">427.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">RSUs and PSUs</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-16<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-21<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602129296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock', window );">Schedule of Fair Value Hierarchy for Financial Assets</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2024, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other long-term assets:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible notes receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">154.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,138.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2023, classified in accordance with the fair value hierarchy:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level 1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Level&#160;3</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash equivalents</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">315.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total assets measured at fair value on a recurring basis</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">331.1&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,488.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock', window );">Schedule of Fair Value of Senior Convertible Notes</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.098%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.937%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fair Value Measurements Using Level 1</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,163.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,262.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,122.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,281.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total fair value of outstanding senior convertible notes</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,286.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,544.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information about fair value of asset and liability not measured at fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046616602816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock', window );">Schedule of Short-Term Marketable Securities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:</span></div><div style="margin-bottom:7pt;margin-top:8pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></div></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,149.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,150.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">312.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">511.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,972.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.1)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,973.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><div style="margin-bottom:7pt;margin-top:3pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.169%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.039%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amortized<br/>Cost</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Gains</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross<br/>Unrealized<br/>Losses</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Estimated<br/>Market<br/>Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Debt securities, available-for-sale:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. government agencies </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,611.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,612.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Commercial paper</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">184.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">360.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total debt securities, available-for-sale</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,157.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock', window );">Schedule of Accounts Receivable</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,014.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">983.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: allowance for doubtful accounts</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts receivable, net</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,005.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">973.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Raw materials</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">327.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">319.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Work-in-process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finished goods</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">187.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">210.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total inventory</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">542.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">559.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock', window );">Schedule of Prepaid and Other Current Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid expenses</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prepaid inventory</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax receivables</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other current assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total prepaid and other current assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Land and land improvements</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Building</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">291.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">190.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furniture and fixtures</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Computer software and hardware</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Machinery and equipment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">908.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">683.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Leasehold improvements</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">293.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">283.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Construction in progress </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">354.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">328.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,018.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,622.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(678.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(509.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total property and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,339.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,113.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Intangible Assets and Weighted Average Amortization Period</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of December&#160;31, 2024 and December&#160;31, 2023:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2024</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible asset</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.5)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.8</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">193.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(90.1)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:45.829%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31, 2023</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted Average Useful Life<br/>(in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Gross Carrying Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Accumulated Amortization</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Carrying Amount</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Verily intangible</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">152.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(31.0)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customer relationships</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Acquired technology and intellectual property</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Trademarks and trade name</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.6</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intangibles, other</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.0</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.1</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">195.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(61.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">See Note 2 &#8220;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">Development and Other Agreements</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#8221; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Excludes Verily intangible asset.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the total amortization expense of finite-lived intangible assets for the twelve months ended December&#160;31, 2024, 2023 and 2022:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:50.800%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.543%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.546%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization expense included in operating expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total amortization of intangible assets</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents estimated future amortization of the Company&#8217;s finite-lived intangible assets as of December&#160;31, 2024:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.157%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.408%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock', window );">Schedule of Other Assets</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-marketable equity securities</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">119.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term deposits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other assets</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">173.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">75.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accounts Payable and Accrued Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts payable trade</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">345.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">276.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued tax, audit, and legal fees</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued rebates </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,135.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">950.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued warranty</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax payable</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred compensation plan liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.6</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued liabilities </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accounts payable and accrued liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,585.1&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,345.5&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock', window );">Schedule of Accrued Payroll and Related Expenses</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued wages, bonus and taxes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">139.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other accrued employee benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total accrued payroll and related expenses</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">171.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock', window );">Schedule of Accrued Warranty</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beginning balance</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Charges to costs and expenses</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(53.9)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(51.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ending balance</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock', window );">Schedule of Other Long-Term Liabilities</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease obligations</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue, long-term</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Asset retirement obligation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other tax liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other long-term liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">147.9&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock', window );">Schedule of Other Income (Expense), Net</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:61.034%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.038%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest and dividend income</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">134.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">135.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(19.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(20.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(18.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total other income (expense), net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109.0&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.7&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid And Other Current Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Accrued Payroll and Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-9<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aaa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 10: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 11: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -SubTopic 10<br> -Topic 360<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483489/210-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513552752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock', window );">Schedule of Carrying Values and Estimated Fair Values of Debt Instruments</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of our senior convertible notes were as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Principal amount:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,207.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,250.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,250.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total principal amount</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,457.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,457.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unamortized debt issuance costs</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16.1)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Carrying amount of senior convertible notes</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,441.4&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,434.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtTableTextBlock', window );">Schedule of Converted Value of Notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total by which the notes&#8217; if-converted value exceeds their principal amount</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">89.7&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes key details of the 2023 Notes, 2025 Notes, and 2028 Notes:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.326%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.180%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.204%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.373%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.695%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.260%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Senior Convertible Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Offering Completion Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Maturity Date</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Stated Interest Rate</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Principal Amount<br/>Issued</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Net Proceeds</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Initial Conversion Rate</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(2)</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(per $1,000 principal amount)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Conversion Price<br/>(per share)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Settlement Methods</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline">(3)</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2023 Notes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">November 2018</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">December&#160;1, 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.75%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$850.0 million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$836.6 million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24.3476&#160;shares </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$41.07</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2025 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2020</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">November&#160;15, 2025</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.25%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.21 billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.19 billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.6620 shares </span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$150.11</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2028 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May 2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">May&#160;15, 2028</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">0.375%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.25&#160;billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$1.23&#160;billion</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6.1571 shares</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">$162.41</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Cash and/or shares</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Net proceeds are calculated by deducting the initial purchasers&#8217; discounts and estimated costs directly related to the offering from the aggregate principal amount of the applicable series of notes.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Subject to adjustments as defined in the applicable indentures.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(3) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2025 Notes and 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The 2023 Notes, while outstanding, could be settled in cash, stock, or a combination thereof, solely at our discretion.</span></div></td></tr><tr><td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(4) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The 2023 Notes matured on December&#160;1, 2023 and are no longer outstanding.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock', window );">Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:57.087%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.350%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.353%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contractual coupon interest</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"> (1)</span></div></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Non-cash interest expense:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of debt issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total interest expense recognized on senior notes</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective interest rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2023 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2025</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Senior Convertible Notes due 2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*</span></td></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;margin-top:7pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Interest on our unsecured senior convertible notes due 2023, or the 2023 Notes, began accruing upon issuance and was payable semi-annually on June 1 and December 1 of each year until the 2023 Notes matured on December 1, 2023. Interest on our unsecured senior convertible notes due 2025, or the 2025 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on our unsecured senior convertible notes due 2028, or the 2028 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The effective interest rate presented represents the rate applicable for the period outstanding. The 2023 Notes matured on December 1, 2023 and are no longer outstanding.</span></div></td></tr><tr><td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* Not applicable as no notes were outstanding in the relevant period.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock', window );">Schedule of Conversion Activity for Senior Convertible Notes</a></td>
<td class="text">See the following table for the details of conversion activity for the 2023 Notes for the fiscal year ended December 31, 2023:<div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:22.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.935%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.344%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:22.147%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Fiscal Period</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Converted Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate Principal Amount Converted</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Issued for Settlement</span></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Received from Exercise of 2023 Note Hedge</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1/1/2023 - 12/31/2023</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 Notes</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$774.8 million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2&#160;million</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2 million</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock', window );">Schedule of Availability and Outstanding Borrowings on Credit Agreement</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:84.864%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.936%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Available principal amount </span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">200.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Letters of credit sub-facility</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding borrowings </span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding letters of credit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total available balance</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">192.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div>The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Loan, each as defined in the Amended Credit Agreement under the captions &#8220;ABR Spread&#8221;, &#8220;Term Benchmark&#8221;, and &#8220;RFR Spread&#8221;, or &#8220;Unused Commitment Fee Rate&#8221;, respectively, are outlined in the following table:<div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"></td><td style="width:17.961%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.879%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.881%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Range</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">ABR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Term Benchmark/RFR Spread</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Unused Commitment Fee Rate</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Minimum</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.375%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.375%</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.175%</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maximum</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.000%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.000%</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.250%</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Conversion Activity For Senior Convertible Notes</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513301744">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases and Other Commitments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Operating Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future lease cost</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of future payments</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-995">Less: Current portion</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term portion</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Maturity of Finance Lease Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.508%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.867%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance Leases</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2025</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.7&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2029</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Thereafter</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total future lease cost</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">99.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: Imputed interest </span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(26.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Present value of future payments</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><span style="-sec-ix-hidden:f-995">Less: Current portion</span></span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.5)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Long-term portion</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">65.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Schedule of Components of Lease Expense and Other Information</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions) </span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance lease cost:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amortization of right-of-use assets</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest on lease liabilities</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use asset impairment</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Short-term lease cost</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Variable lease cost</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.8&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.3&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other information related to our leases is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.642%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended <br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(Dollars in millions)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cash paid for amounts included in the measurement of lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from operating leases</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating cash flows from finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financing cash flows from finance leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Right-of-use assets obtained in exchange for lease liabilities:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average remaining lease term:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.2 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0 years</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.5 years</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.6 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.1 years</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.2 years</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighted average discount rate:</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating leases</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Finance leases</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512005968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock', window );">Schedule of Income (Loss) before Income Taxes Subject to Taxes</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">659.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">732.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">463.5&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outside of the United States</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(22.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">709.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710.4&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock', window );">Schedule of Components of Income Tax Expense (Benefit)</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant components of the provision for income taxes are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Current:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">157.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total current income taxes</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">176.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">223.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(93.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.0)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred income taxes</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(43.8)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(55.0)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(21.6)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock', window );">Schedule of Tax Credit Carryforwards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year of Expiration</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UK</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credits</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California AMT Credits</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock', window );">Schedule of Operating Loss Carryforwards</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant loss and tax credit carryforwards and years of expiration are as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Year of Expiration</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">162.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">167.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2035</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other states</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2028</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">UK</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other foreign</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2027</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credits</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2032</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California R&amp;D credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">124.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">111.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">California AMT Credits</span></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indefinite</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.777%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.598%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax assets:</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net operating loss carryforwards</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Capitalized research and development expenses</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">265.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">233.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Tax credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">79.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">71.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed and intangible assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">263.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">279.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities and reserves</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">91.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Convertible debt</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total gross deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">748.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">741.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less: valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(221.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(264.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total net deferred tax assets</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">526.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">477.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred tax liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fixed assets and acquired intangibles assets</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total deferred tax liabilities</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(59.6)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(60.4)</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net deferred tax assets (liabilities)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">466.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">416.6&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation between Effective Tax Rate and Statutory Rate</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.350%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.600%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">U.S. federal statutory tax rate</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">148.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">149.2&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">82.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">State income tax, net of federal benefit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Permanent items</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.7)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development credits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(24.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(28.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(23.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign tax credit</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Foreign rate differential</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock and officers compensation</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.2)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaboration agreement milestone share-based payment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(32.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(72.1)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(52.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in statutory tax rates</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Intellectual property transfer</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in valuation allowance</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(42.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income taxes at effective rates</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock', window );">Schedule of Unrecognized Tax Benefits</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the activity related to our gross unrecognized tax benefits:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at January&#160;1, 2022</span></div></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Decreases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions </span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">59.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to prior year tax positions</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Increases related to current year tax positions</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">66.2&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock', window );">Schedule of Years Remaining Subject to Audit by Major Jurisdiction</a></td>
<td class="text">The years remaining subject to audit, by major jurisdiction, are as follows:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:86.765%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.035%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Jurisdiction</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Fiscal Year</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States (Federal and state)</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1999 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United Kingdom</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2021 - 2024</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ireland</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2023 - 2024</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income before income tax between domestic and foreign jurisdictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the change in unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfIncomeTaxExaminationsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfIncomeTaxExaminationsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046601361360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-Based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock', window );">Schedule of Treasury Share Activity Table Text Block</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our treasury share activity for the periods shown:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:62.272%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.527%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.381%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.531%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Notes conversions</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares received from Note Hedge</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.2</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with the Restated Collaboration Agreement</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.5)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3.7)</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2.9)</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2022 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.6</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2023 Share Repurchase Program</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.7</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased under the 2024 Share Repurchase Program</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.4</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares repurchased with 2028 Notes proceeds</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shares issued in connection with 2023 Warrants</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12.5)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock', window );">Schedule of RSU and PSU Activity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A summary of RSU and PSU activity under the 2015 Plan for the twelve months ended December&#160;31, 2024, 2023 and 2022 is as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:49.923%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.595%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.602%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Nonvested RSU and PSU Activity</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions, except weighted average grant date fair value)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares Available for Grant</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Weighted&#160;<br/>Average<br/>Grant&#160;Date<br/>Fair&#160;Value</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Aggregate<br/>Intrinsic&#160;Value</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2021</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">76.88&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.9)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">96.79&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">63.90&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">92.54&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2022</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">94.08&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">325.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.6)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.01&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88.57&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.2)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106.34&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2023</span></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.9&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">105.98&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">361.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Granted</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.7)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">131.17&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Vested</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1.3)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">102.09&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Forfeited</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.3)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.59&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Balance at December 31, 2024</span></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.5&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">121.17&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">234.1&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Schedule of Share-Based Compensation Expenses</a></td>
<td class="text">The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:59.280%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.619%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.622%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.4&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">103.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">90.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total share-based compensation expense</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">170.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">150.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">126.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:12pt"><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total tax benefit related to share-based compensation expense</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock', window );">Schedule of Valuation Assumptions for Employee Stock Purchase Plan</a></td>
<td class="text">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods.<div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:55.771%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Risk free interest rate</span></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.80% - 5.27%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.20% - 5.47%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.60%&#160;- 3.34%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dividend yield</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected volatility of Dexcom common stock</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42% - 85%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34% - 48%</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45%&#160;- 55%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected life (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">0.5</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ScheduleOfTreasuryShareActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Schedule of Treasury Share Activity</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ScheduleOfTreasuryShareActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Subparagraph (f)(2)<br> -Name Accounting Standards Codification<br> -Paragraph 2<br> -Section 50<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513571728">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock', window );">Schedule of Revenue from External Customers by Geographic Areas</a></td>
<td class="text">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,889.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,625.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">72&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,142.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">74&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">International</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,143.2&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">997.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">767.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents our long-lived assets, which consists of property and equipment, net, and operating lease right-of-use assets by geographic region:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.034%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.530%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.036%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">United States</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">464.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">544.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Malaysia</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">632.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">515.4&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other countries </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">306.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">125.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total long-lived assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,402.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,184.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> No other individual country represented more than 10% of long-lived assets for the periods presented, except for Ireland with $185.7 million of long-lived assets at December&#160;31, 2024.</span></div></td></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Schedule of Disaggregation of Revenue</a></td>
<td class="text">The following table sets forth revenue by major sales channel for the twelve months ended December&#160;31, 2024, 2023 and 2022:<div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"></td><td style="width:31.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.441%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.532%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.446%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:0 1pt"></td><td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended December 31,</span></td></tr><tr style="height:12pt"><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Amount</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">%<br/>of&#160;Total</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Distributor</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,430.1&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,095.6&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,470.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">85&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Direct</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">602.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">526.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">439.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total revenue</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">100&#160;</span></td><td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">%</span></td></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock', window );">Schedule of Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4,033.0&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3,622.3&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2,909.8&#160;</span></td><td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Less:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of sales </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,594.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,333.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1,026.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Payroll related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">767.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">726.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">621.1&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">156.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">136.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">115.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marketing expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">298.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">264.6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">228.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Travel related expenses</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Supply expenses and clinical trials</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">64.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.5&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consulting &amp; professional fees</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">227.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">222.2&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">196.4&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Equipment, office &amp; facility expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">83.8&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">84.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">80.3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IT software and data</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">130.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">106.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">86.5&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other segment items </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29.3&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">600.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">597.7&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">391.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income (expense), net</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">109.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">112.7&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(0.4)</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">709.0&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">710.4&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">390.8&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">132.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">168.9&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net income</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">576.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">541.5&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">341.2&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes amounts stated in other significant expense captions.</span></div></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(2) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Other segment items are primarily composed of impairment of assets and bad debt expense.</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:47.145%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.420%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.384%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Twelve Months Ended<br/>December 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">(In millions)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2024</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">2022</span></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other segment disclosures</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Depreciation and amortization </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">217.7&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">186.0&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">155.9&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expenditures for long-lived assets</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">358.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">236.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">364.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Significant noncash items other than depreciation and amortization expense:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred income taxes</span></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43.8&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55.0&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#bcedaf;padding:0 1pt"></td><td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$</span></td><td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21.6&#160;</span></td><td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline">(1) </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Includes depreciation and amortization recorded in both cost of sales and operating expenses. </span></div></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515972656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents', window );">Maturity threshold of investments classified to cash equivalents</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Goodwill impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life (in years)</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill', window );">Intangible asset impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnbilledContractsReceivable', window );">Unbilled accounts receivable</a></td>
<td class="nump">15,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="nump">9,500,000<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdvertisingExpense', window );">Advertising costs</a></td>
<td class="nump">$ 194,200,000<span></span>
</td>
<td class="nump">$ 180,800,000<span></span>
</td>
<td class="nump">$ 160,600,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms (in days)</a></td>
<td class="text">30 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Intangible asset, useful life (in years)</a></td>
<td class="text">14 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ContractPaymentTermsNumberofDays', window );">Customer contract payment terms (in days)</a></td>
<td class="text">90 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts', window );">Amortization period for incentive compensation costs (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember', window );">Computer software and hardware | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember', window );">Computer software and hardware | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Organization And Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property, Plant and Equipment, Useful Life (in years)</a></td>
<td class="text">40 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AmortizationPeriodForIncentiveCompensationCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Period For Incentive Compensation Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AmortizationPeriodForIncentiveCompensationCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ContractPaymentTermsNumberofDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contract Payment Terms, Number of Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ContractPaymentTermsNumberofDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maturity Threshold Of Investments Classified To Cash Equivalents</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Organization And Summary Of Significant Accounting Policies [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdvertisingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483385/720-35-55-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 720<br> -SubTopic 35<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483406/720-35-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdvertisingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 24<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482548/350-20-55-24<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482573/350-20-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482598/350-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnbilledContractsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 912<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478345/912-310-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnbilledContractsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515593088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details) - Customer concentration risk<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">40.00%<span></span>
</td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">32.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue | Customer B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue | Customer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">35.00%<span></span>
</td>
<td class="nump">30.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">37.00%<span></span>
</td>
<td class="nump">29.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Revenue | Customer E</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Gross Accounts Receivable | Customer A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">18.00%<span></span>
</td>
<td class="nump">20.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Gross Accounts Receivable | Customer C</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">23.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember', window );">Gross Accounts Receivable | Customer D</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskLineItems', window );"><strong>Concentration Risk [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">27.00%<span></span>
</td>
<td class="nump">27.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478785/954-310-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-21<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-20<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-18<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482861/275-10-50-20<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerDMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerDMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=dxcm_CustomerEMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=dxcm_CustomerEMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513848928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details) - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">$ 576.2<span></span>
</td>
<td class="nump">$ 541.5<span></span>
</td>
<td class="nump">$ 341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestOnConvertibleDebtNetOfTax', window );">Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes</a></td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">11.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAttributableToParentDiluted', window );">Net income - diluted</a></td>
<td class="nump">$ 587.7<span></span>
</td>
<td class="nump">$ 554.1<span></span>
</td>
<td class="nump">$ 352.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Basic net income per share (in usd per share)</a></td>
<td class="nump">$ 1.46<span></span>
</td>
<td class="nump">$ 1.40<span></span>
</td>
<td class="nump">$ 0.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Diluted net income per share (in usd per share)</a></td>
<td class="nump">$ 1.42<span></span>
</td>
<td class="nump">$ 1.30<span></span>
</td>
<td class="nump">$ 0.82<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Basic weighted average shares outstanding (in shares)</a></td>
<td class="nump">393.6<span></span>
</td>
<td class="nump">386.0<span></span>
</td>
<td class="nump">389.4<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Diluted weighted average shares outstanding (in shares)</a></td>
<td class="nump">412.7<span></span>
</td>
<td class="nump">425.5<span></span>
</td>
<td class="nump">427.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_CollaborativeSalesBasedMilestoneMember', window );">Collaborative sales-based milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential securities (in shares)</a></td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential securities (in shares)</a></td>
<td class="nump">0.7<span></span>
</td>
<td class="nump">1.1<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember', window );">Senior convertible notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential securities (in shares)</a></td>
<td class="nump">15.7<span></span>
</td>
<td class="nump">26.2<span></span>
</td>
<td class="nump">26.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements', window );">Dilutive potential securities (in shares)</a></td>
<td class="nump">2.5<span></span>
</td>
<td class="nump">11.5<span></span>
</td>
<td class="nump">10.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 52<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-52<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482635/260-10-55-15<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-7<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-7<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480454/718-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-22<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-23<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-28A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestOnConvertibleDebtNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-40<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestOnConvertibleDebtNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAttributableToParentDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAttributableToParentDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 16<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-16<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_CollaborativeSalesBasedMilestoneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_CollaborativeSalesBasedMilestoneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_ConvertibleDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517710912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=dxcm_RestrictedAndPerformanceStockUnitsMemberMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515750736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Development and Other Agreements (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="5">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 28, 2018</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement', window );">Shares Issued In Connection With The Restated Collaboration Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 195.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 193.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues', window );">Potential common stock issued shares (in shares)</a></td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember', window );">Verily Life Sciences | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1', window );">Amortization period (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">64 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember', window );">Collaborative Arrangement, Initial Payment | Verily Life Sciences | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (in usd per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 29.57<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeArrangementUpfrontFee', window );">Initial payment on collaborative agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with acquisition, shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 87.1<span></span>
</td>
<td class="nump">$ 217.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember', window );">Collaborative Arrangement, Milestone Payments | Verily Life Sciences | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DevelopmentAgreementsLineItems', window );"><strong>Development Agreements [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CollaborativeResearchAndDevelopmentFee', window );">Collaborative research and development fee</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 152.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues', window );">Potential future common stock issuable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,200,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues', window );">Potential common stock issued shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeArrangementUpfrontFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Arrangement, Upfront Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeArrangementUpfrontFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CollaborativeResearchAndDevelopmentFee">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Collaborative Research and Development Fee</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CollaborativeResearchAndDevelopmentFee</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DevelopmentAgreementsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Development Agreements [Line Items]</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DevelopmentAgreementsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Common Stock Issuable Or Issued, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialFutureCommonStockIssuableSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Future Common Stock Issuable, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialFutureCommonStockIssuableSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Issued In Connection With The Restated Collaboration Agreement</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 505<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478448/946-505-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(4)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-03(i)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementInitialPaymentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517150784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 134.2<span></span>
</td>
<td class="nump">$ 315.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,973.3<span></span>
</td>
<td class="nump">2,157.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">2,138.6<span></span>
</td>
<td class="nump">2,488.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">134.2<span></span>
</td>
<td class="nump">315.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">20.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">154.8<span></span>
</td>
<td class="nump">331.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,973.3<span></span>
</td>
<td class="nump">2,157.8<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">1,973.3<span></span>
</td>
<td class="nump">2,157.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NotesReceivableFairValueDisclosure', window );">Convertible notes receivable</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsFairValueDisclosure', window );">Other assets</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total assets measured at fair value on a recurring basis</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,150.1<span></span>
</td>
<td class="nump">1,612.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">1,150.1<span></span>
</td>
<td class="nump">1,612.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">312.1<span></span>
</td>
<td class="nump">184.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">312.1<span></span>
</td>
<td class="nump">184.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">511.1<span></span>
</td>
<td class="nump">360.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">511.1<span></span>
</td>
<td class="nump">360.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt | Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Debt securities, available-for-sale</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of asset recognized for present right to economic benefit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NotesReceivableFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-10<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NotesReceivableFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of other assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516894496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_FairValueAssetsLevel3TransfersAmount', window );">Transfers in or out of Level 3 securities</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount', window );">Carrying values of investments</a></td>
<td class="nump">119,300,000<span></span>
</td>
<td class="nump">38,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember', window );">Designated as Hedging Instrument | Foreign Exchange Forward</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeTermOfContract', window );">Term of derivative contract</a></td>
<td class="text">1 month<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DerivativeNotionalAmount', window );">Notional amount of outstanding hedge to currency risk</a></td>
<td class="nump">$ 66,000,000.0<span></span>
</td>
<td class="nump">$ 71,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_FairValueAssetsLevel3TransfersAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair Value, Assets, Level 3 Transfers, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_FairValueAssetsLevel3TransfersAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeNotionalAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Nominal or face amount used to calculate payment on derivative.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1B<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 815<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480434/815-10-50-1A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeNotionalAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in equity security without readily determinable fair value.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 321<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479536/321-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeForwardMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046618972960">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 2,286.0<span></span>
</td>
<td class="nump">$ 2,544.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes</a></td>
<td class="nump">1,163.7<span></span>
</td>
<td class="nump">1,262.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleDebtFairValueDisclosures', window );">Fair value of outstanding senior convertible notes</a></td>
<td class="nump">$ 1,122.3<span></span>
</td>
<td class="nump">$ 1,281.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleDebtFairValueDisclosures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2E<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleDebtFairValueDisclosures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513419344">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">$ 1,972.7<span></span>
</td>
<td class="nump">$ 2,157.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(1.1)<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,973.3<span></span>
</td>
<td class="nump">2,157.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember', window );">U.S. government agencies</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">1,149.4<span></span>
</td>
<td class="nump">1,611.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">1.3<span></span>
</td>
<td class="nump">1.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.6)<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">1,150.1<span></span>
</td>
<td class="nump">1,612.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember', window );">Commercial paper</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">312.2<span></span>
</td>
<td class="nump">184.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="num">(0.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">312.1<span></span>
</td>
<td class="nump">184.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember', window );">Corporate debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Amortized Cost</a></td>
<td class="nump">511.1<span></span>
</td>
<td class="nump">360.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax', window );">Gross Unrealized Gains</a></td>
<td class="nump">0.4<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax', window );">Gross Unrealized Losses</a></td>
<td class="num">(0.4)<span></span>
</td>
<td class="num">(0.3)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Estimated Market Value</a></td>
<td class="nump">$ 511.1<span></span>
</td>
<td class="nump">$ 360.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 5<br> -Subsection 04<br> -Paragraph c<br> -Subparagraph Schedule I<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 7<br> -Subsection 05<br> -Paragraph c<br> -Subparagraph Schedule II<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 9<br> -Subsection 06<br> -Publisher SEC<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 103<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-1<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CommercialPaperMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513857136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument (in months)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent', window );">Current available-for-sale securities</a></td>
<td class="nump">$ 1,730,000,000<span></span>
</td>
<td class="nump">$ 2,160,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent', window );">Noncurrent available-for-sale securities</a></td>
<td class="nump">247,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss', window );">Unrealized gains recognized during the reporting period on equity investments still held at the reporting date</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount', window );">Cash discounts reserve</a></td>
<td class="nump">17,300,000<span></span>
</td>
<td class="nump">13,700,000<span></span>
</td>
<td class="nump">8,300,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">181,200,000<span></span>
</td>
<td class="nump">147,400,000<span></span>
</td>
<td class="nump">144,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss on disposal of machinery and equipment</a></td>
<td class="nump">$ 5,100,000<span></span>
</td>
<td class="nump">700,000<span></span>
</td>
<td class="nump">2,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument (in months)</a></td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument (in months)</a></td>
<td class="text">18 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember', window );">Receiver Product Component</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CondensedFinancialStatementsCaptionsLineItems', window );"><strong>Condensed Financial Statements, Captions [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Inventory write-down</a></td>
<td class="nump">$ 53,500,000<span></span>
</td>
<td class="nump">$ 16,600,000<span></span>
</td>
<td class="nump">$ 13,900,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accounts Receivable, Allowance for Credit Loss, Cash Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CondensedFinancialStatementsCaptionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 12<br> -Subsection 04<br> -Paragraph a<br> -Publisher SEC<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 5<br> -Subsection 04<br> -Paragraph c<br> -Subparagraph Schedule I<br> -Publisher SEC<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 7<br> -Subsection 05<br> -Paragraph c<br> -Subparagraph Schedule II<br> -Publisher SEC<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Regulation S-X (SX)<br> -Number 210<br> -Section 9<br> -Subsection 06<br> -Publisher SEC<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 6: http://www.xbrl.org/2003/role/recommendedDisclosureRef<br> -Topic 810<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 11<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481231/810-10-45-11<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CondensedFinancialStatementsCaptionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 320<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481830/320-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479130/326-30-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrealized gain (loss) on investment in debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(c))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D)(Footnote 6)(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 320<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 6<br> -Subparagraph (SX 210.12-14(Column D))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(7)(c)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483080/330-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=dxcm_ReceiverProductComponentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602111632">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableGross', window );">Accounts receivable</a></td>
<td class="nump">$ 1,014.9<span></span>
</td>
<td class="nump">$ 983.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivable', window );">Less: allowance for doubtful accounts</a></td>
<td class="num">(9.2)<span></span>
</td>
<td class="num">(9.3)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNet', window );">Total accounts receivable, net</a></td>
<td class="nump">$ 1,005.7<span></span>
</td>
<td class="nump">$ 973.9<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 13<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481990/310-10-45-13<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477802/946-310-45-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-04(5)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 954<br> -SubTopic 310<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479196/954-310-45-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479344/326-20-45-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 310<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481962/310-10-50-4<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 326<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479319/326-20-50-13<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517768240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 327.1<span></span>
</td>
<td class="nump">$ 319.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work-in-process</a></td>
<td class="nump">28.1<span></span>
</td>
<td class="nump">30.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">187.4<span></span>
</td>
<td class="nump">210.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Total inventory</a></td>
<td class="nump">$ 542.6<span></span>
</td>
<td class="nump">$ 559.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 330<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480581/330-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513985072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">$ 76.3<span></span>
</td>
<td class="nump">$ 58.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PrepaidInventoryCurrent', window );">Prepaid inventory</a></td>
<td class="nump">11.2<span></span>
</td>
<td class="nump">31.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredCompensationPlanAssetsCurrent', window );">Deferred compensation plan assets</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxesReceivable', window );">Income tax receivables</a></td>
<td class="nump">27.9<span></span>
</td>
<td class="nump">13.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">39.7<span></span>
</td>
<td class="nump">49.3<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Total prepaid and other current assets</a></td>
<td class="nump">$ 173.7<span></span>
</td>
<td class="nump">$ 168.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredCompensationPlanAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Compensation Plan Assets, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredCompensationPlanAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PrepaidInventoryCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Prepaid Inventory, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PrepaidInventoryCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 852<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481372/852-10-55-10<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 05<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482955/340-10-05-5<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 340<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483032/340-10-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515983936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization', window );">Total cost</a></td>
<td class="nump">$ 2,018.2<span></span>
</td>
<td class="nump">$ 1,622.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(678.3)<span></span>
</td>
<td class="num">(509.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization', window );">Total property and equipment, net</a></td>
<td class="nump">1,339.9<span></span>
</td>
<td class="nump">1,113.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land and land improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">53.1<span></span>
</td>
<td class="nump">34.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">291.0<span></span>
</td>
<td class="nump">190.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">40.2<span></span>
</td>
<td class="nump">36.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember', window );">Computer software and hardware</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">76.6<span></span>
</td>
<td class="nump">65.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">908.9<span></span>
</td>
<td class="nump">683.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">293.8<span></span>
</td>
<td class="nump">283.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Total cost</a></td>
<td class="nump">$ 354.6<span></span>
</td>
<td class="nump">$ 328.1<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 842<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=dxcm_ComputerSoftwareAndHardwareMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_EquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516908592">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">3 years 4 months 24 days<span></span>
</td>
<td class="text">4 years 1 month 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 193.5<span></span>
</td>
<td class="nump">$ 195.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(90.1)<span></span>
</td>
<td class="num">(61.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 103.4<span></span>
</td>
<td class="nump">$ 134.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_VerilyIntangibleMember', window );">Verily intangible asset</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">3 years 3 months 18 days<span></span>
</td>
<td class="text">4 years 3 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 152.4<span></span>
</td>
<td class="nump">$ 152.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(59.5)<span></span>
</td>
<td class="num">(31.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 92.9<span></span>
</td>
<td class="nump">$ 121.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">1 year 9 months 18 days<span></span>
</td>
<td class="text">2 years 4 months 24 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 17.5<span></span>
</td>
<td class="nump">$ 24.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(13.0)<span></span>
</td>
<td class="num">(15.0)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 4.5<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_AcquiredTechnologyAndIntellectualPropertyMember', window );">Acquired technology and intellectual property</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">7 years 2 months 12 days<span></span>
</td>
<td class="text">9 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 19.6<span></span>
</td>
<td class="nump">$ 14.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(14.7)<span></span>
</td>
<td class="num">(12.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 4.9<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember', window );">Trademarks and trade name</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">1 year 7 months 6 days<span></span>
</td>
<td class="text">2 years 7 months 6 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 3.8<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(2.7)<span></span>
</td>
<td class="num">(2.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="nump">$ 2.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Intangibles, other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsLineItems', window );"><strong>Finite-Lived Intangible Assets [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Weighted Average Useful Life (in years)</a></td>
<td class="text">0 years<span></span>
</td>
<td class="text">0 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 0.2<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480265/350-10-S45-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 928<br> -SubTopic 340<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478859/928-340-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-3<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_VerilyIntangibleMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_VerilyIntangibleMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_AcquiredTechnologyAndIntellectualPropertyMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=dxcm_AcquiredTechnologyAndIntellectualPropertyMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_TrademarksAndTradeNamesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514518752">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales', window );">Amortization expense included in cost of sales</a></td>
<td class="nump">$ 29.8<span></span>
</td>
<td class="nump">$ 30.5<span></span>
</td>
<td class="nump">$ 4.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization expense included in operating expenses</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">8.1<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses', window );">Total amortization of intangible assets</a></td>
<td class="nump">$ 36.5<span></span>
</td>
<td class="nump">$ 38.6<span></span>
</td>
<td class="nump">$ 11.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Intangible Assets Included In Cost Of Sales</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amortization Of Intangibles Included In Cost Of Sales And Operating Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482686/350-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046617061296">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 32.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2026</a></td>
<td class="nump">31.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2027</a></td>
<td class="nump">29.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2028</a></td>
<td class="nump">7.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive', window );">2029</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive', window );">Thereafter</a></td>
<td class="nump">1.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 103.4<span></span>
</td>
<td class="nump">$ 134.5<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482640/350-30-55-40<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 985<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481283/985-20-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 350<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482665/350-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 926<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483154/926-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515599680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongTermInvestments', window );">Non-marketable equity securities</a></td>
<td class="nump">$ 119.3<span></span>
</td>
<td class="nump">$ 38.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LongTermDeposits', window );">Long-term deposits</a></td>
<td class="nump">13.8<span></span>
</td>
<td class="nump">14.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherLongTermAssets', window );">Other assets</a></td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">22.1<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Total other assets</a></td>
<td class="nump">$ 173.0<span></span>
</td>
<td class="nump">$ 75.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LongTermDeposits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long -Term Deposits</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LongTermDeposits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherLongTermAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Long -Term Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherLongTermAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(12))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514832064">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Accounts payable trade</a></td>
<td class="nump">$ 345.3<span></span>
</td>
<td class="nump">$ 276.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedTaxAuditAndLegalFeesCurrent', window );">Accrued tax, audit, and legal fees</a></td>
<td class="nump">38.4<span></span>
</td>
<td class="nump">42.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PharmacyRebatesCurrent', window );">Accrued rebates</a></td>
<td class="nump">1,135.9<span></span>
</td>
<td class="nump">950.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Accrued warranty</a></td>
<td class="nump">5.9<span></span>
</td>
<td class="nump">12.6<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedIncomeTaxesCurrent', window );">Income tax payable</a></td>
<td class="nump">3.9<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCompensationLiabilityCurrent', window );">Deferred compensation plan liabilities</a></td>
<td class="nump">18.6<span></span>
</td>
<td class="nump">15.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other accrued liabilities</a></td>
<td class="nump">37.1<span></span>
</td>
<td class="nump">40.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Total accounts payable and accrued liabilities</a></td>
<td class="nump">$ 1,585.1<span></span>
</td>
<td class="nump">$ 1,345.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedTaxAuditAndLegalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of accrued current tax, audit and legal fees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedTaxAuditAndLegalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PharmacyRebatesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Pharmacy Rebates, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PharmacyRebatesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483467/210-10-45-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedIncomeTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedIncomeTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCompensationLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 710<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483070/710-10-25-9<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 710<br> -SubTopic 10<br> -Section 30<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483043/710-10-30-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCompensationLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513289648">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AccruedWagesBonusesAndTaxesCurrent', window );">Accrued wages, bonus and taxes</a></td>
<td class="nump">$ 74.5<span></span>
</td>
<td class="nump">$ 139.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedEmployeeBenefitsCurrent', window );">Other accrued employee benefits</a></td>
<td class="nump">37.5<span></span>
</td>
<td class="nump">31.2<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Total accrued payroll and related expenses</a></td>
<td class="nump">$ 112.0<span></span>
</td>
<td class="nump">$ 171.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AccruedWagesBonusesAndTaxesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Wages, Bonuses and Taxes, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AccruedWagesBonusesAndTaxesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedEmployeeBenefitsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedEmployeeBenefitsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513592640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward', window );"><strong>Movement in Standard Product Warranty Accrual [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Beginning balance</a></td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
<td class="nump">$ 12.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses', window );">Charges to costs and expenses</a></td>
<td class="nump">47.2<span></span>
</td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">43.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualPayments', window );">Costs incurred</a></td>
<td class="num">(53.9)<span></span>
</td>
<td class="num">(51.7)<span></span>
</td>
<td class="num">(43.1)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StandardProductWarrantyAccrual', window );">Ending balance</a></td>
<td class="nump">$ 5.9<span></span>
</td>
<td class="nump">$ 12.6<span></span>
</td>
<td class="nump">$ 12.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Standard Product Warranty Accrual Charges To Costs And Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MovementInStandardProductWarrantyAccrualRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MovementInStandardProductWarrantyAccrualRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StandardProductWarrantyAccrual">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 460<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (c)(5)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482425/460-10-50-8<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StandardProductWarrantyAccrual</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513949808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease obligations</a></td>
<td class="nump">$ 58.5<span></span>
</td>
<td class="nump">$ 58.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue, long-term</a></td>
<td class="nump">9.5<span></span>
</td>
<td class="nump">7.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">17.0<span></span>
</td>
<td class="nump">15.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_OtherTaxLiabilitiesNoncurrent', window );">Other tax liabilities</a></td>
<td class="nump">44.8<span></span>
</td>
<td class="nump">38.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other liabilities</a></td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">5.2<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Total other long-term liabilities</a></td>
<td class="nump">$ 147.9<span></span>
</td>
<td class="nump">$ 125.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_OtherTaxLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Other Tax Liabilities, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_OtherTaxLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481999/410-20-25-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-8<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479837/606-10-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046620840416">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterestAndDividend', window );">Interest and dividend income</a></td>
<td class="nump">$ 134.2<span></span>
</td>
<td class="nump">$ 135.0<span></span>
</td>
<td class="nump">$ 23.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseNonoperating', window );">Interest expense</a></td>
<td class="num">(19.0)<span></span>
</td>
<td class="num">(20.3)<span></span>
</td>
<td class="num">(18.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingExpense', window );">Other expense, net</a></td>
<td class="num">(6.2)<span></span>
</td>
<td class="num">(2.0)<span></span>
</td>
<td class="num">(5.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Total other income (expense), net</a></td>
<td class="nump">$ 109.0<span></span>
</td>
<td class="nump">$ 112.7<span></span>
</td>
<td class="num">$ (0.4)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseNonoperating">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense classified as nonoperating.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseNonoperating</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterestAndDividend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(7)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterestAndDividend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517560160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>May 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 2,457.5<span></span>
</td>
<td class="nump">$ 2,457.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnamortizedDebtIssuanceExpense', window );">Unamortized debt issuance costs</a></td>
<td class="num">(16.1)<span></span>
</td>
<td class="num">(23.3)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConvertibleNotesPayable', window );">Carrying amount of senior convertible notes</a></td>
<td class="nump">2,441.4<span></span>
</td>
<td class="nump">2,434.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">1,207.5<span></span>
</td>
<td class="nump">1,207.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,210.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract', window );"><strong>Senior Convertible Notes</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 1,250.0<span></span>
</td>
<td class="nump">$ 1,250.0<span></span>
</td>
<td class="nump">$ 1,250.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertibleNotesPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertibleNotesPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnamortizedDebtIssuanceExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnamortizedDebtIssuanceExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516622368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Converted Value of Notes (Details) - Senior Notes - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 89.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">56.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal', window );">Total by which the notes&#8217; if-converted value exceeds their principal amount</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 33.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514380656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_CashInterestExpenseAbstract', window );"><strong>Cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebtExcludingAmortization', window );">Contractual coupon interest</a></td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="nump">$ 9.1<span></span>
</td>
<td class="nump">$ 8.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCosts', window );">Amortization of debt issuance costs</a></td>
<td class="nump">7.2<span></span>
</td>
<td class="nump">7.3<span></span>
</td>
<td class="nump">5.9<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Total interest expense recognized on senior notes</a></td>
<td class="nump">$ 14.9<span></span>
</td>
<td class="nump">$ 16.4<span></span>
</td>
<td class="nump">$ 14.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
<td class="nump">1.10%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
<td class="nump">0.50%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NonCashInterestExpenseAbstract', window );"><strong>Non-cash interest expense:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate (as a percent)</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_CashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_CashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NonCashInterestExpenseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Non-Cash Interest Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NonCashInterestExpenseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebtExcludingAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(8))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebtExcludingAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513994352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Schedule of Key Details of Convertible Notes (Details)<br></strong></div></th>
<th class="th" colspan="3">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>May 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>May 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 1,230,600,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember', window );">Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,457,500,000<span></span>
</td>
<td class="nump">2,457,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.75%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 850,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 836,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0243476<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41.07<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,210,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="nump">1,207,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,190,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.006662<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 150.11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateStatedPercentage', window );">Interest rate on convertible notes (as a percent)</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentFaceAmount', window );">Total principal amount</a></td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="nump">$ 1,250,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromConvertibleDebt', window );">Proceeds from issuance of convertible notes, net of issuance costs</a></td>
<td class="nump">$ 1,230,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionRatio1', window );">Conversion ratio</a></td>
<td class="nump">0.0061571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleConversionPrice1', window );">Conversion price of convertible notes (in usd per share) | $ / shares</a></td>
<td class="nump">$ 162.41<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionPrice1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The price per share of the conversion feature embedded in the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionPrice1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-7<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentFaceAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face (par) amount of debt instrument at time of issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentFaceAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateStatedPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Contractual interest rate for funds borrowed, under the debt agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(a)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateStatedPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513582336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - 2023 Note Hedge (Details)<br> shares in Millions</strong></div></th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>purchaser </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions', window );">Number of initial purchasers | purchaser</a></td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Designated as Hedging Instrument | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares', window );">Stock issued upon conversion of senior notes (in shares) | shares</a></td>
<td class="nump">20.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Initial Purchasers For Convertible Note Hedge Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_HedgingDesignationAxis=us-gaap_DesignatedAsHedgingInstrumentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602265424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - 2023 Warrants (Details)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Feb. 13, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>USD ($) </div>
<div>d </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Jun. 30, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1', window );">Stock counterparties to acquire with warrants purchased (in shares)</a></td>
<td class="nump">10.3<span></span>
</td>
<td class="nump">20.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfWarrants', window );">Proceeds from sale of warrants | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 183.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants or rights (in usd per share) | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 49.60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | JPM Warrant Transactions | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants', window );">Stock issued during period, shares, exercise and settlement of remaining warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes | BofA Warrant Transactions | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise and Settlement of Remaining Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise and Settlement of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtConversionConvertedInstrumentSharesIssued1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. "Part noncash" refers to that portion of the transaction not resulting in cash receipts or payments in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-3<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482913/230-10-50-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtConversionConvertedInstrumentSharesIssued1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-14<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dxcm_JPMWarrantTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dxcm_JPMWarrantTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=dxcm_BofAWarrantTransactionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=dxcm_BofAWarrantTransactionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517009072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - 2028 Capped Call Transactions (Details) - USD ($)<br> $ / shares in Units, $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>May 02, 2023</div></th>
<th class="th"><div>May 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 101.3<span></span>
</td>
<td class="nump">$ 0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member', window );">Senior Convertible Notes due 2028 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare', window );">Capped call, cap price (in usd per share)</a></td>
<td class="nump">$ 212.62<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage', window );">Sale of stock premium (as percent)</a></td>
<td class="nump">80.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Closing stock price (in usd per share)</a></td>
<td class="nump">$ 118.12<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions', window );">Purchases of capped call transactions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 101.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCapCallTransactionCapPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Cap Call Transaction, Cap Price Per Share</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCapCallTransactionCapPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsForPurchasesOfCappedCallTransactions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payments For Purchases Of Capped Call Transactions</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsForPurchasesOfCappedCallTransactions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2028Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513634800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Activity for Senior Convertible Notes (Details) - USD ($)<br> shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Senior Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled', window );">Debt instrument, convertible principal amount settled</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 774.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Repurchase and conversions of notes (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromBenefitOfNoteHedge', window );">Shares received from Note Hedge</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Convertible, Principal Amount Exercised And Settled</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromBenefitOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Benefit Of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromBenefitOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515941376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Conversion Rights for Seniors Convertible Notes (Details) - Senior Notes<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Nov. 30, 2018 </div>
<div>d</div>
</th>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>trading_day </div>
<div>d</div>
</th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage', window );">Holder's repurchase price percentage in event of fundamental change (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="nump">60<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Debt Instrument Conversion Term One | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member', window );">Senior Convertible Notes due 2023 | Debt Instrument Conversion Term One | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days | d</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock', window );">Proportion of conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">130.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentRedemptionPricePercentage', window );">Redemption price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Debt Instrument Conversion Term One | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Debt Instrument Conversion Term One | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Debt Instrument Conversion Term Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member', window );">Senior Convertible Notes due 2025 | Debt Instrument Conversion Term Two | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1', window );">Number of trading days</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger', window );">Proportion of applicable conversion price (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">98.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentCovenantRepurchasePricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Covenant Repurchase Price, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentCovenantRepurchasePricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482949/835-30-55-8<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.12-04(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-3<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 5: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69B<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69C<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69E<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69E<br><br>Reference 8: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 69F<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481568/470-20-55-69F<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 11: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1B<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1B<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1D<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1D<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1F<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1F<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1I<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1I<br><br>Reference 26: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482925/835-30-45-2<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 835<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482900/835-30-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentRedemptionPricePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 470<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477734/942-470-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentRedemptionPricePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2023Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_SeniorNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=dxcm_ConvertibleNotesDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DebtInstrumentConversionTermAxis=dxcm_DebtInstrumentConversionTermTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515968576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity', window );">Total available balance</a></td>
<td class="nump">$ 192.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Available principal amount and letters of credit sub-facility</a></td>
<td class="nump">200.0<span></span>
</td>
<td class="nump">$ 200.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCredit', window );">Outstanding borrowings</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="nump">0.175%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">0.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Minimum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">1.375%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage', window );">Unused capacity fee (as a percent)</a></td>
<td class="nump">0.25%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Maximum | Base Rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">1.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Maximum | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Basis spread on variable rate (as a percent)</a></td>
<td class="nump">2.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Letter of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Available principal amount and letters of credit sub-facility</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LettersOfCreditOutstandingAmount', window );">Outstanding letters of credit</a></td>
<td class="nump">$ 7.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LettersOfCreditOutstandingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of the contingent obligation under letters of credit outstanding as of the reporting date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LettersOfCreditOutstandingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -SubTopic 10<br> -Topic 210<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 944<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16)(a)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478777/944-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_BaseRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_BaseRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=dxcm_LondonInterbankOfferedRateLIBOR1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=dxcm_LondonInterbankOfferedRateLIBOR1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_LetterOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602261456">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Revolving Credit Agreement (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">12 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DebtInstrumentTerm', window );">Term of debt instrument (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Available principal amount and letters of credit sub-facility</a></td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount', window );">Option to increase revolving line of credit</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481544/470-10-50-6<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(19)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517396256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases and Other Commitments - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2024 </div>
<div>USD ($) </div>
<div>extensionOption</div>
</th>
<th class="th">
<div>Dec. 31, 2023 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetRetirementObligation', window );">Asset retirement obligation</a></td>
<td class="nump">$ 17,000,000<span></span>
</td>
<td class="nump">$ 15,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">Other long-term liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse', window );">Impairment losses</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 23,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration', window );">Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]</a></td>
<td class="text">Selling, general and administrative<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ImpairedLongLivedAssetsFairValue', window );">Fair value of impaired long-lived asset</a></td>
<td class="nump">$ 2,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization', window );">Amortization of operating lease right-of-use asset</a></td>
<td class="nump">16,700,000<span></span>
</td>
<td class="nump">16,500,000<span></span>
</td>
<td class="nump">$ 16,400,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear', window );">Purchase obligations</a></td>
<td class="nump">$ 954,900,000<span></span>
</td>
<td class="nump">$ 793,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm', window );">Term of purchase obligations (in years)</a></td>
<td class="text">1 year<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm', window );">Remaining lease terms (in years)</a></td>
<td class="text">16 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Renewal term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend', window );">Number of options to extend (in extension options) | extensionOption</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ImpairedLongLivedAssetsFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Impaired Long-Lived Assets, Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ImpairedLongLivedAssetsFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Number Of Options To Extend</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_LesseeOperatingLeasesLeaseCostAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Leases, Lease Cost, Amortization</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_LesseeOperatingLeasesLeaseCostAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetRetirementObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481999/410-20-25-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 410<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481850/410-20-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetRetirementObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes noncurrent finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOfLongLivedAssetsHeldForUse">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 820<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 100<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 360<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-2<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482130/360-10-45-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOfLongLivedAssetsHeldForUse</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRemainingLeaseTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7A<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-7A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRemainingLeaseTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 440<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482648/440-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513426784">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">$ 26.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">26.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">20.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">15.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">99.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(12.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future payments</a></td>
<td class="nump">87.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(22.5)<span></span>
</td>
<td class="num">$ (21.1)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">65.0<span></span>
</td>
<td class="nump">80.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2025</a></td>
<td class="nump">9.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2026</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2027</a></td>
<td class="nump">6.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2028</a></td>
<td class="nump">5.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2029</a></td>
<td class="nump">5.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">54.6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future lease cost</a></td>
<td class="nump">90.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Imputed interest</a></td>
<td class="num">(26.0)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future payments</a></td>
<td class="nump">64.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Less: Current portion</a></td>
<td class="num">(6.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Long-term portion</a></td>
<td class="nump">$ 58.5<span></span>
</td>
<td class="nump">$ 58.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]</a></td>
<td class="text">Property and equipment, net<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R69.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513542352">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityAbstract', window );"><strong>Finance lease cost:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization of right-of-use assets</a></td>
<td class="nump">$ 7.2<span></span>
</td>
<td class="nump">$ 6.5<span></span>
</td>
<td class="nump">$ 5.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest on lease liabilities</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">22.4<span></span>
</td>
<td class="nump">22.9<span></span>
</td>
<td class="nump">22.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseImpairmentLoss', window );">Right-of-use asset impairment</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
<td class="nump">3.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">9.0<span></span>
</td>
<td class="nump">8.3<span></span>
</td>
<td class="nump">8.0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 45.8<span></span>
</td>
<td class="nump">$ 43.3<span></span>
</td>
<td class="nump">$ 49.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-4<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from impairment of right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 6<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479365/842-20-25-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R70.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046513333376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases and Other Commitments - Other Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows from operating leases</a></td>
<td class="nump">$ 27.5<span></span>
</td>
<td class="nump">$ 28.1<span></span>
</td>
<td class="nump">$ 26.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash flows from finance leases</a></td>
<td class="nump">3.4<span></span>
</td>
<td class="nump">3.2<span></span>
</td>
<td class="nump">3.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash flows from finance leases</a></td>
<td class="nump">13.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">15.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for operating lease liabilities</a></td>
<td class="nump">8.8<span></span>
</td>
<td class="nump">7.5<span></span>
</td>
<td class="nump">15.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Right-of-use assets obtained in exchange for finance lease liabilities</a></td>
<td class="nump">$ 14.6<span></span>
</td>
<td class="nump">$ 4.2<span></span>
</td>
<td class="nump">$ 16.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of operating leases (in years)</a></td>
<td class="text">4 years 2 months 12 days<span></span>
</td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years 6 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted average remaining lease term of finance leases (in years)</a></td>
<td class="text">12 years 7 months 6 days<span></span>
</td>
<td class="text">14 years 1 month 6 days<span></span>
</td>
<td class="text">15 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of operating leases (as a percent)</a></td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">6.10%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Weighted average discount rate of finance leases (as a percent)</a></td>
<td class="nump">5.40%<span></span>
</td>
<td class="nump">5.30%<span></span>
</td>
<td class="nump">5.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479041/842-20-45-5<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 53<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479589/842-20-55-53<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 842<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478964/842-20-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R71.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602115072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic', window );">United States</a></td>
<td class="nump">$ 659.8<span></span>
</td>
<td class="nump">$ 732.4<span></span>
</td>
<td class="nump">$ 463.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign', window );">Outside of the United States</a></td>
<td class="nump">49.2<span></span>
</td>
<td class="num">(22.0)<span></span>
</td>
<td class="num">(72.7)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">$ 709.0<span></span>
</td>
<td class="nump">$ 710.4<span></span>
</td>
<td class="nump">$ 390.8<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10A<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10A<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R72.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512473040">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Current:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentFederalTaxExpenseBenefit', window );">Federal</a></td>
<td class="nump">$ 157.4<span></span>
</td>
<td class="nump">$ 149.1<span></span>
</td>
<td class="nump">$ 32.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit', window );">State</a></td>
<td class="nump">16.5<span></span>
</td>
<td class="nump">18.1<span></span>
</td>
<td class="nump">26.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentForeignTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">2.7<span></span>
</td>
<td class="nump">56.7<span></span>
</td>
<td class="nump">12.5<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CurrentIncomeTaxExpenseBenefit', window );">Total current income taxes</a></td>
<td class="nump">176.6<span></span>
</td>
<td class="nump">223.9<span></span>
</td>
<td class="nump">71.2<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract', window );"><strong>Deferred:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit', window );">Federal</a></td>
<td class="num">(55.2)<span></span>
</td>
<td class="num">(93.7)<span></span>
</td>
<td class="num">(4.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit', window );">State</a></td>
<td class="num">(2.0)<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="num">(17.6)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit', window );">Foreign</a></td>
<td class="nump">13.4<span></span>
</td>
<td class="nump">24.1<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Total deferred income taxes</a></td>
<td class="num">(43.8)<span></span>
</td>
<td class="num">(55.0)<span></span>
</td>
<td class="num">(21.6)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="nump">$ 132.8<span></span>
</td>
<td class="nump">$ 168.9<span></span>
</td>
<td class="nump">$ 49.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentFederalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentFederalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentForeignTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentForeignTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CurrentStateAndLocalTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (a)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CurrentStateAndLocalTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFederalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFederalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredForeignIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredForeignIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>R73.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516341232">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 12.1<span></span>
</td>
<td class="nump">$ 20.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | R&amp;D credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal | Foreign tax credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">162.0<span></span>
</td>
<td class="nump">167.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | R&amp;D credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">124.9<span></span>
</td>
<td class="nump">111.9<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | California | AMT Tax Credits</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TaxCreditCarryforwardAmount', window );">Tax credits</a></td>
<td class="nump">0.5<span></span>
</td>
<td class="nump">0.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State | Other states</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">5.8<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | UK</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember', window );">Foreign | Other foreign</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss</a></td>
<td class="nump">$ 0.0<span></span>
</td>
<td class="nump">$ 6.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=dxcm_ResearchDevelopmentTaxCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=dxcm_ResearchDevelopmentTaxCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=dxcm_ForeignTaxCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=dxcm_ForeignTaxCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TaxCreditCarryforwardAxis=dxcm_AMTTaxCreditsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TaxCreditCarryforwardAxis=dxcm_AMTTaxCreditsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dxcm_OtherStatesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dxcm_OtherStatesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_ForeignCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_GB">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_GB</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dxcm_OtherForeignMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dxcm_OtherForeignMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>97
<FILENAME>R74.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046515463408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_UnusedExpiredFederalIncomeTaxCredits', window );">Tax credit carryforwards subject to expiration</a></td>
<td class="nump">$ 1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther', window );">Deferred tax assets</a></td>
<td class="nump">142.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance amount</a></td>
<td class="nump">221.9<span></span>
</td>
<td class="nump">$ 264.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Valuation allowance, deferred tax asset, increase (decrease), amount</a></td>
<td class="num">(42.4)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate', window );">Unrecognized tax benefits that would impact effective tax rate</a></td>
<td class="nump">$ 40.7<span></span>
</td>
<td class="nump">37.0<span></span>
</td>
<td class="nump">$ 32.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PreferentialTaxRatePeriod', window );">Preferential tax rate period (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PossibleExtensionPeriodofTaxHoliday', window );">Possible extension period of tax holiday (in years)</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries', window );">Undistributed foreign earnings</a></td>
<td class="nump">$ 89.3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">24.6<span></span>
</td>
<td class="nump">$ 28.3<span></span>
</td>
<td class="nump">$ 23.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=stpr_CA', window );">California</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance amount</a></td>
<td class="nump">221.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="nump">$ 2.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PossibleExtensionPeriodofTaxHoliday">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Possible Extension Period of Tax Holiday</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PossibleExtensionPeriodofTaxHoliday</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PreferentialTaxRatePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Preferential Tax Rate Period</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PreferentialTaxRatePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_UnusedExpiredFederalIncomeTaxCredits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Federal income tax credits likely to expire unused as a result of limitations</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_UnusedExpiredFederalIncomeTaxCredits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UndistributedEarningsOfForeignSubsidiaries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 740<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 25<br> -Paragraph 3<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482620/740-10-25-3<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 942<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -SubTopic 740<br> -Topic 944<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UndistributedEarningsOfForeignSubsidiaries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=stpr_CA">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=stpr_CA</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>R75.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046618288448">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGrossAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 14.4<span></span>
</td>
<td class="nump">$ 18.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment', window );">Capitalized research and development expenses</a></td>
<td class="nump">265.0<span></span>
</td>
<td class="nump">233.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">79.2<span></span>
</td>
<td class="nump">71.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Share-based compensation</a></td>
<td class="nump">22.5<span></span>
</td>
<td class="nump">27.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets', window );">Fixed and intangible assets</a></td>
<td class="nump">263.6<span></span>
</td>
<td class="nump">279.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued liabilities and reserves</a></td>
<td class="nump">87.4<span></span>
</td>
<td class="nump">91.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredTaxAssetsConvertibleDebt', window );">Convertible debt</a></td>
<td class="nump">16.0<span></span>
</td>
<td class="nump">20.6<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total gross deferred tax assets</a></td>
<td class="nump">748.1<span></span>
</td>
<td class="nump">741.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Less: valuation allowance</a></td>
<td class="num">(221.9)<span></span>
</td>
<td class="num">(264.3)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Total net deferred tax assets</a></td>
<td class="nump">526.2<span></span>
</td>
<td class="nump">477.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets', window );">Fixed assets and acquired intangibles assets</a></td>
<td class="num">(59.3)<span></span>
</td>
<td class="num">(60.4)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilitiesOther', window );">Other</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(59.6)<span></span>
</td>
<td class="num">(60.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets (liabilities)</a></td>
<td class="nump">$ 466.6<span></span>
</td>
<td class="nump">$ 416.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsConvertibleDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Convertible Debt</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsConvertibleDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Assets, Fixed Assets and Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Tax Liabilities, Fixed Assets And Intangible Assets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(26)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 210<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478546/942-210-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGrossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGrossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilitiesOther">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax liability attributable to taxable temporary differences classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilitiesOther</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>R76.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046602213072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract', window );"><strong>Effective Income Tax Rate Reconciliation, Amount [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate', window );">U.S. federal statutory tax rate</a></td>
<td class="nump">$ 148.9<span></span>
</td>
<td class="nump">$ 149.2<span></span>
</td>
<td class="nump">$ 82.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes', window );">State income tax, net of federal benefit</a></td>
<td class="nump">10.2<span></span>
</td>
<td class="nump">7.8<span></span>
</td>
<td class="nump">5.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems', window );">Permanent items</a></td>
<td class="nump">10.5<span></span>
</td>
<td class="num">(2.7)<span></span>
</td>
<td class="nump">0.6<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch', window );">Research and development credits</a></td>
<td class="num">(24.6)<span></span>
</td>
<td class="num">(28.3)<span></span>
</td>
<td class="num">(23.3)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign', window );">Foreign tax credit</a></td>
<td class="num">(1.2)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential', window );">Foreign rate differential</a></td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">15.8<span></span>
</td>
<td class="nump">27.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost', window );">Stock and officers compensation</a></td>
<td class="nump">3.8<span></span>
</td>
<td class="nump">5.6<span></span>
</td>
<td class="num">(1.2)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment', window );">Collaboration agreement milestone share-based payment</a></td>
<td class="num">(32.2)<span></span>
</td>
<td class="num">(72.1)<span></span>
</td>
<td class="num">(52.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate', window );">Change in statutory tax rates</a></td>
<td class="nump">51.5<span></span>
</td>
<td class="nump">19.4<span></span>
</td>
<td class="nump">1.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer', window );">Intellectual property transfer</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">63.9<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationOtherAdjustments', window );">Other</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">1.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Change in valuation allowance</a></td>
<td class="num">(42.4)<span></span>
</td>
<td class="nump">10.0<span></span>
</td>
<td class="nump">8.9<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income taxes at effective rates</a></td>
<td class="nump">$ 132.8<span></span>
</td>
<td class="nump">$ 168.9<span></span>
</td>
<td class="nump">$ 49.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Collaboration Agreement Milestone, Share-based Payment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Rate Reconciliation, Intellectual Property Transfer</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EffectiveIncomeTaxReconciliationPermanentItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Effective Income Tax Reconciliation, Permanent Items</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EffectiveIncomeTaxReconciliationPermanentItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(6)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsForeign">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsForeign</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12A<br> -Subparagraph (b)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12A<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>R77.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046516251520">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Unrecognized Tax Benefits (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward', window );"><strong>Unrecognized Tax Benefits [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at beginning of period</a></td>
<td class="nump">$ 59.4<span></span>
</td>
<td class="nump">$ 52.0<span></span>
</td>
<td class="nump">$ 46.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions', window );">Decreases related to prior year tax positions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(0.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions', window );">Increases related to prior year tax positions</a></td>
<td class="nump">0.1<span></span>
</td>
<td class="nump">0.8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions', window );">Increases related to current year tax positions</a></td>
<td class="nump">6.7<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
<td class="nump">6.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Balance at end of period</a></td>
<td class="nump">$ 66.2<span></span>
</td>
<td class="nump">$ 59.4<span></span>
</td>
<td class="nump">$ 52.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 10B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482525/740-10-45-10B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 217<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-217<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-15A<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>101
<FILENAME>R78.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046507555184">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2023</div></th>
<th class="th"><div>Aug. 31, 2022</div></th>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Mar. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jul. 31, 2024</div></th>
<th class="th"><div>Jun. 30, 2023</div></th>
<th class="th"><div>Aug. 01, 2022</div></th>
<th class="th"><div>Jul. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>May 30, 2019</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate', window );">Maximum payroll deductions (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EmployeePurchasePriceFloorPercentage', window );">Employee purchase price floor (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized', window );">Stock authorized in ESPP (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="nump">$ 688,700,000<span></span>
</td>
<td class="nump">$ 557,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Shares issued in connection with the Restated Collaboration Agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues', window );">Potential common stock issued shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember', window );">Collaborative Arrangement, Milestone Payments | Verily Life Sciences | Collaborative Arrangement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Shares issued in connection with the Restated Collaboration Agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues', window );">Potential common stock issued shares (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=dxcm_AcceleratedShareRepurchaseASRMember', window );">Accelerated Share Repurchase (ASR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="nump">4,700,000<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="nump">$ 557,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount', window );">Accelerated share repurchase agreement, authorized amount</a></td>
<td class="nump">$ 500,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember', window );">Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 142,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 700,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="nump">6,300,000<span></span>
</td>
<td class="nump">6,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Exercise and settlement of warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Shares issued in connection with the Restated Collaboration Agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
<td class="nump">3,700,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">Fair value of vested awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 174,500,000<span></span>
</td>
<td class="nump">$ 157,800,000<span></span>
</td>
<td class="nump">$ 160,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Restricted Stock Units (RSUs) | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Common received vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember', window );">PSUs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Common received vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember', window );">401(k) Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Maximum employee contribution (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">90.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch', window );">Employer matching contribution (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Employee contribution (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanCostRecognized', window );">Total matching contributions</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,600,000<span></span>
</td>
<td class="nump">$ 14,900,000<span></span>
</td>
<td class="nump">$ 11,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member', window );">ESPP 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans', window );">Issuance of common stock for employee stock purchase plan (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock available for issuance for future awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member', window );">EIP 2015</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock available for issuance for future awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="nump">13,900,000<span></span>
</td>
<td class="nump">15,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized', window );">Stock reserved for issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,200,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member', window );">EIP 2015 | RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Stock available for issuance for future awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">12,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="nump">2,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation costs related to unvested restricted stock units</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 203,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized compensation costs recognized weighted average period (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year 8 months 12 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member', window );">EIP 2015 | Restricted Stock Units (RSUs)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member', window );">EIP 2015 | PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Unvested awards (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember', window );">2024 Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Purchases of treasury stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,400,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsForRepurchaseOfCommonStock', window );">Purchases of treasury stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember', window );">2024 Share Repurchase Program | Common&#160;Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StockRepurchaseProgramAuthorizedAmount1', window );">Stock repurchase program, authorized amount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 750,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accelerated Share Repurchase Agreement, Authorized Amount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeePurchasePriceFloorPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee purchase price floor, percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeePurchasePriceFloorPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Employee Stock Purchase Plan (ESPP), Number of Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Potential Common Stock Issuable Or Issued, Shares, New Issues</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise and Settlement of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StockRepurchaseProgramAuthorizedAmount1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 505<br> -SubTopic 30<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481520/505-30-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StockRepurchaseProgramAuthorizedAmount1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>srt_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanCostRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost for defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 715<br> -SubTopic 70<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480794/715-70-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanCostRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage employer matches of the employee's percentage contribution matched.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRepurchaseOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to reacquire common stock during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-15<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRepurchaseOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares authorized for issuance under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of an employee stock purchase plan.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PaymentsUnderCollaborationAgreementsAxis=dxcm_CollaborativeArrangementMilestonePaymentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=dxcm_VerilyLifeSciencesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=us-gaap_CollaborativeArrangementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=dxcm_AcceleratedShareRepurchaseASRMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=dxcm_AcceleratedShareRepurchaseASRMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ShareRepurchaseProgramAxis=dxcm_ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_PerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A401kPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A401kPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>102
<FILENAME>R79.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046518532240">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details) - shares<br> shares in Millions</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Sep. 30, 2024</div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward', window );"><strong>Increase (Decrease) In Treasury Stock [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Shares issued in connection with 2023 Notes conversions (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SharesReceivedFromExerciseOfNoteHedge', window );">Shares received from note hedge (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">12.2<span></span>
</td>
<td class="nump">0.3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone', window );">Shares issued in connection with the Restated Collaboration Agreement (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1.5)<span></span>
</td>
<td class="num">(3.7)<span></span>
</td>
<td class="num">(2.9)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants', window );">Shares issued in connection with 2023 Warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(12.5)<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2022ShareRepurchaseProgramMember', window );">2022 Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward', window );"><strong>Increase (Decrease) In Treasury Stock [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased under the Share Repurchase Program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">6.6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2023ShareRepurchaseProgramMember', window );">2023 Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward', window );"><strong>Increase (Decrease) In Treasury Stock [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased under the Share Repurchase Program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">4.7<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember', window );">2024 Share Repurchase Program</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward', window );"><strong>Increase (Decrease) In Treasury Stock [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased under the Share Repurchase Program (in shares)</a></td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">10.4<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_A2028NotesMember', window );">2028 Notes</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward', window );"><strong>Increase (Decrease) In Treasury Stock [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TreasuryStockSharesAcquired', window );">Shares repurchased under the Share Repurchase Program (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_IncreaseDecreaseInTreasuryStockRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Treasury Stock</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_IncreaseDecreaseInTreasuryStockRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SharesReceivedFromExerciseOfNoteHedge">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares Received From Exercise of Note Hedge</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SharesReceivedFromExerciseOfNoteHedge</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Achievement Of Milestone</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stock Issued During Period, Shares, Exercise and Settlement of Warrants</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481139/470-20-50-1E<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockSharesAcquired">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares that have been repurchased during the period and are being held in treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -SubTopic 10<br> -Topic 505<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 210<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480566/210-10-S99-1<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 505<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockSharesAcquired</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A2022ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A2022ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A2023ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A2023ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A2024ShareRepurchaseProgramMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_A2028NotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_A2028NotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>103
<FILENAME>R80.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046507660160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details) - EIP 2015 - USD ($)<br> $ / shares in Units, shares in Millions, $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward', window );"><strong>Shares Available for Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant at beginning of period (in shares)</a></td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
<td class="nump">16.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted', window );">Granted (in shares)</a></td>
<td class="num">(1.7)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
<td class="num">(1.9)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested', window );">Vested (in shares)</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures', window );">Forfeited (in shares)</a></td>
<td class="nump">0.3<span></span>
</td>
<td class="nump">0.2<span></span>
</td>
<td class="nump">0.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant at end of period (in shares)</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="nump">13.9<span></span>
</td>
<td class="nump">15.3<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member', window );">RSUs and PSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward', window );"><strong>Shares Available for Grant</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for grant at end of period (in shares)</a></td>
<td class="nump">12.5<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Shares</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at beginning of period (in shares)</a></td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">3.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares)</a></td>
<td class="nump">1.7<span></span>
</td>
<td class="nump">1.6<span></span>
</td>
<td class="nump">1.9<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares)</a></td>
<td class="num">(1.3)<span></span>
</td>
<td class="num">(1.4)<span></span>
</td>
<td class="num">(1.6)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited (in shares)</a></td>
<td class="num">(0.3)<span></span>
</td>
<td class="num">(0.2)<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Nonvested at end of period (in shares)</a></td>
<td class="nump">3.0<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
<td class="nump">2.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward', window );"><strong>Weighted&#160; Average Grant&#160;Date Fair&#160;Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at beginning of period (in usd per share)</a></td>
<td class="nump">$ 105.98<span></span>
</td>
<td class="nump">$ 94.08<span></span>
</td>
<td class="nump">$ 76.88<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in usd per share)</a></td>
<td class="nump">131.17<span></span>
</td>
<td class="nump">112.01<span></span>
</td>
<td class="nump">96.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in usd per share)</a></td>
<td class="nump">102.09<span></span>
</td>
<td class="nump">88.57<span></span>
</td>
<td class="nump">63.90<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited (in usd per share)</a></td>
<td class="nump">115.59<span></span>
</td>
<td class="nump">106.34<span></span>
</td>
<td class="nump">92.54<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Nonvested at end of period (in usd per share)</a></td>
<td class="nump">$ 121.17<span></span>
</td>
<td class="nump">$ 105.98<span></span>
</td>
<td class="nump">$ 94.08<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested', window );">Aggregate Intrinsic&#160;Value</a></td>
<td class="nump">$ 234.1<span></span>
</td>
<td class="nump">$ 361.2<span></span>
</td>
<td class="nump">$ 325.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-based Compensation Arrangement by Share-based Payment Award, Shares Available for Grant</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Net number of non-option equity instruments granted to participants.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -SubTopic 10<br> -Topic 718<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EquityIncentivePlan2015Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>104
<FILENAME>R81.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046605157056">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 170.4<span></span>
</td>
<td class="nump">$ 150.8<span></span>
</td>
<td class="nump">$ 126.5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense', window );">Total tax benefit related to share-based compensation expense</a></td>
<td class="nump">43.8<span></span>
</td>
<td class="nump">40.0<span></span>
</td>
<td class="nump">43.2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">14.4<span></span>
</td>
<td class="nump">14.6<span></span>
</td>
<td class="nump">11.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">52.2<span></span>
</td>
<td class="nump">45.5<span></span>
</td>
<td class="nump">42.7<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 103.8<span></span>
</td>
<td class="nump">$ 90.7<span></span>
</td>
<td class="nump">$ 72.7<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479830/718-10-S99-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of tax benefit for recognition of expense of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>105
<FILENAME>R82.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046512018480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details) - Employee Stock Purchase Plan<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield (as a percent)</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected life (in years)</a></td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">6 months<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">4.80%<span></span>
</td>
<td class="nump">5.20%<span></span>
</td>
<td class="nump">0.60%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of common stock (as a percent)</a></td>
<td class="nump">42.00%<span></span>
</td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">45.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk free interest rate (as a percent)</a></td>
<td class="nump">5.27%<span></span>
</td>
<td class="nump">5.47%<span></span>
</td>
<td class="nump">3.34%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility of common stock (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">48.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 1D<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-1D<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 35<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480483/718-10-35-3<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(04)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(02)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(03)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(v)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 718<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=dxcm_EmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>106
<FILENAME>R83.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514735664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2024 </div>
<div>segment </div>
<div>primary_market</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_NumberOfPrimaryGeographicMarkets', window );">Number of primary geographic markets | primary_market</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_NumberOfPrimaryGeographicMarkets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Primary Geographic Markets</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_NumberOfPrimaryGeographicMarkets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 47<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 54<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 18<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-18<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>107
<FILENAME>R84.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046514004128">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Summary (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 4,033.0<span></span>
</td>
<td class="nump">$ 3,622.3<span></span>
</td>
<td class="nump">$ 2,909.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember', window );">Distributor</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 3,430.1<span></span>
</td>
<td class="nump">$ 3,095.6<span></span>
</td>
<td class="nump">$ 2,470.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
<td class="nump">85.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember', window );">Direct</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 602.9<span></span>
</td>
<td class="nump">$ 526.7<span></span>
</td>
<td class="nump">$ 439.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
<td class="nump">15.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 2,889.8<span></span>
</td>
<td class="nump">$ 2,625.3<span></span>
</td>
<td class="nump">$ 2,142.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">72.00%<span></span>
</td>
<td class="nump">74.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember', window );">International</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Total revenue</a></td>
<td class="nump">$ 1,143.2<span></span>
</td>
<td class="nump">$ 997.0<span></span>
</td>
<td class="nump">$ 767.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_RevenuePercentage', window );">Proportion of revenue (as a percent)</a></td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">28.00%<span></span>
</td>
<td class="nump">26.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_RevenuePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Revenue, Percentage</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_RevenuePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types1:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelThroughIntermediaryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerSalesChannelAxis=us-gaap_SalesChannelDirectlyToConsumerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=us-gaap_NonUsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=us-gaap_NonUsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>108
<FILENAME>R85.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517399264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingAbstract', window );"><strong>Segment Reporting [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 4,033.0<span></span>
</td>
<td class="nump">$ 3,622.3<span></span>
</td>
<td class="nump">$ 2,909.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfGoodsAndServicesSold', window );">Cost of sales</a></td>
<td class="nump">1,594.8<span></span>
</td>
<td class="nump">1,333.4<span></span>
</td>
<td class="nump">1,026.7<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_PayrollRelatedExpenses', window );">Payroll related expenses</a></td>
<td class="nump">767.1<span></span>
</td>
<td class="nump">726.9<span></span>
</td>
<td class="nump">621.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_ShareBasedPaymentArrangementOperatingExpense', window );">Stock-based compensation expense</a></td>
<td class="nump">156.0<span></span>
</td>
<td class="nump">136.2<span></span>
</td>
<td class="nump">115.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_MarketingExpense', window );">Marketing expense</a></td>
<td class="nump">298.7<span></span>
</td>
<td class="nump">264.6<span></span>
</td>
<td class="nump">228.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TravelAndEntertainmentExpense', window );">Travel related expenses</a></td>
<td class="nump">64.8<span></span>
</td>
<td class="nump">55.3<span></span>
</td>
<td class="nump">37.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SupplyExpensesAndClinicalTrials', window );">Supply expenses and clinical trials</a></td>
<td class="nump">64.5<span></span>
</td>
<td class="nump">46.5<span></span>
</td>
<td class="nump">50.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProfessionalFees', window );">Consulting &amp; professional fees</a></td>
<td class="nump">227.8<span></span>
</td>
<td class="nump">222.2<span></span>
</td>
<td class="nump">196.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_EquipmentOfficeAndFacilityExpenses', window );">Equipment, office &amp; facility expenses</a></td>
<td class="nump">83.8<span></span>
</td>
<td class="nump">84.7<span></span>
</td>
<td class="nump">80.3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InformationTechnologyAndDataProcessing', window );">IT software and data</a></td>
<td class="nump">130.6<span></span>
</td>
<td class="nump">106.6<span></span>
</td>
<td class="nump">86.5<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">39.9<span></span>
</td>
<td class="nump">41.9<span></span>
</td>
<td class="nump">46.7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingOtherItemAmount', window );">Other segment items</a></td>
<td class="nump">5.0<span></span>
</td>
<td class="nump">6.3<span></span>
</td>
<td class="nump">29.3<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Operating income</a></td>
<td class="nump">600.0<span></span>
</td>
<td class="nump">597.7<span></span>
</td>
<td class="nump">391.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other income (expense), net</a></td>
<td class="nump">109.0<span></span>
</td>
<td class="nump">112.7<span></span>
</td>
<td class="num">(0.4)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Income before income taxes</a></td>
<td class="nump">709.0<span></span>
</td>
<td class="nump">710.4<span></span>
</td>
<td class="nump">390.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">132.8<span></span>
</td>
<td class="nump">168.9<span></span>
</td>
<td class="nump">49.6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net income</a></td>
<td class="nump">576.2<span></span>
</td>
<td class="nump">541.5<span></span>
</td>
<td class="nump">341.2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">217.7<span></span>
</td>
<td class="nump">186.0<span></span>
</td>
<td class="nump">155.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets', window );">Expenditures for long-lived assets</a></td>
<td class="nump">358.8<span></span>
</td>
<td class="nump">236.6<span></span>
</td>
<td class="nump">364.8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredIncomeTaxExpenseBenefit', window );">Deferred income taxes</a></td>
<td class="nump">$ 43.8<span></span>
</td>
<td class="nump">$ 55.0<span></span>
</td>
<td class="nump">$ 21.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_EquipmentOfficeAndFacilityExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equipment, Office And Facility Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_EquipmentOfficeAndFacilityExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_PayrollRelatedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payroll Related Expenses</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_PayrollRelatedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_ShareBasedPaymentArrangementOperatingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Payment Arrangement, Operating Expense</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_ShareBasedPaymentArrangementOperatingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SupplyExpensesAndClinicalTrials">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Supply Expenses And Clinical Trials</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SupplyExpensesAndClinicalTrials</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfGoodsAndServicesSold">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(2)(a))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfGoodsAndServicesSold</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredIncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(1)(Note 1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-9<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredIncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482099/360-10-50-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -SubTopic 10<br> -Topic 230<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(11))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 942<br> -SubTopic 235<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477314/942-235-S99-1<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 12<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 231<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.7)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482685/740-10-50-10<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -SubTopic 20<br> -Topic 740<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482659/740-20-45-2<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -SubTopic 10<br> -Topic 235<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationTechnologyAndDataProcessing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of expenses incurred in the period for information technology and data processing products and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(6))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationTechnologyAndDataProcessing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MarketingExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MarketingExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 31<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfessionalFees">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 3<br> -Subparagraph (k)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-3<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(2)(b))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfessionalFees</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/otherTransitionRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 924<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479941/924-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 5<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-30<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 42<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 40<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 606<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479806/606-10-50-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentExpenditureAdditionToLongLivedAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 49<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-49<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 25<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-25<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentExpenditureAdditionToLongLivedAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingOtherItemAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 48<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 270<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (i)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (ee)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26C<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 26B<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingOtherItemAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TravelAndEntertainmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Expenses incurred for travel and entertainment during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(4))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TravelAndEntertainmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>109
<FILENAME>R86.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517952080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Business Segment and Geographic Information - Geographic Information (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 1,402.7<span></span>
</td>
<td class="nump">$ 1,184.5<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_US', window );">United States</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">464.6<span></span>
</td>
<td class="nump">544.1<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_MY', window );">Malaysia</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">632.1<span></span>
</td>
<td class="nump">515.4<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=dxcm_OtherCountriesMember', window );">Other countries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">306.0<span></span>
</td>
<td class="nump">$ 125.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_StatementGeographicalAxis=country_IE', window );">Ireland</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingInformationLineItems', window );"><strong>Segment Reporting Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NoncurrentAssets', window );">Total long-lived assets</a></td>
<td class="nump">$ 185.7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 280<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_US">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_US</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_MY">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_MY</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=dxcm_OtherCountriesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=dxcm_OtherCountriesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_IE">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_IE</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>110
<FILENAME>R87.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.0.1</span><table class="report" border="0" cellspacing="2" id="idm46046517420800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward', window );"><strong>Accounts Receivable, Allowance for Credit Loss [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Beginning Balance</a></td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
<td class="nump">$ 5.4<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense', window );">Provision for doubtful accounts</a></td>
<td class="num">(0.1)<span></span>
</td>
<td class="nump">2.0<span></span>
</td>
<td class="nump">2.4<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments', window );">Write-offs and adjustments</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="num">(0.5)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesRecoveries', window );">Recoveries</a></td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
<td class="nump">0.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ValuationAllowancesAndReservesBalance', window );">Ending Balance</a></td>
<td class="nump">$ 9.2<span></span>
</td>
<td class="nump">$ 9.3<span></span>
</td>
<td class="nump">$ 7.3<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dxcm_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesBalance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation and qualifying accounts and reserves.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column E))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesBalance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(1))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowancesAndReservesRecoveries">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09(Column C)(2))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-4<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowancesAndReservesRecoveries</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>111
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MX6VAN5*K4WN5[/K[4)ND(1<P"HD>D$=HIF "0UR@$<]2)5[@,S*CM*N/;XP
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M0]%0L]&^AW^Q-<Y96DR^A/(.B 23A*A428*@^7&J8EWVY@!,0EB<333S*-E
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M[!MZ>UU"&)ATZ#IRQ0>)Y,_WA$M7"S:QF#MBW7XR[\L:/+0, 1.;4I4!3"#
M85^R7 >],_(7='9RKSMQJ*G+H%M8^]U=I&91]5-;)(8W^OK?0U=B@69*H]F,
MS[-G5*1/8:HTK:/#EGMB0[[=27-CLH_UU&2B:F4Y6@ZN:$P$56HXDB9'J>KC
M[J,-GK*W3->D!*U5USO5]9&_1DTMM41C5"N0@8<#=@4V<!JM!EA9;D%QZKLX
M<:9Y-)$UQ6K@2<K73C);,M42K6H1M,;NA(. 5J$'1WUQ$0BS"Y!=)&,/%II+
MLJ1KXF:>!D4N%EDH.BEA?MV%S=B1E9(AB^ZD5!I,D)U2XA<VYU1[.I\SELE"
M9L1[[YU&,-T/*FD#QAZSR&OWV"\.4WZ:BN44TBP2;*Q(C<T-CPY:AUY+:6E0
M0"2?*&R[&%V;8]9+3191U974G(2#@$]4;*;Y:X54/)?4?_6#M7@9+?AH(.(J
M'9J,?6$6QW!I*"RONN 5 ;E2,<95!G"KN#R#]''TOG,7^9HN\MW9U:HAZ&#Y
MS[GS?)N*!CU(KV569:M8PXP$V2%<;Y_&7?[[[>@KN<4)@Z=Y1HV%2S-_+C71
MY$NG!D]:MMA7'Y;%/Y2M7F18<B-A)V>YP(<J4"1A[GK"9O@Q'PN$JF>1RV1Y
MU5.84-T9K;DC3"%B><C5H%+BD(I!ORELE"=G6C"([/I -'YDX=*%%I'(9 ,.
MZVOG(]?=\WR?DSBN%4WRIC@)Q5\5*W--KG3\8W2]16EH!H>";4]VY#+/P;]]
M^<VEFQ2;^Y'<2;,^G9O5FSQWJ#<XL7@N$ 5<- F"E/?G-(AXE]*.HTVZ9[7<
M[ I2 ^/%$:(N8LY 3>"W+D=YAFTI&Q5C 9KS1 [E2>A@9'&R_U.\;\#BY&J^
M1EL"X*J3PW6,TKA.=N\"G4SV07BNH'="M%00BTJMTK"9Z#VS6<RRK;05M4)6
MZP3HU$E['K70AERY/RE7VW9AW^M<2"PM+&EH/("3)N6[B6P'X)(]TH@&JODE
M5#)IFHWUE29-E V>8:64*ADTIHPQ.1\54XA3^$GD+!%,1WZP^%.Y"ZAU6]AD
M=XZ"!=^?*WZ7GGAM>V^B;][B.9DODGB@HF3"?'7@*+D3'H93?T!";\)/:FQV
M)U](=%)&-<@-T67):5;X8R:8?FL'#D#6,I1AS<E)$E*E=!P9?)2KMD9J[K69
M*XZ!Y8=CY+I@G+J#!0[B!U-@5_TG[I1V4!  ^<4Y6>JP,#?/Q&DZ;J[68"I+
M6<0D!_92V;X2@9X\!75G;N'>.WTMF[T1*?_J/*W%62/\L0/SRK(RFF2-+=AH
MR\PQB?+P*'XLY.A3-)8ST]GCR;J04(4I*E22&S@/IT!:-.P+#OFA -I7?4_M
MP678(P<O*#O(PP]:+@+2V=ZN1C6_,E?OZ+3>)U[=BANTN=XA-VMP)<ZR:X%9
M$O0JU5( 3ZQ"S[$$BB^,Q:Y0;YRR"V\CX+317"566KS?Q7IC91JN.5=^R,/?
MJY*,GX2!\EQ-=Z()HB T!%Z+4GZIA@")"&9'YT0215VR'?Q(*PXUD8S/V\XY
MQDZ^E.1,;/B23;>02W3N["(99KV\*=M+[0!6(\G$YV"A&]4HGDHN 9\()(+M
M3O%(+I+FON4DM?4-K;^^$*:0N&@6H+"J:V<0\O1I]478=O"VHR%C:B["'HG;
M7*1W9BD[FG5-Z*H8>MA5AP-^C=H;RZ^T<I;<".KFCS/6JCJ-.F:L3Y_8_* T
MWL3]8 ?^.\[/PI^,#B1HI?_E*%T2/L2!=7ND_+"CFJ=>YU 60E#V;ZR\H@$=
M9[[4F$EA.<DR_:;*Y&3F5,P-TB(W76"4^U\:@[$HQEPQ]U[*RCA_C[&.?\&[
ML^E-\*$+ J62N$?7"+C,*KTPT^O"@!>K.QH;L+PQ+SEW$'CU3S=?+&^QJ*RV
M:<'F:PK?"H-0P(P"N_>NJ5/9?1&8K]>8(D[\*:ST-X9/]5-B5I,&;[LTRS.L
MO>>F0<AY#UU&&-P3'TK8Y]4KR9Q.SV'%VR@%>*897RY["^]\S8L>S_%*ZK6^
M  O;_UHF8J!(@6$&"5GO?_K;\@N]NXND@+?WIZ^6CS_RX"/EA?3#/K-C-FNL
MDJ7169.AZ!^M<GVIJ'DA99AO25K:Q_F$@>GN.C?9I2*R<<F?!,(K&B&&-@<*
MZ-CT+!ZXK3Z+Q6IRJ[(WUOZ-:8K=_4I0G<:*K&->9) -;??3#/POX)!10,EU
M&@7A6O<7XALF]L"BV3>^4>>E:___IS7>Z["+S<6N'FD&(D 1NCTSS<7';7KU
M6:TW)WF;+:BJV&F:W]:Q]R;I-@R74\332I47\D-@5!R!X:B%KZ35=18V!@-3
MY!U==O)NXOY0MZ>8WQV'1ZR86(/4[3AP<@8'!^+97=6T1:PUJWXVND%PL_1(
MMX<\XK1"(\>V#F;1+>G8&_"S*XF;H%[CT8!I !R-_9;L%QK?QVP@QOFF:?B+
M,P[<2!:<;<;TC[<39?ZU&Z?XCDN2N(+)3F>@W;\4CN\3AC6OQ0ZC#:F7$0!W
MMA#/!\>\L'U-C(#>BY]O@=[&V>'1G+%Z;N"WYRE"+;VH-+.CH)^^FH:OU]FK
M5@H^-_Q#9N"<#YWRO5HJ:7UX(.N9,T5H/[(S:!BW74MF+_I"=@D3J#_A(,JX
M!J4+RJ8KMA=3*3G0K0;F7-VU%/ Z]W$:<!_IQPB*!N<(8O$KF3X4[K5L0YX.
MU0(0%ZE;%O0+J!P*PL@5EK@=ZC@=-8*YIW, ]]_PI-HOGZ@!-JW>]U>FL\'
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MT[7_6 J,M(8>P/U"@U[Q"VW0_Y!V_C]02P,$%     @ CHY.6G@<F<6I"P
M3B,  !D   !X;"]W;W)K<VAE971S+W-H965T,3$N>&ULS5IM;]LX$OXKA#=8
MM(#C1+*3NFD2H$VNN #M;M&7W0^'^T!+M,V+)+HD%3?[Z^^9(27+;WG9.]SM
M%]N2R.',\)EG9BB?+XV]=7.EO/A1%I6[Z,V]7YP=';ELKDKI!F:A*CR9&EM*
MCTL[.W(+JV3.D\KB*#T^/CTJI:YZE^=\[Y.]/#>U+W2E/EGAZK*4]OZ=*LSR
MHI?TFAN?]6SNZ<;1Y?E"SM07Y;\M/EE<';52<EVJRFE3":NF%[VWR=F[$8WG
M ;]IM72=WX(LF1AS2Q<W^47OF!12A<H\29#XNE-7JBA($-3X'F7VVB5I8O=W
M(_T]VPY;)M*I*U/\KG,_O^B->R)74UD7_K-9_EU%>TY(7F8*QY]B&<8.1SV1
MU<Z;,DZ&!J6NPK?\$?W0F3 ^WC,AC1-2UCLLQ%I>2R\OSZU9"DNC(8U^L*D\
M&\KIBC;EB[=XJC'/7[Z7VHK?9%$K\5%)5UL%CWMW?N0AG(8<95'0NR HW2,H
M2<5'4_FY$W^K<I6O"SB"5JUJ::/:N_1!B=<J&XAATA?I<3IZ0-ZP-77(\H:/
MFWJM7588LM:)?[R=.&^!CG_N,CJ('.T621%SYA8R4Q<]A(13]D[U+G_^*3D]
M?O. PJ-6X=%#TI^S-P\+&@[$'EGBK7,*7[+*Q0<M)[K07L,I<4PNI.].I3 2
MGU566ZNKF7@GG7;B=R64\QH1HH2?*S&E\7=A_%28VHH/ZDX5(A%37<DJT[(0
MNH+/:U:A+Y9SG<V%M JW8Y@"XO96T</:T4IU)?-_(1J@T??:T%<8(!969] 7
M["1T#G$Z6Y<^(/7,Q(.>-I0+DU;JI8^K5QF_2\6I-27\ E6(U_!MILH1:T$2
MZ4<&."R4D7_@T-IA\2>8@8O,E MIY:10ZSI9"6,LB:M$KBTH#D82_B1QG2/'
MQP6BY"VU(R2B*X*',)QM\7-LZT-F9%A6%LZ(B6).S D9S9C2Y*IP<)NR:G*/
M<85P>E;I*8RJ6CV#28N:K-%55M0YSY6^MMK?BQQHHB?. 4;Q DCU!>.VN3-1
M538G@\2]5D5.CE$+8\ENA'3.0ZRY5?8P5[* P]@IK=R8Q[IR'(&;8P!W-3TS
MTZFRCC;#L,_CCEE52%H'FL@^HZ-C&.T<7 3OY,K"Z<&O_;"CUIJ)L3QY<M_O
M3HNB221#P=6@)O@,D"SN WQK>-,K6](.TPU)\<L@QT[JO(G!G>C"CMX!7;0L
MXWX%V+BYT ,#Z7' '=W<#)JUD$[C"JS]RG6"]F!J"@V R (QI9Z\MIQ) OK6
MLIOS=74'TF$LE+)"^6!#J.]AH@V]A[MC?87ENMJ"*7-D@$!<A*H*K[)YI;_3
M"CD0Y4W8%4PFJU=AN+X3)$I7%"#0OY#9+8TL($;G /] ?"7E38&*B;<@N)?+
M)OT'T42KO STS;2R!( ZM-VE8:)MV]+VA&E;LD^09%4Y@4U-HNV+K(!41*O*
M VL L3GOX5+[^2;#S[6RTF;S^[.]*>8;,_B+FPKU2U$0/;UL,T(#HV9;OAH/
MJZZDFPL%;V -%G$@DN%HD.+[YY_&:9*^6?L5GEVKB5\+7WDG=4&N.T0L'3J(
M.A/?!E\&8F;NE*T8.P .' F7ODA>MA*3?G)R/$BVKJ],62K+?E_(!7S6#!@F
M:6=XN+HR=L%1#@J 8LW#DR3I# U7P>C\<?T[&KU^-1P,MZY_97@6IIH=,DD$
M>)Q!&82+]9IP5!$#$AJ4#O!NA+3"C@<GX2.(BQA[D;X$0 :G6^/Y9K A#GT.
M#+%])Z/!F+ZC$0=A\0.1]I/A&+)I;VXX15"4D9O,I-"SF.J8RID7-C;WT"WP
MW) >N%(6L4>)%[RZ#P4#-K)=*EJSRO^!M#2X>(YL(Q:U=36E-$2]I%9 65J,
MN!-=2^"'!>@O<+FJM+&1K&C5IK#(H*1V1&,HW.XI)LO:UW#FM*YR]__D@N%?
ME N&R<G@]1XN",_^FUQPBG ^V;K>RP7)>#1XM7&UAPN&I]UP"E?/YP)$R<DK
M!-#F]5;PPC/I=K#3S?\@>(=#8K"#=M7N7J3]T7B,W?C+Q.__-FJQX%)QUT#%
M:.6XC-05EN6^P].D!NN=VBFOV[K++U5!%7OHJQ7UU=L)FXL)BM:U)@^ROP3=
MN]S_"W/_U[6P[:^J'JJ9:>U8I;QH(C,40"_[31$5O9)M916V5[K(5PVOD"E<
ML$-0CB8 ]=!C#-&LO,X4V[9O4=9^JZD\PX@3SC3)Z1!Q2;_2TQ2P?6S6F.:D
M*;(39HP3S @QL]GK>JK7\U#0[O$1Q44Z/AT<\Z^3T0A1_YXP9K@!#N=L!$(3
M.M9,6GM/$M<+V7WRJ4T*RHO 6NGQ&^;#&)=[+>6QR9NFA"6 F]!1Y)TD _N\
MBITUM%9H[,05. $!>,](O*:&1W*G^;Z===.IL=\23$A\7J-KG5!_CS93S HS
MX38'>0;AAA8D2&7ZPP2*7_5C80BJ4'$:UU8_,O3 ,R687L-O"C^#<KK4/K2R
M/ \(8T',)2$.&R%98P!N+*4E,JCX2,C14G.5SS@(T>>@8Y&K$Y.B<V*"KMV4
M,-B'5+DAFLGI5VS;$Y9L3AI 81C) A%'I 6A8.UL@UF&1/8;T\6.<XX0@DYM
MK $R-VC+_P@**VDKR(>S?6S<T?A2Q]V04=#8MP.%0F.<^2; FWYXR\#=_@IU
M#;@N8GU;1>P;:!T5!8$"S@\T&.>M0,;]8I!N'.6'<([$*8 -"RT;[IA2B1>
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MGRO[H]8E_\]IKFLP=+Y<2Y0:0P/P?*G!9-T/VJ#[X]O+_P!02P,$%     @
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MTJUD"5W5]UPI1!ROW]5NG]\FV;1A8L\6W%"NI?]?&O@YYOSQAY/1</06=Q.
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MJG>BMP$8_AVCEZPY&KPE23[S=R-^,7R[WZQL2]:NDOJ)@B2[LQ?RIL6OIB9
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MQAU ZP *\GM"?^?T-Q/?7O$4.BL0S.S?7WZ:AZ/PLKW.0/4Q@=2U_5_(C@D
MF?=4_(9&@6&VBV,(C#EVSW'U6-=Y>"(F4P;5"8F-RSDNJ KD+ZB*KKV)3C1$
MA<PW+,_9)5:@IW >(Y"24BQ3]:R)-;U@D.8J?]+6Y!X=@ E/,O((Y/L 6H+
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MH0EC\4@YU($S*^VYA*$EMY0<C9/S2+I[A52 -\A^;YY L\*687R5*T*Z_\J
MMC5WXXI N0C#Y^1#1K1F!@8 ;/_]^E-UTXD\.]<+%)L2MC$TW^R.?44JT=0D
M]=ACT#[R+CHN])X;X AFK?F\VD_*32HP_;JPE/G2T?-HJR@B$!8=VW('E0%Z
M"C0D>XOH+"MGM-IN?TJ\D45A8\I' MYD&8GG\RT_#?T7#E"&_0ZY-DN/ ",
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MO(8GK2R=/.Q;!=6W"^8@CLT+R6->-3W6?OU>Y]M7']H'3\BWAMSIU<&4D?R
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M6NH@J"X&R@526Q#[ODN2JC&/PJOP;**W<.J"@/$R LFKLH#_U$(I-<N:B)'
M +0\REI75,0A8RVF5,-B&@'"_<L0V!QR,Z!J%'I"M[E 0T^5*>T0S1E@:JRF
M"TJ[9Z2>*"];/>SRB$Y"Q._TXMKG [0#.'<P!\@Z"V!H,.97+9AYA#\?'2<$
MYAV!GX]P/NAM.9.N@\@9GQ$_X8?TOJ&ZVV5E#4SP0._Q+8-%7$E*A0R5?@'O
M8<@+=84O"H<S&3<)S(4\Q64F8U$D<D%N@>?6S/KU'0M9?5>VR?=N Q#[($D]
M[6 @\ _:(8N*)1EBAQB$1>28#"<CN0;VW-8D3+5'3I5RJ=46B;803!7^JCC
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M_V)DUZ6V2 RVRO2=>\YS?*GBO:&K63]ISE,.?UJY'^GN;TR]V\K43:UYQ@$
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M&,E<]*;(W;JV=T,R'%.6OF^V1C[HAOYLJ+I-G9VS/7 :F[SN_A\C+3EIJ4%
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M9>_M71N0>HI#OEC1537N^+TOSO9S?)W+].OI;;HTY!GNO)]K-!I0&*3;'?<
MBZ9P%P+ $-"@<\]>!%2UIN)<?-5>6]KGK#ON^4G;KV).I\-\98KN5E)Y*\;1
MQ?"E.!63*#E_29_^:8RG833EIQ%"WTOQ0=,5!S"ZT70.W,:MEWN_?6PM$#4J
M+)JW@[WA'F:^79..$UJ#[CG1*J=B?/$26,!<3 )".65]QX V-L<3,#=I__9=
MO3T+[E 7JEKP37%J_J#Z<M>INU^[R^A7[@YV/]S=9/])5@M8'&KC.:8"<29'
M;N?;A]JL^$8V:I[:%/QUJ22""0W ^[E! NP?:('NBOZ[?P-02P,$%     @
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M]$;7NB;1BEUK*%[;Z[_B2HN)79;Z_P#"!.C]->=J;Y@$_1\G_0M02P,$%
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M4!"0&.H+7!3K9QS@F[9TVXZGR)M+L4(/5E041FJXI;&$$VSYGB?7B@J9,JX
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MF82"43N;O'N!??\BAZKA4'[_$>7W3@T<*HI#17&H* X5Q:&BV*HHQ$6P333
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MTA1JCD=/CU^^.!+6_[TZ_Z4V*_X;<3-3UZ;DCTO^RR]T Z[/C:GC%UH@_=7
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MXM=B,6P&?JT!0+2CIZNFHS'H1/\8RGZ?=2(&!2<2,A1BR$B,\$(!K9NVR%:
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M+>R"-GSYXCU*SZ%F(0]C_3$T^ ^P5M1"33[FMWE9"7S%8PB'UGY '$#V 8P
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M<,OK9R]4/1W7X/@CT_Z(8*H/VGP"CZNIN9L^W9<R=J9;(QOOC1GUGNO6\(6
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MMPS4;*J3.IX]NU[YUG&Z4$A<3W<NT45>B.W[*"B>$<+ZI(2,;6PN3_>A^14
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M<3>[6/_77=;)H66Z8@[WQ"*+6! @^/7ZX.!'Z/4K: 3_ T2HB CH9HE,#MT
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M1INU]7V]_O"F#'?DI?$X<\)KCK\XPI( UE<&>=U\D('V3]/T?U!+ P04
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M((Z\\2,2=<-XA-AV;6Y$RJL,'7=IDG/.EM0>)IHPK2LT-7]ZN;BGNL1Q:?U
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MPYBNAA'^#X+AR-]/@F$(CUJMI+$.LQ9KRRL?<O;3#Q,>\E>T'&3H'BTU:VW
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MA=H %;8(K%VM:,<INW9$=^YD5U=.QVI'R[\B?7!]XPVPBYGS3MVREXOWD P
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MH37YK,56,#I<6L!45!-4M @+K4E[K<\"6$/AI06X'T#OPI:=^=R'5@MJK1;
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M\6)SP]F2JSS ?KZ2TKSNY%]0_[QB_A502P,$%     @ CHY.6A!EP2Y1!0
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M\I=;1M>,9P;R^TV2B,<WV6.GY6/&B_\ 4$L#!!0    ( (Z.3EH\V8)-N0,
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M:[7Q-SKB$M7$W2PT[1#B7768]6Q]>SEQ/?O._,C>:ERG_0A378DNF*+JJJ'
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M!.ZLI,JIP:E:^[I00#,'RKD?!<&)GU,FO&3BUN8JF<C2<"9@KH@N\YRJ/^?
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M%?F[*[_*L-]M:$_IE2YH"B,'CZ$&M0$G^?S)C[VO7=G^)[.]W,,F]_"8>_)
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MLCC;W! <$JX#U/D58_*PHR?BY2\@\_\!4$L#!!0    ( (Z.3EJ:2O1\J04
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ML&G&Z]@H[OB]?:/)L5'7CVN;/7F]6E[OW^1A?U*X*Q:[W5:-Y2&G#<\2__1
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MEL:LSEU71TM(J&[(%0A<F4N54(-#M7#U2@&-4U'"7=_S.FY"F7#"03HW4>%
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M[V&&JFS>Y<3(PO6_J3383=UP@=\[4#8 ]V=2FI>);:GU%S3Y U!+ P04
M" ".CDY:9,.7:M\#   L$   &0   'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6RMF&UOVS80Q[\*H15#"Z1ZLN2'S#:0V"D68$6#NMU>#'M!2V>;*"5Z)!TG
M^_0[2HIB/42U ;V))>KNK[O?'2DRTZ.0/]0.0).GA*=J9NVTWE\[CHIVD%!E
MBSVD^&0C9$(UWLJMH_82:)PY)=SQ77?H))2EUGR:C3W(^50<-&<I/$BB#DE"
MY?,M<'&<69[U,O"5;7?:##CSZ9YN807Z^_Y!XIU3JL0L@50QD1()FYEUXUW?
M>:YQR"S^9'!4)]?$I+(6XH>YN8]GEFLB @Z1-A(4?QYA 9P;)8SCWT+4*M]I
M'$^O7]0_9<EC,FNJ8"'X7RS6NYDUMD@,&WK@^JLX_@Y%0J'1BP17V5]R+&Q=
MBT0'I452.&,$"4OS7_I4@#AQ\((W'/S"P3_785 X#,YU" J'X%R'L'#(4G?R
MW#-P2ZKI?"K%D4ACC6KF(J.?>2,OEII&66F)3QGZZ?DMY32-@*RRKER"IHPK
M0M.8?-$[D.032_$YHYS<IWE;FO)^)"OLV/C @8@-N8DB<4BU(@_TF:YQS+CC
MH#Q 3/Y@=,TXTPP4>5_H?T"![ZLE>?_N WE'6$H^,\Y15TT=C3F9R)RHB/\V
MC]]_(_XE1#89>%?$=_V@Q7UQOON@Q7UYOKO?XGYWOKM7=7>PCF4Q_;*8?J8W
M>$/OB]S2E/V7U>B*+!"HX"S.2V9J\B!!0:KS 2S<:W%7. @X_[&(?]^LE98X
M@?]IJT8>0- >@%G5KM6>1C"S]N9=\A&L^:^_>$/WM[;:]"FV[%/LKB>Q2A4'
M914'7>KS<CKMB^F$U8BAK1BY3ICIF"_"XWP0A#;V\>,IY::5/QK:0=5JV1G3
MI?AZ$JO@"TI\P<_P90N/ID]7A!YBIJ^RYN>PQ4;? +2N,KGFZ!3EN,YHT30*
M?'M8 ]D9W:4@>Q*K@ Q+D.%9("6L<7%HI18V@'C>(+0G-6Y-LTGHVJ,:N,YH
M+@77DU@%W+ $-SP+W)%*25/]W$9NV$#2Q-:T\9KM-FS,;C0:5XWN6HU>7U?)
M<E1F.>K,\CZ-1 )FFKTL5&UYCIKSJI%GTV9DA[4T.V.YM#EZ$JM@&Y?8QIW8
MEK !*;$[D![N]E7^,=[C+HSPUZU2&\IQLQW&]798M!B%ME^#V1GAI3![$JO
MG)0P)YTP\STJ+>;;3_A-FJTXLKT:OZ91X#::L3.H2_GU)%;AY[FOVW^WD^ W
MH?&K2.M;#O/!/!-K\8+*XA*.PP;9-CNS7:G#[0[X4KI]J>5XG9.#ECE'?Z9R
MRU*%>XL-RN,G#;.3^=$TO]%BGYV]UD+C22Z[W.%Q'J0QP.<;(?3+C3G.E?\@
MF/\/4$L#!!0    ( (Z.3EKK6TD7Q0(  / &   9    >&PO=V]R:W-H965T
M<R]S:&5E=#4R+GAM;*U534_;0!#]*RL752#1.+83 M2Q!$E1.2 B4MI#U</&
M'B<KUKON[N:#_OK.KAW7@$$<>HGW8][SFY>9<;R5ZD&O  S9%5SHL;<RICSW
M?9VNH*"Z)TL0>)-+55"#6[7T=:F 9@Y4<#_L]T_\@C+A);$[FZDDEFO#F8"9
M(GI=%%0]7@*7V[$7>/N#.[9<&7O@)W%)ES '<U_.%.[\AB5C!0C-I" *\K%W
M$9Q/AC;>!7QGL-6M-;&9+*1\L)OK;.SUK2#@D!K+0/&Q@0EP;HE0QN^:TVM>
M:8'M]9[]RN6.N2RHAHGD/UAF5F/OU",9Y'3-S9W<?H4Z'R<PE5R[7[*M8_L>
M2=?:R*(&HX*"B>I)=[4/+4 P> 40UH#PO8"H!D0NT4J92VM*#4UB);=$V6AD
MLPOGC4-C-DS8?W%N%-XRQ)GDDG(J4B!S5S)3,)1Q3:C(R*U9@2)73. ]HYQ<
MBZIFK/F?R!S+*5MS(#(G%VFJUI"1&7U4DG.'O@-.#9Y]V6&]:=#DL.8^0O#]
M?$H.#X[( 6&"W##.D5/'OL%\K"H_K;5?5MK#5[1/(>V1*#@F83\<=, G[X='
M3^$^NMA8&396AHXO>H7O5BVI8'^<0\=D@BE)SK+*,&O)3($&8:H#M.V?M7,\
M!&P-H\G/BX4V"HO[5Y<?E8!!MP#;\.>ZI"F,O=*^2VW 2SY^"$[ZG[O<^4]D
M3[R*&J^BM]B3?<EL<5+H8[*08EU5G:$[Z"R%BF_H^.QHVB2C06\8^YMV2B^#
M@NBL=]I$/=$Z:+0.WM1:-0*M%4-1<OD(0!8@(&>F4VQ%.&KIB$8OQ'8$!;VP
M6^NPT3I\4^LW:;">]EK+5D.JNB&A;L@NV17W6=N^('RFNB-F%#P3[;?FD?T6
MW%"U9$(3#CFB^KT1DJAJOE8;(TLWHA;2X,!SRQ5^DD#9 +S/I33[C9UZS4<N
M^0M02P,$%     @ CHY.6NIDL] B P  , D  !D   !X;"]W;W)K<VAE971S
M+W-H965T-3,N>&ULK59=3]LP%/TK5H8FD$;3?+1EK*U$FZ'Q@(:H& _3'DQR
MVU@X=F<[+?S[73LA]"-T//#2QLXY)_=<7_MZN);J4>< ACP57.B1EQNS//=]
MG>904-V12Q#X9BY500T.U<+72P4T<Z2"^V&WV_<+RH0W'KJY&S4>RM)P)N!&
M$5T6!57/$^!R/?("[V7BEBUR8R?\\7!)%S #<[>\43CR&Y6,%2 TDX(HF(^\
MB^ \&5B\ _QBL-8;S\0Z>9#RT0ZNLI'7M0$!A]18!8I_*Y@"YU8(P_A;:WK-
M)RUQ\_E%_=)Y1R\/5,-4\GN6F7SDG7DD@SDMN;F5ZQ]0^^E9O51R[7[)NL9V
M/9*6VLBB)F,$!1/5/WVJ\[!!"/IO$,*:$.X2XC<(44V(WDN(:T+L,E-9<7E(
MJ*'CH9)KHBP:U>R#2Z9CHWTF[++/C,*W#'EF/*&<BA3(S-58 H8RK@D5&?EI
M<E#DD@E\SR@G5Z(J,KM:IV2&]9>5'(B<DXLT525DY)XJ185Y)L>US@D"[V8)
M.3XZ(4>$"7+-.$>^'OH&8[<1^&D=YZ2*,WPCSB DUU*87)/O(H-L6\!'TXWS
M\,7Y)#RHF$#:(5'PA83=,&X):/I^>M1"3]Y/#P^XB9IUC)Q>](;>M5P![D9C
MLSPSN'Y49>1&R:Q,S>O"N)7"M?Q]*SDGN''6"/O3MAK5U^+VK]FSZ%PO:0HC
M#P\;#6H%WOCSIZ#?_=:6R8\42SY(;"O+<9/E^)#Z> (+)@03"SQKW+YI2UTE
MT7,2]M1=8?%V^D-_M9F25M#9-BAI!7UM0%L6>HV%WD$+TYRJ!6AB)$FE-M5>
MAR=L(QI:]V4E-]@((AYTPAT[^Z!>T.GMV*E _4VEJ-U,OS'3/VS&.6 B+97:
M/12JZ/M[@9WVHHT<5N&WH8+.8"?^%E0<=8)V"X/&PN"@!3S._E-/@[TJZ.T9
MV,?LUUS2"CK;"=_?Z"4%8*G8GJRQ5DIAJL.UF6W:_H7K=COS$[P.5-W[5::Z
M2UQC!3*A"8<Y2G8[ PQ)5?VY&ABY=!WK01KL?^XQQRL-* O ]W,IS<O ?J"Y
M)(W_ 5!+ P04    " ".CDY:-.>>@A0#  "["   &0   'AL+W=O<FMS:&5E
M=',O<VAE970U-"YX;6RMEE%OFS 0Q[^*Q:IIDUH(! +M$J0VT;1*G58M[?8P
M[<$)E\2JL3/;2;I]^IT-96FA:1_V$K"Y^_.[?\XVPYU4=WH%8,A]R84>>2MC
MUF=!H.<K**GVY1H$/EE(55*#0[4,]%H!+5Q2R8.HUQL$)67"RX=N[EKE0[DQ
MG FX5D1ORI*JWQ? Y6[DA=[#Q%>V7!D[$>3#-5W"%,SM^EKA*&A4"E:"T$P*
MHF Q\L[#LW%FXUW -P8[O7=/;"4S*>_LX+(8>3T+!!SFQBI0O&QA#)Q;(<3X
M56MZS2MMXO[]@_I'5SO6,J,:QI)_9X59C;S,(P4LZ(:;KW+W">IZ$JLWEUR[
M7[*K8WL>F6^TD66=C 0E$]65WM<^["6$\3,)49T0O3:A7R?T7:$5F2MK0@W-
MATKNB++1J&9OG#<N&ZMAPOZ+4Z/P*<,\DU]03L4<R-2US 0,95P3*@KRQ:Q
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M44!51V4U,'+M3IN9-'AVN=L5?EV L@'X?"&E>1C8 ZSY7LG_ E!+ P04
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M90'X?2ZE>>W8";IG5?D_4$L#!!0    ( (Z.3EKQ].6NC0,  (,2   9
M>&PO=V]R:W-H965T<R]S:&5E=#4V+GAM;*V878^;.!2&_XK%5E4K[83O)#--
MD-I M;V8:M39::\=.$FL@LW:)NGLKU\;&!HR!"5:WR0VG/?A^#W.(; X,/Y3
M[  D^E7D5"RMG93EG6V+= <%%A-6 E5G-HP76*HIW]JBY("S6E3DMN<X4[O
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MZGO0M#Z4QE$T720''AT%/7>80;V5@*2Y%>VPLIN5\__Q$X '3>Q#:1Q%T[7
M&BVP_\&H,"?MK1LDS:UHFFYLI\T[\*")?2B-HVBZ;AHSE!KMLT7Y1%N^00ID
MF+2J &J!0FEN1:.V/H^PL3V>.L<R@'J<4!I'T709-#8G-?N<!S)0\\F)@8.<
MA3'99ZO\H:-\R?!6E3W&-PY7YKR]M0,U.RM:/HO7VAG3H34]U@TRJP^E<11-
MUTWCH=).)NK)NGC2H2XVI^@M$:C5"J5Y4)H/I7$431=2X[=2K.%*H8XKE.9"
M:1Z4YD-I'$731=/XKM1LO&*J9*@I6]%>U+7LJ*YUH6D]*,V'TCB*IHND<6ZI
MV;KM425#'=J*IK_<I*V%K0O-[%4T1\MLM?OO/=IRU%7J'=DXJ-3HN;U6B0MU
M6BN:UNGT_$2G0YU4*,V'TCB*IG^3JS%3F=E,[5+CFA%]95#1Z/AH%G <AQVI
M )K8@])\*(VC:+H*&K>4F=W25RMQS7E[2X>^+$KIQ!I2>BP<9%H/2O.A-(ZB
MZ<)IK%5FME:_5^/..M2XYA2]-0(U4J$T#TKSH32.HNE":KQ6AOWF*8/ZKE":
M"Z5Y4)H/I7$431=-X\PRLS,+J7&K'+G'HSV/V,>O6Z_-5]-;)4B:!Z7Y4!I'
MT725-#XL,_NPW8O<"J27I>WO6Z_-27N+ >JE]K@/OT=;CKI*O2,;'Y09+;-7
M*G*KI,=?M&[O=*@7"J5Y4)H/I7$431=.XX4RLQ?:J<B=MKXLM1PZF=)C&4"_
M7@JE>5":#Z5Q%$V70>-V,K/;^7I5[JRE+G78</Q".-"OID)I'I3F0VD<12N%
M,SI8^QF)]*%8UILI*:C'@G*M7'VT7CK\OE@P>W3\BEZXM.6X1R]XN3"XP9?K
ME#\$Z4,89V0KUBJ5-9RJ&34ME_Z6.S+9%2M/[Q,IDZC8W(A@)=*\@3J_3I1(
MJYT\0;T >_$?4$L#!!0    ( (Z.3EK2%HK9C0(  '(&   9    >&PO=V]R
M:W-H965T<R]S:&5E=#8P+GAM;+5546O;,!#^*X<'HX6M=IPF+9UC6!O&"FLI
M+=L>QAX4^Q*+RI(GG9,.^N-WDETW&VD>QO9BZ^2[[[[O=#IG&V/O785(\% K
M[6911=2<Q;$K*JR%.S(-:OZR-+86Q*9=Q:ZQ*,H05*LX39)I7 NIHSP+>S<V
MSTQ+2FJ\L>#:NA;VYSDJLYE%H^AIXU:N*O(;<9XU8H5W2)^;&\M6/*"4LD;M
MI-%@<3F+WH_.SJ?>/SA\D;AQ6VOP2A;&W'OCLIQ%B2>$"@OR"()?:[Q I3P0
MT_C18T9#2A^XO7Y"_Q"TLY:%<'AAU%=94C6+3B,H<2E:1;=F\Q%[/1./5QCE
MPA,VO6\20=$Z,G4?S QJJ;NW>.CKL!4P'KT0D/8!:>#=)0HLYX)$GEFS >N]
M&<TO@M00S>2D]H=R1Y:_2HZC?(X+@K>0)ND8K@TA?,1RA7 P1Q)2N4-PE;#H
M0&JXDDIQ(5T6$R?VX7'1)SGODJ0O)+DVZR,8)V\XS>@4FM86%1?2]MB_X\4L
M8%"1#BK2D&"\3\6E=F1;;AB";Y_8 2X):_=]%]T.[7@WFK\'9ZX1!<XB;G0F
MNL8H?_UJ-$W>[>$Z'KB.]Z'GUVV]8.UFR365)(5Z+HB#QV=C%^\.>1J0_75;
MYVD6KW>0.1[('.\E<X=:&@L71J_1DEPH#%W@H&RQ:XI'F*.3*RT(2Q N](?4
MJ^UJ/T(/$T)W\=Y+XB_K/1DD3OYI;TS^ ]?IP'6Z_SC(%/<@G6NYV&W#4ZL(
M)Q-&('>,Z^JLPQ$=\)WL;M A'\&NN]0)ZE*>;#=-<G3R1]_$6R/$3^,K8?F8
M'2A<<AC[<UEL-^$Z@TP3ILK"$,^HL*SXIX#6._#WI6&2O>$'U?";R7\!4$L#
M!!0    ( (Z.3EHZE.=8G04  $DL   9    >&PO=V]R:W-H965T<R]S:&5E
M=#8Q+GAM;*V:6V_B.!3'OXK%5JNIU"47KNU2I);<.MI6U72[\[#:!Y.8$DT2
M,[8#'6D^_-A)"(2F+FC/"V#'YW><Y(]][./)AK)O?$F(0*]IDO'KSE*(U95A
M\'!)4LR[=$4R>65!68J%++(7@Z\8P5%AE":&;9I#(\5QUIE.BKI'-IW07"1Q
M1AX9XGF:8O;CEB1T<]VQ.MN*+_'+4J@*8SI9X1?R1,3SZI')DE%3HC@E&8]I
MAAA97'=NK*O &BF#HL4_,=GPO=](W<J<TF^J<!===TS5(Y*04"@$EE]K,B-)
MHDBR']\K:*?VJ0SW?V_I7G'S\F;FF),93;[&D5A>=\8=%)$%SA/QA6X"4MW0
M0/%"FO#B$VVJMF8'A3D7-*V,90_2."N_\6OU(/8,;.L= [LRL \,^O8[!KW*
MH'>LAWYET#_68% 9#(XU&%8&PV,-1I7!Z%B#<64P+MYN^3J*=^E@@:<31C>(
MJ=:2IGX4@BBLY2N,,Z7=)\'DU5C:B:E#Y@+]@6S3[J&OF#&<"8X^.43@..'G
MZ P9B"\Q(QS%&7K.8L$O]BKNXR21"I1U9_O%B2%DUY0#(ZRZ,2N[8;_3#0O=
MTTPL.7*SB$0M]H[>OO>1O?>!?UL#,.0SK1^LO7VPM[:6Z)%Y%UF]"_5H^]4C
M:WLN>LH#77=1SU04:XR>GQSTZ>P<1?OOY5VTHT=_SK,M6M=!5T^YQTQ2K(\H
MGI[BD/ 8BG\\I?<^)3B>8K=2&GKHU7^T7H'MZ?YH=QD7+)=#OT#__B4;H#M!
M4OY?2R=O2UJ_G:9FM"N^PB&Y[L@IBQ.V)IWI[[]90_//-I%!PAQ(F L)\R!A
M/B0L ((UE->OE=?7T:?N*V%AS G"680X$2(AA0+I FWJ$5^.WJ74S]O$J'5P
MJA@A80XDS(6$>25L5,!4!+F6DTQW,#'6^R(K&PWW&IG-%H&N14,.@UH. ZT<
MGD@64X9F-%L3)N)Y0M #%7(BB7)2CIP_4=6FJ&_3@];#J7J A#F0,!<2YD'"
M?$A8  1KJ'%8JW$(.BT.(94'"7,@82XDS(.$^9"P  C64-ZH5MY(/PX*&GY#
M(<TS0=@*RZ%0CH&"RM7T]SQF1*[#Q'(W0:YR%B[E&CGZ:*H<O1WVS6ZO.:C/
MWC:RS>ZHV<C1=O]404'"/$B8#PD+@& -08UK08VU@GK(TSEA*JP2#$=Q]H(B
M_(/+V;1M/7JK99TZD(W?! G#@SC"@?3G0L(\2)@/"0N 8 TU7=9JNM2JZ9'1
MD)"(HP6C*>)8AFG[ ?M/=-:F*BWS5%65L,'^4#;N=<<'PH)TZ4+"/$B8#PD+
M@& -85GF;LO//&Y!N&)QV)25#/J9VNTM5X0YC]!*#FG%='>N-%=O.[6)3^_V
M5/55-/55ZZ]_V1T>R _4J0M*\T!I/B@M@*(U-;BW[6R!KD)E\?/C_7:+&OTM
M/SDNTA_JTHRF*<W*[A5Q7:L\M3TZ69Z0- >4YH+2/%":#TH+H&A-%=L[%=N@
MJ]<*!R5!2)H#2G-!:1XHS0>E!5"TI@1W:05+NW<,L;NK]W"R*D&3#: TMZ(U
M5N?=RV9$X8&Z]$%I 12M*;9=)L'2IQ+*/9.8\YQ$<J9F:I$K \281MNL\ 4B
M[PN2$76:0AD=+4W0S ,HS;'>[O#W#\-3%]2E!TKS06D!%*TIS5U6PX)-:\CB
M+5W<_+^($C0/ DIS0&DN*,T#I?F@M "*UI3Q+AUBP>9#+-"$""C- :6YH#0/
ME.:#T@(H6E."N[R(I4^,0$24D)OZ,U": TIS*UICZ_TPG@1-EX#2 BA:*35C
M[QQB2MA+<2:5ESFV\J1475N?>[TI3GL>U#O6E6NUU'OJG&QQ[G&'+P_9WF/V
M$LN9.R$+Z<KLCN0PSLISJV5!T%5Q"G).A:!I\7-)<$28:B"O+ZB,"JJ"<E"?
M'I[^ E!+ P04    " ".CDY:P.<DUMH#  #P$P  &0   'AL+W=O<FMS:&5E
M=',O<VAE970V,BYX;6RUF&]OZC84QK^*E5U-K=21?T!I!TBW)-&MM$[5[;J]
MF/;") >PZMB9[<"]TC[\["1-@86T2-X;$CM^?K;/$Y\83W=<O,@-@$+?<LKD
MS-DH5=RZKDPWD&,YX 4P_63%18Z5+HJU*PL!.*M$.74#SQN[.2;,F4^KND<Q
MG_)24<+@42!9YCD6W^^ \MW,\9W7BJ]DO5&FPIU/"[R&)U#/Q:/0);>E9"0'
M)@EG2,!JYGSV;Q/?,X*JQ>\$=G+O'IFI+#E_,87[;.9X9D1 (54&@?5E"PN@
MU)#T./YNH$[;IQ'NW[_2DVKR>C)++&'!Z1\D4YN9,W%0!BM<4O65[[Y ,Z&1
MX:6<RNH7[9JVGH/24BJ>-V(]@IRP^HJ_-8'8$_CA"4'0"()CP>B$(&P$X;%@
M?$(P; 3#8\'PA&#4"$8?%8P;P;B*?1VL*M(15G@^%7R'A&FM:>:FLJM2ZP 3
M9MZL)R7T4Z)U:A[!4J&?4. %$[3 10&9OE"*?A.825RY+]%%! H3*B]UR^>G
M"%U\ND2?D(OD!@N0B##TS(B25[I2WS\02HULZBH]0-.-FS:#6=2#"4X,QD</
MG*F-1#'+(.O01^_H@QZ JR/3AB=X#<]=T$M\P-^1%UR9^(1=\WE?'?HGU5&_
M.H)T\"H?=LCCC\N[>D\^+@]Z(AFV+UI8\<*^%^V>225*G9@4^O,7W0#=*\CE
M7QVCNZMIPVZ:R;>WLL IS!R=4"6(+3CS'W_PQ][/73;9A$4V8;%-6&()=N#O
ML/5WV$>?/Y8BW>@4+Q%?H;3.)*G))&HODW09W8L]UVB;L*B&W50P\X7>SKVI
MN]UWKVXQVFOA>_X@/&R5]'$.8CUJ8SWJC?43,,(%6G"V!:'(D@+ZE2L=^JR$
M.I7_@YHV57U7V'M[.#?L-F&135AL$Y98@AUX/FX]'UO-GV.;_MJ$139AL4U8
M8@EVX.]UZ^]U[YI>O*7,*Y,_42%("NA";ZA*F:$"1+W=NNPRNT;K_?U;B@G\
M8# .#C/1HG<(Y_IH$Q;;A"668 <^3EH?)_VY&>MLK#^!>N>>OF@3(2=ECBZP
M-!:F>N5V&E@S?7__&S&8'+G7V_&Y[MF$Q39AB278@7LWK7LW_:N0<DG8NG7O
MXTOPYK]+T/<G _]X"?;V?ZZ)-F&Q35AB"79@HN^]_:GU_I_-:#_WW,]F0WMG
M?QA9[32V2DMLT6HCW;V#BAS$NCI2DBCE)5/UG_*VMCVV^EP=UAS51^8XJSH
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M)$L[(MM1,6Y4C-O8DUNH5BHK\/H@5.0D:XI!$[D@PB<\YK%/\*-#PGH'(^?
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M"):D2,0=W;Z'FM!0X84TX>4OVM9C/0>%!1<TK8VE!VF<5?_DH0[$CH$_VF.
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M^Y[6&YZ1SBVC.66EA).42)XG<4A4[H<ZM:N^=KA;F:?JR[9&:_>K0;"'\([
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M7BZ!R]7(:WOK&_=L-C?VAA\.,SJ#!S"/V9W"EE^Z)"P%H9D41,%TY(W;%]'
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MLO+_.DTY?JZJ Z,NJ&4I&FM9LG?<5UAKW=!JEG6:YB7G2E[.N*HGC6J0IF:
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M6IUN"5X1KAK(YVO&Q,N%VFYMMM=G_P-02P,$%     @ CHY.6IM3YW5X P
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M*P.XGS FCPOU@'KL7?X+4$L#!!0    ( (Z.3EI/ ="&Z (  %@(   9
M>&PO=V]R:W-H965T<R]S:&5E=#<Q+GAM;*U676^;,!3]*Q:KIE9:@  A39<@
M-675*JU:U:S;P[0'!VZ"5X,SVR3=OY]M"",)3?O0E^"/<P[WW&M\,]XP_B@R
M (F><EJ(B95)N;IP')%DD&-ALQ44:F?!>(ZEFO*E(U8<<&I(.74\UPV=')/"
MBL9F[8Y'8U9*2@JXXTB4>8[YWRE0MIE8?6N[<$^6F=0+3C1>X27,0#ZL[KB:
M.8U*2G(H!&$%XK"86)?]BSC4> /X3F C6F.DG<P9>]23FW1BN3H@H)!(K8#5
M8PU70*D64F'\J36MYI6:V!YOU:^-=^5EC@5<,?J#I#*;6.<62F&!2RKOV>8S
MU'X&6B]A5)A?M*FQKH624DB6UV0504Z*ZHF?ZCRT"/WP&8)7$[Q]0O ,P:\)
M_FL)04T(3&8J*R8/,98X&G.V05RCE9H>F&0:MK)/"EWVF>1JERB>C&Z*A.6
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MAP%3 /D\HU0<!^H%[<EN\1]02P,$%     @ CHY.6DN%6!E3!   $1L  !D
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M,WTG-K]"E=# Z"4B4\4OV91MHPN')&NE15X%XPARQLM_^E2!V G 1-L#_"K
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M%O=P\,YOH;4[0,4:J9FH9J&:C6H.JKFHYJ&:CVH!JH6H%J%:C&H)I8FQUK7
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MSZN77YH)GO+BY^IN7OP_4$L#!!0    ( (Z.3EKZ,Z9+S00  .$=   9
M>&PO=V]R:W-H965T<R]S:&5E=#<Y+GAM;+U9VV[C-A#]%4(%V@W0M6Z^Q*EM
M((FT:!Y2!'';?2CZP$AC2XA$>DDJWOQ]24F6+5NF;92;%]TXYY \0PXYXF1-
MV2M/  3ZGF>$3ZU$B-6-;?,H@1SS'ET!D24+RG(LY"M;VGS% ,<E*,]LSW&&
M=HY38LTFY;<G-IO00F0I@2>&>)'GF+W?04;74\NU-A^>TV4BU =[-EGA)<Q!
M_+5Z8O+-;ECB- ?"4TH0@\74NG5O0G>L *7%WRFL^<XS4EUYH?15O3S$4\M1
M+8(,(J$HL+R]P3UDF6*2[?A6DUI-G0JX^[QA_U)V7G;F!7.XI]G7-!;)U+JV
M4 P+7&3BF:Y_A[I# \47T8R75[2N;1T+1047-*_!L@5Y2JH[_EX+L0.0/-T
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MDNL)J\X3JQ=!5^6!V0L5@N;E8P)8ND09R/(%E5&N?E$5-*>ZL_\ 4$L#!!0
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MJS-O"]& V<\Z>7/:"^3*A"$M!2;,U*QA7FJ8C[)Y0!TP@[?-O+O8B>6U!!M
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M ]3[#6/RI:$'J/\1F?\/4$L#!!0    ( (Z.3EIXTL9D8P(  '0%   9
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MIA,%<%X51$1)C9C6I;MD@[-28_U;#1A9.7JJA^.6LS&@'*@U)A-JLLO"3BO
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M8UMIKF9%.RIX7>2\W .\+B'J(0]_1*[C^@WIT]>G>_5T6SM4VN26-KD9GG<
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MG 6(\ 8GS%*<;Y4ED!F S'J#/#&;+8', 63>&^2L,7,"60#(HK^1E&Y-($L
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M   :    >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E;'/-VCUNVT 0AN&K"#R
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MK!5%UHHB:T61M:+(6OU/67^,X^$?QR_/M#?M\)R?+?_BN/D%4$L! A0#%
M  @ CHY.6@=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    " ".CDY:@$*$TNX    K @  $0
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M=#(N>&UL4$L! A0#%     @ CHY.6KJ1U]7U!@  _1T  !@
M ("! A,  'AL+W=O<FMS:&5E=',O<VAE970S+GAM;%!+ 0(4 Q0    ( (Z.
M3EIKUC1'$@,  -T*   8              " @2T:  !X;"]W;W)K<VAE971S
M+W-H965T-"YX;6Q02P$"% ,4    " ".CDY:%AJY2>4$  "0$P  &
M        @(%U'0  >&PO=V]R:W-H965T<R]S:&5E=#4N>&UL4$L! A0#%
M  @ CHY.6AR0,W-C P  A L  !@              ("!D"(  'AL+W=O<FMS
M:&5E=',O<VAE970V+GAM;%!+ 0(4 Q0    ( (Z.3EJB,+JU5@P  -5Z   8
M              " @2DF  !X;"]W;W)K<VAE971S+W-H965T-RYX;6Q02P$"
M% ,4    " ".CDY:=R,J&.H)  !H,@  &               @(&U,@  >&PO
M=V]R:W-H965T<R]S:&5E=#@N>&UL4$L! A0#%     @ CHY.6N0SX(4E*@
M[X4  !@              ("!U3P  'AL+W=O<FMS:&5E=',O<VAE970Y+GAM
M;%!+ 0(4 Q0    ( (Z.3EI$,LIQB@D  %0;   9              " @3!G
M  !X;"]W;W)K<VAE971S+W-H965T,3 N>&UL4$L! A0#%     @ CHY.6G@<
MF<6I"P  3B,  !D              ("!\7   'AL+W=O<FMS:&5E=',O<VAE
M970Q,2YX;6Q02P$"% ,4    " ".CDY:V;]V7,P-   $)P  &0
M    @('1?   >&PO=V]R:W-H965T<R]S:&5E=#$R+GAM;%!+ 0(4 Q0    (
M (Z.3EHF-[PV[ @  (D8   9              " @=2*  !X;"]W;W)K<VAE
M971S+W-H965T,3,N>&UL4$L! A0#%     @ CHY.6DD$,AH5"0  ?R<  !D
M             ("!]Y,  'AL+W=O<FMS:&5E=',O<VAE970Q-"YX;6Q02P$"
M% ,4    " ".CDY:Y\],$"X&  #&#@  &0              @(%#G0  >&PO
M=V]R:W-H965T<R]S:&5E=#$U+GAM;%!+ 0(4 Q0    ( (Z.3EIWT]S@8Q
M !,L   9              " @:BC  !X;"]W;W)K<VAE971S+W-H965T,38N
M>&UL4$L! A0#%     @ CHY.6LS6!$_6#P  KB\  !D              ("!
M0K0  'AL+W=O<FMS:&5E=',O<VAE970Q-RYX;6Q02P$"% ,4    " ".CDY:
MAP)R,8<*  ##&@  &0              @(%/Q   >&PO=V]R:W-H965T<R]S
M:&5E=#$X+GAM;%!+ 0(4 Q0    ( (Z.3EK5-61;V (  %X&   9
M      " @0W/  !X;"]W;W)K<VAE971S+W-H965T,3DN>&UL4$L! A0#%
M  @ CHY.6@>H_7Y8 @  ?08  !D              ("!'-(  'AL+W=O<FMS
M:&5E=',O<VAE970R,"YX;6Q02P$"% ,4    " ".CDY:+'5HOD,"  "*!@
M&0              @(&KU   >&PO=V]R:W-H965T<R]S:&5E=#(Q+GAM;%!+
M 0(4 Q0    ( (Z.3EH\I3,X$0(  -T$   9              " @277  !X
M;"]W;W)K<VAE971S+W-H965T,C(N>&UL4$L! A0#%     @ CHY.6E=#Y8F^
M$0  05   !D              ("!;=D  'AL+W=O<FMS:&5E=',O<VAE970R
M,RYX;6Q02P$"% ,4    " ".CDY:UGPTE>(O  !$IP  &0
M@(%BZP  >&PO=V]R:W-H965T<R]S:&5E=#(T+GAM;%!+ 0(4 Q0    ( (Z.
M3EJ>[*7+;P4  $ -   9              " @7L; 0!X;"]W;W)K<VAE971S
M+W-H965T,C4N>&UL4$L! A0#%     @ CHY.6I7\/)_T!   U X  !D
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M=#,P+GAM;%!+ 0(4 Q0    ( (Z.3EH>_-:#1P8  !L0   9
M  " @0-( 0!X;"]W;W)K<VAE971S+W-H965T,S$N>&UL4$L! A0#%     @
MCHY.6I''A,0%!P  9Q$  !D              ("!@4X! 'AL+W=O<FMS:&5E
M=',O<VAE970S,BYX;6Q02P$"% ,4    " ".CDY:AR!V@WD&  !J,0  &0
M            @(&]50$ >&PO=V]R:W-H965T<R]S:&5E=#,S+GAM;%!+ 0(4
M Q0    ( (Z.3EJ\T@J@F 0  &HA   9              " @6U< 0!X;"]W
M;W)K<VAE971S+W-H965T,S0N>&UL4$L! A0#%     @ CHY.6A!EP2Y1!0
M(1L  !D              ("!/&$! 'AL+W=O<FMS:&5E=',O<VAE970S-2YX
M;6Q02P$"% ,4    " ".CDY:R 3 ./D"  "P"   &0              @('$
M9@$ >&PO=V]R:W-H965T<R]S:&5E=#,V+GAM;%!+ 0(4 Q0    ( (Z.3EH9
MY!';T 8  /9!   9              " @?1I 0!X;"]W;W)K<VAE971S+W-H
M965T,S<N>&UL4$L! A0#%     @ CHY.6F;NHF@_!P  <CP  !D
M     ("!^W ! 'AL+W=O<FMS:&5E=',O<VAE970S."YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (Z.3EI$U[T;O@(  /$&   9              "
M@32) 0!X;"]W;W)K<VAE971S+W-H965T-#,N>&UL4$L! A0#%     @ CHY.
M6@4HZ("M @  "0<  !D              ("!*8P! 'AL+W=O<FMS:&5E=',O
M<VAE970T-"YX;6Q02P$"% ,4    " ".CDY:6)?.V!@#  #!"   &0
M        @($-CP$ >&PO=V]R:W-H965T<R]S:&5E=#0U+GAM;%!+ 0(4 Q0
M   ( (Z.3EI\\[2/H00   T9   9              " @5R2 0!X;"]W;W)K
M<VAE971S+W-H965T-#8N>&UL4$L! A0#%     @ CHY.6II*]'RI!0  3R
M !D              ("!-)<! 'AL+W=O<FMS:&5E=',O<VAE970T-RYX;6Q0
M2P$"% ,4    " ".CDY:\?#>GBD#  #J"   &0              @($4G0$
M>&PO=V]R:W-H965T<R]S:&5E=#0X+GAM;%!+ 0(4 Q0    ( (Z.3EIBJ8;(
M"P,  /4)   9              " @72@ 0!X;"]W;W)K<VAE971S+W-H965T
M-#DN>&UL4$L! A0#%     @ CHY.6CWI\??, @  30<  !D
M ("!MJ,! 'AL+W=O<FMS:&5E=',O<VAE970U,"YX;6Q02P$"% ,4    " ".
MCDY:9,.7:M\#   L$   &0              @(&YI@$ >&PO=V]R:W-H965T
M<R]S:&5E=#4Q+GAM;%!+ 0(4 Q0    ( (Z.3EKK6TD7Q0(  / &   9
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M970U-BYX;6Q02P$"% ,4    " ".CDY:BM+X!1P#  "K"P  &0
M    @(&ANP$ >&PO=V]R:W-H965T<R]S:&5E=#4W+GAM;%!+ 0(4 Q0    (
M (Z.3EI+>FK%#P0  )84   9              " @?2^ 0!X;"]W;W)K<VAE
M971S+W-H965T-3@N>&UL4$L! A0#%     @ CHY.6I*A:7"!!@  C#T  !D
M             ("!.L,! 'AL+W=O<FMS:&5E=',O<VAE970U.2YX;6Q02P$"
M% ,4    " ".CDY:TA:*V8T"  !R!@  &0              @('RR0$ >&PO
M=V]R:W-H965T<R]S:&5E=#8P+GAM;%!+ 0(4 Q0    ( (Z.3EHZE.=8G04
M $DL   9              " @;;, 0!X;"]W;W)K<VAE971S+W-H965T-C$N
M>&UL4$L! A0#%     @ CHY.6L#G)-;: P  \!,  !D              ("!
MBM(! 'AL+W=O<FMS:&5E=',O<VAE970V,BYX;6Q02P$"% ,4    " ".CDY:
M-]*"MDT#  #Y#   &0              @(&;U@$ >&PO=V]R:W-H965T<R]S
M:&5E=#8S+GAM;%!+ 0(4 Q0    ( (Z.3EI='XUGP00  )D?   9
M      " @1_: 0!X;"]W;W)K<VAE971S+W-H965T-C0N>&UL4$L! A0#%
M  @ CHY.6H(75M3T!   [QX  !D              ("!%]\! 'AL+W=O<FMS
M:&5E=',O<VAE970V-2YX;6Q02P$"% ,4    " ".CDY:502=$RP#   X#0
M&0              @(%"Y $ >&PO=V]R:W-H965T<R]S:&5E=#8V+GAM;%!+
M 0(4 Q0    ( (Z.3EHX$V?B] 0  .D7   9              " @:7G 0!X
M;"]W;W)K<VAE971S+W-H965T-C<N>&UL4$L! A0#%     @ CHY.6B'L *RS
M!   :A<  !D              ("!T.P! 'AL+W=O<FMS:&5E=',O<VAE970V
M."YX;6Q02P$"% ,4    " ".CDY:FU/G=7@#  "!"P  &0
M@(&Z\0$ >&PO=V]R:W-H965T<R]S:&5E=#8Y+GAM;%!+ 0(4 Q0    ( (Z.
M3EI%WR;!^P,   (/   9              " @6GU 0!X;"]W;W)K<VAE971S
M+W-H965T-S N>&UL4$L! A0#%     @ CHY.6D\!T(;H @  6 @  !D
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M=#<U+GAM;%!+ 0(4 Q0    ( (Z.3EI,@ <QO 0  ,D0   9
M  " @4@. @!X;"]W;W)K<VAE971S+W-H965T-S8N>&UL4$L! A0#%     @
MCHY.6I,]IM@G P  D@H  !D              ("!.Q," 'AL+W=O<FMS:&5E
M=',O<VAE970W-RYX;6Q02P$"% ,4    " ".CDY:FSC*1#X5  !2:P$ &0
M            @(&9%@( >&PO=V]R:W-H965T<R]S:&5E=#<X+GAM;%!+ 0(4
M Q0    ( (Z.3EKZ,Z9+S00  .$=   9              " @0XL @!X;"]W
M;W)K<VAE971S+W-H965T-SDN>&UL4$L! A0#%     @ CHY.6C^VYVM+!0
M-AH  !D              ("!$C$" 'AL+W=O<FMS:&5E=',O<VAE970X,"YX
M;6Q02P$"% ,4    " ".CDY:C\Y;Q_T#  #X$@  &0              @(&4
M-@( >&PO=V]R:W-H965T<R]S:&5E=#@Q+GAM;%!+ 0(4 Q0    ( (Z.3EIT
M^D#HW@,  !T1   9              " @<@Z @!X;"]W;W)K<VAE971S+W-H
M965T.#(N>&UL4$L! A0#%     @ CHY.6GC2QF1C @  = 4  !D
M     ("!W3X" 'AL+W=O<FMS:&5E=',O<VAE970X,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (Z.3EKS-[5M9@,  ($7   -              "
M 0I3 @!X;"]S='EL97,N>&UL4$L! A0#%     @ CHY.6I>*NQS     $P(
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9>&UL4$L%!@    !? %\ $!H  "AC @    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>112
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>113
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>115
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>315</ContextCount>
  <ElementCount>520</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>91</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>10</UnitCount>
  <MyReports>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Document - Audit Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/AuditInformation</Role>
      <ShortName>Audit Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>9952151 - Statement - Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheets</Role>
      <ShortName>Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>9952152 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>9952153 - Statement - Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofOperations</Role>
      <ShortName>Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>9952154 - Statement - Consolidated Statements of Comprehensive Income</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome</Role>
      <ShortName>Consolidated Statements of Comprehensive Income</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>9952155 - Statement - Consolidated Statements of Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity</Role>
      <ShortName>Consolidated Statements of Stockholders' Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>9952156 - Statement - Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows</Role>
      <ShortName>Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>9952157 - Disclosure - Organization and Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>9952158 - Disclosure - Development and Other Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreements</Role>
      <ShortName>Development and Other Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>9952159 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>9952160 - Disclosure - Balance Sheet Details and Other Financial Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation</Role>
      <ShortName>Balance Sheet Details and Other Financial Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>9952161 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>9952162 - Disclosure - Leases and Other Commitments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitments</Role>
      <ShortName>Leases and Other Commitments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>9952163 - Disclosure - Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Contingencies</Role>
      <ShortName>Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>9952164 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>9952165 - Disclosure - Employee Benefit Plans and Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>9952166 - Disclosure - Business Segment and Geographic Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</Role>
      <ShortName>Business Segment and Geographic Information</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>9952167 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>995445 - Disclosure - Insider Trading Arrangements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements</Role>
      <ShortName>Insider Trading Arrangements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure</Role>
      <ShortName>Cybersecurity Risk Management and Strategy Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>9955511 - Disclosure - Organization and Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Organization and Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>9955512 - Disclosure - Organization and Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</Role>
      <ShortName>Organization and Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>9955513 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/FairValueMeasurements</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>9955514 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables</Role>
      <ShortName>Balance Sheet Details and Other Financial Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>9955515 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/Debt</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>9955516 - Disclosure - Leases and Other Commitments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitmentsTables</Role>
      <ShortName>Leases and Other Commitments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/LeasesandOtherCommitments</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>9955517 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/IncomeTaxes</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>9955518 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>9955519 - Disclosure - Business Segment and Geographic Information (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</Role>
      <ShortName>Business Segment and Geographic Information (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformation</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>9955520 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>9955521 - Disclosure - Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>9955522 - Disclosure - Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>9955523 - Disclosure - Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails</Role>
      <ShortName>Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>9955524 - Disclosure - Development and Other Agreements (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails</Role>
      <ShortName>Development and Other Agreements (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/DevelopmentandOtherAgreements</ParentRole>
      <Position>37</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>9955526 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails</Role>
      <ShortName>Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>9955528 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>9955529 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables</ParentRole>
      <Position>42</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>9955530 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>9955531 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>9955532 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>9955533 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>9955534 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>9955535 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>9955536 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>9955537 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>9955538 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>9955539 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>9955540 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>9955541 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>9955542 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails</Role>
      <ShortName>Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>9955543 - Disclosure - Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails</Role>
      <ShortName>Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>9955544 - Disclosure - Debt - Schedule of Converted Value of Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails</Role>
      <ShortName>Debt - Schedule of Converted Value of Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>9955545 - Disclosure - Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>9955546 - Disclosure - Debt - Schedule of Key Details of Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails</Role>
      <ShortName>Debt - Schedule of Key Details of Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>9955547 - Disclosure - Debt - 2023 Note Hedge (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt2023NoteHedgeDetails</Role>
      <ShortName>Debt - 2023 Note Hedge (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>9955548 - Disclosure - Debt - 2023 Warrants (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt2023WarrantsDetails</Role>
      <ShortName>Debt - 2023 Warrants (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>9955549 - Disclosure - Debt - 2028 Capped Call Transactions (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails</Role>
      <ShortName>Debt - 2028 Capped Call Transactions (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>9955550 - Disclosure - Debt - Conversion Activity for Senior Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Activity for Senior Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>9955551 - Disclosure - Debt - Conversion Rights for Seniors Convertible Notes (Details)</LongName>
      <ReportType>Notes</ReportType>
      <Role>http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails</Role>
      <ShortName>Debt - Conversion Rights for Seniors Convertible Notes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>9955552 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails</Role>
      <ShortName>Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>9955553 - Disclosure - Debt - Revolving Credit Agreement (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails</Role>
      <ShortName>Debt - Revolving Credit Agreement (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>9955554 - Disclosure - Leases and Other Commitments - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails</Role>
      <ShortName>Leases and Other Commitments - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>9955555 - Disclosure - Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails</Role>
      <ShortName>Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R69.htm</HtmlFileName>
      <LongName>9955556 - Disclosure - Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails</Role>
      <ShortName>Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>69</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R70.htm</HtmlFileName>
      <LongName>9955557 - Disclosure - Leases and Other Commitments - Other Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails</Role>
      <ShortName>Leases and Other Commitments - Other Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>70</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R71.htm</HtmlFileName>
      <LongName>9955558 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails</Role>
      <ShortName>Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>71</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R72.htm</HtmlFileName>
      <LongName>9955559 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails</Role>
      <ShortName>Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>72</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R73.htm</HtmlFileName>
      <LongName>9955560 - Disclosure - Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails</Role>
      <ShortName>Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>73</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R74.htm</HtmlFileName>
      <LongName>9955561 - Disclosure - Income Taxes - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesNarrativeDetails</Role>
      <ShortName>Income Taxes - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>74</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R75.htm</HtmlFileName>
      <LongName>9955562 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>75</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R76.htm</HtmlFileName>
      <LongName>9955563 - Disclosure - Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>76</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R77.htm</HtmlFileName>
      <LongName>9955564 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails</Role>
      <ShortName>Income Taxes - Schedule of Unrecognized Tax Benefits (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>77</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R78.htm</HtmlFileName>
      <LongName>9955565 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>78</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R79.htm</HtmlFileName>
      <LongName>9955566 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>79</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R80.htm</HtmlFileName>
      <LongName>9955567 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>80</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R81.htm</HtmlFileName>
      <LongName>9955568 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>81</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R82.htm</HtmlFileName>
      <LongName>9955569 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails</Role>
      <ShortName>Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>82</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R83.htm</HtmlFileName>
      <LongName>9955570 - Disclosure - Business Segment and Geographic Information - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails</Role>
      <ShortName>Business Segment and Geographic Information - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>83</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R84.htm</HtmlFileName>
      <LongName>9955571 - Disclosure - Business Segment and Geographic Information - Summary (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails</Role>
      <ShortName>Business Segment and Geographic Information - Summary (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables</ParentRole>
      <Position>84</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R85.htm</HtmlFileName>
      <LongName>9955572 - Disclosure - Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails</Role>
      <ShortName>Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>85</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R86.htm</HtmlFileName>
      <LongName>9955573 - Disclosure - Business Segment and Geographic Information - Geographic Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails</Role>
      <ShortName>Business Segment and Geographic Information - Geographic Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>86</Position>
    </Report>
    <Report instance="dxcm-20241231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R87.htm</HtmlFileName>
      <LongName>9955574 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails</Role>
      <ShortName>SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS</ParentRole>
      <Position>87</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" isDefinitelyFs="true" isUsgaap="true" original="dxcm-20241231.htm">dxcm-20241231.htm</File>
    <File>dxcm-20241231.xsd</File>
    <File>dxcm-20241231_cal.xml</File>
    <File>dxcm-20241231_def.xml</File>
    <File>dxcm-20241231_lab.xml</File>
    <File>dxcm-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>dxcm-20241231_g1.jpg</File>
    <File>dxcm-20241231_g2.jpg</File>
    <File>dxcm-20241231_g3.jpg</File>
    <File>dxcm-20241231_g4.jpg</File>
    <File>dxcm-20241231_g5.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="4">http://fasb.org/srt/2024</BaseTaxonomy>
    <BaseTaxonomy items="1240">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="17">http://xbrl.sec.gov/cyd/2024</BaseTaxonomy>
    <BaseTaxonomy items="38">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="5">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>118
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "dxcm-20241231.htm": {
   "nsprefix": "dxcm",
   "nsuri": "http://www.dexcom.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "dxcm-20241231.htm"
     ]
    },
    "schema": {
     "local": [
      "dxcm-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-2024.xsd",
      "https://xbrl.sec.gov/cyd/2024/cyd-af-sub-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "dxcm-20241231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "dxcm-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "dxcm-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "dxcm-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 448,
   "keyCustom": 72,
   "axisStandard": 29,
   "axisCustom": 2,
   "memberStandard": 51,
   "memberCustom": 39,
   "hidden": {
    "total": 16,
    "http://fasb.org/us-gaap/2024": 11,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://www.dexcom.com/20241231": 1
   },
   "contextCount": 315,
   "entityCount": 1,
   "segmentCount": 91,
   "elementCount": 862,
   "unitCount": 10,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2024": 1240,
    "http://xbrl.sec.gov/dei/2024": 38,
    "http://xbrl.sec.gov/cyd/2024": 17,
    "http://xbrl.sec.gov/ecd/2024": 5,
    "http://fasb.org/srt/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://www.dexcom.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://www.dexcom.com/role/AuditInformation",
     "longName": "0000002 - Document - Audit Information",
     "shortName": "Audit Information",
     "isDefault": "false",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:AuditorName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
     "longName": "9952151 - Statement - Consolidated Balance Sheets",
     "shortName": "Consolidated Balance Sheets",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R4": {
     "role": "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical",
     "longName": "9952152 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "parenthetical",
     "menuCat": "Statements",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R5": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
     "longName": "9952153 - Statement - Consolidated Statements of Operations",
     "shortName": "Consolidated Statements of Operations",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "5",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:GrossProfit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R6": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome",
     "longName": "9952154 - Statement - Consolidated Statements of Comprehensive Income",
     "shortName": "Consolidated Statements of Comprehensive Income",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "6",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R7": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
     "longName": "9952155 - Statement - Consolidated Statements of Stockholders' Equity",
     "shortName": "Consolidated Statements of Stockholders' Equity",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "7",
     "firstAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-9",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R8": {
     "role": "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
     "longName": "9952156 - Statement - Consolidated Statements of Cash Flows",
     "shortName": "Consolidated Statements of Cash Flows",
     "isDefault": "false",
     "groupType": "statement",
     "subGroupType": "",
     "menuCat": "Statements",
     "order": "8",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ShareBasedCompensation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R9": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies",
     "longName": "9952157 - Disclosure - Organization and Significant Accounting Policies",
     "shortName": "Organization and Significant Accounting Policies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "9",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R10": {
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreements",
     "longName": "9952158 - Disclosure - Development and Other Agreements",
     "shortName": "Development and Other Agreements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "10",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CollaborativeArrangementDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R11": {
     "role": "http://www.dexcom.com/role/FairValueMeasurements",
     "longName": "9952159 - Disclosure - Fair Value Measurements",
     "shortName": "Fair Value Measurements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "11",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueMeasurementInputsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R12": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation",
     "longName": "9952160 - Disclosure - Balance Sheet Details and Other Financial Information",
     "shortName": "Balance Sheet Details and Other Financial Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "12",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AdditionalFinancialInformationDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R13": {
     "role": "http://www.dexcom.com/role/Debt",
     "longName": "9952161 - Disclosure - Debt",
     "shortName": "Debt",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "13",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R14": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitments",
     "longName": "9952162 - Disclosure - Leases and Other Commitments",
     "shortName": "Leases and Other Commitments",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "14",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeFinanceLeasesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R15": {
     "role": "http://www.dexcom.com/role/Contingencies",
     "longName": "9952163 - Disclosure - Contingencies",
     "shortName": "Contingencies",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "15",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LegalMattersAndContingenciesTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R16": {
     "role": "http://www.dexcom.com/role/IncomeTaxes",
     "longName": "9952164 - Disclosure - Income Taxes",
     "shortName": "Income Taxes",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "16",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R17": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity",
     "longName": "9952165 - Disclosure - Employee Benefit Plans and Stockholders' Equity",
     "shortName": "Employee Benefit Plans and Stockholders' Equity",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "17",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CompensationAndEmployeeBenefitPlansTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R18": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation",
     "longName": "9952166 - Disclosure - Business Segment and Geographic Information",
     "shortName": "Business Segment and Geographic Information",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "18",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SegmentReportingDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R19": {
     "role": "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS",
     "longName": "9952167 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "19",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R20": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "20",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": null
    },
    "R21": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
     "longName": "995445 - Disclosure - Insider Trading Arrangements",
     "shortName": "Insider Trading Arrangements",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "21",
     "firstAnchor": {
      "contextRef": "c-4",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-4",
      "name": "ecd:Rule10b51ArrAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ecd:NonRule10b51ArrAdoptedFlag",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R22": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "22",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "a",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R23": {
     "role": "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure",
     "longName": "995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure",
     "shortName": "Cybersecurity Risk Management and Strategy Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "23",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R24": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies",
     "longName": "9955511 - Disclosure - Organization and Significant Accounting Policies (Policies)",
     "shortName": "Organization and Significant Accounting Policies (Policies)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "policies",
     "menuCat": "Policies",
     "order": "24",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R25": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables",
     "longName": "9955512 - Disclosure - Organization and Significant Accounting Policies (Tables)",
     "shortName": "Organization and Significant Accounting Policies (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "25",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R26": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsTables",
     "longName": "9955513 - Disclosure - Fair Value Measurements (Tables)",
     "shortName": "Fair Value Measurements (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "26",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R27": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables",
     "longName": "9955514 - Disclosure - Balance Sheet Details and Other Financial Information (Tables)",
     "shortName": "Balance Sheet Details and Other Financial Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "27",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R28": {
     "role": "http://www.dexcom.com/role/DebtTables",
     "longName": "9955515 - Disclosure - Debt (Tables)",
     "shortName": "Debt (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "28",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R29": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitmentsTables",
     "longName": "9955516 - Disclosure - Leases and Other Commitments (Tables)",
     "shortName": "Leases and Other Commitments (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "29",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R30": {
     "role": "http://www.dexcom.com/role/IncomeTaxesTables",
     "longName": "9955517 - Disclosure - Income Taxes (Tables)",
     "shortName": "Income Taxes (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "30",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R31": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables",
     "longName": "9955518 - Disclosure - Employee Benefit Plans and Stockholders' Equity (Tables)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "31",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R32": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables",
     "longName": "9955519 - Disclosure - Business Segment and Geographic Information (Tables)",
     "shortName": "Business Segment and Geographic Information (Tables)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "tables",
     "menuCat": "Tables",
     "order": "32",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R33": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails",
     "longName": "9955520 - Disclosure - Organization and Significant Accounting Policies - Narrative (Details)",
     "shortName": "Organization and Significant Accounting Policies - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "33",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "us-gaap:CashAndCashEquivalentsPolicyTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R34": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails",
     "longName": "9955521 - Disclosure - Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details)",
     "shortName": "Organization and Significant Accounting Policies - Schedule of Percentage of Total Revenues and Accounts Receivable by Customer (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "34",
     "firstAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-46",
      "name": "us-gaap:ConcentrationRiskPercentage1",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R35": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails",
     "longName": "9955522 - Disclosure - Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)",
     "shortName": "Organization and Significant Accounting Policies - Schedule of Basic and Diluted Net Income (Loss) Per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "35",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NetIncomeLoss",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestOnConvertibleDebtNetOfTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R36": {
     "role": "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails",
     "longName": "9955523 - Disclosure - Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details)",
     "shortName": "Organization and Significant Accounting Policies - Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income (Loss) per Share (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "36",
     "firstAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-76",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R37": {
     "role": "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
     "longName": "9955524 - Disclosure - Development and Other Agreements (Details)",
     "shortName": "Development and Other Agreements (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "37",
     "firstAnchor": {
      "contextRef": "c-90",
      "name": "dxcm:SharesIssuedInConnectionWithTheRestatedCollaborationAgreement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-90",
      "name": "dxcm:SharesIssuedInConnectionWithTheRestatedCollaborationAgreement",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "us-gaap:CollaborativeArrangementDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R38": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails",
     "longName": "9955525 - Disclosure - Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value Hierarchy for Financial Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "38",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R39": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
     "longName": "9955526 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "39",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:FairValueAssetsLevel3TransfersAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "0",
      "ancestors": [
       "dxcm:FairValueAssetsLevel3TransfersAmount",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R40": {
     "role": "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails",
     "longName": "9955527 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details)",
     "shortName": "Fair Value Measurements - Schedule of Fair Value of Senior Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "40",
     "firstAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:ConvertibleDebtFairValueDisclosures",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R41": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
     "longName": "9955528 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Short-Term Marketable Securities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "41",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R42": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
     "longName": "9955529 - Disclosure - Balance Sheet Details and Other Financial Information - Narrative (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "42",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-7",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R43": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails",
     "longName": "9955530 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Accounts Receivable (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "43",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsReceivableGross",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R44": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails",
     "longName": "9955531 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Inventory (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "44",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R45": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails",
     "longName": "9955532 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Prepaid and Other Current Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "45",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PrepaidExpenseCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R46": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
     "longName": "9955533 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Property and Equipment (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "46",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R47": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails",
     "longName": "9955534 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Intangible Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "47",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetUsefulLife",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R48": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails",
     "longName": "9955535 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Amortization Expenses of Intangible Assets, Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "48",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R49": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails",
     "longName": "9955536 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Finite-Lived Intangible Assets, Future Amortization Expense (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "49",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R50": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails",
     "longName": "9955537 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Other Assets (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "50",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LongTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LongTermInvestments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R51": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails",
     "longName": "9955538 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Accounts Payable and Accrued Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "51",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AccountsPayableTradeCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R52": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails",
     "longName": "9955539 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Accrued Payroll and Related Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "52",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:AccruedWagesBonusesAndTaxesCurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R53": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails",
     "longName": "9955540 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Accrued Warranty (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "53",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:StandardProductWarrantyAccrual",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R54": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails",
     "longName": "9955541 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Other Long-Term Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "54",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:FinanceLeaseLiabilityNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:OtherTaxLiabilitiesNoncurrent",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R55": {
     "role": "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails",
     "longName": "9955542 - Disclosure - Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details)",
     "shortName": "Balance Sheet Details and Other Financial Information - Schedule of Other Income (Expense), Net (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "55",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InvestmentIncomeInterestAndDividend",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R56": {
     "role": "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
     "longName": "9955543 - Disclosure - Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "shortName": "Debt - Schedule of Carrying Values and Estimated Fair Values of Debt Instruments (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "56",
     "firstAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:DebtInstrumentFaceAmount",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-131",
      "name": "us-gaap:UnamortizedDebtIssuanceExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R57": {
     "role": "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
     "longName": "9955544 - Disclosure - Debt - Schedule of Converted Value of Notes (Details)",
     "shortName": "Debt - Schedule of Converted Value of Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "57",
     "firstAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-166",
      "name": "us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ConvertibleDebtTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R58": {
     "role": "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
     "longName": "9955545 - Disclosure - Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "shortName": "Debt - Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "58",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:InterestExpenseDebtExcludingAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R59": {
     "role": "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
     "longName": "9955546 - Disclosure - Debt - Schedule of Key Details of Convertible Notes (Details)",
     "shortName": "Debt - Schedule of Key Details of Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "59",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:ProceedsFromConvertibleDebt",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-175",
      "name": "us-gaap:DebtInstrumentInterestRateStatedPercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R60": {
     "role": "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
     "longName": "9955547 - Disclosure - Debt - 2023 Note Hedge (Details)",
     "shortName": "Debt - 2023 Note Hedge (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "60",
     "firstAnchor": {
      "contextRef": "c-181",
      "name": "dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
      "unitRef": "purchaser",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-181",
      "name": "dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
      "unitRef": "purchaser",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R61": {
     "role": "http://www.dexcom.com/role/Debt2023WarrantsDetails",
     "longName": "9955548 - Disclosure - Debt - 2023 Warrants (Details)",
     "shortName": "Debt - 2023 Warrants (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "61",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-183",
      "name": "us-gaap:DebtConversionConvertedInstrumentSharesIssued1",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R62": {
     "role": "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
     "longName": "9955549 - Disclosure - Debt - 2028 Capped Call Transactions (Details)",
     "shortName": "Debt - 2028 Capped Call Transactions (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "62",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:PaymentsForPurchasesOfCappedCallTransactions",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-187",
      "name": "dxcm:DebtInstrumentCapCallTransactionCapPricePerShare",
      "unitRef": "usdPerShare",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R63": {
     "role": "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
     "longName": "9955550 - Disclosure - Debt - Conversion Activity for Senior Convertible Notes (Details)",
     "shortName": "Debt - Conversion Activity for Senior Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "63",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-189",
      "name": "dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R64": {
     "role": "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
     "longName": "9955551 - Disclosure - Debt - Conversion Rights for Seniors Convertible Notes (Details)",
     "shortName": "Debt - Conversion Rights for Seniors Convertible Notes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "64",
     "firstAnchor": {
      "contextRef": "c-190",
      "name": "dxcm:DebtInstrumentCovenantRepurchasePricePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-190",
      "name": "dxcm:DebtInstrumentCovenantRepurchasePricePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R65": {
     "role": "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
     "longName": "9955552 - Disclosure - Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "shortName": "Debt - Availability and Outstanding Borrowings under Credit Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "65",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R66": {
     "role": "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails",
     "longName": "9955553 - Disclosure - Debt - Revolving Credit Agreement (Details)",
     "shortName": "Debt - Revolving Credit Agreement (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "66",
     "firstAnchor": {
      "contextRef": "c-7",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-197",
      "name": "us-gaap:DebtInstrumentTerm",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R67": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails",
     "longName": "9955554 - Disclosure - Leases and Other Commitments - Narrative (Details)",
     "shortName": "Leases and Other Commitments - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "67",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:AssetRetirementObligation",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "dxcm:ImpairedLongLivedAssetsFairValue",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R68": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails",
     "longName": "9955555 - Disclosure - Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)",
     "shortName": "Leases and Other Commitments - Schedule of Maturity of Lease and Finance Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "68",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R69": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails",
     "longName": "9955556 - Disclosure - Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details)",
     "shortName": "Leases and Other Commitments - Schedule of Components of Lease Expense and Other Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "69",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:FinanceLeaseRightOfUseAssetAmortization",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LeaseCostTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R70": {
     "role": "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails",
     "longName": "9955557 - Disclosure - Leases and Other Commitments - Other Information (Details)",
     "shortName": "Leases and Other Commitments - Other Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "70",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:OperatingLeasePayments",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R71": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails",
     "longName": "9955558 - Disclosure - Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details)",
     "shortName": "Income Taxes - Schedule of Income (Loss) before Income Taxes Subject to Taxes (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "71",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R72": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
     "longName": "9955559 - Disclosure - Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "shortName": "Income Taxes - Schedule of Components of Income Tax Expense (Benefit) (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "72",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:CurrentFederalTaxExpenseBenefit",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R73": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails",
     "longName": "9955560 - Disclosure - Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details)",
     "shortName": "Income Taxes - Schedule of Tax Credits and Operating Loss Carryforwards (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "73",
     "firstAnchor": {
      "contextRef": "c-207",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-207",
      "name": "us-gaap:OperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock",
       "us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R74": {
     "role": "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
     "longName": "9955561 - Disclosure - Income Taxes - Narrative (Details)",
     "shortName": "Income Taxes - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "74",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:UnusedExpiredFederalIncomeTaxCredits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:UnusedExpiredFederalIncomeTaxCredits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R75": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails",
     "longName": "9955562 - Disclosure - Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "shortName": "Income Taxes - Schedule of Deferred Tax Assets and Liabilities (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "75",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R76": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails",
     "longName": "9955563 - Disclosure - Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "shortName": "Income Taxes - Schedule of Reconciliation between Effective Tax Rate and Statutory Rate (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "76",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R77": {
     "role": "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails",
     "longName": "9955564 - Disclosure - Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "shortName": "Income Taxes - Schedule of Unrecognized Tax Benefits (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "77",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:UnrecognizedTaxBenefits",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R78": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
     "longName": "9955565 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "78",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R79": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails",
     "longName": "9955566 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Schedule of Treasure Share Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "79",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-241",
      "name": "us-gaap:TreasuryStockSharesAcquired",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "dxcm:ScheduleOfTreasuryShareActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R80": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
     "longName": "9955567 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Schedule of RSU and PSU Activity (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "80",
     "firstAnchor": {
      "contextRef": "c-269",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-271",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
      "unitRef": "shares",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R81": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails",
     "longName": "9955568 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Schedule of Share-Based Compensation Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "81",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R82": {
     "role": "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
     "longName": "9955569 - Disclosure - Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details)",
     "shortName": "Employee Benefit Plans and Stockholders' Equity - Schedule of Valuation Assumptions for Employee Stock Purchase Plan (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "82",
     "firstAnchor": {
      "contextRef": "c-294",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-294",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R83": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails",
     "longName": "9955570 - Disclosure - Business Segment and Geographic Information - Narrative (Details)",
     "shortName": "Business Segment and Geographic Information - Narrative (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "83",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:NumberOfReportableSegments",
      "unitRef": "segment",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "INF",
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R84": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
     "longName": "9955571 - Disclosure - Business Segment and Geographic Information - Summary (Details)",
     "shortName": "Business Segment and Geographic Information - Summary (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "84",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:RevenuePercentage",
      "unitRef": "number",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "2",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R85": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
     "longName": "9955572 - Disclosure - Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details)",
     "shortName": "Business Segment and Geographic Information - Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "85",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dxcm:PayrollRelatedExpenses",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    },
    "R86": {
     "role": "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails",
     "longName": "9955573 - Disclosure - Business Segment and Geographic Information - Geographic Information (Details)",
     "shortName": "Business Segment and Geographic Information - Geographic Information (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "86",
     "firstAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-5",
      "name": "us-gaap:NoncurrentAssets",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true,
      "unique": true
     }
    },
    "R87": {
     "role": "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails",
     "longName": "9955574 - Disclosure - SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "shortName": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS (Details)",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "details",
     "menuCat": "Details",
     "order": "87",
     "firstAnchor": {
      "contextRef": "c-6",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "first": true
     },
     "uniqueAnchor": {
      "contextRef": "c-14",
      "name": "us-gaap:ValuationAllowancesAndReservesBalance",
      "unitRef": "usd",
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": "-5",
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "dxcm-20241231.htm",
      "unique": true
     }
    }
   },
   "tag": {
    "dxcm_A2022ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "A2022ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2022 Share Repurchase Program",
        "label": "2022 Share Repurchase Program [Member]",
        "documentation": "2022 Share Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_A2023ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "A2023ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2023 Share Repurchase Program",
        "label": "2023 Share Repurchase Program [Member]",
        "documentation": "2023 Share Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_A2024ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "A2024ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2024 Share Repurchase Program",
        "label": "2024 Share Repurchase Program [Member]",
        "documentation": "2024 Share Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_A2028NotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "A2028NotesMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028 Notes",
        "label": "2028 Notes [Member]",
        "documentation": "2028 Notes"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_A401kPlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "A401kPlanMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "401(k) Plan",
        "label": "401(k) Plan [Member]",
        "documentation": "401(k) Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AMTTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AMTTaxCreditsMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "AMT Tax Credits",
        "label": "AMT Tax Credits [Member]",
        "documentation": "AMT Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AcceleratedShareRepurchaseASRMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AcceleratedShareRepurchaseASRMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated Share Repurchase (ASR)",
        "label": "Accelerated Share Repurchase (ASR) [Member]",
        "documentation": "Accelerated Share Repurchase (ASR)"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AcceleratedShareRepurchaseAgreementAuthorizedAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AcceleratedShareRepurchaseAgreementAuthorizedAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accelerated share repurchase agreement, authorized amount",
        "label": "Accelerated Share Repurchase Agreement, Authorized Amount",
        "documentation": "Accelerated Share Repurchase Agreement, Authorized Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountingPoliciesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounting Policies [Abstract]",
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "totalLabel": "Total accounts payable and accrued liabilities",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsPayableTradeCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accounts payable trade",
        "label": "Accounts Payable, Trade, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r16",
      "r75"
     ]
    },
    "dxcm_AccountsReceivableAllowanceForCreditLossCashDiscount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AccountsReceivableAllowanceForCreditLossCashDiscount",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash discounts reserve",
        "label": "Accounts Receivable, Allowance for Credit Loss, Cash Discount",
        "documentation": "Accounts Receivable, Allowance for Credit Loss, Cash Discount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccountsReceivableGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableGross",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable",
        "label": "Accounts Receivable, before Allowance for Credit Loss",
        "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r235",
      "r334",
      "r335",
      "r1289"
     ]
    },
    "us-gaap_AccountsReceivableMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Accounts Receivable",
        "label": "Accounts Receivable [Member]",
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_AccountsReceivableNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business."
       }
      }
     },
     "auth_ref": [
      "r820",
      "r880",
      "r979",
      "r1288",
      "r1289"
     ]
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccountsReceivableNetCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts receivable, net",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current."
       }
      }
     },
     "auth_ref": [
      "r1150"
     ]
    },
    "us-gaap_AccruedEmployeeBenefitsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedEmployeeBenefitsCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other accrued employee benefits",
        "label": "Accrued Employee Benefits, Current",
        "documentation": "Carrying value as of the balance sheet date of obligations, excluding pension and other postretirement benefits, incurred through that date and payable for perquisites provided to employees pertaining to services received from them. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_AccruedIncomeTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccruedIncomeTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax payable",
        "label": "Accrued Income Taxes, Current",
        "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations."
       }
      }
     },
     "auth_ref": [
      "r78",
      "r152"
     ]
    },
    "dxcm_AccruedTaxAuditAndLegalFeesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AccruedTaxAuditAndLegalFeesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued tax, audit, and legal fees",
        "label": "Accrued Tax Audit And Legal Fees, Current",
        "documentation": "Carrying value as of the balance sheet date of accrued current tax, audit and legal fees."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AccruedWagesBonusesAndTaxesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AccruedWagesBonusesAndTaxesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": "us-gaap_EmployeeRelatedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued wages, bonus and taxes",
        "label": "Accrued Wages, Bonuses and Taxes, Current",
        "documentation": "Accrued Wages, Bonuses and Taxes, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated other comprehensive loss",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source."
       }
      }
     },
     "auth_ref": [
      "r18",
      "r19",
      "r101",
      "r236",
      "r743",
      "r771",
      "r772"
     ]
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accumulated Other Comprehensive Income (Loss)",
        "label": "AOCI Attributable to Parent [Member]",
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r1",
      "r9",
      "r19",
      "r607",
      "r610",
      "r664",
      "r767",
      "r768",
      "r1122",
      "r1123",
      "r1124",
      "r1138",
      "r1139",
      "r1140",
      "r1141"
     ]
    },
    "dxcm_AcquiredTechnologyAndIntellectualPropertyMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AcquiredTechnologyAndIntellectualPropertyMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquired technology and intellectual property",
        "label": "Acquired Technology And Intellectual Property [Member]",
        "documentation": "Acquired Technology And Intellectual Property"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional 402(v) Disclosure",
        "label": "Additional 402(v) Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1037"
     ]
    },
    "us-gaap_AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalCashFlowElementsAndSupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental disclosure of non-cash investing and financing transactions:",
        "label": "Additional Cash Flow Elements and Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalFinancialInformationDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalFinancialInformationDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Balance Sheet Details and Other Financial Information",
        "label": "Additional Financial Information Disclosure [Text Block]",
        "documentation": "The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional paid-in capital",
        "label": "Additional Paid in Capital, Common Stock",
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital."
       }
      }
     },
     "auth_ref": [
      "r92"
     ]
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdditionalPaidInCapitalMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Additional Paid-In Capital",
        "label": "Additional Paid-in Capital [Member]",
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders."
       }
      }
     },
     "auth_ref": [
      "r786",
      "r1138",
      "r1139",
      "r1140",
      "r1141",
      "r1248",
      "r1324"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation, Amount",
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Compensation:",
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote",
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustment To PEO Compensation, Footnote",
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalization of sales-based milestones",
        "label": "Adjustments To Additional Paid In Capital, Collaborative Research And Development Fee",
        "documentation": "Adjustments To Additional Paid In Capital, Collaborative Research And Development Fee"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchase of capped call transactions, net of tax",
        "label": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax",
        "documentation": "Adjustments To Additional Paid-In Capital, Purchase Of Capped Call Transactions, Net Of Tax"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation expense",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r58",
      "r59",
      "r506"
     ]
    },
    "dxcm_AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Tax benefit related to Senior Convertible Notes",
        "label": "Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt",
        "documentation": "Adjustments to Additional Paid in Capital, Tax Benefit from Equity Component of Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adjustments to reconcile net income to cash provided by operating activities:",
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AdvertisingCostsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingCostsPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising Costs",
        "label": "Advertising Cost [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for advertising cost."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "us-gaap_AdvertisingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AdvertisingExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Advertising costs",
        "label": "Advertising Expense",
        "documentation": "Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line."
       }
      }
     },
     "auth_ref": [
      "r546",
      "r940"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table",
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1095"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Amount",
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined",
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1011",
      "r1022",
      "r1032",
      "r1065"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Pension Adjustments Service Cost",
        "label": "Aggregate Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1096"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Adjustments to Compensation",
        "label": "All Adjustments to Compensation [Member]"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Executive Categories",
        "label": "All Executive Categories [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Individuals",
        "label": "All Individuals [Member]"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1057",
      "r1066",
      "r1070",
      "r1078"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "All Trading Arrangements",
        "label": "All Trading Arrangements [Member]"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllocatedShareBasedCompensationExpense",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense",
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized."
       }
      }
     },
     "auth_ref": [
      "r538",
      "r544"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails": {
       "parentTag": "us-gaap_AccountsReceivableNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsReceivableDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: allowance for doubtful accounts",
        "label": "Accounts Receivable, Allowance for Credit Loss",
        "documentation": "Amount of allowance for credit loss on accounts receivable."
       }
      }
     },
     "auth_ref": [
      "r237",
      "r339",
      "r378",
      "r381",
      "r382",
      "r1289"
     ]
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableRollforward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AllowanceForDoubtfulAccountsReceivableRollforward",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "label": "Accounts Receivable, Allowance for Credit Loss [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AmortizationOfFinancingCosts": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfFinancingCosts",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of debt issuance costs",
        "label": "Amortization of Debt Issuance Costs",
        "documentation": "Amount of amortization expense attributable to debt issuance costs."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r466",
      "r1130",
      "r1268"
     ]
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AmortizationOfIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails": {
       "parentTag": "dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization expense included in operating expenses",
        "label": "Amortization of Intangible Assets",
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r402",
      "r408",
      "r923"
     ]
    },
    "dxcm_AmortizationOfIntangibleAssetsIncludedInCostOfSales": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AmortizationOfIntangibleAssetsIncludedInCostOfSales",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails": {
       "parentTag": "dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Amortization expense included in cost of sales",
        "label": "Amortization Of Intangible Assets Included In Cost Of Sales",
        "documentation": "Amortization Of Intangible Assets Included In Cost Of Sales"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAmortizationExpensesofIntangibleAssetsNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total amortization of intangible assets",
        "label": "Amortization Of Intangibles Included In Cost Of Sales And Operating Expenses",
        "documentation": "Amortization Of Intangibles Included In Cost Of Sales And Operating Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_AmortizationPeriodForIncentiveCompensationCosts": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AmortizationPeriodForIncentiveCompensationCosts",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period for incentive compensation costs (in years)",
        "label": "Amortization Period For Incentive Compensation Costs",
        "documentation": "Amortization Period For Incentive Compensation Costs"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r301"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities [Axis]",
        "label": "Antidilutive Securities [Axis]",
        "documentation": "Information by type of antidilutive security."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AntidilutiveSecuritiesNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Securities, Name [Domain]",
        "label": "Antidilutive Securities, Name [Domain]",
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]",
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "us-gaap_AssetRetirementObligation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetRetirementObligation",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Asset retirement obligation",
        "label": "Asset Retirement Obligation",
        "documentation": "The carrying amount of a liability for an asset retirement obligation. An asset retirement obligation is a legal obligation associated with the disposal or retirement of a tangible long-lived asset that results from the acquisition, construction or development, or the normal operations of a long-lived asset, except for certain obligations of lessees."
       }
      }
     },
     "auth_ref": [
      "r423",
      "r424"
     ]
    },
    "us-gaap_Assets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Assets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets",
        "label": "Assets",
        "documentation": "Amount of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r150",
      "r164",
      "r231",
      "r265",
      "r304",
      "r312",
      "r323",
      "r326",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r601",
      "r603",
      "r629",
      "r741",
      "r825",
      "r915",
      "r916",
      "r957",
      "r986",
      "r1200",
      "r1201",
      "r1275"
     ]
    },
    "us-gaap_AssetsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Assets",
        "label": "Assets [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current assets",
        "label": "Assets, Current",
        "documentation": "Amount of asset recognized for present right to economic benefit, classified as current."
       }
      }
     },
     "auth_ref": [
      "r222",
      "r242",
      "r265",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r601",
      "r603",
      "r629",
      "r957",
      "r1200",
      "r1201",
      "r1275"
     ]
    },
    "us-gaap_AssetsCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsCurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current assets:",
        "label": "Assets, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total assets measured at fair value on a recurring basis",
        "label": "Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of asset recognized for present right to economic benefit."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r618",
      "r943"
     ]
    },
    "dxcm_AuditInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "AuditInformationAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Audit Information [Abstract]",
        "documentation": "Audit Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://www.dexcom.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Firm ID",
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015"
     ]
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://www.dexcom.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Location",
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://www.dexcom.com/role/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Auditor Name",
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Unrealized Gains",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax",
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r347"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Gross Unrealized Losses",
        "label": "Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax",
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r348"
     ]
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Amortized Cost",
        "label": "Debt Securities, Available-for-Sale, Amortized Cost",
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r344",
      "r386",
      "r740"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails": {
       "parentTag": "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis",
       "weight": 1.0,
       "order": 3.0
      },
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Debt securities, available-for-sale",
        "terseLabel": "Estimated Market Value",
        "label": "Debt Securities, Available-for-Sale",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r345",
      "r386",
      "r617",
      "r735",
      "r943",
      "r948",
      "r1152",
      "r1252",
      "r1253",
      "r1254"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesCurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current available-for-sale securities",
        "label": "Debt Securities, Available-for-Sale, Current",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as current."
       }
      }
     },
     "auth_ref": [
      "r342",
      "r386"
     ]
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecuritiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AvailableForSaleSecuritiesDebtSecuritiesNoncurrent",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Noncurrent available-for-sale securities",
        "label": "Debt Securities, Available-for-Sale, Noncurrent",
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r226",
      "r342",
      "r386"
     ]
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise Price",
        "label": "Award Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r1073"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value as of Grant Date",
        "label": "Award Grant Date Fair Value"
       }
      }
     },
     "auth_ref": [
      "r1074"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing, How MNPI Considered",
        "label": "Award Timing, How MNPI Considered [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Method",
        "label": "Award Timing Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Considered",
        "label": "Award Timing MNPI Considered [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing MNPI Disclosure",
        "label": "Award Timing MNPI Disclosure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Timing Predetermined",
        "label": "Award Timing Predetermined [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Axis]",
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Securities",
        "label": "Award Underlying Securities Amount"
       }
      }
     },
     "auth_ref": [
      "r1072"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1071"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures",
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table",
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1070"
     ]
    },
    "us-gaap_BaseRateMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BaseRateMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Base Rate",
        "label": "Base Rate [Member]",
        "documentation": "Minimum rate investor will accept."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis of Presentation",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_BofAWarrantTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "BofAWarrantTransactionsMember",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "BofA Warrant Transactions",
        "label": "BofA Warrant Transactions [Member]",
        "documentation": "BofA Warrant Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_BuildingMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "BuildingMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Building",
        "label": "Building [Member]",
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities."
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "stpr_CA": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/stpr/2024",
     "localname": "CA",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "California",
        "label": "CALIFORNIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and cash equivalents",
        "verboseLabel": "Cash and cash equivalents",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r225",
      "r898"
     ]
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash and Cash Equivalents",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value."
       }
      }
     },
     "auth_ref": [
      "r25"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r24",
      "r118",
      "r263"
     ]
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash, end of period:",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Increase (decrease) in cash, cash equivalents and restricted cash",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r118"
     ]
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CashEquivalentsAtCarryingValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash equivalents",
        "label": "Cash Equivalents, at Carrying Value",
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation."
       }
      }
     },
     "auth_ref": [
      "r1118",
      "r1287"
     ]
    },
    "dxcm_CashInterestExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CashInterestExpenseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash interest expense:",
        "label": "Cash Interest Expense [Abstract]",
        "documentation": "Cash Interest Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changed Peer Group, Footnote",
        "label": "Changed Peer Group, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year",
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1045"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested",
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1043"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]",
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r232",
      "r233",
      "r234",
      "r265",
      "r291",
      "r295",
      "r298",
      "r300",
      "r306",
      "r307",
      "r375",
      "r435",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r473",
      "r474",
      "r476",
      "r477",
      "r479",
      "r629",
      "r779",
      "r780",
      "r781",
      "r782",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r812",
      "r834",
      "r852",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r1100",
      "r1133",
      "r1142"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightAxis",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Axis]",
        "label": "Class of Warrant or Right [Axis]",
        "documentation": "Information by type of warrant or right issued."
       }
      }
     },
     "auth_ref": [
      "r55"
     ]
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightDomain",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Warrant or Right [Domain]",
        "label": "Class of Warrant or Right [Domain]",
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise price of warrants or rights (in usd per share)",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding."
       }
      }
     },
     "auth_ref": [
      "r480"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Amount",
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Company Selected Measure Name",
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "us-gaap_CollaborativeArrangementAccountingPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementAccountingPolicy",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration Agreements",
        "label": "Collaborative Arrangement, Accounting Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for collaborative arrangements."
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "us-gaap_CollaborativeArrangementDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development and Other Agreements",
        "label": "Collaborative Arrangement Disclosure [Text Block]",
        "documentation": "The entire disclosure for collaborative arrangements in which the entity is a participant, including a) information about the nature and purpose of such arrangements; b) its rights and obligations thereunder; c) the accounting policy for collaborative arrangements; and d) the income statement classification and amounts attributable to transactions arising from the collaborative arrangement between participants."
       }
      }
     },
     "auth_ref": [
      "r168",
      "r171",
      "r182"
     ]
    },
    "dxcm_CollaborativeArrangementInitialPaymentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CollaborativeArrangementInitialPaymentMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Initial Payment",
        "label": "Collaborative Arrangement, Initial Payment [Member]",
        "documentation": "Collaborative Arrangement, Initial Payment [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CollaborativeArrangementMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CollaborativeArrangementMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement",
        "label": "Collaborative Arrangement [Member]",
        "documentation": "Contractual arrangement that involves two or more parties that both: (i) actively participate in a joint operating activity and (ii) are exposed to significant risks and rewards that depend on the commercial success of the joint operating activity."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "dxcm_CollaborativeArrangementMilestonePaymentsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CollaborativeArrangementMilestonePaymentsMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement, Milestone Payments",
        "label": "Collaborative Arrangement, Milestone Payments [Member]",
        "documentation": "Collaborative Arrangement, Milestone Payments [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CollaborativeArrangementUpfrontFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CollaborativeArrangementUpfrontFee",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Initial payment on collaborative agreement",
        "label": "Collaborative Arrangement, Upfront Fee",
        "documentation": "Collaborative Arrangement, Upfront Fee"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CollaborativeResearchAndDevelopmentFee": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CollaborativeResearchAndDevelopmentFee",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative research and development fee",
        "label": "Collaborative Research And Development Fee",
        "documentation": "Collaborative Research and Development Fee"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CollaborativeSalesBasedMilestoneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CollaborativeSalesBasedMilestoneMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative sales-based milestones",
        "label": "Collaborative Sales-based Milestone [Member]",
        "documentation": "Collaborative Sales-based Milestone"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommercialPaperMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommercialPaperMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commercial paper",
        "label": "Commercial Paper [Member]",
        "documentation": "Unsecured promissory note (generally negotiable) that provides institutions with short-term funds."
       }
      }
     },
     "auth_ref": [
      "r130",
      "r434",
      "r980",
      "r981",
      "r982",
      "r983"
     ]
    },
    "us-gaap_CommitmentsAndContingencies": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingencies",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and contingencies",
        "label": "Commitments and Contingencies",
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur."
       }
      }
     },
     "auth_ref": [
      "r85",
      "r156",
      "r742",
      "r811"
     ]
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]",
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommitmentsAndContingenciesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommitmentsAndContingenciesPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Loss Contingencies",
        "label": "Commitments and Contingencies, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for commitments and contingencies, which may include policies for recognizing and measuring loss and gain contingencies."
       }
      }
     },
     "auth_ref": [
      "r47",
      "r882"
     ]
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common\u00a0Stock",
        "label": "Common Stock [Member]",
        "documentation": "Stock that is subordinate to all other stock of the issuer."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977",
      "r978",
      "r980",
      "r981",
      "r982",
      "r983",
      "r1138",
      "r1139",
      "r1141",
      "r1248",
      "r1321",
      "r1324"
     ]
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, par value (in usd per share)",
        "label": "Common Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of common stock."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock authorized (in shares)",
        "label": "Common Stock, Shares Authorized",
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r812"
     ]
    },
    "us-gaap_CommonStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesIssued",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock issued (in shares)",
        "label": "Common Stock, Shares, Issued",
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury."
       }
      }
     },
     "auth_ref": [
      "r90"
     ]
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock outstanding (in shares)",
        "periodStartLabel": "Balance at beginning of period ( in shares)",
        "periodEndLabel": "Balance at end of period (in shares)",
        "label": "Common Stock, Shares, Outstanding",
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r90",
      "r812",
      "r831",
      "r1324",
      "r1325"
     ]
    },
    "us-gaap_CommonStockValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockValueOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common stock, $0.001 par value, 800.0 million shares authorized; 408.9 million and 390.7 million shares issued and outstanding, respectively, at December\u00a031, 2024; and 407.2 million and 385.4 million shares issued and outstanding, respectively, at December\u00a031, 2023",
        "label": "Common Stock, Value, Outstanding",
        "documentation": "Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r812"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure",
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1054"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Net Income",
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1053"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Other Measure",
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return",
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1052"
     ]
    },
    "us-gaap_CompensationAndEmployeeBenefitPlansTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CompensationAndEmployeeBenefitPlansTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Benefit Plans and Stockholders' Equity",
        "label": "Compensation and Employee Benefit Plans [Text Block]",
        "documentation": "The entire disclosure for an entity's employee compensation and benefit plans, including, but not limited to, postemployment and postretirement benefit plans, defined benefit pension plans, defined contribution plans, non-qualified and supplemental benefit plans, deferred compensation, share-based compensation, life insurance, severance, health care, unemployment and other benefit plans."
       }
      }
     },
     "auth_ref": [
      "r136",
      "r138",
      "r139",
      "r140"
     ]
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomeNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Comprehensive income",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners."
       }
      }
     },
     "auth_ref": [
      "r20",
      "r247",
      "r249",
      "r254",
      "r736",
      "r752",
      "r753"
     ]
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Comprehensive Income",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for comprehensive income."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ComputerSoftwareAndHardwareMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ComputerSoftwareAndHardwareMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Computer software and hardware",
        "label": "Computer Software And Hardware [Member]",
        "documentation": "Computer Software And Hardware"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskBenchmarkDomain",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Domain]",
        "label": "Concentration Risk Benchmark [Domain]",
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r69",
      "r70",
      "r333",
      "r881"
     ]
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Benchmark [Axis]",
        "label": "Concentration Risk Benchmark [Axis]",
        "documentation": "Information by benchmark of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r69",
      "r70",
      "r333",
      "r774",
      "r881"
     ]
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskByTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Axis]",
        "label": "Concentration Risk Type [Axis]",
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r69",
      "r70",
      "r333",
      "r881",
      "r1107"
     ]
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskCreditRisk",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration of Credit Risk and Significant Customers",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for credit risk."
       }
      }
     },
     "auth_ref": [
      "r73",
      "r174"
     ]
    },
    "us-gaap_ConcentrationRiskLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Line Items]",
        "label": "Concentration Risk [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r881"
     ]
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskPercentage1",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration risk (as a percent)",
        "label": "Concentration Risk, Percentage",
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r69",
      "r70",
      "r333"
     ]
    },
    "us-gaap_ConcentrationRiskTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk [Table]",
        "label": "Concentration Risk [Table]",
        "documentation": "Disclosure of information about concentration risk. Includes, but is not limited to, percentage of concentration risk and benchmark serving as denominator in calculation of percentage of concentration risk."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r35",
      "r69",
      "r148",
      "r881"
     ]
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConcentrationRiskTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Concentration Risk Type [Domain]",
        "label": "Concentration Risk Type [Domain]",
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration."
       }
      }
     },
     "auth_ref": [
      "r33",
      "r34",
      "r69",
      "r70",
      "r333",
      "r881"
     ]
    },
    "srt_CondensedFinancialStatementsCaptionsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CondensedFinancialStatementsCaptionsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Financial Statements, Captions [Line Items]",
        "label": "Condensed Financial Statements, Captions [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r213",
      "r214",
      "r215",
      "r270",
      "r1101"
     ]
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConsolidationPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Principles of Consolidation",
        "label": "Consolidation, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary."
       }
      }
     },
     "auth_ref": [
      "r64",
      "r907"
     ]
    },
    "us-gaap_ConstructionInProgressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConstructionInProgressMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Construction in progress",
        "label": "Construction in Progress [Member]",
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ContractPaymentTermsNumberofDays": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ContractPaymentTermsNumberofDays",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer contract payment terms (in days)",
        "label": "Contract Payment Terms, Number of Days",
        "documentation": "Contract Payment Terms, Number of Days"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue",
        "label": "Contract with Customer, Liability, Current",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483",
      "r494"
     ]
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue, long-term",
        "label": "Contract with Customer, Liability, Noncurrent",
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r482",
      "r483",
      "r494"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerSalesChannelAxis",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Sales Channel [Axis]",
        "label": "Contract with Customer, Sales Channel [Axis]",
        "documentation": "Information by sales channel for delivery of good or service in contract with customer."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r1204"
     ]
    },
    "us-gaap_ContractWithCustomerSalesChannelDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ContractWithCustomerSalesChannelDomain",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contract with Customer, Sales Channel [Domain]",
        "label": "Contract with Customer, Sales Channel [Domain]",
        "documentation": "Sales channel for delivery of good or service in contract with customer. Includes, but is not limited to, directly to consumer and through intermediary."
       }
      }
     },
     "auth_ref": [
      "r933",
      "r1204"
     ]
    },
    "us-gaap_ConvertibleDebtFairValueDisclosures": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtFairValueDisclosures",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Fair value of outstanding senior convertible notes",
        "label": "Convertible Debt, Fair Value Disclosures",
        "documentation": "Fair value portion of borrowing which can be exchanged for a specified number of another security at the option of the issuer or the holder, for example, but not limited to, the entity's common stock."
       }
      }
     },
     "auth_ref": [
      "r1251",
      "r1252",
      "r1253",
      "r1254",
      "r1261"
     ]
    },
    "us-gaap_ConvertibleDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior convertible notes",
        "label": "Convertible Debt Securities [Member]",
        "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r1206"
     ]
    },
    "us-gaap_ConvertibleDebtTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleDebtTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Converted Value of Notes",
        "label": "Convertible Debt [Table Text Block]",
        "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleLongTermNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleLongTermNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term senior convertible notes",
        "label": "Convertible Notes Payable, Noncurrent",
        "documentation": "Carrying value as of the balance sheet date of long-term debt (with maturities initially due after one year or beyond the operating cycle if longer) identified as Convertible Notes Payable, excluding current portion. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dxcm_ConvertibleNotesDue2023Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ConvertibleNotesDue2023Member",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2023",
        "label": "Convertible Notes Due 2023 [Member]",
        "documentation": "Convertible Notes Due 2023 [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ConvertibleNotesDue2025Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ConvertibleNotesDue2025Member",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2025",
        "label": "Convertible Notes Due 2025 [Member]",
        "documentation": "Convertible Notes Due 2025"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ConvertibleNotesDue2028Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ConvertibleNotesDue2028Member",
     "presentation": [
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes due 2028",
        "label": "Convertible Notes Due 2028 [Member]",
        "documentation": "Convertible Notes Due 2028"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ConvertibleNotesPayable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Carrying amount of senior convertible notes",
        "label": "Convertible Notes Payable",
        "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of a written promise to pay a note, initially due after one year or beyond the operating cycle if longer, which can be exchanged for a specified amount of one or more securities (typically common stock), at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r155",
      "r1286"
     ]
    },
    "us-gaap_ConvertibleNotesPayableCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ConvertibleNotesPayableCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current portion of long-term senior convertible notes",
        "label": "Convertible Notes Payable, Current",
        "documentation": "Carrying value as of the balance sheet date of the portion of long-term debt due within one year or the operating cycle if longer identified as Convertible Notes Payable. Convertible Notes Payable is a written promise to pay a note which can be exchanged for a specified amount of another, related security, at the option of the issuer and the holder."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CorporateDebtSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Corporate debt",
        "label": "Corporate Debt Securities [Member]",
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment."
       }
      }
     },
     "auth_ref": [
      "r934",
      "r936",
      "r943",
      "r958",
      "r974",
      "r1318"
     ]
    },
    "us-gaap_CostOfGoodsAndServicesSold": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfGoodsAndServicesSold",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Goods and Services Sold",
        "documentation": "The aggregate costs related to goods produced and sold and services rendered by an entity during the reporting period. This excludes costs incurred during the reporting period related to financial services rendered and other revenue generating activities."
       }
      }
     },
     "auth_ref": [
      "r104",
      "r105",
      "r701"
     ]
    },
    "us-gaap_CostOfSalesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CostOfSalesMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cost of sales",
        "label": "Cost of Sales [Member]",
        "documentation": "Primary financial statement caption encompassing cost of sales."
       }
      }
     },
     "auth_ref": []
    },
    "srt_CounterpartyNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "CounterpartyNameAxis",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Axis]",
        "label": "Counterparty Name [Axis]",
        "documentation": "Information by name of counterparty. A counterparty is the other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r268",
      "r269",
      "r448",
      "r475",
      "r665",
      "r682",
      "r739",
      "r904",
      "r906"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CreditFacilityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Axis]",
        "label": "Credit Facility [Axis]",
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r1198"
     ]
    },
    "us-gaap_CreditFacilityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CreditFacilityDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Credit Facility [Domain]",
        "label": "Credit Facility [Domain]",
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r1198",
      "r1199"
     ]
    },
    "us-gaap_CurrentFederalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentFederalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Current Federal Tax Expense (Benefit)",
        "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1136",
      "r1245"
     ]
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current Fiscal Year End Date",
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentForeignTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentForeignTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Current Foreign Tax Expense (Benefit)",
        "documentation": "Amount of current foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1136"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current income taxes",
        "label": "Current Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r585",
      "r1136"
     ]
    },
    "us-gaap_CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current:",
        "label": "Current Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CurrentStateAndLocalTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_CurrentIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Current State and Local Tax Expense (Benefit)",
        "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1109",
      "r1136",
      "r1245"
     ]
    },
    "dxcm_CustomerAMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CustomerAMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer A",
        "label": "Customer A [Member]",
        "documentation": "Customer A [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CustomerBMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CustomerBMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer B",
        "label": "Customer B [Member]",
        "documentation": "Customer B [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CustomerCMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CustomerCMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer C",
        "label": "Customer C [Member]",
        "documentation": "Customer C [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerConcentrationRiskMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer concentration risk",
        "label": "Customer Concentration Risk [Member]",
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer."
       }
      }
     },
     "auth_ref": [
      "r122",
      "r333"
     ]
    },
    "dxcm_CustomerDMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CustomerDMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer D",
        "label": "Customer D [Member]",
        "documentation": "Customer D"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_CustomerEMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "CustomerEMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer E",
        "label": "Customer E [Member]",
        "documentation": "Customer E"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CustomerRelationshipsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CustomerRelationshipsMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer relationships",
        "label": "Customer Relationships [Member]",
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships."
       }
      }
     },
     "auth_ref": [
      "r61",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1179",
      "r1181",
      "r1184",
      "r1185"
     ]
    },
    "cyd_CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1089"
     ]
    },
    "cyd_CybersecurityRiskBoardOfDirectorsOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskBoardOfDirectorsOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Board of Directors Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1089"
     ]
    },
    "cyd_CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Expertise of Management Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1091"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1091"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible Report to Board [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1004",
      "r1093"
     ]
    },
    "cyd_CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Positions or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1002",
      "r1091"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes for Assessing, Identifying, and Managing Threats [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r995",
      "r1084"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1085"
     ]
    },
    "cyd_CybersecurityRiskManagementProcessesIntegratedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementProcessesIntegratedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Processes Integrated [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r996",
      "r1085"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Abstract]"
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1083"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceLineItems",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1083"
     ]
    },
    "cyd_CybersecurityRiskManagementStrategyAndGovernanceTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementStrategyAndGovernanceTable",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management, Strategy, and Governance [Table]"
       }
      }
     },
     "auth_ref": [
      "r994",
      "r1083"
     ]
    },
    "cyd_CybersecurityRiskManagementThirdPartyEngagedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskManagementThirdPartyEngagedFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Management Third Party Engaged [Flag]"
       }
      }
     },
     "auth_ref": [
      "r997",
      "r1086"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Flag]"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1088"
     ]
    },
    "cyd_CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Materially Affected or Reasonably Likely to Materially Affect Registrant [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r999",
      "r1088"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Board Committee or Subcommittee Responsible for Oversight [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1000",
      "r1089"
     ]
    },
    "cyd_CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Process for Informing Management or Committees Responsible [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1003",
      "r1092"
     ]
    },
    "cyd_CybersecurityRiskRoleOfManagementTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskRoleOfManagementTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Role of Management [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1001",
      "r1090"
     ]
    },
    "cyd_CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/cyd/2024",
     "localname": "CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag",
     "presentation": [
      "http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cybersecurity Risk Third Party Oversight and Identification Processes [Flag]"
       }
      }
     },
     "auth_ref": [
      "r998",
      "r1087"
     ]
    },
    "us-gaap_DebtAndEquitySecuritiesUnrealizedGainLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtAndEquitySecuritiesUnrealizedGainLoss",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gains recognized during the reporting period on equity investments still held at the reporting date",
        "label": "Debt and Equity Securities, Unrealized Gain (Loss)",
        "documentation": "Amount of unrealized gain (loss) on investment in debt and equity securities."
       }
      }
     },
     "auth_ref": [
      "r844",
      "r845",
      "r869",
      "r870",
      "r871",
      "r1125",
      "r1126"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares issued for repurchase and conversions of senior convertible notes",
        "label": "Debt Conversion, Converted Instrument, Amount",
        "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock counterparties to acquire with warrants purchased (in shares)",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r29"
     ]
    },
    "us-gaap_DebtDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Disclosure [Abstract]",
        "label": "Debt Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/Debt"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt",
        "label": "Debt Disclosure [Text Block]",
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants."
       }
      }
     },
     "auth_ref": [
      "r129",
      "r264",
      "r417",
      "r418",
      "r419",
      "r420",
      "r421",
      "r433",
      "r434",
      "r444",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r460",
      "r467",
      "r468",
      "r470",
      "r637"
     ]
    },
    "us-gaap_DebtInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentAxis",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Axis]",
        "label": "Debt Instrument [Axis]",
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r77",
      "r78",
      "r151",
      "r155",
      "r270",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r955",
      "r1134",
      "r1189",
      "r1190",
      "r1191",
      "r1267",
      "r1269"
     ]
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basis spread on variable rate (as a percent)",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentCapCallTransactionCapPricePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentCapCallTransactionCapPricePerShare",
     "presentation": [
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capped call, cap price (in usd per share)",
        "label": "Debt Instrument, Cap Call Transaction, Cap Price Per Share",
        "documentation": "Debt Instrument, Cap Call Transaction, Cap Price Per Share"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConversionTermAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term [Axis]",
        "label": "Debt Instrument Conversion Term [Axis]",
        "documentation": "Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConversionTermDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term [Domain]",
        "label": "Debt Instrument Conversion Term [Domain]",
        "documentation": "[Domain] for Debt Instrument Conversion Term [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermOneMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConversionTermOneMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term One",
        "label": "Debt Instrument Conversion Term One [Member]",
        "documentation": "Debt Instrument Conversion Term One [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConversionTermTwoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConversionTermTwoMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument Conversion Term Two",
        "label": "Debt Instrument Conversion Term Two [Member]",
        "documentation": "Debt Instrument Conversion Term Two [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued upon conversion of senior notes (in shares)",
        "label": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares",
        "documentation": "Debt Instrument, Convertible, Associated Derivative Transactions, Number Of Shares1"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage",
     "presentation": [
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Sale of stock premium (as percent)",
        "label": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage",
        "documentation": "Debt Instrument, Convertible, Capped Calls Initial Cap Price, Premium Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleConversionPrice1": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionPrice1",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion price of convertible notes (in usd per share)",
        "label": "Debt Instrument, Convertible, Conversion Price",
        "documentation": "The price per share of the conversion feature embedded in the debt instrument."
       }
      }
     },
     "auth_ref": [
      "r131",
      "r447"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleConversionRatio1": {
     "xbrltype": "pureItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleConversionRatio1",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversion ratio",
        "label": "Debt Instrument, Convertible, Conversion Ratio",
        "documentation": "Ratio applied to the conversion of debt instrument into equity with equity shares divided by debt principal amount."
       }
      }
     },
     "auth_ref": [
      "r50",
      "r81",
      "r133",
      "r134",
      "r447"
     ]
    },
    "us-gaap_DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total by which the notes\u2019 if-converted value exceeds their principal amount",
        "label": "Debt Instrument, Convertible, If-converted Value in Excess of Principal",
        "documentation": "The amount by which the convertible debt's if-converted value exceeds its principle amount at the balance sheet date, regardless of whether the instrument is currently convertible. This element applies to public companies only."
       }
      }
     },
     "auth_ref": [
      "r49"
     ]
    },
    "dxcm_DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt instrument, convertible principal amount settled",
        "label": "Debt Instrument, Convertible, Principal Amount Exercised And Settled",
        "documentation": "Debt Instrument, Convertible, Principal Amount Exercised And Settled"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdConsecutiveTradingDays1": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdConsecutiveTradingDays1",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of trading days",
        "label": "Debt Instrument, Convertible, Threshold Consecutive Trading Days",
        "documentation": "Threshold period of specified consecutive trading days within which common stock price to conversion price of convertible debt instrument must exceed threshold percentage for specified number of trading days to trigger conversion feature."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of applicable conversion price (as a percent)",
        "label": "Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger",
        "documentation": "Minimum percentage of common stock price to conversion price of convertible debt instruments to determine eligibility of conversion."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtInstrumentCovenantRepurchasePricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentCovenantRepurchasePricePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Holder's repurchase price percentage in event of fundamental change (as a percent)",
        "label": "Debt Instrument, Covenant Repurchase Price, Percentage",
        "documentation": "Debt Instrument, Covenant Repurchase Price, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentFaceAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentFaceAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total principal amount",
        "label": "Debt Instrument, Face Amount",
        "documentation": "Face (par) amount of debt instrument at time of issuance."
       }
      }
     },
     "auth_ref": [
      "r445",
      "r637",
      "r638",
      "r925",
      "r926",
      "r955"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective interest rate (as a percent)",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r471",
      "r637",
      "r638",
      "r955"
     ]
    },
    "us-gaap_DebtInstrumentInterestRateStatedPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentInterestRateStatedPercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest rate on convertible notes (as a percent)",
        "label": "Debt Instrument, Interest Rate, Stated Percentage",
        "documentation": "Contractual interest rate for funds borrowed, under the debt agreement."
       }
      }
     },
     "auth_ref": [
      "r80",
      "r446"
     ]
    },
    "us-gaap_DebtInstrumentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentLineItems",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument [Line Items]",
        "label": "Debt Instrument [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r270",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r469",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r955",
      "r1134",
      "r1267",
      "r1269"
     ]
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Debt Instrument, Name [Domain]",
        "label": "Debt Instrument, Name [Domain]",
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r270",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r955",
      "r1134",
      "r1189",
      "r1190",
      "r1191",
      "r1267",
      "r1269"
     ]
    },
    "dxcm_DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of conversion price (as a percent)",
        "label": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock",
        "documentation": "Debt Instrument, Redemption Covenant, Percent Of Conversion Price, Last Reported Sale Price Of Common Stock"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtInstrumentRedemptionPricePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentRedemptionPricePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Redemption price (as a percent)",
        "label": "Debt Instrument, Redemption Price, Percentage",
        "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer."
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "us-gaap_DebtInstrumentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTable",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]",
        "label": "Schedule of Long-Term Debt Instruments [Table]",
        "documentation": "Disclosure of information about long-term debt instrument or arrangement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r50",
      "r51",
      "r72",
      "r132",
      "r134",
      "r270",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r451",
      "r456",
      "r457",
      "r458",
      "r459",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r469",
      "r924",
      "r925",
      "r926",
      "r927",
      "r928",
      "r955",
      "r1134",
      "r1267",
      "r1269"
     ]
    },
    "us-gaap_DebtInstrumentTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtInstrumentTerm",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of debt instrument (in months)",
        "verboseLabel": "Term of debt instrument (in years)",
        "label": "Debt Instrument, Term",
        "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DebtSecuritiesAvailableForSaleAndEquitySecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DebtSecuritiesAvailableForSaleAndEquitySecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term marketable securities",
        "label": "Debt Securities, Available-For-Sale And Equity Securities",
        "documentation": "Debt Securities, Available-For-Sale And Equity Securities"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DebtSecuritiesAvailableForSaleTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Short-Term Marketable Securities",
        "label": "Debt Securities, Available-for-Sale [Table Text Block]",
        "documentation": "Tabular disclosure of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r1154",
      "r1155",
      "r1156",
      "r1157",
      "r1158",
      "r1159",
      "r1160",
      "r1161",
      "r1162",
      "r1163",
      "r1164",
      "r1165"
     ]
    },
    "us-gaap_DeferredCompensationLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredCompensationLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan liabilities",
        "label": "Deferred Compensation Liability, Current",
        "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable within one year (or the operating cycle, if longer). Represents currently earned compensation under compensation arrangements that is not actually paid until a later date."
       }
      }
     },
     "auth_ref": [
      "r54",
      "r137"
     ]
    },
    "dxcm_DeferredCompensationPlanAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DeferredCompensationPlanAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred compensation plan assets",
        "label": "Deferred Compensation Plan Assets, Current",
        "documentation": "Deferred Compensation Plan Assets, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredFederalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Deferred Federal Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1244",
      "r1245"
     ]
    },
    "us-gaap_DeferredForeignIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredForeignIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign",
        "label": "Deferred Foreign Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred foreign income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1244"
     ]
    },
    "us-gaap_DeferredIncomeTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Income Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r555",
      "r556"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred income taxes",
        "totalLabel": "Total deferred income taxes",
        "negatedTerseLabel": "Deferred income taxes",
        "label": "Deferred Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r179",
      "r1136"
     ]
    },
    "us-gaap_DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxExpenseBenefitContinuingOperationsAbstract",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred:",
        "label": "Deferred Income Tax Expense (Benefit), Continuing Operations [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredIncomeTaxLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredIncomeTaxLiabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTotalLabel": "Total deferred tax liabilities",
        "label": "Deferred Tax Liabilities, Gross",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences."
       }
      }
     },
     "auth_ref": [
      "r86",
      "r87",
      "r153",
      "r577"
     ]
    },
    "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "Deferred State and Local Income Tax Expense (Benefit)",
        "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r1136",
      "r1244",
      "r1245"
     ]
    },
    "dxcm_DeferredTaxAssetsConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DeferredTaxAssetsConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Convertible debt",
        "label": "Deferred Tax Assets, Convertible Debt",
        "documentation": "Deferred Tax Assets, Convertible Debt"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DeferredTaxAssetsFixedAssetsAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DeferredTaxAssetsFixedAssetsAndIntangibleAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fixed and intangible assets",
        "label": "Deferred Tax Assets, Fixed Assets and Intangible Assets",
        "documentation": "Deferred Tax Assets, Fixed Assets and Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total gross deferred tax assets",
        "label": "Deferred Tax Assets, Gross",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r578"
     ]
    },
    "us-gaap_DeferredTaxAssetsGrossAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsGrossAbstract",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets:",
        "label": "Deferred Tax Assets, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxAssetsInProcessResearchAndDevelopment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsInProcessResearchAndDevelopment",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Capitalized research and development expenses",
        "label": "Deferred Tax Asset, In-Process Research and Development",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from in-process research and development cost acquired in business combination or from joint venture formation or both."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net deferred tax assets (liabilities)",
        "label": "Deferred Tax Assets, Net",
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting."
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total net deferred tax assets",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsOperatingLossCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss carryforwards",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseOther",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax assets",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Other",
        "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from provisions, reserves, allowances, and accruals, classified as other."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued liabilities and reserves",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxAssetsValuationAllowance",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance amount",
        "negatedTerseLabel": "Less: valuation allowance",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized."
       }
      }
     },
     "auth_ref": [
      "r579"
     ]
    },
    "us-gaap_DeferredTaxLiabilitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred tax liabilities:",
        "label": "Deferred Tax Liabilities, Gross [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Fixed assets and acquired intangibles assets",
        "label": "Deferred Tax Liabilities, Fixed Assets And Intangible Assets",
        "documentation": "Deferred Tax Liabilities, Fixed Assets And Intangible Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DeferredTaxLiabilitiesOther": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DeferredTaxLiabilitiesOther",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails": {
       "parentTag": "us-gaap_DeferredIncomeTaxLiabilities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofDeferredTaxAssetsandLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other",
        "label": "Deferred Tax Liabilities, Other",
        "documentation": "Amount of deferred tax liability attributable to taxable temporary differences classified as other."
       }
      }
     },
     "auth_ref": [
      "r1242"
     ]
    },
    "us-gaap_DefinedContributionPlanCostRecognized": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanCostRecognized",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total matching contributions",
        "label": "Defined Contribution Plan, Cost",
        "documentation": "Amount of cost for defined contribution plan."
       }
      }
     },
     "auth_ref": [
      "r502"
     ]
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee contribution (as a percent)",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercentOfMatch": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercentOfMatch",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employer matching contribution (as a percent)",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Match",
        "documentation": "Percentage employer matches of the employee's percentage contribution matched."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum employee contribution (as a percent)",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Depreciation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Depreciation",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation expense",
        "label": "Depreciation",
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r46"
     ]
    },
    "us-gaap_DepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization, Nonproduction",
        "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r46"
     ]
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DepreciationDepletionAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depreciation and amortization",
        "label": "Depreciation, Depletion and Amortization",
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r304",
      "r316",
      "r326",
      "r915",
      "r916"
     ]
    },
    "us-gaap_DerivativeContractTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeContractTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Contract [Domain]",
        "label": "Derivative Contract [Domain]",
        "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset."
       }
      }
     },
     "auth_ref": [
      "r801",
      "r803",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r840",
      "r841",
      "r842",
      "r843",
      "r846",
      "r847",
      "r848",
      "r849",
      "r862",
      "r863",
      "r866",
      "r867",
      "r976",
      "r978",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_DerivativeInstrumentRiskAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeInstrumentRiskAxis",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Derivative Instrument [Axis]",
        "label": "Derivative Instrument [Axis]",
        "documentation": "Information by type of derivative contract."
       }
      }
     },
     "auth_ref": [
      "r66",
      "r67",
      "r68",
      "r146",
      "r801",
      "r803",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r840",
      "r841",
      "r842",
      "r843",
      "r846",
      "r847",
      "r848",
      "r849",
      "r862",
      "r863",
      "r866",
      "r867",
      "r906",
      "r976",
      "r978",
      "r1255",
      "r1256",
      "r1257",
      "r1258",
      "r1259",
      "r1260",
      "r1262",
      "r1263"
     ]
    },
    "us-gaap_DerivativeNotionalAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeNotionalAmount",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Notional amount of outstanding hedge to currency risk",
        "label": "Derivative, Notional Amount",
        "documentation": "Nominal or face amount used to calculate payment on derivative."
       }
      }
     },
     "auth_ref": [
      "r1246",
      "r1247"
     ]
    },
    "us-gaap_DerivativeTermOfContract": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DerivativeTermOfContract",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of derivative contract",
        "label": "Derivative, Term of Contract",
        "documentation": "Period the derivative contract is outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DesignatedAsHedgingInstrumentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DesignatedAsHedgingInstrumentMember",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Designated as Hedging Instrument",
        "label": "Designated as Hedging Instrument [Member]",
        "documentation": "Derivative instrument designated as hedging instrument under Generally Accepted Accounting Principles (GAAP)."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "dxcm_DevelopmentAgreementsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DevelopmentAgreementsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development Agreements [Line Items]",
        "label": "Development Agreements [Line Items]",
        "documentation": "Development Agreements [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_DevelopmentAgreementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "DevelopmentAgreementsTable",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Development Agreements [Table]",
        "label": "Development Agreements [Table]",
        "documentation": "Development Agreements [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Disaggregation of Revenue",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor."
       }
      }
     },
     "auth_ref": [
      "r1204"
     ]
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement [Abstract]",
        "label": "Share-Based Payment Arrangement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Annual Report",
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015"
     ]
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Financial Statement Error Correction [Flag]",
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015",
      "r1058"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Period Focus",
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Fiscal Year Focus",
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Transition Report",
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r1036"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Documents incorporated by reference",
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r989"
     ]
    },
    "us-gaap_DomesticCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "DomesticCountryMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Federal",
        "label": "Domestic Tax Jurisdiction [Member]",
        "documentation": "Designated federal jurisdiction entitled to levy and collect income tax in country of domicile. Includes, but is not limited to, national jurisdiction for non-U.S. jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year",
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1047"
     ]
    },
    "us-gaap_EarningsPerShareBasic": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareBasic",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Basic net income per share (in usd per share)",
        "label": "Earnings Per Share, Basic",
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r289",
      "r291",
      "r298",
      "r299",
      "r300",
      "r303",
      "r596",
      "r599",
      "r614",
      "r615",
      "r737",
      "r754",
      "r909"
     ]
    },
    "us-gaap_EarningsPerShareDiluted": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerShareDiluted",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Diluted net income per share (in usd per share)",
        "label": "Earnings Per Share, Diluted",
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r255",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r291",
      "r298",
      "r299",
      "r300",
      "r303",
      "r596",
      "r599",
      "r614",
      "r615",
      "r737",
      "r754",
      "r909"
     ]
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EarningsPerSharePolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net Income Per Share",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements."
       }
      }
     },
     "auth_ref": [
      "r30",
      "r31",
      "r302"
     ]
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effect of exchange rate changes on cash, cash equivalents and restricted cash",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations",
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates."
       }
      }
     },
     "auth_ref": [
      "r630"
     ]
    },
    "dxcm_EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaboration agreement milestone share-based payment",
        "label": "Effective Income Tax Rate Reconciliation, Collaboration Agreement Milestone, Share-based Payment",
        "documentation": "Effective Income Tax Rate Reconciliation, Collaboration Agreement Milestone, Share-based Payment"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intellectual property transfer",
        "label": "Effective Income Tax Rate Reconciliation, Intellectual Property Transfer",
        "documentation": "Effective Income Tax Rate Reconciliation, Intellectual Property Transfer"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EffectiveIncomeTaxReconciliationPermanentItems": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EffectiveIncomeTaxReconciliationPermanentItems",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Permanent items",
        "label": "Effective Income Tax Reconciliation, Permanent Items",
        "documentation": "Effective Income Tax Reconciliation, Permanent Items"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EmployeePurchasePriceFloorPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EmployeePurchasePriceFloorPercentage",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee purchase price floor (as a percent)",
        "label": "Employee Purchase Price Floor Percentage",
        "documentation": "Employee purchase price floor, percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedPayrollandRelatedExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and related expenses",
        "totalLabel": "Total accrued payroll and related expenses",
        "label": "Employee-related Liabilities, Current",
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation costs recognized weighted average period (in years)",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r539"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized compensation costs related to unvested restricted stock units",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r1233"
     ]
    },
    "us-gaap_EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total tax benefit related to share-based compensation expense",
        "label": "Share-Based Payment Arrangement, Expense, Tax Benefit",
        "documentation": "Amount of tax benefit for recognition of expense of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r538"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Option",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EmployeeStockPurchasePlan2015Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EmployeeStockPurchasePlan2015Member",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ESPP 2015",
        "label": "Employee Stock Purchase Plan 2015 [Member]",
        "documentation": "Employee Stock Purchase Plan 2015"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock authorized in ESPP (in shares)",
        "label": "Employee Stock Purchase Plan (ESPP), Number of Shares Authorized",
        "documentation": "Employee Stock Purchase Plan (ESPP), Number of Shares Authorized"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EmployeeStockPurchasePlanMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EmployeeStockPurchasePlanMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Employee Stock Purchase Plan",
        "label": "Employee Stock Purchase Plan [Member]",
        "documentation": "Employee Stock Purchase Plan [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Common Stock, Shares Outstanding",
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Current Reporting Status",
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Filer Category",
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Interactive Data Current",
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r1098"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Public Float",
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Shell Company",
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Small Business",
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r988"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Voluntary Filers",
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Well-known Seasoned Issuer",
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r1099"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Footnote",
        "label": "Equity Awards Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table",
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Awards Adjustments",
        "label": "Equity Awards Adjustments [Member]"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table",
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]"
       }
      }
     },
     "auth_ref": [
      "r1094"
     ]
    },
    "us-gaap_EquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquipmentMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_EquipmentOfficeAndFacilityExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EquipmentOfficeAndFacilityExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equipment, office &amp; facility expenses",
        "label": "Equipment, Office And Facility Expenses",
        "documentation": "Equipment, Office And Facility Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquityComponentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquityComponentDomain",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Component [Domain]",
        "label": "Equity Component [Domain]",
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r219",
      "r251",
      "r252",
      "r253",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r286",
      "r288",
      "r305",
      "r376",
      "r377",
      "r414",
      "r481",
      "r586",
      "r587",
      "r593",
      "r594",
      "r595",
      "r597",
      "r598",
      "r599",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r639",
      "r642",
      "r664",
      "r750",
      "r767",
      "r768",
      "r769",
      "r786",
      "r852"
     ]
    },
    "dxcm_EquityIncentivePlan2015Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "EquityIncentivePlan2015Member",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "EIP 2015",
        "label": "Equity Incentive Plan 2015 [Member]",
        "documentation": "Equity Incentive Plan 2015"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_EquitySecuritiesWithoutReadilyDeterminableFairValueAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EquitySecuritiesWithoutReadilyDeterminableFairValueAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Carrying values of investments",
        "label": "Equity Securities without Readily Determinable Fair Value, Amount",
        "documentation": "Amount of investment in equity security without readily determinable fair value."
       }
      }
     },
     "auth_ref": [
      "r374"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Valuation Assumption Difference, Footnote",
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1051"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneous Compensation Analysis",
        "label": "Erroneous Compensation Analysis [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1008",
      "r1019",
      "r1029",
      "r1062"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Erroneously Awarded Compensation Recovery",
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1016",
      "r1026",
      "r1059"
     ]
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Executive Category:",
        "label": "Executive Category [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r618",
      "r625",
      "r943"
     ]
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r617",
      "r618",
      "r625",
      "r943"
     ]
    },
    "dxcm_FairValueAssetsLevel3TransfersAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "FairValueAssetsLevel3TransfersAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Transfers in or out of Level 3 securities",
        "label": "Fair Value, Assets, Level 3 Transfers, Amount",
        "documentation": "Fair Value, Assets, Level 3 Transfers, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value Hierarchy for Financial Assets",
        "label": "Fair Value, Assets Measured on Recurring Basis [Table Text Block]",
        "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3)."
       }
      }
     },
     "auth_ref": [
      "r1250",
      "r1251"
     ]
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r616",
      "r618",
      "r619",
      "r620",
      "r621",
      "r624",
      "r625",
      "r627",
      "r669",
      "r670",
      "r671",
      "r925",
      "r926",
      "r934",
      "r935",
      "r936",
      "r943",
      "r948"
     ]
    },
    "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Fair Value of Senior Convertible Notes",
        "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table Text Block]",
        "documentation": "Tabular disclosure of information about fair value of asset and liability not measured at fair value."
       }
      }
     },
     "auth_ref": [
      "r624"
     ]
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueDisclosuresAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Disclosures [Abstract]",
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel1Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level 1",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r496",
      "r501",
      "r618",
      "r625",
      "r669",
      "r934",
      "r935",
      "r936",
      "r943"
     ]
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel2Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a02",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r496",
      "r501",
      "r618",
      "r619",
      "r625",
      "r670",
      "r925",
      "r926",
      "r934",
      "r935",
      "r936",
      "r943"
     ]
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueInputsLevel3Member",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Level\u00a03",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r618",
      "r619",
      "r620",
      "r621",
      "r625",
      "r671",
      "r925",
      "r926",
      "r934",
      "r935",
      "r936",
      "r943",
      "r948"
     ]
    },
    "us-gaap_FairValueMeasurementInputsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementInputsDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement and Measurement Inputs, Recurring and Nonrecurring [Text Block]",
        "documentation": "The entire disclosure of the fair value measurement of assets and liabilities, which includes financial instruments measured at fair value that are classified in shareholders' equity, which may be measured on a recurring or nonrecurring basis."
       }
      }
     },
     "auth_ref": [
      "r147"
     ]
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Measurements",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value."
       }
      }
     },
     "auth_ref": [
      "r458",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r616",
      "r618",
      "r619",
      "r620",
      "r621",
      "r624",
      "r625",
      "r627",
      "r669",
      "r670",
      "r671",
      "r925",
      "r926",
      "r934",
      "r935",
      "r936",
      "r943",
      "r948"
     ]
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest on lease liabilities",
        "label": "Finance Lease, Interest Expense",
        "documentation": "Amount of interest expense on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r646",
      "r653",
      "r956"
     ]
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from finance leases",
        "label": "Finance Lease, Interest Payment on Liability",
        "documentation": "Amount of interest paid on finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r648",
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Leases",
        "label": "Finance Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Present value of future payments",
        "label": "Finance Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease."
       }
      }
     },
     "auth_ref": [
      "r644",
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityAbstract",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease cost:",
        "label": "Finance Lease, Liability [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Current portion",
        "label": "Finance Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes current finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturity of Finance Lease Liabilities",
        "label": "Finance Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1274"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance lease obligations",
        "verboseLabel": "Long-term portion",
        "label": "Finance Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "label": "Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of financial position that includes noncurrent finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r645"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future lease cost",
        "label": "Finance Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Imputed interest",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeasePrincipalPayments",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing cash flows from finance leases",
        "label": "Finance Lease, Principal Payments",
        "documentation": "Amount of cash outflow for principal payment on finance lease."
       }
      }
     },
     "auth_ref": [
      "r647",
      "r657"
     ]
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of right-of-use assets",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r646",
      "r653",
      "r956"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate of finance leases (as a percent)",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for finance lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r956"
     ]
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term of finance leases (in years)",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r956"
     ]
    },
    "us-gaap_FinancialInstrumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FinancialInstrumentAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instrument [Axis]",
        "label": "Financial Instrument [Axis]",
        "documentation": "Information by type of financial instrument."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r379",
      "r380",
      "r383",
      "r384",
      "r385",
      "r387",
      "r388",
      "r389",
      "r469",
      "r478",
      "r612",
      "r628",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r751",
      "r921",
      "r943",
      "r946",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r958",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1249",
      "r1252",
      "r1253",
      "r1254",
      "r1261",
      "r1264"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible asset, useful life (in years)",
        "verboseLabel": "Weighted Average Useful Life (in years)",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Accumulated Amortization",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r229",
      "r396",
      "r407",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, after Year Five",
        "documentation": "Amount of amortization for asset, excluding financial asset and goodwill, lacking physical substance with finite life expected to be recognized after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r1182",
      "r1330"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets Amortization Expense",
        "label": "Finite-Lived Intangible Assets Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of amortization expense of assets, excluding financial assets, that lack physical substance, having a limited useful life."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFive",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Five",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r409",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "documentation": "Information by major type or class of finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r411",
      "r702",
      "r703",
      "r894"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsGross",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails": {
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Gross Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Gross",
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r396",
      "r407",
      "r703",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r407",
      "r410",
      "r411",
      "r413",
      "r702",
      "r894",
      "r923"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r403",
      "r404",
      "r405",
      "r406",
      "r407",
      "r410",
      "r411",
      "r894"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net Carrying Amount",
        "label": "Finite-Lived Intangible Assets, Net",
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life."
       }
      }
     },
     "auth_ref": [
      "r702",
      "r1181"
     ]
    },
    "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization period (in months)",
        "label": "Finite-Lived Intangible Assets, Remaining Amortization Period",
        "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r702"
     ]
    },
    "us-gaap_ForeignCountryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignCountryMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Foreign",
        "label": "Foreign Tax Jurisdiction [Member]",
        "documentation": "Designated foreign jurisdiction entitled to levy and collect income tax outside country of domicile."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r560"
     ]
    },
    "us-gaap_ForeignExchangeForwardMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ForeignExchangeForwardMember",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign Exchange Forward",
        "label": "Foreign Exchange Forward [Member]",
        "documentation": "Foreign exchange forward traded on an exchange (examples include but are not limited to the International Securities Exchange, Philadelphia Stock Exchange, or the Chicago Mercantile Exchange) for options or future contracts to buy or sell a certain currency, at a specified date, at a fixed exercise exchange rate."
       }
      }
     },
     "auth_ref": [
      "r818",
      "r823",
      "r828",
      "r842",
      "r848",
      "r864",
      "r865",
      "r866",
      "r978"
     ]
    },
    "dxcm_ForeignTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ForeignTaxCreditsMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign tax credits",
        "label": "Foreign Tax Credits [Member]",
        "documentation": "Foreign Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1066"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount",
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1066"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1066"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forgone Recovery, Explanation of Impracticability",
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1066"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1066"
     ]
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year",
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1046"
     ]
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "FurnitureAndFixturesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Furniture and fixtures",
        "label": "Furniture and Fixtures [Member]",
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases."
       }
      }
     },
     "auth_ref": []
    },
    "country_GB": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "GB",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "UK",
        "label": "UNITED KINGDOM"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Loss on disposal of machinery and equipment",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "us-gaap_Goodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Goodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill",
        "label": "Goodwill",
        "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r228",
      "r397",
      "r734",
      "r916",
      "r922",
      "r945",
      "r957",
      "r1171",
      "r1172"
     ]
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill and Intangible Assets and Other Long-Lived Assets",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets."
       }
      }
     },
     "auth_ref": [
      "r1170",
      "r1173"
     ]
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GoodwillImpairmentLoss",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Goodwill impairment charges",
        "label": "Goodwill, Impairment Loss",
        "documentation": "Amount of impairment loss from asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r398",
      "r399",
      "r400",
      "r922",
      "r945"
     ]
    },
    "us-gaap_GrossProfit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "GrossProfit",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Gross profit",
        "label": "Gross Profit",
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity."
       }
      }
     },
     "auth_ref": [
      "r102",
      "r106",
      "r163",
      "r265",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r629",
      "r911",
      "r915",
      "r1144",
      "r1146",
      "r1147",
      "r1148",
      "r1149",
      "r1200"
     ]
    },
    "us-gaap_HedgingDesignationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationAxis",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Axis]",
        "label": "Hedging Designation [Axis]",
        "documentation": "Information by designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r605"
     ]
    },
    "us-gaap_HedgingDesignationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "HedgingDesignationDomain",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Hedging Designation [Domain]",
        "label": "Hedging Designation [Domain]",
        "documentation": "Designation of purpose of derivative instrument."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "country_IE": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "IE",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Ireland",
        "label": "IRELAND"
       }
      }
     },
     "auth_ref": []
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "ICFR Auditor Attestation Flag",
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r991",
      "r992",
      "r1015"
     ]
    },
    "dxcm_ImpairedLongLivedAssetsFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ImpairedLongLivedAssetsFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of impaired long-lived asset",
        "label": "Impaired Long-Lived Assets, Fair Value",
        "documentation": "Impaired Long-Lived Assets, Fair Value"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration": {
     "xbrltype": "enumerationSetItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "label": "Impairment, Long-Lived Asset, Held-for-Use, Statement of Income or Comprehensive Income [Extensible Enumeration]",
        "documentation": "Indicates line item in statement of income or comprehensive income that includes impairment of long-lived asset held for use."
       }
      }
     },
     "auth_ref": [
      "r415"
     ]
    },
    "us-gaap_ImpairmentOfIntangibleAssetsExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfIntangibleAssetsExcludingGoodwill",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible asset impairment charges",
        "label": "Impairment of Intangible Assets (Excluding Goodwill)",
        "documentation": "The amount of impairment loss recognized in the period resulting from the write-down of the carrying amount of an intangible asset (excluding goodwill) to fair value."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r402",
      "r412"
     ]
    },
    "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ImpairmentOfLongLivedAssetsHeldForUse",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsNarrativeDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Impairment losses",
        "label": "Impairment, Long-Lived Asset, Held-for-Use",
        "documentation": "The aggregate amount of write-downs for impairments recognized during the period for long lived assets held for use (including those held for disposal by means other than sale)."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r45",
      "r127",
      "r944"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Domestic",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to domestic operations."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r558"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Income before income taxes",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r103",
      "r158",
      "r163",
      "r738",
      "r748",
      "r911",
      "r915",
      "r1144",
      "r1146",
      "r1147",
      "r1148",
      "r1149"
     ]
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofIncomeLossbeforeIncomeTaxesSubjecttoTaxesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outside of the United States",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Foreign",
        "documentation": "The portion of earnings or loss from continuing operations before income taxes that is attributable to foreign operations, which is defined as Income or Loss generated from operations located outside the entity's country of domicile."
       }
      }
     },
     "auth_ref": [
      "r266",
      "r558"
     ]
    },
    "us-gaap_IncomeStatementAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Statement [Abstract]",
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationAxis",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis]",
        "label": "Statement of Income Location, Balance [Axis]",
        "documentation": "Information by location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r416",
      "r422",
      "r425",
      "r622",
      "r623",
      "r626",
      "r764",
      "r766",
      "r837",
      "r894",
      "r947",
      "r1291"
     ]
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeStatementLocationDomain",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain]",
        "label": "Statement of Income Location, Balance [Domain]",
        "documentation": "Location in statement of income where disaggregated amount has been reported."
       }
      }
     },
     "auth_ref": [
      "r422",
      "r425",
      "r622",
      "r623",
      "r626",
      "r764",
      "r766",
      "r837",
      "r894",
      "r947",
      "r1291"
     ]
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityAxis",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Axis]",
        "label": "Income Tax Jurisdiction [Axis]",
        "documentation": "Information by income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r559",
      "r560",
      "r569",
      "r582",
      "r942",
      "r1241"
     ]
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxAuthorityDomain",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Jurisdiction [Domain]",
        "label": "Income Tax Jurisdiction [Domain]",
        "documentation": "Income tax jurisdiction."
       }
      }
     },
     "auth_ref": [
      "r262",
      "r559",
      "r560",
      "r569",
      "r582",
      "r942",
      "r1241"
     ]
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Tax Disclosure [Abstract]",
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxes"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax Disclosure [Text Block]",
        "documentation": "The entire disclosure for income tax."
       }
      }
     },
     "auth_ref": [
      "r267",
      "r549",
      "r559",
      "r566",
      "r567",
      "r568",
      "r574",
      "r581",
      "r588",
      "r590",
      "r591",
      "r592",
      "r784",
      "r942"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefit",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofComponentsofIncomeTaxExpenseBenefitDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax expense",
        "totalLabel": "Income taxes at effective rates",
        "label": "Income Tax Expense (Benefit)",
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations."
       }
      }
     },
     "auth_ref": [
      "r166",
      "r180",
      "r287",
      "r288",
      "r304",
      "r317",
      "r326",
      "r557",
      "r559",
      "r589",
      "r755",
      "r942"
     ]
    },
    "us-gaap_IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxExpenseBenefitContinuingOperationsIncomeTaxReconciliationAbstract",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Effective Income Tax Rate Reconciliation, Amount [Abstract]",
        "label": "Income Tax Expense (Benefit), Effective Income Tax Rate Reconciliation, Amount [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Taxes",
        "label": "Income Tax, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements."
       }
      }
     },
     "auth_ref": [
      "r250",
      "r553",
      "r554",
      "r574",
      "r575",
      "r580",
      "r584",
      "r778"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in valuation allowance",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to increase (decrease) in the valuation allowance for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r565",
      "r942",
      "r1234"
     ]
    },
    "us-gaap_IncomeTaxReconciliationChangeInEnactedTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationChangeInEnactedTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Change in statutory tax rates",
        "label": "Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations, attributable to increase (decrease) in the income tax rates."
       }
      }
     },
     "auth_ref": [
      "r552",
      "r559",
      "r564",
      "r942"
     ]
    },
    "us-gaap_IncomeTaxReconciliationForeignIncomeTaxRateDifferential": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationForeignIncomeTaxRateDifferential",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Foreign rate differential",
        "label": "Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r560",
      "r563",
      "r942",
      "r1234"
     ]
    },
    "us-gaap_IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. federal statutory tax rate",
        "label": "Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount",
        "documentation": "The amount of income tax expense or benefit for the period computed by applying the domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r559",
      "r942"
     ]
    },
    "us-gaap_IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock and officers compensation",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Amount",
        "documentation": "Amount of reported income tax expense (benefit) in excess of (less than) expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for award under share-based payment arrangement. Includes, but is not limited to, expense determined to be nondeductible upon grant or after for award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r1234",
      "r1236"
     ]
    },
    "us-gaap_IncomeTaxReconciliationOtherAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationOtherAdjustments",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r1234",
      "r1235"
     ]
    },
    "us-gaap_IncomeTaxReconciliationStateAndLocalIncomeTaxes": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationStateAndLocalIncomeTaxes",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State income tax, net of federal benefit",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to state and local income tax expense (benefit)."
       }
      }
     },
     "auth_ref": [
      "r562",
      "r942",
      "r1234"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsForeign": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsForeign",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Foreign tax credit",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to foreign tax credit."
       }
      }
     },
     "auth_ref": [
      "r1234",
      "r1236"
     ]
    },
    "us-gaap_IncomeTaxReconciliationTaxCreditsResearch": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxReconciliationTaxCreditsResearch",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails": {
       "parentTag": "us-gaap_IncomeTaxExpenseBenefit",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofReconciliationbetweenEffectiveTaxRateandStatutoryRateDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development credits",
        "negatedTerseLabel": "Research and development credits",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount",
        "documentation": "Amount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit."
       }
      }
     },
     "auth_ref": [
      "r942",
      "r1234",
      "r1236"
     ]
    },
    "us-gaap_IncomeTaxesPaid": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesPaid",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the year for income taxes",
        "label": "Income Taxes Paid",
        "documentation": "Amount, before refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax."
       }
      }
     },
     "auth_ref": [
      "r26",
      "r120",
      "r1131",
      "r1239",
      "r1240"
     ]
    },
    "us-gaap_IncomeTaxesReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncomeTaxesReceivable",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income tax receivables",
        "label": "Income Taxes Receivable, Current",
        "documentation": "Carrying amount due within one year of the balance sheet date (or one operating cycle, if longer) from tax authorities as of the balance sheet date representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes."
       }
      }
     },
     "auth_ref": [
      "r149",
      "r1120"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts payable and accrued liabilities",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Accounts receivable, net",
        "label": "Increase (Decrease) in Accounts Receivable",
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accrued payroll and related expenses",
        "label": "Increase (Decrease) in Employee Related Liabilities",
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInInventories",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Inventory",
        "label": "Increase (Decrease) in Inventories",
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Changes in operating assets and liabilities:",
        "label": "Increase (Decrease) in Operating Capital [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncreaseDecreaseInOtherDeferredLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInOtherDeferredLiability",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 13.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Deferred revenue and other liabilities",
        "label": "Increase (Decrease) in Other Deferred Liability",
        "documentation": "Amount of increase (decrease) in deferred obligations classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Prepaid and other assets",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_IncreaseDecreaseInTreasuryStockRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "IncreaseDecreaseInTreasuryStockRollForward",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increase (Decrease) In Treasury Stock [Roll Forward]",
        "label": "Increase (Decrease) In Treasury Stock [Roll Forward]",
        "documentation": "Increase (Decrease) In Treasury Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Operating lease right-of-use assets and liabilities, net",
        "label": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net",
        "documentation": "Increase (Decrease) in Operating Lease Assets and Liabilities, Net"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dilutive potential securities (in shares)",
        "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements",
        "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method."
       }
      }
     },
     "auth_ref": [
      "r292",
      "r293",
      "r294",
      "r300",
      "r508"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Individual:",
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1057",
      "r1066",
      "r1070",
      "r1078"
     ]
    },
    "us-gaap_InformationTechnologyAndDataProcessing": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InformationTechnologyAndDataProcessing",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "IT software and data",
        "label": "Information Technology and Data Processing",
        "documentation": "The amount of expenses incurred in the period for information technology and data processing products and services."
       }
      }
     },
     "auth_ref": [
      "r109"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Adopted",
        "label": "Insider Trading Policies and Procedures Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted",
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r993",
      "r1082"
     ]
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangibles, net",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r1181",
      "r1183"
     ]
    },
    "us-gaap_InterestExpenseDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total interest expense recognized on senior notes",
        "label": "Interest Expense, Debt",
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r464",
      "r472",
      "r927",
      "r928"
     ]
    },
    "us-gaap_InterestExpenseDebtExcludingAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseDebtExcludingAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails": {
       "parentTag": "us-gaap_InterestExpenseDebt",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contractual coupon interest",
        "label": "Interest Expense, Debt, Excluding Amortization",
        "documentation": "Represents the portion of interest incurred in the period on debt arrangements that was charged against earnings, excluding amortization of debt discount (premium) and financing costs."
       }
      }
     },
     "auth_ref": [
      "r112",
      "r465",
      "r927",
      "r928"
     ]
    },
    "us-gaap_InterestExpenseNonoperating": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestExpenseNonoperating",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Interest expense",
        "label": "Interest Expense, Nonoperating",
        "documentation": "Amount of interest expense classified as nonoperating."
       }
      }
     },
     "auth_ref": [
      "r315",
      "r1127"
     ]
    },
    "us-gaap_InterestIncomeAndInterestExpenseDisclosureTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestIncomeAndInterestExpenseDisclosureTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Interest Expense and Effective Interest Rates of Senior Convertible Notes",
        "label": "Interest Income and Interest Expense Disclosure [Table Text Block]",
        "documentation": "Tabular disclosure of interest income and expense, including, but not limited to, interest income and expense from investments, loans, and securities."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InterestOnConvertibleDebtNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestOnConvertibleDebtNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes",
        "label": "Interest on Convertible Debt, Net of Tax",
        "documentation": "Amount, after tax, of interest recognized on convertible debt instrument excluding interest on principal required to be paid in cash."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r296",
      "r300"
     ]
    },
    "us-gaap_InterestPaidNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InterestPaidNet",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cash paid during the year for interest",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount."
       }
      }
     },
     "auth_ref": [
      "r258",
      "r260",
      "r261"
     ]
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryDisclosureAbstract",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory Disclosure [Abstract]",
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Finished goods",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r901"
     ]
    },
    "us-gaap_InventoryNet": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryNet",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "totalLabel": "Total inventory",
        "label": "Inventory, Net",
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r239",
      "r899",
      "r957"
     ]
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory",
        "label": "Inventory, Policy [Policy Text Block]",
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost."
       }
      }
     },
     "auth_ref": [
      "r167",
      "r224",
      "r238",
      "r390",
      "r391",
      "r393",
      "r700",
      "r908"
     ]
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryRawMaterialsNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Raw materials",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r903"
     ]
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWorkInProcessNetOfReserves",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails": {
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofInventoryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Work-in-process",
        "label": "Inventory, Work in Process, Net of Reserves",
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing."
       }
      }
     },
     "auth_ref": [
      "r125",
      "r902"
     ]
    },
    "us-gaap_InventoryWriteDown": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InventoryWriteDown",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Inventory write-down",
        "label": "Inventory Write-down",
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels."
       }
      }
     },
     "auth_ref": [
      "r392"
     ]
    },
    "us-gaap_InvestmentIncomeInterestAndDividend": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "InvestmentIncomeInterestAndDividend",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Interest and dividend income",
        "label": "Investment Income, Interest and Dividend",
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income and dividend income on nonoperating securities."
       }
      }
     },
     "auth_ref": [
      "r110",
      "r111"
     ]
    },
    "dxcm_JPMWarrantTransactionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "JPMWarrantTransactionsMember",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "JPM Warrant Transactions",
        "label": "JPM Warrant Transactions [Member]",
        "documentation": "JPM Warrant Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LandMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LandMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Land and land improvements",
        "label": "Land [Member]",
        "documentation": "Part of earth's surface not covered by water."
       }
      }
     },
     "auth_ref": [
      "r1205"
     ]
    },
    "us-gaap_LeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total lease cost",
        "label": "Lease, Cost",
        "documentation": "Amount of lease cost recognized by lessee for lease contract."
       }
      }
     },
     "auth_ref": [
      "r652",
      "r956"
     ]
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseCostTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Lease Expense and Other Information",
        "label": "Lease, Cost [Table Text Block]",
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income."
       }
      }
     },
     "auth_ref": [
      "r1273"
     ]
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeaseholdImprovementsMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Leasehold improvements",
        "label": "Leasehold Improvements [Member]",
        "documentation": "Additions or improvements to assets held under a lease arrangement."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r662"
     ]
    },
    "us-gaap_LeasesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LeasesAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases [Abstract]",
        "label": "Leases [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LegalMattersAndContingenciesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LegalMattersAndContingenciesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/Contingencies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Contingencies",
        "label": "Legal Matters and Contingencies [Text Block]",
        "documentation": "The entire disclosure for legal proceedings, legal contingencies, litigation, regulatory and environmental matters and other contingencies."
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeFinanceLeasesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases and Other Commitments",
        "label": "Lessee, Finance Leases [Text Block]",
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionLineItems",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Line Items]",
        "label": "Lessee, Lease, Description [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r663"
     ]
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeaseDescriptionTable",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Lessee, Lease, Description [Table]",
        "label": "Lessee, Lease, Description [Table]",
        "documentation": "Disclosure of information about lessee's leases."
       }
      }
     },
     "auth_ref": [
      "r651",
      "r663"
     ]
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeLeasesPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases",
        "label": "Lessee, Leases [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee."
       }
      }
     },
     "auth_ref": [
      "r650"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Maturity of Operating Lease Liabilities",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block]",
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position."
       }
      }
     },
     "auth_ref": [
      "r1274"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      },
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total future lease cost",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Thereafter",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2025",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2029",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2028",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2027",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails_1": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "2026",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: Imputed interest",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease."
       }
      }
     },
     "auth_ref": [
      "r661"
     ]
    },
    "dxcm_LesseeOperatingLeaseNumberOfOptionsToExtend": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "LesseeOperatingLeaseNumberOfOptionsToExtend",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of options to extend (in extension options)",
        "label": "Lessee, Operating Lease, Number Of Options To Extend",
        "documentation": "Lessee, Operating Lease, Number Of Options To Extend"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRemainingLeaseTerm",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Remaining lease terms (in years)",
        "label": "Lessee, Operating Lease, Remaining Lease Term",
        "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r663",
      "r1271"
     ]
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Renewal term (in years)",
        "label": "Lessee, Operating Lease, Renewal Term",
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r1272"
     ]
    },
    "dxcm_LesseeOperatingLeasesLeaseCostAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "LesseeOperatingLeasesLeaseCostAmortization",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amortization of operating lease right-of-use asset",
        "label": "Lessee, Operating Leases, Lease Cost, Amortization",
        "documentation": "Lessee, Operating Leases, Lease Cost, Amortization"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LesseeOperatingLeasesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitments"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Leases and Other Commitments",
        "label": "Lessee, Operating Leases [Text Block]",
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r641"
     ]
    },
    "us-gaap_LetterOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LetterOfCreditMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Letter of Credit",
        "label": "Letter of Credit [Member]",
        "documentation": "A document typically issued by a financial institution which acts as a guarantee of payment to a beneficiary, or as the source of payment for a specific transaction (for example, wiring funds to a foreign exporter if and when specified merchandise is accepted pursuant to the terms of the letter of credit)."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LettersOfCreditOutstandingAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LettersOfCreditOutstandingAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding letters of credit",
        "label": "Letters of Credit Outstanding, Amount",
        "documentation": "The total amount of the contingent obligation under letters of credit outstanding as of the reporting date."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_Liabilities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "Liabilities",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities",
        "label": "Liabilities",
        "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r77",
      "r78",
      "r79",
      "r83",
      "r84",
      "r85",
      "r88",
      "r265",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r602",
      "r603",
      "r604",
      "r629",
      "r810",
      "r910",
      "r986",
      "r1200",
      "r1275",
      "r1276"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquity",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total liabilities and stockholders\u2019 equity",
        "label": "Liabilities and Equity",
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any."
       }
      }
     },
     "auth_ref": [
      "r96",
      "r157",
      "r745",
      "r957",
      "r1135",
      "r1169",
      "r1266"
     ]
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Liabilities and Stockholders\u2019 Equity",
        "label": "Liabilities and Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total current liabilities",
        "label": "Liabilities, Current",
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r79",
      "r223",
      "r265",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r602",
      "r603",
      "r604",
      "r629",
      "r957",
      "r1200",
      "r1275",
      "r1276"
     ]
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LiabilitiesCurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Current liabilities:",
        "label": "Liabilities, Current [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCredit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCredit",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding borrowings",
        "label": "Long-Term Line of Credit",
        "documentation": "The carrying value as of the balance sheet date of the current and noncurrent portions of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r155",
      "r1286"
     ]
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityLineItems",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Line Items]",
        "label": "Line of Credit Facility [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r434",
      "r1134",
      "r1198"
     ]
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Available principal amount and letters of credit sub-facility",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r82"
     ]
    },
    "dxcm_LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Option to increase revolving line of credit",
        "label": "Line Of Credit Facility, Maximum Borrowing Capacity, Option To Increase, Amount",
        "documentation": "Line of Credit Facility, Maximum Borrowing Capacity, Option to Increase, Amount"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityRemainingBorrowingCapacity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total available balance",
        "label": "Line of Credit Facility, Remaining Borrowing Capacity",
        "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding)."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r82",
      "r434"
     ]
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityTable",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit Facility [Table]",
        "label": "Line of Credit Facility [Table]",
        "documentation": "Disclosure of information about short-term and long-term contractual arrangements with lender under which borrowing can occur up to maximum amount. Includes, but is not limited to, letter of credit, standby letter of credit, and revolving credit arrangement."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r82",
      "r434",
      "r1134",
      "r1198"
     ]
    },
    "us-gaap_LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unused capacity fee (as a percent)",
        "label": "Line of Credit Facility, Unused Capacity, Commitment Fee Percentage",
        "documentation": "The fee, expressed as a percentage of the line of credit facility, for available but unused credit capacity under the credit facility."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LineOfCreditMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LineOfCreditMember",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Line of Credit",
        "label": "Line of Credit [Member]",
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_LondonInterbankOfferedRateLIBOR1Member": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "LondonInterbankOfferedRateLIBOR1Member",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "London Interbank Offered Rate (LIBOR)",
        "label": "London Interbank Offered Rate (LIBOR) 1 [Member]",
        "documentation": "London Interbank Offered Rate (LIBOR) 1"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_LongTermDeposits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "LongTermDeposits",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term deposits",
        "label": "Long -Term Deposits",
        "documentation": "Long -Term Deposits"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_LongTermInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongTermInvestments",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-marketable equity securities",
        "label": "Long-Term Investments",
        "documentation": "The total amount of investments that are intended to be held for an extended period of time (longer than one operating cycle)."
       }
      }
     },
     "auth_ref": [
      "r226"
     ]
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Axis]",
        "label": "Long-Term Debt, Type [Axis]",
        "documentation": "Information by type of long-term debt."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r1189",
      "r1190",
      "r1191"
     ]
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "LongtermDebtTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtRevolvingCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term Debt, Type [Domain]",
        "label": "Long-Term Debt, Type [Domain]",
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer."
       }
      }
     },
     "auth_ref": [
      "r15",
      "r48",
      "r1189",
      "r1190",
      "r1191"
     ]
    },
    "country_MY": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "MY",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Malaysia",
        "label": "MALAYSIA"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MachineryAndEquipmentMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Machinery and equipment",
        "label": "Machinery and Equipment [Member]",
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment."
       }
      }
     },
     "auth_ref": []
    },
    "srt_MajorCustomersAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MajorCustomersAxis",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Axis]",
        "label": "Customer [Axis]",
        "documentation": "Information by name or description of a single external customer or a group of external customers."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r932",
      "r968",
      "r972",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "us-gaap_MarketableSecuritiesPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketableSecuritiesPolicy",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketable Securities",
        "label": "Marketable Securities, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for investment classified as marketable security."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "us-gaap_MarketingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MarketingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 9.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Marketing expense",
        "label": "Marketing Expense",
        "documentation": "Expenditures for planning and executing the conception, pricing, promotion, and distribution of ideas, goods, and services. Costs of public relations and corporate promotions are typically considered to be marketing costs."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "dxcm_MaturityThresholdOfInvestmentsClassifiedToCashEquivalents": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "MaturityThresholdOfInvestmentsClassifiedToCashEquivalents",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maturity threshold of investments classified to cash equivalents",
        "label": "Maturity Threshold Of Investments Classified To Cash Equivalents",
        "documentation": "Maturity Threshold Of Investments Classified To Cash Equivalents"
       }
      }
     },
     "auth_ref": []
    },
    "srt_MaximumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MaximumMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum",
        "label": "Maximum [Member]",
        "documentation": "Upper limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r188",
      "r190",
      "r191",
      "r193",
      "r217",
      "r218",
      "r427",
      "r428",
      "r429",
      "r430",
      "r503",
      "r545",
      "r621",
      "r698",
      "r763",
      "r765",
      "r773",
      "r802",
      "r803",
      "r855",
      "r857",
      "r859",
      "r860",
      "r868",
      "r892",
      "r893",
      "r920",
      "r929",
      "r937",
      "r948",
      "r949",
      "r953",
      "r954",
      "r969",
      "r1202",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282"
     ]
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Measure:",
        "label": "Measure [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Measure Name"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "srt_MinimumMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "MinimumMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Minimum",
        "label": "Minimum [Member]",
        "documentation": "Lower limit of the provided range."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r188",
      "r190",
      "r191",
      "r193",
      "r217",
      "r218",
      "r427",
      "r428",
      "r429",
      "r430",
      "r503",
      "r545",
      "r621",
      "r698",
      "r763",
      "r765",
      "r773",
      "r802",
      "r803",
      "r855",
      "r857",
      "r859",
      "r860",
      "r868",
      "r892",
      "r893",
      "r920",
      "r929",
      "r937",
      "r948",
      "r949",
      "r953",
      "r969",
      "r1202",
      "r1277",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "MNPI Disclosure Timed for Compensation Value",
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1069"
     ]
    },
    "us-gaap_MovementInStandardProductWarrantyAccrualRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "MovementInStandardProductWarrantyAccrualRollForward",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "label": "Movement in Standard Product Warranty Accrual [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Material Terms of Trading Arrangement",
        "label": "Material Terms of Trading Arrangement [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "srt_NameOfMajorCustomerDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "NameOfMajorCustomerDomain",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Customer [Domain]",
        "label": "Customer [Domain]",
        "documentation": "Single external customer or group of external customers."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r932",
      "r968",
      "r972",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Named Executive Officers, Footnote",
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financing activities",
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash used in investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets."
       }
      }
     },
     "auth_ref": [
      "r259"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Investing activities",
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net cash provided by operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities."
       }
      }
     },
     "auth_ref": [
      "r118",
      "r119",
      "r121"
     ]
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating activities",
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": "us-gaap_NetIncomeLossAttributableToParentDiluted",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income",
        "terseLabel": "Net income",
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r107",
      "r121",
      "r159",
      "r221",
      "r245",
      "r248",
      "r253",
      "r265",
      "r278",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r287",
      "r288",
      "r297",
      "r375",
      "r435",
      "r436",
      "r437",
      "r438",
      "r439",
      "r440",
      "r441",
      "r442",
      "r443",
      "r596",
      "r599",
      "r615",
      "r629",
      "r749",
      "r833",
      "r850",
      "r851",
      "r984",
      "r1200"
     ]
    },
    "us-gaap_NetIncomeLossAttributableToParentDiluted": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLossAttributableToParentDiluted",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Net income - diluted",
        "label": "Net Income (Loss) Attributable to Parent, Diluted",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent, and includes adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recent Accounting Guidance",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_NonCashInterestExpenseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "NonCashInterestExpenseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofComponentsofInterestExpenseandEffectiveInterestRatesofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense:",
        "label": "Non-Cash Interest Expense [Abstract]",
        "documentation": "Non-Cash Interest Expense"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-GAAP Measure Description",
        "label": "Non-GAAP Measure Description [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-NEOs",
        "label": "Non-NEOs [Member]"
       }
      }
     },
     "auth_ref": [
      "r1012",
      "r1023",
      "r1033",
      "r1057",
      "r1066"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount",
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-PEO NEO",
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted",
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated",
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "us-gaap_NonUsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NonUsMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "International",
        "label": "Non-US [Member]",
        "documentation": "Countries excluding the United States of America (US)."
       }
      }
     },
     "auth_ref": [
      "r1326",
      "r1327",
      "r1328",
      "r1329"
     ]
    },
    "us-gaap_NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Acquisition of property and equipment included in accounts payable and accrued liabilities",
        "label": "Noncash or Part Noncash Acquisition, Fixed Assets Acquired",
        "documentation": "The amount of fixed assets that an Entity acquires in a noncash (or part noncash) acquisition. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29"
     ]
    },
    "us-gaap_NoncurrentAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NoncurrentAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total long-lived assets",
        "label": "Long-Lived Assets",
        "documentation": "Long-lived assets other than financial instruments, long-term customer relationships of a financial institution, mortgage and other servicing rights, deferred policy acquisition costs, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r332"
     ]
    },
    "us-gaap_NotesReceivableFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NotesReceivableFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Convertible notes receivable",
        "label": "Notes Receivable, Fair Value Disclosure",
        "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date."
       }
      }
     },
     "auth_ref": [
      "r1265"
     ]
    },
    "dxcm_NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of initial purchasers",
        "label": "Number Of Initial Purchasers For Convertible Note Hedge Transactions",
        "documentation": "Number Of Initial Purchasers For Convertible Note Hedge Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_NumberOfPrimaryGeographicMarkets": {
     "xbrltype": "integerItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "NumberOfPrimaryGeographicMarkets",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of primary geographic markets",
        "label": "Number Of Primary Geographic Markets",
        "documentation": "Number Of Primary Geographic Markets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_NumberOfReportableSegments": {
     "xbrltype": "integerItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NumberOfReportableSegments",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Number of reportable segments",
        "label": "Number of Reportable Segments",
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements."
       }
      }
     },
     "auth_ref": [
      "r912",
      "r919",
      "r1145"
     ]
    },
    "us-gaap_OperatingExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total operating expenses",
        "label": "Operating Expenses",
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingExpensesAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingExpensesAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating expenses:",
        "label": "Operating Expenses [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingIncomeLoss",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Operating income",
        "label": "Operating Income (Loss)",
        "documentation": "The net result for the period of deducting operating expenses from operating revenues."
       }
      }
     },
     "auth_ref": [
      "r163",
      "r911",
      "r1144",
      "r1146",
      "r1147",
      "r1148",
      "r1149"
     ]
    },
    "us-gaap_OperatingLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease cost",
        "label": "Operating Lease, Cost",
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability."
       }
      }
     },
     "auth_ref": [
      "r654",
      "r956"
     ]
    },
    "us-gaap_OperatingLeaseImpairmentLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseImpairmentLoss",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use asset impairment",
        "label": "Operating Lease, Impairment Loss",
        "documentation": "Amount of loss from impairment of right-of-use asset from operating lease."
       }
      }
     },
     "auth_ref": [
      "r1270"
     ]
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Operating Leases",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiability",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Present value of future payments",
        "label": "Operating Lease, Liability",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 1.0
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term operating lease liabilities",
        "negatedLabel": "Less: Current portion",
        "label": "Operating Lease, Liability, Current",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails": {
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofMaturityofLeaseandFinanceLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Long-term operating lease liabilities",
        "verboseLabel": "Long-term portion",
        "label": "Operating Lease, Liability, Noncurrent",
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent."
       }
      }
     },
     "auth_ref": [
      "r644"
     ]
    },
    "us-gaap_OperatingLeasePayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeasePayments",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating cash flows from operating leases",
        "label": "Operating Lease, Payments",
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use."
       }
      }
     },
     "auth_ref": [
      "r649",
      "r657"
     ]
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseRightOfUseAsset",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating lease right-of-use assets",
        "label": "Operating Lease, Right-of-Use Asset",
        "documentation": "Amount of lessee's right to use underlying asset under operating lease."
       }
      }
     },
     "auth_ref": [
      "r643"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average discount rate of operating leases (as a percent)",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "documentation": "Weighted average discount rate for operating lease calculated at point in time."
       }
      }
     },
     "auth_ref": [
      "r660",
      "r956"
     ]
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted average remaining lease term of operating leases (in years)",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r659",
      "r956"
     ]
    },
    "us-gaap_OperatingLossCarryforwards": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwards",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net operating loss",
        "label": "Operating Loss Carryforwards",
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsLineItems",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Line Items]",
        "label": "Operating Loss Carryforwards [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OperatingLossCarryforwardsTable",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Operating Loss Carryforwards [Table]",
        "label": "Operating Loss Carryforwards [Table]",
        "documentation": "Disclosure of information about operating loss carryforward. Includes, but is not limited to, tax authority, amount and expiration date of operating loss carryforward, and likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesLineItems",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "label": "Organization And Summary Of Significant Accounting Policies [Line Items]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_OrganizationAndSummaryOfSignificantAccountingPoliciesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OrganizationAndSummaryOfSignificantAccountingPoliciesTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization And Summary Of Significant Accounting Policies [Table]",
        "label": "Organization And Summary Of Significant Accounting Policies [Table]",
        "documentation": "Organization And Summary Of Significant Accounting Policies [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Organization and Significant Accounting Policies",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r144",
      "r775",
      "r776"
     ]
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAccruedLiabilitiesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Other accrued liabilities",
        "label": "Other Accrued Liabilities, Current",
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r78"
     ]
    },
    "us-gaap_OtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other current assets",
        "label": "Other Assets, Current",
        "documentation": "Amount of current assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r241",
      "r957"
     ]
    },
    "us-gaap_OtherAssetsFairValueDisclosure": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsFairValueDisclosure",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails": {
       "parentTag": "us-gaap_AssetsFairValueDisclosure",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Assets, Fair Value Disclosure",
        "documentation": "Fair value portion of other assets."
       }
      }
     },
     "auth_ref": [
      "r1250",
      "r1251",
      "r1261"
     ]
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherAssetsNoncurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "totalLabel": "Total other assets",
        "label": "Other Assets, Noncurrent",
        "documentation": "Amount of noncurrent assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r230"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Translation adjustments and other",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r145"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other comprehensive income (loss), net of tax:",
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome",
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total other comprehensive income (loss), net of tax",
        "terseLabel": "Other comprehensive income, net of tax",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity."
       }
      }
     },
     "auth_ref": [
      "r3",
      "r9",
      "r145",
      "r246",
      "r249",
      "r284"
     ]
    },
    "us-gaap_OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome": {
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofComprehensiveIncome"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrealized gain (loss) on marketable debt securities",
        "label": "OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax",
        "documentation": "Amount, after tax and before adjustment, of unrealized holding gain (loss) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale). Excludes unrealized gain (loss) on investment in debt security measured at amortized cost (held-to-maturity) from transfer to available-for-sale."
       }
      }
     },
     "auth_ref": [
      "r243",
      "r244",
      "r373"
     ]
    },
    "dxcm_OtherCountriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OtherCountriesMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other countries",
        "label": "Other Countries [Member]",
        "documentation": "Other Countries"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_OtherForeignMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OtherForeignMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other foreign",
        "label": "Other Foreign [Member]",
        "documentation": "Other Foreign"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherIntangibleAssetsMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Intangibles, other",
        "label": "Other Intangible Assets [Member]",
        "documentation": "Intangible assets classified as other."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1181",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0,
       "order": 4.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other long-term liabilities",
        "totalLabel": "Total other long-term liabilities",
        "label": "Other Liabilities, Noncurrent",
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r84"
     ]
    },
    "dxcm_OtherLongTermAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OtherLongTermAssets",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails": {
       "parentTag": "us-gaap_OtherAssetsNoncurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other assets",
        "label": "Other Long -Term Assets",
        "documentation": "Other Long -Term Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherNoncashIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNoncashIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0,
       "order": 12.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other non-cash income and expenses",
        "label": "Other Noncash Income (Expense)",
        "documentation": "Amount of income (expense) included in net income that results in no cash inflow (outflow), classified as other."
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "us-gaap_OtherNonoperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails": {
       "parentTag": "us-gaap_OtherNonoperatingIncomeExpense",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Other expense, net",
        "label": "Other Nonoperating Expense",
        "documentation": "Amount of expense related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherNonoperatingIncomeExpense",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherIncomeExpenseNetDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other income (expense), net",
        "totalLabel": "Total other income (expense), net",
        "label": "Other Nonoperating Income (Expense)",
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other."
       }
      }
     },
     "auth_ref": [
      "r113"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other Performance Measure, Amount",
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r1049"
     ]
    },
    "dxcm_OtherStatesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OtherStatesMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other states",
        "label": "Other States [Member]",
        "documentation": "Other States"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other liabilities",
        "label": "Other Sundry Liabilities, Noncurrent",
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r84",
      "r154"
     ]
    },
    "dxcm_OtherTaxLiabilitiesNoncurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "OtherTaxLiabilitiesNoncurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails": {
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofOtherLongTermLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other tax liabilities",
        "label": "Other Tax Liabilities, Noncurrent",
        "documentation": "Other Tax Liabilities, Noncurrent"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount",
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1010",
      "r1021",
      "r1031",
      "r1064"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Compensation Amount",
        "label": "Outstanding Recovery Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1024",
      "r1034",
      "r1067"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1013",
      "r1024",
      "r1034",
      "r1067"
     ]
    },
    "us-gaap_PaidInKindInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaidInKindInterest",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Non-cash interest expense",
        "label": "Paid-in-Kind Interest",
        "documentation": "Interest paid other than in cash for example by issuing additional debt securities. As a noncash item, it is added to net income when calculating cash provided by or used in operations using the indirect method."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForProceedsFromOtherInvestingActivities",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Other investing activities",
        "label": "Payments for (Proceeds from) Other Investing Activities",
        "documentation": "Amount of cash (inflow) outflow from investing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1103",
      "r1128"
     ]
    },
    "dxcm_PaymentsForPurchasesOfCappedCallTransactions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PaymentsForPurchasesOfCappedCallTransactions",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of capped call transactions",
        "terseLabel": "Purchases of capped call transactions",
        "label": "Payments For Purchases Of Capped Call Transactions",
        "documentation": "Payments For Purchases Of Capped Call Transactions"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PaymentsForRepurchaseOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsForRepurchaseOfCommonStock",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock",
        "terseLabel": "Purchases of treasury stock",
        "label": "Payments for Repurchase of Common Stock",
        "documentation": "The cash outflow to reacquire common stock during the period."
       }
      }
     },
     "auth_ref": [
      "r116"
     ]
    },
    "us-gaap_PaymentsToAcquireAvailableForSaleSecuritiesDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireAvailableForSaleSecuritiesDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchase of marketable securities",
        "label": "Payments to Acquire Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash outflow to acquire investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r21",
      "r256",
      "r341"
     ]
    },
    "us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquired": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireBusinessesNetOfCashAcquired",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Acquisitions, net of cash acquired",
        "label": "Payments to Acquire Businesses, Net of Cash Acquired",
        "documentation": "The cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase."
       }
      }
     },
     "auth_ref": [
      "r22"
     ]
    },
    "us-gaap_PaymentsToAcquireOtherInvestments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquireOtherInvestments",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of non-marketable equity securities",
        "label": "Payments to Acquire Other Investments",
        "documentation": "Amount of cash outflow to acquire investments classified as other."
       }
      }
     },
     "auth_ref": [
      "r114"
     ]
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Purchases of property and equipment",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets."
       }
      }
     },
     "auth_ref": [
      "r115"
     ]
    },
    "dxcm_PaymentsUnderCollaborationAgreementsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PaymentsUnderCollaborationAgreementsAxis",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments Under Collaboration Agreements [Axis]",
        "label": "Payments Under Collaboration Agreements [Axis]",
        "documentation": "Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PaymentsUnderCollaborationAgreementsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PaymentsUnderCollaborationAgreementsDomain",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payments Under Collaboration Agreements [Domain]",
        "label": "Payments Under Collaboration Agreements [Domain]",
        "documentation": "[Domain] for Payments Under Collaboration Agreements [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PayrollRelatedExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PayrollRelatedExpenses",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Payroll related expenses",
        "label": "Payroll Related Expenses",
        "documentation": "Payroll Related Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Issuers, Footnote",
        "label": "Peer Group Issuers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Peer Group Total Shareholder Return Amount",
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Actually Paid Compensation Amount",
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO",
        "label": "PEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r1057"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Name",
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r1050"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PEO Total Compensation Amount",
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r1039"
     ]
    },
    "us-gaap_PerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PerformanceSharesMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "PSUs",
        "label": "Performance Shares [Member]",
        "documentation": "Share-based payment arrangement awarded for meeting performance target."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PharmacyRebatesCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PharmacyRebatesCurrent",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued rebates",
        "label": "Pharmacy Rebates, Current",
        "documentation": "Pharmacy Rebates, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PlanNameAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameAxis",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Axis]",
        "label": "Plan Name [Axis]",
        "documentation": "Information by plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232"
     ]
    },
    "us-gaap_PlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PlanNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Plan Name [Domain]",
        "label": "Plan Name [Domain]",
        "documentation": "Plan name for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1207",
      "r1208",
      "r1209",
      "r1210",
      "r1211",
      "r1212",
      "r1213",
      "r1214",
      "r1215",
      "r1216",
      "r1217",
      "r1218",
      "r1219",
      "r1220",
      "r1221",
      "r1222",
      "r1223",
      "r1224",
      "r1225",
      "r1226",
      "r1227",
      "r1228",
      "r1229",
      "r1230",
      "r1231",
      "r1232"
     ]
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Prior Service Cost",
        "label": "Pension Adjustments Prior Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1041"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Adjustments Service Cost",
        "label": "Pension Adjustments Service Cost [Member]"
       }
      }
     },
     "auth_ref": [
      "r1097"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pension Benefits Adjustments, Footnote",
        "label": "Pension Benefits Adjustments, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1040"
     ]
    },
    "dxcm_PossibleExtensionPeriodofTaxHoliday": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PossibleExtensionPeriodofTaxHoliday",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Possible extension period of tax holiday (in years)",
        "label": "Possible Extension Period of Tax Holiday",
        "documentation": "Possible Extension Period of Tax Holiday"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PotentialCommonStockIssuableOrIssuedSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PotentialCommonStockIssuableOrIssuedSharesNewIssues",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential common stock issued shares (in shares)",
        "label": "Potential Common Stock Issuable Or Issued, Shares, New Issues",
        "documentation": "Potential Common Stock Issuable Or Issued, Shares, New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PotentialFutureCommonStockIssuableSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PotentialFutureCommonStockIssuableSharesNewIssues",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Potential future common stock issuable (in shares)",
        "label": "Potential Future Common Stock Issuable, Shares, New Issues",
        "documentation": "Potential Future Common Stock Issuable, Shares, New Issues"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_PreferentialTaxRatePeriod": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PreferentialTaxRatePeriod",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferential tax rate period (in years)",
        "label": "Preferential Tax Rate Period",
        "documentation": "Preferential Tax Rate Period"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockParOrStatedValuePerShare",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, par value (in usd per share)",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r473"
     ]
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock authorized (in shares)",
        "label": "Preferred Stock, Shares Authorized",
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r812"
     ]
    },
    "us-gaap_PreferredStockSharesIssued": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesIssued",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock issued (in shares)",
        "label": "Preferred Stock, Shares Issued",
        "documentation": "Number of shares issued for nonredeemable preferred shares and preferred shares redeemable solely at option of issuer. Includes, but is not limited to, preferred shares issued, repurchased, and held as treasury shares. Excludes preferred shares classified as debt."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r473"
     ]
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockSharesOutstanding",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock outstanding (in shares)",
        "label": "Preferred Stock, Shares Outstanding",
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r812",
      "r831",
      "r1324",
      "r1325"
     ]
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PreferredStockValueOutstanding",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Preferred stock, $0.001 par value, 5.0 million shares authorized; no shares issued and outstanding at December\u00a031, 2024 and December\u00a031, 2023",
        "label": "Preferred Stock, Value, Outstanding",
        "documentation": "Value of nonredeemable preferred shares and preferred shares redeemable solely at option of issuer, held by shareholders. Excludes preferred shares repurchased and held as treasury shares."
       }
      }
     },
     "auth_ref": [
      "r89",
      "r812"
     ]
    },
    "dxcm_PrepaidAndOtherCurrentAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PrepaidAndOtherCurrentAssetsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Prepaid and Other Current Assets",
        "label": "Prepaid And Other Current Assets [Table Text Block]",
        "documentation": "Prepaid And Other Current Assets"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0,
       "order": 5.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid and other current assets",
        "totalLabel": "Total prepaid and other current assets",
        "label": "Prepaid Expense and Other Assets, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r1121"
     ]
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PrepaidExpenseCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid expenses",
        "label": "Prepaid Expense, Current",
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer."
       }
      }
     },
     "auth_ref": [
      "r240",
      "r394",
      "r395",
      "r900"
     ]
    },
    "dxcm_PrepaidInventoryCurrent": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "PrepaidInventoryCurrent",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails": {
       "parentTag": "us-gaap_PrepaidExpenseAndOtherAssetsCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPrepaidandOtherCurrentAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Prepaid inventory",
        "label": "Prepaid Inventory, Current",
        "documentation": "Prepaid Inventory, Current"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ProceedsFromConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromConvertibleDebt",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from issuance of convertible notes, net of issuance costs",
        "label": "Proceeds from Convertible Debt",
        "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r23"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Net proceeds from issuance of common stock",
        "label": "Proceeds from Issuance of Common Stock",
        "documentation": "The cash inflow from the additional capital contribution to the entity."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromIssuanceOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromIssuanceOfWarrants",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale of warrants",
        "label": "Proceeds from Issuance of Warrants",
        "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromPaymentsForOtherFinancingActivities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other financing activities",
        "label": "Proceeds from (Payments for) Other Financing Activities",
        "documentation": "Amount of cash inflow (outflow) from financing activities classified as other."
       }
      }
     },
     "auth_ref": [
      "r1104",
      "r1129"
     ]
    },
    "us-gaap_ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proceeds from sale and maturity of marketable securities",
        "label": "Proceeds from Sale and Maturity of Debt Securities, Available-for-Sale",
        "documentation": "Amount of cash inflow from sale, maturity, prepayment and call of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale)."
       }
      }
     },
     "auth_ref": [
      "r256",
      "r257",
      "r1153"
     ]
    },
    "srt_ProductOrServiceAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductOrServiceAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Axis]",
        "label": "Product and Service [Axis]",
        "documentation": "Information by product and service, or group of similar products and similar services."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r216",
      "r329",
      "r701",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r896",
      "r930",
      "r967",
      "r969",
      "r970",
      "r973",
      "r975",
      "r1117",
      "r1193",
      "r1194",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "us-gaap_ProductWarrantyAccrualPayments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProductWarrantyAccrualPayments",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Costs incurred",
        "label": "Standard and Extended Product Warranty Accrual, Decrease for Payments",
        "documentation": "Amount of decrease in the standard and extended product warranty accrual from payments made in cash or in kind to satisfy claims under the terms of the standard and extended product warranty."
       }
      }
     },
     "auth_ref": [
      "r432"
     ]
    },
    "srt_ProductsAndServicesDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ProductsAndServicesDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Product and Service [Domain]",
        "label": "Product and Service [Domain]",
        "documentation": "Product or service, or a group of similar products or similar services."
       }
      }
     },
     "auth_ref": [
      "r195",
      "r196",
      "r197",
      "r198",
      "r199",
      "r200",
      "r216",
      "r329",
      "r701",
      "r756",
      "r757",
      "r758",
      "r759",
      "r760",
      "r761",
      "r762",
      "r896",
      "r930",
      "r967",
      "r969",
      "r970",
      "r973",
      "r975",
      "r1117",
      "r1193",
      "r1194",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1294",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "us-gaap_ProfessionalFees": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ProfessionalFees",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 8.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Consulting &amp; professional fees",
        "label": "Professional Fees",
        "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer."
       }
      }
     },
     "auth_ref": [
      "r915",
      "r984",
      "r1322",
      "r1323"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Less: accumulated depreciation and amortization",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, Accumulated Depreciation and Amortization",
        "documentation": "Amount of accumulated depreciation and amortization from plant, property, and equipment and right-of-use asset from finance lease."
       }
      }
     },
     "auth_ref": [
      "r1105",
      "r1108",
      "r1188"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_Assets",
       "weight": 1.0,
       "order": 7.0
      },
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Total property and equipment, net",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization",
        "documentation": "Amount, after accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1108",
      "r1186"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total cost",
        "label": "Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, before Accumulated Depreciation and Amortization",
        "documentation": "Amount, before accumulated depreciation and amortization, of property, plant, and equipment and finance lease right-of-use asset."
       }
      }
     },
     "auth_ref": [
      "r1102",
      "r1119",
      "r1187"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Axis]",
        "label": "Long-Lived Tangible Asset [Axis]",
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r662"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentGross",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails": {
       "parentTag": "us-gaap_PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total cost",
        "label": "Property, Plant and Equipment, Gross",
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r227",
      "r747"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Line Items]",
        "label": "Property, Plant and Equipment [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r662"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property and Equipment",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r175",
      "r178",
      "r746"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Property and Equipment",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Type [Domain]",
        "label": "Long-Lived Tangible Asset [Domain]",
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software."
       }
      }
     },
     "auth_ref": [
      "r126",
      "r662"
     ]
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment, Useful Life (in years)",
        "label": "Property, Plant and Equipment, Useful Life",
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure",
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pay vs Performance Disclosure, Table",
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1038"
     ]
    },
    "srt_RangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeAxis",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Axis]",
        "label": "Statistical Measurement [Axis]",
        "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r188",
      "r190",
      "r191",
      "r193",
      "r217",
      "r218",
      "r427",
      "r428",
      "r429",
      "r430",
      "r495",
      "r503",
      "r534",
      "r535",
      "r536",
      "r545",
      "r621",
      "r672",
      "r681",
      "r698",
      "r763",
      "r765",
      "r773",
      "r802",
      "r803",
      "r855",
      "r857",
      "r859",
      "r860",
      "r868",
      "r892",
      "r893",
      "r920",
      "r929",
      "r937",
      "r948",
      "r949",
      "r953",
      "r954",
      "r969",
      "r978",
      "r1192",
      "r1202",
      "r1253",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282"
     ]
    },
    "srt_RangeMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RangeMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statistical Measurement [Domain]",
        "label": "Statistical Measurement [Domain]",
        "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median."
       }
      }
     },
     "auth_ref": [
      "r186",
      "r188",
      "r190",
      "r191",
      "r193",
      "r217",
      "r218",
      "r427",
      "r428",
      "r429",
      "r430",
      "r495",
      "r503",
      "r534",
      "r535",
      "r536",
      "r545",
      "r621",
      "r672",
      "r681",
      "r698",
      "r763",
      "r765",
      "r773",
      "r802",
      "r803",
      "r855",
      "r857",
      "r859",
      "r860",
      "r868",
      "r892",
      "r893",
      "r920",
      "r929",
      "r937",
      "r948",
      "r949",
      "r953",
      "r954",
      "r969",
      "r978",
      "r1192",
      "r1202",
      "r1253",
      "r1278",
      "r1279",
      "r1280",
      "r1281",
      "r1282"
     ]
    },
    "us-gaap_ReceivablesPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReceivablesPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Accounts Receivables and Allowance for Doubtful Accounts",
        "label": "Receivable [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for receivable. Includes, but is not limited to, accounts receivable and financing receivable."
       }
      }
     },
     "auth_ref": [
      "r336",
      "r337",
      "r338",
      "r340",
      "r1151"
     ]
    },
    "dxcm_ReceiverProductComponentMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ReceiverProductComponentMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Receiver Product Component",
        "label": "Receiver Product Component [Member]",
        "documentation": "Receiver Product Component [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Revenue, Segment Profit or Loss, and Significant Segment Expenses",
        "label": "Segment, Reconciliation of Other Items from Segments to Consolidated [Table Text Block]",
        "documentation": "Tabular disclosure of reconciliation of other items from reportable segments to their consolidated amount. Excludes reconciliation of revenue, profit (loss), and assets."
       }
      }
     },
     "auth_ref": [
      "r42",
      "r43"
     ]
    },
    "us-gaap_ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ReconciliationOfUnrecognizedTaxBenefitsExcludingAmountsPertainingToExaminedTaxReturnsRollForward",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized Tax Benefits [Roll Forward]",
        "label": "Unrecognized Tax Benefits [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RecordedUnconditionalPurchaseObligationDueWithinOneYear": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYear",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Purchase obligations",
        "label": "Recorded Unconditional Purchase Obligation, to be Paid, Year One",
        "documentation": "Amount of recorded unconditional purchase obligation to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)."
       }
      }
     },
     "auth_ref": [
      "r426"
     ]
    },
    "dxcm_RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm": {
     "xbrltype": "durationItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Term of purchase obligations (in years)",
        "label": "Recorded Unconditional Purchase Obligation Due Within One Year Maximum Term",
        "documentation": "Recorded Unconditional Purchase Obligation Due Within One Year, Maximum Term"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1005",
      "r1016",
      "r1026",
      "r1059"
     ]
    },
    "us-gaap_RepaymentsOfConvertibleDebt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RepaymentsOfConvertibleDebt",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Payments for conversions of senior convertible notes",
        "label": "Repayments of Convertible Debt",
        "documentation": "The cash outflow from the repayment of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Counterparty Name [Domain]",
        "label": "Counterparty Name [Domain]",
        "documentation": "Named other party that participates in a financial transaction. Examples include, but not limited to, the name of the financial institution."
       }
      }
     },
     "auth_ref": [
      "r211",
      "r212",
      "r268",
      "r269",
      "r448",
      "r475",
      "r665",
      "r682",
      "r739",
      "r905",
      "r906"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and development",
        "label": "Research and Development Expense",
        "documentation": "Amount of expense for research and development. Includes, but is not limited to, cost for computer software product to be sold, leased, or otherwise marketed and writeoff of research and development assets acquired in transaction other than business combination or joint venture formation or both. Excludes write-down of intangible asset acquired in business combination or from joint venture formation or both, used in research and development activity."
       }
      }
     },
     "auth_ref": [
      "r548",
      "r894",
      "r915",
      "r1283"
     ]
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpenseMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Research and development",
        "label": "Research and Development Expense [Member]",
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Research and Development",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process."
       }
      }
     },
     "auth_ref": [
      "r547"
     ]
    },
    "dxcm_ResearchDevelopmentTaxCreditsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ResearchDevelopmentTaxCreditsMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "R&amp;D credits",
        "label": "Research &amp; Development Tax Credits [Member]",
        "documentation": "Research &amp; Development Tax Credits"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date:",
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1006",
      "r1017",
      "r1027",
      "r1060"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement Determination Date",
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r1007",
      "r1018",
      "r1028",
      "r1061"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restatement does not require Recovery",
        "label": "Restatement Does Not Require Recovery [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1014",
      "r1025",
      "r1035",
      "r1068"
     ]
    },
    "dxcm_RestrictedAndPerformanceStockUnitsMemberMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "RestrictedAndPerformanceStockUnitsMemberMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs and PSUs",
        "label": "Restricted And Performance Stock Units Member [Member]",
        "documentation": "Restricted And Performance Stock Units Member"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RestrictedCash": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedCash",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted cash",
        "label": "Restricted Cash",
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits."
       }
      }
     },
     "auth_ref": [
      "r1118",
      "r1132",
      "r1284",
      "r1287"
     ]
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RestrictedStockUnitsRSUMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Restricted Stock Units (RSUs)",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_RestrictedStockUnitsRSUsAndPerformanceSharesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "RestrictedStockUnitsRSUsAndPerformanceSharesMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "RSUs and PSUs",
        "label": "Restricted Stock Units (RSUs) and Performance Shares [Member]",
        "documentation": "Restricted Stock Units (RSUs) and Performance Shares"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsAccumulatedDeficit",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained earnings",
        "label": "Retained Earnings (Accumulated Deficit)",
        "documentation": "Amount of accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r93",
      "r135",
      "r744",
      "r770",
      "r772",
      "r783",
      "r813",
      "r957"
     ]
    },
    "us-gaap_RetainedEarningsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RetainedEarningsMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Retained Earnings",
        "label": "Retained Earnings [Member]",
        "documentation": "Accumulated undistributed earnings (deficit)."
       }
      }
     },
     "auth_ref": [
      "r219",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r286",
      "r288",
      "r376",
      "r377",
      "r414",
      "r586",
      "r587",
      "r593",
      "r594",
      "r595",
      "r597",
      "r598",
      "r599",
      "r606",
      "r608",
      "r609",
      "r611",
      "r613",
      "r639",
      "r642",
      "r767",
      "r769",
      "r786",
      "r1324"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "verboseLabel": "Total revenue",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise."
       }
      }
     },
     "auth_ref": [
      "r161",
      "r162",
      "r304",
      "r313",
      "r314",
      "r322",
      "r326",
      "r329",
      "r331",
      "r333",
      "r492",
      "r493",
      "r701"
     ]
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue Recognition",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for revenue from contract with customer."
       }
      }
     },
     "auth_ref": [
      "r181",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r895"
     ]
    },
    "us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RevenueFromExternalCustomersByGeographicAreasTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenue from External Customers by Geographic Areas",
        "label": "Revenue from External Customers by Geographic Areas [Table Text Block]",
        "documentation": "Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue."
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "dxcm_RevenuePercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "RevenuePercentage",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Proportion of revenue (as a percent)",
        "label": "Revenue, Percentage",
        "documentation": "Revenue, Percentage"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for finance lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r956"
     ]
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Right-of-use assets obtained in exchange for operating lease liabilities",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability."
       }
      }
     },
     "auth_ref": [
      "r658",
      "r956"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Adopted",
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 10b5-1 Arrangement Terminated",
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]"
       }
      }
     },
     "auth_ref": [
      "r1077"
     ]
    },
    "dxcm_SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Write-offs and adjustments",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction, Write-offs and Adjustments",
        "documentation": "Total of the write-offs and adjustments in a given period to allowances and reserves for doubtful accounts"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SalesChannelDirectlyToConsumerMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesChannelDirectlyToConsumerMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Direct",
        "label": "Sales Channel, Directly to Consumer [Member]",
        "documentation": "Contract with customer in which good or service is transferred directly to consumer."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_SalesChannelThroughIntermediaryMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesChannelThroughIntermediaryMember",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Distributor",
        "label": "Sales Channel, Through Intermediary [Member]",
        "documentation": "Contract with customer in which good or service is transferred through intermediary."
       }
      }
     },
     "auth_ref": [
      "r933"
     ]
    },
    "us-gaap_SalesRevenueNetMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SalesRevenueNetMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofPercentageofTotalRevenuesandAccountsReceivablebyCustomerDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Revenue",
        "label": "Revenue Benchmark [Member]",
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation."
       }
      }
     },
     "auth_ref": [
      "r333",
      "r1106"
     ]
    },
    "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Receivable",
        "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]",
        "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables."
       }
      }
     },
     "auth_ref": [
      "r91",
      "r97"
     ]
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accounts Payable and Accrued Liabilities",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Payroll and Related Expenses",
        "label": "Schedule of Accrued Payroll and Related Expenses [Table Text Block]",
        "documentation": "Schedule of Accrued Payroll and Related Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofOutstandingAntiDilutiveSecuritiesExcludedinDilutedNetIncomeLossperShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "label": "Antidilutive Security, Excluded EPS Calculation [Table]",
        "documentation": "Disclosure of information about security that could potentially dilute basic earnings per share (EPS) in future that was not included in calculation of diluted EPS."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Schedule of Outstanding Anti-Dilutive Securities Excluded in Diluted Net Income per Share",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities."
       }
      }
     },
     "auth_ref": [
      "r30"
     ]
    },
    "us-gaap_ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments",
        "label": "Schedule of Carrying Values and Estimated Fair Values of Debt Instruments [Table Text Block]",
        "documentation": "Tabular disclosure of information pertaining to carrying amount and estimated fair value of short-term and long-term debt instruments or arrangements, including but not limited to, identification of terms, features, and collateral requirements."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Components of Income Tax Expense (Benefit)",
        "label": "Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years."
       }
      }
     },
     "auth_ref": [
      "r1243"
     ]
    },
    "srt_ScheduleOfCondensedFinancialStatementsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfCondensedFinancialStatementsTable",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationNarrativeDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Condensed Financial Statements [Table]",
        "label": "Condensed Financial Statements [Table]",
        "documentation": "Disclosure of information about condensed financial statements, including, but not limited to, the balance sheet, income statement, and statement of cash flows."
       }
      }
     },
     "auth_ref": [
      "r184",
      "r215",
      "r270",
      "r1101"
     ]
    },
    "dxcm_ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Conversion Activity for Senior Convertible Notes",
        "label": "Schedule of Conversion Activity For Senior Convertible Notes [Table Text Block]",
        "documentation": "Schedule of Conversion Activity For Senior Convertible Notes"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Deferred Tax Assets and Liabilities",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r1238"
     ]
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Basic and Diluted Net Income (Loss) Per Share",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r1143"
     ]
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Reconciliation between Effective Tax Rate and Statutory Rate",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations."
       }
      }
     },
     "auth_ref": [
      "r561",
      "r942",
      "r1234"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-Based Compensation Expenses",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement."
       }
      }
     },
     "auth_ref": [
      "r57"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Intangible Asset, Finite-Lived [Table]",
        "label": "Intangible Asset, Finite-Lived [Table]",
        "documentation": "Disclosure of information about finite-lived intangible asset. Excludes indefinite-lived intangible asset."
       }
      }
     },
     "auth_ref": [
      "r401",
      "r407",
      "r410",
      "r411",
      "r413",
      "r702",
      "r894",
      "r923"
     ]
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Intangible Assets and Weighted Average Amortization Period",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1180"
     ]
    },
    "us-gaap_ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Income (Loss) before Income Taxes Subject to Taxes",
        "label": "Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]",
        "documentation": "Tabular disclosure of income before income tax between domestic and foreign jurisdictions."
       }
      }
     },
     "auth_ref": [
      "r1136"
     ]
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Inventory",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process."
       }
      }
     },
     "auth_ref": [
      "r17",
      "r98",
      "r99",
      "r100"
     ]
    },
    "us-gaap_ScheduleOfLineOfCreditFacilitiesTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfLineOfCreditFacilitiesTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/DebtTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Availability and Outstanding Borrowings on Credit Agreement",
        "label": "Schedule of Line of Credit Facilities [Table Text Block]",
        "documentation": "Tabular disclosure of short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line."
       }
      }
     },
     "auth_ref": [
      "r76",
      "r82"
     ]
    },
    "us-gaap_ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Long-Term Liabilities",
        "label": "Schedule of Other Assets and Other Liabilities [Table Text Block]",
        "documentation": "Tabular disclosure of assets and liabilities, classified as other."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherAssetsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherAssetsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Assets",
        "label": "Schedule of Other Assets [Table Text Block]",
        "documentation": "Tabular disclosure of the carrying amounts of other assets. This disclosure includes other current assets and other noncurrent assets."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Other Income (Expense), Net",
        "label": "Schedule of Other Nonoperating Income (Expense) [Table Text Block]",
        "documentation": "Tabular disclosure of the components of non-operating income or non-operating expense that may include amounts earned from dividends, interest on securities, gains (losses) on securities sold, equity earnings of unconsolidated affiliates, net gain (loss) on sales of business, interest expense and other miscellaneous income or expense items."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfProductWarrantyLiabilityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfProductWarrantyLiabilityTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Accrued Warranty",
        "label": "Schedule of Product Warranty Liability [Table Text Block]",
        "documentation": "Tabular disclosure of the changes in the guarantor's aggregate product warranty liability, including the beginning balance of the aggregate product warranty liability, the aggregate reductions in that liability for payments made (in cash or in kind) under the warranty, the aggregate changes in the liability for accruals related to product warranties issued during the reporting period, the aggregate changes in the liability for accruals related to preexisting warranties (including adjustments related to changes in estimates), and the ending balance of the aggregate product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r431"
     ]
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofPropertyandEquipmentDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Property, Plant and Equipment [Table]",
        "label": "Property, Plant and Equipment [Table]",
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation."
       }
      }
     },
     "auth_ref": [
      "r6",
      "r662"
     ]
    },
    "us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsTable",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "label": "Schedule of Revenues from External Customers and Long-Lived Assets [Table]",
        "documentation": "Disclosure of information about revenue from external customer and long-lived asset by geographical area. Long-lived asset excludes financial instrument, customer relationship with financial institution, mortgage and other servicing right, deferred policy acquisition cost, and deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r44",
      "r102"
     ]
    },
    "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfSegmentReportingInformationBySegmentTable",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Segment Reporting Information, by Segment [Table]",
        "label": "Schedule of Segment Reporting Information, by Segment [Table]",
        "documentation": "Disclosure of information about profit (loss) and total assets by reportable segment."
       }
      }
     },
     "auth_ref": [
      "r39",
      "r40",
      "r41"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationActivityTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of RSU and PSU Activity",
        "label": "Share-Based Payment Arrangement, Activity [Table Text Block]",
        "documentation": "Tabular disclosure of activity for award under share-based payment arrangement. Includes, but is not limited to, outstanding award at beginning and end of year, granted, exercised, forfeited, and weighted-average grant date fair value."
       }
      }
     },
     "auth_ref": [
      "r13",
      "r14",
      "r142"
     ]
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "documentation": "Disclosure of information about share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r507",
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ]
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Valuation Assumptions for Employee Stock Purchase Plan",
        "label": "Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]",
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions."
       }
      }
     },
     "auth_ref": [
      "r143"
     ]
    },
    "dxcm_ScheduleOfTreasuryShareActivityTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ScheduleOfTreasuryShareActivityTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Treasury Share Activity Table Text Block",
        "label": "Schedule of Treasury Share Activity [Table Text Block]",
        "documentation": "Schedule of Treasury Share Activity"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Unrecognized Tax Benefits",
        "label": "Schedule of Unrecognized Tax Benefits Roll Forward [Table Text Block]",
        "documentation": "Tabular disclosure of the change in unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r570",
      "r941"
     ]
    },
    "srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTS"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS",
        "label": "SEC Schedule, 12-09, Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]",
        "documentation": "The entire disclosure for valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r185",
      "r274"
     ]
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets."
       }
      }
     },
     "auth_ref": [
      "r923",
      "r1182"
     ]
    },
    "us-gaap_SchedulesOfConcentrationOfRiskByRiskFactorTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SchedulesOfConcentrationOfRiskByRiskFactorTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Percentage of Total Revenues and Accounts Receivable by Customer",
        "label": "Schedules of Concentration of Risk, by Risk Factor [Table Text Block]",
        "documentation": "Tabular disclosure of the nature of a concentration, a benchmark to which it is compared, and the percentage that the risk is to the benchmark."
       }
      }
     },
     "auth_ref": [
      "r32",
      "r33",
      "r34",
      "r35",
      "r69",
      "r148"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r987"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r990"
     ]
    },
    "us-gaap_SegmentExpenditureAdditionToLongLivedAssets": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentExpenditureAdditionToLongLivedAssets",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expenditures for long-lived assets",
        "label": "Segment, Expenditure, Addition to Long-Lived Assets",
        "documentation": "Amount of expenditure for addition to long-lived assets included in determination of segment assets by chief operating decision maker (CODM) or otherwise regularly provided to CODM. Excludes expenditure for addition to financial instrument, long-term customer relationship of financial institution, mortgage and other servicing rights, deferred policy acquisition cost, and deferred tax assets."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r318",
      "r326",
      "r915",
      "r916"
     ]
    },
    "srt_SegmentGeographicalDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "SegmentGeographicalDomain",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Domain]",
        "label": "Geographical [Domain]",
        "documentation": "Geographical area."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r192",
      "r194",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r331",
      "r332",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r798",
      "r799",
      "r800",
      "r856",
      "r858",
      "r861",
      "r872",
      "r879",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r897",
      "r931",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r971",
      "r978",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "us-gaap_SegmentReportingAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting [Abstract]",
        "label": "Segment Reporting [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingDisclosureTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Business Segment and Geographic Information",
        "label": "Segment Reporting Disclosure [Text Block]",
        "documentation": "The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments."
       }
      }
     },
     "auth_ref": [
      "r164",
      "r304",
      "r308",
      "r309",
      "r310",
      "r311",
      "r312",
      "r319",
      "r320",
      "r321",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r912",
      "r913",
      "r914",
      "r915",
      "r917",
      "r918",
      "r919"
     ]
    },
    "us-gaap_SegmentReportingInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingInformationLineItems",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Segment Reporting Information [Line Items]",
        "label": "Segment Reporting Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SegmentReportingOtherItemAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SegmentReportingOtherItemAmount",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Other segment items",
        "label": "Segment Reporting, Other Segment Item, Amount",
        "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)."
       }
      }
     },
     "auth_ref": [
      "r304",
      "r320",
      "r321",
      "r326",
      "r915"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations": {
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expense",
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofShareBasedCompensationExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Selling, general and administrative",
        "label": "Selling, General and Administrative Expenses [Member]",
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorLongtermNotesCurrentAndNoncurrentAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorLongtermNotesCurrentAndNoncurrentAbstract",
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Convertible Notes",
        "label": "Senior Notes [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeniorNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeniorNotesMember",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023NoteHedgeDetails",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtConversionRightsforSeniorsConvertibleNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails",
      "http://www.dexcom.com/role/DebtScheduleofConvertedValueofNotesDetails",
      "http://www.dexcom.com/role/DebtScheduleofKeyDetailsofConvertibleNotesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueofSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Notes",
        "label": "Senior Notes [Member]",
        "documentation": "Bond that takes priority over other debt securities sold by the issuer. In the event the issuer goes bankrupt, senior debt holders receive priority for (must receive) repayment prior to (relative to) junior and unsecured (general) creditors."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensation": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensation",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows": {
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based compensation",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "documentation": "Amount of noncash expense for share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting period (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition."
       }
      }
     },
     "auth_ref": [
      "r938"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r526"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Granted (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan)."
       }
      }
     },
     "auth_ref": [
      "r524"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unvested awards (in shares)",
        "periodStartLabel": "Nonvested at beginning of period (in shares)",
        "periodEndLabel": "Nonvested at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Nonvested at beginning of period (in usd per share)",
        "periodEndLabel": "Nonvested at end of period (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": [
      "r521",
      "r522"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValueRollForward",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Weighted\u00a0 Average Grant\u00a0Date Fair\u00a0Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedLabel": "Vested (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Fair value of vested awards",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash."
       }
      }
     },
     "auth_ref": [
      "r528"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in usd per share)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement."
       }
      }
     },
     "auth_ref": [
      "r525"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Dividend yield (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term."
       }
      }
     },
     "auth_ref": [
      "r535"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected volatility of common stock (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period."
       }
      }
     },
     "auth_ref": [
      "r534"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Risk free interest rate (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares."
       }
      }
     },
     "auth_ref": [
      "r536"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r505",
      "r507",
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Maximum payroll deductions (as a percent)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Maximum Employee Subscription Rate",
        "documentation": "The highest percentage of annual salary that an employee is permitted to utilize with respect to the plan."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Forfeited (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures",
        "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event."
       }
      }
     },
     "auth_ref": [
      "r141"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Granted (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Granted",
        "documentation": "Net number of non-option equity instruments granted to participants."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vested (in shares)",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Vested"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock reserved for issuance (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized",
        "documentation": "Number of shares authorized for issuance under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r939"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock available for issuance for future awards (in shares)",
        "periodStartLabel": "Number of shares available for grant at beginning of period (in shares)",
        "periodEndLabel": "Number of shares available for grant at end of period (in shares)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant",
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable."
       }
      }
     },
     "auth_ref": [
      "r56"
     ]
    },
    "dxcm_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward": {
     "xbrltype": "stringItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantRollForward",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares Available for Grant",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Available for Grant [Roll Forward]",
        "documentation": "Share-based Compensation Arrangement by Share-based Payment Award, Shares Available for Grant"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails",
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Award Type [Domain]",
        "label": "Award Type [Domain]",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r509",
      "r510",
      "r511",
      "r513",
      "r514",
      "r515",
      "r516",
      "r517",
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r533",
      "r534",
      "r535",
      "r536",
      "r537"
     ]
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share-Based Compensation",
        "label": "Share-Based Payment Arrangement [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost."
       }
      }
     },
     "auth_ref": [
      "r504",
      "r512",
      "r531",
      "r532",
      "r533",
      "r534",
      "r537",
      "r540",
      "r541",
      "r542",
      "r543"
     ]
    },
    "dxcm_ShareBasedPaymentArrangementOperatingExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ShareBasedPaymentArrangementOperatingExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 10.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock-based compensation expense",
        "label": "Share-Based Payment Arrangement, Operating Expense",
        "documentation": "Share-Based Payment Arrangement, Operating Expense"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharePrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharePrice",
     "presentation": [
      "http://www.dexcom.com/role/Debt2028CappedCallTransactionsDetails",
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Closing stock price (in usd per share)",
        "label": "Share Price",
        "documentation": "Price of a single share of a number of saleable stocks of a company."
       }
      }
     },
     "auth_ref": []
    },
    "srt_ShareRepurchaseProgramAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramAxis",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Axis]",
        "label": "Share Repurchase Program [Axis]",
        "documentation": "Information by share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "srt_ShareRepurchaseProgramDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ShareRepurchaseProgramDomain",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program [Domain]",
        "label": "Share Repurchase Program [Domain]",
        "documentation": "Name of share repurchase program."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "dxcm_ShareRepurchaseProgramMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "ShareRepurchaseProgramMember",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Share Repurchase Program",
        "label": "Share Repurchase Program [Member]",
        "documentation": "Share Repurchase Program"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "xbrltype": "percentItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Common received vesting percentage",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage",
        "documentation": "Percentage of vesting of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r1207"
     ]
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofRSUandPSUActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Intrinsic\u00a0Value",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Nonvested",
        "documentation": "Intrinsic value of nonvested award under share-based payment arrangement. Excludes share and unit options."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "xbrltype": "durationItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofValuationAssumptionsforEmployeeStockPurchasePlanDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expected life (in years)",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term",
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days."
       }
      }
     },
     "auth_ref": [
      "r533"
     ]
    },
    "dxcm_SharesIssuedInConnectionWithTheRestatedCollaborationAgreement": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "SharesIssuedInConnectionWithTheRestatedCollaborationAgreement",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares Issued In Connection With The Restated Collaboration Agreement",
        "label": "Shares Issued In Connection With The Restated Collaboration Agreement",
        "documentation": "Shares Issued In Connection With The Restated Collaboration Agreement"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_SharesReceivedFromBenefitOfNoteHedge": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "SharesReceivedFromBenefitOfNoteHedge",
     "presentation": [
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Shares received from Note Hedge",
        "label": "Shares Received From Benefit Of Note Hedge",
        "documentation": "Shares Received From Benefit Of Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_SharesReceivedFromExerciseOfNoteHedge": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "SharesReceivedFromExerciseOfNoteHedge",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit of note hedge upon conversions of 2023 Notes (in shares)",
        "verboseLabel": "Shares received from note hedge (in shares)",
        "label": "Shares Received From Exercise of Note Hedge",
        "documentation": "Shares Received From Exercise of Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ShortTermLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShortTermLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 5.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Short-term lease cost",
        "label": "Short-Term Lease, Cost",
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less."
       }
      }
     },
     "auth_ref": [
      "r655",
      "r956"
     ]
    },
    "us-gaap_StandardProductWarrantyAccrual": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StandardProductWarrantyAccrual",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails": {
       "parentTag": "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent",
       "weight": 1.0,
       "order": 4.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccountsPayableandAccruedLiabilitiesDetails",
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Accrued warranty",
        "periodStartLabel": "Beginning balance",
        "periodEndLabel": "Ending balance",
        "label": "Standard Product Warranty Accrual",
        "documentation": "Amount as of the balance sheet date of the aggregate standard product warranty liability. Does not include the balance for the extended product warranty liability."
       }
      }
     },
     "auth_ref": [
      "r1196",
      "r1197"
     ]
    },
    "dxcm_StandardProductWarrantyAccrualChargesToCostsAndExpenses": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StandardProductWarrantyAccrualChargesToCostsAndExpenses",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofAccruedWarrantyDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Charges to costs and expenses",
        "label": "Standard Product Warranty Accrual Charges To Costs And Expenses",
        "documentation": "Standard Product Warranty Accrual Charges To Costs And Expenses"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StandardProductWarrantyPolicy": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StandardProductWarrantyPolicy",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warranty Accrual",
        "label": "Standard Product Warranty, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for standard warranties including the methodology for measuring the liability."
       }
      }
     },
     "auth_ref": [
      "r1195"
     ]
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StateAndLocalJurisdictionMember",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "State",
        "label": "State and Local Jurisdiction [Member]",
        "documentation": "Designated state or local jurisdiction entitled to levy and collect income tax."
       }
      }
     },
     "auth_ref": [
      "r559"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]",
        "documentation": "Information by the different classes of stock of the entity."
       }
      }
     },
     "auth_ref": [
      "r183",
      "r232",
      "r233",
      "r234",
      "r265",
      "r291",
      "r295",
      "r298",
      "r300",
      "r306",
      "r307",
      "r375",
      "r435",
      "r437",
      "r438",
      "r439",
      "r442",
      "r443",
      "r473",
      "r474",
      "r476",
      "r477",
      "r479",
      "r629",
      "r779",
      "r780",
      "r781",
      "r782",
      "r786",
      "r787",
      "r788",
      "r789",
      "r790",
      "r791",
      "r792",
      "r793",
      "r794",
      "r795",
      "r796",
      "r797",
      "r812",
      "r834",
      "r852",
      "r873",
      "r874",
      "r875",
      "r876",
      "r877",
      "r1100",
      "r1133",
      "r1142"
     ]
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementEquityComponentsAxis",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Equity Components [Axis]",
        "label": "Equity Components [Axis]",
        "documentation": "Information by component of equity."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r90",
      "r94",
      "r95",
      "r219",
      "r251",
      "r252",
      "r253",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r286",
      "r288",
      "r305",
      "r376",
      "r377",
      "r414",
      "r481",
      "r586",
      "r587",
      "r593",
      "r594",
      "r595",
      "r597",
      "r598",
      "r599",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r631",
      "r632",
      "r633",
      "r634",
      "r635",
      "r636",
      "r639",
      "r642",
      "r664",
      "r750",
      "r767",
      "r768",
      "r769",
      "r786",
      "r852"
     ]
    },
    "srt_StatementGeographicalAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StatementGeographicalAxis",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails",
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails",
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Geographical [Axis]",
        "label": "Geographical [Axis]",
        "documentation": "Information by geographical components."
       }
      }
     },
     "auth_ref": [
      "r187",
      "r189",
      "r192",
      "r194",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r208",
      "r209",
      "r210",
      "r331",
      "r332",
      "r704",
      "r705",
      "r706",
      "r707",
      "r708",
      "r709",
      "r710",
      "r711",
      "r712",
      "r713",
      "r714",
      "r715",
      "r716",
      "r717",
      "r718",
      "r719",
      "r720",
      "r721",
      "r722",
      "r723",
      "r724",
      "r725",
      "r726",
      "r727",
      "r728",
      "r729",
      "r730",
      "r731",
      "r732",
      "r733",
      "r798",
      "r799",
      "r800",
      "r856",
      "r858",
      "r861",
      "r872",
      "r879",
      "r883",
      "r884",
      "r885",
      "r886",
      "r887",
      "r888",
      "r889",
      "r890",
      "r891",
      "r897",
      "r931",
      "r959",
      "r960",
      "r961",
      "r962",
      "r963",
      "r964",
      "r965",
      "r966",
      "r971",
      "r978",
      "r1204",
      "r1290",
      "r1292",
      "r1293",
      "r1295",
      "r1296",
      "r1297",
      "r1298",
      "r1299",
      "r1300",
      "r1301",
      "r1302",
      "r1303",
      "r1304",
      "r1305",
      "r1306",
      "r1307",
      "r1308",
      "r1309",
      "r1310",
      "r1311",
      "r1312",
      "r1313",
      "r1314",
      "r1315",
      "r1316",
      "r1317",
      "r1319",
      "r1320"
     ]
    },
    "us-gaap_StatementLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementLineItems",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Line Items]",
        "label": "Statement [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r305",
      "r642",
      "r701",
      "r777",
      "r797",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r832",
      "r835",
      "r836",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r852",
      "r979"
     ]
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfCashFlowsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Cash Flows [Abstract]",
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfFinancialPositionAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Financial Position [Abstract]",
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Comprehensive Income [Abstract]",
        "label": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementOfStockholdersEquityAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement of Stockholders' Equity [Abstract]",
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StatementTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementTable",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Statement [Table]",
        "label": "Statement [Table]",
        "documentation": "Disclosure of information about statement of comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity."
       }
      }
     },
     "auth_ref": [
      "r275",
      "r276",
      "r277",
      "r305",
      "r334",
      "r642",
      "r701",
      "r777",
      "r797",
      "r804",
      "r805",
      "r806",
      "r807",
      "r808",
      "r809",
      "r812",
      "r815",
      "r816",
      "r817",
      "r818",
      "r819",
      "r821",
      "r822",
      "r823",
      "r824",
      "r826",
      "r827",
      "r828",
      "r829",
      "r830",
      "r832",
      "r835",
      "r836",
      "r838",
      "r839",
      "r840",
      "r841",
      "r842",
      "r843",
      "r844",
      "r845",
      "r846",
      "r847",
      "r848",
      "r849",
      "r852",
      "r979"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Price or TSR Estimation Method",
        "label": "Stock Price or TSR Estimation Method [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1009",
      "r1020",
      "r1030",
      "r1063"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_StockIssuedDuringPeriodSharesAchievementOfMilestone": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesAchievementOfMilestone",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with achievement of regulatory approval milestone, net of issuance costs (in shares)",
        "terseLabel": "Shares issued in connection with the Restated Collaboration Agreement (in shares)",
        "negatedTerseLabel": "Shares issued in connection with the Restated Collaboration Agreement (in shares)",
        "label": "Stock Issued During Period, Shares, Achievement Of Milestone",
        "documentation": "Stock Issued During Period, Shares, Achievement Of Milestone"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/DebtConversionActivityforSeniorConvertibleNotesDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Conversions of 2023 Notes (in shares)",
        "terseLabel": "Repurchase and conversions of notes (in shares)",
        "negatedNetLabel": "Shares issued in connection with 2023 Notes conversions (in shares)",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r50",
      "r90",
      "r94",
      "r135",
      "r461"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeBenefitPlan": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeBenefitPlan",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock under equity incentive plans (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Benefit Plan",
        "documentation": "Number of shares issued during the period to an employee benefit plan, such as a defined contribution or defined benefit plan."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for employee stock purchase plan (in shares)",
        "label": "Stock Issued During Period, Shares, Employee Stock Purchase Plans",
        "documentation": "Number of shares issued during the period as a result of an employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r89",
      "r90",
      "r135"
     ]
    },
    "dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants",
     "presentation": [
      "http://www.dexcom.com/role/Debt2023WarrantsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock issued during period, shares, exercise and settlement of remaining warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Exercise and Settlement of Remaining Warrants",
        "documentation": "Stock Issued During Period, Shares, Exercise and Settlement of Remaining Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/Debt2023WarrantsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise and settlement of warrants (in shares)",
        "negatedLabel": "Shares issued in connection with 2023 Warrants (in shares)",
        "label": "Stock Issued During Period, Shares, Exercise and Settlement of Warrants",
        "documentation": "Stock Issued During Period, Shares, Exercise and Settlement of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Issuance of common stock in connection with acquisition, shares (in shares)",
        "label": "Stock Issued During Period, Shares, New Issues",
        "documentation": "Number of new stock issued during the period."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r89",
      "r90",
      "r135",
      "r779",
      "r852",
      "r874"
     ]
    },
    "dxcm_StockIssuedDuringPeriodValueAchievementOfMilestones": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodValueAchievementOfMilestones",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock in connection with achievement of sales-based milestone, net of issuance costs",
        "label": "Stock Issued During Period, Value, Achievement Of Milestones",
        "documentation": "Stock Issued During Period, Value, Achievement Of Milestones"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Conversions of 2023 Notes",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r90",
      "r94",
      "r95",
      "r135"
     ]
    },
    "us-gaap_StockIssuedDuringPeriodValueEmployeeStockPurchasePlan": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockIssuedDuringPeriodValueEmployeeStockPurchasePlan",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Issuance of common stock for Employee Stock Purchase Plan",
        "label": "Stock Issued During Period, Value, Employee Stock Purchase Plan",
        "documentation": "Aggregate change in value for stock issued during the period as a result of employee stock purchase plan."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r89",
      "r90",
      "r135"
     ]
    },
    "dxcm_StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Exercise and settlement of warrants",
        "label": "Stock Issued During Period, Value, Exercise and Settlement of Warrants",
        "documentation": "Stock Issued During Period, Value, Exercise and Settlement of Warrants"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_StockIssuedDuringPeriodValueExerciseOfNoteHedge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "StockIssuedDuringPeriodValueExerciseOfNoteHedge",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Benefit of note hedge upon conversions of 2023 Notes",
        "label": "Stock Issued During Period, Value, Exercise of Note Hedge",
        "documentation": "Stock Issued During Period, Value, Exercise of Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "srt_StockRepurchaseProgramAuthorizedAmount1": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "StockRepurchaseProgramAuthorizedAmount1",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stock repurchase program, authorized amount",
        "label": "Share Repurchase Program, Authorized, Amount",
        "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership."
       }
      }
     },
     "auth_ref": [
      "r1203"
     ]
    },
    "us-gaap_StockholdersEquity": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquity",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Equity, Attributable to Parent",
        "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest."
       }
      }
     },
     "auth_ref": [
      "r90",
      "r94",
      "r95",
      "r124",
      "r814",
      "r831",
      "r853",
      "r854",
      "r957",
      "r986",
      "r1135",
      "r1169",
      "r1266",
      "r1324"
     ]
    },
    "us-gaap_StockholdersEquityAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Stockholders\u2019 equity:",
        "label": "Equity, Attributable to Parent [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
     "crdr": "credit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0,
       "order": 3.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "totalLabel": "Total stockholders\u2019 equity",
        "label": "Equity, Including Portion Attributable to Noncontrolling Interest",
        "documentation": "Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity."
       }
      }
     },
     "auth_ref": [
      "r62",
      "r63",
      "r65",
      "r219",
      "r220",
      "r252",
      "r275",
      "r276",
      "r277",
      "r279",
      "r284",
      "r286",
      "r376",
      "r377",
      "r414",
      "r481",
      "r586",
      "r587",
      "r593",
      "r594",
      "r595",
      "r597",
      "r598",
      "r599",
      "r606",
      "r607",
      "r608",
      "r609",
      "r610",
      "r611",
      "r613",
      "r631",
      "r632",
      "r636",
      "r640",
      "r664",
      "r768",
      "r769",
      "r785",
      "r814",
      "r831",
      "r853",
      "r854",
      "r878",
      "r985",
      "r1135",
      "r1169",
      "r1266",
      "r1324"
     ]
    },
    "us-gaap_SummaryOfIncomeTaxExaminationsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SummaryOfIncomeTaxExaminationsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Years Remaining Subject to Audit by Major Jurisdiction",
        "label": "Summary of Income Tax Examinations [Table Text Block]",
        "documentation": "Tabular disclosure of income tax examinations that an enterprise is currently subject to or that have been completed in the current period typically including a description of the examination, the jurisdiction conducting the examination, the tax year(s) under examination, the likelihood of an unfavorable settlement, the range of possible losses, the liability recorded, the increase or decrease in the liability from the prior period, and any penalties and interest that have been recorded."
       }
      }
     },
     "auth_ref": [
      "r1237"
     ]
    },
    "us-gaap_SummaryOfOperatingLossCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SummaryOfOperatingLossCarryforwardsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Operating Loss Carryforwards",
        "label": "Summary of Operating Loss Carryforwards [Table Text Block]",
        "documentation": "Tabular disclosure of pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization."
       }
      }
     },
     "auth_ref": [
      "r1241"
     ]
    },
    "us-gaap_SummaryOfTaxCreditCarryforwardsTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SummaryOfTaxCreditCarryforwardsTextBlock",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesTables"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Schedule of Tax Credit Carryforwards",
        "label": "Summary of Tax Credit Carryforwards [Table Text Block]",
        "documentation": "Tabular disclosure of tax credit carryforwards available to reduce future taxable income, including amounts, expiration dates, limitations on use and the related deferred tax assets and valuation allowances."
       }
      }
     },
     "auth_ref": [
      "r1241"
     ]
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SupplementalCashFlowInformationAbstract",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supplemental cash flow information:",
        "label": "Supplemental Cash Flow Information [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_SupplyExpensesAndClinicalTrials": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "SupplyExpensesAndClinicalTrials",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Supply expenses and clinical trials",
        "label": "Supply Expenses And Clinical Trials",
        "documentation": "Supply Expenses And Clinical Trials"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tabular List, Table",
        "label": "Tabular List [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1056"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAmount",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credits",
        "label": "Tax Credit Carryforward, Amount",
        "documentation": "The amount of the tax credit carryforward, before tax effects, available to reduce future taxable income under enacted tax laws."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardAxis",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward [Axis]",
        "label": "Tax Credit Carryforward [Axis]",
        "documentation": "Information by specific tax credit related to an unused tax credit."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TaxCreditCarryforwardNameDomain",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofTaxCreditsandOperatingLossCarryforwardsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax Credit Carryforward, Name [Domain]",
        "label": "Tax Credit Carryforward, Name [Domain]",
        "documentation": "The name of the tax credit carryforward."
       }
      }
     },
     "auth_ref": [
      "r583"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Amount",
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r1048"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Total Shareholder Return Vs Peer Group",
        "label": "Total Shareholder Return Vs Peer Group [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r1055"
     ]
    },
    "us-gaap_TrademarksAndTradeNamesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TrademarksAndTradeNamesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trademarks and trade name",
        "label": "Trademarks and Trade Names [Member]",
        "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style, or rights either acquired through registration of a business name to gain or protect exclusive use thereof."
       }
      }
     },
     "auth_ref": [
      "r60",
      "r1174",
      "r1175",
      "r1176",
      "r1177",
      "r1178",
      "r1179",
      "r1181",
      "r1183",
      "r1184",
      "r1185"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangement:",
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r1076"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Arrangements, by Individual",
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.dexcom.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Financial Instruments [Domain]",
        "label": "Financial Instruments [Domain]",
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms."
       }
      }
     },
     "auth_ref": [
      "r343",
      "r344",
      "r345",
      "r346",
      "r347",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r354",
      "r355",
      "r356",
      "r357",
      "r358",
      "r359",
      "r360",
      "r361",
      "r362",
      "r363",
      "r364",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r371",
      "r372",
      "r469",
      "r478",
      "r612",
      "r628",
      "r666",
      "r667",
      "r668",
      "r669",
      "r670",
      "r671",
      "r672",
      "r673",
      "r674",
      "r675",
      "r676",
      "r677",
      "r678",
      "r679",
      "r680",
      "r683",
      "r684",
      "r685",
      "r686",
      "r687",
      "r688",
      "r689",
      "r690",
      "r691",
      "r692",
      "r693",
      "r694",
      "r695",
      "r696",
      "r697",
      "r751",
      "r943",
      "r946",
      "r948",
      "r949",
      "r950",
      "r951",
      "r952",
      "r953",
      "r954",
      "r958",
      "r1110",
      "r1111",
      "r1112",
      "r1113",
      "r1114",
      "r1115",
      "r1116",
      "r1165",
      "r1166",
      "r1167",
      "r1168",
      "r1249",
      "r1252",
      "r1253",
      "r1254",
      "r1261",
      "r1264"
     ]
    },
    "us-gaap_TravelAndEntertainmentExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TravelAndEntertainmentExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails": {
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0,
       "order": 11.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSegmentRevenueSegmentProfitorLossandSignificantSegmentExpensesDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Travel related expenses",
        "label": "Travel and Entertainment Expense",
        "documentation": "Expenses incurred for travel and entertainment during the period."
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Adoption Date",
        "label": "Trading Arrangement Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Arrangement Duration",
        "label": "Trading Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Expiration Date",
        "label": "Trading Arrangement Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r1080"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title",
        "label": "Trading Arrangement, Individual Title"
       }
      }
     },
     "auth_ref": [
      "r1078"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Aggregate Available",
        "label": "Trading Arrangement, Securities Aggregate Available Amount"
       }
      }
     },
     "auth_ref": [
      "r1081"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Termination Date",
        "label": "Trading Arrangement Termination Date"
       }
      }
     },
     "auth_ref": [
      "r1079"
     ]
    },
    "us-gaap_TreasuryStockCommonMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonMember",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury Stock",
        "label": "Treasury Stock, Common [Member]",
        "documentation": "Previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_TreasuryStockCommonShares": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonShares",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Treasury stock, at cost (in shares)",
        "label": "Treasury Stock, Common, Shares",
        "documentation": "Number of previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52"
     ]
    },
    "us-gaap_TreasuryStockCommonValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockCommonValue",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets": {
       "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
       "weight": -1.0,
       "order": 7.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedBalanceSheets"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Treasury stock, at cost; 18.2 million shares at December\u00a031, 2024 and 21.8 million shares at December\u00a031, 2023",
        "label": "Treasury Stock, Common, Value",
        "documentation": "Amount allocated to previously issued common shares repurchased by the issuing entity and held in treasury."
       }
      }
     },
     "auth_ref": [
      "r52",
      "r53",
      "r94"
     ]
    },
    "us-gaap_TreasuryStockSharesAcquired": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockSharesAcquired",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityScheduleofTreasureShareActivityDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock, including excise tax (in shares)",
        "terseLabel": "Purchases of treasury stock (in shares)",
        "verboseLabel": "Shares repurchased under the Share Repurchase Program (in shares)",
        "label": "Treasury Stock, Shares, Acquired",
        "documentation": "Number of shares that have been repurchased during the period and are being held in treasury."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r90",
      "r135"
     ]
    },
    "us-gaap_TreasuryStockValueAcquiredCostMethod": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TreasuryStockValueAcquiredCostMethod",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofStockholdersEquity"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Purchases of treasury stock, including excise tax",
        "label": "Treasury Stock, Value, Acquired, Cost Method",
        "documentation": "Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method."
       }
      }
     },
     "auth_ref": [
      "r10",
      "r52",
      "r135"
     ]
    },
    "dxcm_TreasuryStockValueBenefitReceivedFromNoteHedge": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "TreasuryStockValueBenefitReceivedFromNoteHedge",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofCashFlows"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Shares received under note hedge upon conversion of 2023 Notes",
        "label": "Treasury Stock, Value, Benefit Received From Note Hedge",
        "documentation": "Treasury Stock, Value, Benefit Received From Note Hedge"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_TypeOfArrangementAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "TypeOfArrangementAxis",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]",
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations."
       }
      }
     },
     "auth_ref": [
      "r600"
     ]
    },
    "country_US": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/country/2024",
     "localname": "US",
     "presentation": [
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationGeographicInformationDetails",
      "http://www.dexcom.com/role/BusinessSegmentandGeographicInformationSummaryDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "United States",
        "label": "UNITED STATES"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_USGovernmentCorporationsAndAgenciesSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "USGovernmentCorporationsAndAgenciesSecuritiesMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofShortTermMarketableSecuritiesDetails",
      "http://www.dexcom.com/role/FairValueMeasurementsScheduleofFairValueHierarchyforFinancialAssetsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "U.S. government agencies",
        "label": "US Government Corporations and Agencies Securities [Member]",
        "documentation": "This category includes information about debt issued by US Government Corporations and Agencies. Investments in such US Government Corporations may include debt securities issued by the Government National Mortgage Association (Ginnie Mae) and by the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac)."
       }
      }
     },
     "auth_ref": [
      "r1285"
     ]
    },
    "us-gaap_UnamortizedDebtIssuanceExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnamortizedDebtIssuanceExpense",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails": {
       "parentTag": "us-gaap_ConvertibleNotesPayable",
       "weight": -1.0,
       "order": 2.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/DebtScheduleofCarryingValuesandEstimatedFairValuesofDebtInstrumentsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Unamortized debt issuance costs",
        "label": "Unamortized Debt Issuance Expense",
        "documentation": "The remaining balance of debt issuance expenses that were capitalized and are being amortized against income over the lives of the respective bond issues. This does not include the amounts capitalized as part of the cost of the utility plant or asset."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UnbilledContractsReceivable": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnbilledContractsReceivable",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unbilled accounts receivable",
        "label": "Unbilled Contracts Receivable",
        "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet."
       }
      }
     },
     "auth_ref": [
      "r699"
     ]
    },
    "us-gaap_UndistributedEarningsOfForeignSubsidiaries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UndistributedEarningsOfForeignSubsidiaries",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Undistributed foreign earnings",
        "label": "Undistributed Earnings of Foreign Subsidiaries",
        "documentation": "Amount of undistributed earnings of foreign subsidiaries intended to be permanently reinvested outside the country of domicile."
       }
      }
     },
     "auth_ref": [
      "r7",
      "r8",
      "r165",
      "r550"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Underlying Security Market Price Change",
        "label": "Underlying Security Market Price Change, Percent"
       }
      }
     },
     "auth_ref": [
      "r1075"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefits",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Balance at beginning of period",
        "periodEndLabel": "Balance at end of period",
        "label": "Unrecognized Tax Benefits",
        "documentation": "Amount of unrecognized tax benefits."
       }
      }
     },
     "auth_ref": [
      "r551",
      "r570",
      "r941"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "negatedTerseLabel": "Decreases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions",
        "documentation": "Amount of decrease in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r941"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to current year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions that have been or will be taken in current period tax return."
       }
      }
     },
     "auth_ref": [
      "r572",
      "r941"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesScheduleofUnrecognizedTaxBenefitsDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Increases related to prior year tax positions",
        "label": "Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions",
        "documentation": "Amount of increase in unrecognized tax benefits resulting from tax positions taken in prior period tax returns."
       }
      }
     },
     "auth_ref": [
      "r571",
      "r941"
     ]
    },
    "us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Unrecognized tax benefits that would impact effective tax rate",
        "label": "Unrecognized Tax Benefits that Would Impact Effective Tax Rate",
        "documentation": "The total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate."
       }
      }
     },
     "auth_ref": [
      "r573",
      "r941"
     ]
    },
    "dxcm_UnusedExpiredFederalIncomeTaxCredits": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "UnusedExpiredFederalIncomeTaxCredits",
     "crdr": "debit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Tax credit carryforwards subject to expiration",
        "label": "Unused Expired Federal Income Tax Credits",
        "documentation": "Federal income tax credits likely to expire unused as a result of limitations"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_UseOfEstimates": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "UseOfEstimates",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesPolicies"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Use of Estimates",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles."
       }
      }
     },
     "auth_ref": [
      "r36",
      "r37",
      "r38",
      "r170",
      "r172",
      "r176",
      "r177"
     ]
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/IncomeTaxesNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Valuation allowance, deferred tax asset, increase (decrease), amount",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset."
       }
      }
     },
     "auth_ref": [
      "r576"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesBalance": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesBalance",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "periodStartLabel": "Beginning Balance",
        "periodEndLabel": "Ending Balance",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount",
        "documentation": "Amount of valuation and qualifying accounts and reserves."
       }
      }
     },
     "auth_ref": [
      "r271",
      "r273"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesChargedToCostAndExpense": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesChargedToCostAndExpense",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Provision for doubtful accounts",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from charge to cost and expense."
       }
      }
     },
     "auth_ref": [
      "r272"
     ]
    },
    "us-gaap_ValuationAllowancesAndReservesRecoveries": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ValuationAllowancesAndReservesRecoveries",
     "crdr": "credit",
     "presentation": [
      "http://www.dexcom.com/role/SCHEDULEIIVALUATIONANDQUALIFYINGACCOUNTSDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Recoveries",
        "label": "SEC Schedule, 12-09, Valuation Allowances and Reserves, Addition, Recovery",
        "documentation": "Amount of increase in valuation and qualifying accounts and reserves from recovery of amount previously written off or reestablishment of reserve previously utilized."
       }
      }
     },
     "auth_ref": [
      "r1137"
     ]
    },
    "srt_ValuationAndQualifyingAccountsAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/srt/2024",
     "localname": "ValuationAndQualifyingAccountsAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]",
        "label": "SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableLeaseCost": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableLeaseCost",
     "crdr": "debit",
     "calculation": {
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails": {
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0,
       "order": 6.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/LeasesandOtherCommitmentsScheduleofComponentsofLeaseExpenseandOtherInformationDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable lease cost",
        "label": "Variable Lease, Cost",
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases."
       }
      }
     },
     "auth_ref": [
      "r656",
      "r956"
     ]
    },
    "us-gaap_VariableRateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateAxis",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Axis]",
        "label": "Variable Rate [Axis]",
        "documentation": "Information by type of variable rate."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_VariableRateDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "VariableRateDomain",
     "presentation": [
      "http://www.dexcom.com/role/DebtAvailabilityandOutstandingBorrowingsunderCreditAgreementDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Variable Rate [Domain]",
        "label": "Variable Rate [Domain]",
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index."
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_VerilyIntangibleMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "VerilyIntangibleMember",
     "presentation": [
      "http://www.dexcom.com/role/BalanceSheetDetailsandOtherFinancialInformationScheduleofIntangibleNetDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Verily intangible asset",
        "label": "Verily Intangible [Member]",
        "documentation": "Verily Intangible"
       }
      }
     },
     "auth_ref": []
    },
    "dxcm_VerilyLifeSciencesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.dexcom.com/20241231",
     "localname": "VerilyLifeSciencesMember",
     "presentation": [
      "http://www.dexcom.com/role/DevelopmentandOtherAgreementsDetails",
      "http://www.dexcom.com/role/EmployeeBenefitPlansandStockholdersEquityNarrativeDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Verily Life Sciences",
        "label": "Verily Life Sciences [Member]",
        "documentation": "Verily Life Sciences [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year",
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]"
       }
      }
     },
     "auth_ref": [
      "r1044"
     ]
    },
    "us-gaap_WarrantMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WarrantMember",
     "presentation": [
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Warrants",
        "label": "Warrant [Member]",
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount."
       }
      }
     },
     "auth_ref": [
      "r976",
      "r977",
      "r980",
      "r981",
      "r982",
      "r983"
     ]
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": null,
       "weight": null,
       "order": null,
       "root": true
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used to compute diluted net income per share (in shares)",
        "totalLabel": "Diluted weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period."
       }
      }
     },
     "auth_ref": [
      "r290",
      "r300"
     ]
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "calculation": {
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails": {
       "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding",
       "weight": 1.0,
       "order": 1.0
      }
     },
     "presentation": [
      "http://www.dexcom.com/role/ConsolidatedStatementsofOperations",
      "http://www.dexcom.com/role/OrganizationandSignificantAccountingPoliciesScheduleofBasicandDilutedNetIncomeLossPerShareDetails"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Shares used to compute basic net income per share (in shares)",
        "verboseLabel": "Basic weighted average shares outstanding (in shares)",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period."
       }
      }
     },
     "auth_ref": [
      "r289",
      "r300"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested",
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]"
       }
      }
     },
     "auth_ref": [
      "r1042"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "SubTopic": "230",
   "Topic": "830",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "SubTopic": "10",
   "Topic": "220",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r3": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20"
  },
  "r4": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r5": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r6": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "SubTopic": "10",
   "Topic": "360",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r7": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "942",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477617/942-740-50-1"
  },
  "r8": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "740",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478822/944-740-50-1"
  },
  "r9": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(c)(3)",
   "SubTopic": "10",
   "Topic": "810",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A"
  },
  "r10": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "505",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r11": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "SubTopic": "10",
   "Topic": "815",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-2"
  },
  "r12": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r13": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r14": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "718",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r15": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22))",
   "SubTopic": "10",
   "Topic": "210",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r16": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-8"
  },
  "r17": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "210",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r18": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14"
  },
  "r19": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A"
  },
  "r20": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "220",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5"
  },
  "r21": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r22": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r23": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r24": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-4"
  },
  "r25": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-1"
  },
  "r26": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r27": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-3"
  },
  "r28": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-4"
  },
  "r29": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "230",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-5"
  },
  "r30": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r31": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "260",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-2"
  },
  "r32": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-16"
  },
  "r33": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r34": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-20"
  },
  "r35": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-21"
  },
  "r36": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-4"
  },
  "r37": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-8"
  },
  "r38": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "275",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-9"
  },
  "r39": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r40": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r41": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r42": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r43": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r44": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "280",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r45": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482130/360-10-45-4"
  },
  "r46": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "360",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r47": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "460",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r48": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5"
  },
  "r49": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "470",
   "SubTopic": "20",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r50": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r51": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8"
  },
  "r52": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481549/505-30-45-1"
  },
  "r53": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "505",
   "SubTopic": "30",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r54": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "710",
   "SubTopic": "10",
   "Section": "30",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483043/710-10-30-2"
  },
  "r55": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-1"
  },
  "r56": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r57": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r58": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-12"
  },
  "r59": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "718",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481089/718-20-55-13"
  },
  "r60": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "14",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-14"
  },
  "r61": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "805",
   "SubTopic": "20",
   "Section": "55",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479876/805-20-55-20"
  },
  "r62": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-15"
  },
  "r63": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-16"
  },
  "r64": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1"
  },
  "r65": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "810",
   "SubTopic": "10",
   "Section": "55",
   "Paragraph": "4I",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481175/810-10-55-4I"
  },
  "r66": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4A"
  },
  "r67": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4C"
  },
  "r68": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "815",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "4D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4D"
  },
  "r69": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-20"
  },
  "r70": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "825",
   "SubTopic": "10",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r71": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "320",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-5"
  },
  "r72": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "470",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r73": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Name": "Accounting Standards Codification",
   "Topic": "942",
   "SubTopic": "825",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478898/942-825-50-1"
  },
  "r74": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "205",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/205/tableOfContent"
  },
  "r75": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r76": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r77": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r78": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r79": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(21))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r80": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r81": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r82": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(22)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r83": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r84": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r85": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r86": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r87": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r88": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r89": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r90": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r91": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r92": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r93": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r94": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r95": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(31))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r96": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(32))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r97": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r98": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r99": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r100": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r101": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r102": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r103": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r104": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r105": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r106": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r107": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r108": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r109": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r110": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r111": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r112": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r113": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r114": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r115": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r116": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r117": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r118": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r119": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r120": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r121": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r122": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "275",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r123": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r124": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 4.E)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2"
  },
  "r125": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480581/330-10-S99-2"
  },
  "r126": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r127": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r128": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "450",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/450/tableOfContent"
  },
  "r129": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/470/tableOfContent"
  },
  "r130": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481573/470-10-45-12A"
  },
  "r131": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-5"
  },
  "r132": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r133": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6"
  },
  "r134": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7"
  },
  "r135": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r136": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/710/tableOfContent"
  },
  "r137": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "710",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483070/710-10-25-9"
  },
  "r138": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "712",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/712/tableOfContent"
  },
  "r139": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "715",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/715/tableOfContent"
  },
  "r140": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r141": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r142": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r143": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "718",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Section": "50",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r144": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/810/tableOfContent"
  },
  "r145": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19"
  },
  "r146": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4B"
  },
  "r147": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "820",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/820/tableOfContent"
  },
  "r148": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-21"
  },
  "r149": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r150": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r151": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r152": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r153": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r154": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r155": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r156": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r157": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r158": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r159": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r160": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "470",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3"
  },
  "r161": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r162": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r163": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r164": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r165": {
   "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "270",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-6"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "35",
   "Topic": "720",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "SubTopic": "10",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-1"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-11"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-12"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "SubTopic": "360",
   "Topic": "958",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477798/958-360-50-6"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h))",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "606",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/606/tableOfContent"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Accounting Standards Codification",
   "Topic": "808",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/808/tableOfContent"
  },
  "r183": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r184": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "04",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r185": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "09",
   "Publisher": "SEC"
  },
  "r186": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r187": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12",
   "Paragraph": "Column C",
   "Footnote": "5",
   "Publisher": "SEC"
  },
  "r188": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r189": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12A",
   "Paragraph": "Column C",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r190": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(a)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r191": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column A",
   "Subparagraph": "(b)",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r192": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "12B",
   "Paragraph": "Column C",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r193": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r194": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "14",
   "Paragraph": "Column F",
   "Footnote": "7",
   "Publisher": "SEC"
  },
  "r195": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column A",
   "Publisher": "SEC"
  },
  "r196": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r197": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r198": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r199": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r200": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "17",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r201": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column A",
   "Footnote": "2",
   "Publisher": "SEC"
  },
  "r202": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column B",
   "Publisher": "SEC"
  },
  "r203": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column C",
   "Publisher": "SEC"
  },
  "r204": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column D",
   "Publisher": "SEC"
  },
  "r205": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column E",
   "Publisher": "SEC"
  },
  "r206": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column F",
   "Publisher": "SEC"
  },
  "r207": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column G",
   "Publisher": "SEC"
  },
  "r208": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column H",
   "Publisher": "SEC"
  },
  "r209": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "28",
   "Paragraph": "Column I",
   "Publisher": "SEC"
  },
  "r210": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "12",
   "Subsection": "29",
   "Paragraph": "Column A",
   "Footnote": "4",
   "Publisher": "SEC"
  },
  "r211": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(1)(iii)",
   "Publisher": "SEC"
  },
  "r212": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "4",
   "Subsection": "08",
   "Paragraph": "m",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r213": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "5",
   "Subsection": "04",
   "Paragraph": "c",
   "Subparagraph": "Schedule I",
   "Publisher": "SEC"
  },
  "r214": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "7",
   "Subsection": "05",
   "Paragraph": "c",
   "Subparagraph": "Schedule II",
   "Publisher": "SEC"
  },
  "r215": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Regulation S-X (SX)",
   "Number": "210",
   "Section": "9",
   "Subsection": "06",
   "Publisher": "SEC"
  },
  "r216": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 11",
   "Section": "L",
   "Publisher": "SEC"
  },
  "r217": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r218": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 4",
   "Publisher": "SEC"
  },
  "r219": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r220": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "105",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-6"
  },
  "r221": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r222": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r223": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-5"
  },
  "r224": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483489/210-10-50-1"
  },
  "r225": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r226": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r227": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(13))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r228": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r229": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(16))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r230": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r231": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r232": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r233": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(28))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r234": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(29))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r235": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r236": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r237": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r238": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r239": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r240": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r241": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r242": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r243": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10A",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A"
  },
  "r244": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11"
  },
  "r245": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r246": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r247": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r248": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r249": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r250": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-1"
  },
  "r251": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r252": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r253": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r254": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(24))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r255": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r256": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-11"
  },
  "r257": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r258": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-17"
  },
  "r259": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24"
  },
  "r260": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25"
  },
  "r261": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2"
  },
  "r262": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r263": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r264": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r265": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r266": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r267": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r268": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r269": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r270": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-04(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-3"
  },
  "r271": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r272": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r273": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r274": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r275": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r276": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r277": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r278": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r279": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r280": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r281": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r282": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r283": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r284": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r285": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r286": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-7"
  },
  "r287": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r288": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r289": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-10"
  },
  "r290": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-16"
  },
  "r291": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-2"
  },
  "r292": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-22"
  },
  "r293": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-23"
  },
  "r294": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-28A"
  },
  "r295": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-3"
  },
  "r296": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "40",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-40"
  },
  "r297": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r298": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r299": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-7"
  },
  "r300": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r301": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r302": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r303": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-15"
  },
  "r304": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r305": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-1"
  },
  "r306": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-1"
  },
  "r307": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482987/272-10-50-3"
  },
  "r308": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/280/tableOfContent"
  },
  "r309": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-15"
  },
  "r310": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r311": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-21"
  },
  "r312": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r313": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r314": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r315": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r316": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r317": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r318": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-25"
  },
  "r319": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26"
  },
  "r320": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26B"
  },
  "r321": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "26C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-26C"
  },
  "r322": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r323": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r324": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r325": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r326": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r327": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r328": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "34",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-34"
  },
  "r329": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-40"
  },
  "r330": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r331": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r332": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "41",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-41"
  },
  "r333": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "42",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-42"
  },
  "r334": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-13"
  },
  "r335": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r336": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r337": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r338": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r339": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-4"
  },
  "r340": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "310",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481569/310-20-50-1"
  },
  "r341": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r342": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-2"
  },
  "r343": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r344": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r345": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r346": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r347": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r348": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r349": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r350": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r351": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r352": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r353": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r354": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r355": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r356": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r357": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r358": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r359": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r360": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r361": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r362": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r363": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r364": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5"
  },
  "r365": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r366": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r367": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5A"
  },
  "r368": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r369": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r370": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r371": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r372": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-5B"
  },
  "r373": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r374": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r375": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r376": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-4"
  },
  "r377": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "5",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479654/326-10-65-5"
  },
  "r378": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479344/326-20-45-1"
  },
  "r379": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-11"
  },
  "r380": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r381": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r382": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-13"
  },
  "r383": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-14"
  },
  "r384": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-16"
  },
  "r385": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479319/326-20-50-5"
  },
  "r386": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479130/326-30-45-1"
  },
  "r387": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-4"
  },
  "r388": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-7"
  },
  "r389": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479106/326-30-50-9"
  },
  "r390": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/330/tableOfContent"
  },
  "r391": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-1"
  },
  "r392": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-2"
  },
  "r393": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "330",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483080/330-10-50-4"
  },
  "r394": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482955/340-10-05-5"
  },
  "r395": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "340",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483032/340-10-45-1"
  },
  "r396": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480265/350-10-S45-1"
  },
  "r397": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-1"
  },
  "r398": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482598/350-20-45-2"
  },
  "r399": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r400": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-2"
  },
  "r401": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r402": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-2"
  },
  "r403": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r404": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r405": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r406": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r407": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r408": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r409": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r410": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r411": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r412": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r413": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-3"
  },
  "r414": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "350",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476166/350-60-65-1"
  },
  "r415": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-2"
  },
  "r416": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-3"
  },
  "r417": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r418": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r419": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r420": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r421": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r422": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r423": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481999/410-20-25-4"
  },
  "r424": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "410",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481850/410-20-50-1"
  },
  "r425": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "420",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482017/420-10-50-1"
  },
  "r426": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "440",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482648/440-10-50-6"
  },
  "r427": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-4"
  },
  "r428": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r429": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r430": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r431": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r432": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r433": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r434": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r435": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r436": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r437": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r438": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r439": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r440": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r441": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r442": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r443": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r444": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r445": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r446": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r447": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r448": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r449": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r450": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r451": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r452": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r453": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r454": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r455": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1C",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1C"
  },
  "r456": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r457": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r458": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1D",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1D"
  },
  "r459": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r460": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r461": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r462": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1E",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1E"
  },
  "r463": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r464": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r465": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r466": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1F",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1F"
  },
  "r467": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r468": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r469": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r470": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1I",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1I"
  },
  "r471": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r472": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-6"
  },
  "r473": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r474": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r475": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r476": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r477": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-14"
  },
  "r478": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-18"
  },
  "r479": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-2"
  },
  "r480": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-3"
  },
  "r481": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.3-04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480008/505-10-S99-1"
  },
  "r482": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-1"
  },
  "r483": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479837/606-10-45-2"
  },
  "r484": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-17"
  },
  "r485": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r486": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-18"
  },
  "r487": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-19"
  },
  "r488": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r489": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r490": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r491": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-20"
  },
  "r492": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-4"
  },
  "r493": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r494": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-8"
  },
  "r495": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r496": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r497": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r498": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r499": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r500": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r501": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r502": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "70",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480794/715-70-50-1"
  },
  "r503": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480576/715-80-50-5"
  },
  "r504": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/718/tableOfContent"
  },
  "r505": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-1D"
  },
  "r506": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-2"
  },
  "r507": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480483/718-10-35-3"
  },
  "r508": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480454/718-10-45-1"
  },
  "r509": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r510": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r511": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r512": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r513": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r514": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r515": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r516": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r517": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r518": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r519": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r520": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r521": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r522": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r523": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r524": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r525": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r526": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r527": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r528": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r529": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r530": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r531": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r532": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r533": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r534": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r535": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r536": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r537": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r538": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r539": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r540": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.C.Q3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r541": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.1.Q5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r542": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.2.Q6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r543": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.D.3.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r544": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 14.F)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479830/718-10-S99-1"
  },
  "r545": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483359/720-20-50-1"
  },
  "r546": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483406/720-35-50-1"
  },
  "r547": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "05",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483044/730-10-05-1"
  },
  "r548": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "730",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482916/730-10-50-1"
  },
  "r549": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/740/tableOfContent"
  },
  "r550": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482620/740-10-25-3"
  },
  "r551": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-10B"
  },
  "r552": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-15"
  },
  "r553": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-25"
  },
  "r554": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-28"
  },
  "r555": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-4"
  },
  "r556": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482525/740-10-45-6"
  },
  "r557": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10"
  },
  "r558": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-10A"
  },
  "r559": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r560": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r561": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r562": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r563": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r564": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r565": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r566": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12B"
  },
  "r567": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12C"
  },
  "r568": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-14"
  },
  "r569": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r570": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r571": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r572": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r573": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15A"
  },
  "r574": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-17"
  },
  "r575": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-19"
  },
  "r576": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r577": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r578": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r579": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r580": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "20",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-20"
  },
  "r581": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-21"
  },
  "r582": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r583": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r584": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r585": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r586": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r587": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(d)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482615/740-10-65-8"
  },
  "r588": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.5.Q1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r589": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r590": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SAB Topic 11.C)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-2"
  },
  "r591": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "270",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477891/740-270-50-1"
  },
  "r592": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482603/740-30-50-2"
  },
  "r593": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r594": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r595": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r596": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r597": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r598": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r599": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r600": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "808",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479402/808-10-50-1"
  },
  "r601": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r602": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "25",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-25"
  },
  "r603": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r604": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-3"
  },
  "r605": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-4E"
  },
  "r606": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r607": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r608": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r609": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r610": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(h)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r611": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "6",
   "Subparagraph": "(i)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480528/815-20-65-6"
  },
  "r612": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480237/815-40-50-5"
  },
  "r613": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r614": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r615": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r616": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r617": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r618": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r619": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r620": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r621": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r622": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r623": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r624": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r625": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r626": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r627": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r628": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6B"
  },
  "r629": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r630": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "230",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1"
  },
  "r631": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-17"
  },
  "r632": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r633": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r634": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r635": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "20",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20"
  },
  "r636": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "830",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481674/830-30-50-1"
  },
  "r637": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r638": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r639": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r640": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "8",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479832/842-10-65-8"
  },
  "r641": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/842-20/tableOfContent"
  },
  "r642": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "12A",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479165/842-20-35-12A"
  },
  "r643": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r644": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r645": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-2"
  },
  "r646": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r647": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r648": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r649": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-5"
  },
  "r650": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-1"
  },
  "r651": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r652": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r653": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r654": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r655": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r656": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r657": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r658": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r659": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r660": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(g)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r661": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r662": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r663": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-7A"
  },
  "r664": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "848",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483550/848-10-65-2"
  },
  "r665": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "850",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483326/850-10-50-3"
  },
  "r666": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r667": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r668": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r669": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r670": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r671": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(bb)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r672": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r673": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r674": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r675": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r676": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r677": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r678": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r679": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481444/860-30-45-1"
  },
  "r680": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r681": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-7"
  },
  "r682": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481420/860-30-50-9"
  },
  "r683": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r684": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r685": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r686": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(4)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-3"
  },
  "r687": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r688": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r689": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r690": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r691": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r692": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r693": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)(7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r694": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r695": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r696": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r697": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "860",
   "SubTopic": "50",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481229/860-50-50-4"
  },
  "r698": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "910",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482546/910-10-50-6"
  },
  "r699": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478345/912-310-45-2"
  },
  "r700": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "912",
   "SubTopic": "330",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478411/912-330-50-1"
  },
  "r701": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "924",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 11.L)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479941/924-10-S99-1"
  },
  "r702": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "926",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483154/926-20-50-5"
  },
  "r703": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "928",
   "SubTopic": "340",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478859/928-340-50-1"
  },
  "r704": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478934/932-220-50-1"
  },
  "r705": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r706": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r707": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-18"
  },
  "r708": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "19",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-19"
  },
  "r709": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r710": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r711": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r712": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r713": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r714": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-23"
  },
  "r715": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r716": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r717": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r718": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r719": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r720": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-31"
  },
  "r721": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r722": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r723": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r724": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r725": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r726": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-5"
  },
  "r727": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-6"
  },
  "r728": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-7"
  },
  "r729": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r730": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r731": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-8"
  },
  "r732": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "280",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478657/932-280-50-1"
  },
  "r733": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "932",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478988/932-323-50-1"
  },
  "r734": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r735": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r736": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(26))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r737": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(27))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r738": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "942",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477314/942-235-S99-1"
  },
  "r739": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r740": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r741": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r742": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r743": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r744": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r745": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r746": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r747": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r748": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(11))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r749": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r750": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r751": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r752": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r753": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r754": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(23))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r755": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r756": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r757": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r758": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r759": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r760": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r761": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-17(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477965/944-235-S99-2"
  },
  "r762": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4E"
  },
  "r763": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r764": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r765": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r766": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-9"
  },
  "r767": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r768": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r769": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r770": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r771": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r772": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(h)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480016/944-40-65-2"
  },
  "r773": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.W.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479583/944-40-S99-1"
  },
  "r774": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "825",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r775": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-1"
  },
  "r776": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480424/946-10-50-2"
  },
  "r777": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r778": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(h)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r779": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r780": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r781": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r782": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-03(i)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479886/946-10-S99-3"
  },
  "r783": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-11"
  },
  "r784": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480990/946-20-50-13"
  },
  "r785": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-3"
  },
  "r786": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r787": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-2"
  },
  "r788": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "27",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-27"
  },
  "r789": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r790": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r791": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r792": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r793": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r794": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r795": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r796": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478494/946-205-50-7"
  },
  "r797": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477796/946-210-45-4"
  },
  "r798": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r799": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-2"
  },
  "r800": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r801": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r802": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r803": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r804": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r805": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r806": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r807": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(12)(b)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r808": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r809": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(13)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r810": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(14))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r811": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(15))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r812": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(16)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r813": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(17))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r814": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(19))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r815": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r816": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r817": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r818": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r819": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(3)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r820": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(5)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r821": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r822": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r823": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r824": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(6)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r825": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r826": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r827": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r828": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r829": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-04(9)(e))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-1"
  },
  "r830": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r831": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.6-05(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479170/946-210-S99-2"
  },
  "r832": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r833": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r834": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478297/946-220-50-3"
  },
  "r835": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r836": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r837": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(g)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r838": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r839": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r840": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r841": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r842": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r843": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(a)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r844": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r845": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r846": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r847": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r848": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r849": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(7)(c)(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r850": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r851": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r852": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r853": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(6))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r854": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r855": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r856": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column C)(Footnote 5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r857": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r858": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column C)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r859": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r860": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r861": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r862": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column A)(Footnote 3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r863": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 8))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5"
  },
  "r864": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r865": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r866": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5B",
   "Subparagraph": "(SX 210.12-13B(Column E)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5B"
  },
  "r867": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "5C",
   "Subparagraph": "(SX 210.12-13C(Column H)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-5C"
  },
  "r868": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r869": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r870": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D)(Footnote 6)(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r871": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r872": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column F)(Footnote 7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r873": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-1"
  },
  "r874": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r875": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r876": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r877": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-2"
  },
  "r878": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "505",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478448/946-505-50-3"
  },
  "r879": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "948",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-29(Column A)(Footnote 4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479628/948-310-S99-1"
  },
  "r880": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479196/954-310-45-1"
  },
  "r881": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478785/954-310-50-2"
  },
  "r882": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "954",
   "SubTopic": "450",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477850/954-450-50-1"
  },
  "r883": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r884": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r885": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r886": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r887": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r888": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r889": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r890": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r891": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "970",
   "SubTopic": "360",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478979/970-360-S99-1"
  },
  "r892": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "976",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477332/976-310-50-1"
  },
  "r893": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "978",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479230/978-310-50-1"
  },
  "r894": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  },
  "r895": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(e)",
   "SubTopic": "10",
   "Topic": "235",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r896": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(a)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r897": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(b)",
   "SubTopic": "40",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r898": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r899": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r900": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483467/210-10-45-1"
  },
  "r901": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r902": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r903": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r904": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "16",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-16"
  },
  "r905": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-21"
  },
  "r906": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "210",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483444/210-20-55-22"
  },
  "r907": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r908": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483426/235-10-50-4"
  },
  "r909": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "52",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482635/260-10-55-52"
  },
  "r910": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r911": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "31",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-31"
  },
  "r912": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r913": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r914": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "47",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-47"
  },
  "r915": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "48",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-48"
  },
  "r916": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "49",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-49"
  },
  "r917": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r918": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r919": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "54",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482785/280-10-55-54"
  },
  "r920": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481933/310-10-55-12A"
  },
  "r921": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "326",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479081/326-30-55-8"
  },
  "r922": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482548/350-20-55-24"
  },
  "r923": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "40",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482640/350-30-55-40"
  },
  "r924": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r925": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69B"
  },
  "r926": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69C"
  },
  "r927": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69E"
  },
  "r928": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "69F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481568/470-20-55-69F"
  },
  "r929": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "505",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "13",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-13"
  },
  "r930": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r931": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r932": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r933": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r934": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r935": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r936": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480482/715-20-55-17"
  },
  "r937": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "715",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480547/715-80-55-8"
  },
  "r938": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r939": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r940": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "720",
   "SubTopic": "35",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483385/720-35-55-1"
  },
  "r941": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "217",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-217"
  },
  "r942": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "231",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482663/740-10-55-231"
  },
  "r943": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r944": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r945": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "100",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-100"
  },
  "r946": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "101",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-101"
  },
  "r947": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "102",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-102"
  },
  "r948": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "103",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-103"
  },
  "r949": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r950": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r951": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r952": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r953": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r954": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "107",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482078/820-10-55-107"
  },
  "r955": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482949/835-30-55-8"
  },
  "r956": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "53",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479589/842-20-55-53"
  },
  "r957": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481372/852-10-55-10"
  },
  "r958": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "860",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481395/860-30-55-4"
  },
  "r959": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-17"
  },
  "r960": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "21",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-21"
  },
  "r961": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "29",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-29"
  },
  "r962": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477215/932-235-50-3"
  },
  "r963": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-2"
  },
  "r964": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-4"
  },
  "r965": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-5"
  },
  "r966": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "932",
   "SubTopic": "235",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477916/932-235-55-6"
  },
  "r967": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479401/944-30-55-2"
  },
  "r968": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "13H",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-13H"
  },
  "r969": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-29F"
  },
  "r970": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r971": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r972": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9C",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9C"
  },
  "r973": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "9E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480046/944-40-55-9E"
  },
  "r974": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "17",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-17"
  },
  "r975": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480078/944-80-55-18"
  },
  "r976": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-1"
  },
  "r977": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478795/946-210-50-6"
  },
  "r978": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477439/946-210-55-1"
  },
  "r979": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477802/946-310-45-1"
  },
  "r980": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r981": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r982": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r983": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r984": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r985": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-11"
  },
  "r986": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-12"
  },
  "r987": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r988": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r989": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r990": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r991": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r992": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r993": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r994": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K"
  },
  "r995": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r996": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r997": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r998": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r999": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1000": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1001": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1002": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1003": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1004": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16K",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1005": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r1006": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1007": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1008": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1009": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1010": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1011": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1012": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1013": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1014": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r1015": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r1016": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r1017": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1018": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1019": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1020": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1021": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1022": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1023": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1024": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1025": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r1026": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r1027": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r1028": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r1029": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r1030": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r1031": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r1032": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r1033": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r1034": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r1035": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r1036": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r1037": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r1038": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r1039": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1040": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1041": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1042": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r1043": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r1044": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r1045": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r1046": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r1047": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r1048": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r1049": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r1050": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r1051": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r1052": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r1053": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r1054": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r1055": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r1056": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r1057": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r1058": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r1059": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r1060": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1061": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r1062": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r1063": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r1064": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r1065": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r1066": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1067": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1068": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r1069": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r1070": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r1071": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r1072": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r1073": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r1074": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r1075": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r1076": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r1077": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r1078": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r1079": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r1080": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r1081": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r1082": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1083": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106"
  },
  "r1084": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r1085": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r1086": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r1087": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r1088": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "b",
   "Paragraph": "2"
  },
  "r1089": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "1"
  },
  "r1090": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2"
  },
  "r1091": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "i"
  },
  "r1092": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r1093": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "106",
   "Subsection": "c",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r1094": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r1095": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r1096": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r1097": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r1098": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r1099": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r1100": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "272",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483014/272-10-45-3"
  },
  "r1101": {
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef",
   "Topic": "810",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-11"
  },
  "r1102": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-1"
  },
  "r1103": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "12",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12"
  },
  "r1104": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "15",
   "SubTopic": "10",
   "Topic": "230",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15"
  },
  "r1105": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479041/842-20-45-4"
  },
  "r1106": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "SubTopic": "10",
   "Topic": "275",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-18"
  },
  "r1107": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "SubTopic": "825",
   "Topic": "944",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477351/944-825-50-1B"
  },
  "r1108": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "SubTopic": "20",
   "Topic": "842",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1109": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "SubTopic": "10",
   "Topic": "740",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1110": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "a",
   "Publisher": "SEC"
  },
  "r1111": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(1)",
   "Publisher": "SEC"
  },
  "r1112": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(2)",
   "Publisher": "SEC"
  },
  "r1113": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "b",
   "Subparagraph": "(3)",
   "Publisher": "SEC"
  },
  "r1114": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(i)",
   "Publisher": "SEC"
  },
  "r1115": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(ii)",
   "Publisher": "SEC"
  },
  "r1116": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Section": "1402",
   "Paragraph": "c",
   "Subparagraph": "(2)(iii)",
   "Publisher": "SEC"
  },
  "r1117": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Name": "Staff Accounting Bulletin (SAB)",
   "Number": "Topic 5",
   "Section": "Y",
   "Paragraph": "Question 2",
   "Publisher": "SEC"
  },
  "r1118": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1119": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1120": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(3)(a)(4))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1121": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "210",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.5-02(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480566/210-10-S99-1"
  },
  "r1122": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-4"
  },
  "r1123": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-5"
  },
  "r1124": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r1125": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(7)(c))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1126": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(9)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1127": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1128": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "13",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13"
  },
  "r1129": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "14",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-14"
  },
  "r1130": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r1131": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2A"
  },
  "r1132": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-8"
  },
  "r1133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1134": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(f))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1135": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1136": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r1137": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "4",
   "Subparagraph": "(SX 210.12-09(Column C)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-4"
  },
  "r1138": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "23",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-23"
  },
  "r1139": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "24",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-24"
  },
  "r1140": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483421/250-10-45-5"
  },
  "r1141": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r1142": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "55",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-55"
  },
  "r1143": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482662/260-10-50-1"
  },
  "r1144": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "270",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482964/270-10-50-1"
  },
  "r1145": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "18",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-18"
  },
  "r1146": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-22"
  },
  "r1147": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "30",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-30"
  },
  "r1148": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(ee)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1149": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "280",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "32",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482810/280-10-50-32"
  },
  "r1150": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481990/310-10-45-2"
  },
  "r1151": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "310",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481962/310-10-50-2"
  },
  "r1152": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-1"
  },
  "r1153": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "11",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481830/320-10-45-11"
  },
  "r1154": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1155": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1156": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(aaa)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1157": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1158": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1159": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-2"
  },
  "r1160": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1161": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1162": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1163": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1164": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-3"
  },
  "r1165": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "320",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481800/320-10-50-9"
  },
  "r1166": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1167": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1168": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "321",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479536/321-10-50-3"
  },
  "r1169": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r1170": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-20/tableOfContent"
  },
  "r1171": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1172": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(h)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482573/350-20-50-1"
  },
  "r1173": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/350-30/tableOfContent"
  },
  "r1174": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482686/350-30-45-1"
  },
  "r1175": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1176": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1177": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1178": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1179": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-1"
  },
  "r1180": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1181": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1182": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1184": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1185": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "350",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482665/350-30-50-2"
  },
  "r1186": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1187": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1188": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "360",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482099/360-10-50-1"
  },
  "r1189": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1190": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1191": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "405",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477092/405-40-50-1"
  },
  "r1192": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "410",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481931/410-30-50-10"
  },
  "r1193": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483076/450-20-50-9"
  },
  "r1194": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "450",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480102/450-20-S99-1"
  },
  "r1195": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1196": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1197": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "460",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Subparagraph": "(c)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482425/460-10-50-8"
  },
  "r1198": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1199": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-6"
  },
  "r1200": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1201": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r1202": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481139/470-20-50-1B"
  },
  "r1203": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "505",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481520/505-30-50-4"
  },
  "r1204": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-5"
  },
  "r1205": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "606",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "91",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479777/606-10-55-91"
  },
  "r1206": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "715",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(d)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480506/715-20-50-1"
  },
  "r1207": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1208": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1209": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1210": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1211": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1212": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1213": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1214": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1215": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1216": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1217": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1218": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1219": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1220": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1221": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1222": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1223": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1224": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1225": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1226": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1227": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1228": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1229": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1230": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1231": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1232": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1233": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r1234": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1235": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12"
  },
  "r1236": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "12A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-12A"
  },
  "r1237": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "15",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-15"
  },
  "r1238": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-2"
  },
  "r1239": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "22",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-22"
  },
  "r1240": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "23",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-23"
  },
  "r1241": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-3"
  },
  "r1242": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-6"
  },
  "r1243": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1244": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9"
  },
  "r1245": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "740",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SAB Topic 6.I.7)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479360/740-10-S99-1"
  },
  "r1246": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1A"
  },
  "r1247": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480434/815-10-50-1B"
  },
  "r1248": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(e)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r1249": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "35",
   "Paragraph": "54B",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482134/820-10-35-54B"
  },
  "r1250": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1251": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1252": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1253": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1254": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(bbb)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1255": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1256": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1257": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1258": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1259": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1260": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2"
  },
  "r1261": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2E",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-2E"
  },
  "r1262": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1263": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-3"
  },
  "r1264": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "820",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482106/820-10-50-6A"
  },
  "r1265": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-10"
  },
  "r1266": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r1267": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-2"
  },
  "r1268": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482925/835-30-45-3"
  },
  "r1269": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "835",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482900/835-30-50-1"
  },
  "r1270": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479365/842-20-25-6"
  },
  "r1271": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1272": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-3"
  },
  "r1273": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-4"
  },
  "r1274": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "842",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478964/842-20-50-6"
  },
  "r1275": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1276": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "852",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481404/852-10-50-7"
  },
  "r1277": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1278": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1279": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-3"
  },
  "r1280": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1281": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1282": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "860",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481326/860-20-50-4"
  },
  "r1283": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "912",
   "SubTopic": "730",
   "Name": "Accounting Standards Codification",
   "Section": "25",
   "Paragraph": "1",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479532/912-730-25-1"
  },
  "r1284": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478546/942-210-S99-1"
  },
  "r1285": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "942",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477268/942-320-50-2"
  },
  "r1286": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(16)(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1287": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1288": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1289": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "210",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-03(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478777/944-210-S99-1"
  },
  "r1290": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "30",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479432/944-30-50-2B"
  },
  "r1291": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "310",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477363/944-310-50-3"
  },
  "r1292": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1293": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4B"
  },
  "r1294": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4C",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4C"
  },
  "r1295": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4D",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4D"
  },
  "r1296": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4G",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-4G"
  },
  "r1297": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1298": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1299": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1300": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "5",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-5"
  },
  "r1301": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1302": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1303": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1304": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1305": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(4)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1306": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(5)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1307": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(b)(6)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1308": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-6"
  },
  "r1309": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1310": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1311": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1312": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(b)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1313": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1314": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7A",
   "Subparagraph": "(d)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7A"
  },
  "r1315": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1316": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1317": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7B",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480081/944-40-50-7B"
  },
  "r1318": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(e)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-1"
  },
  "r1319": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1320": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "944",
   "SubTopic": "80",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480109/944-80-50-2"
  },
  "r1321": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "205",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "4",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478009/946-205-45-4"
  },
  "r1322": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "3",
   "Subparagraph": "(k)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-3"
  },
  "r1323": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(2)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r1324": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(4)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1325": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(7))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r1326": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.12-12(Column A)(Footnote 2)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-1"
  },
  "r1327": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.12-12A(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-2"
  },
  "r1328": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.12-12B(Column A)(Footnote 1)(b))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-3"
  },
  "r1329": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "946",
   "SubTopic": "320",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "6",
   "Subparagraph": "(SX 210.12-14(Column A)(Footnote 2))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477271/946-320-S99-6"
  },
  "r1330": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "985",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481283/985-20-50-2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>119
<FILENAME>0001093557-25-000036-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001093557-25-000036-xbrl.zip
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M^*DW C)<[C_QC4?S;_S(0YZPS_R6^><A,(,1'P2L'\=LV2L/<9.MI[WRL&V
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M;6M=3Z\;QANE8VN]64^$<>]EP7B3=-RQUF/UNF&\23KN6.N5LN.L-TI/UGJ
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MO1E60:<LSF:MY\$JZ)3$V0ZL]1*L@$[OY4ZA:A_LFFO@68!1$M\ZV#5/P+,
MHRPV9:WA;[*090SX))I,HQ ^QD7G)GP_B4(*6FTQ#OVLXJL0BVX>;BH6?;!K
M7H32=.W#M454\VA#PVK:!]9Y$:@48"D$\G#R/!8PX6+@N'AM__IJVR4NS8V1
MAG5. AL/?TYY@.-?6WEH;DQ>6><P6 M2)8B.]B9%AW6. !OIHWCXO1QU_-SA
M6V?GVWCX\\IT;VUE&B[=$'/J6F?SV\J<-CAYKMW=)>.^C(36U@836KO6&N]5
M%O/V@&ZMDZ#,P[;!?=.UUJ:OR-$2#+'.KV #9 JJ^@89I75^A(H<MP]TZUP2
M-ARV#9&FKG5NBXH<+<,0ZWPK-D!F2XVD#JUSCU3DN'V@5]Z9QWA?24DQAY4K
MI\*0AS&D\OL\S"@WV2K@\+6Z<G:5.*QUK%@.KY)4_</7ZIO94<?EH;5NE>=M
MH?&21=ZN^&>VUCOA)0/76M>*;-EM\HNQ,S<VY)[/*XZ3B^&U&[Q4_:5GK3?&
M,OB4I*_TK'6<6 :?DO23GK7ND[7@H\>W@$*9F^!R=C^%I[$7RO&L=6=8#[&R
M>*"U/A'K(5865[36*[(6Q*Y9$/!P](F%3+@!P*WO3WC(P;!S40E7H'NI&J&U
M'I(=@EU9G-):;\D.P:XLGFFM&^0IG<]_UA7RVAJ']JSUCY0-]9?<//3(6J]+
MV5!_%EHO23H?6>O+*1OJST+K94'=6@]1V5!_%EHO29L[LM;+5#;4GX76RX*Z
MM9ZJ#4)]5W4N:WU2%L&F+!EIK<_)(MB4Q=.L]2F=P$*%ZR6_\V1\DL9)-&&"
M0HTG8S<,63#G7,K]<C,643H:G\-&Q83YW!6S%\KTK'4J[1+PRN**UOJ&=@EX
MY;#-3M-:%\^/ ^^4"^8EP>PF@F?$*=SW(KEFIVFMHV:'8%<.T^PTK76W[!#L
MRN*9UCE-J'.6#EI^8M@2:SKFGJN Y44IP'1V_.WZQ;% ZSP9Y8.B+(YFG>.B
M?%"4Q:"L\U,\ @HM3;Y&X;>7F:_4:5KGG[ ()F6Q+.O<#A;!I"S>99TWH10Q
MLITZIT[+.G._[-/=8/N03LLZ@WS-T_WRKUW 7>M,YK)/=Z.XNVM&+06Y+I(Q
M$R=TSGP;&;?;0N5=,UN?^[ WBMF[:IB>G]F%RN_X_;%@<90*C\7RXYBY/JW'
MY[?O?X5_Z-!YUSWJ'0[V.QV7]?:]P7#0[K1[W?U#UCWH=5O-P_]&09G=$R>S
M  Y_PL/ZF/'1.#EN]:;)+W?<3\;'K6;S;WMTW?M?XZD;OO]U(-[!W?)O^1#S
MJ/>_)NX@8/J)@TC \NI>% 3N-&;'^H]??!Y/ W<&6P]XR.ITTR\35XQ@"8,H
M2:+)\0&LX):)!.%2=P,^"H_Q&-3/V>(:3;G !(XA\?6;U<\-^.G=XO='O<91
M<_E/S4:+OG]'SQ/Z1W4NG6FR1_? 3O  ?MOK[,UM5BV_-4V<. JX[_RE2?_W
MB_H]B:9+?IRZOL_#T7'3@=_,^]_1P2P!%9V$/!0L^6=B3P)'_P[+B\2Q?O@0
M,*@^="<\F!W_1U]P-_B/6NR&<3T&3!O*GV/^/^RXU89#IX]W<K^'<#=!2.-%
M&\_ZV]?SF[-3Y_JF?W-V7<0$:]9X?7;R[>K\YOSLVNE_/77._NOD[_VOG\Z<
MDXLO7\ZOK\\OOJY<>!$/N_"Z<K?RNQN/ 3>2**PYIXV3QK__I=5M_M)N'NP?
M/?OA[Z^UXH\75U^<7X$_A5'X%0,1W',4&[MB0Y0*K3TG=)'C^XP?GT9>BGP4
M>VCL$0<;P@7O6\WZ/XC+94]Y_QC0D+H.5D#L>5E3[[!QV.T]E3.U&D?=]H.,
M:6T>=]#H=7KK\+A5#$WSI/;T'KE2_DP#-EP\@FBZ/I+=@#2.G:_LSKF*)FZX
M+H'L+T6WIV-:/PQ3-[ABTT@D>PZU:4E ;MXGQT-^S_QZ(E*#B6#V_/M?C@[W
MN[^L1,;$+^,,'R+4H[7HM/_UZ[?^9^?J[/+BZL:Y_'9U_:W_]<:YN7" ?=X
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M03&B^A:*".!KBPN)@8[@#!N+)N":UM;1,G.S:/I4ALYK?-1CAH[" @57,'4
M%P/N.S^;*K 94ZB]EBG4OP4)1:A=Z/2PKD>G)(OG0?OFABP4'E#_,-\7Q#J'
M)&['S/7_!.V/K!=@DMW.?A-$Z9\I)B,ZIZ!_@Y)R#0L]Y6P4U9P3@ R<2LB!
MYQRU6^V6XIWPJ(0%;#H&!53KAZ2XP#]!Y!FUY4WOH/?6:3>;]2;\TW NX,8[
M-HA!\3%+@\OH%N"B<+?/[KUHTH#_F3=QI?<Z0J=;FF<4[]47QHWL*0WG=T:Z
M@\-0PH@H1(P#P9%I$F<G]!I7FFY:%\G;;C5''1K<M^3W_UUS0!E!T;GP:P]O
M)J&)=I+49,@0(A5,72Q5&]@@Z&TAC\?P89J*&+O\XL7*/'-:G3?N6[RL=?#&
M?ZM-A;S!19N=H!KC&K2.I**E3@PT!<%(-X>[Q @^>]&4,VUXY!:5":Z\*@JZ
M3!S)_X+M%D<AO&,&8A!373UZ'SGG4!S/G3?!@!1EK140"&JY?3L<]UO+E#;$
M9+,>U':#.,IM#4!^=W?7B)G7  FY1 #:2)V_H](>1JA692>1/V)E)TL-0+5P
M3D$)0"B";N>GQBZ5X-'.B&0LHG0$YI9SZPJ.$_@ IN@\(&4##1!D"$/B"W$!
M_5%G1$H$^F(XR:BF7PZFVA!50@_-S2"(Y878?U4I)H!52NM<AU@!$U%@X Y=
M;\Q!&W0&(G)!>PNCL XD&Z2HN*-YXZ,-P =DXN(^'CB@$$TH6"J8@XJJ<1U^
MU@LCT^=C9=)<L5$J5^=\/"6B(<R"\TL 7HC049R@@:F,QOS;T6UD&,T<=:%=
MAZQH$"$?Q97=,=*'T< DK=0P/[0)"#BX.[58A(]&"7DF:H\%"@S)<:0VC+?\
MT)XQDY.<(L&LEMM//":3> )DFRCS2;L=LFQW!\]% 6;%[N$%15J=.RBDYJD
MHX)^!$4@I@>K!_8!5Q-IR@%N,^)5<"RU0KGDLM^_1F@>F\Z965WXLHMOF#<.
MT?Z9+7_58G6YHS)AP1HA&.#Q?(C _L.%YPK6976Z3WP6ITX R=)W'[0CZ0R0
MP8L;^0HH:3BA<0JGO<"5_0BL)9(>9&GP@(Q;+8)KCO(:&'$/K"(OFX%OW()A
M;X"36<,Y2TI.1@-<>MR9*7DT>G*D#5C$ ]CJ.S1C'V8'V@\")ZJ/FNPHL 45
MSP'TB&H%@Q@I?<"41P^W$Y-!!0NH/>I_);HEHSWO=,"O]>$BM9*8*C)'$M]A
M;F$DPG]LP^01],GK@QL!9/6H#AA58ZE]F'=$83#;$9EV,^>P4HPH\^RB>V(4
M(5FBL@(L5KO[!NBK91-S(,LD(O"2F#0'LO+A<."<W1'+N)9RRH,9[>8$(T%I
M"(9I=">Q5;\Y -FB24&YG&XYNUMPNV6[T**5U!?]G!V!C7+?G9)&K!QW-:?P
MK7,2N%C2:7[%0RE><1&RPJ_*I2%<GZ'?0[, D&K3*8.' :0U%U%TAMBO5)@I
MV'TS, ;H&;$L'R#W"4(R>R1)=OSHA* ]QY(VA$25->(M^$+2$]0+%3/E2)JR
MWQ6 /Z(BU=6@?([P^1/3+K:$)YU-1.[;;2LC]SOBOCKZ09=,9[L>F>=SQJC4
M0:34?+C!XM#SHV)QP%#^Q-G&,#)BHE!*+T->YZ"627((S3924Z2!+T,I=U)_
M '5-2B3% E&% GF% 4S@ODQK8B9B2>H%A4E(BNHXA)28Q;6ID$U$2IF*>X-=
M%.AU\/E0A(H[9682+&H6I5) P!_:F #*]V7HM_"F)!K)^(C1MB:@)60Q(S^;
MZ:9#CSD=50IVE#,D!V+E(Y&V#CX,75WX\Y+P54V),E0?[QCL$/7@(&9W&/]8
M0[3 4?HR6HP:FXR)J@"G=.S(C0*F^.J,(Y'+%7C*JVITRB!404%72F<&4E*-
M33@;=Z'<4'"Q)\T.Z5>B?=*3U-=X0A.-02K^)/5CF=Z D0P:6" CN!A<H??0
M5?B<N5OECPTT=F+4KE"7UE UNE]M"1(7G!7J*#-GA8I1QG'D<3(/<@]5X#]>
M4POK%%D!?E3,L(Z<[WC_L-$^T!R18W5V<EQOMQL'9:AKW5_TKI[KQ<7#:!WA
MKL^'I&_? W YV6,^PX0-<E. [>XI(SCOE](^#X1R&I+(I1 J_"BU/WQ:&+,"
ME$E) ZI-0XZ,)Z8HJ7RB3MK(_%X)$8YB/6YF+[@^.A%@N<,A!BZ5NR$+_8EL
MW.,Z&2">&P./ 11;6\VO$.S)"-8/@%VB747BCN*C=33G9V#4SU \CEVTT/QH
MBK1/2264 H3>:Y26: 1.0;_Q9LHCAC-3TBB-G5&0>LB(E1\+T<AG5*5<]*-J
M<2<U4OD^:>2IY^?Q-,:,$^6RK,L@/.6RJ'BX69)B4O.[,0[!(3EYB$OGB,OU
M00-6F0^W9*T& =-S8V1HF^QG_19R,?#) ,4^.2_F:;'A2 (NTJ)\$KP-U@"T
M VN@_3SAN210,/5!Y0WIKU5RS.*V\6;J-)P:P@W9B+8)KX=#=5%.572V-3J3
M8125EH!("+0 :LF4P L,D^(KA2P8;GJ4).@?EOE@D@)YJ),V.*5'ADKS,EYH
M,J8&D=9*,FK(<A\0"Y#L5%*,4B;RJR(2GTR8\&3ZR"TG!"[( 94LH3W1,5@L
M? C6"^*LQ$V%=1)E%<;C,X8<[ <>\&1M!UN%=4_&NHL\S] 0UW$?4B.YM#%4
MXHSKH4\:4:L"RC9U.J11$+@IVJ IB4;/G4IRH POLDOB%#OM<B:M.@E&=)9F
M9!2G9)0852W!& 08*B("W1 O^).&TLZ< ,E:B8&1B.Z2<>;[U3F0.GIH[%9S
MQ=@5DTHX;!$COA10 1/WN =,627[O5/"'JQ7D4ZE>IP0J. >C3)DHDK]&],B
ME0:^@&9Y4Y6\[K)5ED:?V UTCAWH7&AH%$V&"@>VA@._H_!%>>^D4_+N9$H<
MD3G7C1RC-)'IAJ1*DO<F)]0I Q:T[]LT0,&L-$[%*#(,PHS*= !*/4?'E6(3
M,MY-06VN<] 1^<C0!$LL125;9QV04T*R".0/!=91H<F6'0)%>X+%Z(K%Y!V9
MBJYD>B8F)%5+&:_C\H7LCJ+TD5"G\ ?%?^<>*P3F.N5&9Q8T2T(W%@0F[[GP
M,C;G2E N,3+Z#-^;*15%YF+(A]S!EJ4W%=-NX?GS;HFB.ZS"P&TR*NV(1&QP
MQG U.3LG4\ N,IQSD ?1P[+?,'<'3=1 YKVAX[=NL)=L>;!$0\0B0JR\.0%V
MBDRR)O%4RV?T&S1"[19=4HHNY&NU/XI,W0HOMHD7R)9R90O+7<<JGVK,W #S
M7.(X+;HB80L^FW!O0<C</LG9N,JKN-0)6:'%,Z+%8KS!\5.F0RN8G2-"5T5V
M,A MV\MB@SS5,&Z[IPMRYKE/=N^]*95;JN5G>%^LKZ0LM+RS1:J0\G>,[DAJ
MJ/#_&?&?%&QV3Y!@6.")@/C6N&[HO%*&L^("]\X4XZ5!SF;3F7-402>UL*RZ
M=HKENQYH\JHT*DJD:["&T5GJ&;\D;;F!S>%G6:+C\E?/;4(FO!=J%R7M3@5+
M5%4=17%4_%E[&;W Y1/ 4T]-9%=D;[P.*H^=%-8HA$>)F0-FD1OHDBUIEOHF
M2I4/)6&,EWD(%M('4X"B]G>01CM2U<%S&8V5 ?-\]' R&R#[4@,,L@I8#[]'
M\%+Q:[R -S+9=0(H/>$RR0(SXV6E+ @*PG<J9^>4/2._B&=QPE0%X @U4Z$2
M6*=1HFXDV"-"IS% E F*4U(>HU$9)+%D85,9.T<K&^X#4UEQ5IGW\/?SRWZ_
M1BT&THE,^U4T2'2581XYU^6WN+E($'YK$M,/-Z7WQ!N83Y6)9 -AT66N*I'R
M-9$GT&-\=T*!) K[3-,\069HCXF?RB-PRQ8(,2<H*@UIRQ)"IX28PY>6%7-O
M.94[$1NFREQ9L"H]=.0*&&(B^ESQ!>:JJ%(@P\MS]:LYMDZFDW;T>AA;RO'X
M'-L=8!("%="K0G*R]K$AM2PS"_//!Y0?"7<B+35T)5"ZN*KXAN=2=53>MIN3
M!176/8_/&3@$9EE@CJY@H:_X,!P[YBL:P*I$+C36/!F84#B8M\O"%?:8B?[]
M@.GU>O)^]U?G_5J1PEM1V2;=M7'J@7H;#]- N<T"=%+)-'E61^V5%!C5\8"4
M&OU=@FN,G9#A U S5KY]2N[/\B$OOX &@CG[T:TLWCEH-=]\?ZOE@K$,*2Q@
M6F68S)!LJ5G\'TZ!"/KDTQ>C54F%)Y<R4/388%8)%VNZ92J3]/F0\N\Y;JYR
MMY0$SOOAR"+-,WXAFS\%V!PF4 JE<=ZO[9FKX/J<K@8RME7Q+@: 93H99G[P
M.$L44-D[,L,\80%6C6,ZG2G;$?A>*;BIK*M(Z' 9M7Q'HX640YS%-*5 $Z%
M%F FXXH4067@J%0XP$&RK7();":>%%&QLN(R%*%4>Z$7!,I;>&MZPQ0,*/B$
MJ5)DZ1EW@C2.8A7F_B,-91V2H YAJGY_)LN1BSV=E-VF#A7Y)Z\8U9;3ET!>
M*/L:7<=9RJ2RJXW/>!%IE;N4B@]E4IR,0D4BYTB+\[DU)I9HVCO)+ANZ1KF(
M]CG<4CF42MKE%JQ"4!6.;)/I48Q1E^GDLZ$RWXRBV>6MVA0_(.6$.B]HN[?
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MIV7;((D@A=!8B $P+ 6C*%_EZ-U[?["1!@\'EC1XV-:,DOVYLUS>J$ .7UQ
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M4S*GRL^H^]@ G3K%TKDY]AKG0-YP^@&VVM0#)C,V[:EJ>(T;A?F!JC(+.P>
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M5N_,&K&9LL8"010;(:B;0+N5IH<RG7.*"+9=#U.L;4Y5V72FE>@"2CVH656
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M#2(%2[LGE,4E7\VQ/L67O2IE7UD:"S#!O!1L2*2U>=FDE$Z\ ?J0P#;=,[5
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M3\84"F*#9U*GX7P"4T9/$<DVJ:Q@NG<IFZX9]2/?,17Y!SEA\^YN*H;E*,=
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M#'RJ?*S424_3+7U/T:5LUB.-.I5\>H;YPTC1,6W>D9M'R@(.L# AU<4Y4'(
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MYP:8;2$IE\ GK=8RB'>IYQL#8$BOBF2TB"@8RC72C$8ZC$@)A$3Z>OJ%"@V
M+H1D*9D""XO)A/C_).[EN#YJFQ_(QD%FBHX>-&.28G/$GQ']?"XJE3)2." -
M76H,S8>X%M(><T.T<FFR/B/V)?T$LC-4/E66*A(57'-+$,8-LB13/M>4;D7S
ME-QP)9WFX')I226Z2@JNS<_]4IP(UF,T&8SLKA@2H*8>+7V]#F9P,9\(XRH/
M/S86Q#_!5)$%EAA#HD2+Z$Y?BR$8500P4WD:"0:6*AZSU<2J))5&U3=XIFRW
MA6&Q,GB('J5ANJ4#/\#!G1(1*%BG#3)M/U)07N] C7:9J8[_#6>Y7FK81&PB
MAVA-F@$"\ 1 GSK.RG%HQYJ#U$#Z4N9 Z-ZJQN38J1$-,!<D^2 HN#"7<[)Y
MUH7S?.$$79%YM\EQ>.O"E_C$6Q#6DB6I,XB-D4+MQ[,K52[ LLFF\7SY$'+F
MF**V+LT#QHD#J>[ME6>E\7)>BAUL2470#H(1B^2&=SGOP'IJ/<F2('4L#-T%
M91#K*IM/YQLL%Q2ZOG]%*"<OAW4_)T!UXX*@@'Q1[951>T1;V8JL4%]6E&RR
MJ]C<J/7%Y)YLU$#\G8>REP8]FHI)<*9?349>^?\4#=I\2L)\E,;4TT5R=KHN
MK5L<_4Y11/0/"70M8)5[+D'"S$<&H4Y3)%0A0V%:,M::8&/;&OD]7)*Q )8A
M5WE6<\.!!PQY'KH/[R(1JNU[083;E76'V2!#HV')Y"DGIK%"E)F%;\1_44F@
M47_D&9(I4')DLJ^*EIBL?R&/GH>>3&SBE8J8+18$YK)^54L>K@K_$U5U)7O'
M8NA49F/"SJ;$NFE&KCHZ=R/C;ROV]#A[HG$EMZIHZW<UC#+.ACN )'I^9G6I
M[6E$1SWW<[F^BCXXE-'QG#B=FZN9:VS[0T,U'YE$CF[-6,T(?G@H;*P32^2$
M<^7W7,:8M1]=[ELQOV6C3N<GI)J4*IU6#JQTB"X/GY0#F;.Y;")K+3\3M(8/
M63(@EI@B^7#,V"7<BJF,RG.4E7-C,Q=C[LZY$[U67G,S&G93XV!C;+?I8V_S
M98-A9=?T@(J]S9!8K6O*[K8REJ,'_:#"1S6KCVQH5_._4'&X5K/D=L>]'=%T
M+2Y-#DH"F<C\R4".U-1ZC\B/H#*3M76BBTPA,N.HLK2P!ZHY\$$X;T\I0=36
M'J5NUMY+3Q"(9'99OE16#IG2Q019[>PRYF>"4RKYQN1 S4^JXOF16JK9Y_Q8
M5S-4E9-[8FZLZGSHF/J 4RVFFA4;9Q&<^=FJ_Y>]=V]NXTBR1[\*PO?>#7NC
M2>OAYRBN(VC)]N@WUE@K:=9_WF@"#;!'0#>V&R"-^?2WSLG,JJQ&@Z+&IBVL
ML1&SIDB@'_7(RL?)<Z2(9=47EFS4@Q3F,LB)YHJPO@+FQ4CWGB:JD_KL[+L+
MWX6OF"J$';+-723!L62Q R0%J[&!MZ=C/F^G4E?5HF8JF%QNM>'#Z:+R?O:J
MT@\>%^@M59,_$0#DT7$ 0![GENWQG]C)'+OQF)/YG>'CS#1Y(JA#TM.*R#5C
M'=.2P6# 6N$R*E]M5_$&A#6>32U:DEVYKF?!DE[FTH(D&T(9V-L.AJ562G9%
M\;L>WJ?E\=[+X_66$DL8_:UTW&$VR]6E"?"YDTN@$J6Q:5-K3Y<49A+7$#Q&
M9N'?"G63<$;3&>S8DW](+^TTL[_YS-9-TU[GH)A<Q3V"(3/TRVEN[FUNU$$E
M%BOX4<KYOH9_FG#>==B%72_^CR6:XW:T;IIK@7O7W>P,DP>-W9UYT%$(9*!B
M<)K8^YK8EPQK6+]$U*TH:_KJ745OD#;5SEE& Q+3'"A5 @ZV6'35PN@J@TN\
MW/VK<CF B..,7XK4:4!W7QF!&K]A*>4Z$Z"P:$R^8NY^ZKRLF^MV>1UA8(YQ
MU_OHDL'L[AQKG];7^Z\OQ# \:.$F]9JO=2>W=[ TMI+\#&?&<( *$=*_  BD
MY;<LE-NJG-]M?,U>@IX,# >$YPN/S)255\0'R%I1[.X'((P9S'$(KSRMO-_!
MLI6"1A!>,A2DMGT84U28Q.,H6"JMM>8&A-1[:6^?YN;?MPJ"_%E<L1>_G%<;
M26DIP-^R]D-?XM\7+?[L.$2+OS[_[.'G)]'BDVCQ_8H6(_'])L55+]7+NW?E
MXGLR<*ZX;!":4B.6L9R18(T@T:?G@#B=+B\$(B@CNTYQ3-O=CBL^VLK-:ZD9
MIA5Q'.4; !B0LV%8PD/%UR;L[+!"C;5W7-;,^A-_7DQ6U>JR*]'>9BG_:EE-
M-UT[O:I6R 7)N42D!6IVDU4][5K]3!/<4 &CQ<NX]1;;N++5U"YW\$"TC! ^
M,Z\76X5>][RN%GB6QAOK\)7A[K_X.A1CH%]V"RV6=B4<G9@X(6V5/I?V8T<X
M7+P$JC"H:H91_%=X,H)7V05%R-PO&R!NP#<0'D;>6MJ\41->%@;*8;BUKJ?M
M6;E:5UWDOMK[1N3F895X64;.G;S'=I1 .L0%:T<<:\QB+-@XM"E0(<W(G5ET
M Q7#=-L)5#4^@Q;C,ESNR%,1J((26@F8W/]L*^,K@;>_U<3UO(KBMGG.^CS"
M('T9KLI,%)Z/\YXH6-Q24TS/NIR^I4B)L$4)($AHT6">R#  @>2P463[A*N5
M2^*?(EF:H)RJC))L&M_'P$ZF!XJZ_=$:MU>&;&*W9()3'9VY.P3,&\%>9)"&
M"+]P6#(&W0-@/9FO#@-7]D&\;N'.B8A?UD*P)??I>P^H2#HBO(H:1ZE=9_T]
M&K1)T7D.- Y ]> 8]-?5M.+@E?SK''H34O9B*/-6)+'CV7A<#;Y9$,+!JL-Z
M+3H^C0%G^TE8)%<.[!\!1]6 ?ER[_"/NWR&+RV79K?HTU$04X7[L*F6R JFQ
M2Y6B''%&F#GS)AR#/P<A>-_.-S>4#2V7"_127JU\#FTPEX9@5'1SO*P&T,=+
M4O0TK8H7,K?/) 5Y'#;@9X(<PHKXX0M.W@]?)L=%VG]%]1Y1M/*):OP<'(AJ
M RQ37.(*X72\>LEOT#S=87N08'* ;O[TFO+!S:QKZUG\A'4=ZQ?+M9>/GPU%
MY/;0608\GX;371,SDXOT^$,:0>-F8L_\;M <1+#[Y#*<G,+JL[>WA74S[-M_
M;KNZAU;00(EBOZGX:/> DG2EWK.+E\]_JW?!$"\HN7ZFKS7G_SVYWWWQO)G\
MG^URI\+P-Y4MD]GD^V<7KNK+AG:*B\'*_?Z 56P6U[ "[ZL+$2CEL\>>Y@\:
M3FY;MS[2SH5H#SCI5QC-YZEUY>.PACXQ$DO56)WA[+-S1XC\&K)=L)9$]$0?
M 9*$%@MS4[@H._/5UU>$_.\_6;)//J1IP=*9U0M6&:IPX',5%2D 3N0N6F_A
M8HNG]Y(UC#@C+(',C/M*,*_R67<2L#KX1V"[/[S1SPQF+(:6VQ ]B@JP+V['
M439_N5.2"0-4)E<QSI'!*5FUE%G6>C@<3HG.M&#Z^\\'#&9,%DAEJZ/G/:.W
M,(64H#LN02QCRO!ZQ#H'H)@,_L;W9\4XA 6%&LF(O[;#G YR(629U4A1KC"W
MN]RLI%XXK1DMG \F3SF%TRO@[42W-4SL=1T";DD#X%,:=)'2C7PHT476DQ0/
M^UHL^L?5^>*\2+7 NO%5S4\*Z]/!=?W^NU1O'T+2[R9D.@%!OWGX^#B H+_:
M8_K=W$*3X\,>>):2X4?N&5HLO9 @9X C30#0RYU'QJ,=N*1$D>NG0^84G?ZJ
MAU4O6FG,L:"K5K8#PP-L5XBP(,$M<%'=[2+1(_KNP1X5:M?3?8Q522)S9DIF
MD:C(PBZUFTCMT? AI8?,8_TO-;"S;?2@A#M1^H*J$.1LNMUO%KS\<=.*P]5A
M>TFJ-5;NB;VIB[8D#*!JKI2Y.LLJNWC9TFRQ]O-Q.M@D7H[(E@$ V Z23RS?
MK(O*LTKAN(@5;21[C*G+/BLD7L9I9?3O674C$E:SOT"HK"-CJ/;3EI;2':9X
M4P%,NU1P$D%LJJ(6GJK_JK1MIZ'W3ZH1,@&K!S-&.(H=SYAOUHAOC=-.'FO2
M5)N;-@1B,]<,(DT;:RA?=].K$%Q/A;YL+RIPB;Y>IFRI.;#H\1K7B/6M:7_\
MS^;H#KC0C)!-:P(K48[GW!C:2'R2&3IR.N3?F:,+3@RPQM03)F=OB^,Y0M;#
M6S3$HW=&<F?49!+9J.^"^X21QHIV\H*2MHT/<%FA1[K][7+O?]QF'>GD$3)L
M*<#>WM5C2W*]7:U3+X^U+^F_V#$L= ?<,=Z:'^SO>9]N("&8,<X&V;\:9KT.
MVZ?E9HAM5FM#NKC75.ZI6]X4QAX@R<R0*6E?>E5A8ZRJMZJ\P;[\O;:QM+PL
MJ/CMT[=_K/7G0(<MO51Z=A1,6SUHA>!/>0X=R+#E3* 4-F@'&^('[\)C> #<
M=S>"0RB?;K;"8'!3";,/C4OFHS!(ROI4XJ%T6>W:9G8W(,(=85)?GF!2ITN=
M8%*I6&3TK3]%JM C!DDQ$+K<ULO-L#>J[1;A:)'088_M5 Y:Y0.B$Q/;-8P@
M%>X?:$(B9'IB:/UYU8NXE&-6".:YG09#1?O6@_=\?;7KZS#0C6:Y#+0MF-P0
M9Q4TLO"1Y%=5XE(,IUY.^C8FLC[$D\2V7',#6]-?QJ$<'F7-\ _T,9&79!'%
MH>%H=%N<X9 ?;I>5<)NQNY^)*FL/UOS3V4K4W$T+;MZZOH2(.]>((01J))''
M8QX<3 ^+%V:IMTU[LZQFBXJF6 8EP]D[#4%7)11<"H<#8Z!.3PRHTMMG5'1M
M/DS4]2%3E^-F.<!7,>CR9DNF7XHV(8;7<N7(ZDR[U9$][<,WIU7&536^-I69
M09<_$F^V!>2&X7:_/>O"?4'>6M$I4>V+ V/GZ(XQ(H:Q.MC;.+[CC8WZP(YG
M $JP4KQN*SGN'OV4&6P;2PP^#(2;7*!84\=56RA$6[E:SORTF(0Z-VYZW2)*
M52$A#>H"58BP:'C$JEG<-P,-[D9SV/F[Y0.TZ"H='O:C)($Z"?'YIAJ^$&>8
MK5ZJ,6\0!XJT>(A^?PD_W$!@'(9I<W4L//4_R_8K)]<E( 2LQZ6"*FGR]O=_
M85;,YEJ*!&RSL#;O"9")@%;N2H@O&E[30YLN=W=EBC[U8KQW+P8Q0HQ04:=J
M5 #W_?1X+!GJ*+_W@(\23MUVYA>C!_YO0)WRY+1Z[FOUK&.750]XJN8YA$8S
M=E(9[+;3C.E:P /*O'V@J?-0=ZE:%-!X%NP9$G-BI#B^MU#MQQ-\XK0$[FL)
M>'X.= V7,U&SAHM;B]+JLDJ4@3?5I789TS8PL<'(8M"5!T^S*^%@:S)8027B
M#YK6V"&[,=*1;DX"K8YQOG?5O.J$Z>/^[1""GJ;"N)2_8>GEGO$7]+1 F!N3
MDA\_>_/T$W?X@RV[B9L.K1@U\FJL-)ND!B5P\R-F3Q:&JN&B-WI#*I=^+QOW
M*[BS<+NP]B#!R=@C0_AI=!!>+'^OB P0'JJ( (B!$IHI"/@_H,OSKE9D 1LP
MTRQ<4;-K3?$AO@H;YYJ18\'.BK!.J5DNF! 1#YY5+4$493%Y^NI%H9H<_;IE
MN\L5U<RO0$Z'D;1@C54(+XLF+1A04\'F -X"J6:*,$SESQPE3\?#WBJ60E9A
M._?!Y>O,L!_)T@[#O=FM88"6.Z?S@&)JKU%QH;IN[/D1U[XV75=(3__/-@RI
MD,(QZM^!'-++*#!-L.($L=ED#825)IHA=6=7T$X9N[7>*\P4 A.=(.ZE?YR_
M/@_ST)"['D<ARWLST76 M0TA<:5A_K:9BV3N?%G]PC_V4=5N.FVWM_+9_(DP
M))\=QI#</6G^V8./C@9X<LK3_^DN]>?(TZ_#R0V3<ZS9^3<4.:/\W]S1]XZ(
M%HDR@@JX3^W-K]F10:K(R&5'';F%%MJ3@A%\= 9- C>$SV4E9E_7]MU!^F1)
MI)S8XN KL$'6IX+I82$!:'1[(QE@I?;$DU>:T%ON$DPGB4,3/EN+(X0[7EQB
MLB8_!A>O@W,>'N3)Y$4UD_[(R7HYC=TC\2(_0._OR>05&GKS2Q<L@J2KQX\L
MFA8)PG!M9:U:[L)D+6>3'^MY]3H,81%><GK^1)1Y^BE:L\KAM>D5A*M*\+(J
MFRUHS4,\XXGH^KR[7(C7#^E *>)+OGD^>1JL=>P6YN!MI0FHKQQ4('FN>O#'
M&WE)/?R;6K2@6;?DZ3S3VW5M;!M-VKXG2=<?O,.,)MKA1Q(Z6PG\#Y+A#GK_
M&9P Q1=67:Y'/* =KZU>!-P2]BEXJI?;>D^,0$GQQ_;$7B9=&RCY664<UYV1
M2CP_UI< AW'X\%P><\:W"2MR1Z\U7#-M(5N6JK:,.M.$D$>J7(Z9I8A."<YT
M>)H?@E<;7-YFHI3QA?1%9GGVI35ZC DU,K#PZ@FN74;O\9I9IHYBRJ/%B2-9
MD6G871\F6@C$HH85.FBX14TA6[-%!HWJ4W?!+,*);DG>1@)Y*NI)#BY,P K9
MO/@TS4);"UWK?;]E.'$ *@B3MXQUNVZ/;MT8^0'?;&]B7[[BKZ _!YAF%Q;.
M<MLG-%;;LY#[8_VVNJD!OM$UGQ\7$,;(>K]2QU?6?6$E0RCA1("EVSF)-<(]
MVV%LF,'Z(^J+I6['5QDE4E*'R-ZU#+)X'*O78[!$0$W@F ;'VVX 6[;&\R2I
MFO=]"%MV@K,B[EVMM;048:3.S<GKV<K?M0?D(MR7N,O40L,4Y'*)+!0%#/9H
MWD*07%)0 'V@>BJF%\I/"M=2*,_F/#2N;(I<VSW/4)QO-*TB??JSRH$7CV?*
M]T@YD)N"[[?,)DDD7'JKZZK_J"G<4TWOWE+R*(L4B8F!= OA"V?&J^:1X= 4
MU[UTJI/=7Y65*=AY;K;"_"QJ/4^%.L/5*TZ3<8^3H2I>(BA8.4K2TU:X]]%/
MI5I&F(4[1(U(*:)OM%GD-!WW-QU:Q(F5.?I36LN?@K"'I\3E;E"I]X#.$T3C
M0Y[@5%AW++=69+?FF:ZZ4FJAB-HX6'QU]?$1W,9ISC^ .0^!.1(%<Y?2C8H*
MG*1:./[$])XFXMXFHJL6)DP2NW=.>*1['?*\9PHX$NFM,[N'C"TRWD<2;7^/
M=%_J&O;X>Y6PU)I7.(>7]&:#[17FGKI_._E>5%0A8;M!UI03]>!^)NH@T\#!
M/ ()?@2-4AJ8VR<0K.($3#?TP=WK"O,?$RR%9%<BI-CG5.3H<G6OU#/ +#.E
M?P!;Z[?+3>S 8WL DIU+H4+5C+R3WCOG0#X<,9UWA L\/O78G2YUJMU;$216
M1AT%VK%5[W_V$$%7ZQTT8$FC2/"!9PK^8H+T=7C*9W6U:(O)TS -P<HWM73@
MZ!=6?HA@#HVM(GSY1=67Q22\PK_"(<$OO:R:$I6A%R5H20$/C U04U\R%BIB
M<$O_4J\$H_;5@^*+!P\F/9ZNFLRKBIFKI97;=Y(@-QH$]\6'GW\]]DV4G[J6
M-3M'JC3IVG:51$G3P*$M2R@VMNC. C!A]-797G<!]M5N5TR> Y?6S.1Z380Y
MQ@0U+A._2-*+L"> E4!=DP79_"8@EY@>CY?PAI-+Y:2(JIY>H5#:+#(0+MYM
M_$T+X QF6MA(Y"@'QY^X@D3!L:HDA^,\7B7E7 FJ= '5,)GZX!\HC)]=1.,7
M+R;X^EH9O'""RY*3*IRPARF#.SLJE;.[P#_",QFMR#I1-.S05Z;%94N%Z^*4
M2_>*IPRKB,5+ZY^+_63.C9 6+_'!6%Z%<R8<)RLEC9$FAUC\\*_9QD;BC/_+
M2%+TZ0I]9 VL2<>WWHJ;$AX"7LIBB[KFIM*E?E/)XG;.BPQ )5R,84BQ+1#^
M"R+  L1!&YN'0(BSJ2UM1[(?#!^!(C"M2L+WS@93(2 $0)^Q9MVF0?[CAR^U
M U<N!B<18'#![NPR/A/YJQ)2:WPMS$[$6O?==FT3+NS1OI+.Z;!JM.(7?#73
M4!*"_C68P F\^\W#S_^7$,#=[S 1] 6DG#-M^;&+/+MF[&!(9SL!+Z3]X*V.
M$A_!IVCD<W?<4V:<>(NZ"N?U\SFN.R_K96:L?*=MN2)D;: 85QS81:G2G&['
M%&>[JGMM$!XTU+^C[4RQ*XE'$G=CP<C[=<I$W4#Z4'RK8,U+X"L5W!_F8#EC
M0@+?7[;2!A-A=M*Q%,8,&A.T(OG;RM?7+=CR:\*GPO-(7XTKKE,^D0;J4^VD
M-8%QGN\XU%FD;ZSS7LR6=.2D0PD/L^C:&SE J=%N+W!9Q7,7$"XTK!"$:FC2
M\\GK2@ ?0'4HJA+_=/F(_H-,2. !^\DK[88)<Y1%)<$O'R,"X5 ]'1Z7Y[]W
M)DQ3<&,)B0_1'EW$C!9XCP1!XJFTQ >Y"VQMM45E'7(N@RQ2##I8XPC;+N-T
M9?9;]4\4NFSJT'*VTO,Z6X8/Q-*D>F7IEQ1:66%7 9/Y+$&#?*.4,3++^CCK
M@VM>'?:HKTIY"%JNW+V@,ZU 4C FF$:5#V)<IA"]/Y'N(PQ+-,Q=11,B ^V^
MD)11B^@>1Y>X&/684[ !9F-@/9=L:Z.[)&&7MCL.WCBY8\?C4 XC^G$5%APK
MZL=%KO->SJ9:H/:&B;M&,WPF8>N^8-Z\OZFB7,.6.9_\K=K=_>.1185-D&$5
M:0>NPAMQ/O%(3JO5KJMA4;6Z7!I6>KWMPH&.K^LAE;T- W!*HNC7PLH!4KPP
MP2))PR,?+VUTC21L4U. (N730R,[N^V]I@RZX@K^WHGZ.+"PO=?1+"T;T[&E
M([9$I<J$'IHQ0F9 ,!/2,S Q1IR9V VW;1V!+-P)BI()LRQ;\S>].@/QBBZ6
MAS/!->J#^O/)!1V'9V$>5I< ^3[\XL&3QP\+*#!\5E@M.'\NFU;=$D*>ZTC!
MSR*]N,,Q3^MNN@47A;T_R24<&VA!#ES]NV$_[:IMEY%7J?J:?AB>XZY!QP2/
M OD;0/ JFK:G(7<^.5R3.<8BC&BP3+9KDE\Y[OHX04*:LY$9]$K-G21JE-<J
M'-37VR7@MIIZ4(_<!;]L3R(B((Q;S'* )9Z$1K61U7[*;F*@%>9+$ #8JA7K
M((YH\'17F8?[(3E==ZP"?7&J ITN=:H"Q2PVK,]+6I^G+3F]Q5]XY9&QQUH>
MND"A>=#X('7J'8YC][HY<0F/XA?\'D)[^:F>I2,Y9=9CGX-E-B0%W799AXKV
M,V;&WG^MW!&T+Z)>D?FO,KHY)=<11;[S^&3R"B*_E5SB/=X6/54<$XH7F+1<
M@8F'I?ZX9ULY5E[H 'YGQ0%V<3Q[\5UAA%43$$,N@M-R/GG9A>N$ !)!9OZ<
M&&K<%T]Z4X++ RF,Z[)>VN$5/Q_Y%1'9;,JWE:=TZ\(Y/VM[ZX753JC)K-Q!
M?%/C1-QD,*?AUO$&\MPA.NPB8$%Z>P&!<&0BB3M$//8?6PQ$W"C/*I"QUXTZ
M(N$./SY]5J02V%-F9_O\WO]1KM9/TIIZK9TTDX^?OGC]"5H(JE(]KHNP;)9P
M[!XKMW*?KH(7C,,J\J5IV(1A,[*<? _>"_CO>*;PA-H[! [!/I^;> 6D'#?B
M8]@0UW,O%R=A<PAR>W%6YU8$*D'Q=[5;MXOE+OBH=2D%0MQ1^R?U?K+0;J>0
MQ!S$D8K?Q'QG9=#/OD2SY#U(P]V?7;K5AZ\F_+1@;?K-J/DPFS':S(G?5N#Y
MU\W=;'$C*0U?DY@2K6\@JL&4U'V_K=SXK@$9-2EGD6J0[?UN7KK(_I]QC48.
MT' 5T!3Q9LVF8ZZ6BJ.Z"4EE.]<H9N1M[8%B]':8[A1QOS06KCC*KH7794YJ
M:H=Z.Y%1?H>(.BSPQ-_.."CJ4(P<&H=G*FT#Q^=#WDU-#>17VU3E"FG\;A%[
M2DMM[L]C!KNCCA!"A4L-:'4Z4Q)=-2DX\%E+LW%%#O09G)KILKY$4Q\"MOUU
MLM=B*0_CRVD'1TTCO9C4%[.P1JA13G>)$E%81B%JB0-BI&9P)'O_=G2A'\1L
MH/;"7/PWR^^K); 2P(<8^NZE^U^&@-.2I*,>Y^\W+[\:7OCU*; \7>H46$9A
M6"@;058H&+F7U!7=[(XUC@S/OZFR2EGM7V^MK\< ;B)ZZ@OPXBCN/1YR,6V&
MH[>#YXKN$(2DEQI$T)$N-\8*N-YU> PP0:!S'6ZQ_3QIRE45_]&C,(W/-:@S
M]]-E2["7Y]).I$+A'"$?#KA=(RFTA*E\SWWI:C[$D1RPD).7(9P@D)X')Z5-
MP7 #0DTXK^KT"@)!4'CZ+:^7?0 &A ,Z.M<D\-&HN[ OE(LP](MP07J_L7N?
M@I.$X"F.SJ+]:12LB9@ 6VMIU? IXO(( 1A0^/CO"LW.8955P.RE#T0M,_(M
MQBY0+,='#X2$1M%35U0"E0IB^#72!=E G(!/'WWS\(L3\.D.PX3<SKQ>$FFD
MVN[4J"TL?2#A3;<R_(X)-)Y/L'5U7^HBQN(^&"J+/D"U48$YU.I;UB8GE%C
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M8CW<>8(6JDER['B6;@D3!ZO%N=8FP^85NNU LT-IMZXDX#-F]+*1![F4THE
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M&L?)(?DFJ6,$]_&M];VZA%)"NTVOR* \SV$0L;5$TBSL'TBHMXC31_J2A!(
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M0HM? !Y/WE;5.L(^X<;J+:I^;R'I4HAECT0/>J <$"M/OR+=[YM]5/" 2J;
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M2X+A!NN')?UL5^W9J\E_R3O;R\K5W*F6UK1PZR*D"*]#8UY$ R%L<YWZ:/V
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M UOL%5=,3"5C#(Z_W-,E+;EUP^D.-UWN'SY./^4#<HUOM6,_-6$Q305C\;!
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MW2@X M)B&R61COM=U-L%+1TI>V/K,QGI*DPJV7!]PQXG>R:-"8UT19<T+G'
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MRMYDZ'P,=(/-\5K6JUK#_W+2K^!C:N%?,JM5NS:4P*PN+ZN-'?UB1.(SMYV
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M5+IAA.X:??*-N)VL@'Q<GU?GA?Q,PZOUSJY2YKC@$<S*+JR 9=O.AF53#=F
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M];JP.>8[^:*X=-\_NYB8NJX"L[(T8[RJE+KJ7O 8ML!1^)Y)GQ/E?@G?Y.E
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MK(! /B@!N_7?@_U;K\^0L.V#N<Y9PHP$4\X7WRN[:;YHJ%.?'=-PT[--"#;
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M$=B-/B2I)7E3YKGE4H+C\7/R*$J-#\RM[7O*Z248WA@&\%?I>7H:,7Y<ZM]
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MJ50A[WFOC)])@8@1I-@09 ^L1R+8Q*\H% K$:&%X/=3(0M38R0LQ=9*,AMR
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M,:P^JBZ!7U@2GGE^P)(2-T=B>6(N85P"YI6 2JDR5<NN(/B%UJ?./=Q382I
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M:F&^+TB24W )/Y'N+S5@2F)1CQ;LH&)FH@*9/#49$Y*5"S$T*VZI00X/MXI
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MH\YS.]5&#1SKD=XVAI1]43<"SDE,1Y@:<X8K'#?.==?K$.R,MR8MF?!?UM[
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M$14V";RV=;F*'6/\QV![R\(Q/LB350T("2D)50UE[,)B$C[KM.,4<.,(YRR
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M\,N$A49'J) ?WR9:.W7<WI(O_4;/PII"![9]\,_HSR+.S1%*6$K=.XXPEKS
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M2DG'"9VA6I*P!D5-C&1G1#_FKBW!&5T_!V%L%BF$4MX@ZTK%._4>!X$&,/Y
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M#Z5--=HZQDFQ?4!*0#E&;4AI/\/-NL<>SS"U/V_00RX4L9*@^DO' L02SB)
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M\#]"+=+5PTA1FK]B(:BF1!\$S>K$70LJ-=>+,*$>^<I?O*=X5NNOE6FK2FH
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MTMQ=,&_$'+?10$21YU1%&K0QU.WC^'R,%HG;^F>.(-I%3N@A.71/$\^/)K&
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M//X=5R*,P2O+H- VN^KZ=\B1<9&HL&H1RK/A$F1K<SD--=@*,Z]LG\Y&._=
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M-GG/*.D6&X6%^YH4, ^-??W%!P['N!-]U\A; S1^?,K?.@W?PL$4\;F(_=U
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MC(227Q&7#J2YZWM[8%)8/$EY,FQ'CV)1AB=F@<_=T WN4]EM&86>R0#";X-
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M3:O9C>LGN$)J*8JDP,##VK?&OH=L/@[:E#HC)I^QSD0WX>[UA&,^94S'H8^
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M^IZ-.C=1ENG8O:\HPU1^A.FW^<]X%_.?@H@)\Y]AY'+@8_EQ_AN9$STS=,)
MC/G/V4LQ\TI5_609W?(KV5%!6-]0P)3*1*BV!?].-#"" @ICMPJ)56NCJAAY
MF+>G2+94=.+J<C6*W]*__42&+RI8G,7TDCWSRKSN,+&??&<JG88R#Q^I2):,
M<%6,2F;F-'#/'PX1G$RZ(N .2;":B&K9U%E(1(/(D+<SNRSV,LV9 Q,QOU0&
MFK/SH>**_&1HHR*D:P)U,!@TG 0A3^X27NE\(H2W1)T>S/<"L01.*\XIS,^I
M=_7N9FJMX88'B2"P)E[C[ /2/6>@X?AX5 F5[8_A?FWD!,2L=XGH(,M_IA,Z
M9!E_D%'*N20R3*4SLH RB#8CPM[$\%;Z$-]!5T]FMZO.OX %)",ZCAC+:K+<
MW<NR<E>Q\C2Z%AQPP46SW]:JK#'<QUZ)Y20#7BT2<S;J<#K%9[.^8Z'56-FQ
M,,]54RK,KV^H!Q7FF8;V64W9TJ0]^"<0_E_:'7>_WMFDMCRD_]NXMGP.4T P
MYTUIM/6MN%>+/7CS2>B@7OS-JD1WN%\][!RN3G3-F<:\-:0;.<Z"QY8DL+'O
M>8%XTGST/T812LEN+&9);/[R)85PR^"Y1NAF-P?(=U%GXV?J"NB"V>!Q9$[<
M8,Q8]O9R)C$HPK&/.AR8;XG))@6U"993L3OARE)AU;+)_Z]&/UW86(S*X8X^
M?ZTXR7T"DMO80,:>(@A5U32-X! $7%L,>R%4'H9I^PC/!4HAJ;(#%[.!;JAO
M+TT*%HY9C]2 5\*_[E9/VC^$A0>)>:$WV,Q=84!^BB+&L#Z.I]=.U^K<*ZL-
M/QUW*S/'@X>)5IX?)ZENP$B]XVO[I'0&+JC;(_D8*EOPW+4(5:J=/"XN"94Q
MZ,_[9/)><W3PR)S[9WGN7TU#N1[]GN;W>;_";\:6,C)'3[_='OZ 'S^H;+!%
M]GZUO99?8WZ'[X4-OC?9W7M)ZJ&ME4#KIKT;M__2V]Q+X2)S530VE^[[D83C
MYZM.2-:QXWID69&N/HE%YE)>W4^$TS 7]1:XLLRT1.,,VWW"W"J$FTP9$4AX
MF""Q!W_N22ATS2',!"P8\-VXK=_" "N()4H 2@2XO?^9^IC#HFN**Q8BHG)S
MS'@<IDG^$S@?_9$%#BD9=F76!V%\5?@YQ=/1>(./CS10@@*XPT1O'\XOGH5/
M74)G*U6R4B73=T#6F5Q@SK2=>;;5>MG3I\[WIWZ0(B8O =NHU.7XV@V5_D2=
M8!!?O@N2&V:< ="ACCFAZB0ZIFJ>A+&: FHP)-6C 4$^Q-%0D ?&#4!L*[>K
M"+UH$+./$=0&Q(<9W2=*7R+0'<G0!:@(V,\^J1!O1W<O?R2D0VL83"E71ZIB
M("VBR5)*8-6YBAAV1^I[""-E;XD8#B/J,7,K-RX#N>D1KD^?$5;<.'8EPG92
MO'L)UBM0 ^K"W9.Y;]&M&1<1AS#]2!"*;ZR;X5:+Z#H7Y>8 _4:NNW[LR=_T
MXOG5)_:&'QM[)MD-GK6QXM,\XYI3"B -!6NCWB_0:(?#_8.ZM_%9/(,2_0=U
MI@BY6HC6KB(HQB;BT(L8C)B9"BND:-G/_A@-."PFL))9)<3B#7874W]SCB1"
MSXB0]"AD6 &</7=[('4:>*QM[E6=<Y5Q+-'P4<,DMJEFKX)2]DJ(??.T0/M/
MP33^+@A.,<4)2GT_F@CDKH.1#TO$E5-4-138>H/ZH>"4L=W>V*<V]5CF1=,F
M[C\>(U0]XX#Q<.3U9X=#PE$.Q%,V]5]4Q\76IV3_''60&=P"O09:U.B4XK%
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M6+3)Q*522GE%I*?)#A=Z]@[8,E/>_8$;QP2SCHL6"TXYDZ^/*:>8J (*F$N
M+90>P8M*8$?(R=3-)@BCPB8SA%4R16)3)*^2GY!4HZF3&]7SC=R51E9_C/R
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M2[6@UG%NICI@*L,<1G$U>5^QSI2J.$ H"6F80S^M6&H)VW 5RC-0_\XJ+M1
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M>URKMLI=?O1=WB_W^-'WN-E8O,G%3L[]TLGYNA_;(?!8+.$//2IM,9$";BH
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M;%*-6GMUX6)"ZHI[A%$HEGA\$_'\1MWDUS!3DVQJ<8'Y+&=^S/233DXA75W
M.2"DELA\6[A5AR]FITC([V6%]A(9_)N@MYE-?!C,X.$='/N>%XBGWL%E,BD?
M7.,+WZ3FQB_=;F[%T<C%Z(X?.C+>GZQS\9XA>_;P06MC#BSH:>C Z 'Z:N8#
MN:_,6W::"/*I'AOG&R]DG_Z*WK\K3$,K":<DG))PUM^0F:*&DF2VH81UD\M<
MTEO_+?0QKM%+,0WKJ6N 7A/$X&I+WL8JCD:ETSE<MR?-\Z,,;AX':YL,_&73
ML1L;[R517O*7=<GW&^WJFIV.RDM>7O+RDN_ )=]OK8R&7E[Q;;KB]=JSM*!Y
M!@/E%'<\I.2NI<SW$EVJ7JFWFNNV<]DFR*\?H]^MN:N-SK-V;=X9NCT\/*B^
M>H#(DFIWC&KKK;5;9Y54N_G3:+\6QRV%,YP5(D"/8.[)1)<\'OSK-09_;$.V
MD;VU*K5F<V6QO,%=V1U3\D>7N9T,M59[+F=2R5U>/'=I5O8;C1_T-I?<I>0N
M)7<IN4N![E*OK=P4K^0M+X:WU M,P;DU9UM1Y?G<I5V-_=9&*EX..M7]P_T=
MJWA9.ZU:&_^KEV"O7^3Y&"6=<XO7=V0U<RM-9\!FFT\&-KM"%N7ZR?ZK)TT^
M&XSAIO)N\2+"5N@=E0M:\>K"L63OK?P]#__4R!U7%BJ@'PYBX2;"N75MM XO
M]N%[IW^O'_ D/-M-%$S'0H%Y%< I6F :"&3FPUL\![2"VW2D?G4;Q8%WBW Q
M@VD"DDG$#N*,$: @; QB:DPF<73GCQGSKUVK56 CG#UG7_X+04:FL'R$7[I3
MV&X]>#C20\)7$D5CSNNP&@9Y$Z&CF8WP0P.9Z"(0R#"!E_41>= ?X&L0T>W6
M#SV]U&OX(6(8QJ*/<(D"CMSO,T(:H=:,W# 4@3/V[^;C=LPAB"+DB&TAH^/\
MV3.2)L'"J!U$3*383V9.]+!-N?*,]:L>QI_/H&@^.%312(A*1%C"S-+'S-+%
M @%5=7YH.;6-+:=>--3*ZVDN $S.R:A%S8Z?!K%[A0D5BSFOC_]9UDKY(8DZ
M[U4O4JAF@3G_YHXG'YS/<<1X=D,_+:7M$FPRNXG(%*ZM+;3DJR5]6:[ #&VI
ME)&_1D C7U#HF/B>)Q6=+TF>H1;@";/?F6-B0]N"KE=;D $K1LX[5Y-2\+0Y
MG8#^?8WP=R.8#&SP,*99*?@]?!S,TSW"1(-GXVL-[T=(?LY/C4;U0!6[$L98
M2.B5_:D?>/(7/,Q/C5IUWWK2>MASQ[ H0D4EJ#1?SE."J\JQHG#H7T\ESBU#
M3!.R,U$OK0X'OO=%X,T50"58_2^=^I:#U:/0Z\S!/RJ]5:6WJO16[<YJEO=6
ME8KWMBC>\R"]%4YHJ7@O(64?VL1%JC=J2K)RQ5*7,@C/C#C.<*V,8B]_*]4X
M=!-1BXB*\Q-"<\V.ED<>SZ#HL^-!MARP=<&?VM7#F;$T=C.MU4U=_L6+TL__
M, Y%W.:^@+T"#DA:Z# "^X345XVPRXZ\.22 6S5 V&#:?[9UAM-T"A]+5R7C
M3<-YIS[!;BO=4K4O80AB$,<#J5Q+GZ?]%K#&0G'+ ,$3CRA%]U@A1&/9'X'7
M0'."G\5F2H,(/M,@\@0!+J[O2]_.5HF8O%:VR:?*5[\8F;Y$VX12O*\@#E;8
MSX62OMDLD/16;P392T=U3I"2^*>FSOG9B(+04;G/#PMUJ0;4P6B<^0DL',2/
M?NV<+@G+E"R\3M;R!*\N171I!2XG,4ZY,T;JWI6"844_OC^S==C%$=?LK1$<
MSKGTW10LMOZ4':%I5/0R:ID88D>? #N%8 L1/],D#IO=P!Y2YT238B#NJ$L4
MCJ0:L=&\KT-J+8(SG]>6C;Y4O8@2;L."]D<46JT-=3<B)]NK"K?C=T&+@V,
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MA-Y>--QCS$KKBE C7#*HBD^7"![("%A0_E<2XU.XW+,'908::OP&'%(2&&U
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M6J6R^8(XJD <W8\G#BQW4.\H2D,5Q"&(HTC$T?MXXFBS_H'-_N$'<HN5#5A
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M0GY J8_!EM&^+1FD!9L1>R+V)&?/YK[-.S,P?(4S_(.K- G4%$9A.*6^H&*
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MJ?&UA-]-RHX56OHPMJ1)K%:M#12YF]MYJ (H$.<.E!TJY;Y P9Y]O4Y"BK,
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M^ V'6]+121=+P36[>6BBXNA4.7&65IX?AC.Y-F@WDRK8")R="<[2"O_#<*8
MSA2YV/RL C9WL@KPU;"(I8ES>B49664C)JB*SI;R_@W7]0&:[.2>9D^G-@[$
MUGZ<0[CD2%G^M\&2WH^OV((^X7HFL6055,R>J%U7'9!DR-=/#1(\"Y64^B=
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M4Y7X4#7B.//5NV,W A.+,Z>E.[C 6_C3C*@KA+L046S56&K6RO+5%R%RWKN
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MH7:I^XY.Y@M>!PI@O[FJZH.U.>?V(\;#" _A@8+#])FH=24("C1A5Y2'8P:
MNJW]^/_W2(%ZBO0GSOT7"]'-P/2[B4R_)YB^>)1@^@D\<D%_TH( 2\SP6?YK
M+/MULY'&^#ZH],2PF)<GY/_ 4R,^RHQ9EE7)DNLP;#"%44RX@;5V<Y@Z:@5E
MSR(V[2Y;0PG#858B&SPQ73L^@RRC#P;PXE P!0*7=32:%*.(1U]PY<*D!N['
M93$N$"T^:X[,/R6FR6TZ=FHI\9EPAPMLVAUSGR@7P?A4BU(]RK4-[=2-Z8,%
M!AW0M,:22H-<$!KF?R( >/IGL*#)*\0=#<QHGE$-?8.!$QZ]A-QASMR,FYT/
MJZZ+)0\$!XMOK0QN*3DU<-(2C'NZ/*6)'W,#^/!(FHOMC5##H8X;Q/="3TQ2
MQM!R:FR H$6X)"E)%^.=@6L^EK6[>=2VM74)'+KTQMRR6C=NPKI?*F$;HNFP
MU)XT>\+2=?FH\:N?>&I/M/0+3?: W-P"$Q>?(4[NE3AX<$'RYC/.YU:VO![L
M-Q+3*AK@]A<;!#!+T+]P9[A&F**%5,;OU6QGQL(]ZX]E"7IAFZ^E;UQ_YI!%
MIG[LF^73GM(,U%>'02<(:"WR_1AC91D"+L5P4> >6^PK/]&(\6Z\D0DDT_A!
M68P)-@(_9(&3-X08/&$4900L/77IF2,ZQN=@MCJLRCSPRP%4"3S?8XA$YQ\3
M"&[H L3T,G@XO"J4EL)UE])UAWO(EJE5I&7Z$C#I)V32TC7P,</D>+MGW')1
MX>9VX4@,8G]/3)=X1EUBJQ)9,C?I5DE]5 NZNY\%_1C% 3:[37L9+.A>H@7=
M%Q:T>)2PH!-;2P8!M04A,@XZQ PQQEV1S5S;_L@;^V98YJ:T-O9P/?[(5.V%
M/L-/P*&&ZX5JAVUH^#=+J^<:-V_".04(S%C..D^M $T#%PO^]!QCY'MV<!H.
MGH0WA9GV)@TT:GXQ9E MCL^%R@JH2VLI'8O$>CRK81)CBN?J#!((O0F\UW98
MZI-#C>G(=UR>2(C6@F-0W$Q4XFT?Q_)"'*9?D1=\=)#I"!K1IA5"/2W*/1J!
M10ZW\<@W3Q7A$6H-M#;#>P/9.F&E4YCI%<L861P3C#)08\/V'#Q*6E\YXPG\
M7(]ZGW)C.UHL?M*2G3<UPYR<,=%PZ=G@%ONZDHG%6+B'WRW.&D3/9;>B<X(?
M/;;03Q"C!CVDAB@:C9_.;'8L @?,%B&PA+ &";X,SV&RM0SOP45] \$,=\'$
MQK 1:$,%IUJB][&<#QZ]G@'\/3[RX% G'<.+O:53X.\3PE,B6?X )KYRW5NG
M@(4P12F::3@:O,*/#[/!,Z5^"9>O'H=#=!P]2GA:N)DB?\V,P%PPH,ZSD]C;
MEU]Q1&VDMV<-OBO;PE0@;F4^&NZ/*[:5^-M"'>EG4$?ZR:7WFD(?$8\2^DA2
M&#=.@:R:"&>F2()K1?>N0H9=5G7D:U(B5: !1/($A)?KC_Y -<$/"UHLUH@K
M WR1'%PD%C1VO5C!!KR N)-Z0C[6+I=Z/4RP6M4)F(C$DB,>/Z;W/F-'*-GP
M8H/!RETF88FH43X==Z:NA;#'] W&\(>]FEYF>/["<[F(,2P.N^CL? /%U74#
MQ8;YT%B-L(43.JJ*L>R:XGZC6 0B5K, -1?NA8J4@> H*QX9P!,HX5F5*"P0
M5%' VAJ!+RPV.%XQ DG.Y/&'*?S% PN\/ F>@27Z*V ;"T^@5XMI1.C_FQO4
MU-THEK&2 LXK5$1.U(6GE!=/B!8TS(X5.;HI<W3EHN7HIE=FGC2@#=^D[OUX
MB:O>CY&9?IGCSZ],5U[WN;2:&90<>4.!8;G .<!XDHH?@V+!JX#M<54>V!$J
MX4!#N&CD)4C\M#UF6;%*+Q@;>W&PW$H";V3FP,+280S%H4&](4EN_K<4>NZ"
M<Q7PS8SRLR_A>?:P3")G&2SV^68==&#KM!HD8+K1Y+C.HD*V.J!XMG+1L'J-
M3K^=Z4F;/V^K^6A]U1Z3W)#E;$\JUSIUF]O?G;%#]X[+M[9"WFH&!+6U \ZY
MQ0K@(O68C7]ZJ8IK/W*F^O>_IVA]O759^E5:E5^8?$EPT.[NTK WBE!<E'*Q
MGM^H">+S.\]ONK%TJC,M*M[I(7=TE7:UAD&-RE@7C-Q I59FE=8:@QPPS>HO
ME2J6*NU2*8=RHDJMAJ"Q/6FLA*V84UKGH6-7&F[$AK)[GJDW/+')Y]&;8J9<
MBXU=,2T?A?=J8\Q6)]X94]D9X7J(O!QRU"43B^6'CB"Y-FCEU=,X"P5F:Z!Y
MR@WY[S3\*DL_6H'I79CNYHMII390VP+3 M,?B>E>OIA6 =-Y]3(6F!:8W@O3
M_7PQW:H-Y)[ M,#T!V*ZW<P7TVTTY 2F-V(ZLU&;?PO18QNU7_8BXMWS+,J&
MI@GC[)S?+F>.6)^,3#QA?2K%I^5\^70'= _Y4#Z=C,FRL&)!N8*S';(^9^"?
MOCK$/UU95JSDRXJ[.;KK*LZ*<[+T*HM,-5]D]@"9>1ES IEGC<Q6OLCLUP9*
M1R!3(/-P9+9S16:["<@\V+ 2R!3(O&CGF^K0E@&9ZGDC\PR\K]=[F6Q5]Y[E
MFV$!%N"@=7 T6GC/!#(OVOGF2;0Q3Z(KD"F0>3@R\\UV  MPH/0%,@4R#T9F
M)]^<A3;F+ B>*9"9 S+SC=*"!7CVR#R#*-M-'MZ3 A/1?F'E--XAL3[">[:)
M%><;I6UW:P-9Q,($Y0K.=EC"S-Z5Z\+Y7J#XOE3E1CNOFDK]='.1OF'%5U8&
M5&XN**-T\_B[]+Q4ZPEK,5&B319E4[&9 2\#/*:L^P+6M8N5 >:=/T:L/%O4
M,1V+NFJL"!,K\4X6U7 ;TF-P,>N#"E_S=A]A>P=6CHZ^\VX@G[$NE,,:(-2#
M2O'3$:L2S*L*8YL#N);"!UA8[*AE5M7]RJQBCSG+LYWYII+O[2PEWV4YN?R8
M(HJLBD>)(JL)'"ZBO[+638TF@)R8L;VH7KMIOP'GQ)*GK(^WDUQZ'1@( 6;K
M $G.+_!?K$=NA,4_X[VBQX;#^O?4@]]LWPMZ*,W8>O_%.]/PT<!]NJ_QKD>L
MJW50QY85!%RTTS&)___9^_;FMI$DSZ^"T,Y<=$=07+X?[EU%J.WVC.+<ML-V
M;\?]M0&211%C$&#C(5GSZ2\SJPHHO B"!"6 JHO;'HLD"O7(S,KG+YWE!ON@
M"8#N!<,.23X^O^ WQ$8LAX\8\-8X'&(0\0+OL6$7OI'F^B#@2*.G9'-KW -?
M::M#[7+$"T!CNM_("T3,#/9(8J4J+^\:MP:W(>C&X_#J="?)!J5LI78OHE9@
M@1F$?@QPJ$[8EI"LT>3A?Y:@.W3@\G+ P$!T5M&DRS?^%:[NMZ*+5[0_ZS (
M/77FV-:-W[MYY]V>?E&\_8!AKOX52I1:4 =B"DLBS>,][U.C-A>15%F@$&,'
MVZ$]8O<DTU<&(!I9N8RW8]J9\/A?H4E]\O 2]5S;"+#1@'/?(319%'_4APD;
MSRCC%#0UZ!KO!7U8SAK^=I:"(K#KGK(HT=LL&M#B'=$V!#?L4&, _FILM6:*
M7E"R <)*GG_H(TXN_MX'>Y2C9K(?%DU?$,.CI&(_L2&2JE3$X()],%9F8'(<
M9-\/MSN!J[O /@J\)>!W9EL;UUU1MX.E9^[X$NA(_"4V7N@:GZC]@L#[7[F/
M#@?Z5[8DR5"(_ G<@(1/KQ8M&% G]:C+(5" G6!V2Q6*J*2XU&%AC>0!,UFU
MA D^A5YT9'&[!M*4J;%7])WH4<9[_/E2HZ8^C*AMPU/F@VG97%Y@CP>3 U;#
M&+$T\]W06XH&EE'CS"7<V:9H\R=&YVC/ ?.HW08-ASTY4%WD(U"O Z!1A8CH
M)#D,<T>(8I<WN L\Q)/&Y?FA331&(RIB4BQ\F]/YN*D']\^HD0?VBY!8VXY8
M#@SZP-16%>8*EDA]0Q#1_ &/ WMV+H,0;TC1.^.?<)O#5R"*UO(K>2/:UAI.
MZFEIHP$F/Y2[[\H66''W$.2)]1I>$_7[4-@99,.*_XQ0QR,AIXIA:E+GAC:U
M@L1V>DSH&&LA?9;TI=*_[JRVU^0XV^NSA^#@P=-GVW2"6V>%3;UWN,)"6RRG
MA\5XC@,?;J$-\BVTH;;0]%#:0LN1I9)+Z=Z)6+2MYEIB-4RN!M44TBK)=B-1
MROM-+Y?A-N0ZS0IATT&_Y^:"LY(-/NF#M!TF1;CHDK!%XX+%G1Y$TUS>RX$Y
MO+T2.>IVIN7Y7$TF!8*W*N:MK./A8ZW #^*?1DCM*[BH;'<G314"#=QYEL^N
M;?S&6& 3+UI?U)$!E8=U\&AZ+&J!&E+W5-[0RG[*]G/H&F^3K[>$(JF85>I,
M=J30D&H9K00;0UDV$PN1ZB-<PR T'4>JSMP%"=N/2I-C<NN6NI!@:.=!."9Y
MZU=0-8-KV'";MEN<EO(K<E_2[J\2V]P.Q2;1(SM!D4KK:U3IX)%K?%PTO#9(
MJ\%O8\,%SA<[A]G6 XNL8]!#&&AYQF_YOTKVITNL&U:TO+9^7&^LU8HY;^!:
MG?2N;JC5N]A:/)V]"L)D=+"&\ ?-Z@/H75<&[S@*F@K(4IC$FU7H/8(@]ID3
M*0Z3_M7-&MT5V _,3^LZTB>R"['!6<0'U,@.[#'\0_4I2)X@!I&_[I3NQ@"F
M  QT\&9,SK890]R,=8":;_%^;,TE]LWS4I*2.S;VSWQZMIF/2H]Q'7J.108Y
MEVT_\-] T!]02<:FZ[PS>%8J>TSIV!QQ"S4EXN;9H<QC""$,%A.(:"08FQ1T
M[&S4-7X-+1NIZ- W@G4.1O;&VLD/%F( ?,W^8YB=[1C&2,IXB>:> ]U8TJE"
M^Z)<E+@,L4]1=Z.HSV7HH)M%7DBT;=1'*"'HA/1&-P8\&0C+U.#=+F4[GTY\
M(/PZY[<KOUZ*;W6:S!;.8J6T8E2['XM^@W!*C(F[W'2>J.<\S@!M1=0E<$7W
M#AWL";WD=2NDW#OP/1AQ36N%E&=MDF6ZUQ8=YMNBHP8W*XI;BNWR-6D4PB!9
M08VE/S&L@&X3 P/8PNL4-PA;6AZP(K #]?"T'&Q(%B@AAZ7I>4^D!5(O(A(>
MCF!K#"ZC&S(93>!]8(68%G)8?&EQ=XPBJ[$G''?J2MTI_4+1 5WZ>!T96,>
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M\=M#-@@CWJ<LBMQ1GG5_3_/G3@-KF_@%QI5\[G[DUE*\8S@Y&2$,W(X,)AI
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M$OR#M],5O=.Q,QUVGMC;1?>0%NJ/#'_HBS:^?JK';IH \&^Q\32'Q Z+%8Y
MM4"->.?Z%O[FC<=L2AN->^/^/7DTXDQZ\2/F @@;%E;X2*8OXK,>W_OK_BRU
M4<I_-U$UY@XDRO7"8^;W:W,-DWQCVH_FDX_<IE(F$&%J[]++YHN[H<ZG>2].
M'4O,)\ 31=^.AKWK83_#2/3QH#+OM*6_<F\XJJ?7;_6AGJ$!<6,G-3ND*W*1
MKK17)7H=[8S+MN8%JGOJ:*YZ2!?5@[J&-OC(3^V\K"[SV ZO[=FJD_HOOZZM
MJM2%^>4+I1I8=-5 K^UA>=6'^P'*"?R2C/VRI.D3+=';+6QTD.,#&/8(=.G<
M./KM=4>],C(L<8[61(8'%\F F5=SD8PFT;:3:(E?]&R2<H 5)G6!*IR5#+5&
MU:0)ZL6>LMBL7S_IQLUW["+/6A-S/ILN1L.AR6:CY6*]& P'L\EHRB;CV:3?
MF_[O<#BZ4AR1AT<(/K+'V^42!06PZ6?/=>"?2YY!\ADX>?G$_YOU_P^'&4__
M'A]GTYV9\WEWU!]7]67V9]UYKR8/G1XJ7R0HOL5D5*Y/4;D (R__,1R8J_Y>
MGT%5TU*,>+B&,"AUQ>4[$;XP=&<8,1,:_PBME0E,F'4M)"7(R8&URFOLG;1&
M^\FX7;D[/#!EM4F9DPRL'+_"PJ2U\RJ =X[QT7W@7F1TI'4H8/C><N \$5-)
M6?=7C#V:WLHW?G7A?SJ&ZQGO;[_^VC$LWP^3>Q3_]H_=R@P8_?CVZQ\=>LEU
M;]HQY,8]SR94=#=_9?=XNL87MG,]6M%/W]P=7$Z#6>_G-\;==N?AKB$!8(R4
M_XSDOWSRG>4O;=</O;C^K0''W36^P?'"01@>^RNT,*-O%4T40\,^B!EK#2('
MEN"+I; ?.^;X\--@8P8&QH@]=A_:I@?\@?M@8:@9=H%"S1N+K0UWQQ#T![8-
MK04?K]:M^9UY1 9O/[W[O4/>JBA._6@%&\LQF+G<P-BXEX@1Q,QH5F(F\+:U
M%> @,&._:_S)#%,R**Q)T)8,>Z_=T LVQE^A">-Y. YZU0V8C EO"3S7W[$E
MQ<\7IF_Y'?AP;>,G,&]\WMSM@%JX9@ /XT<.>S1\0=N&G/'.P[)'+R(56+SE
MKKIU2887DWUW&;9.BCZ0'('Q_U@@A63[16$44%-$(4BX2,!%-#9ON/Q*"RC>
M[-/X9OYHCV"Z]YB)? L"RKR'/^XC3K0<[L3"/\V%&P;$T)+]$ TP>,I;VWF7
M0+ZRZ2\-VE3?8.NU$'$!'#W(9)3=8/(L+=L2^X?9/+:-_ZMN*QI#G&;@03B,
MG6FMXC,BR<B(LDQXEG8<__;#Q;_@??AYXFD2]OB"@#GBLM@P>P<?/" ,G.<;
M"Q;@6<,.,8\$+#PC3E+LJX_W$+^GX/$8]7&YP0H"'-SX5^A9_LHBWQ!\@TNV
MV;WEVV*I.*H/%YFOS"ZQ:G[!T9[YQM+T-\;:=A_19<K@KX O!"Q(Y$-<N2MN
M!WG+^?$66>KFPP#P*%B9MK@<<,$@ !U*Y<(DGUCT],>D)(TZ="O"#8/7+-UR
M^"9X?&NA"1&_R=^XH;V" <6QK/@-MTO?;S#A 'YZOTE=?NHU![]2WH#7*VSW
M,O0\?B.P!],.S>B"M+8[$TZ;[D9X,KH8D7Y"3]$L_-HNPV:HR:/"NV%TW1LV
M_&YXEY&GXG8 I3V@*\/X36A\#9)E^9JK7 @<0%*/78+A;()(6+J2;2,M5FB'
M!$TA];IU9/#X<A/V\?+:0A>U\03,6<[)$ZGLPI?6-A( 0N>M--14"X7F:,A&
M'.&@ _[M![^*#*Q_ ZF 6X>&M&U\"6T6:\N@F]E$8:W7F#\YQN^F!Q;0I*-(
MQ:^_O8VL,OSW%V:#)<=@_<!2P^%UOS^8CG\QAJ/K^7PRG76(9G]S-J:P*V@S
MI0/!^G<DI=[:%ES3[/H+9@;#V(HB2TQY)Y6)#BH(0DK0C I$@QC/$^.IB@!\
M[:'F$'C\[U@J<"V"W^5<YX3W<4.6'!]+L'V-/OUJ8#!!!T(#RJBMZ2F ^O)=
MF-D;$[@0O\1C B[C;,6XVX7;X*8/:LX"OK.M[PS^![4J?,J,GHN8T0$9A)G<
M0#.Q/K4(?3A2'WD4-</[)[2 _= .2"P*&QXF3Z^,)22HCRM*N.["EAOHP,0_
M.EQWBZ0I[ Y2?2?:;H7Q#;E>F+'/'C"9_!%T_0T\#G_)37;I \<,0D]]*TI.
MT#D73!XQ&>(F;#^.6"S(%2(0#_+S?"1!21L'XC<$:;H!P0A'B<(9%HY"2QPT
M3:N(+F(:B.>0(BF^-Y&\!_V6?J^F<2(?@:S?N(^X+TA9QNW.L^P4?PFE R0
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M;;FH+N&4,TGC>;DT+KA%R/#"'#_4DZ5A["Y0$V(KD;^\9+YO>D]Y][F,;^Z
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MZ>>WF'QN@[>FYR&@).DO.1'L\>#JIC\<Y61I-K E7PV=(34#O7(&*FE\6<9
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M03_?L.<OUQN@FQV_LN=ULV/=[/@"2S#[_;, 4NZW$'1/T8NDI+/T,3L@'91
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M@,?^"BU,583ERPM0?$;W_<ZF6YAR"0.\%"25^$6SQ9$>H_')(C!0K]B:/BH
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M1C $FK9[&6)X==/+@7G(>*,T+VA>:.;=$+-!DBDJZTLCTI?&O=.[JC81$VU
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M7_#UG]9_^(SJ<GYE:]=CM\MEN UM,V"K=VSGP6NHH@0>O=VZL$G_IC^OL.7
MU@S^^\KZ$;QQPNWUR@VNQ:3R^&L ND:GUY_5!F?6] H[3<$G58\UCX*QV4=G
M,AC4%E=O%OQD:Y3I#Z XOS',^)"!DN)3)J>KJ9SSJU"Q?WKYV^-0KLLRUNCJ
M9C+-J_G,%$YHW;P%Y'4>T7X\>8VO;L:]>8Z7X]G)ZS4I]3NUC#(*@G4,AV5T
M_0/O28U%<+9M::+,:<"-M@Z8=R9E$G$..L/AO#9</XU(HJ7 *Y<"9U(\SB@%
M$."]T^_74*O6""G0YCZOJ@DI>O\85 4#]F7@%J@SU'?SI-ZPQJ/I5VQ=NI_*
MU87DD=P,L;3SF@H<V>*U)#NC;#H([3V:YBCGQ_=V+0FFE\QHB"C2HU$.1\8;
MI'9U3?5*;2I]?W!]'[O%(O:$ZX-^[JZ+:'I50\OCN-VQY1CX%MAN&%,VU:J!
MZGT0/?"O].G^P[0<7.LGYRL<[*=U0NA'$C_OW+'U\=Y3/XTM:I_OX.JFEX-G
M5R/?U#[EX=7-8*_DV<-8^4!9@G<$J8\&W2G:Q-DRQ@C1YN])W"O!G+WX$1-[
M<H=!\2,91(GGK3BZ'DQ2&Z/\MPIVV"S"#MMX,=#*/;M>>,S\?FVBVO/&M!_-
M)Q_O=E6P@0Q+[7AZL_B6W/S7PD.U(#O=8KBR:2Y<V4S#E>FA&@M7EJ5,TJ]'
M17?\LV&9\3OZS@E,Y][")@T=XZ/B?XO+M9.:NV31PW'-OBXW;!7B;0"6E!6P
M#R!T5_%[]W6-G@ZS7:.;JD5] YUH#;+#?20-B8N8< LS@D%\4IFP4Y#K8)XK
MJECWF&X".I#<"(&:W$F$K]1H58?N;8<%F8>,A6FCC>K#GSATOAY&C^=^-7QS
MBJ;:"NBYT;@[&\QKPHL;SJHASQ4*KE%W/!HV;5*][G@^UI,Z:%*3WJ I<'\O
M\C/E"FT!O)H*,FAD8.DN$&GP'4I?#V^92HB#%2FCP2?^)_T!%^DM3 4L&.,/
MGZU#V_A@K1E9(#_!UCPQV*,:]Z7M*(24"&N\-3WO"769VZT;[JE1U B.ZMXI
MT0#C]I!4([U]ZO:!";*7\)X[=>V9X;W^!QZSGS+Z?6O0OG[J_YQC0=:9.G7
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M7Y&\\IRMF'D\C^NFFPR/54-FDV:HU\U0!?!R=3(4-J_LG1Z\T RE&:H%#%4
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M%_LKM((GPV?+T .S06/J:,2"2N;^!]>Y_\:\[9WSP/R T&;S;'S*PYZW Y9
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M[\/80?.8?-O:]8Q@PXS@D=D/S-C";#>^P9P5_%3&0?E-,NQW# R?T7^'9,C
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MQAF=A7%Z;= XY8T?5V[ I67%B$<TFX_&MJX"(N]-"88_=LKE$OC5>*$K?IG
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MT!NFZ4>BK"MR\5H,RS (!;')K_RI@,,$M\]G+K\G-23=N-J;?/@5:QVU5/Z
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MO+V/4F!X"@Q/@>$U)F_>HSKP [3 "2B>PL3+N<>:P[TI3+P<1+H63+P[#%3
MY^0@X1RG/%A#=4:O;[%R[588P2G8"X6C=P&+NPX<O57K>2KG,O.]11S_Q4WI
M"DZOEF!+A3H)XZGETLAY#(:@A$&CU2EP5PQ>!P8OU.VXB\&[;6#P4:NC&%PQ
M>)48O%!'YDX&[V1,2;_H7I2+];]F:?AMA917 E*>8/Y[=\=P:Q #78'FU8M5
M#@#-R\DJ786?5R]6.0 _+R>K])!5CG8>*]CK4EW;RD_K1+:USIW-!6SK5]\&
M$B\-9Z=GV6],.MG5$A<8.ET]BQ2PJ?E89-"8]#+G+BH.N3P.*6!*\W'(D$9S
M5B7!6-\[KFTHOD#SICA]F-]PL9]B,"Y>@95[M_7:-T25^_YU.&KW>ZZ:KEZ7
M[G'(-L9@W MA_>1^$*+ZT?/7\X"[8Y41]N4K!*OZ\,\>;ZUL_AGC(*VJ&&K%
M/R?WY4KFGUZ;/+V:@2Y7W 9_W)D2.3H96)%=YK\JE&WLTL6X!#<B';;M%N(.
M"''O>"&N3G)<R4 =9* $5RB_#.B8U*K1_9 2@3J(0 G>7'X1Z((9&-3MXJN"
M+/TG_8&-B-BG_H@MM@LXMR2IHF&+]F')N3R1T35^_SH"@]S)N>.2WQ53I *&
M9KL7>5=U72R#MUP$O\422&\B%'1GK2$9F[K?69'_P@P_I3%[:TY#C(>CX:=*
M(?ZQR>E+/;S!.0ZOCQ.&V^KPRCX\_2RB-\#3Z^<XO>NXE]F=$RK)?[H(]MMY
M?5T.[^'U=FK27 FJHV2_YU+/;DOOEW]V(\IU==39G5[MEW]X8[IMR.-PU;?F
M8RMZC"&Z-+"Q3-5TJ)H.5=-Q3!;.C1!*92>T5;>0@_M>R.<W$,^OS$<HB"3]
MAA":L7;KMW' 7B6:%L]Y$+^<S.A>,;L.SL"N'<6NBEW+85?]'.I51WZM1&/#
MZ_'K=>3!<R9#KJ)S[A!W9D?@EEO:NIB?JT1K;O6M@VKS/,*9*8-9>\BLE9AY
MIYBU:E0JUY4I@UOIXJH291JO[,AL3R7)G#E2*83EVX4'U!3 \BO\[J3^0S)6
M(8U;F W_AISP1+U=^+D]J.&IQQ1&^LXH3R6D[]\9K)BM^^Q!,B\GO7=9%5)_
M0%5(V^VE,=QKL]A*,XH(RUCID%:ZW3RQ6BFBCY>!D%_&:D>TVFV/+%YM+@1\
MKF,$#'Z/_MNE72*P:!.G"2P9\B!S-L'0\\X(PO7: V,\&DY[W:[!1CUS.IOJ
M77TTZ W9H#\:=-K#_^GA[?W>F39=Z4R;WLZ9-K+OM.D[5<8T'X];O4Z_**1Y
M9]0:[T'75H_*_RAI<)V"&%^?X]6A.5XAZN7_U=4-J[,30+AH9"V>F-]RZ7L!
MN>6(PE\CWYRCT;KS%@L[).M2W%)?CNW>H6YV*Y8>S=\Q?*8M#1\'$WG:D^';
M7A1HRYB&AN]CU2XWT1M3%Y(A'X;3U!:&&\U @=-@*6YG0/<RG$)!?U@XW\);
M$JSQRBF@R5!SP]*,Y=+W?M(@'^>EE!D?246RF!;SAPM?LVR^WIA'[J? M[2'
M]Q'[DT9OW+OLO^F.5V*QQHW)N-]KC;--5F'[.CC;Z@?MQF0XEB&I)*OGGI^[
M.G[2#WQ<$"X;OQ 9CN8E/QS$L-7P20@D?!RL%?D!C7F9XO@E<!&:'-?:^,OS
M<?X5O/,\MY$M@/.LB,4C3W;>Y7?6'(\#J?+9  Z+%GBY+[W;?X:'!LQ-D:RS
MI\1@^#K+TAL3SV549" =?9CZNRDFK,G])3I9Z5O===\ICX;,GCEV5?,5!]GS
M%8NXDZ/$G7R=J8S[17$U>?31<#X;X#CXP:UKW1%//#(7)Y!]A^_]YGCFCQ3W
M@D/+0#TM\;#\B!5P9,?*D;W.1^UU9+>22>4[L.*>[0 '=J>[.FQI:Q*3[:HJ
MOK^Z1UUE /<[6'KN*>T+VZH:DHFP*HBF?X$#E0ZL3,>P%^ 1X_A9^&<\MM9!
M$ZIQ=SS@TV#A"^!&4SHUM!<TDY;^7_C;+OJ)CM3;YIE9@JZ$")CY)NP'7@PB
M'Q/]30TB+2N"9<7 6R_X%8B[',:]>W@?(COPU'%E#-;I$;!:$OXMN*EO:9\@
MWK&XG]N4K/09G?X7;4I3=OG&(4R WX)OX%A=QW@.(AQ=:SP")8(P(1+XQKY%
M02GFC3$\B'U1?+;X>2(0/MF+DFFADB $ ]4]I-FSS<N8I/L;"Y\9A&[_B" P
M /^] P0!@_@X)\)@I+ G<0JG16$>G#R<AG8[Q7UI[X%'6 BG< <,W803-UO:
M&S&/DG]$C)]\"X\/>:(?=H#C9)= 19H"/4,&X .-TFPO#IT9$ IZ8L*CMHB<
MT%Z"F?LK@N.U;"$1\8?CU8FX YGET8E,+Z#LL!UZQ&N"P2GNH<>;?)YV2[MW
M5Z-3]?;&UL66*6B@>PV:M1VP,'3XZO%#8E>F[P4!2!"$&)@E>?09_\B;U!#6
MA]4W;^,/)-2"9P-/>YC7-AP'F3@(X?FT?/X33J(&M:DX7'QX+!;I7UIIS/CY
M+>T/FFU,Z7,(+),)TK)%$04>03L@VPLJX%Y)-F<ST!&PHJ"9)M+VV\D#WK.?
M0&_Y W!@N6.!C0->\KT7PPE?;F:PBB9-\H4O.B"J3_#G+'*<%QJ6=1,M$SH#
MT6(.X$0*TF=B+)<.#APGCN&A)<Z(QEG>AO,""@>"Z("R4RLU@.\"^3EAQ1,#
M8.!P-9!K15P^RU9&03"[0 '7"^/4"-,B4G:"7/ S2P,5ZHO8-IX@#@&#%SCO
M8]Q/@\8Y[C"I]L42%BQ^^3:@D]]]C,3LE,QK:L0V<\.9X5?@(!C\2W8F<P/^
M=@)/>V._W>1]G%ONXFQIW!F\$D0XH3RTG4TIZO9^I8>_L>$A) W6^@)@S8L
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MRT*TNW6MWSTS+XN/,R:3O,*(H)(CGVMEE7PFOSBKC-K *J-J3)-2K')&DWD
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M,'08WRT^/@*?R0\-&SCHF8&MH-\S7%#O]A)/QJ N95BW:>#,9][Q#63:S0]
M5OR "]*DA<_,@;->@'#-@]9&J (\C5)GN[QM<,T\"/7<TUM#=#GC:.<=A43
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MKGY!OK@5OC\*WC=&=^Z68!;9CE/! ^5LXTH,GX'9-)E%=EIOM[.^+JJ45H7
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M_]FV2(IH.8YGT;]]&WTGEC=V89S#2)W>>D$8/,&S/L U/]?D1-G%&'R([T)
MJF;P-B"%)/)B1AX\X84Z).B(<<%\"BL##P&]FFN:7,N9H]]BN_0'\& :QZ"S
M!J(74K5 E;0W@UT?%7;,"*.".*,#"> QWHM[O>/^;: I1:BBD14%6SS8V,.-
MXC  .L><!>1Z\9?WBSH/VZ4@HC]ZOWEWS"/8\G"I!QQ]_?[%'H83P*7  Y!Q
M>Q$?"\1/CK_FX:O?=C]7#5[2D[\"$YGX>=JM1)'71*/0K=(_5^66OY0D[;U5
MP3JIC,OW!II%=>>ZA&B !2)&_&/NGO4MQ9IL%IZB_<R7:#]SA_N9OPW\W_KK
M9T4;N\R<4W.& (B1:1E3<@WNW84_$NR<QR>%C0K$@.NXY'M/_@H.,^L MOE3
ME<[%P:9J:ZJD(HJBP4?JZ,6A=Q3 =B<X&DU"JX+(^4?=^ AS+X.,)MX?D&'R
M]N$N\M(3=]-XJJ^4[R7;$,(.)DD7+DEZ!C5$"4G2J"15U2N(25(-H,4D:8\D
M9:3AEY D/.H7*SN@/*HD55204D/L?R<!,7UK0F.<0_),'&^&0;S+KDE)E(2,
M.H$2DJ!W^JK$"(Q;A9:,G-X2:#$Z?44MGZ'+T%(CM&3D:QR.%ED M"0=))\'
M+>T-[3P2!SX<7W%CXA+?=*A!-8=3V[6#$(_"GLEE\U0DXCXC5Z<$[FE-M9R0
M6]/8/%(&%STCMZD$7*1.WQ#*JTF&EAJA)2._JP1:Y$Z_5X%1/0V59TOH$FA"
M86:.2E&'YL("6(5'W70M<+3PE8R%T#VA_)E*T24YTR:-"=)E"]+QC"F>3:I"
M>4^="1(3I 8(4D;6?0E!PJ-)2:LL,GB*$Y7%2RQG,TK8/2W_V-I $PJW*V<W
MN^2WNZ2M2FB^<@/BDI$=<CYQ:))\Z%6^@VFM26B5UL_8A^2J#WDR7S]$>/KD
M>].\5J'7Z2L5Q$'K<US$!*(- I&QGSBB0.@@$$)YXA<F$$P@3K@O.*) &-1"
MU"7])(4I8K=4MX[5IOLKU.>NORSKY$@0PF*'VUZ@A86>Z_[B%KD$NI:D*"E
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MKCF"E[PVG1?S+4##O:Y50(%LS=WVL*/!]6G)<-*#TQ@ *"CWLFX<0*_1#(8
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MKK>I:],+5Q4!V=P$@X5?6@22++>N.$B0PDV4:D-#S4"2TB^UE+N&C:CA;Q7
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ML@DM__9V\-MQJG8ZMBU_?,615XL 9/"*>YP4=\B]V.&$^TLQ/[RPG4Y0'$C
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M\&XNPCCDWWEGCH'NM,2W[/XT*R&+CK4(!4H)#X:0P7CI@+)URF=M3.R]9_0
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MO#@\^%'+22C45U9]"B9? _7K#M**,>&'#U2^P]GLV@[E:E*R,Z'9X9J=Y!A
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M:F_[YT _ 6I,RG\0%MU=8CW%-%!YA%*,2SD+,$8[,+K=5]1>@'!%!1ED3':
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M\=G&T+U^Z>.(CM7PCSS]VEJ[V3&<4FL34H%$\<!K"7G9!P^NNF(K>]?1]+[
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M<\_KS[AA\]1D=-J'N?::7Q;S?'D9(A5I6]LPGRTS26.!1.A!D"B1=9>0W9M
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M6QIJ*CJY2!RT?:3E>E/M>;&FRSR%B3&.-8JIH&+;$$(O *D:$,78HI5D[W^
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MP?1KDK<%]6:-:WHQ+S_Q+]P#S4@.W4-*H'0MP#@M( 4'407IJ_/98._MD[V
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M5PD.3;=?%BT\NLB;4^O=W#R2DY5-EJ@,0DZYK139RA:&"MG%J"LIJMVW]KH
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MWZ?OC_GK9T'&$B[/EPT1W_WLIGAG%V'24L!W/KH!VM4'P05>1)RWA/K-Y][
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MB&0[0 K2RL*XRK+T4MKS$U/:+H)J>*'V#987&Y.;&1Z+<<"4\;3Y2T_&-]?
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M$'FM )'7^U?F(3HCH7"I>>')"^D:[]_WX7C:!N#>FAG@9OPVIJM7HPNJ@0S
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M#"-W*@A;^Y0)X,:JF-"9H<?9'U\JPR \Z"/G<5,9@HN<.9_ E^I09UIN=.A
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M=A#W>"4['@/CJL[AXH6<(!X4!"=JNH(J'%543V]$Y@ <Z"/E44IVO-!<1RO
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M=:^&L93^R*W$T#KO(]D!=/U36*S0;!I'V*285;2NR,A44"Q 3'6^CE7)*49
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M0(G).=TO@=RO;=-:!"]396C(E8:%L^M1K69&=L#5LL_;!BPG:/76B%];1>
M8K=N][89GW)>T4-H1'T-11#@,WK@@MF06.(A=NJ6>G9"L*GIV]%EH#N-FR=-
MIX27M8P3\SV,%^_?K2("3&M+]QM9UC:!HNL.? W'1QD4%\$;>B>[I?%M7^S(
M_>&:L67<(TU;IUYOS#;TM5MI(%6HL*) %2' H;(U1=P9[W7F'8<*G$>Z9G]<
M;D;%UD=ZJ;Q,/X[HPUZ-+^GGX\E"W?DTP86R,[_,8N \>(:@>!2@0DC@R?H!
MC,5:HQ29.K83J[NN^#+5P/Z8TK"?1F>0RV/3!>;C2N(!,G0*I;!'[NTJ'P>0
M_A1WS*KLSWNI8\C 7;*D,KE 1T837&6MY<ISX;II#Z>6D#4:X_D)R"X4;RT8
MMY!]PUOWZJ_#2YS.QB-<[6,5>6&)A> D:'HPZ]S;#(&K BF&XDV0.1C=23IV
M7/AX&DBOW!L?B?2-?56O:@M"G'P-D]H:9%F&JM!@M#:"3,Z1SA0E*<<B@!8Z
M>1NET.Z>*.QE:CZV]LM43)IPHF$_IGEL]\966AV,^Q"7YZ0+R)9Y0EV!'=]G
M=3@/Q\=B0.MTH\Y@4RFAZ*"J)Y[5\^%KJ3.')'F*G*-$TV)RP8FE9(-3ZT1"
ML@O=6^LB_\#)\/+[+\."[],01^DZQ14Y$Q45L.0S*!9)"4/':K&F<:Q88UVW
MFN-U*QPY'Z8?;HQ;D[*/H7GT>V_+K6=RD8PGI!1*>W Y%%!>9HB"66"98^0Z
MB<A;%V$]"N1EJA7M>+.V5=\!U<RWMGXQRK^-1^'F.Q\FM7]=JB1:R7<7N#WE
MSNP(]43SUP]G\OT:YR-PJ(<LBUUA%YV*\'0!9R?HZ:TY T[2[2F1SI01Z%)J
MW4KT+ 1JVZSVD\O3+HSI)5MGC16_0)>EY=$S"2;2,ZZD8!"92%!;0:A"0-7&
M*4W[I>YL0G3\/)Y>&?H@PZ<9-_J9 S0<U:=]M.BS7#MTU^Y.B]SFB]'H*ES>
M_N'T=YRLN@71'VM+F8%BCF-1#*0MU0MD H1B QAOO!<Y&]?\'FH ^PSK]_IM
MVWEL5A]/6I<H)[^&6?H\''VZ\_,%\K=E_L.!CLX64CV!&Q/)7"V^MBJ+H'7Q
MVM:C&%NWEST8] ])[97-_<S'VG,# Q&"*$I$2+8.0R@)Z82%#(G':BP%3>_.
MV0CH#\GLA[$]M%I:@_S5>#I[=SV49V"RD5Q9 S9905IRG'MW&"0LI)]$YFSS
M0J%.P'X(VL'LZJ&OV]XT6NH<UVTGK^(T389?Z]^>3WPJNA0;T4+.DM2,$B)X
M'[#.RJ338QSCN5/=;\L62'ONY<5)[ED(1>LQ8-=Z\'6JWC#ASY?C\61YO8=/
M.(A$)XNRSJT29,HI6<#GJ*$45KR+.46[6Z_93:N]&+GJA_ZMQXBM[:#[^OWO
MO_]V52F[=*5/+ZYFG\>3^?V=,HO.> 5H=0:5K(? : /).53<>^2NVV"QO99_
MF2+4'X=ZF$TV!_MF.KW"_-/5A#3+Q?BT!<RU.YH.0IT=CW0 F"054R'!CJ6Z
MEC!'(>E0%-^\A^!^4%^,$!Z3I3U,.-N;:O>.UK<PO*QQP9_'D[_3WYT-?!;%
MYDQ'B@MZUEF-#]9TQFP4MU%$[?W9Z'I;]O+R9/D<A**'$&^K?=V\(RRG0L<U
M F<\U--+5 ZDRWJ>G2.[S8?V8ZU:;^*'>!]5#![*M3^97,__\0^<SJ[?*SZ(
MPEF>..G7&&-M*A\ABB3H0:KJ:6(YY]9#VEOB_R'-QV+^(P[V@R-!<Z1Q^V;B
MILV\&W[Z/)O>LB"#"BPXB^!U(1VKSF%PT@5(@NF 6BG!6X?&>]G(RY3MDXK#
M(T)^6$E]M0 >5I!?/R477VI^)A\$GXNK):=.S?N.:=*4''=06#"D,LF06*?@
M^[;J^FYP7HS@]<6B1\3HX-#/APF&Z=7D^QSO4B5)_W4UG)!"(D4A*)Z#,5@S
M6Y"!R\*#9CK;S%D6V#K<N '.BQ&?UJQY1&P.CNZL:KW(*+L1\K?E5L>B072<
M[+3B2'\-!!&Y &], H+))><RAN;!ZNVH7IP0-6;4([)T6/!D0S.+5;'!_4MS
M@,I;%94"1J8^*&,UN, 9I)*5T25)<7](U.X-0]8M_F($Z"C<>42<#@NU;':@
M_DGJVW!:&]V_Q]EL,?OY;?GG/+]S-AV@L44X(R%J)+NE>I><+ C:)14E,RS9
M;A&70U"\+ $[&K\>D;3#FEEL1'Z1/@_QVQ+O=8'T(&OT*I4(6J(%E84%)WR$
M;&Q@W@3AL8& /;[X#[EJR9U'Q&GO*,JB@G\\(SC#FF5[_3)7_-7S_7:RV,D"
M_6_XQ_S+Z2!)QY2D2Q8STZ!(Y0/O) ,5>#$YDPD1NM49[K'XRQ*GOKGSB#B=
M+DZQ&@D[G4VNYKKCV]EGG'SX'$9OYPDWT^H2P?QFM#A3'\:S</ES&$[^$2ZO
M<. R_;>4 "1A=(HL-V309@G(>-0F)\M+:[7_-#M],2?@"0G4(^?H='&1K=O^
M;3SZ-M_Y(B0T$,QJ8\G\8L75?!*A(99$&V>1)UXP:=FIC^Y9')U[F_MQ6LY"
M;!Y)'C\XW'*=EX*3;\/EM*\'&[\&/=_C='[&;_^\)B__-I[]"V^E,-]\TN(O
MW2?$H"@=362,=AY5=9X6"-8$\#)$%D1";#X-]62;?7$'Z&F(U2,'ZO"9"GWM
M?/&^SEV!\V_5W^.#FDW#<DI0>" SVI"B&HRB+P5=(ZZ8PDVG87CG<(H>W>&/
MHW,^ O3(>5G&L/[W7^^QAVCQ[_D/YM^OY'^'Y3_JOS^^>W/-JC_^^.,O&?],
MXR]_H?__=<ZEU?[_AB/ZM-D\1S*,%J-,/X\O:=GIXI5==3(9EV6P94&KBS0;
M?J,?_X2S,+R<WL4^'=*G;QUMW!K"7V\H<9="2QQWQ/?H-,$_R3[.F/_GB53M
MFV/CH[=":;J[-:E B@D+/H8"6EF1)1-:AM;UYH>C/MA$:=:0)QAC8W(,!)HZ
M8$32J^<=K]-+I"RL=G#JU(]_%_*U M_PF@^7E[U>[KM(Z0/#XB3,?JP0^C\J
M_?+L?Z7+,7W^__F?9+#@S3?'HQE="Z\77GNZ-O'3EP=5P7L$GI<3BN=]6Y@T
MFD?MH!AZ'A73->V=(8C$N70A.YML8VF]O?[3[[^UDP3<CRSORXD^)H+?G5O=
M!4U/7;7N(CE-TZS].;.&Q0>0M7]F>Y]*T4Z KJ58RN@(,5L&WI ZYNA'UK3V
MFAV#R5L:6?7%XUVHV7Q8#!%:W,LSN#OW@JZI4%+AA$EB;0<I(4KN@/X>:NNP
M%)3;-/-N2QW?9CR$$>/>J-AZ.$Q%)S>B*\DRE8P 8U,!E2O.*"*XZ(36VB?M
M56<>;USJ:?.X'17[.,=JLP26P&PQ"7C6I/^:E""Z6BL@I9-6&!-XM]$P6Y=Z
MVCQN1\6&76.NT;G?QK-;G7I=U(S'VH'!0^T%!@'I9D$9>=$8;%&I,TMO?_+3
MYN#>-&K8DF4.YLTH57<._H2+?[\9W<DO?C>^O/QY/*FF :D3P1=>(J1<FRZ7
M7,!Y5@"U1*61*6-\)U9V7_-)NFCWL>+[Y$4/3?4VYE&]JA[D2557:T)Q_?-L
M2%;E>TSTJ[,A3@?1J,29EL!L) H5Q<$Q3T:N-2I[79SJ8;;\(8B//+>E+T'8
MI:U 6RZVUB46&-]APN$WS#\3^599H6]+O5K_$W,MQF)2"\,$*(XU6!(<D#G$
MP#D>&5-9!;;58]]]N><E)#V1N;7"L4]&IS5:H\,(-IE<9QTQB(K7Z:I2EIQ+
M#K&;FGG6^;;'$Y*>6=!#%[I--52HT'%D#CB+IK:$HFLMU K.R+,)@4=SOR77
M\RAO.^;+TXK^K7NV'51WH!*I>9[>0Z-,;=3 $7RH:B"9VHGLZRSN=R!\TG4B
MYW&_M&3*V@9OI\U!>/?^(_W&[^\_GB;_8.WRI\@]Z$:+\\D[$$GIVED5A-%T
MF7%+6I'T#C#(7+P(PJ3F3=6>4=Z!X3(P.K2  NL$CJ+ RTP/@O9*A"B=16Q-
MOA>8=["+E/:7=[ +L\\R[X";R'4, 4R<CS8E'284(J-6GML2BL/F&9//*^]@
M)PG8E'>P"R?Z#T5W0?-2\@YVXLSFF/0^9.V?V57%+2)Z$!X1E!$10A(*1##%
MNL2%X:U[4YY;WD%#'N]"S=8^QE7%36WM-/PV;ZDJ&-?+H U'3P8JF1-:6UMC
M:Q49U^!8[=93HJ6WLY.UMW&9DT>Y=F+ N!?J]1"_6+PY],N+>;32$P!3&],Y
M3GODB6Q$54"X5*))Q5K1^LC> ?"R'^[]>='#R)/]"7&S#;)/[YZA+GOJZ?WO
M8S^GT2(.$)-=2S"/Q>,>E)%>]B:Y"%:I4"?QNNJL+^ 3UH%N+BD,F;GV5OB3
MD=LMBM&9B^TNK&VM7[W#Z6PR3+6)5/7X?21N3-^]_UBG:_Z.DS*>? FC997:
M*E-&,BTQ,0:HJV99LH; DP*&J:!B+MJ.*2B[KWV&J2B],WQ\/&ZU3BC=VRNV
MC$;=;R]_.Y*!3B2'C(-WFG3BG!"BSAFR#KKDH"UGNGM:03\@SU!<^_%#GA6W
M^TBUVG=KV^8E2$8GT@;:#9U%N@F4A6#)(K-%6.9RL4HWK^GK:2]'#GJ>C;0=
M:[3&+J)R"J5V[;[&R^8-#YJGS/>%>1 Y/8@N.S!"DN$J.3V'+%JPDJ.)4>84
MQ=D<@FV[^7$,SDE<FF>ZM=_6HL'6@!92J"*"+S7_O)!B&!6]PB%RY44)KJAN
MC7-[@_C")?N,^'].(V'7;XR(77 XNYK4AHM*&QT4;:<X4BJU+>!2(LTR>2$2
METS*\]%SNNSHA1^&,Q2;AFF(O>MR-J+TI+=!+$&#2DZ!RYI!4+11R8K1OG5S
MA..H_6=Q\;R]FDUG893K:)A;<AY(;2A$%Z)R$:0WV #!> 0TA7.E4@I:GPW1
M=]S<B_$TG+?8G)/=M7.ORNRL%[$4T#S70E6A()JJ8?-,YF6(I(@</<+P EN<
M]BN@)^N$NHMT/:EC-'\%IZL&R0,E,&@I->18)[8P%BLW(JDL6J/BR%"VSC\\
MUMY^'*)C'Z(#9.L4>1F-FHP/F,_2*A>!*T8W1.(6O*]6L2R:[@SNLGTZ+]'=
MO?TX0\<^0P?(UCGY6;;N<VDWW]JJ"(:'@+7I0:(G-ZE8ZSME;=:/212O7&Y>
MX7^\[?TX2<<^28=)V#GY9W;67CVBT2H&L"))4('TV%"562N9I[TSAOIL2L@.
MLXW.D@O_Q#KB%_/%-YR$3SA7BWX*,[R>1'+[\)2DC-26@]'(0)F8(184D'CD
M&'U,(9^-<ZT?$CRAJ_'$WJ S$,$GI:AW)\? !R=LG?LG>$Z@O$W@+<] !HQT
MG+AJG^4Q?$)G[QR$_PP/\DZ2^X1=5=L)$4K4KFY?*U<;"P4%04JD+T-6E@B!
M[ND8$#MN_L<Y/L]SW*<,/ZFG^*Y?8SLAF(LBY\C)9M&VSGX6X))59%-*PYE7
MFO.GXYC><?,_#O-Y'N8^9?@I.N]JTLMV*CA9E'(6P5@C02G!P+/B@.PGZ3,7
ME9]/YB3OLO,?Q_@\CW%OTOLT?8;;:2"SD"RBKMELFM@8 L0<R<P@)A994I#L
MZ0QBWM<VWI-W<?L>XLY[N/CT:8*?".N;T6PR'$V':0[X>FL#:61BQCL(0A/'
M,B)$DR.8@I%8R;GOIU#G)+M]0O=L0__A^0O66I7FM+T1'V?>ZS_K'W%ZW$:)
MW;"<HFOB'E1JU$*QT\C1B\OY!PUKJ_'[0T7KN-'IS4DC74-K+S)(TKKII,4
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M43XA?L&_,=3_>/$/ELNQ_4TZU/HU9J!K_?]][O?:@=\#@/@QQC9Q_WW.,@T
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M@,N#*XFKBFN(:X?KBQN&FX+[ ;<:MP-W#'<%]P0/#^\:'B>>&)X*WF,\1[Q
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MN[8W2O)C"I$T<Z/[B9_.0=:<;_I*<7BH0(2J<?XQ(J4@ZW6__<+ND/B'$N_
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M]NL?7B7X D3$".69PG,&:L^D<M7\2P)<-_..=CG93]6V]B1WSQQV:2#?%-
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MU%C59R:'XZSQI&?X*.S6AZF!H"^I:YS=KPM-$O*3\[K%34NNOS@D^X'M^\I
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MS>B\M'D\*_W"LZQ>SOK?$7A,1R?[ENZD/ B2*>CN[H",_KB%[U14<:\L.ZK
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MU,&Q*+M-H4R]B<I@_O$YD?.+B]CA,RO!AA.*&=..C9H=+]]&<&GJ3]9AJ+W
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MP3<<^F@J^L-ER<Y5ES(FHC'B^;;;QROT;T(WG;BKJ<7K91(D]JF77KW(K(D
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MLBZR2[_N7]CA_QZS\QU'-VK7G'!R]$X2[-%/6#@AO!/V_!F]._CP&.)QVKV
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M&5#R9'S-]^F5^3X8**:7!M3O^8 ^"QH@LN</@ETH$905<B(-*+N"[A<B^=.
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M%<[VN4#D:X[DE HI3KQOMS>N5W=;:[(L-T<W?T3'VWUX-DT+KEG+ESI8S \
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M_..8+<Y L8&_[*BI%3S+N/<J]RO7^R]!TE@7U%&9UBAX\'C.DX,:;VZ^^GB
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MG8E5\^'\5GO,5AP&UU*Y%8UVW;JZ&W64( ==1F2;BPU<UCOC4=-_]@XK]\U
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M96SB3^W#028O2 N7)?8+M,K]/,_R?W#QV [HE^V /GF8$NQ.VF0F*</\P3%
MQD98B 8%#=H&W#:CU4^)W6VUWV\#LLZD7LXGQ*5+/ I6<3MB*^6FI> 0:SQQ
M\SG=:XD5&CZ@6KAR'F_K90IQ&Q &5!KE#ZI.<N<[$16C#MJQ/8/,ZR^&?PHC
M_Y(H^?<<A?D>'L,PX@LUA<GNYA']+A]D_8?,Q-:_8O2Q?!$Y$#CQL) *[_N
MZX[,2Q/;@$K8*"P6E#T*'F^@E&#(_ RS&5YNA%\F<:EV2)/21># @5Y-Q$"7
M\_HK)$2"8JX]M[%W@:4-QLOC1*I!55-?)E.AL\#V=2#WF*Y\R^%!BE2U(=R,
MNK.81GQ8L</D;A[^ KRGHA+32\@;BF\ZE=Q9X#1@N\AS$)MF3X/G"7W[,/;<
MZ-,,.(POU:)@$^R_#7C:BR,)@,.2/J24L.&'A$VPX9#V6O(Y1 80]!-]"L)8
MRZFSY'I<T7IREW?Z;<#S>H5CZ;'CM/3W67B.H9Y>E5H1>\5+5U0(7@*16E=E
MM=7XU4*TKR1/)+13+5_H-_NL4==ALWOVQ?JWPNG'QC$OW2$5 5I%':8ZU5TB
MU7M%Z[4!GV_=$K2O9UK)O"'&/_E"SO.F>7H=J0ASXSEK<(I/R.7!7&<#<)B!
MBV'<DY :\)FM<@B'I8M,[+C5P"T=88;'@!.7:S49+'\PZ/DAJP![UY/Y_^K+
M[S_^._KR?T^P_M_1W"\7GUQ5>K#E46 197\U)*Z5A&#EL]%K>"T*P=^'5"\<
M+"SC*OHT9J8TZDS2'E@J.A-\[%*Z#X4]&G/WU&Q&M"4!8O7V#._JW<U H5/S
M]^)57L4 Q?)M]Y_H2TS@%+RE0*,M"Q#@CS!1&U)=F$:\C.?2;[<!H: NV0MY
MO>:[C4S<!#T#TMF@A0QLK+_.?OURK)F!9P.;T$)_722\OCI);,]M;H*.X+%*
M^58]3*L;!0S_:B)])PN[2$>>A0:T8 ?701OA5[]>]!2V8HYXHW*P6"!?JOO]
M:1!?F'*=*4^.B* R3S31TK%3W"1!:>&X>;7/?<[/8:W"\\M>+J8EYD]V)YLT
M6VIC!RU!1PWUP7>.*SM<#I>Z=]TO-.#U^S"[\&IEJ26K-??P:1M0.F2Y@P+[
M'<ES-)#J]^,#8/UP2C?B8QVTFTR%("3'AY40$M6E*8 1W39+O$0(+'^0#5/?
M$SQ6XD YZG5];AM@%H6+>67:&]?O62.,=*:WBS6CE;,56///P879+_43!UM*
ML\1+<B>OZ$6K1R 'D9,#N[90_:X\ZC_MTZN=+.C#3M@\97D;H"0']?"G\&"J
MA)O@OJ; FAWAYML&)(MY9VHT[[9::1BC)O73P,H@]J"\)<')X+//7*3,)[F?
M7L5S.]>5CK/6 8@/[H2E(G1RT>O; !XOE_T=]Q!FN \\)1!6J)K9W$6O4,)/
MN<)WEN)_A[__OY]"IT+L7NTIL[5?%F;^QS2'^(<MF&I93$EN.I%EYMCPTC@'
MVYHM[9KL;!<X\?#V"QZ BZTR P=OK$)J2FOUL -L*J11*C-&TT@H^ 2H27GG
MH"3WN.4*T\O==E-SZW2&\ONMJ#O1G,G1<U*W'M[JE\;JKRB=U8]88*-[)LID
MP^@9P=7MB"8#-;KK^8MT_*UA,KJXJ*)M ,,'HC@8"AWZJYRQ\[2;:,P=X(=?
M1HT^I%GF$W@NVCD)VEY_.\@3_"D@#- @ C!^30_B\>[HJ+_-N-CKXL[:D7K*
M*OHN3U%^V")*5KAJ.'?3K_A<M8AM=QC]/?7.FT_WH)#[]NF\/433MU 6++'2
M[]E7&"'C!:&<AIT^.>9)X7MY:?WRU)1+'R-9V",_@0+:D'^R&K((]_(HDN-J
MN^(H__B5J?R3M[**<\\MN8-UTMT:PA@X3P\I/!D#C6@-:Z=CL>!7:RR9_+&Y
MR<RG-Z**27&YRGAY$P(I8 Q\?-BU?#0S;]]$P;N<M2MF@"SK-!FN/94^]Y@=
M2O<4R_S#0&SU;;T:XVV2F" BISV$&@PB7^X*2M\;!__Q\N]62/=S41B4WTNB
M&OM"IT+DC93KI2 I]O#N^@!9UKW5((%3KQOWG0^9??@%=)BH8+,-4)C&0V'7
MWDR*UC3D'MM,)@@#&UQ:@5UW::_N3.74TE(3E%C)[!DW?.HD&Z_,Q_LVK+$R
MBR?,:C&U_7YGY"N.+VJ)IX[<>Y:MLC/O;V,P>N/#EV]B^3=+8ZAP\IQ2Z:[?
MJC?G<J? 3_GBN&+MY-@#UFJQ4&]^]M<T@V4\[%Z*=T^\@2NV$1$4<S*'3VK>
MJ;"9 76HA3*&?('#4;N- _H'0\#L3%5WM8G'KG5DTJ%O),=2]&-PS*\_'%E\
M\HR]\-Y;:<&K[*'Z!:GVUU5QFX8H*VO@L>9&2P\9L8A%\]O-N*ZFBQY#76O
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M2'IECK$XQ#[INT/,>HXB:PW8;>;$7_+T[/+,71Q,)E!>U*]>A)B]L!QF3^0
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M4U1C;%$B<*G]GDO-$O@IN4'I_KAB,U;6)3_Z)%P ?A;?@S.?Z/%'YO*FK'G
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M)GBQYD:8MP:EA"J.RF9CUE!WZ/%==\K+B<@"JRUSH K%4=C,C,!@W3;@Y3:
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MQ:Z6R.%PXKL5+\]6_,KN4;T6"XO3/A8'SF?5G/*]>8]9\_Y#?N]2@"U@Y)#
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M<R4JX;S(R5'EH9D1F;>JFTZ>V&0Q,[_*?G/TFFE(KO&>UMAS!URQZ.<T;XE
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MD, FF!&[;3?%%AV-&JCP'"N8\;G]:\IW%5$2UP EFE1-P]R<2TH;=[@M<B%
MU)L94Q;"7NL/+%O'RTBK%/!K0C_&-I?"T0-OG^NU,6'-'S2V6E99\-PPE\N=
MW]%&%'CL""__ZH#^PWKXO\IZX$L&EK&VP/&#B0WE]!SK;<4K1E8V4<(]L0&A
MKS3U*XF2'4&-#^-A#Z1;GHTE>8*,9U-P\&T(#2 [R3LU//9*7J_/$YM9O*'K
ML%M3BIMT($U-'#2URX@AO@DS8CB^K"/RHU/ZB4,G0Y&JHU%#;>?OV7B,VPYQ
M6W -@= QCY[CE(:E="MH@!>D73YH@ZE7>5QY[!^>(;UC1A3)A'[/!!^^]('M
MS(6#HO!KFOC,<31Q<W  O="G+DPA68O*TP"8>],5Y,UZRA18)DE_&$Y8G<4L
M$?E27*U.3^32 ,YR.VWNV[4UI:._I76H>(VCF[1KSSC8>\2?[P/%+I[AWWG[
M,I#>Q?+X&,(]Y8%/;E'!\GF1B1E8A ?%<__)OQ/<\IK&'40<)K>B+(U[<K"0
MX05Y6,W\60HR1.)Q37',DXIX+\U+6_R?QS>.76-*/VIT1.OP*;"'7FI60=E=
M2DK84TQ(TKE^,SF*_]*73DP^\P$QOW\6&\BW8.Y2>)!#*E5#IFHE?$P0)R8Y
MGE&H97A.2[*=Q_'(:+NZZ^.K[QO(Y@3S_567&1G19?\0II!KK']G!5,1!99'
MVCG^V)3@)-2L#69?U X;R D2T):]D'V-_NG)TOSHI(W/+JQ=2?0M3,-)%57;
MX.FAF?N33LI8A*S[F'Y_/]8-_F(K)2YG9,DEORFOJ.?$G%-D597\<0:F])>!
MQQ3W+3!]JVJ;+P7)&(_L[3.+&JFS[W15L[^@G-]M:_R*&_\B[@UX:+GK/'<N
MX+&YHK&A]4/8X5*L=<!Q14 20'OY>/:'#Z>A-@54#0]145>WV!"1<G(4Z@?9
MEIBQ+KHT69 ^'-2>9_TTG"LNDO>.MB$VP&3F[1,5DZ0CEEEHNK>-RK<K$:E6
MFI/<X:HFBTD;_3H"51+NFSACDL3!S KZ 1@360X:DM#H>23^ F/?J!;*2UP[
MP#-8Q33DTP7YOI'VXFSVD9<-E,=^-0HPQ.!K9,Q#U1K#6[9/I@>0MDO8TJKA
MG9*B/<'?$_56?Q+URO^-J%=T]]._?P BBE!,O%&%S<8L1ZHW%=, &4$:4K+@
MR\8D-YF3;8]O4 :U72X9 H$)CZ[%E9KGDS%DUHZ"UPWK0J9X?ORGLI"=O.3A
M7K >UJ_"1P#F@FE#?#P@,L: XRNN:#F?<#07N&/T#;=^]- T#8":/@2LX8)N
MZV/Z;3_NHZ@PE6^#!I!"%0-O38SBJ!;?_3_PT !]T'T8HV"(^K]ICLV7""P'
MOAC1^3XQ,!5Q$MO,'].\N4<,/KH<EENE\@+ [Q5W<>2]::V.0EJ'H%QI3,H>
MDL@7#;PR&2HLJ&XH(90WAF8CLP_DC_7<^FVO8 VB^?[,3QBE5P45Y[VT#W^:
M^$+@KIHM-M!@1LWH'!=3L&4KUMOI5D-'O(_<M,]S3U63LTGK&!W9W7S9C1%-
M4CXK!DU/G&R9% SU(K!!WQ)ME96=KU9=XQ1V# T-5SLL':MA!/30*'743%""
MF_&5/+KJTO1-CV6!LD" P=>6;A7D=Q_4,NVO!-F?\MF/I?;0.G/GR9:9$=WR
MR2.DJ\6@:O9[@*SBXZ?.!-S,6KS2,G%URS],([;'L (,4DI;=UH]OFVVH6TF
M-18^ M2-\M+VU'QKG.3]YT3;$0"4:-Y8<9ZE]N6],DB)>6M!=2'#.</R&$$N
M6XM#"B)B?PR6YEQWNV_^Q7UBJ8-53G&5 P%&Z3PE^/?N/1C'<9H15^J9[W06
M!7H(>DD.'F;+RU,Q?/$@T" RYHG%Z5WFLSEY!K&=E)X3;\-%&=/EHY;2QKK\
M$BJFW;>+OO\9C:U65I2.C=DG6X?+B:\TBN9DM3T1#@!,1]?Q]CD/%]L*LGNE
MWL'7L$>TX,+AI].)B#R=ZZU=MB=D/=]&EVI<.1%@J"4=65/!/,Y^4TN]I=[:
M574,LF4FI4=1P*W-PR029UEY#%%[V<-B&:CEBK)MC&WO>3FKYY._:H7'?7TZ
M)#8N_?0H#<8WGTIDKM89TD=IC].U*3^XLWLIC5/8-M>Y3<*RYP?R!8Z%!I@P
MG7<Q_=K40=V=0Y @%[BMN#'3]XIF6 :'T( B9,VW1Y17;$NH;;C"/ SSX2$L
M4UV=#!J+(R*Z\MEC$Y3 V4MEH[Z_!M+^81/]7V03,>S/2"GT)U]J]FF5.&+!
M(J.KG6];)=0UD@:0\%6*V :[PW:$I%(Z95A ;CS;_M5QB)FEBGJ[RM7B&E'0
MV/!]2^4XA%<_!MH=0KJU>5 2X,<?LB>09RS5;6U/Z[K*0,+E%D$/VL8!TJ9O
M&7-.L &$2C-UOWN:E4,T0G/;;C+B:]BHM3O]GK#OQ!/?UH@,=\O[+RA%C5W)
MJ.09C>I3/7&5)ZD$TG8B.2U ;.OLF1BNK()W5+YUX+-O$T8<2?;(XHJ5':@7
M"C+R&6,T=U %9#=5E34_5=5^2?>V[N]?0[.<]5H.RT(#VO4PC"-N]-;VXPGU
M-8)FDE(Y-$ P64_\"?OC[/;$/1U8C_N.N6QR%>)=[;Y/VO(2F;GODSH-;D@K
M,-&U[/NDVAI<-@+,[;?<Y4@4LWW7V6H!\7KRL@ZKPG$H!P:,-G^Z8]G[PI3W
MVP&6W#+Z.$S! 7QL^A&TW%';U,S\^?%A+7[Q5_YMC&&HPG8-!?YEW=I@3AYQ
MU>',*OA@*&%C=/@+W5Y54YEW38VQ'41J)],&%DM6(DY])M^M-^TIGIZCG'72
M5%CG^V"3AQ#E5#57'6C&IT_6HEC#@OQ3:E(BD+B*6]OB+%!-[G3+#')QGR4,
MI.[/4SS6\IMJ@@S\DV"^!5764;D3';Y>)ITIYJVI-U\JYST?(PW?8#S^6#X
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MS-73!*RY>L$.* ;QOZ=!UC_*8?^?*X=MC$*%URLDV)E,A>DH%3'FY.S;K>.
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M[IE^[]>ZENO GN>,64>E&;JD@^C=>)WCKMD^[HMJ[;0F^74<6EG4=,[=I@&
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M?40#G#!OY-MBW[<8ZRK1Q"K5L@>D#!K@!7"3%7^6!MC<@!-YT9W "4?OE]3
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M9B7:KW+"_]C_51"/)@[P#1O"$]<B2 R[W]Y2X>0H/O(;> /(&T4-Y"-)06B
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M)X,X7Z6P.9\V<EQQK-K8=]@.+ [YGQ%T>'1)>;)_EG=*W0\_Y)E@;8L"PX>
MMQ5^>4>GA>0$6)/_<+Y_BU53*C19:V/+"Y8,9U8Q79EV25H_.3V_@JWML8IP
M7ZX>'N K--RQP__"&V.@_@">23@"8ADNGE0WA2H:73C*S/2\3=2MUCKP<SGI
MMOS@0YBC?./(CN,@.)4"F]I<$>Z$.)Q:C$[IR>_#Z19LX?,350'(C\#K!^W-
MKW#KU6!I"RSPC:2U;8C@4_SQPPR1Q5'7WS=<Y+RZD1?:_>/BI.*N<B:S%_Y\
MA_I2"3RSIW5OC*MC-'U)^VFT_B948V>^='AX1W/>PU][]\^%KOX5^F>-\>9K
MT=138JOX1,.FC.7771W3^?VKGG7*KUQ.A'+0O8R(]"L#7DQXI))4.=CGLT0H
M@T>02'PQZ^=-EX7QUFM=2\@1+^CTSE(^P4BSM6R"[^ROGP%=VVSQ K/(7?;@
M,7)JKM/F@J2:O#TR^?@6TY5S6DKFCB\J#<)#5;PT[NC,S:+.$7EM"F/.3/4N
M(AT+<@NH"= JH(-[_OUSSF-BN9XXIO7TR/)CH^&?/XP':*@Q'#ZD%."X=;E-
M5ZC<86D6-J>7FLU^>3$]&M26F]_Q*W6:^RSUA>/D.U,GY&/3_%G+8@WLL<5K
MO($LC(478P(>J@$&/41R0GH,.AWUP[R_ZEK*Y< QH[O.$6WH,-QAY]I36&?+
M?OO^JR?U-"]L;V2T'+HA\[*^]5-QP*U4/SV%PVNKU58]6S X8H9(A7SHH)-<
M@V+CYO?UA K&H%JRNG_N@&3!?R04R!*3YA$,8+4LL_*A_&EC*Q/Z\)R1.U&A
MT@5T/!]BYAW-#,]=$Y'HO^ZR/?,Z(<GK'0B)S2CU59VG%*U]J:0!CJLB'.$E
M'7NZU0^<NO&UCQE&4/2*W3(O4KZR[[*+[&EE>VE3%N=6OCJ,#9]*SN_B:A]9
MB=Y8@0YFWO@S1;5/B3C&'6D3KBXZ7R==7/C-B"'PV/C+;[SW'7:E;=D%[7(<
MNE0,(]I!P_SC:++HR(1<@I9[1XKUDVEU88$Z<X$DNLH3X\51TGB>2F)2 \/V
M<TL_*:CP"!EMSO=^+M[X>Z9W9IM$=4HMG@9@]\?XROO-6>EO'D!6^8\%[!VU
M&UP21V"(RW?4IP$R7 B#W<#O.VQ:K.2RE3?P ?^IO=%CM4BI#I(*:;77<Q,&
MCRO 94R;<A:7F>6.C5WU5\8A;/LQT+^JSOD_TZSF_WA/TT,!P,-BFS*DZ?]Z
M<.V3A,?Y-XO[&K:G5@S>BMXWH#!!..I;GYDF. MX(FZZ1^DJ]0AH=P=($42\
M+2,M$/^+U15-2DNCJ+>#S]@+1 :F7A;O['1AOS$=Y0UP YWIJWV3U=0VY#!2
MK&/\;)4&", 5;UV]617WYA%.#/_4"7=!@X[IK.W4LR3K=J><[$OJ=H^+**H,
M$D:S664+?)L_\Y\=6Q:)KZ.L^JI0G@ZLF>9HX$H-&Q:LOJ/N?W'GS\2:/PMO
M7//JJR*R13^LF_LQ*B@T=J,XD-[Z"-=X81@16_&^/>+U4-'7JU_!>1HC^W"3
M^7GRR9!#2__,L/:8)-97M=P?,KU=M@] G-[R-$!=G$;/_1>?DD3+^]2.F*>)
MB8@V9+5'T1]]L"E"/RG:&R-L+R:S3M;C\#9U,S#R1.LB$JK@4K<^YND=F&?Z
M*_$S!\51NQY4/[RPINTJ8SVCWDWW$/5QZ_:1 ,E&T;FH(XYZ'W*4U"V39:]L
M-NK$'F\CZ'1C_&-1-:=VV]: XZ/ 8^)FTE3(3'-SY?O3)6+)V5R*I-//'KUA
MFHY5Y-%7'3GRRN3I#M03]NV#K2/=":N-F$J$KI1-=<P8JF9/$!\SGS+_MPOX
MQ22";81XO=G_YD)Y Y1'R>U3DKOAJ &G== -K=%&J0>FAEG936W+D3UOD+S*
MO#.E#_Q5\9#<(2^["6INCF[^J(Z'R\ALBF:41AU/\H\27@"@36 <P/#P",Q+
MY%KY&!Y+[OGF8. A,"-AD0@A57@5(>X]^77C@L9QQ[#>*U1F^4Z1%,^+7O(#
M@$.=G?[L:M8!)B^"C)SHR\[JY7TP6EZJG\@(2<ADGMZ=+T?!!9 DOC)5CK4!
M],N\A_UX8R?Y]1PIQN,M1I#/:I[7["XP=^IXR.TRBSHD&1BU\55.S&NR'CF&
M/Q,'0NLX[/@/H<V2?[.V_NL'7,6\.^H5K ZC$;K5C,(O B#YE5H7I(L1&O>Y
M;(X")F+,+\#\S:(SA#FK@$Q-CS*"$C,E)G<=RJO@LJNDI*;';K_BR\[K9?]U
M[8=V:_A^>9LGL3W!#X_=[]=,>I]V8O8"(Z=7@HZS+<."6Y(NVI-BO8O$K +5
M)D*;,9\E\[\Z[UKF;PTOZ>UBTPZL=W,H0%J.<@C3Q%$\9-588MZ)L@FK.O7=
M[=IA7O:'M\0 =8%T>8L/#-E3LC\.IIU==TFH<OQI@5=N8?G"T>RJ[#@_X5KY
MBEM^H-B*K_JO8AA<,8ZA ?/:HEHSD9$CX^LFIH]F["HT<;N+$4TRO%7>W!L=
M!E1N=T?R7D%*++33,73C0+_IKP0KA,BWY@Q]M]/%#1?MQEE;M![#!7=_#^4E
MKY85-K+?.,&;G$4-/W%L77HY=GG'+31_:LYQ^&J%S%+^<EQB"<86;;/OP^1+
M\!>&70SB4)RZEQ5R*"<G],@]10 +@)>NR;_/J)>OI%E4M.-V3)29&(?(GQO^
MT44BYSEJ+Y?%MA,$$\9L1P0@?X2G1;9>&,\]Q&UR]/!)9KO["5EYVW>;R[@P
M[UX-])ME4OQ[OLR3$XG8-8VEB7.#,UCY9)E3AZ?=6,&B%BX"](K*XB$G+A^^
M+MPXY0)BV6O:UW6:<R0J.&)VZ&XAV^I1RA LHF<3Z_'74>G?"'$S,VWXI5N,
MLE%:W_3/<#QYHLCXR4U;&7!-.,0>?-O@\?1R&61(,+=RUW>-A^!6L79&S#^G
MA7<W$6]KQ+@ ">2^Z7'TW@V)RWOID% \TX9_.(.4@;%L61P.2E2%>R$6A^35
M>47GLJ(32^:_^RS,8;>&O."&QJ7^+K_#ZW_DN/XG<ES_^Y21[YHFP:.,:(2#
M5'I4?3>]P7:D_@;CQ."%YP))+T48FZY\/LG)2N 2KWFT[=.Q9H68&RG/7*S4
MT^1E10MW*4$A' DCY*U^'0GH@<5?#A#GGZV+33@GKAL-0,J..#6/I"9(<YBT
M->/S]GT=+ML+V>-3;FE20OS,O#=+:W6=GW\D5Z5<5RZ9WW+4J)'UW0;G:,[R
M-8$"ABOJRZ7OH)^67!/S8"M2YR%D?;#>T7.K9C.('2Z8EE<%LK](X?,W]EC"
M5&QGD_2LHPWJ%BGS-("TWLB(50]4PBE1^4[U5/W?-\@X51Y8M]E<HV7T<[A-
M"203?SH0]0%_+02(%C*LX/<KDC^VJ88$L<9UEZ,D5V>*E]"9\5LF3"'EDMVC
M17 ',_LO'5YI54.J<PO(AM5@'[L&GF?0+TTEL'[Q4!UM,=%QF2*REB%CB&E(
MZLJUW5VNIW\8A6S[@[=W^++'"\^LZ<]\R?>U7,'&E,%3BP>&Q)(/VB;[*[D<
M&C[8-SAR^^U';9D3;PL[T]IU.\X6-F.82$[.)#-VP>?W5;T4D3:?JA8IUV'
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M@+I=SA.YK.9J"Z&"A '@THJ_@N8,HCEB:&QOPGFO%33LWB T\!Z>]X87<CH
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M6HL=R;?KJ$'QM,2$$7)8 7CWHYK->A9'CGS5;2WFRZFW=<W,H\P5)+:LF]$
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M\=QWUWVGW?ON?6O=]=;UCZQ9^;Y9LV9^LV?/WK]OSQXNG[^.5'"@EP;,#M.
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MC#^ W;XMVVM/ \XC5X]254% .<A;'!1&Z#= H71 .2C,P=_P+*8!L5 2VS=
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MQ-TX/\W0\D>'\S8W.:.R+<XXLC]^>,D*R]GF4IGZ<D&BRO<U,>-##U_53,F
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M6-[&";::)1 A/4@1-UW&J1E&IBZC&2P<C MHDTOGU!JR]U18QK$_8AZN2HS
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M@:^^M?W$,@4OT_T^VPG,&3&^D7\KB59]NO%">35I4-2*/NWL-4^1"DIXDD_
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MU3KJ] ^,9#_2:O?)[9FBP6R-9F^RV!-6@APDL-+--=[V6BSLZS\+1AD;XR=
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M0@H4"'5<\M5YZ>"SOH/5V?'UON QP[S0,?6+GI-G_U($)=XM+P ]4W].$Q\
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M\#_ZB(<(_770IJGV[*U'-1_$N=DPR5P[O'-NYHR!: %J+SE[)$$(O7U84]\
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MGW 21[EB8=\>/^^F/+Q/_>[^3VN@ZG?]@GK9!0$\0(\^[N?TLZIJYU>Y9$8
M)43DM_JU"" P9O17_[HG6L,^>,%@G&9TM<ZCI!33@;>"3J1+ N5F[1J8[!'&
M0&-Y3M1MY 57IKE?+GF'"BC,#L"7!%"_ D8J*,>_[H*C>!>DW/B$P6-50TJU
MV]SH)>,I9:P5ZC?7)DG%()V$>H/<-;%PCW[6XD6"0TA]+)<,*@955,T+Z:)0
M02-OOKCE:&8#8.-,:4!QGSF0\K)S,M:/B1&EDF=HYG.2AM:0I/;'8"51&0'
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MQQAD>/YHW="UM&S=-@Y3W\O^H(!M_F@-.=#L'55WX%[I]BQQSQZ5CXLZ,<L
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M%R6E6HK-&8V1*G1.Y5;W3<;@$?#(HP?07H-E^(LM(9U\4"2_$8^*1(^* ")
M#:UFB_VX5"SK5&3\5=^!\V4N>ROATN9T70E,+I0=*V+,LK8+#^OY8\\J,-Q'
M;\B&3CG=T/U3,[N-=_D/G8KT DN,57Y$J2=7F.\R)CS)&E9F[3LE/M?M#^+5
M3P"JFNB6NZ=>>(\8Q\KA0.)Q7"KV^=-)I"DN:9M0F# 6+?VHJM/_%_3S"<#*
M?M0IPDG?SX'6W\%6<P?7S.<WB*I%FBL4#F*."G=P#>0=XX%U5'ABFM3@ VV.
M1.>O6C$DZ/M9!E*&WE"TF7*79 M]X3\0_\[NMYGK_S-B+L[TR*V::\_ L&]F
MET[%XKDIPA_L5_>)QOME\Z3UF.+OW"V\]Z"J#[E.)_0YS%LQ&W5LJWH"4 &-
MW\OR+-"S$F;^C?F=Z#MGD.>C'X#-EQF/?E$[Z=<:W\7^"9D#.TUVX-/KF+1%
M!]C*K:R)8A='B+HE[AO-TJ2%][#EYX#9G<=W[7Y%&= KLJ=7 QE_-#UJ*FN>
MM.%3*8Q'[4 I=QJYUX<&/$>?]2/^0TEBT?W,>S"L8LFJ@T]"_>G#3\7&[E-R
M&^]4& [59+[^3N(:!'A(QV.?G$9LH$,49_&&@<F^IOL>O<FI/8QZ+8%^G!1^
MC2L&S#'[7O=B5O>3X'-O 9-EGK5/[4%(5;0?]RGNI428KH@GG#P^T@4."$7L
M<+^NA96XKS0;D!8N3M?$/)(INZ8,N4/;]N1K@\L.< 1TB1$0:17]9SFB.,#]
M9X"OIOLZ!COU)^.*U0<5X0>3L7MVPEU-(V,A$_332!SCAG)ZCA.Z\SKT=X8_
M8O;<Y=\YZ/4_X/NXSVJBV_PS_YS J5:(.V,=/KYAI:>\QX\H8JK/?RZA$@VK
MXN:^6$BOE/GU,B7@3*/EFF?([URT_3X(Z NSYIR.3WPJ$5I$L"_<\NA1>P #
MX;TXS<CCIZ=*'RW>X]Y;#\L[GRH>L2<$:WR<78XM3[DN?$'L;P4AS!'A\=$:
MD-"Z+98F02MFK6U;_&>1):&>_Q"*'+)?+^:"[G;!G^TV_3&%!1<T<V6GX\.,
MOU<I)'!H>S<^7Z1_S=VG_RBLV(\.GLX+H>^K4_B"S&X\=G8:=M.:UMEK@C9>
MVYOW+>4C0"'Q 2W7]$)?S> ?52W.N?@((E<-M+IL\*]J"]^MHG_4M"B%*()+
M10Z=>,6EYE-8+[%<'O$*X<TDQ>MSXFK>*/PN"BW]56*Q/13_8PD,P_Y8@A7>
M=<OQB+UL]0@K9M\)+F(MN<FSTU'H8;.9]7C";^DGCQ/0"F)879S&O\!O04J$
M;86._2?UK.#3%0B5X-9%C%N78X&BB9FG$LI?_P?TZ?!!8YG!!^SKV34QVM=<
M&)23H[<GM7V](X?D?B!S?Y=:+'2! >Y_5E9^%UJ*P!H(TA^T-VRM!)>-CNNK
M>W@XR=67'[^\WM)#09M9H>7$<5,X=?17L+%D<6ZKA71<KF[AK$17VPH0STF7
MEH@I[BC.E \7B)L%N?&"-'U'L9O)0(ZTQ)7383EY[,>=O]W'.Y=A9< TGK1C
M!^_"#Q_-#SB(^"\3W)>&QV5J7IX3<Z#66W#WN!E.?0W3+MS >>WN:VO:..4+
M=+#LY8-6()NGVY?+-+]J@*ZB/U_+Z$IFF$ASTN)2+W^!O+W@2/HDA#=3:M6+
M>G,6%?W>?F2=BFQYA&(W8U[J_GB= ORJO(UKT(4_V9."?-D+P 18_GH.+_]
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M-$]'7UR^JI?X>#NL5.1/HHQV'Y\ V- *6XT!FT(FZK$!UW-W;\WX7=4Y!)X
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M)OII95H=U*?NFL'0&7[D^6_GG+^VVR<WS=Q];(3\I#QM7DR_I))2(N7+TST
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M%A4K;#.RY-%?#=]R55=^NDN=,1/SEM<YVR+J(ON=J,?3NNO%NNY:>1*V8E[
M822\9O[G\$"! *=4C4TQU]+ F/(#,6;DLR /4?1Y8;HV]A9MUDHB2.1=BC:H
M<&&X/P4!K3KU/%4KGBV $)AL!!^TG8 F JT+QO4$VR"AOS1=*GB,+O@Y%EZP
MR3! <MJXG*XH'K$KJOU[04'.861&L3UA9&/[H,/,J$SK;(',3?.HE!*NTCB2
M1(?X].D2'@RG('BPUA7C[H0 '\[R/L'"2^)EJF?D7F@*WX@VRK;,I^=6-7".
M"Z@;.83STG.K__4]<.5E%>YN44Z"N^&OUJ5IJR*J&Q%3<&Y--[<\'B"R*MG]
M@'!).U7-1D43O7'JM0K+V%85IK=7Q$R<:LJN94BN-)O%J2?.BM<!GI)BXCH2
MX$UG<5_^C<2M,?'T7X95 UM4#4*&1H8O/N3C1:-R%Q@_(BV,D<_;I&-A2R0N
M[$P'IT'A(/^L>(V4.':F_;M*2M3%.3^^=&B$N#C-1[<G-5=( \1DWSVGZ)Q#
M,'C =H0X@*AQ:1U/ZB4O&A![W,E=#S:$\%U<52 S96[8\(">?E;,59V?\1;R
M&>\HV!QMLK@O("[T0D27!K.><TWV98[86J;"]V*-Q@UMKG+4) !'KV0@W-TO
M7[K[V$P9 '/JY4C;TLJ3+H9G([AMC=70]H,>O9JY4MJ^_1S3V[7)]F,H*IF#
M5+F(!!C>?AHJ<*/<3O'Q#]['38\DYS_=#P;V^/8A[F.*;TZ2":H4W+SVF].3
MV[40T/C=E;RQMH?57C/6@^]X8MK?GHEB2:T/5#(.22[0:!N1PG?XY7)W[!"G
MW+A(9);L:6S_V/'!: +4YGBB!VAOS^$9-6T)5WSMH,,9JK7\T&;,N]1&,T]\
M<CDY+EF]VJ-[GVY1.Q:DE6RK/9ILO6,P)[;E,\\%R:U,S8UXQ2E<%:,DRY<P
MFC4C>U8Z70LXD#^=+]71\29[>@^V[E$]=C3I9B/%4X7'0P6MW.96W&KNU& J
M<0'B"_K<L0#[F&'"N2^C#2G4*=0#+BD+\C8P9Y]36AQTG_U]1QXMI4V!L=4?
M(5U.LM^*A)A;EX(<J((M>1]*.S7;].CD=\K&IHR"AYVAUA61A"<DW>Q$CEQN
MUDXUI'AW#6O&Q*XK7\WY [%-N-CN<_W/AK*OLC4"24;]1I"$,[?=EYO;>K ?
M:%CXYQ]8&>AY#ZBHIS9*"59 N=*VU0R.:)P#ZSOAT_ES.J6:OLL\J(&.[%XB
MOL DHUMOH1H<2.9.0IWOMY^]&PH&>UAHTH(&/^5'I)15 5QG 3N]!4\?Y$I5
M+V" MEEJ%?&P[M:V#ARHV8ZW^\<39[=X ]B@8C)4X&:4KC$T[6R9- [.^/[M
M\NBE*S52G<M575*=+B8WW-.%[7<P*\B#\:IU">L-KA7,_CBF@T?L"/1:"._A
M/*=XN7P]GCWGHD"$637KO?)$_OP^V[(4^$&1_6*_;7Q?LE$*PJ$=7V2>\K_A
M3-27N 5Z];=HU+!SLUC@&L"]YJ]XAWSYYQOQZ\XU7%OE/EXY?A<$A0N>7I'D
M&G_ 5^H 44+#+9+<;#TK*:I. *\#M-[M@6_+%M_0 M.?/YIU^&%4#%<2D*W&
MJ!EHF! #,FL.>D1I!YY3Y]XY/8I"Z[2G)T3[$B+E:(0UXL4G1'LA.?)?WO[E
MU42LL7Z9.&YCK'M+-54E^]:O)&@EW6;[85P\IC !W=LZYJ<.OJ(&&9';]X+D
MX0?SO96<)CH>+],C29QPH7CN(N)[MHPFN2B9RVM"VG%,>;=O=!<K['+'A.9D
M]DUE>BMHY1:+;M3];>)RS;^6CQ*K.MM_H(O&AI+=9:R8)<Q3H%TV^X<)VTC,
M?VQ ]T!7V0_N%.__Q_[S"V=^EB&O.+0?5*A932\=;RY*).$\H#7N=BNI8U_/
M7=^ID[#VD\_(,JE(&<SP[V9\)T@[=J&;]X+K^C3AA\)#;MC]LPZ[CPMQ)0'?
M/(!E*WM[K![IN/:-G8" ]MFC\40$X*GY!'-%;>"!/@ZJ/!1R(&I&\8Y^""J,
M1XVV<1'/R#Q)>W3AK4P^8*TKXJ;]]D"B:60,D..92V5Y?F&V4\09*BL.EOCO
MLE,DE\\2EW5<RRWN8W=@:KZ8YC\;HR)_-T9MU/[1%^6QQTIKPO3?;X$_0U?&
M<<XU@L[G!/"X[Y@>):W#AU71</97=0"7[L%[$=+%"2F&Z8D+VR8B_+87._._
M$AC(HYY'4L=NR[(Y3KD\K=E>4[<$GQ>%&RTC=\3\<[^M#S==C\ME]6QLB[%%
MI_9C9XK$V;?;>N^0[C)05GBQM:>WEG_%YK[5MD"H],S8YALHX)^+C97K/-\R
M9$((<.MLB/4+L$UGIB=;COGB?_W/_AWKGX0\\9-F_D#\M;P2%#$U> ) AFW=
M-U^<R%C*PSLCBV))V&K?@S'62'ZH#>VVHVTBHI_L/[YJ'ZK;2J_YCN[L0\_9
MC<7] 9I;QIHZG)H@X)AM9L#$;L"Y6Z%('IYJ6+6'P5QZSOB[9,'/ R< 3+DE
M=2V9.XA\ AB0ZO 1+6.85'#ZK"A( W(MG#S '.^.C"4M]#8KXI:=2L+#>Y/X
MQ&9. !T&#24V:^D)IF9.@W>F%+HVZ",-\_-W5CO%3+?41%-QW.O>V\)YB=K&
M6Y1,G^8MBQWPAVF82.5I?<7INQ^^2A5?=26I&,;?F^+L+A!I3N%46^^0Q';H
M1Q>V_-Z][]8X:YZ[G/X*]1?3@Z^7E>9HIHRWKP-[28NW]A9P6L/U0$GGK?##
M+:F%%9FHXKIM,F965G L:!1VJ;GWG(+!^AJL^[&##TXP?$-V5+O\I='*?.^6
MC,I:]/W[9U&-H[I9PBQ67Q;4)XP^^PH8:ME$V">0:S@WCNB'!Y5HM*Z1@48"
MA.X'Z7LVFH''D$160ZO63HD;05&SO=&/X9L%IE\G3/MMV@@C"[1@\%Q- <'#
MX6EUT?4$UBLZ^1AD469\_[[@_HZ[6,$/6=,O-'Z[CSV++5S>G+E"M\@C]S'^
M[%N9:0:@@D;4UG:2:&^N9J)>A\H)8%+7Q(/]H O9FI,JU;N0C3@!O.,+(!=N
MC>P'S3WY%S/[_UU^<G1ID638>[&@IA@OMHKF^NN:P/C</]T3 '*> ! *M:O5
MNU.DP/]>H'@V>&L"=>:E?4PG74#ZURF,]V=9WD8I%6<20LW8H<WH%EX&^R$K
MN-[O5:N6;_FO8FY247K08 ;HME#./4B3X/C8DGQVP-WFJF+%"O/+/#_;,C.8
M%V5L#GL"4HK(W;?[G;JS4UFHM=D/!_KWLD\ $L4PP;$A9"N_Z=)%YX?2/N9A
M&XZ5^%<V*@6&RS9=235HS$KQX8T@FK $)N>O@S*PLIK^O7%-6]O7*+70W;3I
M??AL@QEW6'*!SAY'1=@2#OF";S"-R[\G%^^J6LH/OMO^/[Z=_V[F/F5G7<WX
M4-EA"T*J/(#'(6Y-CYP /HB=>F5_O&=DR6RD5728Z=)C;?=6"0=U4L0^*Q:U
MN0MW$$90Z][.TW[O946#\MO<([;E$XQH_#$2T;G4SR^D3#&#Y!RPZ3*$:D()
MQH2[XD,'^4OY&=W)=;Y7B:]B#MD3%#[LKAGU/8PO$>#5< ^PSLG$NA_2C\<,
M*UT!7^O)O>4PXZ%AHK!>(VQ6?MP7@ZC2(KD^EV)KHXRJ->?8:O21#/OVO3N*
MYNH4;R0Q&P;J\-O?7 \;%O=&+2A1JD@:7!5TT,=S+)T ;GM[<?;,6'1]V%;]
M2)]ZL:6-^MRH5?0L.*3X0[R\G8X28ZXES+LHJE5@GX!^\FWKJTJZ^#W?,M
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M4<\P'?.]->:DY_$-Z]%Q<;!?+XA',5J>)F2296CY)KG$B4BAZ'L13[:R<&8
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MYUN:E3S#%#'8B7YOH2]*[]P'9@7?9 WZ4:+<%E<?RS#CBF4:$7&?E;++&/B
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M=-'CGT;:2PI&W\H<X'U"!5&]^?3[1HZ0Q2QD<#X:4,8N<^+7[(V '%J@<-&
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M2=JNP;P-4W$"'<TA:7<PC_[>L)FG5R8Q\VT=NT2F@-(0SU[^0?$#6QNMQ)O
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M,\>P4I9+5$<[1!N$@[.X/%6%\1QG>MW]8F88*ZQF,K+# QK+%:_+J<GA%H(
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M_1\@8GOS/-I;7T<.9!ZR%Z^@A'4'Z@G8-9B5W,5!,AGY8:\MZ4)**(:H1N;
M- #Y#/E^!_3W;30#[/A:2U5SJ5TTV'ROT#1BNLZ+O\U^Y[+Z*SU4F;_]CTF3
M$PI2TMIC"ES9QZNLQVJ/9RV?1+HEDS;ZW9&5Y"@,4X)RIO'.) 2N,6)V?]X4
M_>X<5?-8YG7NQ8CHY%96FK2.A\(+2.P(U).!_12P0P#VK1#NM+]]X>0F-^72
MG&2]I/HU^=HX%J[J[.2C-KANZN?NJRPL(N<*;"B3/BU?6?E07HEW6<>'!2"'
M)]0Y&%>M53_38MD2WW35P;+'*6\=&_9^K5M<MD1.*M^R-7?LP,=G<-R2-4D
M/_:!1'-VIG^#,M50GP^44#;]24[EL0WQALH%2T.*%*;HRS.EF>=9KH36A]L:
MB>G+7!W:3)4B#I>I +_H=@V5Y((%ME)S\1ND;AYG&0@51-+-DV6N%5V^NL'W
MP]2#:QB';T\.K\[8)L)G2CO4:]P/OE +B FCSAT;3Q\:X^5$^?BD<N1')&Z&
M_-TO):5],OZ&%D6V#C=?<P;\!/*Y&T%;BP8-5>_\,\FGC:M03O6YB$=?D[I-
MQZG%@?/;I=G752Q_MDL^PBCUIK5]^0W4N<Y-[2FZ+D:+Y;+'5XR);^YXX"].
MZ''NUC]+.=?GP>\8/ X_[5]SR^#^P'98DC"Y8QR);[ZCW H.;LLA<@:W<<EO
M@U;_#BK.TBB9>&US?$L,;4G]U+22=3I7X6M<7=0,)^\"VU8K?97W.P!##_[A
M])S:E2/EA9_T!]GF)P\[>%R\9;#6$8O8#,-A,RW>H]X4+J6DKHBSJ;L3,C+'
M<F?ARW,317)WNV&MC3@'08<P-0PN7)N7';Y?$QB?SSU$-N3)<3N[**:F$PXD
M9'!=@O#_L3QO/O;X;<Q^-)Z]H5?I%B9%S'/ ^Q_8QGO94?!%P;I(AU>IW3&[
M.Q"*],RY.)EJ<3^\K,00^.:I.D$D RW;L\T8QC>8**7.[N]9:PNH<KT<]"S\
MEJ1/+U(9^P->_T,C-H-NTDIOA]QXIW;93$N!J6Y@X.%)@NI-Q;_WKMV?.HYE
M'U@K4<6CS8FPNN@2!?K4<Q6/Y##/77N0'(KKF8^\#*C76LMSW<9#OZFAHZW=
M1FT[(="M/',M:D(NX+VY>^S#CW$B( QP2?6*BJ!_Z@FMR[Z,GW]18[Q !QXN
M.%[XNDH26DZF)\W83\9T.7G U?9)7^C5YNCTI-M('>4DW;BDIRX@U_]6:SG.
M8_B6.=5U9+/'4>=?@SJL@;48B@V^3K@GI?E0N$C2SA='> O?I\-V[;_AWF-&
MON9JZI@\]Z/CMKB77:D/'6P,,:"I%,;-A^9Z(^@G_SP'TH\CHS>.$C*_QU4X
M0,)B)#S?P$=G!+[="QD.%,YV6&-DD#^*C))1N&[V&[@S#7TS=UU7/<L^71O
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M40=)WMR-9K9ZC1QI*NY,<>-(O;XCZS<($6:Q#PQ?'#9@_%EDAU'ZG\&[?QC
M! ?7Z$LG,=*\LX]J>),VA)(0U3TR<:5H4R,=^[@<_!T3C 8H!69$/F25_HI/
M+PH<Y"7HZ Y7.Y.'G$$P:@,01BW \,\TVD!,G3K)PK@^=7^/M^=2-<\[-J@
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ME?EL8>A-0D^2$R(I8X "\4Y'VD;W?>46IK:H;8G")(JY;-YP-E8@PK,1"Z;
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M >ZG0SX]PE$.KI-!OV C&XA!*#-C:;]7A_E>I6"F%<--/R(2ZAJ@H6Y\0TV
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MH(OT+]7_XA_?O\/S>^%? %!+ P04    " ".CDY:]L5)<!WB 0"L:0( %
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MV$ D7X_%_.QMHC;^H5*4'+J2XHRO,G>HY9MSO!8MMWYK8:YGP5'*^_RG=!M
MFB8VVJ4V2(@RPTQ6T];[&@NKCXMM,Z9^UTLO^ZR'N*$G\(TZK<7>QHKG*I3R
M)5PY[OSA3F/>&RM-C)(CB,_A>E8MC6'B+^1[W66I>AJH>PXJ^$GLL_;RNZJF
M_QRJI*-F5/F2/; A+5QYR _\S5YBV<%.$>">:ADK]0 _M<0>R*J2R#F^XBKM
M%#CV 7E/>#'I6]R;_T[N?XT<1OD1I@#V2UX;BO86:*3V$*?-87E4EV/H*18Y
MZZ^:0R].L;TS-?P8F2][*6LE-^QGS9?G_V3/'%08\LNFX4=7IR+YDF$@7 Q.
ME%5;7A,0X30#]*&07%]ZU92II+!:M&/1CM'UK9+M:P>_S,XZQNRZ3%")R#FN
M6?!V:[G "A(RV$ P.Y!<N7F^6"/+G)TUUFC;Q-KFH15L)='C.^,.0Y-=8RRR
M[]O!!ZG(+[>6P2R^))?W' @Q@G3Q7/DQNLCM#40H7C&TC$1LV$#T<**?[6NK
M=HQ2SEQ?<!F-E#_5J]\Q\2+],DMM87Y<' 8.2RGV$Q:1*<%QQL(8DH3&2H"O
M6Q@S'5L%&*6RD%]WT[59'VJ(N4PK9:;<6:NE2%7[[8/;83K?KX@*=WK! I]Q
MD^C&9N8#L)0>E&WJ!&D!L*^G?X[1=%XTC'!#HP)>-=84E=@VQ+%_V9O=#WN3
M7I$D('??ZE(@(N"W-;(9#4:OIG./TU&0IEV_6F(WA;EP_X;0<)KE@UFK)7K1
MT;E=8X5-K=(G+][Y+T$PD[NTJ2) :OD-D*QA!"C=0$BA0E=E8'?;XXPPD:ZL
MIM+8**O" !3%L,9#=3GKLGS#^R'Q;M7\PW[HDP#I$BJ,I\47%X%KXW$HNC$V
M&WRP*OM]3A$M,T.Z:=B(L;2K]*2>D+\QH21SVO70>_FCHH2;?$F A$!=Q><B
M05LD_+TUX+^!H+0-*'4:M((\?E44F'_8W\&SS3-QYEY@TKMG=Y&'!B1.U=Z-
M-,VP2>KZ+#)*!"/M8/]ZX3XB07=4%AJT-U+GCY40^U;3^&KUD[)C%\<;Q5Z7
MO6D=6TS7&5(/RW_@$IM'+Q*ZEG3)Q_X,C%/250P1O*7-!D+$F$_Q42"WAU=1
M@^,.8N97+,(7*@R:V!Q+=&!6G=F5ERDZ)Q%=AY:\X[G*WQAP1CBE\T6A)E02
M4GP!7!VHV4>1B,PP+UFHBXSXZWBTU-AKVOBB-,6D*F.7K9"V&[>_8,T .\P7
M=<)2@K@[9SG7?MC['AUI5K>ZZ^GQ(CA0?U[B8.T6#<5#78*W\@_+;_EMU^.&
M4P-(47 @RHDJEH8PFB; \;FSC!2A@XOIE740 /+7W%+[A\+:WJ94AU/^\(IF
MF44[7.X\+:$O&.6__\K[!J/" "SC!Y!< %H1$3S_04IR$X9-D9G$6FIZ#>O%
MC];A; /LVUU%T_=U,P>_%#FD1QS;4S2WO][VX:V'NH?I4M,%?-&CL'-LN&>@
M')8YW>E6IS96#P:":1H@YU->I.+SM+KZ5F%D>:WL+,E"Y%C^:<7#S?*_=R@>
M1Q_$(J%HCBU :@= ;V+R!N+-8A>5LK[&,+IEI1=Z78V8@=53>)IA:.K)KM./
M]]?)/_2:CO :L% (="QGV@5H((\#I'!4>.F,'YL/6U&% ?BBMAP!KFL[N/MQ
MYS'L<9;9_02=]N(+1XMG?@K6'SM1ZM]4KW'/N?C3_<?FGZ2W;9*,8%0O,&U'
MZR=P['!=, Z?0Z<',380*28MIFX38YQ#R]>Z4NU2YT+=3S2-OA7Y,#?Z,DQ+
M>D<KJX30:[0-3OPCL/M9WO$,$:;1RYXGD"M#!E@AR(7D:C;FJETX=8JY>,!L
M:Z^19NBE.W=>N+S;=;&$-\RK)H:4)E-K!U;HC%)*Y#PJJSJ&NAT*.EGT]WE+
MBPO'/^F ;U.:[EK^$.>\B5=1($(<P8552XH"2)Z=>@#) 46[A6Z FT;_C=#X
M/E0*6@SK6!E*8:9+6U5L*U'XTF21(4.S/9@0K16&4&K>9[9*(4H I&JX7:)V
M\C]2&\. .A&FS3S/XW<76CEB'M]C04B/K"@T(4H+?.U^IUW._[$8.5VJO-7E
M)O>I%_D"7*W?L$A641J<+(&P&K>YB1,F2[Z?N2Y@O?/(GPQW\?*QI77A>D,2
M^ER9\TW_J(>Y3^9+>'@4[>X%@'02H,W86^E@-3Z7.&41Q3KU,&EN8.CT\WVF
M#C:2#[R7;A)T'CD'I,?^?F:K>N+U58%E F5QX/&A.KBG]>*$,;N'^SVJ/4P'
MD@TI\Z>RG O# R)7.KR^/9.LS74Y>VKEJ#[[$['("-)99<ZSI/CBJG B;L&]
M)RIW&LVT8=I.@*5<+2OM\4=UL9X/#/5=G*_?4'>;,[L3Q:$>1.S37W_T1*J+
M"NDM,HTX$7 J ;1:BV:N3#/[*+3\ FL.H6EB$35<H&;IPNF<N,E$)>?65NG6
MH[U17RPH/:$=?L%F;7EM,3&H,  RNS!OSI638U\G;R BG*#=P\Q_K.TH%>[A
MT6_DO[,6<8KG0\SB?@2TYBN'N^/\<[R'9*NS]E;M.JQAAN+*.3'L4E"TQU0P
MELB4 U?9)9,:X'>H\A6FY$./QVN"1JI2\<6)FM@:5 PA92M&6O,AO2+&^=U6
MXF4B[0VZT;S;:5J5+];'BF;8]1'DIMUJUFZ9.FI9U[8\NN3H>J&MH4@B]-2Y
MAX,?M5XSGS"M?^(N7D%8(5#@Q=6=</J>)M+(J.P-1(-YIM$&HMY*"W(X\:"G
MT[A]Y-Y,0NMM.??!YCQ!C=[=21BOE.Z,;:_>NFSMA $XZ1! VKH;?B_ADW J
M/ (6YCM",E '/<?!>\+TB'O,C=V<3TF[0A-T6M\$:W]Q$!3DE, )FQ3(56,5
MWR+2QHTH,XS2C)A_-=66D=7#YFF]KZQ;FAHY0FU?=%_=[V4%<3Z;5VSV-UU8
MQT98,5>N/, 76Z4#E!Z&'=.8=;S'HZGYU8^BL27U'>WU#H>**&PW^1=%(F%U
M3W0-QTL0O#Q8^#Q ,C2A0CJ$GE5%C(@CKYSKQ]+!NE237IBN9;N?:0H\E(WS
MP@3^<[JPZJ7+W5G/D$SLIH(G\+DJ:ZFF;1\MUN?(-K^,PO;Y*/L-IYM,'/$6
MU=*X\]]U6?TY@/:H] WQ%HKV$%WW/(VCBS5G+1 9WKK'VCM:DEU9EK5'O]9$
M1^OTB!AK[E,HU_"]O@5]%"!]HOY*1N52_RX_ 7[8/C\GLK#(E87Y"@,-Z55R
MY5;IJ\R">2=(C]J/W!Z".YAU/K%&U:'C]^4FCEEE?&";C[VYVH>(ZNC9=,(+
M5 0:TBV$Q?WXDLN\\DX5C"Z[E$7,^?G7V^$L>1<+F?XZV[7IS'IJ0=CEC/EK
M+L9B$:(+)PEW8;#"4\$P]$K/YK0!NR@:>XCWFJ^!&T<I8(]60=UJS@038+O/
MM$YA2]-$I 'Y@ZQGO22\ZK6!A4!FWPT2+':9E\M5XVP!2'5(V0V$?V0:_\ D
MUZ8<@[)IS!UV8\GG=3"[WK*.=LPH;PMY]=]87;;>/Y=$F&P\(JKAMG'](;CA
M"#_@"O'><%59<KT]O53Q=G>&6.,,)SR"YA1=1L7D\D?1QH5K]M^&F@PD_#4-
M'@F'LM/X8@7PVMM /!.N<<$LT(XYPS+JS7Q9QCWR>)&A]ON-H>1"@7Q>R($W
MNM^^L$>'MO"5Y;\FE_S[S9=D06JT84H07[(>M%MAL;93ASYS(^FKRM]+[HE*
M:)M;_*R1B1VV\YZY^W?;DVP9=#I.>)/R8\_#YQMP^IFB0@B05GRO0&PH8]:5
M$=!96&E@D]Y@>Y_Y=^(+1J8UF%VKQ]\5K[5E_+/(+,PV9@D#: K_ WL<EG^#
M]6?AVK2O$]+:;2LPE_K#/8(:&SK:4[U/_AX\-N-GQN)EZKV_U:A[>;\%=Q6V
M"V[B26[!:- %?W/N %3/JN>+V["DZ+RUU':O5MO'C_P8"@$MZ90^\Q+LOUN?
MEL19 PH<&XX@OU^ +0&+2MB"4A='.]\Q!,!HM\GVR[GW"C@>_/[$JG3J>*^_
MYW] VU;R/(JKV@PO);&)T#5P:>%S^4;\D0V$+$[G>TEIJF58Z]';ZJ*3)IRK
MVC>G>ZR6%'_TT[-^YJ4>U^O:&017UF99^L%^$>4K\;N)C8&E'#N,.5_<=)Z8
M4>SADY<8-J<T^??0[J:8QRB]]^_S:X4DMFZW8!!/+]/1D,XB5W6)HPQ+Z_ /
M+0-(8I!11JE<8TV0#UC>B6QO8C755WK-Z#04FZWIC(2'&7ZQ[Z3L%[O6YH!M
MT<#CK:QP%"(8]_@6"^Y]G4C(D"-]U2,MJ;K=]Z4GY'2NH$?Q-=G"PWNPJ:[(
M_(=;PRY5'9O#WRW.B10!I.-2 T:0>19?PH:.GAGH6E_+B 6FJ8R%"DLK+7#^
MQT$OSR5&_*7QF#\Y]UZ9A#>QQR5;1'V1!F?/#G,5D]F?H#(X^> $3$K&ZL%G
MF\VTX.\;FMN1Z1D.#. LP8_<TL#=GE'&CRI24CF)#GL<"K\(%BMMU;0<'"4Z
M ;1F5'UE-X'BQQ?S9!&[48J65LV?KZ*D3"/EKA;L$VRR>/X@P'2VFM4D=E[]
M: V^8V?^+OI'7") NHNL+^ZN,6?;0 \X'G;TOP7]ZP.][NVZ^ZKV[2!5>+A-
M>5?+1-V5,IUIN(="%6X')C(1L&\@BS'Z&.Z#&;JV<H4(FC.0&=BC=.:14V03
M=*/-ZZ%]$3*!(_/F2K+"PL$9\7F/6MMJYW=W%/-W^4-"&PC[A]!3N/DNH_DH
MGV"XG;ZZ:H;;"XUQ]#!^Y_(O-H]7L-2J5\6V3&BWC.1EYHN*",YK\/3G-A ,
M\5)(IYBG-$P1V$"(/Y+:0-S]LV5='\XT%J_@#P"/=98@L-)#WT!D6Q#QU>UF
MS<.1#&:<2V*-303AI]&!E>JN%(Y=4;G<KV?DWRZPN[$\ BK,:.8!FP=Q."'\
M]QL(:<OCX2"9'3/>D*,Y<V$D-J.LN;XYZQQ'H>;]*[6Z&\\X3"7Q4YR<X5G"
MEU)H#[(/$ 1(TC#DI9404SJE(,+%8*X6+0L0P![HF(QX=N-8*"?]8V/["LM.
MQ?)-Y?V8N&=)A@\$&G&[ )(I\:H3I9D= ,<Z%.O$RS<!($UD'SKSNN[ C'Y&
M(RJ]226B1M9KZHM;M5EXF.9HI;VLK ]CCV":T9[+UGT(P+X4=#*BK/8 S?@5
M9Y#*;@#?I2CUXW8D+9]OO%77=#TI4'7&=P/A]=JOQ')-[/%?[AH.AL4WZ"RX
M))&@AQ.EAR:2@PJ32N\4'K/<-0\H_&#+0M$7\QUGL"?9'X3?:8NG*WIEQU!$
M3J^'\K>1>01+5_IA*P. M,_*=.J'BAF1GF/#=:+/2GDU)2:V'>PPC'4PSSQ'
MD+/3:RQXK[6KXN&=_:%?B5-M,*I&PJX^"=M)X</<132 5P;SNH]_I%0P1-=D
M-_!9:CX<,;HVYL3YUW]FD:OQTCMD+UZS^"SB!(NA>7>((9&0N11#JAM/0;+=
MX<L\@!9[F]5U)B,FN.8,U7=7]AE:WA=]_,7+TK7IM;9,:ZO>A69E S/@-&H[
MUCEA'DAKE<HQ55-QM)AW':F)#!K[]FG9M4@A[]GA@;UN+]==?[$XFK@/R/IA
MKMPB7R(YF*,-D,*X"J\PLP6N]7@Z&6]Z Q>YXJYB+S9&>%WS]=W;AOOL,N'B
M#TDN,87^+G<(?VVLD7GPD(OFRJ^RGT$ZF\P> ,]$3AWO)7LH]5)SHKN,8GEF
M7TDW0H.C,08&S)J G5UK2IJ7Q_:I*6[;(_0.+0U5P/TJF>L&18%F&XCYX4W"
MZ)H;"U"43HV67DS]IE 3_C?\F,D!5;=]EYRC)>JW9AP9G ZO*-QR) I%^_K@
M/A" AXR:5XHY,5C[IA(48KJ/3FWZ$:CY08GMFK[[;:=+UV'_YO8D:XO\OYQ0
MN'C9#9 JYS#_0Z<&C\"-GO]HS)5[B@GX6S[!C!5]K'8,J8_=$ZFA$Y#P[D3Z
MGB.4$Q(/,Q%<SEB[,QR/HZ, [0LJ]U(I> $M[H.)9Y2F\E5"V>L^K;$?[%?_
M.IJ&'9_Q_G+T[FNMUO/#<OYIOK)'L#_[&^ *&5E5@"K[T>"I#^&A_>HZXZ:>
M/2PMS^/Q+WTL?S&W4B5:WAU2M@QL[-2$@<\.IPB0?%&T9'0#W.FFE^G-V3%'
M'(Q2.W>/_ERQ=*GLV8E/B*Q0O7]).-5=,4;TAT"2F*Z0C: 4"D85\\Y=F".]
M:/!TCD/7=:?T\-V3V".L(Q?Y4V.ROHLSVBQ/^VVYCXX=^J)0FVK\5F1O%P*3
MLM8KI2X%'6T=[O+KIQ#9RF/V%D;LNT3_8:[^8@'O++,46%A::UE&B\&J]>/T
M>4\K-Y,9-V)&E>#K8DKZ/W1?=TUK#*Z.^1BWH)#TY>KUO4?Z\]X*2/VG';:E
M*Y")#H!TO48Z]P*DU?6T=*[0RYY7;AC<Z +5N:WNCOW.\S/0CNFS*<4W_5K\
M)+9_JG#2?(,SQ2+&-A A1,B"S'[$>V"JG5V9BQ-%7ZVU[-A5,D]2"8MR6#E_
MTDZD]MQ5@2449!C$E>>O]:+ \.9DU%4I(>B5IY0<%CO*-:^PBWW^9<=B8VN>
MT-SS%^>2S'B9/V;3EQ;\7BK04&!0X6)_CAR['Z9W<M@@UO/&ER$^<B,K?V9F
M'%U=2NCAKY^,[_.]JY>7N_VK5O-IZ"!;"$IC:?'%!5C'V::P#TY@QDZTJ:"Z
M8<!MG> 3 O8/OAT+:$EV;LT8_Z6R@]EH^O6R&.>7R)(=5]5N [&GA-<!K,2.
M$_]JCNMMK>0J-[($!AZ;0[4<]^/S3JHAZZWN/WQ4%(-?A9S_(BK@]#IB2MNO
M^8CKH>6&ZW#JB=ASK5F+MXFTRM+:N0+ZYN<#:GY6B'8TC?W=XYM+ \+=\8^<
M;^+$=BXF>RURE2<81E)<2QZ!&(J^I:X_&;[2[AQ[H^)#4-F7T[()H]V<2ZG,
M/"G#;QU#6VK'AI0K =)GE86<>;BS&2RN1(.)W:T/S5MYSU]62'PTHUC_ZHHT
M78Z]:9%[D7BW5^#=CJ.B3[97\K??@:I8Q[O0X'GBU ;B.&C>FP/8UHTWZO67
M!94OR\W8QJ":PLBRVF$"W'+\/74Q!<Y]=%(I&+O(+8>+\ ",Q@^!]>MUA+E6
M! T(B:0HD5!U02O4>3P%S3 @Q: %,%=^NW?@,9<>VLA9=-_>0.S,5315FQZ/
M)WP+8JOS6H'PX6ES]B1T'"[,6%XY-HCP$5QD+/8=O4[VS)^_^-CAR(<+)LX_
M/KU1U'LI1J2*;R!PGV_=O$\8)T"6\>S!R78MCC$DPA=;!M_.^D /YD72RSHF
M36K,S(H8-PY\NOC+L/>4Q$$G[&=YA&S_1_).\F(D,X/5P^Z IN&6BX< ^+Q(
MA-- F>L)GBT&XU0=G9R@@JBR'ZM?/PI>4#OVZZJG?<[Y(WBKA> M=_<>U)>=
M<WLB]7V,+Z[#D5\"0.?2:8=SO ?E$)F T22[$6L[\7WJ<GF.HP:RU:]>Q"-<
M6$G1G\F_7\+6P=F3Y(4I96^%W_%805XZ%LFYQG5F"1>R<,OV6>?)IH8NC+=C
M?7.U;&%C3?O&)L(G\UC+& +%"3(K8"]M(%*IL.0ER(@O>S2(Z6, !6T@Y(,R
MN.\.:L&=E[.3^=ASJ#X1V\(9U6[/E\3"(Z&()O >0%U!<\0@F(F>?X58=R6A
MP!.A*$C'=:6-<P8;#U*9!);6P-KUYA4ZHV.OJI3\)\4CBARY+X9#9W)/OW^.
M>))]V7B!"&/292 9I8P*PT.F97""I9L8I3_>W<*J[,'G7D_+PJ)P);.DEJMA
M)D?5?M;TI,T-ANNT:^[_SW\JJH2W#&M="+P_W(D"IN58KOR2?56_\?QM;6,Q
MO""^F#T+:3>Q\JREH0U:K>J)#;?TS7>;.3:BD'<7M!%,DH*Q88Y(FXJ<\?C-
M[H<OY(0Y2>WC:Q:?8]GUZ$]SD0S5K)8/'S0]A?(_73)PD Y;:';L??11_B%H
M#57R1>?G4>DHT 6 #B7/%S.7S'/^/B"DHK8%M:+%IP9>?F"+>=B&&YT>VM5.
M+/DD455&ZGVEFA_O.O!8@O>R'>8=PO]PGZG-KBNB]512.*-4W L.@J3.N8_:
M\?GOJ\KG!$9$QTP/5P9^DIC1Y YL)5X&:!/X*2)?^3A?S)9.4,<DVW-0Z7PC
MZCL&S[[\C,7TZ2K%4O7$IXTYN@*UK8 '@IL.6^2*(TG"V>'.>PU<18MA WD=
M[0D@@]PUMROA3^48UJ9O^BVQ_>09)SV$1DI4,X=ZFF?%RR+29E')F_,^TXF&
MQ\_!DT+2<ZPMJV+U=NS@WT-8PQ<AD[](+_Y=+I#/+##6SRZX>=UU080KDP:[
MA', (/EL(,+PE L]J(;*W/;XIR0:(,VKL@<$0N(N#>M_^6'^3N/>K(>7,.)8
M6UQ*_UG[>>0;XAL1KJHJ!R:^I$/$$,)V/IDH:&7(]9[ .M#O&5UY4\ORZ:@8
M]M-H;2B9=#(V_#/EKZT]Y"J[;\?6:P=$1;[W 99HT)T :7C!C \Y%0JSN*:U
M)(#VE*AD:?/RN\?SQY<_QZI2=T_S9U[.S.PWW/G@ILO#-P.Q"KSMY$6 JP9C
MIYX%!,]CODC864OKW3>M=&";30#2E@+V<UXQ3AP@'6O?I,/"4'W JY#BJ%"R
MNF+JZL<ZPZ"7IYYM'=Z]8*<X'P=T!@.T%\1&.V8+_-%-[W<-PP!PD9>%,T=S
M#T,)M+4BJ72K7:.+16;MB9@B!TY6@41YP7&)UAG;T);S]F\^_?=^!)<&D-X2
M?]U>O8EF&U*!I<E?Q/VH*\ATOCQ\O7C803-$-4L4QS%4&G.=S(!I47H8%U7]
MXY=H>'*H4E-)WZT#G?(&63N:+SQ,R)6F+2+41)CA<*ZU8S<GQFC^\/H&@@E+
M"3)XQ$Y-.Y8 G5U@UE'E]MXVNZ2FHT[Y-38CW-O=ZV0N0UFP:I^9K'GT'[L5
M]'QX)'][(GP!RR4K"6B$->8#Q<Y3MW*/9Y+[Y[1 2_MME,*/-67W@F22JG;&
M2\]I6;R6=]SVP,7U*G)3Y0MPHXZ\#=1N(%9$6 [S4GTPM+A->1"2_NJK:8[^
MB'4W]3Z9Z*[55)?B=,!>.[M,X)#WT'^O>G&QL&QAJ0@V@+8ZI<M ]4M)!__V
M#'Y\$,K5^GSFO75+YOO10U\?'3WWT2#/'Y#??N2<R&(E$UY%L)F%6H'?A>Y#
MA^&?NC^C(M"9%J^3669C)THX?4HE516S>9W$MJ:HG:&[^RE-/WJ..NPD_W3B
MRB;S10?* 9)!.WH>J1A,;!S XW202DM-1?C0><7S158G\JV@-\P/"?>LWNO_
M;N;#_6(#H1_*?P<WJVU@&O]QHP7O%:\:=94HA!LDUJ-RB<'#Z=>VE$&JW6LE
M?>,^ER^]W=\[=&<7:D!_)<<N+E9^"P2/:"(&_!%4PP!S M;8I(.7!?CA998-
M*_G#1(F_WO%]SM\]JM_H>PT$\<I>#/;+6G87L:9GGDF?>MBZ3>D0[RQ,Z*YM
M("*6@$@C2*?R5KLC(R>6T.Y+,[628F47.'0&[S/($U3:[C3$-"R;.?4)]R='
M5U>8N!U%RT4W5S()''.L/T3D)"S!?- H'=UPJ9%5%YINU.Y9MM2:/]55-^<0
M_:(++_PHID L:/]/[YZ@Z6[:(OXRO*H/*@2I@NLK!5V(ROQ>M#).%BJ@YV:Q
M7H_:-R %H?Y)QMSRJ?%P[DR-E1GGC/,1D8;$>R<>2 _Q[0?@@> XII[1W+<#
MIKU_ 2GN?CSC;&>GR@US(_K$I*ZB 4 7>%N\6W+.G4>36L.!PSZA:P>(0I8P
M:NH/8N+YI%+.$R_756^$ G>:_WD#4;>8C:*5 6",7=_J5)L[K](RFG9#F/EX
M_0A1,B1?+B+\C\/A8]IGZ(C 3[AR\I_[Z*%%I@!'\G^>UP.T9:EL=+WA6G^D
M-"1^U/H=G.=BR)1!I2C5&^*?K),-K"Y]3UBR5D6";K"#109*(7@T16_C4V"
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M6L\9A9^NBW0+Q'Y\L]-V]Z3C4VDC3PZLKP)?$M<'@.=6LXB@,UJ8>YEE5LM
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M!R]4]69_:I%TD"D>RWYTJ.U&O']@VJ,:L\)_A:#80>CA1/ SD>&(G+297TS
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M1T-,3[#"VL$I!N+^U;7P5?,35Q(_O*MO8'S\J3KO=>]1SNJ%27SR;@FR$<2
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MC S$!>7-K!R@B%VV!?MXT%P0 @_VZ2W8E_W-J)<4QIFAO]:;O'U??\M.PK_
MAA?P\/^? ^=H>$!+@".!H"YR9$(7T%UHB%PC0"/@3?])X"I\DB-1;!E^%3V0
M>ZC_UI5@\7<&ZOJ=,[:=O8<^&+':KI-%0J6=W[QZ+?1&'Z8$DZYW$H!485T@
M1WR&6KK"ZQQUA)G+D:ZC-O429()SP6.Y%]"2&,$P.K&VU)/E7G+\I* ,;CSY
M6J'YX7AV0S9; D\B\MKQKSBSM;$WN%FWT ]P!YC6]Y@4^QQRM['I;'NMPZ6,
MX.MA'7"=[:O.U[SM^1*LC#8;I+<Q]%;LMF [V> @[PB=E4 FF67*T.@9D@D9
M)RK]MG^NT5V@,4IM\)RQ#SZXO\XJWN]X8K^<05_KO;]%)K3V:LA*(8@=!RY"
MOV/<A^05-'5(]I?/(<9&2.YFKK&R9L/=]L[9A<&$4U:[AJD2L28[XO+^\2K"
MDGA[D4-K4WR]>)EJ**;T0:R(F($3["A5:^]-?/6&XC8C8!)$KU,WL))'K@\6
M9]I8==XMG(5(5 Z1$8Y?@;QM!PF(Q9D'Y96T,J5H;BFV='._!3Y90Y+JX\<5
M] 6GMZUE6B.M=OOE'WM?G'+\R2^]C;E)]X8NBP LV>YXDDV'%)YD9WZ1&=B=
MATH")=TG/9<LE+]0FXZX=HZS?M#/#/SRY\_[_HBN%K][D6?QSD3J$Q0,3RTG
MU%WC%EB8SJ*6KO2[QEU@;,&2Z_TSZ-,.(Y(5P_(RCRHR#7I_OH_=C6A+L1DQ
M=!*XQVL0BJ<2*&+0Z^<3:U8?L!4 J9Y_A!3#8PK+3D\CX.*D77E4[Z\?S).6
M%>YKB<1?3S_^HT.:^QI)'7:<;*)%]I2OI1)K$\D$18[(J)%)4=:R+>.]?>61
MG3=S98=S4CQO^65_3TX-?7_*:EOHGP)H>DG<!#QU% ]H9*QD,BT=@26F?3=.
M&^BBT?6</+D6*'E':8^K<D'LD865AZ\-;!4)E ]:4G%U:D;_8JRDM_V%>"&_
M.A2/(-D6"#'M QKTZ!BV'^8+*Q\BHO<CEF>U/G:[ U>T3TAKA\$?556KRO$G
M^D1/Y'/D_FNE1"W "0%/ YER"QF]U9!;2*O4/ WPYNM6*&YO?SXE8!:NL.O^
MN@;[@%9@A[45KLGY.,(<<FLB]1E!"$^%XG)-VMJ*%0TM0<$8=,D9+%6&&<=7
M[G6I3?]X(6NW;]IH;\T]A9+/^G+W4CCK7Z I'<1/]=O59CB,$*DO" J5E?/>
M-9XS@U>2XCYK'H?]<UTIAD;4S]:!5J$5E.9F66SG! !*C"[6&E!!7K"("R@,
MF5/M.%+KL^3RL T,F99L=2Y)I]D^[=MWX?OMMR+'FOXG02&!^PQ/S43L,J(D
M$/C^>)_W&6US+H> 6P)3ATJ7B(Z2N'TB'%M\T<V7_^-K1)2[(M(8X3)\',$'
M(,%=P@P-ZB9'&EP&A>+8IIP()O[NGUE7URRV#^-L)CIDVN)5DQ#_;['4_&Y7
M>(N+-T6]0NG(H^,M!%Z;WKW(%4_>1Z;Q"E 3>R+?G>'8'79D+(R.O3,OFQS8
M'(\<ZXF43CGW_3Q2&YOUNC-Y>UK#YCYHQ$9L39YX@69SD[26KA!(SIB.8\4Q
MJWO97,D?)K\'%;L99'2I+;/Q9_QH=''6=_&[IZY8I;VU+#R@C2HB- BL-# 0
MK $ 40E^PM<G=LTX2@(VJ+LV,26SLB=3BPQO6JF*,SZF\JDG61[8H_!;09./
MZ=>-8ER!OW<SRJ=KS+OR]B(S$K%R95YR[8R&7@+ZUA<5<&>><8+Q>ZIL_#L^
MD^IA.+ ?SY%$LWBU%><X>NU -/L0QH-ESPU>R.X&]9C\G5XA+5V]NU+M55^I
M6N?G7W5^I;KJ%SLP@,M]==?"E NI;6H:DI\(*>^9T@57^M@\)45Y[T0#.FWD
MEV,U$.G6V,06S9M#/9B2U$E2>F3<QY?]V'S#*X,CF0&*;L&X3_'4+*(\-IA9
M1]WLIDAC,LXQ;R=R,_;@5-*_ZCZ]$BX;F;X_62;_IHV8O118'+IFJLE'14U6
M@[LJV6:\^E]?5#ID&/6(-!^C"8X1$]&5NP[DGV\=\7O7\;;)^TCT'=$*V1K9
M@A.*=0<O*SV]ZR1XU(3 N#JQ$K< GUP#!9>K,)'=!5),Y>02R#/'FVBHG4MS
MAVME6SI_GB.'AOKM^PV#J])L*[HKE7>:D]X/XA*&CROSA!N<F\R1A_[*<-/;
M_-B*V)/,]+(70>!ASVUWRG\.]TX<@0"/V-CN'>MT834ZX'SF< ;6]2Y !G?9
M,\QZ\0P[.!Q/4M6S, *J$(*82&>YVZ!6RMP,V]I%X=$FV_WT'3>*F8;PYH7(
MZA;-%_"#@");'>)$QE#0"F2IC*FA93"6$%K!Z1R56WDKN\@7ORS4RU;5_=^Z
M5)3N_VZZ<!=91^!(GE]82[4PY<"!'AHWHLW]Q8<BO!\F.2S5Q:7WEUG\-/-5
M:^W?TT_#"S4J8Y:M8%@X-+ S4!B!Z @%0MB,EP"S,E1ALZLZ^7./] U@AM2[
M=SJE>WLW>F_F[0'F:Z':<AM-H3=>;[0R]G.3B-11Q\E-5B# +L&-0)""(,-W
M8\.81^*C97ZDH6FO_>(<TW^HBIQWV!7LWQSTL>SB'6Q;QE/%5-QKR%65H->^
MB*>F$7<AJ>4=6H CC9B"E^78SR?C)']%;K9<\$'$SH[_K2KHF0K8>)PD=-5)
M]!V;7C"V,<&1F6 ALEDO(#ON \E$20NYGQU&HU@_*EXFV&,QN2CQY.7Y0;7.
MZ?!BG=\3QG(#]_B_Y0KN.72\RBW6SKE9&%<T?)S_#AX2'SJ 'VN2^[CM.OL
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M@9'JXN&)'B:_\SH@MN'TKB:[ZYIG<[-Q\/9W/#Q!U54=RFB[B0J ;%<63W)
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MTV8#RA2\T*?Q<XOGJYWDS;E-ZP64* 71."0;_>.C3VKNS32.<\%!:3NPN9(
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MVT1W#UO?RJ*#EB=UX:2?J\2Z@V$T9TS==A;@Q> <3ZR/!'THE<3MCU3#])1
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M0]I-"O;WF:EP'UY@"L675Z"TSXO=G-7J@?6[Y^%NY%57N"\-,A@\]%V&]0_
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MN[5F:)7A<>L2E>TCZ$YM['CZ<+CSL^1/%M$GE;V(0K%PLAEB&$&]W/^T^85
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MW;88V;^W]M.<IM"7NWKIKXLPOS^7]:7@(27-WY^("G3_>_?B_%W,;* 8QNA
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M^X(.&;1K)%ZH%&2Y'7]TVSN6K&D86?_SY^33Q[EI97V#WU5H FX4?"W(0GZ
M&IZ=<II)K-M/UF7"GG%/.+$GY<X<2N3=%+G(^5HR1DH.IH$IL,QNW&=D'%GL
M-W4\!_[ :TEF2W=PO,H9X)G]!H8HQ 9EE2;_ZVLW]*6*WR8]8#GU69K$A@&
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M8OO4.C5SJR[^7UGB[_V>?3]'T:[#ZKW(M6KS<O?AT??V5&,W<KA^5H&U8:<
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MYM@[>.:<6TAY4UR-6+:1KGY"5,O$U%(Y@0;)988XI@.UKT:)Z@EN=;<R88*
MJW$*%1<;\".$/ZI+U7O7US8GA]JSG 4#4PX2+R[O-16^>@7&EPX-<NI98S@)
MB7MX]NPPY2#)LPGNL,I8>4%_YEXB.>J%$H,"[GTZ?G(XX%<9A,YN@*-3WF\=
MEH.2.D(\"!3?E3F"1@=-#81BB4, \P5;/ 5]7@/#ZR=%W(RZ;P(W3FI*VT%/
M+X.+&3L=CW^[QZ$B,/:8P_G!2V=&S=MW1W]OY4QQ<:9F,+B:J'M .097-U74
M3Y2"("GGCSR7%.RS==5N?N+OGH/J5ABSLWWQ>432Q?%(:'GST*N3WJ<D)[=G
M'2)=L64JK3:\IC\:1RE*Y-IO=TW);=["G>7#SU596FW26:46;#7K52(QRN3'
M2R73\7L6\!P;J>SSGFQS<[(OWAN))QY(>))_X?6-XO-,V/W!;_V_LRHD8)8F
M786G<XOB-WM[F# N91R4>L-6Z.ME1?HP"+XV&D-.]#4]D D+4H*3$N:9L'5Y
M*-L1C&V$+K$C_I-LO?5D!LM.0G?"5:/JPUUZ3MPNB6?9M3,I8N-*2:1HHV7,
MS@NL[+:2VOWXWUVHPJK)$+!#,<)X"-2YVTQ8:)(E$Y9^9I.Q93WT-A@"WY,R
M_4S8STL02*A+C >-?( M(15@Y5W!MF;_/Y7E>]S*XOUJ\3)=TU6%0+?;R3;1
MD3.<3P_%E!R3%()Q29-@F2,7%B6,[%XF5\013O<N^W1ZGT[N^M+%D;R\_./^
M^<G8T[<>W-*Z"A,P(K*@$N&D2RN@O&\DW@VQ!]?0':HZ80,J\[3$'GAXK1MG
M&]YX4EY\M<FA/3I'Z]:O\MS;VWHU>&+&WNPEF8)VDB8Q=I$,RH[\-/3V@=V0
MQ6M7<+!B#QP_+F>I=0M^7^4K@701"\IVP-GN+.GIT1[T6"#%;,])]]QW"]UY
MN^C#E"$'P_X\@M*Q+VCJ >-DZNR)Q_MO(:4_O[NC T1;9M@E^0P'5="_C=)P
MFIU>-0[Q_@97%2ZA6G)Z"MNW,3YCWKV$P54!)1(F[!GE?NGC:<-6OAW(P&FW
M]][9UEJ7DZ4OGF"5>S6T[QC *6-H(;>(^&T/*ZPO)LG6.YY W_4[/Z*PXIGG
MF0>0A!/.TWD.?_E@=9P;@OSNPG^B 7B0Y^Q?&<=:\]Z_&,D2C4YO,ZQ9G^.S
M)E_5E\O&AXXI.YX,X)Y?^(MULWS_UIZ,?_M^MYM1VR?;_.8:B-]^>?FVFO0_
MC>$K'9)U_:;F,6FOUK#,! .6JZ<^2Z<%[UYG>?%GT6MSC;Q"DQJQ:ZW$_4RX
M-FQ]KG?<WMZV3>C2&W'%Y>;M0U:\4'R8"03I+G*QC:J>TLV"Z3;B:%X1.V.M
MF=RXX!'K<&!Z,TD!6[KG[H.S+W1"#O&C($BS![B-! _C:"(<4TC: 4IVLY[*
M6;7/?*$ZJG?<2]W5!5=K<CDC83I<A;8?YNH>#M$OT7, XB1^J)TH-W*?+SQQ
M$Q#P >_E>4XNE)KH[GL0V"LN%MA8S!#^1:">@OP<C2>^Q9>FY:,/D_*L*TC[
M8Q?3KF8](P;I? :.8^937K%VH";@"GHOUH'%:*BDMAU3PD4Q8>ZHZ.]&/%+@
MV0:E3RO%;L.6)*<XA%WQNL:6%?4DIH50C%_$OE-^1=6C\7[5.3ZEHFQG,-)A
M%*2]9>PC.Y>Y=>SIJ75#8ELP@IB )5U%C5 M)77(0"->H'FP6;S&D'SL:J#_
M:\FS:F.)57>]7T=\PF75"0(-175'7SA4@W/4TS4[@8(^", P89H(X^A(0?CF
M#[RS_!M+YVD$34B3P5E E6- U?(#*I:A!1Y"P%WUY+ZVOJ(H&3=;=U:?%L>:
MEU8\V[QT6NQ FT(PEY;TOM>6W_<#EPD528M0Q>:MI,K[X;9GS$+7&/Q0PF(T
M086W>Q%?3D]9'!S8!.;10Q7+J\>#-EII:S'P+@089LS 0:ZE"C!AZ)][G6>4
MA+?&.6A[>V;=O'\22.-:JS>L=+I!"UWO4?B(CS?CX&4F;!OF=Z"@@J#-<=\;
M3T("X*'XQ0*J$Z9A@@.<FSY< V3Y86WLD$L5#,G^@K#2K/VFRQ/'9KIWOMRA
M]61/?N6!M TL&6#P)H %UTOL:>P@V3V'=%';-VK=H.0&XW,:QTO5S=5O@#;=
ME!X"."'!FXCALXW8$CZ:');T#"I/JI05, UPHD<O(5SJ/E8S8>8_VDL\L24K
MY0^<8X@!&SO'L9VST$!?)X *HC3!V6O/IC@>8^#@6E//Z/Y>OZ1)1H9,LX0H
M^,Y-3O'IQLZ+N;OO&FHL8HN9,-J^2.I-FDPR+Q\EC/3C*5G%*)Y+IKFG,"7W
M4)Q6LM JEI5*2KQYPNLS;GSK%Q-&V=[J@,(TH\JE?47Q8GJ<+I\+Q@Y#-"7[
M-.J#Z^EX<FD/RRS_T$5IE"L'9I:'NKWVR!5_DPD;F7)#[091+0)^OLV#,F8Z
MJE.5;TL^)IZMO^:H>/.C]"QWG&W<A:BMZ-\$,MF0\H4)"W$';B/"^.W -LI%
M<BAJS_KM"B/Z0XQ W[4P[<E[YS2OL29D'9=C<9"M2:&80XVK9Q"VC_40Y@O%
M"PR:DT4>9UY0VN!CH9TRRJC^8!8_WJ0>TEUVX/K.Z^2'3)@B]:N"\N-UOM\F
MAE+@MV@ O4GE 1JL$8[ :&LOKVA]FJ(V1\Q%_X\D9,3,>4\N5D7WT9/*SQYY
MBRO"V@\Y"Z]_W_$_J6S_'Y8E2CZ=^FASG_MU$I7.@;?[W^RJ?K[#7Z-_X#</
MHV# ?PO4^N^QM>>EWMM^ @61!&"(KP$8Q8OK7%'6J/XHOH[D=+E8[*H=.;-#
M4"M*\=&NPC.[]O <%PH.R([ 2(WZ&9ZI)B.BUINR7,I%EG0IZ>_M6G:)D.7;
M3WZ:.2*_+^'\#KP2@IA.('FUE&/9-AL]ATXBC3QW__34.SA_B2-*\"L]G$/L
MR9:)_'##2!QG #B]K3;WZ"%F#$^RA$=1L)PTI3>NAN=KH6&+"IQ,"@U-.'?^
MA,#84=B8=IRUU?'6EXIY8IU!4-[:"7'Z$#\]29J<#5\TOH)[V _7'%WNAMQY
MBG'K17:%&06J6DF?.<21&P=F;IJ%O\F3J21Y+H;]:6=5.41G,6K/IIUCES=2
MD+M=*\+=45,J4>>2!%TYM!SN%!\-+)^6J%!T*WU$#"ZCZE,%&0VHDJ1%T4FS
M#)H@J'I_JX/$N>$IZMIZHNPDXQ6O,D>2Y"F]*S?,@^^:&FT=^?*EVZ3DL6E?
MP:&*BHI(AT><4IQ/W\8<R8V#03]$ELM?99?_QL!)/2<55KX?F>LUY M?=F;_
M8: <\W%G!;*Q]"_BX2_VBOR/@3+_)8:XSQ!B::O?[TSQH6=!'7<;/&E4U;..
M%;;;CS)(1"0M)GV:[WNK1N^55C@R+280K+>$:1@,W0X*Q@X_8'IE,6=*2>5*
M=6E)W5?WT6L]93S#B?+$CP_%7CC?W)$?8:]F5#_!17U;IQ)_CPU[E_8-$6U,
M"%FSP27W#72GKZ*=$_)GI9,?DP]3R1@WGS54+/8TH41NZ0R^C&^Q,QNM'VWH
M66[D1M%%-[87\_QLC#1 A!X_%X6H/C28-^P7?]58ZRE:QJ_^W)NC3@W3!1AM
M1C-088^G2K9-N>]%<B,BU#WYK667CKHBG%>5O])*%(0P[ZVN.?SXM1MC:SF,
M98.H=P6<I<;R_:@?,(5KHJ,:>62'!B\;AWU3<M!J=92//!3O$UM+'JC!B),E
M#K4ZE1Z,;Y:_J>1R6/:9FZF'V[U"]PW709TZ^'1-BG!23_CQXC W:TL3V8&D
M'Q5'ZJ@_@Q[_<66Q^^I#YVO15L)%T#3R1E%SFU\5!WS+O16?(B5VY>4=/OAP
M?XL-KG=:_LOA[/O=>!,CNSM_/1C,Q>/_^&)WS$Y!!/2W!H;_EO(&6H18_EVV
M^G?^_)$KE[3+$?7+;YRNGU78]4B7E[]MGVJ^V8&KEW;DQL X3K$I_;-M!,GJ
M5+<@JZ]]>1_Q+G7\@]!N(^EU(5B2I<6 1:_]Q)CTT<:P[XF6W._?.!;)!<-F
M-7Y!'<^V+:WS= +M]\T#PT+CZG="<IQ&).7.)\X\'G0RW[3<1W_-7\^$)88Z
MDA]:0EF30+K\JDYEW![3#<#*LE'<+0<?VP\JV8;D?]0ZVFI(JP[YQH2UFS/:
M".LKH"P$V4[Y'59$0-5Y1 *"^9'M;-@FR7TUT8S3T[GCIMD,&]]SB'D&^1=)
MD$QCPG0[M-I5_44,%2ZC6O)ZQR\'5;F0:T6K'S!ARETE,9["#A,FST^:0Z3T
M3^\!_C]K1RL"&5P0(=C9APP_.L3H092RATLT)QSIG.SF&S?$+KZ04M#Y GPG
MQEU%;A5FSU*Q]\WT,?%/':T /B=RXPTIQXH@QZUR*K[A=JG>FNQGDI4D.\1%
M[R2NY&,MH 8I)3[4%[(L#DC?GAZ^QI!API[400Z%RF;"3FL4_<4+?[2813\H
MR"G+RB3'U?*IS>AH<^^8+?+ N4@AIU<O26]@1G+!;!@K*.<80VR)P$-#,+Z"
MJE0.VQ&WJI'E1TS8E% /UQW%E'21\V-V6B?H"WS2UX4%0IZP%0:543VW4Q5P
M2V5(HH$)&\7NK;DN,^#Q1B7#S_""@O*[]Y*G%"1/Q>D\VE4L?/H1BU(8(@I>
MCJ0)VU#&H!%/!7L1CR9@/1M*<DT!98-/WZ&U2*[M.B-QIJ>JG@H9/1@25PB+
M<.^J/^WZF *YY:.;F!$4Z2H\XACM-KD+GW/-S_-RK9H;5J#&VC'->(!C5_G[
M&=W1&'=BOE&%B\^!P_0J>A2>F$J @/BBQ"3+&]H>DC;@AH3%6Y)OO1=Q1YKI
M"-;9\D8^X8PZ6A3C[''OO$4$;8[^"$\<53*_8@R/A%=D1TI^8>=1!/AJ$ ]V
M=6@OU52?.1,@1I2&BG[!94[< #P4Q58GB&8EF50T8:&.XE/'[OJ9&+*I_2#^
MUH?T.S"[#\>D7M];-%:=27#+?OO(YN,?J@]8SJ@#)*LA*>@N^SX_J#L,)[V?
M:7LH7K.RCN8ZQ>A?J&#H,6'?LVE4ZN!"I\.%4@544D;1C^_#A:+'*&DM- $O
M8/;GUK;TD.23/V6 >,S -N=;+*-Z^*$8_(01CLF@K QO(5G=D\TB(9^^E=)F
M&#\F#8@LL^WN/<\VG^8-W7[#5X\:;6=PZE(O,]HJ*N#"@/-HRDJ$WNZBI"55
MPFV2FIOV>?./Z@/DU<FC?*F[,7.WKK4\P$)L -0"ICD:C.Y@1!C#7^W!Z<9/
M%F)H<Q$)Z[ZD+"?%4[6G"5X"JZ:;]1?HK;A(!/$MEG2.;[B:,FA,B,#R35:0
M^/XOYMX\'LJW[1\?+810ENRFLE62*$O13!*2I)(EVU24)"1D&S.5[,N$HH@I
MD2V-783!6),]>\P8B2R9L8R+F;GF>_G<W^?Y/??G][F?YW[NW_?[>GY_C'_,
M7->Y'.=QO-_G>9SOH_&:P3G?#JWN8-S5Q(]J[H-<+]-+E!2F57_"]CPA!'?E
M8WA8@8 NTP1]J@3(I6E3]Z12';A7,+/,BZD/6^J43NR:H#YSOJW-UYY^^F,5
M,55Z3 WDVY2;L62_L:(@WDWH#I-YO7FU;>&1[MTK/P+\>$/6SEV[27YMU+\!
MT>9M9&C0Q\$N?/F(#4L3B!NHW08D'K 9-*RIA#QV?^:OU(/X?!&(SL"%=TY<
M>*EZ.@4QGA%U8-?_B9M,Q@$!KMFVICEWQ2_7;]M=FMAU+/1<CY&INAX,II#8
M6TU@5$(HT<5\*'QB%'V6_48O0/!U@HJ FG%Y8U58[G[<ZD/:%O[TTX?O1S]S
M>"XS.$%>@/JR_2Z[ /*1"'4<!=O0L?5J-PN>.\X?K%R'D%I6KAZPP2<NN$N,
MW6_)"3T=>Q]AI5(=<GYZ9%/H&M#QKB?NY,!*$0*8AI)A(+J1OXI_$6XFD6Q6
MZ!$^'^'_^9D,U8 9_^CT<Q%<&-$)"2AE_R&I8 \D^]*3F\%]WQ;T='-0XG2>
M1J+8*R6W<IZ=27F-FGTQ[ESG&U,?)MD?PA<1*2EDFD?GJ[<<F OK-KMV(HI!
M<T\G391EU=W9=TJ?^$)0$;G2<*SD<>7W/?H;Q(R9*NVPE6B4$!!D4EY86/QX
M;TEQ\>.;83N>W[B\^[3EI4TPN^7QF"I.CAV-O X?)C $:'#6/@YL"TNBB&S?
MF%_@C[\T>B0K[^CBX4\2%Y;VGRXB7*I4P-_-B.+]I]/D_XFS8]8@9$0CF+Y
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MP9G4&F(=JLAO/H16X<3292?7PF>66M8\[NG)WTZ$>^_%!<$?F 7>$IMO?G$
MK6[Z _/.6+4=LM.&=Q(;AFK=]W;IN_.-CIZ);XX2VRT*>]?-U9MFB%YG^F+K
MH7!T6VB(OZ%YC3H8%;H6\=O]:PKRR4KX-4W^OLZ!6YU[(YYY'W[I*#@VKY4F
MV/>]>K-:!Y\_#TE[_#B])?*P3[#\A0K755D+BZISJ@L9CA^73O#EG3(AM*"
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MZP] #WD'+R?7X:/^B$ZOL;3+R+#TG<'*5$*#G9DQ1;N1P-6AT1+D[OK>&,G
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MUWW:\(JF>2\JQ/2&Q_,WN[\JP6D%&BBC@2O2NX$EK51N!>3,50QGLY U4!$
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MYL@SMQ]-Y"/^)"X3[8.6AK$V-;V_.*BD?,O8MRT=7T\GCFSH*>_SW>^@J
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M,CJX]( [U[BX?$1+-,]&_Z[E&BV_F??XL\OD'>W;#6]'<'8)9,M7H$S_YFS
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MM$=R5@[CZ0^1DEAY$^PP+Y=6?3U,\P/BS^+AS^.O?E_^.>.Y61UTDS$T?-V
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M4RO^+38$[A5FVD)SX,B'#5@(,@4I@A/E'@&]@)XQ.="+:I3NI]7.?^_S)?[
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M[W3U^XE"H9WRR5.(Z(<?A.<A:[MT=X;_6TA'2 EZWUS<%*$A.H5$?6RM ?H
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MVM.;&)#%*]?9C'.#0+,+I6@5 XBQ;X"UY;XC]##%4RU 82965NM9L^7<RJV
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M5,C \PU8\@MHU3S8@'W@L!0AVY[!LZIX1:5=.?S=+9O_>HORQWP#IAU#^:8
MC;F-!0D2K]K^V(/M$VM\M<OFY(F\PY_)!C6%Z'V]3<_D]YZ-.J1C]H?(D=F
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M*GDW(PXY;S6R.=A+$[_PJF?8(-UMYL=#Q"T:IQWD'[;Y9P]63(T?DWH_EAK
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M0( .' LK4IY01DX9$8[2P\Q/!F*Y4\(DW^F9J$SU_U 7LB$K"2:=/-&(PFQ
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M<;;DNP\ W^@Y8>*WYI_5\RW/6>R_2UYY.)9VZH*=5 ],GXZQ9*@C>5"N0Z1
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MHXVIL,*KSE9NY7NR6)U)G3>7ZCNSAEZH*65B9!>)JH "G,SW; #<1$S'[&5
MN-K-/@"J.)[$WQ_OY<M\R:G<O1RD<UG%W5)-4G312*!+=R5"X8< J2.5-3S6
M+/*(RK9.-_0XI>D#?KQ[?'$/MY[T&\(6&7++O+C"X?O2G_T;GR8H)2:>8AH'
M"5X<:QK^!S6#TMG'>?B,U0\9^)#5V"?XBLO3#1Q+$)Z-"_,]T14N#7TS@^F,
M^9Z9+5$B<5\?>;P!75!\__[)'7(R!!^([H4#D5"R4N(7/))\/@BX20,UPNL,
MO\LM0>J.*,7;AB8Y3?22_1NV1P/9'X1A4;<[+I*E\/8#J(25<X J0=C2OY"G
M]_C:<7BI0$!#[\.S+H/S^BYFG%4++R5GIJPN[XX/[B4A\!900-F>S(^V(@CW
MH.:=<<F)AQDL_G/IP1PK0_<S!!*O*O<XKUP;828)&HGDS\15AS1<I?P%!AET
M&WC [E!2QI]V*%(GT*+K!.WT]MMIV;Z-8J6]B[%%63=D<X;R? K6S!ASL^\N
MQ0E\]I+;*9#G0!32VV,DF6^=F MPT15Z%T@A^0)84@\/A@82V)*4:9TZ5S/C
MD?5;AK)1Q$5XE7-[&Z(E@OD]ZD#?<9E>8RZ@?,& O$EJK*0_A '9?I'34'CJ
M4"3L+'(SRSEKZDN;;&>FX>K3U[K].LAOJ?3]Y.EK;.&8P@(ZH. AWIXR%(JT
MZ9W5,WEFH/;1J-Q'V"F)!JH=/=>-'PI2/%=W3J_#*/&>F 9.%)EMR ?OTH9C
MZE<@ #NJ9F  M6ABA&_J3M>^X2\X]9OT++K0Z%9#NEE2GUSJZ:U T]NR9H8.
M@RY9\OM;ATFIC.O=:+QQ!B [T&\Y'[\JW M/@M>WNXI/NQ%*R2S*H?Y'+:G.
M;D'2UB5MN'\">=)"7EA$<M.UREST]V26#HZH%R.S>_\>,J'2"H3>K8+Y&F<G
M&Y:>VH6E.!9(-Z>N7>3,$"+:%FEQ=C;:&@E"*G_?$C:D)Y$X-WB7*LI/-0X*
M#D,OR1$7@5_'<^F:_<VYJCP^BY5(G[IEKMKEY9W;*<MGY3//B>!8S_R0MT1]
M?/\$_ K1U$3FBR9.)A-)&51V81(H<N0Z]7MK2]+^^C\SNY-L]ZMGYYT&;49M
M!+Z9G]+/R7<0E0!=88ZB@79BZ(R'TS>OIBZWVF40(H@)P"$FQJ8_O/:UN27;
M%:G%C47#HMMUZN82T@;C9UQZ?#$\*Q<8[ ]W4UE#,"A 89S,/T!\2VE#>5HF
M@KE@)U9$Z@DFB3^3UGL)FT[MF4M**#=>T\^#GVM>L(7$V3YLUCFM^ O- 6,F
MC*73=]Z?0GENM=SG20F(Y31:]?4P3])"!;I(._&! V&H"S$[+4MC^O9U$Y<S
M$E&85 3^)O@Y_+/)X]AS@ GQ*9QK!=[M#/>4*7%2)GTW)I@(#)T;E$Y10US@
MO!MW$6K@!\>;! 'G>;8U23?\(?PH3!Y4)/25@2XR+UU9TWG>SM_<*P:[LB;^
ML21IU5V.3?[K*^8=ZYOP._)O(R!GVMWIW%V@H,ANI'\ 86(AD$- ]\1J$2YN
M-8H-]"K?H(%N9;$D.:A,)'YYK]S,(W9%C 4K,S[\\=-;Q-RB_%M[ QJ(KI5\
MJF#L'(*Y ?D8(:J1W#H1]O&R^N55N?K\F[^JSS[D'N)]? 83/_Q9P1226Q!$
MYD53V8](/,!KFSI*',I/WWR<R\]>UE(6[41B&IJ_U%<X_ 7U2H!EY7GOD_E@
M:$WH+7U$^K$P^50(E5V&!(49-Q)H(+* (O%#DJ+/\UGPXOZ66-SU-_6WSG($
MW"^;<7@<M3]N1&0E"\13V9IPJL^A>$LP&[4/7CO:EP#!/]TLN#6%Z!-[?4;+
M+G?**"]'*F#R]&;D+9Y+.H+$1 &6<5&ZDSRBVVU@&T42H1<'N=[\^^ [^-EL
MF<;WQYX]Y@PAP4KQ[K7E;@T#MW1'89GT#$%OXN,NT+OI=R2S 5(PM0LA6 63
M(C OFT25^\[EJ3N5S&6^M6QP'A=KRI-ZRTYHW<Y6,N?ZRO-K1^ D^1F]3<9D
M_3TW0"R1L"<>PS&EX/K U_ZKRHP!:*^I0&77U9<X>&:0-W,XULZJ:>QE[JU'
M.N+^6QF ? 29#]&-:D!N(U81"R0,*I4&6CW9!L#]&JE<-DH?^G9ZS?B=7!3X
MQM*DTOXT>]NYS =\%=\:EC\]/C1J3[2DXYMDF"U>!3J_W@OAA;&JQE>'PK?U
MJQZMWVKP_3#U3ZQ5XMHIT85_X&>#5$>E=*7?S$VBZJ!DWJU.] D(IDA2FI)"
M-B+('KLX]T\VOL.J"ONTO?6/,>&-4@YLX?IY_4>_5HVDSX%V )\@M.[C6Y78
MFS A2@H<\P7Q.2]IKX.%^A4J8,"&! R=_U1KC+0-[:"W,Q0]2Z^UIQG\,[#F
M<R#MUL2;U=O4!N^2IB.6HDN45'(P%KD();X XMVP/"F&:HVYBZL:X=Z-M4F^
ML]APW].G1C2R2CQ>I)9_3E02R3P*$&#I1EWBI[+!269(LA":*LD=U'Z1#N7
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M 2\RX0JI;\_BO\=;AH5]9/:^EKB[&ZB=_C:742>_F1FWY;I N@;O4HH5(_L
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MDZ"*.]K)7OUBU+=_9Y.+)Y&L&7 W<*'85T8\[N+[@+B3Q5>^)!E\?6PZ2%'
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M#+8C+F- @LD,2-\'!F1J@P$940;^O4*-NI2^(S!S_5U@!OM-8";[N\ ,_9O
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M/?H=QSI%G5[C$SHYIRH&NXR$Q;:KGLM=[V"8<XLR)BZUSK=<>D.*%]0O;$"
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MS'1DKW0C&Z!X7 1,O?<INL:K@',='<U4.QALZ4T[TN?6-WLZ]W),HQ@*"^H
MUA$DF*<O59@JY=CA&6E@G/$FS'TX>IF1COBXAUFD*LI9M>W."5=/U-81KU;<
M5'20D*DCD.2#,/V Y5;//>C-\__0N(@21B>!N'"F8<AFN H1%7?N=7-VS)GI
M1/W<T8N)MZSV+G?PIL&D4@'&9S<@$M@A&,AO:*4D5F$7 RG$,_]@1.U4FXO+
MU[9//QGEV=\#N>FV]9BQGYAZ!)EXDE])HB43-F&-,1?&;&PP"L *8R75:CPS
M^#;/!44O4YMB?XD>-:Y&SYCHA#R(KU,^('%@\+4 ]#[+;3 !SD(8I1>WRP '
MQ)C+Y<_ZM\UHLW>^^+9>DOQ06W')XW2FA4W?A\ +YUSV&]J.]+[Y9PF:!>$U
M@C'YR$8&+3Q/4TG A0>5I[!=BW,4NLH$UB)F*9SF^)V[+?O/%WU2G/_R(UC
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M6[WSM>$6?OH94AKG[?Z]/\..2K'?*VT].Q?2OTMIDG<1'*,V5T70@1/Y29+
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MNIO8Z=W.IE$:D8NGFIWW-$K7#)B/KS?KJ]SRJ31^X=]"UK!\2FA\7LC]LTV
M*3X1%ZG(;^-YL4V.?\!<KPIO/\@JSC9M#:YO3?K6]&O/R?W99\YK>UP]N1"_
MI<)G [+-1A/XO=Y!8"$L#7G09\<%,+9X&BS J>&M]_>G)3<*6EX)X2XK/A%M
MWW=X\-C:"K 7E<SSFT5-2G=-(9*M]U0OK%_BG1ZJ*AAW>5G L,\,\/_+<Y^3
M>W[A4&B"S7MB@8T91I]?+1#!?BXA, NY5CSQ=$9:\2PB?4R@.<ZS@&9%F]X;
ML.*,Q>BJN.R8E&O;G**C7[!P>4(+@FU^1M!$SW929=KD:G@.[)Z7RH3R<*O@
MWVDU-_;_"FQ.E2DX\%N_T!;_UP"<!J6@I$#.;\23;Z;,Z#0B%7D>[$T5LR!I
M]KJVY^V6<*RZ1>F-@3IG,K+!2;O>Y\!)3Q1=:WP<+D1"42=0LWJYM0(1C#CP
MN0P96=0T8O?XNWE1S#0Y1O;%U&*(;KZNA8O:HPW(B;^$GQP2,J.1)&PD>4B0
M^'&W8M#\9XU[-!G3C#"F+(WIVK:CTFDZ=*1A?XBIE?G]JC*3GDZOD)[Y5S(.
MGFTX,ES)1E4P4JK"S_YS],!DKVL;*@,FU>;WB,H[,JIRM'0&)37Q?<Q!P].@
M!_W!;OZ8>8);2*!5@;$,_UA9UJY_7DOTGVR>\3G6>O0-B";@<IIED6UH,UX1
MY7N%H_: 6,+^-?;#8;COWLVT,S5RM[5RYK9$.63=[33;/KOCREK$SYWN.0SP
MW>!_:M4[^]\L>\^<^Z=U[^MX<0#1)1!F%1734)(3-PJ/#5_Y9FC:CS2;6XVF
MYP;E6APPG/ 0,72V?*L[EJLTG?3.^%F3F_=QZ]W-Y1=3@G!^.V*(DD4AKR0/
MG*T^<N_Z:L]^4FV!U*ZR-R+_>-S.WYN&]('Z>() :V9^9OFNT.9[#NEQ1\.O
M?:DSFEJ[_N:5#SWHES'L]GCR!!Y9EF"=S-G%SQ1(8SOA8K4VFS';1G"MYBW/
MSY3QB=ZMTVFEH;""A[_<T1IO?_[^IW6;_YM6C:[I&L/N9?54T \Y,+ZJWSC9
M&>7\M?Y^M[%NAOO=;9=S1.2W7MXL"X[#1H?EM30/%J-20)V6S%*GAS$/L9(I
M M7&B+/#O*MLX2Z/8LI8T?+[_A:%&VVKCJU2P:%;(=L2(.O$"2^.+6MER8Y[
M:(*G,,P[%4NDFOWLJ6(8;9EQK',]Y?XJ<-3ME%X@W<-+-]7^;5#!C:Q_^6EW
MO9TLQ56&;5 N8VPU)[<L:Y4%L?>PE\B"B$"$.A2S%<.9VQT>W><MB>^9)OC&
M_M\)V?_'FM#&Y'\#4$L#!!0    ( (Z.3EJS[\2@"?4  -%O 0 4    9'AC
M;2TR,#(T,3(S,5]G-2YJ<&?LO =44V^T+WCH7:2KE(B H(@H74%BHXD2BH+4
MB(B "(B*@(1$D%X%!!24B(BHE$B7(J&C]"(@04@""E(""6HXDC:'^V9>F7?O
M6_?->C-WS<S_L'9(UCG[.WM_N_WV*1_G*X<$[#QG;F4.<'%S 5>@/X"S!NPX
M=2WHJC?@#4 ;%V<:. -P<VUOVY_<VQLOS_8G'R\O#R\_'S__OY" D"!$ OS\
M@B*"0L+;&_1-5$18=/O']B#_B96;CX>'3UB 7T#X?WKCM (2@CR2?%=XN/8!
MW!)</!)<G$X !LG(]R_B<0'_^\;%S</+QR\ B2$"'5"[$Q*?AP<2F@^2&-H;
M">T'>"7X))6/GN*7LO,4V!<LK1.542BH<KJR3<9^A*JJ>_5VM)"PK-RNW7O4
M]JMK'#BHIV]@:'3L^)FS9N86EE;G'"Y><G2Z[.SB=<W[NH^OWXT[=T/NA8:%
MWW\8$QL7GY"8E)GU.#LG]\G3O)=%KXI?E[QY^ZZJNJ:VKOY#0V-[1V=7=\^G
MS[VC8U_&)R:_3A'(<_/??RPL_EQ:IFW\^OV'O@G^W=K6BPO@X?H_MG]5+PE(
M+^YM&PALZ\7%';I]@ 0OG_)1?LE3=@*>P5+[=*($I4]G%%:V":GHVE-EKMX>
M$995U2.KT;95^Q?-_GV*1?]?TNP_*_9?]"( HCQ<D/%X)  XP&*^3-( _J'_
M+Q*N] ;!,:KXFW_>6DF0M[</SX70\%"='FF)-WW&33ME3O)FV@#27%>3_OIT
M<@"J"Q%4(\8T6[)EQC'^D?M<WWS7&%W*,RB*"'@VGYP<X1.3?@O<Q&% "UH1
M6;MGB*^-)D>J[W17Z=Q2ZY-)MQ_!989UI'C+^_4:?>HUV.7S2(.GY#^+TH!(
MA2N82J,'\>*!;$V4/ZT<%]]L[*EJ-[.<F[1@E.<LJ\>[K_+'E(7-;SP?VX!Y
MD%7(5G)&70:UYJV1.\-"[<+M^RY5.TGTCEB.6 (A#AU%VC9?N,;MS*0!.P\5
M&HXM#&?L9 ]B=@:VR*!NLE[J!8F'Q?5J%#>.KBL_^[S',FHX,^/]#\L3$9,'
M.(!X!@>(OH89(88%<0"N-3PX $3JFH6']%!*&%H$]N P>R(4MENO"PP)5L\5
M3TJYS7H^3='R?V  '>Y1#IM9/G&LHHC4TST4BZF!=S1I)\/XF#[^<^([EK4/
M.M^HNS%WS.7 G@/ CG=A=[V_ATAS?1G9%O._I@MYON5S?HO9=A+6QDU7-!0R
MK7YJ+F@GP*C.1'"_=@=<<H"L+<6>R-/+?63I]?AGHSN[1/B]D<I@=7V.RE"1
MK<#8;R<N!IS]A5B-ISB0WZ)<&2=0'B,H)^^;O?7QYQOZZ\I:LZ5.MUH)[540
MN#2X0Q/_@CM)XQ_Z'Q%>&4Z:&R+$SZ6GM>B#ZFRA*2KV4I[\!1=YXQGTQ.Q5
M+"&TWHE?WMC9\GMW/F\^>LGOT:/S_NF3C4QCR)O&=IOR8]K\FOEH'=UVQWU3
MV'*3CJ1"C8#5M?;S)SX9K%JNQ"F]C"H?JD'OPK0UP:@(;5'FOCJJ3V>ZX(JI
M&LWX<NP7$T\.(*0X4]9.PO533TE'\YZ<^HI3B!$-/'P;(<(!>&NATSBRI^%4
M!'%:L[-%N19\^&*(&LU:6PV\N5;K++:&N]F4U[OJVB-OH?!S^HQLB+*'K<XN
MIR6SU#\Y)=X[BE_/= 4'!4OV!07S1HU>],SV]FSCW7E*8:?_(B(62;V$F1*8
M%Z!XEJ&[E:1I!N60+'79I>Y+PQ;[TS9<;NBZ=*\'?T<(A0A''^/2^1M^])%N
MQJ/#@X9T%B35,'J  [P/ZA1$BRPK[9I@^LS[U"?Y/Q<YN3%^R-%6U-JD NVL
M:.F=>FG:CS=6M*EYD^[+ 1[&X:]S@%3L'CU\%%&J13RLA+Q64KXL<7FI/J\F
MXYNK5G^9K-'B7I6.AB<: ;&G]E;:91H%$>KI1%:!B0H'X-N=VXJLS&5*X6W
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MDPIF^4$CM%)8>C?[4&6DRR_7L1JC"<W(@T+ZFKEG3-9V[,[(?G#),]I0YI/
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MNSOZ06$R5).=^OT@9_8")[ * NW%K!KT?@[0_@(FBJ_<4;@PA?&5A]4''A?
M;C*QVHO$'S>G&<T!?_W7AQX2!=DP)A_H6<A4 )W(X&^\>%@HPOK$X6X#K1_=
M'Z?2#Z]:7??*[._,M-(3_2L_I\TL$Z)"=6%@<)T#V#AETRGALDV,O6'6'JRZ
M&L0T&B.S?*#<MX WJYWJ^RF#E6.I%'Y=I[*;]?=Q"D\*EYL34_HA.1VJ)%NP
M#D5#TGI"LY]7A2O*<73_--EY?]+X:F<;3MX^QX2WUOK2TP=>O_I^[!5UY95
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MG.;DF8((>3-2*49@VB C1**EAZX0G+:[]YG6X(B*J=0M@7[8BQ8NUHMK8QS
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MG72'@>?%H?$9!6)/5.HL91TFK;FW_Q=L7.B'4(!Z._KX=YS!GS.$L;$"8)P
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M^J;.X<YZ?WG8#W\!T8[>?%3Z%2.G[[9*%G/<F<PY@^;6YFBPHM\YW%(?([X
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M\C_,@C_0,SIQ)MK\:33B7P5=AG+?6P@ D#9Q$)K0'%7XI_J._7O7P8XO*P0
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MZKB[[VK>^(OYE! 7AYV<S[.4.]TN%)4K]YR\ FQ7QOC.VU:PJ^N,V&TW\LF
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M' 2 7NK<H'[.K''ZN4\>_XVFA5ZV#*DCRXS1N.@L #+0O.K%T"]H[O@99-1
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M7&<B%\-R[?.H!KOH5:(L>E_RN8=FQG<L U?5!KO?BC@JW7AR/,RZ2=7!T?+
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MD*(^WTR-C[EW>-0T\]G%[C<B-_OWBHHJ9;O[;>R;Y]T >4"P5B3S"/<@H7N
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MMV+*DW=P0WB&&U3M"A)"#"+?(3.<IL!GL@S@U*T?=WQD2AS0WC_XG35@E7R
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MD$(/_I;?E&+>Y#DB[O%!*[X?!1P<;&/*B.=M"V.F=O%!8MC0L"2,#C,J!5K
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M?NRFW;JM]&";E>GT9<(=/BB0"$"36A'WX*IFB#M$"#PP3!F]=\C:6=\9%2F
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M.7Y4NN?PCR55KF2K[\ZZIL9*IVCK.MT<.2$UKPIA8]4R!Y&;OA_9,,P ?*M
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MV?VD8H$#*4U5P1 EK/_*X:<^JY-&W",_PKQUVKHUBDS#D ]NO;QY\7[G4OL
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M%2?8+G1LKZSC'7U"W<]_ :_]F(71?N^N*Z!>@JJ/-^Z1*?<5_^8.+K(19D<
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MGMN@]'\^Q5SY+'DWES"=^?"N4I!X:<;!JX)D<L[+')!-+HXKRF(I8;O<?%_
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MT^(BAV@_,%'_<N)^EX\,?6(VY04R9$&GZ/">I+O=!Y$WPN%2:#4&IH;E@#[
M>4(D%ZMK8:TOTHD]M+.0>\R2KPZ^E.5 IRB^E3SM47M3]GG))VXC<!6;W9A1
M91CM\1+/\MR8((!*W[K B%A/*Y]!GP3"EC[T5"GW[_$,^*S] =FV=X^;R:[+
M<S'\R: M'OTK9Q(!%9;[C^:J_BYOS!HI2%$?N20AYC9>6D<<UPF=<PWR!V72
M;AS\F%=IFJ\1'8O.8LEC1A5]#G(JH8'T0F8R)^\W*64;I(SO=OU75E?QP^+\
MP@G"C]'Z6]H)_A_XG.SE(XE\M<<N-/P9_'\;'.7$'>51J3/#<S']Q'H+'#2<
M DO (L8:"$JKA?_\I]G:13<P$:W3MS^HT&)R/N5?O=4A_41*(@Q/7P7/;7'O
MZ7&]C[AM@W3<UA;D_][4ZCJKTN/V],KEBBCSA5+)ZFW0KS7V:E/*%8GHL=<'
M\I&ZI%[UYFV0)O!A&R19PB%B5Q*PW\9+L9N7,3M9+_MWDJ<S>"PT<.U7):!"
M=4O"UD1X$I7FX7.SG/;%Y=@6#P][0K.(FKW'?D&1X4]/KF9RS.RBYV&4[T[=
M4>E]E#>7PD]5G.JMBM7 +T5'Z?%_LY*TND[_]3C/.6;($/%#;ALD57V"2NC
M)6/K"[N=3U @?2ZB)RJ#BM)QYB(B;NEVWW2RIB54TZ/$7ZJ_R'$\&BN_E3H#
M@7CPUF:$,0KR.,?#D0U@OT4OS:(SJ/C,$<CL];Q5,4S"GHU#E>F*<;NN2IKX
M_&$=Q'R$[2;Z&:=BZ55<,50$+;3TR7R(1_+7Q8CO+V[9BX]_M#7ZL@(2;9.W
M)3@\CX.9\N@6OM8BJWT_(+2DV M/)#7H97"5?[K!Y/]4F5Y1-CBWX!&B,'K8
M12E(=\^I!X,:5RXE\/O*,X?7AEFJ:"W.PW;E$*(D&UK8_+M=IZ5HHT]Y.:U,
MT:WHS^>/KE>,W#,/:N36[>DVO_WY\V(6!2<(G.A4" ]>%*>7/7[I.;]P=+!'
MV3OS[@^#C:S-VCY0X WQFJ]DOZE\$#IW)Y_H'<.A^[':B0YL72&-R%#I\!&8
MJ-;)9T,"-)H]-??K.M*,=-1#:_-.[?GDE^<DXQRIW,26?4R^RDEK@'SQ[73S
M*$BEM#E?1PRZ*IXBE#^]>?U=3)K:-&* )IIP"^1U(%FT)(8CQ]?#$^&*<1A=
M-G\SYTEK%-)L*W6CU:;(>5%[1M_^WIM:?;[DW-,5B9F"YSM_^$A37 #=R$P:
M5 U!=UO2H_4R%'O@$@95!6.0W09W&YV/YL55!(;%B/[=['Q[8U]E'.&C>;;^
MZNP^_N6-5#S]+"FY6)"3^6?X"V:CMWFHE.+LOP%M>7WF_,+,R\VT./O+LZ=/
M6[SVMUHY)C]$8,L>-2/.])_B/,'H<,?5C1EF!8E4)[48NTFS?<\L%'(]CN]-
MZ0U_%Z4A_N_K$U^S/VH[58JWU@B4V!AFZ\@VZ(8(VQE3U)Y,_HL^*IAW#Q^0
MIZ23=T)+Q@(I>-S2DGR>4<YTIQ/[B%G;('$;*X2/+K&N#8!CL1%E5SR>[R$H
MKUJ^N+;_JJ/H7H'0_HM%?P[LXR>3<%N06N/L;5#H-DC>$Y5*W4@G!B+3,6KC
MH1KXWAH@8?I,+0/S5/M:;OR3A^O0MV^(YE-_;;O_8O6L6""T*>!?@>UT:?5F
MF#)C&>OOJ00Q5#BEGXE,PV@A/![#S=\3YKT=M*3#XO*N[Q:&OI4RX%<:"&"U
M+%ETPA+A>YXGD):6NUS$4676%YQK43C;IG:IY>K10^:DK@:H%IDHA(:-/*,W
MQ;'URH**_-LQP^7!"M)SQQ2B:=D'Y;%\MLH1OU)I.]E^"W2+7GP&@66'U@(:
MEHC)>"DC#:D0'TUZZ)>3$R,@4',<^?2M-X=$EX/F5?@A#J.V$ .V*0^ X2NN
M)(4[.-Y^-0C1)*C@3.5M4*J.#' 3(N=8$SQ[IR1!Q^F2@47*98WUN1R1"\=S
M)S!C^+?Y37WXS%D+VGX>^0N\9Z/"/CY:7S8VW:.LUFIAXG-%(4!J&'EP9I_X
M9WN7L)RYBTCB>5N(/L]%";P?@1YCF'9N@]0QNMQ1KB4#CF/K+%E[GX5(KVYV
M?CLE+NZY9C)KGR'?*DXRO:'R07M].8N8":&[O(8Z,[HO<5Y@ XFS^KTP4?:5
M)17'*K:+43)R]V1!Y5[OF@^&]=W((CF^%AM W+UIM/Z<4#)Z%R<)K4EW1XWW
M^F@"^4L0911I:3=N!NI,14I_4O%JW6NJ?$(\Z)EFVC$!C>&%<V?ECS-AM:EK
M/R@;,Z9D(9Y\#R2) @E;E][2-^<S8CC'S@<4#C47D->%=]''I0X>X?-)LP-%
M(=>>LO0!./,T/?(>5(GB(@M?S0$2^Q07-=\]/G?2-1V1NR=H^BK_U<T^TV'=
M!E@(..X(F.9 A_3 ^: NU0L_&M6UFM)5,G[NOGCXF&[VN4N6^E,'K=1$JO^E
M@WH !#G#. 4KB8;12<YM!=])W?]TRAXCPRSYOCEJNN?/J?HE"5 SB[YA$9"9
M3]W$!L+:-F@)//.K%Z/1-O:;YYTSSH=AR]\<'HU2/#=?/4(F& H+:3TS6^'M
M3B;F/[M5=X-G'3IL%.E#1 +"PZB%?#<=+@0,=V\=)UT8*S]IMXA+$&TJ2'Z0
MJ?:&Q\$L\;R[UFE1/MF^#X5=:J)=9)U%-2U-3B<9)4\GWWEZ<U;LZ)&/9"E7
M"CGN>O"E9,TTU?B<>;[?-#F^)7B3PYHIG<ID ,A2-A2(7U)S<N .3-D_\W_]
M0U_IJ4N^MHOB!I^*JJ5>]JOV?$_F)TY<NRQWAKC[-S@!HS>Y\5L,+!%RT.N'
M1?01>_]DK7CRIL-#X2_G^U"K&3]\:+QCZ._CL0@W\D8_[X>+G*GH/Z*:1BFK
M:6JL]10Y&>X>Q8=.T[PM.>U<D9D@/*#Q6@/(VJF$R=^'E3[\V"455@^C#3,4
M^WUVU14KJ70IAGG.<MY?NSK:'QF^Y]"\[B79)S*V&A4@AZGZ<P*NKJ[1H4^.
MW,4C5!68#(-;)V1VNX_:RU^2!(% NYW^E[1]P)AU#=NI2"27$GE(B4"FPV5;
MA5CFL<03#$A/*/+2*(%(,1E]SK(K[66/=>M^,)8?OWWD:>6SE%NV4+<GO+.Y
M1R170'XC('_105CV4_AHA/QR:W-B9 L;-@!\;)5X,/EZ__LA6E-K]#9HKOS7
M"QX'V,NSZ4KL:"7V&^/9-F@S L.C#)UB,+_A62&F!2</;4?O9^;0A=A:1=^V
M03V(M@M3_2S7L5^Q+[X$,PP>T_QS!7U$[,<ZV[VH K+,+/DJ5?D#LM\SL-,#
MZQ\!3^./80AI^PNWZSP:0F/W)K3BF?F<O-;]K#.H)DI_QDZ$R(FSA92F+,-6
MAW*[Z[GY+45*6F%RCSLU13+YFX3N^]381>!/1]ULVS$7'P[A,&QN%U867D9X
MAK*!@X^]?*XW\S+EE%_.0$_67&=.MJ2E'#J84P#E:7$J3VQE>TRG$=8V,(HD
MTD)P@>NK%/V^YNQ]7TZ[R^RZ%Z\2-O&][70ZB$&:0S*-@2C6;;9V(L6E1R)D
M&W3:T]#CZ/'NRV.34%:4O+KY^5:IRV,.%ZR_JG>UR7;A):!*/*&8XA'9):%_
M,KD55K82%BP5/-ZG;E[O>'*OA<"U^&,)PLNZ3:]*P'D&,'*A^CX@W/<5"LR\
MS6GB:J'$.HKR>VJ)B6L]BDY^.MH?U$I[7@PV7CBEI70C[]3U4X3CJ5R189:)
M)W?@/J8W!PA80YT-^SX8R7S&W&I;A-#Z0M_]VGIE-=<$TEW Z\14R?%M.O/N
MI<PVJ \O=0?ADD*L5Z2-,Q3[N'SU18I886\[9 @R3T%"U<WM?*+!C_P+X0F.
M O(:TBN0!N+:?@IN-JI5NAK +@6TD<%2;.OB2'I9"^5Z^E3NH&JPMJ<P?[#[
M"WZ!J[NLQ.UB&N3XJ,4*'%Q]J!#ST1@LY*GGDA'A#9#A#"# B>L*ZY8]D:_R
MTCP8= L1[TU'(>11?0>F#R>?;<PR] #&IKO5=8D3_5FM$;%+&>.8>S;#1P=L
M1W4[#B5>[83^\BFU Z&F$XD!! GN,$G:YA!W3%EVM5U[ J-U#!'["KC1*RT^
M93[^QK/CH(72R=);7S.IC8BEC11E)%OVOA?@_ J8Z\33S[FHH@_0U5^;]0ZG
M840^4!_'G*K2GN]".-+>3HOFA6J\]/ST6L/"GV->K>+#>4@,(,H!;P%6#X_O
M3L<WJ$64_E+Q(-+SGTS[;X/:EJ'^OS:>C @-8^DGB:D>N'B8KW56"%;<:^4?
M-@.-?(THAKQM<;VB-?Y2JI=/,\U27_"8]OJ%2A$!V3^-%:7!1>N%X<\1'FC%
MNY$%&[L72C\?HQ;I7:C,+D^Y("*@+FQVZ,WS)#L^VP[0K=V&('2\(EL&=PGP
M?0VW8VEC9F'2.R_ YYL1::UZ_H=([G,MD,=K/_7W9]B\K+MUJ!\$/L?)@UTE
M)4-J?9Y5 B3GZ3_#"L!<S[MM4!*NW\:@C77V&>J]T"<)7-[1#E7QO,N1IJ%>
M,;&\JU+]B(>IHPR+;N,]0/86,Y!3PPZE_^Q6-YC\-O$')Q)<%/MTXOS\)YQ)
ME?]3D<8!T"Z^J_+VCN>$G%@[Z8J6-I*80;PTVY^*%44]]IFD0:-*^LN!QZ<9
M9E_:6.A$7<_7 6%M7Q^TEG;^/97_5NXJ^%E0"3BW'@GHD+)MU(/<8&(8$<PB
M3 :M1V=^/]6(LE_41Z36IKL::IM/WS9^M.O;XST""3UY/7DQ<.4=W. * XE,
M?WKDVFN*L]/%$:@5>5AZ%F%NZE'K%!8>)G9Z+2#0RR3WV]WKH*\46Q#?;QTY
MOF52@\/:'PI/3Q+(D'L8$*K<IW7< &HG)Q(66_Y&Z;FTEYWEK*K\UYX=6/N"
M.M%=P 73"PHI*M:I!8;Z9Q.&]OOQAU>>?R-H2=4V0MBG@S:Q69!:MV0;,S06
M"&0=0]CLGS#8X.Z97QPL<_=X&:#2?3NW0L1I5[>Z>]_8D:(_.V]%AD#:CL=:
M,J:=H/]BEDY G;'(-VCKNHFJWYQ#<B=VC[0UH50''.=%4[6O9CN8=:/]=]Z)
M/  "E6?*-"66#3N& >O"*_UT?8U<LAX&VTGT%E>_.H@+0QS\,@8"B0O_Z5MR
MYRCR+ :_5L<" UI,!.,LD0&_Q!AJH^+NJ1^PP_6H6S#.K&Y=Z'JGCY1Y)2:@
M%8).A(79W[JG4$;@78%M$.!<P9V?Q=)(1H17>O=NW.F\<2??G?OA<->LD__[
MFQ9(J0&Y\/@:YY@V.3[RORVV[!9%[Q[VIK,ID]8ZB>R_=WC0P-,H1\8TV*!+
MQ'#J6ZV%HOM+4:N.?>6O*B ->FO'*#S6U:^N#@Q2<&F+&G1P#UCLF$XCC@H6
M'R@.;KSMY#FL&E<YZO\DV?+;W*OKX'<\OG<4+<U)@%&$@/% E@,[DE,"=6$X
M]<W:/S7$I?Z1B-X3&GKG8>F%VGJ%$8D*K8I#!=I?3:C0Z9'Z_UG70#V,=1T0
MZ\7+P_R0Z5AQZ.[26*(W0Z\[*]QI] 8:6&+9+?0F,4ZH_U4Z;V']:OZS7*!V
M_'UX/$]]4XC @0V.,H$+/Z*X#=)S^XVTXS_;_RN7!Y JO+/A8>+HFVW0MU_/
ML)L1D/_MO[\'/L'PR  CL(LXHT()[ :K_X!?G49;T*DGQOY40&RL,,.1R&L"
M%QW:S?UBJS,M].4M![2O3K\8M1,H=B&39O2[BL4XU6PXZ^H5H/S<8S=&=CRB
MU"?XT$ML0(*E@KS;<<&E_@&OK]0=4.1IG&)^3C[4D&P\&[.D2+.[MA1[/-9E
M21U?[A&B?&,@0>QR?;RF?6;\NP)AD0_08IZJKUE>:Z+@OI#(9Y_25;K4=8B3
M:W?F*AY1VR=R%0)-3X_E' <=%+L:-M9V/!WTET<DL/2SA,1H9)=Q.DF [5*Y
MVCR4QD#V3K=K3!7<S=YOL&ZD;@6*S[\%?;_7X7AGN[^20)A7>2J67.1CTDS/
M(G1N9&(;EWM@BN@CM4U.0:U*W^;<Q2HN\;G.KJ[+LTXR0D'R\^]!DJ#>6#<[
M$+H[C'<CB4!4!$O" ]-E 9%K8-+_I+Q%5OX)%X @,F.KUEMKS=>T/N?^[;N%
MF,4&$1.BC6EJ]!,]>/Y6NTKO8*:/SGC1T'?FATN?1 N$;J<(!&;_F1VU5=_/
M\&7* J<8A<P[=/P::VGAHEM\*SCP:K$<PR?_MN&?H^:K0_+I^J]>@I)O2RGL
MF8V.$WWM ^LDT<^&7CP/%%*&TW8J[M%<J.#T[L["BAB*LZQG8U-]37T+_'VX
MP2W<[[2+H(H:U3\#EH2RE1+P7CID+9%B#&(' #6,LN[>Z,PMHD));<;END=:
MFY5V#:TY^^_%W\_5U+L;M:N!Z$>8:>G&UUKP^'<)=[A8EB&Q7E&^(KC2B7WU
MQF#L[]9%KT9RG+&$"3]_B?S*[W-"GZ=)==N@+N07!!,*U @V44(CEV I$0N(
M"PQ(6CT?4OI=D4JG>*1)']^Q6LN1#WDG0"\3A 7;SS V4HE7U?B9IR;,CLIR
M1:VI+E+ /B#Z"MN0[D'MOW5*LR6HR=/=&2&3<5\U7(XS'GI)0^$ZG]Z?@W'V
MPM4JISD/80%/Q7J[EP336%"4\K#/E=9O4S2T3J#:E_M6I&6#8UN![>&VJL9L
M62<*/ATCA>G"2J#YJ=Y&"+4+<[:_-@RJI2H+:&&'"W=97/Q8FV9[($I *DI^
M=1LDPU4&%*F*<0WP%(@,VP)9L>(Q^<(SQ"-BQ%HG\]>$U.5XOOP'*:[G.A+X
MJC[NXZ=6F7)%W!AZ%.Y#M C=FBNJPX!WM4OL+ICK3D"M>PQI;8,,JI8_[KGD
M1PUA3-_/BRUDWN2DVO!A/L-$(K!)&)&1Z@@5K*P!D5ZPVOQM&!]3??C> "U,
M0RSG\OSN<V\L3/@->EB[>0@)C\.2'Q:; YZ49<".Y[TW@/P7:#/3CR,H^RY]
ML_>-Z0Z!J.L3X@'N.07(=XH;LA/WO=TZB8 NDG>0]!B*8@]RACGX1\*E8QLD
M':'7\G[$^-LP\^Y7404EXI1:R]X#ZT[Z)\NUIT<OG1,:X'E[@0;&]W+R2T!M
MB3#W:RF@E#ZHX721HI RJI<W:$.K6$PR&@WENTOC#^H#=:C74(E?'E,*,UH#
MZ3$]_\PXBZG!=(\K+BEW0H]*=1HXBQ^LO*"XN_%-USN-KU^_%C$]]O%_PH:0
M9N!=/+&.2T$;4W#RJ*)MD%-&UZ)%#<.PLBA:,[B\X<KEZZ%D=NJ@53]4],\!
M'GSIW>=)TY?X1@_,K%#OD53F1Y0Q5[KSY0W<6A_$\M/W996MK]1JD__AAYJ-
MUVHHL8I,XA3LAB7:&?.OO88\P+8RSQO !V3+%5LEE5#OLGN$]/;HMA)[('3G
MF UQ]C&&4#;1WWCV11]$I(01^LL'P'7/&C:T?7]J]BGV+R7E&A>G%5YP(:S#
M^\TNW"L>C3[ N;\-\@.G0&HA20V&LAW3S655%:C$<T=2T]$7E\2(]2'*O3-#
M_D5GQ./?ORVY>M/WDZG),D9DI^0)5X8MQJF$1K \49YN$SI3T'#53^%E0S6<
MX@_E!5;5R@82,WF.^=DNM_47>"8L!)CQCH0#.-!=F$V,?EH\9="5&QO>QSA]
M_\>6"&1F[<R8@\&&@N+=']J9)MJ,]ZG1+QAS3/Z,)7#?#V(P/)X$@3K36_HM
M_H6X(XK*XL4M%&;K]X%P-(5QB=HCR782N5W&2J#ID8ES0O>XG_$U1O%T_O[9
MK3Z2(OL\ XSC:@ %0]9'+_8NZJ FQT:%_1L3]CW0-O$_GY[YM>0K7SIS]?^V
M].I_C_\>_SW^?QW@[9G_ %!+ P04    " ".CDY:,GB<<%Y^ 0"EH0X %0
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MXYR]7W<Q4H.3Y)*0(*8(A9!Z?@I1EGB0A"&"-,2$>!D2*##*"KE,<O)5UC,
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MV=MVVN13?<]+Y18O^;TJLO/$VP@0]45\Y/4G<8N_M2U%#U.)MZZ6,*5I1IB
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M":59-(R%Z+T*L7G5SJR2PZIHV=^QBJ>NGYNVCZIL;A-E72T]$E%I&'DPSL(
M(LQBB#D/534Z+^))Y'E!9'$X&Z<ZSZ&LZ3ROS"'5SE*S[;HF:GJ&C0,0[!2
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M1RF'0>!C:9Q3=36%!$0^0RD1(4G,LI_T24]L&_2,-,MBQTIWU='\='<-HE?
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MLZ0F-A>VA)M3@>A(&Z[N\SAIKFPGTANNZCW!>ZH3E"J]+)RKU7R>T+PK^:+
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MPQ[(VW_5BD'C_IV3S9:>]?J=S(&9UNK@_U&Q_1-0JQ#L. <[UOL)ZIYON%^
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M>MDI,_0C#N;J7(#D=GJZBYHMQ^JEGN>F"G?#]2SETMQCZ[AHFD,&7Z1TFGN
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M%42EMDK>\?J_'U?W%7_&)6N9L!ORJ/F*:7I052ZUW2R(= L,!SZ*$Y7N)K!
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M_4#1X:<H9T2@5!0BRQ+5*]*H@,M(VH2!:J.'C'_T"D3]RB*%HA\[LV#2&2+
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MOBIH8D+O(8//B;T'[X!_RN8[5LHG\ZGIB;>0(6;$0YJ@ N?R:X8)181@@;)
MQ+$("&'$:,)>&'OD&=I(VW==-/^DG6(P_%6[P3+8_#,V"O1INZ*^U=?M=*S)
M/G!7C.A^XZY=8LMO(+B<=BJ&U'V"-VHAW?RNZ771LBFVI4%XN;E0#Q>$!0Y2
MGR-*TTC.,2H_CT&!):XLBCG)*,5&!W"N%1M[@IZ7'QX1DT()#QP]#;./[X_
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M>UR0.,!JVR#*N:^(HA@B"<E0GI,\)GGJ,PYJXM C:V0/\*N+8* /*K,I[P@
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M,+^(<N(7U,]0EN0)BGW&5"\4BGQ!.0T*EA'&(5' =5$CAP+U:=!R3YJP/.@
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MZ#?H,NGN5<VPJIG-6CV]O:(>>?4.JGI:5Y@/N^61F/FSB8"&^38+7$?=L7(
MDB.O=XLFDWI !Y"=>D,70SHB?OUKM=YLYF2SK3#=+ECL^T$<"N07D6K-E12(
M9#F5J^<\"** 97$ VKOO%S>R?[M \OI?-[*\'J-EYI?<80!S/1<97;5L[_=6
MNE.:-A,SQR)O/1;V8RE;+QH^2-1Z^2[;64ZV!Y:W^?=RL_!Q3%/F!R@C,4%Q
MP"-$>$84)7R<AJ$H? *<V:<B1I_-9'M$-*AD G>D+N!B.H=OL18Z;T&&6DS4
M:[8XFYQG B:>D-<,/)^$5Z^\N1.N&GN_"?.NW-#E6NVY;!89$SXO<HQHP!6E
M.I.3,"MRA,,PPG)UX>.$+>0H9&W1#_>:5,CKVI4-V]%\:8F[UKOM1J5?J\6\
M\RZY5Y$UF\N.T8)-[FZW7"5]UF4\ZV@P2L/<(7/=-\V]*O%'-<X=@J"G>>[@
MK78NXS/?UD?5G^3W?\&%'R1^K%P""5&<8H+R,"((^TF6^P'S$P*J9#P:'?2%
MAA<O2EE>J87!IO8Q GE.>9:DJB=P&*EFX0G"6<J07)?PG&5)2#B(_L(> 7B,
MX@8!,S=F;1?,82F3F@R;7Y2D/WGS[;8JR6ZK-RFV:^\>NRW,O&B8(]=T//:D
M3NBB6:?NYO)%-HDI.@UB7E4ZR#7.2.G>-78JRGFFAN'J_(*!_5/F-MM@\^52
M HJK"/ZZ'9;Y)D=#39AH<LF$XPR3BU?8'@9T<[_NA*YJ_EH^KDI14KS:[O^^
M>M2'G6I7[BM_;!@@9 "P62]+IJA3#CO2/L_EYS@3* URH=JDIHCX6" _IF&<
MR?@>"U"W@Q%TG/#PH-'$V_?U:G]Q7ZU%N95/RU/^K*9 Z5BUOZ[I3 ,^4G#_
M8$V/&G[HXX)YI$;P[#0Q5CZXFFI!JUB?4+1*JN]Z5\V1SR1&0]/9685[#2<^
MPQ@-XO.SC?%$P0.A^Y?GD\-$PUCH[,:1_>D]?O5>-JHCHEA73[K#TF&-J3JQ
M25W,PZ-SLX<CI)LLAKFD"\:.X6!ZK;(*F<Y'FRQJNFI(-W"Z?A%\ZNP9VN?L
MGYOWW^GR\6]X^>6Y4C3M7W=/3]6K*D?:;%</9 GKZ@ ?>>3)=]QG0&JUV]1U
MGS-/J;?3$7V]1_>%J[ZT;>N!3A\4X RU0'=X"H\++&R.6V(JOQ87<'7<V,$>
M)RNO82%N,K=B#T77[]PP"K#7-2\7[U=;^69]*)?\\TY/C#B/XH)$&4I3WT<Q
M#B)$(A8AS*+$3WF8Q8D1(_:EP<?V/%J<I^1YM4##OL^7<.AW$+=:!YS^YH:9
MMWCNL:!G8LK;ZHDI?SA,S(N#3=/WN<>,?=?GOFLLVL/_C5?E\O53*?A76G*I
MWJ;YJ(B$1E% %:. GCL)1S@+8A0$<<["+!-9842KUBMEY$E4B_647*\5#&B?
M?A6;@?GDRF+8Q+ID[/#G$6 UH'>\"^OM6LC;H0!K)C]D76]/^:LW3]=:?DC_
MHP[S@Q??P'#[>;U:MYG?S5;?(J"$A%&:H"1-4Q1')$9YD1.4QVD8%V&8!TG1
MLF8_ &EN+\@S>B./B;(?X(ZHWD_C;:/T%0>28U]%RVQ;\B;C;^!J[8IL]W(=
M$[7V6.62IO62F.E)6GN,O4C1VG?]+9TI%$F%/L':9[P*EH9)D! D"B*CA5A@
MA'D4(IXG:< #RF)88>T5.2/'"\UY]EZL23XL"":SZ>K >-ALM;';LD/%5:N<
M]J@XE_(#NE1<-?5RGXKKE]NNA.>,R8>^:?[SJ5SQ8)&QH"AXS!&-<"$_KT&&
M<"[G;>8'+&(934EF5,74*V6:M7$C<=;^X"G9WMW*<+.M'R?3)?.-UENMG>&&
M6ZRD>PR[84E]:=2)U]8]AITOLOLNMLP$KHG2/W!Y"UX^X._-A_D-7W%1RB^I
M(#B+XAA1(3^B<8X)(J$,AS,Y3?V ! 4O0&6& _)&GJJ-6&!*[P!$9E]1AX;#
M9FDCV&LDZS*;1K;W2R/]3P[S>,WL=)7#.R!MVOQ=,]//<G<-;[.;X#71U)UX
M_YU^4YE>BF;J;O46;[ZI_U.G'R]XJ<X[OG#YG2^I7%&J/\Q7[/@7G2L71>#'
M@< A$FDDG4(J(D02/T4TC[(B#\,X\D%-7T;0<>QOOM98Y:;P1F>O4J1N]<\;
M189"I4(S_;^Z!U6CE\XMJO9:Z[_#W-$8#]3,A?W@QP0,3O9/J%6WIMV33^:M
M?C+J?[V.*BKQ:/]8ZDO4LSKYY?$=-=GN3NTG-)P!ZY7#FH@1 7?D?\?0<%*?
M/2+$IWY^3%$WMX3XN&*?\9,Q*>#ENT=VNDJ$=9>&UL!^5^?&-IBG.NVX,/.D
MR/*E9*K;2Z_-MW15.#'+1>^$=L@?U2'AQ*2>/@BG5UH>&AS1Q/R=EX_?Y!2=
M2P%8SF[^A,M5^T?%0A@L@H+QE"8AHCS*42S\ .4)YB@.& ]BD7,2@VJ&H J,
M/#];!3Q<:R#CG$8%;ZET\'27.%5VN=^%U[_?>+^4*^^5XVIS?2'BY@D8'E",
MB"OPX.*4:VJ/<:.-MU>GOD*SB#H\U+!$PM5A!U3\M(<@EN"<'8[8CG/;6:=:
M>M1[O>WQ'0ER'(:ACXB?4Q03'",<D +%H4JXH$&8Y_2&P\XS@5.>=J[6*Z07
M8W7A8]T;V*J>XSI^L.-/.SAN.__4"+1UDHU8AYL_@Z8Y/@0]E_-#3D&OFGOM
M&/3Z#?! 7F>N/CP]_KIZ+M^N-JQB'Y;XT320OWSWR(&"%NH]E$_JL_7KY_N/
MNHBGE/9R9A[@7S%\.,"_W6;8[.LSU_M=R7:4+]QOF%6(?V7(R4+\?I.Z(?[
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M=VV@B$B+2B B"M.7E6)M)V6%5)G1E&<4\\Q]#. 98F,'/%KJ49OUW]*/# ,
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M9YRFLHJ50%5BNJ[P#.N?>(K25&H'NE",E@SJ+T,8F,9;WK)AS"??U4;O64J
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M+U;:1T]97H%.@Z<HC7T4-'2-R]U2UO!$EG;TS5 '#C$[C9>CTQT"!:#'[0L
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MJ1V(HD"93/.",T6+TBGSY"RED0U 0]LV<-RGWL9/W3/0AO$:M@)!48"IOC<
MH,PR)^&\LLF&5YXL@\Q)P'[6F-L#GM?=_+L43PMYJP:*I9LY9#$K>)82CE)F
M&BLH*A EA"%9*%J))!5$@I)8W$F/?^)_T1U@KWG N0%FE^+J>#$U"EHP W A
M4/";(K#,H>Y^W E/>YL#!N3@?@:^@I]A^7U92[ZZ7\[_)84V76U?6Y/X6MLJ
MK,]R_;0PP<KW6LJ[>KZJFZ$2^K-WJ_7<]F2:I:1*2I(PQ# 6"!.E$$D410IG
M:2X4KF(&:I80@JG1C5'+R[:MPF85/1I6HF?3G&2C=]_'CA>830KR2MRLU=1
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M(C#M/05&=TM^%34<1-_:_QUE1!$ @D!:[T)Q4C, @."E78 \ZF<H^JW53&N
M+U)O:[:YC;DCV_TV4U+0E%)J !<(2WT IZ102)9Q6F)5YK)DL*1=5](0%?'*
MX#7DHO66WM6NIR52JQJM-6\P"^(,:J4TICF1B):":Q,<4U11E2(9RR)/<AE3
M6&.$,2#U"6NL-_,'6ZWT&ZW_(3?1'W0!;9'@C*&;*1X#&9@]MM^R+[UOV?7>
MM^S+T+<,;':AX@:RO<YD)S7 4#!>6F'P\S!3O*XWN\C+7Z6I#WC\/N>T:0^$
MJSPNJ[A$)5,8X2K)$(DS;HJM*R%*H11S"G<.4AG9'O3)@2*<P] ,:WXP@6%J
M#I'56:V=9!G28;U 3W_U;SO='5Y[$D5U$J_32K</ ]N6_.0/L_X0^%OUL@KZ
M@ZTL,]719C;(K;)]E&:BR@I.,JD/37F)L(@%HD(JE&892;.4QQ7+W+PB7Q9&
M]X[Z/'6I@VV=G=[@YTL;UK3)@88=Q[8GOG@/J_P4&,*LP1YXMRIZV3/!CNEJ
MD/RPM,-]S*>^3("D:(=/V8=>%=$]3EX56??.-!?"TIAJLXJUPTF:)4U?&M]U
MIVE7<Z'4VRXVEZ[C=]0UAY"F__ABL?K3Q+S-Z&]SQ*Y_F&IMOM+VT9[*9)GJ
M ZT^Z@JL72Z>)XBF&3.#/2I"4\DR"0J,N1(>/3K6$8*=Q)QQ<SN)C8$&S"A_
M>7<3=9U/KJ(D17%U%6W9BG9\V=!9QYD^L EAJ_:OHI;+YW '-B@J@0YLSF0G
M/;!!P7AY8 ,_?UFEZU?ZL[%:'W>MH3_)S:RJ.)."*91G)@%<$(982C.D%],6
MA/%"%@)RHWV&WL@7VJ:H0735G;9DI-EF_])KB VL93\'H)M!"0@+-*+3HF&*
M6[MK,DTQ?%GK&=$"U[.>HO8JA:QG1#]5P7KN,3^-_RCUFO)$9_W>G?DV?9/G
M*>>\RA O4HEP3"O$E'8J4E$F(J%%+!7(E8 R,+)+H;]"%4SEP0BZV8 Q<8$9
MA8:3JVAH3$8_&W:$/%A?, *9$3#Y2>V*+S@O#8WW.KYUJ]ISV9A%FZ+\KJS-
MW S.?\R%7(I9*E/*DXP@&9O*U924B$JAD$J*HJP836+84&<'FB/;EVV9I7'$
M14O33GU_ %XGN>#G9FH"HP*S+COB;6.-WD .>\_?<A"R[M19W&"5I^<I3EQ[
MZ@S!8?6I^Z.AHAHO72#3[/]>4[Y^6#V99OR\PE7,<U2JPC3C3U-](*$YHHF@
M,E9IFA:@QF50!D8V&;MS/.WXN3IR;K&MXIK>CG\1LOGIWZ\B:EF\-#YRY@WX
MQDG"X0HS.D="(U?1X>&GUR[S+V]WD%X/0QH@4N*&RV@1DS/D7SERX@;.^0B*
MXSHP(R:YF+W[Y^;Y^L]:K#\LOSP]/-2V[&"]67YEB_>K^OIQP1;_7;=%XPYF
M";CDR-;H^OZ^MITNF[&IT5OSXWLZKYN4&'-MUI; V+&7K;*L3<? 5;UI[M>,
M"+1^WA_G:ILRN]DI*,C#YFE$?(%7:Z-"&[#>WQ.Q@:$&>L765'&QLU!0.I,8
M)D_A.WOD^_@EX1U[E'LKU[R>/YHOQ,?Y4G[8R(?U#!-LVN9R)#DN$)9QCEB6
M*<13B7F:5 P34.GA&7HCVZ8N4M'&)WH<1-\,#Y%E EB+> Y"2#@G"#!^T1M?
M3#QC-6<E#1J:.4WM%2(Q9T4_'G@Y_YAO[?&*_^/#>OTDQ=NG>KZ\;WIV-QU2
MWST\+E;/4MH/=6V337.%]2R+XPKSDNM35241%E6%*$XR5 F>LUQ@DI09K"K9
MBX^QXS&:(5O/IS=7WO3%:?I$F\'PLN6J_:=MR^-'T]##N]^Q[PMQ,S03P R\
MF[;8-1Q%#4OMG(%=S^2.KZ9#4=1Q%EG60E9.7X1-L)IJ/RXFKK:^"*K#.NS+
MEO,=Y;AS@J^7HJ/3-GVU%$R)D*T0FI594L@X+1 M6(DPYS$B)*M026+"J:!I
MFH/Z)D&(CVSDMNK5$F_TRH97+>;?5PL-ZOK_:X\7T,F/ )#=;-A8T,$,U]X1
MRF!U L9OHY29^6 0;#8D@/3$,R+AH!S.BO18P]/^T/5W\_]&K7[0A;D_^RS7
MFWK.]6G=_*')X>G]0^^3L[1*2%H)B;C@J;G\8H@IH1!-*5.%B%/]@=EC8T<W
MM-XXFJ5+>((HVTO.W/5.T[R*N/YO)'>DK0;66\;LWZ\B)N_GRZ5Q*;3_UE $
M6J_+7E&)25:H"DF2<X0SO6=0I?>,+(W+F+*,8\7:5_1N*7[)%]3Q-<KK,7>;
MK_)B6,*8RO(2%3$3"%=:@9A(&$HJQHG,N2J3&)*H-ME+\>[+PIU?RY3OP7&_
MGPI=H -@(37_C7KT3*[L%L_F(VU2;?\?^T\$= I" !7*2[B(EVG=AA"P'?@1
M01;UJ.K:C;B\YKS6)ZH[^JS16%AZ=J1BUU_>QOUWSK>4"E=9DJ""2H:PR=]C
M6/L7N4H2'%.A*'>:-GD1%R,?=3JVS+;3,A:UG+5JV@R=[)@#U"1YXSYL!"=#
M$QBV 0+93L=UZKD1$%M T=<4&/M5?@7[TL+*O2X%9+#FRWOQZ0J_+I5_K_KK
MXL4\CYA-<Z5VO-'AC"TE6$X)SE"9,6WS*U4B(O0A,I=E3N(B360%BVH-TQO9
MNGM-(SL'D:./&DYPH!?:-F7KQH^-/'?,4<Y03N09:M.ZB6ZB'SB"CH]YMC/J
M]U"[9F:$$-_,X@HK4F4YBGFIM"O'*&(F S)-4Z**2A2B $WB.$IE9&6^V>LV
M^)_ 9CI'87%3Y8N%A2GPBW:#T;>.9,!H\:!(H5KA'*4Q;=^;(3$/FMP,?CC8
M;)SF#FM&*U96J1(HICE&F"88$4IRE*@R4;&2C*I+9^,TE$;6RJ\OYD_33=,.
M(\QXWSW(W+0U"! PC3T^,*>[KAYU7LZ^:./-RVGIO/:\G'UQ'>;EO'@ GIRK
MM^G[U5)V]>YOG^37U=OY^I]/=#%7<]YV;]"[>+M]KZ\?-JY9NCYKC^\Q&Y:V
M]?V1>++3\%ZRU4YWZZXVUV>SW,, .VP"IL 49AE&@Q.4>WL))EY)N%X$)\O&
MO02.?EKN1>O .^3=U2OQQ#>FD<,76?^8<[E^NWJ@\^6,525EA&5(5)PCG&LW
M@M'2./L<9TF>\JQRFB0^2&5DP]/2;9),&L+1MX8RH%7>:8R&+4<PR6'FP4MH
M4,^\LT)=T#/O]-J3]<P[*UZ_9][Y#WMFS'Y?U9NOLGZP*;FF7=,L+Y3I$IRA
MLLRH]NYQAA@K4I33HA1Y4>4%!14B'Y(8^U[$$$3ZP0?OT1U'8''SX"\3%GAM
M8>4TQ+J,]YLA0>$II"=E"94=>DA@VL3/DP(>Y'2>_J2OWFG?_HU>2^SE:-6U
MJ<LSMRIOGG<?:1L2V$JH)FWQPU(?\>WMR]I.'_CZG2YO;2K]^@^YWIC6:TW6
MZ=_E_/Z[_OU:[_+T7MIB*U-K94JM;*75C&95DI-,(<S,1"Y*,:H2H5!:IEE>
M"9G)BL#4_1>1;&0KTW!C8P5/:V'R?IJ8 31#_E>!R]G _2+\CFE7-?_("K!?
M6]B3,F+/4?]SK:1-M>)55[O8DS9JYK%LM+Q1*_!5U'Z']%>HJQ+HQ(Y:N8^7
M1X:T\;_8ZPRVM?PJ<DV\H_TJ8I_<2'\U!CT'XG7KZ$,S7ZS63]J>;*]F:,E9
M1G*&JHK%"*=Z2R7,M'[/RH*6517'#-2D8XC8V#&U74EVC[C+O0X<-K<-*!08
MP&"8-P[P.7@. H::@3=$:MKY=PY"'\R^<WG&)^EPL(#KIZSY?"WM07RS65BC
M=:O^3HT)VZQG.<^*K. 2L:S0NI](BJ@D%"68,)Y3+FE"W1,/+^!D9,/04;?Q
MG_66O@D&_]ER +]'NQS^5,8)3?(,T23+$"8T1ZPH"Z32')=5%A/*DMG2=IXX
M4Z,PS0NHFA?0YPCFIZZC>5-N:GOY+Y>26U?US_GF>Z3U/8O^_HIO8]BB3_H5
M!QX!7 IY^QKP94\#.@:GPAF2&3H1WI[9H2/C#DP:#8#5<.+H)00F3!X-@,-^
M FF(!?T<][NZ;85E>6@HWCYMUAO];=*,S)*2%VDF]0925DIO()G>0*JJT X\
M9559XD+1%.*[GZ$W^LU4U^BM:>NPVE'VSW(Y!Z&;'Q\0&.C%58=)F_+2[J,]
MXN&<>4<I _GSYZA-ZM([BO[2JW=]S$_]6RO2-DO+DCBF>4%0*@N*<!SGVEFG
M)2K+-)<ED;BD3E5"1U<?6;5A/L9Q^=TTU5LJF%ZV9 +V;AL4()#*[:\]J8(=
M%>NE.AW_$/!4+.>S=E#B\[N?W/:._$0?Y(R7!6=Y7" >QRG"A58BIF*)M%J5
M)$]47 KI=-@]06#LB^*69-31C Q11Z?]%"9GSCP!) 4>96!"NGO(9R092+[2
MCS:JI7_8:=3)!:=Q=,^(L_5?SWW.9W:AP<#N=)]EUWCKKC:S$1]:0\TS3I**
M)HA)PLTP&HPJ5F0HCA-%&:]22IQR,MS(C:QVAGSC=$4[!J*6 \C@O+.P.<0?
M@H(!T\Q!',YO@SZ 0.8&A@3&+QK@]T4!S@%T%7-XZM_952:<\><JT?Y$/^>G
M?,=ML<WN]NX-7<_77QYK2<7M\@]:STV=Z&>ZD<DL55DBDER@DC-LDE(DJG*<
M:-#SHLS+0A6Q4T(HE/#(1L\2CM:6<K1:1C]:VE%MKO;_0M<1-3DD7/,(GL/E
MB*R;MS\&7C"[:&>M[UBXBAKLOFRQZ_B(#",AYW7!) \VN,N1[,03O&!@'([R
M C[O&<ZC<_%A^?_/EZ(;SC&3B4I+(4S6*B^TKT1CQ)*T0*H2M" X)2EWNH$[
M36)D4_%IM42VN=&\&P[3#FX&AND.H7&,S%TD,# 8IVFA^1(9:MMA. '#;R=%
M"15Q.R0P;9#MI( '<;73G_1,8353?<T@B:5<O)W7DF\6SU]7-ZOE6JM\-XY
MQ4F,S=A,D50)PI44>C?/8U3F/,EI6>*J@"63.Q =63T;LL L3Q>LW+0S- +
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M&(DBJQ N<HYH422(\"I):5%5199/TN@(ROG89[SA3K^O_-;<K.LO^2Y@UCA
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M(H]ED2+*E58^II6.8I(("BIB.T-O9 5L*45V0S37%L^2UM!;BW.0.6Z*X8
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M_/J'[M_:VM$]7I>BZW=Y7!@S0V.6)I5DE)>H$KA F%:F8L<T4>,J(54:"YZ
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M),E0654<8<&5R826B.1YCIEB.8U36$W$,$'(]]:K)*))@>GZ]<N6"WV ;-@
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M!P3PTHBUB4^AEIOH<Q_.'D,C1JX=H1@KJGV._.M&O!W!.1L-=UW'MZ_ETL3
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M(C9YD&+SJ\J*M,"L8 4E@'W/C>HTFUF/ATC:_HKSCHM(K.HU,$?I#(QNX;X
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M"*0BE;A(*>(V;X1DRH 4,XJRC(C2N%$TC>7LNZKX:AJ8^J2" /6L6!4 )\?
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M'D(<B^?"OC,W&S;YFX"9N+<-F(<=DW8L1>U'[$O8^\?^$]$?&UX#MU0*AEW
MEDN7\S1Y2Z9@,!YKV11N<8_FU?]Y^UMW8+LS_U.S)JEN,XH[X>:@A5EL*QHY
M(F62VC&@!"6ZH 2GB4X3)_?M+*61;:4AO0D71'WB@ ;-@S@-V[*@TL/LTRG!
M?>:X#R( :$\="@F_UM3@KP*L&[6+<(.=J <7F*X+M8L<+SI0.ST 3Y&XEK+)
MZF4+$J??W\UKL5C9JUQPAL39A48V03OZD6'@S?>_1#L>W!,DSL,Q;(J"(P$S
M1T,@C) >X2RI5W;$^=4G2XYP%K2?&^'^D&]6\==O:K'8I,BF(L=9:@]EN+!G
M-!$C1E2&<)%AR033A73*4CR^_-BQVC:1MJ'HFSG\ HTS'L/%,@(#LQ#Q/+*#
MCTEQ05+PB^4FS@4^)LIA"O#13_FJD6W97CVNJL;1:4(P;^UE?O7\=B75C.*4
M%X1*I&)9(&+\<L1SHE!,F>2\3+&2&4RO!NE-HV@O6+AJ(X8V=-@Q$EE.H/HW
M#*.K0@8#QTM#+\+%0W&=I+U DX?7GUBUG80]U'6WQSS#H\:$5.J;6M;S[ZH=
MW="V<]YO,:Z)2*DL2E1F)3-60&C$5*G-F3W+<VJ.[[0$I1*Z$A[9'+Q@HYL[
M @Q6NB+H&(\< 1=@R/$()!.U: ?*'BIDZ$IVVJ@@$(R#P!_T>>\\O'4S(J\M
M>DDS)G6N*"I4FB"2:^..E\(FWZ5",9PKG#@Y"\>7']D8;(EY3JE_"86;OOL+
M"--J=]E\LIF.B! N>ZF_^-392D<$.Y*==.Q3,'42[8X^^_A^1DDL."ND35VU
M(QPSA5@N!!)FA\U%'&>J<.J!NUMR9+7Y:+OS+4\WB3@EZ+""^+$/4XJ/7]Y_
MNO[\[G)5.&1VP&?M/MQ^^[M?=E_\WE*3?-D/6=]\P8_\Q;/W\])\JU2][MI*
M-^,F<\RXP"0Q7VN-$=$%193('!4DIHD@A&A)9NO5FBW<-HHC-$!?^RTEYR_/
MG7TDFG=T(]4-JNLU4K0-)=1R;HY/R]4:W/?Y"&AN6\J%4 !5:"-_1^TJT.A-
M!V%"=6L^0F':WLRG13SHQ#SP4?A@O>88J:I'5JV?/[.'MF-QREA:",:1R+%"
M1.D2T12G**%)7. R3^+,*=7E%('1#W0[DI&E>:[GL1LJPYH70E;H(0TH)FA,
MWI L%XS'.[KL9&/QAH3JC\,;_)Q' D3;/5W)O<[IV]'A,Q%+7A*5H#@FS&@<
M4ZB4<8%P0C*14:6+Q&F$I1.UD=7/TNE255<ZFG?,1 O;[7_1=/MGEA] 5L!9
M^,X$5D.# MP>-PCLSSNHKZ(&JX9^2#@ B1(A8?%+EK@0'ECJA*NX@^D39Q>9
M+H7"59X7:13.#UWFZM^RN?RLUK.R4-P<837"N)2(Y$F..,\XT@66*1>:Q@R4
MG[^W_MC.A,VB-'C)2+:-S=;?5-MX7ANG?N/Z^_GU&X1@/KV'W)[^O*5DQT2)
MQ5-3$/B6/<[-@:<YV&P^=!7MFBY?B_7\^W!9O;?SOR=U8,=_L_JK./U[HIUR
M^/<_YCU;T[RO]?.M>>7KZZ6TJ9Z/UFJ;GS_,E[;@LVE!\V5^_VU]HW^OV]E0
MORCS=5?7PECXIV8.PSOU:(ZY;6*X+?7NC8Z:L;B4F.,2Y=Q>%^<L0XP0BLHT
M-><'03'-..1@/P'/DP0*Q IJ*:9X6V[6YT_V#F 6;</\5=2PWZ;*;R5H?NMD
M:/MA18T4:*7M(*K-<"K>B!+U9(GZPK1M,'KB!!T&.A7VX0:'CL[QU$-&IWH%
M1P:23D;:<WCIQG/\N'Q\6M>?U'>U2+JD;:$5I[S B&NA$<F*'#&99HAHK>-8
M9UE>@J86#= :V1-L2$4)</+H #1NAC>0P#"#N3MXV>D_EJ[M%-C(?SZM'SX8
M]+R(H09_#E":=K#G>9$/!G<Z/.*; 61X7J[;[*(O\_J?OSS_HI;BFQTCWH0^
MN9*9))BBF*4Y(K'YB:=Y@7*LA4HDC74,NM(_1W#T '&/?&3I1UORH%BQ,X!N
MJAX2%F@LV1\1CQP?-S&#Y?:<(3=Q3H^;\(>Y/([/^9F -@34C>6:Y9QCJM(2
MB5)PLU7C G&1E8@F"2\5YT;I$\@![L7JTQRUNM%T3:@9>.WZ$@LWU?66$*:G
MF\!H1RB<3A[E/Y "OEQ[4FT[*M:^:AW_D*<>=4WPOBBAYM]M-M"OU:JN9S3+
M2)I)A>*4VXY"!44,EP62--$IPT4B4Z<V]V?HC+QQ;EL_5ENR0-4Z 8^CDETN
M-%#=-O+N*.[B (O%ZD<3,K"!X+>5DO-U,W8NH%(.RQM*/4]0F591AT4]4-DS
M'[\PD?5&V[#_!_."=[TDJ,"8Z-+H;4J(T> \M3EY"<HTX3J1&4]24/^/(6(C
MJ_$N$72EVS81#767!A%PW-Q4.Q0:,/V^  C_%-D!"4,GS!XC]3KILP-"GTRF
M'7K&4\&;5+S/-A-O$Y[*B<YSB8VGVP2ES*&6D;1 @A"F$AW+O("UQ]ZG,+8J
MM\F%G^')A8=8.&KJ)1("U;,GW AAIY.2A%+#@_6GU;U3XATHW,D/^FF934DT
MQ]7OYMMLSJKM3VLE/RZ-#C<)(M</=O-.S#$3XT)HC'*!$T3B0J,RC14J<J;C
MDN1Y5G"(\KD2'ELGV]EP\W8>FO4.*_5H/OO-WBS96R*QY;&V&T^7(-S^ZWIN
M>Z9[) L[H^ZFYF-@"=-^RT&T8^$JVC(1[;BXBEH^PED%J."!C(4SV4EM"!2,
M?=,"?MYS7W]Z>&#5\XUNB]SNV,_W/]G#?-D$R^I=_:62(L^5-)Y[0K3MUITB
MFI<,:9YGLJ0YR5.G-$L@W;'M36\XP]\5J^QQU;9?M2DY7Y_X/Y181^M5=/UD
M3ZC\.?J-_<.8F_]\JN:UG OWZ3E0M!W]B? 8 KV,E@&+7LM"9'B(^DR,.\D"
M)G\HW\21ZK0>"PR* S\&^+B_=[.S7VV=9Z[*(LFX0CK.;0\[I8U=D0*5F&0Y
MH9S$.>A^[ B-"6U(DXAKUGAHZGAZFVWM5Q1[##%W)^0"'(!V8!^".R\(O!R.
M$T(&]"WV*4SN1IP0\9C'<.JCEW3W_ZJ$V?!L;NK?YNMOJZ?U%\7D?/'\3MEO
MNC$2AM#VAKWU2F:B*'12I@SEMBLE25F.F*(IBDNE.)<QSA-0<,";D['OPUE5
M/5MOH:G::,XD<^.IU>OF&^\S*L ';3>3, F&,,/1C1S8\=3,"S=,11U749^M
MJ)];$_KP<C$Z0<<7^/#Q"B,.+H#K^!B$2Q;T;>#U-[58_-=R]6/Y5;%ZM31G
M+!M^J&8RP4*4LD2ER"4BA30VS)@M5-(D)81K+(C3M<592B/;J*XYE26._FFI
M1QOR[5CY"MJJZQ1@PV8H* Q ,^.-@$=3KC/27=".Z]3*$S?B.B/@80NN<P_X
M.2<WZV^J^KA<FQ=M W]M*L*FW['*19X7',6ICA$1B48LRP3"BF>:YUHQG, &
MV U0@WQOO:;7[<C65]'*,@)S+(:0<G,= DD/T]J&:+2CVM4VCG"=X2!>H-U]
MB-*D^[>#R/L[M,LCOG6/7=3A6,MD@@7#&'-4%IFRP\0RQ&*%$668L\1LQ3I6
ML"+(T\1&WHEW03)X/Y,!A-QT.)3<,"7NQ05':R8-D3!8]>, J8E+(<\+?5@7
MZ?",GRI_4L8LJ&UA:U->LYEB^WS+GIMS\;LG9:/M'\R79D8*1I10'!4%M>I=
MQHB7&45%CG,N\B1/8U!R$)2!D57>?',H3-7!"+JI_YBXP$Q"RTF_^KEAYFH[
M ?OYREZZ<-5545N.(LM2.$OA"T8@ZP$F/ZE%\05GW\IXK^/1)N;]P^-B]:Q4
M.PRMRQBP97]IG&2;0P&..4UMIY@RM=,.B74I)$8J5E+'4F1EXE1/YTIP[&/]
MU]O;R%(#]#]Q@>G,*7X$X8&'^8YX.[8PVI!OZI,;/'RFYSA]?]Q[PP0&R*\]
MS%F@ G6& 0@[V!S&99WI^L, I'K1(@;RG(>A:S*DOFR3HFZKU7W%'KIO:"Y5
M(=*X1-K.[R \48BGVA@\2LJ2%CA-F-.MRUE*4Z2!13O:44<<H-"#.#F8N%#2
MPVS;*<%]3-H@ @!;%@H)/R,&_BK ;)>+<(-&:W"!Z:R5BQPOS)33 Q>FE.U<
MOU5=-S>E>E7]8)7L93I)>[X3.$9%9@P5H;9*I$PQ(LJV.2"2YQHT*AY"?,+$
MD-Y9Q[ 3O>#',X7,!5VWH^%8F %MWRZ9; BM:3+* $B$3BMS(?TZN64 4$XF
MF$'6\+P7JN[9LNO.\G:UK%>+N=QT;KDUW[_-%G2CVQ8P<[;8ULWT:M8H)8IR
MB5AB!ZRR3".:V!(7729Q(E622Z<^\D&Y&ME@]7EL<L9W7#;)]WT^K9IN.8UV
MK'I7PH5Y;8[765._#.#%UT3O 7Y/%A*W4#=J07B:]NXM)(P'MW1!%_<XH;[=
M%>,TA5'OGI1Y:;@[>)2"I").$R3,R=3856R.J,+\3Y(SD>2Q,(;5_8@Z2&IL
M[ZXM/>JQT%7;R2<562X 1[5AR!Q.J\& @!FJ0^'?=<+['%B'40"<6(.AX7=D
MO005V.G52=#!X^OP"M.=7YTD>7& =7O"TX5\<6?Q-V7; RIY;>BQ>V7O3&W>
MX1=C-&]595L+S3*<9D42IXCG:8I(I@I$&8F1%I(5!2&J2 N0MPAD8&1;MV$@
M8BT'D>Q8B*IFPJ6.5ML3V\)R7$=O6!VQZ+%E[R] 5Q *OZ/7-R*H0 =O_^9S
M"W#'3;1A)[+\7$4=1P$].4\L0CEM4/+3^F>>X!RX8K[K^%FMSVIMNS[<5JOO
M<ZGD+\^_U[9>M'/SEO>['N-V2EI::)T; \421$J9H[*4"BF-,<ES44J:0;J4
MN9,&62IX"S/#2"1L-Y(GPT T7T9ZPT+$SK=8OQ16-SLT#E@P"V1Q:KJV;+BP
MU:UO?F]!^TNTY664QO1P  *9'0#A20T.')!]4^.QPJ6NT7[\[M-\J3Z:<V0]
MR[@B4O$4J9@4QAMB*:(\SA&1F+!,QIKEH(YM#C3'CHP-!J0M%U'#!C3FY0 F
MU+<) I&W.^.)S@7^RUEY@[LLIRF^DI=R%H+3CLGY1SW[(C=-_3XPT21[-8U\
MA<9E4102224$(K'&J*2R1%24!=4BS7$"2O0\)#&R$>@:%6XH^K4[/L3%3<$O
MDQ88UH$)"N]B?%*64'V+#PE,VZGXI( 'O8E/?](C]/I%U>MJ+NPA8RG-H<)H
M]8/ML]GD(OV^G&_*-3;I0G9#+E6"5&I\?Y(+C:C$*9))&4N=RYB73KT7/&B/
MK*I?OOY>MU<EY@= "!((H$-D=CQ88#J]XR.ZMKCL..G2 QM>HI8-G^@M$#I
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M5=10C_YHZ4,[P ^@YJ:0@;  AB_\88"G!9X7,%1:X "E:=,"SXM\D!;H\$A
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MC;%0.!).B,5;S#I@.V!<6WT_='2<Y6PFVIX@\GZQ6H?9_SW]NO&=4K EF.)
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M0Q2&BI/_R#TCGH*I-__<099<)*=UY+'U4_X'2!H[7SL"M Y52 ?XVKGJN/.
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M?-$Z\#%D*,IY)S2/N?F3L?TH&]<%&@9@ ^BD Z3=D-4D,<U\\!JD)+=.J:S
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MSKV3<\Y^3)QW+(6<ZDT_;3*3& 2L0T\-4QE5":KY)?2^M/76NO2)0-A 41T
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M>5W-O@%43&3K.<^V=4R^/W7C9L^?&)4#*:W?Q.7KZ3S,T^V"S%$'Y*[6W+D
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M>Q[67=]5Q%6P3)*XO,QDPKT"ETEFK,Y6D(H",=[Z@F1_ZO9#Y4]\13*0(ON
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M\OH\RD).(KAB4>G2^F;Y'G):OB6MBSS'LECBY8+TG]5ZTQ&. E2<?IY?Q[K
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MUVR3FZL_Z0(N;W6PDJRN3[5IJJYC,^KP193* FE8LMW1(&@4A;$0K+][7Q[
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M!R'&/F_$',SO#K!R]2J_FU<#\EUYOUQ\Q>7%]_?G87Y1'_.OE6%GF6=G0C'
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M$HYK;CWCS8L\'Z/I)71@'*/'FLJL%PSN/DD.@LY!.EG$RB:1Z$S<U!XF&4W
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MK@ENA652% PPU@$1&CGI:5['I4<;8V(QVW]B6GR48 ?,0AS!Y>YP<BM$K[7
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MM@X4/H]>]6.>H*,YW2%:ME<)37 ZHP5F,K$E1U\W>#F(P2%*S#[AJ6<;]/
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M:FTZ/V$;2'3&!:,!?28WG"L$^@L!DJ'%:*1TV#I ^VS:0$;(?5 ;R A6=^
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M-P_K/8NTZ"C)/IH6'</F#G#R4!@KLBASS *8* *4(/O-JRCKNUVT53;ZV'I
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MQ_8KSK/F-H*4(I..Y!+(4A/D'W(??='%-9_!^3S2J*,D^_B2L1%LGMI0V96
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M><[/X2O]EXOO9[5HE:6L@+$Z-RP)1UPK 7QPVG+2O,FW?KK&T-=?9<"!L!@
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MTC,K"OTC?<9\>8Z+\ENXN%S.+KXOROH?T[^]BCIL PXS7)VB<O0P"DY97MJ
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MFI#<*,=(9#RQAE!./2U]O?Z8BMK=/XJ!Y4P!-P"1/^QLG)O+W3$@'4LVUQF
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M!77Q=+HF=T#B!+'63D2\X)C\,]/_>[QR<38207$7=6Z1&(#VW)#:>6.15C&
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MX8EU7WL;/IG=]>W49FN5^W<345.O(R;(: '.0? 1.1$""L**%*Q0!(M>^_6
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M9E(@KAU#QJ6 *$TV&"(EX\4+Y UTG-T+V&_,<$_68$6N/ER'YAV13C"-B,;
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MYSWR&WY'7W^0_^'L//Z?__'_ 5!+ P04    " ".CDY:;4$WN!A)  #XP@$
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MD&<+%!9:UX;;Q!7ITKCX=37)"U(."CD#604_"+YO; 4&7 @/SN157B6TKT5
M?AE@7? ]"0R]6K3X(PGZQ+CC$3FN-XA06)FJ@O'0@$? 5O2%,-_/("=0W;C)
M S#LOYC9S^I1FD3PM@S6-&*_"?WD;E;80:T5:"PER4R8I1$NR@8)BCRER7Z[
MR8%COYA)^FH07R=@)_-V-;YLC0E6&I0JO)VDW/"4:#QA HZ4+!5XLZ1?RGI&
M-RBR;A\Z.T/O^FN0VWD-A"$EJ @WDR2:D%8 :T)32\:);WF!+@&D02NK%+YQ
M7=6%W'I*PJ2__L+DPJI&;V0&JGI5LH9]"'I"G5:HBZW0%0=4?E;DUT!#,?-
M2]\;8C.HDJE$TYZ^E$I/S24SJ$)>YU]DZ]1NC#;M#<3K+$D[D[Z0Q34</>=6
M>&-5B6C"0LS$%C9!>TJ8Y[2/2YN/;D2;K(*SBE\Q,SZ7954DY+2"05S+3"!_
MVX#W:/-I)$'?V@SU488=Q2'-\/E5Q6=+S."I$0FJ5-S J^*[KI#4TZ5!6K]P
MUX3[FUV<;Z9WR4R)-42V[;0I-U(DAK-@)N$\*:]!FN"P+.N&!R/SJ$ *WK>F
M>=#?VGWQP/QA(]E<,8/8W]K?O8U!J,U;R>$?9$JQ">2_Z^1:I$CT0#Q(4EFP
M<; 93.$QD](3J^;T:<$[0F(N!2B+6D.$9U2"=*?_VMGOA_V][:W>?AC 604A
MYIPCI&;4<F#%P" FZPCMT0!M5#QF]70&,G"*NJ>Q/$F>)44U#S9VMC>#6,Q+
MYS#PX9TEO@'F6V5LS%_G2BV%0Y[D(%8[?"0=AY8$/-O,N$C*ZA:H0P$'S8(/
MHH!S9^.AWV$_][?V[D1Z.;/95^S"N):O\7 ^WZ&[@<HJ6/14'5'<,B; :O+P
ME*>W92[!OFCL'7H_Q\II8*3%&6U1!\.^;X_"P?96_Z'5FHWD$? M. [Z_!SF
M9;6"2 NPKW-M1K*W*2]<8[*P(XQPA,&&W+K:"N@4/Q_!A5_X^Q .?IHBE45
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M4!\?KZ\GW6IP(JAB7RGSRJ&NG.C7(M+0%]ISKN-ZA=MEM73T7Z%J%9?5@+)
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MNP/:=CS&K ;LYWF..;^U9"06*M1[L>\6ZGEYD=PVDQ-8&)LL23;]7!'E'&C
M"5%L;O'TR'L 6J5ZC4&85^\R2I_:B*X)X=#(!YSQR]3^<H!-;;7G+4*;6 6,
MI^0G<E)-.?T>'XWDPM0S2PJO1629? TV]C=QB-LO7WMI&%,I,"H:6SC5Q5!*
M>LJ-#E- [ABLU NP@2B2>@T)9\)97R  J@=*,J_AX?*UVFS1E'80\*8N'W4L
M!=QLTTTX]KIH#JJM-RE*H0.\2/%EO)-)&,'O:(?R+*4@A3283MX15C%H1K<C
M<$$=1?';MKFIA#X$LC1A#7@GUT?@WD7$((!O;-*34*5KL@:N9+1!#Q@EVNYI
M%VENB,V-WN;&FTUWW74&!,A/J7+VO278"C[J&%";YAS 9[-DNGC#8VH\; <I
MRQTQ'!$B_K@NC#&F*'=#PW6ATS3  %**,)!3Y2%$XP\VB-ZQV3$3SM("(K@J
MQ&QB/8:$ENF5EL+SNO"-,;$R2C!>  _'X$9:3V<T@ T=,:!\+%E6E$%'/EOA
M1J$LCI51S34/]JF(C,DN3%$-1F:SS92MG&3JL%,;! V)U6EE;&A+EL;4D@>;
MS"F9(6KOJ<NR-Y"Y(J,"+6\Z8\3IS>5\SP'[-/AA:GX@R4!G(<<XTK0WV_#;
MIAOJC8E$"O(!U-LYZKB6LSI0NW=XNZ(K]PVE6@VS?<I_K_)EW-?28+(\8&QR
ME=!HM[5D=''UNM@I&$@%MG<6%M/2FXR?1>?_9JJ^7/ SI:A[2ZYJMSK'YY1+
M_'ZZ\PDF38 GQB8H+;]&$P$6KFJ6Z:'9;34T(BX%S^;^B]L9S6(Z2J[JO"9,
M-HS\<5$0D*>)A/M&LTNN86-J%-.F[1&T2K1V&!L''0G(*5>C@HL,3\.CHQ*I
M&!U)'PS_7*A3/A5?DRGP#4J<5E$AGG"H\M6+)LO$'$]&)>2P!C]4P=G"G<AW
M0QW(050_<R_-?-Z>]>V#:6Z&,Z1NSJ+B]U&*^7;<A:=T-*=)7E2*6DA5T&)"
M*Q).72!H*9D*@_D[Y>E/S:@/2(5%[PB)T+%>,5& %HB)B(WH,3V-%]RAF/;6
MZ7::V@?HD*-[W1;VM>>%IU"XT+GZ+1;L,-Y63L8FTP'9Z8Y<PZ4I9#X.6X"<
MCLJM-!V' L8:=A?9CC/>WA:.6*U6?V.TN=$WZL!R96TK&*";W]>9EW8K;<"?
M.>,5BW0SFU]".VP$$M6'EI5G>A1U*OTVVN*.VFM3>744ULN"=&5L#Z$7HWOM
M>D_*K=9_!#"])SELBINHNWK7FHEOF.24.1]@TG$G@O-C\AGF8M:9JCQ8!&<1
M*B-*.>>4X&:N0,^+@ -0'4(78!7;@%$^4S6+K/;<*2TH./%B@8R(E2:Z4(@Q
MSKV%-V$69C:DO:MXOQL=Y(BOTZ&FU4YX28[:TSI?CP!5DZMX5IAA<ZS,S.L%
M6F [C5$[QE!K1S8.6DBS$FC,;B@2';^!@5G&2:3S![$&/*6L;,R,=\I\0]TF
M8$&IL*Z4PR$1&C<WZ' .GK8.2[0T[11 _T@13E&4.FM1))D!/.(3RE^2Z$RU
MH:*!FNFEI*B/4VW6Y*"^)^@X(&%KSOS9$RR7Z3^",MDA[%(A+<FL.EFM _V]
M@;[D.:(N$06!,VR=BJP+5J"\P"60I/J:BFAU0ZV06X48D'H1@3F*O\OI*(^3
MJ4.B5GI1<R-5Z^6,G6)H*FG7@*0GZ*3#5A$R5K#@7/AK^XL%NO>-?K8OHM3)
M,#EVV@4?^=6E6.V7/;=%)2$B1# \.(BU4#6RT//! HFL:G95X4,L.7&7DQBJ
MN7O8V][^+DWZ1IB"9'>_/%&ZM#Y65V*2:FT8C&96\&B59&U]4@N#>=;/OJST
M<\&;2.?!PLI&*& GV# UL)N*M/B7_6#C%RQJRG#;0+5"\^%2?)7EIK6,K(*A
M:L.]:E.WS%2'Q%F-6U #Y#:#FP+)HE5KB 6>-JUI.U5B<I/?!F0GZ3[=?'^D
MU":-/ )"JHY4ZT$'@41U4&ED3K*@,I 4/X*I?Y)@:K^[-G0$'/VJR(&_/5?O
M']/_7J^5%&RFQ%S4$>*\Y46GT;:2.8&@7$%+Z\Z.WBN:_V6KF$*74RJ//6^9
MC<)P.:KNRT2?R6&C?D9TI[J()J0%3&5QA5$U9)-YJGS!8=,Q;((2FZ:@IR!Y
M!)*[4IU46E4K[6)WI^$AB&5)#<_F9%Q;CW&FGZLT=4SD4YC\(J(*1-U.T4&L
MI'Y5];0)(:2K1.GQ3HP'*S)E04]N.JS9N"G%5&JOLGJ&^5J[7$LOLFZP2MTP
MHWY)8A[L1+V$WKJEA92/D2,^@F+!X!=*/$61_EXP!-\G3&A8AWX43=\Y$!(Y
MEB@$:W"JJ&I/I@BP+&/707]1J?B[;9NCHDI=U<DA1T;A9%3XAVY.'+J06AQ,
MBV =8QNFX8#8C6F+T?E:;5]S<R=RJTUR!?X&-Z-)D$7)+"6%S',L^.7\M]>9
M<*2(DU),M(W,>OT(&SLJ,8'8.K#A\C,<AZR0\YW(F^"_T6R9*_43"UX$=RQF
M- "52J_*:.Y6C^?5OE$ANBAS"@UUY_4I5T)9/3'/P",H<SO$>#B<"-CK5;FN
MNT)WYN"K2#IB*^24E6R'&P::#A7]-Z-PF7%#<4VM$MH:D?2*%03C/=.!('R?
M<5ZC#$R(>SP]_^\CJ"+Y)<_CX*W0H$(<.5]YB(4U+ J;, 8-L=4K'.M8< 0E
M5D@EE!0_(7>/096FDF,RG6MN6?QT0PR/H&3CD\*1-I"7[&!:K:^TW;3+<$0'
M]UI%IEGK( 6B+@AFBUR-I!N,TYI5<(M7Q;T*@>N-&VXB4P]K5!YRF%H7ONG
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MSCMZR]'PC3<EN(-FM$7K])2.X:\M$>% S>$Q0UG+&3%)IEQGG=S:.XOX'(R
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M+-&ZOP5<CJ>R+KDQ?\=>4/"?235-?_[_4$L#!!0    ( (Z.3EJI9JUD#T\
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MLI \@73]90"*;PH2S?@'A4]1G?_.X=9C=,8=;:XSC@:W 9[-[24KVH9*5IV
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MU2<3Q)HN/I/FZGF>S./4^%#*2GOIZ^E(O>7V#*T!X,[/J<=_XSLQ5*R2>U#
MA3X5QM,X91N#L;!!/O"%J#_SDS,-K[!E<J'EG.1-E@OLH6M;($CT+Q+H2Y8
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M SLTH-O=VG2*YJ+,"TW=% 6#.;X;3# AH3P%#!VCA(/K'7%3SP$Z]2PYVN2
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M($<-2'@XP5@!Z-2QK0^TKQX[DS1@#^P59:]EI^X^#8CP]V54;7<9.9#Y3@*
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MR-R.],1XCN[<D.3:GEAWA)0H+N4(A1-A;6'XH)MI("E60WY5$557GO,.AE?
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M!VF9\_2(BZ9_5W&&(@LW;R,ERJE?A?G<.3/?TZ1S80TF7\VIGPS49#.Q2IT
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M*,LXO<Y'-<_--79,]"O@T (YP!2[J8H(3B-PCHHYAP1 :A)8<?"&=+#9?E*
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M[(;CM.F4BPLEXS>5DW!88%)7(* 2R%/2A <I6FJ'H+T5G][ZI)Y$&1C);N2
M$,A%GJ%ECFZ8M#C!FTQS,O5[PL.A%/8N<4QTQ%%Z+OB6'VLEL7"'6RQ<OK'\
M6$=KPH_U$QS#,&FB%:\4Z"HD]5P2PZ-/88&:T2#Q&A%,*BDFQZQ@2!;1-N(W
M]7 D,NY(Y!%K X=*G#J,LV)Q>*VC@Q_?-'7*#<(?4+M>NRC\T-1,EQ*.59PN
M 4] &S@.CMGR)3GUU99BN59*&':XLZ%X :9BCVL,Z32JU^X%!I'C9NCQ]1:]
MBO$RAOF=K<'TPH$[2=>-W9?4D>26,'+AU]HW^F898(>M@=#DR>X3T%#5G"V&
M-<#ZG$Q"UE'G;OH,.%5T3.1$T3?<)IDICP =F WGYN7UVT_R.-%4Z-W9]EH%
M"J7=_7? ^<"P.;$Z=,X:)H3E8G^$>)O:3G!,!'TM;HP0Q"5%)E_XUQ T9SZI
M[17]BG?RAK;H5#(9?+V\N%,"8Q(B-H=GI\1^'=8Z+3@T41TQZD80P"..(JMH
M)^J!]RP=89QAZG0-C5;H[+1\@S@5W&]AK)A8W4EEEJ1KHO8&:KO[PJ?-K#:#
M'EY"ST8T!292PZ<-!5VFJHJ&8YVK=!HAP3HJ$!:S,O1(O3B4;&82'%8- X6+
M3?-'_6T,#"<I*4066H(M-\DL2U *VT/'0F"(9, -_,C!X^RL)W08_:+LSRVJ
MCHRL_U3[;WE! C.Q/6CT?3Z%T BC);7W+VUQ%YOG65Z/$\H>E'FXSV=I'-PE
M>4HAH+H_ZYGPSH;R=Z5/]J:'&JM'_IQG2K+#A,3!RJ<O'C%_5G-H.<;04VDP
M+M\A_<7UM\$?U#?M:!(.97(K;=V6@C+*IG*/CF3IV: ) KVRPJ$J2!&X2?)D
MY AY^!2:(680XS@0\Q9I2LWZOJUW9ZEY]QL5YCE>$V*1&UUY*XNV#%_B#"L\
M1;Z[>@;I\@ZDSX7539@K%;ZP+?NNB2%7"Y\#!YJH*)-\JU'O.RO4UN_\^G*9
M_?P*)FQ%\E&>6'<B5VJB+I8Y4:#;K!7@> GU"F\RJ90E:)6LO7(IB9%5JV3:
M,W)[K/_K@-JH*1D7:EO"5[=^_#9'U\$\N W3&!.2#X.;SI?P[R2/=1<D:7$%
MEJ+NO]8"8=J5EH)U"C3;)XVKY'0;(,:+?XE7J%N/=*C4VKK5:I$C[OB<JNR6
MS%IL0( N*HS+M"3%6JOFE&A$#;]3K>.:,$T0B64TR<7,[4"2@D3H3EV@?LIZ
MTVAZ;SYUI:*+?8-A^QLM8G66J6YF<G=;WI#%%8W6-)IRV,&+>Q/9J./.E\F$
M3GF5STKM)SB)4:ULVWI6@J<T4E3-UC8,?+1DPQ?(0_L]]#1;7U7CJS?,A%@/
MH,H;V5,_HU)8#A+%;%A-;2M#DFH^L1U(2OFK6J#0>*8?I+N2#_@ :>8[46"
MGQ5J#Y$I*9C6GFYN%7X]^-&>U-+#<Q-4#52&F#.1BVTF3(QMA>N]](;MA/7
M"UC:<])RJ]$MG-ECK%D,PM;"6$,"Y=C,3'6CK1")WVN3)ZHU*&@Q&.A,6[T5
MTI''YU^:</4F0[@*ES 7K(HS;4!8!E]'&*UB4Q^GB8-MQNXC^WL],:+)'&NH
M/V-2K=ZLU[LF+,.CH?"S+ %XGUZX1\,=[L=YZ*$O\1]X<5+:0*RIUF%BSZAR
MT _WZ!P9[F5<-L/1OK]G2=JK'*/,S-$ 0[C+N7"&\F+2;)!:VG!K%^F$WJ@
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MR# "VP?+MT YYKJ[L$UY/4O4C+J2E/5Q?@I%P2:Y+[!-URR4UER]-0VLM>W
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M0:/AL)BU$I^1^B\UA:=+\%FC_&PA\VRE\JRIC<U;^'BU%MZ/BD@U1[V)2(W
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M 2?17 :A1R.'@I.9;A.<9%E^MZ%*9[Q*8,I^545)IMN^8#^QJ$ 6<U#^[F$
MSU.P.;)-C!4DJP2W= X!XMV0W4%-3#=OZO^U2JC*'_/\PV;647U8)5"EKW%L
M7:W-@W#5)ZH@T_-JHJHB&?+2X#<;M3SI*B$Q^X8*E.><>QXG2' Q90SX2!<'
MLYM0NL3]]?+<C:-CV;9L:1V*2PX _T[RI?.Q2"FYM-8NI>G= E$-B6<1NXI_
M'"KLA81*:>>X%\S!)"K#()X51.]%]7+TF7OCO/ *U[%90HZM\70=O>D-2T7I
MF[8M#K>=6![<%L1]N.Q=83@OOBI!T9H*\9;,O$N(I7W$#?*!8^NW%9#C>3 <
M)VD<PM/55/Z)0AW+OZ?2#Q6_UO^F[\T7TWQ6@M;'#8I8>_FS3 ;(I@"G0:*&
M>"BHZ5C=A\&$C"*0SQ=I!'^.(N_/,L_,O^-H!L-VOAP4_F^1)0R;<^A/7'Q0
M%"-MZIW&*.99.4ZF9<]0IXM!'#I=90E&G0ACC;[  $['^%J(?O38+:.@4EG$
M=,':R.Z%^'$!NY'"C[JY3JGD.24U^G,?TF-N%>*?I-L>[_U5CW2@,H5-8:/4
M%)#C_4?Y+(N9;?/1#QGF5()(GX(NC6Z5:5-+*&:N.[<<]AA&JN:/OW]^G[6_
M@[!GZO&7&Z?QMF3U71JO7":=,C<[I[U%,@\J3_I6$0TKFK!H8<Y*)K*20[J4
M4_IP)^[1CM@_PG]] TT7#E>+WYZ?OCK2#+;:LL]K,AK?J(_@;87!>3;<#0[V
M]H^#,X)_XP>HLT'<<:R;W&CY<$M@WRZCFB%^%5J^.CU6V8F?1@D[\,)?'PU!
M;M&IKY$/ARZ==^/:[G:O>.?^U<;)^I;[OJ,>H\3 *O>AP6JPE> O=ILW/-2F
MX>5#H0'FG2S+62W"0$2249'.VS?"QNV +;7\XW8 MF5:@0WPR-#8R3<7&=N2
MT+?#Y\Y.ERVUS:9FU[:5*SJ!QN^C1 =A_39./+>,W>WB:24!G/Z5EE08'VK0
M_9/#P\>Y?]OBF&46Q[S>%L?DSU4<LQ2-NH4Y=&A4RO8O.S*,"M4@#Z+2;0X9
MPCF?E;.TBC#'93I)PO^U-KL,ZRT(D*]76DF&3K,!_+P_&B5I(LW=G=^$;LM?
M"E"/9H6TH)\DE?00BTHB&1XH&'B%P10FYS VL^Z<7>?OM]T9=H.^TP3S/H&)
M0,3&@!NC<S<%BID/553RGXBE3&+3UU7W,!Y&['CN)#V82\1ZIT&JX*=A@&A0
M1+O"N.&MY4,8&GR>])P<$WU#SNN@5)C>AW$C<-/%E>#D[ ;G_C/Q%K:3)[=0
MT#^MWS34+0QXV?%MD<!!0U%HKIN_0?S*E(!9._V>GO1"21@*AN=,\5O)1^[\
MV/-YFF7F6AHNV [GW-TN"^[Q$,]N87TJ25" NC?9"O.R3*Q%P)A"W<[2J" #
M%;-[23;+9Z41Z48+/=N' S]MOC(EZV!F:%:&8Q7/4D^21,B]V80- ._$OX=Q
MA-BGSVWK;KOI61A1ZW-($@?2(4.F+ JRV63 /?=B.&"0Z 3N)./@V]:N@/\V
MDK>=B\N@O Q$(D#VPXJ6V7BP-!B.K\0!G7/2PF.:2*=#2B'5-F++AKN&#9QB
MO(9FIS$\,P54IZA*YM-)L;A<LLRC69J^('$PZJHHT!WA=BM65#]+\FK[A/8(
M=3B!>TWA!>&-06VE<Y$W7/5R5O!'94J]$?6K//<,7^3!J. 6Z\A#QX$WV;,<
M0#,:A(>!\,N:>DI&7=L[C>[+T$HLS8[L-T4!;50I=KUH<^6P.C!_(O0T#?H&
M^J>E!+ZM.BQ!S<_@/*&#PK2SZ=)KO-\H($Z'C>XS: 2+507SI>23V@L'._QT
M&$V<\.%"H[S/9VG,R7]X]7$RP;%0.)X.@HH#-OQ8TDS\%!/$)_<$T2#ZN"A%
MXDTYW)52]H,K/)[)<^F%P9BDLX3_\"3#ZMV"&Y+9J>,*TWJW&I%;T0LEN#VF
MT4XI+T1'FFX8-(YBNM*9-+,JWHE7ZE>HG>_5N,AGM^-\5KFJ-+./1[FET]J^
MTCW\Q?<E*=)W3B9X=O(NFH*P%.;\I[ON8NA!=G?SR)?P64#&)BI@B_5VL]\$
MUHS09W1F/BJU+H[1&K$#I8._;#GXX2B$(P>FFF0=?NPV'-(/(4P*%5V@@\ -
M6],<;0/GV;BC.+@-_\1M3X 6R1,EV1T8DI)]=WYDC^_Z,0$K A^C7M2'3!'@
M.$%R>&G 6XHCZ6?%@R$(D5&28]!>=PKM.-P"42#!'J(]@RU92D<K9WI)1P^-
MD4@67WR7E#2'>IQFXEDP1'?+4PNS3V5Z82]G-+,+X;4PI@0V3)R4L!DHW!_<
MU%HYZ74OL066O;"]692G.N!W9;?AQZ$P4J*CD=0;D.SD#D;(WU2=M]JTZ-G1
M%KO;[NO16;SLJ)E8!+['9?8?[AT084ZB:!$?\H?,-"D>1\F%WKC'.>@VWS@Q
MWJ)WV\684\Q@BJEAPH<<62[+%NS'I]M>?VOIMJ,M+'.!*/^89[.EJ^7'2^^K
M;TYZ5PN,N3K2:X*IRQ=>[ 9;3',)5;B% 8Z5T9,FN;-L4.0?P",!WP(^ =EU
M?HP=X$ BR5=OA.V24: =*39,G)_5GIE&9>4-2@(F]8??9X9#.R]+Y*[!($$R
MJN:Z*TBP<[SWUQ[N.L+TR[,YY,8]<&&["K)_2K$?M)$P,))B.0%7]=$3\'F9
MN0,/V'N'1 ()-+:-V\=;J&KK4&X**NF<!U<4Q"9)6/:.+NQ0T%^=S-+;R&F"
M[:?=S0N\45/P>"D.N6FRNX6>M@[EO28 7PWG5G"F%+JBN ^&GN:* \Z*@F%P
M@9M>C(("[\9<-5,-&@<]/(KN\J+F)E.IE^_]H@Y75=[; DM6$UARLE[ $ES,
M)/[/[Y+CD]')ZZ/X^-7^T?#H\$A%+]7HY/#DU?')\?[1P?'>_QR<''^W G"4
MSQ"Y+Z"9WYS]\_3RUS XOSCMWH#+'6+_U[.+-V=O@O[%F^#J[/JF?P-_<*W2
M?[\_O_D#QWYV<7/^VUGP[FW_8D7?XN+RYOST++C\B=[AZOP4W^+ZYO+T_P3O
M+\YO@O[O_:LW*SKVGZ_Z%S?!Q?M??SR[^MM?CE\WJ9@ZQ?V![Q;8-$T;YBN]
M<_NQ^)[3)S8)'JL1^2EX7"59:/)4I?E&_".OIFX'/UDA<T/.X:69&;V@SSA2
MR=YB2@S^Z"X]7+D97&KM9J]>B$P)8JE&+DTJ]X(3F&![M=9U2*!LU6:61[V\
MN>T^ *=1C(GV%ZD:P8]>D_=4$9S#F)I%K(H70^S*/"W5]_H?/\1).4VC^?=)
M1L^E'_W@:[MC&.2=PCQGE(K"(]W'7XME<;B_MWN\QP\&/5K%^LEB>.SR=_]1
MQ<TO#_;W=U\==W^_\,<+OSPY>OR-_X/&7=2->GDG! &E):BF__SN\+O:M']_
M,/T8[/M' JY$8];RZ7?=RW:P^^K5\[F]9 A>1-2;]?4/P?/;[?_3]?]JYJBL
MVX+9W\.Y7S"QQ[O(S_>#_HR\P>]?'.R^/#33W68'?Z,RT8]C<+#+%1.+3Q:*
M;WP9@X.56LCM,CYQ&4_!X PY"AO\_\ET=1;S2VAI)RI\0.?T#U]4;_\'&3.+
MG57?<ULW'_"/?!;LK)"![*#AENB!D.\Q4"HSF7:7J*#5X2A7:AJOKM\O+\[>
M<\#-Y-\ZH70;4I J# VFEB Z\SBX'IX&F$55%2%<OHYF#W;:UZ,7[' <@X'R
MJ[4X=OA;7[#-%SPYV3W8>_G7;E?PKYT.V<'NP>%AY]=[N_O=/UUPV]?'N\<O
M7SWJMF)C^*?9RXVQ)RY, 1$JF=4P)Q[M=[U^A*'G&8Q/MRTW==W?2 WFSP75
MS*S"LF]7_EE6_C>I)CJ5RD4Z=5$<5D0*'BT#^\?/+02=;F2 _SVDM7R</#S?
M<I_9<D*SR&:*'YZ4ITKY<PK.S;A>@5.JJDHMLV^:TJEFS'ZT(-F8S8?#&1+R
M$]P0V<02[IBIITKJ"MVR+N0TL^7RC:I,SPS<?;P0'VV%^/$ZZUHJ;+^V%#\8
M&'@> ;_V/2V7"J%9#<D.5FC]-.UJ>9(9ZH]*+I6C.F?$Z Z'X 50DP$#P;45
M\V7KO#\VO.)[#"]]^-_+>I1'/)2'PR_+]VN.#@]T.NG).:[]5Z^_4H[KX'AO
M=^^Q/_Z,H_5S#:"V^-W7AX?L8GB8QQRKH<"POZ=3 2^LU^P].ISY1<S!P]VC
MAR*<*S!#J(W%F#AZ]8/;G^341( >?P"^_#H'8%=8^75S?O=V#U[[*T=??%(J
M</LZG_<ZQU_Y?0Z?\#Y/F/-')2%6::4?>5CO'S2.YZ.CA_'Z+^BJ9TU]_.TO
M)_O/' ]N'\B-T#C #2G54#ID*D]))77-^G-,<7ND6UOA_>%0I:K0K75?+Z4>
MHAUF#48PFJ]E!<:OIGJ"TTG=YOA7W8UPC&&L$5 @SPG:C\AJHTE7(N=EG4Q(
MO8K^&ADT(N&E"4X-@P:<B-1WAC,ACTF=4'E!/MH%@3[L;B'Z#"4&#R#"EXY#
MWVJJK:9ZJJ9:B3(5C1U]DJ9*1@U^F:3TRYK^>P8+/YKC[VZ<P-5.9!'? P4>
M?4^3_T5MBHHYA)H_(F7IZ[ VVJT8M"BHPGF#%'($C[M5&:P&\N:ER(V#3<NH
MGU<Q":;@= V+9-!@/^SI4-Z'#)MLH;:<9?SO81HE$ZG]<B<&N<]PL,)[=1N!
MC%=UBDK=RRO2E)1QL_AXU0#'5SQOR\LR<YNT$@2K'#'CG*E\=DZP'%;@ \.]
M9<26,XECKECUG'RL8(9?[O68N]!&F]K$JDNVJ7;:OY708/'AOGJ+M^S>MCVI
M!(']\6*F:SG)!F*DOC%XV)09(,6ETM64M/H49(\;/'1XAFO@AU .&5W!)9-/
M*A%^U%G^K <WYAOL[,3&1(R-YHH&^9U#WV>)PBS=7+L@>VK5J%#YB;V-B!"W
M,-?\;<S;9DX(?@ 2_;D;A1,>EF./M%Q#^7=I?:J -<(B=)@XO+:M:H/+A9H0
MX<*L,L<<MS N%.C^PUXP@>>.RQHU:]=6-WQU#5I->I@QY5N>.E#S7*+A2(PX
MAO?)<(K+R,ZREQ'OU1@SZ9'<TBD'RUFUF?C8K]ER#>+N0(9$.()X!,@_ <=*
MJBI<LB=/:#2#G1%1*#&=&[Y8F,Z1PL+\-=]:=6O(LH+2JI<.FX?&E"E3-"3=
MLRR&3.2;>G[""INM86NXL:B;FFHQ):G#8Y(0V5FO7@9>J-%,>"&CLIQ-X!R#
MVV-P-\0J\C3B@< NALFK9D)ZZ.O7!"4@RX2UDM0G6&#R<,6=<>50=3>B\]Y$
ML&SV@6W;&!SL[^[707=*F$6>1[<[6JJ5U+-5X:RYU*Z0<7$:S99H%PH7 W*A
MUYT4Y-04Y9?=,:PS'Q%?.'X#ZC!"4;Z=)6E%9GD&XZ6=BT67V$\W9V4Y@N.(
M#7<X:R?$DYJGI%HG.;H4U:R8PL:+-?]ZVSAV_MD+5'8;W?+F024ZFJ7!)"G1
M>IV!,#.,@!A<_P4^$A**-\GM)TC:FI >'D5)RB03K""8[9,S(O0S?2VX7-2D
M)(WND<^:::211"7/P-V>HU(!*>;?UX>NYXIO"]?0MJ[?F;;L;9&799"I6]@3
MQ)*,O.Q_](2-5G&'8_-+XI?.'1;D6@.VVD#,@63HV-_!:5@DBGB5SS-* ]%M
M\.7.,SPYR2&PFKGN8?':(@4WK+>9XVD.0C^O<76;I^NKAWFLF$F*UTXH0$3<
M)B!7070'ZZ/9V]TI];F&-5>ORT9M)BE:,/B$+2/BY6=@LAZ<,/+ZKBS10M':
M&8D+];)2[)#8NL/65;1\PAPUS#WR:FY>'>13-"5F&58EP\N!R:>TNP7_4Z"3
M=*C]+3V6VH@E_,B<O][+"C_O9[Y 4H8X*PBQ!T,)!A@28PL,E2GS39^$M@T\
M%)Y?EN.(&_Z,BFC&WMX(Z> G _7GGZF '6"<Q" .ZVU0/*-9%N,@S(2.$G@1
MZE !6XG$CD5 ZP=YCMUP23G.,S@TYZVQ!9)#."%G:45GOOD=G)N3FCI9*H?,
MI@9XOUD;H&Y>+<T>^((/?KE[_(@GMVP0S)J^.-QM ?(,0%TSDN%YT:XT0[:1
M&;GD!:M'9E@6 ]NZP^1\"BI_1WK'B,!Q^%+;7SL/]74/'M'2O2<.0>E&S@8J
M S]DB/HKO\^8MUT_T?%0KK"%Q_YA_.*P]<XA*$WL%I22>DTR_5=(QY#MX=;P
MNC LC&8$VWF*R1Y;N1I=CD:/FM'<I!%:-B8%.4MNP$!N8$?&(1<^G'K:NP0_
M<!)9NPG)+5(ZZQ!@)@+98@*@)Z9]13C9V)*D#]L9NI%2LO)&T#&$".SPXE85
M8AR VD]B;WQZ$.Q[&EO'<8"]]M/=]V,[F9M+\%&GW=3&S-6?[4YSBZ<HWJ0T
MI*"84&Z7,-A1"8UO,)<X#U[AWC*G[P9*>HW<<6XKR> NG4,K9\5=0KX$=?Y@
M&87#>TH]K&#78(,3)!?];,%[>'8*WL>+A]0YB6R$LHG6OG1.WP<3U*J<R /1
MNQ=Z9/8+OY4SRJ[6+*"8Q.>R/:[2,@_^+8%(Z@02:7UBFTL,)6Y&2DZK%<ZP
MO]^]W@U:2#*#_=VCO9/^BT-XYL[Q@IJWK>GPF:;#LK,46POB$1:$]'N1'F0<
M/Z^%UHVCVY;KW<FSE!B666U$P;L<P^-XUC<NEH8TDJR^5RDV4=H_:(GAMSQI
MNU&_U$9] P[M %M9+8\1;;LU.V<(8Q04]6-^,[]*P\3J#W94#[>H.?ICM=T@
M7VJ#_)SG2-.'@=5EA\.?Y.3Y ;W0Y _;XJ_JXY2X?&PD-"N5E/%^NB"]WFL5
M)!_+]169N-NG%"R]YUY'?UX.7NWB9'WWC\A&\JA7I6XQT+9"J(70&\2@(C?7
M-;W3ZDX>>'6;MV9+7[2CW9-%:]:5V>!<2DBI3]A4"1VUY P5F($?Y]CV*HBJ
MQA+"!1NXBDM?QH/=EZ]Y':W?B%-_J_+;(IJ.DR%U-.2DDT[?>5# &?<AI82<
M;6A9"]%'*!3#0@D1/"EN&-=]-"?C>L;($/>^X,_;>-3Q'K87?6);O]4[Q7^O
M)?UU?L0Z^];79R"@>/N(>@I;IEVZ'NK,4@,0*C$LR3W><KRC0.YBN%9L"N<\
MUZ>K9+2PK\IXEL78LA8<D@RS6_ B-KW5ML$1.)JJ^-;H8?4Q*2M]/G,G%CVB
MT)30VKB9I;*MI=.<8EF\B7WG ON*SVNWWFW.%DP\+'S[>6_;@&:Y] R5KC>=
MHW"*V3O"BK4?<[:07<HU%^05,D<7>-2K8)[& GI3']5P9L/(%-A/&+EHTM^V
M?2^"^-KB"8GL(#>>F)0V3+WV,+45$JQVE.0V*+!Z00%IF%8G$W&4.ELBB6Y5
M3ID^[_)F#JG+@'7N.A(\"Z.,W+P.@<5"V.511:@7&U0RQWH/-S.QH.2%/G Q
MW,?E,H^)^<&M@KL\G66$#N+3S7L;#^(T"A!V),W6:R_AF "['B0XGM6!/4X9
MBKQ;VY?V??E$=['$J*P$P=E54;,MS?L$Y,;R.GQU4Z52LHGR:.P1S/.9)WR2
M.Y.]R0L(?X^3*3?D9#:@1M60X-:PR.D.A=MV;<33D+<E/!OM; ;JQS.=?!W"
M-P.O9SUV9$=0$6(>=Y)=M1OB3>0@BN E08 -4Z>;NT4@/"*<I4N\J>QS6\";
M-P=S=4RYQ!8R&8\_1K\<,<RP3\:6!(.Y6#61<^5,5F;ZPJ./55&*/,*N&C8P
M\M!\-R89WND.[->9,IA%"P>G=9SJC>_Y_$]MEKJ*8AL-K1=C<KBZ&$7.!@)]
MNQE;=XK\PD&:+<FW(^#58;F"Y=%8SQ"T)F(V&#Q_RLLDJON1PK_C59CV=@-Z
M&4P5US=B]V [RZ9A&+!NXQ:)U4X<8UKI(KB80P58]@V>O\;@ZV8Y#"\8*0K<
M?J:\/&]WK*B*@G=%<A<-Y\P2/OF4P/"J2?V/X#_#8+B0!DR.4& >6,\PK3CQ
MV>08]L7@+HE:W>!8+!-8?)#9(9@N63*4.Q.F%?R>H8H)J0I;!65NE!"ZFT\,
MC@> 7HL?4IV^(.)/R;E"L0:=/\AGF<:)3.A:O&($%PA:?)9%DT%RBWLTG>N8
MOZUU25..T82(_>)GH1L&0DPX9>?=#, 5@V*$P&*%28@RQ+>B$!&\2]>U/7PL
M, !9 XH6-?$A,CX3EBUKMFU(*!=3D\O;W.@0C,3NP'Y-9^2'.N>U*B0DQ0C<
M!!Y$!P"A3\J$=:,< @E68>&HY="-8CALX9+"@M<G408VDR82M(LV$O6F/L(8
M2O2/0<=B01A>9NX+S[)W55QJK6]JQKVYYU-3F]>6]W'K267<(M=A,,[3..2]
M6)8()RR':5X3]& (;A_6_M5$>8")-+CY;O"3K)^L6EDW'A9PYA&R\FL& !Y4
M[#I\LRP7MC&[,%M$ 4:8L:SD@%'BUH'HF4<5)*L,1_",#$[F,Z22EY"7'A2<
MPI4&4S>2=B6T(*"[IHBXIX>-HH]!1JS5H0E?#< 2'(=!F1-.-0';A+E8,F&W
MU@HOP4T!-K=D#/1M>*8"G)$0I*[ ($R C=YF(&FW5(@$H]9 6#3C[3MBQ0$B
M[;(AZ>0J&E;PHRDH'2S%H!'?@;OI_T1G!JD&#V];^=^;&1Y$V0?B9IQA[%>&
M6\$,D'%,FMGY&7[1\8KLN4;LX_\K'X!#46&Y!:I+::%+N%4V\=#D+L$62DWU
MH=F_L0(92$N/7]4KG"&\8FH*,>7FU&X!"U^'N# I_DM]5,4P*?&?7($8VGI)
M7#$7XIBQ@'"'7O^L<>7-]7@D^U"41FE_BJK>6*5,EJ(N(]8*M. "M+/_?7/5
M?W,6_ 0^:$9;2G?#D&^LPRE@4UX*;GD_I281XD3H54![ O4Y/*PD4Z0!QM:2
M-IIQ59 IQ;/G=P/"_%FG.?L?;8<5;()DFC J8\0S)6.G9*.MR?6;HL-DJ+14
M]^A#X/BQ?!%M./PMZCN_!R)1M94">'7<<SJR8-HJ2;GAR*9BT8/3CA.IMP-I
M2JQ3+.-DR&DE<JDX4?VG\G>N7E5_^\".*(GTRGEIF@@<-4^]-^\[@FG62'YG
MS7J\*$_>6YPE&RIB!\'QT E/(<I"T8GC'?(X00^8M'K'EWGZI2VTZ1.4P4-4
MMP>:7O%966N/#W:/7YU\2C>.D]>[)WO=7S_8-F.C.&07M:)^CBEP!.O5[G$+
M;^9#G)3M]]K;W6NYU^'NX>OG.[0.:0SH]B\DG/Z\C@"='+S[NZ]??2+#YRH/
MJY/Q<U7R%7CK)/[/[Y+CD]')ZZ/X^-7^T?#H\$A%+]7HY/#DU?')\?[1P?'>
M_QSNO_YN!;(<R^UQWJU]5F:(U"(^Z/]\=7;VZ]G%3;#3VDG^NA?<7 8WOYRM
MZ%NX$QWTX47>P/#[%V\"?)L^O@LW __O]^<W?^!5\*KGOYT%[][V+[Y>;_GE
M>A3;9O-?!46Q;3;_%9K-:P%L-)U_?.O!%9ODE6XWN ;::]LFM6WO--ND;ENC
M/JAO6C+35#U \V:H>;H[HUH6NXY.M**E5DT%\:B7./,<L'-I_]8I3[^_^]PI
MI$91TTO3YZNC#X[II?;\J_SLL[,48.BUUZW.H6D<**8O,]1=RO2H@PL1'GJR
M5\?[XT5^%)ETBH8%V<X%^A/=T\N0FOP:%<-Q ):FJ*@Y/+/V /K(N6M;(SS6
M#+O!HK?#:EC*"ZW3GCU8_3V+%3R8*"? :O11+>%HW$6Z#CBQV#\<::(VC*"[
M:00G==P-8U;%CK6^#X]6XN 3/%RQC*,/IJ 75$BM7N=G)8;,'%SO6P2IJ!A9
M]D-*83.E'F,^$>D&#E$5?6S)E3LXC&2$&>A)(IDAUAT>;'3.Z?$J+^9FK<SB
M$;%+,N!Z$B2+J3VJ9]/1SO/=7U$&?5[D2.N,@X4_6)%D.AD>VI0/7/%"I\/O
MG0U0GR/?6@B9E4;(BSJJQ3HQ.J[\DCCS4USPY<[*B"QH@A=7,D'GE9HLQ6!&
MV?5K! G\)M25%M%:VC0LXH 1)Q:DB8;K$W@:I*+Q2L2^3:E;IW!W7J_:;(,D
MN4M)O&5&G-<<-$FF\LMG;VWB'UJ'![N4_4"@+>; )]$'S>]MZ+$BA\-4+A.B
M3Z'_(I5G#Q)$MN,1HV^$PA!XTO @W(AJB L'OHQ;-NP"4O,7+BV_H%JH0*;S
M!U0W^^\9*BXFAC._8^YQ&$OW#302C1+CTTH?I2""B/")A0X.KMJ*Z!<2T3AW
M1(_.K:J8#:FJP4:S98U$=CJ5/R$:XAF7(RB4/$08MYXQOG)K*+:U#K3]J- H
M,9O4U]C"/A_/:K7C!$J"$Y^IMG'GQ["+B+.^*+#@9$(@%=.$)F\V&^I0Z;2H
M]#-$'B$FI#G=P?D#QH]WGFBD3?G8QVL#A4XQQU]K3D\*.@Z)(6$FZ(H!30B6
MO#6-/_,XK*Y3X&6-6O@*L%Z>"G=AV@=.(:+'1K-&IUZ[L;,3+9NSXG#W%6$E
M7%LT,E!4<P8PZI\(L^4<\+O7:UWR*?0B*[<H@^4ORL%1?5&HV)80Y2JV7*"+
M3NKV%0J$D[0:%_GL=NS5O6I&6/O=!+9K1$J+OG-T6AT0N7,_5K4;#XK\@P-H
MQM1K#S=]*P<1*X)&$9A66A8?J;FF1K.B8CY8JBU9ZZ/GIEF39O0P0AN-(J96
M, RP;CV <55P0A#%2EO9*FWK WM[?8(W*ZV#ZOS"O0X+SEQ+%8;U,9G,)OH+
MYV<=+%,N]'.G[.T&?M,B$-$<#-87SD-K+"W17 ,OR15&9OP&\7]C]C2/F;DU
MPL3YI8G6-2K'(E4Z%8O%U3XJG 8).^L.M@#_3.*! 9Z_:(;Q:! 47A]QIABE
M7"KUH678Q@-,*=+AT#;IYWY$2HZ:R5&.627G P:<RFUY/,0'- #9YBW3+B:)
M-DD2AC8_H/Z]^BJ-FFB800-T.Y! !L=F$W1R:C#T%BYK.UR:7$@P0EF&N*85
MVLM'48K03F+5XS2I8MM)'J7':42A!6XO1I<.([=87<%/K'NH5U-WD\N6:<\<
M(B8T<=Q-4;/66J,,#QEM.SFCBI4M30K]7JD]C0XWY0>NH?>@?EGX!ML&$>M-
M,X E%"GRW+=Z.,W>0I[HD5BR8H5-U)2<A@RW'72/E,O/BH8N<(1QB,/_R]Z;
M-[>-7>G#7P75J<E(*9K1:K?3[TR56E)W]$M;[DCJ23+_3('$I808!!B D*Q\
M^O>L=\%"4FY;)-U*U4S;)@G<Y=QSS_H\<8XJ'7L_? WI09EP@UFCX12[1^!V
M(@T*[XX)\6T8^3<[WV#(O.01)WI*,- DH6*94!L3<I4:,T?T$3K]>%\[5>]Z
MAUJ+/^C2X-N4SCK<_'369<&%$"BOV%5,'3,OV>@O,TLIZ>1.\WF:"907XHZ
MI*O54EJ7-6VZ0Q[58:CNO*(\L 2)180Q5/CLZZ,S;:X2K<BTETA*&/R>"M_I
MM&LH-&*$\_MB;M@,I)%O7X+Y:"M.Y(WT8;V<PR_GN%K1Y[Y(L*5,)4R;>.SH
M/.B-2GWQ2A\X\%LY!TBO",8N_.'N<8:^*)VO01 ^$*X:HF7<IL-RO/F'9:VX
M?+^-PW+=A0PD]XJ"E:3=UJS"'%FLK:J!F#>@&'T71;I/O-RTX:D6"HUL@2-!
M&FSN]&U$Y)5\TIYU2GF3])"C+-<BO]'G^+$#=G 6\7V1)K& V"9%/9IWW<"B
M,6P,0.I&D)7:Y)6+;> 3L\*5[^CX2X]?$I$[7$T9.P%S'WS,L@Q-&-1ORZSC
MUUN@7N*/A,-%*>;Q6FJ]?A,Z9FD(J33J:&.\<>QMR:*L@105>$QQ@3U,>HOZ
M]B5"FS3XP^G%K&A0;<U]( :TVKTV_I%Y>C"95%*H0XCM30#Z$* 4@ZO)/=@0
MI5>0T?5H_*;O5"_^=C\PTN+Q6- 4.S".W 4((5*&&(_G-0/81#.+T-S:/04'
M@NW:)MWU9O-UUXD[1R\5YL^3!&N>9\&>TQ BFR&EL<T_ DP"O[K%5$_N %L<
M"IQ?4&EM&+KYJV:SRS \ZY;1U%>H?JT3G,39H_^  #X/7T+!1D1HHNIU6TTF
M>J]%'1UCG! +*@BJ#Q^&8*RXUFE<6CB9M/3&[Y,<H+:UB(.56S(O.>%1>'9"
M5+I2>7'D>$:8(VE5T0<SEI+Z+5)!WVZ^"CK%T'?Y^.J:87C'A/#,>W9J]^Q%
M,7UQFVJ%](*F&/VSAB7HN'-X;R\^;/"DD]D,F0L_1B?M0O"-:F=T UUC:]VD
MIRECS"<&=1S"N2=H)*F9.O37V&&H\ZY:0^IS]>JM-Z?WKB@-7HFM7'5I.(1=
ML80JN3*MVF"YR'HV.OR>;A>]C#'JQP0RO 4$S@5??VPFN<(:!S\PD1@.'/BY
M;WFC>A^60;PU--@[\#M,56%-$[H;:%ZK-T& 51&1-D]Q2'27VHI)_/HD'F.)
M*]9PTFM#B#;?2MAFN;C($;92J(/\I4?#I+R7(E&;OTBG7!Y!4B(I6BYM%2<E
MB *WZM&"X,M@M8U/Y\^VDU+!7NC,6K$O)#LBNU26#-TQ50\4;*(9SJE?(/1E
MW?CQF(UIK&EU)X6LX%P6\)-MLI;>;KZU= XN,FRB5>!<E7J.GO78-7F^)&B_
MJ#,7]J_UN D^@PEI!-ZY./#3'.JE5_2E@-E<0B2M-W?.[)K&<V0>\YR7JL:@
MBTD,^3[,-8W(S'7%_M_(S!\,%9&9*5@(^:-\QQWT@?1;V%.?P_&=IQ(H@JF,
MP?74NK%978[OXLHT,L<X(/%62^/&E QA1:)ID3@T7*R(%.H)5XD8KFHN.8"'
MF$I)PA"X*MWP)S8I8"83#,[=8QR?DNFP3,C1JO"2G*-3-UJ7NS4(+G'!^A3L
M/8%O2WTQ_H!TGN%CMVQD8=B?Q*+$S#V5^G3.3VT >M,V:=#]O76KT(/A_OXR
MAQ/O*<K2T+WZ4_Q0"<[3;2U4)R^Z\\L%PK!N17-DC=K5P+'T#%^M^Q^[K6O4
MZ#>C:K2SC=X>:L.F;TIG-AI3O/6EVWI;B=_\>6@:3J3[&O%AS$=A165VVH(H
M]J)_U06W5$;58S4W4S0GN1C8&[A+@_)**+YQJO#;^!2F'Z)X%I8!J79P"UG:
M<H.7.M5?6Z?ZO/IR[0 TR_7ECQ1VQKL3-&5T;>!OTBGYHB6_D ,[T29!*DAO
M!O+#J)GK6T$%H=&?7;+!J ^ &]SJ7*R5V'53^F1DV%+I6T.6$J<T:@H:,4IT
M.&A6W2(G()A(\[MAV/1B8QOZ0"D^+HG-.(ZF-6;^D%('7T1C0,7K#[(TLRP6
MKV:B"/?V[31<8D)N#LO9@<@.0[4/W)02FHN4KL 1CN),[Z-.PXV <D _S4HS
M9[--"5;=.Q\P^UP5[I4N8['B*_R9IXRO42;.2D' -PH)H57:RO?0536>5PZA
M75OT;8,)6N=RK]KP!W_?3PDW7!#YD1VDIJ &OAF+*1QO?3H&3Y4L>->JPS 7
M6*13Y'4L0+O$@^B7X?7P9&";X(2&FFUY%$1P67*XW3-.""/]$P@O7\7P;&ZZ
M<G$?%!B?7<;!%@QH*'4Z=YUATGQ($8X1]?C-??N^*3F^8Y8R!$I<@AQH+V,Z
M'[16<834TR/I:!?CQB>.(HA\.@&6TLBO!+!MD2T;9ES4Y7S1RFZ5_[!V<*?E
M]R$XLU=R>*JEM'SK 'ZZ;)!(-I5-S$<JY;C?%/0R'($'T-=5@9>[%QW%,U0\
ML'OJ&:TL\6AO"UND1R[8_":*MQ;*^1;ZMA 5BX'^_/M8*7?+H%4/23I5^(!1
M58Z91]CSGL8-'[>+=G2K:O+WU]XFLUPQ7"ES2^33/[X8R5\JE,#-^%T94H\U
M4BTNRN"%U;AR+9N/>#;2^2)ZQ^KS\#MZW-J+R=OZJ1^38EPK2 %9?M.".'3\
MM.4@5,$=3([X3Y7/_O=Y"!5_11FABX1W]%-BX]FG\][=I5-9]:5X5-X&O9#@
MO9#@]9'@=<GY^CCQOFSES%(ZS#6"WX>%E"&#=;6"-D?8JLC1\&GU>,C"]V69
M;%7750'S6YOF;F$A4$!X9\$5%_T$7T"=G$DZ(7[MN1+>68:[2BCOE &OXIX2
MZ\O+W.VH_],^?8EFOZ/05G5GI&W\7S5VU<44]';Q M2_4G;!ZM?Y\:Y4/&0(
MQ)_11HZL^L--\I0Z&[]W->P&5H. ZSRF1*M#0+PW#:D*H<5\=KXGL>7IV%9D
MS/-#%U_F^O41;]BY /T$=ZB3?YMH.!-KI /&H 6%Y!T5J5MY@#NT!1Y#*\!8
M >27==76+!&C@#F3KH<B1QNN@EUF3.R@QH8K?3(%G;6KZ)W.P#[[1+,E$.X!
MYFU(?Z1H3-RGYD&$P$J]J[II&RX<\ %/X];H6<392*F >U JV'YNLC:U3F)*
M*U64BM @GF-2Q@]BTXI65/@;B0R,,<5O?<RB@F4+#Y8];\IT_QZLS+&A+IC?
M_^[M_G=_^,,?X+^'W_6N&1I8#X9J^&CU:(0T/S?&QA'6N!F5WG$DP_M4,1PQ
M7FAWT(3[]X,&UCL:4II])UU'B@:)Q8.%'8PWW#B3\&1EF@['$DTH*_N$9=TF
M!W[M7?4K1/9B0AF%[?NQ7$_L[BD;&LSNS0J%F*^>O1)S<T @OW_T6ESTXN0P
M 6LR;B_K"A,(/K9U2NDKMEQ+?I=6'',SU!HLW\02++ %O/#]*>,I&],"_O*L
M0?_E20&O1B_5?&284?P"T_RR&^.*)\*&(??,P"&:N9+0YJNH$JEBS9_%X#-/
M"+">#"_W3!=,]GN"PI9(MN%<USU5>G P<QA%)S!<.'^2T6R"J,K<<$VM24$S
M\SHQ=<:RS)0Z6;#67]VIV@ 43SY5@I$A,,QH;A7Y*^L^V:0N_BLC8^ _O92H
M/*U$91LD<KQNB3P:'AZI1+)&JB*D;1QA13HH146"Q=!:6#HVD&I\IT XJ(91
M*M*RY!Z0X\,UK!@;BID>$G,NU8R9(M%QTT27K2W]OD#2,,\)^.IT4;+NG?=U
MD4<ED$J8CP3A(]WSZ&4-/$Q@JGT8@Y>3:C397;<@"IQH9[.\E$9U>R79[A'%
M;95[BZ\J"E30[4S7KX15*622I:;V/R9PSU3_WD'^5YH9#B7)'BT:7UP]K7%K
M&^3(;(H<-4!/?<7AQ01<[._)[5+;L!N3=>_&Z^'Q&S[5OF%NJY<4E">$'0H9
M.X1EB2IR\-_NXZP6%%P,QL2DV[%1JXP+1,$@M8]UNF096Q8*V\01X/-()/)#
MFC.RCN3JJ^"#DK(U;6PBQ,( ;7#M)^!VO,Q41S)/H409#X3+B#'J4<^Q 93-
MX'$Q,WTQ"T594F5F^T6_-LF]7;?DNOOH2THNRJ:V].88Q**[B9U$DS1DM=0<
MGQ:22'1Y:3IT'&?C6FK=J-R=BG^IW1@[CV]SS?4Y7V] A"LY%O^!:67PBIWH
MZ5#^,)CJJ,CK"M%U,%;[2C_72_&NR-(D)LX-S#_FE4P#[;-2,/KU3L79P9!A
M?O;Q7YU0WVV.4%M+QPKEO!,O+<6@ 09<. _BH(=G(!],KDNNOR3UG]CFM V;
MEJY[T]X,<:TLHJR#FJ2(5N)2;7HON3:Y0=CX_$3%M4!GJ54;5Y;,P0+>D:W<
MCB0)B9>HB&8B25+IW$R7V!I,1*YQ58E?G6S]<U-DZX=&F;63B456B ;P5 3P
MNG&^<VR?E#2*1CG$1'<&ID.HQS-3&2 R737#0HLKM*$T(MI;M1KME %W*B=^
ML?;2]2'XX4TVR9@C!EMG\1:-YY33K7-MP$AS.!)I(C(^XCX(>#B3&="=YJ?5
M@^)ORNRW."1X.HFBS5O0S:Z5U^-3E/X+8U?3SN;@[D"J)AH: PP+3,';M?8*
MTKR <.DP#I)6E*4SDZ9>-%;:Z,Q)ZS2#V$'HUQ44QZY7-M'">/J*8FPB#$/B
M8.YS;LV>P0DHDFCG>:%FNL^R&=ZN(='4O1^R+I[%]D#@?KB:;"JV0R+ADJJ!
M:1\DI4EXG$P>92:^-U*^$UAN_'WF9+(YC$\[&E_D7 PCY3N0_(T'AA[637J)
M""IOD .! \V7Z[+?_V[_]=YW'0JMV<]B3XK7 *8ZJ'E'PI75UK>HE'K?!@XF
M\F4A 0]M&5VHHPK3XKM?W67Z8=V7J0:O+RV!6=_-E2^[NGX3I=^V'0TY.S-C
MW5IAWG;]V,C@%4TR9 _EFUJ!,#H)0*DV;%R7)=7/JDW[2T[N,#565=%9D:&^
MLC X4H&"7PP<(BU%%=R.)O]L)Y)0B%&[5<4=:T>!7U[<07P)+_ .7[IQ.<1A
MH]Q(U6$HNHH$V]!0E(1!4^=:+JYEY5Z%!!\I;>>@0C4P#?+;&DOD/.#S\_R6
MH*CT$".OD1>SGSM9X-2?UL#2C^5+^HQ[4]I^8S$FQ!QV!$F-[[(-RLVR+^GN
M[4)D6#OB_')5=L%6'%+ ),05?/3FNW=Q^<',HY,15G@BI,TZ.D];EF>(Z9+*
MN.<\;HPAS\MT;&%7M)EGRG.):2YJ^7LMC+X#L)QC?D$9_$ R*=Y-WME.YHI*
MN61LH+?V "[L+.MF<G'X-@/MMG<M*)OB>GY18>]^JXLM[E),GY<&OO?!Z7IK
M2\ER-2@NDIJ*WRTS%K5B-WRKT-<A1TU\419#O_I7/5('B!]$@Z@1;^)'-7QW
MM$\PT6?\B6S*IMQWP@Y),/,N':5L3W)S4F9S. XNC>#3J'W(GS.!96 /%W&]
M!Y]P=P)=5\VI.\I/+(D.*Q_'Y/Q3S)['I5 :._$N^;E94>EBM9_<[IUY%"#O
MT:YNQ3R=S4B#\?J';39H$,2UOF'JG3!T7FO*H^+Q@_\'5CMQH6!Y(0-].L5B
M94>5"262/+PG1.XP2&PX]W)NJ0.3T(D$3_6!,!E!U$&U/_HRX8+KH1#,"OC&
M(PRXP^OK\O,T9NKSZMIH9# T+-MTCM'<P[#K8:BF1"),$M,U7!@[PKTDR(K&
MPQLZOD'^P+WFKF,P@_.460X(0M2H<!S-]O0M[4E?.\'#*CWI).@%WG5(5(.[
M^X.XR2=510BB<.F>2%?GE2%Z81#/*P_M;.VF1#=CL(\HHWUM:=Y-N/Q0E!\H
MBQWBJ$FYMV5=%H<]Y)ZWQ"\M"G>7WM]I-%/5F6DIFEL+I.44UJ 5M*#.6<2H
M&4E&C-T:!OVLF.-8;:H&EJ_73$2M0G!-<EU ::4@1+%KU8"GE0NA,ZF=(::&
M4.50220<."2]GL!78;?.#.%.P=PHC.%OB>7 IOWJYI1NLXO3A:T=W[I&,4@L
M"ZRV(?MLT2#>6"TG MR>Z%.L/&ZJPJ8BY.CMMD+H?JKNG'S0Y=%;).;+B%PS
MCR%YIO[%HV2OI'K#*$91%4(-M<5UE[UB;LN+&90PZ-S6FJ%5H>7#L]C92:I-
M:"UYXNW@:T3>3XR]L(V5A2U4J"JQ_;R[4SGCT1I8W /;5!C8"]S1K@CCB>$N
MPYO^25L7HKNWU@ O,5IU#Z) \A],W(K.M-*J-(::5JWS994=APJ3-IQ+;J_F
M$+=2[N-J!BY\ZS9FO<)7,I:MI3D\,747M$\(A5G[K;J+ORS3R0I!?+Z+L3G]
M[?XS<UCT *1(VAD>*%EU=[*8^.>+1@@[S9>%L+R@DZZE[N-H[^T:F#>X-33,
MLH7(;W&SK<E+&NJEZ>7 R0>MYORI%-NP:>!#R,7J#8D70N4PQ)_,Z3CUCCPW
M%%2,OU1J!5T@#!\>]2LL*Z_1GTB,@_SSE,7<@76OAW>EAT=TK?OO<"4NBSEN
MF,7\ (7+F&J(L^!J(+1A.B1]H 2XE"*Z[WK(X&@VNFAX1^]<)WE?K^!Y-<H@
M'XQ;$12 >B$X?X$'+=1DC(7CJ+KQAOM'P!4N3HZ9R@D>([EX*\*\".$@YI@8
M%[CSQS9>^C1.C.8&T!P15G1:[QAT!^,4[ C0IODX2T,2C"K]^&H*6W]GBPQ,
MC$ZHW/G=10&=Y]!97%XAMT415?B?K@<F)H;W3XHL*QYLX"KN>P]S.JC@-%OD
MN=B%]AF!@6BI"/C  M^[,)H(9 #8@!2U>.,C.#_9S'-L==%M#*3!Q545!8#B
MJEKT>V=\CP,?A<9+V_WB&A(7O7&)V[8X[,2[._N[.]_OVN@:5QU8(8SMW(?1
M3=^QZS]L8A..,^Q')!&EPD$57+ VYZ]0SNU;5'+%Q/.32=35ZDMRAQ#3?< G
M*NIXNNO_2<4_0</U7S6"=VJY-F(336=.2@+%KR$GBV,J>+2-L2$ @RJDIA-;
MR??BDG%NJ5Y*L U$K=CPF%5KS7(4?=G^$%_WZF!GM+MSL*MG\*:D,_?H0^P/
M"<+@$TW,L<&;[EG+1/[PAS]L,RG2]X_=JHZ*^+7/D?6E_DM86>+!7_AH.0J<
MH624Z&T^-H(W09>].XOW:=SY @\=QP/RTXA&(T:MP[9$ #Z=IFO.7\ZFV<FW
MU8!JLMPN_-:0+*3)=%D:Q'LQR:I/$(V7ED(5@^%R?,X=T61ZG-\4HBA&Y&BR
M$N82M@GYHY51!AB,MWXTX[IC[?GJ9Q[. #*+Z&.Z>$.?-GTAZ13D!$V;H:X=
MI3E?*<@I(R5SZHUF]'Z'#4"EL@(L'>)3NSH\"C?AQA.>3LJTQB%OSI.'/^&$
MB#=^+'*<A(P3]L52:]03G[!A%(6QVOQZ 'QTFOS7-^GQV\G;;X^2XS?[1^.C
MPR,3OS:3MX=OWQR_/=X_.CC>^[_#H[UO-J"*X+DNAAZNR)]_/K\\N_B[XXJT
M ^R=PN8,_NSLXN;B_>7)3]'I^U\N;Z[^\>KZY_/3BQ\N3J.;\ZMWU]')Y1E\
M=,E?NX[>_Q#=_/D\.CO_^^G[=X/HXO)T&)V\@P4X/Z.O7IU?WYS<P%\.]O:/
MH_.__G)Q\P_\UOGES<7_G$<__W1R&>W@EZXN3O%KUS?O3_\2_7)Y<7.]^VO7
M[PL%GGI]V.XE7<1?N_KHUSWI%2C0'-&HU(97@3_0=9_2O<PWKRN3U+NYX7XT
MHNTMCD_4JQ06)JX,/PV$X6)AT!D9<+F&T6D\H_W[MW2:5 C4E]AR$2^L,F],
M#:WBX&-']F83#SXL#M^LMBY<? 6?!W?.48/^>V [9:)1^X>9I&@,V_YO(ZV;
M= ]:4G'),[B2/5PMW,F^#!X7YB)*L\WEN2V@IW/?FJ#/='&_2AQ^SOAJ#NB+
M&\^"DI$X''#C.8R,I'2<Z@>%9*/D_Q&6'G:INJZ @=<3X'FO-DM&-O@B>EJ"
MB2-Y% 9 ZVF&Q+7>^FVAK#U1Z:)EISC#7[NVI1B!5;DAQK#F;VP)/+7J%)E(
MD:2G!)VXJFKVWML'3A))(^[)-BV8KB<B?=_<A:5!,"&D6$C4>_03XLVA,TX+
MC5C+KHQEL."X-@T+/0FG_[DS[!*N&D+=/M@[.!I&U[6FH6/R;^'D"6P;5T;(
MBR<EE^MG2*==L2ZHLWGC?*.+>DO9<0Y-)AWY=&8\@B_)//TUR(MYSY53B3)$
M&'""J"44V&"?0P]G%=3*?EKWD2$"B=8 )5:&<3]X)O?7>6'AUF2QBL)6Q6D#
M!!9H54M8D[=0/3V-@-I?U9;ZQNB$R8G+IXTZA0+413#>V-8:FU+ ^:L5@+H1
M%4DKZ>'#?+!XB71!5E2/Y>\BW<_>4UGVX2 0IU.*(C]HW?280&8+KC+F XZX
M+&:<9X<_34RE&$L<JHCI=KXK'N3\9N8^]IK\EI4;+%P0NPI?FU3]@!$27/QT
MTRPMOW/R&2RLA:=)#\TB<ZA]/E8RU@HB2?*IW9]BGY'0;J],/CF=?W)Y<M:.
MB&S\='_+SG[W%.DFOZ:^1"X\X+O\/9@G6SO3;@W;D?7WV[G=P0Y@]+7EW:?%
M#$("GI4&.A,K<6E)K=LVBU-_81G%GL (&>9)$4Z4'YR48Z/T4V$(8ZYKDSS=
MUZ5N^+1)!<+6SJR?&-O5!SA9$@Y4]@BHD9CSK#O_M,G5!FJYS>?*QU8,J>:K
M=_Y:S%;RH/:&^\>+JOH6+^:F9#(V(R>Q#GFZ#F&:+ :&GZI-%T,%6I25JD5
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MTLEXA_CX49$\=DOV\7Y$8F%#B?)+VY?@[)F=-'2!O6-@Y5Y(SZYE2/B $_>
M'RXNWYWL+N"KW71M]-2;%5'4SL^BOUQ<_GCV_MWV3?O%2?SM.8D+:\;7[!N^
MI$O7+1]_:^&.Z]VUNFB$OF@#FK:# ,DGE8;;L,-5SA-]S!AN1;B,F-IQ1OC=
MF7/PRM"GC(5<"5.BA##%"(6/S1Q;V'\8\'8HOO*?WUF*A]__[O#;[Z)3V)QB
M^H4-P(6JZL_OKD[76 ZX$QA"M@7"VA.[87\"8:BU8(H1G'N:8VX;-XI*_/6?
M4I,TW?_%&Q7?QBG8_#2HM@PIB=DC(9'YY78H186+WE#@&TTT0HE0$XV^U V4
M-#)W<3;!)^&.K+(N&,[7LM:B$3<2_/;6^#TN*W\5_A-\P52(M 8^80GA<.XJ
M#I6?E7Z[9[/27K<>_O&7OQ"IP*.)2X=5A#;R/8[TEO/7I?!!MH=(3<@P4B[#
M/3S:"*?HK&9DI'6<%%B"W4@9(X4P@"DQ'&&''_D[.$ JAK$%FOAE^!=,3(V+
M*4E$M',>EPQN2CPB)J?>OUUR3P_V]@Z%(H*KLJ6TH(:?9QF35+2WC&0[<)6S
M @-I#ZPG&R@!X?%SO:K2=ZY+#0(>'GU/]7,C?YRKXQ.7KOA!L>Y 7;\22*SH
M_622DN=Q)>A6>,8&2-Z@GI./0Y#41FA>X7B)5F@ 3S7[Z9E-#:^5$I\:L_X0
MO#T8%[>UHM+*'W5?$&,6G2BA?B$]]L0[LHL^K2=JBYU:L&E\:V&.4U$5)##;
M0O&E("K.VQ&WT))3I09JM>UUT%:#$6JWCR\H 2L5LQ\%&:6-^6W\'=A9S$6R
M?[CSP3NSU\/(B]3A/MC>'HHC3:+]MX='?'U-B?QCMZ?5'_N?85%#YEDYHL07
M<B\A\G9P&_/9I-WO&3JM@W9RR1KHP>DPQ^ "Q>$YQ4+Y<(3 P"NSH3?$W%+E
M\#ETU,CD<,NUZ',LAH$'BIVR]IP+$RL#4#!#=%W202*0*(PN4:[F$Z]954:B
M=H;M_>P@$G;%4#@T^*E"8#W3H%%;%H*&ZBV9KBZ+!Q<.D&7CRAHKDTU>Q<1Q
M/66^H]MT$7WAIJN5;M/A_X'ZF$?G&1]SRCW)3:',I9:4"]9EV2YM[>+T="H1
M"*:&@9Z.@:OJQ3(!NURF11H:=)H1CMP$CDJF LX*TN"(,"5XBGQ3T?X*9V>C
MK-6NH[LVR]757#G-UO2>&TE9:U9U] 3:[=7L>J];$37NLAO:<BKTK.Z:MWNW
MB/!]AI?%/^D4FZPYE&4SV##!D/&O2Q@&NNQ3B[*D0P+I$*BA*?5BVMP%A4W0
M6O?K#JQG'*LI7 T83EO@F72GJI!%+]Q_A<)5M=%U;IJ0_$L8AU1B/&<M%!T8
MYZHCW_$Z43=!>M[3N*WSL5/MKC%P%%>MIL<5E<K(S!],H[VAX=\-E*H9&Y6Y
MB&5%=<7MZ/A]E2W_&_9&ZQ,OYLYR3U$0446O*TTZ'=5E%92>+GAZM_>]9![;
M:X&MU+R3%(;#643;A($#B4E8Y=YL?F%+H6K54TW"WY%G?%]\0)1L3U>-"E0X
M3,YJHP*BU6B_P^%-XC1C5>*&AS]KG+XHKOHD_].D-Z1)P+,UOBN*REAX[:J
MB]O'V,8UQ,%AL6!3S%K097+"'L41,S%?U/B] 5(9H*N2UQG31B#JHQ0"%!J@
M4/^GAXS D9V&!ETX^4%X8!M7BM\ALTC-:PAJF3Z@162?M/]^Z0H*!25]3PP)
M?66'=Q$2*/F<7@L0RXBM4X]#(#C9. 3'UV6ET*A"^'%M!\95*1#!Q9'SN[*H
M;^\")T,I@ZUL=U<=!LY[7 7O;/ T2R%FN<40=+^N]H'(Y[[^-J2OJO3ADTH#
M, %QZM/>!-S'+[4!7W]MP"]><;>G13N"U\*51?:'Q#+1>XQ3K9(+D3C$3JA"
M"&UXM/)8T=,2C1JK/4$\ZDPH3H5OW E-KVLR(F,5@/S*>XN?>&VX(+9F0*TT
MKXDUBQ^&$2V&-/+ZUSG/10VY$1\7HG8OR7+"]E\C?X;EX77HF)''74XHI_DM
M_V7,Q(K1+=&*$?YIA:0I1&:%^Q(VA"D/5&FB.Y,Q]/64D7]C)G*D;*^%8=8;
MTM7M#Z,?V(C".1&[LU*Z^]0RRJ_.I,@>1BO=W/(+;^D#3G6;;DG,L/<3;/RC
MWG7EZN/>-L5;3Z<BE=-8&70T0^FUYU'"19"@!<0*9]0D6[,5I[*QQ$NAZ3Y_
M>J&UN:2%F>+YTL \(7?1]?Q)"C7&AD*VI&<%LMZD\KLFX9@._6LB-SYZH3;V
M67Y7N4#706#\-.[A#9W%Y?N;B]-S)%?NI$:.3OYV<M7?+0.7V"W(G!R5@Z.0
MN&,-T_GQZN3R)KK\Y=WWYU=D??W^=_NOOVQ16K>-\'_^_U9<O_V#1<0GSV3;
M<-6$W^0V\2C%'(]#U20G/C,?P6@88)W.<.,"OV+.K#':>\(E#G2E71G$?X>_
ML+H XVK^B.N&]]R]Y 4W;05Q4&M</L9UM^S6%1@PCN):J4PO+<L&KG"94B'%
M];P8?XA^R=-Y=/(0E\G&K2R/>GUKVW_!*C539B;P([ G0!7-R?2W-A*&^5]A
MA#">5>9/^H?OT"'(XL<_I3F]EW[T7:CMD.7IWJ#1&&>B\$CW\<=BN1P=[PWW
M]OC%8++,$WVS&#9#_NR/\Z3](9A2PS?'_9\O_/'B#]\>#P]6??(?:>!ETQR5
M2:&5G%6@F_[KF\-O&NO^IX/9QV@_O!-P*UK+5LR^Z=^W@^&;-_2N9[F%R=*\
MA--)M^_S E_NM2[>_DM8]VW!ZN_AVO^&=_$D2< 5K#9L(U^V\=.V,3K8J(U\
MV<8G;N,I%2\B_K6)_C>=;<YF?H:=_"/9!YX!LDH<?/-\IW\4]4;UP7LAN35:
M[J[-FW*$Y (1X%G2:ZAO%IP )DC7N'X-*L>JBU^S003ND>,, L](BX3B^3P>
M8T$'>T2N)&.G>S]VHQWV_[D+9+,VQPW_Q8?J\J'>OAT>[+W^CWX7ZC]Z_9B#
MX<'A8>_'>\/]_I\N>.RWQ\/CUV]6>JQ<].&5\OJKN=0OZ^F(BS=1R6S&G=YQ
MGW>;6]^N8&T%=_W3#;RO==_/)+M(O-F;L>TO._\L._\_4C9P6DRGF,2D6Q?%
M84.D8&49V#]^;B'H]>4B_.\A[>5J\O!\VWW^<98*8Z'=9+O$RQ>E0\K%L7F^
MB76+S<U=DS Y!!3&:#U5%JK1C_8CF[+<'L_5KD+)C7V7=J$(.Y$JK3RJ;.JG
M#E:N1RR/7L1R=2UTC4Y G7U%<GD=ND<.OJ55DFR]HD&[&2_P*@:N3);JD[0P
MG''&J*#7-E,YW-FJ=VD_/>2Q?E_B5^5C]O:&QY^<<EGXY*/CU9_\ZV.'&WNP
M%X*?4@'<T\_X5DX6]9M<N$=OOOO9E%1@AB>UHVIYP67R#(;NRRN_R"M;^O5)
M86/^)T1@RN=_.GS]Q7R$_C@R"3,!>7#EZ&-1*ZVSPB5)>263R&1\R=VE,P+:
M85C6=I.O;<(3-":?.XD!NN$6K','RY/4?+H&T3C.J317C+)&-]A..C3# 3Y$
M@H,Q3!)N2QO&]-%&J]Z*XF*,# OQ@^+5Q @TBI@CMYV7=G!/Z^3H)F>@$:[8
MA]'62J\1S\/%RHGP%:W5,=4<.RC49<O<6EN8RGU:SK6<VZM'*7G[>D$ ^J.'
M6R*M\?A#7CQD)KDUKK>L"]%@!I9_;?LXW1+!G\ 3P&JR(L]H*1&=(,UK,J5$
MF@G&3EO00 +./-R64]XE#PW>8MEC > "N=\)X--VAQ%-"'&(FF>P,> 5(_&P
M=W<=PJJF)@?IZ4O4>46X+245^Q?E#.\V6WR'RT)@2V8AR].F%#ROL7BY?6R>
MMWHYGL?1SV5Z'X\?.66[O!MH"T[Z]X]1!8.A+A%$SD&MAL(^2<NIO:4XWP=[
MG2Q3U^$)P)]2=RJ>)[AG1@4</^E&F=)W\1L3^$+V**!>\724WM9%766/BC^@
MAU%Z5NGBJBM)?$D_.[4#.][L2)&T";EA@*>0M;6V*R2XFX0:5(W+=*05KTOG
MYB >%E4C<N.D0P)O-D)C-C2>3-(,H=U8OUCE1?S'#O/(LQ%,*3#D=$'?I67"
MMP\^H:I25LQR Z53Z6^3BSY.X"ABXX>P,,%3P':.;X..?=XT;>HW'V$,%=:N
M@H+'[A3\FGTNP9/H4TVI72GT4#ONK_=R;%\CC>U=;3_]7NQ!A.U: VP]Q [Y
M 36U9T5#T&VW3T.4B58+'CZ,M#59=JUJ6BX+XB'4A+4VS%?4L&):/G_25UK<
M6ZOK-=%7B$E)Q=QM0C-8^4%D=QGN_IJ,7(Y5$<K+@+<>%)S!G0;S.I8B+MH0
M9?.FETWBCU%.:<2!;5H;@1EZ-XBJ@OK#'.)3+NE&57@I'@K'W:J/X:6*<$D&
MV*=(?798L5Z#I-UB&7LY$'2TL="NVCD.0&!-"5\:LPD7CQ$=9@9*!S'>:,3W
M:16'/ZGB#!^#DU/0M>!SN\)$IHYQ-VQ_U.%B6Y@"'@<_PP]ZIJAP6%14]<]B
M!$[,G%$R'SWF'P4&1'N_XK[!D)@4&P[GA';AA[P#>!]\O<?\HWV(J/M-0E[5
M&/83_F0^FG*,[ 8#LISQOW7.?Z(=J^<6UQ$&00(RB>^+LG'7^/+F>UF"PU)6
M5FE_BJK^:I4RF6RN_905J& NG?_AYNKD[-RC?]#R)/G$.;D!QFU%=_V,JG;$
MA=%=\,!_*B.(CXW.6Y&T28W.JQ(_IO[]'?3IJC?ZR;<Y.SY=EQ4<@G26:K,H
MK92,'?WUN6L!0K.&;!PR50@)JC(/Z+S@^.$_9,/A;U'?A<T<)6Z04D9[(0&Z
MLF#9YM(.2RVA8EIG\4/$L!1T'$A3_K,NTRI)Q]R52KZ<PLF&)U=W-3P^<"(8
MF-*;M&W=Y:4/UGUG!L<9OI4]"O"1V[-=WI0GGRT4.2&K'M!XZ(:O$<>F--R]
MZU_RN$!+3%H]\81_\WDMM-D3E 'U!X8)^/TO=_9_16/ILXVQS\]:["INBH._
M>D?SFY>.YFWH:,9>W^CDQZOS\W?GES?13F=+\/5N=/,^NOGS^2>: &M>^^AS
M]6UO@:'STLS[A6JR7YIY/WLSKPI@JZEW]1+U#5ODC2Y+WP+M]=).LUH[S4L+
MS5)]TY&I0V>*UXT2=8L[:,P+M, G8ASGD@9: =USG0U]W<NW/WSNR';#/7XS
M?&WKKGK*NFS5[?/O\C"*KH.B7XI^\N4^,@'7%B6)I-07OKB3[EKZ+5<R29UI
M0>2'#IS6$;A&./T7K;'$>,=."L]\%Y?CNPC,,#F_C.D6O(#^R7MJDW[>'?8E
MTT/"*@KF;I-$'VR^1/<RCSZK8%\%@+@$D3P6'+].U.0NT@]-W>TXXW136!1D
M9&NCU)C''TP+;1"7% DMX' ,H@E3C@\H\<3TDUP=YDB!.C)<7O8TG6#>:)I*
M/)>U1U!@]LA)+:)_-DT$>I\=!0?7?-7N8"FG"N:]'DO0/CQ8RW28:PIKX *U
M<X^UTX?C;*Y1>)DR>19^CCB+G\(]XX.'Q_R6@(%F8T2VQ8>U/@:0#J852B*X
M(C@/81U+![&ZH\'0TTWPFE:2<!&"+,NNU&9Z6 W _<DU1X&V?K."6_CJV?U"
M,BY?/WO>/UR:PX,A-< I!YQ%6\42/<D)Q<ZU<%1QTVDZGPLY/6E!=[<H#+L^
MJ"4?2\L&<.L%B=T=XD%?-29_D)@LO3?EH\>D6'<#',L//#3?*LY\!D9';-#[
M *THH037S#+?@5!BIC[!'NBWW^&W7H3VRPEM4GC"2)?;O*S'5"3M(L*R;1;8
MO^>&H&1E4G.9LT%AQ.)PSAB&*J]-SKC-T:GO#9HJ/23+P@:2U*8#%%QXEJ=T
M^!,X251V7I98L,Z0S(BI7$WB,5DF*S+WX"[2S["* /.['5R8Q+>\R"8*KIEN
M%M8%[[?,T;%P6(@CUUZ?#/0<4F1Y9&I8;E-WV83V=<2P1133C0L1?YV3_"$3
MWW2D/:,BIM;_VZ("W&X;:"=>"U\5%M"W_[]OI5K8=$?%.V*.7BQCHAX,BW0A
M7[F+B>XN[D##WTD,=YE0.T!DX=BMT>-84['$BU]&PZ$*+4QFZ>]W(SQ?F1XB
M^:%/J.;_M%-+H9&^U4(SVB"A834GY@^%LBNBFE_,*"\,-E1:Q;67<:B4L#C'
M;GH/VU.TX_@ ^'EQ-"J+#UY!).9(=^&?JYK8MHTM,O19IE$(L5WEU\H5J.,;
M;PH<5Y)K@+2Y@;_##YU6C1[N<$IN2)4];4[UFPBK>*;UE,Z&?TB+$0BE5H7E
MB8X=9--2(U.U./S,?34:Q1EYMJ69QBGZM$R^S!.VP3 W5=0$7)QHPV[J!8\?
MQ]F"OI6-.DN]/&RX9-[R=&XM=0?1CJ1<U^=O0]R6J:"Y0'/S7<S)";K]B3T[
ME 9B+2MU9TB8W9+80HH'&\374IF:-)JRNANWD*,4#0L^-\37K#<L&AL-AK-
M\ANUIB*J&H_]NJQ"2Q'2H,2[HYY'+9=$NP8TTX1:N>9!R:+E=K2WGB774M=)
M_U4.*QE01"';L-\ZPQ%+V5Z9DV-J7.<!!YE<AUR+M=(W_= (D_KLGJ.1-WA7
M@H+-C:]YVZBFMLT3?S"]P:[O<7H:GDQ3]$@LK677EIR6#'>1%:XHE[\J;+K
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MS7C!,X"O2ZM@(PN 43#4F]YST^D4%#0,!=FT=5@PRT6,W&UC14Z-#9=(I4K
M[JEV,[*0JF^NPX23,\. 29VG!,#0 '0/@9&D090C)V)EPPU'MY!QV=)J5L_I
M:J'@#E]5/EPFQAL(9[/4 /PI9YZ-\>^.9HB4G H-H^IS:57['FZC$L(Q>N]1
MIS9^MTVJXLT6J(H&#_5:],72@%/ID?HVZ5NI2B"T@ZRM3]WWO:3";*4-M$V6
M#"IX=&YLC5YIG,Y80$T;.S):D'17?M&EX,+ .![5E)T-$G1_'L'8896PDZ'Q
MXA!BYGD9<3?ON'V[^<?MQ$GWVJJM;\( ;KL0S<7(V!PLC>T2D<9Z^-5M<6\(
M:DT !QR*D5]::!6[I;</NB+"L\_@Y5C5'2@!O\@'Y'3VZ#\AP'_"MU X#2%&
MJ)3;5E&)+FE&T\<Q!L*PB("PIO!AB&"(ZYW&I<5#2$MO JP.X/'P?%01&)4;
MC\UL7KDU\WI%\)J4 7>"N[FZ<;&R>4:8YVB5E <SEOKR+3J@;S?_@)YB<+=\
M?'7-V)5C,CUXS]J@K^NZ)%>(+NMUZ0LBYH>%[7V)),*33F9@ER;IQ^BD73"\
M45UA;J!K[%":]!3OCUF<4 & 'L)(C/@^L!FPI]XBXP4,KD&-'@]NJ[V$/U?/
MTWIS.N^*TN"-T<II:CZS8A%E/T:6;;!<9KT",?A]P!6  0NTJ70/"'L%OO[8
M#+0U2QC<]6C=&"]O)&]4@Y)#=%U#@[T#4])4%:)2H0^+IAF--,7L3\+E;N@
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M&KMY-4 =FU$;FG:C78(:7NF;T@.+U@BO2^G6A?[>]?/0MII(GRL"59B/S(I
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MN\*.)<F>6 A\WJ(&SY6%G0I3((%;L=.H4:@SK@;S6[AN;==.9<9U2?!P Z5
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MEQ</W0>:FW\"!<C&"S1>L]KE\35),G446'$.NSD4\M:B0U#:J<A$RJ572?I
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MEJP'4JYUB,.AA)"=4BRKZ(>:$EM!LE6 1Z8!Z@G3:(LL); &2M+J2ND&'O4
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M;_XY *U](^TDZQ#_&U\]<NL3V**F$FXSE#42%[5(J.%7"9L&?H_:  FMP%F
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M5##,E?-U+K=<[!J4?-X1[%+R;U$+:U\:-2&,7&8Z'+R.;Y'Y!Z[6^1VEULA
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M4[@DQ;BFTSSBX<;3@E"A_9CW(#R$'8PLU+3HLWA\'F*4)^6BPMH.%RGJ:+_
M.O5/YZ^X2Z>RZDNQ*[P->B&S>"&SZ".SZ)+S]7%;;%3:=:U$-[N->K&0]:Y:
M0;\C!D;D"#8D'M'@U_BR'%6J_:J W:!-Y; PKQR0.EAHID4_P1=0Q:;K%A52
M!\OB4 FM@[(\5)&0E8L7(W.WHVZ^8XG&OR/7OL*N->H^^U>-Q>4Q18.<OX1Z
M67)YK):-#4>YNK60"P-_1MLYLFH1M\I3]FPPWM6P)YAB+.IR3 D*AZ)T;QJR
M%:*5^#P43^*%T+&MR WA$U^MK"BFC_VWL'<EBOT-:@JN4B?T-N!V)D9)1_-C
M"]_ .Q^2^WR JS1807P,39AK@BE6WY6?72(U 1$.W1)$% KCS J&TPSRM)PM
MSA2KSBZ:=R0#,^T3K9= E@<^(2Y<,*EYD#VW0NXRMVW[A7)C<!'BT.0 XFPD
MH^8>E HZD)NLS4"15-)*%:7V=8ISE93Q@YBVH@H5%D!<1"H+MVY84<&RA>?(
MRS[]JB/E+2(:7@^&"D.$F1>&3!-V@VZ\3PD5J9Z#?5SO4X6%PGB)W5(3;N@/
M&ECLJ(YM%L%V:5(:)"-UZ&"\X<:9A&>J5O_\$DTH2_WDQ=TFUW?M[5<K1'XL
M6?2/Y7IB.]M<T;,Y4%+?/WIEQ'I7<L2 K6HN;^^*& BLIO5/Z2NVLD%^EU8<
MFC+4$B3?]#I@7(Q,NF6:H"B>&>B_/"G@U>BPFH\,5H9?8 XK]FA<(C$LRG;/
M#'RCF2LM:KZ*DO85:_\L!O=Y0EBW9&NY9WK\ZE[===@HP6:;U]D#7W4LZB^I
M_^T&X=@<M"]I3A7\&K3XBOR5==ML&@W_E5M2\9^V6Z&.U[WV1\/#(UU[/OI5
MA-1#(RPA!.US#^<.;)$2PUEMEFB"SK-:D0-9&!DB=4:V.'D97%>%\9B8*8XP
M!U#-F.T(G2)-+]AZI^\+)+[P+.[MWN9DW=OL'S$/US>5.!KNH^XT1Q&+,;@,
MJ49HW;T%6\T5*&S2EM)Q9EU&6\XK[K->;O12=O+IFJ-[3$*5%'3(4E/['Q."
M6*I_[R"H 4,9AY)DEK]S%E?;74F_8S9%3AK8;[X6\+QI%RK;^F+UG<FZE_[U
M\/@-'U'?=B4:VASKV,NXP*Y34K)8BD4&GSN7KI W:#B7J-J'-.=6<<G55L$'
M)64DVBWUV&0:YIUVO-Q+(UVUB*Z"*7LLKRY&XM-$\$C&Q<ST>>/.RK3:QG;8
M;+6TW:Y;VMR%T)0VE";M4LHQA$+:G?T5DS2DJ]3,DZ;^);:Y-$DWCK-Q+:7C
M5(5(96G4087-5+>Y9J"<VS$@R/ <2V_ ^$"X&PQJ*MNS1>49%7E=8?LWA@Y?
MZ>=ZK>#89>1HM' MI+N(<$(P2IB2?>)V"]K=Y@B:M048LUG\30]N2&+&*?JG
MZ-MSE-WAX\T00FFL5"::2EY4?+X-.Y2N>X?>#'%AOOGO'SK2$\VZPD840$^7
MK:'C-%*%:2<J)(JYQ:'!R4YF?D>;GG?O4(WHI*OL@8L38=Y%T@!>P5ZOQ*$G
MYI9<+QBU=\+Y(6'N1/X1850QP0R&J8FW+ Z[=O2BY7%8PL!:8Q'_1;-3E9R5
MJEEM%\3:;-5.45(C4IUK38363GBQ/T8;U9HE2L/ P<AO:TP >5 ^Y_DM->MI
MZ:H0U:I=/7?KQ+ZVIG7IQ_(E?0;<H+9X6/I6X=JF]&K2\UV.-G+EZU;)^-J1
M=Y;+^,74!Z9Y3WM^Y35@K!L=Y!/:<)]4&S9H->X6^9I[=ZG-)F@,>%H[=F<B
MX1F:=R,!"L?,YBJPW7X]NM:&I'DWKOM#43+E5-B>(YD3"^[.&]3@:;+(2F'Z
M(W I=AJU"77&I6%^O]*M;5&IS+@N"?]LH*1]MC=IP(1W63PJ2H_CCEM-*P8:
MU]KBAG7A;0QEWI.Z9+]&1H&4.8&PM](IJ79529M7D1D"EA$ZM<R("Y1$4]"'
MB*T/5DNVU:;I]X^,0,7NF,9T20SLOX3%XEX:W<]BJR)0%*$VY9S7!>=C%+EL
MW'*(HDZ@AC[&Y0X&X0X ?BSR,,FJ3Q#=EY;21HV%D?B<.\(>\L#]Z*P7(ZHC
M8H5S+X8JGM7*9 XTS'R$\^!2FCY#(P9T"-PH*(ZCUNHN,*:G35^0CZR&X]0J
MAGQ&:<Y>/?9;2YDQC24EK0?OA]M07U^ZYIFP!\<E3JDI$C>>BFB$O2[L*7_R
M\">L+;WQHR\P"=LM[8NE\;&G&L]"NVBIVDN^<[M:G=<.&[=*JW-BHFO)MA_M
MO5T#VA%73BUR_>/^$@"/<,;2<&% &HOR<J_LD^]^_WC'2F!<&20Q8(Q40F+G
MB('4!',;Q80>C!S9WE*I1KE 18,JZ HS1S6>\\1=6+ZQ,7<8$.LINN[>@?7N
MORN^!AV+&V9+Y4%%<C,:%B.["(X6&(;&.D50%'G<?M<#G,#K/+@QFW4FG9B:
MO8+GI3U /KBX.XA0>[UF_@*W(3^)!([HDKKZU/M'P!W(3HX96@X>([D/*\*\
M".$@J,M74#0>VS <1'8OT0:Z@IA?@=8[Y+WG+9BEH<]2I1]?36'K;;QL:N*J
M+K5IN+N7K_,<.KX^+T9GFXRU:Z;K@8F)X?V.W8OYP/K>PS Z*CC-"E+Z+>\S
M]M/04E&AL,53<4$8$<B@P!EAG-':0LP7)@+$;+9N8R -+GNA5;.4O="L!%EM
MUJ7 1Z'UW_:O'@C/U>&ACYBLV7:I^^*P$^_N[._N?+^K3C18 4;:WV35=.[@
MR/<=N_[#)A[G.,/B&1)1 G=1P;T#Z_05RKE]BTHNKH ,2<-3Z (&DMPAQ(Z
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MO4ON,_M9+>%[_T_U>1, E[9/5.WJT"9P*CHD@S^_OSQM3_X0K%>Z=*/%(IQ
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MP_:Z80\>*EN&)86\0A@CC%ZU;AUD0F-*6SM50.F(,K(+FQS;$C0NH<.,OTX
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M@^.Z&<FP25C(Z( ;_4\\M.&\/)1U,^B<B/ ,VG2#>.D7&D%$!J4D!#81$T
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MP9^DI--JS=OEDCD:'K^'>F@PA9S<Q51G)F^T$C*7ZDY2[YB\.*Q]\J !@WE
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MZOLRR[H-TK;RZY[:(Q\+0^Z\/]!;> W,5>%^,F,4H_A._OC#R=OWC!G!VYU
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M&C,B76"N58,_PP6N\=*973<3H6W'2!%]!$I6O*%: I1<+S*=U9TA+GA.QS1
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MQXT39+2<<30J,G@(5/]OS#8JJP$"M[;% '4Y.>ZI167.UG>;NCMPVQJ3W
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M;]C#E=XSM(<0I)][;P_8UD%\2'#GHDX8FL(6!)5MIC.ZE1N^5L$''0T$8U*
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MCC>ANHNMDYOPA)*\(\9V2T!FDEA$(Z[O&H0YB=DD1=5RM>N+'7[KP/.H)E=
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MX@.HHVX13MRH_\W%6:N,^XG\E!OI@?YI% <+^+]I/@M_^7]02P,$%     @
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M.>Z_5QK';_I!D?AI<.#'2ZDVL+0\F$G=!,_S+-<. J?;J+X=Q[&=!C 15?/
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M%RP\0(W([<,LS_@UR\JG__77@?O5V7\!4$L#!!0    ( (Z.3EH$_E6UV0<
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M22OLTRRO^ G&RJ?_R=*1^ZG4?P%02P,$%     @ CHY.6FA=_QD=!   WP\
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MBQ:$ XP^O<RB\W!D!O0,%GA <E:3+*/#^.B,=T9 CIE%GVKT^2L-W*K<X0/
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M+3(P,C0Q,C,Q+FAT;5!+ 0(4 Q0    ( (Z.3EHHDI"2P1D  .LK 0 1
M          "  ?+* P!D>&-M+3(P,C0Q,C,Q+GAS9%!+ 0(4 Q0    ( (Z.
M3EKIXU 9C#<  #4\ @ 5              "  >+D P!D>&-M+3(P,C0Q,C,Q
M7V-A;"YX;6Q02P$"% ,4    " ".CDY:D**BNZ9Z  !;=@4 %0
M    @ &A' 0 9'AC;2TR,#(T,3(S,5]D968N>&UL4$L! A0#%     @ CHY.
M6H?VU_;3'@$ A+$! !0              ( !>I<$ &1X8VTM,C R-#$R,S%?
M9S$N:G!G4$L! A0#%     @ CHY.6NS$C(PD(P$ O74! !0
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M &1X8VTM,C R-#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( (Z.3EKNKNH<>^@
M +S:"@ 5              "  :_>"P!D>&-M+3(P,C0Q,C,Q7W!R92YX;6Q0
M2P$"% ,4    " ".CDY:;4$WN!A)  #XP@$ '               @ %=QPP
M9'AC;3$R,S$R,#(T+65X:&EB:70Q,#$U+FAT;5!+ 0(4 Q0    ( (Z.3EJI
M9JUD#T\  $QM @ <              "  :\0#0!D>&-M,3(S,3(P,C0M97AH
M:6)I=#$P,38N:'1M4$L! A0#%     @ CHY.6NJ7[GFD,P$ 0!8) !P
M         ( !^%\- &1X8VTQ,C,Q,C R-"UE>&AI8FET,3 Q-RYH=&U02P$"
M% ,4    " ".CDY:L=:QUMDN   370$ &P              @ '6DPX 9'AC
M;3$R,S$R,#(T+65X:&EB:70Q.3$N:'1M4$L! A0#%     @ CHY.6GSP8C<O
M P  +A4  !L              ( !Z,(. &1X8VTQ,C,Q,C R-"UE>&AI8FET
M,C$Q+FAT;5!+ 0(4 Q0    ( (Z.3EISE'6 C0,  )$.   ;
M  "  5#&#@!D>&-M,3(S,3(P,C0M97AH:6)I=#(S,2YH=&U02P$"% ,4
M" ".CDY:Q*0=+=D'  !\)@  &P              @ $6R@X 9'AC;3$R,S$R
M,#(T+65X:&EB:70S,3$N:'1M4$L! A0#%     @ CHY.6@3^5;79!P  ,24
M !L              ( !*-(. &1X8VTQ,C,Q,C R-"UE>&AI8FET,S$R+FAT
M;5!+ 0(4 Q0    ( (Z.3EIH7?\9'00  -\/   ;              "  3K:
M#@!D>&-M,3(S,3(P,C0M97AH:6)I=#,R,2YH=&U02P$"% ,4    " ".CDY:
MX_(*7R0$   *#P  &P              @ &0W@X 9'AC;3$R,S$R,#(T+65X
M:&EB:70S,C(N:'1M4$L! A0#%     @ CHY.6M=(+!])$P  +UP  !H
M         ( ![>(. &1X8VTQ,C,Q,C R-"UE>&AI8FET-#4N:'1M4$L%!@
0   6 !8 ^04  &[V#@    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>120
<FILENAME>dxcm-20241231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2024"
  xmlns:cyd="http://xbrl.sec.gov/cyd/2024"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:dxcm="http://www.dexcom.com/20241231"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2024"
  xmlns:stpr="http://xbrl.sec.gov/stpr/2024"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="dxcm-20241231.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2024-06-28</instant>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2025-02-06</instant>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2024-10-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-22">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-23">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-24">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-25">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-27">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-30">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-32">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-34">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-35">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-37">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-38">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-40">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-43">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-44">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-45">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockCommonMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-46">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-47">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-48">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-49">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-50">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-51">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerBMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-53">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-54">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-55">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-56">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerCMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-57">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-58">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-59">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-60">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerDMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-62">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">dxcm:CustomerEMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-64">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-65">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-66">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-67">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-68">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-69">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-70">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-72">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-73">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-74">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-75">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:CollaborativeSalesBasedMilestoneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-76">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-78">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">dxcm:RestrictedAndPerformanceStockUnitsMemberMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-79">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-80">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-81">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:ConvertibleDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-82">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-83">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-84">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-85">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="c-86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="c-87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-10-01</startDate>
            <endDate>2018-12-31</endDate>
        </period>
    </context>
    <context id="c-88">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="c-89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementInitialPaymentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-10-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="c-91">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-92">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-28</instant>
        </period>
    </context>
    <context id="c-93">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-94">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">dxcm:VerilyLifeSciencesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">us-gaap:CollaborativeArrangementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:PaymentsUnderCollaborationAgreementsAxis">dxcm:CollaborativeArrangementMilestonePaymentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-98">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-99">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-100">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-102">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-103">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-104">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-105">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-106">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-107">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-108">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-109">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-110">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-111">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-112">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-113">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-114">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-115">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-116">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-117">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-118">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USGovernmentCorporationsAndAgenciesSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-119">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-120">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-121">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-122">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CommercialPaperMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-123">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-124">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-125">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-126">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-127">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-128">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-129">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-130">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-131">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-132">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-133">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-134">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-135">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DerivativeInstrumentRiskAxis">us-gaap:ForeignExchangeForwardMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-136">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-137">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-138">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">dxcm:ReceiverProductComponentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-139">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-140">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-141">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-142">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-143">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-144">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-145">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">dxcm:ComputerSoftwareAndHardwareMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-146">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-147">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:EquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-148">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-149">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-150">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-151">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-152">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:VerilyIntangibleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-153">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-154">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:AcquiredTechnologyAndIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-155">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-156">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-157">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:VerilyIntangibleMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-158">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-159">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">dxcm:AcquiredTechnologyAndIntellectualPropertyMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-160">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:TrademarksAndTradeNamesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-161">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-162">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-163">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-164">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-165">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-166">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-167">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-168">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-169">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-170">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-171">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-172">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-173">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-174">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-175">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-176">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2018-11-01</startDate>
            <endDate>2018-11-30</endDate>
        </period>
    </context>
    <context id="c-177">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-05-31</instant>
        </period>
    </context>
    <context id="c-178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-05-01</startDate>
            <endDate>2020-05-31</endDate>
        </period>
    </context>
    <context id="c-179">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-31</instant>
        </period>
    </context>
    <context id="c-180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-01</startDate>
            <endDate>2023-05-31</endDate>
        </period>
    </context>
    <context id="c-181">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-182">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:HedgingDesignationAxis">us-gaap:DesignatedAsHedgingInstrumentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-11-30</instant>
        </period>
    </context>
    <context id="c-183">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-02-13</startDate>
            <endDate>2024-02-13</endDate>
        </period>
    </context>
    <context id="c-184">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:BofAWarrantTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-185">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:JPMWarrantTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-03-31</endDate>
        </period>
    </context>
    <context id="c-186">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">dxcm:JPMWarrantTransactionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-04-01</startDate>
            <endDate>2024-06-30</endDate>
        </period>
    </context>
    <context id="c-187">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-02</startDate>
            <endDate>2023-05-02</endDate>
        </period>
    </context>
    <context id="c-188">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2028Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-05-02</instant>
        </period>
    </context>
    <context id="c-189">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-190">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-191">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-192">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2023Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-193">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-194">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-195">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-196">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">dxcm:ConvertibleNotesDue2025Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:SeniorNotesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="dxcm:DebtInstrumentConversionTermAxis">dxcm:DebtInstrumentConversionTermOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-197">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-06-01</startDate>
            <endDate>2023-06-30</endDate>
        </period>
    </context>
    <context id="c-198">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-199">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-200">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:LetterOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-201">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-202">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-203">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-204">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:BaseRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-205">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">dxcm:LondonInterbankOfferedRateLIBOR1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-206">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-207">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-208">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-209">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-210">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-211">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-212">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherStatesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-213">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-214">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:GB</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-216">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherForeignMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:ForeignCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-217">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-218">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-219">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ForeignTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-220">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ForeignTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-221">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-222">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:ResearchDevelopmentTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-223">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:AMTTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-224">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TaxCreditCarryforwardAxis">dxcm:AMTTaxCreditsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-226">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">stpr:CA</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-228">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-229">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A401kPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-230">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-232">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-233">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-234">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-05-30</instant>
        </period>
    </context>
    <context id="c-235">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-236">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-237">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-238">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-239">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-240">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-241">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-242">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-243">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2022ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-244">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-245">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-246">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2023ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-247">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-248">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-249">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-250">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-251">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-252">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2028NotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-253">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-07-31</instant>
        </period>
    </context>
    <context id="c-254">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:A2024ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-07-01</startDate>
            <endDate>2024-09-30</endDate>
        </period>
    </context>
    <context id="c-255">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-10-31</instant>
        </period>
    </context>
    <context id="c-256">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-10-01</startDate>
            <endDate>2023-10-31</endDate>
        </period>
    </context>
    <context id="c-257">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-07-31</instant>
        </period>
    </context>
    <context id="c-258">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-08-01</instant>
        </period>
    </context>
    <context id="c-259">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:AcceleratedShareRepurchaseASRMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-08-01</startDate>
            <endDate>2022-08-31</endDate>
        </period>
    </context>
    <context id="c-260">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ShareRepurchaseProgramAxis">dxcm:ShareRepurchaseProgramMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-06-30</instant>
        </period>
    </context>
    <context id="c-261">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-262">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="c-263">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-264">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-265">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-266">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="c-267">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-268">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-269">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-270">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-271">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-272">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-273">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-274">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-275">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-276">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">dxcm:RestrictedStockUnitsRSUsAndPerformanceSharesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-277">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-278">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:PerformanceSharesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EquityIncentivePlan2015Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-279">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-280">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-281">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-282">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-283">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-284">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-285">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-286">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-287">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-288">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-289">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-290">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-291">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-292">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-293">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-294">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-295">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-296">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">dxcm:EmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-297">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-298">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-299">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelThroughIntermediaryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-300">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-302">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ContractWithCustomerSalesChannelAxis">us-gaap:SalesChannelDirectlyToConsumerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-306">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-307">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-308">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">us-gaap:NonUsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-309">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-310">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:US</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-311">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:MY</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-313">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <context id="c-314">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">dxcm:OtherCountriesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-12-31</instant>
        </period>
    </context>
    <context id="c-315">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001093557</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:IE</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2024-12-31</instant>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="purchaser">
        <measure>dxcm:purchaser</measure>
    </unit>
    <unit id="d">
        <measure>utr:D</measure>
    </unit>
    <unit id="trading_day">
        <measure>dxcm:trading_day</measure>
    </unit>
    <unit id="extensionoption">
        <measure>dxcm:extensionOption</measure>
    </unit>
    <unit id="segment">
        <measure>dxcm:segment</measure>
    </unit>
    <unit id="primary_market">
        <measure>dxcm:primary_market</measure>
    </unit>
    <dei:AmendmentFlag contextRef="c-1" id="f-32">false</dei:AmendmentFlag>
    <dei:DocumentFiscalYearFocus contextRef="c-1" id="f-33">2024</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus contextRef="c-1" id="f-34">FY</dei:DocumentFiscalPeriodFocus>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-35">0001093557</dei:EntityCentralIndexKey>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-63" id="f-460">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-65" id="f-462">P4Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-69" id="f-470">P1Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <dxcm:AmortizationPeriodForIncentiveCompensationCosts contextRef="c-72" id="f-485">P1Y</dxcm:AmortizationPeriodForIncentiveCompensationCosts>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-176" decimals="7" id="f-967" unitRef="number">0.0243476</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-178" decimals="7" id="f-968" unitRef="number">0.006662</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:DebtInstrumentConvertibleConversionRatio1 contextRef="c-180" decimals="7" id="f-969" unitRef="number">0.0061571</us-gaap:DebtInstrumentConvertibleConversionRatio1>
    <us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList contextRef="c-5" id="f-995">http://fasb.org/us-gaap/2024#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization</us-gaap:FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-5" id="f-1002">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList contextRef="c-6" id="f-1003">http://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent</us-gaap:FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration contextRef="c-1" id="f-1027">http://fasb.org/us-gaap/2024#SellingGeneralAndAdministrativeExpense</us-gaap:ImpairmentLongLivedAssetHeldForUseStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-236" id="f-1231">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType contextRef="c-1" id="f-1">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport contextRef="c-1" id="f-2">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-3">2024-12-31</dei:DocumentPeriodEndDate>
    <dei:CurrentFiscalYearEndDate contextRef="c-1" id="f-4">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentTransitionReport contextRef="c-1" id="f-5">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber contextRef="c-1" id="f-6">000-51222</dei:EntityFileNumber>
    <dei:EntityRegistrantName contextRef="c-1" id="f-7">DEXCOM, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-8">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-9">33-0857544</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-10">6340 Sequence Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-11">San Diego</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-12">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-13">92121</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-14">858</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-15">200-0200</dei:LocalPhoneNumber>
    <dei:Security12bTitle contextRef="c-1" id="f-16">Common Stock, $0.001 Par Value Per Share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-17">DXCM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-18">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer contextRef="c-1" id="f-19">Yes</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers contextRef="c-1" id="f-20">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus contextRef="c-1" id="f-21">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent contextRef="c-1" id="f-22">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory contextRef="c-1" id="f-23">Large Accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness contextRef="c-1" id="f-24">false</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-25">false</dei:EntityEmergingGrowthCompany>
    <dei:IcfrAuditorAttestationFlag contextRef="c-1" id="f-26">true</dei:IcfrAuditorAttestationFlag>
    <dei:DocumentFinStmtErrorCorrectionFlag contextRef="c-1" id="f-27">false</dei:DocumentFinStmtErrorCorrectionFlag>
    <dei:EntityShellCompany contextRef="c-1" id="f-28">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat contextRef="c-2" decimals="-8" id="f-29" unitRef="usd">45300000000</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding contextRef="c-3" decimals="INF" id="f-30" unitRef="shares">390772018</dei:EntityCommonStockSharesOutstanding>
    <dei:DocumentsIncorporatedByReferenceTextBlock contextRef="c-1" id="f-31">&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Portions of the registrant&#x2019;s definitive proxy statement relating to its 2025 Annual Meeting of Stockholders (the &#x201c;Proxy Statement&#x201d;) are incorporated by reference in Part&#160;III, Items 10 through 14 of this Annual Report on Form 10-K, as specified in the responses to those item numbers, which proxy statement will be filed with the Securities and Exchange Commission within 120 days after the end of the fiscal year covered by this Form 10-K.&lt;/span&gt;&lt;/div&gt;</dei:DocumentsIncorporatedByReferenceTextBlock>
    <cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock contextRef="c-1" id="f-36">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have processes in place for assessing, identifying, and managing material risks from cybersecurity threats, which are integrated into our overall enterprise risk management processes. The processes for assessing, identifying and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include identifying the relevant assets that could be affected, determining possible threat sources and threat events, assessing threats based on their potential likelihood and impact, and identifying controls that are in place or necessary to manage and/or mitigate such risks.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have established cybersecurity and privacy programs to maintain the confidentiality, integrity, availability, and privacy of protected information and ensure compliance with relevant security/privacy regulations, contractual requirements, and industry-standard frameworks. Our cybersecurity program includes annual review and assessment by external, independent third parties, who certify and report on these programs. For example, our Information Security Management System (ISMS) is certified as being in conformity with ISO/IEC 27001 by SRI Quality System Registrar. We maintain cybersecurity and privacy policies and procedures in accordance with industry-standard control frameworks and applicable regulations, laws, and standards. All corporate cybersecurity policies are reviewed and approved by senior leadership at least annually as part of our ISMS.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our cybersecurity controls, which are the mechanisms in place to prevent, detect and mitigate threats in accordance with our policies and procedures, are based on the regulatory requirements to which we are subject and are monitored and tested both internally and externally by third parties at least annually. These controls include regular system updates and patches, employee training on cybersecurity and privacy requirements, incident reporting, and the use of encryption to secure sensitive information. In addition, we also regularly perform phishing tests of our employees and update our training plan at least annually. We maintain business continuity and disaster recovery capabilities to mitigate interruptions to critical information systems and/or the loss of data and services from the effects of natural or man-made disasters to Dexcom locations. We also provide annual privacy and security training for all employees. Our security training incorporates awareness of cyber threats (including but not limited to malware, ransomware and social engineering attacks), password hygiene, incident reporting process, as well as physical security best practices.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the last three fiscal years, we have not experienced any material cybersecurity incidents and the expenses we have incurred from security incidents were immaterial. As a result, we do not believe that risks from cybersecurity threats, including as a result of any previous cybersecurity incidents, have materially affected us, our results of operations and financial condition. However, as discussed under &#x201c;Risk Factors&#x201d; in Part I, Item 1A of this Annual Report, cybersecurity threats pose multiple risks to us, including potentially to our results of operations and financial condition. See &#x201c;Risk Factors &#x2014; Risks Related to Privacy and Security.&#x201d; As cybersecurity threats become more frequent, sophisticated and coordinated, it is reasonably likely that we will be required to expend greater resources as we pursue our strategy of continuously modifying and enhancing our protective measures while developing and commercializing products that incorporate our CGM technologies and integrate with the insulin delivery systems or data platforms of our partners. The technology integration and cloud-based depository platforms we continue to focus on can make us more vulnerable to cybersecurity threats, thereby making our pursuit of such strategies more costly.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesForAssessingIdentifyingAndManagingThreatsTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock contextRef="c-1" id="f-37">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have processes in place for assessing, identifying, and managing material risks from cybersecurity threats, which are integrated into our overall enterprise risk management processes. The processes for assessing, identifying and managing material risks from cybersecurity threats, including threats associated with our use of third-party service providers, include identifying the relevant assets that could be affected, determining possible threat sources and threat events, assessing threats based on their potential likelihood and impact, and identifying controls that are in place or necessary to manage and/or mitigate such risks.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementProcessesIntegratedTextBlock>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-38">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskManagementProcessesIntegratedFlag contextRef="c-1" id="f-39">true</cyd:CybersecurityRiskManagementProcessesIntegratedFlag>
    <cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag contextRef="c-1" id="f-40">true</cyd:CybersecurityRiskThirdPartyOversightAndIdentificationProcessesFlag>
    <cyd:CybersecurityRiskManagementThirdPartyEngagedFlag contextRef="c-1" id="f-41">true</cyd:CybersecurityRiskManagementThirdPartyEngagedFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-42">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag contextRef="c-1" id="f-43">false</cyd:CybersecurityRiskMateriallyAffectedOrReasonablyLikelyToMateriallyAffectRegistrantFlag>
    <cyd:CybersecurityRiskRoleOfManagementTextBlock contextRef="c-1" id="f-46">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors is responsible for exercising oversight of management&#x2019;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#x2019;s Technology Committee. The Technology Committee reports to the Board as necessary with respect to its activities, including making such reports and recommendations to the Board and its other committees as necessary and appropriate and consistent with its purpose, described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Technology Committee, comprised of independent Board members, is responsible for reviewing cybersecurity, privacy, data protection and other major technology risk exposures of the Company, the steps management has taken to monitor and control such exposures, and the Company&#x2019;s compliance with applicable cybersecurity and data privacy laws and industry standards. These reviews are provided at least annually. The Technology Committee receives management updates and reports, primarily through the Company&#x2019;s Cybersecurity and Privacy Committee, a multidisciplinary team responsible for the overall governance, decision-making, risk management, awareness and compliance for cybersecurity and privacy activities across the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Cybersecurity and Privacy Committee is co-chaired by our Information Security Officer (ISO), Product Security Officer (PSO), and Chief Privacy Officer (CPO), and its members include executive officers of the Company, including our Chief Technology Officer, Chief Financial Officer, Chief Information Officer, and Chief Legal Officer, as well as representatives from the finance, internal audit, quality, regulatory, and legal teams. Management&#x2019;s role in assessing and managing the material risks from cybersecurity threats is accomplished primarily through the committee.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Members of the Cybersecurity and Privacy Committee have broad ranges of expertise and experience in information technology and security. Our ISO, a co-chair of the committee, has over fifteen years of experience in the field of information security management, having previously led security operations and infrastructure and IT functions for a public university campus and a non-profit organization, and holds several licenses and certifications relating to information security, including a Certified Information Systems Security Manager from the Information Systems Audit and Control Association (ISACA), a Certified Information Systems Security Professional (CISSP) from the International Information Security System Security Certification Consortium (ISC2) and several technical cybersecurity certifications from the Global Information Assurance Certification (GIAC). Our PSO, also a co-chair of the committee, has over twenty-five years of previous experience in cyber security architecture and cyber security management for a number of large Fortune 500 technology companies and holds several certifications including CISSP from the International Information Security System Security Certification Consortium, C-CISO from EC-Council, Numerous certifications from Microsoft, CISCO, Juniper, Checkpoint among others and has completed several advanced GIAC security classes from the SANS Institute.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ISO reports directly to our Senior Vice President, Chief Information Officer (CIO), who is a member of the committee. She has held this role at Dexcom since 2024 and is responsible for global information technology at Dexcom. Our CIO brings 30 years of diverse strategic and operational experience in IT management, data engineering, AI, digital, ecommerce, infrastructure modernization and supply chain. Prior to Dexcom, our CIO served as Senior Vice President, Chief Information Officer at Bausch + Lomb. Additionally, our CIO has held transformational roles at Johnson &amp;amp; Johnson, Bristol Myers Squibb, American Standard and Price Waterhouse Coopers. She holds a Bachelor of Science degree in Economics and Management Information Systems from the University of Delaware. Our Executive Vice President, Chief Technology Officer (CTO) is also a member of the committee. Our CTO has held this role since 2022 and has 25 years of experience spanning consumer electronics, data storage, IoT and broadband industries. From 2011 to 2022 he worked at Technicolor (now known as Vantiva), most recently serving as Chief Technology Officer and General Manager of the Broadband Business Division. In addition to an MBA, he holds a Master of Science in Mechanical Engineering and a Bachelor of Mechanical Engineering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The prevention, detection, mitigation and remediation of cybersecurity incidents at Dexcom is accomplished pursuant to various policies, procedures and processes, including incident response plans and the cybersecurity and privacy programs and controls described above under &#x201c;Risk Management and Strategy.&#x201d; These measures include escalation protocols through which the Cybersecurity and Privacy Committee is informed about cybersecurity and incidents by our ISO and PSO, who are informed through our business units. As described above, members of the Cybersecurity and Privacy Committee provide updates to the Technology Committee of the Board on a regular basis, and the full Board receives updates from the Technology Committee. In addition, there are protocols in place for immediate escalation in the event of any cybersecurity issues or developments that may require consideration between regularly scheduled Technology Committee or Board meetings.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskRoleOfManagementTextBlock>
    <cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock contextRef="c-1" id="f-44">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our Board of Directors is responsible for exercising oversight of management&#x2019;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#x2019;s Technology Committee. The Technology Committee reports to the Board as necessary with respect to its activities, including making such reports and recommendations to the Board and its other committees as necessary and appropriate and consistent with its purpose, described below.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskBoardOfDirectorsOversightTextBlock>
    <cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-45">Our Board of Directors is responsible for exercising oversight of management&#x2019;s identification and management of, and planning for, risks from cybersecurity threats. While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#x2019;s Technology Committee.</cyd:CybersecurityRiskBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-47">While the full Board has overall responsibility for risk oversight, the Board has delegated oversight responsibility related to risks from cybersecurity threats to the Board&#x2019;s Technology Committee.</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock contextRef="c-1" id="f-48">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Technology Committee, comprised of independent Board members, is responsible for reviewing cybersecurity, privacy, data protection and other major technology risk exposures of the Company, the steps management has taken to monitor and control such exposures, and the Company&#x2019;s compliance with applicable cybersecurity and data privacy laws and industry standards. These reviews are provided at least annually. The Technology Committee receives management updates and reports, primarily through the Company&#x2019;s Cybersecurity and Privacy Committee, a multidisciplinary team responsible for the overall governance, decision-making, risk management, awareness and compliance for cybersecurity and privacy activities across the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Cybersecurity and Privacy Committee is co-chaired by our Information Security Officer (ISO), Product Security Officer (PSO), and Chief Privacy Officer (CPO), and its members include executive officers of the Company, including our Chief Technology Officer, Chief Financial Officer, Chief Information Officer, and Chief Legal Officer, as well as representatives from the finance, internal audit, quality, regulatory, and legal teams. Management&#x2019;s role in assessing and managing the material risks from cybersecurity threats is accomplished primarily through the committee.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingBoardCommitteeOrSubcommitteeResponsibleForOversightTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag contextRef="c-1" id="f-49">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleFlag>
    <cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock contextRef="c-1" id="f-50">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Members of the Cybersecurity and Privacy Committee have broad ranges of expertise and experience in information technology and security. Our ISO, a co-chair of the committee, has over fifteen years of experience in the field of information security management, having previously led security operations and infrastructure and IT functions for a public university campus and a non-profit organization, and holds several licenses and certifications relating to information security, including a Certified Information Systems Security Manager from the Information Systems Audit and Control Association (ISACA), a Certified Information Systems Security Professional (CISSP) from the International Information Security System Security Certification Consortium (ISC2) and several technical cybersecurity certifications from the Global Information Assurance Certification (GIAC). Our PSO, also a co-chair of the committee, has over twenty-five years of previous experience in cyber security architecture and cyber security management for a number of large Fortune 500 technology companies and holds several certifications including CISSP from the International Information Security System Security Certification Consortium, C-CISO from EC-Council, Numerous certifications from Microsoft, CISCO, Juniper, Checkpoint among others and has completed several advanced GIAC security classes from the SANS Institute.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskManagementExpertiseOfManagementResponsibleTextBlock>
    <cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock contextRef="c-1" id="f-51">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our ISO reports directly to our Senior Vice President, Chief Information Officer (CIO), who is a member of the committee. She has held this role at Dexcom since 2024 and is responsible for global information technology at Dexcom. Our CIO brings 30 years of diverse strategic and operational experience in IT management, data engineering, AI, digital, ecommerce, infrastructure modernization and supply chain. Prior to Dexcom, our CIO served as Senior Vice President, Chief Information Officer at Bausch + Lomb. Additionally, our CIO has held transformational roles at Johnson &amp;amp; Johnson, Bristol Myers Squibb, American Standard and Price Waterhouse Coopers. She holds a Bachelor of Science degree in Economics and Management Information Systems from the University of Delaware. Our Executive Vice President, Chief Technology Officer (CTO) is also a member of the committee. Our CTO has held this role since 2022 and has 25 years of experience spanning consumer electronics, data storage, IoT and broadband industries. From 2011 to 2022 he worked at Technicolor (now known as Vantiva), most recently serving as Chief Technology Officer and General Manager of the Broadband Business Division. In addition to an MBA, he holds a Master of Science in Mechanical Engineering and a Bachelor of Mechanical Engineering.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The prevention, detection, mitigation and remediation of cybersecurity incidents at Dexcom is accomplished pursuant to various policies, procedures and processes, including incident response plans and the cybersecurity and privacy programs and controls described above under &#x201c;Risk Management and Strategy.&#x201d; These measures include escalation protocols through which the Cybersecurity and Privacy Committee is informed about cybersecurity and incidents by our ISO and PSO, who are informed through our business units. As described above, members of the Cybersecurity and Privacy Committee provide updates to the Technology Committee of the Board on a regular basis, and the full Board receives updates from the Technology Committee. In addition, there are protocols in place for immediate escalation in the event of any cybersecurity issues or developments that may require consideration between regularly scheduled Technology Committee or Board meetings.&lt;/span&gt;&lt;/div&gt;</cyd:CybersecurityRiskProcessForInformingManagementOrCommitteesResponsibleTextBlock>
    <cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag contextRef="c-1" id="f-52">true</cyd:CybersecurityRiskManagementPositionsOrCommitteesResponsibleReportToBoardFlag>
    <dei:AuditorFirmId contextRef="c-1" id="f-53">42</dei:AuditorFirmId>
    <ecd:NonRule10b51ArrAdoptedFlag contextRef="c-4" id="f-54">false</ecd:NonRule10b51ArrAdoptedFlag>
    <ecd:Rule10b51ArrAdoptedFlag contextRef="c-4" id="f-55">false</ecd:Rule10b51ArrAdoptedFlag>
    <ecd:NonRule10b51ArrTrmntdFlag contextRef="c-4" id="f-56">false</ecd:NonRule10b51ArrTrmntdFlag>
    <ecd:Rule10b51ArrTrmntdFlag contextRef="c-4" id="f-57">false</ecd:Rule10b51ArrTrmntdFlag>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-58">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <dei:AuditorName contextRef="c-1" id="f-59">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation contextRef="c-1" id="f-60">San Diego, California</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-5" id="f-61" unitRef="usd">606100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-62" unitRef="usd">566300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-5" decimals="-5" id="f-63" unitRef="usd">1973300000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities contextRef="c-6" decimals="-5" id="f-64" unitRef="usd">2157800000</dxcm:DebtSecuritiesAvailableForSaleAndEquitySecurities>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-5" decimals="-5" id="f-65" unitRef="usd">1005700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent contextRef="c-6" decimals="-5" id="f-66" unitRef="usd">973900000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-5" id="f-67" unitRef="usd">542600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-5" id="f-68" unitRef="usd">559600000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-5" id="f-69" unitRef="usd">173700000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-6" decimals="-5" id="f-70" unitRef="usd">168300000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-5" decimals="-5" id="f-71" unitRef="usd">4301400000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent contextRef="c-6" decimals="-5" id="f-72" unitRef="usd">4425900000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-5" id="f-73" unitRef="usd">1339900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-74" unitRef="usd">1113100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-5" decimals="-5" id="f-75" unitRef="usd">62800000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset contextRef="c-6" decimals="-5" id="f-76" unitRef="usd">71400000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:Goodwill contextRef="c-5" decimals="-5" id="f-77" unitRef="usd">22800000</us-gaap:Goodwill>
    <us-gaap:Goodwill contextRef="c-6" decimals="-5" id="f-78" unitRef="usd">25200000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-5" decimals="-5" id="f-79" unitRef="usd">103400000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill contextRef="c-6" decimals="-5" id="f-80" unitRef="usd">134500000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-5" decimals="-5" id="f-81" unitRef="usd">481200000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:DeferredIncomeTaxAssetsNet contextRef="c-6" decimals="-5" id="f-82" unitRef="usd">419400000</us-gaap:DeferredIncomeTaxAssetsNet>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-5" id="f-83" unitRef="usd">173000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-5" id="f-84" unitRef="usd">75000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets contextRef="c-5" decimals="-5" id="f-85" unitRef="usd">6484500000</us-gaap:Assets>
    <us-gaap:Assets contextRef="c-6" decimals="-5" id="f-86" unitRef="usd">6264500000</us-gaap:Assets>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-87" unitRef="usd">1585100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-88" unitRef="usd">1345500000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-89" unitRef="usd">112000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-90" unitRef="usd">171000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-5" decimals="-5" id="f-91" unitRef="usd">1204400000</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:ConvertibleNotesPayableCurrent contextRef="c-6" decimals="-5" id="f-92" unitRef="usd">0</us-gaap:ConvertibleNotesPayableCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-5" id="f-93" unitRef="usd">22500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-6" decimals="-5" id="f-94" unitRef="usd">21100000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-5" decimals="-5" id="f-95" unitRef="usd">8000000.0</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent contextRef="c-6" decimals="-5" id="f-96" unitRef="usd">18400000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-97" unitRef="usd">2932000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-98" unitRef="usd">1556000000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-5" decimals="-5" id="f-99" unitRef="usd">1237000000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:ConvertibleLongTermNotesPayable contextRef="c-6" decimals="-5" id="f-100" unitRef="usd">2434200000</us-gaap:ConvertibleLongTermNotesPayable>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-101" unitRef="usd">65000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-102" unitRef="usd">80100000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-5" id="f-103" unitRef="usd">147900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-104" unitRef="usd">125600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities contextRef="c-5" decimals="-5" id="f-105" unitRef="usd">4381900000</us-gaap:Liabilities>
    <us-gaap:Liabilities contextRef="c-6" decimals="-5" id="f-106" unitRef="usd">4195900000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies contextRef="c-5" id="f-107" unitRef="usd" xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies contextRef="c-6" id="f-108" unitRef="usd" xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-109"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-110"
      unitRef="usdPerShare">0.001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-5" decimals="-5" id="f-111" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized contextRef="c-6" decimals="-5" id="f-112" unitRef="shares">5000000.0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-6" decimals="INF" id="f-113" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued contextRef="c-5" decimals="INF" id="f-114" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued contextRef="c-6" decimals="INF" id="f-115" unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding contextRef="c-5" decimals="INF" id="f-116" unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-5" decimals="-5" id="f-117" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding contextRef="c-6" decimals="-5" id="f-118" unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-5"
      decimals="INF"
      id="f-119"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="c-6"
      decimals="INF"
      id="f-120"
      unitRef="usdPerShare">0.001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-6" decimals="-5" id="f-121" unitRef="shares">800000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized contextRef="c-5" decimals="-5" id="f-122" unitRef="shares">800000000.0</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued contextRef="c-5" decimals="-5" id="f-123" unitRef="shares">408900000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-5" decimals="-5" id="f-124" unitRef="shares">390700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesIssued contextRef="c-6" decimals="-5" id="f-125" unitRef="shares">407200000</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-6" decimals="-5" id="f-126" unitRef="shares">385400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-5" decimals="-5" id="f-127" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding contextRef="c-6" decimals="-5" id="f-128" unitRef="usd">400000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-5" decimals="-5" id="f-129" unitRef="usd">2093800000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock contextRef="c-6" decimals="-5" id="f-130" unitRef="usd">3514600000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-5" decimals="-5" id="f-131" unitRef="usd">-8000000.0</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax contextRef="c-6" decimals="-5" id="f-132" unitRef="usd">-16700000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-5" decimals="-5" id="f-133" unitRef="usd">1597600000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit contextRef="c-6" decimals="-5" id="f-134" unitRef="usd">1021400000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:TreasuryStockCommonShares contextRef="c-5" decimals="-5" id="f-135" unitRef="shares">18200000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonShares contextRef="c-6" decimals="-5" id="f-136" unitRef="shares">21800000</us-gaap:TreasuryStockCommonShares>
    <us-gaap:TreasuryStockCommonValue contextRef="c-5" decimals="-5" id="f-137" unitRef="usd">1581200000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:TreasuryStockCommonValue contextRef="c-6" decimals="-5" id="f-138" unitRef="usd">2451100000</us-gaap:TreasuryStockCommonValue>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-5" decimals="-5" id="f-139" unitRef="usd">2102600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest contextRef="c-6" decimals="-5" id="f-140" unitRef="usd">2068600000</us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-5" decimals="-5" id="f-141" unitRef="usd">6484500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity contextRef="c-6" decimals="-5" id="f-142" unitRef="usd">6264500000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-143" unitRef="usd">4033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-144" unitRef="usd">3622300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-145" unitRef="usd">2909800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-146" unitRef="usd">1594800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-147" unitRef="usd">1333400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-8" decimals="-5" id="f-148" unitRef="usd">1026700000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:GrossProfit contextRef="c-1" decimals="-5" id="f-149" unitRef="usd">2438200000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-7" decimals="-5" id="f-150" unitRef="usd">2288900000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit contextRef="c-8" decimals="-5" id="f-151" unitRef="usd">1883100000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-1" decimals="-5" id="f-152" unitRef="usd">552400000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-7" decimals="-5" id="f-153" unitRef="usd">505800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense contextRef="c-8" decimals="-5" id="f-154" unitRef="usd">484200000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-1" decimals="-5" id="f-155" unitRef="usd">1285800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-7" decimals="-5" id="f-156" unitRef="usd">1185400000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense contextRef="c-8" decimals="-5" id="f-157" unitRef="usd">1007700000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses contextRef="c-1" decimals="-5" id="f-158" unitRef="usd">1838200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-7" decimals="-5" id="f-159" unitRef="usd">1691200000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses contextRef="c-8" decimals="-5" id="f-160" unitRef="usd">1491900000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-161" unitRef="usd">600000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-162" unitRef="usd">597700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-8" decimals="-5" id="f-163" unitRef="usd">391200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-164" unitRef="usd">109000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-165" unitRef="usd">112700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-5" id="f-166" unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-167" unitRef="usd">709000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-168" unitRef="usd">710400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-169" unitRef="usd">390800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-170" unitRef="usd">132800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-171" unitRef="usd">168900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-172" unitRef="usd">49600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-173" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-174" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-175" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-176"
      unitRef="usdPerShare">1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-177"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-178"
      unitRef="usdPerShare">0.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-179" unitRef="shares">393600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-180" unitRef="shares">386000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="-5" id="f-181" unitRef="shares">389400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-182"
      unitRef="usdPerShare">1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-183"
      unitRef="usdPerShare">1.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-184"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-185" unitRef="shares">412700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-186" unitRef="shares">425500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-8" decimals="-5" id="f-187" unitRef="shares">427500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-188" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-189" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-190" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-191" unitRef="usd">8600000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-192" unitRef="usd">-9200000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent contextRef="c-8" decimals="-5" id="f-193" unitRef="usd">-9800000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-1" decimals="-5" id="f-194" unitRef="usd">100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-7" decimals="-5" id="f-195" unitRef="usd">4100000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax contextRef="c-8" decimals="-5" id="f-196" unitRef="usd">-2300000</us-gaap:OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-197" unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-198" unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-8" decimals="-5" id="f-199" unitRef="usd">-12100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-1" decimals="-5" id="f-200" unitRef="usd">584900000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-7" decimals="-5" id="f-201" unitRef="usd">536400000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax contextRef="c-8" decimals="-5" id="f-202" unitRef="usd">329100000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-9" decimals="-5" id="f-203" unitRef="shares">388000000.0</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-9" decimals="-5" id="f-204" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-10" decimals="-5" id="f-205" unitRef="usd">2108700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-11" decimals="-5" id="f-206" unitRef="usd">500000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-12" decimals="-5" id="f-207" unitRef="usd">138700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-13" decimals="-5" id="f-208" unitRef="usd">-206200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-14" decimals="-5" id="f-209" unitRef="usd">2042100000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-15" decimals="-5" id="f-210" unitRef="shares">1600000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-15" decimals="-5" id="f-211" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-16" decimals="-5" id="f-212" unitRef="usd">22500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-8" decimals="-5" id="f-213" unitRef="usd">22500000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-15" decimals="-5" id="f-214" unitRef="shares">2900000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-16" decimals="-5" id="f-215" unitRef="usd">-189300000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-17" decimals="-5" id="f-216" unitRef="usd">189200000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-8" decimals="-5" id="f-217" unitRef="usd">-100000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-15" decimals="-5" id="f-218" unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-17" decimals="-5" id="f-219" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-8" decimals="-5" id="f-220" unitRef="usd">557700000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt contextRef="c-16" decimals="-5" id="f-221" unitRef="usd">400000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt contextRef="c-8" decimals="-5" id="f-222" unitRef="usd">400000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-15" decimals="-5" id="f-223" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-16" decimals="-5" id="f-224" unitRef="usd">4200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-17" decimals="-5" id="f-225" unitRef="usd">13200000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-8" decimals="-5" id="f-226" unitRef="usd">17400000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-15" decimals="-5" id="f-227" unitRef="shares">300000</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-16" decimals="-5" id="f-228" unitRef="usd">-33500000</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-17" decimals="-5" id="f-229" unitRef="usd">33500000</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-8" decimals="-5" id="f-230" unitRef="usd">0</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-16" decimals="-5" id="f-231" unitRef="usd">126500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-8" decimals="-5" id="f-232" unitRef="usd">126500000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee contextRef="c-16" decimals="-5" id="f-233" unitRef="usd">152400000</dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee contextRef="c-8" decimals="-5" id="f-234" unitRef="usd">152400000</dxcm:AdjustmentsToAdditionalPaidInCapitalCollaborativeResearchAndDevelopmentFee>
    <us-gaap:NetIncomeLoss contextRef="c-18" decimals="-5" id="f-235" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-236" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-19" decimals="-5" id="f-237" unitRef="usd">-12100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-8" decimals="-5" id="f-238" unitRef="usd">-12100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-20" decimals="-5" id="f-239" unitRef="shares">386300000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-20" decimals="-5" id="f-240" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-21" decimals="-5" id="f-241" unitRef="usd">2258100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-22" decimals="-5" id="f-242" unitRef="usd">-11600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-23" decimals="-5" id="f-243" unitRef="usd">479900000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-24" decimals="-5" id="f-244" unitRef="usd">-595000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-25" decimals="-5" id="f-245" unitRef="usd">2131800000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-26" decimals="-5" id="f-246" unitRef="shares">1400000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-26" decimals="-5" id="f-247" unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-27" decimals="-5" id="f-248" unitRef="usd">26600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-7" decimals="-5" id="f-249" unitRef="usd">26600000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-26" decimals="-5" id="f-250" unitRef="shares">3700000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-27" decimals="-5" id="f-251" unitRef="usd">-323400000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-28" decimals="-5" id="f-252" unitRef="usd">323200000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-7" decimals="-5" id="f-253" unitRef="usd">-200000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-26" decimals="-5" id="f-254" unitRef="shares">6300000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-27" decimals="-5" id="f-255" unitRef="usd">200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-28" decimals="-5" id="f-256" unitRef="usd">689000000.0</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-7" decimals="-5" id="f-257" unitRef="usd">689200000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt contextRef="c-27" decimals="-5" id="f-258" unitRef="usd">4400000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt contextRef="c-7" decimals="-5" id="f-259" unitRef="usd">4400000</dxcm:AdjustmentsToAdditionalPaidInCapitalTaxBenefitFromEquityComponentOfConvertibleDebt>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-26" decimals="-5" id="f-260" unitRef="shares">12200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-27" decimals="-5" id="f-261" unitRef="usd">-13100000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities contextRef="c-7" decimals="-5" id="f-262" unitRef="usd">-13100000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-26" decimals="-5" id="f-263" unitRef="shares">12200000</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-27" decimals="-5" id="f-264" unitRef="usd">-1496500000</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-28" decimals="-5" id="f-265" unitRef="usd">1490300000</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge contextRef="c-7" decimals="-5" id="f-266" unitRef="usd">-6200000</dxcm:StockIssuedDuringPeriodValueExerciseOfNoteHedge>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-27" decimals="-5" id="f-267" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax contextRef="c-7" decimals="-5" id="f-268" unitRef="usd">76300000</dxcm:AdjustmentsToAdditionalPaidInCapitalPurchaseOfCappedCallTransactionsNetOfTax>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-27" decimals="-5" id="f-269" unitRef="usd">150800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-7" decimals="-5" id="f-270" unitRef="usd">150800000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-29" decimals="-5" id="f-271" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-272" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-30" decimals="-5" id="f-273" unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-7" decimals="-5" id="f-274" unitRef="usd">-5100000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-31" decimals="-5" id="f-275" unitRef="shares">385400000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-31" decimals="-5" id="f-276" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-32" decimals="-5" id="f-277" unitRef="usd">3514600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-33" decimals="-5" id="f-278" unitRef="usd">-16700000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-34" decimals="-5" id="f-279" unitRef="usd">1021400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-35" decimals="-5" id="f-280" unitRef="usd">-2451100000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-6" decimals="-5" id="f-281" unitRef="usd">2068600000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan contextRef="c-36" decimals="-5" id="f-282" unitRef="shares">1300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeBenefitPlan>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans contextRef="c-36" decimals="-5" id="f-283" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-37" decimals="-5" id="f-284" unitRef="usd">28200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan contextRef="c-1" decimals="-5" id="f-285" unitRef="usd">28200000</us-gaap:StockIssuedDuringPeriodValueEmployeeStockPurchasePlan>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-36" decimals="-5" id="f-286" unitRef="shares">1500000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-37" decimals="-5" id="f-287" unitRef="usd">-188100000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-38" decimals="-5" id="f-288" unitRef="usd">188100000</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones contextRef="c-1" decimals="-5" id="f-289" unitRef="usd">0</dxcm:StockIssuedDuringPeriodValueAchievementOfMilestones>
    <us-gaap:TreasuryStockSharesAcquired contextRef="c-36" decimals="-5" id="f-290" unitRef="shares">10400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-38" decimals="-5" id="f-291" unitRef="usd">749500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <us-gaap:TreasuryStockValueAcquiredCostMethod contextRef="c-1" decimals="-5" id="f-292" unitRef="usd">749500000</us-gaap:TreasuryStockValueAcquiredCostMethod>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants contextRef="c-36" decimals="-5" id="f-293" unitRef="shares">12500000</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants contextRef="c-37" decimals="-5" id="f-294" unitRef="usd">-1431300000</dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants contextRef="c-38" decimals="-5" id="f-295" unitRef="usd">1431300000</dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants contextRef="c-1" decimals="-5" id="f-296" unitRef="usd">0</dxcm:StockIssuedDuringPeriodValueExerciseAndSettlementOfWarrants>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-37" decimals="-5" id="f-297" unitRef="usd">170400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue contextRef="c-1" decimals="-5" id="f-298" unitRef="usd">170400000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss contextRef="c-39" decimals="-5" id="f-299" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-300" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-40" decimals="-5" id="f-301" unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent contextRef="c-1" decimals="-5" id="f-302" unitRef="usd">8700000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding contextRef="c-41" decimals="-5" id="f-303" unitRef="shares">390700000</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity contextRef="c-41" decimals="-5" id="f-304" unitRef="usd">400000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-42" decimals="-5" id="f-305" unitRef="usd">2093800000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-43" decimals="-5" id="f-306" unitRef="usd">-8000000.0</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-44" decimals="-5" id="f-307" unitRef="usd">1597600000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-45" decimals="-5" id="f-308" unitRef="usd">-1581200000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity contextRef="c-5" decimals="-5" id="f-309" unitRef="usd">2102600000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-310" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-311" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-312" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-313" unitRef="usd">217700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-5" id="f-314" unitRef="usd">186000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-8" decimals="-5" id="f-315" unitRef="usd">155900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:ShareBasedCompensation contextRef="c-1" decimals="-5" id="f-316" unitRef="usd">170400000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-7" decimals="-5" id="f-317" unitRef="usd">150800000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation contextRef="c-8" decimals="-5" id="f-318" unitRef="usd">126500000</us-gaap:ShareBasedCompensation>
    <us-gaap:PaidInKindInterest contextRef="c-1" decimals="-5" id="f-319" unitRef="usd">7500000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest contextRef="c-7" decimals="-5" id="f-320" unitRef="usd">7800000</us-gaap:PaidInKindInterest>
    <us-gaap:PaidInKindInterest contextRef="c-8" decimals="-5" id="f-321" unitRef="usd">6300000</us-gaap:PaidInKindInterest>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-322" unitRef="usd">-43800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-323" unitRef="usd">-55000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-324" unitRef="usd">-21600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-1" decimals="-5" id="f-325" unitRef="usd">47300000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-7" decimals="-5" id="f-326" unitRef="usd">85800000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:OtherNoncashIncomeExpense contextRef="c-8" decimals="-5" id="f-327" unitRef="usd">-34500000</us-gaap:OtherNoncashIncomeExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-1" decimals="-5" id="f-328" unitRef="usd">35000000.0</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-7" decimals="-5" id="f-329" unitRef="usd">260100000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable contextRef="c-8" decimals="-5" id="f-330" unitRef="usd">199900000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-1" decimals="-5" id="f-331" unitRef="usd">-12400000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-7" decimals="-5" id="f-332" unitRef="usd">252600000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories contextRef="c-8" decimals="-5" id="f-333" unitRef="usd">-49300000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-1" decimals="-5" id="f-334" unitRef="usd">5800000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-7" decimals="-5" id="f-335" unitRef="usd">-19300000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets contextRef="c-8" decimals="-5" id="f-336" unitRef="usd">131600000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-1" decimals="-5" id="f-337" unitRef="usd">6500000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-7" decimals="-5" id="f-338" unitRef="usd">4500000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet contextRef="c-8" decimals="-5" id="f-339" unitRef="usd">5800000</dxcm:IncreaseDecreaseinOperatingLeaseAssetsandLiabilitiesNet>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-1" decimals="-5" id="f-340" unitRef="usd">211700000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-7" decimals="-5" id="f-341" unitRef="usd">466500000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities contextRef="c-8" decimals="-5" id="f-342" unitRef="usd">295100000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-1" decimals="-5" id="f-343" unitRef="usd">-60000000.0</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-7" decimals="-5" id="f-344" unitRef="usd">37200000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities contextRef="c-8" decimals="-5" id="f-345" unitRef="usd">8500000</us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-1" decimals="-5" id="f-346" unitRef="usd">-8000000.0</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-7" decimals="-5" id="f-347" unitRef="usd">-2600000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:IncreaseDecreaseInOtherDeferredLiability contextRef="c-8" decimals="-5" id="f-348" unitRef="usd">11100000</us-gaap:IncreaseDecreaseInOtherDeferredLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-1" decimals="-5" id="f-349" unitRef="usd">989500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-7" decimals="-5" id="f-350" unitRef="usd">748500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities contextRef="c-8" decimals="-5" id="f-351" unitRef="usd">669500000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-1" decimals="-5" id="f-352" unitRef="usd">2576300000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-7" decimals="-5" id="f-353" unitRef="usd">3200400000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt contextRef="c-8" decimals="-5" id="f-354" unitRef="usd">2266300000</us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-1" decimals="-5" id="f-355" unitRef="usd">2824400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-7" decimals="-5" id="f-356" unitRef="usd">2947400000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities contextRef="c-8" decimals="-5" id="f-357" unitRef="usd">2127800000</us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-1" decimals="-5" id="f-358" unitRef="usd">358800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-7" decimals="-5" id="f-359" unitRef="usd">236600000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment contextRef="c-8" decimals="-5" id="f-360" unitRef="usd">364800000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-1" decimals="-5" id="f-361" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-7" decimals="-5" id="f-362" unitRef="usd">0</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired contextRef="c-8" decimals="-5" id="f-363" unitRef="usd">3900000</us-gaap:PaymentsToAcquireBusinessesNetOfCashAcquired>
    <us-gaap:PaymentsToAcquireOtherInvestments contextRef="c-1" decimals="-5" id="f-364" unitRef="usd">81300000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments contextRef="c-7" decimals="-5" id="f-365" unitRef="usd">19500000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsToAcquireOtherInvestments contextRef="c-8" decimals="-5" id="f-366" unitRef="usd">14500000</us-gaap:PaymentsToAcquireOtherInvestments>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-1" decimals="-5" id="f-367" unitRef="usd">15500000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-7" decimals="-5" id="f-368" unitRef="usd">-1900000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:PaymentsForProceedsFromOtherInvestingActivities contextRef="c-8" decimals="-5" id="f-369" unitRef="usd">-200000</us-gaap:PaymentsForProceedsFromOtherInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-1" decimals="-5" id="f-370" unitRef="usd">-207500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-7" decimals="-5" id="f-371" unitRef="usd">-507200000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities contextRef="c-8" decimals="-5" id="f-372" unitRef="usd">-521500000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-1" decimals="-5" id="f-373" unitRef="usd">28200000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-7" decimals="-5" id="f-374" unitRef="usd">26600000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock contextRef="c-8" decimals="-5" id="f-375" unitRef="usd">22500000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-1" decimals="-5" id="f-376" unitRef="usd">750000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-7" decimals="-5" id="f-377" unitRef="usd">688700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-8" decimals="-5" id="f-378" unitRef="usd">557700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-1" decimals="-5" id="f-379" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-7" decimals="-5" id="f-380" unitRef="usd">1230600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-8" decimals="-5" id="f-381" unitRef="usd">0</us-gaap:ProceedsFromConvertibleDebt>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-1" decimals="-5" id="f-382" unitRef="usd">0</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-7" decimals="-5" id="f-383" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-8" decimals="-5" id="f-384" unitRef="usd">0</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-1" decimals="-5" id="f-385" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-7" decimals="-5" id="f-386" unitRef="usd">787300000</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:RepaymentsOfConvertibleDebt contextRef="c-8" decimals="-5" id="f-387" unitRef="usd">0</us-gaap:RepaymentsOfConvertibleDebt>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-1" decimals="-5" id="f-388" unitRef="usd">-13000000.0</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-7" decimals="-5" id="f-389" unitRef="usd">1500000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:ProceedsFromPaymentsForOtherFinancingActivities contextRef="c-8" decimals="-5" id="f-390" unitRef="usd">-17300000</us-gaap:ProceedsFromPaymentsForOtherFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-1" decimals="-5" id="f-391" unitRef="usd">-734800000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-7" decimals="-5" id="f-392" unitRef="usd">-318600000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities contextRef="c-8" decimals="-5" id="f-393" unitRef="usd">-552500000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-1" decimals="-5" id="f-394" unitRef="usd">-7400000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-7" decimals="-5" id="f-395" unitRef="usd">1500000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-8" decimals="-5" id="f-396" unitRef="usd">-5800000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-1" decimals="-5" id="f-397" unitRef="usd">39800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-7" decimals="-5" id="f-398" unitRef="usd">-75800000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect contextRef="c-8" decimals="-5" id="f-399" unitRef="usd">-410300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-400" unitRef="usd">567500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-25" decimals="-5" id="f-401" unitRef="usd">643300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-14" decimals="-5" id="f-402" unitRef="usd">1053600000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-5" id="f-403" unitRef="usd">607300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-404" unitRef="usd">567500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-25" decimals="-5" id="f-405" unitRef="usd">643300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-5" decimals="-5" id="f-406" unitRef="usd">606100000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-407" unitRef="usd">566300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue contextRef="c-25" decimals="-5" id="f-408" unitRef="usd">642300000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash contextRef="c-5" decimals="-5" id="f-409" unitRef="usd">1200000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-6" decimals="-5" id="f-410" unitRef="usd">1200000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash contextRef="c-25" decimals="-5" id="f-411" unitRef="usd">1000000.0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-5" decimals="-5" id="f-412" unitRef="usd">607300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-6" decimals="-5" id="f-413" unitRef="usd">567500000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents contextRef="c-25" decimals="-5" id="f-414" unitRef="usd">643300000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-1" decimals="-5" id="f-415" unitRef="usd">0</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-7" decimals="-5" id="f-416" unitRef="usd">1501900000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <us-gaap:DebtConversionConvertedInstrumentAmount1 contextRef="c-8" decimals="-5" id="f-417" unitRef="usd">35900000</us-gaap:DebtConversionConvertedInstrumentAmount1>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-1" decimals="-5" id="f-418" unitRef="usd">0</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-7" decimals="-5" id="f-419" unitRef="usd">1490300000</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge contextRef="c-8" decimals="-5" id="f-420" unitRef="usd">33500000</dxcm:TreasuryStockValueBenefitReceivedFromNoteHedge>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-1" decimals="-5" id="f-421" unitRef="usd">75400000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-7" decimals="-5" id="f-422" unitRef="usd">53200000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 contextRef="c-8" decimals="-5" id="f-423" unitRef="usd">25700000</us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1>
    <us-gaap:InterestPaidNet contextRef="c-1" decimals="-5" id="f-424" unitRef="usd">11400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-7" decimals="-5" id="f-425" unitRef="usd">12400000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet contextRef="c-8" decimals="-5" id="f-426" unitRef="usd">12200000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaid contextRef="c-1" decimals="-5" id="f-427" unitRef="usd">198000000.0</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-7" decimals="-5" id="f-428" unitRef="usd">212300000</us-gaap:IncomeTaxesPaid>
    <us-gaap:IncomeTaxesPaid contextRef="c-8" decimals="-5" id="f-429" unitRef="usd">114200000</us-gaap:IncomeTaxesPaid>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock contextRef="c-1" id="f-430">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;border-bottom:1pt solid #ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;1. Organization and Significant Accounting Policies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Organization and Business&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring, or CGM, systems for the management of diabetes and metabolic health by patients, caregivers, and clinicians around the world. Unless the context requires otherwise, the terms &#x201c;we,&#x201d; &#x201c;us,&#x201d; &#x201c;our,&#x201d; the &#x201c;company,&#x201d; or &#x201c;Dexcom&#x201d; refer to DexCom, Inc. and its subsidiaries.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in comprehensive income. Interest income and realized gains and losses on marketable debt securities are included in other income (expense), net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income (loss) from equity investments in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities, supranational securities, and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; and Note 4 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Details and Other Financial Information&#x2014;Short-Term Marketable Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information on our marketable securities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are generally recorded at the invoiced amount, net of prompt pay discounts, for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectible.&#160;Generally, receivable balances that are more than one year past due are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.115%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.701%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** Total revenue for each customer is net of fees, cash discounts, and rebates directly allocable to that customer. Rebates paid to other entities are excluded; therefore, the combined value may exceed 100%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We capitalize inventory produced in preparation for commercial launches when it becomes probable that the product will receive regulatory approval and that the related costs will be recoverable through the commercialization of the product. A number of factors are considered, including the status of the regulatory application approval process, management&#x2019;s judgment of probable future commercial use, and net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record adjustments to inventory for potential excess or obsolete inventory, as well as inventory that does not pass quality control testing, in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is disposed of or sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of sales could be required.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We also capitalize certain costs incurred for the development of enterprise-level business and finance software that we use internally in our operations. Costs incurred in the application development phase are capitalized while costs related to planning and other preliminary project activities and to post-implementation activities are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally &lt;span style="-sec-ix-hidden:f-460"&gt;three&lt;/span&gt; to five years for computer software and hardware, including internal use software, &lt;span style="-sec-ix-hidden:f-462"&gt;four&lt;/span&gt; to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold and land improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but are tested annually for impairment during the fourth fiscal quarter and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#x2019;s reporting structure and the availability of discrete financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no significant goodwill impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in goodwill for the twelve months ended December&#160;31, 2024 and 2023 primarily consisted of the divestiture of our non-diabetes distribution business and translation adjustments on our foreign currency denominated goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are included in intangibles and other assets, net in our consolidated balance sheets. We amortize intangible assets with a finite life, such as the customer relationships, acquired technology and intellectual property, trademarks and trade name, and other intangibles, on a straight-line basis over their estimated useful lives, which range from &lt;span style="-sec-ix-hidden:f-470"&gt;one&lt;/span&gt; to fourteen years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For transactions other than a business combination, we also capitalize as intangible assets the cost of certain milestones payable by us to collaborative partners and incurred at or after the product has obtained regulatory approval for marketing. The intangible assets associated with these milestones are amortized over the remaining estimated useful life of the underlying asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded no significant intangible asset impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rate on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under tax law and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income tax expense for basis differences related to global intangible low-taxed income (&#x201c;GILTI&#x201d;) as a period cost if and when incurred. GILTI is a category of income that is earned abroad by U.S.-controlled foreign corporations (CFCs) and is subject to special treatment under the U.S. tax code.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Accrual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income consists of two elements, net income and other comprehensive income (loss). We report all components of comprehensive income, including net income, in our financial statements in the period in which they are recognized. Total comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income and the components of other comprehensive income (loss), including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. We also refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining how revenue should be recognized, a five-step process is used, which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes, but is not limited to: rebates, chargebacks, product returns provision, and prompt payment discounts. We classify these items as a reduction of accounts receivable when we are not required to make a payment and as a liability when we are required to make a payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We estimate our product returns primarily based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prompt Payment Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customers with prompt payment discounts, which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discounts based on eligible sales and contractual discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record revenue from sales of Components upon transfer of control of the product to the customer. We typically determine transfer of control based on when the product is shipped or delivered and title passes to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December&#160;31, 2024 included unbilled accounts receivable of $15.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when cash payments have been received prior to satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months were $9.5 million as of December&#160;31, 2024 and $7.4 million as of December&#160;31, 2023. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incentive Compensation Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;span style="-sec-ix-hidden:f-485"&gt;one&lt;/span&gt; year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consists of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our technology includes certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may enter into agreements with collaboration partners for the development and commercialization of our products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When we account for these agreements, we consider the unique nature, terms and facts and circumstances of each transaction. Below are some example activities and how we account for them:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;Payments to collaboration partners through issuance of common stock as consideration in an asset acquisition are considered share-based payment to non-employees in exchange for goods within the scope of ASC Topic 718, &#x201c;Compensation - Stock Compensation.&#x201d; The amount and the timing of the cost recognition of such milestones in our financial statements is driven by the accounting for the specific type of equity instrument under ASC 718 that aligns with the terms of the agreement, including any performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;The value associated with in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in an asset acquisition incurred prior to regulatory approval is expensed as it does not have an alternative future use and is recorded as research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;The value associated with IPR&amp;amp;D in an asset acquisition incurred at or after regulatory approval is usually capitalized as an intangible asset and amortized over the periods in which the related products are expected to contribute to future cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses. Advertising expense was $194.2 million, $180.8 million and $160.6 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease right-of-use assets and liabilities with terms of more than 12 months are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to determine the present value is our collateralized incremental borrowing rate unless the interest rate implicit in the lease is readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases, lease expense is recognized on a straight-line basis within operating expenses over the lease term. For finance leases, lease expense is recognized as interest and depreciation; interest using the effective interest method and depreciation on a straight-line basis over the shorter of the estimated useful lives of the assets or, in the instance where title does not transfer at the end of the lease term, the lease term. Short-term leases with lease terms of 12 months or less are not recorded on the balance sheet and are recognized on a straight line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain lease components and non-lease components. For certain asset classes, we have elected to account for both of those components as a single lease component. We use a portfolio approach to account for the right-of-use assets and liabilities associated with certain machinery and equipment leases. Variable lease payments may include payments associated with non-lease components, payments that do not depend on a rate or index, or other costs. Variable lease payments are recognized in the period in which the obligation for those payments are incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value time-based restricted stock units, or RSUs, at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. We estimate the fair value of these performance/market-based RSUs, or PSUs, at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the PSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of PSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the PSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from RSUs, PSUs, warrants, our senior convertible notes, and collaborative sales-based milestones. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;576.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;341.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;587.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;393.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;389.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive potential securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaborative sales-based milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs and PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;427.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs and PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2023-07, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, or CODM, and included within each reported measure of segment profit or loss. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, reflecting the application of the new standard in each prior reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires greater disaggregation of information about a reporting entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s effective tax rate reconciliation as well as information on income taxes paid. The ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity&#x2019;s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires disaggregated disclosure of certain costs and expenses in the notes of the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Securities and Exchange Commission Final Rules Not Yet Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 6, 2024, the SEC adopted SEC Release Nos. 33-11275; 34-99678, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to require the disclosure of certain climate-related information in registration statements and annual reports, including Scope 1 and 2 emissions and information about climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, a company&#x2019;s business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in audited financial statements. The disclosure requirements would have begun phasing in for our reports and registration statements including financial information in the fiscal year ending December 31, 2025, however, in April 2024, the SEC issued an order staying the final rules until the completion of judicial review. The SEC has since indicated that it intends to establish a new implementation period following the stay order. We are currently evaluating the impact of this final rule on our disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock contextRef="c-1" id="f-432">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock contextRef="c-1" id="f-431">&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Principles of Consolidation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;These consolidated financial statements include the accounts of DexCom, Inc. and our wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated in consolidation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have reclassified certain amounts previously reported in our financial statements to conform to the current presentation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine the functional currencies of our international subsidiaries by reviewing the environment where each subsidiary primarily generates and expends cash. For international subsidiaries whose functional currencies are the local currencies, we translate the financial statements into U.S. dollars using period-end exchange rates for assets and liabilities and average exchange rates for each period for revenue, costs and expenses. We include translation-related adjustments in comprehensive income and in accumulated other comprehensive loss in the equity section of our consolidated balance sheets. We record gains and losses resulting from transactions with customers and vendors that are denominated in currencies other than the functional currency and from certain intercompany transactions in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates contextRef="c-1" id="f-433">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of consolidated financial statements in conformity with U.S. generally accepted accounting principles, or GAAP, requires us to make certain estimates and assumptions that affect the amounts reported in our consolidated financial statements and the disclosures made in the accompanying notes. Areas requiring significant estimates include rebates, excess or obsolete inventories and the valuation of inventory, accruals for litigation contingencies, and the amount of our worldwide tax provision and the realizability of deferred tax assets. Despite our intention to establish accurate estimates and use reasonable assumptions, actual results may differ from our estimates.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock contextRef="c-1" id="f-434">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The authoritative guidance establishes a fair value hierarchy that is based on the extent and level of judgment used to estimate the fair value of assets and liabilities. In general, the authoritative guidance requires us to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. An asset or liability&#x2019;s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the measurement of its fair value. The three levels of input defined by the authoritative guidance are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;1&#x2014;Uses unadjusted quoted prices that are available in active markets for identical assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;2&#x2014;Uses inputs other than quoted prices included in Level&#160;1 that are observable, either directly or indirectly, through correlation with market data. These include quoted prices in active markets for similar assets or liabilities; quoted prices for identical or similar assets or liabilities in markets that are not active; and inputs to valuation models or other pricing methodologies that do not require significant judgment because the inputs used in the model, such as interest rates and volatility, can be corroborated by readily observable market data for substantially the full term of the assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Level&#160;3&#x2014;Uses unobservable inputs that are supported by little or no market activity and that are significant to the determination of fair value. Level 3 assets and liabilities include those whose fair values are determined using pricing models, discounted cash flow methodologies, or similar valuation techniques and significant judgment or estimation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of most of our cash equivalents using Level 1 inputs. We estimate the fair value of our marketable equity securities using Level 1 inputs and we estimate the fair value of our marketable debt securities using Level 2 inputs. We carry our marketable securities at fair value. We carry our other financial instruments, such as cash and cash equivalents, accounts receivable, prepaid expenses and other current assets, accounts payable and accrued liabilities, at cost, which approximates the related fair values due to the short-term maturities of these instruments. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock contextRef="c-1" id="f-435">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider highly liquid investments with a maturity of 90 days or less at the time of purchase to be cash equivalents.&lt;/span&gt;&lt;/div&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents contextRef="c-1" id="f-436">P90D</dxcm:MaturityThresholdOfInvestmentsClassifiedToCashEquivalents>
    <us-gaap:MarketableSecuritiesPolicy contextRef="c-1" id="f-437">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have classified our marketable securities with remaining maturity at purchase of more than three months and remaining maturities of one year or less as short-term marketable securities. We have also classified marketable securities with remaining maturities of greater than one year as short-term marketable securities based upon our ability and intent to use any and all of those marketable securities to satisfy the liquidity needs of our current operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate realized gains or losses on our marketable securities using the specific identification method. We carry our marketable debt securities at fair value with unrealized gains and losses reported as a separate component of stockholders&#x2019; equity in our consolidated balance sheets and included in comprehensive income. Interest income and realized gains and losses on marketable debt securities are included in other income (expense), net in our consolidated statements of operations. We carry our marketable equity securities at fair value with realized and unrealized gains and losses reported in income (loss) from equity investments in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We invest in various types of debt securities, including debt securities in government-sponsored entities, corporate debt securities, U.S. Treasury securities, supranational securities, and commercial paper. We do not generally intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity. See Note 3 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; and Note 4 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Details and Other Financial Information&#x2014;Short-Term Marketable Securities&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information on our marketable securities.&lt;/span&gt;&lt;/div&gt;</us-gaap:MarketableSecuritiesPolicy>
    <us-gaap:ReceivablesPolicyTextBlock contextRef="c-1" id="f-438">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable are generally recorded at the invoiced amount, net of prompt pay discounts, for distributors and at net realizable value for direct customers, which is determined using estimates of claim denials and historical reimbursement experience without regard to aging category. Accounts receivable are not interest bearing. We evaluate the creditworthiness of significant customers based on historical trends, the financial condition of our customers, and external market factors. We generally do not require collateral from our customers. We maintain an allowance for doubtful accounts for potential credit losses. Uncollectible accounts are written off against the allowance after appropriate collection efforts have been exhausted and when it is deemed that a customer account is uncollectible.&#160;Generally, receivable balances that are more than one year past due are deemed uncollectible.&lt;/span&gt;&lt;/div&gt;</us-gaap:ReceivablesPolicyTextBlock>
    <us-gaap:ConcentrationRiskCreditRisk contextRef="c-1" id="f-439">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments which potentially subject us to concentrations of credit risk consist primarily of cash, cash equivalents, short-term marketable securities, and accounts receivable. We limit our exposure to credit risk by placing our cash and investments with a few major financial institutions. We have also established guidelines regarding diversification of our investments and their maturities that are designed to maintain principal and maximize liquidity. We review these guidelines periodically and modify them to take advantage of trends in yields and interest rates and changes in our operations and financial position.&lt;/span&gt;&lt;/div&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock contextRef="c-1" id="f-440">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the percentages of total revenue or gross accounts receivable for customers that represent 10% or more of the respective amounts for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:46.414%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.115%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.701%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Revenue**&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Accounts Receivable&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;As of December 31, &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer A&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer B&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer C&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer D&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer E&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Less than 10%&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:31.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;** Total revenue for each customer is net of fees, cash discounts, and rebates directly allocable to that customer. Rebates paid to other entities are excluded; therefore, the combined value may exceed 100%.&lt;/span&gt;&lt;/div&gt;</us-gaap:SchedulesOfConcentrationOfRiskByRiskFactorTextBlock>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-46" decimals="2" id="f-441" unitRef="number">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-47" decimals="2" id="f-442" unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-48" decimals="2" id="f-443" unitRef="number">0.32</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-49" decimals="2" id="f-444" unitRef="number">0.18</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-50" decimals="2" id="f-445" unitRef="number">0.20</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-51" decimals="2" id="f-446" unitRef="number">0.11</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-52" decimals="2" id="f-447" unitRef="number">0.35</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-53" decimals="2" id="f-448" unitRef="number">0.30</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-54" decimals="2" id="f-449" unitRef="number">0.26</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-55" decimals="2" id="f-450" unitRef="number">0.21</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-56" decimals="2" id="f-451" unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-57" decimals="2" id="f-452" unitRef="number">0.42</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-58" decimals="2" id="f-453" unitRef="number">0.37</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-59" decimals="2" id="f-454" unitRef="number">0.29</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-60" decimals="2" id="f-455" unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-61" decimals="2" id="f-456" unitRef="number">0.27</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1 contextRef="c-62" decimals="2" id="f-457" unitRef="number">0.10</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:InventoryPolicyTextBlock contextRef="c-1" id="f-458">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is valued at the lower of cost or net realizable value on a part-by-part basis that approximates first in, first out. We capitalize inventory produced in preparation for commercial launches when it becomes probable that the product will receive regulatory approval and that the related costs will be recoverable through the commercialization of the product. A number of factors are considered, including the status of the regulatory application approval process, management&#x2019;s judgment of probable future commercial use, and net realizable value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record adjustments to inventory for potential excess or obsolete inventory, as well as inventory that does not pass quality control testing, in order to state inventory at net realizable value. Factors influencing these adjustments include inventories on hand and on order compared to estimated future usage and sales for existing and new products, as well as judgments regarding quality control testing data and assumptions about the likelihood of scrap and obsolescence. Once written down the adjustments are considered permanent and are not reversed until the related inventory is disposed of or sold.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our products require customized products and components that currently are available from a limited number of sources. We purchase certain components and materials from single sources due to quality considerations, costs or constraints resulting from regulatory requirements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Historically, our inventory reserves have been adequate to cover our actual losses. However, if actual product life cycles, product quality or market conditions differ from our assumptions, additional inventory adjustments that would increase cost of sales could be required.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock contextRef="c-1" id="f-459">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment is stated at cost less accumulated depreciation and amortization. We capitalize additions and improvements and expense maintenance and repairs as incurred. We also capitalize certain costs incurred for the development of enterprise-level business and finance software that we use internally in our operations. Costs incurred in the application development phase are capitalized while costs related to planning and other preliminary project activities and to post-implementation activities are expensed as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We calculate depreciation using the straight-line method over the estimated useful lives of the assets. Estimated useful lives are generally &lt;span style="-sec-ix-hidden:f-460"&gt;three&lt;/span&gt; to five years for computer software and hardware, including internal use software, &lt;span style="-sec-ix-hidden:f-462"&gt;four&lt;/span&gt; to fifteen years for machinery and equipment, and five years for furniture and fixtures. Leasehold and land improvements are amortized over the shorter of the estimated useful lives of the assets or the remaining lease term. Buildings are amortized over the shorter of the ownership of the building or forty years. We include the amortization of assets that are recorded under finance leases in depreciation expense. On retirement or disposition, the asset cost and related accumulated depreciation are removed from our consolidated balance sheets and any gain or loss is recognized in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review property and equipment for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the recoverability of the asset by comparing the carrying amount to the future undiscounted cash flows that we expect the asset to generate. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-64" id="f-461">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-66" id="f-463">P15Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-67" id="f-464">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife contextRef="c-68" id="f-465">P40Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock contextRef="c-1" id="f-466">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record goodwill when the fair value of consideration transferred in a business combination exceeds the fair value of the identifiable assets acquired and liabilities assumed. Goodwill and other intangible assets that have indefinite useful lives are not amortized, but are tested annually for impairment during the fourth fiscal quarter and whenever events or changes in circumstances indicate that it is more likely than not that the fair value is less than the carrying value. Events that would indicate impairment and trigger an interim impairment assessment include, but are not limited to, current economic and market conditions, including a decline in market capitalization, a significant adverse change in legal factors, business climate or operational performance of the business, and an adverse action or assessment by a regulator.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform our goodwill impairment analysis at the reporting unit level, which aligns with Dexcom&#x2019;s reporting structure and the availability of discrete financial information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We perform the first step of our annual impairment analysis by either comparing a reporting unit&#x2019;s estimated fair value to its carrying amount or doing a qualitative assessment of a reporting unit&#x2019;s fair value from the last quantitative assessment to determine if there is potential impairment. We may do a qualitative assessment when the results of the previous quantitative test indicated the reporting unit&#x2019;s estimated fair value was significantly in excess of the carrying value of its net assets and we do not believe there have been significant changes in the reporting unit&#x2019;s operations that would significantly decrease its estimated fair value or significantly increase its net assets.&#160;If a quantitative assessment is performed the evaluation includes management estimates of cash flow projections based on internal future projections&#160;and/or use of a market approach by looking at market values of comparable companies. Key assumptions&#160;for these projections include revenue growth, future gross margin and operating margin growth, and weighted cost of capital and terminal growth rates. The revenue and margin growth are based on increased sales of new and existing products as we maintain investments in research and development. Additional assumed value creators may include increased efficiencies from capital spending. The resulting cash flows are discounted using a weighted average cost of capital. Operating mechanisms and requirements&#160;to ensure that growth and efficiency assumptions will ultimately be realized are also considered in the evaluation, including the timing and probability of regulatory approvals for our products to be commercialized. We also consider Dexcom&#x2019;s market capitalization as a part of our analysis.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the estimated fair value of a reporting unit exceeds the carrying amount of the net assets assigned to that unit, goodwill is not impaired and no further analysis is required. If the carrying value of the net assets assigned to a reporting unit exceeds the estimated fair value of the unit, we perform the second step of the impairment test. In this step we allocate the fair value of the reporting unit calculated in step one to all of the assets and liabilities of that unit, as if we had just acquired the reporting unit in a business combination. The excess of the fair value of the reporting unit over the total amount allocated to the assets and liabilities represents the implied fair value of goodwill. If the carrying amount of a reporting unit&#x2019;s goodwill exceeds its implied fair value, we would record an impairment loss equal to the difference. We recorded no significant goodwill impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The change in goodwill for the twelve months ended December&#160;31, 2024 and 2023 primarily consisted of the divestiture of our non-diabetes distribution business and translation adjustments on our foreign currency denominated goodwill.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangible assets are included in intangibles and other assets, net in our consolidated balance sheets. We amortize intangible assets with a finite life, such as the customer relationships, acquired technology and intellectual property, trademarks and trade name, and other intangibles, on a straight-line basis over their estimated useful lives, which range from &lt;span style="-sec-ix-hidden:f-470"&gt;one&lt;/span&gt; to fourteen years. We review intangible assets that have finite lives and other long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. We estimate the fair value of the asset based on the present value of future cash flows for those assets. If the carrying value of an asset exceeds its estimated fair value, we would record an impairment loss equal to the difference.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For transactions other than a business combination, we also capitalize as intangible assets the cost of certain milestones payable by us to collaborative partners and incurred at or after the product has obtained regulatory approval for marketing. The intangible assets associated with these milestones are amortized over the remaining estimated useful life of the underlying asset.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recorded no significant intangible asset impairment charges for the twelve months ended December&#160;31, 2024, 2023 or 2022.&lt;/span&gt;&lt;/div&gt;</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-7" decimals="0" id="f-467" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-1" decimals="0" id="f-468" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:GoodwillImpairmentLoss contextRef="c-8" decimals="0" id="f-469" unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-70" id="f-471">P14Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-8" decimals="0" id="f-472" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-1" decimals="0" id="f-473" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill contextRef="c-7" decimals="0" id="f-474" unitRef="usd">0</us-gaap:ImpairmentOfIntangibleAssetsExcludingGoodwill>
    <us-gaap:IncomeTaxPolicyTextBlock contextRef="c-1" id="f-475">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for income taxes under the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the financial statements. The effect of a change in tax rate on deferred tax assets and liabilities is recognized in income in the period that includes the enactment date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize deferred tax assets to the extent that we believe that these assets are more likely than not to be realized. In making such determination, we consider all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, carryback potential if permitted under tax law and results of recent operations. If we determine that we would be able to realize our deferred tax assets in the future in excess of their net recorded amount, we would make an adjustment to the deferred tax asset valuation allowance, which would reduce the provision for income taxes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record uncertain tax positions in accordance with ASC 740 on the basis of a two-step process in which (1) we determine whether it is more likely than not that the tax positions will be sustained on the basis of the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold, we recognize the largest amount of tax benefit that is more than 50 percent likely to be realized upon ultimate settlement with the related tax authority.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We file federal and state income tax returns in the United States and income tax returns in various other foreign jurisdictions with varying statutes of limitations. Due to net operating losses incurred, our income tax returns from inception to date are subject to examination by taxing authorities. We recognize interest expense and penalties related to income tax matters, including unrecognized tax benefits, as a component of income tax expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We recognize income tax expense for basis differences related to global intangible low-taxed income (&#x201c;GILTI&#x201d;) as a period cost if and when incurred. GILTI is a category of income that is earned abroad by U.S.-controlled foreign corporations (CFCs) and is subject to special treatment under the U.S. tax code.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:StandardProductWarrantyPolicy contextRef="c-1" id="f-476">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Warranty Accrual&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Estimated warranty costs associated with a product are recorded at the time revenue is recognized. We estimate future warranty costs by analyzing historical warranty experience for the timing and amount of returned product, and expectations for future warranty activity based on changes and improvements to the product or process that are in place or will be in place in the future. We evaluate these estimates on at least a quarterly basis to determine the continued appropriateness of our assumptions.&lt;/span&gt;&lt;/div&gt;</us-gaap:StandardProductWarrantyPolicy>
    <us-gaap:CommitmentsAndContingenciesPolicyTextBlock contextRef="c-1" id="f-477">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Loss Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to certain legal proceedings, as well as demands, claims and threatened litigation that arise in the normal course of our business. We review the status of each significant matter quarterly and assess our potential financial exposure. If the potential loss from a claim or legal proceeding is considered probable and the amount can be reasonably estimated, we record a liability and an expense for the estimated loss and disclose it in our financial statements if it is significant. If we determine that a loss is possible and the range of the loss can be reasonably determined, we do not record a liability or an expense but we disclose the range of the possible loss. We base our judgments on the best information available at the time. As additional information becomes available, we reassess the potential liability related to our pending claims and litigation and may revise our estimates. Any revision of our estimates of potential liability could have a material impact on our financial position and operating results.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesPolicyTextBlock>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock contextRef="c-1" id="f-478">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Income&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Comprehensive income consists of two elements, net income and other comprehensive income (loss). We report all components of comprehensive income, including net income, in our financial statements in the period in which they are recognized. Total comprehensive income is defined as the change in equity during a period from transactions and other events and circumstances from non-owner sources. We report net income and the components of other comprehensive income (loss), including foreign currency translation adjustments and unrealized gains and losses on marketable securities, net of their related tax effect to arrive at total comprehensive income.&lt;/span&gt;&lt;/div&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock contextRef="c-1" id="f-479">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generate our revenue from the sale of disposable sensors and our reusable transmitter and receiver, collectively referred to as Reusable Hardware. We also refer to Reusable Hardware and disposable sensors in this section as Components. We generally recognize revenue when control is transferred to our customers in an amount that reflects the net consideration to which we expect to be entitled.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In determining how revenue should be recognized, a five-step process is used, which includes identifying performance obligations in the contract, determining whether the performance obligations are separate, allocating the transaction price to each separate performance obligation, estimating the amount of variable consideration to include in the transaction price and determining the timing of revenue recognition for separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contracts and Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We consider customer purchase orders, which in most cases are governed by agreements with distributors or third-party payors, to be contracts with a customer. For each contract, we consider the obligation to transfer Components to the customer, each of which are distinct, to be separate performance obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Transaction Price&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Transaction price for the Components reflects the net consideration to which we expect to be entitled. Transaction price is typically based on the contracted rates less an estimate of claim denials and historical reimbursement experience by payor, which include current and future expectations regarding reimbursement rates and payor mix.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Variable Consideration&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We include an estimate of variable consideration in the calculation of the transaction price at the time of sale, when control of the Components transfers to the customer. Variable consideration includes, but is not limited to: rebates, chargebacks, product returns provision, and prompt payment discounts. We classify these items as a reduction of accounts receivable when we are not required to make a payment and as a liability when we are required to make a payment.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We review the adequacy of our estimates for transaction price adjustments and variable consideration at each reporting date. If the actual amounts of consideration we receive differ from our estimates, we would adjust our estimates and that would affect reported revenue in the period that such variances become known. If any of these judgments were to change, it could cause a material increase or decrease in the amount of revenue we report in a particular period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Rebates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to rebates on pricing programs with managed care organizations, such as pharmacy benefit managers, governmental and third-party commercial payors, primarily in the U.S. We estimate rebates based on contractual arrangements, estimates of products sold subject to rebate, known events or trends and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Chargebacks&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We participate in chargeback programs, primarily with government entities in the U.S., under which pricing on products below negotiated list prices is provided to participating entities and equal to the difference between their acquisition cost and the lower negotiated price. We estimate chargebacks primarily based on historical experience on a product and program basis, current contract prices under the chargeback programs and channel inventory data.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Product Returns&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with the terms of their distribution agreements, most distributors do not have rights of return. The distributors typically have a limited time frame to notify us of any missing, damaged, defective or non-conforming products. We estimate our product returns primarily based on historical experience by applying a historical return rate to the amounts of revenue estimated to be subject to returns. Additionally, we consider other specific factors such as estimated shelf life of inventory in the distribution channel and changes to customer terms.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Prompt Payment Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We provide customers with prompt payment discounts, which may result in adjustments to the price that is invoiced for the product transferred, in the case that payments are made within a defined period. We estimate prompt payment discounts based on eligible sales and contractual discount rates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record revenue from sales of Components upon transfer of control of the product to the customer. We typically determine transfer of control based on when the product is shipped or delivered and title passes to the customer.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract balances represent amounts presented in our consolidated balance sheets when either we have transferred goods or services to the customer or the customer has paid consideration to us under the contract. These contract balances include accounts receivable and deferred revenue. Payment terms vary by contract type and type of customer and generally range from 30 to 90 days.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable as of December&#160;31, 2024 included unbilled accounts receivable of $15.2 million. We expect to invoice and collect all unbilled accounts receivable within twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We record deferred revenue when cash payments have been received prior to satisfaction of the related performance obligation.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our performance obligations are generally satisfied within twelve months of the initial contract date. The deferred revenue balances related to performance obligations that will be satisfied after twelve months were $9.5 million as of December&#160;31, 2024 and $7.4 million as of December&#160;31, 2023. These balances are included in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Deferred Cost of Sales&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred cost of sales are included in prepaid and other current assets in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Incentive Compensation Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We generally expense incentive compensation associated with our internal sales force when incurred because the amortization period for such costs, if capitalized, would have been &lt;span style="-sec-ix-hidden:f-485"&gt;one&lt;/span&gt; year or less. We record these costs in selling, general and administrative expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-71" id="f-480">P30D</dxcm:ContractPaymentTermsNumberofDays>
    <dxcm:ContractPaymentTermsNumberofDays contextRef="c-72" id="f-481">P90D</dxcm:ContractPaymentTermsNumberofDays>
    <us-gaap:UnbilledContractsReceivable contextRef="c-5" decimals="-5" id="f-482" unitRef="usd">15200000</us-gaap:UnbilledContractsReceivable>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-483" unitRef="usd">9500000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-484" unitRef="usd">7400000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ResearchAndDevelopmentExpensePolicy contextRef="c-1" id="f-486">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We expense costs of research and development as we incur them. Our research and development expenses primarily consists of engineering and research expenses related to our sensing technology, clinical trials, regulatory expenses, quality assurance programs, employee compensation, and business process outsourcers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our technology includes certain software that we develop. We expense software development costs as we incur them until technological feasibility has been established, at which time we capitalize development costs until the product is available for general release to customers. To date, our software has been available for general release concurrent with the establishment of technological feasibility and, accordingly, we have not capitalized any development costs.&lt;/span&gt;&lt;/div&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:CollaborativeArrangementAccountingPolicy contextRef="c-1" id="f-487">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We may enter into agreements with collaboration partners for the development and commercialization of our products. These arrangements may include payments contingent on the occurrence of certain events such as development, regulatory or sales-based milestones.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;When we account for these agreements, we consider the unique nature, terms and facts and circumstances of each transaction. Below are some example activities and how we account for them:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;Payments to collaboration partners through issuance of common stock as consideration in an asset acquisition are considered share-based payment to non-employees in exchange for goods within the scope of ASC Topic 718, &#x201c;Compensation - Stock Compensation.&#x201d; The amount and the timing of the cost recognition of such milestones in our financial statements is driven by the accounting for the specific type of equity instrument under ASC 718 that aligns with the terms of the agreement, including any performance conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;The value associated with in-process research and development (&#x201c;IPR&amp;amp;D&#x201d;) in an asset acquisition incurred prior to regulatory approval is expensed as it does not have an alternative future use and is recorded as research and development expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:3pt;padding-left:47.25pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:19pt"&gt;The value associated with IPR&amp;amp;D in an asset acquisition incurred at or after regulatory approval is usually capitalized as an intangible asset and amortized over the periods in which the related products are expected to contribute to future cash flows.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementAccountingPolicy>
    <us-gaap:AdvertisingCostsPolicyTextBlock contextRef="c-1" id="f-488">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Advertising Costs&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We expense costs to produce advertising as we incur them whereas costs to communicate advertising are expensed when the advertising is first run. Advertising costs are included in selling, general and administrative expenses.</us-gaap:AdvertisingCostsPolicyTextBlock>
    <us-gaap:AdvertisingExpense contextRef="c-1" decimals="-5" id="f-489" unitRef="usd">194200000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-7" decimals="-5" id="f-490" unitRef="usd">180800000</us-gaap:AdvertisingExpense>
    <us-gaap:AdvertisingExpense contextRef="c-8" decimals="-5" id="f-491" unitRef="usd">160600000</us-gaap:AdvertisingExpense>
    <us-gaap:LesseeLeasesPolicyTextBlock contextRef="c-1" id="f-492">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determine if an arrangement is a lease at inception. Lease right-of-use assets represent our right to use an underlying asset for the lease term and lease liabilities represent our obligation to make lease payments arising from the lease. Lease right-of-use assets and liabilities with terms of more than 12 months are recognized at commencement date based on the present value of lease payments over the lease term. The discount rate used to determine the present value is our collateralized incremental borrowing rate unless the interest rate implicit in the lease is readily determinable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For operating leases, lease expense is recognized on a straight-line basis within operating expenses over the lease term. For finance leases, lease expense is recognized as interest and depreciation; interest using the effective interest method and depreciation on a straight-line basis over the shorter of the estimated useful lives of the assets or, in the instance where title does not transfer at the end of the lease term, the lease term. Short-term leases with lease terms of 12 months or less are not recorded on the balance sheet and are recognized on a straight line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease right-of-use assets and lease liabilities are presented separately in our consolidated balance sheets. Finance lease right-of-use assets are included in property and equipment and finance lease liabilities are included in accounts payable and accrued liabilities and in other long-term liabilities in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our lease agreements may contain lease components and non-lease components. For certain asset classes, we have elected to account for both of those components as a single lease component. We use a portfolio approach to account for the right-of-use assets and liabilities associated with certain machinery and equipment leases. Variable lease payments may include payments associated with non-lease components, payments that do not depend on a rate or index, or other costs. Variable lease payments are recognized in the period in which the obligation for those payments are incurred.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy contextRef="c-1" id="f-493">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense is measured at the grant date based on the estimated fair value of the award and is recognized straight-line over the requisite service period of the individual grants, which typically equals the vesting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value time-based restricted stock units, or RSUs, at the date of grant using the intrinsic value method. Certain RSUs granted to senior management vest based on the achievement of pre-established performance or market goals. We estimate the fair value of these performance/market-based RSUs, or PSUs, at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We update our assessment of the probability that the specified performance criteria will be achieved each quarter and adjust our estimate of the fair value of the PSUs if necessary. The Monte Carlo methodology that we use to estimate the fair value of PSUs at the date of grant incorporates into the valuation the possibility that the market condition may not be satisfied. Provided that the requisite service is rendered, the total fair value of the PSUs at the date of grant must be recognized as compensation expense even if the market condition is not achieved. However, the number of shares that ultimately vest can vary significantly with the performance of the specified market criteria.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If any of the assumptions used change significantly, share-based compensation expense may differ materially from what we have recorded in the current period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for forfeitures as they occur by reversing any share-based compensation expense related to awards that will not vest.&lt;/span&gt;&lt;/div&gt;</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock contextRef="c-1" id="f-494">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income Per Share&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income per share attributable to common stockholders is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share is computed using the weighted average number of common shares outstanding during the period and, when dilutive, potential common share equivalents.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Potentially dilutive common shares consist of shares issuable from RSUs, PSUs, warrants, our senior convertible notes, and collaborative sales-based milestones. Potentially dilutive common shares issuable upon vesting of RSUs, PSUs, and exercise of warrants are determined using the average share price for each period under the treasury stock method. Potentially dilutive common shares issuable upon conversion of our senior convertible notes are determined using the if-converted method. In periods of net losses, we exclude all potentially dilutive common shares from the computation of the diluted net loss per share for those periods as the effect would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock contextRef="c-1" id="f-495">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the computation of basic and diluted net income per share for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.601%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:21pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions, except per share data)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;576.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;341.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Add back interest expense, net of tax attributable to assumed conversion of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income - diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;587.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;554.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;352.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income per common share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.40&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.30&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.82&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;393.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;386.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;389.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dilutive potential securities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaborative sales-based milestones&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs and PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Diluted weighted average shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;412.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;425.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;427.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-496" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-497" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-498" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-1" decimals="-5" id="f-499" unitRef="usd">11500000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-7" decimals="-5" id="f-500" unitRef="usd">12600000</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:InterestOnConvertibleDebtNetOfTax contextRef="c-8" decimals="-5" id="f-501" unitRef="usd">11000000.0</us-gaap:InterestOnConvertibleDebtNetOfTax>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-1" decimals="-5" id="f-502" unitRef="usd">587700000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-7" decimals="-5" id="f-503" unitRef="usd">554100000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:NetIncomeLossAttributableToParentDiluted contextRef="c-8" decimals="-5" id="f-504" unitRef="usd">352200000</us-gaap:NetIncomeLossAttributableToParentDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-1"
      decimals="2"
      id="f-505"
      unitRef="usdPerShare">1.46</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-7"
      decimals="2"
      id="f-506"
      unitRef="usdPerShare">1.40</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="c-8"
      decimals="2"
      id="f-507"
      unitRef="usdPerShare">0.88</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-1"
      decimals="2"
      id="f-508"
      unitRef="usdPerShare">1.42</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-7"
      decimals="2"
      id="f-509"
      unitRef="usdPerShare">1.30</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="c-8"
      decimals="2"
      id="f-510"
      unitRef="usdPerShare">0.82</us-gaap:EarningsPerShareDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-1" decimals="-5" id="f-511" unitRef="shares">393600000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-7" decimals="-5" id="f-512" unitRef="shares">386000000.0</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic contextRef="c-8" decimals="-5" id="f-513" unitRef="shares">389400000</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-73" decimals="-5" id="f-514" unitRef="shares">200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-74" decimals="-5" id="f-515" unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-75" decimals="-5" id="f-516" unitRef="shares">0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-76" decimals="-5" id="f-517" unitRef="shares">700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-77" decimals="-5" id="f-518" unitRef="shares">1100000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-78" decimals="-5" id="f-519" unitRef="shares">1000000.0</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-79" decimals="-5" id="f-520" unitRef="shares">15700000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-80" decimals="-5" id="f-521" unitRef="shares">26200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-81" decimals="-5" id="f-522" unitRef="shares">26900000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-82" decimals="-5" id="f-523" unitRef="shares">2500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-83" decimals="-5" id="f-524" unitRef="shares">11500000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements contextRef="c-84" decimals="-5" id="f-525" unitRef="shares">10200000</us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-1" decimals="-5" id="f-526" unitRef="shares">412700000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-7" decimals="-5" id="f-527" unitRef="shares">425500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding contextRef="c-8" decimals="-5" id="f-528" unitRef="shares">427500000</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock contextRef="c-1" id="f-529">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding anti-dilutive securities not included in the calculations of diluted net income per share attributable to common stockholders were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;RSUs and PSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-76" decimals="-5" id="f-530" unitRef="shares">1300000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-77" decimals="-5" id="f-531" unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount contextRef="c-78" decimals="-5" id="f-532" unitRef="shares">400000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock contextRef="c-1" id="f-533">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Guidance&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2023, the Financial Accounting Standards Board, or FASB, issued Accounting Standards Update, or ASU, 2023-07, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires disclosure of significant segment expenses that are regularly provided to the chief operating decision maker, or CODM, and included within each reported measure of segment profit or loss. We adopted ASU 2023-07 in the fourth quarter of 2024 on a retrospective basis, reflecting the application of the new standard in each prior reporting period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2023, the FASB issued ASU 2023-09, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Improvements to Income Tax Disclosures&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires greater disaggregation of information about a reporting entity&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2019;&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;s effective tax rate reconciliation as well as information on income taxes paid. The ASU applies to all entities subject to income taxes and is intended to help investors better understand an entity&#x2019;s exposure to potential changes in jurisdictional tax legislation and assess income tax information that affects cash flow forecasts and capital allocation decisions. The ASU is effective for annual periods beginning after December 15, 2024, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In November 2024, the FASB issued ASU 2024-03, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Disaggregation of Income Statement Expenses&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The ASU requires disaggregated disclosure of certain costs and expenses in the notes of the financial statements. The ASU is effective for fiscal years beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027, with early adoption permitted. The ASU should be applied on a prospective basis although retrospective application is permitted. We are currently evaluating the impact of this standard on our disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Securities and Exchange Commission Final Rules Not Yet Implemented&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On March 6, 2024, the SEC adopted SEC Release Nos. 33-11275; 34-99678, The Enhancement and Standardization of Climate-Related Disclosures for Investors, to require the disclosure of certain climate-related information in registration statements and annual reports, including Scope 1 and 2 emissions and information about climate-related risks that have materially impacted, or are reasonably likely to have a material impact on, a company&#x2019;s business strategy, results of operations, or financial condition. In addition, under the final rules, certain disclosures related to severe weather events and other natural conditions will be required in audited financial statements. The disclosure requirements would have begun phasing in for our reports and registration statements including financial information in the fiscal year ending December 31, 2025, however, in April 2024, the SEC issued an order staying the final rules until the completion of judicial review. The SEC has since indicated that it intends to establish a new implementation period following the stay order. We are currently evaluating the impact of this final rule on our disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:CollaborativeArrangementDisclosureTextBlock contextRef="c-1" id="f-534">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;2. Development and Other Agreements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Collaboration with Verily Life Sciences&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On November 20, 2018, we entered into an Amended and Restated Collaboration and License Agreement with Verily Life Sciences LLC (an Alphabet Company) and Verily Ireland Limited (collectively, &#x201c;Verily&#x201d;), which we refer to as the Restated Collaboration Agreement. This replaced our original Collaboration and License Agreement with Verily dated August 10, 2015, as amended in October 2016, including the royalty obligations provisions under that original agreement. Pursuant to the Restated Collaboration Agreement, we and Verily agreed to jointly develop a certain next-generation CGM product, and potentially additional CGM products, for which we will have exclusive commercialization rights.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Restated Collaboration Agreement also provides us with an exclusive license to use intellectual property of Verily resulting from the collaboration, and certain Verily patents, in the development, manufacture and commercialization of blood-based or interstitial glucose monitoring products more generally (subject to certain exclusions, which are outside of the CGM field as it is commonly understood). It also provides us with non-exclusive license rights under Verily&#x2019;s other intellectual property rights to develop, manufacture and commercialize those kinds of glucose monitoring products and certain CGM-product companion software functionalities. In connection with the Restated Collaboration Agreement, we developed, launched and commercialized a CGM product in connection with the collaboration.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In consideration of Verily&#x2019;s performance of its obligations under the joint development plan of the Restated Collaboration Agreement, the licenses granted to us and the amendment of the original agreement, we made upfront, incentive, and the product regulatory approval payments, and payments for contingent sales-based milestones upon the achievement of certain revenue targets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We account for the contingent milestones payable in shares of our common stock as equity instruments within the scope of ASC Topic 718. The product regulatory approval and sales-based milestones are accounted for as performance-based awards that vest when the performance conditions have been achieved and are recognized when the achievement of the respective contingent milestone is deemed probable. The value of the contingent milestones is based on our closing stock price on December 28, 2018, which was $29.57 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Upfront and Incentive payments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2018, we made an initial payment for an upfront fee of $250.0 million through the issuance of 7.4 million shares of our common stock. We recorded a $217.7 million charge in our consolidated statements of operations during 2018 relating to the issuance of this common stock because this milestone payment did not meet the capitalization criteria. The value of the charge was based on our closing stock price of $29.57 per share on December 28, 2018, the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. In 2019, we made a cash incentive payment of $3.2 million due to the completion of certain development obligations and we recorded these payments as research and development expense in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Contingent milestones&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2021, we determined the achievement of the regulatory approval milestone to be probable and recorded an $87.1 million research and development charge in our consolidated statements of operations. This charge is associated with in-process research and development obtained in an asset acquisition prior to regulatory approval and therefore does not have an alternative future use.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2022, we received regulatory approval and issued 2.9 million shares of our common stock in connection with our achievement of the related milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2022, we received approval from the Food and Drug Administration and determined the achievement of the sales-based milestones to be probable. As such, we capitalized the full value of the sales-based milestones, $152.4 million, as an intangible asset. The sales-based milestones are contingent upon the achievement of certain revenue targets. The value of the sales-based milestones is based on: 1) 5.2 million shares of our common stock, as agreed upon in November 2018 and 2) our closing stock price on December 28, 2018 of $29.57 per share. December 28, 2018 is the date on which we obtained the necessary regulatory approvals and represents the date the performance- based awards were issued. The intangible asset will be amortized using the straight-line method over its estimated useful life of 64 months through March 2028. The related amortization expense is recognized in cost of sales in our consolidated statements of operations and disclosed in Note 4 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Details and Other Financial Information&#x2014;Intangibles, Net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the fourth quarter of 2023, we issued 3.7 million shares of our common stock in connection with our achievement of the first sales-based milestone. See the effective tax rate reconciliation in Note 8 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information on the tax benefits related to the collaboration agreement milestone share-based payments for the periods presented.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In the first quarter of 2024, we issued 1.5 million shares of our common stock in connection with our achievement of the second sales-based milestone.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All milestones were paid in cash or shares of our common stock, at our election.&lt;/span&gt;&lt;/div&gt;</us-gaap:CollaborativeArrangementDisclosureTextBlock>
    <us-gaap:SharePrice
      contextRef="c-85"
      decimals="INF"
      id="f-535"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeArrangementUpfrontFee contextRef="c-86" decimals="-5" id="f-536" unitRef="usd">250000000.0</dxcm:CollaborativeArrangementUpfrontFee>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues contextRef="c-87" decimals="-5" id="f-537" unitRef="shares">7400000</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-87" decimals="-5" id="f-538" unitRef="usd">217700000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <us-gaap:SharePrice
      contextRef="c-85"
      decimals="INF"
      id="f-539"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-88" decimals="-5" id="f-540" unitRef="usd">3200000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:CollaborativeResearchAndDevelopmentFee contextRef="c-89" decimals="-5" id="f-541" unitRef="usd">87100000</dxcm:CollaborativeResearchAndDevelopmentFee>
    <dxcm:SharesIssuedInConnectionWithTheRestatedCollaborationAgreement
      contextRef="c-90"
      decimals="INF"
      id="f-542"
      unitRef="shares">2900000</dxcm:SharesIssuedInConnectionWithTheRestatedCollaborationAgreement>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-91" decimals="-5" id="f-543" unitRef="usd">152400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <dxcm:PotentialFutureCommonStockIssuableSharesNewIssues contextRef="c-92" decimals="-5" id="f-544" unitRef="shares">5200000</dxcm:PotentialFutureCommonStockIssuableSharesNewIssues>
    <us-gaap:SharePrice
      contextRef="c-85"
      decimals="INF"
      id="f-545"
      unitRef="usdPerShare">29.57</us-gaap:SharePrice>
    <us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1 contextRef="c-93" id="f-546">P64M</us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1>
    <dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues contextRef="c-94" decimals="-5" id="f-547" unitRef="shares">3700000</dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-95" decimals="-5" id="f-548" unitRef="shares">1500000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues contextRef="c-96" decimals="-5" id="f-549" unitRef="shares">1500000</dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues>
    <us-gaap:FairValueMeasurementInputsDisclosureTextBlock contextRef="c-1" id="f-550">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;3. Fair Value Measurements&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair value of our Level 1 financial instruments, which are in active markets, using unadjusted quoted market prices for identical instruments.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We obtain the fair values for our Level 2 financial instruments, which are not in active markets, from a primary professional pricing source that uses quoted market prices for identical or comparable instruments, rather than direct observations of quoted prices in active markets. Fair values obtained from this professional pricing source can also be based on pricing models whereby all significant observable inputs, including maturity dates, issue dates, settlement dates, benchmark yields, reported trades, broker-dealer quotes, issue spreads, benchmark securities, bids, offers or other market related data, are observable or can be derived from, or corroborated by, observable market data for substantially the full term of the asset. We validate the quoted market prices provided by our primary pricing service by comparing the fair values of our Level 2 marketable securities portfolio balance provided by our primary pricing service against the fair values provided by our investment managers.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We estimate the fair values of our Level 3 financial instruments based on unobservable inputs and other estimation techniques due to the absence of quoted market prices and inherent lack of liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2024, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;154.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,138.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,488.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers into or out of Level 3 securities during the twelve months ended December&#160;31, 2024 and 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Fair Value of Senior Convertible Notes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,262.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,281.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For more information on the carrying values of our senior convertible notes, see Note 5 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt&#x2014;Senior Convertible Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency and Derivative Financial Instruments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As we conduct business globally in many currencies, we are exposed to foreign exchange rate changes. To limit this exposure, we enter into foreign currency forward contracts to hedge monetary assets and liabilities denominated in foreign currencies. Our foreign currency forward contracts are not designated as hedging instruments. Therefore, changes in the fair values of these contracts are recognized in earnings, thereby offsetting the current earnings effect of the related foreign currency assets and liabilities. The duration of these contracts is generally one month. The derivative gains and losses are included in other income (expense), net in our consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; As of December&#160;31, 2024 and December&#160;31, 2023, the notional amounts of outstanding foreign currency forward contracts were $66.0 million and $71.0 million, respectively. The resulting impact on our consolidated financial statements from currency hedging activities was not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We monitor the costs and the impact of foreign currency risks upon our financial results as part of our risk management program. We do not use derivative financial instruments for speculation or trading purposes or for activities other than risk management. We do not require and are not required to pledge collateral for these financial instruments and we do not carry any master netting arrangements to mitigate the credit risk.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Assets and Liabilities Measured at Fair Value on a Non-Recurring Basis&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In accordance with authoritative guidance, we measure certain non-financial assets and liabilities at fair value on a non-recurring basis. These measurements are usually performed using the discounted cash flow method or cost method and Level 3 inputs. These include items such as non-financial assets and liabilities initially measured at fair value in a business combination and non-financial long-lived assets measured at fair value for an impairment assessment. In general, non-financial assets, including goodwill, intangible assets, and property and equipment, are measured at fair value when there are indicators of impairment and are recorded at fair value only when an impairment is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We hold certain other investments that we do not measure at fair value on a recurring basis. The carrying values of these investments were $119.3 million as of December&#160;31, 2024 and $38.5 million as of December&#160;31, 2023. We include the carrying values of these investments in other assets in our consolidated balance sheets. It is impracticable for us to estimate the fair value of these investments on a recurring basis due to the fact that these entities are privately held and limited information is available. We monitor the information that becomes available from time to time and adjust the carrying values of these investments if there are identified events or changes in circumstances that have a significant effect on the fair values.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no significant impairment losses on assets and liabilities measured at fair value on a non-recurring basis during the twelve months ended December&#160;31, 2024 and December&#160;31, 2023. During the fourth quarter 2022, we vacated a leased building and made it available for sublease, resulting in an impairment of its asset group which consisted primarily of leasehold improvements and right-of-use asset. We recorded $23.0&#160;million in impairment losses during the twelve months ended December&#160;31, 2022. See Note 6 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases and Other Commitments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueMeasurementInputsDisclosureTextBlock>
    <us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock contextRef="c-1" id="f-551">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2024, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other long-term assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible notes receivable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;154.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,138.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are primarily held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes financial assets that we measured at fair value on a recurring basis as of December&#160;31, 2023, classified in accordance with the fair value hierarchy:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level 1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash equivalents&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;315.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total assets measured at fair value on a recurring basis&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;331.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,488.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:3pt;padding-left:31.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes assets which are held pursuant to a deferred compensation plan for senior management, which consist mainly of mutual funds.&lt;/span&gt;&lt;/div&gt;</us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-97" decimals="-5" id="f-552" unitRef="usd">134200000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-98" decimals="-5" id="f-553" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-99" decimals="-5" id="f-554" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-5" decimals="-5" id="f-555" unitRef="usd">134200000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-100" decimals="-5" id="f-556" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-101" decimals="-5" id="f-557" unitRef="usd">1150100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-102" decimals="-5" id="f-558" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-5" id="f-559" unitRef="usd">1150100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-104" decimals="-5" id="f-560" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-105" decimals="-5" id="f-561" unitRef="usd">312100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-106" decimals="-5" id="f-562" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-5" id="f-563" unitRef="usd">312100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-108" decimals="-5" id="f-564" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-109" decimals="-5" id="f-565" unitRef="usd">511100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-110" decimals="-5" id="f-566" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-567" unitRef="usd">511100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-97" decimals="-5" id="f-568" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-98" decimals="-5" id="f-569" unitRef="usd">1973300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-99" decimals="-5" id="f-570" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-5" decimals="-5" id="f-571" unitRef="usd">1973300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-97" decimals="-5" id="f-572" unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-98" decimals="-5" id="f-573" unitRef="usd">0</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-99" decimals="-5" id="f-574" unitRef="usd">10500000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:NotesReceivableFairValueDisclosure contextRef="c-5" decimals="-5" id="f-575" unitRef="usd">10500000</us-gaap:NotesReceivableFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-97" decimals="-5" id="f-576" unitRef="usd">20600000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-98" decimals="-5" id="f-577" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-99" decimals="-5" id="f-578" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-5" decimals="-5" id="f-579" unitRef="usd">20600000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-97" decimals="-5" id="f-580" unitRef="usd">154800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-98" decimals="-5" id="f-581" unitRef="usd">1973300000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-99" decimals="-5" id="f-582" unitRef="usd">10500000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-5" decimals="-5" id="f-583" unitRef="usd">2138600000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-112" decimals="-5" id="f-584" unitRef="usd">315900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-113" decimals="-5" id="f-585" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-114" decimals="-5" id="f-586" unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue contextRef="c-6" decimals="-5" id="f-587" unitRef="usd">315900000</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-115" decimals="-5" id="f-588" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-116" decimals="-5" id="f-589" unitRef="usd">1612500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-117" decimals="-5" id="f-590" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-5" id="f-591" unitRef="usd">1612500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-119" decimals="-5" id="f-592" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-120" decimals="-5" id="f-593" unitRef="usd">184700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-121" decimals="-5" id="f-594" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-122" decimals="-5" id="f-595" unitRef="usd">184700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-123" decimals="-5" id="f-596" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-124" decimals="-5" id="f-597" unitRef="usd">360600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-125" decimals="-5" id="f-598" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-126" decimals="-5" id="f-599" unitRef="usd">360600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-112" decimals="-5" id="f-600" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-113" decimals="-5" id="f-601" unitRef="usd">2157800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-114" decimals="-5" id="f-602" unitRef="usd">0</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-6" decimals="-5" id="f-603" unitRef="usd">2157800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-112" decimals="-5" id="f-604" unitRef="usd">15200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-113" decimals="-5" id="f-605" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-114" decimals="-5" id="f-606" unitRef="usd">0</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:OtherAssetsFairValueDisclosure contextRef="c-6" decimals="-5" id="f-607" unitRef="usd">15200000</us-gaap:OtherAssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-112" decimals="-5" id="f-608" unitRef="usd">331100000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-113" decimals="-5" id="f-609" unitRef="usd">2157800000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-114" decimals="-5" id="f-610" unitRef="usd">0</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure contextRef="c-6" decimals="-5" id="f-611" unitRef="usd">2488900000</us-gaap:AssetsFairValueDisclosure>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-7" decimals="0" id="f-612" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <dxcm:FairValueAssetsLevel3TransfersAmount contextRef="c-1" decimals="0" id="f-613" unitRef="usd">0</dxcm:FairValueAssetsLevel3TransfersAmount>
    <us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock contextRef="c-1" id="f-614">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value, based on trading prices (Level 1 inputs), of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:70.098%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.937%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements Using Level 1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,163.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,262.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,122.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,281.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total fair value of outstanding senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,286.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,544.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTableTextBlock>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-127" decimals="-5" id="f-615" unitRef="usd">1163700000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-128" decimals="-5" id="f-616" unitRef="usd">1262800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-129" decimals="-5" id="f-617" unitRef="usd">1122300000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-130" decimals="-5" id="f-618" unitRef="usd">1281800000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-131" decimals="-5" id="f-619" unitRef="usd">2286000000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:ConvertibleDebtFairValueDisclosures contextRef="c-132" decimals="-5" id="f-620" unitRef="usd">2544600000</us-gaap:ConvertibleDebtFairValueDisclosures>
    <us-gaap:DerivativeTermOfContract contextRef="c-133" id="f-621">P1M</us-gaap:DerivativeTermOfContract>
    <us-gaap:DerivativeNotionalAmount contextRef="c-134" decimals="-5" id="f-622" unitRef="usd">66000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:DerivativeNotionalAmount contextRef="c-135" decimals="-5" id="f-623" unitRef="usd">71000000.0</us-gaap:DerivativeNotionalAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-5" decimals="-5" id="f-624" unitRef="usd">119300000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount contextRef="c-6" decimals="-5" id="f-625" unitRef="usd">38500000</us-gaap:EquitySecuritiesWithoutReadilyDeterminableFairValueAmount>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-7" decimals="0" id="f-626" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-1" decimals="0" id="f-627" unitRef="usd">0</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-8" decimals="-5" id="f-628" unitRef="usd">23000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <us-gaap:AdditionalFinancialInformationDisclosureTextBlock contextRef="c-1" id="f-629">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;4. Balance Sheet Details and Other Financial Information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #58a618;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Short-Term Marketable Securities&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,972.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,611.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the estimated market values of our short-term debt securities with contractual maturities up to 12 months and up to 18 months were $1.73&#160;billion and $247.7&#160;million, respectively. As of December 31, 2023, the estimated market value of our short-term debt securities with contractual maturities up to 12 months was $2.16&#160;billion. Gross realized gains and losses on sales of our short-term debt securities for the twelve months ended December&#160;31, 2024, 2023 and 2022 were not significant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We periodically review our portfolio of debt securities to determine if any investment is impaired due to credit loss or other potential valuation concerns. For debt securities where the fair value of the investment is less than the amortized cost basis, we have assessed at the individual security level for various quantitative factors including, but not limited to, the nature of the investments, changes in credit ratings, interest rate fluctuations, industry analyst reports, and the severity of impairment. Unrealized losses on available-for-sale debt securities at December&#160;31, 2024 were primarily due to changes in interest rates, including market credit spreads, and not due to increased credit risks associated with specific securities. Accordingly, we have not recorded an allowance for credit losses. We do not intend to sell these investments and it is not more likely than not that we will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Investments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2024, unrealized gains or losses on equity investments were not significant. During the twelve months ended December&#160;31, 2023, and 2022, we had no unrealized gains or losses on equity investments. Realized gains from the sale of an equity investment were not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,014.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;983.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,005.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;973.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Reserve for prompt payment cash discounts recorded against accounts receivable, excluding allowance for doubtful accounts, was $17.3&#160;million, $13.7&#160;million, $8.3&#160;million as of December&#160;31, 2024, 2023, and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;319.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;210.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;559.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2024, 2023 and 2022, we recorded excess and obsolete inventory charges of $53.5 million, $16.6 million and $13.9 million respectively, in cost of sales as a result of our ongoing assessment of sales demand, inventory on hand for each product and the continuous improvement and innovation of our products.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Prepaid and Other Current Assets&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Building&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;291.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;908.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;683.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;293.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;283.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;328.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,018.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,622.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(678.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(509.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,339.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,113.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation expense related to property and equipment for the twelve months ended December&#160;31, 2024, 2023 and 2022 was $181.2 million, $147.4 million and $144.1 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Loss on disposal of property and equipment during the twelve months ended December&#160;31, 2024, 2023 and 2022 recorded in operating expenses was $5.1 million, $0.7 million and $2.2 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;&#160;Intangibles, Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of December&#160;31, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Verily intangible asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired technology and intellectual property&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks and trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;193.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(90.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Verily intangible&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired technology and intellectual property&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks and trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;195.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(61.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;See Note 2 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Development and Other Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Excludes Verily intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total amortization expense of finite-lived intangible assets for the twelve months ended December&#160;31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense included in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense included in operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents estimated future amortization of the Company&#x2019;s finite-lived intangible assets as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Assets&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Payable and Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;276.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,135.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;950.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,345.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:14pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Payroll and Related Expenses&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;139.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Warranty&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:12pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Long-Term Liabilities&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset retirement obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:18pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Income (Expense), Net&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and dividend income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;135.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AdditionalFinancialInformationDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock contextRef="c-1" id="f-630">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term marketable securities, consisting of available-for-sale debt securities, were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:8pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,149.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,150.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;312.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;511.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,972.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,973.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:7pt;margin-top:3pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:48.169%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.039%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amortized&lt;br/&gt;Cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Gains&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross&lt;br/&gt;Unrealized&lt;br/&gt;Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Estimated&lt;br/&gt;Market&lt;br/&gt;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Debt securities, available-for-sale:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. government agencies &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,611.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,612.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Commercial paper&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;184.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Corporate debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;360.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total debt securities, available-for-sale&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,157.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;padding-left:22.5pt;text-indent:-7.2pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Includes debt obligations issued by U.S. government-sponsored enterprises or U.S. government agencies.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtSecuritiesAvailableForSaleTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-103" decimals="-5" id="f-631" unitRef="usd">1149400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-103" decimals="-5" id="f-632" unitRef="usd">1300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-103" decimals="-5" id="f-633" unitRef="usd">600000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-103" decimals="-5" id="f-634" unitRef="usd">1150100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-107" decimals="-5" id="f-635" unitRef="usd">312200000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-107" decimals="-5" id="f-636" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-107" decimals="-5" id="f-637" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-107" decimals="-5" id="f-638" unitRef="usd">312100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-111" decimals="-5" id="f-639" unitRef="usd">511100000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-111" decimals="-5" id="f-640" unitRef="usd">400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-111" decimals="-5" id="f-641" unitRef="usd">400000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-111" decimals="-5" id="f-642" unitRef="usd">511100000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-5" decimals="-5" id="f-643" unitRef="usd">1972700000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-5" decimals="-5" id="f-644" unitRef="usd">1700000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-5" decimals="-5" id="f-645" unitRef="usd">1100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-5" decimals="-5" id="f-646" unitRef="usd">1973300000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-118" decimals="-5" id="f-647" unitRef="usd">1611800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-118" decimals="-5" id="f-648" unitRef="usd">1200000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-118" decimals="-5" id="f-649" unitRef="usd">500000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-118" decimals="-5" id="f-650" unitRef="usd">1612500000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-122" decimals="-5" id="f-651" unitRef="usd">184800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-122" decimals="-5" id="f-652" unitRef="usd">0</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-122" decimals="-5" id="f-653" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-122" decimals="-5" id="f-654" unitRef="usd">184700000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-126" decimals="-5" id="f-655" unitRef="usd">360800000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-126" decimals="-5" id="f-656" unitRef="usd">100000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-126" decimals="-5" id="f-657" unitRef="usd">300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-126" decimals="-5" id="f-658" unitRef="usd">360600000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis contextRef="c-6" decimals="-5" id="f-659" unitRef="usd">2157400000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax contextRef="c-6" decimals="-5" id="f-660" unitRef="usd">1300000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax>
    <us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax contextRef="c-6" decimals="-5" id="f-661" unitRef="usd">900000</us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities contextRef="c-6" decimals="-5" id="f-662" unitRef="usd">2157800000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:DebtInstrumentTerm contextRef="c-71" id="f-663">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:DebtInstrumentTerm contextRef="c-72" id="f-664">P18M</us-gaap:DebtInstrumentTerm>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-5" decimals="-7" id="f-665" unitRef="usd">1730000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent contextRef="c-5" decimals="-5" id="f-666" unitRef="usd">247700000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent>
    <us-gaap:DebtInstrumentTerm contextRef="c-7" id="f-667">P12M</us-gaap:DebtInstrumentTerm>
    <us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent contextRef="c-6" decimals="-7" id="f-668" unitRef="usd">2160000000</us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-1" decimals="INF" id="f-669" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-7" decimals="INF" id="f-670" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss contextRef="c-8" decimals="INF" id="f-671" unitRef="usd">0</us-gaap:DebtAndEquitySecuritiesUnrealizedGainLoss>
    <us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock contextRef="c-1" id="f-672">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,014.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;983.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(9.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accounts receivable, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,005.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;973.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock>
    <us-gaap:AccountsReceivableGross contextRef="c-5" decimals="-5" id="f-673" unitRef="usd">1014900000</us-gaap:AccountsReceivableGross>
    <us-gaap:AccountsReceivableGross contextRef="c-6" decimals="-5" id="f-674" unitRef="usd">983200000</us-gaap:AccountsReceivableGross>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-5" decimals="-5" id="f-675" unitRef="usd">9200000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AllowanceForDoubtfulAccountsReceivable contextRef="c-6" decimals="-5" id="f-676" unitRef="usd">9300000</us-gaap:AllowanceForDoubtfulAccountsReceivable>
    <us-gaap:AccountsReceivableNet contextRef="c-5" decimals="-5" id="f-677" unitRef="usd">1005700000</us-gaap:AccountsReceivableNet>
    <us-gaap:AccountsReceivableNet contextRef="c-6" decimals="-5" id="f-678" unitRef="usd">973900000</us-gaap:AccountsReceivableNet>
    <dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount contextRef="c-5" decimals="-5" id="f-679" unitRef="usd">17300000</dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount>
    <dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount contextRef="c-6" decimals="-5" id="f-680" unitRef="usd">13700000</dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount>
    <dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount contextRef="c-25" decimals="-5" id="f-681" unitRef="usd">8300000</dxcm:AccountsReceivableAllowanceForCreditLossCashDiscount>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock contextRef="c-1" id="f-682">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;327.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;319.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Work-in-process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;187.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;210.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total inventory&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;542.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;559.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-5" decimals="-5" id="f-683" unitRef="usd">327100000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves contextRef="c-6" decimals="-5" id="f-684" unitRef="usd">319500000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-5" decimals="-5" id="f-685" unitRef="usd">28100000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves contextRef="c-6" decimals="-5" id="f-686" unitRef="usd">30000000.0</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-5" decimals="-5" id="f-687" unitRef="usd">187400000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves contextRef="c-6" decimals="-5" id="f-688" unitRef="usd">210100000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet contextRef="c-5" decimals="-5" id="f-689" unitRef="usd">542600000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet contextRef="c-6" decimals="-5" id="f-690" unitRef="usd">559600000</us-gaap:InventoryNet>
    <us-gaap:InventoryWriteDown contextRef="c-136" decimals="-5" id="f-691" unitRef="usd">53500000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-137" decimals="-5" id="f-692" unitRef="usd">16600000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown contextRef="c-138" decimals="-5" id="f-693" unitRef="usd">13900000</us-gaap:InventoryWriteDown>
    <dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock contextRef="c-1" id="f-694">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prepaid inventory&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation plan assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax receivables&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other current assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total prepaid and other current assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:PrepaidAndOtherCurrentAssetsTableTextBlock>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-5" decimals="-5" id="f-695" unitRef="usd">76300000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent contextRef="c-6" decimals="-5" id="f-696" unitRef="usd">58700000</us-gaap:PrepaidExpenseCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-5" decimals="-5" id="f-697" unitRef="usd">11200000</dxcm:PrepaidInventoryCurrent>
    <dxcm:PrepaidInventoryCurrent contextRef="c-6" decimals="-5" id="f-698" unitRef="usd">31500000</dxcm:PrepaidInventoryCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-5" decimals="-5" id="f-699" unitRef="usd">18600000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <dxcm:DeferredCompensationPlanAssetsCurrent contextRef="c-6" decimals="-5" id="f-700" unitRef="usd">15200000</dxcm:DeferredCompensationPlanAssetsCurrent>
    <us-gaap:IncomeTaxesReceivable contextRef="c-5" decimals="-5" id="f-701" unitRef="usd">27900000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:IncomeTaxesReceivable contextRef="c-6" decimals="-5" id="f-702" unitRef="usd">13600000</us-gaap:IncomeTaxesReceivable>
    <us-gaap:OtherAssetsCurrent contextRef="c-5" decimals="-5" id="f-703" unitRef="usd">39700000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent contextRef="c-6" decimals="-5" id="f-704" unitRef="usd">49300000</us-gaap:OtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-5" decimals="-5" id="f-705" unitRef="usd">173700000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent contextRef="c-6" decimals="-5" id="f-706" unitRef="usd">168300000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentTextBlock contextRef="c-1" id="f-707">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Land and land improvements&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;53.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Building&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;291.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;190.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Computer software and hardware&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;908.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;683.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;293.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;283.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Construction in progress &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;354.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;328.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,018.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,622.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(678.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(509.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total property and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,339.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,113.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-139" decimals="-5" id="f-708" unitRef="usd">53100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-140" decimals="-5" id="f-709" unitRef="usd">34500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-141" decimals="-5" id="f-710" unitRef="usd">291000000.0</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-142" decimals="-5" id="f-711" unitRef="usd">190500000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-67" decimals="-5" id="f-712" unitRef="usd">40200000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-143" decimals="-5" id="f-713" unitRef="usd">36900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-144" decimals="-5" id="f-714" unitRef="usd">76600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-145" decimals="-5" id="f-715" unitRef="usd">65800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-146" decimals="-5" id="f-716" unitRef="usd">908900000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-147" decimals="-5" id="f-717" unitRef="usd">683300000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-148" decimals="-5" id="f-718" unitRef="usd">293800000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-149" decimals="-5" id="f-719" unitRef="usd">283400000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-150" decimals="-5" id="f-720" unitRef="usd">354600000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross contextRef="c-151" decimals="-5" id="f-721" unitRef="usd">328100000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-5" id="f-722" unitRef="usd">2018200000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-723" unitRef="usd">1622500000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-5" id="f-724" unitRef="usd">678300000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-725" unitRef="usd">509400000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-5" decimals="-5" id="f-726" unitRef="usd">1339900000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization contextRef="c-6" decimals="-5" id="f-727" unitRef="usd">1113100000</us-gaap:PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization>
    <us-gaap:Depreciation contextRef="c-1" decimals="-5" id="f-728" unitRef="usd">181200000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-7" decimals="-5" id="f-729" unitRef="usd">147400000</us-gaap:Depreciation>
    <us-gaap:Depreciation contextRef="c-8" decimals="-5" id="f-730" unitRef="usd">144100000</us-gaap:Depreciation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-1" decimals="-5" id="f-731" unitRef="usd">-5100000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-7" decimals="-5" id="f-732" unitRef="usd">-700000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment contextRef="c-8" decimals="-5" id="f-733" unitRef="usd">-2200000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock contextRef="c-1" id="f-734">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of gross intangible assets, accumulated amortization, and net intangible asset balances as of December&#160;31, 2024 and December&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Verily intangible asset&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(13.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired technology and intellectual property&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(14.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks and trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;193.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(90.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:45.829%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted Average Useful Life&lt;br/&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Verily intangible&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;152.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(31.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(15.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Acquired technology and intellectual property&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Trademarks and trade name&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intangibles, other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;195.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(61.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;See Note 2 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;Development and Other Agreements&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report for more information.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Excludes Verily intangible asset.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-152" id="f-735">P3Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-152" decimals="-5" id="f-736" unitRef="usd">152400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-152" decimals="-5" id="f-737" unitRef="usd">59500000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-152" decimals="-5" id="f-738" unitRef="usd">92900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-153" id="f-739">P1Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-153" decimals="-5" id="f-740" unitRef="usd">17500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-153" decimals="-5" id="f-741" unitRef="usd">13000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-153" decimals="-5" id="f-742" unitRef="usd">4500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-154" id="f-743">P7Y2M12D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-154" decimals="-5" id="f-744" unitRef="usd">19600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-154" decimals="-5" id="f-745" unitRef="usd">14700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-154" decimals="-5" id="f-746" unitRef="usd">4900000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-155" id="f-747">P1Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-155" decimals="-5" id="f-748" unitRef="usd">3800000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-155" decimals="-5" id="f-749" unitRef="usd">2700000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-155" decimals="-5" id="f-750" unitRef="usd">1100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-156" id="f-751">P0Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-156" decimals="-5" id="f-752" unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-156" decimals="-5" id="f-753" unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-156" decimals="-5" id="f-754" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-5" id="f-755">P3Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-5" decimals="-5" id="f-756" unitRef="usd">193500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-5" decimals="-5" id="f-757" unitRef="usd">90100000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-5" id="f-758" unitRef="usd">103400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-157" id="f-759">P4Y3M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-157" decimals="-5" id="f-760" unitRef="usd">152400000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-157" decimals="-5" id="f-761" unitRef="usd">31000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-157" decimals="-5" id="f-762" unitRef="usd">121400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-158" id="f-763">P2Y4M24D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-158" decimals="-5" id="f-764" unitRef="usd">24100000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-158" decimals="-5" id="f-765" unitRef="usd">15000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-158" decimals="-5" id="f-766" unitRef="usd">9100000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-159" id="f-767">P0Y9M18D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-159" decimals="-5" id="f-768" unitRef="usd">14600000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-159" decimals="-5" id="f-769" unitRef="usd">12600000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-159" decimals="-5" id="f-770" unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-160" id="f-771">P2Y7M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-160" decimals="-5" id="f-772" unitRef="usd">4200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-160" decimals="-5" id="f-773" unitRef="usd">2200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-160" decimals="-5" id="f-774" unitRef="usd">2000000.0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-161" id="f-775">P0Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-161" decimals="-5" id="f-776" unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-161" decimals="-5" id="f-777" unitRef="usd">200000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-161" decimals="-5" id="f-778" unitRef="usd">0</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife contextRef="c-6" id="f-779">P4Y1M6D</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross contextRef="c-6" decimals="-5" id="f-780" unitRef="usd">195500000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization contextRef="c-6" decimals="-5" id="f-781" unitRef="usd">61000000.0</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-6" decimals="-5" id="f-782" unitRef="usd">134500000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock contextRef="c-1" id="f-783">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the total amortization expense of finite-lived intangible assets for the twelve months ended December&#160;31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:50.800%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.543%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.546%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense included in cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;30.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization expense included in operating expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total amortization of intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;36.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseTableTextBlock>
    <dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales contextRef="c-1" decimals="-5" id="f-784" unitRef="usd">29800000</dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales>
    <dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales contextRef="c-7" decimals="-5" id="f-785" unitRef="usd">30500000</dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales>
    <dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales contextRef="c-8" decimals="-5" id="f-786" unitRef="usd">4300000</dxcm:AmortizationOfIntangibleAssetsIncludedInCostOfSales>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-1" decimals="-5" id="f-787" unitRef="usd">6700000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-7" decimals="-5" id="f-788" unitRef="usd">8100000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets contextRef="c-8" decimals="-5" id="f-789" unitRef="usd">7500000</us-gaap:AmortizationOfIntangibleAssets>
    <dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses contextRef="c-1" decimals="-5" id="f-790" unitRef="usd">36500000</dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses>
    <dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses contextRef="c-7" decimals="-5" id="f-791" unitRef="usd">38600000</dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses>
    <dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses contextRef="c-8" decimals="-5" id="f-792" unitRef="usd">11800000</dxcm:AmortizationOfIntangiblesIncludedInCostOfSalesAndOperatingExpenses>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock contextRef="c-1" id="f-793">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents estimated future amortization of the Company&#x2019;s finite-lived intangible assets as of December&#160;31, 2024:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:85.157%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.408%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths contextRef="c-5" decimals="-5" id="f-794" unitRef="usd">32700000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo contextRef="c-5" decimals="-5" id="f-795" unitRef="usd">31500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree contextRef="c-5" decimals="-5" id="f-796" unitRef="usd">29600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour contextRef="c-5" decimals="-5" id="f-797" unitRef="usd">7600000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive contextRef="c-5" decimals="-5" id="f-798" unitRef="usd">500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive contextRef="c-5" decimals="-5" id="f-799" unitRef="usd">1500000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive>
    <us-gaap:FiniteLivedIntangibleAssetsNet contextRef="c-5" decimals="-5" id="f-800" unitRef="usd">103400000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:ScheduleOfOtherAssetsTableTextBlock contextRef="c-1" id="f-801">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-marketable equity securities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;119.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term deposits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;173.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;75.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsTableTextBlock>
    <us-gaap:LongTermInvestments contextRef="c-5" decimals="-5" id="f-802" unitRef="usd">119300000</us-gaap:LongTermInvestments>
    <us-gaap:LongTermInvestments contextRef="c-6" decimals="-5" id="f-803" unitRef="usd">38500000</us-gaap:LongTermInvestments>
    <dxcm:LongTermDeposits contextRef="c-5" decimals="-5" id="f-804" unitRef="usd">13800000</dxcm:LongTermDeposits>
    <dxcm:LongTermDeposits contextRef="c-6" decimals="-5" id="f-805" unitRef="usd">14400000</dxcm:LongTermDeposits>
    <dxcm:OtherLongTermAssets contextRef="c-5" decimals="-5" id="f-806" unitRef="usd">39900000</dxcm:OtherLongTermAssets>
    <dxcm:OtherLongTermAssets contextRef="c-6" decimals="-5" id="f-807" unitRef="usd">22100000</dxcm:OtherLongTermAssets>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-5" decimals="-5" id="f-808" unitRef="usd">173000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent contextRef="c-6" decimals="-5" id="f-809" unitRef="usd">75000000.0</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock contextRef="c-1" id="f-810">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts payable trade&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;345.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;276.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued tax, audit, and legal fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued rebates &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,135.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;950.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued warranty&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax payable&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred compensation plan liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued liabilities &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accounts payable and accrued liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,585.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,345.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-5" decimals="-5" id="f-811" unitRef="usd">345300000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent contextRef="c-6" decimals="-5" id="f-812" unitRef="usd">276400000</us-gaap:AccountsPayableTradeCurrent>
    <dxcm:AccruedTaxAuditAndLegalFeesCurrent contextRef="c-5" decimals="-5" id="f-813" unitRef="usd">38400000</dxcm:AccruedTaxAuditAndLegalFeesCurrent>
    <dxcm:AccruedTaxAuditAndLegalFeesCurrent contextRef="c-6" decimals="-5" id="f-814" unitRef="usd">42600000</dxcm:AccruedTaxAuditAndLegalFeesCurrent>
    <dxcm:PharmacyRebatesCurrent contextRef="c-5" decimals="-5" id="f-815" unitRef="usd">1135900000</dxcm:PharmacyRebatesCurrent>
    <dxcm:PharmacyRebatesCurrent contextRef="c-6" decimals="-5" id="f-816" unitRef="usd">950700000</dxcm:PharmacyRebatesCurrent>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-5" decimals="-5" id="f-817" unitRef="usd">5900000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-6" decimals="-5" id="f-818" unitRef="usd">12600000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-5" decimals="-5" id="f-819" unitRef="usd">3900000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:AccruedIncomeTaxesCurrent contextRef="c-6" decimals="-5" id="f-820" unitRef="usd">7500000</us-gaap:AccruedIncomeTaxesCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-5" decimals="-5" id="f-821" unitRef="usd">18600000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:DeferredCompensationLiabilityCurrent contextRef="c-6" decimals="-5" id="f-822" unitRef="usd">15200000</us-gaap:DeferredCompensationLiabilityCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-823" unitRef="usd">37100000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-824" unitRef="usd">40500000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-825" unitRef="usd">1585100000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-826" unitRef="usd">1345500000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock contextRef="c-1" id="f-827">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued wages, bonus and taxes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;139.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other accrued employee benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;31.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total accrued payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;171.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</dxcm:ScheduleOfAccruedPayrollAndRelatedExpensesTableTextBlock>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-5" decimals="-5" id="f-828" unitRef="usd">74500000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <dxcm:AccruedWagesBonusesAndTaxesCurrent contextRef="c-6" decimals="-5" id="f-829" unitRef="usd">139800000</dxcm:AccruedWagesBonusesAndTaxesCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-5" decimals="-5" id="f-830" unitRef="usd">37500000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:AccruedEmployeeBenefitsCurrent contextRef="c-6" decimals="-5" id="f-831" unitRef="usd">31200000</us-gaap:AccruedEmployeeBenefitsCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-5" decimals="-5" id="f-832" unitRef="usd">112000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent contextRef="c-6" decimals="-5" id="f-833" unitRef="usd">171000000.0</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock contextRef="c-1" id="f-834">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Warranty costs are reflected in our statements of operations as cost of sales. Reconciliations of our accrued warranty costs for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Charges to costs and expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;47.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(53.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(51.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfProductWarrantyLiabilityTableTextBlock>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-6" decimals="-5" id="f-835" unitRef="usd">12600000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-25" decimals="-5" id="f-836" unitRef="usd">12800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-14" decimals="-5" id="f-837" unitRef="usd">12900000</us-gaap:StandardProductWarrantyAccrual>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses contextRef="c-1" decimals="-5" id="f-838" unitRef="usd">47200000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses contextRef="c-7" decimals="-5" id="f-839" unitRef="usd">51500000</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses contextRef="c-8" decimals="-5" id="f-840" unitRef="usd">43000000.0</dxcm:StandardProductWarrantyAccrualChargesToCostsAndExpenses>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-1" decimals="-5" id="f-841" unitRef="usd">53900000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-7" decimals="-5" id="f-842" unitRef="usd">51700000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:ProductWarrantyAccrualPayments contextRef="c-8" decimals="-5" id="f-843" unitRef="usd">43100000</us-gaap:ProductWarrantyAccrualPayments>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-5" decimals="-5" id="f-844" unitRef="usd">5900000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-6" decimals="-5" id="f-845" unitRef="usd">12600000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:StandardProductWarrantyAccrual contextRef="c-25" decimals="-5" id="f-846" unitRef="usd">12800000</us-gaap:StandardProductWarrantyAccrual>
    <us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock contextRef="c-1" id="f-847">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease obligations&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue, long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Asset retirement obligation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;17.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;44.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;38.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other long-term liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;147.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherAssetsAndOtherLiabilitiesTableTextBlock>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-848" unitRef="usd">58500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-849" unitRef="usd">58600000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-850" unitRef="usd">9500000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent contextRef="c-6" decimals="-5" id="f-851" unitRef="usd">7400000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:AssetRetirementObligation contextRef="c-5" decimals="-5" id="f-852" unitRef="usd">17000000.0</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="c-6" decimals="-5" id="f-853" unitRef="usd">15700000</us-gaap:AssetRetirementObligation>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-5" decimals="-5" id="f-854" unitRef="usd">44800000</dxcm:OtherTaxLiabilitiesNoncurrent>
    <dxcm:OtherTaxLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-855" unitRef="usd">38700000</dxcm:OtherTaxLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-5" decimals="-5" id="f-856" unitRef="usd">18100000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-857" unitRef="usd">5200000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-5" decimals="-5" id="f-858" unitRef="usd">147900000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent contextRef="c-6" decimals="-5" id="f-859" unitRef="usd">125600000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock contextRef="c-1" id="f-860">&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest and dividend income&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;134.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;135.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;23.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(19.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(20.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(18.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other expense, net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(5.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfOtherNonoperatingIncomeExpenseTableTextBlock>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-1" decimals="-5" id="f-861" unitRef="usd">134200000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-7" decimals="-5" id="f-862" unitRef="usd">135000000.0</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InvestmentIncomeInterestAndDividend contextRef="c-8" decimals="-5" id="f-863" unitRef="usd">23800000</us-gaap:InvestmentIncomeInterestAndDividend>
    <us-gaap:InterestExpenseNonoperating contextRef="c-1" decimals="-5" id="f-864" unitRef="usd">19000000.0</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-7" decimals="-5" id="f-865" unitRef="usd">20300000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:InterestExpenseNonoperating contextRef="c-8" decimals="-5" id="f-866" unitRef="usd">18600000</us-gaap:InterestExpenseNonoperating>
    <us-gaap:OtherNonoperatingExpense contextRef="c-1" decimals="-5" id="f-867" unitRef="usd">6200000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-7" decimals="-5" id="f-868" unitRef="usd">2000000.0</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingExpense contextRef="c-8" decimals="-5" id="f-869" unitRef="usd">5600000</us-gaap:OtherNonoperatingExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-870" unitRef="usd">109000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-871" unitRef="usd">112700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-5" id="f-872" unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:DebtDisclosureTextBlock contextRef="c-1" id="f-873">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;5. Debt&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,457.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,457.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,441.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,434.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual coupon interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest on our unsecured senior convertible notes due 2023, or the 2023 Notes, began accruing upon issuance and was payable semi-annually on June 1 and December 1 of each year until the 2023 Notes matured on December 1, 2023. Interest on our unsecured senior convertible notes due 2025, or the 2025 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on our unsecured senior convertible notes due 2028, or the 2028 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The effective interest rate presented represents the rate applicable for the period outstanding. The 2023 Notes matured on December 1, 2023 and are no longer outstanding.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding in the relevant period.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:1pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revolving Credit Agreement&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Terms of the Revolving Credit Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2023, we entered into the First Amendment to the Second Amended and Restated Credit Agreement, as amended, or the Amended Credit Agreement, which we had previously entered into in October 2021. The Amended Credit Agreement is a five-year revolving credit facility, or the Credit Facility, that provides for an available principal amount of $200.0 million which can be increased up to $500.0 million at our option subject to customary conditions and approval of our lenders. The Amended Credit Agreement will mature on October&#160;13, 2026. Borrowings under the Amended Credit Agreement are available for general corporate purposes, including working capital and capital expenditures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;192.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revolving loans under the Amended Credit Agreement bear interest at our choice of one of three base rates plus a range of applicable rates that are based on our leverage ratio. The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Loan, each as defined in the Amended Credit Agreement under the captions &#x201c;ABR Spread&#x201d;, &#x201c;Term Benchmark&#x201d;, and &#x201c;RFR Spread&#x201d;, or &#x201c;Unused Commitment Fee Rate&#x201d;, respectively, are outlined in the following table:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.961%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.881%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ABR Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Term Benchmark/RFR Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unused Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Minimum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.175%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maximum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.000%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.000%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.250%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our obligations under the Amended Credit Agreement are guaranteed by our existing and future wholly-owned domestic subsidiaries, and are secured by a first-priority security interest in substantially all of the assets of Dexcom and the guarantors, including all or a portion of the equity interests of our domestic subsidiaries and first-tier foreign subsidiaries but excluding real property and intellectual property (which is subject to a negative pledge). The Amended Credit Agreement contains covenants that limit certain indebtedness, liens, investments, transactions with affiliates, dividends and other restricted payments, subordinated indebtedness and amendments to subordinated indebtedness documents, and sale and leaseback transactions of Dexcom or any of its domestic subsidiaries. The Amended Credit Agreement also requires us to maintain a maximum leverage ratio and a minimum fixed charge coverage ratio. We were in compliance with these covenants as of December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, we have no other material guarantee facilities or lines of credit.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock contextRef="c-1" id="f-874">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of our senior convertible notes were as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Principal amount:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,207.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,250.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total principal amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,457.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,457.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unamortized debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(16.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Carrying amount of senior convertible notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,441.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,434.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCarryingValuesAndEstimatedFairValuesOfDebtInstrumentsTableTextBlock>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-127" decimals="-5" id="f-875" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-128" decimals="-5" id="f-876" unitRef="usd">1207500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-129" decimals="-5" id="f-877" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-130" decimals="-5" id="f-878" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-131" decimals="-5" id="f-879" unitRef="usd">2457500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-132" decimals="-5" id="f-880" unitRef="usd">2457500000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-131" decimals="-5" id="f-881" unitRef="usd">16100000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:UnamortizedDebtIssuanceExpense contextRef="c-132" decimals="-5" id="f-882" unitRef="usd">23300000</us-gaap:UnamortizedDebtIssuanceExpense>
    <us-gaap:ConvertibleNotesPayable contextRef="c-131" decimals="-5" id="f-883" unitRef="usd">2441400000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleNotesPayable contextRef="c-132" decimals="-5" id="f-884" unitRef="usd">2434200000</us-gaap:ConvertibleNotesPayable>
    <us-gaap:ConvertibleDebtTableTextBlock contextRef="c-1" id="f-885">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For our senior convertible notes for which the if-converted value exceeded the principal amount, the amount in excess of principal was as follows as of the dates indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;33.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total by which the notes&#x2019; if-converted value exceeds their principal amount&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;89.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes key details of the 2023 Notes, 2025 Notes, and 2028 Notes:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.326%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.180%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.204%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.373%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.695%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:8.260%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Senior Convertible Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Offering Completion Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Maturity Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Stated Interest Rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Principal Amount&lt;br/&gt;Issued&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Net Proceeds&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Initial Conversion Rate&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(per $1,000 principal amount)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Conversion Price&lt;br/&gt;(per share)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Settlement Methods&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.2pt;font-weight:700;line-height:120%;position:relative;top:-2.8pt;vertical-align:baseline"&gt;(3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;November 2018&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;December&#160;1, 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.75%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$850.0 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$836.6 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;24.3476&#160;shares &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$41.07&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and/or shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2025 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;May 2020&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;November&#160;15, 2025&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.25%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.21 billion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.19 billion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6.6620 shares &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$150.11&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and/or shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;2028 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;May 2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;May&#160;15, 2028&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.25&#160;billion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$1.23&#160;billion&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;6.1571 shares&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;$162.41&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Cash and/or shares&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Net proceeds are calculated by deducting the initial purchasers&#x2019; discounts and estimated costs directly related to the offering from the aggregate principal amount of the applicable series of notes.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; Subject to adjustments as defined in the applicable indentures.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(3) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2025 Notes and 2028 Notes may be settled in cash, stock, or a combination thereof, solely at our discretion. The 2023 Notes, while outstanding, could be settled in cash, stock, or a combination thereof, solely at our discretion.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="27" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(4) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The 2023 Notes matured on December&#160;1, 2023 and are no longer outstanding.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ConvertibleDebtTableTextBlock>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-162" decimals="-5" id="f-886" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-163" decimals="-5" id="f-887" unitRef="usd">56100000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-164" decimals="-5" id="f-888" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-165" decimals="-5" id="f-889" unitRef="usd">33600000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-166" decimals="-5" id="f-890" unitRef="usd">0</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal contextRef="c-167" decimals="-5" id="f-891" unitRef="usd">89700000</us-gaap:DebtInstrumentConvertibleIfConvertedValueInExcessOfPrincipal>
    <us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock contextRef="c-1" id="f-892">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the components of interest expense and the effective interest rates for our senior convertible notes for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:57.087%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.353%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:11.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contractual coupon interest&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt; (1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Non-cash interest expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of debt issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total interest expense recognized on senior notes&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Effective interest rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2023 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Senior Convertible Notes due 2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;*&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:5pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;margin-top:7pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Interest on our unsecured senior convertible notes due 2023, or the 2023 Notes, began accruing upon issuance and was payable semi-annually on June 1 and December 1 of each year until the 2023 Notes matured on December 1, 2023. Interest on our unsecured senior convertible notes due 2025, or the 2025 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year. Interest on our unsecured senior convertible notes due 2028, or the 2028 Notes, began accruing upon issuance and is payable semi-annually on May 15 and November 15 of each year.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:2pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;The effective interest rate presented represents the rate applicable for the period outstanding. The 2023 Notes matured on December 1, 2023 and are no longer outstanding.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="18" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-top:6pt;padding-left:22.5pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;* Not applicable as no notes were outstanding in the relevant period.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InterestIncomeAndInterestExpenseDisclosureTableTextBlock>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-1" decimals="-5" id="f-893" unitRef="usd">7700000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-7" decimals="-5" id="f-894" unitRef="usd">9100000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:InterestExpenseDebtExcludingAmortization contextRef="c-8" decimals="-5" id="f-895" unitRef="usd">8800000</us-gaap:InterestExpenseDebtExcludingAmortization>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-1" decimals="-5" id="f-896" unitRef="usd">7200000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-7" decimals="-5" id="f-897" unitRef="usd">7300000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:AmortizationOfFinancingCosts contextRef="c-8" decimals="-5" id="f-898" unitRef="usd">5900000</us-gaap:AmortizationOfFinancingCosts>
    <us-gaap:InterestExpenseDebt contextRef="c-1" decimals="-5" id="f-899" unitRef="usd">14900000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-7" decimals="-5" id="f-900" unitRef="usd">16400000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt contextRef="c-8" decimals="-5" id="f-901" unitRef="usd">14700000</us-gaap:InterestExpenseDebt>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-168" decimals="3" id="f-902" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-169" decimals="3" id="f-903" unitRef="number">0.011</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-170" decimals="3" id="f-904" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-171" decimals="3" id="f-905" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-172" decimals="3" id="f-906" unitRef="number">0.005</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-173" decimals="3" id="f-907" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage contextRef="c-174" decimals="3" id="f-908" unitRef="number">0.007</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-175"
      decimals="INF"
      id="f-909"
      unitRef="number">0.0075</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-175" decimals="INF" id="f-910" unitRef="usd">850000000.0</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-176" decimals="-5" id="f-911" unitRef="usd">836600000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-175"
      decimals="2"
      id="f-912"
      unitRef="usdPerShare">41.07</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-177"
      decimals="INF"
      id="f-913"
      unitRef="number">0.0025</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-177" decimals="-7" id="f-914" unitRef="usd">1210000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-178" decimals="-7" id="f-915" unitRef="usd">1190000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-177"
      decimals="2"
      id="f-916"
      unitRef="usdPerShare">150.11</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <us-gaap:DebtInstrumentInterestRateStatedPercentage
      contextRef="c-179"
      decimals="INF"
      id="f-917"
      unitRef="number">0.00375</us-gaap:DebtInstrumentInterestRateStatedPercentage>
    <us-gaap:DebtInstrumentFaceAmount contextRef="c-179" decimals="-7" id="f-918" unitRef="usd">1250000000</us-gaap:DebtInstrumentFaceAmount>
    <us-gaap:ProceedsFromConvertibleDebt contextRef="c-180" decimals="-7" id="f-919" unitRef="usd">1230000000</us-gaap:ProceedsFromConvertibleDebt>
    <us-gaap:DebtInstrumentConvertibleConversionPrice1
      contextRef="c-179"
      decimals="2"
      id="f-920"
      unitRef="usdPerShare">162.41</us-gaap:DebtInstrumentConvertibleConversionPrice1>
    <dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions
      contextRef="c-181"
      decimals="INF"
      id="f-921"
      unitRef="purchaser">2</dxcm:NumberOfInitialPurchasersForConvertibleNoteHedgeTransactions>
    <dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares
      contextRef="c-182"
      decimals="-5"
      id="f-922"
      unitRef="shares">20700000</dxcm:DebtInstrumentConvertibleAssociatedDerivativeTransactionsNumberOfShares>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-176"
      decimals="-5"
      id="f-923"
      unitRef="shares">20700000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-176" decimals="INF" id="f-924" unitRef="d">60</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:ProceedsFromIssuanceOfWarrants contextRef="c-176" decimals="-5" id="f-925" unitRef="usd">183800000</us-gaap:ProceedsFromIssuanceOfWarrants>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="c-175"
      decimals="2"
      id="f-926"
      unitRef="usdPerShare">49.60</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DebtConversionConvertedInstrumentSharesIssued1
      contextRef="c-183"
      decimals="-5"
      id="f-927"
      unitRef="shares">10300000</us-gaap:DebtConversionConvertedInstrumentSharesIssued1>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants
      contextRef="c-184"
      decimals="-5"
      id="f-928"
      unitRef="shares">6000000.0</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants
      contextRef="c-185"
      decimals="-5"
      id="f-929"
      unitRef="shares">1900000</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants
      contextRef="c-184"
      decimals="-5"
      id="f-930"
      unitRef="shares">6000000.0</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants
      contextRef="c-186"
      decimals="-5"
      id="f-931"
      unitRef="shares">4600000</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfRemainingWarrants>
    <dxcm:DebtInstrumentCapCallTransactionCapPricePerShare
      contextRef="c-187"
      decimals="INF"
      id="f-932"
      unitRef="usdPerShare">212.62</dxcm:DebtInstrumentCapCallTransactionCapPricePerShare>
    <dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage
      contextRef="c-187"
      decimals="INF"
      id="f-933"
      unitRef="number">0.80</dxcm:DebtInstrumentConvertibleCappedCallsInitialCapPricePremiumPercentage>
    <us-gaap:SharePrice
      contextRef="c-188"
      decimals="INF"
      id="f-934"
      unitRef="usdPerShare">118.12</us-gaap:SharePrice>
    <dxcm:PaymentsForPurchasesOfCappedCallTransactions contextRef="c-180" decimals="-5" id="f-935" unitRef="usd">101300000</dxcm:PaymentsForPurchasesOfCappedCallTransactions>
    <dxcm:ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock contextRef="c-1" id="f-936">See the following table for the details of conversion activity for the 2023 Notes for the fiscal year ended December 31, 2023:&lt;div style="margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.730%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.935%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:22.147%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Fiscal Period&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Converted Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate Principal Amount Converted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Issued for Settlement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Received from Exercise of 2023 Note Hedge&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1/1/2023 - 12/31/2023&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 Notes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$774.8 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.2&#160;million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.2 million&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dxcm:ScheduleOfConversionActivityForSeniorConvertibleNotesTableTextBlock>
    <dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled contextRef="c-189" decimals="-5" id="f-937" unitRef="usd">774800000</dxcm:DebtInstrumentConvertiblePrincipalAmountExercisedAndSettled>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="c-189"
      decimals="-5"
      id="f-938"
      unitRef="shares">12200000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromBenefitOfNoteHedge
      contextRef="c-189"
      decimals="-5"
      id="f-939"
      unitRef="shares">12200000</dxcm:SharesReceivedFromBenefitOfNoteHedge>
    <dxcm:DebtInstrumentCovenantRepurchasePricePercentage
      contextRef="c-190"
      decimals="INF"
      id="f-940"
      unitRef="number">1</dxcm:DebtInstrumentCovenantRepurchasePricePercentage>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-191" decimals="INF" id="f-941" unitRef="d">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 contextRef="c-192" decimals="INF" id="f-942" unitRef="d">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-191"
      decimals="INF"
      id="f-943"
      unitRef="number">1.30</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c-193"
      decimals="INF"
      id="f-944"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c-194"
      decimals="INF"
      id="f-945"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c-194"
      decimals="INF"
      id="f-946"
      unitRef="trading_day">5</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger
      contextRef="c-194"
      decimals="INF"
      id="f-947"
      unitRef="number">0.98</us-gaap:DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger>
    <dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock
      contextRef="c-162"
      decimals="INF"
      id="f-948"
      unitRef="number">1.30</dxcm:DebtInstrumentRedemptionCovenantPercentOfConversionPriceLastReportedSalePriceOfCommonStock>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c-195"
      decimals="INF"
      id="f-949"
      unitRef="trading_day">20</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1
      contextRef="c-196"
      decimals="INF"
      id="f-950"
      unitRef="trading_day">30</us-gaap:DebtInstrumentConvertibleThresholdConsecutiveTradingDays1>
    <us-gaap:DebtInstrumentRedemptionPricePercentage
      contextRef="c-162"
      decimals="INF"
      id="f-951"
      unitRef="number">1</us-gaap:DebtInstrumentRedemptionPricePercentage>
    <us-gaap:DebtInstrumentTerm contextRef="c-197" id="f-952">P5Y</us-gaap:DebtInstrumentTerm>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-198" decimals="-5" id="f-953" unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount contextRef="c-198" decimals="INF" id="f-954" unitRef="usd">500000000.0</dxcm:LineOfCreditFacilityMaximumBorrowingCapacityOptionToIncreaseAmount>
    <us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock contextRef="c-1" id="f-955">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Information related to availability and outstanding borrowings on our Amended Credit Agreement is as follows as of the date indicated:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:84.864%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.936%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Available principal amount &lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;200.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Letters of credit sub-facility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;25.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding borrowings &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding letters of credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total available balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;192.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The minimum and maximum range of applicable rates per annum with respect to any ABR Loan, Term Benchmark Revolving Loan, or RFR Revolving Loan, each as defined in the Amended Credit Agreement under the captions &#x201c;ABR Spread&#x201d;, &#x201c;Term Benchmark&#x201d;, and &#x201c;RFR Spread&#x201d;, or &#x201c;Unused Commitment Fee Rate&#x201d;, respectively, are outlined in the following table:&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:17.961%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.879%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:25.881%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Range&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;ABR Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Term Benchmark/RFR Spread&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Unused Commitment Fee Rate&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Minimum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.375%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.175%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maximum&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.000%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.000%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.250%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-bottom:1pt solid #d9d8d6;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfLineOfCreditFacilitiesTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-199" decimals="-5" id="f-956" unitRef="usd">200000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity contextRef="c-200" decimals="-5" id="f-957" unitRef="usd">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCredit contextRef="c-199" decimals="-5" id="f-958" unitRef="usd">0</us-gaap:LineOfCredit>
    <us-gaap:LettersOfCreditOutstandingAmount contextRef="c-200" decimals="-5" id="f-959" unitRef="usd">7700000</us-gaap:LettersOfCreditOutstandingAmount>
    <us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity contextRef="c-5" decimals="-5" id="f-960" unitRef="usd">192300000</us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-201"
      decimals="INF"
      id="f-961"
      unitRef="number">0.00375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-202"
      decimals="INF"
      id="f-962"
      unitRef="number">0.01375</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-203"
      decimals="INF"
      id="f-963"
      unitRef="number">0.00175</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-204"
      decimals="INF"
      id="f-964"
      unitRef="number">0.01000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="c-205"
      decimals="INF"
      id="f-965"
      unitRef="number">0.02000</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
      contextRef="c-206"
      decimals="INF"
      id="f-966"
      unitRef="number">0.00250</us-gaap:LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage>
    <us-gaap:LesseeFinanceLeasesTextBlock contextRef="c-1" id="f-971">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;6. Leases and Other Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have leases for certain machinery and facilities, including office, manufacturing and warehouse space facilities under various domestic and international operating and finance lease arrangements. We also have land leases in Penang, Malaysia that expire through 2082 and in Athenry, Ireland that expire in 3023 for the build-out of our international manufacturing facilities. Our leases, excluding our land leases in Malaysia and Ireland, have remaining lease terms of up to sixteen years. Some of the leases include one or more options to extend the leases for up to five years per option. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-995"&gt;Less: Current portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $17.0&#160;million and $15.7&#160;million as of December&#160;31, 2024 and 2023, respectively, are included in &lt;span style="-sec-ix-hidden:f-1002"&gt;&lt;span style="-sec-ix-hidden:f-1003"&gt;other long-term liabilities&lt;/span&gt;&lt;/span&gt; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the result of the Company&#x2019;s transition to a flexible working environment, we vacated a building in San Diego during the fourth quarter of 2022 and made it available for sublease. This resulted in an impairment indicator. We tested the asset group as of November 30, 2022 consisting primarily of the leasehold improvements and right-of-use asset for recoverability by comparing its carrying value to an estimate of future undiscounted cash flows. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group were below its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the asset group by discounting the estimated future cash flows using level 3 fair value inputs under ASC 820 as described in Note 1 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Organization and Significant Accounting Policies&#x2014;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;. As a result of the impairment test, we recorded a non-cash charge of $23.0&#160;million for the twelve months ended December 31, 2022 in the &#x201c;&lt;span style="-sec-ix-hidden:f-1027"&gt;Selling, general and administrative&lt;/span&gt;&#x201d; caption of our consolidated statements of operations. The fair value of the asset group immediately subsequent to the impairment was $2.5&#160;million and was categorized as Level 3 within the ASC 820, &#x201c;Fair Value Measurements&#x201d; fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to our leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was $16.7 million, $16.5 million, and $16.4 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We are party to various purchase arrangements related to our operational, manufacturing, and research and development activities. We had approximately $954.9 million and $793.0 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year, as of December&#160;31, 2024 and December&#160;31, 2023, respectively</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock contextRef="c-1" id="f-970">&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;6. Leases and Other Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have leases for certain machinery and facilities, including office, manufacturing and warehouse space facilities under various domestic and international operating and finance lease arrangements. We also have land leases in Penang, Malaysia that expire through 2082 and in Athenry, Ireland that expire in 3023 for the build-out of our international manufacturing facilities. Our leases, excluding our land leases in Malaysia and Ireland, have remaining lease terms of up to sixteen years. Some of the leases include one or more options to extend the leases for up to five years per option. Our lease terms include options to extend or terminate the lease when it is reasonably certain that we will exercise that option.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-995"&gt;Less: Current portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain lease agreements require us to return designated areas of leased space to its original condition upon termination of the lease agreement, for which we record an asset retirement obligation and a corresponding capital asset in an amount equal to the estimated fair value of the obligation. In subsequent periods, the asset retirement obligation is accreted for the change in its present value and the capitalized asset is depreciated, both over the term of the associated lease agreement. Asset retirement obligations of $17.0&#160;million and $15.7&#160;million as of December&#160;31, 2024 and 2023, respectively, are included in &lt;span style="-sec-ix-hidden:f-1002"&gt;&lt;span style="-sec-ix-hidden:f-1003"&gt;other long-term liabilities&lt;/span&gt;&lt;/span&gt; in our consolidated balance sheets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As the result of the Company&#x2019;s transition to a flexible working environment, we vacated a building in San Diego during the fourth quarter of 2022 and made it available for sublease. This resulted in an impairment indicator. We tested the asset group as of November 30, 2022 consisting primarily of the leasehold improvements and right-of-use asset for recoverability by comparing its carrying value to an estimate of future undiscounted cash flows. Based on the results of the recoverability test, we determined that the undiscounted cash flows of the asset group were below its carrying value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We determined the fair value of the asset group by discounting the estimated future cash flows using level 3 fair value inputs under ASC 820 as described in Note 1 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Organization and Significant Accounting Policies&#x2014;Intangible Assets and Other Long-Lived Assets&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d;. As a result of the impairment test, we recorded a non-cash charge of $23.0&#160;million for the twelve months ended December 31, 2022 in the &#x201c;&lt;span style="-sec-ix-hidden:f-1027"&gt;Selling, general and administrative&lt;/span&gt;&#x201d; caption of our consolidated statements of operations. The fair value of the asset group immediately subsequent to the impairment was $2.5&#160;million and was categorized as Level 3 within the ASC 820, &#x201c;Fair Value Measurements&#x201d; fair value hierarchy.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to our leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of operating lease right-of-use asset included in cash flows from operating activities in our consolidated statements of cash flows was $16.7 million, $16.5 million, and $16.4 million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Purchase Commitments&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;We are party to various purchase arrangements related to our operational, manufacturing, and research and development activities. We had approximately $954.9 million and $793.0 million of open purchase orders and contractual obligations in the ordinary course of business, the majority of which are due within one year, as of December&#160;31, 2024 and December&#160;31, 2023, respectively</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRemainingLeaseTerm contextRef="c-70" id="f-972">P16Y</us-gaap:LesseeOperatingLeaseRemainingLeaseTerm>
    <dxcm:LesseeOperatingLeaseNumberOfOptionsToExtend
      contextRef="c-69"
      decimals="INF"
      id="f-973"
      unitRef="extensionoption">1</dxcm:LesseeOperatingLeaseNumberOfOptionsToExtend>
    <us-gaap:LesseeOperatingLeaseRenewalTerm contextRef="c-70" id="f-974">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-976">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-995"&gt;Less: Current portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock contextRef="c-1" id="f-975">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, the maturities of our operating and finance lease liabilities were as shown in the table below:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:75.508%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.867%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2029&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;54.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total future lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;99.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: Imputed interest &lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(26.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Present value of future payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&lt;span style="-sec-ix-hidden:f-995"&gt;Less: Current portion&lt;/span&gt;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(6.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Long-term portion&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;65.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;58.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-5" decimals="-5" id="f-977" unitRef="usd">26800000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths contextRef="c-5" decimals="-5" id="f-978" unitRef="usd">9700000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo contextRef="c-5" decimals="-5" id="f-979" unitRef="usd">26100000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo contextRef="c-5" decimals="-5" id="f-980" unitRef="usd">8800000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree contextRef="c-5" decimals="-5" id="f-981" unitRef="usd">20900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree contextRef="c-5" decimals="-5" id="f-982" unitRef="usd">6900000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour contextRef="c-5" decimals="-5" id="f-983" unitRef="usd">15900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour contextRef="c-5" decimals="-5" id="f-984" unitRef="usd">5400000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive contextRef="c-5" decimals="-5" id="f-985" unitRef="usd">2900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive contextRef="c-5" decimals="-5" id="f-986" unitRef="usd">5500000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-5" decimals="-5" id="f-987" unitRef="usd">6900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive contextRef="c-5" decimals="-5" id="f-988" unitRef="usd">54600000</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue contextRef="c-5" decimals="-5" id="f-989" unitRef="usd">99500000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue contextRef="c-5" decimals="-5" id="f-990" unitRef="usd">90900000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount contextRef="c-5" decimals="-5" id="f-991" unitRef="usd">12000000.0</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount contextRef="c-5" decimals="-5" id="f-992" unitRef="usd">26000000.0</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability contextRef="c-5" decimals="-5" id="f-993" unitRef="usd">87500000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability contextRef="c-5" decimals="-5" id="f-994" unitRef="usd">64900000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseLiabilityCurrent contextRef="c-5" decimals="-5" id="f-996" unitRef="usd">22500000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent contextRef="c-5" decimals="-5" id="f-997" unitRef="usd">6400000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-998" unitRef="usd">65000000.0</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent contextRef="c-5" decimals="-5" id="f-999" unitRef="usd">58500000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:AssetRetirementObligation contextRef="c-5" decimals="-5" id="f-1000" unitRef="usd">17000000</us-gaap:AssetRetirementObligation>
    <us-gaap:AssetRetirementObligation contextRef="c-6" decimals="-5" id="f-1001" unitRef="usd">15700000</us-gaap:AssetRetirementObligation>
    <us-gaap:LeaseCostTableTextBlock contextRef="c-1" id="f-1004">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The components of lease expense for the twelve months ended December&#160;31, 2024, 2023 and 2022 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions) &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance lease cost:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amortization of right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Interest on lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use asset impairment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Short-term lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Variable lease cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other information related to our leases is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.642%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended &lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(Dollars in millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cash paid for amounts included in the measurement of lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financing cash flows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Right-of-use assets obtained in exchange for lease liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average remaining lease term:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.2 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.5 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.6 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.1 years&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.2 years&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Weighted average discount rate:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-1" decimals="-5" id="f-1005" unitRef="usd">7200000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-7" decimals="-5" id="f-1006" unitRef="usd">6500000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization contextRef="c-8" decimals="-5" id="f-1007" unitRef="usd">5600000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-1" decimals="-5" id="f-1008" unitRef="usd">3400000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-7" decimals="-5" id="f-1009" unitRef="usd">3200000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense contextRef="c-8" decimals="-5" id="f-1010" unitRef="usd">3300000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:OperatingLeaseCost contextRef="c-1" decimals="-5" id="f-1011" unitRef="usd">22400000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-7" decimals="-5" id="f-1012" unitRef="usd">22900000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost contextRef="c-8" decimals="-5" id="f-1013" unitRef="usd">22600000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-1" decimals="-5" id="f-1014" unitRef="usd">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-7" decimals="-5" id="f-1015" unitRef="usd">0</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:OperatingLeaseImpairmentLoss contextRef="c-8" decimals="-5" id="f-1016" unitRef="usd">6300000</us-gaap:OperatingLeaseImpairmentLoss>
    <us-gaap:ShortTermLeaseCost contextRef="c-1" decimals="-5" id="f-1017" unitRef="usd">3800000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-7" decimals="-5" id="f-1018" unitRef="usd">2400000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost contextRef="c-8" decimals="-5" id="f-1019" unitRef="usd">3500000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-1" decimals="-5" id="f-1020" unitRef="usd">9000000.0</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-7" decimals="-5" id="f-1021" unitRef="usd">8300000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost contextRef="c-8" decimals="-5" id="f-1022" unitRef="usd">8000000.0</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost contextRef="c-1" decimals="-5" id="f-1023" unitRef="usd">45800000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-7" decimals="-5" id="f-1024" unitRef="usd">43300000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost contextRef="c-8" decimals="-5" id="f-1025" unitRef="usd">49300000</us-gaap:LeaseCost>
    <us-gaap:ImpairmentOfLongLivedAssetsHeldForUse contextRef="c-8" decimals="-5" id="f-1026" unitRef="usd">23000000</us-gaap:ImpairmentOfLongLivedAssetsHeldForUse>
    <dxcm:ImpairedLongLivedAssetsFairValue contextRef="c-5" decimals="-5" id="f-1028" unitRef="usd">2500000</dxcm:ImpairedLongLivedAssetsFairValue>
    <us-gaap:OperatingLeasePayments contextRef="c-1" decimals="-5" id="f-1029" unitRef="usd">27500000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-7" decimals="-5" id="f-1030" unitRef="usd">28100000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments contextRef="c-8" decimals="-5" id="f-1031" unitRef="usd">26000000.0</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-1" decimals="-5" id="f-1032" unitRef="usd">3400000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-7" decimals="-5" id="f-1033" unitRef="usd">3200000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability contextRef="c-8" decimals="-5" id="f-1034" unitRef="usd">3100000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-1" decimals="-5" id="f-1035" unitRef="usd">13000000.0</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-7" decimals="-5" id="f-1036" unitRef="usd">4700000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments contextRef="c-8" decimals="-5" id="f-1037" unitRef="usd">15500000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-1" decimals="-5" id="f-1038" unitRef="usd">8800000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-7" decimals="-5" id="f-1039" unitRef="usd">7500000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability contextRef="c-8" decimals="-5" id="f-1040" unitRef="usd">15600000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-1" decimals="-5" id="f-1041" unitRef="usd">14600000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-7" decimals="-5" id="f-1042" unitRef="usd">4200000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability contextRef="c-8" decimals="-5" id="f-1043" unitRef="usd">16100000</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1044">P4Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-1045">P5Y</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-25" id="f-1046">P5Y6M</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-5" id="f-1047">P12Y7M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-6" id="f-1048">P14Y1M6D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1 contextRef="c-25" id="f-1049">P15Y2M12D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-1050" unitRef="number">0.061</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-1051" unitRef="number">0.061</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent contextRef="c-25" decimals="3" id="f-1052" unitRef="number">0.060</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-5" decimals="3" id="f-1053" unitRef="number">0.054</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-6" decimals="3" id="f-1054" unitRef="number">0.053</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent contextRef="c-25" decimals="3" id="f-1055" unitRef="number">0.051</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization contextRef="c-1" decimals="-5" id="f-1056" unitRef="usd">16700000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization contextRef="c-7" decimals="-5" id="f-1057" unitRef="usd">16500000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <dxcm:LesseeOperatingLeasesLeaseCostAmortization contextRef="c-8" decimals="-5" id="f-1058" unitRef="usd">16400000</dxcm:LesseeOperatingLeasesLeaseCostAmortization>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear contextRef="c-5" decimals="-5" id="f-1059" unitRef="usd">954900000</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear contextRef="c-6" decimals="-5" id="f-1060" unitRef="usd">793000000.0</us-gaap:RecordedUnconditionalPurchaseObligationDueWithinOneYear>
    <dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm contextRef="c-1" id="f-1061">P1Y</dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm>
    <dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm contextRef="c-7" id="f-1062">P1Y</dxcm:RecordedUnconditionalPurchaseObligationDueWithinOneYearMaximumTerm>
    <us-gaap:LegalMattersAndContingenciesTextBlock contextRef="c-1" id="f-1063">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;7. Contingencies&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="border-bottom:1pt dotted #32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;Litigation&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are subject to various claims, complaints and legal actions that arise from time to time in the normal course of business, including commercial insurance, product liability, intellectual property and employment related matters. In addition, from time to time we may bring claims or initiate lawsuits against various third parties with respect to matters arising out of the ordinary course of our business, including commercial and employment related matters.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Between June 2021 through the year ended December&#160;31, 2024, we and certain Abbott Diabetes Care, Inc. (&#x201c;Abbott&#x201d;) entities served patent infringement complaints against each other in multiple jurisdictions against certain continuous glucose monitoring products of each company. On December 20, 2024, we and Abbott entered into a settlement and patent cross license agreement (the &#x201c;Settlement Agreement&#x201d;) to resolve all outstanding patent litigation between the parties (the &#x201c;Litigation&#x201d;). Under the terms of the Settlement Agreement, we granted Abbott and its affiliates, and Abbott and its affiliates granted Dexcom and its affiliates, a worldwide, royalty-free, non-exclusive, fully paid-up license to certain patents and patent applications relating to analyte sensing, including to all the patents asserted in the Litigation. The Settlement Agreement does not obligate us or Abbott to pay any royalties or any other form of financial compensation. As part of the Settlement Agreement, each party, on behalf of itself and its affiliates, has also (i) entered into a covenant not to sue until December 20, 2034; and (ii) agreed on behalf of themselves and their affiliates to refrain from challenging the patents and patent applications licensed under the Settlement Agreement for periods of time which vary depending on the relevant patents or patent applications.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to uncertainty surrounding the securities class action litigation and the derivative action, we are unable to reasonably estimate the ultimate outcome of any of the litigation matters at this time. We intend to defend against these claims vigorously in all of these actions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We do not believe we are party to any other currently pending legal proceedings, the outcome of which could have a material adverse effect on our business, financial condition, or results of operations. There can be no assurance that existing or future legal proceedings arising in the ordinary course of business or otherwise will not have a material adverse effect on our business, financial condition, or results of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:LegalMattersAndContingenciesTextBlock>
    <us-gaap:IncomeTaxDisclosureTextBlock contextRef="c-1" id="f-1064">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;8. Income Taxes&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;659.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;732.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;463.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;709.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;710.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(55.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(93.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(55.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other states&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California AMT Credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Utilization of net operating losses and credit carryforwards is subject to an annual limitation due to ownership change limitations provided by Section&#160;382 and 383 of the Internal Revenue Code of 1986, as amended, and similar state provisions. An ownership change limitation occurred as a result of the stock offering completed in February 2009. The limitation will result in approximately&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; $1.1 million&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; of U.S. research and development tax credits that will expire unused, and is therefore, not reflected in the tax credit carryforwards above. In addition, the related deferred tax assets have been removed from the components of our deferred tax assets as summarized in the table below. The tax benefits related to the remaining federal and state net operating losses and tax credit carryforwards may be further limited or lost if future cumulative changes in ownership exceed 50% within any three-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of our deferred tax assets and liabilities as of December&#160;31, 2024 and 2023 are shown below. Significant judgment is required to evaluate the need for a valuation allowance against deferred tax assets. We review all available positive and negative evidence, including projections of pre-tax book income, earnings history, reliability of forecasting, and reversal of temporary differences. A valuation allowance is established when it is more likely than not that some or all of the deferred tax assets will not be realized. Realization of deferred tax assets is dependent upon future earnings in applicable tax jurisdictions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;265.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;233.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;263.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;748.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;741.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(221.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(264.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;526.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;477.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;466.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;416.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2024, we further analyzed the prior year intra-entity asset transfer of certain intellectual property between two of our wholly owned foreign subsidiaries. As a result, we reclassified the specific intellectual property from a patent to patent rights according to Irish law. This changed the applicable enacted statutory tax rate from capital gains to passive at 25%.There was no impact to the income statement as the change in rate was fully offset by a change in valuation allowance. The total ending deferred tax asset as of December&#160;31, 2024 is $142.4&#160;million, which remains fully offset by a valuation allowance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We maintain a valuation allowance of $221.9 million against our California research and development tax credits, foreign tax credits, and certain foreign intangible assets. During the year ended December&#160;31, 2024, the valuation allowance decreased by $42.4 million primarily due to the change in tax rate applied to the fair value of certain intellectual property located in Ireland in connection with the intra-entity transfer of this property, partially offset by the generation of California research and development tax credits.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;148.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock and officers compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaboration agreement milestone share-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(52.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in statutory tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January&#160;1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to prior year tax positions &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Of the total unrecognized tax benefits at December 31, 2024, 2023, and 2022, $40.7 million, $37.0&#160;million and $32.5&#160;million, respectively, would affect our annual effective tax rate if recognized. The indirect effect of the unrecognized tax benefits that, if recognized, would affect our annual effective tax rate is not material for all years presented. Also, the amount of unrecognized tax benefits that, if recognized, would result in adjustments to other tax accounts, is not material for all years presented. Interest and penalties are classified as a component of income tax expense and are not material for all years presented. Although the timing and outcome of audit settlements are uncertain, we do not anticipate a significant change to the unrecognized tax benefits in the next twelve months.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Due to our global business activities, we file income tax returns and are subject to routine compliance audits in numerous jurisdictions, including those material jurisdictions listed in the following table. The U.S. net operating losses generated since 1999 and utilized in recent years are open for examination. The years remaining subject to audit, by major jurisdiction, are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States (Federal and state)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1999 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We currently operate under a Special Corporate Income Tax Preferential rate in the Philippines, which is in effect for the next 10 years. The prior tax holiday ended in 2023. The impact of the both the tax holiday and preferential rate is immaterial for all years presented. We have been granted a tax incentive by the Malaysian Investment Development Authority (MIDA) in Malaysia, which provides for a tax holiday of up to 15 years, which will not be triggered until we meet certain milestones related to the commencement of operations. The tax incentive had no effect on foreign taxes during 2024, 2023, or 2022. As of December&#160;31, 2024, the tax holiday in Malaysia has not yet been triggered, therefore we are subject to the statutory rate and the related tax expense has been included in total tax expense for 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have approximately $89.3&#160;million of undistributed earnings attributable to operations in our controlled foreign corporations as of December&#160;31, 2024. We assert that any foreign earnings will be indefinitely reinvested. Accordingly, we have not recorded a liability for taxes associated with these undistributed earnings. If we determine that all or a portion of such foreign earnings are no longer indefinitely reinvested, we may be subject to additional foreign withholding taxes and U.S. state income taxes. Determination of the amount of unrecognized deferred tax liability on these unremitted earnings is not practicable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Organization for Economic Co-operation and Development has a framework to implement a global minimum corporate tax of 15% for companies with global revenues and profits above certain thresholds (referred to as Pillar 2), with certain aspects of Pillar 2 effective January 1, 2024 and other aspects effective January 1, 2025. While it is uncertain whether the United States will enact legislation to adopt Pillar 2, certain countries in which we operate have adopted legislation, and other countries in which we operate are in the process of introducing legislation to implement Pillar 2. We have assessed the impact of Pillar 2 on our financial statements and the impact is immaterial.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2024, the State of California enacted S.B. 167, which suspends the use of net operating losses (&#x201c;NOLs&#x201d;) for the tax period from January 1, 2024 to December 31, 2026 for net business income of $1.0&#160;million or more, as well as limits the utilization of research and development tax credits to $5.0&#160;million each year. The State of California also passed S.B. 175 to provide for a potential early sunset of NOLs in either 2025 or 2026 if necessary. We have analyzed the effect of both these laws on our financial statements. We are estimating $2.8&#160;million utilization of our California research and development tax credits for tax year ending December&#160;31, 2024, resulting in a corresponding valuation allowance release of the same amount.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock contextRef="c-1" id="f-1065">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income (loss) before income taxes subject to taxes in the following jurisdictions is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;659.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;732.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;463.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outside of the United States&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(22.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;709.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;710.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIncomeBeforeIncomeTaxDomesticAndForeignTableTextBlock>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-1" decimals="-5" id="f-1066" unitRef="usd">659800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-7" decimals="-5" id="f-1067" unitRef="usd">732400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic contextRef="c-8" decimals="-5" id="f-1068" unitRef="usd">463500000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-1" decimals="-5" id="f-1069" unitRef="usd">49200000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-7" decimals="-5" id="f-1070" unitRef="usd">-22000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign contextRef="c-8" decimals="-5" id="f-1071" unitRef="usd">-72700000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1072" unitRef="usd">709000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-1073" unitRef="usd">710400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-1074" unitRef="usd">390800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock contextRef="c-1" id="f-1075">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant components of the provision for income taxes are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Current:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;157.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;32.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;56.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total current income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;176.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;223.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(55.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(93.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(4.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(17.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;24.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(43.8)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(55.0)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(21.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1076" unitRef="usd">157400000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1077" unitRef="usd">149100000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentFederalTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1078" unitRef="usd">32600000</us-gaap:CurrentFederalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1079" unitRef="usd">16500000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1080" unitRef="usd">18100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentStateAndLocalTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1081" unitRef="usd">26100000</us-gaap:CurrentStateAndLocalTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1082" unitRef="usd">2700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1083" unitRef="usd">56700000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentForeignTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1084" unitRef="usd">12500000</us-gaap:CurrentForeignTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1085" unitRef="usd">176600000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1086" unitRef="usd">223900000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:CurrentIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1087" unitRef="usd">71200000</us-gaap:CurrentIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1088" unitRef="usd">-55200000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1089" unitRef="usd">-93700000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredFederalIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1090" unitRef="usd">-4300000</us-gaap:DeferredFederalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1091" unitRef="usd">-2000000.0</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1092" unitRef="usd">14600000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1093" unitRef="usd">-17600000</us-gaap:DeferredStateAndLocalIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1094" unitRef="usd">13400000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1095" unitRef="usd">24100000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredForeignIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1096" unitRef="usd">300000</us-gaap:DeferredForeignIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1097" unitRef="usd">-43800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1098" unitRef="usd">-55000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1099" unitRef="usd">-21600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1100" unitRef="usd">132800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1101" unitRef="usd">168900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1102" unitRef="usd">49600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock contextRef="c-1" id="f-1104">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other states&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California AMT Credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfTaxCreditCarryforwardsTextBlock>
    <us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock contextRef="c-1" id="f-1103">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Significant loss and tax credit carryforwards and years of expiration are as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Year of Expiration&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;162.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;167.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2035&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other states&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;UK&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other foreign&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2027&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Federal&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 18.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2032&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California R&amp;amp;D credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;124.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;111.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;California AMT Credits&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Indefinite&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfOperatingLossCarryforwardsTextBlock>
    <us-gaap:OperatingLossCarryforwards contextRef="c-207" decimals="-5" id="f-1105" unitRef="usd">12100000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-208" decimals="-5" id="f-1106" unitRef="usd">20400000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-209" decimals="-5" id="f-1107" unitRef="usd">162000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-210" decimals="-5" id="f-1108" unitRef="usd">167700000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-211" decimals="-5" id="f-1109" unitRef="usd">5800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-212" decimals="-5" id="f-1110" unitRef="usd">7800000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-213" decimals="-5" id="f-1111" unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-214" decimals="-5" id="f-1112" unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-215" decimals="-5" id="f-1113" unitRef="usd">0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:OperatingLossCarryforwards contextRef="c-216" decimals="-5" id="f-1114" unitRef="usd">6000000.0</us-gaap:OperatingLossCarryforwards>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-217" decimals="-5" id="f-1115" unitRef="usd">0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-218" decimals="-5" id="f-1116" unitRef="usd">0</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-219" decimals="-5" id="f-1117" unitRef="usd">100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-220" decimals="-5" id="f-1118" unitRef="usd">100000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-221" decimals="-5" id="f-1119" unitRef="usd">124900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-222" decimals="-5" id="f-1120" unitRef="usd">111900000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-223" decimals="-5" id="f-1121" unitRef="usd">500000</us-gaap:TaxCreditCarryforwardAmount>
    <us-gaap:TaxCreditCarryforwardAmount contextRef="c-224" decimals="-5" id="f-1122" unitRef="usd">500000</us-gaap:TaxCreditCarryforwardAmount>
    <dxcm:UnusedExpiredFederalIncomeTaxCredits contextRef="c-1" decimals="-5" id="f-1123" unitRef="usd">1100000</dxcm:UnusedExpiredFederalIncomeTaxCredits>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock contextRef="c-1" id="f-1124">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:74.777%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.598%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax assets:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net operating loss carryforwards&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;18.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Capitalized research and development expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;265.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;233.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Tax credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;79.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;71.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;22.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed and intangible assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;263.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;279.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities and reserves&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;87.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;91.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Convertible debt&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;20.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total gross deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;748.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;741.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less: valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(221.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(264.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total net deferred tax assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;526.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;477.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fixed assets and acquired intangibles assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(59.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(60.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net deferred tax assets (liabilities)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;466.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;416.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-5" decimals="-5" id="f-1125" unitRef="usd">14400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwards contextRef="c-6" decimals="-5" id="f-1126" unitRef="usd">18100000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-5" decimals="-5" id="f-1127" unitRef="usd">265000000.0</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment contextRef="c-6" decimals="-5" id="f-1128" unitRef="usd">233400000</us-gaap:DeferredTaxAssetsInProcessResearchAndDevelopment>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-5" decimals="-5" id="f-1129" unitRef="usd">79200000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards contextRef="c-6" decimals="-5" id="f-1130" unitRef="usd">71400000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-5" decimals="-5" id="f-1131" unitRef="usd">22500000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost contextRef="c-6" decimals="-5" id="f-1132" unitRef="usd">27000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets contextRef="c-5" decimals="-5" id="f-1133" unitRef="usd">263600000</dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets>
    <dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets contextRef="c-6" decimals="-5" id="f-1134" unitRef="usd">279800000</dxcm:DeferredTaxAssetsFixedAssetsAndIntangibleAssets>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-5" decimals="-5" id="f-1135" unitRef="usd">87400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities contextRef="c-6" decimals="-5" id="f-1136" unitRef="usd">91000000.0</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <dxcm:DeferredTaxAssetsConvertibleDebt contextRef="c-5" decimals="-5" id="f-1137" unitRef="usd">-16000000.0</dxcm:DeferredTaxAssetsConvertibleDebt>
    <dxcm:DeferredTaxAssetsConvertibleDebt contextRef="c-6" decimals="-5" id="f-1138" unitRef="usd">-20600000</dxcm:DeferredTaxAssetsConvertibleDebt>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-5" decimals="-5" id="f-1139" unitRef="usd">748100000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross contextRef="c-6" decimals="-5" id="f-1140" unitRef="usd">741300000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-5" decimals="-5" id="f-1141" unitRef="usd">221900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-6" decimals="-5" id="f-1142" unitRef="usd">264300000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-5" decimals="-5" id="f-1143" unitRef="usd">526200000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet contextRef="c-6" decimals="-5" id="f-1144" unitRef="usd">477000000.0</us-gaap:DeferredTaxAssetsNet>
    <dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets contextRef="c-5" decimals="-5" id="f-1145" unitRef="usd">59300000</dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets>
    <dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets contextRef="c-6" decimals="-5" id="f-1146" unitRef="usd">60400000</dxcm:DeferredTaxLiabilitiesFixedAssetsAndIntangibleAssets>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-5" decimals="-5" id="f-1147" unitRef="usd">300000</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredTaxLiabilitiesOther contextRef="c-6" decimals="-5" id="f-1148" unitRef="usd">0</us-gaap:DeferredTaxLiabilitiesOther>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-5" decimals="-5" id="f-1149" unitRef="usd">59600000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredIncomeTaxLiabilities contextRef="c-6" decimals="-5" id="f-1150" unitRef="usd">60400000</us-gaap:DeferredIncomeTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-5" decimals="-5" id="f-1151" unitRef="usd">466600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet contextRef="c-6" decimals="-5" id="f-1152" unitRef="usd">416600000</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther contextRef="c-5" decimals="-5" id="f-1153" unitRef="usd">142400000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseOther>
    <us-gaap:DeferredTaxAssetsValuationAllowance contextRef="c-225" decimals="-5" id="f-1154" unitRef="usd">221900000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount contextRef="c-1" decimals="-5" id="f-1155" unitRef="usd">-42400000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock contextRef="c-1" id="f-1156">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The reconciliation between our effective tax rate on income (loss) from continuing operations and the statutory rate is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.350%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.600%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;U.S. federal statutory tax rate&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;148.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;149.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;82.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;State income tax, net of federal benefit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Permanent items&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development credits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(24.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(28.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(23.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign tax credit&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Foreign rate differential&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;27.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock and officers compensation&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Collaboration agreement milestone share-based payment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(32.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(72.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(52.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in statutory tax rates&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;51.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;19.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Intellectual property transfer&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Change in valuation allowance&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(42.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;8.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income taxes at effective rates&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-1" decimals="-5" id="f-1157" unitRef="usd">148900000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-7" decimals="-5" id="f-1158" unitRef="usd">149200000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate contextRef="c-8" decimals="-5" id="f-1159" unitRef="usd">82100000</us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-1" decimals="-5" id="f-1160" unitRef="usd">10200000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-7" decimals="-5" id="f-1161" unitRef="usd">7800000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes contextRef="c-8" decimals="-5" id="f-1162" unitRef="usd">5400000</us-gaap:IncomeTaxReconciliationStateAndLocalIncomeTaxes>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems contextRef="c-1" decimals="-5" id="f-1163" unitRef="usd">10500000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems contextRef="c-7" decimals="-5" id="f-1164" unitRef="usd">-2700000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <dxcm:EffectiveIncomeTaxReconciliationPermanentItems contextRef="c-8" decimals="-5" id="f-1165" unitRef="usd">600000</dxcm:EffectiveIncomeTaxReconciliationPermanentItems>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-1" decimals="-5" id="f-1166" unitRef="usd">24600000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-7" decimals="-5" id="f-1167" unitRef="usd">28300000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-8" decimals="-5" id="f-1168" unitRef="usd">23300000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="c-1" decimals="-5" id="f-1169" unitRef="usd">1200000</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="c-7" decimals="-5" id="f-1170" unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationTaxCreditsForeign contextRef="c-8" decimals="-5" id="f-1171" unitRef="usd">0</us-gaap:IncomeTaxReconciliationTaxCreditsForeign>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-1" decimals="-5" id="f-1172" unitRef="usd">1600000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-7" decimals="-5" id="f-1173" unitRef="usd">15800000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential contextRef="c-8" decimals="-5" id="f-1174" unitRef="usd">27700000</us-gaap:IncomeTaxReconciliationForeignIncomeTaxRateDifferential>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-1" decimals="-5" id="f-1175" unitRef="usd">3800000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-7" decimals="-5" id="f-1176" unitRef="usd">5600000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost contextRef="c-8" decimals="-5" id="f-1177" unitRef="usd">-1200000</us-gaap:IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost>
    <dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment contextRef="c-1" decimals="-5" id="f-1178" unitRef="usd">-32200000</dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment>
    <dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment contextRef="c-7" decimals="-5" id="f-1179" unitRef="usd">-72100000</dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment>
    <dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment contextRef="c-8" decimals="-5" id="f-1180" unitRef="usd">-52900000</dxcm:EffectiveIncomeTaxRateReconciliationCollaborationAgreementMilestoneShareBasedPayment>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-1" decimals="-5" id="f-1181" unitRef="usd">51500000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-7" decimals="-5" id="f-1182" unitRef="usd">19400000</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate contextRef="c-8" decimals="-5" id="f-1183" unitRef="usd">1000000.0</us-gaap:IncomeTaxReconciliationChangeInEnactedTaxRate>
    <dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer contextRef="c-1" decimals="-5" id="f-1184" unitRef="usd">0</dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer>
    <dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer contextRef="c-7" decimals="-5" id="f-1185" unitRef="usd">63900000</dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer>
    <dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer contextRef="c-8" decimals="-5" id="f-1186" unitRef="usd">0</dxcm:EffectiveIncomeTaxRateReconciliationIntellectualPropertyTransfer>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-1" decimals="-5" id="f-1187" unitRef="usd">6700000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-7" decimals="-5" id="f-1188" unitRef="usd">300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationOtherAdjustments contextRef="c-8" decimals="-5" id="f-1189" unitRef="usd">1300000</us-gaap:IncomeTaxReconciliationOtherAdjustments>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-1" decimals="-5" id="f-1190" unitRef="usd">-42400000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-7" decimals="-5" id="f-1191" unitRef="usd">10000000.0</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance contextRef="c-8" decimals="-5" id="f-1192" unitRef="usd">8900000</us-gaap:IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1193" unitRef="usd">132800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1194" unitRef="usd">168900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1195" unitRef="usd">49600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock contextRef="c-1" id="f-1196">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the activity related to our gross unrecognized tax benefits:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at January&#160;1, 2022&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Decreases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to prior year tax positions &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;59.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to prior year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Increases related to current year tax positions&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;66.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlock>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-14" decimals="-5" id="f-1197" unitRef="usd">46800000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions contextRef="c-8" decimals="-5" id="f-1198" unitRef="usd">900000</us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-8" decimals="-5" id="f-1199" unitRef="usd">6100000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-25" decimals="-5" id="f-1200" unitRef="usd">52000000.0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-7" decimals="-5" id="f-1201" unitRef="usd">800000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-7" decimals="-5" id="f-1202" unitRef="usd">6600000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-6" decimals="-5" id="f-1203" unitRef="usd">59400000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-1204" unitRef="usd">100000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions contextRef="c-1" decimals="-5" id="f-1205" unitRef="usd">6700000</us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions>
    <us-gaap:UnrecognizedTaxBenefits contextRef="c-5" decimals="-5" id="f-1206" unitRef="usd">66200000</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-5" decimals="-5" id="f-1207" unitRef="usd">40700000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-6" decimals="-5" id="f-1208" unitRef="usd">37000000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate contextRef="c-25" decimals="-5" id="f-1209" unitRef="usd">32500000</us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate>
    <us-gaap:SummaryOfIncomeTaxExaminationsTextBlock contextRef="c-1" id="f-1210">The years remaining subject to audit, by major jurisdiction, are as follows:&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:86.765%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.035%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Jurisdiction&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"&gt;Fiscal Year&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States (Federal and state)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1999 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United Kingdom&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2021 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ireland&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2023 - 2024&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SummaryOfIncomeTaxExaminationsTextBlock>
    <dxcm:PreferentialTaxRatePeriod contextRef="c-1" id="f-1211">P10Y</dxcm:PreferentialTaxRatePeriod>
    <dxcm:PossibleExtensionPeriodofTaxHoliday contextRef="c-1" id="f-1212">P15Y</dxcm:PossibleExtensionPeriodofTaxHoliday>
    <us-gaap:UndistributedEarningsOfForeignSubsidiaries contextRef="c-5" decimals="-5" id="f-1213" unitRef="usd">89300000</us-gaap:UndistributedEarningsOfForeignSubsidiaries>
    <us-gaap:IncomeTaxReconciliationTaxCreditsResearch contextRef="c-226" decimals="-5" id="f-1214" unitRef="usd">2800000</us-gaap:IncomeTaxReconciliationTaxCreditsResearch>
    <us-gaap:CompensationAndEmployeeBenefitPlansTextBlock contextRef="c-1" id="f-1215">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;9. Employee Benefit Plans and Stockholders&#x2019; Equity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Defined Contribution Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We offer various defined contribution plans for U.S. and international employees. The largest defined contribution plan is the 401(k) retirement plan (the 401(k) Plan) covering substantially all employees in the United States that meet certain age requirements. Employees who participate in the 401(k) Plan may contribute up to 90% of their compensation each year, subject to Internal Revenue Service limitations and the terms and conditions of the plan. Under the terms of the 401(k) Plan, we may elect to match a discretionary percentage of contributions. We match 50% of contributions up to 6% of eligible compensation. Total matching contributions under the 401(k) Plan were $17.6 million, $14.9 million and $11.1&#160;million for the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. Our contributions for other defined contribution plans are not significant for the twelve months ended December&#160;31, 2024, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the 2015 Employee Stock Purchase Plan (the 2015 ESPP), amended in December 2019, eligible employees may purchase shares of our common stock at semi-annual intervals through periodic payroll deductions during defined Offering Periods. Payroll deductions may not exceed 10% of the participant&#x2019;s cash compensation subject to certain limitations, and the purchase price will be 85% of the lower of the fair market value of the common stock at either the beginning of the applicable Offering Period or the Purchase Date. A total of 6.0 million shares of common stock are reserved for issuance under the 2015 ESPP. The 2015 ESPP shall continue until the earlier to occur of (a) termination of the 2015 ESPP by our Board of Directors, (b) issuance of all of the shares of common stock reserved for issuance under the plan, or (c) May&#160;28, 2025.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We issued approximately 0.4 million, 0.3 million and 0.3 million shares of common stock under the 2015 ESPP during the twelve months ended December&#160;31, 2024, 2023 and 2022, respectively. As of December&#160;31, 2024, approximately 2.1 million shares remained available for future issuance under the 2015 ESPP.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In May 2015, we adopted the Amended and Restated 2015 Equity Incentive Plan (the 2015 Plan), which replaced our 2005 Equity Incentive Plan and provides for the grant of incentive and nonstatutory stock options, restricted stock, stock bonuses, stock appreciation rights, RSUs, and PSUs to employees, directors or consultants of the Company. On May 30, 2019, our stockholders approved an increase to the maximum number of shares that may be issued under the 2015 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are authorized to issue up to&#160;39.2 million&#160;shares of our common stock under the 2015 Plan. As of December&#160;31, 2024, approximately 12.5 million shares remained available for future issuance under the 2015 Plan. We issue new shares of common stock to satisfy RSU and PSU vesting under our employee equity incentive plans.&lt;/span&gt;&lt;/div&gt;RSU awards typically vest in annual installments over &lt;span style="-sec-ix-hidden:f-1231"&gt;three&lt;/span&gt; or four years and vesting is subject to continued service. PSUs are granted to a group of senior officers and the number of shares of our common stock to be received at vesting will range from 0% to 200% of the target award based on the achievement of pre-established performance and market goals. PSUs vest approximately three years from the date of grant, subject to continued employment through that date and certification by the Compensation Committee&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share Repurchase Program and Treasury Shares&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Repurchased shares of our common stock are held as treasury shares until they are reissued or retired. When we reissue treasury stock, if the proceeds from the sale are more than the average price we paid to acquire the shares we record an increase in additional paid-in capital. Conversely, if the proceeds from the sale are less than the average price we paid to acquire the shares, we record a decrease in additional paid-in capital to the extent of increases previously recorded for similar transactions and a decrease in retained earnings for any remaining amount.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have not yet determined the ultimate disposition of repurchased shares and, consequently, we continue to hold them as treasury shares rather than retiring them. Authorization of future stock repurchase programs is subject to the final determination of our Board of Directors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our treasury share activity for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with 2023 Notes conversions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares received from Note Hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with the Restated Collaboration Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2022 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2023 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2024 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased with 2028 Notes proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with 2023 Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2024 Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2024, our Board of Directors authorized and approved a share repurchase program of up to $750.0 million of our outstanding common stock, with a repurchase period ending no later than June 30, 2025 (the &#x201c;2024 Share Repurchase Program&#x201d;). Repurchases of our common stock under the 2024 Share Repurchase Program were permitted to be made from time to time in the open market, in privately negotiated transactions or by other methods, including through the use of trading plans intended to qualify under Rule 10b5-1 under the Exchange Act, at our discretion, and in accordance with the limitations set forth in Rule 10b-18 promulgated under the Exchange Act and other applicable federal and state laws and regulations. The 2024 Share Repurchase Program was completed in August 2024. We repurchased 10.4 million shares of our common stock for $750.0 million under the 2024 Share Repurchase Program.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2023 Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In October 2023, our Board of Directors authorized and approved a share repurchase program of up to $500.0 million of our outstanding common stock, with a repurchase period ending no later than October 31, 2024 (the &#x201c;2023 Share Repurchase Program&#x201d;). On October 31, 2023, we entered into an accelerated share repurchase agreement (&#x201c;2023 ASR&#x201d;) with Bank of America, N.A. to repurchase $500.0 million of our common stock. The final notional amount under the 2023 ASR was $500.0 million or approximately 4.7 million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2023 ASR, less a discount. The 2023 ASR concluded on December 14, 2023. The 2023 Share Repurchase Program was completed in December 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;2022 Share Repurchase Program&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In July 2022, a duly authorized committee of our Board of Directors authorized and approved a share repurchase program of up to $700.0&#160;million of our outstanding common stock, with a repurchase period that ended on June 30, 2023 (the &#x201c;2022 Share Repurchase Program&#x201d;). On August 1, 2022, we entered into an accelerated share repurchase agreement (&#x201c;2022 ASR&#x201d;) with JPMorgan Chase Bank, National Association to repurchase up to $700.0&#160;million of our common stock on an accelerated basis. The final notional amount under the 2022 ASR was $557.7&#160;million or approximately 6.6&#160;million shares of our common stock based on the daily average volume-weighted average price of our common stock during the term of the 2022 ASR, less a discount. The 2022 ASR concluded on September 1, 2022. The 2022 Share Repurchase Program and the remaining authorization of $142.3&#160;million expired on June 30, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The 2022 ASR and 2023 ASR were forward contracts indexed to our own common stock. The forward contracts met all of the applicable criteria for equity classification, so we did not account for them as a derivative instrument. We have reflected the shares delivered to us by the financial institution as treasury shares as of the dates they were delivered to us in computing weighted average shares outstanding for both basic and diluted net income per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Other Treasury Share Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2024, we issued 12.5 million treasury shares to settle the 2023 Warrants. See Note 5 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Debt&#x2014;Senior Convertible Notes&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2024, we issued 1.5 million treasury shares in connection with our achievement of the second sales-based milestone under the Restated Collaboration Agreement. See Note 2 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;&#x201c;Development and Other Agreements&#x2014;Collaboration with Verily Life Sciences&#x201d;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; to the consolidated financial statements for more information.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Equity Award Activity&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU and PSU activity under the 2015 Plan for the twelve months ended December&#160;31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nonvested RSU and PSU Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions, except weighted average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Available for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&#160;&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;94.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;325.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;361.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;234.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The total vest-date fair value of RSUs and PSUs that vested during the twelve months ended December&#160;31, 2024, 2023 and 2022 was $174.5 million, $157.8 million and $160.1 million, respectively. As of December&#160;31, 2024, 2.7 million unvested RSUs and 0.3 million unvested PSUs were outstanding under the 2015 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our share-based compensation expense is associated with RSUs, PSUs, and ESPP. The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total tax benefit related to share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of December&#160;31, 2024, unrecognized estimated compensation costs related to RSUs and PSUs totaled $203.8 million and are expected to be recognized over a weighted-average period of approximately 1.7 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We value RSUs at the date of grant using the intrinsic value method. We estimate the fair value of PSUs at the date of grant using the intrinsic value method and the probability that the specified performance criteria will be met. We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.771%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.80% - 5.27%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.20% - 5.47%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.60%&#160;- 3.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility of Dexcom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42% - 85%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34% - 48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45%&#160;- 55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:CompensationAndEmployeeBenefitPlansTextBlock>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="c-227"
      decimals="INF"
      id="f-1216"
      unitRef="number">0.90</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
      contextRef="c-227"
      decimals="INF"
      id="f-1217"
      unitRef="number">0.50</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercentOfMatch>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="c-227"
      decimals="INF"
      id="f-1218"
      unitRef="number">0.06</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-227" decimals="-5" id="f-1219" unitRef="usd">17600000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-228" decimals="-5" id="f-1220" unitRef="usd">14900000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:DefinedContributionPlanCostRecognized contextRef="c-229" decimals="-5" id="f-1221" unitRef="usd">11100000</us-gaap:DefinedContributionPlanCostRecognized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate
      contextRef="c-5"
      decimals="INF"
      id="f-1222"
      unitRef="number">0.10</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate>
    <dxcm:EmployeePurchasePriceFloorPercentage
      contextRef="c-1"
      decimals="INF"
      id="f-1223"
      unitRef="number">0.85</dxcm:EmployeePurchasePriceFloorPercentage>
    <dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized
      contextRef="c-5"
      decimals="INF"
      id="f-1224"
      unitRef="shares">6000000.0</dxcm:EmployeeStockPurchasePlanESPPNumberOfSharesAuthorized>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-230"
      decimals="-5"
      id="f-1225"
      unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-231"
      decimals="-5"
      id="f-1226"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans
      contextRef="c-232"
      decimals="-5"
      id="f-1227"
      unitRef="shares">300000</us-gaap:StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-233"
      decimals="-5"
      id="f-1228"
      unitRef="shares">2100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
      contextRef="c-234"
      decimals="-5"
      id="f-1229"
      unitRef="shares">39200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-235"
      decimals="-5"
      id="f-1230"
      unitRef="shares">12500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-237" id="f-1232">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-238"
      decimals="INF"
      id="f-1233"
      unitRef="number">0</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="c-239"
      decimals="INF"
      id="f-1234"
      unitRef="number">2</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1 contextRef="c-240" id="f-1235">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dxcm:ScheduleOfTreasuryShareActivityTableTextBlock contextRef="c-1" id="f-1236">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes our treasury share activity for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:62.272%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.527%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.381%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.531%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with 2023 Notes conversions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares received from Note Hedge&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with the Restated Collaboration Agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(3.7)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(2.9)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2022 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.6&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2023 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased under the 2024 Share Repurchase Program&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;10.4&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares repurchased with 2028 Notes proceeds&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shares issued in connection with 2023 Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(12.5)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</dxcm:ScheduleOfTreasuryShareActivityTableTextBlock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-1" decimals="-5" id="f-1237" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-7" decimals="-5" id="f-1238" unitRef="shares">0</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities contextRef="c-8" decimals="-5" id="f-1239" unitRef="shares">400000</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-1" decimals="-5" id="f-1240" unitRef="shares">0</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-7" decimals="-5" id="f-1241" unitRef="shares">12200000</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:SharesReceivedFromExerciseOfNoteHedge contextRef="c-8" decimals="-5" id="f-1242" unitRef="shares">300000</dxcm:SharesReceivedFromExerciseOfNoteHedge>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-1" decimals="-5" id="f-1243" unitRef="shares">1500000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-7" decimals="-5" id="f-1244" unitRef="shares">3700000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone contextRef="c-8" decimals="-5" id="f-1245" unitRef="shares">2900000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-241"
      decimals="-5"
      id="f-1246"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-242"
      decimals="-5"
      id="f-1247"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-243"
      decimals="-5"
      id="f-1248"
      unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-244"
      decimals="-5"
      id="f-1249"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-245"
      decimals="-5"
      id="f-1250"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-246"
      decimals="-5"
      id="f-1251"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-247"
      decimals="-5"
      id="f-1252"
      unitRef="shares">10400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-248"
      decimals="-5"
      id="f-1253"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-249"
      decimals="-5"
      id="f-1254"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-250"
      decimals="-5"
      id="f-1255"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-251"
      decimals="-5"
      id="f-1256"
      unitRef="shares">1600000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-252"
      decimals="-5"
      id="f-1257"
      unitRef="shares">0</us-gaap:TreasuryStockSharesAcquired>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants contextRef="c-1" decimals="-5" id="f-1258" unitRef="shares">12500000</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants contextRef="c-7" decimals="-5" id="f-1259" unitRef="shares">0</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants contextRef="c-8" decimals="-5" id="f-1260" unitRef="shares">0</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-253" decimals="-5" id="f-1261" unitRef="usd">750000000.0</srt:StockRepurchaseProgramAuthorizedAmount1>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-254"
      decimals="-5"
      id="f-1262"
      unitRef="shares">10400000</us-gaap:TreasuryStockSharesAcquired>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-254" decimals="-5" id="f-1263" unitRef="usd">750000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount contextRef="c-255" decimals="INF" id="f-1264" unitRef="usd">500000000.0</dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount>
    <dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount contextRef="c-255" decimals="INF" id="f-1265" unitRef="usd">500000000.0</dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-256" decimals="-5" id="f-1266" unitRef="usd">500000000.0</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-256"
      decimals="-5"
      id="f-1267"
      unitRef="shares">4700000</us-gaap:TreasuryStockSharesAcquired>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-257" decimals="-5" id="f-1268" unitRef="usd">700000000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount contextRef="c-258" decimals="-5" id="f-1269" unitRef="usd">700000000</dxcm:AcceleratedShareRepurchaseAgreementAuthorizedAmount>
    <us-gaap:PaymentsForRepurchaseOfCommonStock contextRef="c-259" decimals="-5" id="f-1270" unitRef="usd">557700000</us-gaap:PaymentsForRepurchaseOfCommonStock>
    <us-gaap:TreasuryStockSharesAcquired
      contextRef="c-259"
      decimals="-5"
      id="f-1271"
      unitRef="shares">6600000</us-gaap:TreasuryStockSharesAcquired>
    <srt:StockRepurchaseProgramAuthorizedAmount1 contextRef="c-260" decimals="-5" id="f-1272" unitRef="usd">142300000</srt:StockRepurchaseProgramAuthorizedAmount1>
    <dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants
      contextRef="c-36"
      decimals="-5"
      id="f-1273"
      unitRef="shares">12500000</dxcm:StockIssuedDuringPeriodSharesExerciseAndSettlementOfWarrants>
    <dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone
      contextRef="c-95"
      decimals="-5"
      id="f-1274"
      unitRef="shares">1500000</dxcm:StockIssuedDuringPeriodSharesAchievementOfMilestone>
    <dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues
      contextRef="c-96"
      decimals="-5"
      id="f-1275"
      unitRef="shares">1500000</dxcm:PotentialCommonStockIssuableOrIssuedSharesNewIssues>
    <us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock contextRef="c-1" id="f-1276">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A summary of RSU and PSU activity under the 2015 Plan for the twelve months ended December&#160;31, 2024, 2023 and 2022 is as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:49.923%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.595%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.602%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Nonvested RSU and PSU Activity&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions, except weighted average grant date fair value)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares Available for Grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Weighted&#160;&lt;br/&gt;Average&lt;br/&gt;Grant&#160;Date&lt;br/&gt;Fair&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Aggregate&lt;br/&gt;Intrinsic&#160;Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;16.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;76.88&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.9)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;96.79&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;63.90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;92.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;94.08&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;325.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.6)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.01&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;88.57&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.2)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106.34&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;13.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;105.98&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;361.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.7)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;131.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(1.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;102.09&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Forfeited&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.3)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.59&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Balance at December 31, 2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;12.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;121.17&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;234.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-261"
      decimals="-5"
      id="f-1277"
      unitRef="shares">16800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-262"
      decimals="-5"
      id="f-1278"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-262"
      decimals="2"
      id="f-1279"
      unitRef="usdPerShare">76.88</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-263"
      decimals="-5"
      id="f-1280"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-264"
      decimals="-5"
      id="f-1281"
      unitRef="shares">1900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-264"
      decimals="2"
      id="f-1282"
      unitRef="usdPerShare">96.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested
      contextRef="c-263"
      decimals="-5"
      id="f-1283"
      unitRef="shares">0</dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-264"
      decimals="-5"
      id="f-1284"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-264"
      decimals="2"
      id="f-1285"
      unitRef="usdPerShare">63.90</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c-263"
      decimals="-5"
      id="f-1286"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-264"
      decimals="-5"
      id="f-1287"
      unitRef="shares">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-264"
      decimals="2"
      id="f-1288"
      unitRef="usdPerShare">92.54</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-265"
      decimals="-5"
      id="f-1289"
      unitRef="shares">15300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-266"
      decimals="-5"
      id="f-1290"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-266"
      decimals="2"
      id="f-1291"
      unitRef="usdPerShare">94.08</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-266" decimals="-5" id="f-1292" unitRef="usd">325600000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-267"
      decimals="-5"
      id="f-1293"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-268"
      decimals="-5"
      id="f-1294"
      unitRef="shares">1600000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-268"
      decimals="2"
      id="f-1295"
      unitRef="usdPerShare">112.01</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested
      contextRef="c-267"
      decimals="-5"
      id="f-1296"
      unitRef="shares">0</dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-268"
      decimals="-5"
      id="f-1297"
      unitRef="shares">1400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-268"
      decimals="2"
      id="f-1298"
      unitRef="usdPerShare">88.57</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c-267"
      decimals="-5"
      id="f-1299"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-268"
      decimals="-5"
      id="f-1300"
      unitRef="shares">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-268"
      decimals="2"
      id="f-1301"
      unitRef="usdPerShare">106.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-269"
      decimals="-5"
      id="f-1302"
      unitRef="shares">13900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-270"
      decimals="-5"
      id="f-1303"
      unitRef="shares">2900000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-270"
      decimals="2"
      id="f-1304"
      unitRef="usdPerShare">105.98</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-270" decimals="-5" id="f-1305" unitRef="usd">361200000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
      contextRef="c-271"
      decimals="-5"
      id="f-1306"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="c-272"
      decimals="-5"
      id="f-1307"
      unitRef="shares">1700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-272"
      decimals="2"
      id="f-1308"
      unitRef="usdPerShare">131.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested
      contextRef="c-271"
      decimals="-5"
      id="f-1309"
      unitRef="shares">0</dxcm:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="c-272"
      decimals="-5"
      id="f-1310"
      unitRef="shares">1300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="c-272"
      decimals="2"
      id="f-1311"
      unitRef="usdPerShare">102.09</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures
      contextRef="c-271"
      decimals="-5"
      id="f-1312"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="c-272"
      decimals="-5"
      id="f-1313"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="c-272"
      decimals="2"
      id="f-1314"
      unitRef="usdPerShare">115.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="c-273"
      decimals="-5"
      id="f-1315"
      unitRef="shares">12500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-235"
      decimals="-5"
      id="f-1316"
      unitRef="shares">3000000.0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="c-235"
      decimals="2"
      id="f-1317"
      unitRef="usdPerShare">121.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested contextRef="c-235" decimals="-5" id="f-1318" unitRef="usd">234100000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-274" decimals="-5" id="f-1319" unitRef="usd">174500000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-275" decimals="-5" id="f-1320" unitRef="usd">157800000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue contextRef="c-276" decimals="-5" id="f-1321" unitRef="usd">160100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-277"
      decimals="-5"
      id="f-1322"
      unitRef="shares">2700000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="c-278"
      decimals="-5"
      id="f-1323"
      unitRef="shares">300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock contextRef="c-1" id="f-1324">The following table summarizes our share-based compensation expense included in our consolidated statements of operations for the periods shown:&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:59.280%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.619%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.622%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;14.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;11.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;52.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;103.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;90.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;170.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;150.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;126.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total tax benefit related to share-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;40.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-279" decimals="-5" id="f-1325" unitRef="usd">14400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-280" decimals="-5" id="f-1326" unitRef="usd">14600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-281" decimals="-5" id="f-1327" unitRef="usd">11100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-282" decimals="-5" id="f-1328" unitRef="usd">52200000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-283" decimals="-5" id="f-1329" unitRef="usd">45500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-284" decimals="-5" id="f-1330" unitRef="usd">42700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-285" decimals="-5" id="f-1331" unitRef="usd">103800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-286" decimals="-5" id="f-1332" unitRef="usd">90700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-287" decimals="-5" id="f-1333" unitRef="usd">72700000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-1" decimals="-5" id="f-1334" unitRef="usd">170400000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-7" decimals="-5" id="f-1335" unitRef="usd">150800000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense contextRef="c-8" decimals="-5" id="f-1336" unitRef="usd">126500000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-1" decimals="-5" id="f-1337" unitRef="usd">43800000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-7" decimals="-5" id="f-1338" unitRef="usd">40000000.0</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense contextRef="c-8" decimals="-5" id="f-1339" unitRef="usd">43200000</us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions contextRef="c-235" decimals="-5" id="f-1340" unitRef="usd">203800000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1 contextRef="c-272" id="f-1341">P1Y8M12D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock contextRef="c-1" id="f-1342">We estimate the fair value of ESPP purchase rights on the date of grant using the Black-Scholes option pricing model and the assumptions below for the specified reporting periods.&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:55.771%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:12.793%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Risk free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4.80% - 5.27%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.20% - 5.47%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.60%&#160;- 3.34%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected volatility of Dexcom common stock&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;42% - 85%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;34% - 48%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:right"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;45%&#160;- 55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expected life (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;0.5&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-288"
      decimals="4"
      id="f-1343"
      unitRef="number">0.0480</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-289"
      decimals="4"
      id="f-1344"
      unitRef="number">0.0527</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-290"
      decimals="4"
      id="f-1345"
      unitRef="number">0.0520</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-291"
      decimals="4"
      id="f-1346"
      unitRef="number">0.0547</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-292"
      decimals="4"
      id="f-1347"
      unitRef="number">0.0060</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="c-293"
      decimals="4"
      id="f-1348"
      unitRef="number">0.0334</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-294"
      decimals="2"
      id="f-1349"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-295"
      decimals="2"
      id="f-1350"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="c-296"
      decimals="2"
      id="f-1351"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-288"
      decimals="2"
      id="f-1352"
      unitRef="number">0.42</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-289"
      decimals="2"
      id="f-1353"
      unitRef="number">0.85</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-290"
      decimals="2"
      id="f-1354"
      unitRef="number">0.34</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-291"
      decimals="2"
      id="f-1355"
      unitRef="number">0.48</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-292"
      decimals="2"
      id="f-1356"
      unitRef="number">0.45</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="c-293"
      decimals="2"
      id="f-1357"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-294" id="f-1358">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-295" id="f-1359">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 contextRef="c-296" id="f-1360">P0Y6M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SegmentReportingDisclosureTextBlock contextRef="c-1" id="f-1361">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.561%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.430%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:20.780%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;10. Business Segment and Geographic Information&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We manage our business on a global consolidated basis within one reportable segment, which is consistent with how our chief operating decision maker (CODM), our President and Chief Executive Officer, reviews our business, makes investment and resource allocation decisions, and assesses operating performance. The majority of our revenue is generated in the United States. The CGM segment derives revenues from the sale of disposable sensors and our Reusable Hardware.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The measures of segment profit or loss that are most consistent with U.S. GAAP used by the CODM to assess performance and allocate resources are operating income and net income. Our CODM also reviews total assets, as reported on our consolidated balance sheets, and purchases of property and equipment, as reported on our consolidated statements of cash flows.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our CODM uses operating income and net income to evaluate income generated from segment assets (return on assets) in deciding whether to reinvest profits into the Company, acquire companies, or invest in other companies. Operating income is also used to monitor budget versus actual results.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,594.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,333.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,026.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payroll related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;767.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;726.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;621.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;228.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Travel related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supply expenses and clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consulting &amp;amp; professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;196.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment, office &amp;amp; facility expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;84.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IT software and data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;597.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;391.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;709.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;710.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;576.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;341.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes amounts stated in other significant expense captions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other segment items are primarily composed of impairment of assets and bad debt expense.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other segment disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;217.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;155.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;358.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;236.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Significant noncash items other than depreciation and amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes depreciation and amortization recorded in both cost of sales and operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 4 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Balance Sheet Details and Other Financial Information&#x2014;Other Income (Expense), Net&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our interest income and interest expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 9 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Employee Benefit Plans and Stockholders&#x2019; Equity&#x2014;Share-Based Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our share-based compensation expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We disaggregate revenue by major sales channel and by geographic region. We have determined that disaggregating revenue into these categories achieves the ASC Topic 606 disclosure objectives of depicting how the nature, amount, timing and uncertainty of revenue and cash flows are affected by economic factors.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;See Note 1 &#x201c;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Organization and Significant Accounting Policies&#x2014;Concentration of Credit Risk and Significant Customers&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x201d; to the consolidated financial statements in Part II, Item 8 of this Annual Report on Form 10-K for information about our major customers that represent 10% or more of our total revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by Customer Sales Channel&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We sell our CGM systems through a direct sales organization and through distribution arrangements that allow distributors to sell our products. The following table sets forth revenue by major sales channel for the twelve months ended December&#160;31, 2024, 2023 and 2022:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.989%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,430.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,095.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,470.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;526.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;439.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue by Geographic Region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the twelve months ended December&#160;31, 2024, 2023 and 2022, no individual country outside the United States generated revenue that represented more than 10% of our total revenue. The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.989%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,889.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,625.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,142.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;997.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;767.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#32ad10;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets by Geographic Region&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our long-lived assets, which consists of property and equipment, net, and operating lease right-of-use assets by geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;464.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;544.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;632.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;515.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other countries &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,402.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; No other individual country represented more than 10% of long-lived assets for the periods presented, except for Ireland with $185.7 million of long-lived assets at December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SegmentReportingDisclosureTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="c-1"
      decimals="INF"
      id="f-1362"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock contextRef="c-1" id="f-1363">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth our segment information for revenue, measures of segment profit or loss, and significant expenses:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Less:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Cost of sales &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,594.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,333.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,026.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Payroll related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;767.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;726.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;621.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;156.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;136.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;115.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Marketing expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;298.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;264.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;228.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Travel related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;37.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Supply expenses and clinical trials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;64.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;50.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consulting &amp;amp; professional fees&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;227.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;222.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;196.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Equipment, office &amp;amp; facility expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;83.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;84.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;80.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IT software and data&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;130.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;106.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;86.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;39.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;41.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;46.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other segment items &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;6.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;29.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;600.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;597.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;391.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other income (expense), net&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;109.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;112.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.4)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income before income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;709.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;710.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;390.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Income tax expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;132.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;168.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;49.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Net income&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;576.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;541.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;341.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes amounts stated in other significant expense captions.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(2) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Other segment items are primarily composed of impairment of assets and bad debt expense.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:47.145%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.823%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.420%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.384%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:15.424%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other segment disclosures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Depreciation and amortization &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;217.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;186.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;155.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Expenditures for long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;358.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;236.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;364.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Significant noncash items other than depreciation and amortization expense:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred income taxes&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;43.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;55.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;21.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1) &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt;Includes depreciation and amortization recorded in both cost of sales and operating expenses. &lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ReconciliationOfOtherSignificantReconcilingItemsFromSegmentsToConsolidatedTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1364" unitRef="usd">4033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1365" unitRef="usd">3622300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-1366" unitRef="usd">2909800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-1" decimals="-5" id="f-1367" unitRef="usd">1594800000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-7" decimals="-5" id="f-1368" unitRef="usd">1333400000</us-gaap:CostOfGoodsAndServicesSold>
    <us-gaap:CostOfGoodsAndServicesSold contextRef="c-8" decimals="-5" id="f-1369" unitRef="usd">1026700000</us-gaap:CostOfGoodsAndServicesSold>
    <dxcm:PayrollRelatedExpenses contextRef="c-1" decimals="-5" id="f-1370" unitRef="usd">767100000</dxcm:PayrollRelatedExpenses>
    <dxcm:PayrollRelatedExpenses contextRef="c-7" decimals="-5" id="f-1371" unitRef="usd">726900000</dxcm:PayrollRelatedExpenses>
    <dxcm:PayrollRelatedExpenses contextRef="c-8" decimals="-5" id="f-1372" unitRef="usd">621100000</dxcm:PayrollRelatedExpenses>
    <dxcm:ShareBasedPaymentArrangementOperatingExpense contextRef="c-1" decimals="-5" id="f-1373" unitRef="usd">156000000.0</dxcm:ShareBasedPaymentArrangementOperatingExpense>
    <dxcm:ShareBasedPaymentArrangementOperatingExpense contextRef="c-7" decimals="-5" id="f-1374" unitRef="usd">136200000</dxcm:ShareBasedPaymentArrangementOperatingExpense>
    <dxcm:ShareBasedPaymentArrangementOperatingExpense contextRef="c-8" decimals="-5" id="f-1375" unitRef="usd">115400000</dxcm:ShareBasedPaymentArrangementOperatingExpense>
    <us-gaap:MarketingExpense contextRef="c-1" decimals="-5" id="f-1376" unitRef="usd">298700000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="c-7" decimals="-5" id="f-1377" unitRef="usd">264600000</us-gaap:MarketingExpense>
    <us-gaap:MarketingExpense contextRef="c-8" decimals="-5" id="f-1378" unitRef="usd">228300000</us-gaap:MarketingExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c-1" decimals="-5" id="f-1379" unitRef="usd">64800000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c-7" decimals="-5" id="f-1380" unitRef="usd">55300000</us-gaap:TravelAndEntertainmentExpense>
    <us-gaap:TravelAndEntertainmentExpense contextRef="c-8" decimals="-5" id="f-1381" unitRef="usd">37600000</us-gaap:TravelAndEntertainmentExpense>
    <dxcm:SupplyExpensesAndClinicalTrials contextRef="c-1" decimals="-5" id="f-1382" unitRef="usd">64500000</dxcm:SupplyExpensesAndClinicalTrials>
    <dxcm:SupplyExpensesAndClinicalTrials contextRef="c-7" decimals="-5" id="f-1383" unitRef="usd">46500000</dxcm:SupplyExpensesAndClinicalTrials>
    <dxcm:SupplyExpensesAndClinicalTrials contextRef="c-8" decimals="-5" id="f-1384" unitRef="usd">50300000</dxcm:SupplyExpensesAndClinicalTrials>
    <us-gaap:ProfessionalFees contextRef="c-1" decimals="-5" id="f-1385" unitRef="usd">227800000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-7" decimals="-5" id="f-1386" unitRef="usd">222200000</us-gaap:ProfessionalFees>
    <us-gaap:ProfessionalFees contextRef="c-8" decimals="-5" id="f-1387" unitRef="usd">196400000</us-gaap:ProfessionalFees>
    <dxcm:EquipmentOfficeAndFacilityExpenses contextRef="c-1" decimals="-5" id="f-1388" unitRef="usd">83800000</dxcm:EquipmentOfficeAndFacilityExpenses>
    <dxcm:EquipmentOfficeAndFacilityExpenses contextRef="c-7" decimals="-5" id="f-1389" unitRef="usd">84700000</dxcm:EquipmentOfficeAndFacilityExpenses>
    <dxcm:EquipmentOfficeAndFacilityExpenses contextRef="c-8" decimals="-5" id="f-1390" unitRef="usd">80300000</dxcm:EquipmentOfficeAndFacilityExpenses>
    <us-gaap:InformationTechnologyAndDataProcessing contextRef="c-1" decimals="-5" id="f-1391" unitRef="usd">130600000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:InformationTechnologyAndDataProcessing contextRef="c-7" decimals="-5" id="f-1392" unitRef="usd">106600000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:InformationTechnologyAndDataProcessing contextRef="c-8" decimals="-5" id="f-1393" unitRef="usd">86500000</us-gaap:InformationTechnologyAndDataProcessing>
    <us-gaap:DepreciationAndAmortization contextRef="c-1" decimals="-5" id="f-1394" unitRef="usd">39900000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-7" decimals="-5" id="f-1395" unitRef="usd">41900000</us-gaap:DepreciationAndAmortization>
    <us-gaap:DepreciationAndAmortization contextRef="c-8" decimals="-5" id="f-1396" unitRef="usd">46700000</us-gaap:DepreciationAndAmortization>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-1" decimals="-5" id="f-1397" unitRef="usd">5000000.0</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-7" decimals="-5" id="f-1398" unitRef="usd">6300000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:SegmentReportingOtherItemAmount contextRef="c-8" decimals="-5" id="f-1399" unitRef="usd">29300000</us-gaap:SegmentReportingOtherItemAmount>
    <us-gaap:OperatingIncomeLoss contextRef="c-1" decimals="-5" id="f-1400" unitRef="usd">600000000.0</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-7" decimals="-5" id="f-1401" unitRef="usd">597700000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss contextRef="c-8" decimals="-5" id="f-1402" unitRef="usd">391200000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-1" decimals="-5" id="f-1403" unitRef="usd">109000000.0</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-7" decimals="-5" id="f-1404" unitRef="usd">112700000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense contextRef="c-8" decimals="-5" id="f-1405" unitRef="usd">-400000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-1" decimals="-5" id="f-1406" unitRef="usd">709000000.0</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-7" decimals="-5" id="f-1407" unitRef="usd">710400000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest contextRef="c-8" decimals="-5" id="f-1408" unitRef="usd">390800000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1409" unitRef="usd">132800000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1410" unitRef="usd">168900000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1411" unitRef="usd">49600000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-1412" unitRef="usd">576200000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-7" decimals="-5" id="f-1413" unitRef="usd">541500000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss contextRef="c-8" decimals="-5" id="f-1414" unitRef="usd">341200000</us-gaap:NetIncomeLoss>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-1" decimals="-5" id="f-1415" unitRef="usd">217700000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-7" decimals="-5" id="f-1416" unitRef="usd">186000000.0</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization contextRef="c-8" decimals="-5" id="f-1417" unitRef="usd">155900000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-1" decimals="-5" id="f-1418" unitRef="usd">358800000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-7" decimals="-5" id="f-1419" unitRef="usd">236600000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:SegmentExpenditureAdditionToLongLivedAssets contextRef="c-8" decimals="-5" id="f-1420" unitRef="usd">364800000</us-gaap:SegmentExpenditureAdditionToLongLivedAssets>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-1" decimals="-5" id="f-1421" unitRef="usd">-43800000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-7" decimals="-5" id="f-1422" unitRef="usd">-55000000.0</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DeferredIncomeTaxExpenseBenefit contextRef="c-8" decimals="-5" id="f-1423" unitRef="usd">-21600000</us-gaap:DeferredIncomeTaxExpenseBenefit>
    <us-gaap:DisaggregationOfRevenueTableTextBlock contextRef="c-1" id="f-1424">The following table sets forth revenue by major sales channel for the twelve months ended December&#160;31, 2024, 2023 and 2022:&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.989%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="3" rowspan="2" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:12pt"&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Distributor&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,430.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,095.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,470.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;85&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Direct&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;602.9&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;526.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;439.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-297" decimals="-5" id="f-1425" unitRef="usd">3430100000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-297"
      decimals="2"
      id="f-1426"
      unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-298" decimals="-5" id="f-1427" unitRef="usd">3095600000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-298"
      decimals="2"
      id="f-1428"
      unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-299" decimals="-5" id="f-1429" unitRef="usd">2470800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-299"
      decimals="2"
      id="f-1430"
      unitRef="number">0.85</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-300" decimals="-5" id="f-1431" unitRef="usd">602900000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-300"
      decimals="2"
      id="f-1432"
      unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-301" decimals="-5" id="f-1433" unitRef="usd">526700000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-301"
      decimals="2"
      id="f-1434"
      unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-302" decimals="-5" id="f-1435" unitRef="usd">439000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-302"
      decimals="2"
      id="f-1436"
      unitRef="number">0.15</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1437" unitRef="usd">4033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-1438" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1439" unitRef="usd">3622300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-1440" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-1441" unitRef="usd">2909800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-8" decimals="2" id="f-1442" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock contextRef="c-1" id="f-1443">The following table sets forth revenue by our two primary geographical markets, the United States and International, based on the geographic location to which we deliver the components, for the periods shown:&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:31.989%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.441%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.532%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.446%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="33" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;%&lt;br/&gt;of&#160;Total&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,889.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,625.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;72&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,142.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;74&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;International&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,143.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;997.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;767.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;4,033.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;3,622.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2,909.8&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;100&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents our long-lived assets, which consists of property and equipment, net, and operating lease right-of-use assets by geographic region:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:73.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.036%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;United States&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;464.6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;544.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Malaysia&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;632.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;515.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other countries &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;306.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;125.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total long-lived assets&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,402.7&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;1,184.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:6pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:3pt double #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="12" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:5.85pt;font-weight:400;line-height:120%;position:relative;top:-3.15pt;vertical-align:baseline"&gt;(1)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"&gt; No other individual country represented more than 10% of long-lived assets for the periods presented, except for Ireland with $185.7 million of long-lived assets at December&#160;31, 2024.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:RevenueFromExternalCustomersByGeographicAreasTableTextBlock>
    <dxcm:NumberOfPrimaryGeographicMarkets
      contextRef="c-1"
      decimals="INF"
      id="f-1444"
      unitRef="primary_market">2</dxcm:NumberOfPrimaryGeographicMarkets>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-303" decimals="-5" id="f-1445" unitRef="usd">2889800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-303"
      decimals="2"
      id="f-1446"
      unitRef="number">0.72</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-304" decimals="-5" id="f-1447" unitRef="usd">2625300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-304"
      decimals="2"
      id="f-1448"
      unitRef="number">0.72</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-305" decimals="-5" id="f-1449" unitRef="usd">2142000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-305"
      decimals="2"
      id="f-1450"
      unitRef="number">0.74</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-306" decimals="-5" id="f-1451" unitRef="usd">1143200000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-306"
      decimals="2"
      id="f-1452"
      unitRef="number">0.28</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-307" decimals="-5" id="f-1453" unitRef="usd">997000000.0</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-307"
      decimals="2"
      id="f-1454"
      unitRef="number">0.28</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-308" decimals="-5" id="f-1455" unitRef="usd">767800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage
      contextRef="c-308"
      decimals="2"
      id="f-1456"
      unitRef="number">0.26</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-1" decimals="-5" id="f-1457" unitRef="usd">4033000000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-1" decimals="2" id="f-1458" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-7" decimals="-5" id="f-1459" unitRef="usd">3622300000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-7" decimals="2" id="f-1460" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax contextRef="c-8" decimals="-5" id="f-1461" unitRef="usd">2909800000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <dxcm:RevenuePercentage contextRef="c-8" decimals="2" id="f-1462" unitRef="number">1</dxcm:RevenuePercentage>
    <us-gaap:NoncurrentAssets contextRef="c-309" decimals="-5" id="f-1463" unitRef="usd">464600000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-310" decimals="-5" id="f-1464" unitRef="usd">544100000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-311" decimals="-5" id="f-1465" unitRef="usd">632100000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-312" decimals="-5" id="f-1466" unitRef="usd">515400000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-313" decimals="-5" id="f-1467" unitRef="usd">306000000.0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-314" decimals="-5" id="f-1468" unitRef="usd">125000000.0</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-5" decimals="-5" id="f-1469" unitRef="usd">1402700000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-6" decimals="-5" id="f-1470" unitRef="usd">1184500000</us-gaap:NoncurrentAssets>
    <us-gaap:NoncurrentAssets contextRef="c-315" decimals="-5" id="f-1471" unitRef="usd">185700000</us-gaap:NoncurrentAssets>
    <srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock contextRef="c-1" id="f-1472">&lt;div style="margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:18.900%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;DexCom, Inc.&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;SCHEDULE II&lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%"&gt; &#x2013; &lt;/span&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"&gt;VALUATION AND QUALIFYING ACCOUNTS&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="15" style="background-color:#32ad10;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#ffffff;font-family:'Arial',sans-serif;font-size:12pt;font-style:italic;font-weight:700;line-height:120%"&gt;(In millions)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;margin-top:2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:61.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.034%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.530%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.038%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;Twelve Months Ended&lt;br/&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Allowance for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Beginning Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;5.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Provision for doubtful accounts&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.1)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.0&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2.4&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Write-offs and adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#bcedaf;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(0.5)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Recoveries&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Ending Balance&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.2&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;9.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#bcedaf;padding:0 1pt"&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;7.3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#bcedaf;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</srt:ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-6" decimals="-5" id="f-1473" unitRef="usd">9300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-25" decimals="-5" id="f-1474" unitRef="usd">7300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-14" decimals="-5" id="f-1475" unitRef="usd">5400000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-1" decimals="-5" id="f-1476" unitRef="usd">-100000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-7" decimals="-5" id="f-1477" unitRef="usd">2000000.0</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense contextRef="c-8" decimals="-5" id="f-1478" unitRef="usd">2400000</us-gaap:ValuationAllowancesAndReservesChargedToCostAndExpense>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments contextRef="c-1" decimals="-5" id="f-1479" unitRef="usd">0</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments contextRef="c-7" decimals="-5" id="f-1480" unitRef="usd">0</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments contextRef="c-8" decimals="-5" id="f-1481" unitRef="usd">500000</dxcm:SECSchedule1209ValuationAllowancesandReservesDeductionWriteoffsandAdjustments>
    <us-gaap:ValuationAllowancesAndReservesRecoveries contextRef="c-1" decimals="-5" id="f-1482" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries contextRef="c-7" decimals="-5" id="f-1483" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesRecoveries contextRef="c-8" decimals="-5" id="f-1484" unitRef="usd">0</us-gaap:ValuationAllowancesAndReservesRecoveries>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-5" decimals="-5" id="f-1485" unitRef="usd">9200000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-6" decimals="-5" id="f-1486" unitRef="usd">9300000</us-gaap:ValuationAllowancesAndReservesBalance>
    <us-gaap:ValuationAllowancesAndReservesBalance contextRef="c-25" decimals="-5" id="f-1487" unitRef="usd">7300000</us-gaap:ValuationAllowancesAndReservesBalance>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
